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Dear Participants and Guests,
I would like to thank all the participants of 12th International Symposium on Pharmaceutical 
Sciences for their valuable contributions. You had spent your days in a charming country that shelters 
the oldest and the greatiest cultures and civilizations of the world. 
The development of Symposiums on Pharmaceutical Sciences, which is held in our faculty, is 
getting more expanded through the 1989. This symposium was organized bianually until 1997 and then 
every three years. The previous 11 symposiums were held as;      
1st International Symposium on Pharmaceutical Sciences 21-23 June 1989
2nd International Symposium on Pharmaceutical Sciences 11-14 June 1991
3rd International Symposium on Pharmaceutical Sciences 15-18 June 1993
4th International Symposium on Pharmaceutical Sciences 27-30 June 1995
5th International Symposium on Pharmaceutical Sciences 24-27 June 1997
6th International Symposium on Pharmaceutical Sciences 27-29 June 2000
7th International Symposium on Pharmaceutical Sciences 24-27 June 2003
8th International Symposium on Pharmaceutical Sciences 13-16 June 2006 
9th International Symposium on Pharmaceutical Sciences 23-26 June 2009 
10th International Symposium on Pharmaceutical Sciences 26-29 June 2012  
11th International Symposium on Pharmaceutical Sciences   9-12 June 2015  
The second institution in pharmacy education, Faculty of Pharmacy of Ankara University was 
founded in 1960 and started education in 1961-1962 semester. The length of pharmacy education had 
been 4 years until 2005 and increased to 5 years starting by that date. The new 5-year educational 
program has been updated according to the suggestions of the Advisory Committee on Pharmaceutical 
Training. This new program covers the basic courses such as mathematics, physics, chemistry as well 
as the basics in pharmacy education. Fifth year consists of some elective courses and the preparation 
of a graduation project. During the 5 years, students have to complete the 6-month training program 
mandatory in pharmacy/hospital or optionally in the industry. Our faculty has 6904 graduates since the 
established and the current number of students is 967. 
Present educational and scientific resources allow a total of 138 faculty members, 49 professors, 
13 associate professors, 16 assistant professors, 60 research assistants in our faculty. Moreover, 66 
administrative staff members and other personnel are working at different offices. 
The mission of 12th International Symposium of Pharmaceutical Sciences was to perform a 
broad scientific perspective by the invitation of distinguished scientists having national / international 
reputation in their areas, so most recent advances were discussed interactively and empower the 
knowledge-based drug research development and multidiciplinary collaborations. It was our intention to 
make this symposium a memorable event, both scientifically and socially for the attendees. 
We are pleased to announce that around 800 scientists were registered to ISOPS-12 in which 
664 oral/poster presentations participated as well as 41 distinguished lecturers invited from several 
countries. 
In addition to general sessions and the posters, the exhibitors of some companies from drug 
industry that had introduced their equipments and products. 
The topic of the Panel was “The road to the strong Turkish Pharmaceutical Industry”. The 
lecturers were: Dr Hakkı Gürsöz, Prof.Dr.Nurten Özdemir, Ali Alkan, Turgut Tokgöz, Kemalettin Akalın, 
Ümit Dereli, Fatma Taman. 
On the behalf of the Organizing Committee, I would like to mention my gratitude to the President 
of Ankara University who gave the whole support for the Symposium Organization. I would like to thank 
Turkish Ministry of Culture, Turkish Cooperation and coordination Agency,The Scientific and Technological 
Research Council of Turkey (TUBITAK), Turkish Pharmacist’s Association and Pharmacist's Chamber 
of Ankara, Trabzon, İzmir, İstanbul and valuable represents of the pharmaceutical industry for their 
financial supports and pharmaceutical companies for their valuable sponsorship. I congratulate the 
organizing committee and all the other committees with all my heart and also all academic and managing 
personnel because of their extensive work. . 
                                        
Prof. Dr. Gülbin ÖZÇELİKAY
Chair of ISOPS-12
Honory President of the Symposium
Prof. Dr. Erkan İBİŞ
President of Ankara University 



























Ceyda Tuba ŞENGEL TÜRK
SCIENTIFIC COMMITTEE
Dilek AK (Turkey) 
Mehmet ALP (Turkey) 
Nurten ALTANLAR (Turkey) 
İlker ATEŞ (Turkey) 
Özlem BAHADIR ACIKARA 
Rudolf BAUER (Austria)
Arzu BEŞİKCİ (Turkey) 
Zeliha BÜYÜKBİNGÖL (Turkey)
Afonso Miguel Neves CAVACO (Portugal) 
Bezhan CHANKVATADZE (Georgia)
Paolo COLOMBO (Italy) 
Ursula GROHMANN (Italy) 
Zuhal GÜVENALP (Turkey) 
Nilgün KARALI (Turkey) 






















PL-1: QUICK, EASY, CHEAP, EFFECTIVE, RUGGED, AND SAFE “QUECHERS” SAMPLE PREPARATION APPROACH FOR RESIDUE ANALYSIS USING 
TRADITIONAL DETECTORS IN CHROMATOGRAPHY .......................................................................................................................................................3
EL-ATY, A.
PL-2: COULD STRESSED PLANTS HEAL STRESSED MANKIND? ROLE OF PLANT STRESS IN BIOACTIVE NATURAL PRODUCT BIOSYNTHESIS ........3
1,2 Matkowski, A., 1 Zielińska, S., 3 Libik-Konieczny,M., 4 Konieczny, R., 1 Kozłowska, W., 2 Jaśpińska,J., 2,5 Pawlikowska, A., 1,6 Ślusarczyk, S.
PL-3: CLINICAL COMMUNICATION SKILLS: DOES IT REALLY MATTER IN PHARMACY PRACTICE .......................................................................................4
Cavaco, A.M.
PL-4: MICRONUTRIENT PROFILING IN FOOD AND BIOLOGICAL SAMPLES: STRATEGIES FOR TARGETED AND UNTARGETED ANALYSIS OF 
VITAMINS AND CAROTENOIDS. ..........................................................................................................................................................................................4
Gentili, A., Tomai, P., Dal Bosco, C.,Curini, R.
PL-5: APPLICATION OF TEXT MINING APPROACHES TO DRUG DISCOVERY ........................................................................................................................5
Tropsha, A.
PL-6: WHEN EXCIPIENTS BECOME THE ACTIVE – NEW DRUG DELIVERY STRATEGIES IN CANCER AND ANTI-INFLAMMATORY THERAPY ................5
Lamprecht, A.
PL-7: DIAGNOSTICS USING PAPER-BASED PLATFORMS  ........................................................................................................................................................6
Merkoci, A.
PL-8: PEARLS AND PITFALLS OF CLINICAL PHARMACY IN TURKEY .......................................................................................................................................6
Bayraktar-Ekincioglu, A
PL-9: RECENT DEVELOPMENTS IN ENANTIOSEPARATION OF CHIRAL DRUGS BY USING CAPILLARY ELECTROPHORESIS ........................................7
Chankvetadze, B.
PL-10: DEVELOPMENT OF NOVEL TARGETED THERAPIES FOR BREAST CANCERS .............................................................................................................7
Ozpolat, B
PL-11: NOVEL PROSPECTIVES FOR ORGANOSELENIUM COMPOUNDS IN MEDICINAL CHEMISTRY. ..................................................................................8
Santi C.
PL-12: SYNTHESIS AND BIOLOGICAL APPLICATION OF PORPHYRINS .....................................................................................................................................8
1 Kurniawan, F., 1 Muhammad, HN.,2 Arba, M, 1 Tjahjono, DH.
PL-13: PHARMACY EDUCATION AND CLINICAL PRACTICE IN THE UNITED STATES ...............................................................................................................9
1 -2 Hawes, EM.
PL-14: DESIGN AND ACTIVITY MECHANISM DESCRIPTION OF ANTICANCER ACTIVE BENZAZOLES AGAINST DNA TOPOISOMERASE-II BY USING 
MOLECULAR MODELING TECHNIQUES ............................................................................................................................................................................9
1 Aki-Yalcin, E., 2 Yilmaz, S., 1 Bolelli, K., 1 Ozturk, O., 1 Ertan-Bolelli, T., 3 Taskin-Tok, T., 1 Yalcin, I.
PL-15: AURAPTENE: A SURVEY OF ITS PHYTOCHEMICAL AND PHARMACOLOGICAL PROFILE .........................................................................................10
Epifano F.
PL-16: OPPORTUNITY AND CHALLENGES OF NASAL POWDERS: DRUG FORMULATION AND DELIVERY .........................................................................10
1,2 Tiozzo Fasiolo, L., 2  Bortolotti, F., 1 Sonvico, F., 1,3 Balducci, A.G., 4 Russo, P., 2 Colombo, G.
PL-17: HYBRID NANO(BIO)MATERIALS: NEW ANALYTICAL TOOLS FOR THE DEVELOPMENT OF (BIO)SENSORS ............................................................11
Rivas, G. 
PL-18: WHAT IS HAPPENING AT THE NANOENVIRONMENT OF CARBON NANOSTRUCTURES? DEMOLITION OF TABOOS! ...........................................11
 Degim, IT., Degim, Z., Camlik,G.
PL-19: ANTIVIRULANCE STRATEGIES AGAINST MEDICALLY IMPORTANT CANDIDA SPP. ....................................................................................................12
Kosalec, I.
PL-20: SIMPLE, RELIABLE AND VERSATILE ELECTROANALYTICAL BIOPLATFORMS FOR EARLY DIAGNOSIS OF CANCER AT DIFFERENT 
MOLECULAR LEVELS ........................................................................................................................................................................................................12
Pingarrón, J.M., Campuzano, S., Torrente-Rodríguez, R.M., Ruiz-Valdepeñas Montiel, V., Vargas, E., Povedano, E., Pedrero, M. 
PL-21: GLYCOPHARMACY: A NEW STAR ON THE HORIZON  ....................................................................................................................................................13
Dumić, J.
PL-22: MOLECULARLY IMPRINTED POLYMERS FOR A TARGET COMPOUND AND ITS HALOGENATED DERIVATIVES AND THEIR IMPRINTING 
EFFECTS .............................................................................................................................................................................................................................13
Haginaka, J.
PL-23: SEARCH FOR BIOACTIVE MOLECULES FROM OKINAWAN CORAL REEF ORGANISMS AND METABOLITE DIVERISTY OF SOME ORGANISMS ...
14
Tanaka, J.
PL-24: ANTI-INFLAMMATORY ACTIVITY OF VARIOUS PRENYLATED PHENOLIC COMPOUNDS ...........................................................................................14
1 Šmejkal,K. 1 Brezáni, V. 2 Hošek, J.
PL-25: POTENT AND BROAD SPECTRUM MEDICINAL DRUGS AGAINST ALL GENOTYPES OF HEPATITIS C VIRUS (HCV) ..............................................15
 1 Elsebai, MF. , 2 Hakkola, J., 3 Mehiri, M., 4  Diez, J.
PL-26: TOXIC EFFECTS OF MYCOTOXINS IN HUMANS .............................................................................................................................................................16
Peraica M.
XII
PL-27: NEW TRENDS IN THE RESEARCH OF BIOACTIVE PLANT SAPONINS .........................................................................................................................16
Lacaille-Dubois, MA. 
PL-28: POTENTIAL SECONDARY METABOLITES FROM INDONESIAN FUNGI AND ALGAE FOR PHARMACEUTICALS AND COSMETICS........................17
Singgih Wibowo, M.
PL-29: GUT MICROBIOTA AND PROBIOTICS ...............................................................................................................................................................................18
Yalınay, M.
PL-30: THE SIGNIFICANCE OF XENOBIOTIC/DRUG METABOLIZING ENZYME POLYMORPHISMS IN RESPONSE TO CHEMOTHERAPY AND SURVIVAL 
IN LUNG CANCER PATIENTS.............................................................................................................................................................................................20
Iscan, M.
PL-31: 2-AZAALLYL ANIONS AND SULFENATE ANIONS: UNUSUAL AND UNEXPECTED REACTIVITY ..................................................................................21
Walsch, P
PL-32: DESIGN AND EVALUATION OF A 3D BIOPRINTED IMPLANTABLE DRUG DELIVERY SCAFFOLD FOR APPLICATION IN BONE TISSUE 
ENGINEERING ....................................................................................................................................................................................................................21
Kondiah, P.P.D, Kondiah, P.J., Choonara,Y.E., Marimuthu, T., du Toit, L.C., Kumar, P.,Pilla, V.
PL-33: AN OVERVIEW ON NANO-LIQUID CHROMATOGRAPHY: MAIN FEATURES AND RECENT APPLICATIONS TO THE ANALYSIS OF 
NUTRACEUTICAL COMPOUNDS.......................................................................................................................................................................................21
1 Fanali,S.,2 D’Orazio, G., 3 Fanali, C.
PL-34: TOWARDS ADVANCED ELECTROANALYTICAL NANOSENSORS: A PROMISING TOOL FOR THE ANALYSIS OF PHARMACEUTICALS ................22
Ozkan, SA.
PL-35: CONTEMPORARY APPROACH TO EXTRACTION AND ANALYSIS OF BIOACTIVE COMPOUNDS - ANALYTICAL CHALLENGES AND CASE 
STUDIES. .............................................................................................................................................................................................................................23
1 Ražić, S., 2 Cvetanović, A.
PL-36: NEW GENERATION OF CARBON–BASED SENSORS IN VOLTAMMETRIC DETERMINATION OF BIOLOGICALLY ACTIVE COMPOUNDS ..............23
1 Skrzypek, S., 1 Brycht, M., 1 Konecka, K., 2 Nosal-Wiercińska, A.
PL-37: SOME PERSPECTIVES FOR MARINE BIODISCOVERY IN IRELAND .............................................................................................................................24
Olivier, PT.
PL-38: DOES ENVIRONMENTAL CADMIUM INCREASE THE RISK OF PANCREATIC CANCER ...............................................................................................24
Matovic, V., Buha, A.
PL-39: DEVELOPMENT OF NEXT GENERATION GALETERONE ANALOGS FOR PROSTATE AND PANCREATIC CANCERS THERAPY ............................25
Njar, V.C.O.
PL-40: NANOPARTICLES DRUG DELIVERY IN CANCER  ...........................................................................................................................................................25
Al-Jamal W.T.
PL-41: THE FUTURE OF PERSONALIZED MEDICINE: MICROPHYSIOLOGICAL SYSTEMS (ORGAN-ON-A-CHIP) AND 3D-BIOPRINTING .........................26
1,2 Elçin, Y. M.
ORAL PRESENTATIONS
OP-001: ALBUMIN-BASED NANOPARTICULATE DRUG DELIVERY SYSTEMS  ...........................................................................................................................29
Ilem Ozdemir, D., Ozgenc, E., Ekinci, M., Gundogdu, E., Asikoglu, M.
OP-002: THE EFFECT OF POLY VINYL PYRROLIDONE AND MACHINE SETTING (DPI) ON THE SKIN PERMEATION OF INDOMETHACIN LOADED TO 
FILMS BY PEIZOELECTRIC INKJET PRINTER .................................................................................................................................................................29
1 Arshad, MS., 1 Shahzad, A.,2 Ahmad Z., 2 Nazari, K., 3 Hussain, A.
OP-003: CLINICAL PHARMACY SERVICES IN INTERNAL MEDICINE UNIT ..................................................................................................................................30
1 Balli, FN., 1 Kandemir, EA., 1 Kara, E., 1 Demirkan, K., 2 Sain Guven, G.
OP-004: CLINICAL PHARMACY PRACTICES IN PSYCHIATRY SERVICES AND OUTPATIENT CLINICS ....................................................................................30
Yalcin, N., Kelleci Cakir, B., Surmelioglu, N., Celiker, A.
OP-005: THE EVALUATION OF PHARMACEUTICAL CARE SERVICES FOR CORTICOSTREOID THERAPY IN COMMUNITY PHARMACIES IN TURKEY ....31
Ertuna, E.
OP-006: EXPRESSION, ACTIVITY AND DRUG INTERACTIONS OF MRP1 IN HUMAN DISTAL LUNG EPITHELIAL CELLS IN VITRO ......................................32
1,2 Selo, MA., 2 Springer, L., 2 Nickel, S., 2 Delmas, AS., 2 Ehrhardt, C.
OP-007: CORRELATION BETWEEN METABOLOMIC PROFILING AND ANTIOXIDANT ACTIVITIES OF METHANOLIC EXTRACTS FROM 8 CULTIVATED 
MEDICINAL PLANTS ...........................................................................................................................................................................................................32
1 Gonulalan, E.M., 2 Nemutlu, E., 1 Demirezer L.O.
OP-008: THE AFFECT OF THE RUN TIME OF GC-MS ON METABOLOMIC AND FLUXOMIC ANALYSIS  ...................................................................................33
1 Eylem, CC., 2 Erikci, A., 2 Yabanoglu Ciftci, S., 1 Kir, S., 1 Nemutlu, E.
OP-009: COMPARISON OF CHEMICAL COMPOSITION OF VOLATILE OILS BY SPME AND HYDRODISTILLATION OF CYCTOSEIRA BARBATA SEAWEED 
AND DETERMINATION OF ANTIMICROBIAL ACTIVITY OF SOLVENT EXTRACTS ........................................................................................................34
1 Yücel, T.B., 2 Korkmaz, B., 3 Fandakli, S., 4 Yucel, M., 1 Cebeci, T.
OP-010: UTILITY OF POLYSACCHARIDE-BASED CHIRAL SELECTORS IN COMBINATION WITH SUPERFICIALLY POROUS SILICA PARTICLES FOR 
SEPARATION OF ENANTIOMERS IN HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY ........................................................................................34
1 Jibuti, G., 1 Chankvetadze, B., 1 Kharaishvili, Q., 2 Farkas, T.
XIII
OP-011: BIOLOGICAL ACTIVITIES, PHENOLIC, VOLATILE AND ESSENTIAL OIL COMPOSITION OF CAMPANULA LATIFOLIA L. SUBSP. LATIFOLIA ..........35
1 Korkmaz, B., 2 Fandaklı, S., 1 Barut, B., 1 Yildirim, S., 1 Sener, SO, 3 Ozturk, E., 4 Yavuz, MH, 4 Karaca, HS, 1 Yayli, N
OP-012: IN-VITRO EQUILIBRIUM AND KINETIC BINDING STUDIES TO DEMONSTRATING BIOEQUIVALENCE OF SEVELAMER CARBONATE IN COATED 
TABLETS DOSAGE FORM BY ION CHROMATOGRAPHY ................................................................................................................................................36
1 Sarisan, S., 1 Vural, A., 1 Kayar, G., 1 Gokalp, M., 1 Knezevic, Z.
OP-013: TOWARD NEW PROBIOTIC PRODUCTS MANUFACTURING: “BACILLUS SUBTILIS AND BACILLUS AMYLOLIQUEFACIENS” ON DIARRHEA .......36
1 Demirhan, B., 2 Güragac, FT., 1 Er Demirhan, B., 3 Tastan, H., 2 Kupeli Akkol, E.
OP-014: SEPARATION OF ENILCONAZOLE ENANTIOMERS IN CAPILLARY ELECTROPHORESIS AND INVESTIGATIONOF STRUCTURE OF SELECTOR-
SELECT AND COMPLEXES BY USING NUCLEAR-MAGNETIC RESONANCE SPECTROSCOPY ................................................................................37
1 Chankvetadze, L., 1 Gogolashvili, A., 1 Tatunashvili, E., 2 Sohajda, T., 2 Szemann, J., 3 Salgado, A., 1 Chankvetadze, B.
OP-015: INVESTIGATION OF CLONAL RELATIONSHIP BETWEEN GRAM NEGATIVE BACTERIA ISOLATED FROM INTESTINAL FLORA AND DIFFERENT 
CLINICAL MATERIALS OF HEMATOLOGIC MALIGNANCY PATIENTS ............................................................................................................................38
1 Kaskatepe, B., 2 Suzuk, S., 3 Mumcuoglu, I., 4 Ozet, G., 5 Gunes, E.
OP-016: THE USEFUL EFFECT OF Β-GLUCAN ON OXIDATIVE AND NEURONAL DAMAGE CAUSED BY GLOBAL CEREBRAL ISCHEMIA/ REPERFUSION 
IN A C57BL/J6 MOUSE MODEL ..........................................................................................................................................................................................39
1 Kaya, K., 2 Ciftci, O., 3 Oztanir, M.N., 4 Taslidere, E., 5 Basak Turkmen, N.
OP-017: A STUDY ON THE DETERMINATION OF MYCOPLASMA HOMINIS PROFILE WITH DIFFERENT METHODS IN SEXUALLY ACTIVE WOMEN, 
ANTIMICROBIAL RESISTANCE AND TREATMENT ...........................................................................................................................................................39
1 Ozturk S., 2 Yildiz S., 3 Dursun P., 4 Yener Ilce B., 5 Kaymaz O.
OP-018: MODES OF ACTION OF CYTOTOXICITY OF ALOE-EMODIN ON LEUKEMIA CELLS .....................................................................................................40
1 Ozenver N., 2 Saeed M., 1 Demirezer LO., 2 Efferth T. 
OP-019: THE RELATIONSHIP BETWEEN CYTOKINE GENE POLYMORPHISMS AND TYPE 2 DIABETES IN A GROUP OF TURKISH POPULATION. ...........41
1 Ates, I, 2 Guvenc, A., 3 Altuner, D.,1 Karakaya, A. 
OP-020: RETROSPECTIVE ANALYSIS OF HACETTEPE DRUG AND POISON INFORMATION UNIT –TERATOGENICITY  CONSULTANCY SERVICES 
(HIZBIB-TDS)’ DATA ABOUT DRUG USE IN PREGNANTS ...............................................................................................................................................41
1,2 Celiker, A., 1 Ozdemir, N.
OP-021: ANTI-ANGIOGENIC AND TOXICITY EFFECTS OF DERRIS TRIFOLIATA EXTRACT IN ZEBRAFISH EMBRYO ............................................................42
1 Wan Azizi, WS., 2 Unal, K.
OP-022: DRUG INTERACTION OF TACROLIMUS AND CYCLOSPORINE IN RENAL TRANSPLANT PATIENTS .........................................................................42
Tecen Yucel, K., Ozdemir, N., Aras, E., Bayraktar Ekincioglu, A., Demirkan, K.
OP-023: EFFECTS OF URSOLIC ACID AGAINST STREPTOZOTOCIN INDUCED DIABETES IN WISTAR ALBINO RATS ..........................................................43
1 Bacanli, M., 1 Aydin, S., 2 Anlar, HG.,1,3 Cal, T., 4 Ari, N., 1 Undeger Bucurgat, U., 5 Basaran, AA., 1 Basaran, N.
OP-024: A NOVEL OPTICAL BIOSENSOR PLATFORM FOR LABEL-FREE DNA SEQUENCING ..................................................................................................44
Cetin, AE.
OP-025: ENANTIOSEPARATION OF KETOCONAZOLE ANTIFUNGAL DRUG USING CAPILLARY ELECTROPHORESIS .........................................................44
1,2 Bounoua, N., 1 Sekkoum, K., 2,3 Gumustas, M., 1 Belboukhari, N., 2 Ozkan, SA.
OP-026: EVALUATION OF GENOTOXICITY IN TURKISH WELDERS BY COMET ASSAY .............................................................................................................45
1 Aksu, I., 2 Anlar, HG., 1 Bacanli, M., 3 Iritas, S., 4 Tutkun, E.,5 Yilmaz, OH.,1 Basaran, N.
OP-027: THE EVALUATION OF THE PROTECTIVE ACTIVITY OF ANGIOTENSIN II RECEPTOR BLOCKER LOSARTAN AGAINST CISPLATINE INDUCED 
NEPHROTOXICITY IN MICE ...............................................................................................................................................................................................45
1 Teke, S., 2 Bayrak, G., 2 Kibar, D., 1 Citak, EC., 2 Yilmaz, SN.
OP-028: PATIENT-TAILORED PATCH PRODUCTION WITH 3D PRINTER ......................................................................................................................................46
Azizoglu, E., Serim, I., Arslan Azizoglu, G., Ozer, O.
OP-029: SYNTHESIS OF CHIRAL SULFOXIDES AND HYDANTOINS AND SEPARATION OF THEIR ENANTIOMERS BY HPLC METHOD ..............................47
1 Kakava, R., 1 Konjaria, ML., 1 Shashviashvili, N., 2 Volonterio, A., 1 Chankvetadze, B.
OP-030: SYNTHESIS OF NOVEL IMIDAZOPYRIDINES AND THEIR BIOLOGICAL EVALUATION AS POTENT ANTICANCER AGENTS: A PROMISING 
CANDIDATE FOR GLIOBLASTOMA ...................................................................................................................................................................................47
1,2 Guclu, D., 2,3 Kuzu, B., 1 Tozlu, I., 4 Taspinar, F., 5 Canpinar, H., 6 Taspinar, M., 2,3 Menges, N. 
OP-031: H2S FORMATION IN LIVER IS INDUCED BY ZMP17 AND ZMP20 ...................................................................................................................................48
1 Yetik Anacak, G., 1 Alancay, E., 1 Sevin, G., 2 Jakopin, Ž., 2 Tomašič,T. 
OP-032: MAY TEUCRIUM MULTICAULE HAVE A ROLE IN PROTECTION OF CCL4 INDUCED LIVER DAMAGE IN RATS? ......................................................49
1 Yalcin, A., 2 Yumrutas, O., 3 Kuloglu, T., 4 Pehlivan, M., 5 Uckardes, F., 2 Bozgeyik, I., 6 Parlar, A., 7 Yilmaz, I., 8 Dogukan, M., 9 Aydin H., 8 Uludag, O.
OP-033: THE COMPARISON OF DIFFERENT DOSES OF ALOE VERA AND THE BURN DRUGS ON BURN MODELS OF RATS .............................................50
1 Macit, C., 1 Tatlipinar, ME., 1 Caglar, ES.,1 Taner, N., 1 Turgut, S., 1 Sarikaya, EG.
OP-034: ANTIEPILEPTIC ACTIVITY OF FOUR SELECTED SKULLCAP (SCUTELLARIA) SPECIES ON MICE. ...........................................................................50
1 Arihan, O., 2 Yildiz Yilmaz, G., 3 Cicek, M.,4 Demirkol, H.
OP-035: ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY SOLUBLE DRUG TAMOXIFEN THROUGH COMPLEXATION WITH DIFFERENT 
CYCLODEXTRINS ...............................................................................................................................................................................................................51
1 Erdogar, N., 2 Teksin, ZS., 3 Nemutlu, E., 4 Iskit, AB., 1 Bilensoy, E.
XIV
OP-036: A STUDY ON CURRICULUM DEVELOPMENT OF A COMMUNICATION AND COUNSELING SKILLS COURSE FOR PHARMACY STUDENTS: A 
SIMULATION BASED APPROACH  ....................................................................................................................................................................................51
1 Gulpinar, G., 1 Ozcelikay, G. 
OP-037: GENOTOXICITY, ANTIOXIDANT ACTIVITY, TOTAL PHENOLIC AND FLAVONOID CONTENTS OF EIGHT RESEDA L. (RESEDACEAE) SPECIES 
FROM TURKEY. ...................................................................................................................................................................................................................52
1 Zare, G., 1 Arituluk, Z.C., 2 Emecen, G., 2 Cilden, E.
OP-038: INVESTIGATION OF THE RELATIONSHIP BETWEEN CHRONIC MONTELUKAST ADMINISTRATION AND DEPRESSION IN MICE. ........................53
Telli, G., Bozkurt, TE., Tel, BC.
OP-039: FLOATING DRUG DELIVERY SYSTEM OF ITRACONAZOLE: FORMULATION, IN VITRO AND IN VIVO STUDIES ......................................................53
1 Gokbulut, E., 2 Vural, I., 3 Asikoglu M., 4 Ozdemir, N.
OP-040: THE RECENT STATUS AND A PREDICTION OF THE SOCIAL PHARMACY STUDIES IN TURKEY. ..............................................................................54
Sozen Sahne, B., Ulutas Deniz, E., Yegenoglu, S.
OP-041: MORPHOLOGIC REVISION OF FOUR ALLIUM L. SPECIES IN TURKEY ........................................................................................................................54
1 Eksi Bona, G., 2 Koyuncu, M., 3 Duman, H., 1 Gencler Ozkan, A.M.
OP-042: EVALUATION OF TURKISH OTC AND NON-PHARMACEUTICAL PRODUCTS INDUSTRY USING AN INTEGRATED SWOT AND  
PESTEL ANALYSIS ..............................................................................................................................................................................................................55
1 Memisoglu, M.
OP-043: ESTABLISHMENT OF A DIRECT-INJECTION ELECTRON IONIZATION–MASS SPECTROMETRY METABOLOMICS METHOD AND ITS 
APPLICATION TO LICHEN PROFILING .............................................................................................................................................................................55
1 Kai, H., 2 Kinoshita, K., 3 Harada, H.,4 Uesawa, Y., 1 Maeda, A., 5 Suzuki, R., 
6 Okada, Y., 2 Takahashi, K., 1 Matsuno, K.
OP-044: DETERMINATION OF INTERGENERATIONAL CONSUMER BEHAVIOUR DIFFERENCES AMONGST GENERATIONS IN  
SKIN CARE PRODUCTS. ....................................................................................................................................................................................................56
Demir, N., Yegen, G., Aksu B.
OP-045: STEM ANATOMY OF THE GENUS ORIGANUM L. (LABIATAE) IN TURKEY ....................................................................................................................57
1 Sadikoglu, N., 2 Efe, M.
OP-046: PROBING PHARMACY TECHNICIANS’ SKILLS AND STATUS IN TURKEY: A FOCUS GROUP STUDY. ........................................................................57
1 Cavaco AM., 2 Tarhan N., 2 Arslan M., 2 Sar S.
OP-047: MEDICINAL PLANTS USED FOR THE TREATMENT OF DIABETES IN ELMADAG (TURKEY) .......................................................................................58
1 Koroglu, A., 2 Kendir, G., 1 Hurkul, M.M., 3 Koruklu, S.T., 3 Ayyildiz, G., 1 Kose, E.C.,4 Vural, M.
OP-048: THE POSSIBLE EFFECTS OF NEBIVOLOL TREATMENT ON CARDIAC CALCIUM HANDLING AND MITOGENIC ACTIVATION INDUCED BY ACUTE 
BETA-ADRENOCEPTOR STIMULATION. ...........................................................................................................................................................................59
Ozakca I, Koroglu G.
OP-049: PATIENT SATISFACTION: AS A PARAMETER OF EFFECTIVE PHARMACY MANAGEMENT ........................................................................................59
1 Sencan, NM.
OP-050: VOLTAMMETRIC DETERMINATION OF OPHTHALMIC DRUG PROPARACAINE USING MULTI-WALLED CARBON NANOTUBE PASTE 
ELECTRODE .......................................................................................................................................................................................................................60
1 Demir, E., 2 İnam, O., 3 İnam, R.
OP-051: CHEMICAL CONSTITUENTS OF PRANGOS UECHTRITZII BOISS&HAUSKN ROOTS ..................................................................................................60
1,2 Albayrak, G., 1 Demir, S., 1 Baykan, S.
OP-052: ANTIVIRAL, ANTINOCICEPTIVE AND ANTI-INFLAMMATORY ACTIVITIES OF THE STERILE SOLUTIONS OF ILWENSISAPONIN A AND C .............61
1 Diker, N.Y., 2 Kupeli, E., 3 Karaoglu, M.T., 4 Çomoglu, T., 5 Akdemir, Z.S., 
1 Tatli Cankaya, I.I.
OP-053: PROTECTIVE EFFECT OF MTOR INHIBITION ON LPS-INDUCED SYSTEMIC INFLAMMATION AND TISSUE INJURY: CONTRIBUTION OF MTOR/
IΚB-Α/NF-ΚB/HIF-1Α SIGNALING PATHWAY AND NADPH OXIDASE SYSTEM ACTIVITY ..............................................................................................62
Guden, DS., Temiz Resitoglu, M., Kucukkavruk, SP., Tunctan, B., Sahan Firat, S.
OP-054: DESIGN OF OXYGEN-RICH ELECTRODE PLATFORMS FOR ENZYMATIC SENSING ..................................................................................................62
Uzunoglu, A.
OP-055: IN VITRO ANTIMICROBIAL AND ANTIBIOFILM EFFECTS OF THYMOL AGAINST CLINICAL METHICILLIN RESISTANT STAPHYLOCOCCUS 
AUREUS ISOLATES ............................................................................................................................................................................................................63
1 Ates, A., 1 Temel, A., 2 Kayin, M., 2 Tunger, A., 1 Ermertcan, S.
OP-056: ELECTROCHEMICAL DETECTION OF NASAL DECONGESTANT DRUG OXYMETAZOLINE BY -COOH FUNCTIONALIZED MWCNTS AND TITANIA 
NANOPARTICLES MODIFIED ELECTRODE ......................................................................................................................................................................64
1 Munir, A., 2 Bozal Palabiyik, B., 1 Shah, A., 2 Uslu, B.
OP-057: APPLICATION, CHARACTERIZATION AND COMPARATIVE ANTIMICROBIAL ACTIVITY OF HYPERICUM AUCHERI JAUB. & SPACH VE 
HYPERICUM PERFORATUM L. EXTRACTS CONJUGATED HYBRID NANOFLOWERS ................................................................................................64
1 Ildiz, N., 2 Baldemir, A., 1 Ince, U., 2 Ilgun, S., 3 Ocsoy, I.
OP-058: NOSE TO BRAIN DELIVERY OF ELETRIPTAN HYDROBROMIDE PLGA NANOPARTICLES .........................................................................................65
Esim O., Savaser A., Ozkan CK., Tas C., Ozkan Y.
OP-059: ESTIMATION AND PREPARATION OF DRY POWDER INHALER FORMULATIONS THAT CONSISTING OF CIPROFLOXACIN HCL LOADED NANO 
AND MICROCOMPOSITE PARTICLES FOR PULMONARY ADMINISTRATION ...............................................................................................................65
1 Topal, GR., 1 Devrim, B., 2 Eryilmaz, M., 1 Bozkir, A.
XV
OP-060: INVESTIGATION OF PERFLUOROALKYL SUBSTANCES IN TAP WATER SAMPLES TAKEN FROM SEVERAL PROVINCES IN TURKEY ................66
1 Unlu Endirlik, B., 1 Bakir, E., 1 Bosgelmez, II.,1 Eken, A., 2 Narin, I., 3 Gurbay, A.
OP-061: DETERMINATION OF ANTI-INFLAMMATORY AND ANTIDIABETIC ACTIVITIES OF 14 BALLOTA TAXA GROWING IN TURKEY ................................67
1 Yazgan, A.N., 2 Yilmaz Sarialtin, S., 3 Can Agca, A., 2 Coban, T., 1 Saltan Iscan, G., 1 Sever Yilmaz, B.
OP-062: DEVELOPMENT AND EVALUATION OF ETOPOSIDE LOADED POLYMERIC TUBULAR NANOSTRUCTURES ...........................................................68
Algan, AH, Karatas, A. 
OP-063: PREPARATION AND IN VITRO CHARACTERIZATION OF DEXAMETHASONE LOADED ETHOSOME FORMULATIONS ...........................................68
Rencber, S., Tuncay Tanriverdi, S.
OP-064: HIGH PERFORMANCE LIQUID CHROMATOGRAPHY ANALYSIS OF SECONDARY METABOLITES FROM  
VAGINAL LACTOBACILLUS SPECIES  ..............................................................................................................................................................................69
1 Gurpinar, S.S., 1 Eryilmaz, M., 2 Palabiyik, I.M.,3 Gerceker, D. 
OP-065: ASSESSMENT OF PERFLUOROOCTANOIC ACID TOXICITY MECHANISMS IN PANCREATIC CELLS ........................................................................70
1 Abudayyak, M., 2 Oztas, E., 2 Baran, T., 2 Ozhan, G.
OP-066: GREEN SYNTHESIS OF SILVER NANOPARTICLES FROM THE EXTRACT OF MOLLUGO CERVIANA (L.) SER. FOR ANTIMICROBIAL 
APPLICATIONS ...................................................................................................................................................................................................................70
1 Napagoda, M., 1 De Soyza, S., 2 Wijayaratne, G., 3 Witharana, S.
OP-067: METABOLITE CHANGES OF PROTEUS MIRABILIS IN POLY-SPECIES BIOFILM MODELS ..........................................................................................71
1 Kart, D, 2 Nemutlu, E.
OP-068: ANTIMICROBIAL SUSCEPTIBILITY OF ESCHERICHIA COLI ISOLATED FROM VARIOUS CLINICAL SAMPLES .........................................................72
1 Kayan, S., 1 Gurpinar, S.S., 1 Eryilmaz, M., 2 Vuran, S., 2 Gerceker, D.
OP-069: ESTROGEN RECEPTOR MODULATING EFFECTS OF ST. JOHN’S WORT ....................................................................................................................73
1 Tascioglu, A., 1 Uslu, D., 1 Toker, Y., 2 Bedir, E., 1 Gurer Orhan, H.
OP-070: ANTIOXIDANT ACTIVITY, HPTLC FINGERPRINT AND DISCRIMINANT ANALYSIS OF PLANTAGO MAJOR LEAVES FROM  
DIVERSE ORIGINS IN INDONESIA ....................................................................................................................................................................................73
Kartini, K.
OP-071: PYOCYANIN PRODUCTION OF PSEUDOMONAS AERUGINOSA ISOLATES AND DETERMINATION OF ANTIMICROBIAL ACTIVITY ......................74
Erol, H.B., Yildiz, S.
OP-072: STUDIES ON MICROORGANISMS TO BE USED IN EFFICACY TESTS FOR ANTIMICROBIAL AGENTS .....................................................................74
Kiymaci, M.E., Yildiz, S.
OP-073: EFFECT OF ANTICOAGULANTS ON ETHINYL ESTRADIOL AND LEVONORGESTREL ANALYSIS IN PLASMA USING LIQUID  
CHROMATOGRAPHY TANDEM MASS SPECTROMETRY  ...............................................................................................................................................75
1 Yahdiana, H., 1 Devina, 1 Firda Zakiatun, N., 2 Sunarsih
OP-074: POLY(2-ETHYL-2-OXAZOLINE) AS AN ALTERNATIVE TO POLY(VINYLPYRROLIDONE) IN SOLID DISPERSIONS FOR SOLUBILITY AND 
DISSOLUTION RATE ENHANCEMENT OF DRUGS ..........................................................................................................................................................76
1 Fael, H., 2 Ràfols, C., 1 Demirel, AL.
OP-075: A NEW LC METHOD FOR QUANTITATIVE ESTIMATION OF AVANAFIL IN COMBINATION TABLETS ...........................................................................76
1,2 Levent, S., 2,3 Ozcan, S., 2,3 Can, NO.
OP-076: DEVELOPMENT AND VALIDATION OF AN HPLC METHOD FOR AMLODIPINE BESYLATE AND ENALAPRIL MALEATE USING AN  
EXPERIMENTAL DESIGN AND ITS APPLICATION TO SOLUBILITY AND DISSOLUTION TESTS ..................................................................................77
1 Sarisaltik Yasin, D., 2 Arslanturk Bingul A., 3 Karakucuk, A., 3 Teksin ZS.
OP-077: DETERMINATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN HUMAN MILK BY DLLME-HPLC .............................................................78
Alsoul, S., Hassan, M., Alshana, U.
OP-078: COVALENT IMMOBILIZATION OF Γ-GLUTAMYL TRANSPEPTIDASE ON TANNIC ACID MODIFIED MAGNETIC NANOPARTICLES ..........................78
Daana, J., Turan, E., Tumturk, H.
OP-079: LARGE VOLUME SAMPLE STACKING IN CAPILLARY ELECTROPHORESIS FOR THE QUANTITATIVE DETERMINATION OF PHENOLIC 
COMPOUNDS FROM FOOD SAMPLES .............................................................................................................................................................................79
1,2 Memon, AM, 1 Palabiyik, IM, 2 Solangi, AR, 3 Memon, SQ, 3 Mallah, A.
OP-080: THERMOSENSITIVE-PNVCL-BASED HYBRID HYDROGELS FOR BIOMEDICINAL APPLICATIONS ............................................................................79
Durkut, S., Elcin, YM., Elcin, AE.
OP-081: EXPERIMENTAL DESIGN APPROACH TO OPTIMIZE HPLC SEPARATION OF ACTIVE INGREDIENTS, PRESERVATIVES AND  
COLORANTS IN SYRUP FORMULATION ..........................................................................................................................................................................80
Dinc Zor, S., Asci, B., Aksu Donmez, O., Hacimustafa, O.
OP-082: MIR-185-5P RESPONSE TO USNIC ACID INHIBITS THE PROLIFERATION IN BREAST CANCER CELL......................................................................80
Değerli, E., Torun, V., Yangın, S., Cansaran Duman, D.
OP-083: DRUG-DRUG INTERACTIONS IN PEDIATRIC PATIENTS TAKING CLARITHROMYCIN .................................................................................................81
1 Macit, C., 2 Taner, N., 2 Simsek, A., 3 Olguner Mercanoglu, HG.
OP-084: DEVELOPMENT AND CHARACTERIZATION OF COMPOSITE SCAFFOLDS .................................................................................................................82
Koc Demir, A. 
OP-085: DEVELOPMENT OF A VALIDATED HPLC METHOD FOR DETERMINATION OF OLANZAPINE AND ARIPIPRAZOLE IN HUMAN PLASMA ...............82
Yeniceli Ugur, D.
XVI
OP-086: URINARY TGF-Β1 AND SERUM NADP+/NADPH RATIO OF TYPE 2 DIABETES MELLITUS PATIENTS AND  
THEIR CORRELATION WITH UACR ..................................................................................................................................................................................83
Sauriasari, R., Nurtanio, BW., Pratiwi, MY.
OP-087: EVALUATION OF RATIONAL ANTIBIOTIC USE IN A CHILDREN’S HOSPITAL. ...............................................................................................................83
1 Ozdemir, N., 1 Kara, E., 2 Buyukcam, A., 2 Aykac, K.,1 Celiker, A., 1 Demirkan, K., 2 Cengiz, AB., 2 Kara, A.
OP-088: PREPARATION AND CHARACTERIZATION OF ION EXCHANGE RESIN COMPLEX OF DIDANOSINE ........................................................................84
Inal, O., Akman, R.
OP-089: MALDI ORBITRAP DETECTION AND IDENTIFICATION OF SIMVASTATIN AND METABOLITES IN THE RAT TISSUE ................................................85
Yin, W., Alwabli, R., Rahman, AFM., Kadi, A.
OP-090: AXITINIB REDUCE APOPTOSIS IN EXPERIMENTAL CORNEAL NEOVASCULARIZATION MODEL IN RATS. ..............................................................85
1 Canacankatan N., 2 Dinc E., 3 Yalaza C., 4 Antmen ES.
OP-091: EVALUATION OF DRUG-DRUG INTERACTIONS OF ANTIHYPERTENSIVE DRUGS .....................................................................................................86
1 Kandemir, EA., 1 Balli, FN., 1 Kara, E., 1 Demirkan, K., 2 Sain Guven, G.
OP-092: PREPARATION, OPTIMIZATION AND IN VIVO EVALUATION OF HYDROQUINONE LOADED MICROEMULSION FORMULATIONS  
FOR MELASMA TREATMENT .............................................................................................................................................................................................87
1 Caglar, ES., 2 Pekcan, AN., 3 Okur, E., 4 Ayla, S.,1 Ustundag Okur, N. 
OP-093: TWO DIFFERENT SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATON OF METHIMAZOLE IN TABLET PREPARATIONS  ................87
Dermis, S., Beyaztas, S.
OP-094: BRASSININ SYNERGISTICALLY INDUCED THE ANTICANCER EFFECTS OF IMATINIB IN SW480 COLON CANCER CELLS ...................................88
Ozkan, E., Bakar Ates, F.
OP-095: PATIENTS’ ATTITUDES ON SAFE HANDLING OF ORAL CHEMOTHERAPEUTICS ........................................................................................................88
1 Aras, E., 1 Tecen Yucel, K., 1 Ozdemir, N., 1 Bayraktar Ekincioglu, A., 2 Aktas, BY., 2 Kilickap, S.
OP-096: RATIO DERIVATIVE AND DIFFERENCE SPECTROPHOTOMETRIC TECHNIQUES FOR SIMULTANEOUS DETERMINATION OF  
CARVEDILOL AND HYDROCHLOROTHIAZIDE  IN MARKETED   TABLETS ...................................................................................................................89
1 Erk, N., 2 Tiris, G.
OP-097: INOSITOL- REQUIRING ENZYME 1 (IRE1) INHIBITOR, STF-083010, DOWNREGULATES PROATHEROGENIC GENE EXPRESSION IN BONE 
MARROW DRIVED MACROPHAGES .................................................................................................................................................................................90
1 Telkoparan Akillilar, P., 2 Tufanli, O., 3 Acosta Alvear, D.,4 Walter, P., 2 Erbay, E.
OP-098: INFLUENZA VACCINE: WHY WE ARE NOT VACCINATED? .............................................................................................................................................90
1 Bahap, M., 1 Kara, E., 1 Bayraktar Ekincioglu, A., 1 Demirkan, K., 2 Unal, S.
OP-099: NOVEL TRANSETHOSOME CONTAINING GREEN TEA (CAMELLIA SINENSIS L. KUNTZE) LEAVES EXTRACT FOR ENHANCED  
SKIN DELIVERY OF EGCG: FORMULATION AND IN VITRO PENETRATION TEST .......................................................................................................91
Effionora A., Delly R., Ghina DA.
OP-100: ALHAGI MAURORUM: A PHARMACEUTICALLY IMPORTANT ‘MANNA OR BLESSİNG PLANT’ OF SINDH, PAKİSTAN. ..............................................92
Memon, S
OP-101: CLIPS (CHEMICAL LINKAGE OF PEPTIDES ONTO SCAFFOLDS) TECHNOLOGY APPLIED TO OPIOID PEPTIDES RESEARCH ............................92
Mollica A.
OP-102: BIOASSAY-GUIDED ISOLATION AND IDENTIFICATION OF ANTI INFLAMMATORY SESQUITERPENE LACTONES FROM  
CHRYSOPHTHALMUM MONTANUM (DC.) BOISS ............................................................................................................................................................93
1 Ayaz, F., 2 Kupeli Akkol, E., 3,4 Goren, N., 5 Calis, I., 
2 Guragac F.T., 6 Duman, H., 4 Choudhary, M.I., 2 Kucukboyaci, N.
OP-103: OPTIMIZATION THE PREPARATION PROCESS OF METHOTREXATE LOADED HUMAN SERUM ALBUMIN NANOPARTICLES ...............................93
Ilem Ozdemir, D., Ekinci, M., Ozgenc, E., Gundogdu, E., Asikoglu, M.
OP-104: BIOMASS AS A SOURCE OF MICROCRISTALLINE CELLULOSE – CHEMICAL AND TECHNOLOGICAL CHARACTERIZATION ................................94
1 Bakic, T., 2 Krstic, M., 3 Maksimovic, Z., 1 Razic, S.
OP-105: STUDIES ON ANTIFUNGAL KETOXIMES ..........................................................................................................................................................................95
Karaburun, AC.
OP-106: THERAPEUTIC EFFICIENCY OF CICHORIUM INTYBUS L. IN A RAT MODEL OF SURGICALLY-INDUCED ENDOMETRIOSIS BY AUTO-
TRANSPLANTATION OF UTERINE TISSUE ......................................................................................................................................................................95
1,2,3 Ilhan, M., 2 Ali Z., 2 Khan, IA.,1 Kupeli Akkol E.
OP-107: SYNTHESIS OF NOVEL CONDENSED 1,4-DIHYDROPYRIDINE DERIVATIVES AND THEIR BINDING MECHANISM TO L-TYPE CALCIUM 
CHANNEL ............................................................................................................................................................................................................................96
1 Gunduz, MG., 2 Schaller, D., 3 Zhang, FX., 3 Zamponi, GW.,2 Wolber, G.
OP-108:WOUND HEALING EFFECTS OF SALVIA HYPARGEIA ETHANOL EXTRACTS ON  EXCISIONAL AND INCISIONAL WOUND MODELS IN  
DIABETIC RATS ..................................................................................................................................................................................................................97
1 Ozay, Y., 2 Guzel, S., 3 Gokalp Ozkorkmaz, E., 4 Kumas, M., 5 Uzun, C., 
6 Yildirim, Z.
OP-109: THE 5-HYDROXYTRIPTAMINE 2A RECEPTOR -1438A/G AND 102T/C POLIMORPHISMS AND NAUSEA SIDE EFFECT IN CITALOPRAM  
TREATED MAJOR DEPRESSIVE DISORDER PATIENTS .................................................................................................................................................97
1 Demirbugen, M., 2 Uckun, Z., 1 Yuce Artun N., 3 Devrimci Ozguven, H., 1 Suzen, HS.
OP-110: SYNTHESIS AND EVALUATION OF BENZIMIDAZOLE AND 2-PYRAZOLINE DERIVATIVES AS MULTI-TARGET-DIRECTED LIGANDS  
AGAINST ALZHEIMER’S DISEASE ....................................................................................................................................................................................98
1 Ozadali Sari, K., 2 Tuylu Kucukkilinc, T., 2 Ayazgok, B., 1 Balkan, A., 1 Unsal Tan, O.
XVII
OP-111: BISMUTH OXIDE NANOPARTICLES CAUSED NEUROTOXICITY VIA OXIDATIVE STRESS IN VITRO. ........................................................................99
Oztas, E., Aykanat, B., Can, Z., Baram, E., Ozhan, G.
OP-112: ENUMERATION OF ESCHERICHIA COLI BASED ON SERS TECHNIQUE IN A PASSIVE TYPE MICROFLUIDIC CHIP ...............................................99
1 Dogan, U., 1 Kasap, EN., 2 Çogun, F., 2 Yildirim, E., 3 Cetin, D., 4 Suludere, Z., 5,6 Boyaci, IH., 1 Ertas, N., 1 Tamer, U.
OP-113: SYNTHESIS AND CHOLINESTERASE INHIBITORY POTENTIAL OF SOME PYRIDINIUM-3-CARBOHYDRAZIDE-HYDRAZONE DERIVATIVES .....100
Parlar, S.
OP-114:THE EFFECTS OF BISPHENOL A AND/OR MONO(2ETHYLHEXYL)PHTHALATE ON CYTOTOXICITY AND ENDOPLASMIC RETICULUM  
STRESS IN HUMAN HEPATOMA CELL LINE ...................................................................................................................................................................101
1,2 Ozkemahli, G., 3 Ercan, A., 1 Erkekoglu, P., 1,4 Kocer Gumusel, B.
OP-115: SURFACE-ENHANCED RAMAN SPECTROSCOPY BASED DETECTION STRATEGIES FOR GROUP A STREPTOCOCCUS PYOGENES .............102
1 Eryilmaz, M., 2 Soykut Acar, E., 3 Cetin, D., 4 Suludere, Z., 5 Boyaci, IH., 
1 Tamer, U.
OP-116: Α-GLUCOSIDASE INHIBITORY EFFECTS OF SOME FUNCTIONALIZED AMINO ACID DERIVATIVES .......................................................................102
Uysal, S., Ayan, EK., Soyer, Z.
OP-117: IN VITRO APPROACHES TO EVALUATE THE IRRITATION POTENTIAL OF ELECTROLYZED WATER FOR SKIN AND EYE:  
A BIOCOMPABILITY STUDY .............................................................................................................................................................................................103
1,2 Reis, R., 1 Sipahi, H., 1 Kavaz, T., 3 Turkay, O., 3 Ozcelik, H., 1 Aydin, A.
OP-118: LFIA ENUMERATION OF E.COLI USING FE3O4/AU-PEI NANOPARTICLES IN BLOOD ...............................................................................................104
1 Ilhan, H., 2 Dogan, U., 3 Suludere, Z., 4 Boyaci, IH, 5 Cetin, D., 
1 Saglam, N., 2 Tamer, U.
OP-119: NEW THIAZOLE DERIVATIVES AS POTENTIAL ALDOSE REDUCTASE INHIBITORS. ...................................................................................................104
1 Sever, B., 1 Altintop, MD., 2 Beydemir, S., 3 Demir, Y., 1 Ozdemir, A.
OP-120: LIVE ORGANIC SPICE-DERIVED FLAVORINGS IN NUTRITIONAL PHARMACOLOGY ................................................................................................105
1 Gavrylova, I., 2 Onder, A., 1 Protsenko, O., 1 Zazhyhina, K.
OP-121: INVESTIGATION OF MITOCHONDRIAL RESPIRATION DYSFUNCTION CAUSED BY SOME DRUGS .......................................................................106
Arzuk, E., Orhan, H.
OP-122: NEW PURINE AND PYRIMIDINE NUCLEOSIDE ANALOGS: SYNTHESIS AND CYTOTOXIC ACTIVITY ON SELECTED  
HUMAN CANCER CELL LINES .........................................................................................................................................................................................106
1 Altiparmak, D.,1 Tuncbilek, M.,2 Durmaz,I., 3 Cetin-Atalay, R.
OP-123: INVOLVEMENT OF REACTIVE METABOLITES IN CYTOTOXIC EFFECTS OF VARIOUS FREQUENTLY USED DRUGS IN VITRO ..........................107
Erguc, A., Mutlu, N., Arzuk, E., Karakus, F., Orhan, H.
OP-124: APPLICATION OF COMPUTER-BASED METHODS TO SEARCH FOR NOVEL SIRTUIN INHIBITORS: POTENTIAL OF NATURAL PRODUCTS .....108
1,2 Karaman Mayack, B., 2 Alhalabi, Z., 3 Swyter, S.,4 Mihigo, SO., 5 Andrae-Marobela, K., 3 Jung, M., 2 Sippl, W., 2,6 Ntie-Kang, N.
OP-125:TURKISH SEA SPONGES AND THEIR IMPORTANCE .......................................................................................................................................................108
1 Gözcelioğlu B., 2 Konuklugil B.
OP-126: SEMI-RAPID MAXILLARY EXPANSION ORTHODONTIC TREATMENT DECREASED KALLIKREIN-1 LEVELS IN CHILDREN WITH  
OBSTRUCTIVE SLEEP APNEA SYNDROME ...................................................................................................................................................................109
1 Kaya-Sezginer E., 1 Bakar-Ates F., 2 Hoxha S., 2 Toygar-Memikoğlu U.
OP-127: INVESTIGATION OF CYTOTOXIC/APOPTOTIC EFFECTS OF AZD3463, A NEW ALK/IGF-1R DUAL INHIBITOR, IN  
BREAST CANCER CELL LINE ..........................................................................................................................................................................................109
1 Demir, B., 2 Ozates, NP., 2 Biray Avcı, C., 2 Gunduz, C., 1 Karadagli Sozer, S., 1 Erciyas Lermioglu, F.
OP-128: EXPLORING CELL DEATH MECHANISM IN A375 HUMAN MALIGN MELANOMA CELLS UPON TREATMENT A MANNICH BASE DERIVATIVE .....110
1 Ercan, A., 2 Aytemir MD.
OP-129: IN VITRO BIOCOMPATIBILITY OF FLOWABLE BULK-FILL DENTAL COMPOSITES ..................................................................................................... 111
1 Demirel, G., 1 Gurkan, G.,2 Demirsoy, F., 2 Altuntas, EG., 2 Yener Ilce, B., 3 Kilicarslan, MA.
OP-130:THE ANTICANCER EFFECTS OF CAMALEXIN-IMATINIB COMBINATION ON MCF-7 BREAST CANCER CELLS .........................................................112
Ozmen, N., Bakar Ates, F.
OP-131: IN-VITRO TOXICITY EVALUATION OF NEONICOTINOID INSECTICIDE ACETAMIPRID ON AR42J PANCREATIC CELL LINE. ................................112
Kara, M., Oztas, E., Ozhan, G.
OP-132: INVESTIGATION OF THE EFFECT OF PUNICALAGIN ON ADIPOCYTE DIFFERENTION ............................................................................................113
1 Berkoz, M., 2 Yalin, S., 2 Yildirim, M., 3 Comelekoglu, U., 2 Yalin, AE.
OP-133: HISTOPATHOLOGICAL EFFECTS OF SILYMARIN IN THE LIVER TISSUES OF VANCOMYCIN-ADMINISTERED RATS ...........................................113
1 Uckun, Z., 2 Kibar, D., 3 Guzel, S., 2 Bayrak, G.
OP-134: INDOLE-DERIVED SPIROTHIAZOLIDINONES AS INHIBITORS OF INFLUENZA VIRUS FUSION ...............................................................................114
Cihan Ustundag, G.
OP-135: VOLTAMMETRIC DETERMINATION OF AN ANTIGUNGAL DRUG FROM PHARMACEUTICAL DOSAGE FORMS USING MODIFIED GLASSY 
CARBON ELECTRODES ...................................................................................................................................................................................................115
Ozturk, G., Kul, D.
OP-136: THE EFFECTS OF IL-6 ON MMP-2 MRNA EXPRESSION IN MCF-7 BREAST ADENOCARCINOMA CELLS ...............................................................115
Celik, A., Bakar Ates, F.
XVIII
OP-137: EVALUATION OF TERATOGENIC EFFECTS OF CALCITRIOL TREATMENT IN PREGNANT WOMEN ........................................................................116
1 Cavusoglu, I., 1 Erkoseoglu, I., 1 Kadioglu, M., 2 Aran, T., 1 Kalyoncu, N.
OP-138: SYNTHESIS AND DETERMINATION OF POTENTIAL BIOLOGICALLY ACTIVE SOME NEW N’-(SUBSTITUTED BENZYLIDENE)-2,2-
BIS(SUBSTITUTED PHENYL)-2-HYDROXYACETOHYDRAZIDE DERIVATIVE COMPOUNDS .....................................................................................117
1 Dogan, IS., 1 Kayiki, N., 1 Sellitepe, HE., 2 Yayli, N.
OP-139: SYNTHESIS, ANTIMICROBIAL ACTIVITY AND ELECTROCHEMICAL BEHAVIOUR OF ALKYL 4-(4-(3-METHOXYCARBONYL)-2,6,6-TRIMETHYL-5-
OXO-1,4,5,6,7,8-HEXAHYDROQUINOLINE-4-YL)PHENYL)-6,6-DIMETHYL-5-OXO-1,4,5,6,7,8-HEXAHYDROQUINOLINE-2-CARBOXYLATE .........117
1 Celik, H., 1 Eroglu, A., 2 Baymak, MS., 3 Cetin, G., 3 Simsek, R., 3 Safak, C.
OP-140: PHENOTHIAZINE-STRUCTURED COMPOUNDS HAVE DIFFERENT EFFECTS ON SECRETASES WITH THERAPEUTIC POTENTIAL IN 
ALZHEIMER’S DISEASE ...................................................................................................................................................................................................118
Yuksel M., Tacal O.
OP-141: MOLECULAR MODELLING OF THE ANTICONVULSANT ACTIVITY OF 1-PHENYL/1-(4-CHLOROPHENYL)-2-(1H-1,2,4-TRIAZOL-1-YL)ETHANOL 
ESTERS .............................................................................................................................................................................................................................119
1 Sari, S., 2 Dogan, IS., 3 Ozdemir, Z., 3 Bozbey, İ., 3 Karakurt, A., 1 Sarac, S.
OP-142: A HIGHLY SENSITIVE ELECTROCHEMICAL NANOBIOSENSOR FOR THE ANALYSIS OF PRANGOS MELIOCARPOIDES AND  
DNA INTERACTION ...........................................................................................................................................................................................................119
1,2 Subak, H., 3 Dalar, A., 1 Ozkan Ariksoysal, D.
OP-143: ANTICANCER AND ANTI-INFLAMMATORY ACTIVITIES OF EDIBLE MUSHROOM HYDNUM REPANDUM ................................................................120
1 Shomali N., 1 Onar O., 1 Akata I.,1 Yildirim O.
OP-144: A NOVEL OXIDATIVE PRETREATED PENCIL GRAPHITE BASED PARACETAMOL SENSOR: PREPARATION, CHARACTERIZATON AND 
APPLICATION TO TABLET ANALYSIS ..............................................................................................................................................................................120
Keskin, E., Erturk, AS
OP-145: ENHANCEMENT OF YAMANAKA FACTORS EFFECIENCY BY USING AXOLOTL OOCYTES......................................................................................121
1 Bereketoglu S., 2 Alberio R., 3 Johnson A.
OP-146: ELECTROCHEMICAL CHARACTERIZATION OF VARIOUS BY SUBSTITUTED PERYLENE DIIMIDE LIGANDS AND THEIR PLATINUM(II) AND 
PALLADIUM(II)-2,2′:6′,2″-TERPYRIDYL COMPLEX IONS ................................................................................................................................................122
1 Orman, EB., 2 Buyukeksi, SI., 2 Sengül, A., 1 Ozkaya, AR.
OP-147: IN VITRO ANTIPLATELET STUDIES ON VIRTUALLY DISCOVERED GPVI DRUG CANDIDATES ................................................................................122
1 Olgac S., 2,3 Olgac A., 1 Ozkan, Y.
OP-148: DETERMINATION OF ACIDITY CONSTANTS AND THERMODYNAMIC PROPERTIES OF STATINS ...........................................................................123
Bakirhan, NK
OP-149: ANALYSIS OF POSITIVE EFFECTS OF TWO LACTOBACILLUS STRAIN IN MICE FED HIGH FAT DIET ....................................................................123
1 Ivanović, N., 1 Đorđević, B., 2 Minić, R., 3 Michaličková, D.
POSTER PRESENTATIONS
P-001: THE EFFECT OF LED ILLUMINATION ON METABOLIC PROFILE OF MEDICINAL PLANTS IN VITRO CULTURES ...................................................126
1 Kozłowska, W., 1 Zielińska, S., 2 Bohater, A., 2 Chmara, S., 2 Grzelka, K.,2 Kostyrka, K., 2 Niewiadomski, M., 2 Smakosz, A., 2 Treter, N., 3 Libik, M., 4 
Kolniak Ostek, J., 4 Oszmiański, J., 5 Sowa, I., 
5
 Wójciak Kosior, M., 
6 Matkowski, A.
P-002: EVALUATION OF DRUGS SOLD UNDER THE NAME OF GÜL (ROSA × DAMASCENA) IN TURKEY VIEW OF MORPHOLOGYCAL AND 
ANATOMICAL PROPERTIES ............................................................................................................................................................................................126
1 Kendir, G., 2 Koroglu, A.
P-003: INVESTIGATION OF MORPHOLOGICAL AND MICROMORPHOLOGICAL FEATURES OF HERBAL MATERIALS SOLD UNDER THE NAME OF 
KİRAZ SAPI ........................................................................................................................................................................................................................127
1 Kendir, G., 2 Koroglu, A.
P-004: INVESTIGATION OF THE SAMPLES WHICH IS SOLD BY FUMARIA OFFICINALIS L. (ŞAHTERE) NAME IN TURKEY’S MARKET ..........................127
Biyik, B., Koroglu, A.
P-005: ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITY OF THE FRUITS, STEMS AND LEAVES OF SAMBUCUS EBULUS L. ...................................128
1 Cumhur, B., 2 Yilmaz Sarialtin, S., 1 Gumusok S., 2 Coban T., 1 Kilic C.S.
P-006: ANTICANCER EFFECT OF EXTRACTS AND ISOLATED COMPOUNDS FROM THE ROOTS OF FERULAGO BLANCHEANA POST EX BOİSS. 
(APIACEAE) ON CANCER CELL PROLIFERATION .........................................................................................................................................................128
1 Karakaya, S., 2 Bakar, F., 3 Kilic, C.S., 4 Duman, H.
P-007: ANTICANCER EFFECT OF EXTRACTS AND ISOLATED COMPOUNDS FROM THE ROOTS OF FERULAGO PACHYLOBA (FENZL) BOISS., 
(APIACEAE) ON CANCER CELL PROLIFERATION .........................................................................................................................................................129
1 Karakaya, S., 2 Bakar, F., 3 Kilic, C.S., 4 Duman, H.
P-008: DETERMINATION OF ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITIES OF WALNUT LEAVES (JUGLANS REGIA L.) ...................................130
1 Cicek Polat, D., 2 Yilmaz Sarialtin, S., 2 Coban, T., 1 Coskun, M.
P-009: ANTIOXIDANT POTENTIAL AND ANTI-INFLAMMATORY ACTIVITY OF OLIVE LEAF (OLEA EUROPAEA L.) ..............................................................130
1 Cicek Polat, D., 2 Yilmaz Sarialtin, S., 2 Coban, T.,1 Coskun, M.
P-010: INVESTIGATION OF THE SAMPLES WHICH IS SOLD AS PASSIFLORA (ÇARKIFELEK) NAME IN MARKET .............................................................131
Kose E.C., Koroglu A.
XIX
P-011: EXAMINATION OF CAPSELLA BURSA-PASTORIS L. SPECIMENS SOLD IN THE MARKET IN TERMS OF MORPHOLOGICAL  
CHARACTERISTICS AND MICROBIOLOGICAL CONTAMINATION ................................................................................................................................132
1 Koroglu A., 1 Kose E.C., 2 Simsek, D., 2 Altanlar, N.
P-012: TOTAL PHENOLIC CONTENT AND ANTIOXIDANT CAPACITY OF SOME SELECTED TURKISH ECHINOPHORA L. SPECIES ................................132
1 Yuzbasıoglu Baran, M., 2 Zare, G., 3 Dogru Koca, A., 1 Kuruuzum Uz, A.
P-013: COMPARATIVE STUDY OF ANTICANCER ACTIVITIES OF FOUR ALLIUM L. SPECIES EXTRACTS AGAINST MCF-7 CELLS .................................133
1 Eksi Bona, G. 2 Akalin Ciftci, G. 1 Gencler Ozkan, A.M.
P-014: ANATOMICAL STUDY ON CORDIA MYXA L. (BORAGINACEAE) LEAF .........................................................................................................................133
1 Kendir, G., 2 Koroglu, A.
P-015: COMPARATIVE FRUIT ANATOMY AND MORPHOLOGY OF SOME SPECIES KNOWN AS CUMIN (KIMYON) WHICH IS  
USED TRADITIONALLY IN TURKEY.................................................................................................................................................................................134
Tuncay, H.O., Yesil, Y.
P-016: ENDEMISM IN ISTANBUL PLANTS ..................................................................................................................................................................................134
Tuncay, H.O., Akalın, E.
P-017: HPTLC EXAMINATION OF VARIOUS KEDIOTU (VALERIAN; VALERIANA OFFICINALIS L.) SAMPLES SOLD IN THE MARKET OF TURKEY .........135
1 Gumusok, S., 2 Gokbulut, A., 1 Koroglu, A.
P-018: DETERMINATION OF ANTI-INFLAMMATORY AND ANTI-ANTIOXIDANT ACTIVITIES OF OPOPANAX HISPIDUS .....................................................136
1 Gumusok, S., 2 Yilmaz Sarialtin, S., 2 Coban, T., 1 Kilic, C.S.
P-020: THE ANTITYROSINASE ACTIVITY OF ARBUTUS UNEDO L. LEAVES ..........................................................................................................................136
1 Koyu, H., 2 Demir, S., 2 Baykan, S.
P-021: THE EFFECT OF PRANGOS PABULARIA LINDL. ON ERECTILE DYSFUNCTION ASSOCIATED WITH H2S .............................................................137
1 Baykan, S., 2 Sevin, G., 2 Alancay, E., 1 Albayrak, G., 2 Yetik, G.
P-022: MAJOR FURANOCOUMARINS OF PRANGOS PABULARIA LINDL. ...............................................................................................................................137
Demiroz, T., Demir, S., Baykan, S.
P-024: EFFECT OF ANTI-BIOFILM AGENTS AND ANTIBIOTICS ALONE AND IN COMBINATIONS AGAINST BIOFILMS OF CATHETER-ASSOCIATED 
COAGULASE-NEGATIVE STAPHYLOCOCCI ..................................................................................................................................................................138
 1 Ozturk, I., 1 Tekintas, Y., 2 Temel, A., 2 Ermertcan, S., 3 Kurutepe, S., 3 Hosgor Limoncu, M.
P-025: ANTIBIOFILM ACTIVITIES OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AGAINST CLINICAL CANDIDA ISOLATES .................................138
1 Tekintas, Y., 2 Temel, A., 2 Ates, A., 2 Erac, B., 3 Metin, D.Y., 3 Hilmioglu Polat, S., 2 Hosgor Limoncu, M.
P-026: DETERMINATION OF ACID DISSOCIATION CONSTANT AND ANTI MICROBIAL ACTIVITY OF CONDENSED  
1,4-DIHYDROPYRIDINE DERIVATIVES ...........................................................................................................................................................................139
1 Gunduz, MG., 2 Ozkul C., 3 Kocak E.
P-027: ANTIBACTERIAL, ANTICHOLINESTERASE, Α-AMYLASE AND Α-GLUCOSIDASE INHIBITORY ACTIVITIES OF FERULAGO  
MUGHLAE PEȘMEN AND FERULAGO SANDRASICA PESMEN & QUÉZEL GROWING IN TURKEY ..........................................................................140
1 Karakaya, S., 2 Bostanlik, F.D., 3 Koca, M., 4 Simsek, D., 5 Gozcu, S., 
1 Yuca, H., 1 Ozbek, H., 2 Kılıc, C.S., 1 Guvenalp, Z., 4 Altanlar, N.
P-028: ANTHELMINTIC ACTIVITY OF NIGELLA SATIVA AGAINST CAENORHABDITIS ELEGANS .........................................................................................140
1 Sen, E., 2 Ogut, T., 3 Olgun, A., 4 Kisa, O.
P-029: DETERMINATION OF LACTIC ACID CONTENT OF A LACTIC ACID BACTERIUM BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY .........141
1 Kiymaci, M.E., 2 Gumustas, M., 1 Altanlar, N.,1 Akin, A., 3 Zenciroglu, A., 4 Ozkan, S.A.
P-030: ENZYME INHIBITORY EFFECT OF IBERIS SEMPERVIRENS EXTRACTS....................................................................................................................141
Zengin, G. Aktumsek, A
P-031: ANTIOXIDANT PROPERTIES OF LOTUS AEGAEUS EXTRACTS ..................................................................................................................................142
Zengin, G. Aktumsek, A
P-032: PHYTOCHEMICAL STUDIES ON SESELI PETRAEUM M. BIEB. (APIACEAE) ..............................................................................................................142
Onder, A., Cinar, A.S.
P-033: CHEMICAL COMPOSITION OF THE ESSENTIAL OIL FROM THE FRUITS OF SESELI PETRAEUM M. BIEB. (APIACEAE) ......................................143
1 Onder, A., 1 Cinar, A.S., 2 Carbonell Barrachina, A.A.
P-034: CRANBERRY EXTRACT ELICITS THE RELAXATION IN RAT CORPUS CAVERNOSUM TISSUE  ...............................................................................143
1 Onder, A, 2 Gur, S, 2,3 Yilmaz Oral, D
P-036: IN VITRO EFFECTS OF FLUOROQUINOLONE ANTIBIOTICS ON PROBIOTICS ..........................................................................................................144
1 Cimik, A., 2 Demirci, F.
P-037: ANTIMICROBIAL ACTIVITY POTENTIAL OF SOME SPICES MARKETED IN TURKEY .................................................................................................145
1 Akay, BK, 1 Onder, A, 2 Gurpinar, SS, 2 Eryilmaz, M
P-038: ANIOXIDANT ACTIVITY OF LYCIUM BARBARUM L. CULTIVATED IN TURKEY.............................................................................................................145
Heydari, H., Konuklugil, B. 
P-039: STANDARDIZATION OF THE ETHYL ACETATE EXTRACT FROM QUERCUS MACRANTHERA SUBSP. SYSPIRENSIS ...........................................146
1 Dursunoglu, B., 1 Yuca, H., 2 Gozcu, S., 1 Guvenalp, Z.
P-040: ANATOMY OF ANCHUSA AZUREA MILLER (BORAGINACEAE) ....................................................................................................................................146
Dursunoglu, B., Karakaya, S., Guvenalp, Z.
XX
P-041: ANATOMY OF EPILOBIUM ANGUSTIFOLIUM L. (ONAGRACEAE) ................................................................................................................................147
1 Akcil, B., 2 Karakaya, S., 2 Guvenalp, Z.
P-042: COMPARISON OF ALPHA-GLUCOSIDASE INHIBITORY AND ANTIOXIDANT ACTIVITIES OF DIFFERENT SUMAC PRODUCTS ............................148
1 Akcil, B., 2 Sevindik, H.G., 2 Yuca, H., 1 Gozcu, S., 2 Guvenalp, Z.
P-043: ANTIMICROBIAL ACTIVITIES AND FATTY ACID COMPOSITIONS OF KUMQUAT, LIMEQUAT AND MEXICAN LIME SEEDS ....................................148
Agalar, HG.,Temiz, B.,Ozturk, G.,Demirci B., Kirimer N.
P-044: NEW HPLC METHOD FOR THE PHARMACOPOEIA ANALYSIS OF VIOLA HERBA CUM FLORE................................................................................149
Ergene Oz, B., Bahadir Acikara, O., Ozbilgin, S.,Ileri, H.K., Saltan Iscan, G.
P-045: ISOLATION AND QUANTIFICATION OF FLAVONOIDS FROM ZOSIMA ABSINTHIFOLIA  ............................................................................................149
1 Yaylaci, B., 1 Bahadir Acikara, O., 1 Kurtul, E.
P-046: GAS-CHROMATOGRAPHIC PROFILING OF PHYSOSPERMUM CORNUBIENSE (L.) DC. ESSENTIAL OIL ...............................................................150
1 Ozek, G., 1 Berdanoglu, C.A., 2 Celik, M., 3 Cetin, O., 4 Baser, K.H.C.
P-047: SIMULTANEOUS ANALYSIS OF LYCORINE AND GALANTHAMINE IN NARCISSUS TAZETTA L. SUBSP. TAZETTA L. BY HPLC-PDA .....................150
1 Karakoyun, C., 1 Onur, MA., 1 Unver Somer, N.
P-048: PHYTOCHEMICAL STUDIES ON NARCISSUS TAZETTA L. SUBSP. TAZETTA L. .........................................................................................................151
1 Karakoyun, C., 1 Onur, MA., 2 Masi, M., 2 Cimmino, A., 2 Evidente, A., 1 Unver Somer, N.
P-049: ANTIMICROBIAL ACTIVITY AND CHEMICAL COMPOSITION OF ESSENTIAL OILS FROM AERIAL PARTS AND RADIX OF  
HYPERICUM HİRCİNUM L. SUBSP. MAJUS (AİTON) N. ROBSON ................................................................................................................................152
1 Kirci D., 2 Kose YB.,1 Demirci B.
P-050: ESSENTIAL OIL COMPOSITION OF ROOTS, AERIAL PARTS AND FRUITS OF FERULAGO MACROSCIADIA BOISS. ET BAL. ..............................152
1 Demirci, B., 1 Kirci, D., 2 Kilic, C. S., 3 Gurbuz, I., 4 Duman, H.
P-051: ANTIOXIDANT, ANTI-UREASE AND ANTICHOLINESTERASE ACTIVITIES OF ALCEA DISSECTA  .............................................................................153
1 Kahvecioglu, D., 1 Taskin, T., 2 Sahin, T., 3 Dogan, A.
P-052: THE INVESTIGATION OF BIOLOGICAL ACTIVITIES OF PLANTAGO LANCEOLATE AERIAL PARTS AND ROOTS ...................................................154
1 Taskin, T., 2 Sahin, T., 1 Kahvecioglu, D., 3 Senkardes, İ.
P-053: IN VITRO BIOLOGICAL ACTIVITIES OF DIFFERENT EXTRACTS FROM RUSCUS ACULEATUS L. ...........................................................................154
1 Guler, E., 1 Taskin, T., 2 Sahin, T., 3 Bulut, G.
P-054: INVESTIGATION OF ANTICHOLINESTERASE ACTIVITIES OF DIFFERENT PARTS OF RHEUM RIBES ....................................................................155
1 Sahin, T., 2 Taskin, T., 2 Guler, E.
P-055: FLAVONOIDS FROM THE ETHYLACETATE EXTRACT OF SCORZONERA CANA VAR JACQUINIANA AERIAL PARTS  ...........................................155
Kurtul, E., Bahadir Acikara, O.
P-056: NEUROPROTECTIVE EFFECTS OF SOME FRITILLARIA L. SPECIES GROWING IN EAST ANATOLIA ......................................................................156
1 Yaris, E., 2 Kilic, M., 3 Aslay, M., 4 Kaya, E., 2 Sener, B. 
P-057: EVALUATION OF ENZYME INHIBITORY ACTIVITY OF ETAHOLIC EXTRACTS OF THE ROOTS OF TWO FERULAGO SPP.  ..................................156
1 Demirci, F., 1 Karaca, N., 2 Kilic, C.S., 3 Duman, H, 4 Gurbuz, I. 
P-058: ACETHYLCHOLINE AND BUTYRYLCHOLINE ESTERASE INHIBITORY ACTIVITY OF PRANGOS TURCICA FRUITS ...............................................157
1 Erucar, F.M, 2 Ozden Yilmaz, T., 1 Yazici Tütünis, S., 3 Akalin Urusak, E. 1 Tan, N., 1 Miski, M.
P-059: VOLATILE COMPONENTS OF THE N-HEXANE EXTRACT OF NEOMURETIA PISIDICA (KIT TAN) KLJUYKOV, DEGTJAREVA & ZAKHAROVA .....158
1,2 Karadag A.E.,3 Demirci B., 4 Cecen O., 1 Tosun F.,
P-060: DETERMINATION OF THE VOLATILE COMPOUNDS OF ANTHEMIS CRETICA SUBSP. ANATOLICA (BOISS.) GRIERSON .....................................158
1 Tosun F., 2 Kurkcuoglu M.
P-061: FROM NATURE TO NOVEL SOURCES OF PHYTO-PHARMACEUTICALS:  AJUGA CHAMAEPITYS SUBSP. CHIA VAR. CHIA AND AJUGA 
BOMBYCINA ......................................................................................................................................................................................................................159
1 Zengin, G. 2 Mahomoodally, F.M., 1 Aktumsek, A
P-062: ESSENTIAL OIL OF MENTHA LONGIFOLIA VAR. CALLIANTHA: CHEMICAL COMPOSITION, ANTIOXIDANT, AND ENZYME INHBITORY 
PROPERTIES ....................................................................................................................................................................................................................159
1 Bahadori, MB., 2 Zengin, G
P-063: CHEMICAL CHARACTERIZATIONS OF CARICA PAPAYA L. FATTY ACIDS AND ESSENTIAL OIL ...............................................................................160
1 Turker, E., 2 Gubbuk, H., 3 Ozturk, G., 3 Demirci, B. 
P-064: ANTI-ALZHEIMER ACTIVITY OF SALVIA ARAMIENSIS ROOT EXTRACTS ...................................................................................................................160
1 Alim, G.O., 2 Ozden Yilmaz, T., 1 Yazici Tütünis, S., 1 Tan, N., 1 Miski, M.
P-065: SECONDARY METABOLITE ISOLATION FROM AGRICULTURAL CROP RESIDUES OF HAZELNUT (CORYLUS AVELLANA) .................................161
1 Renda, G., 2 Mutlu, M., 1 Korkmaz, B., 1 Yaylı, N.
P-066: ESSENTIAL OIL COMPOSITION OF XERANTHEMUM ANNUUM L. FROM TURKEY ....................................................................................................162
1 Yildiz G., 2 Kose YB., 1 Kurkcuoglu M.
P-067: QUANTITATIVE ANALYSIS OF FLAVONOIDS OF CRATAEGUS MONOGYNA AND CRATAEGUS OXYACANTHA  
BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) .................................................................................................................................162
Ileri , H.K., Ergene Oz, B., Ozbilgin, S., Bahadir Acikara, O., Yaylaci, B., Saltan Iscan,G.
XXI
P-068: INHIBITORY EFFECT OF ELAEAGNUS RHAMNOIDES (L.) A. NELSON SUBSP. CAUCASICA ROUSI ON ALPHA-GLUCOSIDASE  ........................163
1 Yuca, H., 2 Akcil, B., 1 Ozbek, H., 3 Demirezer, LO., 1 Guvenalp, Z.
P-069: SCREENING FOR ALPHA-GLUCOSIDASE INHIBITION ACTIVITY OF ..........................................................................................................................163
PALIURUS SPINA-CHRISTI MILLER
P-070: A SURVEY OF OPUNTIA FICUS – INDICA (L.) MILL. FRUITS.........................................................................................................................................164
1 Keles, HB., 2 Dogan, Z., 2 Saracoglu, I., 2 Basaran, A.A.
P-071: EVALUATION OF Α-AMYLASE, Α-GLUCOSIDASE AND PANCREATIC LIPASE INHIBITION OF TWO PHLOMIS SPECIES ........................................165
Ekin, H.N., Deliorman Orhan, D., Aslan, M.
P-072: SESQUITERPENE LACTONES FROM TANACETUM BALSAMITA L. .............................................................................................................................165
1 Servi, H., 2 Goren, N., 
P-073: CHEMISTRY OF TANACETUM MUCRONIFERUM HUB.-MOR. & GRIERSON ..............................................................................................................166
1 Servi, H., 2 Goren, N., 
P-074: ESSENTIAL OIL QUANTITY AND COMPOSITION FROM 4 CULTIVARS OF ORGANICALLY GROWN LAVENDER AND LAVANDIN .........................166
1 Uras, IS., 1 Torun, Z., 1 Pilevneli, AD., 1 Konuklugil, B.
P-075: VOLATILE COMPOSITION OF SERAPIAS ORIENTALIS SUBS. ORIENTALIS ...............................................................................................................167
1 Erik, I., 1 Korkmaz, B, 2 Terzioglu, S., 1 Yayli, N.
P-076: ESSENTIAL OIL AND SPME ANALYSIS OF IPOMEA PURPUREA ..................................................................................................................................168
Erik, I., Korkmaz, B., Yayli, N.
P-078: EVALUATION OF ANTIMICROBIAL ACTIVITY IN SECONDARY METABOLITES FROM PLECTRANTHUS ZEYLANICUS:  
A SEARCH FOR NOVEL DISINFECTANTS ......................................................................................................................................................................168
1 Napagoda, M., 1 De Soyza, S., 2 Qader, M., 3 Lorenz, S., 3 Schneider, B., 3 Svatoš, A., 1 Wijayaratne, G., 1 Nagahawatte, A., 2 Jayasinghe, L.
P-079: INHIBITORY EFFECT OF ANCHUSA STRIGOSA BANKS & SOL. ON 5-LIPOXYGENASE ENZYME IN VITRO ...........................................................169
1 Icen, M.S., 2 Temel, H.E., 3 Gurbuz, I., 4 Demirci, F. 
P-080: DETERMINATION OF PHENOLIC CONSTITUENTS FROM MARRUBIUM HETEREDON (BENTH.) BOISS. & BALANSA USING LC-MS/MS ............170
1 Icen, M.S., 2 Goger, F., 3 Arabaci, T.,4 Dirmenci, T., 5 Baser, K.H.C. 
P-081: ANTIOXIDANT CAPACITY, TOTAL PHENOLIC AND FLAVONOID CONTENTS OF POLYGONUM EQUISETIFORME SIBTH. & SM. .........................170
1 Uzun, M., 1 Yuzbasioglu Baran, M., 2 Arituluk, Z.C., 1 Kuruuzum Uz, A.
P-082: COMPARISON OF DIFFERENT EXTRACTION TECHNIQUES WITH REGARD TO THE ANTI-INFLAMMATORY ACTIVITY OF ASPARAGUS 
OFFICINALIS .....................................................................................................................................................................................................................171
1 Karacaoglu, M., 2 Yilmaz Sarialtın, S., 1 İscan Saltan, G. H., 2 Coban, T.
P-083: THERAPEUTIC AND ECONOMIC ASPECTS OF CYANOBACTERIA FROM GEOTHERMAL SOURCES IN AFYONKARAHISAR PROVINCE ...........171
1 Sensoy, M. , 1 Dogan, Z., 2 Conk Dalay, M., 2 Demirel, Z.,1 Saracoglu, I.
P-084: DETERMINATION OF ANTIAGING POTENTIAL OF RUMEX CRISPUS’  MAIN COMPOUNDS BY MOLECULAR DOCKING STUDIES .....................172
Uzun, M., Demirezer, LO. 
P-085: THE ROLE OF RUMEX CRISPUS EXTRACTS ON MATRIX METALLOPROTEINASE-13 (MMP-13) ENZYME INHIBITION AGAINST SKIN AGING ..173
Uzun, M., Demirezer, LO. 
P-087: PHYTOCHEMICAL INVESTIGATIONS ON ROOTS OF RUMEX ACETOSELLA L.: ISOLATION OF A NEW COMPOUND  ...........................................173
1 Ozenver N., 2 Kauhl U., 2 Opatz T., 3 Efferth T., 1 Demirezer LO.
P-088: ANTIMICROBIAL ACTIVITIES OF CEPHALARIA PROCERA FISCH. & AVÉ-LALL. IN TURKEY ....................................................................................174
1 Mataraci Kara, E., 2 Yazici Bektas, N., 3 Yesil, Y.
P-089: POTENTIAL THERAPEUTIC USAGE IN NEURODEGENERATIVE DISEASES OF CEPHALARIA PROCERA FISCH. & AVÉ-LALL. IN TURKEY .......175
1 Yazici Bektas, N., 2 Barut, B., 3 Yesil, Y.
P-090: ANTIPLATELET ACTIVITY OF LIGNANS FROM TAXUS BACCATA ................................................................................................................................175
1 Kucukboyaci, N., 2 Ozkan, Y., 2 Olgac, S., 1 Sener, B.
P-091: ANTIPLATELET ACTIVITY OF SOME FLAVONOLS FROM SALSOLA GRANDIS AERIAL PARTS ................................................................................176
1 Kucukboyaci, N., 2 Calis, I., 3 Ozkan, Y., 3 Olgac, S. 
P-092: ISOLATION OF SECONDARY METABOLITES FROM MARINE FUNGI TRICHODERMA SATURNISPORUM ..............................................................177
1 Demir, O., 2 Gozcelioglu, B., 1 Konuklugil, B.
P-093: ANTIMICROBIAL ACTIVITY OF ENDOPHYTIC FUNGI FROM PANCRATIUM MARITIMUM L. ......................................................................................177
1 Ozcinar, O., 2 Ozturk, I., 3 Ermertcan, S., 1 Kivcak, B.
P-094: COMPOUNDS FROM AERIAL PARTS OF SCORZONERA TOMENTOSA  .....................................................................................................................178
Bahadir Acikara, O., Ozbilgin, S., Ergene Oz, B., Kurtul, E., Saltan Iscan, G.
P-095: ENZYME INHIBITORY EFFECT OF TWO SIDERITIS SPECIES ENDEMIC TO TURKEY ...............................................................................................178
1 Ceylan, R., 1 Zengin, G., 1 Aktumsek, A.
P-096: CHOLINESTERASE INHIBITION AND ANTIOXIDANT PROPERTIES OF ONOSMA SERICEA AND ONOSMA STENOLOBA  
METHANOL EXTRACTS ...................................................................................................................................................................................................179
1 Zengin, G., 1 Ceylan, R., 2 Katanić, J., 1 Aktumsek, A.
P-097: ANTIOXIDANT ACTIVITY OF TARAXACUM MIRABILE WAGENITZ AERIAL PARTS, AS AN ENDEMIC SPECIES OF TURKEY .................................179
1,2 Karahuseyin, S., 3 Ozsoy, N., 1 Sari, A.
XXII
P-098: PHYTOCHEMICAL STUDIES  ON ACANTHUS DIOSCORIDIS L. VAR. DIOSCORIDIS .................................................................................................180
1 Sarikaya Aydin, S., 2 Duez, P., 3 Harput, U.S., 1 Saracoglu, I.
P-099: ISOLATION OF POTENT LIVER X RECEPTOR AGONIST COMPOUNDS FROM HYPERICUM MICROCALYCINUM BOISS. & HELDR.   .................180
1 Sarikaya Aydin, S., 1 Kutluay, V.M., 2,3 Bai, F., 2 Makino, T., 4 Harput, U.S., 1 Saracoglu, I.
P-100: EFFECT OF POLYGONUM COGNATUM ON ALPHA-GLUCOSIDASE INHIBITORY ACTIVITY .....................................................................................181
1 Gozcu, S., 2 Ozbek, H., 2 Guvenalp Z.
P-101: ANATOMY OF PAEONIA MASCULA (L.) MILL. (PAEONIACEAE) ....................................................................................................................................181
1 Gozcu, S., 2 Karakaya, S., 2 Guvenalp, Z.
P-102: DETERMINATION OF OLEUROPEIN IN OLIVE LEAVES (OLEA EUROPAEA L.) AND COMMERCIAL OLIVE LEAF EXTRACTS ...............................182
1 Isik, S., 2 Kartal, M.
P-103: FATTY ACID PROFILE OF SOME COMMERCIAL BLACK CUMIN (NIGELLA SATIVA L.) SEED OIL CAPSULES .........................................................183
1 Isik, S.,2 Aslan Erdem, S.,3 Kartal, M.
P-104: ANTIOXIDANT AND ANTIMICROBIAL EFFECTS OF EXTRACTS PREPARED FROM ANTHEMIS TINCTORIA VAR. TINCTORIA ..............................183
1 Tufan, S., 2 Taşkin, T., 3 .Tuysuz, M.,1 Mat, A.
P-105: COMPARISON OF THE VOLATILE COMPOSITION OF SOME FENNEL HERBAL TEAS (FOENICULUM VULGARE MILL.) FROM TURKEY ............184
1 Sabanoglu, S.,1 Karacaoglu, M., 2 Kilic, E., 1 Aslan Erdem, S.
P-106: ESSENTIAL OIL COMPOSITION OF ACHILLEA COARCTATA POIR ..............................................................................................................................184
Sabanoglu, S., Aslan Erdem, S., Altun, M.L.
P-107: THE ESSENTIAL OIL CONTENT OF SOME ENDEMIC PEUCEDANUM SPECIES ........................................................................................................185
1 Arabaci Anul, S., 2 Aslan Erdem, S.,3 Coskun, M.
P-108: INFLUENCE OF DIFFERENT EXTRACTION MODE ON THE YIELD OF HYPEROSIDE AND VITEXIN-2-O-RHAMNOSIDE FROM CRATAEGUS 
MONOGYNA ......................................................................................................................................................................................................................185
Ozbilgin, S., Ergene Oz, B., Bahadir Acikara, O., Saltan-Iscan, G.
P-109: THE ESSENTIAL OIL COMPOSITION OF THREE ACHILLEA SPECIES USING GS-MS/FID ........................................................................................186
1 Akdeniz, M., 2 Senturk, K., 3 Yilmaz, M.A., 3 Temel, H., 1 Bakir, D., 4 Yener, I., 5 Tokolmez, O., 
6 Yigitkan, S., 7 Kolak, U., 8 Ertas, A.
P-110: THE ESSENTIAL OIL COMPOSITION OF THYMUS BRACHYCHILUS SUBSP. BRACHYCHILUS AND T. BRACHYCHILUS SUBSP. 
BAHCESARAYENSIS USING GC-MS/FID ........................................................................................................................................................................187
1 Akdeniz, M., 2 Senturk, K., 3 Firat, M., 4 Yener, I., 4 Varhan Oral, E., 5 Hasimi, N., 
4 Seker, Z., 6 Yigitkan, S., 7 Ertas, A.
P-111: THE ANTIBIOFILM ACTIVITY OF ERICA MANIPULIFLORA SALISB. ..............................................................................................................................187
1 Omuzbuken, B.,1 Kacar, A., 2 Avunduk, S.
P-112: THE ANTIFUNGAL ACTIVITY OF ERICA MANIPULIFLORA SALISB.  .............................................................................................................................188
1 Avunduk, S., 2 Omuzbuken, B., 2 Kacar, A. 
P-113: FATTY ACID COMPOSITION OF BLACK CUMIN (NIGELLA SATIVA L.) SEED OIL PRODUCTS FROM TURKEY ........................................................189
1 Aslan Erdem, S., 2 Isik, S., 3 Kartal, M.
P-114: ENZYME INHIBITORY, ANTIOXIDANT ACTIVITES AND PHYTOCHEMICAL STUDIES ON JUNIPERUS MACROCARPA ...........................................189
Orhan, N., Pekacar S., Ozupek, B., Deliorman Orhan, D.
P-115: ANTIOXIDANT CAPACITY AND TOTAL PHENOLIC CONTENT OF LAVANDULA STOECHAS L. SUBSP. STOECHAS................................................190
Coban S, Yuzbasioglu M, Kuruuzum-Uz A.
P-116: CYTOTOXIC ACTIVITY OF ETHANOLIC EXTRACT AND SOME FRACTIONS OF THE ROOTS OF FERULAGO  
MACROSCIADIA BOISS & BALANSA AGAINST SW480 AND MCF-7 CANCER CELL LINES ........................................................................................191
1 Gunbatan, T., 2 Bakar, F., 1 Gurbuz, I., 3 Kilic, C.S., 1 Karakucuk, M., 4 Duman, H.
P-117: COMPARATIVE LC-MS/MS STUDIES ON THREE DIFFERENT DIGITALIS SPECIES ...................................................................................................191
1 Kutluay, V.M., 2 Goger, F., 2 Kirimer, N.,1 Saracoglu, I.
P-118: LIVER X RECEPTOR AGONIST ACTIVITY OF SOME MEDICINAL PLANTS FROM TURKEY .......................................................................................192
1 Kutluay, V.M., , 1 Genc, Y., 1 Dogan, Z., 2 Inoue, M., 1 Saracoglu, I.
P-119: COMPARATIVE LC-MS/MS STUDIES ON PHYTOCHEMICAL CONTENTS OF THREE ENDEMIC SCUTELLARIA SPECIES. ....................................192
1 Dogan, Z., 2 Goger, F., 2 Kirimer, N.,1 Saracoglu, I.
P-120: IN VITRO ALPHA-GLUCOSIDASE INHIBITORY ACTIVITY OF QUERCUS MACRANTHERA SUBSP. SYSPIRENSIS .................................................193
1 Gozcu, S., 2 Yuca, H., 2 Dursunoglu, B., 2 Guvenalp, Z.
P-121: DIFFERENCES BETWEEN GG4 MOTIFS ON TRPM2 ION CHANNELS OF HUMAN, RAT AND MOUSE.  ...................................................................194
1 Cakmak, A., 2 Aydin, S.
P-122: THE NORMALIZATION OF CONTRACTILE RESPONSE IN DIABETIC RAT AORTA ......................................................................................................194
1 Muderrisoglu, AE., 1 Erdogan, BR., 1 Karaomerlioglu, I., 2 Martin, MC., 1 Arioglu Inan, E.
P-123: EFFECTS OF ALISKIREN TREATMENT ON CARDIAC MYOCYTE DYSFUNCTION IN A RAT MODEL OF INSULIN RESISTANCE  ..........................195
1 Tufan, C., 1 Tarhan, N., 1 Ozansoy, G., 2 Ceylan Isik, A., 1 Kayki Mutlu, G.,1 Ari, N.
P-124: CLINICAL PHARMACIST’S CONTRIBUTION TO ROUTINE TREATMENT IN INTENSIVE CARE UNIT .........................................................................195
1 Uysal, C., 1 Savas, M., 1 Balli, N., 1 Celiker, A., 1 Demirkan, K., 2 Topeli Iskit, A.
P-125: THE FORMATION OF COMPLEXES BETWEEN GLUTATHIONE REDUCED- OXIDIZED AND COPPER IONS ...........................................................196
Catapano, MC., Mladěnka, P.
XXIII
P-126: THE EFFECT OF CARVEDILOL TREATMENT ON ERECTILE DYSFUNCTION IN STREPTOZOTOCIN INDUCED DIABETIC RATS. ........................197
1,2 Yilmaz Oral, D., 2 Guven, B., 2 Kara, Z., 2 Gur, S., 2 Onay Besikci, A.
P-127: THE POSSIBLE BENEFICIAL EFFECT OF IVABRADINE TREATMENT ON ERECTILE TISSUE IN A DIABETIC RAT MODEL ....................................197
1,2 Yilmaz Oral, D., 2 Kara, Z., 2 Guven, B.,2 Onay Besikci, A., 2 Gur, S. 
P-128: ANTI-NOCICEPTIVE ACTIVITIES OF SOME THIADIAZOLE DERIVATIVES ...................................................................................................................198
Eker, D., Ucel, UI., Can, OD., Ozkay Demir, U. 
P-129: A RISK ASSESSMENT OF FEBRILE NEUTROPENIA IN AN ONCOLOGY OUTPATIENT CLINIC..................................................................................198
1 Aras, E., 1 Ozdemir, N., 1 Tecen Yucel, K., 1 Bayraktar Ekincioglu, A., 2 Kilickap, S.
P-130: PROTECTIVE EFFECTS OF A RIPK1 INHIBITOR, NECROSTATIN-1 ON CISPLATIN-INDUCED NEPHROTOXICITY IN RATS ..................................199
1 Erdinc, M., 1 Aslantas, M., 1 Uyar, E.,1 Ozgen, ZE., 1 Kelle, I., 1 Akkoc, H., 2 Erdinc, L. 
P-131: EVALUATION OF DRUG-DRUG INTERACTIONS ENCOUNTERED IN PEDIATRIC INFECTIOUS DISEASES UNIT ...................................................200
Polat, EC., Ozdemir, N., Bayraktar Ekincioglu, A., Demirkan, K.
P-132: EVALUATION OF POTENTIAL DRUG-DRUG INTERACTIONS AMONG PRESCRIPTIONS OF OUTPATIENTS FROM TRABZON, TURKEY ............200
1 Engin, S., 1 Barut, EN., 1 Eroglu, G., 2 Yaris, E., 1 Sezen, FS
P-133: EFFECTS OF THREE DIFFERENT FLAVONOIDS ON CARDIAC CONTRACTILITY UNDER HIGH GLUCOSE CONCENTRATIONS  ........................201
Kayki Mutlu, G., Yesilyurt, ZE., Erdogan, BR., Karaomerlioglu, I., Muderrisoglu, AE., Ari, N.
P-134: RATIONAL DRUG USE IN THE MANAGEMENT OF HYPERTENSION AND THE ROLE OF THE COMMUNITY PHARMACIST ..................................201
1 Aylak, S., 2 Telli, G., 2 Tel, BC.,2 Gumusel B.
P-135: ULTRASTRUCTURAL INVESTIGATION OF THERAPEUTIC EFFECTS OF HUPERZINE-A ON OPTIC NERVE IN ALZHEIMER’S MODEL  ...............202
1 Bayrak, G., 2 Turkseven, CH., 3 Marasligil, B., 4 Dinc, E., 1 Balli, E., 2 Buyukakilli, B.
P-136: EVALUATION OF THE QUALITY OF LIFE, ATTITUDES AND PERCEPTIONS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA .................203
1 Algorane, I., 1 Okuyan, B. 1 Sancar, M., 2 Cam, K.,1 Izzettin, FV.
P-137: ADHERENCE TO IMMUNOSUPPRESIVE MEDICATIONS IN RENAL TRANSPLANT PATIENTS. .................................................................................203
Tecen Yucel, K., Aras, E., Ozdemir, N., Bayraktar Ekincioglu, A., Demirkan, K.
P-140: A PROMISING SOLUTION FOR RHEUMATOID ARTHRITIS: CHARACTERIZATION, IN VITRO AND IN VIVO STUDIES ............................................204
1 Siafaka, P., 2 Okur, ME., 3 Ayla, S., 4 Karantas, I., 1 Ustundag Okur, N.
P-141: INCREASED ANTILEUKEMIC EFFECTS IN HUMAN CHRONIC MYELOID LEUKEMIA BY COMBINING EVEROLIMUS AND SUNITINIB .................205
1 Ergul, M., 2 Ergul, M., 3 Terzi, H., 4 Altun, A.
P-142: EVALUATION OF IN VITRO ANTICANCER ACTIVITY OF VERONICA OFFICINALIS LEAVES EXTRACTS ON BREAST CANCER CELLS MDA-
MB-231. ..............................................................................................................................................................................................................................205
1 Ergul, M., 2 Ergul, M., 3 Eruygur, N.
P-143: A COMPARISON OF THE ANTIOXIDANT PROPERTIES OF FLUOXETINE AND MELATONIN IN MICE BRAIN TISSUE ............................................206
1 Erdinc, M., 1 Inci Camci, M., 1 Uyar, E., 1 Kelle,I., 1 Akkoc, H., 2 Erdinc, L. 
P-144: HEPATOPROTECTIVE EFFECT OF GENTIANA OLIVIERI ON CHRONIC UNPREDICTABLE STRESS MODEL OF DEPRESSION IN THE RATS ....206
1 Berk, A., 2 Kaymaz, MB., 2 Yilmaz, I., 3 Abacioglu, N. 
P-145: EFFECTS OF COTINUS COGGYGRIA LEAF EXTRACT AND PHENYTOIN ON BURN WOUNDS ................................................................................207
Kaymaz, MB., Berk, A., Aktay, G.
P-146: THE EFFECT OF PREGABALIN ON ELECTROCONVULSIVE THERAPY ......................................................................................................................208
Yalcin, N., Kelleci Cakir, B., Surmelioglu, N., Celiker, A., Bayraktar Ekincioglu, A., Demirkan K.
P-147: CONTRIBUTION OF DELTA OPIOID RECEPTORS TO ANTI-HYPERALGESIC EFFICACY OF REBOXETINE  ...........................................................208
Turan Yucel, N., Demir Ozkay, U., Can, OD.
P-148: ANTIDEPRESSANT-LIKE EFFECT OF SOME BENZIMIDAZOLE-PIPERIDINE DERIVATIVES ......................................................................................209
Ucel, UI., Turan Yucel, N., Demir Ozkay, U., Can, OD.
P-149: MODIFICATIONS OF SOLID DRUG DOSAGE FORMS IN PEDIATRIC PATIENTS .........................................................................................................209
Ozdemir, N., Tecen Yucel, K., Aras, E., Celiker, A.
P-150: CLINICAL PHARMACIST INTERVENTIONS IN GERIATRIC OUTPATIENT CLINIC AND CLINICAL NUTRITION UNIT ................................................210
1 Firat, O., 1 Kelleci, B., 2 Balci, C., 2 Esme, M., 2 Aycicek Sengul G., 1 Ekincioglu, A., 2 Halil, M., 1 Demirkan, K.
P-151: DETERMINATION OF POTENTIAL DRUG-DRUG INTERACTIONS IN NEPHROLOGY CLINIC ....................................................................................211
Gun, ZU., Gok, S., Bahcecioglu, OF.
P-152: EVALUATION OF KNOWLEDGE AND ATTITUDES OF PATIENTS USING EYE DROPS / OINTMENTS .......................................................................211
Kilicaslan, O., Sancar, M., Tezcan, S., Izzettin, FV.
P-153: THE EFFECT OF ATOMOXETINE TREATMENT ON MECHANICAL- AND THERMAL-HYPERALGESIA DEVELOPING IN DIABETIC RATS..............212
Barbaros, MB., Can, OD. Demir Ozkay, U.
P-154: ANTI-NOCICEPTIVE EFFECT OF SOME BENZOTHIAZOLE DERIVATIVES ..................................................................................................................212
Turan Yucel, N., Ucel, UI., Can, OD., Demir Ozkay, U.
P-155: WOUND HEALING EFFECT OF VITEXIN FORMULATION ..............................................................................................................................................213
1 Arslan, R., 1 Bektas Turkmen N., 2 Senel B., 3 Yenilmez E., 4 Ozatik O.,
XXIV
P-156: THE PERCEPTION OF COMMUNITY PHARMACIST TO ANTIDEPRESSANT MEDICATIONS DURING PATIENT COUNSELING IN NICOSIA, 
NORTHERN CYPRUS .......................................................................................................................................................................................................214
1 Khamis, S., 1 Abdi, MA.,1,2 Basgut, B.
P-157: IN VIVO ANTINOCICEPTIVE AND ANTIINFLAMMATORY EFFECTS OF FRAXINUS ANGUSTIFOLIA EXTRACTS  ....................................................214
1 Sevgi S., 2 Cavusoglu I., 1 Eroglu G., 3 Temiz B., 3 Tetik S., 4 Renda G., 1 Kaya Yasar Y.
P-158: ASSESSMENT OF BREAST CANCER THERAPY IN A HOSPITAL: A RETROSPECTIVE STUDY .................................................................................215
1 Durmazpinar, S., 2 Taner, N., 1 Macit, C.
P-159: PRESENCE OF GXSXGY MOTIF ON N-TYPE VOLTAGE-DEPENDENT CALCIUM CHANNELS AND ANDROCTONUS CRASSICAUDA  
SCORPION TOXINS. .........................................................................................................................................................................................................216
1 Aydin, S., 2 Cakmak, A.
P-160: BEXAROTENE, A RXRΑ AGONIST, PREVENTS LIPOPOLYSACCHARIDE-INDUCED INFLAMMATORY HYPERALGESIA IN MICE ..........................216
Kucukkavruk, SP., Temiz Resitoglu, M., Guden, DS., Sari, AN., Sahan Firat, S., Tunctan, B.
P-161: COMPARATIVE ASSESSMENT OF AWARENESS AND ATTITUDES OF COMMUNITY PHARMACISTS IN NORTHWEST NIGERIA AND MUĞLA, 
TURKEY TOWARDS CHRONOTHERAPY ........................................................................................................................................................................217
Chukwunyere, U., Bilge, S., Abacioglu, N.
P-162: THE EFFECT OF TOFISOPAM TREATMENT ON GLIAL PLASTICITY IN RAT HIPPOCAMPI ........................................................................................217
1 Ucel, UI., 1 Demir Ozkay, U., 2 Ulupinar E, 1 Can OD.
P-163: ANXIOLYTIC-LIKE EFFECT OF METHANOLIC EXTRACT PREPARED FROM HYPERICUM HIRCINUM L. SUBSP. MAJUS (AITON) N. ROBSON 
HERBA ...............................................................................................................................................................................................................................218
1 Saltan, N., 2 Ucel UI., 1 Kose YB., 2 Can OD. 
P-164: ANXIOLYTIC-LIKE ACTIVITIES OF SOME 1,3,4-THIADIAZOLE DERIVATIVES .............................................................................................................218
1 Can, OD., 1 Demir Ozkay, U., 2 Altintop, MD., 2 Kaplancikli, ZA. 
P-165: ANTIDEPRESSANT-LIKE EFFECT OF NOVEL BENZAZOLE DERIVATIVES .................................................................................................................219
1 Tokgoz, G., 1 Demir Ozkay, U., 2 Osmaniye, D.,1 Can, OD.
P-166: CENTRALLY MEDIATED ANTINOCICEPTIVE ACTIVITIES OF SOME PIPERAZINE DERIVATIVE COMPOUNDS .......................................................220
Ucel, Uİ., Kandemir, U., Ozkay Demir, U., Can, OD.
P-167: DEONTOLOGICAL VIOLATIONS IN TURKEY’S COMMUNITY PHARMACIES ...............................................................................................................220
Kiran, B., Karaca, EG.
P-168: A VIEW ON PATIENTS’ VIEW TO PHARMACIST-PATIENT COMMUNICATION FROM COMMUNITY PHARMACIES ..................................................221
Kiran, B., Karaca, EG., Hizal, OG.
P-169: STRATEGIC COOPERATION IN THE TURKISH PHARMACEUTICAL INDUSTRY .........................................................................................................221
Aydin Guldur, E., Ozcelikay, G.
P-170: A STUDY ON PHARMACY SOFTWARE PRODUCTS IN TURKEY ..................................................................................................................................222
1 Bulmus, G., 2 Ozcelikay, G.
P-171: AN ANALYSIS OF WORKFLOW AND WORK POWER IN COMMUNITY PHARMACIES IN ANKARA ............................................................................223
1 Zanbak, M., 2 Uzun, MB, 2 Ozcelikay, G.
P-172: DIETARY SUPPLEMENT REGULATIONS IN TURKEY AND COMPARISON WITH USA, EU AND JAPAN LEGISLATIONS .........................................223
Kartal, ME., Ozcelikay, G., 
P-173: A STUDY ON PHARMACOECONOMIC EVALUATIONS AND THE ETHICAL APPROACH OF THE TURKISH PHARMACEUTICAL INDUSTRY  
TO THIS SUBJECT ............................................................................................................................................................................................................224
1 Oral, M., 2 Ozcelikay, G.
P-174: ATTITUDE SCALE DEVELOPMENT STUDY FOR DRUG SIDE EFFECT PICTOGRAMS. .............................................................................................224
Tarhan, N., Arslan, M., Sar, S.
P-175: KNOWLEDGE AND ATTITUDE OF COMMUNITY PHARMACY PERSONNEL ABOUT IMPLEMENTING OF THE PHARMACEUTICAL TRACK & 
TRACE SYSTEM ...............................................................................................................................................................................................................225
1 Sayar, A., 2 Erdogan, ON., 3 Akbal Dagistan, O., 4 Erdogan MS.
P-176: PERCEPTION OF GENERAL SELF EFFICACY AND OCCUPATIONAL COMMITMENT OF ACADEMIC PERSONNEL WHO IS  
WORKING AT ANKARA UNIVERSITY FACULTY OF PHARMACY  ..................................................................................................................................226
Kilicdagi Y., Ozcelikay G. 
P-177: PREDICTION OF BIORELEVANT PKA VALUES OF SOME AMPHOTERIC DRUGS FROM THEIR PKA AT 25˚C BY USING ABRAHAM’S 
DESCRIPTORS .................................................................................................................................................................................................................226
Sogut, O., Ortak, H., Cubuk Demiralay, E., Alsancak, G.
P-178: PREDICTION OF RETENTION BEHAVIOUR OF SOME NSAIDS: RELATION BETWEEN CHROMATOGRAPHIC DATA AND ABRAHAM SOLUTE 
DESCRIPTORS .................................................................................................................................................................................................................227
1 Cubuk Demiralay, E., 1 Sogut, O., 2 Secilmis Canbay, H., 1 Ortak, H., 1 Alsancak, G.
P-181: QUANTITATIVE ANALYSES OF DAPAGLIFLOZIN, A SODIUM-GLUCOSE COTRANSPORTER II INHIBITOR, BY DIFFERENTIAL PULSE 
VOLTAMMETRY .................................................................................................................................................................................................................227
Ates, AK., Erk, N.
P-182: INDUCED DUAL WAVELENGTH SPECTROPHOTOMETRIC METHOD FOR THE SIMULTANEOUS ANALYSIS OF  NEBIVOLOL AND  
AMLODIPINE IN BULK AND  THEIR MIXTURES .............................................................................................................................................................228
1 Erk, N. 1 Ates, AK.
XXV
P-183: DETERMINATION OF GRANISETRON IN PHARMACEUTICAL PREPARATIONS BY CE-DAD .....................................................................................228
1 Ozyurek, B., 1 Cecen, SD., 2 Dal, AG.
P-184: DEVELOPMENT AND VALIDATION OF A NEW HPLC METHOD FOR QUANTITATIVE ESTIMATION OF CEFTIOFUR IN VETERINARY 
SUSPENSIONS .................................................................................................................................................................................................................229
1 Geven, A., 2,3 Ozcan, S., 3,4 Levent, S., 2,3 Can, NO.
P-185: GREEN HPLC USING ECO-FRIENDLY ETHANOL BASED MOBILE PHASES IN PHARMACEUTICAL ANALYSIS ......................................................230
Dogan, A., Eylem, CC., Basci, N.
P-187: HPLC DETERMINATION OF EPIRUBICIN IN NANOPARTICULATE DRUG DELIVERY SYSTEM .................................................................................230
1 Gencer, A., 1 Duraloglu, C., 2 Kocak, E., 2 Celebier, M., 1 Arica Yegin, B.
P-188: PREPARING A NEW BIOSENSOR FOR HYPOXANTHINE DETERMINATION ...............................................................................................................231
1 Gorgulu, M., 1 Kabasakal, DC., 2 Akin, D.,2 Cete, S., 1 Yasar, A.,
P-189: STABILITY-INDICATING HILIC METHOD FOR THE DETERMINATION OF SOME ANTIVIRALS FROM THEIR PHARMACEUTICAL  
DOSAGE FORMS  .............................................................................................................................................................................................................231
1 Erkmen, C., 2 Gumustas, M., 1 Ozkan, SA.,1 Uslu, B.
P-190: INVESTIGATION OF MICROBIOLOGICAL PROPERTIES OF SOME NEW GENERATION SOLVENTS ........................................................................232
1 Dogan Calhan, S., 2 Ulger, M., 3 Efeoglu, C., 3 Dincer Kaya, FN.
P-191: A GREEN EXTRACTION METHOD FOR QUANTIFICATION OF PHENOLIC SPECIES FROM OLIVE FRUITS ............................................................233
1 Efeoglu, Ç., 1 Dincer Kaya, FN., 2 Dogan Calhan, S.
P-192: DETERMINATION OF ANTAZOLINE, NAPHAZOLINE, EPHEDRINE, CHLORBUTANOL IN PHARMACETICAL POMADE  USING RP- HPLC ...........233
Kanbes Dindar, C., Günden Göğer, N.
P-193: OPTIMIZATION OF EXTRACTION PARAMETERS OF REVERSE IONTOPHORETIC DETERMINATION OF BLOOD GLUCOSE IN AN ARTIFICIAL 
SKIN MODEL .....................................................................................................................................................................................................................234
1 Yengin, C., 2 Der, FG., 2 Sezgin MC., 2 Alcin I., 2 Kilinc E.
P-194: LC-MS/MS METHOD FOR THE DETERMINATION OF LAMOTRIGINE IN RAT PLASMA AND BRAIN MICRODIALYSATE ..........................................235
1 Dogrukol Ak, D., 1 Sener, E., 2 Korkmaz, OT. 
P-195: AN ELECTROCHEMICAL SENSOR FOR SENSITIVE AND FAST DETECTION OF MITOXANTRONE BASED ON  
NANO-SEPIOLITE ELECTRODE ......................................................................................................................................................................................235
Eskikoy Bayraktepe, D., Yildiz, C., Yazan, Z.
P-196: ELECTROCHEMICAL SENSOR FOR THE DETERMINATION OF ANTI-CANCER SHIKONIN BASED ON NSC/TIO2/MWCNTS COMPOSITE ..........236
Eskikoy Bayraktepe, D., Yazan, Z.
P-198: VOLTAMMETRIC AND SPECTROELECTROCHEMICAL BEHAVIOR OF NOVEL OCTA SUBSTITUTED METALLOPHTHALOCYANINES .................237
Orman, EB., Huraibat, B., Atajanov, R., Odabas, Z., Ozkaya, AR.
P-199: DEVELOPMENT OF AN ACCURATE AND SENSITIVE ANALYTICAL METHOD FOR THE DETERMINATION OF DIOSMIN BY USING HPLC...........237
1 Erk, N., 2 Sari, MT.,1 Sahin, E. 
P-200: HIGH YIELD SYNTHESIS OF MOF FUNCTIONALIZED NANOPARTICLE FOR DETERMINATION OF HCG ................................................................238
1,5 Ahi, EE., 1 Torul, H., 2 Zengin, A., 3 Suludere, Z., 4 Selbes, Y.,5 Durmus, M.,
1 Tamer, U.
P-201: NEW SAMPLE PREPARATION METHOD FOR ANALYSIS OF POLAR AND NON-POLAR METABOLITES  .................................................................238
Kocak, E., Kaplan, O., Celebier, M.
P-202: DETERMINATION OF FATTY ACID SYNTHASE PROTEIN IN MCF-7 CANCER CELLS BY USING UPLC/MS METHOD ............................................239
1 Kocak, E., 1 Kaplan, O., 1 Celebier, M., 2 Ercan, A.
P-203: PLS AND PCR CALIBRATION MODELS FOR SPECTRAL ANALYSIS OF ATORVASTATIN AND EZETIMIBE  .............................................................239
Dinc, E., Ertekin, ZC.
P-204: SIMULTANEOUS DETERMINATION OF ATENOLOL AND CHLORTHALIDONE IN TABLETS BY PLS AND PCR METHODS ......................................240
Dinc, E., Ertekin, ZC.
P-205: LC-MS/MS METHOD FOR THE DETERMINATION OF OXCARBAZEPINE IN RAT PLASMA AND BRAIN MICRODIALYSATE ....................................240
1 Sener, E., 1 Dogrukol Ak, D., 2 Korkmaz, OT.
P- 206: LC-MS/MS METHOD FOR THE DETERMINATION OF TOPIRAMATE IN RAT PLASMA AND BRAIN MICRODIALYSATE ...........................................241
1 Sener, E., 1 Dogrukol Ak, D., 2 Korkmaz, OT. 
P-207: ELECTROCHEMICAL DETECTION OF ISOQUINOLINES IN HUMAN SERUM AND URINE SAMPLES .......................................................................241
1,4 Kivrak, E., 2 Bozkurt, B., 3 Durmaz Armagan, G., 1,4 Yuksel, S. 2 Unver Somer, N., 1 Kara, P.
P- 208: VOLTAMMETRIC DETERMINATION OF EPHEDRINE ON POLY (NILE BLUE) MODIFIED GLASSY CARBON ELECTRODE IN  
PHARMACEUTICAL DOSAGE FORMS AND URINE SAMPLES .....................................................................................................................................242
Agin, F., Ozturk, G., Kul, D.
P-209: ELECTROANALYTICAL DETERMINATION OF NIMESULIDE USING MULTIWALLED CARBON NANOTUBES MODIFIED CARBON PASTE 
ELECTRODE .....................................................................................................................................................................................................................243
Agin, F., Serdaroglu, V.
P-212: QUANTITATIVE ANALYSIS OF AMLODIPINE AND ATORVASTATIN BY USING CONSTANT CENTER SPECTROPHOTOMETRIC TECHNIQUE......243
1,2 Lotfy, HM., 3 Erk, N. , 4 Tiris,  G., 3 Sahin, E.
XXVI
P-213: VOLTAMMETRIC DETERMINATION OF CETIRIZINE IN PHARMACEUTICALS BY DIFFERENTIAL PULSE AND SQUARE  
WAVE VOLTAMMETRIC METHODS .................................................................................................................................................................................244
Sofu, U., Ifsat, ZD., Ozturk, G., Kul, D.
P-214: ELECTROCHEMICAL MIP SENSOR FOR DETECTION OF BUTYRYLCHOLINE ESTERASE  .....................................................................................245
1 Ozcelikay, G., 2 Yarman, A., 1 Kurbanoglu, S., 1 Ozkan, SA., 3 Wollenberger, U., 3 Scheller, FW.
P-215: ELECTROCHEMICAL INVESTIGATION OF ENTACAPONE USING NH2 FUNCTIONALIZED MULTI WALLED CARBON NANOTUBES  
MODIFIED NANOSENSOR ...............................................................................................................................................................................................245
1,2 Aftab, S., 1 Ozcelikay, G., 1 Kurbanoglu, S. 1,2 Shah, A., 1 Ozkan, SA. 
P-216: NOVEL “TURN OFF-ON” SENSORS FOR DETECTION OF DNA-ACRYLAMIDE INTERACTION USING ZNS QUANTUM DOTS AS A 
PHOSPHORESCENT PROBE ...........................................................................................................................................................................................246
Satana Kara, HE.
P-217: INVESTIGATION OF CHROMATOGRAPHIC BEHAVIOUR OF CLASS III ANTIARRHYTHMIC AGENT IN ACETONITRILE-WATER  
BINARY MIXTURES ..........................................................................................................................................................................................................246
Konce, I., Ortak, H., Daldal, YD., Nane, ID., Cubuk Demiralay, E., Alsancak, G.
P-218: OPTIMIZATION AND VALIDATION OF VALPROIC ACID BY REVERSED PHASE LIQUID CHROMATOGRAPHY METHOD  ......................................247
Cengiz, A., Nane, ID., Ustun, Z., Konce, I., Ortak, H., Alsancak, G., Cubuk Demiralay, E.
P-219: SEPARATION OF ENANTIOMERS OF CHIRAL WEAK ACIDS WITH POLYSACCHARIDE-BASED CHIRAL COLUMNS AND AQUAOUS-ORGANIC 
MOBILE PHASES IN HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY: TYPICAL REVERSED-PHASE BEHAVIOR  .........................................247
1 Matarashvili, I., 2 Ghughunishvili, D., 1 Chankvetadze, L., 1 Takaishvili, N.,  1 Khatiashvili, T., 2 Tsintsadze, M., 3 Farkas, T., 1 Chankvetadze, B.
P-220: ELECTROCHEMICAL DETECTION OF ANTIOXIDANT ACTIVITIES OF 4-INDOLYL-5-OXO-6,6 (OR 7,7)- DIMETHYL-1,4,5,6,7,8-
HEXAHYDROQUINOLINE DERIVATIVES.........................................................................................................................................................................248
1 Suslu, I, 2 Simsek, R., 2 Gunduz, MG., 1 Kablan Erdogan, S., 2 Safak, C.
P-221: A NOVEL APPROACH FOR LABEL-FREE GENOSENSING: THE USE OF PENCIL GRAPHITE ELECTRODE MODIFIED WITH GOLD 
NANOPARTICLES   DISPERSED OVER METAL OXIDE FILMS  .....................................................................................................................................249
1 Aydin, I., 2 Durusoz, H., 1 Ertas, FN, 2 Kara, P.
P-222: ELECTROCHEMICAL INVESTIGATION OF ELETRIPTAN USING GO/PT/IR BASED NANOSENSOR .........................................................................249
1 Kaya, SI., 2 Demirkan, B., 1 Kurbanoglu, S., 2 Kuyuldar, E., 2 Sen, F., 1 Ozkan, SA.
P-223: DEVELOPMENT AND VALIDATION OF GREEN CAPILLARY ELECTROPHORETIC METHOD FOR DETERMINATION OF GLIBENCLAMIDE IN 
PHARMACEUTICAL DOSAGE FORMS ............................................................................................................................................................................250
1 Sanli, S., 2 Sardogan, S., 3 Palabiyik, IM, 2 Sanli, N.
P-224: GOLD NANOPARTICLES MODIFIED SCREEN PRINTED ELECTRODE FOR SENSITIVE DETECTION/ENHANCED SENSING OF ANTICANCER 
DRUG IRINOTECAN-DNA INTERACTION ........................................................................................................................................................................251
1,2 Shahzad, S., 2 Kurbanoglu, S., 2,3 Karadurmus, L., 1 Shah, A., 2 Ozkan, SA.
P-225: ELECTROCHEMICAL NANOSENSOR FOR THE ELECTROCHEMICAL INTERACTION OF IDARUBICIN WİTH DNA ................................................251
1,2 Karadurmus, L., 1 Kurbanoglu, S., 3 Shah, A., 1 Ozkan, SA.
P-226: EVALUATION OF CHIRAL STATIONARY PHASES PREPARED BY COVALENT IMMOBILIZATION OF CELLULOSE 
3,5-DICHLOROPHENYLCARBAMATE ON CORE-SHELL SILICA  ..................................................................................................................................252
1 Bezhitashvili, L., 1 Bardavelidze, A., 1 Kakava, R., 2 Gumustas, M., 3 Ozkan, SA., 1 Chankvetadze, B.
P-227: SEPARATION OF ENANTIOMERS OF NOVEL CHIRAL PYRAZOLINE DERIVATIVES IN HPLC WITH POLYSACCHARIDE BASED CHIRAL 
COLUMNS BY USING POLAR ORGANIC MOBILE PHASES ..........................................................................................................................................253
1,2 Gumustas, M., 3 Bezhitashvili, L., 4 Gokhan Kelekci, N., 2 Ozkan SA., 3 Chankvetadze, B.
P-228: REDUCTION MECHANISM AND ELECTROCHEMICAL DETERMINATION OF OF RISPERIDONE  .............................................................................253
1 Baymak, MS., 2 Celik, H.
P-229: PREPARATION OF A NEW BIOSENSOR BASED ON GRAPHENE FOR GLUCOSE DETERMINATION  ......................................................................254
 1 Oncul, MA., 2 Cete, S., 2 Yasar, A.,
P-230: EFFECT OF PARTICLE SIZE AND PARTICLE SIZE DISTRIBUTION ON MONTELUKAST SODIUM DISSOLUTION ...................................................254
Dalkiran, M., Akkoyun Muhiddin, O., Seyidoglu Koksal, A., Usluer, O., Acar Karakoy, B., Onuk Goren, F. 
P-231: INVESTIGATION OF THE EFFECT OF COMMERCIAL HERBAL MIXTURE ON HEPG2 LIVER CANCER CELL LINE BY  
PROTEOMIC APPROACH  ................................................................................................................................................................................................255
1,2 Nenni, M., 3 Oncul, S., 3 Ercan, A., 1 Suslu, I., 1 Celebier, M., 4 Haznedaroglu, IC.
P-232: IDENTIFICATION OF ORGANOCHLORINE PESTICIDES (OCPS), IN SPIKED COMMERCIAL COW MILK SAMPLES BY GC-MS  ...........................256
1,2 Nenni, M., 1 Zeki, OC., 1 Suslu, I., 1 Celebier, M., 1 Altinoz, S. 
P-233: A COMPARISON BETWEEN EXPERIMENTAL AND THEORETICAL SPECTROSCOPIC DATA OF GATIFLOXACIN ...................................................256
 Mimouni, FZ., Belboukhari, N., Sekkoum, K.
P-235: DETERMINATION OF RIVAROXABAN IN TABLETS USING ULTRA HIGH PERFORMANCE LIQUID CHROMATOGRAPHY ......................................257
1,2 Kozanli, M., 1,2 Can, NO.
P-236: THE EFFECT OF POLYCATIONIC AMPHIPHILIC CYCLODEXTRIN NANOPARTICLES ON MDA-MB CANCER CELLS: A METABOLOMIC 
APPROACH TO UNDERSTAND THE MECHANISM ........................................................................................................................................................257
1 Celebier, M., 1 Kaplan, O., 1 Varol, I., 2 Varan, G. 3 Oncul, S., 1 Kocak, E., 3 Ercan, A., 2 Bilensoy, E.,
P-237: ENANTIOSEPARATION OF 4 IMINOFLAVAN DERIVATIVES ON POLYSACCHARIDE BASED CHIRAL STATIONARY PHASES BY HPLC ................258
1 Rahou, I., 1 Belboukhari, N., 1 Sekkoum, K., 1 Bounoua, N.,2 Cheriti, A., 3 Aboul Enein, HY.
XXVII
P-238: A NOVEL LC-MS/MS METHOD FOR DETERMINATION OF TASIMELTEON ..................................................................................................................259
1,2 Can, NO., 1,2 Ozcan, S., 2,3 Levent, S., 1,2 Kozanli, M. 2,3 Ozkay, Y., 3 Kaplancikli, ZA.
P- 241: NEW APPLICATIONS OF SPECTROPHOTOMETRIC  TECHNIQUES FOR  THE SIMULTANEOUS DETERMINATION  OF ZOFENOPRIL  
CALCIUM AND HYDROCHLOROTHIAZIDE  IN PHARMACEUTICAL   FORMULATIONS ..............................................................................................259
1,2 Lotfy, HM., 3 Tiris, G., 4 Erk, N.
P-242: RESOLUTION OF TWO-COMPONENT MIXTURE IN COMBINED DOSAGE FORMS CONTAINING PROTON PUMP INHIBITORS BY  
USING RATIO FIRST DERIVATIVE UV SPECTROPHOTOMETRY .................................................................................................................................260
1 Erk, N. , 2 Bay, MS.
P-243: ELECTROCHEMICAL BEHAVIOURS OF ANTHISTAMINES; LEVOCETRIZINE AND DESLORATADINE IN AQUEOUS SOLUTIONS .........................260
1,2 Bakirhan, NK. Ozturk, K., Uslu, B., Ozkan, SA.
P-245: COMPARISON OF SAMPLE PREPERATION TECNIQUES ON HUMAN BLOOD PLASMA FOR LC/MS METABOLOMIC STUDIES ...........................261
Kaplan, O., Kocak, E., Celebier, M.
P-246: ANALYTICAL METHOD DEVELOPMENT ON LIQUID CHROMATOGRAPHY/ MASS SPECTROMETRY (LC/MS Q-TOF) FOR METABOLOMIC 
STUDIES AT DIFFERENTIAL DIAGNOSIS OF ASCITES .................................................................................................................................................261
Kaplan, O., Celebier, M., Suslu, I.
P-247: DEVELOPMENT AND VALIDATION OF A HILIC METHOD FOR SIMULTANEOUS DETERMINATION OF CARBOPLATIN AND DECITABINE  ..........262
1 Esim, O., 2 Gumustas, M., 1 Hascicek, C., 3 Ozkan, SA.
P-248: QUANTITATIVE ANALYSIS OF A BINARY MIXTURE IN A PHARMACEUTICAL DOSAGE FORM BY CONTINUOUS WAVELET TRANSFORM 
TECHNIQUE ......................................................................................................................................................................................................................262
Ustundag, O., Dinc, E.
P-249: SIMULTANEOUS QUANTITATIVE RESOLUTION OF ACTIVE COMPOUNDS IN A TABLET DOSAGE FORM BY UPLC TECHNIQUE ........................263
Ustundag, O., Dinc, E.
P-250: INTERACTION STUDIES OF CARBIDOPA WITH FISH SPERM DOUBLE STRAIN DNA USING UV-SPECTROSCOPIC TECHNIQUE ......................263
Senel, P., Golcu, A.
P-251: ELECTROCHEMICAL INVESTIGATION OF DNA BINDING ON SULPIRIDE BY CYCLIC VOLTAMMETRY ...................................................................264
Senel, P., Golcu, A.
P-253: DEVELOPMENT OF NEW MONOLITHIC POLYSACCHARIDE-BASED CHIRAL HPLC COLUMNS FOR ENANTIOMERIC SEPARATION  ................264
Ratih, Asmari, M., El Deeb, S.
P-254: DETERMINATION OF CIPROFLOXACIN IN AN OPHTHALMIC SOLUTION BY DERIVATIVE SPECTROPHOTOMETRIC METHOD ..........................265
Dermis, S., Kilic, S., Ertekin, ZC., Dinc, E.
P-255: A COMPARATIVE STUDY ON THE LIQUID CHROMATOGRAPHIC RETENTION & SEPARATION CHARACTERISTICS OF SEVEN PARABEN 
DERIVATIVES IN DIFFERENT COLUMNS  ......................................................................................................................................................................265
1,2 Ozcan, S., 1,2 Kozanli, M., 1,2 Can, NO.
P-256: DETECTION OF TYROSINE NITRATION WITH VOLTAMMETRIC TECHNIQUES .........................................................................................................266
1 Topkaya, SN., 2 Ozyurt, VH., 3 Cetin, AE., 2 Otles, S.
P-257: STABILITY-INDICATING UPLC METHOD FOR THE DETERMINATION OF MONTELUKAST SODIUM, DESLORATADINE AND THEIR IMPURITIES  
FROM FIXED DOSE COMBINATION TABLETS ...............................................................................................................................................................267
1,2 Zengin Kurnali, S., 1 Ozturk, C., 1 Uslu, A., 2 Uslu, B.
P-258: DETERMINATION OF GRANISETRON IN PHARMACEUTICAL PREPARATIONS BY RRLC WITH FLUORESCENCE DETECTION ..........................267
1 Ozyurek, B., 1 Cecen, SD., 2 Dal AG.
P-259: SPECTROPHOTOMETRIC AND POTENTIOMETRIC DETERMINATION OF ACID DISSOCIATION CONSTANT (PKA) VALUES OF SOME 
NONSTEROİDAL ANTİ-INFLAMMATORY DERIVATIVES OF 3-SUBSTITUTED PIPERAZINOMETHYL BENZOXAZOLINONES .................................268
1 Altunterim, S., 2 Nalbur, AM., 2 Guzeldag, HB., 2 Durmaz, NA., 2 Hekimoglu, HE., 3 Baymak, MS., 4 Palaska, E., 1,2 Celik, H.
P-260: AN ELECTROCHEMICAL SENSOR FOR SENSITIVE DETECTION OF KETOCONAZOLE BASED ON SEPIOLITE CLAY ELECTRODE ...................269
1 Aydar, S. 2 Yazan, Z.
P-261: A NOVEL DNA NANOBIOSENSOR BASED ON GRAPHENE OXIDE DECORATED WITH GOLD NANOPARTICLES FOR THE DETECTION OF  
DNA INTERACTION WITH ANTICANCER DRUG .............................................................................................................................................................269
1,2 Shahzad, S., 2 Kurbanoglu, S., 2,3 Karadurmus, L., 1 Shah, A., 2 Ozkan, SA.
P-262: COMPARISON BETWEEN LIQUID CHROMATOGRAPHY AND RATIO DERIVATIVE SPECTROPHOTOMETRY FOR THE SIMULTANEOUS 
DETERMINATION OF PERINDOPRIL, INDAPAMIDE, AND AMLODIPINE TERNARY MIXTURES  ...............................................................................270
1,3 Karadurmus, L., 2 Gumustas, M., 3 Kurbanoglu, S., 3 Uslu, B., 3 Ozkan, SA.
P-264: SYNTHESIS, CHARACTERIZATION, SPECTROSCOPIC STUDIES AND ANTIMICROBIAL ACTIVITY OF NEW SCHIFF BASES DERIVED FROM 
SALICYLALDEHYDES .......................................................................................................................................................................................................270
Tuna Yildirim, S.
P-265: SYNTHESIS, SPECTROSCOPIC CHARACTERIZATION AND BIOLOGICAL ACTIVITIES OF SCHIFF BASES AND  
THEIR METAL (II) COMPLEXES .......................................................................................................................................................................................271
Tuna Yildirim, S.
P-266: METABOLOMIC PROFILING OF THE MOUSE PLASMA IN AIRWAY INFLAMMATION BY A GC-MS ............................................................................272
1 Recber, T., 2 Abohalaka, R., 1 Nemutlu, E., 2 Bozkurt, ET., 1 Kir, S., 2 Sahin Erdemli, İ.
XXVIII
P-267: METABOLIC INFRASTRUCTURE OF PREGNANT WOMEN WITH METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISMS; 
METABOLOMIC ANALYSIS  ..............................................................................................................................................................................................272
1 Recber, T., 2 Orgul, G., 2 Aydin, E., 2 Tanacan, A., 1 Nemutlu, E., 1 Kir, S., 2 Beksas, MS.
P-268: VOLTAMMETRIC DETERMINATION OF MERCURY USING A PENCIL GRAPHITE ELECTRODE ................................................................................273
1 Capan, T., 2 Arslan, H.
P-269: PREPARATION OF A NEW MODIFIED CARBON PASTE ELECTRODE FOR ADRENALINE DETERMINATION ..........................................................273
1 Capan, T., 2 Uzun, D., 2 Hasanoglu Ozkan, E., 2 Sari, N., 2 Arslan, F., 2 Arslan, H.
P-270: DETERMINATION AND VALIDATION OF SILODOSIN IN PURE AND PHARMACEUTİCAL DOSAGE FORMS VIA HPLC-UV .....................................274
1 Akman, CT., 2 Atila, A., 2 Senol, O., 2 Yaman, E., 2 Kadioglu, Y.
P-271: DETERMINATION AND VALIDATION OF SOLIFENACIN IN PURE AND PHARMACEUTICAL DOSAGE FORMS VIA HPLC-UV .................................275
1 Akman, CT., 2 Atila, A., 2 Senol, O., 2 Yaman, E., 2 Kadioglu, Y.
P-272: DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF BETAMETHASONE DIPROPIONATE AND 
KETOCONAZOLE IN CREAM FORMULATIONS ..............................................................................................................................................................275
1 Karabulut, TC., 2 Amasya, G., 1 Kurbanoglu, S., 1 Ozkan SA.
P-273: FORMATION OF PT(II) - EPIRUBICIN METAL BASED COMPOUND IN ANALYTICAL CONDITIONS ...........................................................................276
1 Adimcilar, V., 2 Cesme, M., 3 Unal, D., 1 Golcu, A.
P-274: ANALYSIS OF CORDYCEPIN AND ITS METABOLITES IN HELA CELLS BY LC-MS/MS ...............................................................................................277
1 Utami, W., 2 De Moor, C., 2 Barrett, DA.
P-275: USE OF DAUBECHIES WAVELET FAMILY FOR THE ANALYSIS OF ATENOLOL AND CHLORTHALIDONE IN TABLETS ..........................................277
Ertekin, ZC., Dinc, E., Ardic, AH.
P-276: MULTICOMPONENT ANALYSIS OF ROSUVASTATIN AND AMLODIPIN BY PARTIAL LEAST SQUARES AND PRINCIPLE COMPONENT 
REGRESSION ...................................................................................................................................................................................................................278
Ertekin, ZC., Dinc, E.
P-278: SOLIDIFICATION OF FLOATING ORGANIC DROP MICROEXTRACTION OF PIPERINE FROM BLACK AND WHITE PEPPER PRIOR TO ITS 
DETERMINATION BY HPLC..............................................................................................................................................................................................278
Ur Rahman, Z., Caleb, J., Al Nidawi, M., Alshana, U.
P-279: DEVELOPMENT AND VALIDATION OF A SELECTIVE HPLC METHOD FOR THE DETERMINATION OF S-ADENOSYL L-METHIONINE ISOMERS 
FROM RAT PLASMA..........................................................................................................................................................................................................279
1 Ergin, AD., 2 Gumustas, M., 3 Ozcelikay, T., 1 Yuksel, N., 4 Ozkan, SA.
P-280: IN VITRO EVALUATION OF CAPSAICIN PATCHES FOR TRANSDERMAL DRUG DELIVERY ......................................................................................280
1 Uzunovic, A., 2 Osmancevic, S., 1 Pilipovic, S., 3 Sapcanin, A., 2 Ademovic, Z.
P-281: IN VITRO STUDIES OF THE ORALLY DISINTEGRATING TABLET FORMULATIONS CONTAINING MIRTAZAPIN ......................................................280
Arslan A., Atalay F., Esim O., Köse Ozkan C., Tas C., Savaser A., Ozkan Y.
P-282: EXTENDED RELEASE PLGA NANOPARTICLES FOR CHRONIC PAIN .........................................................................................................................281
1 Ozturk AA., 2 Banderas LM, 2 Cayero Otero M, 1 Yenilmez E., 1 Yazan Y.
P-283: CARVEDILOL LOADED PLGA NANOPARTICLES FOR HYPERTENSIVE TREATMENT ................................................................................................282
1 Ozturk AA., 2 Martin BL., 2 Cayero Otero, MD., 1 Yenilmez E., 1 Yazan Y.
P-284: DETERMINING THERAPEUTIC RESPONSE OF MULTIPLE MYELOMA BY MASS ACCUMULATION AT SINGLE CELL LEVEL ................................282
1,2 Cetin, AE., 2,3 Stevens, MM., 2 Calistri, NL.,3 Fulciniti, M., 2 Olcum, S., 2 Kimmerling, RJ., 3 Munshi, N., 2 Manalis, SR.
P-285: EVALUATION OF PHYSICOCHEMICAL CHARACTERIZATION OF BERBERINE FOSPHOLIPID COMPLEX ..............................................................283
1 Karatas, A., 2 Gungor, A.,
P-286: DEVELOPMENT SOFT GELATIN CAPSULE CONTAINING IBUPROFEN. .....................................................................................................................284
1 Mehmetoglu, A., 1,2 Karasulu, E., 1,2 Yildiz Turkyilmaz, G.
P-287: ENCAPSULATION OF ELETRIPTAN HYDROBROMIDE IN PLGA NANOPARTICLES BY W/O/W EMULSIFICATION SOLVENT EVAPORATION 
METHOD ............................................................................................................................................................................................................................284
Savaser, A., Esim, Ozgur., Ozkan, CK., Tas, C., Ozkan, Y. 
P-288: THE EFFECT OF POLYMERIC STABILIZER ON STABILITY OF OPTIMUM FLURBIPROFEN NANOSUSPENSION  ..................................................285
Oktay, A., Karakucuk, A., Ilbasmis Tamer, S., Celebi, N. 
P-289: INVESTIGATION OF HEALTH MINISTRY OF LICENSED BIOTECHNOLOGICALLY MEDICINES FOUND IN PHARMACIES IN TURKEY..................286
Onbasli, D., Yuvali Celik, G., Ceylan, A., Dal, A.
P-291: DESIGN AND EVALUATION OF ORODISPERSIBLE TABLETS (ODTS) CONTAINING CARBAMAZEPINE AND LEVETIRACETAM  ..........................286
Kandilli, B., Ugur, AB., Cetin, M.
P-292: INVESTIGATION OF THE SOLUBILITY OF NYSTATIN AND NIFURATEL FOR SELECTING THE APPROPRATE DISSOLUTION MEDIA FOR THE 
OVULE FORMULATION ....................................................................................................................................................................................................287
1 Ayan, C., 1,2 Karasulu, E. 
P-293: DEVELOPMENT OF TIME CONTROLLED MULTI-COPMRESSED DEXKETOPROFEN TROMETAMOL TABLETS. ....................................................287
Hascicek, C., Doburlu, H., Esim, O.
P-294: EFFECT OF POLYMER TYPE AND CONCENTRATION ON CHARACTERISTICS OF DIHYDROERGOTAMINE MESYLATE SUBLING FILMS .........288
1 Ozkan, CK.; 1 Esim, O.; 2 Kurbanoglu, S., 1 Savaser A.,1 Tasi C., Arslan, A. 2 Ozkan SA., 1 Ozkan, Y.
XXIX
P-295: PREPARATION AND OPTIMIZATION OF CUCURBITACIN B LOADED CORE-SHELL TYPE HYBRID NANOPARTICLES USING A FULL FACTORIAL 
DESIGN STUDY  ...............................................................................................................................................................................................................289
1 Sengel Turk, C.T., 2 Ozmen, N., 2 Bakar Ates, F.
P-296: INFLUENCE OF THE LIPID MATERIAL ON PHYSICOCHEMICAL PROPERTIES OF SOLID LIPID NANOPARTICLES ...............................................289
Ozturk, C., Amasya, G., Tarımci, N.
P-297: DEVELOPMENT OF A FILM FORMULATION CONTAINING DOXYCYCLINE HYCLATE FOR THE TREATMENT OF PERIODONTAL DISEASES .....290
1 Dayıoglu, D., 1,2 Cetin Uyanikgil, EO.
P-298: PREPARATION AND CHARACTERIZATION OF W/O/W DOUBLE EMULSION CONTAINING TENOFOVIR .................................................................290
Bektas, D., Tugcu Demiroz, F., Teksin ZS.
P-299: EFFECT OF SOLVENT RATE MIXTURES ON THE RUTIN RELEASE RATE FROM POLY-Ε-CAPROLACTONE NANOPARTICLES ..........................291
1 Gecgel, DS., 2 Yazeji, T., 2 Lamprecht, A. 2, 1 Kilicarslan, M.
P-300: MECHANICAL PROPERTIES AND EX-VIVO SKIN PERMEATION EVALUATIONS OF IBUPROFEN EMULSION GEL FOR TOPICAL DELIVERY .....292
Yilmaz Usta, D., Tugcu Demiroz, F., Teksin, ZS.
P-301: DEVELOPMENT AND CHARACTERIZATION OF NANOEMULSIONS CONTAINING SILYMARIN FOR COSMETIC PURPOSES ...............................293
Altuntas, E., Yener, G., Akar, E.
P-302: EVALUATION OF IN VITRO EFFECTIVENESS OF NANOEMULSIONS CONTAINING PIPERINE FOR THE TREATMENT OF VITILIGO DISEASE  .293
1 Ozkan B., 1 Budama Kilinc, Y., 1 Cakir Koc, R., 1 Kaya, Z., 2 Altuntas, E. 
P-304: PREPARATION OF SIO2 DOPED BIODEGRADABLE POLYACRYLIC ACID NANOCOMPOSITE HYDROGELS FOR UPGRADING OF LIFE UNDER 
WATER ...............................................................................................................................................................................................................................294
Gokmen, F.O., Yaman, E., Temel, S. 
P-305: BIOCOMPATIBLE TIO2 DOPED HYDROGEL PRODUCTION FOR DRUG DELIVERY SYSTEMS ................................................................................294
1 Gokmen, FO., 1 Yaman, E., 1 Temel, S., 2 Ozbay, N.
P-307: INVESTIGATION OF RIBOFLAVIN AND RIBOFLAVIN-5-PHOSPHATE SODIUM RELEASE FROM OCULAR HYDROGELS .......................................295
Aytekin, E., Bozdag Pehlivan, S., Calis,S.
P-308: DETERMINATION OF CYTOTOXICITY OF LAMOTRIGINE ON L929 CELL LINE. .........................................................................................................295
1,2 Pezik, E., 2 Oztürk, N., 2 Sahin, S., 2 Vural, I.
P-309: POLY-LACTIC-CO-GLYCOLIC ACID NANOPARTICLES CONTAINING KETOPROFEN LYSINE: PREPARATION AND CHARACTERIZATION  ..........296
Elmaskaya, A., Özturk, AA., Yenilmez, E. 
P-310: PREPARATION AND CHARACTERIZATION OF KETOCONAZOLE AND CAFFEINE LOADED SELF-NANOEMULSIFYING DRUG DELIVERY 
SYSTEMS ..........................................................................................................................................................................................................................297
 1 Gulpinar E., 2 Tirnaksiz F.
P-311: OPTIMIZATION OF POLY (ACRYLIC ACID-CO-N-VINYL 2-PYRROLIDONE) / SIO2 NANOCOMPOSITE HYDROGELS FOR DRUG DELIVERY 
SYSTEMS ..........................................................................................................................................................................................................................297
Gokmen, FO., Temel, S., Yaman, E.
P-312: PREPARATION, CHARACTERIZATION AND SWELLING BEHAVIOR OF PAA/PVP COPOLYMERIC HYDROGEL AS A DRUG CARRIER AGENT ...298
1 Gokmen, FO., 1 Temel, S., 1 Yaman, E., 2 Ozbay, N.
P-313: EVALUATION OF INTRAVAGINAL DELIVERY OF POLYVINYLPYRROLIDONE- METRONIDAZOLE NANOFIBERS FOR THE TREATMENT OF 
BACTERIAL VAGINOSIS ...................................................................................................................................................................................................298
Tugcu Demiroz, F., Saar, S., Tort, S., Kara, AA., Acartürk, F.
P-314: DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLET FORMULATIONS OF VENLAFAXINE HYDROCHLORIDE  ........................299
Saar, S., Yıldız A., Unal, IS., Ozdal, ZD., Olgac, S., Kodan, E., Duran, C., Tort S., Tugcu Demiroz, F. 
P-315: METRONIDAZOLE INCORPORATED POLYMERIC NANOPARTICLES FOR VAGINAL APPLICATION.........................................................................300
1 Katerji, F., 2 Basaran, E.
P-316: PREPARATION OF HEPARIN-LOADED NANOFIBERS USING TWO DIFFERENT CORE SOLUTIONS .......................................................................300
Ruzgar Ozemre, G., Tort, S., Acarturk, F.
P-317: SOLID LIPID NANOPARTICLES FOR ORAL ADMINISTRATION: HIGH PRESSURE HOMOGENIZATION METHOD ...................................................301
Erkan, O., Amasya, G., Sezgin-Bayındır, Z., Yuksel, N.
P-318: FORMULATION AND EVALUATION OF SPRAY DRIED CHITOSAN NANOPARTICLES OF LEVOCETIRIZINE DIHYDROCHLORIDE FOR 
ANTIHISTAMINIC TREATMENT ........................................................................................................................................................................................302
 Yurtdas Kirimoglu, G., Özturk, AA., 
P-319: NOVEL STRATEGIES TO SYNTHSESIS OF POLYMER-DRUG CONJUGATE BY CHARGE TRANSFER COMPLEX COPOLYMERIZATION  ...........302
Kaplan Can, H., Parvizi Khosroshahi, S.
P-320: DETERMINATION OF IN-VITRO SIMILARITY BY AERODYNAMIC PARTICLE SIZE DISTRIBUTION BETWEEN TEST PRODUCT AND REFERENCE 
PRODUCT IN NEBULISATION FORM INCLUDING SABA / ANTICHOLINERGIC COMBINATION .................................................................................303
Icin H., Turk M., Keskin G., Isik E., Tanriver K., Gokalp M., Dude U.
P-321: 3D PRINTING AS A NEW TOOL FOR THE DEVELOPMENT OF SOLID DOSAGE FORMS ...........................................................................................304
Gultekin, HE., Tort, S., Acarturk, F.
P-322: PREFORMULATION STUDIES OF NANOPARTICLES FOR PSORIASIS DISEASE TREATMENT ................................................................................304
1 Erol, I., 2 Ustundag Okur, N., 1 Ozer, O. 
XXX
P-323: PREPARATION, CHARACTERIZATION AND CELL VIABILITY STUDIES OF CISPLATIN LOADED SELF-MICROEMUSIFYING DRUG DELIVERY 
SYSTEM (SMEDDS) ..........................................................................................................................................................................................................305
1 Akartas, I., 2 Karasulu, HY.
P-324: TRANSDERMAL DELIVERY OF AN ANTIEPILEPTIC DRUG: LACOSAMIDE  ................................................................................................................306
1 Aykac, K., 2 Basaran, E.
P-325: PREPARATION AND CHARACTERIZATION OF QUERCETIN LOADED CYCLODEXTRIN/CHITOSAN/TPP NANOPARTICLES .................................307
1 Guven, UM., 2 Gulec, K., 3 Berkman, MS., 3 Demirel, M.
P-326: PHYSICOCHEMICAL STABILITY AND COMPATIBILITY TESTING OF METRONIDAZOLE IN PARENTERAL NUTRITION MIXTURES ......................307
Dettlaff K., Popielarz Brzezińska M., Gostyńska A.
P-327: IS COMBINING OF DRUGS WITH TPN MIXTURES SAFE? COMPATIBILITY STUDIES OF SOME FLUOROQUINOLONES WITH TPN ....................308
Gostyńska A., Stawny M., Dettlaff K., Jelińska A.
P-328: VALIDATION OF AN HPLC METHOD FOR THE DETERMINATION OF BESIFLOXACIN HCL FROM OCULAR INSERT BASED ON 
POLYCAPROLACTONE ....................................................................................................................................................................................................309
1 Polat, K., 1 Bozdag Pehlivan S., 2 Kır, S.,1 Calıs S., 
P-329: BIOFUNCTIONALIZATION OF GRAPHENE OXIDE FOR DRUG DELIVERY APPLICATIONS .......................................................................................309
Demirhan, K.,Caliskan Salihi, E.
P-332: DEVELOPMENT AND CHARACTERIZATION OF SELF NANOEMULSIFIYING FORMULATION FOR ORAL PEPTIDE DELIVERY ............................310
1,2 Celik Tekeli, M.,2 Aktas, Y.,1 Celebi, N.
P-333: THE EFFECT OF CHITOSAN TYPE AND CONCENTRATION ON COMPLEXATION WITH SODIUM ALGINATE IN FILM FORMULATIONS  .............310
Ilhan, M., Kilicarslan, M.
P-334: FORMULATION AND CHARACTERIZATION STUDIES OF ORNIDAZOLE INCORPORATED EUDRAGIT® S 100 BASED NANOPARTICLES  .........311
1 Ali, MS., 2 Basaran, E.
P-335: DRY GRANULATION: DETERMINATION OF OPTIMUM TABLETTING PARAMETERS USING COMPACTION SIMULATOR ......................................311
Chunu, JT., Jiwa, N.,Ozalp Y.
P-336: IN VITRO EVALUATION OF ANTIOXIDANT & CYTOTOXICITY ACITIVITIES OF AL2O3 NANOPARTICLES, BLACK CUMIN OIL AND CO-ENZYME 
Q10 ON MCF-7 CELL LINE ...............................................................................................................................................................................................312
1 Sahin, NO., 1 Cavdar, B., 2 Cetin, B.,3 Sirin, S.
P-337: POLYMERIC MICROPARTICLES AS ANTIDIABETIC CARRIERS; PREPARATION AND CHARACTERIZATION AS PRELIMINARY STUDIES...........313
1 Siafaka, P., 1 Caglar, ES.,1 Ustundag Okur, N.
P-338: DERMAL FILMS CONTAINING MUPIROCIN: CHARACTERIZATION, EX VIVO PERMEATION AND BIOADHESION STUDIES ..................................314
1 Ustundag Okur, N., 1 Hokenek, N., 1 Siafaka, P, 2 Erdal C.
P-340: EUDRAGİT® S 100 NANOPARTICLES CONTAINING KETOPROFEN LYSNE: PREPARATION AND CHARACTERIZATION ......................................315
1 Cinar, Nİ., 2 Ozturk, AA., 2 Yenilmez, E. 
P-341: FACTORIAL DESIGN AND DEVELOPMENT OF PLGA MICROPARTICLES FOR PROTIEN DELIVERY SYSTEM .......................................................315
1 Yurtoglu K., 1 Arslan A.,1 Ozhan G.,1 Devrim B., 2 Nemutlu E.,1 Saka O.M., 1 Bozkir A.
P-342: PREPARATION AND CHARACTERIZATION OF SEMI-SOLID FORMULATIONS CONTAINING LOCAL ANESTHETIC AGENTS ................................316
Urfa E., Sayiner O., Arisoy S., Comoglu T.
P-343: ANTI-PROLIFERATIVE EFFECT OF NOVEL MELOTONIN ANALOGS ON BREAST CANCER CELLS .........................................................................317
1 Onar, O., 2 Telkoparan Akillilar, P., 3 Durgun, K., 3 Suzen, S., 1 Yildirim, O.
P-344: PREPARATION AND IN-VITRO CHARACTERIZATION OF AMPICILLIN SODIUM-LOADED ALGINATE BEADS FOR ORAL  
ANTIBIOTIC TREATMENT: A PRELIMINARY STUDY.......................................................................................................................................................318
Duman, S., Sevinc Ozakar, R., Ozakar, E.
P-345: NOVEL GASTRORETENTIVE DRUG DELIVERY SYSTEMS: PREFORMULATION STUDIES OF AMPICILLIN SODIUM-LOADED GELISPHERES  .318
Ince, AY., Sevinc Ozakar, R., Ozakar, E.
P-346: PREPARATION AND CELL CULTURE STUDIES OF DEXAMETHASONE NANOPARTICLES FOR ORAL CANCER CHEMOPREVENTION ..............319
1 Rencber, S., 2 Aydin Köse, F., 1 Karavana, SY.
P-347: A COMPERISON OF PLGA NANOPARTICLE PREPARATION METHODS FOR BEVACIZUMAB ENCAPSULATION ...................................................320
1 Akbas, S., 2 Ultav, G., 3 Tonbul, H., 4 Sahin, A., 4 Capan, Y. 
P-348: DEVELOPMENT OF MONO AND BILAYERED BIOADHESIVE FILM FORMULATIONS FOR ORAL MUCOSAL DRUG DELIVERY .............................320
Timur, SS., Yüksel, S., Senel, S.
P-349: COMPARISON OF DIALYSIS VS SAMPLE AND SEPARATION METHODS FOR IN VITRO RELEASE DETERMINATION OF LEVODOPA FROM 
NANOPARTICLES .............................................................................................................................................................................................................321
Arısoy, S., Sayıner, O., Comoglu, T.
P-350: PREPARATION AND CHARACTERIZATION OF NANOFIBERS CONTAINING ORNIDAZOLE FOR BUCCAL APPLICATION  .....................................322
Tort,S., Yıldız, A., Tugcu Demiroz, F., Tuncel, E., Acarturk F.
P-352: PH-DEPENDENT DISSOLUTION BEHAVIOR OF A WEAKLY BASIC BCS CLASS II DRUG, CLOPIDOGREL  .............................................................323
Olgac, S., Yildiz, A., Saar, S., Kodan, E., Incecayir, T.
P-353: FORMULATION AND EVALUATION OF DEXKETOPROFEN MINI TABLETS FOR CHRONOTHERAPY .......................................................................323
Ilhan, E., Sahbaz, S., Ugurlu, T., Aldeniz, EE. 
XXXI
P-354: PREPARATION AND CHARACTERIZATION OF EGF CONTAINING HYDROGEL FORMULATIONS ............................................................................324
1 Dogan, M., 1 Sezer, AD., 2 Sahbaz S., 2 Ugurlu, T.
P-355: PREFORMULATION STUDIES OF CYCLOSPORINE A NANOSUSPENSION STABILIZED BY HYDROXYPROPYL METHYLCELLULOSE AND 
SOLUPLUS® ......................................................................................................................................................................................................................325
Gulbag, S., Karakucuk, A., Mutlu Agardan, B., Celebi, N.
P-356: CONTROLLED DRUG RELEASE FROM 2-HYDROXYETHYLCELLULOSE-GRAPHENE NANOCOMPOSITE FILMS .................................................325
Salih Hussein, H., Alemdar, S., Pekel Bayramgil, N.
P-357: PREPARATION OF POLY N-VINYLTRIAZOLE HYDROGELS HAVING ACID FUNCTIONALITIES FOR CONTROLLED DRUG RELEASE .................326
Alemdar, S., Pekel Bayramgil, N.
P-358: STABILITY OF GEMCITABINE HYDROCHLORIDE LOADED LPHNS IN PHOSPHATE BUFFER SOLUTION AND FETAL BOVINE SERUM ..............326
Yalcin, TE., Ilbasmis Tamer S., Takka S.
P-359: STABILITY OF GEMCITABINE HYDROCHLORIDE LOADED LPHNS ON DIFFERENT STORAGE CONDITIONS .......................................................327
Yalcin, TE., Ilbasmis Tamer S., Takka S.
P-360: EFFECT OF VARIOUS FORMULATION PARAMETERS ON THE CHARACTERISTICS OF BLANK PLGA NANOPARTICLES  ...................................327
Copur, T., Bozdag Pehlivan, S., Öner,L. 
P-361: THE EFFECT OF TYPE AND CONCENTRATION OF CHITOSAN ON THE ELECTROSPUN POLY(CAPROLACTON) NANOFIBERS ........................328
Eren Boncu, T., Ozdemir, N.
P-362: THE EFFECT OF GOLD NANOPARTICLES, SOLID LIPID NANOPARTICES AND GLYCOIN COMBINATIONS ON THE VIABILITY OF DERMAL 
FIBROBLASTS ...................................................................................................................................................................................................................328
1 Payze, U., 2 Aydın Kose, F., 1 Gokce, EH.
P-363: PREPARATION AND IN VITRO CHARACTERIZATION OF CARVEDILOL LOADED POLYMERIC NANOPARTICLES FOR DRUG DELIVERY ..........329
1 Guven, UM., 2 Ozturk AA., 2 Yenilmez E.
P-364: IN VITRO RELEASE STUDIES AND HPLC METHOD FOR THE DETERMINATION OF CARVEDILOL IN NANOPARTICLE SYSTEMS ......................330
1 Guven, UM., 2 Ozturk, AA., 2 Yenilmez, E.
P-365: DEVELOPMENT AND IN VITRO / IN VIVO EVALUATION OF BISPHOSPHONATE LOADED MEMBRANES FOR GUIDED  
BONE REGENERATION ....................................................................................................................................................................................................330
1 Oz, UC., 1 Kucukturkmen B., 1 Saka,OM., 1 Devrim B., 2 Toptas, M., 3 Ozdemir, Ozge., 4 Bilgili, HM. 5 Deveci, S., 
6 Unsal, E., 1 Bozkir, A.
P-366: MICROBIOLOGICAL AND EX VIVO PERMEATION/PENETRATION STUDIES OF  VORICONAZOLE LOADED IN SITU GELS ..................................331
1 Ustundag Okur, N., 1 Yozgatli V., 2 Yoltas, A. 
P-367: PREPARATION AND CHARACTERIZATION OF PLGA-LECITHIN NANOPARTICLES ...................................................................................................332
Ozkan,Y., Esim, O., Savaser, A., Ozkan, CK., Tas.,C. 
P-368: EXPERIMENTAL EVALUATION OF ANTINOCICEPTIVE ACTIVITY OF END-LAA LOADED POLYMERIC MICELLES WITH TAIL FLICK MODEL ......332
1 Sezgin Bayindir, Z., 1 Yuksel, N., 2 Kose Ozkan, C., 3 Savaser, A., 4 Varamini, P., 3,4 Toth, I.
P-369: EFFECTS OF ANTIHYPERGLYCEMIC AGENTS ON QT INTERVAL  VALUE OF DIABETIC RATS................................................................................333
1 Yalin, AE., 2 Comelekoglu, U., 2 Ozbay, E., 1 Yildirim, M., 3 Berkoz, M.,1 Yalin, S.
P-370: MODULATION OF HCT 116 P53 -/- CELL VIABILITY BY COENZYME Q0  .....................................................................................................................333
Yaprak, A , Karabay, AZ 
P371: CYTOTOXIC EFFECTS OF SILICON PHTHALOCYANINE, NAPHTHALOCYANINE AND THEIR WATER SOLUBLE DERIVATIVES  ..........................334
1 Ozel, A., 1 Barut, B., 2 Biyiklioglu, Z.
P372: COMPARISON OF THE CYTOTOXIC EFFECTS OF DIFFERENT SOLVENTS ON HCT 116, HL-60 AND K562 CELL PROLIFERATIONS .................335
Koc, A., Karabay, AZ., Buyukbingol, Z., Aktan, F.
P-373: HYPERFERRITINEMIA AND INFLAMMATION IN METABOLIC SYNDROME PATIENTS DIAGNOSED WITH OR WITHOUT DIABETES  ...................335
1 Aca, HT., 2 Baba B., 3 Kirac CO., 4 Ozturk B., 2 Hacisevki A.
P-374: PHENYLBUTYRIC ACID MAY BE PHARMACOLOGICAL AGENT TO OBESITY ASSOCIATED INFLAMMATION .........................................................336
1 Baba, B., 2 Caliskan, M., 2 Boyuk, G., 1 Hacısevki, A.
P-375: HSP70 INHIBITOR MKT-077 ENHANCES THE ANTICANCER EFFECT OF PACLITAXEL IN MDA-MB-231 CELL LINES. ...........................................337
1 Erdas, B., 2 Ergul, M.
P-376: USNIC ACID INHIBITS PROLIFERATION AND THE PROFILES OF EXPRESSION OF APOPTOSIS-RELATED GENES IN  
BREAST CANCER CELLS ................................................................................................................................................................................................337
Cansaran Duman, D.
P-377: LEUKOTRIENE D4 LEVELS IN PATIENTS WITH BREAST CANCER .............................................................................................................................338
1 Miser Salihoglu, E., 1 Akbas, KK., 2 Karanlik, H., 3 Demokan, S., 1 Yardim-Akaydin, S. 
P-378: MRNA AND PROTEIN EXPRESSION LEVELS OF P53 IN MOLECULAR SUBTYPES OF BREAST CANCER .............................................................338
1 Miser Salihoglu, E., 2 Demokan, S., 3 Karanlik, H., 4 Karahalil, B., 1 Yardim-Akaydin, S., 
P-379: SYNTHESIS AND APPLICATION OF NOVEL ACETYLCHOLINESTERASE INHIBITORS. .............................................................................................339
Doganer, M., Ozkan Hasanoglu, E., Sari, N., Arslan, F.
P-380: IMIDAZOLE-LINKED MONO AND DI-KETOXIME DERIVATIVES ON GLIOBLASTOMA: SYNTHESIS AND IN VITRO STUDIES .................................340
1,2 Kuzu, B., 3 Taspinar, F, 1,2 Menges, 4 Taspinar, MN., 5 Tasdemir, V., 
6 Genc, H., 
XXXII
P-381: MLH1 -93G >A AND I219V POLYMORPHISMS AND SPORADIC COLORECTAL CANCER: A CASE-CONTROL STUDY IN  
TURKISH POPULATION ....................................................................................................................................................................................................340
1 Oztas, E., 1 Cilingir, U., 1 Akyuz, A., 2 Yanar, HT., 1 Ozhan, G.
P-382: THE INHIBITORY EFFECTS OF PHENOTHIAZINE DYES ON Β-SECRETASE  .............................................................................................................341
Biberoglu, K., Yuksel, M., Onder, S.,Tacal, O. 
P-383: INCREASED ANTICANCER EFFECTS IN HUMAN PROSTATE CANCER BY COMBINING VER-155008 AND CISPLATIN. ........................................342
1 Varol, K., 2 Ergul, M.
P-384: ATTENUATION OF TESTIS DAMAGE IN STREPTOZOTOCIN-INDUCED DIABETIC RATS BY VACCINIUM MYRTILLUS L. EXTRACT .....................342
1 Berkoz, M., 2 Kahraman, T., 3 Yildirim, M., 4 Allahverdiyev, O., 3 Yalin, S., 1 Saeed, KM., 5 Turel, I.
P-385: SYNTHESIS AND EVALUATION OF NEW 2-SUBSTITUTED BENZOXAZOLE DERIVATES AS ANTICANCER AGENTS .............................................343
1 Aksoy, MO., 2 Kaya Cavusoglu, B., 1 Akalın Ciftci, G.,2 Yurttas, L.
P-386: PROTECTIVE ROLE OF FERULIC ACID AGAINST LIPID PEROXIDATION AND PROTEIN OXIDATION INDUCED BY IMIDACLOPRID IN LIVER 
TISSUE OF CYPRINUS CARPIO ......................................................................................................................................................................................343
1 Ozkan Yilmaz, F., 1 Onder, S., 1 Ozluer Hunt, A., 2 Yildirim, M., 3 Berkoz, M., 2 Yalin, S.
P-387: THE EFFECTS OF RADIOFREQUENCY ELECTROMAGNETIC RADIATION FROM CELL PHONE CAUSES  OXIDATIVE STRESS ON HEART 
TISSUE IN WISTAR ALBINO RATS ...................................................................................................................................................................................344
1 Yildirim, M., 2 Arslan, B., 3 Berkoz, M., 2 Aras, N., 1 Yalin, S.
P-388: MOLECULAR, BIOCHEMICAL AND IN SILICO ANALYSES OF COMMERCIAL AND NOVEL PHENOTHIAZINES AS ANTICANCER AGENTS ..........345
1,2 Yaman, M., 1 Tiryaki, RS., 4 Zengin, F., 4 Kisla, MM., 1 Bayazeid, O., 1,2 Keskus, AG., 4 Ates Alagoz, Z., 1,2,3 Konu O.
P-389: CYTOTOXIC EFFECTS OF PLK1 INHIBITORS RO3280 AND SBE 13 HYDROCHLORIDE ON BREAST CANCER CELLS MDA-MB-231. .................345
1 Ergul, M., 2 Ergul, M., 3 Altun, A.
P-390: CYTOTOXIC EFFECTS OF PLK1 INHIBITORS RO3280 AND SBE 13 HYDROCHLORIDE ON DU 145 AND SH-SY5Y CELL LINES. .........................346
1 Ergul, M., 2 Ergul, M., 3 Altun, A.
P-391: THE EFFECT OF FUNCTIONALIZED PYRROLIDINE - INDOLE HYBRID HETEROCYCLES ON VEGF IN MCF-7 CELLS  .........................................346
1 Canacankatan, N., 2 Belveren, S., 2 Poyraz, S., 3 Kibar, D., 3 Yetkin, D., 3 Yilmaz, SN. 2 Dondas, HA.
P-392: INVESTIGATION OF POLYPHENOL CONTENTS AND ANTIOXIDANT ACTIVITIES OF LACTARIUS DELICIOUS AND LACTARIUS  
SALMONICOLOR MUSHROOMS .....................................................................................................................................................................................347
1 Shomali, N., 1 Onar, O., 1 Akata, I.,1 Yildirim, O. 
P-394: INVESTIGATION OF THE EFFECT OF VACCINIUM MYRTILLUS L. ON OXIDATIVE STRESS IN LUNG TISSUE OF DIABETIC RATS......................347
1 Yalin, S., 2 Berkoz, M., 3 Kahraman, T., 1 Yildirim, M., 4 Allahverdiyev, O., 2 Saeed, KM., 5 Turel, I.
P-395: EFFECT OF COMBINED RADIOTHERAPY AND IMIPRAMINE ON OXIDATIVE STRESS IN PROSTATE CANCER CELLS ........................................348
1 Barlaz Us, S. 2 Yildirim, M., 3 Yetkin, D., 2 Yalin, S., 4 Sogut, F., 5 Yilmaz, SN., 6 Comelekoglu, U
P-396: INVESTIGATION OF GGT1 AND GGT6 MRNA EXPRESSIONS IN PATIENTS WITH BREAST CANCER .....................................................................349
1 Yardim Akaydin, S., 1 Miser Salihoglu, E., 1 Ramadan, SS., 2 Karanlik, H.,              3 Demokan, S. 
P-397: THE ROLES OF HSSB1 AND HSSB2 IN THE DNA DAMAGE CHECKPOINT SIGNALLING  .........................................................................................349
1 Bereketoglu, S., 2 Sancar, A.
P-398: PREDICTIVE VALUE OF SERUM INHIBIN B CONCENTRATION IN WOMEN WITH UNEXPLAINED INFERTILITY .....................................................350
1 Turan, T., 2 Pekel, A., 2 Iltemir Duvan, ZC., 1 Gonenc, A.
P-399: SERUM CARBONIC ANHYDRASE 1 AND TOS LEVELS IN PATIENTS WITH UNEXPLAINED INFERTILITY ...............................................................351
1 Taskan, T., 1 Turan, T., 2 Pekel, A., 2 Iltemir Duvan, CZ., 1 Gonenc, A.
P-400: ANTIOXIDANT AND ENZYME INHIBITION ACTIVITIES ON DIABETES MELLITUS OF DIFFERENT MOLECULAR WEIGHT CHITOSANS ...............351
1 Cakmak, YS., 1 Kaya, M., 2 Zengin, G.
P-401: COMPARISON OF ANTI-INFLAMMATORY ACTIVITIES OF TENOXICAM AND ITS TRANSITION METAL COMPLEXES ............................................352
1 Kalaycioglu, Z., 2 Muslu, H., 1 Erim, FB., 1 Golcu, A.
P-402: SYNTHESIS AND EVALUATION OF NEW BENZAZOLE DERIVATIVES AS POTENTIAL ANTICANDIDAL AGENTS. ...................................................353
1 Ozdemir, A., 1 Altintop, MD., 1 Sever, B.
P-403: SYNTHESIS, IN VITRO AND IN SILICO STUDIES OF NEW PYRAZOLINE DERIVATIVES AS POTENTIAL ANTICANDIDAL AGENTS. .....................353
1 Ozdemir, A., 1 Altintop, MD., 1 Sever, B.
P-404: SYNTHESIS AND E/Z SEPARATION OF NEW NAPHTHYL ETHANONE OXIME ESTER DERIVATIVES BEARING PYRAZOLE MOIETY ..................354
Bozbey, I., Karakurt, A. 
P-405: MOLECULAR DOCKING STUDIES ON NEW 1-(4-TRIFLOUROMETHYL)PHENYL-2-(1H-IMIDAZOL-1-YL) 
ETHANONE OXIME ESTER COMPOUNDS  ....................................................................................................................................................................354
 1 Bozbey, I., 1 Uslu, H., 1 Karakurt, A.
P-406: RESTRICTED ROTATION AROUND THE METHYLENE BRIDGE OF 5-(2-P-(CHLOROPHENYL)BENZIMIDAZOLE-1-YL)METHYL-4-(O 
SUBSTITUTEDPHENYL)-2,4-DIHYDRO-[1,2,4]-TRIAZOLE-3-THIONES AS EVIDENCED BY NMR, X-RAY AND DFT STUDIES ................................355
1 Karayel, A., 2 Ozbey, S., 3 Kus, C., 3 Ayhan Kilcigil, G.
P-407: SYNTHESIS OF NOVEL N-NAPHTHALENE-2-YL PROPANAMID DERIVATIVES AND EVALUATION THEIR ANTIMICROBIAL ACTIVITY ..................355
1 Evren, AE., 1 Yurttas, L., 2 Yilmaz Cankilic, M.
XXXIII
P-408: DESIGN, SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF TRIAZOLE DERIVATIVES .............................................................................................356
1 Kubilay, A., 1 Evren, EA., 1 Yurttas, L., 2 Kisacik, I., 2 Gencer Karaca, H.
P-409: INDOLE-BASED MELATONINE ANALOGUES AS POTENT INHIBITOR OF ROS ..........................................................................................................357
1 Yilmaz, AD., 2 Coban, T., 1 Suzen, S.
P-410: SYNTHESIS AND CYTOTOXIC ACTIVITIES OF NOVEL CHIRAL SULFONAMIDES AS HYPOXIA INDUCED FACTORS INHIBITORS.......................357
1 Karakucuk Iyidogan, A., 2 Bayram, H., 3 Tasdemir Kahraman, D., 4 Saygideger Kont, Y., 1 Taskin Tok, T., 1 Basaran, E., 3 Ilhan, S., 1 Oruc Emre, EE.
P-411: SYNTHESIS AND BIOLOGICAL EVALUATION OF 3-[(4-SUBSTITUTED-1-YL)PHENYL]-1-ARYL/HETEROARYL-2-PROPEN-  
1-ONE DERIVATIVES ........................................................................................................................................................................................................358
1 Karakucuk Iyidogan, A., 2 Sicak, Y., 1 Kakaj Mohamad, H., 3 Ozturk, M., 1 Oruc Emre, EE.
P-412: IN VITRO ANTI-INFLAMMATORY ACTIVITY OF NOVEL  5-FLUORO AND 5-METHOXY INDOLE-PIPERAZINE DERIVATIVES  .................................359
1 Altuntas, TG., 1 Baydar, A., 2 Yilmaz, S., 2 Coban, T. 
P-413: SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF AMIDE, SULFONAMIDE AND THIOUREA DERIVATIVES BEARING 1,3-OXAZOLIDINONES ......359
1 Karaman, N., 1 Karakucuk Iyidogan, A., 2 Kocyigit Kaymakcioglu, B., 3 Kapkac, HA., 4 Karaca Gencer, H., 5 Ilgin, S., 
5 Karaduman, B., 1 Zainel, RA., 1 
Oruc Emre, EE.
P-414: SYNTHESIS OF SOME NOVEL THIOUREAS DERIVATED FROM 4-METHYLBENZENE-1-SULFONAMIDE................................................................360
1 Karakucuk Iyidogan, A., 2 Kocyigit Kaymakcioglu, B., 1 Demircan, B., 1 Fusseini A., 1 Oruc Emre, EE.
P-415: SYNTHESIS, ANTIOXIDANT ACTIVITY AND ANTICHOLINESTERASE INHIBITORY ACTIVITY OF SOME NEW PYRAZOLE DERIVATIVES ............360
1 Sicak, Y., 2 Kursun Aktar, BS., 3 Emre Oruc, EE.,4 Ozturk, M., 1 Aydogmus Ozturk, F., 5 Demirtas, I., 4 Nademm, S., 4 Ozler, MA., 3 Iyidogan Karakucuk, 
A.
P-416: SYNTHESIS AND BIOLOGICAL ACTIVITIES OF CHIRAL PYRAZOLE DERIVATIVES  ..................................................................................................361
1 Sicak, Y., 2 Kursun Aktar, BS., 3 Emre Oruc, EE., 4 Ozturk, M., 1 Aydogmus Ozturk, F., 5 Demirtas, .I, 4 Nademm, S., 4 Ozler, MA., 3 Iyidogan Karakucuk, 
A.
P-417: DETERMINATION OF FREE RADICAL SCAVENGING CAPACITY OF 4,5-DIHYDRO-1H-PYRAZOLE AND HYDRAZONE DERIVATIVES .................362
1 Evranos Aksoz, B., 2 Yilmaz Sarialtın, S., 2 Coban, T.
P-418: INVESTIGATIONS ON SYNTHESIS AND ANTIOXIDANT ACTIVITY OF SOME PYRAZOLINE DERIVATIVES ..............................................................362
1 Evranos Aksoz, B., 2 Yilmaz Sarialtin, S., 2 Coban, T.
P-419: SYNTHESIS OF NEW BENZOTHIAZOLE-THIADIAZOLE DERIVATIVES AS CHOLINESTERASE AND MONOAMINE OXIDASE INHIBITORS ..........363
1,2 Saglik, BN., 1 Kaya Cavusoglu, B., 1 Kaplancikli, ZA., 1,2 Acar Cevik, U., 1,2 Osmaniye, D., 1,2 Levent, S., 3 Inci, B., 1,2 Ozkay, Y.
P-420: NEUROPROTECTIVE EFFECTS OF SOME PYRAZOLINE DERIVATIVES AGAINST 6-OHDA INDUCED NEURODEGENERATION. ........................364
1 Sever, B., 1 Altintop, MD., 1 Ozdemir, A., 2 Kaya Tilki, E., 2 Dikmen, M. 
P-421: 1,3,4-THIADIAZOLE DERIVATIVES BEARING BENZYLAMINE MOIETY: SYNTHESIS AND MONOAMINE OXIDASE INHIBITORY ACTIVITY 
EVALUATION .....................................................................................................................................................................................................................364
1 Kaya Cavusoglu, B., 1 Kaplancikli, ZA., 1,3 Acar Cevik, U., 1,3 Levent, S., 1,3 Osmaniye, D., 1,3 Ozkay, Y., 2 Karaduman, AB., 1,3 Saglik, BN.
P-422: ANTINEOPLASTIC EVALUATION OF SEVERAL BENZIMIDAZOLE DERIVATIVES .......................................................................................................365
1 Kus, C., 2 Yurtcu, E., 2 Korkmaz, Y. 
P-423: SYNTHESIS AND BIOLOGICAL ACTIVITIES OF 4-(5-CHLORO-6-FLUORO-1H-BENZO[D]IMIDAZOL-2-YL)-N-ISOPROPYLBENZAMIDINE.HCL .....365
1 Kus, C., 2 Altanlar, N., 3 Basaran, R., 3 Can Eke, B.
P-424: INVESTIGATION OF ANTIMICROBIAL PROPERTIES OF SOME BENZOXAZOLE DERIVATIVES ................................................................................366
1 Acar, C., 1 Temiz Arpaci, O., 2 Kaynak Onurdag, F., 2 Okten, S.
P-425: SYNTHESIS OF SOME 6,7-DIMETHOXY QUINAZOLINE DERIVATIVES AS EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE 
KINASE INHIBITORS .........................................................................................................................................................................................................366
Acar, C., Altuntas, TG., Goker, H.
P-426: EVALUATION OF MELATONIN AND NEW SYNTHETIC ANALOGUES AS ANTIOXIDANT AND CYP1 INHIBITOR. ......................................................367
1 Karaaslan, C., 1 aNeuhaus, E., 2 Ince, E., 2 Tascioglu, A., 3 Shirinzadeh, H., 2 Gurer Orhan, H., 1 Suzen, S.
P-427: ANTIOXIDANT PROPERTIES OF CARBAZOLE DERIVATIVES; EVALUATION OF THE ACTIVITY ON AMYLOID Β-INDUCED DAMAGE ..................367
1 Karaaslan, C., 2 Ince, E.,3 Tavakkoli, M.,3 Firuzi, O.,4 Saso, L., 2 Gurer Orhan, H., 1 Suzen, S.
P-428: SYNTHESIS AND STRUCTURAL CHARACTERIZATION OF SOME THIOSEMICARBAZIDES DERIVED FROM INDOMETHACIN ............................368
1,2 Yilmaz, D, 1 Yanik, H, 1 Yilmaz, O, 2 Kucukguzel, SG. 
P-429: SYNTHESIS OF NEW THIAZOLYLHYDRAZINE DERIVATIVES AS MONOAMINOXIDASE INHIBITORS  .....................................................................369
1,2 Osmaniye, D., 1,2 Levent, S., 1,2 Ozkay, Y., 1 Kaplancikli, ZA., 1,2 Saglik, BN., 1 Cavusoglu Kaya, B., 3 Inci, B., 1,2 Acar Cevik, U.
P-430: SYNTHESIS AND CHARACTERIZATION OF NOVEL INDOLE DERIVATIVES................................................................................................................369
Cosar, ED., Demiray S., Ulusoy Guzeldemirci N.
P-431: IN VITRO AND IN SILICO STUDIES OF A SERIES OF 1,3,4-THIADIAZOLES AS ACETYLCHOLINESTERASE INHIBITORS .....................................370
1 Altintop, MD., 1 Sever, B., 1 Ozdemir, A., 1 Zeytun, E., 2 Temel, HE.
P-432: STUDIES ON THE SYNTHESIS OF SOME NEW FLAVONE SULFONAMIDE COMPOUNDS AS ANTICANCER AGENTS AND HDAC6  
INHIBITORS  ......................................................................................................................................................................................................................370
Sari, E., Bozdag Dundar, O.
P-433: SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF NEW ARYL SULFONYL HYDRAZONES ..........................................................................................371
1 Karakucuk Iyidogan, A., 1 Oruc Emre, EE., 1 Koseli, MB., 2 Aygun, A., 2 Sen, F.
XXXIV
P-434: SYNTHESIS AND CHARACTERIZATION OF NOVEL AMIDE DERIVATIVES BEARING MORPHOLINE RING .............................................................372
Oruc Emre, EE., Ece, S., Karakucuk Iyidogan, A.
P-435: SYNTHESIS AND EVALUATION OF NEW PYRAZOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS. .....................................................................372
1 Ozdemir, A., 1 Altintop, MD., 1 Sever, B., 2 Bulbul, EF., 3 Karadag, AE.
P-436: NEW THIAZOLYL-PYRAZOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS. ...........................................................................................................373
1 Ozdemir, A., 1 Altintop, MD., 1 Sever, B., 2 Bulbul, EF., 3 Karadag, AE.
P-437: SYNTHESIS OF SOME NEW BENZOXAZOLES AS HTOPO IIΑ INHIBITORS ................................................................................................................373
1 Karatas, E., 2 Foto, E., 3 Zilifdar, F., 1 Yildiz I.
P-439: DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NICOTINATE DERIVATIVES FOR CANCER THERAPY .................................................374
1 Tok, F., 1 Kocyigit Kaymakcioglu, B., 2 Gunal, S., 2 Ilhan, R., 2 Ballar Kirmizibayrak, P.
P-440: SYNTHESIS OF NOVEL ANTIPYRINE DERIVATIVES AS CHOLINESTERASE INHIBITORS ........................................................................................374
1 Tok, F., 1 Kocyigit Kaymakcioglu, B., 2,3 Saglik, BN., 2,3 Ozkay, Y.
P-441: SYNTHESIS, STRUCTURAL IDENTIFICATION AND ANTICANCER EFFECTS OF NOVEL PHENOTHIAZINES FOR  
HEPATOCELLULAR CANCERS ........................................................................................................................................................................................375
1 Zengin, F., 2,3 Yaman, M., 1 Kisla, MM., 2,3,4 Konu, O., 1 Ates Alagoz, Z. 
P-442: SYNTHESIS, BIOLOGICAL ACTIVITY AND STRUCTURAL CHARACTERIZATION OF BENZYL 4-([1,1’-BIPHENYL]-4-YL)-2-METHYL-5-OXO-
1,4,5,6,7,8-HEXAHYDROQUINOLINE-3-CARBOXYLATE: A NON-MEROHEDRAL TWIN ..............................................................................................376
1 Cetin, G., 1 Simsek, R., 1 Safak, C.,2 Yildirim Ozturk, S., 3 Butcher, RJ., 4 Wikara, J. 
P-443: MOLECULAR DOCKING STUDIES ON DESIGNED BENZOTHIAZOLE DERIVATIVES AS K-RAS(G12C) INHIBITORS  .............................................376
Yenice, G., Yilmaz, S.
P-444: STRUCTURAL ELUCIDATION OF SOME CINICALLY USED KINASE INHIBITORS BY 2D ROESY NMR SPECTRA ...................................................377
1 Karaaslan, C., 2 Goker, H.,
P-445: SYNTHESIS OF CONDENSED 1,4-DIHYDROPYRIDINE DERIVATIVES AND THEIR EFFECTS ON L-/T-TYPE CALCIUM CHANNELS. ...................377
1 Aygun, H., 2 Zhang, FX., 2 Zamponi, GW.,1 Gunduz, MG.
P-446: ANTI-BACTERIAL AND ANTI-FUNGAL PROPERTIES OF INDOLE-HYDRAZONE DERIVATIVES ................................................................................378
1 Shirinzadeh, H., 2 Altanlar, N., 3 Suzen, S
P-447: ANTIOXIDANT PROPERTIES OF NEW MELATONIN ANALOGUES: SYNTHESIS AND IN VITRO BIOLOGICAL ACTIVITY STUDIES .......................379
1 Shirinzadeh, H., 2 Karaaslan, C., 3 Eren, B., 3 Gurer Orhan, H., 2 Suzen, S
P-448: MOLECULAR DOCKING STUDIES, SYNTHESIS AND DETERMINATION OF ACHE/BCHE INHIBITION OF NEW HYDRAZONE DERIVATES .........379
1 Bozbey, I., 1 Uslu, H., 2 Senol, FS.
P-449: IN VITRO ANTICANCER ACTIVITY OF NEW NAPHTHYL ETHANONE OXIME ESTER DERIVATIVES BEARING PYRAZOLE MOIETY ....................380
1 Bozbey, I., 1 Uslu, H., 2 Salva, E., 1 Karakurt, A.
P-450: MODIFICATION OF MALEIC ANHYDRIDE-ALT-ACRYLIC ACID COPOLYMER AS A POTENTIAL ANTICANCER AND ANTIBACTERIAL ACTIVE 
CONJUGATES ...................................................................................................................................................................................................................380
1 Karakus, G., 2 Kaplan Can, H., 3 Sahin Yaglioglu, A.
P-451: SYNTHESIS AND MOLECULAR DOCKING STUDIES OF NOVEL HYDRAZONES BASED ON BENZOXAZOLINE SCAFFOLD AS  
SELECTIVE MAO-B INHIBITORS. ....................................................................................................................................................................................381
1 Tasci, H., 2 Saglik, BN., 2 Ozkay, Y., 1 Tozkoparan, B., 1 Gokhan Kelekci, N.
P-452: SYNTHESIS, CHARACTERIZATION AND PHARMACOLOGICAL STUDIES OF SOME NEW MANNICH BASES DERIVED  
FROM 1,2,4-TRIAZOLES ...................................................................................................................................................................................................382
1 Avci, A., 1 Tasci, H., 1 Gokhan Kelekci, N., 2 Aztopal, N., 2 Ulukaya,E., 1 Tozkoparan, B.
P-453: SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF TRIFLOUROMETHYL ACETOPHENONE OXIME ESTER DERIVATIVES ......................................382
1 Bozbey, I., 2 Kart, D., 1 Karakurt, A. 
P-454: CYTOTOXIC EFFECTS OF NEW TRIFLOUROMETHYL OXIME ESTER COMPOUNDS BEARING IMIDAZOLE MOIETY ON  
NEUROBLASTOMA CELL LINE ........................................................................................................................................................................................383
1 Bozbey, I., 2 Salva, E., 1 Karakurt, A.
P-455: SYNTHESIS OF SOME 1H-BENZIMIDAZOLE COMPOUNDS BEARING BIS-THIOSEMICARBAZIDE AND TRIAZOLE D 
ERIVATIVES AS INHIBITORS OF EGFR TYROSINE KINASE .........................................................................................................................................384
1 Celı̇k, I., 1 Ayhan Kilcigı̇l, G., 2 Guven, B., 2 Kara, Z., 2 Onay Besı̇kcı̇, A.
P-456: SYNTHESIS OF SOME CYCLOHEXYL SUBSTITUTED OXADIAZOLE DERIVATIVES LINKED 1H-BENZIMIDAZOLE  ...............................................384
Celı̇k, I., Ayhan Kilcigı̇l, G.
P-457: SYNTHESIS AND ANTICANCER ACTIVITY OF NEW (S)-NAPROXEN DERIVATIVES AS METHIONINE  
AMINOPEPTIDASE (TYPE II) INHIBITORS ......................................................................................................................................................................385
1,2 Birgul, K., 3 Uba, AI., 4 Bekci, H., 4 Cumaoglu, A., 5 Yilmaz, O., 3 Yelekci, K., 1 Kucukguzel, SG.,
P-458: IN SILICO STUDIES OF SOME 2-AMINO BENZOTHIAZOLE DERIVATIVES AS ALDOSE REDUCTASE ENZYME INHIBITORS ................................386
Bolelli, K., Ertan Bolelli, T., Yalcin, I.
P-459: SYNTHESIS AND EVALUATION OF ANTIOXIDANT ACTIVITY OF MELATONIN ANALOGUE NEW INDOLE DERIVATIVES .......................................386
1 Durgun, K., 1 Karaaslan, C., 2 Ince, E., 2 Gurer Orhan, H., 1 Suzen, S
P-460: SYNTHESIS, IN VITRO AND IN SILICO STUDIES OF A SERIES OF 1,3,4-OXADIAZOLES AS FAK INHIBITORS. ......................................................387
1 Altintop, MD., 1 Sever, B., 1 Ozdemir, A., 2 Akalin Ciftci, G
XXXV
P-461: SYNTHESIS OF SOME NOVEL N-SUBSTITUTED 4-(1H-BENZIMIDAZOL-1-YL)-BENZAMIDE DERIVATIVES ............................................................387
Alp, M.
P-462: STUDIES ON THE SYNTHESIS AND ALDOSE REDUCTASE ENZYME INHIBITION PROPERTIES OF NOVEL THIAZOLE DERIVATIVES  ..............388
1 Ceylan Unlusoy, M., 2 Sarikaya, M., 2 Das Evcimen, N., 1 Bozdag Dundar, O.
P-463: STUDIES ON SOME BENZOTHIAZOLE DERIVATIVES...................................................................................................................................................389
1 Zengin, M., 1 Balkan, A., 1 Tan Unsal, O., 2 Kucukkilinc Tuylu, T., 2 Ayazgok, B.
P-464: STUDIES ON ANTIMICROBIAL PROPERTIES OF SOME BENZIMIDAZOLES  ..............................................................................................................389
1 Erol, M., 2 Temiz Arpaci, O., 2 Goker, H., 3 Kaynak Onurdag, F., and 3 Okten, S.
P-465: SYNTHESIS AND STRUCTURE ELUCIDATION OF SOME NOVEL BENZOXAZOLE DERIVATES ...............................................................................390
1 Erol, M., 2 Temiz Arpaci, O.
P-466: SYNTHESIS AND ANTITUBERCULAR ACTIVITY EVALUATION OF 4-NAPHTHYL-1,4-DIHYDROPYRIDINE DERIVATIVES  .....................................391
1 Gunduz, MG., 2 Krishna, VS., 2 Sriram, D.,3 Weiss, N., 1 Simsek, R., 1 Safak, C.
P-467: SYNTHESIS AND ANTICANCER ACTIVITY OF 4-HYDROXY BENZOIC ACID HYDRAZIDE-HYDRAZONES ...............................................................391
 1 Han, MI., 1 Cagan, B., 2 Dinparvar, S., 2 Allahverdiyev, A., 1 Kucukguzel, SG.
P-468: SYNTHESIS AND SCREENING FOR CYTOTOXIC EFFECTS OF KOJIC ACID DERIVATIVES ON A375 HUMAN MALIGNANT MELANOMA  ...........392
1 Aytemir, MD., 1 Karakaya, G., 2 Ercan, A., 2 Oncul, S. 
P-469: DOCKING STUDIES OF KOJYLMETHYL DICHLOROBENZYL PIPERAZINE AS A TYROSINASE INHIBITOR .............................................................393
1 Aytemir, MD., 2 Demirci, A., 1 Karakaya, G. 
P-470: SYNTHESIS, IN VITRO AND IN SILICO STUDIES OF A SERIES OF DITHIOCARBAMATE DERIVATIVES AS ANTICANDIDAL AGENTS. .................393
Ozdemir, A., Yilmaz, N.,Sever, B., Altintop, MD.
P-471: DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR MODELING STUDIES OF NOVEL 5-ARYLIDENE-4-THIAZOLIDINONES AS 
SELECTIVE COX-2 INHIBITORS ......................................................................................................................................................................................394
1 Kulabas, N., 2 Bingol Ozakpinar, O., 1 Kucukguzel, I.
P-472: SYNTHESIS AND ANTICANCER ACTIVITY OF NEW FLURBIPROFEN THIOETHERS AS METHIONINE AMINOPEPTIDASE (TYPE II) INHIBITORS ....
395
1 Bayer, B., 2 Bekci, H., 3 Uba, AI., 2 Cumaoglu, A., 3 Yelekci K, 4 Yilmaz O., 1 Kucukguzel, SG. 
P-473: ANTIMICROBIAL EVALUATION OF 2-METHYLINDOLE-HYDRAZONE DERIVATIVES ..................................................................................................396
1 Ozturk Ceylan, O., 1 Karaaslan, C., 2 Altanlar, N., 1 Suzen, S.
P-474: ANTIMICROBIAL EVALUATION OF SOME HETEROCYCLIC COMPOUNDS .................................................................................................................396
1 Temiz Arpaci, O., 2 Erol, M., 3 Kaynak Onurdag, F. 3 Okten, S. ..............................................................................................................................................
P-475: SYNTHESIS OF SOME NOVEL AMIDINE DERIVATIVES ................................................................................................................................................397
1 Temiz Arpaci O., 2 Tasci, M., 1 Goker, H.
P-476: NOVEL 2-(PYRROLIDIN-1-YL)THIAZOLE DERIVATIVES AND THEIR ANTI(MYCO)BACTERIAL ACTIVITIES .............................................................397
1 Belveren, S., 1 Poyraz, S., 2 Ulger, M., 1 Dondas, HA.
P-477: COPPER(II) COMPLEXES OF N-BENZOYL-2-(1H-INDOL-2-YL)PYRROLIDINE-1-CARBOTHIOAMIDE AND THEIR BIOLOGICAL EVALUATION .....398
1 Poyraz, S., 1 Belveren, S., 2 Ulger, M., 1 Dondas, HA.
P-478: SYNTHESIS, CHARACTERIZATION AND ANTI(MYCO)BACTERIAL ACTIVITY OF THIOESTER DERIVATIVES BEARING  
BENZAMIDO-2-OXO ALKYL MOIETY ...............................................................................................................................................................................399
1 Belveren, S., 1 Poyraz, S., 2 Ulger, M., 1 Dondas, HA.
P-479: SYNTHESIS AND ANTICANCER ACTIVITY STUDIES OF SOME NOVEL INDOLE RETINOID DERIVATIVES .............................................................399
1 Gurkan Alp, AS., 2 Koc, A., 2 Karabay, AZ., 1 Buyukbingol E. 
P-480: MOLECULAR DOCKING STUDIES OF SOME NOVEL BENZIMIDAZOLE DERIVATIVES AS EGFR INHIBITORS........................................................400
Gurkan Alp, AS., Celik, I., Ayhan Kilcigil, G. 
P-481: IN VIVO ANTICONVULSANT ACTIVITY AND MOLECULAR MODELING STUDIES OF SOME NEW 1-PHENYL-2-(1H-IMIDAZOL-1-YL) 
ETHANONE OXIME ESTERS ...........................................................................................................................................................................................401
1,2 Yurtoglu, S., 1 Sari, S., 1 Sarac, S., 1 Dalkara, S.
P-482: ANTICANCER ACTIVITIES OF NEW SILVER COMPLEXES ON DU-145 HUMAN PROSTATE CANCER CELLS .........................................................401
1 Sahin Bolukbasi, S.,2,3 Sahin, N.,3 Gurbuz, N.,3 Ozdemir, I.,1 Cevik, E.,4 Cummings, BS.
P-483: CYTOTOXIC ACTIVITIES OF NEW NHC COMPOUNDS ON MCF-7 AND MDA-MB-231 HUMAN BREAST CANCER CELLS .....................................402
1 Sahin Bolukbasi, S.,2,3 Sahin, N.,3 Gurbuz, N.,3 Ozdemir, I.,1 Cevik, E.,4 Cummings, BS.
P-484: SYNTHESIS, STRUCTURAL IDENTIFICATION OF NOVEL INDOL-THIAZOLIDINEDIONE DERIVATIVES ...................................................................403
Baran, S., Zengin, F., Ates Alagoz, Z. 
P-485: DESIGN, SYNTHESIS AND MAO ENZYMES INHIBITORY ACTIVITY EVALUATION OF NEW BENZOTHIAZOLE-THIAZOLYLHYDRAZINE 
DERIVATIVES ....................................................................................................................................................................................................................403
 1,2 Levent, S., 1,2 Acar Cevik, U., 1,2 Saglik, BN., 1,2 Ozkay, Y., 1 Kaya Cavusoglu, B., 1 Kaplancikli, ZA., 3 Korkut, B., 1,2 Osmaniye, D. 
P-486: SYNTHESIS, CHARACTERIZATION AND ANTI-BIOFILM ACTIVITY STUDIES ON NOVEL UREA/THIOUREA DERIVATIVES ....................................404
1 Turk, S., 1 Tok, F., 2 Ulusoy, S., 1 Karakus, S., 1 Kocyigit Kaymakcioglu, B., 3 Bosgelmez Tinaz, G.
P-487: SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF NOVEL ETHER-LINKED DERIVATIVES OF ORNIDAZOLE ............................................................404
1 Senkardes, S., 1 Kulabas, N., 2 Kalayci, S., 2 Sahin, F., 1 Kucukguzel, I., 1 Kucukguzel, SG.
XXXVI
P-489: ANTIBACTERIAL SCREENING OF AN IN-HOUSE AZOLE OXIME ESTER LIBRARY ....................................................................................................405
1 Sari, S., 2 Kart D., 3 Karakurt, A.,1 Sarac, S., 1 Dalkara, S.
P-490: SYNTHESIS AND CYTOTOXIC ACTIVITY OF SOME QUINOXALINE DERIVATIVES ....................................................................................................406
1 Soyer , Z., 1 Uysal, S., 1 Tarikogulları, AH.,2 Ilhan, R., 2 Kirmizibayrak, PB.
P-491: DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITY STUDY OF DISUBSTITUTED 1,3,4-OXADIAZOLE DERIVATIVES .............................................406
1 Ozyazici, T., 2 Sahin, F., 1 Koksal, M. 
P-492: DETERMINATION OF RISPERIDONE AND 9-HYDROXYRISPERIDONE IN HUMAN PLASMA BY LC-MS ...................................................................407
1 Altuntas, TG., 2 Demiray Yıldırım, G.
P-493: SYNTHESIS, CHARACTERIZATION AND ANTIFUNGAL EVALUATION OF BENZAZOLE DERIVATIVES .....................................................................408
1,2 Acar Cevik, U., 1,2 Saglik, BN., 1,2 Levent, S., 1,2 Osmaniye, D., 1,2 Ozkay, Y., 1 Kaplancikli, ZA., 3 Korkut, B., 1 Kaya Cavusoglu, B.
P-494: INVESTIGATION OF SOME 3-ARYL AMINE 2-METHLY-SUBSTITUTED 3H-QUINAZOLIN-4-ONES IN VITRO ANTIMICROBIAL EFFECT AND 
CYTOTOXICITY ON HUMAN GINGIVAL FIBROBLASTS .................................................................................................................................................408
1 Demirel, UU., 2 Yilmaz, A., 3 Arslan, U.
P-496: SYNTHESIS OF NOVEL SCHIFF BASE DERIVATIVES AND EVALUATION OF THEIR MONOAMINE OXIDASE INHIBITORY ACTIVITY  ..................409
1 Pirincci, Y., 1 Tok, F., 1 Kocyigit-Kaymakcıoglu, B., 2,3 Levent, S., 2,3 Kaplancikli, ZA.
P-497: SYNTHESIS AND CHARACTERIZATION OF SOME NEW 6-SUBSTITUTED BENZOXAZOLINONEDERIVATIVES .....................................................410
Mulazim, Y. , Kesanli, B.
P-498: SYNTHESIS AND ANTICANCER ACTIVITY POTENTIAL OF BIS(1,3,4-THIADIAZOLE) DERIVATIVES ........................................................................410
1,3 Ozkay, Y., 1,3 Osmaniye, D., 1 Kaya Cavusoglu, B., 1,3 Saglik, BN., 1,3 Levent, S., 1,3 Acar Cevik, U., 2 Atli, O., 1 Kaplancikli, ZA.
P-499: SYNTHESIS OF NEW THIADIAZOLE DERIVATIVES AS ANTICANDIDAL AGENTS.......................................................................................................411
1 Kaplancikli, ZA., 1,2 Ozkay, Y. 1,2 Osmaniye, D., 1 Cavusoglu Kaya, B., 1,2 Acar Cevik, U., 1,2 Saglik, BN., 3 Ilgin, S., 4 Behcet, M., 1,2 Levent, S.
P-500: SYNTHESES AND ANTIMICROBIAL ACTIVITIES OF NOVEL MONOCATIONIC INDOLE-BENZIMIDAZOLE DERIVATIVES .......................................411
1 Ates Alagoz, Z., 2 Yildiz, S., 1 Goker, H. 
P-501: THE RECEPTOR TYROSINE KINASE INHIBITORY ACTIVITIES AND MOLECULAR DOCKING STUDIES OF  
SOME PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES ......................................................................................................................................................412
1 Kilic Kurt, Z., 2 Kurt, EE., 3 Bakar-Ates,F.
P-502: THE ROLE OF GSTM1 AND GSTT1 POLYMORPHISMS IN OBESE PATIENTS ............................................................................................................413
1 Unsal, A., 1 Cihan, M., 1 Bulus, H., 2 Dirican, O., 2 Oguztuzun, S., 3 Ada, AO., 2 Gurbuz, N., 2 Kaygin, P., 3 Iscan, M.
P-503: INVESTIGATION OF GST ISOENZYMES AND APOPTOTOTIC EFFECT IN MCF7 HUMAN BREAST CANCER CELL LINE BEFORE AND AFTER 
DOXORUBICIN TREATMENT ...........................................................................................................................................................................................413
1 Oguztuzun, S., 2 Kocdogan, AK., 3 Simsek, GG., 1 Gurbuz, N., 4 Turk, M., 5 Isgor, Y., 6 Ada, AO., 6 Iscan, M.
P-504: HEALTH RISK ASSESSMENT OF CHILDREN PLAYGROUNDS IN SARAJEVO ............................................................................................................414
1 Sapcanin, A., 1 Smajovic, A., 1 Salihovic, M., 2 Uzunovic, A., 1 Spirtovic Halilovic, S., 3 Pehlic, E., 4 Jancan, G.
P-505: IN VITRO GENOTOXICITY AND CLASTOGENICITY EVALUATION OF CARBON-BASED ENGINEERED NANOPARTICLES (CDS)  ........................415
1 Sukuroglu, AA., 2 Simsek, S., 3 Yetkin, D., 2 Ozbek, B., 3,5,6 Battal, D., 3,4 Genc, R.
P-506: EFFECTS OF PRENATAL BISPHENOL A AND/OR DI(2-ETHYLHEXYL) PHTHALATE EXPOSURE ON TESTICULAR OXIDATIVE STRESS AND 
SPERM PARAMETERS .....................................................................................................................................................................................................416
1 Balci, A., 1,2 Ozkemahli, G., 1 Erkekoglu, P., 3 Zeybek, ND., 3 Yersal, N. 1,4 Kocer Gumusel, B.
P-507: EVALUATION OF CYTOTOXIC AND GENOTOXIC EFFECTS OF BORIC ACID AND ZINC BORATE ON HUMAN SERTOLI CELLS ..........................416
 Ustundag, A., Eroglu, M., Duydu, Y.
P-508: INVESTIGATION OF IRRITATION EFFECTS OF SUNSCREEN FORMULATIONS CONTAINING TIO2 NANOPARTICLES BY USING THE EPIDEM 
SKIN IRRITATION TEST ....................................................................................................................................................................................................417
1 Ulker, OC., 2 Teker, E.,1 Ustundag, A., 3 Sezgin Bayindir, Z., 1 Duydu, Y., 1 Karakaya, A.
P-509: PROTECTIVE EFFECTS OF CHLOROGENIC ACID AND VITAMIN C AGAINST OXIDATIVE STRESS CAUSED BY DIMETHOATE IN HUMAN 
ERYTHROCYTES ..............................................................................................................................................................................................................418
Eken, A., Bakir, E., Okcesiz, A.
P-510: EVALUATION OF CD33 LEVELS IN ALZHEIMER’S DISEASE: A PRELIMINARY STUDY ..............................................................................................418
1 Perk, BO., 2 Ozkan, T., 1 Guven, NM., 2 Sunguroglu, A., 1 Eke, BC.
P-511: GENOTYPING  RS2414096  VARIANT OF CYP19A1 GENE IN TURKISH POPULATION ..............................................................................................419
1 Altun, B., 1 Kadioglu, E., 1 Ipek, C., 2 Doger, E., 2 Bideci, A., 1 Attaran, H., 1 Cok, I.
P-512: TERATOGENICITY AND TESTIS TOXICITY IN OFFSPRING OF PREGNANT RATS EXPOSED LEVETIRACETAM ....................................................419
1 Kaya, C., 2 Cavusoglu, I., 1 Uzun, F., 2 Kadioglu, M., 1 Kerimoglu, G., 1 Yenilmez, E.
P-513: QUANTITATIVE DETERMINATION OF URINARY DOPAMINE BY A HIGHLY SENSITIVE LC-MS/MS ASSAY...............................................................420
1,2 Battal, D., 3 Aktas Sukuroglu, A., 2 Alkas, FB.,4 Unlusayin, I.
P-514: CYTOTOXIC AND GENOTOXİC EFFECTS OF FLURBİPROFEN IN HELA CELLS ........................................................................................................421
1 Bakir, E., 2 Aydin, S., 1 Eken, A., 2 Undeger Bucurgat, U.
P-515: ADSORPTION CHARACTERISTICS OF ISONIAZID ON GRAPHENE OXIDE ................................................................................................................421
1 Caliskan Salihi, E., 1 Kirkulak, S., 2 Wang, J., 2 Siller, L.
XXXVII
P-516: INVESTIGATION OF THE ANTI-GENOTOXIC PROPERTIES OF METHİONİNE-SCHIFF BASE. ..................................................................................422
1 Ozkan Hasanoglu, E., 2 Kizil, HE., 3 Yetim Kurnaz, N., 4 Sakiyan, I., 5 Agar, G., 1 Sari, N.
P-517: MEH3 (TYR113HIS) POLYMORPHISM , RESPONSE TO CHEMOTHERAPY AND SURVIVAL IN NON-SMALL CELL LUNG CANCER PATIENTS ....423
1 Soydas, E., 1 Ada, AO., 2 Gulhan, M., 1 Iscan, M.
P-518: HISTOPATHOLOGICAL BRAIN TISSUE EVALUATIONS AFTER REPETITIVE LOW-DOSE KETAMINE ADMINISTRATIONS IN MICE .......................423
1 Erdinc, M., 1 Kelle, I., 1 Akkoc, H., 1 Uyar, E., 2 Erdinc, L., 3 Nergiz, Y., 3 Seker, U.
P-519: MONITORING OF ADVERSE EFFECTS OF PRESCRIBED DRUGS  IN ERZINCAN PROVINCE .................................................................................424
1 Polat, EC., 2 Nemutlu, N., 3 Sarikaya, B., 4,5 Gumusel, B., 6,7 Kocer Gumusel, B.
P-520: INVESTIGATION OF CYP1B1 (CYP1B1*2 M1AND M2) GENE POLYMORPHISMS IN A TURKISH POPULATION .......................................................425
Kargin Solmaz, FO., Ada, AO.
P-521: INVESTIGATION OF POLYMER COATED GOLD NANOPARTICLES INDUCED LIPID PEROXIDATION AND PROTEIN OXIDATION ON HEPG2 
CELLS ................................................................................................................................................................................................................................425
1,2 Sen, TG., 3,4 Ozkemahli, G., 2 Shahbazi, R., 3 Erkekoglu, P., 2,5 Ulubayram, K., 2,3,6 Kocer Gumusel, B.
P-522: A STUDY ABOUT ANTI-PROLIFERATIVE EFFECT OF A4B3 ON HUMAN LUNG CANCER CELLS (A549) ..................................................................426
1 Aydin, H., 2 Yumrutas, O., 3 Lolak, N., 3 Akocak, S.
P-523: ASSESMENT OF OXIDATIVE DNA DAMAGE IN CERAMIC WORKERS.........................................................................................................................427
 1 Anlar, HG., 2 Bacanli, M., 3 Iritas, S., 4 Tutkun, E., 5 Yilmaz, OH., 1 Basaran, N.
P-524: THE RELATIONSHIP BETWEEN CYTOKINE GENE POLYMORPHISMS AND TYPE 2 DIABETES IN A GROUP OF TURKISH POPULATION. .........427
1 Ates, I, 2 Guvenc, A., 3 Altuner, D.,1 Karakaya, A. 
P-525: ASSESSMENT OF URINARY 8-HYDROXYL-2′-DEOXYGUANOSINE (8-OHDG) AND 1-HYDROXYPYRENE LEVELS AS BIOMARKERS OF 
EXPOSURE TO PAHS IN ELECTRONIC CIGARETTE (E-CIGARETTE) USERS ............................................................................................................428
1 Cok, I., 2 Koc Morgil, G., 1 Ali, AA.,1 Ulutas, OK.,3 Yilmaz, O., 1 Aysal, IA.
P-526: THE ANTIOXIDANT AND CYTOTOXIC ACTIVITIES OF TWO THYMUS SPECIES ESSENTIAL OIL .............................................................................429
1 Yaris, E., 2 Yigitkan, S., 3 Yener, I., 4 Alkan, H., 5 Firat, M., 3 Varhan Oral, E., 6 Yolcu, M., 6 Senturk, K., 7 Irtegun Kandemir, S., 1 Ertas, A.
P-527: THE CYTOTOXIC EFFECTS OF ESSENTIAL OILS OF FIVE SALVIA SPECIES ON THREE CELL LINES....................................................................429
1 Yaris, E., 2 Yigitkan, S., 3 Firat, M., 4 Irtegun Kandemir, S., 5 Yener, I., 6 Alkan, H., 7 Senturk, K., 1 Ertas, A., 8 Kolak, U.
P-528: NOVEL LIGANDS FOR CANNABINOID RECEPTOR AND IN VITRO INVESTIGATION ON THEIR ANTIPROLIFERATIVE EFFECTS ON BRAIN 
TUMOR CELL LINE  ..........................................................................................................................................................................................................430
1 Kuzu, B.,2 Taspinar, M., 1 Menges, N. 
P-529: CYTOTOXIC EFFECTS OF BARIUM SULFATE (BASO4) NANOPARTICLES IN A549 CELLS .......................................................................................430
1 Bacanli, M., 2 Schumann, B., 2 Glahn, F.,2 Thomas, S., 2 Foth, H., 1 Basaran, N.
P-530: INTERACTIONS OF CURCUMIN WITH CISPLATIN ON V79 CELL VIABILITY ...............................................................................................................431
1 Becit, M., 1 Aydin, S., 2 Basaran, AA., 1 Basaran, N.
P-531: THE POSSSIBLE ASSOCIATION BETWEEN BRAIN-DERIVED NEUROTROPHIC FACTOR GENETIC POLYMORPHISM VAL66MET AND 
SUSCEPTIBILITY TO BIPOLAR DISORDERS  .................................................................................................................................................................431
1 Demirbugen, M., 2 Hosgoren, Y., 3 Duman, B., 3 Baskak, B., 3 Devrimci Ozguven, H., 1 Suzen, HS.
P-532: DETERMINATION OF REGIONAL DIFFERENCES IN THE ADVERSE DRUG REACTIONS OBSERVED IN ANKARA PROVINCE  ............................432
1,2 Nemutlu, N., 2,3 Kocer Gumusel, B.
P-533: EVALUATION OF OXYDATIVE LIPID AND CHOLESTEROL DAMAGES IN SILICOSIS..................................................................................................433
1 Aksu, N., 2 Samadi, A., 2 Lay, I., 1 Nadir Ozis, T., 1 Sabuncuoglu, S.
P-534: BENEFICIAL EFFECTS OF Β-GLUCAN AGAINST CISPLATIN SIDE EFFECTS ON THE KIDNEY TISSUE. .................................................................433
1 Taslidere, A., 2 Ciftci,O., 3 Turkmen, NB., 4 Kaya,K., 1 Gul, CC.
P-535: BENEFICIAL EFFECTS OF DIOSPHORUS LOTUS AGAINST CISPLATIN SIDE EFFECTS ON THE HEARTH TISSUE ..............................................434
1 Ciftci, O., 2 Turkmen, NB., 3 Taslidere, A., 3 Gul, CC.
P-536: EVALUATION OF GENOTOXIC EFFECTS IN ORAL MUCOSAL CELLS UNDERGOING NICKEL-TITANIUM ORTHODONTIC  
ARCHWIRES THERAPY....................................................................................................................................................................................................434
1 Cetinkaya, S., 1 Erdem, O., 2 Kaplan, M., 3 Cirak, E., 4 Gokce, S., 3 Akay, C.
P-537: INVESTIGATION OF TRACE ELEMENT LEVELS IN PATIENTS WITH FANCONI APLASTIC ANEMIA  .........................................................................435
1 Erdem, O., 1 Cetinkaya, S., 2 Cirak, E., 3 Bayhan, T., 3 Unal, S., 3 Gumruk, F., 4 Eker, I.
P-538: PRELIMINARY SCREENING OF METHANOL EXTRACTS OF VIOLA SP. FOR ANTI-TYROSINASE ACTIVITY ...........................................................435
2 Ozbay, O., 1 Yilmaz Sarialtin, S., 2 Koroglu, A., 1 Coban, T.
P-539: SYNTHESIS AND ANTIOXIDANT ACTIVITY OF SOME PYRAZOLINE DERIVATIVES ...................................................................................................436
1 Evranos Aksoz, B., 2 Yilmaz Sarialtin, S., 2 Coban, T.
P-540: INVESTIGATION OF DNA-DAMAGING EFFECT OF C. CASSIA CHLOROFORM EXTRACT IN HL-60 CELLS ............................................................437
Sozer Karadagli, S., Agrap, B., Lermioglu Erciyas, F.
P-541: EFFECT OF METFORMIN ON THE OXIDATIVE DNA DAMAGE IN HUMAN LIVER CANCER CELLS ..........................................................................437
Cal, T., Sariaydin, T., Aydin, S., Undeger Bucurgat, U.
P-542: EXPRESSIONS OF GST AND P53 IN HUMAN OVER TUMOR AND NON-TUMOR TISSUES .......................................................................................438
1 Kaygin, P., 2 Erdem, A., 2 Simsek, GG.,1 Oguztuzun, S., 3 Coban,T., 1 Barmaksiz, G.,1 Hayat, B., 4 Kocdogan, AK., 5 Kilic, M., 1 Dirican, O.
XXXVIII
P-543: MITOCHONDRIAL GST KAPPA1 ISOENZYME PROTEIN EXPRESSION IN BLADDER CANCER ................................................................................438
1 Oguztuzun, S., 1 Kaygin, P., 2 Simsek, GG., 3 Kocdogan, AK., 4 Kilic, M., 5 Bulus, H., 6 Coban, T., 1 Dirican, O.
P-544: IS THERE A NEGATIVE ASSOCIATION BETWEEN BORON EXPOSURE AND BIRTH WEIGHT OF NEWBORNS? ....................................................439
1 Duydu, Y., 2 Basaran, N., 1 Ustundag, A., 2 Aydin, A., 3 Yalcin, CO., 2 Anlar, HG., 2 Bacanli, M., 4 Aydos, K., 4 Atabekoglu, CS., 5 Golka, K., 6 Ickstadt, K., 7 
Schwerdtle, T., 7 Werner, M., 6 Meyer, S., 5 Bolt, HM.
P-545: Y:X SPERM RATIO IN MALE WORKERS EMPLOYED IN BORIC ACID PRODUCTION PLANT ....................................................................................440
1 Yalcin, CO., 2 Ustundag, A., 2 Duydu, Y.
P-546: MORPHINE DETECTION BY SURFACE ENHANCED RAMAN SPECTROSCOPY ........................................................................................................440
1 Akcan, R., 1 Yildirim, MS., 2 Ilhan, H., 3 Tamer, U., 3 Saglam, N.
P-547: PHYSICAL COMPATIBILITY OF LOOP DIURETICS IN TOTAL PARENTERAL NUTRITION IN Y-SITE ADMINISTRATION ...........................................441
Tomczak SZ., Stawny M., Dettlaff K., Jelińska A.
P-548: THE INFLUENCE OF TPN MIXTURES COMPOSITION ON AMPICILLIN STABILITY .....................................................................................................441





12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 3
PL-1: QUICK, EASY, CHEAP, EFFECTIVE, 
RUGGED, AND SAFE “QUECHERS” 
SAMPLE PREPARATION APPROACH FOR 
RESIDUE ANALYSIS USING TRADITIONAL 
DETECTORS IN CHROMATOGRAPHY
EL-ATY, A.
Department of Veterinary Pharmacology and 
Toxicology, College of Veterinary Medicine, Konkuk 
University, Seoul, Republic of Korea
Department of Pharmacology, Faculty of Veterinary 
Medicine, Cairo University, Giza, Egypt
In residue analysis, relatively low-sensitivity traditional 
detectors, such as UV, diode array, electron-capture, 
flame photometric, and nitrogen-phosphorus 
detectors, have been used following classical sample 
preparation (liquid-liquid extraction and open glass 
column cleanup); however, the extraction method 
is laborious, time-consuming, and requires large 
volumes of toxic organic solvents. A quick, easy, cheap, 
effective, rugged, and safe method was introduced 
in 2003 and coupled with selective and sensitive 
mass detectors to overcome the aforementioned 
drawbacks. Compared to traditional detectors, mass 
spectrometers are still far more expensive and not 
available in most modestly equipped laboratories, 
owing to maintenance and cost-related issues. Even 
available, traditional detectors are still being used for 
analysis of residues in agricultural commodities. It is 
widely known that the quick, easy, cheap, effective, 
rugged, and safe method is incompatible with 
conventional detectors owing to matrix complexity and 
low sensitivity. Therefore, modifications using column/
cartridge-based solid-phase extraction instead of 
dispersive solid-phase extraction for cleanup have 
been applied in most cases to compensate and 
enable the adaptation of the extraction method to 
conventional detectors. In gas chromatography, the 
matrix enhancement effect of some analytes has 
been observed, which lowers the limit of detection 
and, therefore, enables gas chromatography to be 
compatible with the quick, easy, cheap, effective, 
rugged, and safe extraction method. For liquid 
chromatography with a UV detector, a combination 
of column/cartridge-based solid-phase extraction and 
dispersive solid-phase extraction was found to reduce 
the matrix interference and increase the sensitivity. A 
suitable double-layer column/cartridge-based solid-
phase extraction might be the perfect solution, instead 
of a time-consuming combination of column/cartridge-
based solid-phase extraction and dispersive solid-
phase extraction. Therefore, replacing dispersive 
solid-phase extraction with column/cartridge-based 
solid-phase extraction in the cleanup step can 
make the quick, easy, cheap, effective, rugged, and 
safe extraction method compatible with traditional 
detectors for more sensitive, effective, and green 
analysis.
PL-2: COULD STRESSED PLANTS HEAL 
STRESSED MANKIND? ROLE OF PLANT 
STRESS IN BIOACTIVE NATURAL PRODUCT 
BIOSYNTHESIS
1,2 Matkowski, A., 1 Zielińska, S., 3 Libik-Konieczny,M., 
4 Konieczny, R., 1 Kozłowska, W., 2 Jaśpińska,J., 2,5 
Pawlikowska, A., 1,6 Ślusarczyk, S.
1Dept. Pharmaceutical Biology and Botany, Medical 
University in Wroclaw, Poland;
2Botanical Garden of Medicinal Plants, Wroclaw 
Medical  University, Poland;
3Dept. Stress Biology, Institute of Plant Physiology, 
Polish Academy of Science, Krakow, Poland;
4Dept. Plant Cytology and Embryology, Jagiellonian 
University, Krakow, Poland;
5Dept. Horticulture, Wroclaw University of Life 
Sciences, Poland
6Dept. Biochemistry and Crop Quality, IUNG-Institute 
of Plant Cultivation and Soil Science, Pulawy, 
Poland.
An imbalance between the reactive oxygen species 
(ROS) production and antioxidant defense leads to 
oxidative stress in a plant organism. The paradox 
of aerobic life is that organisms cannot exist without 
oxygen though oxygen is dangerous to their existence. 
Oxygen serves as a terminal electron acceptor during 
cellular respiration, which provides a high yield 
of energy. In green plants, oxygen and oxidating 
molecules are generated during photosynthesis. 
One of the most important evolutionary achievement 
of higher eukaryotic aerobic organisms is that they 
can cope with “double-edge sword” – the oxygen 
molecule.  All aerobic organisms are equipped with 
a redox regulation system (antioxidant system) that 
can keep ROS level at the physiological concentration 
required for normal cellular functions. ROS have 
dual role that depend upon their concentration in 
the cell. Thus, the role of antioxidant systems is not 
to remove oxidants entirely, but of keeping them at 
an optimum level. ROS can serve as intra-, and 
intercellular messengers in physiological processes 
such as the activation of cell signaling cascades, 
gene expression or apoptosis. The accumulation 
of ROS in response to biotic and abiotic stress can 
cause the metabolic changes and physiological 
damage of plant cell despite the activity of efficient 
antioxidant systems. Plant organisms being devoid 
of motility and immune system have elaborated 
strategies resting on synthesis of variety of secondary 
metabolites playing important function in defense 
against oxidative stress. Plant-derived antioxidant 
compounds may be able to bolster significantly 
biological resistance against oxidants in animal cells. 
In the last decades, secondary metabolites became 
a subject of increasing interest relevant to their 
significant practical implication for medicinal, nutritive 
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and cosmetic purposes. The entire category of herbal 
adaptogens is considered as essential to improving 
the quality of life in the hectic modern societies. 
Plant antioxidants, such as flavonoids, carotenoids, 
tocopherols, betalains, resveratrol, rosmarinic acid, 
and other are involved in a set of reactions to protect 
cell functions. For instance, chelation of transition 
metals by flavonoids that interferes with the generation 
of reactive oxygen species (ROS), thus contributing to 
a powerful antioxidant/antiradical performance. The 
presence of conjugated double bonds (delocalized 
π-electrons) in flavonoids (including anthocyanins), 
hydroxycinnamic acids and xanthophylls predispose 
them to photoprotective function. 
In our research program, we employ various 
experimental systems, reaching from conventional 
field cultivation, through hydroponics and in vitro 
cell, tissue and organ culture of medicinal plants. We 
use several non-model species of Asian origin and 
their European relatives. The metabolic profiles of 
plants or in vitro cultures challenged by stress factors 
are monitored by targeted metabolomic approach 
using hyphenated chromatography-spectroscopy 
techniques as well as qNMR followed by multivariate 
statistics. In conclusion, results of many advanced 
experiments on the oxidative stress responses in 
plants support the hypothesis that the trade-off 
between growth and defense in plant cells exist, 
and that it is mediated by the resources availability. 
In that way, plant important antioxidants production 
is orchestrated by the regulation mechanisms of 
plant response to environmental conditions. These 
mechanism can be exploited by humans in form of 
improving medicinal properties of herbs, especially 
those that are known as adaptogens. 
PL-3: CLINICAL COMMUNICATION 
SKILLS: DOES IT REALLY MATTER IN 
PHARMACY PRACTICE
Cavaco, A.M.
Pharmacy practice encompasses a number of 
professional activities, usually associated with 
medicines usage by patients. These pharmacists’ 
duties comprise the optimization of the clinical 
effectiveness and safety of medicines taken by 
patients. To be able to manage pharmacotherapy and 
evaluate its success with each patient, pharmacists 
need to collect and provide information. The 
individual patient is the main source of information, 
both objective and subjective. However, patients are 
more than data providers. Human nature is complex, 
suggesting the use of proper clinical interviewing 
skills. Although widely recognized as a key element 
in healthcare, clinical communication skills are usually 
less covered in pharmacy education and research. 
This presentation aims to address and debate 
how communication skills are essential to take full 
advantage of the existing pharmaceutical knowledge 
i.e. to achieve the aim of translating science into 
pharmacy practice, and care for persons with health 
conditions. 
PL-4: MICRONUTRIENT PROFILING 
IN FOOD AND BIOLOGICAL SAMPLES: 
STRATEGIES FOR TARGETED AND 
UNTARGETED ANALYSIS OF VITAMINS AND 
CAROTENOIDS.
Gentili, A., Tomai, P., Dal Bosco, C.,Curini, R.
La Sapienza University, Department of Chemistry, 
Rome, Italy.
Elucidation of natural distribution of vitamins and 
carotenoids is a challenging and quite non-trivial 
analytical task. The difficulties in large scale profiling 
of fat-soluble micronutrients as well as in speciation of 
homologues belonging to the same vitamin group are 
numerous and occur at different levels of the analytical 
procedure. They can arise from the commercial 
unavailability and/or cost of authentic standards, 
large number of forms, definition of common analysis 
conditions, chemical instability, creation of artefacts 
and occurrence of isomers. Our research team has 
a ten-year experience in this field and has developed 
effective approaches to solve the above-mentioned 
difficulties [1-5]. Extraction procedures have been 
developed to preserve vitamins in their natural forms 
and to easily discriminate between free and esterified 
forms. Non-aqueous reversed phase conditions 
have been studied to be compatible with APCI-MS 
detection and to obtain an effective chromatographic 
resolution. UV/Vis-MS parameters have been 
individuated to quickly distinguish structural isomers 
and related families of geometrical isomers. Aim 
of this communication is: i) to shortly review the 
importance of vitamins for human health, ii) illustrate 
the potential of liquid chromatography- diode array 
detector/quadrupole linear ion trap hyphenation for 
the targeted and untargeted analysis of vitamins and 
carotenoids in food and biological samples and iii) 
report some examples of practical applications.
REFERENCES:
1.  Gentili A. et alt. (2008). Rapid Communications in 
Mass Spectrometry, 22:2029-2043.
2.  Gentili A., Caretti, F. (2011). Journal of 
Chromatography A, 1218:684-697.
3.  Gentili A. et alt. (2012). Journal of Agricultural and 
Food Chemistry, 61:1628-1639.
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and Food Chemistry, 63:7428-7439.
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PL-5: APPLICATION OF TEXT MINING 
APPROACHES TO DRUG DISCOVERY
Tropsha, A.
K.H. Lee Distinguished Professor
Associate Dean for Pharmacoinformatics and Data 
Science
UNC Eshelman School of Pharmacy
UNC Chapel Hill
UNC Chapel Hill, NC 27599, USA
Text mining approaches find growing application in 
disciplines as diverse as health care analytics and 
politics. I will discuss applications of text mining to 
areas of interest to drug discovery including prediction 
of drug side effects, drug repurposing, and establishing 
clinical outcomes pathways for therapeutic effects of 
drugs. I will discuss the use of diverse sources of 
knowledge to enable the above applications such as 
social media and biomedical literature. Finally, I will 
discuss the unique application of text mining concepts 
combined with artificial intelligence approaches to the 
difficult task of designing new chemical libraries with 
the desired properties. In this proof-of-concept study, 
we have employed an integrative strategy to design 
chemical libraries biased toward compounds with 
either maximal, minimal, or specific ranges of physical 
properties, such as melting point and hydrophobicity, 
as well as to develop novel putative inhibitors of JAK2. 
The approach that I will discuss can find general use 
for generating targeted chemical libraries optimized 
for a single desired property or multiple properties.
REFERENCES
1.  Tropsha, A. Uncommon Data Sources for 
QSAR Modeling. In: Applied Chemoinformatics: 
Achievements and Future Opportunities. T. Engel 
and J. Gasteiger, Eds., 2018, Wiley-VCH Verlag 
GmbH & Co (in press).
2.  Baker NC, Ekins S, Williams AJ, Tropsha A. A 
bibliometric review of drug repurposing. Drug 
Discov Today, 2018, pii: S1359-6446(17)30287-
8. doi: 10.1016/j.drudis.2018.01.018
3.  Popova, M., Isayev, O., and Tropsha, A. Deep 
Reinforcement Learning for De-Novo Drug 
Design, 2017, https://arxiv.org/abs/1711.10907
4.  Miftahutdinov, Z., Tutubalina, E., Tropsha, A. 
Identifying disease-related expressions in reviews 
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PL-6: WHEN EXCIPIENTS BECOME 
THE ACTIVE – NEW DRUG DELIVERY 
STRATEGIES IN CANCER AND ANTI-
INFLAMMATORY THERAPY
Lamprecht, A.
University of Bonn, Department of Pharmaceutics, 
Bonn, Germany
Pharmaceutical excipients possess a great variety of 
physicochemical functions in dosage forms, mainly 
based on the prerequisite to be inert against other 
formulation components as well as being inactive 
from pharmacologic point of view. However, in recent 
years more and more studies appear in the literature 
highlighting certain therapeutic benefits from such 
“inert” excipients. This presentation will focus on the 
use of several examples where a clear therapeutic 
effect is btained from the sole excipient.
Chitosan, with initial intention to formulate a 
bioadhesive dosage form for a better therapy of 
inflammatory bowel disease showed signifcant anti-
inflammatory effects itself (1). Similarly, other natural 
polymers showed an anti-inflammatory effect without 
the need of the additional use of an anti-inflammatory 
drug (2). 
Another aspect is the pharmacological activity of 
excipients providing inhibitory effects on multidrug 
resistance phenomena in cancer therapy. The use of 
certain amphiphilic components in a drug formulation 
help to increase the intracellular level of cytotoxic 
drugs, turning into a more efficient therapy (3). 
Finally, a very recent discovery is the use of approved 
pharmaceutical excipients for efficient cancer 
immune therapy (4). Cargo-free nanoparticles allow 
to reactivate the immune system against a xenograft 
tumor in mice leading to full remission in about 25% 
of the case and also providing a memory effect which 
potentially is beneficial to prevent recurrencies. 
REFERENCES:
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Y, Lamprecht A. (2012) Eur J Pharm Biopharm., 
81:379-85.
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4.  Shetab Boushehri MA, Stein V, Lamprecht A. 
(2018) Biomaterials, 166:1-12. 
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PL-7: DIAGNOSTICS USING PAPER-
BASED PLATFORMS 
Merkoci, A.
Catalan Institute of Nanoscience and 
Nanotechnology (ICN2), CSIC and The Barcelona 
Institute of Science and Technology, Campus UAB, 
Bellaterra, 08193 Barcelona, Spain.
ICREA - Institucio Catalana de Recerca i Estudis 
Avançats, 08010 Barcelona, Spain.
Biosensors field is progressing rapidly and the 
demand for cost efficient platforms is the key factor 
for their success. Physical, chemical and mechanical 
properties of cellulose in both micro and nanofiber-
based networks combined with their abundance in 
nature or easy to prepare and control procedures are 
making these materials of great interest while looking 
for cost-efficient and green alternatives for device 
production technologies. Both paper and nanopaper-
based biosensors are emerging as a new class of 
devices with the objective to fulfil the “World Health 
Organization” requisites to be ASSURED: affordable, 
sensitive, specific, user-friendly, rapid and robust, 
equipment free and deliverable to end-users. How to 
design simple paper-based biosensor architectures? 
How to tune their analytical performance upon 
demand? How one can ‘marriage’ nanomaterials such 
as metallic nanoparticles, quantum dots and even 
graphene with paper and what is the benefit?  How 
we can make these devices more robust, sensitive 
and with multiplexing capabilities? Can we bring 
these low cost and efficient devices to places with low 
resources, extreme conditions or even at our homes? 
Which are the perspectives to link these simple 
platforms and detection technologies with mobile 
phone communication? I will try to give responses 
to these questions through various interesting 
applications related to protein, DNA and even 
contaminants detection all of extreme importance for 
diagnostics, environment control, safety and security. 
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PL-8: PEARLS AND PITFALLS OF 
CLINICAL PHARMACY IN TURKEY
Bayraktar-Ekincioglu, A
Hacettepe University, Faculty of Pharmacy, 
Department of Clinical Pharmacy, Ankara-Turkey
Clinical pharmacy has received increasing attention 
of healthcare professionals in the view of pharmacy 
practice over 15 years in Turkey. As a health science 
discipline, clinical pharmacy aims to optimise drug 
therapy, promotes health and prevents diseases where 
a patient is the focus of provision of pharmaceutical 
care. Pharmaceutical care is defined as ‘responsible 
provision of drug therapy for the purpose of achieving 
definite outcomes that improve a patient’s quality of 
life’. Clinical pharmacists are responsible of provision 
of pharmaceutical care in collaboration with other 
healthcare professionals.
Since the pharmacy has gone through many changes 
as a profession, the practice of pharmacy evolved 
according to the needs and regulations of the 
countries. In Turkey, the concept has been introduced 
into the pharmacy area at the end of 1990s and it 
became well-known and accepted by the 2000s. 
Although there has been debates about the terms 
‘clinical pharmacy / pharmacist’, ‘hospital pharmacist’ 
and ‘clinical pharmacology’ at the beginning, the 
concept is well-understood and appreciated amongst 
pharmacists as well as other healthcare professionals 
by now. A widespread implementation of clinical 
pharmacy is expanded by the active involvement 
of postgraduate pharmacy students and the 
establishment of the Residency Programme in Clinical 
Pharmacy in 2016 and the National Residency Exam 
in 2017. 
According to the statistics of the Ministry of Health, 
there are about 35.000 pharmacists in Turkey, of 
those 90% work in the community and approximately 
6% employed in the hospitals. In regards to increasing 
number of graduated pharmacists from the faculties 
each year and regulations on limitations in the number 
of pharmacies per population, new areas for practice 
of pharmacy have been discussed and specialization 
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in clinical pharmacy appeared as solution for the 
profession’s obstacle.
Although the concept of clinical pharmacy, implications 
in practice and its outcomes in healthcare services 
are having great attention of pharmacists as well as 
legislative authorities in Turkey; clinical pharmacist’s 
authority, responsibilities and professional statutory 
rights should be clearly defined and qualified 
specialized pharmacists should be designated in 
relevant institutions according to the requirements of 
healthcare system. 
Furthermore, there is still a need for many research 
studies at national level that focus on the impact 
of clinical pharmacy on health-related outcomes. 
The outcomes related with patient and disease 
management, drug usage and utilization of healthcare 
services should be manifested precisely and the 
results shared with other healthcare professionals 
and legislative authorities. 
PL-9: RECENT DEVELOPMENTS IN 
ENANTIOSEPARATION OF CHIRAL DRUGS 
BY USING CAPILLARY ELECTROPHORESIS
Chankvetadze, B.
Institute of Physical and Analytical Chemistry, 
School of Exact and Natural Sciences, Tbilisi State 
University, Chavchavadze Ave 3, Tbilisi 0179, 
Georgia.
INTRODUCTION:
Capillary electrophoresis (CE) is very useful technique 
for analytical scale separation of enantiomers. It is 
clear that even only at the expense of higher peak 
efficiency CE may allow to observe enantioseparation 
for certain chiral analyte-selector pairs where the 
separation power of HPLC is insufficient for achieving 
this goal. In addition, chiral CE offers almost unlimited 
possibility from the viewpoint of adjustment of 
separation factor. Together with aforementioned 
conceptual advantages CE offers some favorable 
technical characteristics for achieving high separation 
selectivity. Chiral CE is a powerful technique not 
only for separation of enantiomers but also for 
understanding fine mechanisms of enantioselective 
selector-selectand interactions. However, in order to 
achieve this goal CE must be used in combination 
with other instrumental (for instance, nuclear magnetic 
resonance spectroscopy) and calculation (molecular 
modeling, molecular mechanics) techniques.
MATERIALS AND METHODS:
The results included in this presentation were obtained 
by using CE, various methods of nuclear magnetic 
resonance (NMR) spectroscopy and molecular 
modeling/molecular mechanics (MM) calculations.
RESULTS:
Our recent results on separation mechanisms of some 
chiral drugs, such as enilconazole, clenpenterol and 
terbutaline will be used in order to illustrate the power 
of the combination of CE, NMR spectroscopy and MM 
calculations for better understanding of noncovalent 
intermolecular interactions between chiral drugs and 
cyclodextrins [1, 2].
CONCLUSIONS:
This presentation illustrates the power of the 
combined use of CE, nuclear magnetic resonance 
spectroscopy and molecular modeling calculations for 
separation of enantiomers of chiral drugs, as well as 
for understanding of chiral recognition mechanisms of 
cyclodextrins. 
ACKNOWLEDGEMENTS:
This project was supported financially in part by the 
Rustaveli National Science Foundation (RNSF) of 
Georgia (Project No. 217642).
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PL-10: DEVELOPMENT OF NOVEL 
TARGETED THERAPIES FOR BREAST 
CANCERS
Ozpolat, B
Currently breast cancer is most commonly diagnosed 
cancer in women. Triple negative breast cancer 
(TNBC)  is the most aggressive subtype of breast 
cancer and associated with poor patient survival and 
high mortality rates.  Due to highly heterogeneous 
genetic feature  of the diseases has prevented 
identification of therapeutic targets  and development 
of targeted therapies for TNBC . We recently 
discovered that eEF-2 Kinase (eEF2K) is highly 
overexpressed in TNBC patients and its expression is 
associated with significantly shooter patient survival. 
Using in vitro and in vivo tumor models in mice, we 
demonstrated that eEF2K promotes cell proliferation, 
invasion,  metastasis and tumorigenesis. We also 
developed siRNA, microRNA-based  therapeutics and 
demonstrated for the first time that in vivo  targeting 
of this previously untargeted kinase by systemic 
administration inhibits tumor growth  in several 
preclinical TNBC tumor xenograft models. The talk 
will also give background in targeted therapies used 
in cancer patients and   our novel targeted therapies.
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PL-11: NOVEL PROSPECTIVES FOR 
ORGANOSELENIUM COMPOUNDS IN 
MEDICINAL CHEMISTRY.
Santi C.
Group of Catalysis and Organic Green Chemistry 
Department of Pharmaceutical Sciences University 
of Perugia
INTRODUCTION:
The biological activity of organoselenium compounds 
is an attractive topic of research after a long period in 
which the perception about selenium toxicity strongly 
limited this of investigations. With the only exception 
of ebselen, that is the most pharmacologically 
studied seleniumcontaining compound, several other 
classes of derivatives were studied in the past almost 
exclusively as antioxidant and glutathione peroxidase 
(GPx)-mimicking agents.
RESULTS:
In this context we gave our contribution with the 
development of a number of selenium derivatives 
that have been tested, looking beyond the classical 
concept of antioxidant agents, for their ability to act 
as antiretrovirals targeting the key HIV protein NCp7 
(1), as inhibitors of biofilm formation (2) as hormetic 
agents activated by mild stressors (3) or as selective 
enzymatic inhibitors (4). In addition, we developed a 
simple and versatile procedure for a quick conversion 
of diselenides into bensoisoselenazolones and non-
conventional selenium derivatives were prepared and 
tested as mimetic of selenoenzymes, in particular 
glutathione peroxidase and deiodinases. Novel 
results obtained in the elucidation of the development 
of small molecules forr the the activation od tyroid 
hormones will be presented.
ACKNOWLEDGEMENTS:
These studies were performed under the umbrella 
of the international scinetific network SeSRedCat 
(Selnium sullfur and Redox Catalysts)
REFERENCES:
1.  Sancineto L, Mariotti A, Bagnoli L, Marini F, 
Desantis J, Iraci N, Santi C, Pannecouque 
C, Tabarrini O. Design and Synthesis of 
DiselenoBisBenzamides (DISeBAs) as 
Nucleocapsid Protein 7 (NCp7) Inhibitors with 
anti-HIV Activity. Journal of medicinal chemistry 
2015; 58(24): 9601-9614.
2.  Sancineto, L., Piccioni, M., De Marco, S., 
Pagiotti, R., Nascimento, V., Braga, A.L., Santi, 
C., Pietrella, D. Diphenyl diselenide derivatives 
inhibit microbial biofilm formation involved in 
wound infection (2016) BMC Microbiology, 16 (1), 
art. no. 220.
3.  Bartolini D, Commodi J, Piroddi M, Incipini 
L, Sancineto L, Santi C, Galli F. Glutathione 
Stransferase pi expression regulates the Nrf2-
dependent response to hormetic diselenides. 
Free radical biology & medicine 2015; 88(Pt B): 
466-480.
4.  Bartolini, D., Piroddi, M., Tidei, C., Giovagnoli, S., 
Pietrella, D., Manevich, Y., Tew, K.D., Giustarini, 
D., Rossi, R., Townsend, D.M., Santi, C., Galli, 
F. Reaction kinetics and targeting to cellular 
glutathione S-transferase of the glutathione 
peroxidase mimetic PhSeZnCl and its d,l-
polylactide microparticle formulation  (2015) Free 
Radical Biology and Medicine, 78, pp. 56-65.
PL-12: SYNTHESIS AND BIOLOGICAL 
APPLICATION OF PORPHYRINS
1 Kurniawan, F., 1 Muhammad, HN.,2 Arba, M, 1 
Tjahjono, DH.
1 Bandung Institute of Technology, School of 
Pharmacy, Bandung, Indonesia
2 Halu Oleo University, Faculty of Pharmacy, Kendari, 
Indonesia
INTRODUCTION:
Porphyrin derivatives have become increasingly 
important reagent candidates in analytical chemistry 
because of its persistent UV-visible spectra as well as 
large molar absorption coefficient and high stability. It 
has been reported that porphyrin derivatives interact 
with DNA (1), and it has telomerase inhibition activity 
(2). Porphyrins also show a selectivity to melanoma 
and hepatoma cancer (3).
MATERIALS AND METHODS:
Porphyrin derivatives have been designed and 
synthesized according to previous method (1,4). The 
designed cationic porphyrins has been applied to 
study the interaction model of molecules to double 
stranded-DNA. The SOD activity of manganese-
porphyrin complexes were studied in silico as well 
as  in vitro. Some porphyrins were also labeled with 
radionuclide to study their characteristic as ligand for 
radiopharmaceuticals.
RESULTS:
Based on the change in UV-visible, CD and MCD 
spectra of cationic porphyrin, and change in 
viscosity of DNA upon interaction with porphyrin, 
the binding mode of interaction may be classified 
as intercalation, outside binding, or outside binding 
mode with stacking. Electron-withdrawing effects 
and charge distribution within isomeric imidazolium 
and pyrazolium derivatives of meso-substituent are 
remarkably different and has high influence on SOD 
activity. The moiety of porphyrins for labeling process 
determine labeling efficiency.  
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CONCLUSIONS:
Porphyrins are versatile molecule to study binding 
mode of interaction. Imidazoliumylporphyrin 
has higher SOD activity compare to those of 
porphyrins with other meso-substituents. Porphyrin 
derivatives show a potential properties as ligand for 
radiopharmaceutical.
ACKNOWLEDGEMENTS:
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PL-13: PHARMACY EDUCATION AND 
CLINICAL PRACTICE IN THE UNITED 
STATES
1 -2 Hawes, EM.
1 University of North Carolina Eshelman School of 
Pharmacy, Chapel Hıll, North Carolina, USA
2 University of North Carolina Eshelman School of 
Medicine, Chapel Hıll, North Carolina, USA
In the United States, pharmacists are responsible 
for the provision of safe, effective, efficient, and 
accountable medication related-care for patients [1]. 
The Pharm.D. curriculum consists of education that 
meets the standards set by the Accreditation Council 
for Pharmacy Education (ACPE). İn 2016, ACPE 
released updated curriculum standards in order to 
incorporate advances in real-world pharmacy practice 
with more emphasis on patient-centered care, 
multidiscplinary teams, evidence-based practice, 
quality improvement, and information technology [2]. 
Pharmacist education, post-graduate training, and 
practice models closely mimics those of physicians. 
Advanced training, in addition to credentialing, 
privileging, and collaborative practice agreements 
have placed pharmacists in a position to serve as 
stewards of the medication use process, champions 
of patient safety, and critical contributors to optimal 
clinical outcomes [3].
1.  American Society of Health-System Pharmacists. 
The consensus of the pharmacy practice model 
summit. Am J Health-Syst Pharm. 2011;68:1148–
52.
2.  Accreditation Council for Pharmacy Education. 
Accreditation Standards and Key Elements for 
the Professional Program in Pharmacy Leading 
to the Doctor of Pharmacy Degree. https://www.
acpe-accredit.org/pdf/Standards2016FINAL.pdf 
(Accessed April 2018)
3.  Knoer SJ, Eck AR, Lucas AJ.A review of American 
pharmacy: education, training, technology, 
and practice. J Pharm Health Care Sci. 2016 Nov 
9;2:32. eCollection 2016.
PL-14: DESIGN AND ACTIVITY 
MECHANISM DESCRIPTION OF 
ANTICANCER ACTIVE BENZAZOLES 
AGAINST DNA TOPOISOMERASE-II 
BY USING MOLECULAR MODELING 
TECHNIQUES
1 Aki-Yalcin, E., 2 Yilmaz, S., 1 Bolelli, K., 1 Ozturk, O., 
1 Ertan-Bolelli, T., 3 Taskin-Tok, T., 1 Yalcin, I.
1Ankara University, Faculty of Pharmacy, Department 
of Pharmaceutical Chemistry, Ankara, Turkey
2Trakya University, Faculty of Pharmacy, Department 
of Pharmaceutical Chemistry, Edirne, Turkey
3Gaziantep University, Faculty of Science, 
Department of Chemistry, Gaziantep, Turkey
INTRODUCTION:
Most effective therapeutically active drugs have 
been discovered and put into market by the use of 
computer aided drug design studies in the recent 
years. There has been considerable interest in 
DNA topoisomerases over the last decade, as they 
are shown to be one of the major cellular targets 
in anti-cancer drug development [1]. Formation of 
protein-concealed DNA strand breaks, resulting in the 
stabilization by the drug of an intermediary complex 
of the Topoisomerase-II reaction is related to the 
antitumor activity. In the recent years our research 
team have been working with heterocyclic compounds, 
benzazoles and their DNA Topoisomerase-II inhibitory 
activities. Some of them were found to be more active 
than the reference drug, Etoposide [2-6]. 
MATERIALS AND METHODS:
CoMFA/CoMSIA analysis were performed, 
pharmacophore and molecular docking studies were 
carried out to predict the binding properties between 
Topoisomerase-II enzyme and the synthesized 
benzazole compounds using the Sybyl 6.6 Software 
and Discovery Studio 3.5 [7].
RESULTS:
The results observed by CoMFA/CoMSIA studies were 
revealed that the electrostatic and the hydrophobic 
molecular descriptors are more significant than the 
molecular steric fields of the tested compounds. The 
observed pharmacophore hypothesis and docking 
performed were shown that hydrogen bond acceptor 
groups are important for binding to the receptor side. 
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CONCLUSIONS:
Some of the synthesized benzazole derivatives 
are found appreciable for the treatment of different 
multidrug-resistant cancer cells with cross resistance 
against ‘‘classical’’ Topo II-targeting drugs.
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PL-15: AURAPTENE: A SURVEY 
OF ITS PHYTOCHEMICAL AND 
PHARMACOLOGICAL PROFILE
Epifano F.
University “G. d’Annunzio” of Chieti-Pescara, 
Department of Pharmacy, Chieti Scalo (CH), Italy
Auraptene (7-geranyloxycoumarin) 1 is the most 
abundant prenyloxycoumarin occurring in nature (1). 
O OO
1
This secondary metabolite has been isolated for the 
first time at the beginning of 30’s by Komatsu and 
cowokers from fruit peels of Citrus aurantium L. (bitter 
orange) and then shown to be a common coumarin-
based phytochemical of plants belonging to the families 
of Rutaceae, Apiaceae, Compositae, Euphorbiaceae, 
and Polygalaceae, including several medicinal 
and edible herbs (2,3). Among such plant species, 
the genus Citrus still represent the most abundant 
source of auraptene. This coumarin has been also 
recently revealed as a component of bee products 
like propolis (4). Furthermore this oxyprenylated 
coumarin can be obtained in very high yield and purity 
by an easy to handle one-step synthetic scheme from 
commercially available umbelliferone. During the last 
two decades auraptene was found to possess a great 
therapeutic potential and several beneficial effects 
for human welfare both in vitro and in vivo as dietary 
feeding cancer chemopreventive, neuroprotective, 
immunomodulatory, anti-bacterial, anti-protozoal, anti-
inflammatory, anti-platelet aggregation, spasmolytic 
and anti-oxidant agent. The mechanism of action 
underlying the observed effects comprise triggering 
important biological targets like metalloproteinases, 
PPARs, monoaminooxidase, GLUT4, FXR, hOAT1 
and hOAT3, and several others. The aim of this 
lecture will be the provided an updated and detailed 
survey of the phytochemical and pharmacological 
properties of the title natural products.
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PL-16: OPPORTUNITY AND CHALLENGES 
OF NASAL POWDERS: DRUG 
FORMULATION AND DELIVERY
1,2 Tiozzo Fasiolo, L., 2  Bortolotti, F., 1 Sonvico, F., 1,3 
Balducci, A.G., 4 Russo, P., 2 Colombo, G.
1 University of Parma, Department of Food and Drug 
Sciences, Parma, Italy
2 University of Ferrara, Department of Life Sciences 
and Biotechnology, Ferrara, Italy
3 University of Parma, Biopharmanet TEC, Parma, 
Italy
4 University of Salerno, Department of Pharmacy, 
Fisciano (SA), Italy
Nowadays, the majority of marketed nasal products 
are liquids, delivered as sprays or drops. However, 
instability, drug dosage requirements and rapid 
clearance from the nasal cavity are significant 
drawbacks. Solid dosage forms, mostly powders, 
are more stable than liquids. They denote a 
simpler composition in excipients, allowing for the 
administration of larger drug doses. Powders also 
facilitate the formulation of poorly water-soluble 
compounds (Tiozzo Fasiolo et al., 2018). They 
enhance drug diffusion and absorption across the 
mucosa, thus improving drug bioavailability at the site 
of action.
This paper focuses on the opportunities and 
challenges of developing powders for nasal drug 
delivery. Thalidomide, desmopressin and ribavirin 
are examples of molecules of interest respectively for 
12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 11
local and systemic action as well as for nose-to-brain 
delivery. Nasal powder formulations of thalidomide 
were designed for use in hereditary hemorrhagic 
telangiectasia as a local anti-epistaxis therapy after 
discontinuing oral treatment (Colombo et al., 2016).
The antidiuretic peptide desmopressin, formulated as 
chimera agglomerates to improve drug bioavailability 
and provide a flexible drug product, significantly 
reduced urine production in rats after nasal 
administration (Balducci et al., 2013).
Finally, ribavirin, an antiviral drug potentially useful 
to treat viral infections both in humans and animals, 
was formulated in the form of agglomerates 
comprising micronized drug and spray-dried 
microparticles containing excipients with potential 
absorption enhancing properties (mannitol, chitosan, 
and  α-cyclodextrin). In vivo nasal administration to 
rats of the agglomerates containing α-cyclodextrin 
led to higher drug accumulation in all the brain 
compartments analyzed as compared with the 
micronized administered as such without excipient 
microparticles (Colombo et al., 2011; Giuliani et al., 
2017).
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PL-17: HYBRID NANO(BIO)MATERIALS: 
NEW ANALYTICAL TOOLS FOR THE 
DEVELOPMENT OF (BIO)SENSORS
Rivas, G. 
INFIQC (CONICET)-Departamento de Fisicoquímica. 
Facultad de Ciencias Químicas. Universidad 
Nacional de Córdoba. Ciudad Universitaria. 5000 
Córdoba. Argentina 
This presentation will describe new avenues for the 
design of (bio)analytical platforms based on the use of 
carbon nanomaterials. Special emphasis will be given 
to the rational selection of the functionalizing agent 
to obtain nanostructures with particular recognition 
properties, either DNA-intercalator; enzyme-substrate 
and avidin-biotin, among others. The importance 
of the strategy used to functionalize the carbon 
nanomaterials will be critically discussed with different 
examples: a)multi-walled carbon nanotubes non-
covalently modified with proteins, DNA and peptides; 
b) single-walled carbon nanotubes covalently modified 
with aminoacids and peptides; and c)graphene 
oxide integrated in supramolecular architectures 
by self-assembling of polymers/biomolecules. The 
advantages of electrochemical and plasmonic (bio)
sensors obtained by modification of glassy carbon 
and gold surfaces with the resulting functionalized 
carbon nanomaterials will be demonstrated in 
connection with the quantification of different (bio)
markers of clinical and environmental relevance 
like neurotransmitters, DNA, glucose, galectine 3, 
purines, phenolic compounds and heavy metals.
In summary, the judicious functionalization of 
carbon nanomaterials, the robust immobilization of 
the resulting modified nanohybrid materials at the 
transducer surfaces, and their efficient incorporation 
in supramolecular architectures, make possible 
the development of highly sensitive and selective 
bioanalytical platforms for the quantification of (bio)
markers.  
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PL-18: WHAT IS HAPPENING AT THE 
NANOENVIRONMENT OF CARBON 
NANOSTRUCTURES? DEMOLITION OF 
TABOOS!
 Degim, IT., Degim, Z., Camlik,G.
Biruni University, Department of Pharmaceutical 
Technology, Zeytinburnu 34010, Istanbul, Turkey
Nanotechnology provides new insights and a variety 
of tools for developing new and futuristic drug delivery 
systems1. These types of systems can enhance 
solubility or stability of active molecules and modified 
surfaces can provide a better delivery, precise targeting 
etc. Many attempts have been trying to develop these 
nanosystems considering their surfaces, physical 
properties and some size related characteristics. 
Most of them have been only focusing on the drug 
delivery systems but the characteristics of water in 
the formulation or at the site of action can actually 
be altered with these nanomaterials when they are 
formulated together.  For instance, if nanotubes are 
formulated in water; they can have water molecules 
on the surfaces or water molecules can go inside 
of the nanotubes. If any of these happened, the 
thermodynamic and properties of water molecules 
can be totally changed. These alterations affect the 
energy state, dissolving or solvation capability of 
water molecules at the nanoenvironment. All these 
have not been considered and all interpretations 
have been made in wrong direction so far. Positive or 
gained properties have been always attributed only to 
the nanodelivery system. Recent reports from other 
scientific fields2 have mentioned that water molecules 
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can travel to the inside of the carbon nanotubes and 
in this condition, water molecules squeezed in the 
tubular structures in a very small scale, it forms into 
an entirely new type of molecule, a new state of water 
occurs and these molecular arrangements actually 
change the properties of water molecules in the 
formulation unexpectedly.  
This talk aims to announce and highlight how the 
alterations of water or solvent molecule properties 
by these nanosystems can be possible when they 
formulated together. Some new interpretations with 
supporting evidences by focusing on the results and 
properties of water molecules at nanoenvironment 
will be provided and the key structure–property 
relationships, interactions and their effects on drug 
release, delivery and their penetrations will be 
discussed. 
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PL-19: ANTIVIRULANCE STRATEGIES 
AGAINST MEDICALLY IMPORTANT 
CANDIDA SPP.
Kosalec, I.
University of Zagreb, Faculty of Pharmacy and 
Biochemistry, Schrottova 39, HR-10000 Zagreb, 
Croatia; e-mail: ikosalec@pharma.hr
Since the well-known physiological way of disruption 
of life cycle of medically important fungi by active 
substances currently registered as medicines and 
consequently the emerging of resistance to such 
medicines, the new paradigmatic shift at microbial 
target started. Knowing the complex life of Candida 
spp. and interaction between the host’s attributes are 
possible way to find a new target for medicines. Since 
we know the atributes of fungal virulence and steps 
during interaction between the host’s factors, we 
could modulate those complex systems.  The yeast 
such such as Candida spp. are as the most potent 
target for such a research. New strategies towards 
eradication or prevention of fungal infection include 
inhibition of adherence to biological and non-biological 
surafces, such as catheters or implants by modulation 
of cell-curface hydrophobicity (CSH) and modulation 
of surface-based receptors. Small molecular weight 
inhibitory molecules against yeast germination and 
with inhibitory activity against hydrolitic enzymes such 
as proteases and phospholipases are also in antifungal 
medicines pipeline. New strategies include also new 
targets in yeast cells. Fungicidal activity of ROS-
producing molecules or nanoparticles, modulation of 
not well studied steps in survival and fitness of yeast 
cells in host (modulation of calcineurin or Hsp90 or 
sphinglipid sythesis pathways); application of specific 
monoclonal antibodies or radioimmunotherapy; 
potentisation of known antifungals with molecules 
not indicated for fungals infection (statins, NSAIDs) 
are examples of novel targets. The use of synthetic 
peptides (antimicrobial peptides, AMP) or those 
derived from human source (defensins, histatins) 
against fungal infection are in late clinical phases. 
Many medicines express also antifungal activity 
against medically important fungi and such medicines 
could be repurposed (verapamil, rifampin, rapamycin 
etc.). Besides the improvents of current antifungals 
by structural modification brand new paradigmatic 
research area emerge within the antifungal pipeline. 
During the presentation examples of methodological 
approach in vitro and examples of novel molecules 
together with a clinical outcome will be given. 
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PL-20: SIMPLE, RELIABLE AND 
VERSATILE ELECTROANALYTICAL 
BIOPLATFORMS FOR EARLY DIAGNOSIS 
OF CANCER AT DIFFERENT MOLECULAR 
LEVELS
Pingarrón, J.M., Campuzano, S., Torrente-Rodríguez, 
R.M., Ruiz-Valdepeñas Montiel, V., Vargas, E., 
Povedano, E., Pedrero, M. 
Unıversıdad Complutense de Madrid, Facultad de 
Ciencias Químicas, Madrid, 28040, Spain
INTRODUCTION:
Giving the increasing cancer incidence and 
prevalence in the last years, the development of 
efficient, simple, quantitative and disposable devices 
with short response times, low-cost, and suitable to 
perform decentralized and reliable determination of 
early diagnosis biomarkers could help significantly 
reducing cancer mortality. Within this context, this 
talk will present different strategies based on the 
use of novel electrochemical bio-platforms for the 
sensitive, selective and rapid biosensing, individually 
or multiplexed, of biomarkers of different molecular 
levels associated with early cancer diagnosis
MATERIALS AND METHODS:
The developed methodologies are based on the 
appropriate use and coupling of novel bioreceptors, 
functionalized magnetic microcarriers, attractive 
bioassays formats and amperometric transduction 
at disposable transducers, both unmodified and 
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nanostructured.
RESULTS:
In particular, the most relevant characteristics of 
new electroanalytical platforms for the determination 
of human protein biomarkers of well-accepted and 
emerging clinical relevance [1], autoantibodies 
against tumor associated antigens (TAAs) [2], 
specific mutations [3], miRNAs [4], and altered DNA 
methylation patterns [5] will be discussed. All the 
developed methodologies demonstrated excellent 
features and reliable determination of the target 
analytes at clinically relevant levels in highly complex 
biological samples: cancer cells, human tissues (fresh 
and paraffin) and liquid biopsies.
CONCLUSIONS:
These platforms for individual or multiple analysis 
of cancer biomarkers provide results in line with 
those of conventional methodologies but in less time 
and with simpler protocols and lower cost. These 
features made them particularly attractive for their 
implementation in easy-to-use and affordable devices 
to perform routine determinations in both clinical and 
basic research settings to improve cancer diagnosis. 
In addition, the methodologies developed can easily 
be extended to the determination of other biomarkers 
of clinical relevance.
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PL-21: GLYCOPHARMACY: A NEW STAR 
ON THE HORIZON 
Dumić, J.
University of Zagreb Faculty of Pharmacy and 
Biochemistry, 
Department of Biochemistry and Molecular Biology, 
Zagreb, Croatia
Glycosylation is a complex and structurally most 
diverse posttranslational modification that affects 
>80% of all human cell membrane and secreted 
proteins, as well as many intracellular proteins. Due 
to their huge structural diversity, glycans are ideal 
molecular media for storing biological information. 
Their highly specific interaction with physiological 
receptors enable variety of biological processes 
(cell proliferation, differentiation, motility, adhesion, 
apoptosis, cell-cell and cell-matrix interactions etc.), 
thus being involved in numerous physiological and 
pathophysiological processes, from fertilization 
through embryogenesis and development, to 
immunity, aging, cancer and metastasis spreading. 
Consequently, glycan-protein interactions have 
become potential targets for therapeutic intervention, 
while carbohydrate-based drugs started to attract 
huge attention of pharmaceutical industry. Recent 
developments in the field of glycan analysis and 
synthesis enabled, not only development of new 
therapeutic compounds based on carbohydrates, 
but also understanding of glycosylation changes 
related to different diseases. Some of them seem 
to be highly specific and may serve as valuable 
diagnostic or prognostic biomarkers. Furthermore, 
changes in glycosylation of transportation proteins in 
serum may affect bioavailability of drugs while correct 
glycosylation of therapeutic proteins (monoclonal 
antibodies, hormones, growth factors etc.) is of 
utmost importance for their biological and therapeutic 
activity. This is why glycopharmacy arises as a new 
star on the horizon not only in the pharmacy field but 
also in personalised medicine, in general. The recent 
achievements, as well as further challenges in the 
field will be overviewed in the presentation.
PL-22: MOLECULARLY IMPRINTED 
POLYMERS FOR A TARGET COMPOUND 
AND ITS HALOGENATED DERIVATIVES AND 
THEIR IMPRINTING EFFECTS
Haginaka, J.
Mukogawa Women’s University, School of Pharmacy 
and Pharmaceutical Sciences, Nishinomiya, Japan
INTRODUCTION:
Molecularly imprinted polymers (MIPs), which 
selectively recognize a target compound and its 
structurally related analog(s), have been shown 
to be useful as selective sorbents. Suspension 
polymerization, seed polymerization (multi-step 
swelling and polymerization) and precipitation 
polymerization give microspherical beads. Among 
those, the latter two methods could yield monodisperse 
MIPs. In this study, we prepared monodisperse 
MIPs for warfarin (WF) and its halogenated 
derivatives [4ʹ-chlorowarfarin (coumachlor, cWF) and 
4ʹ-bromowarfarin (bWF)] by multi-step swelling and 
polymerization and evaluated their imprinting effects 
by LC. Furthermore, MIPcWF was used for the assay 
of WF as a pretreatment column by column-switching 
technique.
MATERIALS AND METHODS:
MIPs for WF, cWF and bWF (MIPWF, MIPcWF and MIPbWF, 
respectively) were prepared using 4-vinylpyridine (4-
VPY) and ethylene glycol dimethacrylate (EDMA) as 
a functional monomer and crosslinker, respectively. 
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Similarly, non-imprinted polymers (NIPs) were 
prepared. The retenton factor (k) and imprinting factor 
(IF = kMIP/kNIP) of WF, cWF and bWF on the obtained 
MIPs were evaluated in reversed-phase LC. 
RESULTS:
In addition to shape recognition, hydrogen bonding, 
ionic and hydrophobic interactions work for the 
retenition and recogntion of WF, cWF and bWF on 
the MIPs. The IFs for WF, cWF and bWF were in the 
order of MIPWF < MIPcWF < MIPbWF. It is interesting that 
WF is more recognized on MIPcWF and MIPbWF than 
MIPWF, i.e. IF of WF is larger on MIPcWF and MIPbWF 
than MIPWF. This suggests that in the imprinting 
sites, microenvironmental changes of 4-VPY-co-
EDMA MIPcWF and MIPbWF might occur. Furthermore, 
MIPcWF was successfully used for the assay of WF in 
rodenticides and biological fluids as a pretreatment 
column by column-switching technique.
CONCLUSIONS:
The above results indicate that the use of cWF or 
bWF as a template molecule instead of WF could be 
useful for getting a higher IF for WF and for avoiding 
the leakage problem in the assay of WF in LC.
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PL-23: SEARCH FOR BIOACTIVE 
MOLECULES FROM OKINAWAN CORAL 
REEF ORGANISMS AND METABOLITE 
DIVERISTY OF SOME ORGANISMS
Tanaka, J.
University of the Ryukyus, Department of Chemistry, 
Biology and Marine Science, Okinawa 903-0213, 
Japan
INTRODUCTION:
Marine organisms in Okinawa, southwest part of 
Japan, have been the subjects for bioprospective 
studies from late 1970s. As results, a large number 
of unique molecules both in structure and bioactivity 
have been reported. Although there are many chances 
to encounter known metabolites in a classical natural 
products study, thanks to the species diversity, there 
still exists a chance to discover newer bioactive 
molecules. In this talk, our recent works together with 
biodiversity aspects will be presented. 
MATERIALS AND METHODS:
Coral reef organisms were collected by hand using 
scuba or rebreather diving. The material were mostly 
screened by collaborators and the hit molecules were 
characterized with spectroscopic data, chemical 
conversions, and calculation study. 
RESULTS:
In addition to known metabolites, aromatic sulfates 
from the crinoid Alloeocomatella polycladia have 
been identified as enzyme inhibitors against HCV 
NS3 helicase.1 Spongian diterpenes from the 
sponge Hyattella aff. intestinalis,2 a new cyclic imine 
named kabirimine from a cultured dinoflagellate, and 
metachromin B from the sponge Dactylospongia 
metachromia3 were found to show antiviral activity 
against AdV, RSV, and HBV, respectively. In addition, 
severlal natural products, a macrolide named 
acidiscalide4 and a few terpenoids, have been 
reported. 
On our interest on the relation of metabolite 
diversity with genetic variation of marine organisms, 
diterpene constituents of the soft corals of the 
genus Sarcophyton were reported previously. 5 We 
examined the chemical and genetic variations of the 
nudibranch Phyllidiella pustulosa, a common species 
in Okinawan coral reef. 
CONCLUSIONS:
We still believe that macro- and micro-organisms in 
coral reefs provide newer and bioactive molecules. 
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PL-24: ANTI-INFLAMMATORY ACTIVITY 
OF VARIOUS PRENYLATED PHENOLIC 
COMPOUNDS
1 Šmejkal,K. 1 Brezáni, V. 2 Hošek, J.
1 University of Veterinary and Pharmaceutical 
Sciences Brno, Faculty of Pharmacy, Department 
of Natural Drugs, Palackého 1946/1, 61242, Czech 
Republic, karel.mejkal@post.cz
2 University of Veterinary and Pharmaceutical 
Sciences Brno, Faculty of Pharmacy, Department of 
Molecular biology and Pharmaceutical Biotechnology, 
Palackého 1946/1, 61242, Czech Republic
INTRODUCTION:
Phenolic compounds can be divided into several 
categories with the common structural feature of 
phenolic hydroxyl. Their biological activity is often 
enhanced by so called prenylation, where the type 
of the prenyl connection and modification affects the 
bio-activity. The lecture would shortly summarize the 
effects of prenylated phenolics in vitro in cellular or 
biochemical systems on the production and release 
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of inflammation-related cytokines; their effects on the 
inhibition of cyclooxygenases and lipoxygenases; the 
effects on the production of nitric oxide, an antiradical 
and antioxidant activity, and the effect on the inhibition 
of the release of enzymes and mediators from 
neutrophils, mast cells and macrophages. Some 
selected prenylated flavonoids, 2-arylbenzofurans, 
and stilbenes as potential antiphlogistic substances 
will be discussed in detail.
The information about the antiphlogistic potential of 
prenylated phenolics gives the idea that a big pool 
of natural prenylated phenols represents a source of 
inspiration for synthesis, and that prenylated phenols 
are active principles of various medicinal plants used 
to combat inflammation (1).
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PL-25: POTENT AND BROAD SPECTRUM 
MEDICINAL DRUGS AGAINST ALL 
GENOTYPES OF HEPATITIS C VIRUS (HCV)
 1 Elsebai, MF. , 2 Hakkola, J., 3 Mehiri, M., 4  Diez, J.
1Department of Pharmacognosy, Faculty of 
Pharmacy, Mansoura University, Egypt.
2Pharmacology and Toxicology Unit, Institute of 
Biomedicne, University of Oulu, FIN-90014, Finland.
3Nice Institute of Chemistry, University Nice Sophia 
Antipolis, France.
4Department of Experimental and Health Sciences, 
Universitat Pompeu Fabra, Barcelona, Spain.
As many as 200 million people worldwide are infected 
with hepatitis C virus (HCV). About 3–4 million people 
are infected per year, and ~500,000 people die yearly 
from hepatitis C-related diseases, (WHO, June 
2011). The Egyptian community is suffering from the 
prevalence of HCV infections 1. Even in the advanced 
countries hepatitis C is common. HCV is the most 
common chronic blood-borne infection and it is the 
most frequent indication for liver transplantation 2. In 
the United States, hepatitis C is the most common 
chronic blood-borne infection (http://www.cdc.gov/
hepatitis/HCV/ index.htm). 
The infection with HCV is often asymptomatic 
but chronic infection leads to liver cirrhosis which 
usually develop into liver failure, liver cancer or life-
threatening esophageal and gastric varices. The 
diseased-liver person usually undergoes subsequent 
psychological disorders due to the stress of disease 
which complicates the illness 3. There is no preventive 
vaccine available for HCV due to its highly mutable 
nature evidenced by the presence of more than 
50 subtypes of HCV; in addition HCV infects only 
humans and chimpanzees 4. Fortunately, Dorner et al 
5and a vaccine is not available. Development of more 
efficient therapies has been hampered by the lack of 
a small animal model. Building on the observation that 
CD81 and occludin (OCLN, were able to complete 
the entire HCV life cycle in genetically humanized 
transgenic mice with stably expressing human CD81 
and OCLN and blunting the antiviral immunity in these 
mice infected with HCV. 
In the present study, the water extract of the leaves 
of the wild Egyptian artichoke (WEA) (Cynara 
cardunculus L. var. sylvestris (Lam.) Fiori) showed 
improvement of HCV infection symptoms. Therefore, 
our study was divided into two main strategies: 
1) The clinical investigation of WEA extract on some 
infected Egyptian patients (approved by the Ethical 
Committee of Research at the Faculty of Pharmacy, 
Mansoura University, Egypt, code number 2014/71). 
The results showed outstanding activity against HCV 
and its complications such as ascites and jaundice 
by measuring the PCR, and liver functions such as 
ALT, AST6identify bioactive chemicals in its extract 
and to tentatively examine the potential inhibitory 
interactions of WEA with human drug-metabolizing 
enzymes. The current pilot clinical trial revealed that 
the water extract of a WEA plant decreased the HCV 
viral load below the detection level in 12 out of 15 
patients. Furthermore, the liver enzymes ALT and 
AST, as well as the level of bilirubin were normalized. 
The total WEA extract inhibited CYP2B6 (OH-BUP.
2) The phytochemistry of the WEA extract and 
its subsequent evaluation of inhibition capacity in 
vitro using cell-culture derived HCV: The chemical 
investigation of the WEA extract resulted in the 
identification of six compounds: a new sesquiterpene 
lactone (1), in addition to the known compounds 
(2-6). Their structural elucidation was done by 
extensive spectroscopic tools such as NMR and 
HR-MS spectroscopy. The absolute configuration 
was determined by TDDFT ECD calculations and 
comparison with the experimental CD spectra. The 
quantitative determination was achieved through 
UPLC-MS quantitation. Importantly, all compounds 
inhibited HCV infection; compounds 1 and 2 were the 
most potent among the six. The EC50 were estimated 
at 1.03 μM, 1.27 μM and 299 μM for compounds 1, 2 
and WEA extract, respectively, by using a luciferase-
carrying reporter virus. Time-of-addition experiments 
revealed that compounds 1 and 2 inhibit HCV virus 
at a time-point during entry. Furthermore, compounds 
1 and 2, apart from cell-free infection inhibited HCV 
cell-cell transmission. Finally, the results showed 
that compounds 1 and 2 inhibited HCV particles 
from genotypes 1a, 1b, 2b, 3a, 4a, 5a, 6a and 7a 
indicating that these compounds inhibit HCV cell entry 
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independently of viral genotype or subtype. Thus, 
these compounds are promising candidates for the 
development of new pangenotypic entry inhibitors for 
the HCV infection7,8. All of these results were applied 
for patenting.
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PL-26: TOXIC EFFECTS OF MYCOTOXINS 
IN HUMANS
Peraica M.
Institute for Medical Research and Occupational 
Health, Zagreb, Croatia
Mycotoxins are products of moulds that contaminate 
all kinds of food and feed. Humans are continuously 
exposed to mycotoxins mostly by ingestion, but other 
ways of exposure (such as respiratory and dermal) 
are also possible. Foods of plant origin, such as grains 
and bread, coffee, grapes and vine, beer and spices 
are contaminated following infection with mycotoxin-
producing moulds, while food of animal origin contains 
mycotoxins if animals are fed with contaminated feed. 
Mycotoxins may cause intoxications (either acute or 
chronic) called mycotoxicoses with high variability of 
target organs. These may be hepatotoxic, nephrotoxic, 
immunotoxic, neurotoxic, cardiotoxic, haematotoxic 
and also have carcinogen and teratogen properties. 
The severity of mycotoxicoses depends on the toxicity 
of the mycotoxin, extent of exposure and nutritional 
status of the individual and possible synergistic effect 
of other chemicals to which an individual is exposed. 
The toxic effects of mycotoxins are mostly known 
from veterinary practice. Mycotoxicoses, which can 
occur both in industrialized and developing countries, 
appear when environmental, social and economic 
conditions are combined with meteorological 
conditions (humidity and temperature) that favour the 
growth of moulds. 
Mycotoxins have highly variable chemical structures, 
but being organic compounds of low molecular 
mass, they do not cause allergies. Out of about 400 
mycotoxins, only a few have known toxic effects in 
experimental animals, and even fewer possess effects 
known to be toxic in humans. Most mycotoxicoses 
were first recognized in domestic animals and it is 
difficult to diagnose them in humans. In humans, 
mycotoxicosis should be considered in case when a 
disease appears in several persons, with no obvious 
connection to a known etiological agent, such as 
microorganisms. Unfortunately, medical doctors are 
not trained well to diagnose them, and mycotoxicoses 
very often remain unrecognized. 
There are several international organizations and 
agencies (such as World Health Organization, 
International Agency for Research on Cancer and 
European Food Safety Agency) that deliver scientific 
opinions on various chemicals in food. The scientific 
opinion is based on results published in scientific 
literature on the effects of a toxin in laboratory 
animals. Researchers have realised that, in the field 
of mycotoxin toxicology, a particular problem is co-
contamination of food with several mycotoxins with 
antagonistic, additive and synergistic toxic effects. 
Unfortunately, studies on the combined exposure to 
two or more mycotoxins are rare and inconclusive.  
PL-27: NEW TRENDS IN THE RESEARCH 
OF BIOACTIVE PLANT SAPONINS
Lacaille-Dubois, MA. 
Université de Bourgogne Franche-Comté, UFR des 
Sciences de Santé, Laboratoire de Pharmacognosie, 
PEPITE EA 4267,  BP 87900, 21079 Dijon cedex, 
France 
E-mail address: m-a.lacaille-dubois@u-bourgogne.fr
Saponins are a vast group of triterpene or steroid 
glycosides, widely distributed in the terrestrial plants 
and in some marine organisms, including a high 
number of biologically active compounds. They are 
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constituents of many plant drugs and folk medicines 
with veinotonic, anti-edematous, anti-phlogistic, 
expectorant, adaptogenic, wound healing activities 
amongst others and are rarely toxic when taken 
orally... Their amphiphilic character and biological 
properties have led to increasing applications in the 
food, cosmetic and pharmaceutical sectors. For more 
than twenty years, our research group has been 
deeply involved in the discovery of new bioactive 
plant saponins, understanding their mechanism of 
action, and structure/activity relationships. Thanks 
to worldwide collaborations, mainly in Asia, South 
America and Africa, we have selected plants according 
to chemotaxonomic and ethnopharmacological 
criteria. We used conventional and more recently 
innovative procedures in accordance with green 
chemistry leading to the extraction and isolation 
of these highly complex glycosides possessing 
up to nine sugar units. Their structural elucidation 
is performed by sophisticated 2D NMR and mass 
spectroscopic techniques. The pharmacological 
potential is evaluated by using bioassays mainly in the 
field of cancerology, immunology and microbiology. 
Thus, we isolated and characterized a large number 
of new bioactive saponins from the Polygalaceae, 
Caryophyllaceae, Mimosaceae, Pittosporaceae, 
Fabaceae, Apiaceae, Sapindaceae, Dioscoreaceae, 
and Asparagaceae families, to mention just a few. 
Some of them were found to be cytotoxic on cancer 
cells, immunomodulators, apoptosis inducers on 
Jurkat cells, inhibitors of the production of Il-1β, and 
antifungal on Candida yeast species. 
This lecture will broadly cover our most relevant 
findings from this multidisciplinary approach, and 
some future challenges, with latest developments 
of the scientific literature on saponins as potential 
adjuvants when they are co-administered with 
anticancer, antimicrobial, anti-inflammatory drugs, 
and with antigens in vaccines. This may provide an 
exciting road for further developments in the treatment 
of some cancers, parasitic and inflammatory diseases 
and in the rational design of vaccines against infectious 
diseases. We will highlight the potential benefit of the 
most promising immunoadjuvant saponin QS-21 from 
Quillaja saponaria in several vaccine clinical trials 
with a favorable ratio efficacy/toxicity. 
PL-28: POTENTIAL SECONDARY 
METABOLITES FROM INDONESIAN FUNGI 
AND ALGAE FOR PHARMACEUTICALS AND 
COSMETICS
Singgih Wibowo, M.
School of Pharmacy, Bandung Institute of 
Technology (ITB), Indonesia
Fungi has tremendous benefits to Pharmacy and 
Cosmetic area. In Indonesia, some of indigenous 
fungal isolates had been explored to be developed 
as active ingredients or some excipients for 
Pharmaceuticals and Cosmetic preparations. Their 
role and activities in pharmacy can be ranged from 
active ingredient for lowering cholesterol level such 
as lovastatin or monacolins from Aspergillus terreus 
and Monascus purpureus , to as food colorants for 
meats and possibly as cosmetic colorants in lipsticks 
and rouge products.
Many scientific researches in Indonesia have been 
focused on development of secondary metabolites 
of Indonesian fungi, such as Monascus purpureus, 
Neurospora intermedia, and Aspergillus terreus. 
Besides, there are some microalgae have been 
explored to be utilised for their secondary metabolites 
for some potential ingredients, such as anti-diabetic 
polysaccharides from red microalgae Porphyridum sp., 
DHA from Thraustochytrium sp.  and phycocyanin 
from Spirulina platensis.
Secondary metabolites from Monascus spp, which 
also developed as natural pigments, have been 
investigated for its toxicity aspects to guarantee their 
uses in cosmetics. New azaphilone derivates of 
Monascus pigments are further modified to be less 
toxic.
KEYWORDS :
Secondary metabolites, Fungi, Microalgae
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PL-29: GUT MICROBIOTA AND 
PROBIOTICS
Yalınay, M.
Gazi University Faculty of Medicine Department of 
Medical Microbiology Beşevler Ankara
The gut microbiota (GM) is the whole of commensal, 
symbiotic, and pathogenic microorganisms living 
in our intestine. The human GM forms a complex 
ecological community that influences normal 
physiology and susceptibility to disease through its 
collective metabolic and immunological activities 
and host interactions. The GM–host interactions 
contribute to the maturation of the host immune 
system, modulating its systemic response. It is well 
documented that GM can interact with non-enteral 
cells such as immune cells, dendritic cells, and 
hepatocytes, producing molecules such as short-
chain fatty acids, indole derivatives, polyamines, and 
secondary bile acid. 
A wide variety of commensal microorganisms colonize 
our body surfaces and gut lumen. For example, there 
are more than 100 trillion commensal microbes 
classified into at least 1000 different species in our 
gastrointestinal tract. Nevertheless, our understanding 
of the diversity of the gut microbiota was largely 
limited, and it showed that the gut microbiota is 
mainly composed of four phyla, namely, Firmicutes, 
Bacteroidetes, Actinobacteria, and Proteobacteria. 
This diversity is very important for health and related 
conditions. But when one of these bacterial colonies 
is out of balance, it can lead to dysbiosis. 
Moreover, the gut microbiota contains 600,000 genes 
that called as microbiome, and it is approximately 
25 times more than the number of genes in our own 
genome, highlighting the existence of a highly complex 
microbiota ecosystem with the potential for profound 
effects on metabolism and immune function. Intestinal 
immune, nerve, and endocrine cells are tightly 
interlinked and form a highly complex gut ecosystem, 
along with the gut microbiota, through host microbial 
crosstalk, which contributes to homeostatic balance in 
the host. Dysbiosis typically occurs when the bacteria 
in your gastrointestinal (GI) tract which includes 
your stomach and intestines become unbalanced. 
Dysbiosis is a term for a microbial imbalance or 
maladaptation on or inside the body, such as an 
impaired microbiota. For example, a part of the 
human microbiota, such as the skin flora, gut flora, 
or vaginal flora, can become deranged, with normally 
dominating species underrepresented and normally 
outcompeted or contained species increasing to fill 
the void. Dysbiosis is most commonly reported as a 
condition in the GI tract.
The connection between the microbial world of our 
gut and other important aspects of health, including 
immune functioning, chronic gastrointestinal 
dysfunction, metabolism, and obesity has a substantial 
interest for health and disease outcomes. Gut 
dysbiosis, has been associated with several clinically 
relevant conditions. These conditions include obesity, 
cardiovascular diseases, liver diseases, kidney 
diseases, type 1 and type 2 diabetes, rheumatoid 
arthritis, cancer, and allergic diseases. Moreover, 
several neurological disorders have been associated 
with gut dysbiosis. 
Gut microbiota metabolic end products are low weight 
molecular molecules such as short-chain fatty .The 
receptors for some of these molecules are expressed 
on immune cells, and modulate the differentiation 
of T effector and regulatory cells: this is the reason 
why dysbiosis is correlated with several autoimmune, 
metabolic, and neurodegenerative diseases. An 
expanding branch of this research of particular interest 
to mental health professionals is providing evidence 
that supports a strong link between the microbial state 
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of our gut and our emotional functioning, particularly 
in relation to stress, anxiety and depression. 
Furthermore, the microbial functions of our gut may 
also have significant influence on more profound 
disorders, such as autism. Biologically classified as 
the enteric nervous system, consisting of nearly 100 
million neuronal connections, and the ability to function 
independently, it is often referred to as the second 
brain. An abnormal microbiota associated with a 
disrupted gut barrier and the activation of the mucosal 
immune system leads to the release of inflammatory 
mediators and other neuroactive molecules into the 
systemic circulation from where they reach the brain 
and result in changes in cognition and behavior. 
Alternately, central stimuli, such as stress, can disrupt 
mucosal immunity, the gut microbiota and gut barrier 
function and lead to gut dysfunction. One example of 
the microbiota–gut–brain axis is in the production and 
use of serotonin, a neurotransmitter whose imbalance 
is strongly correlated with depression. Although 
serotonin is commonly associated with location in 
the central nervous system, it is found not only in the 
brain but is also created in the gut. Strikingly, about 
95 percent of our serotonin is synthesized by bacteria 
in the gut.
A discussion about the impact of our gut health 
and related diseases due to dysbiosis of gut 
microbiota cannot occur without addressing two 
very important players: probiotics and prebiotics. 
Generally, probiotics are known as “friendly bacteria” 
or “good bacteria.” Probiotics are defined by the 
World Health Organization and the Food and 
Agriculture Organization of the United Nations as 
“live microorganisms, which, when administered in 
adequate amounts, confer a health benefit on the 
host”. It is interesting to note that the modern word 
“probiotic” is derived from words meaning “for life” 
(Greek pro: for and bios: life).
Most probiotics are microorganisms known as lactic 
acid bacteria (LAB) and are normally consumed in the 
form of yogurt, fermented milks, or other fermented 
foods. LAB are known to exert a wide range of 
effects on the immune system, and are defined as 
“generally recognized as safe” (GRAS). While the 
most common microorganisms used as probiotics 
are from the LAB such as lactobacilli, lactococci, 
and streptococci, these are not the only good bugs 
in our gut. Bifidobacterium genera and other bacterial 
genera, including Enterococcus, Streptococcus, and 
Escherichia, and the yeast Saccharomyces boulardii, 
are also used as probiotics. A probiotic has been 
defined as a live microbial food ingredient that, when 
ingested in sufficient amounts, exerts beneficial 
effects on health. In order to consider organisms as 
probiotics, it has to be demonstrated that it should 
(a) be nonpathogenic and nontoxigenic, (b) have a 
proven beneficial effect on health, (c) protect against 
pathogenic microorganisms, (d) be isolated from 
the same species as its intended host, (e) be able 
to survive transit of the upper GI tract, (f) adhere to 
mucus or the intestinal epithelium, (g) temporarily 
colonize sites in the GI tract, and (h) remain viable for 
a long time.
Probiotics may help prevent infections, reduce 
cholesterol levels, promote vitamin and cytokine 
synthesis and inhibit cancer progression. The safety 
and efficacy of a given strain in the context of these 
properties must be scientifically demonstrated for 
it to be considered a probiotic. Psychobiotics is an 
interesting defined probiotics group related to gut 
brain axis and all the conditions (emotional well-being, 
stress, depression, neurodevelopmental disorders) 
up to this connection.
Prebiotics, on the other hand, have been defined 
as nonabsorbable food ingredients that promote the 
growth or activity of a limited number of bacterial 
species for the benefit of human health. Prebiotics are 
found naturally in many foods that provide fermentable 
fiber, and can also be isolated from plants. The 
most commonly used prebiotics are carbohydrate 
substrates such as fructans and nonfructan prebiotics 
like resistant starch. Synbiotics is the word used for 
the combined administration of probiotic bacteria with 
prebiotics that support their growth to provide definite 
health benefits by synergistic action.
The human gut microbiota forms a complex ecological 
community that influences normal physiology 
and susceptibility to disease through its collective 
metabolic and immunological activities and host 
interactions. Current studies suggest that manipulation 
of the gut microbiota could be a promising approach 
for the prevention and management of disorders.
Moreover, the evidence showed that attempts to treat 
acute infectious and post-antibiotic gastroenteritis 
with some probiotics were significantly effective in 
a great number of patients, leading many experts 
to suggest the use of probiotics to address all of 
the clinical problems associated with dysbiosis. 
The available data are promising, but presently, 
further studies are needed before probiotics can be 
considered a reliable treatment for dysbiosis related 
clinical conditions. Gut microbiota related health and 
diseases and probiotics are currently most interesting 
topics in medicine. Personalized medicine essentially 
will obtain crucial data by means of metagenomic 
analysis of gut microbiome.
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PL-30: THE SIGNIFICANCE OF 
XENOBIOTIC/DRUG METABOLIZING 
ENZYME POLYMORPHISMS IN RESPONSE 
TO CHEMOTHERAPY AND SURVIVAL IN 
LUNG CANCER PATIENTS.
Iscan, M.
Ankara University, Faculty of Pharmacy, Department 
of Toxicology, Tandogan, Ankara, Turkey
Lung cancer is an increasing worldwide public health 
problem particularly in men. The 28 % of deaths 
arising from cancers are caused by lung cancer. Non-
small cell lung cancer (NSCLC) patients represent 
the majority of lung cancer cases and they are mainly 
treated with platinum based chemotherapy. However, 
the poor response and a great interindividual variety 
in response to this chemotherapy occur in these 
patients. Thus, the reasons behind the failure and 
interindividual variety of response to chemotherapy 
and thus possibly poorer survival in these patients 
are very important. There is accumulating evidence 
to support the hypothesis that genetic polymorphisms 
alter the xenobiotic/drug response and survival. It is 
well known that majority of lung cancer patients are 
cigarette smokers. Cigarette smoke has been reported 
to cause elevated levels of carcinogen DNA-adducts 
which in turn form aggressive tumors by mutating 
and thus inactivating tumor suppressor genes (such 
as TP53) and thereby decrease the survival rates of 
patients with NSCLC. Carcinogens such as polycyclic 
aromatic hydrocarbons (PAHs) and nitrosamines in 
cigarette smoke are activated by cytochrome P450s 
(CYP)s mainly CYP1A1, CYP1B1 and CYP2E1 and 
inactivated by Glutathione S-transferases (GST)s 
such as GSTM1, GSTO1, GSTP1 and GSTT1. These 
enzymes also play an important role in the metabolism 
of a number of chemotherapeutic agents and thus 
involve in the drug efficacy, toxicity and resistance 
in cancer chemotherapy. CYP and GST genes are 
found to be polymorphic and the polymorphisms in 
these genes are associated with changes or loss 
in enzyme activity. In addition, CYP and GST gene 
polymorphisms can be associated especially with 
TP53 (Arg72Pro) gene polymorphism, the mutant 
genotype of which has reduced apoptotic potential, in 
the occurrence of more aggressive tumor phenotypes. 
Thus, CYP, GST and TP53 gene polymorphisms 
may influence the response to therapy and survival 
in patients with lung cancer.  Herein, recent findings 
with respect to the role of CYPs (CYP1A1, CYP1B1 
and CYP2E1), GSTs (GSTM1, GSTO1, GSTP1 and 
GSTT1) and TP53 (Arg72Pro) gene polymorphisms 
in response to mainly platinum-based chemotherapy 
and survival in patients with NSCLC will be evaluated. 
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PL-31: 2-AZAALLYL ANIONS AND 
SULFENATE ANIONS: UNUSUAL AND 
UNEXPECTED REACTIVITY
Walsch, P
The seminar will outline the Walsh Group’s efforts in 
C–C and C–S bond forming reactions.  The Walsh 
lab has developed a series of Pd and Ni catalyzed 
deprotonative cross-coupling processes (DCCP) that 
enable the synthesis of a variety of small molecule 
building blocks for use in the pharmaceutical industry. 
The second part of the seminar will outline the 
introduction of a novel organocatalysts, sulfenate 
anions, that facilitate the dehydrocoupling of 
benzylic halides and the formation of alkynes.  The 
dehydrocoupling of benzylic chloromethyl groups to 
form polymers will also be introduced.
PL-32: DESIGN AND EVALUATION OF 
A 3D BIOPRINTED IMPLANTABLE DRUG 
DELIVERY SCAFFOLD FOR APPLICATION 
IN BONE TISSUE ENGINEERING
Kondiah, P.P.D, Kondiah, P.J., Choonara,Y.E., 
Marimuthu, T., du Toit, L.C., Kumar, P.,Pilla, V.
Wits Advanced Drug Delivery Platform Research 
Unit, Department of Pharmacy and Pharmacology, 
School of Therapeutic Sciences, Faculty of 
Health Sciences, University of the Witwatersrand, 
Johannesburg, 7 York Road, Parktown, 2193, South 
Africa 
INTRODUCTION: 
A 3D bioprinted drug delivery scaffold was synthesised 
and optimized as a thermo-responsive implantable 
technology, possessing similar matrix hardness and 
resilience properties as healthy bone tissue, once 
incorporated in situ. The 3D bioprinted scaffold was 
developed using computer aided design (CAD) 
software, with further optimization of the designed 
formulations, employing MATLAB® programing and 
artificial neural networks. 
METHODS:
3D bioprinting was undertaken to design an 
implantable drug delivery scaffold for controlled 
release of loaded drug. Morphological, artificial neural 
network studies, in vitro release and optimization 
studies were undertaken on the implantable scaffold. 
The prepared formulations were synthesised and 
polymerically blended to obtain a stimuli-responsive 
implant. TGA was also undertaken to determine 
the degree of thermodegradation in the implantable 
system. Biomaterial testing was employed using a 
BioTester 5000 Cell scale system, evaluating the 
tensile strength and viscoelastic nature of the implant.
RESULTS:
The designed scaffold displayed significant bone filling 
and matrix hardening properties. The 3D bioprinted 
scaffold demonstrated remarkable properties as a 
controlled release platform, biodegrading gradually 
over 20 days and releasing its loaded contents in 
a sustained manner, allowing contact adhesion 
between fractured/damaged bone and formation 
of artificial bone matrix within these sites. SEM 
analysis confirmed the programmed architecture of 
the scaffold, with precise pore dimensions for cell 
biocompatibility. 
DISCUSSION:
It was confirmed that the 3D bioprinted drug 
delivery scaffold has great potential for application 
in bone fractures, due to its physicochemical and 
phsicomechanical properties. In vitro release further 
confirmed gradual biodegradation of the scaffold, 
with ideal bone matrix hardness and resilience to 
healthy bone tissue. The elastic nature of the scaffold 
displayed promising properties for resistance of 
internal stresses that can be experienced in situ, once 
implanted. It can thus be confirmed that 3D Bioprinting 
has significant value in advanced biomaterial design, 
with optimum properties for site specific controlled 
drug delivery.
PL-33: AN OVERVIEW ON NANO-LIQUID 
CHROMATOGRAPHY: MAIN FEATURES AND 
RECENT APPLICATIONS TO THE ANALYSIS 
OF NUTRACEUTICAL COMPOUNDS
1 Fanali,S.,2 D’Orazio, G., 3 Fanali, C.
1PhD School in Natural Science and Engineering, 
University of Verona, Italy
2Institute of Chemical Methodologies, C. N. R. 
Monterotondo, Rome, Italy
3University Campus Bio-Medico, Rome, Italy
Miniaturization has been introduced several years 
ago in analytical chemistry including also Liquid 
Chromatography. Nano-liquid chromatography 
(nano-LC) has been developed and commercial 
instrumentation is available. The main features 
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of nano-LC can be summarized as following: low 
consumption of both mobile phase and sample 
volumes, high mass sensitivity, high resolution, perfect 
coupling of the technique with mass spectrometry 
(MS). The last advantage over conventional LC is due 
to the low flow rates applied (nL/min). Compounds’ 
separation is carried out in capillaries of thin diameter 
(10-100 mm) containing a selected stationary phase 
(SP). The column contains either packed particles 
or monolithic material, in addition the SP could be 
bonded or adsorbed on the capillary wall [1, 2].
Aim of this communication is to present the main 
features of this technique considering its advantages 
over high-performance liquid chromatography (HPLC) 
and also the problems related to its practical used 
especially when analyzing complex matrices. The 
selection of the appropriate experimental conditions, 
e.g., mobile phase type (pH, buffer, organic modifier), 
SP type, flow rate etc. will also be discussed. 
Recently nutraceutical compounds have gained 
special attention in current research in various field 
such as pharmaceutical, food chemistry, industry etc. 
Therefore analytical methods have been developed 
for qualitative and quantitative analysis utilizing LC-
MS and recently also nano-LC. Some examples of 
applications related to the analysis of nutraceutical 
compounds reported in literature will be presented 
focusing on the methodological approach [2, 4].
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PL-34: TOWARDS ADVANCED 
ELECTROANALYTICAL NANOSENSORS: A 
PROMISING TOOL FOR THE ANALYSIS OF 
PHARMACEUTICALS
Ozkan, SA.
Ankara University, Faculty of Pharmacy, Department 
of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
Nanotechnology has become very popular in the 
sensor fields in recent times. It is thought that the 
utilization of such technologies, as well as the use 
of nanosized materials, could well have beneficial 
effects for the performance of sensors. Nanomaterials 
have an impact in each and every sphere of human 
lives, from cosmetics to drug research. The small 
size, amazing nature, and unique optical absorption 
properties of nanomaterials make them quite useful 
for therapeutic applications in the pharmaceutical 
drug development, selective destruction of cancer 
cells and their selective assay. Nanoscience deals 
with the objects whose smallest dimensions range 
from several nanometers up to 100 nanometers. 
MATERIALS AND METHODS:
Nanomaterials exhibit properties that are quite different 
from those of materials at large scales. The objects 
under study in nanotechnology are the nanomaterials, 
also called as nanostructured materials. All materials 
are composed of grains, which in turn are made of 
molecules and atoms. Nanomaterials are those 
having grain sizes in the range of nanometers.
RESULTS:
The unique properties of these different types 
of nanomaterials have novel electrical, catalytic, 
magnetic, mechanical, thermal, or imaging 
characteristics. Hence, they are highly desirable 
for applications such as in medical, military, 
and environmental sectors. The currently used 
nanomaterials could be classified into four types 
as; carbon based materials, metal based materials, 
dendrimers, and composites.
CONCLUSIONS:
Using sensitive pulse methods, the electroanalytical 
studies are more regularly used on industrial, 
environmental applications and on the drug analysis 
in their dosage forms and especially in biological 
samples. The field of micro-electromechanical systems 
coupled with biosensors and nanosensors will be 
everywhere in the near future. This studies provides 
an overview of some of the important and recent 
developments brought about by the application of 
electroanalytical nanosensors based nanostructures 
to nanotechnology for both chemical and biological 
sensor development and their application examples 
on pharmaceutical and biomedical area.
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PL-35: CONTEMPORARY APPROACH 
TO EXTRACTION AND ANALYSIS OF 
BIOACTIVE COMPOUNDS - ANALYTICAL 
CHALLENGES AND CASE STUDIES.
1 Ražić, S., 2 Cvetanović, A.
1University of Belgrade – Faculty of Pharmacy, 
Department of Analytical Chemistry, Belgrade, Serbia
2University of Novi Sad - Faculty of Technology, 
Department for Biotechnology and Pharmaceutical 
Engineering, Novi Sad, Serbia.
INTRODUCTION:
Plants are promising source of biologically active 
compounds. There are many available techniques 
for extraction from natural sources. However, bearing 
in mind a priori knowledge, present requirements, 
potential risks and principals of green chemistry, the 
choice becomes very limited. With subcritical water 
extraction (SWE) we have a possibility to replace 
toxic organic solvents with benign fluids. Is it so 
good? In this work a comparison between several 
extraction techniques was done, based on analysis 
of flowers of Chamomilla matricaria L. (1). In the 
second case study SWE was applied in analysis of 
bioactive compounds from leaves, roots and fruits of 
Sambucus ebulus L. (2). The obtained extracts were 
characterized in terms of biological and chemical 
fingerprints.
MATERIALS AND METHODS:
Samples: Chamomile Ligulate Flowers and leaves, 
roots and fruits of Sambucus ebulus L.. Extraction 
techniques:  subcritical water extraction was 
compared with Soxhlet, ultrasonic-assisted and 
microwave-assisted extraction. Determination of total 
phenolics: Folin-Ciocalteu’s method. Determination 
of total flavonoids: Markham’ method. Analysis 
of polyphenolic  compounds: UHPLC-DAD-ESI-
MS/MS. Quantitative analysis: HPTLC-UV/VIS. 
Antioxidant activity of extracts was tested using the 
stable DPPH radical. Antimicrobial activity was tested 
by microdilution method and cytotoxic activity with 
several cancer cell lines.
RESULTS:
SWE was proved as an excellent choice in terms of 
its solvating properties and selectivity. In both case 
studies the subcritical water extracts exhibited a strong 
antioxidant power, enzyme inhibitory, antimicrobial, 
antiproliferative and cytotoxic properties.
CONCLUSIONS:
Contemporary analytical approach, validation of 
selected methods and confirmation of biological 
activity of analysed extracts is on a road map for new 
challenges, new solutions in order to protect human 
health and environment. 
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PL-36: NEW GENERATION OF CARBON–
BASED SENSORS IN VOLTAMMETRIC 
DETERMINATION OF BIOLOGICALLY 
ACTIVE COMPOUNDS
1 Skrzypek, S., 1 Brycht, M., 1 Konecka, K., 2 Nosal-
Wiercińska, A.
1 University of Lodz, Faculty of Chemistry, Lodz, 
Poland
2 Maria Skłodowska–Curie University, Faculty of 
Chemistry, Lublin, Poland
INTRODUCTION:
Rapidly increasing progress in the field of the 
pharmaceutical and biomedical sciences brought in a 
revolution on human health. New drugs are synthesized 
and their determination is of high importance. The 
sensitive determinations in clinical samples at low 
concentrations along with high selectivity is required 
to perform successful drug analysis. Until recently, 
principally spectrophotometric, and chromatographic 
techniques were applied to pharmaceutical analysis. 
Nowadays, the modern electrochemical methods 
are rapidly gaining popularity in the determination 
of these agents and their metabolites, and at 
the same time, they are inexpensive and highly 
sensitive. With the recent significant progress in the 
electrochemical techniques, the advancements with 
regard to instrumentation involving the development 
and application of the range of solid carbon–based 
electrodes to the detection of pharmaceutical 
preparations and biological fluids is observed. In 
this work, the different solid carbon-based working 
electrode materials were applied in the analysis 
of drugs (imatinib, teriflunimide, oxolinic acid, and 
bithionol).
MATERIALS AND METHODS:
Voltammetric measurements were performed using 
an EmStat USB potentiostat (Palm Instruments BV, 
The Netherlands) or µAutolab type II potentiostat-
galvanostat (EcoChemie, Autolab B.V., The 
Netherlands). A three–electrode system was used 
with platinum wire as counter electrode, silver chloride 
electrode as reference electrode, and a boron–doped 
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diamond electrode (BDDE, Windsor Scientific Ltd., 
United Kingdom), a bare egde plane pyrolytic graphite 
electrode (EPPGE, ALS Company Ltd, Japan) or 
EPPGE modified with graphene nanoplatelets (GNPs) 
as the working electrodes.
RESULTS:
The effect of pH on the electrochemical behavior 
of drugs was studied using DPV or SWV in Britton-
Robinson buffer solutions (pH range of 2.0–12.0). 
The impact of the influence of the DPV or SWV 
parameters was also tested. Further, the linear 
calibration curves were constructed, and a biological 
relevance of the developed DPV or SWV procedures 
was demonstrated by quantitative analysis of drugs 
in the spiked human urine samples with satisfactory 
recoveries. The influence of some interfering 
compounds and ions was also evaluated, and good 
selectivities of the proposed procedures was obtained. 
CONCLUSIONS:
The electrochemical sensors were applied for the 
sensitive and selective determinations of imatinib, 
teriflunimide, oxolinic acid, and bithionol. The sensors 
provided the excellent results for DPV or SWV 
determinations of drugs.
PL-37: SOME PERSPECTIVES FOR 
MARINE BIODISCOVERY IN IRELAND
Olivier, PT.
Marine Biodiscovery, School of Chemistry and Ryan 
Institute, National University of Ireland Galway 
(NUI Galway), University Road, H91TK33, Galway 
IRELAND
Oceans represent an appealing source of curiosity 
mainly because of the difficulties associated with 
underwater explorations. In recent years, some 
scientific landmarks have paved the way for a deeper 
understanding of the biological and chemical wealth of 
the Big Blue and today more than ever, the idea that the 
future of mankind also lies in the marine environment 
is largely accepted. Since the first explorations of the 
Commandant Cousteau in the 1960s, the interest 
towards marine biodiversity has clearly shifted from 
macro-organisms to the microworld especially when 
industrial applications industries are sought. Does 
it mean that no novelty should be expected from 
the diversity of sponges, cnidarians or other unique 
sessile invertebrates inhabiting our oceans? 
As an introduction, we will show the benefits of a 
national initiative to foster the development of Marine 
Biodiscovery in Europe. We will then scrutinize the 
potential for novelty of remote and underexplored 
maritime ecoregions with a particular focus on marine 
invertebrates from the Pacific Ocean. For instance, 
the interplay between natural product chemists and 
marine biologists might lead to a better understanding 
of the systematics and evolution of zoantharians.1 
Then, the interaction between natural product 
chemists, synthetic chemists and microbiologists 
can give some important insights into the unknown 
metabolic pathways of sponge natural products. 
These scientific data are essential not only for their 
basic applications in ecology or molecular biology but 
also because they will contribute to the sustainable 
applications of marine natural products in industry.
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PL-38: DOES ENVIRONMENTAL CADMIUM 
INCREASE THE RISK OF PANCREATIC 
CANCER
Matovic, V., Buha, A.
University of Belgrade-Faculty of Pharmacy, 
Department of Toxicology “Akademik Danilo 
Soldatović”, Belgrade, Serbia
INTRODUCTION:
Pancreatic cancer (PC) is one of the most lethal 
human cancers and hence, an aggressive 
worldwide health concern (1). Although profoundly 
studied, its etiology is still rather scant. Exposure to 
environmental cadmium (Cd), a ubiquitous metal with 
well-established toxic and carcinogenic properties, 
has been hypothesized to one putative cause of PC 
(2,3). This case-control prospective study determined 
Cd levels in tissues from pancreatic cancer patients 
with the aim to determined Cd levels in pancreatic 
tissue.
MATERIALS AND METHODS:
The cases were a consecutive series of pancreatic 
tissue excised from 31 patients with no previous 
occupational exposure to Cd and a histologically 
based diagnosis of PC, while as controls, pancreatic-
tissue samples were taken during routine postmortem 
examinations from 29 accidental fatalities or subjects 
who died from a nonmalignant illness. Tissue samples 
were wet digested and Cd content was assessed using 
graphite furnace atomic absorption spectrometry. 
RESULTS:
Cd content in cancer tissue significantly differed from 
the content in controls. High concentrations of Cd 
(1.27-18.64 μg/g) were found in cancerous tissue 
when compared to control levels (0.27-2.50 μg/g) with 
median concentration almost 30 times higher in cancer 
samples. Furthermore, Cd content in cancerous 
tissue was three times greater than in surrounding 
non-cancerous tissue (P<0.05). Interestingly, Cd 
levels were significantly higher even in surrounding 
non-cancerous tissue when compared to the controls. 
Furthermore, a dose-response relation between 
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Cd exposure i.e. Cd levels in pancreatic tissue and 
pancreatic cancer risk was observed, since odds ratio 
levels were 2.79 (95% CL 0.91-8.50) and 3.44 (95% 
CL 1.19-9.95) in the third and fourth quartiles of Cd 
distribution in the population, respectively. 
CONCLUSIONS:
Results of this study indicated a significant association 
between PC development and Cd exposure. However, 
further investigations are needed to achieve a better 
understanding of the environmental Cd involvement 
in PC which could facilitate its prevention, diagnosis, 
and therapy.
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PL-39: DEVELOPMENT OF NEXT 
GENERATION GALETERONE ANALOGS 
FOR PROSTATE AND PANCREATIC 
CANCERS THERAPY
Njar, V.C.O.
Department of Pharmacology, and Center for 
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Greenebaum Comprehensive Cancer Center, 
University of Maryland School of Medicine, 685 west 
Baltimore Street, Baltimore, MD, 20201, USA. 
My talk will focus on the development of the next 
generation galeterone analogs (NGGAs). Galeterone 
(Gal) progressed into pivotal Phase III clinical trial 
in patients with metastatic castration-resistant 
PC (mCRPC) whose tumor cells express splice 
variant AR-V7 (ARMOR3-SV). However, the recent 
termination of this trial (due to trial design flaws) 
and the required 2550 mg/day high therapeutic dose 
of gal underscores the need to further systematic 
refinements to enable development of the NGGAs 
with enhanced efficacies and high therapeutic 
indices at low dose-administration expected to 
result in safer, more effective treatments across 
all stages/forms of PC. During studies to develop 
NGGAs to modulate androgen receptor (AR/AR-
V7) signaling in PC models, we discovered that gal 
and its new more efficacious analogs (VNPP414 
and VNPP433-3β) also effectively target oncogenic 
eukaryotic protein translation, via modulation of Mnk-
eIF4E axis. These compounds suppress oncogenic 
peIF4E via degradation of Mnk1 and Mnk2. The AR/
AR-V7 and Mnk1/2-eIF4E signaling pathways are 
implicated in PC and pancreatic cancer (pancreatic 
ductal adenocarcinoma, PDAC) disease progression/
metastasis and associated with drug-induced 
resistance in these two cancers. The properties and 
mechanisms of action of the lead NGGAs in clinically 
relevant in vitro and in vivo models of prostate and 
pancreatic cancers and their translational potential 
will be discussed.
PL-40: NANOPARTICLES DRUG DELIVERY 
IN CANCER 
Al-Jamal W.T.
Queen’s University Belfast, School of Pharmacy, 
Northern Ireland, United Kingdom
Most cancer chemotherapeutics lack tissue specificity, 
resulting in many undesirable side effects. Selective 
drug delivery to tumour tissues could ultimately 
increase local drug concentrations at the tumour 
without the need to escalate the administered doses 
in patients. A wide range of drug delivery systems 
has been developed to alter the pharmacokinetics of 
drug molecules, and enhance their tumour targeting. 
Furthermore, several approaches have been explored 
to increase drug bioavailability at the site of action, 
utilising either the unique characteristics of the tumour 
microenvironment, such as overexpressed enzymes, 
acidic pH, and hypoxia, or using external triggers, 
such as heat, ultrasound, and light. This talk will give 
an overview of the latest nanoparticles that we have 
developed in our laboratory to enhance the tumour 
accumulation of anticancer drugs. 
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PL-41: THE FUTURE OF PERSONALIZED 
MEDICINE: MICROPHYSIOLOGICAL 
SYSTEMS (ORGAN-ON-A-CHIP) AND 
3D-BIOPRINTING
1,2 Elçin, Y. M.
1 Tissue Engineering, Biomaterials & 
Nanobiotechnology Laboratory, Ankara University 
Faculty of Science, Ankara, Turkey (www.elcinlab.
org)
2 Biovalda Health Technologies, Inc., Ankara, Turkey 
(www.biovalda.com.tr)
Personalized medicine, also termed precision 
medicine, is a new type of therapeutic procedure in 
which treatment is tailored for an individual patient. 
In this modality, medical decisions, practices, and 
products are customized to the individual patient 
based on the predicted response or risk of disease 
(1,2). This involves harnessing of the individual’s 
genetic and epigenetic information to customize 
drug therapy or preventive care. Microphysiological 
systems based on engineered tissue templates (so 
called the organ-on-a-chip systems) have come into 
prominence as three-dimensional (3D) microfluidic 
cell cultures simulating physiological responses and 
activities of organs/organ systems, and as novel 
in-vitro multicellular human organism models for 
toxicology, drug discovery and personalized medicine 
research (1). It is anticipated that organ-on-a-chip 
systems will address the challenging pharmacological 
and physiological gaps between humans, animal 
models and classical monolayer cultures. Mimicking 
the conditions of tissues or organ systems is a 
step forward to multi-organ systems known as the 
body-on-a-chip. This approach recapitulates organ 
functions under biomimetic conditions for “micro-
organs” inter-connected with microfluidic channels 
that serve as arterial and venous lines. 3D-Bioprinting 
systems are used to develop microconstructs having 
optimal micro-architecture and cell positioning 
with the aid of biological molecules and cells with 
a carrier bioink in gel form (3-5). Both technologies 
demand tissue-engineering expertise, as they 
involve use of cells, biochemical molecules, and 
tunable microenvironments. While the ultimate goal 
of 3D-bioprinting is to engineer personalized human 
tissues and organs for transplantation, in the current 
time it is harnessed to develop better functional 
organ-on-a-chip systems.
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OP-001: ALBUMIN-BASED 
NANOPARTICULATE DRUG DELIVERY 
SYSTEMS 
Ilem Ozdemir, D., Ozgenc, E., Ekinci, M., Gundogdu, 
E., Asikoglu, M.
Ege University, Faculty of Pharmacy, Department of 
Radiopharmacy, Izmir, Turkey
INTRODUCTION:
Nanoparticles (NPs) are colloidal drug delivery 
systems which have advantages like improving 
bioavailability, increasing drug resistance time, 
targeting the drug to a specific location in the body (1)
the quality of different HSA batches was analysed by 
size exclusion chromatography (SEC. The objective 
of the study is to develop new human serum albumin 
(HSA) based NPs which can be used as potential 
radiopharmaceutical drug delivery system.
MATERIALS AND METHODS:
Several process parameters were examined to 
achieve a suitable size of NP such as dissolution 
medium, pH, HSA and crosslinker concentration. 
Briefly, HSA was dissolved in purified water or 10 mM 
NaCl solution, adjusted to pH 7-9. Under constant 
stirring, desolvating agent was added drop wisely. 
After a desolvation process, 8% glutaraldehyde 
solution was put into the system to induce particle 
cross-linking. The resulting NPs were purified by 
centrifugation and particle yield was calculated. The 
particle size, zeta potential, polydispersity index (PDI) 
of NPs were measured by using a Zetasizer Nano ZS. 
RESULTS:
According to the particle size, zeta potential, 
polydispersity index (PDI) and particle yield results, 
the ideal formulation (228,2±49,051 nm, -26,53 ±9,74 
mV, 0.138± 0.05) was obtained with 150 mg HSA 
in 10 mM NaCl, 8mL desolvating agent and 35 µL 
crosslinker at pH 9. 
CONCLUSIONS:
HAS NPs were prepared by modification of a 
desolvation technique which described previously (2). 
In our experiments, the effects of varying production 
parameters on NP properties were studied. Although 
the interrelationships between the mentioned 
parameters are complex, pH was found as the most 
influencing parameter on NP size. 
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OP-002: THE EFFECT OF POLY VINYL 
PYRROLIDONE AND MACHINE SETTING 
(DPI) ON THE SKIN PERMEATION OF 
INDOMETHACIN LOADED TO FILMS BY 
PEIZOELECTRIC INKJET PRINTER
1 Arshad, MS., 1 Shahzad, A.,2 Ahmad Z., 2 Nazari, K., 
3 Hussain, A.
1 Bahauddin Zakariya University, Faculty of 
Pharmacy, Multan Pakistan
2 De Montfort University, Leicester School of 
Pharmacy, Leicester, United Kingdom
3 University of the Punjab, College of Pharmacy, 
Lahore, Pakistan.
INTRODUCTION:
The application of inkjet printing has been favoured 
as a methodology for personalized medication for 
last one decade (1). The technique is of particular 
interest for drug delivery to special need groups 
such as pediatrics where in smaller dose of medicine 
to be administered (2). This techniques has been 
evaluated for the properties of substrate affecting 
the performance of printed drug (3). Purpose of this 
study was to explore the application of piezoelectric 
inkjet technology in customized drug delivery to the 
laboratory animals.
MATERIALS AND METHODS:
Alcoholic solutions of Indomethacin with or without 
PVP were printed onto polymeric sheets using a 
commercial Inkjet printer. Drug loading was varied 
by selecting a different dot per inches (DPI) onto 
the dermal Patches of 2×2 cm². The printed patched 
were evaluated for drug morphologies loading in-
vitro release and ex-vivo skin permeation and anti-
inflammatory effects using hind paw inflammation 
model.
RESULTS:
Dermal patches 2×2cm² sprayed at 96, 300 and 600 
DPI were calculated to contain indomethacin 3.33ug, 
32ug and 130.176ug respectively. In vitro release 
studies showed 60 to 70% of loaded drug was released 
in the dissolution medium drug release being higher 
in the patches loaded with drug solution containing 
PVP. The SEM results revealed that indomethacin 
loaded from its alcoholic solution crystallized following 
solvent evaporation while the drug solution with PVP 
lack or minimally contain drug crystals. The results 
of drug permeation studies performed through rat 
skin using modified Franz diffusion cell recorded 
permeation of 40 to 50% of loaded drug. Patches 
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demonstrated a significant anti-inflammatory activity 
as compared to blank films evaluated by hind paw 
inflammation model.
CONCLUSIONS:
The personalized medication can be achieved by 
controlling the amount of drug loading through an 
inkjet printer head by selecting suitable droplet 
density. Desired Physicochemical form of drug can 
be achieved by including appropriate excipient in the 
formulation.
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OP-003: CLINICAL PHARMACY SERVICES IN 
INTERNAL MEDICINE UNIT
1 Balli, FN., 1 Kandemir, EA., 1 Kara, E., 1 Demirkan, 
K., 2 Sain Guven, G.
1Hacettepe University, Faculty of Pharmacy, 
Department of Clinical Pharmacy, Ankara
2Hacettepe University, Faculty of Medicines, 
Department of Internal Medicine, General Internal 
Medicine, Ankara
INTRODUCTION:
In Hacettepe University Hospitals, clinical pharmacy 
postgraduate program students participate in 
clinical visits with physicians and other health care 
professionals, thus they provide clinical pharmacy 
services. The treatments of patients were reviewed 
by pharmacists in order to provide rational drug use 
and to identify drug related problems. The aim of this 
study was to explore the role of clinical pharmacist in 
pharmaceutical care of internal medicine in patients.
MATERIAL AND METHODS:
Hospitalized patients were followed up between 22 
December 2017 and 23 February 2018 in the Internal 
Medicine ward of Hacettepe University Hospitals. 
The data were collected from patient file, hospital 
information database (Nucleus®) and via verbal 
communication with patients and physicians. Three 
postgraduate students of clinical pharmacy program 
were participated in clinical visit. They collected data, 
evaluated patients and provided interventions about 
problems related to drug therapy. 
RESULTS:
In this study, 39 (%46.4) women, a total of 84 
patients of whom the median age was 58 years 
(18-97 years) were included. The most observed 
admission reason was dyspnea associated with 
pneumonia, asthma/COPD. Median drug number 
per patient was 6 (0-21). Pharmacists made 15 
recommendations, of those 14 (%93.3) were accepted 
and 12 (%80,0) recommendations were applied.The 
recommendations were about drug-drug interactions 
(n=7), switching drugs (n=3), dose adjustment (n=2), 
drug-food interactions (n=1), non-treated indication 
(n=1) and discontinuation of the drug (n=1). Besides 
that, with the request of physicians, the clinical 
pharmacists provided information about steroid side 
effects, usage and interactions of enoxaparin and 
warfarin, penetration profiles of antibiotics into the 
bile and interactions between clopidogrel and protein 
pump inhibitors. 
CONCLUSION:
Clinical pharmacy services can improve the patient 
care, prevent the drug related problems and reduce 
the workload of physicians. With clinical pharmacy 
specialists regularly visiting clinics, rational use of 
drugs can be achieved.
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OP-004: CLINICAL PHARMACY PRACTICES 
IN PSYCHIATRY SERVICES AND 
OUTPATIENT CLINICS
Yalcin, N., Kelleci Cakir, B., Surmelioglu, N., Celiker, 
A.
Hacettepe University Faculty of Pharmacy, 
Department of Clinical Pharmacy, Ankara, Turkey
INTRODUCTION:
Problems in drug administration such as dose 
adjustment, drug/medication adherence, 
polypharmacy, monitoring of serum levels, drug 
interactions, adverse effects and complications 
etc. are very common in psychiatry services and 
outpatient clinics (1).
MATERIALS AND METHODS:
Between January 2016 and June 2017, 22 patients 
were consulted to the clinical pharmacist by 
physicians and nurses working in the psychiatry 
service and outpatient clinic. The consultations were 
evaluated whether the recommendation was accepted 
or refused. Subsequent problems were categorized.
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RESULTS:
Twenty-one (95.45%) of the recommendations were 
accepted by physicians and nurses. When drug-
related problems are classified; drug administration 
time (6, 27.2%), drug administration (4, 18.2%), drug 
interactions (4, 18.2%), adverse effects (3, 13.6%), 
inappropriate dosing (2, 9.1%), drug formulation (2, 
9.1%) and polypharmacy (1, 4.6%) were determined. 
When suggestions made to the problems are 
classified, regulation of drug administration time 
(8, 36.4%), drug administration form (crushing/
splitting) (4, 18.2%), alternative drug (3, 13.6%), dose 
adjustment (2, 9.1%), formulation change (1, 4.6%) 
and clinical follow-up (1, 4.6%) were applied. Three 
of the consultant patients (3, 13.6%) did not have any 
problems and no intervention was reported. 
CONCLUSION:
Drug-related problems can be minimized and 
workload of physicians and nurses can be reduced 
with the contribution of clinical pharmacy services.
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OP-005: THE EVALUATION OF 
PHARMACEUTICAL CARE SERVICES 
FOR CORTICOSTREOID THERAPY IN 
COMMUNITY PHARMACIES IN TURKEY
Ertuna, E.
Ege University, Faculty of Pharmacy, Department of 
Clinical Pharmacy, Bornova – Izmir, Turkey
INTRODUCTION:
Corticosteroids are used in outpatient setting for 
treatment of various diseases including asthma, 
chronic obstructive pulmonary disease (COPD), 
rheumatologic conditions, severe psoriasis, adrenal 
insufficiency and prevention of host versus graft 
reactions. Delivery of patient-centred pharmaceutical 
care by pharmacists ha been shown to improve 
therapy outcomes for many conditions including 
asthma, COPD and rheumatologic diseases [1-
3]. The purpose of this study was to determine and 
evaluate pharmaceutical care services provided by 
community pharmacists in systemic or high-dose 
inhaled corticosteroid therapy management in Turkey.
MATERIALS AND METHODS:
A self-administered survey was completed by 
community pharmacists between March and April 
2018. Collected data included demographics, 
self-reported knowledge about corticosteroids, 
related adverse events, patient counselling and 
pharmaceutical care activities.
RESULTS:
100 community pharmacists completed the survey. 
32% of pharmaceutical care and patient counselling 
services provided by participating pharmacists was 
about corticosteroids. Only 46% of the pharmacists 
agreed/strongly agreed that they have enough 
knowledge about corticosteroids and their indications. 
79% agreed/strongly agreed that the patients did 
not have enough knowledge about their drugs and/
or therapies. However, 79% of the pharmacists 
reported that they did not hand out written information 
to patients about their therapy. Common reasons 
for patient counselling request about corticosteroids 
included administration information (85%), adverse 
events (54%), compliance issues (44%), dietary 
advice (44%), alternative therapies to corticosteroids 
(37%), drug interactions (35%), disease information 
(29%) and preventive measures against adverse 
events (26%). 76% of pharmacists always/usually 
gave information about healthy nutrition with calorie 
and salt restriction to the patients. Only 24% of the 
pharmacists always/usually informed the patients 
taking corticosteroids about immunisation and other 
preventive measures against infection. 71% of the 
pharmacists warned their patients against detrimental 
effects of abrupt discontinuation of corticosteroids. 
Only 19%, 22%, 21% and 36% of pharmacists always/
usually referred the patients to their physician for 
annual eye exams, cardiovascular risk assessments, 
diabetes/blood glucose assessment and osteoporosis 
and bone health assessment, respectively.
CONCLUSIONS:
Pharmacists should be encouraged to keep their 
knowledge up to date regarding the aforementioned 
counselling issues in Turkey. Community pharmacists 
must implement pharmaceutical care interventions 
more proactively. Supporting counselling services 
with written information leaflets and improving referral 
rates to physicians for routine assessments might 
improve the quality of care. Further studies are 
warranted to determine the best possible strategy to 
improve therapy outcomes, patient safety and quality 
of care.
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OP-006: EXPRESSION, ACTIVITY AND 
DRUG INTERACTIONS OF MRP1 IN HUMAN 
DISTAL LUNG EPITHELIAL CELLS IN VITRO
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1. University of Kufa, Faculty of Pharmacy, Al-Najaf, 
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INTRODUCTION:
Multidrug resistance-associated protein 1 (MRP1) is 
highly expressed in human lung tissues (1). However, 
lower MRP1 expression was observed in bronchial 
biopsies from chronic obstructive pulmonary disease 
(COPD) patients in comparison to healthy controls 
(2). The aims of this project were to investigate the 
expression, subcellular localisation and activity of 
MRP1 in freshly isolated human alveolar epithelial 
type 2 (AT2) and type 1-like (AT1-like) cells in primary 
culture and in the NCI-H441 cell line. Moreover, the 
effect of inhaled drugs and tobacco smoke extract 
(CSE) on MRP1 expression and activity was studied.
MATERIALS AND METHODS:
MRP1 expression in AT2 and AT1-like cells from three 
different patients as well as over the course of 30 
passages of NCI-H441 cells was studied using q-PCR 
and immunoblot. Confocal laser scanning microscopy 
and cell surface biotinylation were used to confirm 
transporter localisation. Transporter activity was 
assessed by bidirectional transport and efflux studies 
of the MRP1 substrate, 5(6)-carboxyfluorescein (CF). 
Furthermore, the effect of budesonide, salbutamol 
and CSE on MRP1 expression and CF efflux were 
investigated.
RESULTS:
MRP1 protein abundance increased upon 
differentiation from AT2 to AT1-like phenotype, 
however, ABCC1 gene expression remained 
constant. MRP1 was stably expressed in NCI-H441 
cells at similar levels to those in AT1-like cells. The 
transporter was localised to the basolateral cell 
membranes. Bidirectional transport studies across 
monolayers of AT1-like and NCI-H441 cells showed 
MK-571 sensitive net absorption of CF. Budesonide 
decreased CF efflux at a concentration-dependent 
manner, without influencing MRP1 expression, 
whereas salbutamol had no effect. Despite causing 
a significant increase in MRP1 abundance, CSE 
exposure resulted in a significant and dose-dependent 
decrease in CF efflux. 
CONCLUSIONS:
MRP1 increases upon transdifferentiation of AT2 
to AT1-like cells in primary culture. In AT1-like and 
NCI-H441 cells, transporter expression levels, 
localisation and activity are comparable. Thus, the 
cell line is a useful in vitro model to study MRP1 in 
distal lung epithelium. Furthermore, budesonide and 
CSE reduce MRP1 activity in vitro.
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OP-007: CORRELATION BETWEEN 
METABOLOMIC PROFILING AND 
ANTIOXIDANT ACTIVITIES OF METHANOLIC 
EXTRACTS FROM 8 CULTIVATED 
MEDICINAL PLANTS
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Department of Pharmacognosy, Ankara, Turkey
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INTRODUCTION:
Free radicals and reactive oxygen species play an 
important role on many diseases such as inflammatory 
disorders and cancer. in this study, we aimed to 
investigate the antioxidant activity and to evaluate 
the correlation between metabolomic profiling and 
antioxidant activity.
MATERIALS AND METHODS:
In this study methanolic extracts of 8 cultivated 
plant material (Achillea millefolium, A. filipendulina, 
Mentha piperita, Nigella damascena, N. sativa, Salvia 
officinalis, Silybum marianum, Echinacea purpurea) 
are used to determine antioxidant activity. Different 
assays (ABTS, DPPH, NO, FRAP, CUPRAC) 
were chosen to investigate different antioxidant 
mechanisms. Finally univariate, multivariate and 
correlations analysis were applied to evaluate 
correlation between metabolomic profiling and 
antioxidant activity. 
RESULTS:
Antioxidant activity results, at 100 µg/mL concentration 
are (with the order DPPH, ABTS, NO, FRAP (KEAK), 
CUPRAC (GAEAK)) A. millefolium (1.34, 42.52, 
20.19, 188.09, 118.2), A. filipendulina (24.12, 64.29, 
22.98, 223.81, 150.39), M. piperita (91.5, 79.76, 
31.99, 605.9, 485.39), N. damascena (0, 4.93, 16.46, 
83.33, 31.46), N. sativa (0, 11.22, 19.57, 92.86, 
13.96), Salvia officinalis (58.89, 84.01, 25.47, 417.24, 
389.59), Silybum marianum (0, 7.99, 13.35, 150.57, 
72.91), Echinacea purpurea (0, 17.18, 26.09, 141.05, 
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59.68). Also the metabolomics analysis of eight 
cultivated plant has been performed by using gas 
chromatography-mass spectrometry (GC-MS). After 
deconvolution and aligned of the chromatograms, 
279 mass spectral features have been detected and 
129 of them were annotated using retention index 
libraries. 
CONCLUSIONS:
It is a fact that synergy and antagonism play an 
important role of the whole metabolite instead of 
single metabolite. Therefore, we compared the 
whole metabolomic profile of different species and 
antioxidant activity in order to find metabolites 
that have negative positive activity. We found 12 
metabolites have negative correlation between 
metabolites levels and antioxidant activity, while 69 
positive correlation (r > 0.70). 15 metabolites are 
common for positive and no metabolite is common for 
negative correlation of 8 plants. 
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INTRODUCTION:
In metabolomics and fluxomics, the purpose is to 
identify and quantify as much as metabolites in a 
biological system, although, analytes in a metabolomic 
sample comprise highly complex mixture. GC-MS is 
one of the most powerful techniques and commonly 
used in metabolomics studies. The main advantages 
of GC-MS are its high chromatographic separation 
power, high peak capacity, reproducible retention 
times, robust quantitation, high selectivity and 
sensitivity, and fast compound identification. There 
has been an increasing interest in reducing running 
costs and environmental stress in many analytical 
laboratories as well as in GC-MS analysis. GC-MS 
uses helium as the carrier gas, which offers high 
chromatographic resolution at a wide range of flow 
rates. Morover the other consumables may also 
reduced with shorter analysis time. In this study, we 
investigated the effect of analysis time on metabolomic 
and fluxomic studies as means of addressing the 
number of mass future detected and repeatability of 
the method.
MATERIALS AND METHODS:
Metabolomic and fluxomic (18O based labeling for 5 
min) analysis were performed on Caco-2 and FHC 
cell lines. A 200 µL of Caco-2 and FHC cell extracts 
was evaporated to dryness in a vacuum dryer 
concentrator and methoxyamineted and derivatized 
MSTFA with 1% TMCS. Analysis was performed 
using GC-MS (Shimadzu GCMS-QP2010 Ultra) 
with DB-5MS stationary phase column (30 m +10 m 
duraguard × 0.25 mm i.d. and 0.25-µm film thickness). 
Three different oven temperature programing were 
used for long run time (60 min), standard analysis 
time (37 min) and short analysis time (25 min). Once 
analysis completed, the complex chromatograms 
were deconvoluted using AMDIS and the retention 
time correction and data matrixes creation were done 
using SpectConnect software. 
RESULTS:
After deconvolution and aligned of the chromatograms, 
the mass spectral features have been detected 244, 
306 and 305 for short, standard and long run time, 
respectively. The overall repeatability (RSD %) of the 
methods was around 25%. The numbers of missing 
mass features in data matrix were 7.08% for short, 
6.58% for standard and 9.21% for long analysis time. 
CONCLUSION:
The analysis time effects on untargeted (metabolomic) 
and targeted (fluxomic) analysis were compared. 
According to these results, it was found that the long 
analysis time gave better selectivity and repeatability 
for fluxomics analysis. For metabolomic analysis, 
the repeatability and the number of missing mass 
features were close to for three methods. However, 
the number of metabolites analysed is 20% higher in 
normal and long run time methods compare to shorter 
analysis time.  It can be concluded that long runtime 
can be used for fluxomic analysis and standard run 
time can be used for metabolomic studies. 
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INTRODUCTION:
Seaweeds are photosynthetic-like plants and either 
microalgae or macroalgae vegetative organisms. 
Around of the world, there are approximately 9000 
seaweed species, which are broadly classified into 
three main groups based on their pigmentation: 
brown (Phaeophyta), red (Rhodophyta) and green 
(Chlorophyta) seaweeds (1). Also, in Turkey, algae 
includes about 5000 species and 600 bibliographies 
and distribution record. Seaweeds have been 
reported as one of the rich source possessing novel 
bioactive compounds such as polyunsaturated fatty 
acids, vitamins, sterols, amino acids and minerals 
with the variety of biological active such as antitumor, 
antiviral, antifungal, insecticidal, cytotoxic, phytotoxic 
and antiproliferative actions (2).
Literature review on the chemistry of seaweeds 
mentioned the bioactive compounds and biological 
activity but, at the present time investigations on 
the composition and structure of biologically active 
compounds have increased (3). In the literature, 
there is no published record on the volatile chemical 
composition by SPME and antimicrobial activity of the 
solvent extracts of C. barbata.
MATERIALS AND METHODS:
In this study, C. barbata, as a brown seaweed was 
obtained volatile oils by SPME and hydrodistillation 
and antimicrobial activity tests were done. C. barbata 
was collected from Akliman location, Sinop coast, 
Turkey in November 2017, and identified by Ali 
Karacuha. Antimicrobial activity tests were done 
according to the literature (4). All test microorganisms 
were as follows: E. coli ATCC 25922, P. aeruginosa 
ATCC 27853, S. aureus ATCC 25923, B. cereus 
10876, C. albicans ATCC 10231 and methicillin 
resistant S. aureus.
RESULTS:
The essential oil of C. barbata was identified by SPME 
and hydrodistillation representing 99.9% and 99.81% 
of the total oil, respectively. Main component class 
in SPME analysis; 54.48% hydrocarbon, 18.93% 
aldehyde; Clevenger extract was found to contain 
51.88% aldehyde, 25.23% terpene and terpenoid 
compounds. According to antimicrobial activity studies 
exracts of C. barbata showed good activity against S. 
aureus, MRSA, E. coli.
CONCLUSIONS:
The quantitative and qualitative determination of 
essential oils of C. barbata showed that major 
constituents were hydrocarbon (54.48%) and 
tetradecane (16.38%) in SPME analyses and 
aldehydes (51.88%) and hexanal (27.27%) in 
hydrodistillation, respectively. 
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INTRODUCTION:
Use of polysaccharide based chiral selectors (CS) in 
combination with superficially porous silica particles 
(SPS) was first reported by our group (1). Resulting chiral 
stationary phase (CSP) showed distinct advantages 
over columns prepared with fully porous silica 
(FPS). Later was also shown use of polysaccharide 
based SPS CSP in nano-liquid chromatography and 
capillary electro chromatography. For first studies 
cellulose tris(4-chloro-3-methylphenylcarbamate) 
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was used as CS, in recent ones, amylose tris(3,5-
dimethylphenylcarbamate, (ADMPC) and cellulose 
tris(3,5-dimethylphenylcarbamate, (CDMPC)(2).
MATERIALS AND METHODS:
Benzoin, trans-stilbene oxide, Tröger’s base and 
Etozoline where used as chiral compounds for this 
study. ADMPC and CDMPC where used as chiral 
selectors. 2.8 μm SPS particles where coated by 
CDMPC while 3.6 μm SPS particles were coated 
with a ADMPC using method described earlier(1). 
n-Hexane, 2-propanol and methanol was used as 
mobile phase. Experiments where conducted on 
Agilent 1290 Infinity UHPLC system.
RESULTS:
The enantiomers of Tröger’s base where marginally 
resolved on the FPS-based column in contrasts to 
almost baseline resolved on the column packed with 
SPS-based CSP, while both CSPs were prepared with 
the same percentage content (w/w) of chiral selector. 
This significant difference in resolution was observed 
along with higher retention time but lower retention 
factor (k = 0.83) on the FPS-based CSP compared to 
the SPS-based CSP (observed retention factors for 
the latter were k1= 0.95 and k2= 1.15).
SPS CSP’s showed better separations especially at 
high speeds of mobile phase (5 ml/min) it is possible to 
coat small amount of CS on SPS particles to get very 
fast separations. In case, when 2 % (w/w) ADMPC 
was coated on 3.6 μm SPS particles, baseline 
separations of all four tested chiral compounds was 
achieved under 30 seconds of analysis time.
CONCLUSIONS:
 The results of this study indicate that a combination 
of polysaccharide based chiral selectors with 
superficially porous silica is a very useful approach 
for the preparation of highly efficient chiral stationary 
phases for HPLC enantioseparations. When working 
with adequate instrumentation the decrease in column 
performance at higher flow rates is minimal and highly 
efficient separation of enantiomers can be achieved 
with the analysis time in the range of 15–30 s.
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INTRODUCTION:
Campanula latifolia L. is a species of Campanulaceae 
family and grows in western Asia and Europe, which 
has a total of 8 genera and 160 species in Turkey 
(1). In this work, volatile and phenolic constituents, 
antioxidant and enzyme inhibition of essential oil (EO) 
and solvent extracts (n-hexane, acetonitrile, methanol 
and water) obtained from Campanula latifolia L. 
subsp. latifolia were investigated. 
MATERIALS AND METHODS:
The plant (195 g) used in this study was collected 
from Ataköy-Çaykara, Trabzon (560 m). Essential oil 
(0.0723 g) of plant (grounded, 132 g) was obtained 
by Clevenger method (3 h, at -15 °C, cooling bath). 
Plant (10 g, each) was extracted separately with 
n-hexane, acetonitrile, methanol and water (15 mL 
x 3 times, each) and the extracts were combined 
and evaporated to give 0,1096 g, 0,0540 g, 0,2310 
g, and 0,6137 g crude extract, respectively. Phenolic 
compound analyzes were performed using the 
Prominence series HPLC apparatus using the 
previously developed method. Zorbax Eclipse 
Plus-C18 (150 mm × 4.6 mm, 5 μm) was used as the 
analytical column. The mobile phase forms methanol 
(A, 2% acetic acid solution (pH: 2.65) and water (B). 
The sample injection volume was 20 μL and the flow 
rate was 1.5 mL / min. The column oven temperature 
was set at 25 ° C. The photodiode array detector 
was used at 270 nm wavelength. Comparative 
volatile organic compound analyses for the essential 
oil (0.0723 g), SPME (1 g) and SPME of n-hexane 
extract (0.0896 g) of the plant were made by GC-FID/
MS method.
RESULTS:
GC-FID/MS analyzes for EO, SPME, and SPME of 
the hexane extract of the plant revealed 36, 31 and 36 
natural compounds and n-hexanal (23.1%), limonene 
(44.0%) and 1,2,3-trimethylbenzene (27.4%) were 
found as major compounds, respectively. Acetonitrile 
extract showed higher antioxidant activity (266.16 ± 
2.94 (IC50 µg/mL, DPPH), 84.77 ± 3.59 (µM QEE/g, 
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PRAP), 124.02 ± 3.95 (µM BHAE/g, FRAP) than 
other extracts. In addition, tyrosinase inhibition, 
acetylcholinesterase and α-glucosidase enzymes 
activities was highest in acetonitrile and methanol 
extracts, and the inhibition results were 53.41 ± 
0.64, 100.94 ± 3.59 and 30.42 ± 1.04 μg / mL, 
respectively. Phenolic compounds in solvent extracts 
were analyzed by HPLC which revealed 7 phenolic 
compounds in amounts of 0.1-2.2 mg/g, respectively. 
CONCLUSIONS:
Limonene (44.0%) found to be major compound in 
the SPME and 4-hydroxybenzoic acid, vanillic acid, 
syringic acid, coumaric acid, sinapic acid, benzoic 
acid and quercetin were the identified phenolic 
compounds. Acetonitrile extract showed better 
antioxidant activity than other extracts. α-Glucosidase 
enzymes activity was highest in methanol extract 
which was better then used standard.
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INTRODUCTION:
Sevelamer Carbonate is effective for the control of 
hyperphosphatemia in patients. The efficacy of the 
drug is determined by measuring the phosphate 
binding capacity (1). In this study, in vitro equilibrium 
binding and in vitro kinetic binding studies were 
performed for test product and reference product 
to demonstrate the bioequivalence study by 
determining the phosphate binding capacity by ion 
chromatography.
MATERIALS AND METHODS:
The equilibrium binding study is considered the pivotal 
bioequivalence (BE) study and the kinetic binding 
study is used to support the pivotal equilibrium binding 
study (2). Starting from published study (3), we 
developed approach for the in vitro efficacy evaluation 
of Sevelamer Carbonate. Analyses were performed 
using validated method by Ion Chromatography. The 
equilibrium binding study which is performed under 
conditions of constant time and varying concentrations 
of phosphate solution was conducted by designing 
the test and reference products with eight different 
phosphate concentrations ranged from 1 mM to 40 
mM with and without acid pre-treatment. For kinetic 
binding study, two constant phosphate concentrations 
at pH 4.0 and pH 7.0 were designed with the test and 
reference products at eight different times. 
RESULTS:
Langmuir binding capacity constant (k2) and affinity 
constant (k1) were calculated with respect to 
equilibrium binding study results. The 90% confidence 
interval for k2 ratio determined by statistical analysis 
using SAS® statistical software (Version 9.4,SAS 
Institute Inc, USA). According to FDA Draft Guidance 
on Sevelamer Carbonate, the 90% confidence interval 
for k2 ratio meet an acceptance criteria of within 80% 
to 120% for both pH conditions (2). In the kinetic 
binding study, the ratio of test product / reference 
product bound phosphate was compared. 
CONCLUSIONS:
The comparative equilibrium and kinetic in vitro 
phosphate binding study of Sevelamer Carbonate is 
proved the bioequivalence between reference and 
test product which developed and produced in Abdi 
İbrahim R&D center.
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INTRODUCTION:
Diarrhea is defined as frequent and watery defecation 
syndrome(1), a serious cause of neonate morbidity 
and mortality (2). It leads to both the water and 
electrolyte loss, varying depending on age and 
nutritional factors (3) Various causes, especially 
infectious diseases, can lead to diarrhea (4) 
Worldwide, more than 520.000 children under five die 
each year from  diarrhea.(5)
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MATERIALS AND METHODS:
In this study, we researched the effects of Bacillus 
subtilis and Bacillus amyloliquefaciens strains on 
antibiotic-induced diarrhea model in rats. Within the 
research, total aerobic mesophilic, total anaerobic 
mesophilic and total lactic acid bacteria analyses 
were performed on the stool samples taken from 
non- diarrheic, diarrheic and probiotic-administered 
diarrheic rats. 
RESULTS:
The number of bacteria found in normal flora and 
antibiotic-inhibited flora was compared with the 
number of bacteria found in flora with Bacillus 
spores added, and it was determined that the latter 
inhibited the lactase-positive enteric bacteria and 
Staphylococcus and Micrococcus re-growth but did 
not prevent resettling of the anaerobic bacteria on the 
flora. In addition, when the total aerobic mesophilic 
bacteria counts were compared, it was found that a 
2-log increase originated from the Bacillus species.
CONCLUSIONS:
Biological activity and morphometry findings indicated 
that the probiotic product prepared from the B. 
subtilis strain was highly effective in the microbial and 
antibiotic-associated diarrhea. It is therefore believed 
that significant medical and economic contributions 
will be provided through this study’s complete 
analysis of the new probiotic product, which can be 
used in the treatment of various disorders, such as 
Clostridium difficile infection, irritable bowel syndrome 
and inflammatory bowel diseases.
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INTRODUCTION:
The enantiomer migration order (EMO) of 
enilconazole in the presence of various cyclodextrins 
(CDs) was investigated by capillary electrophoresis 
(CE). Opposite EMO of enilconazole were observed 
with β-CD and heptakis(2-di-O-methyl-3,6-O-sulfo)-β-
CD (HMDS-β-CD) were used as the chiral selectors. 
Nuclear Magnetic Resonance (NMR) spectroscopy 
was used to study the mechanism of chiral recognition. 
MATERIALS AND METHODS:
All CE experiments were carried out on a CE system 
from Agilent Technologies (Germany). Fused-silica 
capillaries were provided by Polymicro Technologies 
(USA). A Varian NMR System (USA), was used for 
all NMR experiments. The spectrometer resonance 
frequency for 1H was 499.61 MHz. Racemic 
enilconazole, deuterium oxide (D2O), sodium 
deuteroxide (NaOD, 40% wt.), phosphoric acid (85%), 
85% deuterated phosphoric acid were from Sigma-
Aldrich (Germany). Native β-CD was kindly provided 
by Cyclolab (Budapest, Hungary). Heptakis(2,3-di-
O-acetyl)-β-CD (HDA-β-CD) was synthesized in our 
laboratory according to ref. (1). 
RESULTS:
On the basis of rotating frame nuclear Overhauser 
(ROESY) experiments, the structure of an inclusion 
complex between enilconazole and β-CD was 
postulated, in which (+)-enilconazole seemed to 
form a tighter complex than the (-)-enantiomer. This 
correlates will with the migration order of enilconazole 
enantiomers observed in CE. No evidence of 
complexation between enilconazole and HMDS-β-
CD could be gathered due to lack of intermolecular 
NOE interactions. Most likely the interaction between 
enilconazole and HDMS-β-CD leads to formation 
of shallow external complex that is sufficient for 
separation of enantiomers in CE but cannot be 
evidenced based on ROESY experiment. 
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CONCLUSIONS:
Opposite affinity of enilconazole enantiomers was 
observed to native b-CD and its single component 
derivative HMDS-b-CD based on CE experiment. 
1D ROESY experiments showed the formation of an 
inclusion complex of both enilconazole enantiomers 
with ²-CD. On the other hand, no interaction of 
enilconazole with HMDS-²-CD could be detected 
from 1D- and 2D-ROESY data, although based on 
the results of CE experiments these interactions are 
definitely there.
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INTRODUCTION:
Infections are the most important cause of morbidity 
and mortality especially in hematologic malignancy 
and chemotherapy patients. Especially in patients with 
febrile neutropenia, it is aimed to reduce mortality with 
empirically effective and broad spectrum antibiotic 
treatment. The choice of empirical treatment is of vital 
important in these patient groups. Escherichia coli, 
Acinetobacter baumannii and Klebsiella pneumoniae 
are among the most frequently isolated Gram 
negative bacteria in neutropenic patients. The aim 
of this study was to investigate clonal relationship 
between the potential pathogen Gram negative 
bacteria isolated from intestinal flora of hematological 
malignancy patients and the same bacteria isolated 
during chemotherapy period from infectious clinical 
material of same patient and to determine whether 
Rectal swab (RS) sample can be guided for empirical 
treatment in this patient group. 
MATERIALS AND METHODS:
RS samples were obtained from hematologic 
malignancy patients not yet on chemotherapy or 
have no infection on chemotherapy period. E. coli 
was isolated from these samples, and A. baumannii 
and K. pneumoniae colonization were investigated. 
The isolates were identified by Maldi-Tof MS (Bruker/
Germany) instrument with using MALDI-TOF MS 
Bruker Micro ex LT model Flex Control 3.0 software 
(Bruker Biotyper; Bruker Daltonics, Bremen, 
Germany).  Colistin susceptibility was determined 
by broth microdilution method. Susceptibilities of 
bacteria against meropenem (MRM), imipenem 
(IMP), piperacillin-tazobactam (TZP), cefepime 
(FEP), ceftazidime (CAZ) were determined with using 
Gradient test strips and evaluated according to the 
EUCAST recommendation (1). The clonal relationship 
between Gram negative bacteria of intestinal flora 
and infection agents of same patient was investigated 
by Pulsed-Field gel electrophoresis. 
RESULTS:
All isolates are sensitive against colistin. The resistant 
rates of antibiotics are 39.1 %, 9.4 %, 6.8 %, 35.1 
%, 31 %, and 39.1 % for CIP, MRM, IMP, TZP, FEP, 
and CAZ respectively. Clonal relationship between 
30 pairs (RS and clinical isolates) had the same 
sensitivity profile was investigated with Pulsed-Field 
gel electrophoresis.  Twenty-three (76.6 %) of 30 pairs 
were found to have a clonal relationship between the 
bacterial isolates before and after infection.
CONCLUSIONS:
According to our results, it was determined that it can 
be able to predict with RS samples about possible 
agents of infection and their antibiotic susceptibility 
patterns in the management of hematologic 
malignancy patients.   
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INTRODUCTION:
Stroke is one of the most common causes of death 
and disability in developing countries (1). Beta-
glucans (βg), that have many useful effects on human 
health, are natural polysaccharides (2, 3). Our aim in 
this study was to determine useful effect of βg against 
oxidative and neuronal damage caused by global 
cerebral ischemia/reperfusion (IR) in stroke imitated 
mice via surgical operation. 
MATERIALS AND METHODS:
A total of 40 mice divided into four equal groups 
randomly. The groups were named; group 1 (sham 
operated (SH)), group 2 (I/R), group 3 (βg) and group 
4 (I/ R + βg). The group 1 (SH) was kept as control. 
Bilateral carotid arteries of subjects in group 2 (I/R) 
and group 4(I/ R + βg) were clipped for 15 min, and 
the mice in group 4 (I/R + βg) were treated with βg 
(50 mg/kg/day), while the mice in group 2 (I/R) were 
treated with only vehicle for 10 days. The mice of 
group 3 (βg) were treated with βg for 10 days without 
carotid occlusion. 
RESULTS:
Global cerebral I/R significantly increased oxidative 
stress (TBARS: 11.9±0.92 nmol/g) and decreased 
members of anti-oxidant defense system (GSH: 
184.3±14.1 nmol/ml, CAT: 0.027±0.002 k/mg, 
SOD:14.60±2.81 U/mg and GPx:154.9±18.3 U/mg)  . 
In addition, I/R caused histopathological damage in 
the brain tissue (histopathological score:1.57±0.20) 
. However, βg treatment ameliorated both oxidative 
(TBARS: 9.32±0.91 nmol/g, GSH: 206.8±15.2 nmol/
ml, CAT: 0.030±0.004 k/mg, SOD: 15.23±1.38 U/
mg and GPx: 173.7±16.2 U/mg (P<0.01)) and 
histopathological effects of I/R (histopathological 
score: 0.85±0.14 (P =0.05)). 
CONCLUSIONS:
Our present study showed that βg treatment 
significantly ameliorated oxidative and histological 
damage in the brain tissue caused by cerebral 
I/R. The useful effects of βg are probably due to 
its antioxidant and radical scavenging properties. 
Therefore, βg treatment can be used as supportive 
care for ischemic stroke patients.
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INTRODUCTION:
Mycoplasma hominis (M.hominis) infections are 
sexually transmitted and usually associated with 
urogenital and respiratory system diseases (1, 2). 
The aim of our study was to detect M. hominis in the 
vaginal and urine samples of sexually active women 
(SAW) using three different detection methods and to 
determine antimicrobial susceptibility and resistance 
after treatment. 
MATERIALS AND METHODS:
Both vaginal and urine samples were collected from 
110 SAW at the Başkent University Ankara Hospital 
for Obstetrics and Gynecology Clinic between 
March 2015 and February 2016. The presence of M. 
hominis methods in the vaginal and urine samples 
was detected by in vitro culture, biochemical test 
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kits, and PCR (3, 4). The antibiotic susceptibility of 
each sample was also tested using the kits, single 
and couple tetracycline treatment was given to the 
patients.
RESULTS:
M. hominis was detected in 72 of 220 (32.7%) 
samples, out of which 37 showed inconsistent results 
with the kits and were validated by PCR. The highest 
susceptibility rate was observed against pristinamycin 
(100%), followed by 91%, 83% and 75% for 
doxycycline, tetracycline, and josamycin, respectively. 
Twenty-five patients treated with tetracycline were 
followed up after the end of treatment. M. hominis was 
not observed in 18 cases where the couple received 
treatment and was re-isolated in the five monotherapy 
patients.
CONCLUSIONS:
The rate of M. hominis detection was significantly 
higher in the vaginal specimens compared to the urine 
specimens. Antibiotic susceptibility tests indicated that 
the tetracycline group of antibiotics was successful 
when given as a treatment to couple. 
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INTRODUCTION:
Rumex acetosella has a long tradition in folk 
medicine for the treatment of cancer (1). Rumex 
species were reported to have anthraquinone-rich 
phytochemical contents in previous studies (2,3). 
The main anthraquinone aglycones (emodin, aloe-
emodin, physcion, rhein), reported to be present in 
R. acetosella previously (1,4,5). Structural similarities 
of anthraquinone aglycones to anthracyclines 
allow to speculate on their possible anticancer 
activities.  
MATERIALS AND METHODS:
In this study, main anthraquinone aglycones and 
isolated compounds were tested for their cytotoxicities 
by resazurin reduction and protease viability marker 
assays. Detection of inducement of reactive oxygen 
species (ROS), apoptosis and necrosis, DNA damage 
as well as cell cycle analysis were performed. 
RESULTS:
Aloe-emodin as the most cytotoxic compound revealed 
IC50 values from 9.872 to 22.3 μM in drug-sensitive 
wild-type cell lines and from 11.19 to 33.76 μM in 
drug-resistant sublines, was selected to investigate 
its mechanism against cancer. Aloe-emodin induced 
S phase arrest, ROS generation, DNA damage and 
apoptosis. Microarray hybridization revealed a profile 
of deregulated genes in aloe-emodin-treated CCRF-
CEM cells with diverse functions such as cell death 
and survival, cellular growth and proliferation, cellular 
development, gene expression, cellular function and 
maintenance, which was validated by qPCR analysis. 
COMPARE and hierarchical cluster analyses of 
transcriptome-wide mRNA expression were examined 
to predict sensitive or resistant cells in 60 tumor 
cell lines of DTP (Developmental Therapeutics 
Programme) (NCI, USA) to aloe-emodin.  
CONCLUSIONS:
Aloe-emodin as well as R. acetosella deserve 
further investigations as possible antineoplastic drug 
candidates.
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INTRODUCTION:
Type 2 diabetes is a hyperglycaemic metabolic 
disease related with the decrease of insulin secretion. 
Genetic and environmental factors are playing major 
role in the development of the disease. Relationship 
between the inflammation generation and diabetic 
complications has been showed in recent studies. 
Following the formation of the oxidative stress after 
the disorder of the lipid metabolism, the levels of 
the reactive oxygen species (ROS) increase and 
insulin resistance develops consequently. Cytokines 
are important in regulation of the homeostatic 
mechanisms such as inflammation and tissue 
repair. Thus, variations in their levels and structures 
can cause several diseases. The single nucleotide 
polymorphisms (SNP) forming on the cytokine genes 
increase the risk of disease development. Recent 
studies showed the relationship between some 
inflammatory cytokine gene polymorphisms and the 
development of complication in patients with diabetes. 
Based on this, our aim was searching and the 
evaluating the possible relations between the TNF-α 
(-308), IL-1β (+3953), IL-6 (-174) gene polymorphisms 
and the development of the complications in a Type 
2 diabetic Turkish patient population by using PCR-
RFLP method.
MATERIALS AND METHODS:
A total of 150 Turkish individual participants were 
grouped in three groups as controls, patients with 
and withoutdiabetic complications consisting of 50 
individuals in each. All the patients were selected 
from the the Diabetes Clinic at the Ankara Training 
and Research Hospital. 50 patients were free of 
complications, whereas the others suffered from 
complications including nephropathy, retinopathy, 
neuropathy and coronary heart disease. DNA 
samples of all the subjects were isolated from the 
blood samples and stored at -200C until the analysis. 
Genotyping was performed using a polymerase chain 
reaction-restriction fragment length polymorphism 
(PCR-RFLP) technique. 
RESULTS:
Due to our data, both TNF-α and IL-1β gene 
polymorphisms are significantly related with the 
development of both disease and complications. 
CONCLUSIONS:
TNF-α and IL-1β gene variations enhance the risk of 
Type 2 diabetes and its complications development.
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INTRODUCTION:
Exposure to drugs, radiation, etc in pregnancy can 
lead to notorious consequences on the fetus. The 
alarming case reports caused anxiety in both patients 
and physicians about fetus and drug relationship 
in 1960s.  Eventually, Teratogenicity Consultation 
Centers have been established all over the world since 
1970s to provide information especially for physicians 
(1). Hacettepe Drug and Poison Information Unit has 
been in service to give drug information to health 
care personnel and public also since 1992. HIZBIB 
started a project in 2015 for providing consultancies 
to obstetricians in Hacettepe University (HU) 
about xenobiotics, radiation etc. exposures during 
pregnancy. After the interviews with the patients 
referred to HIZBIB, the evaluation reports about the 
determinants affecting the prognosis of pregnancy 
were submitted. In this study, it was aimed to evaluate 
the efficiency of consultancy services provided by 
HIZBIB-TDS. 
MATERIALS AND METHODS:
Between October 2015 and April 2018,  79 patients 
referred to HIZBIB from HU Faculty of Medicine, 
Department of Obstetrics and Gynecology were 
recorded  and the descriptive statistical analysis was 
made retrospectively.
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RESULTS:
The range of the ages was 19-41, mean age was 31,54 
years.  Seventy three pregnants had USG outcome 
with a range of 4-23 weeks and an average of 8.78. 
In addition to drugs, other co-agents were radiation 
(8), herbs (10), kin marriages (4), Rh incompatibility 
(3), smoking (12), alcohol (3) and illicit substances 
(2). Antidepressants ranked at first with 22,7 8 % 
and antibiotics followed them with 21,51%. HIZBIB 
recommended in 49,36% of pregnants a normal or 
careful follow-up, in 36,70% warned about a raise in 
risk for a healthy prognosis,  and in 8,86% suggested 
therapeutic abortus. One month later, the pregnant 
women were called by telephone and inquired about 
the current situation; 5 of the 7 abortion proposals 
(71,42%) had been carried out. 
CONCLUSION:
Physicians should be very careful while prescribing 
during pregnancy and pregnants should also be 
aware of the probable factors endangering the 
course of their pregnancies. Being overly cautious or 
underestimating the situation may lead to negative 
consequences. HIZBB provides a substantial 
contribution to the physicians  by keeping them as 
updated, especially in prescribing for  pregnants. 
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INTRODUCTION:
Derris trifoliata has been traditionally used as folk 
for the treatment of, rheumatic joints, diarrhoea, 
and dysmenorrhea, and rotenoids isolated from the 
plant have shown to exhibit anti-cancer properties. 
This study aimed to assess the toxicity effects and 
antiangiogenic activity of extract of Derris trifoliata on 
zebrafish embryo model.
MATERIALS AND METHODS:
Zebrafihs embryos were treated with aqueous 
extract of Derris Trifoliata to evaluate its effects on 
angiogenesis and zebrafish-toxicity. Angiogenic 
response was analyzed using whole-mount alkaline 
phosphatase (AP) vessel staining on 72 hours post 
fertilization (hpf) zebrafish embryos. 
RESULTS:
1.0 mg/ml concentration was toxic to zebrafish 
embryos and embryos exposed to concentrations at 
0.5 mg/ml and below showed some malformations. 
Derris trifoliata aqueous extract also showed some 
anti-angiogenic activity in vivo  in the zebrafish 
embryo model wereby at high concentration inhibited 
vessel formation in zebrafish embryo.
CONCLUSIONS:
The anti-angiogenic response of extract of Derris 
trifoliata in zebrafish in vivo model suggest its 
therapeutic potential as anti-cancer agent. 
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INTRODUCTION:
Immunosuppressive drugs are used to prevent 
organ rejection after transplantation. Most 
immunosuppressive drugs have narrow therapeutic 
ranges which increases the risk of clinically 
relevant drug interactions. The study aimed to assess 
possible and clinically relevant drug interactions of 
tacrolimus and cyclosporine individually in patients 
with renal transplantation (1).
MATERIALS AND METHODS:
A prospective, observational study was conducted 
in nephrology outpatient clinic at the Hacettepe 
University Hospitals between November 
2017-February 2018. Renal transplantation patients 
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using tacrolimus or cyclosporine for >1 month were 
included in the study. A clinical pharmacist attended 
clinic visits with the physician and evaluated drug 
interactions. An evaluation of drug interactions was 
performed using Micromedex© information source 
and then classified as minor, moderate, major and 
contraindicated. The change in serum concentration 
of immunosuppressive drugs by ≥30% was 
considered as ‘clinically significant’. ‘Drug Interaction 
Probability Scale (DIPS) was used to determine drug-
drug interactions that thought to be responsible for the 
change in serum concentration and then evaluated for 
its clinical significance.
RESULTS:
A total of 93 patients (67 in tacrolimus; 26 
in cyclosporine) were included in the study; 
52.69% were male and average (±standard 
deviation) age was 40.1±1.27 years. 
The median (range) daily drug dose of patients was 
calculated as 3 mg (1-10) for tacrolimus and 100 
mg (50-150) for cyclosporine. In total, 135 potential 
drug interactions (86 with cyclosporine; 49 with 
tacrolimus) were identified by a clinical pharmacist; of 
those 90 were moderate, 41 were major and 4 were 
contraindicated. The most common drug interaction 
of cyclosporine and tacrolimus was with prednisolone 
(n=23; 25.56%) and lansoprazole (n=18;36.73%) 
respectively.  According to the DIPS evaluation; 
cyclosporine-prednisolone (n= 6), tacrolimus-
lansoprazole (n=1), cyclosporine-lercanidipine 
(n=1), cyclosporine-amlodipine (n=1), cyclosporine-
prednisolone-allopurinol (n=1) and cyclosporine-
colchicine (n=1) interactions are classified as 
‘possible’. Although daily doses of immunosuppressive 
drugs were not too high, the serum concentration 
of these drugs have been increased. As a result, in 
order to maintain normal therapeutic range of serum 
concentrations, dose reduction or drug change was 
applied where appropriate.
CONCLUSIONS:
The monitoring of possible drug interactions in 
the treatment process of transplant patients by a 
multidisciplinary healthcare team that includes a 
clinical pharmacist, will help to identify and prevent 
potential drug interactions and to ensure desired 
outcomes.
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INTRODUCTION:
Diabetes, a heteregenous metabolic and chronic 
disease, is a growing health problem in most countries 
(1). It has claimed that diabetes is associated 
with the increased formation of free radicals and 
decreased antioxidant potential (2). Ursolic acid, a 
well-known pentacylic triterpene which is commonly 
used in traditional Chinese medicine due to its health 
beneficial effects (3). The aim of this study was to 
investigate the effects of ursolic against streptozotocin 
(STZ)-induced diabetes in Wistar albino rats. 
MATERIALS AND METHODS:
DNA damage was evaluated by single cell gel 
electrophoresis (Comet) assay. Catalase (CAT), 
superoxide dismutase (SOD), glutathione reductase 
(GR) and glutathione peroxidase (GPx) enzyme 
activities and 8-hydroxy-2’-deoxyguanosine (8-
OHdG), total glutathione (GSH) and malondialdehyde 
(MDA), insulin, total bilirubin and bicinchoninic acid 
(BCA) protein, alanine aminotransferase (ALT), 
aspartate aminotransferase (AST) and gamma-
glutamyl transferase (GGT), high density lipoprotein 
(HDL), low density lipoprotein (LDL), total cholesterol 
and triglyceride levels were also evaluated.
RESULTS:
Ursolic acid treatment was found to significantly 
decrease DNA damage, GR enzyme activities and 
MDA levels and significantly increase GSH levels and 
CAT, SOD and GSH-Px enzyme activities and altered 
lipid and liver enzyme parameters in diabetic rats.
CONCLUSIONS:
According to our results, it seems that ursolic acid 
might be beneficial against diabetes induced renal 
damage.
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INTRODUCTION:
The demand for cost-effective sequencing drove the 
development of high-throughput sequencing, e.g., 
next generation sequencing (NGS). The development 
of fluorescence-based sequencing platforms 
dramatically improved the throughput and speed. 
However, these platforms suffer from problems 
related to the use of labels such as the complexity 
and the high cost of labeling, mismatch between 
number of fluorescence dyes and nucleotides, and 
photobleaching.
MATERIALS AND METHODS:
In order to address these problems, we introduced 
a nucleic acid sequencing platform that employs 
sequencing by binding (SBB) in a label-free biosensing 
platform. The platform employs gold nanohole arrays 
that support optical resonances, which are highly 
sensitive to the presence of the biomolecules on the 
sensing surface. In the SBB method, immediately 
before the incorporation of the nucleotide, a complex 
consisting of the primer-template, polymerase and the 
correct nucleotide is formed (Figure A). Formation of 
protein complexes on the sensing surface triggers a 
spectral shift within the optical resonances supported 
by the nanohole arrays, and accurately identifies the 
correct sequence of different DNA templates with high 
signal-to-noise ratio (SNR).
RESULTS:
Figure B shows the change in the optical response of 
the label-free platform due to the formation of protein 
complexes on the sensing surface for 11 sequencing 
cycles for a GC50-A DNA template, where the primer. 
We successfully predicted the correct bases and the 
spectral variations due to the incorrect bases are 
negligible. The correct bases yield approximately one 
order of magnitude larger optical response change 
compared to the incorrect bases. This distinct signal 
difference between correct and incorrect interrogation 
steps demonstrates the reliability of our label-
free sensing platform for sequencing applications. 
We further developed our sequencing platform by 
integrating it with an imaging based device. In our 
lens-free platform, we provided the sequencing 
data by monitoring the intensity variations within the 
diffraction patterns due to the formation of protein 
complexes on the sensing surface.
CONCLUSIONS:
Our platform accurately provides sequencing data by 
detecting protein complexes formed by polymerase 
mediated pairing of a correct nucleotide with a primed-
template DNA resulting in spectral variations within 
optical resonances. Enabling the utilization of the 
whole sensing surface for sequencing, our lens-free 
platform is an ideal candidate for low-cost and high-
throughput label-free DNA sequencing applications.
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INTRODUCTION:
Chiral imidazole and triazole derivatives are 
widely used human and veterinary drugs and also 
agrochemicals (fungicides) (1), ketoconazole as an 
important category of antifungal agents, inhibit the 
synthesis of ergosterol, the essential composition, on 
the cell membrane to prohibit the growth of fungus 
(2, 3). Analytical methods used for chiral separations 
of itraconazole and ketoconazole include several 
methods, CE has attracted greatly increasing interest 
for chiral separations (4).
MATERIALS AND METHODS:
the separation of enantiomers of some chiral 
antifungals was studied by CE. The separation was 
achieved using heptakis (2, 3, 6-tri-O-methyl)-β-
cyclodextrin (TM-β-CD). The influence of TM-β-
CD concentration, phosphate buffer concentration, 
buffer pH, Temperature and applied voltage were 
investigated. The optimum conditions for chiral 
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separation of ketoconazole was achieved using 50 
mM phosphate buffer at pH 2.5 containing 1-100 mM 
TM-β-CD with an applied voltage of 30 kV at 15°C 
with a 3-s injection time (hydrodynamic injection).
RESULTS:
Ketoconazole was successfully resolved. Under 
described conditions, the increase of concentration 
leads to an increase of resolution for this we chose 100 
mM of Heptakıs (2, 3, 6 tris-O-methyl)-β-CD for this 
study, it gave the highest resolution for ketoconazole 
(R= 1.10, α= 1.06) for the first time within 7 min.
CONCLUSIONS:
In this present work the CE method is more selective 
and rapid to achieve a fast and very efficient 
separations of variety of antifungals.
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INTRODUCTION:
Worldwide, an estimated 11 million workers 
have a job title of welder, and around 110 million 
additional workers probably incur welding related 
exposures. In the present evaluation, welding fumes 
and UV radiation from welding were classifed as 
“carcinogenic to humans” (Group 1) (1). The single cell 
electrophoresis (COMET) assay has been found to be 
a very sensitive, rapid, reliable and fairly inexpensive 
way of measuring DNA damage (2). The aim of this 
study was to investigate the possible genotoxic 
effects associated with occupational exposure in 
Turkish welders using COMET assay in lymphocytes 
and whole blood cells. 
MATERIALS AND METHODS:
The study group consisted of 48 male welders. 
Male office workers (n=48) without any occupational 
exposure comparable for age and smoking habits 
to the workers were selected as the control group. 
Approximately 3 ml whole blood samples were taken 
and lymphocytes were isolated by Ficoll-Hypaque 
density gradient procedure (3). The basic alkaline 
COMET assay of Singh et al., as further described by 
Collins et al., was performed (4,5).
RESULTS:
DNA damage in the lymphocytes and the whole blood 
cells of the workers were found to be significantly 
higher than the control group (p<0.05).  
CONCLUSIONS:
The findings of increased DNA damage in peripheral 
lymphocytes and whole blood of welding workers 
demonstrate the possibility of genotoxic risk. The 
workers in this study must be examined in detail to 
avoid the development of a carcinogenic process. 
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INTRODUCTION:
Cisplatin is one of the most commonly used 
antineoplastic agents today. However, especially 
dose-related and cumulative nephrotoxicity is the 
most important dose-limiting factor in clinical use 
(1,2). Our study aimed to demonstrate the role of 
angiotensin 2 receptor blocker losartan (Los) against 
cisplatin (Cis) induced nephrotoxicity.
MATERIALS AND METHODS:
15 BALB-C female mice were divided into three 
groups as control, Cis and Cis + Los groups. Saline 
was injected to the animals in the control group 
intraperitonealy (i.p.). A single dose of cisplatin 
(12.7mg/kg/dose) and after one hour 5 ml of 0.9% 
sterile saline was injected to the animals in Cis group 
(i.p.). A single dose of cisplatin (12.7mg/kg/dose) and 
after one hour 5 ml of 0.9% sterile saline was injected 
to the animals in the Cis+Los group (i.p). Four days 
before the injection of cisplatin, losartan (10mg/kg/
day) po was started and given for nine days in the 
third group. On the fifth day after cisplatin injection, 
all groups were injected with 5-bromo 2-oxyuridine 
(BrdU, 200mg/kg) and after four hours, kidneys 
were removed and fixed in formalin. Right kidneys 
were stained with hematoxylin and eosin (H&E) 
for morphological examinations. Left kidneys were 
examined for tubular proliferation and apoptosis by 
immunohistochemistry. Approval for the study was 
obtained from the Animal Experiments Local Ethics 
Committee in Mersin University. 
RESULTS:
Glomeruli and tubules had normal morphology in 
control group. Examination of the Cis group revealed 
cast formation, thyroidisation, and tubular dilatation. 
There were locally degenerated tubules and atrophic 
glomeruli. Congestive changes were also observed. 
In the Cis+Los group, similar features were observed 
as in the Cis group but the pathological findings were 
decreased. For the active caspase-3 labeling, there 
were very few positive cells in the control group 
which is increased significantly in the Cis group, while 
those in the Cis+Los group decreased significantly 
compared to the Cis group. For the anti-BrdU labeling 
examinations, positively stained cells were found in 
the control group which was decreased significantly 
in the Cis group, and increased significantly in the 
Cis+Los group.
CONCLUSIONS:
It was concluded that losartan could be used as a 
protective agent against cisplatin nephrotoxicity. 
However, further studies are needed to determine 
optimal doses to maximize its protective effects.
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INTRODUCTION:
3D printing is a novel and revolutionary production 
technique of our era. Since 3D printing technology 
makes it possible to manufacture patient-tailored 
implants and medical devices, studies for personalized 
treatment are rapidly increasing (1).
Salicylic acid (SA) is one of the most consumed 
drugs today. In addition to oral route, it is also used 
for topical keratolytic, bacteriostatic, fungicidal and 
photoprotective effects. If SA is applied to large 
surfaces by dermal route, acute salicylate poisoning, 
in other words salicylism may occur. Therefore, 
to minimize systemic absorption due to topical 
application, SA should not be used for long periods 
and at high concentrations (2).
The aim of this study is to prepare patient-tailored 
dermal patches for the treatment of acne vulgaris 
which is one of the most common skin diseases and 
leaves both physical symptoms and psychological 
and social problems especially in adolescence, with a 
modified 3D printer (3).
MATERIALS AND METHODS:
At the first stage, face of the patient was imaged 
and custom design was made with Fusion 360 
software. We then created layers in 2 different 
combinations with our modified 3D printer (Ultimaker 
2, Netherlands). The first layer was composed of 
PLA layers without active substance as a support 
layer, whereas the second layer was made with SA 
solutions. SA solutions were prepared with 2%, 5%, 
10% and 20% PVA solutions.
RESULTS:
We have successfully produced patient-tailored 
patches using the formulation we have selected 
through our system which we have modified for our 
studies. By examining the solutions prepared for 
use in production, 5% PVA and 2% SA containing 
formulation were considered suitable and patches 
containing active substance were successfully 
produced.
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CONCLUSIONS:
Patient-tailored patch production becomes easier to 
implement with our developed production system. 
Non-toxic and non-irritant production can be made 
with low-dose, patient-tailored medicines and a more 
effective treatment can be provided.
Although our study is related to acne vulgaris, there 
are many illnesses that can be worked with our 
modified 3D printer. As a result, the system we have 
developed will be able to produce patient-tailored 
products for many diseases.
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INTRODUCTION:
Enantiomeric separation of chiral compounds is 
extremely important because most of the bioorganic 
molecules, synthetic drugs and agrochemicals 
are chiral compounds. Enantiomers in racemic 
drug compounds are characterized with different 
biological activities, including pharmacodynamics, 
pharmacokinetics and toxicology. That is why, 
enantiomerically pure drug forms are more safe and 
efficient (1,2). The main goal of the present study 
was to determine relationships between chemical 
structure of chiral compound and enantioselectivity in 
high-performance liquid chromatography. 
MATERIALS AND METHODS:
In order to understand the relationships between 
chemical structure and enantioselectivity, about 50 
new chiral sulfoxides and hydantoins were synthezised 
and their chiral separations were performed with 
polar organic and normal-phase mobile phases using 
variety of cellulose based chiral selectors. Majority of 
these chiral selectors were not described in literature 
before. 
RESULTS:
The main factors contributing in molecular recognition 
of macromolecules were revealed. Correlation 
between chemical structure and enantioselectivity 
was established. 
CONCLUSIONS:
Distribution of electron density and geometry of 
analyte molecules seem to be the major factors 
affecting enantioselectivity and molecular recognition 
ability of chiral molecules. 
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INTRODUCTION:
Gliomas account for approximately 30% of all central 
nervous system tumors, with glioblastoma being 
the most aggressive and common type of malignant 
brain tumor, accounting for approximately 50% of all 
gliomas.1 The standard treatment for glioblastoma 
patients is currently surgical resection followed by 
radiotherapy and/or chemotherapy. The development 
of chemotherapeutic drug resistance in cancer therapy 
is an important point that should be considered in the 
development of new drugs. Imidazopyridine is one of 
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the most important structural skeletons in the area 
of natural and pharmaceutical products owing to the 
broad biological activities of imidazopyridines, such 
as breast cancer,2 tuberculosis treatment.3 In this 
work we synthesized new imidazopyridine derivatives 
with substituents on both imidazole and pyridine rings, 
and then evaluated their biological activity against a 
glioblastoma cell line (LN-405).
MATERIALS AND METHODS:
The N-propargyl imidazole derivatives we published 
in our previous work were used as starting material 
in this study. These starting materialswere cyclized 
in a microwave synthesizer using a secondary cyclic 














We used the MTT test to identify the cytotoxicities of 
the prepared compounds in the first stage of the cell 
study. To test the antitumor activity, we evaluated the 
activity of compounds against a glioblastoma cell line 
(LN-405).
RESULTS:
Various imidazopyridine derivatives bearing different 
functional groups have been synthesized and their 
cytotoxicities against a glioblastoma cell line (LN-405) 
were investigated experimentally.
CONCLUSIONS:
Two lead compounds with IC50 values of 10 and 75 µM 
were identified for glioblastoma. Pharmacomodulation 
of these compounds and their structure–activity 
relationship are currently under investigation, which 
will hopefully reveal a new promising candidate for 
glioblastoma.
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INTRODUCTION:
Hydrogen sulfide (H2S) is getting attraction as a 
new therapeutic target in hepatoprotection through 
anti-oxidative, anti-inflammatory, cytoprotective and 
anti-fibrotic actions (1). The novel gasotransmitter 
H2S is synthesized from L-cysteine by 3 enzymes 
whose expressions are mostly in liver; cystathionine-
β-synthase (CBS), cystathionine-γ-lyase (CSE) 
and  3-mercaptopyruvate sulfurtransferase 
(3MPST) [2]. Resveratrol (RVT) has a potential as 
a hepatoprotective  agent (3). We have shown that 
RVT induces H2S synthesis (4). However it is not 
clear whether H2S formation in liver could be induced 
by RVT derivatives. Thus we have synthesized new 
RVT derivatives and investigated the effects of RVT 
analogues ZMP-17 and ZMP-20 on the formation of 
H2S in the liver.
MATERIALS AND METHODS:
The effect of ZMP 17 and ZMP 20 (10 μM, 30 minutes) 
on basal (L-cysteine free) and stimulated H2S 
formation by the substrate L-cysteine and cofactor 
pyridoxal phosphate(10 and  2mM, respectively) 
in the presence or absence of CSE and CBS 
inhibitor aminooxyacetic acid; AOAA (10 mM,10 min 
before ZMP17 or ZMP20 treatment) in mouse liver 
homogenates were measured by an amperometric 
H2S microsensor  for 30 minutes at 37°C(UnisenseA/
S,Aarhus, Denmark). 
RESULTS:
ZMP 17 and 20 were synthesized in Lubiana 
University [5]. ZMP17 or ZMP 20 did not raise the 
signals in PBS without biological sample, suggesting 
that it is not an H2S donour. L-cysteine stimulated 
H2S formation and AOAA inhibited it it significantly, 
confirming endogenous H2S synthesis in liver. 
ZMP17 and ZMP20 increased L-cysteine-induced 
endogenous H2S formation which were reversed 
back by H2S synthesis inhibitors. 
CONCLUSIONS:
We found that ZMP-17 and ZMP-20 induces 
endogenous H2S formation in liver. Since H2S has 
been found to be beneficial in liver degeneration (1) 
the beneficial effect of RVT in hepatoprotection (3) 
might be related with induction of H2S synthesis.
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INTRODUCTION:
Liver is the largest gland that performs important 
metabolic functions in the human body and its 
treatment is a difficult process. The liver diseases 
remain a problem across the world, and many studies 
have been continued to search to find the new 
treatment agents. The synthetic drugs have been 
used to treat lots of diseases, but it is known that they 
have a side effect, and so many people have been 
used the plant and plant extraction to treat some 
disease for a long time. In this study, hepatoprotective 
effects, cytotoxic potentials and antioxidant activities 
of Teucrium multicaule Montbret Et Aucher Ex 
Bentham have been investigated in CCl4 induced 
liver damage.
MATERIALS AND METHODS:
By using male rats, groups (n:6) were designed 
as following; control, CCl4, CCl4+200mg/ml T. 
multicaule MeOH extract and CCl4+400 mg/ml T. 
multicaule MeOH extract. CCl4 induced liver damage 
was generated during 7 days. The others groups 
were administered with 200mg/ml and 400mg/ml T. 
multicaule extract for seven days. In end of the study, 
rats were sacrificed and livers were removed.  mRNA 
levels of SOD, CAT and GPx antioxidant enzymes 
and MDA levels in liver tissues were determined. 
Apoptotic protein Bax and Caspase 3 levels were 
determined by immunohistochemical staining, and 
apoptotic index was estimated by tunnel method. 
Cytotoxic effect of the extract on murine LR 7 cell was 
determined as well. Antioxidant activity of the extract 
was determined by using in vitro method DPPH (1).
RESULTS:
When compared to control and CCl4 group, mRNA 
expression levels of SOD, CAT and GPx decreased 
(p<0.05). While the expression of Bcl2 was decreased, 
which of Caspas3 did not change when compared 
to all of the groups. Immunohistochemically, when 
compared to CCl4 group, a reduction in expressions 
of Bax and Caspas3 was detected both in dose of 
200 mg/ml and 400 mg/ml of T. multicaule extract (p ˂ 
0.05). It was observed that the high dose of the extract 
exhibited a cytotoxic effect on murine LR7 cells. The 
extract also exhibited a strong antioxidant activity in a 
dose-dependent manner.
CONCLUSIONS:
Consequently, it is determined that T. multicaule have 
a strong hepatoprotective activity in CCL4-induced 
liver damage as well as its antioxidant and cytotoxic 
activities
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INTRODUCTION:
Burn injuries may have serious traumatic 
consequences.the degree of tissue damage depends 
on the degree of heat and duration of contact. There 
are 4 levels of burns (1). Herbal treatments could 
be applied for alleviating the symptoms in addition 
to pharmacological treatments. Aloe vera is used 
for burn wounds for many years because of its 
antiinflammatory, antiviral, antifungal, antibacterial 
and rapid burn wound healing effects (2). Aim of this 
study was to compare different doses of Aloe vera gel 
with burn medications in the market.
MATERIALS AND METHODS:
48 female Sprague-Dawley rats divided into 8 
groups (negative control, positive control, Silverdin®, 
Bepanthol®, Sudocrem®, Aloe vera 30 mg, Aloe vera 
60 mg, Aloe vera 90 mg). The back of the rats were 
exposed to 90oC hot water for 10 seconds (burnt area: 
7,069 cm2). After the modelling, serum physiologic 
was applied to each rat. Their treatments were 
always given at the same time. Experimental study 
was approved by Istanbul Medipol University Animal 
Experiments Local Ethical Committee. Obtained data 
were evaluated with SPSS v21 program.
RESULTS:
After 15-day-treatment, 30 mg of Aloe vera was more 
effective than Silverdin® cream (Aloe vera decreased 
burnt area: 3,064 cm2, Silverdin® decreased burnt 
area: 3,731 cm2). The most effective drug among 
these medications was Sudocrem® with decreased 
burnt area 2,302 cm2.
CONCLUSIONS:
It could be concluded as Sudocrem® is the most 
effective drug when compared to the medications for 
burn treatment. Furthermore, 30 mg dose of Aloe vera 
is more effective than Silverdin® cream.
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INTRODUCTION:
Epilepsy is a disorder of central nervous system 
and has different types. Modern treatment against 
convulsions includes drugs and surgical treatments 
(1). Since some of the patients still have convulsions 
although they are administered with antiepileptic 
drugs, new molecules are needed (2). Plants have 
been offered as new candidate molecules in this 
regard (3). Thus, in this study, we aimed to test 
anticonvulsive activity of four different Skullcap 
(Scutellaria) species.
MATERIALS AND METHODS:
Scutellaria brevibracteata Stapf subsp. brevibracteata, 
S. galericulata L., S. megalaspis Rech.f. and 
S. orientalis L. subsp. pichleri (Stapf) J.R.Edm. 
methanolic extracts (aerial parts) were tested on 
mice in pentylentetrazol induced convulsions. Mice 
were administered with 200 mg/kg i.p. plant extracts 
dissolved in physiological saline for 5 days. 80 mg/
kg pentylentetrazol was injected in the last day to 
all groups. Pentylentetrazol group was administered 
solely with pentylentetrazol.
RESULTS:
Number of animals having tonic clonic convulsions 
(p>0.05) and number of ex animals due to convulsions 
(p>0.05) were decreased after treatment. The latency 
for tonic-clonic convulsions (p>0.05) in all tested 
Scutellaria groups was increased. A marked increase 
in latency for first myoclonic convulsion (p<0.05) 
in S. orientalis L. subsp. pichleri (Stapf) J.R.Edm. 
was observed against pentylentetrazol induced 
convulsions.
CONCLUSIONS:
The present study may suggest a potential 
anticonvulsive activity of tested Scutellaria species. 
Further studies are needed to determine the 
molecules that are responsible for this activity.
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INTRODUCTION:
Tamoxifen (TMX) is used clinically as a nonsteroidal 
antiestrogen for first-line endocrine treatment as 
well as adjuvant therapy in metastatic breast cancer. 
TMX, a BCS class II drug, shows low plasma drug 
levels leading to therapeutic failure due to low 
aqueous solubility.  Hence, there is need to develop 
a new formulation of TMX which can minimize the 
side effects. Complexation with cyclodextrins is an 
effective pharmaceutical technique to enhance the 
bioavailability of poorly soluble substances. The aim 
of this study is to evaluate in vitro/in vivo properties 
of cyclodextrin complexes and to improve solubility 
and oral bioavailability tamoxifen with water soluble 
cyclodextrins.
MATERIALS AND METHODS:
Tamoxifen citrate (MW: 371.51 g/mol) was kind 
gifts from TEVA Pharmaceuticals, Israel. Methyl-
β-cyclodextrin (M-β-CD) and hydroxypropyl-
β-cyclodextrin (HP-β-CD) were supplied as 
Cavasol® W7M and Cavasol® W7HP respectively, 
as kind gifts of Wacker Chemie, Germany. Sulfobutyl 
ether β-cyclodextrin (SBE7-β-CD) was supplied as 
Captisol®, as kind gift of Cydex Inc. (Lenexa, KS). 
The inclusion complexes were prepared by two 
methods (kneading and co-liyophilization) using 
different CD derivatives and characterized by different 
techniques including fourier transform infrared 
spectroscopy, differential scanning calorimetry and 
scanning electron microscopy. The in vitro properties 
of tamoxifen as a drug-cyclodextrin inclusion complex 
were evaluated with solubility and dissolution studies. 
Oral bioavailability studies were carried out with tablet 
formulation of tamoxifen with M-β-CD and commercial 
tablet formulation (Tamoxifen-TEVA). 
RESULTS:
The results showed that co-liyophilization method 
comprises true inclusion complexes between TMX 
and both cyclodextrins. A dissolution study showed 
that the solubility and dissolution rate of TMX were 
significantly enhanced by complexation with M-β-
CD. Tablet formulation using 1:1 co-liyophilization 
complex of TMX and M-β-CD with drug equivalent 
to 10 mg was prepared by a direct compression 
method. A dissolution study of prepared tablets was 
performed in 0.02 N HCl medium. 99% drug was 
released from the formulation at the end of 30 min. 
From the comparative results of dissolution study, 
it was found that the prepared formulation showed 
better release than a commercially tablet formulation. 
Tablet formulation of tamoxifen with M-β-CD and 
commercial tablet formulation (Tamoxifen-TEVA) were 
administered to male Sprague–Dawley rats by oral 
gavage. The oral bioavailability of tablet formulation 
containing TMX/M-β-CD inclusion complex in mice 
was effectively increased 2-fold over commercial 
tablet.
CONCLUSIONS:
Complexation of TMX with M-β-CD results in a more 
efficient tablet formulation with improved dissolution 
and an enhancement oral bioavailability of the drug.
OP-036: A STUDY ON CURRICULUM 
DEVELOPMENT OF A COMMUNICATION 
AND COUNSELING SKILLS COURSE FOR 
PHARMACY STUDENTS: A SIMULATION 
BASED APPROACH 
1 Gulpinar, G., 1 Ozcelikay, G. 
1 Ankara University, Faculty of Pharmacy, 
Department of Pharmacy Management and History, 
Ankara, Turkey
INTRODUCTION:
The aim of this thesis study is to develop a 
“Pharmacist-Patient Communication and Counseling 
Skills” lecture-laboratory course and to determine the 
impact of this course with standardized patients (SPs) 
on pharmacy students. 
MATERIALS AND METHODS:
The course was a 14-week educational interventional 
study done at Ankara University Faculty of Pharmacy. 
A single group pre-test, post-test trial was conducted 
with the fifth-year pharmacy undergraduate students 
(n=21). Student SP encounters were assessed by 
Patient-centered Communication Tools (PaCT) that 
was adapted to Turkish (1). A two-facet generalizability 
study was performed to investigate the reliability of the 
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instrument. The impact of the course was assessed 
by comparing pre- and post-test scores. Additionally, 
qualitative data were collected on evaluating the 
laboratory at the end of the course by a survey.
RESULTS:
Students had significantly higher final assessment 
scores across all subsections in the instrument 
(p≤0.001).  The greatest improvements were seen 
in “demonstrate interest and empathy”. Students 
reported general satisfaction with the content and 
format of the course and the assessment process. 
CONCLUSIONS:
The improvement in demonstrating empathy has 
come from the understanding of patient centeredness 
that was underlying the course (2). Additionally, as 
a recommendation, the course should be designed 
as spiral curriculum rather than 14-week to enhance 
the development of students’ communication and 
counseling skills. 
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INTRODUCTION:
The genus Reseda L. is represented by 15 species 
in Turkey which 7 of them are endemic (1). R. lutea 
L. is known as a folk medicine and R. luteola L. as 
a dyeing plant due to its high flavonoid content. 
Flavonoids, due to their strong anti-oxidative potential, 
might be the subject of interest for developing anti-
photoageing, anti-cancer strategies and cosmetic 
products (2). Thus, we investigated total flavonoid 
and phenolic contents, antioxidant and genotoxic 
effect of 8 species to find more effective alternative 
natural resources.
MATERIALS AND METHODS:
In this study, 5 species consisting of R. alba L., R. 
aucheri Boiss., R. luteola, R. lutea, Reseda orientalis 
(Müll.Arg.) Boiss. and 3 endemics consisting of; 
R. balansae Müll.Arg., R. coodei Hub.-Mor., R. 
tomentosa Boiss. were investigated. To assess 
the antioxidant activity, methanol extracts of the 
aerial parts were prepared and examined by DPPH, 
ABTS, CUPRAC and FRAP assays. Moreover, 
total phenolic contents were measured by Folin-
Ciocalteu’s reagent and their flavonoid contents were 
measured by aluminum chloride colorimetric methods 
(3). To test the genotoxicity, The Somatic Mutation 
and Recombination Test- SMART in Drosophila 
melanogaster was applied. To determine the potential 
genetic toxicity of these taxa, the larvae–adult 
viability was measured in 100 larvae in different 6 
concentrations (4).
RESULTS:
For the methanol extracts of Reseda species, the 
DPPH, ABTS, CUPRAC and FRAP assays revealed 
comparable results with various potencies. Three 
species of R. luteola, R. lutea and R. tomentosa in 
all methods demonstrate significant antioxidant 
activity compare with the other taxa. R. luteola have 
the high level of total phenolic (104.31 mg gallic 
acid equivalents/g extract) and flavonoid (262.88 
mg quercetin equivalents/g extract) contents that 
provided more evidence to their antioxidant activity. 
No significant toxic effects and morphological changes 
were observed for none of the Reseda extracts. 
CONCLUSIONS:
Various Reseda species extracts show positive 
antioxidant activities, however doesn’t show any 
potential toxicity on larvae. Also R. luteola and 
R. lutea as widespread and R. tomentosa as an 
endemic species can be recommended as plants with 
antioxidant activity. 
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OP-038: INVESTIGATION OF THE 
RELATIONSHIP BETWEEN CHRONIC 
MONTELUKAST ADMINISTRATION AND 
DEPRESSION IN MICE.
Telli, G., Bozkurt, TE., Tel, BC.
1 Hacettepe University, Department of.Pharmacology, 
Ankara, Turkey
INTRODUCTION:
Montelukast is a leukotriene receptor antagonist 
which is widely used in inflammatory diseases of 
the respiratory tract such as asthma prophylaxis 
and treatment. Although many of the guidelines 
recommend montelukast (1), many neuropsychiatric 
side-effects of montelukast especially in children have 
been reported in recent years. In 2008, FDA has issued 
a warning about these side-effects of montelukast and 
recommended that patients should be informed for 
them. However, these neuropsychiatric side-effects 
have been poorly investigated and the results were 
contraversial (2). Although some significant cases 
have been reported, animal studies are lacking about 
the relationship between depression and montelukast 
treatment. In this study, we investigated the effect of 
chronic montelukast treatment on depression in mice. 
MATERIALS AND METHODS:
Porsolt’s forced swim (PFST) test was used for the 
assessment of depression like behavior. Swiss 
mice (8-12 weeks) from both sex were used in 
the experiments (Hacettepe University Animal 
Experimentations Local Ethics Board (2018-3/2). 
Montelukast was administered p.o. 20 mg/kg in the 
drinking water of the mice. PFST was performed on 
both control and montelukast-treated animals on the 
days 15, 30 and 60. Briefly, the mice were placed 
into 19 cm height 12 cm diameter glass cylinders that 
were filled with 25±1ºC water with a 15 cm depth for 8 
minute and the immobility time of last 6 minutes was 
counted.
RESULTS:
In PFST, there was no significant change in 
the immobility at three time-points with chronic 
montelukast treatment compared to control group.
CONCLUSIONS:
Our results indicate that chronic montelukast 
treatment do not induce depression-like behavior 
in mice. However, neuropsychiatric side-effects of 
montelukast should be investigated in the presence of 
asthma pathophysiology.
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INTRODUCTION:
A multiple unit oral floating drug delivery system of 
itraconazole (an antifungal agent) was developed 
to prolong gastric residence time, target stomach 
mucosa and increase drug bioavailability (1). 
MATERIALS AND METHODS:
To prepare non-effervescent floating microspheres/
beads by ionotropic gelation method, acetic acid 
solution containing itraconazole and chitosan was 
dropped through a syringe needle into DOS or TPP 
(as a crosslinking agent) solution in which buoyancy is 
provided by swollen matrix, when the entrapped air get 
in touch with the gastric medium. Since the solubility 
of itraconazole is low at pH 1.2,  it was attempted 
to increase the solubility by preparing inclusion 
complexes using RAMEB and with PVP-CL and starch. 
In this study, the effects of formulation parameters 
like concentration and types of polymer, crosslinking 
agent and the excipients were investigated. The 
floating ability, surface characteristics and drug 
release profiles were investigated in non-effervescent 
floating microspheres/beads. Since the drug release 
of formulation NG17 was much closer to zero order 
kinetics (r2=0.982), NG17 was used for cell culture 
studies. In Caco-2 cell culture studies, 3 different pH 
values (pH 5, 6 ve 7.4) were used (2).
RESULTS:
In permeability studies, with both itraconazole powder 
and the formulation NG17; the formulation NG17 at 
pH 5, which is the pH of the proximal region, showed 
the highest (two times of the itraconazole powder 
permeability) permeability value. NG17 was also used 
for in vivo imaging studies. NG17 was conducted in 
rabbits for in-vivo imaging studies by using gamma 
scintigraphy. It was obtained that the formulation 
NG17 floated for 6.5 hr in the stomach.
CONCLUSIONS:
In our study it was found that, with non-effervescent 
floating microsphere/bead formulations, the 
bioavailability of itraconazole can be improved.
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OP-040: THE RECENT STATUS AND A 
PREDICTION OF THE SOCIAL PHARMACY 
STUDIES IN TURKEY.
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Hacettepe University Faculty of Pharmacy, 
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INTRODUCTION:
The social pharmacy researches are becoming more 
crucial with the rapid developments in pharmacy 
education and services (1).  Pharmacy management 
researchers are working on the social pharmacy-
related issues in Turkey in this context. It is essential 
to collaborate in social pharmacy studies because 
of its wide scope. Besides, the collaboration, which 
is the core of the scientific studies, is increasingly 
becoming important in terms of making contribution 
to the improvements and maintain the scientific 
existence (2). In this study, the current status of social 
pharmacy field was examined and some suggestions 
were made to improve its quality in Turkey.  
MATERIALS AND METHODS:
Within the scope of this study, it is aimed to predict 
for the future of social pharmacy studies in Turkey 
by considering the scientific studies (articles, 
proceedings, books/book chapters, projects) 
between the years of 2013-2017 and the number of 
academicians who had finished or still continue their 
graduate education on pharmacy management.
RESULTS:
There were 15 academicians who were working in 
the Pharmacy Management Departments and had 
the above-stated qualifications in Turkey by the end 
of 2017. The topics of their scientific studies varied 
from history of pharmacy to pharmacoeconomics 
and ethics. According to the results of this study, the 
average article number per researcher was 2. Taking 
into account the highest and lowest article number 
per researchers, it’s determined that this number 
could be increased to 6. Moreover, the lowest number 
of scientific studies belonged to the projects. 
CONCLUSIONS:
Social pharmacy is very important for the future 
of the pharmacy profession in Turkey wherein the 
uncertainty are increasing daily for pharmacists. 
However, this field has its own problems like the 
limited number of researchers. So to contribute to 
the profession, this rare number of researchers 
should work cooperatively. Thus, it will be possible 
to make projects ensuring the continuity of graduate 
education. Creating workgroups and establishing 
an association will be also beneficial to increase the 
scientific production and visibility of the field.
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INTRODUCTION:
Allium L. (Amaryllidaceae) is one of the large 
genera of Monocotyledons, it comprises of more 
than 900 species in the world and approximately 
200 of them grow naturally in Turkey. Allium is an 
important genus due to its usages as food, spice, and 
being ornamental plants and medicinal plants. The 
genus is characterized by having bulbs enclosed in 
membranous tunics, free or almost free tepals, and 
often a subgynobasic style. Most species produce 
remarkable amounts of cysteine sulphoxides causing 
the well-known characteristic odor and taste. The 
genus is naturally distributed only in the Northern 
Hemisphere, mainly in regions that are seasonally 
dry. It has a main center of diversity in southwest 
and central Asia and a second smaller one in North 
America (1). Allium includes some economically 
important species like common onion, garlic, 
chives, and leek under worldwide cultivation, and 
also species with medicinal properties. It has been 
investigated under 14 sections in “Flora of Turkey” 
(3). Sect. Cupanioscordum (1) is one of the most 
complicated group in Allium due to its almost similar 
appearances.  In this study, the general morphology 
of the species belong to sect. Cupanioscordum has 
been investigated. Detailed morphological drawings, 
distribution maps and the descriptions are provided.  
MATERIALS AND METHODS:
This study was carried out using living plants and 
herbarium materials belong to sect. Cupanioscordum.
RESULTS:
The diagnosis, descriptions, identification key and 
detailed morphological drawings are presented in 
detail for four Allium species distributed in Turkey.
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CONCLUSIONS:
As a result, morphological characteristics of the 
investigated species have been expanded. 
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OP-042:EVALUATION OF TURKISH OTC 
AND NON-PHARMACEUTICAL PRODUCTS 
INDUSTRY USING AN INTEGRATED SWOT 
AND PESTEL ANALYSIS
1 Memisoglu, M.
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INTRODUCTION:
In our previous study we conducted an interview-
based qualitative analysis using in-depth, semi 
structured interviews of marketing professionals 
representing over-the counters companies as well as 
over-the-counter consultants in Turkey. We identified 
five basic themes: General Perspectives About 
Turkish OTC Market, Opportunities and Threats,  Role 
of Pharmacists in Marketing Communication Process, 
Marketing Communication Techniques, Types of 
Advertising, and Internet and Social Media Usage 
(1). As to this study, it is a follow-up of our previous 
qualitative study carried out in 2015 (1).
MATERIALS AND METHODS:
In this research, by conducting a strength, weakness, 
opportunity, and threat analysis (SWOT), it was aimed 
to investigate the OTC and non-pharmaceutical 
products industry in Turkey. Macro-environment 
factors were identified by using PESTEL analysis.
Data supporting these strategic analyses were derived 
from multiple sources including statistical reports, 
literature review, and in particular our previous study. 
RESULTS:
According to the results obtained, it is expected that 
the over the counter drugs and non-pharmaceutical 
products market will grow significantly. It turns out 
that there is a regulations requirement in this area. 
It has been highlighted that pharmacists who are 
seen as the most accessible healthcare professionals 
should underline their consultant identity and actively 
participate.
CONCLUSION:
Through conducting a thorough SWOT-PESTEL 
analysis, a picture of internal and external conditions 
of OTC and non-pharmaceutical products industry 
have been further clarified.
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INTRODUCTION:
Electron ionization-mass spectrometry (EI-MS) is 
popular due to its exceptionally wide application range 
with regard to sample materials. Direct-injection EI-
MS (DI-EI-MS) is an ideal methodology for quality 
control analyses of crude drugs or other materials 
containing a large number of constituents. Lichens 
are symbiotic associations of fungi and algae found 
mainly in terrestrial habitats. Subtle differences in 
morphologic characteristics between species makes 
lichen identification difficult for non-taxonomists. In 
this study, we established a metabolomics lichen-
identification method by analyzing various well-known 
lichen species using a combined DI-EI-MS/statistical 
approach.
MATERIALS AND METHODS:
Cladonia lichens were extracted with methanol at 
70°C for 3 h. The extract was dried and redissolved to 
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5 mg/mL in dimethyl sulfoxide (DMSO). A 1-μL aliquot 
of test sample was injected into the DI-EI-MS system. 
All statistical analyses were carried out using JMP Pro 
12.2 software to identify features contributing to group 
separation.
RESULTS:
Reproducibility of the proposed DI-EI-MS–based 
metabolomics method was assessed by repeated 
analysis of the same sample. Trough point to end 
of the scan in the total ion chromatogram (TIC) 
were integrated to account for variation in the point 
of maximum TIC intensity for each extract. All 
three reproducibility test spectra exhibited several 
common peaks and the same base peak at m/z 73. 
The established DI-EI-MS metabolomics method 
was then used to classify four Cladonia lichen 
samples. Each integrated mass spectrum exhibited 
characteristic peaks. For example, a peak at m/z 368 
with a relative intensity of 14% was observed in the C. 
krempelhuberi integrated spectrum, as well as those 
of the other lichen extracts. All four lichen samples 
could be differentiated using this method. Integrated 
mass spectra of each extract were collected at 
electron energies of 70, 50, 30, and 20 eV. Minor 
and undistinguishable peaks were extracted for use 
in classification based on the absolute ion intensity 
at each m/z integer value. The ability to clearly 
distinguish four different lichen species within the 
same genus demonstrates the utility of the DI-EI-MS 
method. 
CONCLUSIONS:
Our results suggest that metabolic profiling using DI-
EI-MS is useful for discriminating between subgroups 
within the same species. This is the first study to report 
the use of DI-EI-MS in a metabolomics application.
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BEHAVIOUR DIFFERENCES AMONGST 
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INTRODUCTION:
In this new time of globalization, change in science, 
society and strides of innovation allows individuals 
to have better way of life and more expectations for 
everyday comforts. This advancement in innovation 
and individual’s mindfulness prompts quick 
development of dermocosmetic products industry, 
especially over the most recent ten years with the 
Millennial generation (1). It is a crystal-clear fact that 
the Millennial generation is giving more importance to 
their look and well-being. This brings the development 
of the dermocosmetic items hence this can be 
seen as energizer for the market (2,3). In this way, 
it is critical to know the effect of various factors on 
decision making while purchasing a dermocosmetic 
item (4). This can be comprehended by looking into 
the Millennial’s dermocosmetic market and other 
generation’s dermocosmetic market. Our study aims 
to search and establish purchasing habits of Millennial 
and other generations on dermocosmetic products 
and evaluate the results.
MATERIALS AND METHODS:
A Unipolar Likert Scale questionnaire was developed 
and distributed to Turkey consumers from different 
ages. A total of 100 completed questionnaire were 
planned to evaluate by SPSS program; upon now part 
of them returned and analysed manually. The sample 
size of 100 people includes male and female as well 
a working and non-working groups and also students.
RESULTS:
The aim of the study was the behaviour of different 
ages in Turkey with respect to dermocosmetic 
products. According to results of completed 
questionarries, for the babyboomers it’s not so easy 
to make a purchasing decision and the quality of the 
product is important. Babybommers prefer to buy 
dermocosmetics from pharmacist and also the price 
is important. X generation prefer the online shopping 
however they also effected by friends and family 
members. They want to know more detail about the 
product that they will buy; but they are more positive 
than babyboomers when it comes to purchase 
anything. Y generation slightly know the difference 
between cosmetic and dermocosmetic, the product 
has to be trend in social media for them to buy; they 
don’t have any preference for shopping place but 
online shopping more common choice. 
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CONCLUSIONS:
Study shows that generations have common 
consumption patterns, and marketing studies 
conducted accordingly these patterns with 
consideration the differences of the generations will 
definitely have effect the orientation of cosmetics and 
dermocosmetic market and the rate of sales.
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INTRODUCTION:
In Turkey except hybrides, 25 taxa are naturally grow 
in the genus Origanum L., commonly used as oregano 
(1). In particular, there are difficulties in distinguishing 
closely allied taxa. A detailed study has been carried 
out in order to distinguishing these taxa according to 
anatomical characteristics.
MATERIALS AND METHODS:
In this study, 24 taxa of Origanum naturally growing 
in Turkey, are evaluated for their stem anatomical 
characteristics. Cross-sections are taken from the 
stem at 50 microns in thickness using a microtome 
and photographed.
RESULTS:
It has been found that the anatomical structure of 
cross-sections has similarity in many directions. Stem 
is usually quadrangular, with the outermost layer 
of cuticles. Under the cuticle, 1-layered epiderma 
usually consisted of rectangular cells, surrounded all 
the stem. Below the epidermal layer there is a layer 
of collenchyma which varies in thickness according 
to the species. Under the epidermis there is a 
layer, thickness varies depending on the species. A 
discontinuous sclerenchyma layer is occur. Phloem is 
usually 2-8 layered variable according to the species. 
Pith is spread over a large area, parenchymatous, 
contains starch grains.
CONCLUSIONS:
In the genus Origanum, it is shown that the 
characteristics belong to stem of which cuticle shape, 
layer of epidermal cells, hair presence on epiderm, 
collenchyma layers both on the corners and between, 
layer of endodermal cells and layer of sclerenchyma 
are important in differentiating the taxa. All the 
characteristics of the stem anatomy of the genus 
Origanum is presented for the first time in this study.
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OP-046: PROBING PHARMACY 
TECHNICIANS’ SKILLS AND STATUS IN 
TURKEY: A FOCUS GROUP STUDY.
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INTRODUCTION:
Pharmacy technicians play important roles in the 
services provided in community pharmacies (1), 
many expanding in scope all over the world. As 
healthcare professionals, pharmacy technicians’ work 
may affect directly or indirectly health outcomes (1,2). 
Besides technicians’ roles (3), pharmacy practice 
research has searched the impact of education and 
training programs, besides professionals’ certification 
(4,5). The aim of this study was to explore feelings, 
attitudes, expectations, and beliefs of pharmacy 
technicians regarding their duties, responsibilities 
and tasks, as well as educational status, therefore 
contributing to pharmacy practice and patient care 
improvement.
MATERIALS AND METHODS:
A Focus Group methodology was used to get in-
depth and rich information from pharmacy technicians 
and pharmacists related to practice. Four focus 
groups were designed as follows; (i) community 
pharmacists only (np1=7, np2=5), (ii) pharmacy 
technicians only (nt1=4, nt2=7). A purposive 
sampling method was used to select both pharmacy 
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technicians and community pharmacists based on 
demographics heterogeneity (varying gender and 
age). Community pharmacists comprised those who 
were practicing as community pharmacy owners and 
had work experience with technicians as an employer. 
Pharmacy technicians selected were those with at 
least one-year of community pharmacy experience. A 
semi-structured interview schedule was developed to 
guide the moderation of the focus group discussions. 
Focus groups were audiotaped, transcribed verbatim 
and analysed thematically.
RESULTS:
Four main themes were obtained named as; 
professional responsibilities, daily tasks and duties, 
issues related to job conditions, communication 
features, and technicians’ education. Extracted data 
showed pharmacists complaints on finding qualified 
technicians, contributing to a lack of staff that causes 
work problems, such as labour overload. Participants 
emphasized the importance of technicians’ effective 
communication in education and training. The current 
technicians’ education programs are found inadequate 
by pharmacists, being required more practice-based 
training.
CONCLUSIONS:
The initial evidence gathered in this study shows both 
community pharmacists’ and technicians’ feelings, 
attitudes and expectations about technicians’ status 
and skills to be convergent, particularly in education 
and communication. Educational strategies can be 
re-regulated to promote technicians’ qualifications, 
releasing pharmacists’ time to more patient-centred 
practices.
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INTRODUCTION:
Elmadağ town is located in the northeast foothills of 
Elmadağ; located  41 km east of Ankara. The town 
which was established in the northeastern skirts 
of Elmadag, is a very old settlement. Elmadağ is 
connected to 7 neighbourhoods and 4 villages. Steppe 
vegetation is dominant and usually concentrated in 
stream beds (1, 2). The plants are used for different 
purposes in Elmadağ where intense urbanization 
is present, and  they are mostly used for medicinal 
purposes. The aim of this study was to determine the 
plants used in the treatment of diabetes in Elmadağ.
MATERIALS AND METHODS:
The visits were made to the town center and villages 
during between 2015 to 2018. There is conducted 
face to face interviews with local people for collect to 
ethnobotanical data. The plants used by local people 
for diabetes in direction of the findings from interviews 
were determined.
RESULTS:
Due to intense urbanization in Elmadağ, much 
ethnobotanical information has not been obtained. 
In this study, it was found that more than 10 species 
were used  in the treatment of diabetes in Elmadağ. 
It was observed that decoction was the most common 
method of preparing a herbal medicine. Findings from 
previous studies of Ankara towns were compared with 
the results obtained from this study (3, 4).
CONCLUSIONS:
When the studies of folk medicine conducted in the 
towns of Ankara are examined, it was determined that 
Astragalus sp., Prunus divaricata Ledeb., Paliurus 
spina-christi Mill., Berberis crataegina DC., Tribulus 
terrestris L. have been used against diabetes in 
Elmadağ, unlike these towns. 
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OP-048: THE POSSIBLE EFFECTS OF 
NEBIVOLOL TREATMENT ON CARDIAC 
CALCIUM HANDLING AND MITOGENIC 
ACTIVATION INDUCED BY ACUTE BETA-
ADRENOCEPTOR STIMULATION.
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Ankara University, Faculty of Pharmacy, Department 
of Pharmacology, Ankara, Turkey.
INTRODUCTION:
Nebivolol is a member of third-generation β-blocker 
which has been approved for the treatment of 
hypertension. It has been known that nebivolol has 
cardioprotective effects including the prevention of 
desensitization of beta-adrenoceptor signaling and 
reduction of cardiac hypertrophy development (1). 
The aim of the present study was to investigate the 
possible effects of nebivolol treatment on calcium 
handling and mitogenic activation in the presence of 
acute isoprenaline stimulation in mice.
MATERIALS AND METHODS:
Twelve-week old male C57BL/6 mice were 
randomized into four groups (n=12): (i) Saline-injected, 
(ii) nebivolol-treated saline-injected, (iii) isoprenaline-
injected and (iv) nebivolol-treated isoprenaline-
injected. Isoprenaline was diluted in 0.9% saline and 
administered via intraperitoneal injection (25mg/kg). 
Saline control mice were injected with a calculated 
volume of 0.9% saline. Nebivolol hydrochloride was 
dissolved in drinking water (0.05g/L) for a dose of 10 
mg/kg/day (1). The control group received regular 
drinking water. Mice were administered nebivolol for 
5 days, and on day 5, they were injected with saline 
or isoprenaline. Mice were anesthetized by ether 
inhalation after 1 hour following isoprenaline injection. 
The heart was quickly dissected, the left ventricle 
tissue was immediately frozen in liquid nitrogen and 
stored at -80°C for western blot experiments.
RESULTS:
Nebivolol treatment significantly reduced the protein 
levels of phosphorylated TnI and p44/42 MAPK in 
controls. Phospholamban/SERCA ratio, a hallmark 
for evaluation of cardiac calcium handling, was not 
altered after 5-day nebivolol treatment. The increase 
in the TnI phosphorylation and Phospholamban/
SERCA ratio in response to acute isoprenaline 
stimulation revealed the activation of cardiac beta-
adrenergic signaling. Nebivolol treatment partially 
antagonized the acute isoprenaline-mediated calcium 
turnover. The increase in phosphorylation of MAPK 
in response to acute isoprenaline injection was not 
altered in the presence of nebivolol treatment.  
CONCLUSIONS:
Nebivolol treatment modulates PKA-mediated 
signaling pathway and MAPK activation under 
basal conditions and in response to acute beta-
adrenoceptor stimulation in different manner. 
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INTRODUCTION:
Researches done for various industries, teaches 
that “measuring satisfaction” is a driving force for 
management. Not only pharmacists’ but also patient’s 
satisfaction is a quality parameter for pharmacy and 
pharmaceutical services. Historically, researchers 
such as Donabedian, suggested measuring “patient 
satisfaction” as an outcome of care. This idea was 
expanded further by following researchers such as 
Ware et al., who conceptualised patient satisfaction 
to be a multi-dimensional construct and explained 
it as “an individual’s assessment of clear properties 
of the health care” (1).  As Naik Panvelkar et. Al. 
reasoned out that pharmacy research needs a 
strong measurement of patients’ satisfaction in 
community pharmacy because of a deficiency of 
comprehemacists and nsive theoretical frameworks 
and well-designed instruments (2). 
MATERIALS AND METHOD:
A patient satisfaction survey was designed as a new 
proprosed  instrument for Turkey. Both closed and 
open ended questions were installed. Hard copy of 
2 pages were given to patients and consumers who 
visited to 2 retail pharmacies in Istanbul. The reseach 
was conducted for 3 days. 
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RESULTS:
Survey itself was satisfactory practice for the patients. 
Nearly all the patients stated positive feedbacks both 
for the pharmacists and pharmaceutical services. As 
this is one the first researches conducted for Turkish 
culture, the instrument and evaluation/assesment 
system needed to be revised.
Conclusion: Patient satisfaction indicates consumer 
centered outcome. Community pharmacy services 
become an increasingly imperative part of the 
global health care system.  Effects of successful 
implementation of pharmacy management in long-
term needs to be improved and patient satisfaction 
measurement is a must for the evaluation.
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INTRODUCTION:
Proparacaine (PPC) (2-(diethylamino)ethyl 3-amino-
4-propoxybenzoate) is one of the most commonly used 
local anesthetic agents due to its high efficacy and 
fewer side effects in ophthalmic examination, minor 
and cataract surgeries (1). No voltammetric studies 
were found for the proparaine assay according to the 
literature review. This study is a new and sensitive 
method for the determination of PPC by multi-wall 
carbon nanotube paste electrode (MWCNTPE).
MATERIALS AND METHODS:
Voltammograms were obtained using a Bioanalytical 
Systems-Epsilon potentiostat/galvanostat connected 
to a BAS-C3 voltammetric cell stand. The MWCNTPE, 
Ag/AgCl (3 mol/L NaCl) and platinum wire were used 
as an indicator electrode, reference electrode and 
auxiliary electrodes, respectively.
RESULTS:
Using cyclic voltammetry, proparacaine exhibited a 
single irreversible anodic peak at around + 900 mV 
vs Ag/AgCl in pH 6.0 Britton-Robinson buffer solution. 
In square wave stripping voltammetry (SWSV), the 
deposition potential (Ed), deposition time (td), pulse 
amplitude (ΔE), step potential (ΔEs) and frequency (f) 
parameters were optimized. Proparacaine exhibited 
two linear sections and the dynamic linear range 
was found to be 0.5‒12.5 mg/L with a detection 
limit of 0.11 mg/L. The results for the determination 
of proparacaine in pharmaceutical local anesthetic 
(Alcone®) showed that relative standard deviation 
(RSD) and relative error (RE) were 3.75 % and – 1.25 
%, respectively. The selectivity of the method has 
also been examined by the recoveries of 5.0 mg/L 
proparacaine in the presence of 5.0 mg/L dopamine, 
ascorbic acid and uric acid and recoveries were 106.9 
± 0.8, 99.9 ± 1.2 and 94.1 ± 0.7, respectively.
CONCLUSIONS:
The resulting low relative standard deviation, low 
relative error and high recoveries showed that the 
reproducibility, accuracy and selectivity of the method 
are quite good. Thus, the voltammetric method 
developed for PPC is also applicable to natural 
samples.
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INTRODUCTION:
Prangos genus., an Iran-Turan element, consisting 
of 17 species, is a member of Apiaceae family (1). 
Roots of the plant are used as aphrodisiac and wound 
healing agent in Anatolian folk medicine. According 
to previous phytochemical studies, roots of Prangos 
sp. are rich in coumarins, furanocoumarins and its 
derivatives. Osthol, imperatorin, oxypeucedanin, 
heraclenol etc. are major components of the plant (2-
4). Prangos uechtritzii Boiss&Hauskn is a perennial 
herb and endemic species which is distributed in 
Central, East and Southeast Anatolia and the plant is 
known as ‘’Deli çakşır’’ (1). There are studies related 
to essential oil of fruits of the plant (5, 6). However, the 
pyhtochemistry of the plant has not been investigated 
previously. The aim of this study is to isolate and 
elucidate secondary metabolites from P. uechtritzii.
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MATERIALS AND METHODS:
Air dried roots were extracted with chloroform using 
ultrasonic water bath. Fractionation and isolation 
studies were carried out with column chromatography 
and preparative TLC. Structural elucidation of the 
compounds was based on both spectroscopic 
evidence (1D, 2D NMR and MS) and reference data 
comparison.
RESULTS:
7 molecules have been isolated which 3 of them are 
coumarins and 4 are furanocoumarin derivatives. 
Isolated compounds were identified as suberosin, 
psoralen, oxypeucedanin, peucedanol, imperatorin, 
prantschimgin and 7-demethyl suberosin.
CONCLUSIONS:
 Through our ongoing study on Prangos uechtritzii, 7 
molecules have been isolated and identified so far. 
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INTRODUCTION:
The genus Verbascum L. (Scrophulariaceae) is 
represented by 228 species in the flora of Turkey (1). 
Infusion and decoctions of the leaves and flowers 
have been used for haemorrhoid, rheumatism and 
respiratory problems such as bronchitis, asthma 
and commonly used to treat wounds in traditional 
Turkish medicine (2, 3). Phytochemical studies of 
Verbascum species have revealed the presence of 
saponins, iridoids, phenylethanoids, monoterpene 
and neolignan glycosides, flavonoids, steroids and 
spermine alkaloids (4).  Antiviral, antinociceptive and 
anti-inflammatory activities of the 1% sterile solutions 
of Ilwensisaponin A and C isolated from Verbascum 
pterocalycinum var. mutense Hub.-Mor. were 
assessed in this research.
MATERIALS AND METHODS:
1 % solution of the Ilwensisaponin A and C prepared 
by using sterile distilled water were surveyed for in 
vitro antiviral activity and cytotoxicity, against Rota 
and BHV-1 viruses. In vivo antinociceptive and 
anti-inflammatory activities were determined by 
p-benzoquinone-induced writhing and carrageenan-
induced paw oedema tests in mice, respectively.
RESULTS:
According to results, antiviral activities of the 1% 
sterile solutions of Ilwensisaponin A and C were not 
mean because of cytotoxicity effect. Both solutions 
showed antinociceptive and anti-inflammatory activity, 
but solution including Ilwensisaponin A (36.8% and 
9.6-36.6%, respectively) showed a high inhibition 
compared to Ilwensisaponin C solution (28.6% and 
14.3-25.5%, respectively) for both activity methods. 
For anti-inflammatory activity, 1% sterile solution 
of Ilwensisaponin A effected phase II of acute 
inflammation and showed a significant inhibition 
compared to standard indomethacin. 1% sterile 
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solutions of Ilwensisaponin A and C exhibited a 
moderate antinociceptive activity compared to acetyl 
salicylic acid without gastric lesion or bleeding.
CONCLUSIONS:
1% sterile solutions of the Ilwensisaponin A isolated 
from V. pterocalycinum var. mutense have anti-
inflammatory activity and these results are congruent 
with previous study (5).
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HIF-1Α SIGNALING PATHWAY AND NADPH 
OXIDASE SYSTEM ACTIVITY
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INTRODUCTION:
Recently, it has become clear that the hypoxia-
inducible transcription factor (HIF) pathway plays a 
key role in the regulation of immunity and inflammation 
(1). However, the relationship between nuclear 
factor (NF)-κB and HIF-1α is proved elusive (2,3). 
Rapamycin (RAPA) is a potent immunosupressant 
agent that effects cell cycle, growth, autophagy, 
and protein synthesis through mammalian target of 
rapamycin (mTOR) activity (4). As a continuation of 
our previous studies, we hypothesized that mTOR 
inhibition may prevent LPS-induced hypotension, 
inflammation and oxidative stress via modulation of 
mTOR/IκB-α/NF-κB/HIF-1α signaling pathway.
MATERIALS AND METHODS:
Male Wistar rats received saline (4 ml/kg, i.p.), LPS 
(10 mg/kg, i.p.) and/or RAPA (1 mg/kg, i.p.) at time 
0. Mean arterial pressure (MAP) and heart rate (HR) 
were measured by using a tail-cuff device. Rats were 
sacrificed 4 h after LPS challenge. Blood, kidney, 
heart, and lung were harvested for the measurement 
of expression and/or phosphorylation of rpS6, IκB-α, 
NF-κB p65, HIF-1α, iNOS, TNF-α, IL-1β, gp91phox, 
p47 phox, and β-actin, also nitrite levels in tissues 
and/or sera.
RESULTS:
MAP decreased and HR increased in the LPS 
administered rats. LPS caused an increase in 
expression and/or phosphorylation of rpS6, IκB-α, 
NF-κB p65 and HIF-1α, TNF-α, IL-1β, iNOS and 
oxidative stress markers (gp91phox and p47 phox), 
a decrease in IκB-α expression with increased nitrite 
levels in tissues and/or sera. These changes caused 
by LPS were prevented by RAPA, the selective mTOR 
inhibitor. RAPA alone had no effect on the parameters 
measured.
CONCLUSIONS:
These findings suggest that mTOR activation 
enhances the expression of proinflammatory 
mediators and contributes to the development of 
tissue injury by inducing stimulation of IκB-α/NF-
κB/HIF-1α signaling pathway and NADPH oxidase 
system activity.
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INTRODUCTION:
Oxidase enzymes have been widely used as 
biological elements in electrochemical biosensors for 
both lactate and glucose detections. Although oxidase 
enzymes pose many advantages including high 
sensitivity and selectivity towards the corresponding 
analytes, they suffer from oxygen dependency. Since 
oxidase enzymes use oxygen as an electron accepter 
(mediator) in enzyme reactions, any fluctuation in 
dissolved oxygen concentration in environments 
results in false readings. In addition, it is noteworthy 
that the dissolved oxygen concentration in human 
blood fluctuates significantly depending on the health 
conditions. In the present work, we designed novel 
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electrode surfaces by exploiting oxygen-rich surfaces 
of CeO2 and CeO2-based nanoparticles to eliminate 
the oxygen dependency challenge.
MATERIALS AND METHODS:
The nanoparticles were synthesized by a facile co-
precipitation method and characterized by SEM, 
TEM, XRD, XPS, Raman, and TGA methods. The 
biosensors were constructed by drop casting certain 
amount of nanoparticle and enzyme solutions 
on polished glassy carbon electrode surface. 
Amperometry and cyclic voltammetry techniques 
were employed to evaluate the performance of the 
biosensors. 
RESULTS:
It was observed that the oxygen release property 
of the nanoparticles had a profound impact on 
the performance of the biosensors in O2-depleted 
environments. While unmodified biosensors 
experienced a significant decrease in their response 
in oxygen-lean medium, the modification of enzyme 
layer with CeO2-based nanoparticles declined the 
O2-susceptibility of the sensors significantly.
CONCLUSIONS:
False readings and errors in biosensor responses 
were minimized by the modification of enzyme layer 
with O2-rich materials.
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Pharmaceutical Microbiology, Izmir, Turkey
2Ege University, Faculty of Medicine, Department of 
Medical Microbiology, Izmir, Turkey
INTRODUCTION:
Methicillin-resistant Staphylococcus aureus (MRSA) 
is a multidrug resistant bacteria and one of the 
most prominent bacterial pathogens which causes 
medical device associated infections by biofilm 
formation (1,2). Bacteria are can be more resistant 
to antibiotics in the biofilm layer (3). The increase of 
antibiotic resistance increased interest in studying the 
antimicrobial potency of phytochemicals.In this study, 
we investigated antimicrobial and antibiofilm efficacy 
of thymol  which is a phenolic monoterpene, on MRSA 
strains.
MATERIALS AND METHODS:
Twenty MRSA strains isolated from clinical samples 
at Ege University, Faculty of Medicine, Bacteriology 
Laboratory of Medical Microbiology Department. 
Identification and the antimicrobial susceptibility 
profiles of isolates was performed using VITEK 2 
system. Minimum inhibitory concentrations (MIC) 
of thymol were determined by broth microdilution 
method according to EUCAST criteria. The biofilm 
production of isolates and anti-biofilm effects of thymol 
were investigated by spectrophotometric microplate 
method.
RESULTS:
The MIC values of thymol was detected 64 μg/ml in 
one isolate and was 256 μg/ml in nineteen isolates. 
Sixteen isolates and four isolates were identified as 
moderate and strong biofilm producers, respectively. It 
was determined that biofilm formation was decreased 
in twelve isolates and increased in one isolates, by 
addition of sub-MIC/2 of thymol. The effects of sub-
MIC of thymol on mature biofilm formation in isolates 
are shown in Table 1.
Table 1. Effect of thymol on mature biofilm in moderate 
and strong biofilm producers  




















In this study, we have demonstrated that thymol which 
is a major phenolic component of oregano oil, may 
have inhibitory effects on mature biofilm structure 
and may help to prevent MRSA-associated biofilm 
infections.
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OP-056: ELECTROCHEMICAL 
DETECTION OF NASAL DECONGESTANT 
DRUG OXYMETAZOLINE BY -COOH 
FUNCTIONALIZED MWCNTS AND TITANIA 
NANOPARTICLES MODIFIED ELECTRODE
1 Munir, A., 2 Bozal Palabiyik, B., 1 Shah, A., 2 Uslu, B.
1Quaid-i-Azam University, Department of Chemistry, 
Islamabad, Pakistan
2Ankara University, Faculty of Pharmacy, Department 
of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
Oxymetazoline, a nasal vasoconstrictor drug, has 
been used as nasal decongestant for more than forty 
years (1). No electrochemical study has previously 
been performed on oxymetazoline to illustrate the 
electrochemical fate of this drug. Moreover, not any 
modification of electrodes has been reported in the 
literature for this drug. However, the present study 
was conducted in order to bridge this gap and to get 
useful insights about the fabrication of electrode and 
redox mechanism of oxymetazoline.
MATERIALS AND METHODS:
-COOH functionalized multi-walled carbon nanotubes 
(MWCNTs) and TiO2 nanoparticles (NPs) were used 
for the modification of glassy carbon electrode (GCE). 
Differential pulse voltammetry and cyclic voltammetry 
was employed for the illustration of electrochemical 
redox mechanism. While, electrochemical impedance 
spectroscopy and differential pulse voltammetry was 
used for the determination of performance of sensor 
developed.
RESULTS:
The results revealed enhanced electrochemical 
behavior of oxymetazoline by TiO2NPs/fMWCNTs/
GCE as compared to bare GCE. The conditions 
were optimized at pH 7.0 phosphate buffer solution, 
0 V accumulation potential, and 180 s accumulation 
time. The differential pulse voltammetric response of 
oxymetazoline was determined between the linear 
concentration range of 0.05 µM to 1.5 µM. In pH 7.0 
phosphate buffer solution, oxymetazoline gave three 
anodic peaks in the studied potential range. The 
possible redox mechanism was proposed for all the 
three peaks. While, only two of these peaks were 
studied for the determination of oxymetazoline with 
the limit of detection values of 4.40 nM and 9.84 nM 
for both peaks.
CONCLUSIONS:
The nanomolar concentration of oxymetazoline drug 
was successfully determined by the current developed 
method. The possible electron transfer mechanism 
of this novel drug was suggested effectively. The 
validation of present technique was assessed and 
the amount of oxymetazoline in pharmaceutical nasal 
spray was successfully determined.
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CHARACTERIZATION AND COMPARATIVE 
ANTIMICROBIAL ACTIVITY OF HYPERICUM 
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PERFORATUM L. EXTRACTS CONJUGATED 
HYBRID NANOFLOWERS
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INTRODUCTION:
 Hypericum L. genus (Hypericaceae) are represented 
a hundered species in Turkey (1). In this study, 
the upper parts of the flowering soil of Hypericum 
perforatum (Balikesir-Edremit) and H. aucheri species 
were collected from Balıkesir-Kazdağları Sarıkız hill 
and diagnosed (ERCH 5112, 5113). 
MATERIALS AND METHODS:
Methanol extracts of the plants were prepared from 
the underground parts of H. perforatum and H. aucheri 
by maceration method. The total phenol contains 
of the extracts were calculated using the Folin-
Ciocalteu method as the gallic acid equivalent. The 
scavenging activity of DPPH radicals of the extracts 
were also studied. In addition, for the first time the 
synthesis, characterization and antimicrobial activities 
of extract+Cu2+ hybrid nanoflowers (NFs) from both 
methanol extracts were investigated according to 
CLSI) standards at 7,825 – 500 µg/ml concentrations. 
Synthesized nanoflower structures were identified by 
SEM, EDX and FTIR. 
RESULTS:
According to the results, H. aucheri species is 
richer in phenolic content than H. perforatum. The 
antimicrobial activity about four times higher than 
H. perforatum on other tested microorganisms 
(Staphylococcus aureus ATCC 29213, Bacillus subtilis 
ATCC 6633, Acinetobacter baumanni ATCC 19606, 
Pseudomonas aeruginosa ATCC 27853, Candida 
albicans ATCC 90028) than Escherichia coli ATCC 
35218 and Enterococcus faecium ATCC 8459 in their 
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antimicrobial activity experiments. Also antimicrobial 
effect of hypericin was tested. There were no effect of 
hypericin and hypericin NF on tested microorganisms. 
NFs were two fold more effective on tested 
microorganisms than extracts at low concentrations 
(7,825 µg/ml) against especially Gram negatives. In 
addition, A. baumannii and P.aeruginosa, which have 
high resistance to treatment, appear to have high 
antimicrobial activity at low dose (62.5 µg/ml). Both 
extracts were evaluated for DPPH radical scavenging 
effects as percent inhibition and were equally effective 
when compared to the standard materials used. 
CONCLUSIONS:
As a result, H. aucheri species may be a candidate 
plant species for which standardization studies can 
be performed when comparing activity and content 
with H. perforatum. Interestingly, nanoflowers that 
synthesized from plant extracts have promising with 
high stability and antimicrobial effect.
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OP-058: NOSE TO BRAIN DELIVERY OF 
ELETRIPTAN HYDROBROMIDE PLGA 
NANOPARTICLES
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Turkey
INTRODUCTION:
The objective of this study was to prepare 
Eletriptan Hydrobromide loaded PLGA 
nanoparticles and provide brain targeting, 
and sustained release of Eletriptan Hydro-
bromide with-in the brain. This benefit would 
help to improve its clinical utility in migraine, 
reduce side effects and improve therapeutic 
efficacy.
MATERIALS AND METHODS:
PLGA nanoparticles (NP) were prepared using the 
W/O/W emulsion technique. Release of Eletriptan 
Hydrobromide from the nanoparticles was studied 
at 37°C using a dialysis bag diffusion technique. 
The released drug in the buffer was collected at 
predetermined time intervals and frozen for further 
quantitative analysis using HPLC (1). To investigate 
the cytotoxicity of Eletriptan Hydrobromide with or 
without encapsulation into PLGA, CaCo2 cells. The 
intracellular Eletriptan Hydrobromide accumulation 
was examined as described (2). Nanoparticulate 
formulation and drug solution were administered 
intranasal (IN) or intravenously (IV). Subsequently, 
rats were sacrificed at different time intervals and their 
brains were removed and homogenized in PBS (pH 
7.4). 
RESULTS:
Nanoparticles were prepared with a particle size 
244.3±28.1 nm and 0.110± 0.05 PDI. More than 80 
% of drug was released after 24 h and cell viability 
of Eletriptan Hydrobromide with encapsulation into 
PLGA in CaCo2 cells were higher than free drug. The 
highest brain drug concentration was observed after 
intranasal nanoparticle administration.
CONCLUSIONS:
It can be concluded from study that it is possible 
to prepare Eletriptan Hydrobromide−PLGA 
nanoparticles. PLGA NP showed no significant 
toxicity on CaCo2 cells, Drug efflux studies showed 
that PLGA nanoparticles can inhibit the function of 
P-gp and increase. From the results of in vivo studies, 
one can conclude that the NP provided a higher 
brain concentration of drug after IN administration 
compared with IN- and IV-administered drug solution. 
Thus, it can be concluded that drug-loaded PLGA NP 
are capable of providing direct nose-to-brain delivery, 
thereby enhancing drug concentration in the brain.
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INTRODUCTION:
Pulmonary delivery of antibiotics has many 
advantages for treatment of lung infections comparing 
to others. Inhalation of drugs may lead to much 
higher drug concentrations in pulmonary tissue (1). 
However, drugs of conventional inhalation therapy 
results in a short duration of drug action at the target 
site. Therefore, there is a need to design of sustained 
release formulations to localize the drug action in 
the lungs (2, 3). The most important advantage of 
nanoparticles is their small size and ability to cross 
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various barriers, increase the contact surface with the 
tissue. However high cohesive properties due to the 
large surface area is a problem in the preparation. 
Preparation of low-density microparticles provide 
controlling of nanoparticle sizes and surface charges, 
and agglomerates. They are called nanocomposite 
microparticles, they will be easily separated into 
nanoparticles in aqueous media in the lungs and 
aerosolized. In this study, ciprofloxacin(CIP)-loaded 
nanoparticles and nanocomposite microparticles for 
pulmonary delivery were developed and evaluated 
in-vitro. The nanoparticles were prepared in order 
to encapsulate the hydrophilic CIP. Nanocomposite 
microparticles were prepared using nanoparticle to 
obtain micron size required for pulmonary delivery. 
MATERIALS AND METHODS:
CIP was gift from Zentiva-Turkey. Dichloromethane, 
poly-€-caprolactone (PCL), PLGA-50/50 (MA=40000-
75000/MA=24000-38000), polyvinyl alcohol 
(Mw=30000–70000) were obtained from Sigma 
(Germany). Chitosan-HCl was purchased from 
NovaMatrix (Norway). CIP-loaded nanoparticles 
were prepared by solid-in-oil-in-water emulsion-
solvent evaporation method and the effects of various 
formulation parameters on the physicochemical 
properties of the nanoparticles were investigated. 
Composite microparticles were prepared using 
mannitol as a carrier and aerodynamic proporties 
were investigated. Antibacterial activity test was 
carried out with agar diffusion method employing the 
cup plate technique (4).
RESULTS:
PCL-nanoparticles showed spherical shapes with 
particle sizes around 143-489nm. Encapsulation 
efficiency was found to be low because of water-
solubility properties of CIP. CIP-loaded PCL-
nanoparticles showed initial burst effect for 4h and 
continuously released for 72h. Tapped density 
and MMADt results showed nanocomposite 
microparticles have suitable aerodynamic properties 
for pulmonary administration. Antimicrobial activity 
test indicated CIP-encapsulated PCL-nanoparticles 
and nanocomposite microparticles inhibited growth of 
bacteria.
CONCLUSIONS:
Surface modification of nanoparticles with chitosan 
caused an increase in encapsulation efficiency. 
Antibacterial activity test indicated, ciprofloxacin 
retained its antimicrobial efficacy when incorporated 
in the particular system. Considering nanoparticles 
0 and 6th month activities, the particular system was 
stabile. As a result, nanocomposite microparticles 
containing CIP-loaded nanoparticles can be used for 
pulmonary delivery.
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INTRODUCTION:
Perfluorinated compounds, which are widely used in 
many industrial and consumer products for over 60 
years, bioaccumulate in the environment due to their 
high persistence. Several human and animal studies 
have shown an association between exposure to 
these compounds and adverse health effects on many 
organs and systems (1). The most common exposure 
pathway for humans to perfluorinated compounds 
are considered to be contaminated drinking water 
and foods (2). In the literature, levels of perfluoroalkyl 
substances (PFASs) were investigated in ground, 
surface, tap or bottled water in various countries 
(3) and, to our knowledge, present study is the first 
research performed in Turkey.
MATERIALS AND METHODS:
Forty-nine samples of tap water were collected from 
33 provinces of Turkey. The samples were extracted 
by solid phase extraction and analyzed via ultra 
performance liquid chromatography-tandem mass 
spectrometry for the presence of 10 different PFASs: 
PFBA, PFPeA, PFHxA, PFHpA, PFOA, PFNA, PFDA, 
PFBS, PFHxS and PFOS.
RESULTS:
Method detection limit was calculated separately for 
each PFAS and ranged between 0.07 and 0.12 ng/L. 
Highest concentrations of PFOA, PFOS, PFHxA, and 
PFBA in tap water samples was determined as 1.37, 
1.25, 1.82 and 1.69 ng/L, respectively, while other 
PFASs were also detected in considerable levels. In 
general, tap water samples from İstanbul, Eskişehir, 
İzmir and Ankara were found to have highest PFAS 
levels.
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CONCLUSIONS:
The results show that PFAS levels tend to be higher in 
urbanized and industrialized places. Since this is the 
first investigation measuring tap water PFAS levels in 
different locations in Turkey, additional studies with 
other water sources (groundwater, surface waters, 
wastewater, etc.) should be performed to confirm our 
results.
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INTRODUCTION:
Ballota species belong to Lamiaceae family 
commonly distributed in the mild climate locations 
and have been used in folk medicine as antiulcer, 
antispasmodic, antihemorrhoidal and sedative 
agents (1). Inflammation is a protective mechanism 
in response to an abnormal stimulation caused by a 
physical, chemical, or biological agent. Some non-
steroidal drugs and corticosteroids currently used 
for inflammatory conditions have toxic effects (2, 3). 
Diabetes mellitus is a major endocrine disorder and is 
characterized by abnormalities in carbohydrate, lipid 
and lipoprotein metabolisms (4). Plants secondary 
metabolites have extensively different bioactivity 
properties. The aim of this study was to examine 14 
Ballota taxa from Turkey for their antidiabetic and 
anti-inflammatory activities.
MATERIALS AND METHODS:
In this study aqueous and alcoholic extracts of 14 
Ballota taxa were examined for their antidiabetic 
and anti-inflammatory activities by using in vitro 
α-glucosidase inhibitory activity and membrane 
stabilization method, respectively (3, 5).
RESULTS:
Aqueous extract of B. nigra subsp. anatolica 
exhibited the maximum anti-inflammatory effect 
following by ethanolic extracts of B. acetabulosa 
and B. glandulosissima. And for antidiabetic activity, 
aqueous and ethanol extracts of B. glandulosissima 
(IC50=2.18 and 2.30 µg/ml respectively) exhibited the 
maximum α-glucosidase inhibitory activity.
CONCLUSIONS:
The ethanolic extracts showed higher membrane 
stabilization profile than aqueous extracts generally. 
In contrast, the aqueous extracts showed higher 
α-glucosidase inhibitory activity than the ethanol 
extracts. It is concluded that the solvent type could 
affect the profile of biologically active components.
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OP-062: DEVELOPMENT AND EVALUATION 
OF ETOPOSIDE LOADED POLYMERIC 
TUBULAR NANOSTRUCTURES
Algan, AH, Karatas, A. 
 Ankara University, Faculty of Pharmacy, Department 
of Pharmaceutical Technology, Ankara, Turkey
INTRODUCTION:
Besides nanocarrier size, shape of the nanocarrier is 
a critical parameter which has an impact on circulation 
time (1). Studies have shown that cylindrical 
nanostructures, circulate longer than spherical 
particles with the same diameter (2). Template 
synthesis is one of promising ways of fabrication of 
tubular nanostructures (3). Etoposide (ETP) is a 
chemotherapeutic agent with poor aqueous solubility 
and short half-life (4). The aim of the study was to 
produce ETP loaded polymeric tubular nanostructures 
by template wetting of nanoporous membranes.
MATERIALS AND METHODS:
Anodic aluminum oxide(AAO) (Whatman™, 
GE Healthcare) was template membrane. 
Poly-ε-caprolactone(PCL), Poly-d,l-lactide-co-
glycolide(PLGA), poly(l-lacticacid-co-caprolactone-
co-glycolic acid) (PLCG) were purchased from Sigma-
Aldrich. 
Preparation of etoposide loaded polymeric tubular 
nanostructures
Polymer and ETP were dissolved in a mixture of 
dichloromethane (DCM) and dimethyl formamide 
(DMF). For wetting AAO membrane template, 
immersion technique was applied in ETP/polymer 
solution for a predetermined time in tightly close 
glass containers. Drug/polymer embedded AAO 
membranes were dried at room temperature in order 
to remove all residual solvent. AAO template etching 
was performed with aqueous phosphoric acid to 
dissolve AAO completely. After etching of the template 
membranes, liberated tubular nanostructures were 
collected by vacuum filtration, washed with pure 
water, and they were freeze dried.
RESULTS:
ETP assay was conducted by HPLC analysis which 
was described in our previous work (5). Entrapment 
efficiency (EE%) and drug loading (DL%) were 
calculated.






EE (%) DL (%)
F1 PCL DCM:DMF 10:2 10.25 1.71
F2 PLGA DCM:DMF 10:2 18.21 3.04
F3 P(LCG) DCM:DMF 10:2 12.08 2.01
The morphology of the polymeric tubular 
nanostructures were examined by scanning electron 
microscopy(SEM). Images showed that ETP loaded 
nanostructures were obtained successfully in nano 
dimensions and with smooth surfaced tubular forms.
CONCLUSIONS:
Consequently, the developed polymeric tubular 
nanostructures was found promising and improvable 
for the delivery of antineoplastic agents.
ACKNOWLEDGEMENTS:
This work was supported by the Scientific and 
Technological Research Council of Turkey (TUBITAK) 
under Grant 113S201.
REFERENCES:
1.  Maeda H, Wu J, Sawa T, Matsumura Y, Hori K 
(2000). J. Control. Release, 65 (1-2): 271-28. 
2.  Champion JA, Katare YK, Mitragotri S (2007). J. 
Control. Release, 121 (1-2): 3-9. 
3.  Son SJ, Bai X, Nan A, Ghandehari H, Lee SB. 
(2006) J. Control. Release, 114:143-152.
4.  Najar IA, Johri RK (2014). J. Biosci., 39 (1):139-
144.
5.  Algan AH, Gumustas M, Karatas A, Ozkan SA 
(2016). J Pharm Biomed Analysis, 124: 382-389. 
OP-063: PREPARATION AND IN 
VITRO CHARACTERIZATION OF 
DEXAMETHASONE LOADED ETHOSOME 
FORMULATIONS
Rencber, S., Tuncay Tanriverdi, S.
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INTRODUCTION:
The purpose of this study was to prepare and 
characterized ethosomal formulation containing 
Dexamethasone (DEX) for topical application. 
METHODS:
Ethosomal formulations were prepared according 
to the method reported by Tanrıverdi et. al., 2013. 
Phospholipid and DEX were dissolved in ethanol. 
Distilled water was added slowly to the lipid mixture 
with constant stirring. The resulting vesicle suspension 
was homogenized with using probe sonicator. The 
formulations were prepared with two different ratio 
of phospholipid. The zeta potential (ZP), particle 
size (PS) and polydispersity (PI) were determined 
by light scattering spectroscopy. The pH values of 
the formulations were determined by using a pH 
meter. For encapsulation efficiency (EE), ethosomal 
formulations were ultracentrifuged, the supernatant 
was used for DEX analysis by validated HPLC 
method and the quantity of free drug was determined. 
The drug loading (DL) and amount of drug were 
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determined by dissolving the ethosome suspensions 
in methanol. Morphological analysis was performed 
by transmission electron microscopy. The dialysis bag 
diffusion technique was used to study the in vitro drug 
release. 1 mL of ethosome suspensions was placed 
in the dialysis bag, hermetically sealed and immersed 
into pH 5.5 sorenson buffer.  Samples were withdrawn 
from the receptor compartment at predetermined 
time intervals. The amount of drug released was 
determined by HPLC. The dissolution data were fit 
to Peppas equation, and best-fit parameters were 
calculated to determine the release mechanism of 
formulations.
RESULTS:
Ethosomal formulations were successfully prepared 
using modified ethanol injection method. The pH 
values of the F1 and F2 formulations were found to 
be 7.68 and 7.53, respectively. Neutral pH values 
indicated the formulation could be used as topical 
delivery with low risk skin irritation. PS, PI and ZP of 
the formulations were given in Table 1.The EE% of 
DEX from the ethosomal formulations was as high as 
84.119%–77.254%. The amount of drug was found 
95.099 and 95.133%, respectively. Also, DL capacity 
was found 5.039% and 8.648%, respectively. Figure 1 
shows that prepared all formulations controlled drug 
release. According to Peppas equation, the values of 
n fell within the range of 0.671-0.756, indicating that 
the drug release from the NPs is non-Fickian.
CONCLUSION:
The objective of the present work of formulation and 
evaluating of DEX ethosomal formulations for topical 
delivery has been achieved with success. 
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INTRODUCTION:
Inefficiency in treating the infections caused by multi-
resistance microorganisms have brought about the 
necessity for new compounds with antimicrobial 
activity. The genus Lactobacillus has recently been 
focal point of researchers due to their ability to produce 
secondary metabolites with antimicrobial effects such 
as lactic acid, acetic acid and hydrogen peroxide (1). 
The aim of this study was to determine the quantities 
of lactic acid, acetic acid and hydrogen peroxide in 
secondary metabolites from vaginal Lactobacillus 
species by High Performance Liquid Chromatography 
(HPLC).
MATERIALS AND METHODS:
Vaginal isolates were identified through 16S rRNA 
method. Lactobacillus isolates were inoculated into 
tubes containing De Man-Rogosa Sharpe Broth at 
37 ºC, under anaerobic conditions for 72 hours. After 
incubation, cells were removed by centrifugation 
(12000 g, 10 min, 4 °C). Cell free supernatants were 
filter-sterilized (2). HPLC analysis of secondary 
metabolites were carried out on Agilent 1100 series. 
Separation was carried out on Inertsil ODS-3 (150 
length x 4.6 mm i.d., 5 µm). Elution was performed 
with a mobile phase as % 0.025 phosphoric acid 
solution. The flow rate was set at 0.75 mL/min, 
injection volume was 5 µL and temperature of the 
column was maintained at 25ºC. Compounds were 
detected at a wavelength of 210 nm.
RESULTS:
In this study, of the 53 vaginal isolates identified 
through 16S rRNA method, 18 were established to be 
L. crispatus, 17 L. gasseri, 5 L. jensenii, 4 L. vaginalis, 
3 L. fermentum, 2 L. coleohominis, 1 L. saerimneri, 1 
L. reuteri, 1 L. johnsonii and 1 L. helveticus species. 
According to the HPLC analysis results, secondary 
metabolites of all tested isolates contain hydrogen 
peroxide between 0,007306 and 0,00033 mg/µL 
range. It was found that the secondary metabolites of 
some isolates contained both acetic and lactic acid, 
while some of them contained either acetic or lactic 
acid at various concentrations. 
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CONCLUSIONS:
Lactobacillus species are different from each other in 
terms of secondary metabolites production quantities. 
Lactic acid, acetic acid and hydrogen peroxide may 
be responsible for their antimicrobial activity. Based 
on this difference, the antimicrobial activity of these 
species may change. 
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INTRODUCTION:
Perfluorooctanoic acid (PFOA) has been widely used 
in the industrial field since 1950’s, and detected in 
surface waters, house dusts, and in human blood 
serum due to direct or indirect exposure during 
production, uses and disposal. PFOA, considered 
to be endocrine disrupting and teratogenic agent, 
has been investigated as a cause of cardiovascular 
disease, peripheral arterial disease, immunological 
system impairment and liver damage. In 2017, PFOA 
was classified by the International Cancer Research 
Agency (IARC) as a possible carcinogen for humans 
(group 2B). The in vivo studies have reported that 
PFOA might lead to hepatic, testicular and pancreatic 
cancers. However, the mechanism in pancreatic 
tissues is still unclear and insufficiently discussed. 
Inflammation effects are the most important 
mechanisms leading to pancreatitis and afterwards 
cancer. Activation of trypsinogen is one of the 
important biomarkers in acute pancreatitis and other 
pancreatic injuries (1,2). In this study, it has been 
aimed to investigate whether inflammation effect is 
one of the PFOA-induced cancer mechanisms in the 
pancreatic tissue
MATERIALS AND METHODS:
The cytotoxic activity was measured by MTT 
assay, the apoptotic effect was evaluated using 
annexin V/PI, caspase-3/7 and by Bax levels. The 
chymotrypsin, trypsin, IL-6, IL-8, MAPκ-8, TNFβ and 
TNFα inflammation related enzyme and cytokine 
levels were measured using flow cytometry, RT-PCR, 
and spectrophotometry. The oxidative stress MDA, 
GSH, CAT and SOD levels were evaluated by ELISA 
kits, and the ROS level was measured using flow 
cytometry. 
RESULTS:
Our results show that PFOA caused a cell death in 
concentration dependent manner (IC50 195.6 µM), 
and apoptosis might not be the major cell death 
pathway. A significant increase in chymotrypsin but 
not in trypsin levels were detected in the exposed 
cells. The significant change in some oxidative stress 
end points and inflammation related proteins/gene 
levels indicated the role of oxidative damage and 
inflammation in PFOA induced toxicity. 
CONCLUSIONS:
Inflammation and oxidative stress play an important 
role in PFOA induced toxicity. Further studies should 
be conducted to better understand how effect the 
inflammation mechanisms-induced ROS in the 
toxicity of PFOA. 
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INTRODUCTION:
Silver has a long empirical history of human usage 
in medicine to treat and prevent microbial infections. 
Silver is found to be even more effective in antimicrobial 
activity when the particles are at nanoscale. The 
conventional physio-chemical approaches in the 
synthesis of silver nanoparticles involve expensive 
and often hazardous chemical agents. Therefore, the 
development of cost-effective and greener methods 
to synthesize silver nanoparticles has become a 
research highlight in recent times [1]. Present study 
was undertaken to synthesize silver nanoparticles 
using methanol extract of Mollugo cerviana (L.) Ser. 
and to evaluate its antimicrobial and disinfectant 
properties subsequently.
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MATERIALS AND METHODS:
Methanolic extract prepared from the seeds of M. 
cerviana (L.) Ser. was tested against Gram positive 
and Gram negative bacteria by disc diffusion and 
broth micro-dilution methods. Thereafter, the extract 
was treated with silver nitrate. The subsequent 
development of silver nanoparticles was observed 
using UV-visible spectrophotometer and scanning 
electron microscopy. The antibacterial and antifungal 
activity of the resulted nanopreparation was evaluated 
thereafter. 
RESULTS:
Despite the wide utility of this plant as an antimicrobial 
medication, the original plant extract was not capable 
of inhibiting the growth of the tested bacteria even at 
a high concentration of 1000 µg/mL. Nevertheless, 
when the silver nanopreparation was obtained from 
this extract, a noticeable activity was observed. The 
change in the original colour of the reaction mixture 
and the increased UV-Visible absorbance indicated 
that phytochemicals present in the extract could 
reduce silver ions into elemental silver. The size and 
morphology of the synthesized nanoparticles were 
revealed by scanning electron microscopy as clusters 
in the vicinity of 100 nm.  Although the antifungal 
activity of this nanopreparation against Candida 
albicans was negligible, the antibacterial potential 
was conspicuous against Staphylococcus aureus, 
Enterococcus faecalis and methicillin-resistant S. 
aureus with minimum inhibitory concentration values 
in the range of 125-250 µg/mL.
CONCLUSIONS:
The use of natural plant extracts such as methanolic 
extract of M. cerviana (L.) Ser. in the preparation 
of silver nanoparticles by a greener route would 
provide advancement over conventional methods 
due to the cost effective and eco-friendly features. 
The preliminary results of this study suggest that the 
synthesized silver nanoparticles has a high potential 
to be developed into a novel disinfectant. Thus, the 
experiments are in progress to confirm its’ disinfectant 
potential, mechanism of action and also to exclude 
the possible cytotoxic effects on human.
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BIOFILM MODELS
1 Kart, D, 2 Nemutlu, E.
1Hacettepe University, Faculty of Pharmacy, 
Department of Pharmaceutical Microbiology, Ankara, 
Turkey
2Hacettepe University, Faculty of Pharmacy, 
Department of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
Proteus mirabilis is one of the major agents in a 
variety of hospital acquired infections and also 
isolated from the biofilm related infections. Differantial 
dynamic relations and interactions have been found 
in mixed-species biofilms by comparison with their 
single-species biofilms. P. mirabilis, E. faecalis and 
C. albicans are frequently grow together and isolated 
from the samples of infected patients. Our goal was to 
establish an poly-species biofilm model in vitro and to 
find out the impact of presence of the C. albicans and 
E. faecalis on metabolite profile of P. mirabilis.
MATERIALS AND METHODS:
Proteus mirabilis ATCC 29906, Enterococcus 
faecalis ATCC 47077 and Candida albicans SC5314 
were used in the study. Polymicrobial biofilms were 
reproducibly grown, consisting of C. albicans, E. 
faecalis and P. mirabilis in a 96-well microtiter plate. 
Comparative metabolomic analysis of mono and 
polymicrobial biofilm samples was carried out based 
on the GC-MS metabolomic profiling to scan wide 
range of metabolites. Distribution of metabolites was 
analysed by the Kyoto Encyclopedia of Genes and 
Genomes metabolic pathways database. 
RESULTS:
The number of P. mirabilis biofilm cells was found 
significantly higher in dual and triple species biofilms 
than single-species. The multivariate metabolomic 
analysis shows clear separation between mono and 
polymicrobial biofilm groups of E. faecalis (Figure 1). 
After deconvolution and aligned of the chromatograms, 
189 mass spectral features have been detected and 
118 of them were annotated using retention index 
libraries. Aminoacyl-tRNA synthesis, D-glutamine 
and D-glutamate, glutathione, alanine, aspartate and 
glutamate and nitrogen metabolisms significantly 
changed in multi-species biofilms compared to single-
species biofilm by the pathway analysis method.




Figure 1:The metabolomic profile of P.mirabilis in 
mono, dual and triple species biofilms. 
CONCLUSIONS:
E. faecalis and P. mirabilis association in dual and triple 
biofilm resulted in increased amino acid and pipecolic 
acid synthesis intermediates when compared to only 
E. faecalis biofilm, displaying a rerouting of metabolic 
pathways.
OP-068: ANTIMICROBIAL SUSCEPTIBILITY 
OF ESCHERICHIA COLI ISOLATED FROM 
VARIOUS CLINICAL SAMPLES
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INTRODUCTION:
Increased resistance to antimicrobials is a major 
problem in the treatment of infections caused by 
resistant microorganisms in worldwide. Escherichia 
coli is a Gram-negative, rod-shaped bacterium 
that is one of the most frequent cause of many 
common bacterial infections, including bacteremia, 
cholecystitis, cholangitis, urinary tract infection, and 
traveler’s diarrhea, and other clinical infections such 
as neonatal meningitis and pneumonia (1, 2). This 
study was conducted to determine the antimicrobial 
susceptibility patterns of 80 Escherichia coli strains 
isolated from various clinical samples. 
MATERIALS AND METHODS:
A total of 80 E. coli isolates (59 urine, 9 sputum, 4 
blood, 3 tissue, 2 drain, 2 vagina, 1 peritoneum) 
were obtained from Ankara University, Faculty of 
Medicine, Cebeci Hospital Central Laboratory. 
Isolates were identified both by the conventional 
methods and MALDI-TOF MS. Antimicrobial 
susceptibility testing was conducted on Mueller-
Hinton Agar plates (Merck, Germany) using disc 
diffusion method in accordance with EUCAST (The 
European Committee on Antimicrobial Susceptibility 
Testing) recommendations. Results were expressed 
as susceptible or resistant according to the criteria 
recommended by EUCAST (3, 4). 
RESULTS:
The resistance rates detected were 42.5 % to 
amoxicillin clavulanic acid, 36.25 % to cefotaxime, 
32.5 % to ceftazidime, 7.5 % to gentamicin, 1.25 % to 
amikacin, 42.5 % to cephalothin, 3.75 % to imipenem, 
8.75 % to ertapenem, 47.5 % to ciprofloxacin, 
46.25 % to levofloxacin, 57.5 % to trimethoprim/
sulphamethoxazole, 1.25 % to nitrofurantoin, 11.25 % 
to piperacillin/tazobactam, 13.75 % to cefoxitin, 33.75 
% to fosfomycin, 32.5 % to cefepime and 71.25 % to 
ampicillin.
CONCLUSIONS:
When the high resistance rates are taken into 
consideration, antibiotic usage policies and empirical 
therapies should be based on antimicrobial resistance 
surveillance studies.
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OP-069: ESTROGEN RECEPTOR 
MODULATING EFFECTS OF ST. JOHN’S 
WORT
1 Tascioglu, A., 1 Uslu, D., 1 Toker, Y., 2 Bedir, E., 1 
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1 Ege University, Faculty of Pharmacy, Department of 
Toxicology, Izmir, Turkey
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INTRODUCTION:
Exposure to phytoestrogens is associated with the 
increased risk of hormone-related breast cancer 
in postmenopausal women (1). St John’s Wort 
(SJW-Hypericum sp.) is a dietary supplement that 
is commonly used in the treatment of depression 
in postmenopausal women. The present study is 
undertaken to evaluate estrogen receptor (ER) 
modulatory effects of SJW and its biflavonoid 
constituents, biapigenin and amentoflavone.
MATERIALS AND METHODS:
SJW extracts were prepared by ethanol:distilled 
water:DMSO (70:25:5) extraction. The biflavonoids of 
SJW were isolated with LC and identified by ESI-MS, 
NMR and ESI-TOFMS analysis. Estrogenic activities 
of SJW extract, amentoflavone and biapigenin were 
investigated by in vitro fluorescence based ER-
binding and cell proliferation-based E-Screen assays. 
In vivo uterotrophic assay was also performed as the 
gold standard estrogenicity assay.
RESULTS:
Biflavonoid constituents of SJW were separeted with 
HPLC and identified in NMR analysis. Binding affinity 
of SJW to ER was detected as IC50:2,2 mg/ml. 
Although SJW extract has proliferative effect on MCF-
7/BUS cells (EC50:0,0124 mg/ml), its biflavonoids 
didn’t induce proliferation of cells. In vivo uterotrophic 
assay didn’t confirm the estrogenic effect of the 
extract. 
CONCLUSIONS:
SJW extract is found to cause proliferation of 
ER(+) breast cancer cells probably by binding of 
its component(s) to the ER. On the other hand 
amentoflavone and biapigenin, did not cause 
proliferation in MCF-7/BUS cells and did not bind to the 
ER. Furthermore neither SJW extract nor biapigenin 
administration to Wistar rats  altered the uterus 
weight in in vivo uterotrophic assay at physiologically 
relevant concentrations. As a conclusion, SJW etract 
seem to have an estrogenic effect and some of its 
secondary metabolites, other than biflavonoids, 
should be responsible for this action. However this 
effect seems not to be relevant physiologically with 
the consumption of dietary supplements.    
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OP-070: ANTIOXIDANT ACTIVITY, HPTLC 
FINGERPRINT AND DISCRIMINANT 
ANALYSIS OF PLANTAGO MAJOR LEAVES 
FROM DIVERSE ORIGINS IN INDONESIA
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INTRODUCTION:
Plantago major L. (Plantaginaceae) is a perennial 
herb having contribution to the folk medicine all 
around the world [1], including Indonesia with wide 
geographical distribution [2]. Plant materials origin is 
one factor that significantly influences the quality of 
herbal medicines.
MATERIALS AND METHODS:
In this paper, HPTLC method using pattern-oriented 
approach has been employed to evaluate the quality 
of Plantago major leaves collected from seven 
origins in Indonesia. To differentiate the antioxidant 
capacities of those plant materials, the crude extracts 
were tested using DPPH, total phenolics, and total 
flavonoids assay methods.  
RESULTS:
The results showed that radical scavenging activity, 
total phenolics, and total flavonoids of plant material 
from seven origins were significantly different. 
Moreover, HPTLC fingerprints analyzed with 
chemometrics showed an ability to discriminate the 
leaves samples from various origins. Two models 
using principal component analysis (PCA) and partial 
least squares (PLS-DA) were built in chemometrics 
test. The PCA model was able to describe the studied 
samples by using four principal components with a 
value of explained variance of 95%, whereas PLS-DA 
model accurately classified the leaves samples with 
prediction ability of 100%. 
CONCLUSIONS:
Plantago major collected from different origins revealed 
different radical scavenging activity and concentration 
of total phenolics as well as total flavonoids. HPTLC 
fingerprints analyzed with chemometrics can be 
used as an alternative of marker-oriented method to 
evaluate the quality of Plantago major.
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INTRODUCTION:
Pseudomonas aeruginosa is Gram-negative 
bacterium found in almost every ecological niche as 
soil, water and plants. It is often isolated from the 
contaminant regions and may produce metabolites 
(ie, rhamnolipid, pyocyanin) that enhance its 
competitiveness and survival (1). Pyocyanin is 
the characteristic blue-green phenazine pigment 
produced by P. aeruginosa. The presence of P. 
aeruginosa and the production of pyocyanin may alter 
the microbial community structure by inhibiting the 
growth of microorganisms sensitive to pyocyanin (2). 
The optimization of pyocyanin production was carried 
out in the different conditions of cultivation. The 
objectives of this study were: [1] to isolate different P. 
aeruginosa strains from soil sample; [2] to enhance 
pyocyanin production of isolates [3] and study the 
functional activity of pyocyanin against standart 
strains. 
MATERIALS AND METHODS:
Thirty-one soil sample were collected from different 
region in Ankara. Four P. aeruginosa isolates [A-D] 
producing the finest pigments were selected for this 
study. For comparison; four different synthetic artificial 
media [1-4] were used for P. aeruginosa proliferation 
and pigment production. These media are listed 
in Table 1. Pyocyanin production were carried out 
according to Priyaja method and weight of the dried 
pyocyanin was determined gravimetrically (3).
Table 1: Comparison of media for pyocyanin 
production (mg/L) by 4 strains of Pseudomonas 
aeruginosa in 72 hours at 37 °C.
Media* Strain A Strain B Strain C Strain D
1 2,86 0,93 3,33 1,2
2 0,73 0,8 1,2 0,46
3 0,33 0,33 0,26 0,33
4 0,86 0,93 0,93 0,53
* Mediums with different contents.
The assay of antibacterial and antifungal of pyocyanin 
was carried out in agar well diffusion and disc 
diffusion method (4). Escherichia coli ATCC 25922, 
Escherichia coli ATCC 35218, Staphylococcus aureus 
ATCC 25923, Staphylococcus aureus ATCC 43300, 
Staphylococcus epidermidis ATCC 12228, Klebsiella 
pneumoniae ATCC 13883 and Candida albicans 
ATCC 10231 standard strains were used in this study. 
RESULTS:
The production of pyocyanin can be improved by 
culture 1 ve 2. The present study has demonstrated 
that pyocyanin production by all isolates had 
antimicrobial activity against Gram-positive bacteria 
more than Gram negative bacteria and the yeast. 
CONCLUSIONS:
As a result, production of the pyocyanin has been 
found to depend on the media content and properties 
of the isolates. Pyocyanin produced in different media 
showed various antibacterial and antifungal activity 
spectrum. 
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INTRODUCTION:
The methods applied to test the efficacy of antimicrobial 
agents used to interfere with antimicrobial functions 
differ depending on the nature of the agents. In some 
of these standard test methods like “The Society of 
Industrial Technology for Antimicrobial Articles or 
ASTM E.2149 methods” etc., spesific microorganisms 
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are suggested for testing the antimicrobial activity 
of antimicrobial agents under dynamic contact 
conditions, but it is mentioned that some of Gram 
positive or negative microorganisms may be used as 
standards too. In this study, we aimed to investigate 
the usability of eleven microorganisms in one of these 
standard test methods.
MATERIALS AND METHODS:
The antibacterial performance test method for 
antibacterial products specified in Term 2 of JIS 
Z28015 was used (1). Staphylococcus aureus 
ATCC 6538, Staphylococcus aureus ATCC 25923, 
Staphylococcus aureus ATCC 29213, Staphylococcus 
aureus ATCC 43300, Staphylococcus epidermidis 
ATCC 35984, Staphylococcus epidermidis ATCC 
12228, Escherichia coli ATCC 25922, Escherichia 
coli ATCC 35218, Klebsiella pneumoniae ATCC 
13883, Klebsiella pneumoniae RSKK 574 and 
Pseudomonas aeruginosa ATCC 27853 were tested 
as microorganisms.
RESULTS:
The results of the tested microorganisms at the 0th 
and 24th h were shown in the Table 1. and Table 2. 
as cfu/mL.
Table 1. Growth results of tested Gram (+) bacteria at 
0th and 24th hour as cfu/mL.
Table 2. Growth results of tested Gram (-) bacteria at 
0th and 24th hour as cfu/mL.
CONCLUSIONS:
A standard test method based on determining the 
antibacterial activity performance of antibacterial 
agents was investigated. In this method, 1/500 diluted 
nutrient broth (with sterile distilled water, pH 7.0) 
was used for production of microorganisms and this 
medium was not provide a convenient environment 
for each microorganism. It was determined that the 
use of S. aureus ATCC 25923, S. epidermidis ATCC 
35984 and S. epidermidis ATCC 12228 was not 
appropriate in “The Society of Industrial Technology 
for Antimicrobial Articles: Test Method II” shake flask 
method due to their 24 h growth results. On the other 
hand all Gram negative microorganisms were found 
to be suitable for this test method.
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INTRODUCTION:
There are many kinds of anticoagulants often used to 
obtain plasma from whole blood. The most commonly 
used anticoagulants are ethylenediamintetraacetic 
acid (EDTA), heparin, and citrate. Different types 
of anticoagulants may cause suppression or 
enhancement ionization efficiency of analytes or 
metabolites. This research investigated the effect 
of the various anticoagulants on the recovery, peak 
area, stability, and matrix effects of ethynil estradiol 
and levonorgestrel analysis in plasma using LC-MS/
MS (1,2).
MATERIALS AND METHODS:
Analysis was performed on Waters Xevo TQD 
using positive electrospray ionization with Acquity 
UPLC BEH Waters C18 (2,1 × 100 mm; 1,7 μm) 
column; mobile phase consisted of 0.1% (v/v) formic 
acid in water and acetonitrile in gradient elution; 
flow rate of 0.3 ml/min; and prednisone as internal 
standard. Analyte extraction from human plasma 
was conducted using a combination of liquid-liquid 
extraction (LLE) and solid phase extraction (SPE). 
Detection of the mass was performed for ethinyl 
estradiol, levonorgestrel and prednisone with m/z 
value: 530.1596 > 171.0781; 313.1596 > 245.1044; 
359.0957 > 147.0364, respectively.
RESULTS:
This method was linear in the concentration range of 
5-500 pg/ml for ethinyl estradiol and 100-1000 pg/ml 
for levonorgestrel with r value > 0,999. Comparisons of 
some parameter analysis indicated that there were no 
statistically significant differences (p > 0,05; ANOVA) 
in citrate, heparin, and EDTA of ethinyl estradiol and 
levonorgestrel analysis in human plasma for recovery 
and stability. On the other hand, peak area response 
ratio for the three plasma showed a significant 
difference (p < 0,05).
CONCLUSIONS:
There was no statistically significant differences in 
citrate, heparin, and EDTA plasma in recovery and 
stability, but for peak area response ratio for the three 
plasma showed a significant difference.
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DISSOLUTION RATE ENHANCEMENT OF 
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INTRODUCTION:
Amorphous solid dispersions effectively enhance 
solubility, dissolution rate and thus, the bioavailability 
of poorly soluble drugs. Solid dispersion consists 
mostly of a hydrophilic polymer and a hydrophobic 
drug (1). Poly(2-ethyl-2-oxazoline) (PEOX), a 
biocompatible polymer and a pseudo polypeptide, has 
recently received significant attention for its biomedical 
applications (2). While poly(vinylpyrrolidone) (PVP) 
is a commonly used polymer for solid dispersion 
preparation, PEOX has not been used before for this 
purpose. The different dynamic and conformational 
properties of PEOX and PVP chains in aqueous 
solution are expected to have a potential impact 
on PEOX ability to stabilize the saturated solution 
induced after the dissolution of amorphous drugs 
by inhibiting the crystal nucleation and the crystal 
growth of the drug molecules (3). This work reports 
the first investigation of PEOX solid dispersion with a 
BCS class II model drug, glipizide (GPZ), introducing 
PEOX as an alternative to PVP for the preparation of 
solid dispersions.
MATERIALS AND METHODS:
GPZ-polymer solid dispersions were prepared by 
solvent evaporation and characterized by PXRD, DSC, 
SEM, and FTIR. The impact of polymers on crystal 
nucleation kinetics was investigated. Solubility and 
dissolution behavior of the prepared solid dispersions 
were in-vitro evaluated at different pH values and in 
fasted simulated intestinal fluid (FaSSIF).
RESULTS:
PEOX exhibited strong crystal nucleation inhibitory 
effect compared to PVP. A significant enhancement in 
glipizide solubility was obtained with PEOX compared 
to the pure drug and solid dispersion with PVP. A big 
improvement in the intrinsic dissolution rate (45 times) 
and dissolved amount of glipizide was achieved with 
PEOX in FaSSIF. 
CONCLUSIONS:
The findings of this study with glipizide as a model 
drug introduce PEOX as a good alternative to PVP 
and promising polymeric carrier toward better oral 
bioavailability of poorly soluble drugs.  
ACKNOWLEDGEMENTS:
This study was supported by Koc University and IIE-
SRF.
REFERENCES:
1.  Chiou et al., (1971). Journal of pharmaceutical 
sciences, 60:1281-1302.
2.  Mero et al., (2008). Journal of Controlled Release, 
125:87-95.
3.  Ilevbare et al., (2012). Crystal Growth & Design, 
12:3133-3143.
OP-075: A NEW LC METHOD FOR 
QUANTITATIVE ESTIMATION OF AVANAFIL 
IN COMBINATION TABLETS
1,2 Levent, S., 2,3 Ozcan, S., 2,3 Can, NO.
1Anadolu University, Faculty of Pharmacy, 
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Turkey
2Anadolu University, Faculty of Pharmacy, Doping 
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INTRODUCTION:
Avanafil (AVA), a pyrimidine–derivative 
phosphodiesterase-5 inhibitor, is one of the most 
effective drugs prescribed for erectile dysfunction 
(1). In the current work, a new LC method, in which 
MS/MS or photodiode array detector (PDA) can be 
utilized, was developed for determination of AVA in 
dapoxetine (DPX)/AVA combination tablets.
MATERIALS AND METHODS:
The separation of AVA and DPX was carried out 
using a second generation C18-bonded monolithic 
silica column (Chromolith® High Resolution RP-18e, 
100×4.6 mm, Merck KGaA) as stationary phase, and 
a solution consisted of 0.1% (v/v) formic acid in water 
and 0.1% (v/v) formic acid in acetonitrile (75: 25 (v/v), 
pH=2.6) as mobile phase. The flow rate was 0.5 mL/
min, and the column temperature was maintained at 
40.0 °C. Sample injection volume was 1 μL for LC-
PDA and 0.3 μL for LC–MS/MS analyses. The method 
was validated according to ICH Q2(R1); moreover, 
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the specificity and robustness of the method, as well 
as stability of AVA solutions were studied.
RESULTS:
The limit of quantitation (LOQ) and limit of detection 
(LOD) were found to be 3.55 ng/mL and 1.17 ng/
mL for MS/MS detection; LOQ and LOD were 0.217 
µg/mL and 0.072 µg/mL, for PDA respectively. The 
developed method allowed quantitative determination 
of AVA in combination tablets with high accuracy 
(%95.43 for LC-PDA; %102.09 for LC-MS/MS) and 
precision (0.229 %RSD for LC-PDA and 0.401 %RSD 
for LC-MS/MS). 
CONCLUSIONS:
The method proposed in this study has a high level of 
flexibility due to use of very similar chromatographic 
conditions for MS/MS and PDA detection, and also 
reliable and easily applicable. Any analyst can select 
one of the two detection techniques and related 
injection volume, according to the instrumental 
facilities of the laboratory. 
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OP-076: DEVELOPMENT AND VALIDATION 
OF AN HPLC METHOD FOR AMLODIPINE 
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INTRODUCTION:
The aim of this study was to develop a simple, rapid 
and robust HPLC method for the determination and 
separation of AB and EM according to design of 
experiment (DoE) for development of fixed dose tablet 
combinations. The solubility of APIs and dissolution 
studies of commercial products (Norvasc® and 
Enalap®) were also performed using the optimized 
method. 
MATERIALS AND METHODS:
The validation of the method was carried out according 
to ICH guidelines (1) using HPLC (Shimadzu LC-20A, 
photodiode array detector) with RP-C18 column (5 
μm, 250x4.6 mm, Waters) at 215 nm. Box-Benkhen 
design was used to test robustness of the method 
(Design Expert® Version 9.0). Flow rate (1, 1.2, 
and 1.4 mL/min), column temperature (20, 25, and 
30 oC), methanol ratio (5, 10, and 15%), and pH of 
the mobile phase (2.8, 3, and 3.2) were selected 
as independent variables. 29 experiments were 
performed. Concentrations and retention times of AB 
and EM were evaluated. Shake flask method (2) was 
used for solubility of drugs. Solubility was conducted 
at pH 1.2 in 37˚C (n=3).  Dissolution was performed 
using USP apparatus II at pH 1.2 (n=3)
RESULTS:
Two-way interactions between independent variables 
were found insignificant (p>0.05). Linear models were 
used for all variables. The optimized method was 
selected as following parameters: 25oC of column 
temperature, 10.6% methanol, pH 2.95 and 1.205 
mL/min of flow rate. Retention times were 3.79 min 
and 7.93 min for EM and AB, respectively. Linearity 
was shown with coefficient of correlation (r2) of 0.999. 
Solubility values were found 27.1 ± 2.7 mg/mL and 
2.68 ± 0.1 mg/mL for EM and AB, respectively. Both 
AB and EM were dissolved more than 85% in 10 min. 
CONCLUSIONS:
DoE was found useful tool for developing analytical 
method validation of AB and EM. The optimized 
method can be used for in vitro performance and 
quality control tests of fixed dose tablet combinations 
containing AB and EM.
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OP-077: DETERMINATION OF NON-
STEROIDAL ANTI-INFLAMMATORY DRUGS 
IN HUMAN MILK BY DLLME-HPLC
Alsoul, S., Hassan, M., Alshana, U.
Near East University, Department of Analytical 
Chemistry, Faculty of Pharmacy, Nicosia, TRNC, 
Mersin 
INTRODUCTION:
Since the discovery of dispersive liquid-liquid 
microextraction (DLLME) in 2006 by Assadi Y. (1), 
it gained a pronounced reputation among other 
techniques due to its simplicity, cost-effectiveness, 
rapidity and low organic solvent consumption while 
providing excellent sample clean-up and high 
preconcentration factors. In this study, DLLME with 
back-extraction was used prior to HPLC for the 
extraction and determination of four nonsteroidal anti-
inflammatory drugs (NSAIDs) [i.e., ketoprofen (KET), 
etodolac (ET), flurbiprofen (FBP) and ibuprofen (IBU)] 
in human milk.
MATERIALS AND METHODS:
The analytes were separated using a 1200 SERIES 
Agilent Technologies Gradient HPLC with a Diode-
Array Detector (DAD), a reversed-phase column (i.e., 
Grom-Sil 80 Octyl-4 FE, 4.6 mm ID  250 mm, 3 µm), a 
mobile phase consisting of ACN:1.0% TFA, 40:60 (%, 
v/v) at pH* 1.4, flow rate 0.8 mL min-1, temperature 
40 °C and injection volume of 20 μL.
RESULTS:
The analytes were extracted from milk (2.0 mL) into 
ACN (4.0 mL) by salting-out extraction, 2.5 mL of 
which then were used as the disperser solvent in 
DLLME. Other optimum DLLME conditions were 
achieved using 200 μL chloroform (extraction solvent), 
aqueous solution completed to 11 mL with 3% (w/v) 
NaCl and extraction time of 1 min. Back-extraction of 
NSAIDs into 100 μL of ACN:1.0 M NaOH, 30:70 (%v/v) 
solution within 1 min resulted in enrichment factors of 
7.2 to 10.0 and limits of detection (LOD) as low as 
0.20 mg L-1. Coefficients of determination (2) of the 
calibration graphs were higher than 0.9951. Three 
different human milk samples with breastfeeding age 
of 2, 6 and 12 months from three healthy volunteers 
were studied and showed minimum matrix effect on 
the extraction efficiency of the proposed method. 
Finally, DLLME-HPLC was applied to determine FBP 
in genuine milk samples at different time intervals (0.5-
3.5 h) after administration; the highest concentration 
in the milk was found to be reached after 2.0 h.
CONCLUSIONS:
DLLME-HPLC was demonstrated to be a simple 
and rapid method for the determination of NSAIDs 
in human milk with percentage relative recoveries 
(%RR) in the range of 93.1-104.6%.
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OP-078: COVALENT IMMOBILIZATION 
OF Γ-GLUTAMYL TRANSPEPTIDASE 
ON TANNIC ACID MODIFIED MAGNETIC 
NANOPARTICLES
Daana, J., Turan, E., Tumturk, H.
Gazi University, Faculty of Science, Department of 
Chemistry, Ankara, Turkey
INTRODUCTION:
In recent years, noticeable achievements have 
been spent in the development of magnetic 
nanoparticles(MNPs). Enzymes ability to catalyze 
reactions and engage in complex syntheses has 
long made them attractive for use in a multitude of 
industrial, and research applications(1). This work 
presents the synthesis and uses surface modified 
magnetite nanoparticles for the covalent attachment 
of γ-Glutamyl transpeptidase enzyme. γ-glutamyl 
transpeptidase (γ-GGT; EC 2.3.2.2) is an enzyme 
that catalyzes the transfer of the γ-glutamyl group of 
glutathione to an amino acid or a peptide. 
MATERIALS AND METHODS :
Fe3O4 MNPs were prepared via well-known co-
precipitation reaction. Subsequently, the surface of 
magnetic nanoparticles was modified by employing a 
plant-derived polyphenol(rich with hydroxylic groups) 
tannic acid as the structure-directing agent as well as 
the stabilize to enhance the ability to immobilize GGT 
covalently.
RESULTS:
GGT was covalently immobilized on tannic acid 
modified MNPs after exposing nanoparticles to pH 
9.2. Enzyme loading was 92.98% onto the MNPs. 
The immobilized enzyme demonstrated maximum 
catalytic activity at pH 8.5  and 60 °C. The kinetic 
parameters of free and immobilized enzyme were 
evaluated according to the Lineweaver–Burk plot 
(KM) 0.907 mM and 1.19  mM, respectively.
CONCLUSION: 
in this study, MNPs were successfully prepared by 
co-precipitation reaction. Subsequently, the surface 
of magnetic nanoparticles was modified by  Tannic 
acid.Moreover, the immobilized enzyme shows good 
durability and could be easily recovered by magnetic 
separation.
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OP-079: LARGE VOLUME SAMPLE 
STACKING IN CAPILLARY 
ELECTROPHORESIS FOR THE 
QUANTITATIVE DETERMINATION OF 
PHENOLIC COMPOUNDS FROM FOOD 
SAMPLES
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INTRODUCTION:
Because of these health promoting benefits and 
biological properties of phenolic compounds, 
researches are interested in developing different 
methods for their identification, extraction and 
separation from natural sources. In the present study, 
a simple and rapid CZE method was developed and 
LVSS with polarity switching was applied for the 
simultaneous separation of naringin, rutin, carnosic 
acid, apigenin, quercetin, morin and chicoric acid in 
different food samples. To perform method validation, 
we used RSM to examine the effect of buffer pH, 
buffer concentration and applied voltage.
MATERIALS AND METHODS:
CE separations were carried out in an Agilent 
1100 (Agilent Technologies, Germany) capillary 
electrophoresis system equipped with a photodiode 
array detector and automatic injector. Uncoated 
fused silica capillaries of 50 µm diameter and 56 
cm effective length with extended light path (Agilent 
Technologies, Germany) were used throughout the 
experiments. The detection wavelength of 214nm was 
used and the temperature of capillary was maintained 
at 25 oC. The background electrolyte (BGE) used for 
separation was 20 mM borate buffer (pH 9.2).
RESULTS:
Optimized LVSS conditions: sample injection at 100 
mbar for 20 sec, matrix removal at -20 kV for 6 sec, 
followed by separation with 20 mM borate buffer (pH 
9.2) at +16 kV. Under these optimized conditions, all 
seven analytes were baseline separated within 20 
min. LVSS resulted in a two fold increase in peak 
areas (when compared with same concentration 
injected during 10 s) and three fold increase in peak 
heights, resulting in considerable improvement in 
detectability. The developed and optimized methods 
were applied to determine phenolic compounds from 
18 different samples.
CONCLUSIONS:
In this method, we have developed a fast, reliable, 
sensitive and accurate CZE-LVSS method for the 
simultaneous determination of naringin, rutin, carnosic 
acid, apigenin, quercetin, morin and chicoric acid from 
a number of food samples.
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OP-080: THERMOSENSITIVE-PNVCL-BASED 
HYBRID HYDROGELS FOR BIOMEDICINAL 
APPLICATIONS
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INTRODUCTION:
Stimuli-responsive hydrogels are used to deliver drugs 
with safe and effective concentrations in response to 
an external stimulus (1). Because of the difference 
between the normal and pathological tissues, which 
are accompanied with local temperature increase 
by 1–5°C, thermosensitive polymers may have the 
potential to modulate drug release. Hybrid biopolymer 
systems, composed of a thermosensitive synthetic 
polymer and a natural-origin hydrogel can produce 
a biomimetic system with potential biomedicinal 
applications (2), biotechnology and tissue 
engineering (3). Poly(N-vinylcaprolactam) (PNVCL) 
is a biocompatible thermosensitive polymer with a 
LCST of ~32oC. In this study, PNVCL based hybrid 
hydrogels were evaluated in terms of composition, 
structure, release and mechanical properties. 
MATERIALS AND METHODS:
PNVCL-COOH was synthesized by free radical 
polymerization, and then conjugated with the natural 
biopolymers by utilizing covalent bonding between 
the carboxylic acid groups at the chain ends and 
amine groups of the polymers using the EDC/NHS 
cross-linker. Phase transition temperatures were 
determined by measuring the optical transmittance at 
480 nm over the temperature range of 20-50oC. The 
swelling and release kinetics of the biopolymers were 
determined. To assess the in-vitro release properties 
of the PNVCL based scaffolds, experiments were 
carried out with a model protein (bovine serum lbümin, 
BSA etc.) and a model drug (Doxorubicin, Dox, a 
widely used anticancer agent etc.) at two different 
temperatures of 4oC and 40oC. 
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RESULTS:
The PNVCL-based biopolymers exhibited a distinct 
phase transition temperature between 32 and 38oC. 
Drug release was influenced by environmental 
temperature in terms of the change in the hydrophilic-
hydrophobic character, gel forming and swelling 
properties of the hybid biopolymer. In this way, the 
thermosensitive PNVCL-based hydrogel underwent 
reversible structural transitions from a closed state to 
an open state with the help of external temperature 
stimuli, giving on-off switches for modulated drug 
delivery.
CONCLUSIONS:
Thermosensitive PNVCL with various combinations of 
natural polymers may have potential in bio-relevant 
applications. 
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OP-081: EXPERIMENTAL DESIGN 
APPROACH TO OPTIMIZE HPLC 
SEPARATION OF ACTIVE INGREDIENTS, 
PRESERVATIVES AND COLORANTS IN 
SYRUP FORMULATION
Dinc Zor, S., Asci, B., Aksu Donmez, O., 
Hacimustafa, O.
Yildiz Technical University, Department of Chemistry, 
Davutpasa Campus, Istanbul, Turkey
INTRODUCTION:
In this study, a simple, accurate, precise and rapid 
HPLC method was developed for the simultaneous 
analysis of pseudoephedrine HCl (PSE) and 
guaifenesin (GU), along with synthetic preservatives, 
methyl paraben (MP) and propyl paraben (PP), and 
colorants, ponceau 4R (PO) and sunset yellow (SY) 
in syrup samples. Optimum conditions of HPLC 
separation were performed with Box-Behnken 
experimental design. Four independent variables of 
the separation were pH (6.0, 6.5, and 7.0) and flow 
rate of the mobile phase (2.0, 2.2 and 2.4 mL/min) and 
mobile phase ratios for the first and second gradient 
elution (75, 80, and 85% for Gradient 1 and 50, 55, 
and 60% for Gradient 2 in terms of phosphate buffer 
percent, respectively). Resolution between adjacent 
peaks was used for the response of the variables. 
MATERIALS AND METHODS:
Chromatographic separation was achieved using 
reversed phase C18 column (4.6 mm x 250 mm x 5 
μm particle size) and the eluents were monitored via a 
diode array detector at 215 nm. 
RESULTS:
According to the results of the optimization procedure, 
the optimum variables were found to be pH, 6.3; flow 
rate, 2.4 mL/min; mobile phase ratios for gradient 
1 and 2, 85 and 60%, respectively. Therefore, 
chromatographic procedure of the method was 
determined with 0.025M phosphate buffer, pH 6.3, 
acetonitrile gradient that follows 0–4 min, 85 : 15 (v/v); 
4–9 min, 60 : 40 (v/v) and 9-10 min, 30 : 70 (v/v). 
The mobile phase flow rate was 2.4 mL/min and the 
injection volume was 20 𝜇L in all the chromatographic
runs. 
CONCLUSIONS:
Under these conditions, the developed method was 
validated in accordance with ICH guidelines and the 
method was successfully applied for the simultaneous 
determination of PSE, GU, MP, PP, PO and SY in a 
commercial syrup sample. 
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OP-082: MIR-185-5P RESPONSE TO USNIC 
ACID INHIBITS THE PROLIFERATION IN 
BREAST CANCER CELL
Değerli, E., Torun, V., Yangın, S., Cansaran Duman, 
D.
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INTRODUCTION:
Breast cancer (BC) is one of the major deadly 
cancer type among women. Due to side effects 
of commercially drugs and other treatments, the 
usage of alternative biological sources becomes has 
quite significantly important in effective treatment 
of BC. Usnic acid (UA) is one of the secondary 
metabolites extracted from lichen species. In recent 
years, increasing evidence shows that dysregulated 
miRNAs serve function as key regulators of biological 
processes including proliferation, differentiation, 
apoptosis etc. (1, 2). In our previous study, microarray 
experiments showed that miR-185-5p were 
specifically responsive to UA in BT-474 BC cell. In 
this study, we aimed to investigate the antiproliferative 
effect of miR-185-5p in BC cell and to provides a new 
target for the treatment of BC.
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MATERIALS AND METHODS:
BT-474 cell was seeded in a 96-well plate (5x103/
well) and were transfected with miR-185-5p using 
Transfection Reagent (Qiagen) according to the 
manufacturer’s instructions. Transfection of miR-185-
5p were performed at different concentrations as 0, 
5, 10, 25, 50, 75 and 100 nM in BT-474 cells. The 
miR-185-5p transfected cells incubated for 24 and 48 
h. After the incubation time, total of 20 µl MTT reagent 
was added to the BT-474 cells for the evaluation of 
antipoliferative effect. The absorbance of the plate 
was measured using a microplate reader at the 570 
nm. 
RESULTS:
Results from the our study demonstrated that the 
transfection of miR-185-5p mimics inhibited the 
cell viability in BT-474 breast cancer cells. Further, 
we showed that the cell viability was reduced by 
approximately 30 % in 48 h after 30 nM miR-185-5p 
mimic was transfected to BT-474 cells. 
CONCLUSIONS:
In present study, for the first time we revealed the 
antiproliferative effect of miR-185-5p in breast cancer. 
miR-185-5p has potent inhibitory effect on breast 
cancer cell proliferation. Therefore, miR-185-5p may 
represent a novel therapeutic target for the treatment 
of breast cancer. However, further research is needed 
to investigate of miR-185-5p at molecular level. 
Thanks to these investigations, new therapies based 
on miR-185-5p can be developed and miR-185-5p 
might be used for treatment of breast cancer in the 
future. 
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INTRODUCTION:
Antibiotics are one of the most prescribed drugs 
among the pediatric patients. Usually, penicillins are 
used for pediatric populations, however, in some 
cases such as penicillin allergy, clarithromycin is 
preferred because of its safety profile when compared 
with other antibiotics. The objective of this study was 
to examine the drug-drug interactions associated with 
clarithromycin in the pediatric patients.
MATERIALS AND METHODS:
This study was performed at the community 
pharmacies located in the Uskudar and Umraniye 
during 10 months. Totally, 100 (60 males and 40 
females) pediatric patients who were prescribed with 
clarithromycin, were included into the study. Their 
prescription was examined in terms of clarithromycin 
interaction by the use of RxMedia Pharma 2017 during 
their visit to the pharmacy. Finally, the obtained data 
was analysed with SPSS v22 program and the value 
of p<0.05 was considered as statistically significant.
RESULTS:
Overall, the results showed that the rate of drug-drug 
interaction was 16%, and no significant relationship 
between the gender and drug-drug interaction rate 
was found. Among 3 drugs with high drug interactions, 
lidocaine (cause QT prolongation) has been written 
3 times with claritromycin in the same prescription. 
Overall, 68,75% of the drug-drug interactions were 
occured by use of other drugs while 31,25% were 
caused by clarithromycin use.
CONCLUSIONS:
In conclusion, health workers, the patients and their 
relatives should be trained on the prevention of drug-
drug interactions and the adverse effects of multi-drug 
use (polypharmacy). Moreover, more importance 
should be given to the pharmacovigilance studies.
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OP-084: DEVELOPMENT AND 
CHARACTERIZATION OF COMPOSITE 
SCAFFOLDS
Koc Demir, A. 
Ankara University, Faculty of Science, Tissue 
Engineering, Biomaterials and Nanobiotechnology 
Laboratory, Ankara, Turkey
INTRODUCTION:
Development of an ideal scaffold for bone tissue 
engineering applications is an ongoing goal for 
the biomaterials scientists. Natural polymers are 
generally preferred to synthetic ones due to their 
biological response and degradation properties 
in the human body (1). Among numerous natural 
polymers, chitosan (C) and gelatin (G) are considered 
as promising polymers because of their non-toxicity, 
excellent biocompatibility and biodegradability (2). 
Trace elements found in bone (magnesium, zinc, 
strontium) are known to be necessary for healthy 
growth, development and functioning of the bone. 
Developing functional biomaterials capable of 
releasing osteogenic ions is crucial to promote bone 
formation around the implant. Montmorillonite (MMT) 
may be considered as an ‘ion reserve’, and can be 
enriched with osteogenic ions, such as Mg, Sr, or Zn 
to enhance its osteogenic capacity. In this study, MMT 
was modified with Mg2+ before blending with gelatin 
and chitosan to produce a promising biomaterial for 
bone tissue engineering applications.
MATERIALS AND METHODS:
MMT with a cation exchange capacity (CEC) of 
102 meq/100 g was obtained from Unye Bentonite 
Company (Ordu, Turkey). Composite scaffolds were 
produced through freeze drying method. Briefly, the 
G/C solution was prepared and then required amount of 
Mg-modified and non-modified MMT were introduced 
to the solution and stirred overnight to get a perfectly 
homogenous solution. Then, glutaraldehyde solution 
was added dropwise into the solution with vigorous 
stirring at 40°C. The obtained suspension was poured 
into a plastic mold and frozen; then lyophilized in a 
freeze dryer. The sponges were soaked in 1M NaOH 
for insolubilization, rinsed a few times with double-
distilled water and lyophilized again. The synthesized 
scaffolds were characterized by XRD, FTIR, TGA and 
SEM. The release of Mg2+ from scaffolds into cell 
culture medium was determined by ICP-OES. The 
pore size distribution of scaffolds was determined by 
MIP.
RESULTS:
The results of FTIR and XRD confirmed intercalation 
of G/C into MMT layers. TGA studies concluded that 
the MMT in polymer matrix promoted the thermal 
degradation of the matrix. Morphology results 
of scaffolds had highly porous morphology with 
interconnected pores. 
CONCLUSIONS:
The data suggest that G/CS/MMT composite scaffold 
may be a suitable option for bone tissue engineering 
research.
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OP-085: DEVELOPMENT OF A VALIDATED 
HPLC METHOD FOR DETERMINATION 
OF OLANZAPINE AND ARIPIPRAZOLE IN 
HUMAN PLASMA
Yeniceli Ugur, D.
 Anadolu University, Faculty of Pharmacy, 
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INTRODUCTION:
In the present study, a HPLC method was developed 
and validated for determination of olanzapine (OLA) 
and aripiprazole (ARI) in spiked human plasma 
considering their combined use for treatment of drug-
resistant schizophrenia patients (1, 2).
MATERIALS AND METHODS:
Separation was achieved on a monolithic column (Rp-
18, 100-4.6 mm) set at 35°C with a flow rate of 0.8 
ml/min. Gradient elution was performed with a mobile 
phase consisting of phosphate buffer (pH 3.14, 20 
mM) and acetonitrile. Carbamazepine was used as 
internal standard. Detection was performed at 255 
nm. Fractional factorial design and Box-Behnken 
design were used during optimization studies.
RESULTS:
Retention times of OLA and ARI were 2.34 and 6.90 
minutes, respectively. The method was linear in the 
range of 0.125-50.0 µg/ml for OLA and 0.500-50.0 µg/
ml for ARI. The quantification limits for OLA and ARI 
were found 0.0686 and 0.4984 µg/ml, respectively. 
The method was found accurate and precise based 
on recovery (99-102%), and RSD (<2%) values. 
Robustness of the method and the stability of analytes 
were also investigated.
Figure 1. The chromatogram of OLA and ARI in 
standard solution. Counter plot and surface plot 
graphics are represented above.
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CONCLUSIONS:
In this study, a HPLC method for the simultaneous 
determination of OLA and ARI was developed and 
validated for the first time. 
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OP-086: URINARY TGF-Β1 AND SERUM 
NADP+/NADPH RATIO OF TYPE 2 
DIABETES MELLITUS PATIENTS AND THEIR 
CORRELATION WITH UACR
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University Indonesia, Clinical Pharmacy, Faculty of 
Pharmacy, Depok, Indonesia
INTRODUCTION:
Hyperglycemia conditions in diabetes mellitus can 
activate reactive oxygen species (ROS) mainly 
through activation of NADPH oxidase (NOX), which 
further will transcribe TGF-β1 (1-3). As a fibrogenic 
cytokine, TGF-β1 is considered as a key mediator in 
diabetic nephropathy (1). This study aimed to confirm 
the activity of NOX by measuring NADP+/NADPH 
ratio and TGF-β1 in serum of type 2 diabetes mellitus 
patients.
MATERIALS AND METHODS:
This was a cross sectional study undertaken in April 
2017 and approved by the Ethical Committee. Blood 
dan urine samples were collected from 89 type 2 
diabetes outpatients (62 normoalbuminuric and 27 
albuminuric patients) at Pasar Minggu Community 
Health Center and 10 non-diabetes volunteers as 
control. Urinary TGF-β1 was measured by ELISA, 
NADP+ and NADPH by colorimetric assay kit 
and urine albumin to creatinine ratio (UACR) was 
measured in an accredited laboratory.
RESULTS:
There was no statistical difference in urinary TGF-β1 
concentrations (p = 0.790) of the three group samples, 
but there was increasing of concentrations of urinary 
TGF-β1 in albuminuria conditions. Serum NADP+/
NADPH was higher in albuminuria (1.40) rather than 
normoalbuminuria (1.24) and non-diabetic subjects 
(0.97) (p<0.001). In addition, no correlation between 
urinary TGF-β1 with UACR in normoalbuminuria and 
albuminuria groups (r = -0.079; p = 0.462). However, 
there was a correlation between NADP+/NADPH 
serum ratio with UACR in the same groups (r = 0.297; 
p = 0.008).
CONCLUSIONS:
There was a significant increased of serum NADP+/
NADPH, but not urinary TGF-β1 in type 2  diabetes 
mellitus patients, especially patients with albuminuria. 
Increased activity of  NOX might play a role in the 
mechanism of  albuminuria in type 2 diabetes mellitus, 
thus potential to be a targeted therapy for preventing 
diabetic nephropathy in early stage.
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OP-087: EVALUATION OF RATIONAL 
ANTIBIOTIC USE IN A CHILDREN’S 
HOSPITAL.
1 Ozdemir, N., 1 Kara, E., 2 Buyukcam, A., 2 Aykac, 
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INTRODUCTION:
Upon introduction into medicine in the 1940s, 
antibiotics have been centered in modern healthcare. 
Nowadays, they are the most commonly used drug 
group throughout the world. Unfortunately in terms 
of antibiotics consumption Turkey leads Europe. In 
this study, it was aimed to evaluate antibiotic related 
medication errors in pediatric inpatients’ service.
MATERIAL AND METHODS:
This study was carried on at Hacettepe University 
Ihsan Dogramacı Children’s Hospital. It is a tertiary 
care hospital with 250 acute-care beds and 215,000 
admissions per year. It includes a bone-marrow 
transplantation unit, newborn intensive care unit, 
pediatric intensive care unit and cardiovascular 
surgery intensive care unit. On November 16, 2016, 
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hospitalized patients’ orders were evaluated regarding 
to rational antibiotic use by point prevalence method 
by two clinical pharmacists and three pediatric 
infectious diseases physicians. Antibiotic related drug- 
drug interactions, dose accuracy, and administration 
time were evaluated.
RESULTS:
At the time of the study 89 inpatients were using 
antibiotics. Median age was 42 months (range 1 to 
226 months) and 40 (44.9%) of the patients were 
female. Twenty-one (23.6%) of these patients were 
in surgical units and, 68 (76.4 %) were in pediatric 
medicine units. When evaluated for antimicrobial 
drug use, 64% of the patients were using at least 
one antimicrobial drug. The median number of 
antimicrobial drugs used in surgical services was 2 
(range: 1-3) and in pediatric services was 2 (range: 
1-8). There were no statistically significant differences 
between the surgical and pediatric services in terms 
of the number of antimicrobial and antibacterial drugs 
(p> 0.05). Twenty nine patients’ orders had medication 
errors. Twelve patients’ antibiotic orders had antibiotic 
related errors, and total of 17 inappropriate treatments 
(2 drug-drug interactions, 3 administration time errors, 
12 dose errors) were observed. 
CONCLUSIONS:
Evaluation of antibiotic use in pediatric inpatients’ 
service by a clinical pharmacist in terms of drug 
related problems such as drug interactions, side 
effects and prescribing errors will improve treatment-
related outcomes of the patients. Clinical pharmacists’ 
involvement in the multidisciplinary team will alleviate 
physicians’ increased workload. 
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OP-088: PREPARATION AND 
CHARACTERIZATION OF ION EXCHANGE 
RESIN COMPLEX OF DIDANOSINE
Inal, O., Akman, R.
Ankara University, Department of Pharmaceutical 
Technology, Ankara, Turkey
INTRODUCTION:
Didanosine is an antiretroviral drug used in the 
treatment of HIV. Although it has lower toxicity than 
zidovudine, didanosine has limited use due to the low 
bioavailability caused by hypoxanthine degradation 
in the acidic environment and the instability problem 
due to the enolic structure (1). Didanosine used to 
apply orally by providing an alkaline environment and 
nowadays the only marketed form is enteric-coated 
granule.
In this study, we aimed to prepare ion-exchange resin 
complex of didanosine in order to enhance the acid 
stability and to obtain intestinal drug delivery. 
MATERIALS AND METHODS:
Didanosine was converted to -Na+ form in order to 
produce a complex with Amberlite CG-50 which is 
a weak acidic resin consisting –COOH groups. The 
drug-resin complex was produced by batch method 
in pH 7.4 HEPES medium (2). Loading capacity 
was evaluated during process. Characterization of 
Na-didanosine was evaluated by XRD and HPLC. 
Drug-resin complex was evaluated by zeta potential, 
particle size, FTIR and SEM analysis. The drug 
release from the complex was studied using dialysis 
bag for 2 hours at pH 1.2 and for 6 hours at 6.8. UV 
spectrophotometric method at 250 nm was used for 
drug assay.
RESULTS:
As converting didanosine to the Na+ form, affinity 
for resin binding sites were provided and drug 
was complexed with Amberlite with a drug loading 
capacity of 30%. The best results were obtained by 
mixing for 30 minutes in a pH-controlled environment 
using HEPES 7.4, which provides ionization for both 
resin and drug. Formation of Na+ salt and drug-resin 
complex was confirmed by the decrease in zeta 
potential. The characteristic peaks for both of drug and 
resin were observed by FTIR and complex formation 
was confirmed by SEM. Amount of didanosine 
released from the complex in pH 1.2 medium was 
about 3% within 15 minutes. This released amount 
could be due to unbound drug at the surface of 
resin. Due to the ionization of drug and resin in pH 
6.8 approximately 30% of drug was released within 6 
hours in this medium. Ionic interaction of Na+ at the 
environment may be responsible of the release profile 
and amount (3).
CONCLUSIONS:
Didanosine was loaded onto Amberlite resin at about 
38% and this complex was carried drug from acid 
medium by ionic bonding with its -COOH functional 
group. Drug release at gastric pH value was negligible 
due to adsorption of free drug onto the resin, and 
the drug was release was approximately 15% for 4 
hours in pH 6.8. The released amount of didanosine 
can be modified by increasing loading capacity of 
resin or using resins with different properties such as 
swelling and/or functional groups in further studies. 
However, results give rise to thought that preparation 
of Na-didanosine resin complexes can be used as 
drug delivery systems in order to minimize the gastric 
degradation and to obtain intestinal drug delivery. 
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OP-089: MALDI ORBITRAP DETECTION AND 
IDENTIFICATION OF SIMVASTATIN AND 
METABOLITES IN THE RAT TISSUE
Yin, W., Alwabli, R., Rahman, AFM., Kadi, A.
King Saud University, Department of Pharmaceutical 
Chemistry, College of Pharmacy, Riyadh, Saudi 
Arabia
INTRODUCTION:
Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme 
A(HMG-CoA) reductase inhibitor, is a commonly sold 
hypolipidemic drug (1). The metabolic profiling of 
simvastatin has been done using some conventional 
technique like LC-MS (2), yet so far no studies have 
been reported for complete study of distribution of this 
drug and its metabolites, which might be due to its 
trace amount of metabolites in complex endogenous 
background. MALDI-LTQ Orbitrap XL provides high 
resolution, high mass accuracy and high sensitivity, 
which allows better detection of desired analytes in the 
background of matrix and endogenous compounds, 
thus was used to determine the distribution for 
simvastatin (SV) as well as its metabolites in selected 
rat tissues and biological matrices in this study.
MATERIALS AND METHODS:
Tissue samples (brain, liver, lung, heart, and kidney) 
and biological matrices (blood, urine, and feces) 
were collected from Sprague-Dawley rats 1 hour 
after the animals had been dosed with 100 mg/
kg SV (diluted in 0.5 % methylcellulose) orally 
using gastric gavage. The extraction of SV and 
its metabolites was done by mixture of methanol–
water (9:1, v/v) for all the samples except for urine 
extraction, which was done with pure methanol. Mass 
spectra were collected on a high-resolution MALDI 
LTQ Orbitrap XL, with 2,5-Dihydroxybenzoic acid 
(DHB) and 1,5-Diaminonaphthalene (DAN) used as 
matrix in positive and negative mode, respectively. 
Dried droplet crystallization was used for the sample 
deposition (triplicates) on the target plate. Xcalibur 
software was used for data analysis.
RESULTS:
SV was administerd in 6 rats and altogether 13 
metabolites were identified in different biological 
samples. A list of some major metabolites of 
simvastatin detected by MALDI-LTQ-Orbitrap XL 
showing their accurate mass, elemental compositions, 
possible metabolic reactions and the list of rat samples 
containing particular metabolites is given below. It is 














































Simvastatin and its thirteen metabolites were detected 
in high resolution and their distribution over major 
organs were demonstrated on a MALDI-LTQ Orbitrap 
XL. At least one metabolite, tentatively assigned as a 
reduced product, is being reported for the first time.
REFERENCES:
1.  Simvastatin. The American Society of Health-
System Pharmacists; 2015.
2.  Fenne OS. (2003). In vitro studies suggest 
involvement of CYP2D6 in the metabolism of 
simvastatin and active metabolites. 
OP-090: AXITINIB REDUCE APOPTOSIS 
IN EXPERIMENTAL CORNEAL 
NEOVASCULARIZATION MODEL IN RATS.
1 Canacankatan N., 2 Dinc E., 3 Yalaza C., 4 Antmen 
ES.
1Mersin University, Faculty of Pharmacy, Department 
of Biochemistry, Mersin, Turkey.
2 Mersin University, Faculty of Medicine, Department 
of Ophthalmology, Mersin, Turkey.
3Toros University, Vocational School, Department of 
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4Mersin University, Vocational School of Medical 
Services, Mersin, Turkey.
INTRODUCTION:
Ischemia, chemical burns, infection, trauma and 
inflammation cause corneal neovascularization (NV). 
Abnormal vascularization, decreases in visual acuity 
by blocking the light due to the corneal scarring 
and leads permanent vision loss (1,2). This study 
investigated the efficacy of topical application of 
vascular endothelial growth factor (VEGF) receptor 
inhibitor, Axitinib on apoptosis in experimental corneal 
NV model in rats. Caspase-9 was determined for 
mitochondria-dependent pathways, caspase-8 was 
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evaluated for death receptor-induced pathways and 
caspase-3 was investigated for overall apoptosis 
(3,4). 
MATERIALS AND METHODS:
Experimental corneal NV model was formed by silver 
nitrate cauterization. 6 groups (n=7) were included as 
Control; Corneal NV; Corneal NV + DMSO; Corneal 
NV + 0,04% Axitinib; Corneal NV + 0,08% Axitinib and 
Corneal NV + 0,24% Axitinib. Treatment with Axitinib 
eye drops of varying concentrations were carried out 
four times a day for five day in right eye. The aqueous 
humor was collected and caspase -3, -8 and -9 as 
apoptotic markers were determined by colorimetric 
methods according to the assay instructions. 
RESULTS:
Caspase -3 and -8 enzyme activities were significantly 
suppressed by 0,04%, 0,08% and 0,24% Axitinib 
whereas no effect was observed on Caspase -9. 
CONCLUSIONS:
Axitinib reduced apoptosis by suppressing caspase-8 
enzyme activity, suggesting that it has potential effect 
on the death receptor induced pathway of apoptosis.
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OP-091: EVALUATION OF DRUG-DRUG 
INTERACTIONS OF ANTIHYPERTENSIVE 
DRUGS
1 Kandemir, EA., 1 Balli, FN., 1 Kara, E., 1 Demirkan, 
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Department of Clinical Pharmacy, Ankara, Turkey
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INTRODUCTION:
Antihypertensives are one of the most commonly 
used drugs. Due to co-morbidities, polypharmacy 
is common among the hypertensive patients. The 
patients with polypharmacy are at risk of drug-drug 
interactions (DDIs). Potential DDIs could be evaluated 
by different online databases and the results of these 
databases may vary from one to another (1,2). The 
aim of this study was to demonstrate and to analyze 
the difference between three different drug-drug 
interaction databases.
MATERIALS AND METHODS:
Hospitalized patients were followed up between 25 
December 2017 and 15 March 2018 in the university 
hospital general medicine ward. Only the patients 
who were using antihypertensive drugs for any 
reason were included. The drugs used by the patients 
were evaluated by 3 different online databases 
(Micromedex®, Medscape® and Drugs.com®).
RESULTS:
Total of 42 patients [24 (%57.1) females)] were 
included in the study and the mean age of the 
patients was 65.3±17.97 years. Thirty of the patients 
(71.4%) were suffering from hypertension and the 
remaining patients were taking antihypertensive 
drugs due to different problems. The patients had 
a median 4 (range: 1-9) different disease (including 
hypertension). Twenty-two (52.4%) of the them were 
using beta-blocker, 21 (50%) were using angiotensin 
II receptor blocker (ARB)/angiotensin-converting 
enzyme inhibitors (ACEI), 18 (42.9%) were using 
calcium channel blocker (CCB), 17 (40.5%) were 
using diuretic and 5 (11,9%) were using alpha 
blockers. Patients were using median 2 (1-5) different 
antihypertensive drugs (range: 1 - 5) and 9 (range: 
1-18) non-antihypertensive drugs. According to 
Micromedex, Medscape and Drugs.com databases 
29 (%59), 37 (%88.1) and 36 (%85.3) patients had 
potential DDIs, respectively. 
CONCLUSIONS:
The patients using antihypertensive drugs are 
relatively older and have numerous comorbidities 
and comedications. More than half of the patients 
have a potential to have DDIs. Clinicians should be 
aware of the rate of determination of DDIs and that 
the categorizations of DDIs differ between online 
databases.
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TREATMENT
1 Caglar, ES., 2 Pekcan, AN., 3 Okur, E., 4 Ayla, S.,1 
Ustundag Okur, N. 
1Istanbul Medipol University, School of Pharmacy, 
Department of Pharmaceutical Technology, İstanbul, 
Turkey
2Istanbul Medipol University, Graduate School of  
Health Sciences, Department of Clinical Pharmacy, 
Istanbul, Turkey
3University of Anadolu, School of Pharmacy, 
Department of Pharmacology, Eskişehir, Turkey
4Istanbul Medipol University, School of Medicine, 
Department of Histology and Embryology, İstanbul, 
Turkey
INTRODUCTION:
Melasma is an acquired disorder of pigmentation that 
presents as symmetric darkening on the face. It has a 
multifactorial etiology and influencing factors include 
increased UV exposure, pregnancy, cosmetics, 
genetic factors, endocrine factors, and hormonal 
therapy (1, 2). In our study, we aimed to develop 
and evaluate the strengthening of penetration to the 
epidermis of the hydroquinone (HKN) loaded new 
alternative drug carrier systems for the treatment of 
melasma.
MATERIALS AND METHODS:
For the preparation of hydroquinone loaded 
microemulsions, isopropyl myristate as the oil phase, 
Cremophor EL, Span 20, Span 80 and Tween 20 as 
surfactant, ethanol as co-surfactant, distilled water 
as aqueous phase were used. In vitro drug release 
studies were performed. Conductivity, viscosity, pH, 
refractive index, zeta potential, PDI, droplet size 
were measured in terms of characterization studies. 
Furthermore, a skin irritation experiment was achieved 
with healthy BALB-c mice. Mice were divided into five 
groups: HKN loaded microemulsion 1 (M1HKN), HKN 
loaded microemulsion 2 (M2HKN), HKN loaded cream 
(CHKN), HKN solution (SHKN), and Control group 
(serum physiologic, (SF) Histopathological analysis of 
the formulations on mice skin was carried out. 
RESULTS:
As results of the study, it was measured that 
conductivity between 16.667 ± 5.774 and 43.333 
± 5.774, viscosity between 8.97 ± 0.082 and 45.67 
± 2.259, pH between 3.3 ± 0.436 and 5.7 ± 0.2 and 
refractive index between 1.4032 ± 0.0002 and 1.4299 
± 0.0002. Formulations showed that zeta potential 
between  -0.461±0.009 and 0.359±0.223, PDI between 
0.08±0.02 and 0.196±0.067,and droplet size between 
24.27±3.559 and 324.9±16.8 nm. Furthermore, in 
vitro drug release studies showed that formulation M2 
released 87.405 % of the drug at the end of the 24h. 
According to the results of histopathological analysis 
(Figure 1), the stratum corneum layer turned thinner 
after application of formulations; nevertheless, it is not 
observed any visible difference in skin morphology 
after 24h. 
Figure 1: Formulation (SF, M1HKN, M2HKN, CHNK, 
SHNK) applied mice skin. 40 x (magnification value), 
H&E (Hematoxylene and Eosin).
CONCLUSIONS:
According to results of our study, hydroquinone 
loaded microemulsions can be seen as a promising 
alternative for the treatment of melasma disease.
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OP-093: TWO DIFFERENT 
SPECTROPHOTOMETRIC METHODS FOR 
THE DETERMINATON OF METHIMAZOLE IN 
TABLET PREPARATIONS 
Dermis, S., Beyaztas, S.
Ankara University, Faculty of Pharmacy, Department 
of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
Thyroid disorder refers to abnormalities in the 
functions of the thyroid gland which is a hormone-
releasing organ. Methimazole, an antithyroid agent, 
has gained a distinct value in the medical world 
because it is very effective in hyperthyroidism (1,2). 
We aim to develop a fast analysis method to quantify 
methimazole in tablets.
MATERIALS AND METHODS:
Two different spectrophotometric methods, based on 
direct absorbance measurement and first derivative 
absorbance measurement were performed for the 
quantitative analysis of the methimazole in commercial 
tablets. The linear working range of methimazol for 
both methods were 2.0-24.0 μg/mL. The solutions 
were prepared in methanol and their absorbance 
spectra were recorded in the range of 200.0-320.0 
nm. The direct absorbance spectra and first derivative 
spectra of the calibration set were given in Figure 1.
The absorbance values used to obtain the calibration 
curves of direct and first derivative methods were at 
260.0 nm and 268.6 nm, respectively. The correlation 
coefficiens were calculated as 0.99897 and 0.98898, 
respectively. These two methods were validated by 
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recovery and standard addition studies. Then, the 
commercial samples were analyzed by the proposed 
methods.
RESULTS:
Mean recovery results for standard addition samples 
were found as 103.3 and 98.0 for direct and first 
derivative methods, respectively. Ten tablets was 
analyzed by the proposed methods and succesful 
results were obtained.  
CONCLUSIONS:
Two different spectrophotometric methods were 
developed by means of direct absorbance spectra 
and first derivative absorbance spectra. Both methods 
were validated and used to analyse methimazol in 
tablets and satisfactory results were obtained. 
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OP-094: BRASSININ SYNERGISTICALLY 
INDUCED THE ANTICANCER EFFECTS OF 
IMATINIB IN SW480 COLON CANCER CELLS
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INTRODUCTION:
Colorectal cancer has been identified as the third 
most common cancer and the fourth cause of death 
related with cancer worldwide (1). Hence, treatment 
of this disease has gained much importance as 
well as its diagnosis and prevention. Some natural 
compounds have potent cytotoxic effects against 
cancer cells. Brassinin, a kind of phytoalexin, is one 
of the challenging compounds within this scope. 
Brassinin is supposed to have anticancer effects 
because of its structure that contains an indole 
nucleus and a dithiocarbamoyl-aminomethyl moiety 
(2). Researchers have shown the antiproliferative 
effects of brassinin on in vivo and in vitro models 
of colon cancer through the inhibition of the PI3K 
signaling pathway (3). It has also been demonstrated 
that brassinin may induce apoptosis by blocking 
PI3K/Akt/mTOR/S6K1 signaling pathways (4). In 
the present study we aimed to evaluate the effects 
of brassinin in combination with imatinib, a clinically 
used chemotherapeutic drug.
MATERIALS AND METHODS:
The effects of brassinin alone and in combination with 
imatinib on cell proliferation were determined by MTT 
assay. The effects of combination therapy on cell cycle 
arrest and annexin v binding have been measured by 
cell analyzer. The apoptotic cell population has also 
been shown by fluorescence imaging studies. 
RESULTS:
The results showed that brassinin has significantly 
inhibited the proliferation of SW480 cells at 50, 100 
and 200 μM brassinin in combination with imatinib 
(14.05 μM), whereas brassinin alone could inhibit cell 
growth only at 200 μM. Our results also demonstrated 
that brassinin-imatinib combination has caused a cell 
cycle arrest at G0/G1 phase and it has significantly 
increased the apoptotic cell population when 
compared to control (p<0.05).
CONCLUSIONS:
Results of this study indicated that brassinin has 
synergistically increased the anticancer effects of 
imatinib in SW480 human colorectal cancer cells. 
Further studies are required to identify the underlying 
mechanisms of effects.
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OP-095: PATIENTS’ ATTITUDES 
ON SAFE HANDLING OF ORAL 
CHEMOTHERAPEUTICS
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INTRODUCTION:
Safe handling and appropriate storage of oral 
chemotherapeutics are crucial for maintaining the 
success of chemotherapy. It is also important for 
patients and their caregivers to avoid unexpected 
and hazardous exposures during treatment. Although 
guidelines are available for aseptic drug preparation, 
safe handling and administration of parenterally 
administered chemotherapy drugs, there are few 
recommendations issued for safe handling and 
disposal of oral chemotherapeutics. The aim of this 
study was to evaluate patients’ attitudes in drug usage 
and handling of oral chemotherapeutics.
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MATERIALS AND METHODS:
This study was conducted at an outpatient clinic in 
the Hacettepe University Oncology Hospital between 
29th March and 19th April 2018. The patients who 
are older than 18 years of age and currently use 
oral chemotherapeutics were included in the study. 
The patients were asked 15 questions regarding 
demographics (age, gender and educational level), 
drug usage, storage/disposal conditions and hand 
hygiene in the use of oral chemotherapeutics.
RESULTS:
A total of 24 patients were included, of those 5 (20.8%) 
were male and the mean (± standard deviation) age 
was 54.29 (±8.73) years. Among the participants, 11 
(45.83%) indicated to have an education on the use of 
oral chemoterapeutics, of those 9 (81.8%) indicated to 
have before the chemotherapy initiated. They stated 
that information was given by nurses (n=7, 63.6%) 
and doctors (n= 4, %36.3). All patients indicated not 
to crush / split their medication and 95.8%(n=23) take 
the dose correctly in terms of timing. About 45.8% and 
33.3% of the patients indicated that they wash their 
hands ‘before’ and ‘after’ taking oral chemotherapy 
drugs, respectively. However, none of the patients use 
gloves while taking their oral chemotherapy drug. In 
regards to correct storage of drugs, 87.5% of patients 
indicated to keep their medicines in their original box 
and 79.2% stored medicines at room temperature.  
CONCLUSIONS:
Unfortunately the concept of rational drug use which 
includes aspects of safe handling and proper storages/
disposal of medicine,  can be ignored by patients 
and healthcare professionals in routine practice. 
Therefore, practice standards on each aspects of 
chemotherapy drug usage should be established and 
patients should be informed about the correct use of 
oral chemotherapeutics by healthcare professionals. 
ACKNOWLEDGEMENTS:
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INTRODUCTION:
Hypertension is the leading risk factor for 
cardiovascular disease and mortality worldwide. 
Carvedilol  (CAR) and Hydrochlorothiazide (HYD) are 
used alone or as combination therapy in the treatment 
of patients whose blood pressure is not adequately 
controlled with any of the substances alone.
METHODS:
Ratio derivative and difference spectrophotometric 
techniques  were developed for analyzing a binary 
mixtures of CAR and HYD. In this technique the 
absorption spectrum of binary mixture was divided 
by the absorption spectrum of the standard solution. 
The ratio spectra were recorded.  The ratio derivative 
amplitudes   were measured  at 236.7 nm  for CAR and 
261.8 nm for  HYD, respectively. On the other hands 
,in the ratio difference spectrophotometric technique 
which measures the difference in amplitudes between 
241.3 -285.8 nm for CAR and 226.45 – 269.03 nm for 
HYD, respectively.  
RESULTS:
The calibration curves were linear over the ranges 
of 2-10 mug mL(-1) and  3 -20 mug mL(-1)  for CAR 
and HYD,  respectively.  In order to access the validity 
and applicability of the described method, recovery 
studies were performed by analyzing  synthetic 
laboratory mixtures of each drug in different ratios. 
The results obtained were statistically compared to 
each other and to that of the reported HPLC method. 
The statistically comparison showed that there is no 
significant difference regarding both accuracy and 
precision.
CONCLUSIONS:
The developed methods could be successfully 
applied for the routine analysis of binary mixtures in 
quality control laboratories without any preliminary 
separation steps.
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OP-097: INOSITOL- REQUIRING ENZYME 
1 (IRE1) INHIBITOR, STF-083010, 
DOWNREGULATES PROATHEROGENIC 
GENE EXPRESSION IN BONE MARROW 
DRIVED MACROPHAGES
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D.,4 Walter, P., 2 Erbay, E.
1 Yuksek Ihtisas University, Faculty of Medicine, 
Department of Medical Biology, Ankara, Turkey
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3Department of Biochemistry and Biophysics, 
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INTRODUCTION:
The endoplasmic reticulum (ER) is a central organelle 
for protein biosynthesis, folding, and traffic (1). 
Perturbations in any of these functions results in 
ER stress and aggregation of misfolded/unfolded 
proteins.  Accumulation of unfolded proteins can 
initiate ER stress and activate the Unfolded Protein 
Response (UPR) (2). UPR activation is a hallmark 
of atherosclerotic plaque formation (3). The most 
conserved ER-resident UPR regulator, inositol-
requiring enzyme 1 (IRE1), is activated in lipid-laden 
macrophages on atherosclerotic lesions. Several 
lines of evidence support the notion that selective 
pharmacological targeting of IRE1 is a desirable 
therapeutic approach for treatment of atherosclerosis. 
In this study we aimed to investigate the direct 
contribution of IRE1 to atherosclerotic disease 
progression.
MATERIALS AND METHODS:
Bone marrows were collected from the tibia and 
femurs of mice into RPMI-1640 medium and 
resuspended in RPMI-1640 medium enriched with 
15% (vol/vol) L929 conditioned medium and seeded 
on Petri dishes for 7 d. Then, BMDM cells were treated 
with STF-083010 60 μ for 6 hours. Total RNA was 
isolated using Trisure (Bioline). Sequencing libraries 
for whole-transcriptome analysis were prepared 
using the ScriptSeq v2 RNA-Seq Library Preparation 
Kit (Epicentre Biotechnologies) and sequenced in 
Illumina HiSeq2500 Deep-Sequencer. To estimate 
the changes in gene expression levels, the number 
of sequenced reads that align to a gene of interest 
was then compared among biological samples using 
Cuffdiff tool. 
RESULTS:
We analyzed differentially regulated mRNAs at 
early time points (6 hours) after IRE1 inhibition. 
We observed increased expression of 169 genes 
and decreased expression of 135 genes on IRE1 
inhibition. To categorize the affected genes we 
used the Ingenuity Pathway Analysis (IPA) tool. IPA 
identified the down-regulation of many important pro-
atherogenic genes (such as Il-1β, Ccl2, S100a8, and 
Mmp9) on inhibition of the steady-state IRE1 activity. 
We next validated our findings using quantitative 
(q)RT-PCR method. Our results suggest that the 
IRE1-XBP1 signaling branch of the UPR maintains 
the expression of key proatherogenic cytokines and 
chemokines in macrophages.
CONCLUSIONS:
Our findings suggest that IRE1 plays an important 
role in atherosclerosis progression. Therefore, 
pharmacological inhibition of IRE1 represents 
a promising therapeutic approach to manage 
atherosclerosis.
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1 Bahap, M., 1 Kara, E., 1 Bayraktar Ekincioglu, A., 1 
Demirkan, K., 2 Unal, S.
1 Hacettepe University, Faculty of Pharmacy, 
Department of Clinical Pharmacy, Ankara-Turkey 
2 Hacettepe University, Faculty of Medicine, 
Department of Infectious Diseases and Clinical 
Microbiology, Ankara-Turkey 
INTRODUCTION:
Despite recent widespread awareness campaigns 
on influenza vaccination in Turkey, vaccination rate 
in adult population remains low due to misperception 
among the public. Therefore, this study aimed to 
explore perceptions and attitudes on influenza 
vaccination in the community.
MATERIAL AND METHODS:
This study was carried out between October-
December 2017 in five different community & 
solidarity centers in Yenimahalle District Municipality 
in Ankara. The people were invited to take part in the 
study by a pharmacist and those who are voluntarily 
agreed to participate and gave a written consent were 
included. The participants were asked questions 
about demographics and influenza vaccination.
RESULTS:
A total of 139 people were included (74.8% male) 
where the mean (±standard deviation) age was 
69.3±9.15 year. Of those, 133 (95.7%) participants 
indicated that they were familiar about influenza 
vaccination and therefore, further questions were 
asked on perceptions and attitudes. There were no 
differences observed between participants vaccinated 
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and not vaccinated in terms of educational level, 
monthly income and being alone/living with family 
(p>0.05). However, vaccinated participants (n=41) 
are more likely to be older than non-vaccinated 
(n=92) (mean age: 72 vs 68 years, p= 0.024). Only 
38 (27.3%) participants indicated to be vaccinated 
regularly at each year; the remaining who were not 
vaccinated regularly each year (n=95) indicated the 
reasons for not being vaccinated as; not necessary 
(n=22), inefficacious (n=7), pay no attention (n=6), 
distrust (n=6), not suggested by a doctor (n=4) and 
allergy (n=2). Among the participants, 41 (29.5%) 
indicated to be vaccinated in the last year; of those 
29 (71%), 11 (27%), 5 (12%) and 4 (10%) were 
recommended by physicians, media, pharmacists 
and friends/relatives, respectively.
CONCLUSIONS:
Despite the fact that public has a common view on 
influenza vaccination, vaccination rate is still lower 
than expected. Although demographic features seem 
not to have an effect on vaccination; prejudices 
and misunderstanding, lack of information and 
disinformation and inadequate involvement of 
healthcare professionals in public health issues may 
lead to lower rate of vaccination in the community. 
Therefore, there is a need for active involvement 
of primary care health professionals in order to 
increase awareness among public. Pharmacists have 
opportunity to reach those people in the community 
and may have influence on misperceptions by 
provision of information. 
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OP-099: NOVEL TRANSETHOSOME 
CONTAINING GREEN TEA (CAMELLIA 
SINENSIS L. KUNTZE) LEAVES EXTRACT 
FOR ENHANCED SKIN DELIVERY OF 
EGCG: FORMULATION AND IN VITRO 
PENETRATION TEST
Effionora A., Delly R., Ghina DA.
Universitas Indonesia, Faculty of Pharmacy, Depok, 
16424, Indonesia
INTRODUCTION:
Green tea (Camellia sinensis L. Kuntze) is one of 
the plants that widely available with antioxidant 
activity (1). The major bioactive compounds present 
in green tea leaves are flavonoids, phenols, that are 
responsible for antioxidant activities (2). Antioxidant 
activity in green tea extract depends on the flavonol 
monomers known as catechins, and epigallocatechin 
gallate (EGCG). EGCG is the major catechin in green 
tea which is believed to be the primary source of 
green tea’s beneficial effect (3). Unfortunately, EGCG 
is hydrophilic in nature and has a low skin penetration 
and absorption (4). To overcome this problem, 
transethosome is used as nanolipid vesicle system 
that can enhance the drug penetration through the 
skin. Transethosome can be used to entrap the 
chemical compound or natural ingredients such as 
EGCG. This study aims to formulate transethosome 
cream that can enhance the penetration of green tea 
leaves extract through the skin.
MATERIALS AND METHODS:
Transethosomes were made using thin layer hydration 
method in three formulations with concentration 
variation of Span 80 and ethanol. Transethosomes 
were characterized for morphology using 
Transmission Electron Microscopy (TEM); particle 
size, polidispersity index and zeta potential by Particle 
Size Analizer (PSA); and entrapment efficiency.
RESULTS:
The result showed transethosome F2 containing 
green tea extract equivalent to 3% EGCG, Lipoid 
P30 4%, Span 80 0.75% and 30% of ethanol 95% 
had the best characteristic, which had a spherical 
shape; particle size 35.35 nm; polidispersity index 
0.32; zeta potential -29.97 ± 3.05 mV; and entrapment 
efficiency 45.26 ± 8.15%. Penetration test of creams 
was performed using in vitro Franz diffusion cell with 
the female Sprague Dawley rats skin as a membrane. 
Transethosome cream had a flux at the first and second 
phase of 60.56 ± 4.52 and 23.13 ± 1.38 µg.cm-2.hour-
1 respectively. Nontransethosome cream had a flux of 
25.69 ± 0.83 and 7.36 ± 1.59 µg.cm-2.hour-1 at the 
first and second phase, respectively.
CONCLUSION:
It can be concluded that transethosome cream could 
enhance the penetration of EGCG through the skin.
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OP-100: ALHAGI MAURORUM: A 
PHARMACEUTICALLY IMPORTANT 
‘MANNA OR BLESSİNG PLANT’ OF SINDH, 
PAKİSTAN.
Memon, S
National Center of Excellence in Analytical 
Chemistry, University of Sindh, Jamshoro-Pakistan
INTRODUCTION:
From the advent of civilizations, it came to be known 
that human being generally depend on plants to 
cure their illnesses through plants, which in fact are 
major contributors to the possible source of remedies. 
Nevertheless, it took time to understand that how to 
use the plants and their parts before assuming them a 
blessing. It has been observed that nature has added 
some toxic matter-with useful bioactive constituents-
in plants for their defense mechanism.
MATERIALS AND METHODS:
Herein, a brief but comprehensive emphasis will 
be given with some aspects concerning foremost 
pharmaceutical uses of Alhagi Maurorum, an 
indigenous plant of Sindh, province of Pakistan, 
followed by discussion about isolation and bioactivity 
studies of its constituents using with GC-MS.
RESULTS:
It is important that some useful constituents be 
isolated through separation from plants and used after 
analyzing and testing their bioactivity, side effects and 
performing dosage study as well as possible related 
influencing issues. In this regard, enormous studies 
have been made on millions of plant species. Many 
of them have chemically been explored following 
the studies about their previous uses in traditional 
medications and focusing on responsible constituents 
of those bioactivities.
CONCLUSIONS:
In this study, isolation and bioactivitiy studies of 
constituents of Alhagi Maurorum were done.
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OP-101: CLIPS (CHEMICAL LINKAGE 
OF PEPTIDES ONTO SCAFFOLDS) 
TECHNOLOGY APPLIED TO OPIOID 
PEPTIDES RESEARCH
Mollica A.
Dipartimento di Farmacia, Università di Chieti-
Pescara “G. D’Annunzio”, Chieti, Italy
INTRODUCTION:
CLIPS (Chemical LInkage of Peptides onto Scaffolds) 
technology [1] is a novel and still unexplored versatile 
method for constraining and functionalizing the 
3D-conformation of peptides.
MATERIALS AND METHODS:
This novel cyclization type involves the cyclization of 
linear peptides via reaction with a small scaffold like 
dibromoxylenes. The bromine anchor points react 
exclusively with the thiols of the Cys or Pen in the 
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Figure 1. CLIPS Scaffolds.
RESULTS:
Six cyclic analogues of DPDPE, biphalin and three 
fluorescent probes were prepared and characterized 
as m/d-opioid receptors agonists.[2,3]
CONCLUSIONS:
The novel biphalin and DPDPE derivatives were 
tested by in vitro and by in vivo animal model of pains 
showing higher potency and efficacy than the parent 
compounds..
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INTRODUCTION:
Asteraceae family is well-known as a good source of 
sesquiterpene lactones (SLs) responsible for different 
biological activities. The genus Chrysophthalmum 
Schultz. Bip (Asteraceae) is represented by four 
species worldwide. Among them, C. montanum (DC.) 
Boiss. is distributed Turkey, the North of Iraq and Syria 
(1). C. montanum, commonly called “tutça” or “nezle 
otu”, is a herbaceous perennial herb growing in the 
rock crevices and limestone cliffs of the Eastern region 
of Turkey. In Turkish folk medicine it is used to treat 
eye diseases, sinusitis, flu and other inflammatory 
respiratory diseases as well as for wound healing (2). 
In the light of this information, we aimed to isolate and 
evaluate the potential anti-inflammatory compounds 
from the aerial parts of C. montanum.
MATERIALS AND METHODS:
The anti-inflammatory activity of C. montanum 
aerial parts, carrageenan- and PGE2-induced hind 
paw edema, and acetic acid-induced increase in 
capillary permeability models were used on mice. The 
methanol extract of the plant was first fractionated 
into four subextracts; namely, n-hexane, chloroform, 
n-butanol, and remaining aqueous subextracts. 
Among them, the CHCl3 subextract exhibited the 
most potent anti-inflammatory activity and was thus 
subjected to bioassay-guided fractionation and 
isolation procedures.
RESULTS:





12,8α-olide (3), and (4α,5α,8β,10β)-4,10-dihydroxy-
1,11(13)-guaidien-12,8-olide (4) were isolated 
from the CHCl3 subextract. The structures of the 
isolated compounds were elucidated by means of 
spectroscopic techniques (UV, IR, 1D and 2D NMR, 
and EI-MS and HREI-MS). The methanol extract, 
CHCl3 subextract and compounds 3 and 4 were 
shown to possess anti-inflammatory activity on 
mentioned in vivo models at 100 mg/kg dose. The 
rest of the subextracts and isolated sesquiterpene 
lactones displayed to be inactive in all of the assays.
CONCLUSIONS:
The results provide a biological and phytochemical 
basis for the traditional use of C. montanum for the 
inflammatory diseases in Turkish folk medicine.
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OP-103: OPTIMIZATION THE PREPARATION 
PROCESS OF METHOTREXATE LOADED 
HUMAN SERUM ALBUMIN NANOPARTICLES
Ilem Ozdemir, D., Ekinci, M., Ozgenc, E., Gundogdu, 
E., Asikoglu, M.
Ege University, Faculty of Pharmacy, Department of 
Radiopharmacy, Izmir, Turkey
INTRODUCTION:
Methotrexate (MTX) is a most widely used anticancer 
drug. However, the clinical application of MTX 
is limited by side effects and drug resistance. 
Nanoparticulate delivery systems containing 
anticancer drugs have been continued to develop due 
to their tumor-targeting abilities (1). Human serum 
albumin (HSA) based nanoparticulate systems are 
play an important role because of the ideal properties 
such as being non-toxic, non-antigenic, having active 
targeting ability (2, 3). The objective of the present 
study is the optimization of the preparation process of 
MTX loaded HSA nanoparticles (NPs).
MATERIALS AND METHODS:
HSA-NPs were prepared by small modification on the 
desolvation technique as described previously (2)in 
particular for the in vivo behaviour of nanoparticles 
after intravenous injection. The objective of the 
present study is the development of a desolvation 
procedure for the preparation of HSA-based 
nanoparticles under the aspect of a controllable 
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particle size between 100 and 300nm in combination 
with a narrow size distribution. A pump-controlled 
preparation method was established which enabled 
particle preparation under defined conditions. Several 
factors of the preparation process, such as the rate 
of addition of the desolvating agent, the pH value 
and the ionic composition of the HSA solution, the 
protein concentration, and the conditions of particle 
purification were evaluated. The pH value of the 
HSA solution prior to the desolvation procedure was 
identified as the major factor determining particle 
size. Varying this parameter, (mean. Different drug 
concentrations were examined to achieve ideal 
properties of NPs. In principle, HSA and 0.5-15 
mg MTX dissolved in 10 mM NaCl solution under 
constant stirring for 2 h. Desolvating agent was added 
drop wisely. Particle crosslinking was induced by 
addition of 8% glutaraldehyde in water under stirring 
of the suspension over a time period of 24 h. After 
incubation of crosslinking process, the resulting NPs 
were purified by two cycles of centrifugation. The 
supernatants were collected and the concentration 
of free MTX was analyzed by High Performance 
Liquid Chromatography (HPLC) for the encapsulation 
efficiency (EE). Particle size, polydispersity index 
(PDI) and zeta potential value of MTX-HSA-NPs were 
measured by a Zetasizer Nano ZS.
RESULTS:
According to HPLC study results, the EE of MTX-
HSA-NPs was found over 80%. The average particle 
size, PDI and zeta potential of ideal MTX-HSA-
NP formulation were found as 365.9±54.39 nm, 
0.370±0.092 and -39.0±1.33 mV, respectively.
CONCLUSIONS:
NPs with incorporated MTX were prepared by 
incubation the drug with matrix protein prior to 
the desolvation and crosslinking process. The 
characteristics of NPs were found to be depend on the 
concentration of MTX. The ideal NPs were obtained 
at MTX concentration 1 mg with 150 mg of HSA.
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INTRODUCTION:
It has been estimated that as much as 140 billion 
metric tons of biomass is generated every year from 
agriculture worldwide. Serbia’s annual production is 
about 12.5 million tons of biomass, where over 50% 
lie in corn biomass. Widely available, renewable, 
and virtually free, waste biomass has already 
become an interesting and important potential 
source for microcrystalline cellulose (MCC). This 
work was focused on extraction and characterization 
of microcrystalline cellulose from agricultural 
biomass and testing it as potential excipients in the 
pharmaceutical industry.
MATERIALS AND METHODS:
Samples: agricultural waste (corn) collected in 
Belgrade. Isolation: extraction with hexane and 
methanol, delignification, bleaching, hydrolysis, 
rinsing and drying. Identification and chemical 
characterization: Infrared Spectroscopy with Fourier 
transformation (FTIR), Scanning Electron Microscopy 
(SEM), Inductively coupled plasma atomic emission 
spectrometry (ICP-AAE) and Ionic chromatography 
(IC).
Pharmaceutical-technological tests: flow, bulk and 
taped density, Carr’s index and Hausner’s ratio, 
determination of true density, simulation of material 
compaction using Gamlen Tableting D series, 
determination of compatibility and compressibility, 
disintegration and tablet’s dissolution rate. All 
results were compared with commercially available 
microcrystalline cellulose (Vivapur®).
RESULTS:
Microcrystalline cellulose was successfully isolated 
from lignocellulosic biomass (corn). The obtained 
MCC showed excellent features in terms of safety, 
physical-chemical and pharmaceutical-technological 
properties, as well.
CONCLUSIONS:
The results of this work indicate that corn has a 
high potential as a source of MCC with satisfactory 
characteristics, with perspective of implementing the 
methodology presented in this work on a large scale 
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production.
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INTRODUCTION:
World Health Organisation (WHO) considers 
antimicrobial resistance as a complex problem 
that affects all of society and is driven by many 
interconnected factors. Greater innovation and 
investment are required in research and development 
of new antimicrobial medicines, vaccines, and 
diagnostic tools. Particularly, in fungus infections 
the problem is more complexed hence, biochemical 
similarity of the human cell and fungi forms is a 
handicap for selective activity. As part of the efforts 
of finding novel antifungals, studies on oxime moiety 
bearing compounds is of interest. Notable antifungal 
results obtained from the oximes in these works (1-3). 
One of the aryl/alkyl residues of ketoxime was replaced 
with benzofuran and obtained significant antifungal 
activity, against Candida albicans, from previous 
works referred above. In a 3-D molecular modelling 
study of aryl benzofuran-2-yl ketoxime derivatives as 
Candida albicans N-myristoyl transferase inhibitors, 
among some other quantitative structure activity 
relationship and molecular docking data, it was 
reported that the lipophilic interaction between phenyl 
of benzofuran core is important for antifungal activity 
(4). In light of these findings, chlorinated derivatives of 
those mentioned ketoximes aimed.
MATERIALS AND METHODS:
Previously reported procedures (1-3) were used for 
the synthesis of the aimed molecules.
RESULTS:
The structure elucidation of the compounds was 
performed by IR, 1H-NMR and mass spectroscopic 
data and elemental analyses results. Antifungal 
activities of the compounds were examined.
CONCLUSIONS:
The compounds were successfully obtained and 
elucidated as ketoximes, oxime ethers and esters 
of chlorobenzofuran aryl ketones. They showed 
moderate antifungal activity as expected.
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INTRODUCTION:
The leaves of Cichorium intybus L. are used for 
treating of menopausal symptoms and the roots are 
used against menstrual diseases, and also the all 
plant is used for the uterine diseases and infections 
(1-4).
MATERIALS AND METHODS:
The aerial parts of C. intybus were extracted 
with n-hexane, ethyl acetate and methanol, 
successively. To evaluate efficacy potential of the 
extracts and fractions from C. intybus, surgically-
induced endometriosis rat model was used. In this 
model, adhesion scores of endometriotic implant, 
endometriotic implant volumes, and the cytokine 
levels of peritoneal fluids were evaluated. After 
biological activity studies, phytochemical analyses 
were performed on the active extract and the fractions 
obtained from the active extract.
RESULTS:
According to the results, the methanol (MeOH) 
extract significantly decreased the adhesion scores, 
endometriotic implant volumes, and the cytokine 
levels of peritoneal fluids. Following the biological 
activity studies, the MeOH extract was applied to 
RP-18 column to get four main fractions (Frs. A-D). 
The efficacies of those fractions were evaluated 
again to exhibit the compound/s responsible for 
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the activity. At the end of the biological activity 
experiments, Frs. B and C showed significant 
activity compared to the control group. 6,8,11-Epi-
desacetylmatricarin, cichorioside B, and two new 






were isolated from Fr. B. Quercetin 3-O-β-D-
glucuronide, quercetin 3-O-β-D-glucoside, kaempferol 
3-O-β-D-glucoside were isolated from Fr. C.
CONCLUSIONS:
As a conclusion, the MeOH extract could be used 
for treating endometriosis due to its sesquiterpene 
lactones and flavonoids. In this study, two new 
sesquiterpene lactones were isolated from the aerial 
parts of C. intybus.
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INTRODUCTION:
Although dihydropyridines (DHP) like nifedipine and 
isradipine have been successfully used as anti-
hypertensive drugs for decades, the detailed structure 
activity relationships between DHPs and their 
interaction sites within the DHP binding pocket of the 
L-type calcium channel (Cav1.2) are still incompletely 
understood (1). In this study, we aimed at rationalizing 
the binding mode of DHPs to Cav1.2 and explaining 
the structure activity relationship of a DHP compound 
class with a condensed ring system.
MATERIALS AND METHODS:
A homology model was created based on the recently 
released crystal structure of the closely related calcium 
channel Cav1.1 (2). Twenty two novel DHPs with a 
condensed ring system were synthetized according to 
a modified Hantzsch reaction and tested in-vitro using 
whole-cell patch clamp technique for ability to block 
Cav1.2 to challenge our binding hypothesis.
RESULTS:
Patch clamp assays revealed two novel compounds 
with comparable activity to our reference molecules. 
Docking studies were performed on developed 
homology model of Cav1.2 to gain insights into the 
binding modes. Poses were analyzed to support 
the results of the structure activity relationship 
analysis discussed before. Identified binding poses 
of the compounds were subjected to an unrestrained 
molecular dynamics simulation and the compounds 
stayed stable at their binding sites over the whole 
simulation time.
CONCLUSIONS:
In this study, 22 novel DHPs were synthetized and 
tested for effective inhibition of Cav1.2. We aimed at 
rationalizing the binding mode of DHPs with special 
focus on derivatives with a condensed ring system. 
We identified a binding mode for nifedipine, isradipine 
and our active 1,4-DHP analogs to Cav1.2 that is also 
able to explain the structure activity relationships.
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INTRODUCTION:
Diabetes mellitus is a well known disease causing 
hyperglycemia, impaired homeostatic process, 
inhibition of inflammatory response, generation of 
reactive oxygen species (1) with reduction in collagen 
production, differentiation of the extracellular matrix 
and fibroplasia (2). A wide variety of medicinal 
plants for wound healing in diabetes can be found 
in literature and widely used in folk medicine (3). 
The aim of this study was to indicate the effects of 
ointment prepared with Salvia hypargeia, an endemic 
plant from Turkey, on diabetic wounds.
MATERIALS AND METHODS:
Male Wistar albino rats were used in this study 
(n:60), divided into 5 groups. A single dose of 45 mg/
dl streptozotocin was given to rats (i.p.) to introduce 
diabetes. Excisional  and incisional wounds were 
created under anesthesia. Ethanol extracts of 0.5% 
and 1% of S.  hypargeia  were added respectively 
in mixtures to prepare the simple ointment and were 
topically applied to wounds. Tissues were evaluated 
with macroscopic, histopathological and biochemical 
analysis.
RESULTS:
Wound healing ratios of 0.5% S. hypargeia group 
(63.4 ±7.7&99,3±1,6)  and 1% S. hypargeia group 
(65.5±12.3&99.9±0.01) were statistically significant 
(P<0.01) compared to diabetic control group 
(35.9±22.8&75.1±18.8) in excisional skin wounds on 
the 7th and 14th days. Also healing ratios in incisional 
skin wounds of 0.5% (78.1±7.4&98.5±2.2) and 1% 
S. hypargeia groups (84.4±15.9&99.4±0.8) were 
statistically significant (P<0.01) compared to diabetic 
control group (30.5 ±17.1&72.9±10.8) on the 7th 
and 14th days. Hydroxyproline (0.31±0.3&0.34±0.2) 
and GSH(10.7±3.1&7.6±0.9) levels of 0.5%and 
1%S. hypargeia groups  were statistically significant 
(P<0.01) on the 14th day. Histopathological results 
revealed reepithelialization and  formation of 
granulation tissue in all S. hypargeia groups as well.
CONCLUSIONS:
In conclusion, ointment prepared with extract of 
Salvia hypargeia has a healing effect on excisional 
and incisional diabetic wounds.
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OP-109: THE 5-HYDROXYTRIPTAMINE 
2A RECEPTOR -1438A/G AND 102T/C 
POLIMORPHISMS AND NAUSEA SIDE 
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INTRODUCTION:
Major depressive disorder (MDD) is the most 
common mental disorder all around the world and 
today approximately 350 million people suffer from 
MDD. Citalopram is a widely prescribed agent of 
SSRIs[1]. Despite, SSRIs are associated with less 
adverse drug reactions, nausea and vomiting is 
observed approximately 40% of the MDD patients 
[2].  There are different mechanisms and factors for 
the occurrence of nausea and vomiting. Serotonine 
receptor polymorphisms might be one of these factors, 
which contribute nausea and vomiting. Our aim was to 
evaluate the associations between the Serotonine-2A 
receptor (HTR2A) gene 102T/C and -1438A/G single 
nucleotide polymorphism and nausea in citalopram 
treated patients.
MATERIALS AND METHODS:
Genomic DNA was isolated from 63 MDD patients 
who were treated with daily CIT. The HTR2A 102T/C 
and -1438A/G polymorphisms analyzed by using 
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PCR-RFLP techniques.
RESULTS:
We have found that, in the patients treated with CIT, 
there was a significant difference in the genotypic 
distribution associated with -1438A/G polymorphism 
between patients with and without nausea (X2=6.894, 
p=0.032). Moreover, logistic regression analysis 
revealed a significant association between nausea/
vomiting side effect and -1438A/G polymorphism. 
That is patients with the G allele were at a higher risk 
for developing nausea/vomiting (p=0.030, OR=2.469). 
The 102T/C polymorphism in the HTR2A gene had no 
significant effect on the nausea/vomiting side effect 
among participants.
CONCLUSIONS:
The present study demonstrates that the HTR2A 
gene -1438A/G polymorphism might be associated 
with nausea/vomiting side effect in patients who were 
treated with CIT.
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INTRODUCTION:
Alzheimer’s disease (AD) is a multifactorial complex 
neurodegenerative disorder and apparently involves 
several different cellular and molecular processes. 
However the main therapeutic strategy today is 
the use of acetylcholinesterase (AChE) inhibitors; 
the elevation of butyrylcholinesterase (BChE) 
levels, the accumulation of Aβ peptides, tau protein 
phosphorylation, neuroinflammation of the central 
nervous system are the other important factors in 
the pathogenesis of the disease (1,2). Multifactorial 
nature of AD with complex pathological mechanisms 
fits well with Multi Target Directed Ligand (MTDL) 
development strategy (3). Considering this strategy, 
the study is focused on synthesis and biological 
evaluation of some new benzimidazoles and 
2-pyrazolines to obtain novel MTDLs by combining 
BChE and Aβ aggregation inhibitory activities in one 
neuroprotective structure.
MATERIALS AND METHODS:
 The structures of the synthesized compounds were 
elucidated by spectral and elemental analysis data. 
Inhibitory effects of the compounds on AChE/BChE 
enzymes and fibril formation were evaluated by 
using Ellman’s method and fluorimetric methods in 
respectively. Further, H2O2- and Aβ1–40-induced 
cytotoxicity tests were performed to evaluate the 
neuroprotective effects of the compounds. The 
binding mode of the the compounds in the active site 
of the cholinesterase enzymes were tried to identify 
by molecular modeling studies.
RESULTS:
Among the benzimidazole derivatives, Compound 
12 (IC50 BChE: 5.18±1.22 µM, SI: 6.7) showed the 
highest inhibitory activity on BChE. Compound 20, a 
member of 2-pyrazoline series, selectively inhibited 
(IC50 BChE: 0,34 µM, SI: 114,2) BChE. H2O2  and 
Aβ1-40 induced cytotoxicity studies showed that the 
most of the compounds possessed neuroprotective 
feature by increasing cell viability (compared to 
control).
CONCLUSIONS:
All these results suggested that some of benzimidazole 
and 2-pyrazoline derivatives could be a promising 
multi-target lead candidate against AD.
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OP-111: BISMUTH OXIDE NANOPARTICLES 
CAUSED NEUROTOXICITY VIA OXIDATIVE 
STRESS IN VITRO.
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Istanbul, Turkey
INTRODUCTION:
Nanotechnology Consumer Products Inventory listed 
over 500 consumer products contains metals and 
metal oxides (1). Bismuth based nanoparticles have 
attracted the attention especially in biological sciences 
and commonly used in medical applications. By our 
group, the bismuth oxide nanoparticles (Bi2O3-NPs) 
were reported to induce oxidative stress and cause 
apoptosis and DNA damage in several mammalian 
cell lines including HepG2, NRK-52E, Caco-2 and 
A549 (2). Therefore, in the present study, we aimed to 
assess the neurotoxic potential and possible toxicity 
mechanisms of Bi2O3-NPs in SH-SY5Y cells.
MATERIALS AND METHODS:
Cytotoxic activities of the Bi2O3-NPs were determined 
by MTT and LDH assays. ROS production was 
determined by flow cytometry using H2DCFDA and 
GSH, CAT and SOD levels were measured by ELISA. 
The mRNA expression levels of inflammation related 
genes were determined using LightCycler 480 Probes 
Master and Catalog Assays on the Roche RealTime 
LightCycler 480 II platform.
RESULTS:
Bi2O3-NPs decreased the cell viability through 
disruption on mitochondrial activity (IC50: 77.57 
µg/mL) and membrane integrity (IC50: 16.97 µg/
mL) which are determined using MTT and LDH 
assays, respectively. At 50 µg/mL of Bi2O3-NPs, 
ROS production significantly induced as well as,the 
levels of CAT and SOD.  In immune response, mRNA 
expression levels of IL-6 were increased more than 
1.5-fold in all doses; whereas, MAPK8, NF-ĸB and 
TNF-α expressions were remained unchanged.
CONCLUSIONS:
Bi2O3-NPs induced inflammation-related oxidative 
stress via activation of pro-inflammatory cytokine, IL-
6. It should raise concern about the safety associated 
with their applications in consumer products 
according to the obtained results and the mentioned 
literature. Also, supporting studies in vivo are needed 
to fully understand the toxicity mechanism of Bi2O3 
nanoparticle.
ACKNOWLEDGEMENTS:
This work was conducted as “Final Project” of 
Pharmacy students namely Aykanat B, Can Z. and 
Baram E., and, funded by the Research Fund of 
Istanbul University (Project No. TLO-2017-27472). 
Oztas E. (Supervisor) and Ozhan G. (Promoter) thank 
to undergraduate students for their great effort and 
commitment.
REFERENCES
1.  Vance ME, Kuiken T, et al., (2015). 
Nanotechnology in the real world: Redeveloping 
the nanomaterial consumer products inventory. 
Beilstein Journal of Nanotechnology, 6, 1769.
2.  Abudayyak M, Oztas E, et al., (2017). Investigation 
of the toxicity of bismuth oxide nanoparticles in 
various cell lines. Chemosphere, 169, 117-123.
OP-112: ENUMERATION OF ESCHERICHIA 
COLI BASED ON SERS TECHNIQUE IN A 
PASSIVE TYPE MICROFLUIDIC CHIP
1 Dogan, U., 1 Kasap, EN., 2 Çogun, F., 2 Yildirim, E., 
3 Cetin, D., 4 Suludere, Z., 5,6 Boyaci, IH., 1 Ertas, N., 
1 Tamer, U.
1Gazi University, Faculty of Pharmacy, Department of 
Analytical Chemistry, Ankara, Turkey
2Cankaya University, Faculty of Engineering, 
Department of Mechanical Engineering, Ankara, 
Turkey
3Gazi University, Gazi Faculty of Education, 
Department of Mathematics and Science Education, 
Ankara, Turkey
4Gazi University, Faculty of Science, Department of 
Biology, Ankara, Turkey
5Hacettepe University, Department of Food 
Engineering, Ankara, Turkey
6Hacettepe University, Food Research Center, 
Ankara, Turkey
INTRODUCTION:
Microorganism detection and quantification is a 
vital research area for human being in diagnosis, 
medicine, pharmacy, food industry etc. (1). Classical 
colony counting methods needs at least 12-48 hours 
to give a reliable result which is very time consuming 
especially when fast result is crucial. In the present 
study, rapid, sensitive and specific biosensor 
have been developed by using modified magnetic 
nanoparticles and modified gold nanorods tagged with 
a Raman reporter molecule to enumerate Escherichia 
coli (E.coli).
MATERIALS AND METHODS:
Iron oxide core gold shell magnetic nanoparticles 
(MNPs) were synthesized and modified with 
biotinylated antibodies specific to E.coli. Similarly, 
gold nanorods were synthesized and modified with 
a Raman label and biotinylated E.coli antibodies. 
Modified nanoparticles were interacted with E.coli 
solutions which have different initial bacteria 
concentrations and SERS measurements were taken 
(Fig. 1).
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Figure 1. SERS signals obtained from E. coli 
solutions (101–105 cfu/mL)
RESULTS:
Our results showed that modified MNPs and gold 
nanorods were successfully conjugated with E. coli. 
The developed method could detect 101–105 cfu/
mL of E. coli in 1h, reliably. A linear relationship of 
the Raman peak intensity and logarithmic bacteria 
concentrations was observed in calibration graph. 
Selectivity of the method was also examined by taking 
SERS measurements for Enterobacter dissolvens (E. 
dissolvens), and Staphylococcus aureus (S. aureus) 
by utilizing the same procedure, and no significant 
interference was observed.
CONCLUSIONS:
A fast, sensitive and selective biosensor system was 
developed and applied to spiked milk samples to 
show the applicability of this biosensor to real samples 
with a total analysis time less than 60 minutes, 
successfully. Furthermore, many other samples like 
urine, contaminated water and food products etc. 
can be examined by using this developed biosensor 
system due to its significant advantages.
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OP-113: SYNTHESIS AND 
CHOLINESTERASE INHIBITORY 
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INTRODUCTION:
Inhibition of acetylcholinesterase (AChE) enyzme is 
the therapeutic target of drugs designed to manage 
various disorders such as myasthenia gravis, 
glaucoma, Lewy body dementia, and Alzheimer’s 
disease (1). AChE inhibitors are used for the treatment 
of these disorders, which improve cholinergic functions 
by elevating acetylcholine (ACh) levels in cholinergic 
synapses. AChE is the primary enzyme responsible for 
the degradation of ACh, while butyrylcholinesterase 
(BuChE) plays a secondary role (2). Pyridostigmine, 
a reversible AChE inhibitor used for the treatment of 
myasthenia gravis, includes a quaternary pyridinium-
carbamate moiety in the molecule structure. Based on 
the AChE protein structure, this cationic nitrogen atom 
plays an important role in enzyme-ligand interactions 
(3). Within this contex, in this study, pyridinium 
moiety was chosen as a core structure and a series 
of quaternary pyridiniumhydrazide-hydrazone 
derivatives were designed to synthesize as potential 
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Fig. 1. The structure of the synthesized compounds
MATERIALS AND METHODS:
The final compounds were synthesized according 
to the reported method (4). Their AChE and BuChE 
inhibitory activities were assayed using the method of 
Ellman et al (5).
RESULTS:
In the present study, a series of pyridiniumhydrazide-
hydrazone derivatives were synthesized and evaluated 
for their anti-ChE activities. Chemical structures of the 
synthesized compounds were confirmed by spectral 
IR, 1H NMR, and ESI-MS analysis. According to the 
biological activity results, the compounds were found 
to have inhibitory potential in different ratios against 
AChE/BuChE.
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CONCLUSION:
The obtained activity results suggested that these 
pyridiniumhydrazide-hydrazone derivatives might 
be promising leads for the development of anti-ChE 
drugs.
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INTRODUCTION:
Bisphenol A (BPA) is used primarily for production 
of polycarbonate plastics. Di(2-ethylhexyl)
phthalate (DEHP) is used in the manufacturing of 
polyvinylchloride (PVC). They are suggested to act 
as peroxisome proliferators and exert hepatotoxicity. 
Mono (2-ethylhexyl)phthalate is the main metabolite 
of DEHP. MEHP is even more toxic than the parent 
compound. However, combined effects of these 
chemicals are not well-studied. Endoplasmic 
reticulum (ER) functions to fold and process secreted 
and transmembrane proteins. Environmental and 
genetic factors that disrupt ER function can lead to 
the accumulation of misfolded/unfolded proteins 
in the ER lumen. This phenomenon is called “ER 
stress”. A signaling network called the “Unfolded 
Protein Response (UPR)” is activated after ER stress 
is induced. UPR usually restores ER homeostasis, 
and later promotes cell survival. However, under 
unresolvable ER stress conditions, the UPR promotes 
apoptosis. Many environmental chemicals can induce 
ER stress and finally apoptotic cell death. The aim of 
this study was to determine cytotoxicity and ER stress 
caused by BPA and/or MEHP exposure in human 
hepatoma cell line (HepG2 cells).
MATERIALS AND METHODS:
The study groups were determined as control, BPA, 
MEHP, BPA+MEHP. Cytotoxicity was determined by 
MTT assay. Expressions of ER stress marker proteins 
(PERK, Grp78, XBP1 and CHOP) in both cytoplasmic 
and nuclear cell fractions were determined by Western 
blotting. The expression profiles were quantitated by 
using ImageLab program.
RESULTS:
HepG2 cells were exposed to BPA, MEHP and 
BPA+MEHP at different concentrations for 24 h. 
Median inhibitory concentrations (IC50) of BPA, 
MEHP and MEHP+BPA were found to be 615 µg/
ml, 17.4  µg/ml and 15+500 µg/ml, respectively. 
Inhibitory concentration 30 (IC30) for BPA, MEHP and 
MEHP+BPA were found to be 343 µg/ml, 4.5 µg/ml and 
10+400 µg/ml, respectively. In cytosolic fraction, there 
was only an increase in Grp78 protein expression 
only in MEHP and BPA-exposed HepG2 cells when 
IC30 doses were applied. In nuclear fraction, we 
observed increases in all of ER stress related protein 
expressions in BPA-exposed cells. However, MEHP 
caused a slight increase in only Grp78 expression. In 
BPA-MEHP-exposed cells, PERK, XBP1 and CHOP 
expressions were higher vs. control cells.
CONCLUSIONS:
Both BPA and MEHP are cytotoxic in HepG2 cells 
after 24 h. These chemicals can cause induction 
of ER stress-related proteins, mostly in nuclear 
cellular fractions. Combined exposure to these 
compounds seems to aggravate their cellular toxicity. 
Comprehensive studies are needed to enlighten 
the toxicity mechanisms of these chemicals and 
combined exposures should be taken into account 
when assessing their toxic effects on biological 
systems. 
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DETECTION STRATEGIES FOR GROUP A 
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Suludere, Z., 5 Boyaci, IH., 
1 Tamer, U.
1Gazi University, Faculty of Pharmacy, Department of 
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2Abant Izzet Baysal University, Yenicaga Vocational 
High School, Bolu, Turkey
3Gazi University, Faculty of Education, Science 
Teaching Program, Ankara, Turkey
4Gazi University, Faculty of Science, Department of 
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5Hacettepe University, Department of Food 
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INTRODUCTION:
Group A beta-hemolytic Streptococcus pygogenes 
is the main cause of acute pharyngitis and patients 
are tested by either a throat culture or a rapid antigen 
detection (1). However, it takes 48 hours to obtain 
results and if there are any negative test results, there 
is a verification needed (2). In this study, a batch 
analysis was performed to detect the bacteria in the 
presence of modified nanoparticles using surface-
enhanced Raman spectroscopy (SERS) and then, 
lateral flow immunoassay (LFIA) test strips were 
prepared for more accurate and a fast detection.
MATERIALS AND METHODS:
Magnetic gold nanoparticles and rod-shaped gold 
nanoparticles were synthesized for the batch analysis 
and they were modified with antibody of the target 
bacteria. LFIA test strips were constructed with 
different membranes including a sample pad, a 
conjugation pad, test area and an absorbent pad. 
Raman reporter labeled gold nanoparticles were 
employed as a capture probe in the conjugation pad 
and color change on the test zone was the sign of 
group A Streptococcus. In addition, the SERS signal 
of the reporter was evaluated as a confirmation of the 
target. Different cell concentrations (15-1x108 cfu/
mL) were used for quantitative detection of group A 
Streptococcus by using plotted calibration curve for 
both systems.
RESULTS:
In batch analysis, interaction time of cotton swab in the 
bacteria culture was one minute. Modified magnetic 
gold nanoparticles caught the bacteria in 15 minutes 
and after 10 minutes of washing, final immunoassay 
reaction was 30 minutes of time. It was clear that it 
took 75 minutes to quantify the bacteria with a LOQ 
of 400 cfu/mL in the batch system. Therefore, the 
obtained results were the basis for LFIA test. In LFIA 
strips, it was shown that SERS enabled more sensitive 
detection of Group A Streptococcus. Comparing the 
commercial strips, 2x102 cfu/mL of bacteria could be 
detected and there was no need for verification with 
the plate counting technique.
CONCLUSIONS:
Both colorimetric and SERS detection of Group A 
Streptococcus were performed for the first time. The 
SERS signal enabled the fast and more accurate 
detection with a lower detection limit comparing the 
conventional methods.
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OP-116: Α-GLUCOSIDASE INHIBITORY 
EFFECTS OF SOME FUNCTIONALIZED 
AMINO ACID DERIVATIVES
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Ege University, Faculty of Pharmacy, Department of 
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INTRODUCTION:
According to the first World Health Organization 
(WHO) Global report on diabetes, it caused 1.5 
million deaths worldwide in 2012 and type 2 
diabetes mellitus (T2DM) is the most common form 
in the society (1). As it is known, only three agents 
namely acarbose, voglibose and miglitol are used 
in the treatment of T2DM by the way of inhibition of 
α-glucosidase but they have various side effects. 
Therefore, there is an urgent need to discover and 
develop new chemical agents with enhanced activity 
profile and reduced side effects. For this purpose, in 
this study, as functionalized amino acid derivatives, 
fourteen 2/3-(acylamino)propionanilide derivatives 
(Figure 1) have been prepared and evaluated for their 
α-glucosidase inhibitory activities.
MATERIALS AND METHODS:
The synthesis of the title compounds was realized in 
2 steps. Structures of the compounds were confirmed 
by spectral (UV, IR, 1H NMR, MS) and elemental 
analyses. All compounds were evaluated with regard 
to α-glucosidase inhibition compared to acarbose as 
reference compound. The enzyme inhibition assay 
was carried out spectrophotometrically by using 
slightly modified method of Zawawi et al (3)
RESULTS:
Based on biological activity results,  most of the tested 
compounds showed moderate to weak α-glucosidase 
inhibitory activity in comparison to the acarbose.
CONCLUSIONS:
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A series of 2/3-(acylamino)propionanilide derivatives 
have been evaluated for their α-glucosidase 
inhibitory activity profile. The biological activity results 
demonstrated that further structural modification of 
this class of functionalized amino acid derivatives may 
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INTRODUCTION:
Electrolyzed Water (EW) is a novel technology based 
on electrolysis of water containing sodium chloride or 
potassium chloride in an electrolysis chamber where 
anode and cathode electrodes are separated by an 
ion-permeable diaphragm (1). EW produced in a 
variety of forms is widely used as a sanitizer, sterilizer 
for surgical and dental equipment, topical disinfectant 
and to treat contaminated water (2, 3). The use of 
the EW is particularly important because chemical 
disinfectants such as benzalkonium chloride, 
formaldehyde and glutaraldehyde are potentially toxic 
to human and corrosive to application area (4). In the 
present study, we have evaluated antimicrobial activity 
of three types of EWs and then their biocompability 
was assessed by cytotoxicity, ocular irritation and skin 
irritation assays in vitro.
MATERIALS AND METHODS:
The EWs are produced by the electrolysis of tap 
water containing 5 g/L of sodium chloride in a divided 
electrochemical reactor. Three types of EWs as acidic 
(A-EW), slightly acidic (Sa-EW) and mixed (M-EW) 
were freshly prepared. Microbiological assay was 
performed according to TS EN 1276 and TS EN 1650 
standards on Staphylococcus aureus, Escherichia 
coli, Pseudomonas aeruginosa and Candida albicans. 
Cell viability was tested on mice fibroblast cell line 
(L929, ATCC) for 24 h exposure to serial dilutions of 
10% EWs (v/v) and the viability was determined with 
MTT assay. To evaluate the potential ocular irritancy 
of EWs, ICCVAM recommended Hen’s Egg Test - 
Chorioallantoic Membrane (HET-CAM) test method 
was applied and reactions on the CAM were scored 
according to lysis, hemorrhage and coagulation within 
300 sec of EW exposure. To predict skin irritation 
potential of EWs, ECVAM validated reconstructed 
human epidermal model EpiDerm™ (EPI-200, 
MatTek) was used.
RESULTS:
In microbiological assay, A-EW, Sa-EW, M-EW 
provided complete bacteria inactivation in 10 minutes. 
In cytotoxicity assay, no significant difference was 
observed between EW groups. In HET-CAM assay, 
none of tested EWs caused ocular irritation according 
to testing score. Besides, skin irritation test showed 
that none of tested EWs caused dermal irritation 
compared to positive control (5% SDS).
CONCLUSIONS:
Based on the biocompability results presented in our 
study, EWs are not cytotoxic and has no irritating and 
corrosive properties. Accordingly, EWs can reliably be 
used as an alternative disinfectant agent.
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INTRODUCTION:
Paper based microfluidic systems are one of the 
most commonly utilized commercial test kits for 
the determination of bacteria, drugs of abuse and 
pregnancy etc. because of its low cost, simplicity 
and user-friendliness advantages. Most of these 
lateral flow immunoassay systems has been used 
for qualitative detection, but various new paper 
based biosensor systems have been developed 
by using fluorescence, electrochemistry and SERS 
etc. for the quantitative investigations (1). Magnetic 
nanoparticles have been used as a powerful way in 
various bioassays and used as solid support owing to 
its advantages such as biocompatibility, stability and 
immunomagnetic extraction. Modification of these 
nanoparticles enable to straightforward conjugation 
with bacteria or biomolecules of interest (2).
MATERIALS AND METHODS:
Casein modified Fe3O4/Au-PEI nanoparticle provides 
immunomagnetic separation and specific detection of 
the target bacteria. Enzyme substrate is covalently 
linked between magnetic particle and target bacteria 
to cleave bond easily using an enzyme. Then, 
magnetic nanoparticle is cleaved from E. coli in order 
not to prevent bacteria movement on the test strip. 
The magnetic particles are removed by a magnet, and 
E.coli can be detected efficiently on the test strips. 
E.coli is also labeled with DTNB to enable SERS 
signals on the test strip. Test line is spotted with E. coli 
antibody in order to catch labelled bacteria (3).
RESULTS:
The SERS signals were obtained and calibration 
curve was plotted by using SERS peaks area at 1330 
cm-1 versus logarithmic initial bacteria concentrations. 
This method was applied to E.coli spiked blood 
with different concentrations. The selectivity of this 
developed biosensor system was investigated by 
applying the same procedure to Salmonella enteritidis 
and Bacillus subtilis solutions. The results obtained 
for the SERS intensities of different bacteria were 
measured to be compared with the SERS signals 
acquired for E.coli as demonstrated in Fig 1.
Figure 1. SERS signals of Selectivity of Different 
Bacteria
CONCLUSIONS:
This new nano-immunomagnetic extraction for paper 
based system can be used in many application 
areas including food quality, water contamination, 
clinical diagnosis and environmental monitoring due 
to its attractive advantages such as simple, low-cost, 
portable and disposable features.
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OP-119: NEW THIAZOLE DERIVATIVES 
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INTRODUCTION:
Aldose reductase (ALR2), the first and rate limiting 
enzyme of the polyol pathway, is responsible for 
NADPH-dependent reduction of glucose to sorbitol. 
Blocking the polyol pathway of glucose metabolism 
related to inhibition of ALR2 has been reported to be 
effective in reducing long-term diabetic complications 
including retinopathy, nephropathy, neuropathy 
and cataract (1). Due to the significance of thiazole 
scaffold for antidiabetic drug design (2), we aimed 
to design and synthesize new thiazole-based ALR2 
inhibitors.
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MATERIALS AND METHODS:
New thiazole-based compounds 1-12 were 
synthesized via the ring closure reaction of 
3,4-dihydro-2H-1,5-benzodioxepine-7-carbaldehyde 
thiosemicarbazone with aryl acyl bromides. These 
compounds were evaluated for their in vitro inhibition 
behaviors on ALR2 which was purified from rat liver 
using several chromatographic methods. Then, Ki 
parameters were determined via Lineweaver–Burk 
(1/V–1/[S]) graph (3). Moreover, molecular docking 
studies were performed for the most effective 
compound in the active site of ALR2 (PDB code: 





was detected as the most potential ALR2 inhibitor in 
this series with the Ki constant value of 0,018±0,005 
µM and the compound showed competitive inhibitory 
activity. Molecular docking studies indicated that 
compound 3 presented hydrogen bonds with Asp217, 
Gln184 and Lys22 residues in the active site of ALR2. 
Besides, ADME results revealed that all compounds 
were within the acceptable range intended for human 
use.
CONCLUSIONS:
Both in vitro and in silico studies emphasize 
that compound 3 stands out as a potential orally 
bioavailable ALR2 inhibitor for further studies.
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FLAVORINGS IN NUTRITIONAL 
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INTRODUCTION:
Live organic spice-derived flavorings are a category 
of palatability defining ingredients vital in nutritional 
pharmacology. They are used in the production 
of functional foods for preventive and therapeutic 
treatments (1-3). The aim of the study is to prove 
that palatability and variety of foods are important 
and health-wise can be achieved by application 
of ingredients that are safe, sustainable and have 
recognizable properties. Therefore, flavorings 
derived from some spices are analyzed in the 
context of actual examples in health food and fitness 
industry. Briefly, the eco-tech oil extraction has been 
mentioned together with the other necessary details 
and experiences.
MATERIALS AND METHODS:
The study has been carried out firstly via market 
survey with spice material collection. Then, the spices 
have been validated by expert examinations. The oil 
spices have been subjected to innovational eco-tech 
oil extraction. In the laboratory studies, the spices and 
oils have been tested, then performed data analysis 
and economic analysis – data and reports displayed 
in the study.
RESULTS:
Live spice-derived flavorings serve as important 
ingredients for functional foods due to their bioactive 
content as well as stimulation of pleasure gained 
from food via improvements in palatability. “Let food 
be your medicine” is the moto of superfoods these 
days while nutritional pharmacology has always been 
a vivid but silent part of the food industry and now 
it becomes officially powerful with the help of spices 
and spice-derived components getting popular in the 
modern world.
CONCLUSIONS:
Live spice-derived flavorings are the next stage of 
evolution of functional aromas and flavors and are 
a perfect solution for nutritional pharmacology and 
ingredient dilemmas with diverse positive effects on 
human health and wellbeing as well as marketing 
attraction and business solution for a wide range of 
nutrition-focused businesses.
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OP-121: INVESTIGATION OF 
MITOCHONDRIAL RESPIRATION 
DYSFUNCTION CAUSED BY SOME DRUGS
Arzuk, E., Orhan, H.
Ege University, Department of Pharmaceutical 
Toxicology, Izmir, Turkey
INTRODUCTION:
Mitochondria are cell energy powerhouses and 
produce ATP by oxidative phosphorylation (OXPHOS). 
Mitochondria may be the targets of multiple drugs and 
chemical substances due to their unique structure 
and substantial functions (1).The aim of our study 
was to assess the mitochondrial toxicity of eight drugs 
(clozapine -CLZ-, olanzapine -OLA-, nifedipine -NIF-
, diclofenac -DIC, valproic acid -VPA- dapson -DAP, 
tiaprofenic acid -TIA-, and sulfafenazol -SULP) by 
oxygen consumption rate (OCR) measurement.
MATERIALS AND METHODS:
In our experiments, CHO-K1 cells were used as an 
in vitro model. The cells were treated with three final 
doses (1, 10, and 100 µM) of test drugs during 16 
hours. OCR measurement was performed by Luxcel 
Biosciences’ MitoXpress® Xtra Oxygen Consumption 
Assay (2).
RESULTS:
DAP, TIA and VPA at 100 µM, and OLA at 10 and 100 
µM caused significant decrease in OCR compared to 
control.
CONCLUSIONS:
Our results suggest that DAP, TIA, VPA and 
OLA interfere with mitochondrial respiration and 
therefore may lead to mitochondrial dysfunction. The 
determination of mechanism(s) of drugs’ toxicity is 
also useful for preventing potential adverse effects. 
Thus, further studies are underway in our laboratory 
to investigate whether additional  mechanisms play a 
role in in vitro, and possibly in vivo toxicity of these 
drugs
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INTRODUCTION:
Cytotoxic nucleoside analogues and nucleobases 
are a pharmacologically diverse family, which has 
grown to include a variety of purine and pyrimidine 
nucleosides with activity in both solid tumours and 
malignant disorders of the blood (1, 2). These agents 
have many intracellular targets to induce cytotoxicity: 
they behave as antimetabolites, competing with 
physiological nucleosides during DNA or RNA 
synthesis, and as inhibitors of key cell enzymes (2, 3).
MATERIALS AND METHODS:
In this study, we synthesized novel purine and 
pyrimidine ribonucleoside analogs as putative 
cytotoxic agents. The 5’, 6-disubstituted 9-(β-D-
ribofuranosyl)purine derivatives were readily obtained 
from commercially available inosine in seven steps 
and the 4-substituted-1-(β-D-ribofuranosyl)-2(1H)-
pyrimidinone derivatives were prepared from uracil/
thymine in four steps in very cost effective synthesis 
approach. The newly obtained compounds were 
characterized for their cytotoxicity in human cancer 
cell lines. The cytotoxicities of the compounds were 
initially analyzed on liver (Huh7), colon (HCT116) and 
breast (MCF7) carcinoma cell lines by SRB assay for 
determining the IC50 values. The IC50 values after 
72 hours of treatment with each molecule were also 
calculated in comparison with DNA topoisomerase 
inhibitor camptothecin (CPT), the nucleobase 
analog 5-fluorouracil (5-FU) and nucleoside analogs 
fludarabine, cladribine, pentostatine.
RESULTS:
N6-Bromophenylsulfonyl purine nucleoside analog 
demonstrated significant cytotoxic activity for the 
cell lines tested and was more cytotoxic (IC50 = 1.5-
30.8) than 5-FU, fludarabine on Huh7, HCT116 and 
MCF7 cell lines. We then tested the cytotoxic effect 
of the most potent nucleoside derivative on additional 
hepatocellular carcinoma (HCC) cell lines: Huh7, 
Hep3B, HepG2, PLC, Mahlavu, FOCUS, SNU475, 
SNU182, SNU387, SNU398, SNU423 and SNU449. 
N6-(4-Bromophenyl)sulfonylpiperazine derivative 
displayed the best cytotoxic activity, with IC50 values 
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of 15.5-22.5 μM against Hep3B and SNU423 cell lines 
and had a better cytotoxic activity than Fludarabine 
and Pentostatine on Hep3B and SNU423 cell lines.
CONCLUSIONS:
 A series of new purine and pyrimidine nucleoside 
analogs were prepared and their cytotoxic activities 
identified. 6-(4-bromophenyl)purine derivative showed 
potent anticancer activity at low concentrations against 
Huh7, HCT116, MCF7 cell lines when compared 
to 5-FU and Fludarabine as potent cytotoxic drugs. 
Among the 47 compounds investigated, the most 
potent purine and pyrimidine derivatives were further 
analyzed for their activity on HCC cells. The molecule 
bromo analog exhibited promising cytotoxic activity 
with IC50 value of 15.5 μM on Hep3B cell line.
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VARIOUS FREQUENTLY USED DRUGS IN 
VITRO
Erguc, A., Mutlu, N., Arzuk, E., Karakus, F., Orhan, H.
Ege University, Department of Pharmaceutical 
Toxicology, Izmir, Turkey
INTRODUCTION:
Cytotoxicity tests provide information about test 
compounds to us whether they have toxic effects 
when incubated under the defined conditions in 
the cell culture (1). In the present study cytotoxicity 
of eight drugs (clozapine, olanzapine, nifedipine, 
diclofenac, valproic acid, dapson, tiaprofenic acid 
and sulfaphenazole) were investigated by using the 
MTT and LDH leakage assays at three dose levels 
(1, 10, 100 µM). MTT test was also carried out in the 
presence and absence of GSH (soft nucleophile) and 
KCN (hard nucleophile) in order to figure out whether 
cytotoxicity of these drugs are caused by reactive 
metabolites (RM) of the test drugs.
MATERIALS AND METHODS:
In both assay CHO-K1 cells were used as an in vitro 
model. The cells were treated with test drugs (1, 10. 
100 µM) with/without trapping agent and incubated 
for 16 hours. After incubation cells were treated with 
MTT for 4 hours. Then DMSO was added to dissolve 
the formazan crystals. The optic dansity was read at 
570 nm (2). In LDH leakage assay, NADH (300 µM) 
and Na-pyruvate (770 µM) were added to medium 
taken from the wells after 16 hours incubation. The 
changes of NADH absorbance was monitored at 340 
nm for 4 minutes (3).
RESULTS:
In MTT, Clozapine and Nifedipine at 100 µM and 
Diclofenac at three doses led to significant decrease 
when compared to control. In addition, presence of 
both trapping agents prevented cytotoxicity, which 
suggested the occurrence of RMs in this effect. In 
LDH, Clozapine and Nifedipine at 100 uM caused 
considerable toxicity similarly in MTT.
CONCLUSIONS:
Clozapine and Nifedipine showed substantial toxicity 
at 100 µM. They need to be investigate of toxicity 
mechanism to overcome the adverse effects.
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INTRODUCTION:
Sirtuins are nicotinamide adenine dinucleotide (NAD+)-
dependent class III histone deacetylases, which play 
a role in the pathogenesis of several diseases such as 
metabolic disorders, neurodegeneration and cancer 
(1). Structure-based virtual screening (VS) studies on 
pan-African natural products library (p-ANAPL) (3) led 
the identification of bichalcones as novel inhibitors of 
sirtuins. Moreover, we proposed workflows for ligand-
based VS campaigns to guide the hit identification 
and lead optimization of these compounds.
MATERIALS AND METHODS:
Protein structures were prepared by using Protein 
Preparation Wizard module in Schrödinger. Docking 
studies were performed using the GOLD and GLIDE 
programs. Calculation of fingerprints and generation 
of pharmacophore groups using docked bischalcones 
were suggessted for further ligand-based VS 
campaigns.
RESULTS:
Virtual screening of the p-ANAPL database resulted 
in the identification of two bichalcones, which showed 
inhibitory activity against both Sirt1  (1; IC50 = 46.7 
± 6.0, 2; IC50 = 40.8 ± 8.5) and Sirt2 (1; IC50 = 48.5 
± 39.5, 2; IC50 = 44.8 ± 5.1). These compounds 
were selected for futher hit identification and lead 
optimization via ligand-based VS approaches.
CONCLUSIONS:
Natural products (NPs) or NP derivatives coming 
from Northern Africa showed a great potential 
for the identification of novel scaffolds for sirtuins 
which prompted us to design comprehensive virtual 
screening campaigns to evaluate the potential 
of different publicly available naturally occuring 
compound collections.
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INTRODUCTION:
Drug discovery from marine natural products has 
gained importance in the past few years. Ziconotide, 
a peptide originally discovered in a tropical cone 
snail, was the firstmarine-derived compound to be 
approved in the United States, in December 2004, for 
pain treatment. In October 2007, trabectedin became 
the first marine anticancer drug. Approximately 10–
15 different marine natural products are currently in 
clinical trials, mostly in the areas of cancer, pain or 
inflammatory diseases (1,2). Among the groups of 
marine invertebrates, the sponges (Phylum Porifera) 
are  receiving much attention mainly because 
of  the unique natural compounds characterized 
by a huge variety of biological activities such as; 
antioxidant, antiviral, antibacterial, antifungal, 
antitumor, anticancer, antifouling  activities  which 
acts as potential  natural compounds of interest for 
pharmaceutical applications (3-5).Turkish coastline 
is almost 8400 km long in total. The sponges found 
in the seas  surrounding Turkey have not yet been 
intensively studied. During the course of our studies 
on Turkish marine sponges, we have  identified  4 new 
species and  isolated some  secondary metabolites 
from  marine sponges extracts collected from the 
different costs of Turkey.
MATERIAL AND METHODS:
12 sponges were collected from different locations, 
at depths varying from 10-30 m by scuba diving. The 
sponges were collected and identified by Dr. Bulent 
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Gozcelioglu. Sponge samples were deposited at 
Ankara University, Faculty of Pharmacy, Ankara, 
Turkey.
RESULTS:
We have  identified  4 new  species and  isolated 
some  secondary metabolites from  marine sponges 
extracts collected from the different costs of Turkey
CONCLUSIONS:
Studies on Demospongiae diversity in the Aegean and 
Mediterranean coast of Turkey are scarce. During our 
search for Turkish marine sponges, we have identified 
new species and also isolated  several secondary 
metabolites from five different marine sponges which 
have been collected from the different costs of Turkey
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INTRODUCTION:
Obstructive sleep apnea syndrome (OSAS) is a 
prevalent disease in children, defined by habitual 
snoring associated with prolonged, repeated events 
of partial and/or complete upper airway obstruction, 
hypercapnia and hypoxemia during sleep (1). Rapid 
maxillary expansion (RME) is an efficient orthodontic 
treatment approach for the treatment of OSAS in 
children with maxillary constriction (2, 3). The purpose 
of this study was to investigate the effect of semi-rapid 
maxillary expansion (SRME) orthodontic treatment on 
levels of some biomarkers related with OSAS.
MATERIALS AND METHODS:
Thirty children with OSAS were included in this 
study. Fifteen children were enrolled as control, and 
15 children were subjected to SRME orthodontic 
treatment method for 5 months. The levels of OSAS 
biomarkers in serum and urine were measured.
RESULTS:
Serum kallikrein (KLK)1 levels decreased significantly 
in the treatment group. There was a significant 
increase in serum orosomucoid (ORM)2 levels and 
a decrease in urine perlecan levels in the control 
group after a 5-month follow-up. A significant 
negative correlation between serum ORM2, perlecan, 
gelsolin, and KLK1 levels and intercanin width, as 
well as between serum ORM2 and KLK1 levels and 
intermolar width, was observed.
CONCLUSIONS:
The results of this study indicated that KLK1 and 
ORM2 levels are important biomarkers to evaluate 
in children with OSAS. A further investigation of 
OSAS-related biomarkers and their relationship with 
orthodontic parameters is needed for providing easier 
and reliable modulatory strategies in the treatment of 
OSAS.
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INTRODUCTION:
Targeting multiple signaling pathways for development 
of new drugs seems the best strategy for managing 
cancer. AZD3463 is a potent ALK/IGF-1R inhibitör 
and shows oncogenic activity via activation of PI3-
kinase/AKT pathway or by inhibition of apoptosis 
(1). We aimed to investigate the cytotoxic/apoptotic 
activity of AZD3463 in MCF-7 cell line and underlying 
mechanism regarding the implication of ALK and 
IGF-1/IGF-1R pathways in the development of breast 
cancer (2,3).
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MATERIALS AND METHODS:
In our experiments, MCF-7 is used as an in vitro 
model of human breast cancer cells. MCF-7 cells 
were treated with dose range of 0,39μM to 50μM 
AZD3463 during 24, 48, 72 hours and cytotoxicity was 
evaluated by using WST-1 assay. Using IC50 dose, 
apoptotic effects of AZD3463 were assessed by flow 
cytometric analysis. We investigated the alterations of 
gene expressions with qRT-PCR.
RESULTS:
The IC50 dose of AZD3463 was determined as 
0.765µM for 72nd hour. Results showed that 
IC50 dose of AZD3463 induced apoptosis 2.4 fold 
when compared to control cells that untreated with 
AZD3463. In addition, qRT-PCR results showed 
that the expression of PTEN, an important tumor 
suppressor gene, increased 9,75 fold and ILK, IRS1, 
PIK3R2, MTCP1, HRAS, MAPK3 genes which 
associated with PI3K/AKT pathway  and cancer 
progression  decreased 2.03, 2.02, 3.7, 2.7, 2.02, 
2.43 fold, respectively in MCF-7 cells treated with 
AZD3463 to control cells.
CONCLUSIONS:
These novel findings show that AZD3463 has an 
important role in preventing breast cancer progression 
and could be used as a pioneering target agent in 
breast cancer treatment.
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INTRODUCTION:
Having high mortality rates and increasing prevalence 
malign melanoma is one of the most aggressive 
types of cancer and is responsible for 75 % of skin 
cancer-related deaths. Characterized by melanin 
accumulation, one approach to prevent this process 
is tyrosinase inhibition. Kojic acid, a potent inhibitor 
of tyrosinase, currently features in dermocosmetics 
used against hyperpigmentation. In our previously 
study, chlorination of the 2-hydroxymethyl moiety of 
kojic acid using thionyl chloride at room temperature 
produced chlorokojic acid (2-chloromethyl-5-
hydroxy-4H-pyran-4-one), with the ring hydroxyl 
being unaffected. Mannich base with the structure of 
6-chloromethyl-2-((3,4-dichlorobenzyl)piperazin-1-yl)
methyl-3-hydroxy-4H-pyran-4-one (compound 1) was 
synthesized by the reaction of chlorokojic acid and 
substituted 3,4-dichlorobenzylpiperazine in presence 
of formaline at room temperature. Compound 1 has 
high antibacterial and antiviral activity (2). Especially, 
compound 1 appeared the most active derivative 
against Parainfluenza-3 virus.
In addition, cytotoxic effects of Compound 1 on A375 
human malignant melanoma, HGF-1 human gingival 
fibroblasts and MRC-5 human lung cell lines were 
investigated. The results of cytotoxicity have been 
patented (3). In the presented work we aimed to 
clarify the cell death mechanism at the cellular and 
genomic level.
MATERIALS AND METHODS:
Cultured A375 cells were treated with compound 
1 or vemurafenib, a commercially avalable drug 
used in malign melanoma treatment. SRB assay 
was conducted in order to detect cytotoxicity. 
Cells treated with reagents were subjected to flow 
cytometry analysis. RT-PCR was performed in order 
to determine the gene expression levels of specific 
genes of the apoptotic pathway.
RESULTS:
Apoptotic, necrotic and live cell populations were 
detected following flow cytometry measurement. The 
gene expression levels of apoptotic proteins were 
normalized against housekeeping gene GAPDH.
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CONCLUSIONS:
Compared to Vemurafenib which is a gold standard, 
Compound 1 previously synthesized by our team is a 
promising agent against human malign melanoma, as 
it triggers controlled cell death mechanisms without 
harming healthy cell lines.
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INTRODUCTION:
Conventional dental composites are usually placed in 
2mm increments to reduce ensure proper light curing. 
Nevertheless; the incremental technique extends the 
restoration procedure and increases the risk of air 
bubble formation between layers. These limitations 
led to the development of a new class of composite 
resin type known as “bulk-fill” (1). These materials 
can be properly photo-polymerized even when 
applied in thick layers up to 4–5mm. During the light 
polymerization, not all of the monomers participate in 
the polymer network. Cytotoxicity mechanisms are 
predominantly associated with the short-term release 
of free monomers formed during monomer-polymer 
conversion(2). The aim of this study was to evaluate 
the cytotoxicity of bulk-fill composites, with real-time 
cell vitality.
MATERIALS AND METHODS:
To assess the cytotoxicity of composite materials, L-929 
mouse fibroblast cell line was seeded into the wells of 
E-plate with a concentration of 25000cells/300μl/well. 
Cell proliferation was performed with Real-Time Cell 
Analysis and proliferation was monitored for 48 hours.
RESULTS:
Varying degrees of morphologic alterations were 
observed with the various composites, depending on 
chemical composition. Among the bulk-fill composites, 
VBF caused the majority of cells to become 
small, retracted, and rounded, with condensed 
and fragmented nuclei morphology, other tested 
composites had little effects on the cell morphology 
approximately 70% of cells remained spindle shaped. 
Varying levels of cytotoxic effects were observed 
tested composites. At the end of the 48 hours, SDR 
was significantly more cytotoxic than the other tested 
composites (Figure 1).
CONCLUSIONS:
In the present study, it was demonstrated that there 
was a difference among the tested materials when 
evaluating their cytotoxicity results.
Figure 1: Real-time monitoring of cultured L-929 cells 
adhesion and cell proliferation.
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INTRODUCTION:
Phytoalexins are firstly identified as antimicrobial 
compounds which are produced as secondary 
metabolites by plants against various forms of stress 
(1). Studies have also shown that some phytoalexins 
may have anticancer effects. Among these, 
camalexin (CMX) is a natural phytoalexin and it’s 
been demonstrated to mediate cytotoxicity towards 
aggressive prostate cancer cells (2). Smith et.al. 
(3) have shown that camalexin induced apoptosis 
of prostate cancer cells through an alteration on 
expression and activity of lysosomal protease 
Cathepsin B. The aim of present study is to evaluate 
the effects of camalexin in combination with imatinib 
(IM) on MCF-7 breast cancer cell growth.
MATERIALS AND METHODS:
In order to evaluate the effects of camalexin alone 
and in combination with imatinib on cell growth, MTT 
assay was performed. The cells were treated with 
camalexin alone in a concentration range between 
5-50 μM and in combination studies cells were treated 
with 10 μM camalexin and 3.01 μM imatinib. The 
effects of combination therapy on cell cycle arrest 
were measured by cell analyzer. Apoptosis was 
detected by annexin v binding assay and also by 
fluorescence imaging studies.
RESULTS:
MTT results showed that camalexin significantly 
inhibited the growth of MCF-7 cells at 10 μM and 
higher concentrations (p<0.01). The viable cell amount 
was detected as 77.74±1.61, and 45.89±2.05 for 
treatments of 10uM CMX, and CMX-IM combination, 
respectively. The results of cell cycle assay has 
shown that camalexin induced a cell cycle arrest of 
MCF-7 cells at S phase.
We also observed that the total apoptotic cell 
population was significantly increased in combination 
group, when compared to camalexin and imatinib 
alone (p<0.05).
CONCLUSIONS:
This study has demonstrated that camalexin 
attenuates the anticancer effect of imatinib against 
MCF-7 breast cancer cells. Further studies are 
required to identify the underlying mechanisms of 
effects.
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INTRODUCTION:
Neonicotinoid insecticides, nicotinic acetylcholine 
receptor agonists, have selective toxicity on insects 
through α4p2 nicotinic acetylcholine receptors 
(nAChR). They are used 30% part of insecticide 
marketing in the world. Acetamiprid is one of the 
selective neonicotinoid insecticides, and is used alone 
or combination with other pesticides. Its toxic effects 
and mechanism of action have not been clarified 
on pancreas, although it is known to have toxic 
on several organ systems, including the nervous, 
respiratory and immune systems. It has been reported 
that LD50 value is the range of 140-417 mg/kg b.w. 
in rodents, and NOAEL level is 400 ppm in 13 week 
mice for acetamiprid. There are a few studies about 
its genotoxic effects (1,2)
MATERIALS AND METHODS:
Cytotoxic and genotoxic effects of acetamiprid on 
AR42J pancreas cell line in the present study. For 
cytotoxicity and genotoxicity assays, MTT test and 
comet assay were respectively performed. 1mM, 
2mM, 4mM and 6mM doses were administrated to 
AR42J cell line. For oxidative stress analysis ROS 
detection performed by flowcytometry and levels 
of GSH were determined in the cell homogenates 
according to the method of Beutler.
RESULTS:
LC50 value was 12,61 mM. According to the results 
of comet assay performed in the range of 1-70 mM 
exposure concentration, acetamiprid induced DNA 
damage in groups depending on concentration. The 
mean tail intensity values of groups were 1.83 for 
control 9.83, 16.72, 29.31 and 34.07 for exposure 
groups. GSH was significantly increased in 6mM dose 
group.
CONCLUSIONS:
It is believed that the data obtained contributes to the 
literature due to the lack of research on the potency of 
acetamiprid’s toxic effects on pancreas.
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INTRODUCTION:
The inhibition of adipocyte differentiation have a 
significant role on prevention of obesitiy and obesitiy-
associated complications (1). To date, the inhibitory 
effect of numerous natural substances on adiposit 
differention have been investigated; however, a 
very small number of these substances have been 
reported to be capable of exhibiting a required level of 
inhibition (2). In this study, we aimed to detect whether 
punicalagin, substances found in pomegranate peel, 
are able to inhibit the conversion of pre-adiposits into 
mature adiposits.
MATERIALS AND METHODS:
3T3-L1 adipocyte precursor cells were stimulated 
so as to differentiate into mature adipocyte. 
Punicalagin solutions, with no cytotoxic effect, of 
varying concentrations of 2, 4, 6, 8 ve 10 µM were 
seperately applicated to differentiated 3T3-L1 
cells. In all groups consisiting non-diffrentiated and 
differentianted cells that were applicated various 
concentrations of punicalagin, glyceraldehyde-
3-phosphate dehydrogenase (GPDH) activity, 
Oil red O staining was performed to examine the 
cell morfology, and cellular trigliceride levels was 
measured spectrophotometrically. Furthermore, gene 
expressions of transcription factors (Peroxisome 
proliferator-activated receptor-γ (PPARγ), CCAAT-
enhancer-binding proteins-α (C/EBPα) ve Sterol 
regulatory element-binding protein 1c (SREBP-1c)) 
were examined in order to investigate the effect of 
punicalagin on adipocyte differentiation.
RESULTS:
Although cellular trigliceride levels exhibited dose-
related decrease, a statistical significance was not 
found (p>0.05). As a result of the morphological 
examination, punicalagin application caused 
a continuous decrease in cell size and cellular 
triglyceride accumulation. Despite the fact that 
GPDH activity decreased in all groups that were 
applicated punicalagin, this decrease was found 
to be statistically significant in groups that were 
applicated punicalagin at a concentration of 4-10 µM 
(p<0.05). The application of punicalagin at different 
concentrations showed a dose dependent lowering 
effect on expression of all three transcription genes. 
However, this decrease was found to be significant in 
groups that were applicated 6-10 µM punicalagin for 
PPARγ, 6-10 µM punicalagin for C/EBPα and 10 µM 
punicalagin for SREBP-1c (p<0.05).
CONCLUSIONS:
In line with these findings, it can be concluded 
that punicalagin was able to inhibit the adipocyte 
differentiation.
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INTRODUCTION:
Silymarin (SLY) is a flavonolignan from the seeds 
of the milk thistle Silybum marinum L. (Asteraceae) 
and widely used as a hepatoprotective agent in 
the treatment of various liver disorders such as 
hepatitis, cirrhosis and fatty acid infiltration due to 
toxic chemicals and alcohol (1). Vancomycin (VCM) 
is a glycopeptide antibiotic and has an antibacterial 
action towards anaerobic and aerobic gram-positive 
bacteria (2). The present study aimed to evaluate 
histopathological effects of SLY in the liver tissues of 
VCM-administered rats.
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MATERIALS AND METHODS:
Adult male Wistar albino rats were divided into 
seven groups; (i) Control group: saline was injected 
intraperitoneally (i.p.) at a dose of 0.5 ml/day, (ii) 
DMSO group: DMSO was injected at a dose 0.5 ml/
day (i.p.), (iii) VCM group: VCM was injected i.p. at a 
dose of 400 mg/kg, (iv) SLY group: SLY dissolved in 
DMSO was injected intraperitoneally at a dose of 100 
mg/kg, (v) VCM+SLY50 group: VCM and SLY was 
injected at a dose of 50 mg/kg i.p., (vi) VCM+SLY100: 
VCM and SLY was injected at a dose of 100 mg/kg 
i.p., (vii) VCM+SLY200 group: VCM and SLY was 
injected at a dose of 200 mg/kg i.p. The experiment 
was performed throughout 7 days for VCM group 
and 8 days for other groups. On 9th day, liver tissues 
were taken from tested animals under anesthesia. For 
light microscopic evaluation the tissues were fixed 
in formalin and processed by conventional method. 
They were stained with hematoxylin and eosin (H&E). 
For the histopathological examinations, sinusoidal 
dilatation, vacuolization, nuclear pleomorphism, 
necrosis, inflammation, picnosis and capsule 
thickening were evaluated and scored. Grading was 
applied as follows: (–) no meaningful histopathological 
damage; (+) mild degree of damage; (++) moderate 
degree of damage and (+++) severe degree of 
damage. Approval for the study was obtained from 
the Animal Experiments Local Ethics Committee in 
Mersin University.
RESULTS:
Histopathological changes were not detected in saline, 
DMSO and SLY100 groups. Besides, sinusoidal 
dilatation, vacuolization, nuclear pleomorphism were 
not observed at the corresponding groups. However, 
necrosis, inflammation, picnosis, capsule thickening 
were prominently observed in the liver tissues of rats 
treated with VCM. These alterations were significantly 
diminished in VCM+SLY50, VCM+SLY100, and 
VCM+SLY200 groups compared to VCM group.
CONCLUSIONS:
VCM administration cause some histopathologic 
changes in the liver tissues. The histopathological 
alterations can attenuate by administration of SLY.
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OP-134: INDOLE-DERIVED 
SPIROTHIAZOLIDINONES AS INHIBITORS 
OF INFLUENZA VIRUS FUSION
Cihan Ustundag, G.
Istanbul University, Faculty of Pharmacy, Department 
of Pharmaceutical Chemistry, İstanbul, Turkey
INTRODUCTION:
Seasonal influenza is a serious public health problem 
caused by influenza viruses which circulate in all 
parts of the world. To face the emerging resistance 
to presently available drugs, new anti-influenza 
drugs, preferably with different mechanisms of action, 
are needed (1). Targeting viral entry is an attractive 
antiviral strategy as it offers the advantage to combat 
viral pathogens at the very early steps of infection (2). 
Various compounds possessing spirothiazolidinone 
moiety have been reported as hemagglutinin-
mediated fusion inhibitors during the past years 
(3,4). On this basis, we have designed a series of 
compounds by the introduction of an indole ring into 
the spirothiazolidinone scaffold.
MATERIALS AND METHODS:
Indole-spirothiazolidinones were synthesized in five 
steps starting from aniline derivatives. The structures 
of obtained compounds were established by using 
spectroscopic and microanalytical data. Anti-influenza 
activity was evaluated in MDCK cells infected with 
influenza A and B viruses. The mechanism of action 
was elucidated by performing HA-mediated fusion 
(syncytium formation) assay.
RESULTS:
Some of the compounds exhibited significant and 
selective inhibitory effect on the replication of 
Influenza A/H3N2 virus at nanomolar concentrations. 
The inhibitory effect of the lead compound on 
syncytium formation indicated that compounds block 
hemagglutinin mediated membrane fusion. 
CONCLUSIONS:
The promising anti-influenza A virus activity of indole-
based spirothiazolidinone derivatives makes them 
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OP-135: VOLTAMMETRIC DETERMINATION 
OF AN ANTIGUNGAL DRUG FROM 
PHARMACEUTICAL DOSAGE FORMS 
USING MODIFIED GLASSY CARBON 
ELECTRODES
Ozturk, G., Kul, D.
Karadeniz Technical University, Faculty of Pharmacy, 
Department of Analytical Chemistry, Trabzon, Turkey
INTRODUCTION:
Fungal infections which affects skin, hair, and nails 
are treated using antifungal medicines. Antifungal 
medicines can be found as topical, oral, intravenous, 
and intravaginal (1). Oral antifungals used commonly 
are fluconazole, itraconazole, ketoconazole, and 
terbinafine. The aim of this study to develop a 
sensitive determination method for terbinafine (TER) 
using voltammetry at polymer modified electrodes.
MATERIALS AND METHODS:
All experiments were achieved using a three-electrode 
electrochemical cell containing a glassy carbon 
(GC) working electrode, a platinum wire as counter 
electrode, and an Ag/AgCl electrode as reference. 
Polymer film modification was achieved using the 
procedure in the literature (2). All measurements were 
performed using an Autolab Pgstat128n potentiostat/
galvanostat with Nova 1.10 software (Metrohm). 
Stock solution of TER (1x10-3 M) was prepared in 
deionized water. Phosphate (PB), Britton Robinson 
(BRB), and acetate (AcB) buffer solutions at different 
pH values were used.
RESULTS:
Electrochemical properties of TER were investigated 
on the anodic direction using cyclic (CV), differential 
pulse (DPV), and square wave (SWV) voltammetry 
methods, after the polymer film modification of GC 
electrode. The effect of pH on the redox process 
of TER was studied by CV. A well-defined anodic 
peak with the highest peak current was obtained in 
pH 3.5 AcB, thus, this buffer was selected for the 
further studies. Scan rate study with CV showed a 
diffusion controlled process under adsorption effect. 
The linearity range of the calibration graphs were 
determined as 0.04 - 20 μM (r = 0.997) for DPV with 
a detection limit of 0.008 μM. Finally, quantitative 
analysis of TER from its pharmaceutical dosage form 
was performed without any separation and filtration 
without the effect of the excipients.
CONCLUSIONS:
GC electrode was modified with polymer film and 
used for the determination of TER. Consequently, 
effective and economical modified electrode with 
high sensitivity and selectivity was obtained for the 
electrochemical analysis of TER.
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OP-136: THE EFFECTS OF IL-6 ON MMP-
2 MRNA EXPRESSION IN MCF-7 BREAST 
ADENOCARCINOMA CELLS
Celik, A., Bakar Ates, F.
Ankara University, Faculty of Pharmacy, Department 
of Biochemistry, Ankara, Turkey
INTRODUCTION:
Cytokines are intracellular signalling molecules and 
they regulate the homeostasis of the immun system 
(1). Recently, the studies have been focused on 
the treatment of cancer by cytokines. Among these, 
interleukin-6 (IL-6) is identifed as a pleiotrophic 
cytokine and studies have shown many cellular 
functions of IL-6 in immune, hepatic, hematopoietic 
and neural cells (2). The studies have shown that IL6 
expression has reduced in invasive breast tumors and 
inversely associated with histological tumor grade 
(3,4). There is little information about the role of IL-6 in 
breast cancer, so it’s been suggested that IL-6 might 
be involved in regulating the growth of breast cancer 
cells. At present study we aimed to evaluate the effect 
of IL-6 on cell growth, apoptosis and MMP-2/-9 mRNA 
expression in MCF-7 breast carcinoma cells.
MATERIALS AND METHODS:
MCF-7 cells were treated with IL-6 in a concentration 
range between 10 – 100 nM and the cell growth were 
determined by MTT assay following a 24 hour of 
treatment. Apoptotic cell population was measured by 
annexin V binding assay and the mRNA expression 
levels of treated concentrations were performed by 
real-time PCR experiments.
RESULTS:
Our results showed a significant decrease in cell 
growth at 25, 50 and 100 nM IL-6 doses. The viable 
cell population was 85.111.86% in 25 nM treated 
group (p=0.005), whereas it has decreased to 
70.044.85% at 100 nM treated group (p<0.0001). 
The results also showed that IL-6 has inducible 
efffect on apoptosis of MCF-7 cells. Real-time PCR 
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experiments have showed that IL6 has decreased 
MMP-9 mRNA expression at 100 nM concentration, 
whereas no significant decrease has been observed 
in MMP-2 expression.
CONCLUSIONS:
The present study has demonstrated that IL-6 has 
significant effects on cell growth and apoptosis of 
MCF-7 breast cancer cells. The inhibitory effect of IL-6 
at MMP-9 expression suggests that IL-6 may prevent 
the metastasis of MCF-7 cells. Further studies are 
required to identify the underlying effects of IL-6 in 
cancer cells.
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OP-137: EVALUATION OF TERATOGENIC 
EFFECTS OF CALCITRIOL TREATMENT IN 
PREGNANT WOMEN
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INTRODUCTION:
Calcitriol or 1,25-dihydroxycholecalciferol (abbreviated 
1,25-(OH)2-D3) is the active form of vitamin D3. 
Calcitriol is used to treat hyperparathyroidism and 
hypocalcemia in people who have chronic kidney 
failure. It is also used to treat calcium deficiency 
in people with hypoparathyroidism. In terms of 
teratogenicity of calcitriol, some animal studies 
showed external and skeletal abnormalities. High 
doses (about 6 times the maximum human dose) is 
reported to show maternal mortality, decreased fetal 
weight, reduced newborn survival and hypercalcemia 
in the offspring. Hypercalcemia during pregnancy 
has been associated with suppression of parathyroid 
hormone in the neonate. This situation can lead to 
mental retardation and congenital aortic stenosis 
(1). There are no adequate controlled data on the 
use of calcitriol in pregnant women. In this study, we 
evaluated the outcomes of pregnant women used 
calcitriol.
MATERIALS AND METHODS:
22 pregnant women who were referred to Teratology 
Information Service (TIS) of Karadeniz Technical 
University, between 1999 and 2017 because of 
exposure to fetal calcitriol were evaluated. The age 
range of pregnant women was 22-40 years.  Patient 
specific risk assessment and counseling were 
done. Data about the delivery information and fetal 
malformation were collected from hospital records 
and infants were followed up.
RESULTS:
Four cases lost follow-up were excluded. There were 
13 healthy infants, 2 spontaneous abortus and 1 
elective terminations among 18 pregnancies. One of 
healthy babies was premature. Elective termination 
was occurred at the 9th weeks of pregnancy because 
of the choice of family. One baby had hyperthyroidism. 
Unilateral renal agenesis was found in one case in 
terms of major malformations. Maternal characteristics 
of women who used calcitriol during pregnancy and 
outcomes excluding healthy and inaccessible cases 
are shown in Table 1.
Table 1. Maternal characteristics of women used 
calcitriol during pregnancy and outcomes excluding 
healthy and inaccessible cases
Age Periods 
(weeks)
Additional  drugs Other risk 
factors
Risks Results







34 3-4 Allopurinol, ferrous 
sulphate, amlodipine
- High Spontaneous 
abortus  
(at 8th weeks of 
gestation)
32 0-6 Telmisartan - High Spontaneous 
abortus 
(at 10th weeks of 
gestation)






(at 9th weeks of 
gestation)
34 0-6 Alendronate 
sodium, acemetacin, 
vitamin D, calcium 
carbonate+calcium 
lactate gluconate
- High Unilateral renal 
agenesis
CONCLUSIONS:
The outcome of exposure to calcitriol in the first 
trimester of pregnancy in our case series resulted with 
an anomaly (renal agenesis). However, it is difficult 
to attribute these anomaly to calcitriol because of 
the limited numbers of cases. Further studies are 
clearly needed to confirm the safety of calcitriol in the 
pregnancy.
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OP-138: SYNTHESIS AND DETERMINATION 
OF POTENTIAL BIOLOGICALLY 
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INTRODUCTION:
The hydrazide-hydrazone derivatives are noted for 
their ability for ring closure and suitable for substitution 
(1,2).The compounds obtained are known to exhibit 
activities such as antituberculer, antimicrobacterial, 
antitumoral, anticancer (3,4). In this work, the synthesis 
of biologically active hydrazide-hydrazone derivatives 




4,4’-bis(substituted)benzoin derivative compounds 
1a,b were obtained by the reaction of potassium 
cyanide with p-substituted benzaldehyde (5) and 
4,4’-bis (substituted)benzyl derivative compounds 
2a,b were obtained by reaction of compounds 1a,b 
with concentrated nitric acid (6). 2,2-bis(substituted 
phenyl)-2-hydroxyacetic acid derivative compounds 
3a,b were obtained by the reaction of compounds 
2a,b in a potassium hydroxide medium. Methyl 
2,2-bis(substituted phenyl)-2-hydroxyacetate 
derivative compounds 4a,b have been obtained 
according to the Fischer esterification reaction (7). 
Reaction of the compounds 4a,b with hydrazine 
hydrate gave the resulting hydrazide derivative 
compound 5a,b and its reaction with the appropriate 
substituted benzenaldehyde derivatives gave the 
resultant compounds 6a-e (3,4 (Scheme 1). This 


















































Scheme 1. Synthesis of new biologically active 
hydrazone derivatives
RESULTS:
Structures of synthesized 5 new compounds were 
identified by spectroscopic methods such as IR, 
1H-NMR, 13C-NMR and mass.
CONCLUSIONS:
The acetylcholinesterase enzyme inhibition and 
anticancer activities of the compounds have begun to 
be studied.
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OP-139: SYNTHESIS, ANTIMICROBIAL 
ACTIVITY AND ELECTROCHEMICAL 






1 Celik, H., 1 Eroglu, A., 2 Baymak, MS., 3 Cetin, G., 3 
Simsek, R., 3 Safak, C.
1Yeditepe University, Department of Analytical 
Chemistry, Istanbul, Turkey
2Marmara University, Department of Chemistry, 
Istanbul, Turkey
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INTRODUCTION:
1,4-Dihydropyridine (1,4-DHP) derivatives are 
classified as calcium channel modulators and 
have vasodilator, antihypertensive, bronchodilator, 
antiatherosclerotic, antitumor, antimutagenic, 
hepatoprotective, geroprotective, antidiabetic, 
antiinflammatory, antiallergic, neurotropic, 
antibacterial, antimicrobial, antioxidant and analgesic 
activities (1,2). Studies on the antibacterial and 
antifungal activity of the compounds obtained by 
condensing dialdehydes with various ring systems 
containing nitrogen atoms are continuing (3). In view of 
the mentioned findings, we have some effort to identify 
new molecules that may be valuable in designing new, 
active and less toxic antimicrobial agents. In this study 
we have used dialdehyde compounds to synthesize 
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new condensed 1,4-DHP derivatives. The structure 
of the compounds was proven with instrumental 
techniques. The antibacterial and antifungal activities 
of the synthesized compounds were realized. 
Electrochemical behaviour of the compounds was 
determined and correlated with biological activity.
MATERIALS AND METHODS:
In this study, the electrochemical behavior of studied 
compounds have been investigated by using cyclic 
voltammetry and polarography. Simple buffer systems 
were used with pH values between 1 and 12 and the 
chemicals used to prepare these buffer solutions 
were of analytical grade.
RESULTS:
In this study, 5 new alkyl 4-(4-(3-methoxycarbonyl)-
2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-
4-yl)phenyl)-6,6-dimethyl-5-oxo-1,4,5,6,7,8-
hexahydro quinoline-2-carboxylate derivatives 
(RGs) synthesized via a modified Hantzsch reaction. 
The structure of the compounds were elucidated 
by using spectral methods. The synthesized 
compounds were subjected to in vitro antibacterial 
and antifungal studies. In the electrochemical part, 
oxidation mechanism was elucidated by using cyclic 
voltammetry (see Figure) with a glassy carbon 
electrode in aqueous buffer solution pH between 1 
and 12. It was observed that peak potentials were 
function of acidity of the solution. Electrooxidation 
mechanism is suggested based on experimental 
data. Further studies on electrochemical reduction 
mechanism are currently under investigation.
CONCLUSION:
Electrochemical behavior of above mentioned 
compounds has been elucidated by using cyclic 
voltammetry and DC polarography.
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OP-140: PHENOTHIAZINE-STRUCTURED 
COMPOUNDS HAVE DIFFERENT EFFECTS 
ON SECRETASES WITH THERAPEUTIC 
POTENTIAL IN ALZHEIMER’S DISEASE
Yuksel M., Tacal O.
1 Hacettepe University, Department of Biochemistry, 
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INTRODUCTION:
According to the amyloid hypothesis, the accumulation 
of the amyloid-β (Aβ) peptides in protein aggregates 
causes various pathological changes, ultimately 
leading to neurodegeneration and dementia. The 
formation of Aβ peptides is a consequence of the 
processing of amyloid precursor protein (APP) via the 
amyloidogenic pathway, in which APP is successively 
cleaved by β- and γ-secretases while α-secretase 
is responsible for the formation of sAPPα and C83 
fragment through the non-amyloidogenic pathway (1). 
These major secretases involved in the processing 
of APP are the enzymes with therapeutic potentials 
in Alzheimer’s disease (AD) (2). Our earlier studies 
showed that two phenothiazine compounds with 
potent anti-cholinesterase activities (3), toluidine 
blue O (TBO) and thionine (TH), ameliorate amyloid 
metabolism by decreasing Aβ levels secreted by 
PS70 cells in a dose-dependent manner (4). In the 
present study, we tested whether TBO and TH show 
these mitigating effects by targeting the secretases 
involved in APP processing.
MATERIALS AND METHODS:
We treated Chinese hamster ovary cells 
overexpressing human wild type APP751 and 
PSEN1, namely PS70 cells, with 0-15 µM TBO or TH 
for 6-24 hours. After treatment, the levels of PSEN1 
(γ-secretase) and ADAM10 (α-secretase) were 
analyzed in PS70 cell lysates by Western blot.
RESULTS:
Our results showed that both TBO and TH reduced 
the levels of PSEN1 in a dose-dependent manner 
significantly. On the other hand, the compounds had 
reverse effects on the levels of ADAM10. While 15 
µM TBO decreased the levels of ADAM10 by 33% (*, 
p<.05), 15 µM TH caused almost 90% increase (***, 
p<.001) when compared to control.
CONCLUSIONS:
Overall, these preliminary results suggest that TBO 
and TH may be AD therapeutic candidates targeting 
secretases as well as the cholinergic system.
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OP-141: MOLECULAR MODELLING OF 
THE ANTICONVULSANT ACTIVITY OF 
1-PHENYL/1-(4-CHLOROPHENYL)-2-(1H-
1,2,4-TRIAZOL-1-YL)ETHANOL ESTERS
1 Sari, S., 2 Dogan, IS., 3 Ozdemir, Z., 3 Bozbey, İ., 3 
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1 Hacettepe University, Department of 
Pharmaceutical Chemistry, Ankara, Turkey
2 Karadeniz Technical University, Department of 
Pharmaceutical Chemistry, Trabzon, Turkey
3 Inonu University, Department of Pharmaceutical 
Chemistry, Malatya, Turkey
INTRODUCTION:
(Arylalkyl)azoles are a class of antiepileptic 
compounds known for nafimidone, denzimol, and 
loreclezole (1). Potent anticonvulsant activity of some 
1-phenyl/1-(4-chlorophenyl)-2-(1H-triazol-1-yl)ethanol 
esters was previously determined (2). In this study 
we modelled their ADMET properties and possible 
anticonvulsant mechanisms.
MATERIALS AND METHODS:
The compounds were modelled and minimized 
using MacroModel (Schrödinger, LLC, NY, 2018), 
PRCG method, and OPLS_2005 force field.  Their 
physicochemical and pharmacokinetic properties were 
calculated using QikProp. The GABAAR homology 
model obtained from the study of Bergmann et al. (3) 
was prepared for docking by the Protein Preparation 
Wizard of Maestro (Schrödinger, LLC, NY, 2018) 
where the ionization states and proton orientations 
were set. Ligands were docked to the benzodiazepine 
(BZD) binding site by Glide at extra precision mode 
(4).
RESULTS:
QikProp results show that the active compounds 
are drug like and have favorable pharmacokinetics. 
Docking simulations predicted high affinity binding 
to the BZD binding site of the GABAAR model with 




1-yl)ethanol esters were identified as promising 
anticonvulsant compounds with predictably good 
ADMET properties. Their anticonvulsant action might 
be the result of BZD-type activation of GABAAR.
ACKNOWLEDGEMENTS:
This study was supported by a grant of TUBITAK 
(SBAG 114S862).
REFERENCES:
1.  Dalkara S, Karakurt A (2012). Current Topics in 
Medicinal Chemistry, 12:1033-1071.
2.  Doğan İS et al., International Multidisciplinary 
Symposium on Drug Research and Development, 
5-7 October 2017, Erzurum, Turkey.
3.  Bergmann R, et al., (2013). PLoS One, 8(1): 
e52323.
4.  Friesner RA, et al., (2006). Journal of Medicinal 
Chemistry, 49:6177–6196.
OP-142: A HIGHLY SENSITIVE 
ELECTROCHEMICAL NANOBIOSENSOR 
FOR THE ANALYSIS OF PRANGOS 
MELIOCARPOIDES AND DNA INTERACTION
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INTRODUCTION:
 Prangos meliocarpoides boiss. Var. Meliocarpoides 
belong to Appiaceae is an endemic plant taxa which 
has been used as food and medicine in eastern 
Anatolia. The extract obtain from this plant has 
pronounced capacity of oxygen radical suppression. 
The effect of the extract on the oxygen radicals are 
still being investigated in continuing studies. The 
subject of “nanoparticle (NP) modified electrodes” with 
their excellent features of such as enhanced surface 
area, good conductivity and biocompatibility have still 
been under investigation (1-3). NPs not only provide 
a suitable environment for biomaterial modification, 
but also improve the detection limit of biosensors. 
In this study, the metal NPs modified biosensor was 
developed for the detection of the plant extract-DNA 
interaction based on guanine/adenine signal. There 
is no report about Prangos meliocarpoides and DNA 
interaction by using metal NP immobilized pencil 
graphite electrode (PGE) in the literature.
MATERIALS AND METHODS:
NPs modification was tested with cyclic voltammetry 
by PGE. The change in the oxidation signal of guanine 
(+1.0 V) or the extract (+0.36V) were measured 
by using differential pulse voltammetry (DPV) via 
AUTOLAB 12 potatiostat/galvanostat device.
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RESULTS:
The interaction type of the extract with DNA was 
studied with bare or nanomaterial modified PGE 
and some optimum detection parameters were 
determined. The nanoparticle modification was found 
to increase the electrode conductivity and DNA 
binding capacity by nearly 3-fold.
CONCLUSIONS:
Newly-developed biosensor could be used for the 
rapid, cost effective and highly sensitive detection 
of plant extract–DNA interaction as a powerful 
alternative method for investigating the effects of 
medicinal plants on DNA.
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OP-143: ANTICANCER AND ANTI-
INFLAMMATORY ACTIVITIES OF EDIBLE 
MUSHROOM HYDNUM REPANDUM
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INTRODUCTION:
Mushrooms are one of the most important food 
sources for humanity, with a large number of edible 
species with different nutritional values and they also 
naturally contains a wide range of biologically active 
compounds. Nowadays there is a growing interest in 
the therapeutic use of bioactive metabolites derived 
from natural products. These bioactive components are 
defined as natural sources of antioxidant, antitumor, 
antiviral, antimicrobial and immunomodulatory 
agents. In this study, we investigated the ethanolic 
extract of an edible mushroom Hydnum repandum to 
find a new bioactive agent with anti-inflammatory and 
anticancer activities.
MATERIALS AND METHODS:
The mushroom material was obtained from the 
bazaar of the Black Sea region and analyzed for 
the flavonoids and phenolic compound content. The 
antioxidant capacity of the extract was determined by 
DPPH method. Its effect on aldose reductase activity 
was examined by the kinetic assay. Furthermore, 
extract-induced cell growth inhibition was performed 
in two different human cell lines (colorectal and 
breast) using the MTT assay.
RESULTS:
Total phenolic and flavonoid content of the ethanolic 
extract of H. repandum was determined as 3.30 ± 
0.0016 mg GAE/g and 2.547± 0.0016 QE/g values, 
respectively. DPPH radical scavenging capacity was 
determined as 35% and aldose reductase enzyme 
activity was effectively inhibited as 45%. Also, H. 
repandum extract induced the cell growth inhibition of 
HT-29 cells as 16% and MCF-7 cells as 30% at the 
500 µg/mL final concentration.
CONCLUSIONS:
Aldose reductase plays important role in the cellular 
oxidative defense. In addition, some studies show 
that inhibition of Aldose reductase can prevent colon 
cancer (1). Therefore, new therapeutic methods for 
the colon cancer can be developed by investigating 
the ability of H. repandum to inhibit aldose reductase.
ACKNOWLEDGEMENTS:
This study was supported by a grant of TUBITAK 
(116Z125)
REFERENCES:
1.  Tammali R, Srivastava SK, Ramana KV (2011). 
Curr Cancer Drug Targets, 11:560-71.
OP-144: A NOVEL OXIDATIVE 
PRETREATED PENCIL GRAPHITE BASED 
PARACETAMOL SENSOR: PREPARATION, 
CHARACTERIZATON AND APPLICATION TO 
TABLET ANALYSIS
Keskin, E., Erturk, AS
Adiyaman University, Department of Analytical 
Chemistry, Faculty of Pharmacy, Adiyaman, Turkey
INTRODUCTION:
Analytical assay and quality control of paracetamol 
(PAR), N-acetyl-p-aminophenol or acetaminophen, 
are of great importance as its one of the most frequently 
used analgesics and antipyretics (1). Overdose of 
PAR can cause serious harms in liver and kidney (2). 
Therefore, there has been a growing interest towards 
developing simple, rapid, sensitive and selective 
methods for the detection and quantification of PAR in 
biological samples and pharmaceuticals (3).
MATERIALS AND METHODS:
Surface morphology of the OP-PGE was characterized 
by scanning electron microscopy (SEM) and 
attenuated total reflectance Fourier-transform infrared 
spectroscopy (ATR-FTIR). Electrochemical behavior 
of PAR on the OP-PGE was investigated with cyclic 
voltammetry (CV) and electrochemical impedance 
spectroscopy (EIS). Measurements were performed 
by adsorptive stripping voltammetry (AdSWV).
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RESULTS:
Under optimized experimental conditions, the linear 
dynamic range of calibration was between 0.052-2.85 
µM with a detection limit of 18.4 nM (S/N=3). The 
OP-PGE showed a good sensitivity, selectivity, and 
stability compared to the bare PGE. The developed 
oxidative pretreated PGE (OP-PGE) sensor was used 
for the first time to determine PAR from pure and 
commercial tablet dosage forms.
CONCLUSIONS:
Results revealed that the OP-PGE could successfully 
determine PAR from the tablets with no tedious 
electrode fabrication and sample pretreatment 
methods, and in situ oxidative pretreatment could be 
an alternative, simple and sensitive approach for the 
fabrication of PGE based electrodes to use them in 
the pharmaceutical analysis in the future studies.
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INTRODUCTION:
Reprogramming of somatic cells requires a complex 
mechanism in which chromatin environment alters by 
epigenetic remodelling and reactivating pluripotency 
genes (1, 2). Yamanaka factors, Klf4, c-Myc, Oct4 
and Sox2, induce pluripotency in differentiated cells 
to generate induced pluripotent cells (iPSCs) (2). 
However, previous studies showed that epigenetic 
inheretance of iPSCs is a limiting factor to establish 
pluripotency (3). Reprogramming of differentiated 
cells by using Axolotl oocyte extract (AOE) can 
reactivate the Nanog gene in mammalian cells, ‘the 
gateway to the pluripotent ground state’ (4, 5). In 
this study, we aimed to accelerate the efficiency of 
Yamanaka factors by using the capacity of Axolotl 
oocytes to remodel epigenetic pattern of somatic 
chromatin by providing AxNanog, an ortholog of 
mammalian Nanog.
MATERIALS AND METHODS:
Inducible NIH3T3 cell line expressing Oct4 and Sox2 
was generated and treated with AOE for 6 hours. ChIP 
was carried out using Oct4 antibody and Oct4-bound 
immunoprecipitated DNA was analysed by qPCR for 
the regulatory regions of the mouse Nanog gene.
RESULTS:
We first showed that AOE is capable of remodelling 
the epigenetic environment in the mammalian 
chromatin. Then, we demonstrated that endogenous 
Oct4/Sox2 expression procure around 2 fold increase 
on the Oct4 binding on the mouse Nanog promoter 
and enhancer while AOE can enhance this binding 
to about 14 fold. This suggests that the factors 
AOE contains prepare the epigenetic profile of the 
somatic chromatin and make the regulatory regions of 
pluripotency genes more accessible to Oct4.
CONCLUSIONS:
This study clarifies that the efficiency of iPSCs can 
be enhanced by reducing the effects of epigenetic 
memory in somatic chromatin by using Axolotl oocytes, 
which provides AxNanog. Further experiments are 
still required to use this synergy between iPSCs and 
Axolotl oocyte in therapeutics.
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OP-146: ELECTROCHEMICAL 
CHARACTERIZATION OF VARIOUS BY 
SUBSTITUTED PERYLENE DIIMIDE 
LIGANDS AND THEIR PLATINUM(II) AND 
PALLADIUM(II)-2,2′:6′,2″-TERPYRIDYL 
COMPLEX IONS
1 Orman, EB., 2 Buyukeksi, SI., 2 Sengül, A., 1 
Ozkaya, AR.
1Marmara University, Department of Chemistry, 
Istanbul, Turkey
2Bülent Ecevit University, Department of Chemistry, 
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INTRODUCTION:
Macrocyclic compounds involving conjugated 
p-electron sytems usually display reversible electron 
transfer processes at modest potentials and thus, 
good chromophore, electron acceptor/donor and 
conducting properties. Due to their mentioned 
properties, these compounds have potential for 
usage in various electrochemical systems, for 
instance in electrochromic devices (1, 2). In this 
study, electrochemical, spectroelectrochemical and 
electrochromic characterization of various bay-
substituted perylene diimide (PDI) ligands and their 
platinum(II) and palladium(II)-2,2′:6′,2″-terpyridyl 
complexes have been performed in solution medium. 
In addition, electrochromic measurements for the cast 
films of a group of PDI compounds on indium tin oxide 
(ITO) were performed.
MATERIALS AND METHODS:
Cyclic voltammetry (CV), square wave voltammetry 
(SWV), in-situ spectroelectrochemical (SEC) and 
spectrochronoamperometric (SCA) measurements 
were carried out both in solution and in the film 
environment.
RESULTS:
It is clear from the electrochemical redox potentials of 
PDI compounds that these compounds are reduced 
easily and thus, can be used as electron acceptors in 
the construction of new optoelectronic devices.
CONCLUSIONS:
The compounds displayed enriched redox properties 
with low HOMO-LUMO band gaps. Also, the cast 
film of the platinum complex of pyridine substituted 
perylene diimide ligand on ITO glass illustrated a 
distinct color transition between blue and turquoise.
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Fig.1 Cyclic waves and in-situ spectral changes of 
PDI
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INTRODUCTION:
Platelet activation is essential for hemostasis, 
however uncontrolled and excessive platelet 
activation and aggregation are harmful for the health 
(1). Therefore, new drugs without bleeding risk and 
preventing undesired plug formation are needed.
MATERIALS AND METHODS:
Marketed drugs, aiming to drug repurposing, and 
Molport compounds, a library of in stock and ready 
to order chemical compounds, were used to discover 
novel Glycoprotein VI (GPVI) receptor inhibitors. 
After physicochemical filters, lead compounds were 
chosen to test their in vitro antiplatelet activities. 
Platelet aggregation was measured by using an 
aggregometer according to the turbidimetric method 
described by Born et. al. (2). In vitro aggregation 
studies were performed with collagen, thrombin and 
arachidonic acid as inducers in washed platelets.
RESULTS:
16 Molport compounds and 8 marketed drugs, 
chosen by an e-pharmacophore model which is 
designed from GPVI receptor antagonists, were 
tested in vitro. Moreover, the molecules’ docking 
scores, structural interactions and positions of binding 
to GPVI were taken into consideration while choosing 
the compounds. All compounds tested both at 1 mM 
and 100 µM against various platelet agonists. Molport 
compounds at 100 µM significantly showed inhibitor 
activities on platalet aggregation induced with 
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collagen (Z16043060; 88.17±1.78, AE641/05538014; 
79.69±2.78, STK763609; 76.12±2.43), whereas 
they did not show any significant inhibition at 100 
µM against thrombin induced platelet aggregation 
(Z16043060; 0.51±0.89, AE641/05538014; 0.00±0.00, 
STK763609; 6.79±2.05).
CONCLUSIONS:
Results imply that some tested compounds may 
have inhibitory activity against to GPVI. Our studies 
in which convulxin is used as GPVI-selective agonist 
have been going on to be able to find whether the 
active compounds specific to GPVI receptor.
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INTRODUCTION:
Statins are primarily the most therapeutically effective 
drugs which reduce LDL cholesterol and triglyceride 
levels in the bloodstream of patients at risk of 
cardiovascular disease. Statins can lower cholesterol 
by 20 to 60%. Their water solubility depends to their 
chemical structures which affect their metabolism, 
distribution, absorption and excretion. Most drugs 
have ionization sites that can be protonated or 
deprotonated at different pH values. Hence, the 
pharmacodynamics and pharmacokinetic properties 
of drugs can be very important. The acidity constant 
value may be helpful in predicting the behavior of 
a drug under in vivo conditions. Various analytical 
methods have been used for the determination of 
acidity constants such as spectrometry, potentiometry 
and chromatography. Up to date, there is no publish 
study about determination of acidity constants for 
rosuvastatine by electrochemical methods. These 
methods have excellent features such as rapid, 
precise, cheap and do not require pretreatments. 
In this study, voltammetry and electrochemical 
impedance spectroscopy methods have been 
applied to investigation of acidity constants and 
thermodynamic parameters of statins in aqueous 
mediums.
MATERIALS AND METHODS:
Electrochemical experiments were performed by 
cyclic voltammetry and electrochemical impedance 
spectroscopy. Current-voltage curves were recorded 
by using Palmsens 5.2. Pyrolytic graphite electrode 
(BASi; ø: 3 mm, diameter) was used as working 
electrode, platinium as counter and Ag/AgCl (BASi; 3 
M KCl) used as reference electrode. pH effect study 
was applied between pH 2.0-11.0 Britton-Robinson 
buffers (0.04 M). Rosuvastatine stock solution (1×10-
3 M) was prepared with methanol. In measurement 
solution, it was fixed to 10% ratio. 0.01 M sodium 
dodecylsulphate solution (1 mL) was added to 
measurement solution.
RESULTS:
Dissociation constant of the basic drug rosuvastatine 
was found by using cyclic voltammetry and 
electrochemical impedance spectroscopy. pKa value 
of rosuvastatine calcium was obtained as 3.8 and 3.9 
by CV and EIS methods, respectively. The obtained 
pKa value is in close agreement with reported in the 
literature. ∆G, ∆H and ∆S parameters were calculated.
CONCLUSIONS:
This work shows that electrochemical methods are 
reliable and simple for pKa detection of drugs.
OP-149: ANALYSIS OF POSITIVE EFFECTS 
OF TWO LACTOBACILLUS STRAIN IN MICE 
FED HIGH FAT DIET
1 Ivanović, N., 1 Đorđević, B., 2 Minić, R., 3 
Michaličková, D.
1 Faculty of Pharmacy, Department of Bromatology, 
Belgrade, Serbia
2 Institut of virology, vaccines and sera “Torlak”, 
Belgrade, Serbia
3 First Faculty of Medicine, Department of 
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INTRODUCTION:
Modern lifestyle has been responsible for the 
increased incidence of obesity and obesity-induced 
comorbidities in modern age (1). High fat diet 
induces similar changes in mice. These changes 
can be ameliorated by the administration of some 
Lactobacillus species (2,3). The aim of this study 
was to evaluate positive effects of two Lactobacillus 
strains on high fat diet induced pathology in mice and 
durability of these effects upon the 8 weeks wash out 
period.
MATERIALS AND METHODS:
Mice on high fat diet were given Lactobacillus 
plantarum WCFS1 or Lactobacillus rhamnosus LA68 
for three months followed by a two month wash 
out period. Mouse sera was collected and various 
parameters analyzed.
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RESULTS:
After 16 weeks of HFD regime, in experimental 
group on HFD regime alone there was a significant 
increase in weight and liver steatosis developed. This 
was accompanied by increased levels of blood lipids 
and increased leptin levels. Administration of WCFS1 
strain in HFD regime prevented the increase in mice 
body weight and led to a significant decrease in serum 
triglycerides and LDL cholesterol. The administration 
of LA68 also resulted in significantly lower body weight 
of the animals, led to a significant decrease in serum 
total and HDL cholesterol. Upon the 8 weeks wash 
out period the only remaining beneficial effect was 
significantly lower mouse weight in the supplemented 
groups compared to the HFD group.
CONCLUSIONS:
Active probiotic administration of two Lactobacillus 
species/strains had positive influence on metabolic 
parameters in mice on HFD regime, but these positive 
outcomes were short term after ending probiotic 
administration.
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INTRODUCTION:
Cell, tissue, and organ cultures of medicinal 
plants proved to be essential for the discovery of 
biosynthetic pathways and their regulation, providing 
means for influencing pharmacologically relevant 
natural products. In the present study, we used in 
vitro cultures of several medicinal plants (Agastache 
rugosa, Salvia yangii, Moluccella laevis, Chelidonium 
majus, Stevia rebaudiana) to test the influence of 
different illumination regimes and media composition 
on morphogenesis and bioactive metabolite contents.
MATERIALS AND METHODS:
Tissue and organ cultures were initiated from 
explants obtained from various organs of aseptically 
germinated seedlings. Callus tissue was induced 
on various media based on Murashige and Skoog 
salts supplemented with a combination of auxins - 
IAA, NAA, 2,4-D and cytokinins - BAP and kinetin. 
Microshoot cultures were obtained from excised 
apices placed on shoot multiplication medium. The 
cultures were maintained in different illumination 
regimes - white fluorescent and LED of various 
spectra. Phytochemical screening was performed 
using spectrophotometry and HPLC.
RESULTS:
The morphogenic response of explants differed 
between white and photosynthetically active radiation 
(PAR) light. Callus induction percent, number and 
length of axillary shoots, rooting and biomass increase 
was among the parameters that were determined. 
Conditions of culture, including illumination spectrum, 
influenced content of rosmarinic acid and isoquinoline 
alkaloids significantly. However, response to each of 
the tested factor differed between species. Precursor 
(amino acids) feeding influenced developmental 
processes but did not increase level of the respective 
metabolites. Surprisingly, feeding resulted in marked 
decrease of alkaloid production in vitro in Chelidonium.
CONCLUSIONS:
The spectrum of light illuminating plant in vitro 
cultures can influence morphogenic processes and 
accumulation of specialized metabolites that are 
important for pharmacological properties. However, 
each species reacts differently and to improve 
accumulation of desired substances, the conditions of 
culture must be established experimentally.
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UNDER THE NAME OF GÜL (ROSA × 
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INTRODUCTION:
Rosa × damascena Herrm. (Rosaceae) is one of the 
most important ornamental plant, cultivated due to its 
high value aromatic oil, which is used especially in 
perfumery and pharmaceutical industries (1, 2). Since 
ancient times, the plant has been used as astringent, 
analgesic, cardiac and intestinal tonic in folk medicine 
(1). Turkey is one of the most important rose oil which 
is known as “Turkish oil rose” and rose concrete 
producers in the world. It is cultured in especially 
Isparta, Burdur, Afyon and Denizli, is known as 
“gül” (2, 3).  The aim of this study was to determine 
whether the samples in different cities of Turkey sold 
with the name of “gül” carry appropriate qualities for 
the definition of herbal drug.
MATERIALS AND METHODS:
Rose samples were purchased from different cities of 
Turkey. Morphological characteristics of all samples 
were investigated and their purities were checked. 
The standard sample was obtained from Isparta. The 
flower materials preserved in 70% alcohol. The cross 
and surface sections from the sepals and petals were 
investigated with Sartur reagent (4) under the light 
microscope. The pollen grains also were surveyed. 
Furthermore, the characteristic anatomical structures 
of the powdered samples (standard sample and 
purchased samples) were determined. 
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RESULTS:
It was observed that the samples sold were usually 
composed of rose buds. In the markets, the drug 
has been sold as an aromatic agent and for the 
upper respiratory tract. In anatomical examinations, 
unicellular trichomes were densely observed in the 
sepal. Druses were determined on the inner surface 
of sepal. Stomata were present on the outer surface 
of sepal. Conical papillae with epidermal cells were 
seen on the petal.
CONCLUSIONS:
The samples do not carry the proper conditions or 
qualifications for herbal drug description.
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INTRODUCTION:
Prunus avium (L.) L. (Rosaceae) is a deciduous tree, 
usually called sweet cherry, and widely cultured due 
to its fruits (1).Turkey is one of the biggest sweet 
cherry producers in the world.The fruits  are not only 
consumed fresh but also used to prepare products, 
for instance,  jam, marmalade, syrup and drinks. 
Its fruits, fruits stalks and leaves  are also used for 
medicinal purposes (2, 3).This plant grows naturally 
in northern of Turkey and known as “kiraz” (1).The 
fruits stalks are used as diuretic and strengthening, 
and also against diarrhea in Turkey (4). The purpose 
of present study was to evaluate whether the samples 
sold under the name of kiraz sapı are suitable for the 
definition of herbal drug. 
MATERIALS AND METHODS:
The fruit stalk samples were purchased from different 
provinces of Turkey. Morphological properties of 
these samples were examined and their purities were 
checked. The standard sample of sweet cherry was 
obtained from Ankara.The petiole samples preserved 
in 70% alcohol. The cross and surface sections from 
the petiole were prepared with Sartur reagent, and 
demonstrated. Besides, the distinctive anatomical 
structures of the powdered samples (standard sample 
and purchased samples) were indicated.
RESULTS:
Open or packed samples are sold. Different 
morphological characteristics were determined in 
the samples. In the samples, the fruit parts were 
observed. It was determined that some samples 
which sold with the name of kiraz sapı were found to 
be Prunus cerasus fruits stalks.
CONCLUSIONS:
It is not certain whether the herbal materials sold 
under the name of kiraz sapı in the market are the 
right drugs. However, purchased materials are not 
suitable for human health due to organic and inorganic 
impurities.
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P-004: INVESTIGATION OF THE SAMPLES 
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INTRODUCTION:
Fumariaceae family is represented by 7 genera and 
more than 350 species in the world (1). Fumaria 
officinalis L., known as ‘’fumitory’’ in English, ‘’fumus 
terrae’’ in Latin and ‘’şahtere’’ in Turkish is a perennial 
plant that has been used in empirical medicine for 
centuries, in Asia and Europe (2). According to Ibn-i 
Sina ‘’Şahtere’’ has been effected on purge blood 
purifiers, itch and scabies and liver congestion (3). 
This plant is used for rheumatism, skin disorders, 
hypertension in many countries (4). The aerial parts of 
this plant is known to be used as a diuretic and blood 
purifying agent in gall bladder disorders in Turkey; 
İzmir, Aydin (5). F. officinalis contains isoquinolein 
alkaloids and flavone heterosides (2). 
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MATERIALS AND METHODS:
The samples which known as şahtere were purchased 
from different provinces of Turkey [Ankara (5), 
Sivas (3), Konya (1), Tokat (1), totally 10 samples]. 
Information about use of these samples was 
received. The morphological properties and purities 
of all samples were examined and photographed 
(Samsung Galaxy Note 5).
RESULTS:
Findings related to use were matched with the 
sources. As a result of the morphological studies, the 
presence of other plants parts (especially Calendula 
officinalis seeds and Papaver sp. fruits) and foreign 
matter were determined. Insect infested plant 
materials were also observed.  
CONCLUSIONS:
It has been determined that all of the samples 
presented to the sale are morphologically formed from 
the correct drug, namely ‘’şahtere’’ herba. In addition, 
organic and inorganic contaminants of the samples 
were not considered suitable for human health.
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INTRODUCTION:
Sambucus ebulus L. (Adoxaceae)(dwarf elder) is a 
widespread annual herbaceous plant which is known 
as ‘cüce mürver’ in Anatolia (1).This plant is used 
for common cold, inflammation, rheumatism, burns 
and infectious wounds cancer treatment traditionally 
in Turkey, and also has diuretic, expectorant and 
diaphoretic activities (2).The aim of this study is to 
investigate the antioxidant activity by using in vitro 
ABTS and DPPH free radical scavenging assays and 
in vitro anti-inflammatory activity by using human red 
blood cell membrane stabilization assay of Sambucus 
ebulus extracts.
MATERIALS AND METHODS:
Methanol extracts were prepared from the fruits, stems 
and leaves of the species and evaluated for their 
free-radical scavenging capacities and antioxidant 
activities using a number of chemical assays; DPPH 
and ABTS (2, 3). Human red blood cell membrane 
stabilization effects of the extracts were evaluated as 
a mechanism of their anti-inflammatory activities (4).
RESULTS:
ABTS and DPPH free radical scavenging activities 
were higher for stems than leaves and fruits. Similar 
to these results, stems showed the strongest anti-
inflammatory activity with IC50 values of 1.08 mg/ml, 
followed by leaf and fruit, respectively (2.4 mg/ml and 
6.34 mg/ml). 
CONCLUSIONS:
Our results suggest that S. ebulus can be used as a 
source of natural antioxidants and anti-inflammatory 
components.
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INTRODUCTION:
Ferulago species have been utilized since 
ancient times as aphrodisiac, antihelmentic, tonic, 
carminative, digestive and sedative (1). Apart from 
its medicinal uses, they have been used as salad or 
spice by virtue of their special odors. However recent 
studies report that some Ferulago species have 
anticancer activity, as well (2). This study reports the 
in vitro anticancer activity of the aqueous, ethanol 
extracts and bioactive compounds isolated from the 
roots obtained from F. blancheana wereinvestigated 
on MCF-7 human breast and PC3 human prostate 
cancer cells proliferation.
MATERIALS AND METHODS:
The structures of isolated compounds from the roots 
of F. blancheana were elucidated by detailed analyses 
of 1D and 2D NMR and ESI-MS data. Human breast 
adeno carcinoma cells (MCF-7) and human prostate 
(PC-3) cells were utilized and measurements were 
performed via MTT test.
RESULTS:
Five known coumarins such as osthol (1), 
prantschimgin (2), xanthotoxin (3), felamidin (4), 
umbelliferone (5) and a knownflavonoid such as rutin 
(6) were isolated from the roots of F. blancheana. 
Ethanolic extract of roots from F. blancheana and 
prantschimgin showed significant anticancer activity 
on MCF-7 cells with 0.625 and 0.472 mg/mL IC50 
values, respectively. On theotherhand, aqueousextract 
of rootsfrom F. blancheana and umbelliferone showed 
significant anticancer activity on PC-3 cells with 1.219 
and 1.689 mg/mL IC50values, respectively.
CONCLUSIONS:
This study aims to give first report on isolation and 
characterization of the bioactive compounds from root 
extracts of F. blancheana and to report anticancer 
activity on MCF-7 and PC-3 cells of this species.
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INTRODUCTION:
Cancer is still a major public health problem in many 
parts of the world although remarkable progress in 
decreasing cancer incidence and the developments 
in chemotherapeutic strategies (1). Ferulago species 
have been utilized since ancient times as aphrodisiac, 
antihelmentic, tonic, carminative, digestive and 
sedative (2). Apart from its medicinal uses, they have 
been used as salad or spice by virtue of their special 
odors (3). This study reports the in vitro anticancer 
activity of the aqueous, ethanol extracts and bioactive 
compounds isolated from the roots obtained from F. 
pachyloba were investigated on MCF-7 human breast 
and PC3 human prostate cancer cells proliferation.
MATERIALS AND METHODS:
The structures of the compounds were elucidated by 
detailed analyses of 1D and 2D NMR and ESI-MS 
data. Human breast adenocarcinoma cells (MCF-7) 
and human prostate (PC-3) cells were utilized and 
measurements were performed via MTT test.
RESULTS:
Five known coumarins such as osthol (1), 
prantschimgin (2), xanthotoxin (3), felamidin (4), 
umbelliferone (5) and a known flavonoid such as 
rutin (6) were isolated from the roots of F. pachyloba. 
Ethanolic extract of roots and prantschimgin showed 
significant activity on MCF-7 cells with 0.559 and 
0.472 mg/mL IC50 values, respectively. Also, 
ethanolic extract of roots and umbelliferone showed 
significant activity on PC-3 cells with 1.038 and 1.689 
mg/mL IC50values, respectively.
CONCLUSIONS:
This study aims to give first report on isolation and 
characterization of the bioactive compounds from 
root extracts of F. pachyloba and to report anticancer 
activity on MCF-7 and PC-3 cells of this species.
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INTRODUCTION:
Walnut tree (Juglans regia L.) can grow naturally in 
every region of Turkey (1). Walnut leaf is a widely 
used folk medicine. It has vascular strengthening, 
anthelmintic, antidiarrheal, antifungal, hypoglycemic, 
hypotensive and sedative properties. It is used 
externally as an antiseptic for skin diseases (1, 2). The 
phytochemicals it contains provide a protective effect 
against degenerative diseases by reducing oxidative 
stress and inhibiting macromolecular oxidation (3, 
4). In this study, antioxidant and anti-inflammatory 
activities of walnut leaves were determined. 
MATERIALS AND METHODS:
Walnut leaves samples were collected from 
Savaştepe, Balıkesir. Samples were powdered and 
extracted with methanol. DPPH• and ABTS•+ free 
radical scavenging capacity of extract were evaluated 
for antioxidant activity. The membrane stabilizing 
activity of the extract was evaluated by using heat-
induced human erythrocyte hemolysis as an indicator 
of anti-inflammatory activity. 
RESULTS:
The results of antioxidant and anti-inflammatory 
activity of Walnut leaves are given in the table.
Antioxidant activity Extract 
























(*) Statistically significant as compared to control, 
p<0.05 (one-way ANOVA, SPSS 20.0)
CONCLUSIONS:
In conclusion, this study showed that walnut leaves 
which were collected from Savaştepe (Balıkesir) 
have significant antioxidant and anti-inflammatory 
activities. The results we found were similar to other 
studies (3-5). 
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INTRODUCTION:
Olive leaf (Olea europaea L.) has been used in 
folk medicine for several thousand of years within 
Mediterranean countries (1). Olive leaf extract 
contains many different compounds, which are 
thought to give the extract its varied therapeutic 
properties (1,2). Many studies have shown that 
12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 131
olive leaf extract had antiarrhythmic, spasmolytic, 
immunostimulatory, cardioprotective, hypotensive, 
anti-inflammatory, antioxidant and anti-thrombotic 
(1-3). In this study, antioxidant and anti-inflammatory 
activities of olive leaf collected from two different 
regions were examined.
MATERIALS AND METHODS:
Olive leaf samples were collected from Edremit 
(Balıkesir) and Tirilye (Bursa). Samples were 
powdered and extracted with methanol. DPPH• and 
ABTS•+  free radical scavenging capacity of extract 
were evaluated for antioxidant activity. The membrane 
stabilizing the activity of the extract was evaluated by 
using heat-induced human erythrocyte hemolysis as 
an indicator of anti-inflammatory activity. 
RESULTS:
The results of antioxidant and anti-inflammatory 






Extract (Edremit) Extract (Tirilye) BHT
IC50 ±SD  




Extract (Edremit) Extract (Tirilye) Trolox 
IC50 ±SD  








Extract (Edremit) Extract (Tirilye) Acetylsalicylic acid
IC50 ±SD  
(mg/ml) 0,4462*±0,0074 0,4769*±0,0104 0,2910*±0,08
(*) Statistically significant as compared to control, 
p<0.05 (one-way ANOVA, SPSS 20.0)
CONCLUSIONS:
In conclusion, this study showed that olive leaf 
samples which were collected from Tirilye (Bursa) 
have significant antioxidant and anti-inflammatory 
activity. The results we found were similar to other 
studies (2-4).
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INTRODUCTION:
Passiflora L. (Passifloraceae) consists herbaceous 
or woody tendril climber plants, commonly spread in 
the warm temperate and tropical regions of the World 
(1). It is especially used for the treatment of insomnia 
and anxiety (2).  This genus is known usually as 
“çarkıfelek or passiflora” in Turkey. Aim of the study 
is to investigate suitability of the samples sold in the 
market from a morphological point of view, for public 
health.
MATERIALS AND METHODS:
The samples which known as çarkıfelek or passiflora 
were purchased from  the markets in Ankara. It is used 
as a standard for the identification of the morphological 
characteristics of the fruit obtained from the culture 
form of Passiflora incarnata L. The samples were 
examined morphologically according to the drug 
character defined in the Turkish Pharmacopoeia and 
European Pharmacopoeia.
RESULTS:
Despite herba of Passiflora incarnata being used as 
a  drug, it has been determined that there is no sale 
of drug obtained from this plant in the Ankara market. 
As a result of the studies, it was determined that two 
of the samples are fruits of Paliurus spina-christi Mill. 
It  is sold under the name of passiflora or çarkıfelek 
roots was found to be Caiophora lateritia (Hook.) 
Benth. (Loasaceae)  fruits which does not grow in our 
country.
CONCLUSIONS:
The products sold under the name of çarkıfelek 
(passiflora) in Ankara are not the right drugs obtained 
from the right plant. For this reason, it can not be 
expected to show the intended effect in terms of 
health. These products should be inspected before 
and during sales.
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INTRODUCTION:
Capsella bursa-pastoris (L.) Medik. is an annual 
or biennial herb (Brassicaceae). Diverse groups 
of biological activities are reported to be present 
in the different plant parts of C. bursa-pastoris 
which possessed, anti-inflammatory, antioxidant, 
antimicrobial, and antihypertensive activities. It 
is usually used for liver and kidney inflammation 
(1). This genus is known usually as ‘çoban çantası’ in 
Turkey. Aim of the study is to evaluate the suitability 
of the samples sold in the market for public health in 
terms of microbiological contamination.
MATERIALS AND METHODS:
Seven different samples known as ‘çoban çantası’ 
were purchased from  the markets in Ankara. 
Morphological studies were carried out on the 
standard sample (AEF 27190) and purchased market 
samples. These 7 different samples purchased were 
examined for microbiological contamination. Microbial 
contamination studies were done by plate counting 
method. The presence of contamination in the 
samples was determined according to the European 
Pharmacopoeia (2011) (2).
RESULTS:
As a result of the microbiological studies, pathogen 
microorganism are not shown to be present in any 
samples, however number of microorganisms have 
been found to be higher than the limits provided in 
the European Pharmacopoeia. As a result of the 
morphological study, foreign matter and foreign plants 
were encountered.
CONCLUSIONS:
Usage of samples in the market for treatment is 
inconvenient because samples are not suitable for 
the number of bacteria and molds according to the 
European Pharmacopoeia. According to our findings, 
it is not appropriate to use these specimens sold on 
the market as a therapeutic.
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INTRODUCTION:
The genus Echinophora L. (Apiaceae) with eleven 
species in the world is represented by six species in 
the flora of Turkey which three of them are endemics 
(1). The aerial parts of some species are used in 
folk medicine to wound-healing properties and to 
treat gastric ulcers. E. tenuifolia subsp. sihthorpiana 
known as “Çörtük, Cördük and Tarhana Otu” in 
Turkey also used as spice for food (2, 3). In this study 
total phenolic contents and antioxidant capacity of 
these taxa contain: E. orientalis Hedge & Lamond, 
E. tenuifolia subsp. sihthorpiana (Guss.) Tutin, E. 
tournefortii Jaub. & Spach and E. lamondiana Yildiz & 
Z.Bahcecioglu (endemic) have been studied.
MATERIALS AND METHODS:
Antioxidant capacity of the Echinophora MEOH 
extracts were determined by DPPH radical scavenging 
and ABTS total antioxidant capacity assays (5).
RESULTS:
Results of the DPPH assay showed E. tournefortii 
(IC50=61.72 µg/mL), E. lamondiana (IC50= 108.10 
µg/mL) E. orientalis (IC50=123.90 µg/mL), E. 
tenuifolia subsp. sihthorpiana,(IC50=193.50 µg/ml) 
showed low and moderate radical scavenging activity. 
ABTS+ total antioxidant capacities of the extracts 
found as 229.74mg/g, 69.6mg/g, 194.15mg/g and 
166.2mg/g trolox equivalent, respectively.
CONCLUSIONS:
The results showed that all MeOH extracts possessed 
antioxidant properties including DPPH radical 
scavenging and ABTS antioxidant capacity assays. 
Total phenolic content will be determined for each 
extract. Our antioxidant activity studies are continuing 
and isolation studies will be carried on the most active 
extract. 
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INTRODUCTION:
Allium L. species are the one of the oldest plants 
cultivated for its utilization as food and medicine. It 
has numerous useful impacts such as antithrombotic, 
antimicrobial, antiarthritic, antitumor, hypoglycemic 
activities (1, 2). Various studies have showed 
chemopreventive action of the organosulfur 
compounds and anticancer activity has been ascribed 
to organosulfur compounds in Allium species. This 
also leads to its impact on inhibition of tumor growth 
(3). In this study, four Allium species (A. callidyction, A. 
peroninianum, A. hirtovaginatum and A. callimischon 
subsp. haemostictum) have been investigated and 
their anticancer activities are compared (4). 
MATERIALS AND METHODS:
Plants were collected from Muğla, Kahramanmaraş 
and İstanbul provinces in Turkey. Ethanol extracts 
were prepared from the plant and cytotoxicity tests of 
the extracts were performed. In vitro cytotoxic effects 
of the extracts were determined by MTT assay using 
MCF-7 (human breast cancer) cell lines. 
RESULTS:
Cytotoxic effect was found to be high in ethanolic 
extracts. In the DNA synthesis inhibition tests, the 
extracts were found to show high inhibition compared 
to the cisplatin used as control. Extracts have shown 
to have significant cytotoxic effect on MCF‒7 cell 
lines. 
CONCLUSIONS:
While the extract of A. callimischon subsp. 
haemostictum has showed to have best early 
apoptotic effect, the extract of A. callidyction has 
showed the best late apoptotic effect. Thus, the 
examined Allium species can be promising agents in 
respect to their anticancer effects.
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INTRODUCTION:
Cordia L. (Boraginaceae) is represented by one 
species (Cordia myxa L.) in Turkey. It is estimated 
that Cordia myxa originates from the eastern 
Mediterranean region of eastern India. It is a 
deciduous tree, known as “Yellim ağacı” and grows 
only in Hatay province of Turkey. The plant is cultured 
for various purposes, and has edible fruits (1-3). 
Decoction of the leaves has been used against cough 
and cold in India (4). The objective of this study is to 
investigate anatomical properties of the Cordia myxa 
leaves growing in Turkey.
MATERIALS AND METHODS:
The plant materials were collected from Hatay. The 
leaf materials stored in 70% alcohol. The cross and 
surface sections of the leaves were examined with 
Sartur reagent (5) under the microscope and, the 
images on the light microscope were taken with a 
Leica DM 4000 B camera.
THE RESULTS:
The leaf is hypostomatic and bifacial.  In palisade 
parenchyma, cystoliths cells were determined. 
Many unicellular trichomes with cuticle striated were 
observed. The trichomes with cystolith also were 
seen. Glandular hairs composed of a one or two-
celled stalk and a unicellular head are present in 
the lower epidermis. Crystals include formations in 
different shapes such as prismatic and crystal sand. 
The stomata are anomocytic type (3-6 subsidiary 
cells).
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CONCLUSIONS:
Anatomical structure of Cordia myxa leaves growing 
in Turkey was demonstrated for the first time.
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INTRODUCTION:
Herbs and spices have long been used to improve the 
flavour of food. Cumin, one of these spices, is widely 
used all over the world. However different species 
known as Cumin are used for the same purpose (1, 
2). According to the data obtained from ethnobotanical 
studies in Turkey, four species are known and used 
as Cumin (Kimyon) in Turkey; Carum carvi, Cuminum 
cyminum, Laser trilobum and Grammosciadium 
daucoides. In this study, comparative fruit anatomy 
and morphology of these species were studied (3, 4).
MATERIALS AND METHODS:
Anatomical research material was dried, so first of 
all they were kept in distilled water, then they were 
preserved in 70% ethanol. In this study at least 6 
mature fruits of each of 4 species were studied. 
All transverse sections were cut by hand from the 
middle of the mericarps using a blade. Samples were 
examined in Sartur reagent (5).
RESULTS:
Considerable differences were observed in the fruit 
morphology of these species having different fruit 
shapes. Also, the fruit surface patterns of species 
show important differences, the only similarity 
related to their surfaces was being striated. However, 
Carum carvi and Grammosciadium daucoides have 
prominent striae, Cuminum cyminum and Laser 
trilobum have slight striae. Fruits have anatomical 
shapes and extent of costal channels and the 
presence of secondary and primary ribs are important 
differences. An identification key based on both 
morphological and anatomical characters is presented 
for the studied species.
CONCLUSIONS:
The anatomical and morphological results will allow 
separation of the species known as cumin.
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P-016: ENDEMISM IN ISTANBUL PLANTS
Tuncay, H.O., Akalın, E.
Istanbul University, Department of Pharmaceutical 
Botany, Istanbul, Turkey
INTRODUCTION:
Istanbul has an extraordinary plant variety due to its 
diversity of soil, geographical position between two 
seas and two continents, climate, topography and 
traditional land use. Istanbul is also home to many 
endemic plants in the same way. At the same time 
these plants are threatened by intensive urbanization 
in recent years (1). 
MATERIALS AND METHODS:
Firstly, a list of endemic plants from İstanbul was 
created according to “Flora of Turkey and the East 
Aegean Islands”, articles and books (2). Previously 
created lists were also checked (3, 4). Herbarium 
records of the plants in this list have been checked. 
The plants collected from outside Istanbul were 
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identified and only a list of plants growing in Istanbul 
was established. Literature records of the plants were 
checked (5).
RESULTS:
With this study, endemic plants growing in Istanbul 
were detected. 60 plants endemic to Turkey are 
growing up in Istanbul. Only 10 of these plants are 
endemic to Istanbul. 25 of these plants are found 
in Istanbul and its surrounding areas (neighboring 
cities). The remaining 25 plants are more common 
endemics and also are found in Anatolia.
CONCLUSIONS:
This study shows that among 60 of Turkey’s endemic 
plants that are found in Istanbul only 10 of them are 
endemic to Istanbul. It is very important to follow 
up these plants immediately and protect them from 
harmful effects of urbanization.
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P-017: HPTLC EXAMINATION OF VARIOUS 
KEDIOTU (VALERIAN; VALERIANA 
OFFICINALIS L.) SAMPLES SOLD IN THE 
MARKET OF TURKEY
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INTRODUCTION:
“Kediotu” (Valeriana officinalis L.) samples were 
investigated and findings were compared with the 
monographs found in European Pharmacopoeia 2011 
and Turkish Pharmacopoeia II, as well as chemical 
profile of the samples were examined (1-3). 
MATERIALS AND METHODS:
20 different samples of kediotu were purchased 
from local markets in different cities of Turkey. 
Morphological structure of the kediotu samples was 
determined. The chemical profile of the investigated 
samples was compared with the valerianic acid 
(=standard sample) by using a HPTLC method.
RESULTS:
Kediotu samples were determined that the majority of 
the samples purchased from the market consisted of 
leaves or parts of herbs, which were not identified as 
root samples. This finding was especially striking for 
the 10 different samples which were purchased from 
the capital city markets. Among the 10 samples sold 
under the name of kediotu, only two of them belong 
to the root, and the other 8 samples consist of leaf 
and aerial parts of the different plants. Moreover, in 
parallel to the morphological study results, chemical 
composition of the samples was not found to be 
identical with the standard sample. Chemical profile 
of most of the samples was different from each other 
according to the HPTLC results.
CONCLUSIONS:
It has been observed that the investigated kediotu 
samples which are offered for sale in the market of 
Turkey do not confirm to the definition of scientific 
drug in terms of morphological characteristics and 
chemical content. Most of the investigated samples 
which are not supposed to be kediotu, are possibly 
contaminated with organic and inorganic substances 
so that they should not be used for public health.
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P-018: DETERMINATION OF ANTI-
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ACTIVITIES OF OPOPANAX HISPIDUS
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INTRODUCTION:
Opopanax W. Koch (Apiaceae) species, belonging to 
Apiaceae family are known with the names Kaymakotu 
in our country and known as Hercules’ all-heal 
throughout the world. English name of the species 
gives us a hint on the medicinal usage of them. In 
respect to etymology “opos” means vegetable juice 
and “panax” (panacea) means all-healing, universal 
remedy. Traditional use of Opopanax ssp. are 
expectorant and antispasmodic (1). This study was 
designed to assess the in vitro antioxidant activity, 
anti-inflammatoryactivity and free radical scavenging 
capacity of O.hispidus.
MATERIALS AND METHODS:
Methanol extracts were prepared and evaluated for 
their free-radical scavenging capacity and antioxidant 
activity using a number of chemical assays; DPPH 
and ABTS (2, 3). Human red blood cell membrane 
stabilization effects of extracts were evaluated as a 
mechanism of the anti-inflammatory activity (4).
RESULTS:
The DPPH and ABTS radical scavenging activities 
were higher for herbs than flowers. Flowers were 
found to be more effective in anti-inflammatory assay 
than herbs with IC50 values of 3.31 mg/ml and 4.75 
mg/ml, respectively.
CONCLUSIONS:
Phenolic substances are known to be responsible from 
the antioxidant effect that medicinal plants possess. 
Flowers and especially yellow flowers are known to 
be rich in flavonoids, therefore it is not surprising that 
flowers were found to be more effective than aerial 
parts and further studies have to be performed to 
determine the flavonoid and total phenolic content of 
this species (5).
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P-020: THE ANTITYROSINASE ACTIVITY 
OF ARBUTUS UNEDO L. LEAVES
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INTRODUCTION:
Arbutus unedo L. (Koca yemiş) is an evergreen 
shrub in the family Ericaceae and widespread in the 
Mediterranean regions. Different parts of this plant 
have long been used in folk medicine against several 
diseases, mainly gastrointestinal and urological 
problems (1). Tyrosinase is a well-known key enzyme 
in melanin biosynthesis in skin, hair and has also 
been proposed to contribute to the formation of 
neuromelanin. In cell culture systems, expression 
of tyrosinase increases neuronal susceptibility to 
oxidizing conditions, including dopamine itself which 
is related to Parkinson disease (2). Tyrosinase 
inhibitors have become increasingly important 
because of their potential use as hypopigmenting 
agents. Antityrosinase activity of A. andrachne was 
previously reported (3). In this study antityrosinase 
activity of A. unedo leaves was evaluated.
MATERIALS AND METHODS:
Air dried A. unedo leaves were extracted with 
dichloromethane and ethanol separately. Extracts 
were fractionated with RP-C18 and antityrosinase 
activity of fractions were investigated with an assay 
that 96-well microplate was adopted and optimized 
for tyrosinase inhibitory activity from a previously 
described method using kojic acid as reference drug 
(4).
RESULTS:
EtOH fractions (water:MeOH 50:50, 75:25 and 
25:75 elutes) were found as  mainly responsible 
for tyrosinase inhibitory activity at 1.25 mg/ml 
concentration and the % inhibition values were 89.14, 
81.22 and 58.01 respectively.
CONCLUSIONS:
The fractionation process with water and methanol 
demonstrated that A. unedo leaves hold a potential for 
tyrosinase inhibitory activity. Active fractions proved 
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to be promising for future research as a natural 
alternative for inhibition of tyrosinase activity and 
further phytochemical studies for active secondary 
metabolites are scheduled. 
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P-021: THE EFFECT OF PRANGOS 
PABULARIA LINDL. ON ERECTILE 
DYSFUNCTION ASSOCIATED WITH H2S
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INTRODUCTION:
Prangos pabularia Lindl. is a perennial herb which is 
distributed in North, East and Southeast Anatolia and 
the plant is known as ‘’Beyik and Caksır’’ in Anatolia 
(1). P. pabularia has been used as aphrodisiac 
in traditional medicine. However the scientific 
background of this has not been investigated enough. 
Thus, we aimed to study i) whether the extract of 
the root of P. pabularia (10-12-10-4 g/mL) has a 
relaxant effect ii) the role of H2S; a strong erectile 
gasotransmitter (2),  in the mechanism of this possible 
relaxation response caused by P. pabularia extract in 
mice penile tissues.
MATERIALS AND METHODS:
Air dried roots were extracted with hexane, chloroform 
and methanol sequentially.  DMT strip myograph is 
used to measure relaxation response on chloroform 
extract.
RESULTS:
P. pabularia caused concentration-dependent 
relaxation responses (P<0,001, ANOVA, vehicle vs 
extract). However, propargylglycine (PAG; 30 min., 
10mM), an inhibitor of the H2S producing enzyme-
cystathionine γ lyase (CSE) did not inhibit these 
relaxations.
CONCLUSIONS:
This results show that the extract has relaxant effects 
on penile tissue and H2S formation is not involved in 
relaxant effects of the extract of P. pabularia.
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P-022: MAJOR FURANOCOUMARINS OF 
PRANGOS PABULARIA LINDL.
Demiroz, T., Demir, S., Baykan, S.
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INTRODUCTION:
Prangos sp. (Apiaceae) includes 17 species in 
flora of Turkey, 9 of which are endemic (1). Roots 
of the Prangos species, called as “Caksir” are used 
as aphrodisiac, wound healing and haemostatic 
in Anatolian traditional medicine (2). Previous 
phytochemical investigations on roots of Prangos 
indicate the major compounds as coumarins and 
furanocoumarins derivatives (3, 4). The aim of this 
study is to determine the major chemical compounds 
of Prangos pabularia Lindl.
MATERIALS AND METHODS:
Roots of plant extracted by n-hexane, chloroform 
and methanol, sequentially. Major compounds 
in chloroform extract were isolated by different 
chromatographic techniques and characterized by 
spectroscopic methods such as 1-D, 2-D NMR and 
LC-MS. Percentage of relative amounts of three major 
compounds in extract were determined by HPLC.
RESULTS:
Three major compounds of P. pabularia were 
identified as oxypeucedanin (9.96%), isoimperatorin 
(9.26%) and imperatorin (5.2%).
CONCLUSIONS:
Major compounds are well known furanocoumarins 
and should be responsible for the possible effects of 
the plant.
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P-024: EFFECT OF ANTI-BIOFILM 
AGENTS AND ANTIBIOTICS ALONE AND 
IN COMBINATIONS AGAINST BIOFILMS OF 
CATHETER-ASSOCIATED COAGULASE-
NEGATIVE STAPHYLOCOCCI
 1 Ozturk, I., 1 Tekintas, Y., 2 Temel, A., 2 Ermertcan, 
S., 3 Kurutepe, S., 3 Hosgor Limoncu, M.
1Izmir Katip Çelebi University, Faculty of Pharmacy, 
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INTRODUCTION:
In this study, the effects of antibiotics and antibiofilm 
agents alone and in combination were investigated 
against biofilms of coagulase-negative Staphylococci 
(CNS) isolates that were isolated from catheters at 
Celal Bayar University Hospital.
MATERIAL AND METHODS:
Minimum inhibitory concentrations (MIC) of antibiofilm 
agents (N-acetylcysteine, EDTA, nisin, farnesol) and 
antibiotics (gentamicin, ciprofloxacin, doxycycline, 
rifampicin) against 45 isolates were determined by 
microdilution method according to EUCAST.The 
combined effects of the agents were investigated 
by checkerboard method.The biofilm production of 
isolates were investigated by spectrophotometric 
microplate method.
RESULTS:
The MIC of N-acetylcysteine was 1024 μg/ml in 33 
isolates, MIC of EDTA was 256 μg/ml in 25 isolates, 
MIC of nisin was 128 μg/ml in 29 isolates and MICs 
of farnesol was 512 μg/ml in 13 isolates, respectively. 
The biofilm production capacities and resistance 
profiles to antibiotics of isolates are shown in Table 1.
Table 1. Biofilm production and resistance profiles to 







Non-biofilm - Gentamicin 28 (% 62.2)
Weak 6 (% 13.3) Ciprofloxacin 29 (% 64.4)
Moderate 15 (% 33.3) Doxycycline 7 (% 15.6)
Strong 24 (% 53.3) Rifampicin 19 (% 42.2)
Biofilm production was inhibited with the combinations 
of EDTA+rifampicin in total of nine isolates that produced 
strong biofilm, with nisin+doxycycline combinations in 
seven isolates, with nisin+gentamicin combinations. 
The mature biofilm levels were decreased with the 
combinations of farnesol+rifampicin in six isolates 
and with nisin+ciprofloxacin, nisin+doxycycline and 
nisin+rifampicin combinations in five isolates.
CONCLUSIONS:
The antibiofilm agents alone and in combination with 
antibiotics could prevent catheter colonization and it 
is thought that morbidity and health care costs will be 
positively affected with using of these agents.
P-025: ANTIBIOFILM ACTIVITIES OF 
SELECTIVE SEROTONIN REUPTAKE 
INHIBITORS AGAINST CLINICAL CANDIDA 
ISOLATES
1 Tekintas, Y., 2 Temel, A., 2 Ates, A., 2 Erac, B., 3 
Metin, D.Y., 3 Hilmioglu Polat, S., 2 Hosgor Limoncu, 
M.
1Izmir Katip Celebi University, Faculty of Pharmacy, 
Department of Pharmaceutical Microbiology, Izmir, 
Turkey
2Ege University, Faculty of Pharmacy, Department of 
Pharmaceutical Microbiology, Izmir, Turkey
3 Ege University, Faculty of Medicine, Department of 
Medical Microbiology, Izmir, Turkey
INTRODUCTION:
Candida spp. are opportunistic fungi that often cause 
hospital infections.. Biofilm formation is an important 
virulence factor of Candida sp. because its resistance 
to several antifungal drugs makes it difficult to 
eradicate.The aim of this study was to determine 
antibiofilm activity of selective seratonin reuptake 
inhibitors (SSRIs) sertraline, paroxetine, fluoxetine 
against different Candida spp.
MATERIALS AND METHODS:
Twenty Candida sp. (C. albicans: 6, C. glabrata: 
3, C. krusei: 4, C. tropicalis: 4, C. parapsilosis: 3) 
isolated from Ege University Hospital and Candida 
parapsilosis ATCC 22019 strain were examined. The 
inhibitory concentrations of the SSRIs were evaluated 
by broth microdilution method according to EUCAST 
criteria in a previous study (Microbiologica Balkanica 
2017/AntM-43). The biofilm production of isolates and 
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the effects of the SSRI molecules on mature biofilm 
were determined by spectrophotometric microplate 
method.
RESULTS:
Seven of the isolates were weak, nine of them were 
moderate, four isolates were identified as strong 
biofilm producers. C. parapsilosis showed the highest 
biofilm production, whereas C. albicans showed the 
lowest one. The effects of SSRIs on mature biofilm 
structure in moderate and strong biofilm producer 
isolates were shown in Table 1.
Table 1. Effects of SSRIs to biofilm production in 
moderate and strong biofilm producer isolates
 Selective Seratonin Reuptake Inhibitors






















Reduced 6 4 3 - 5 3
Induced 2 4 7 7 3 3
Stable 5 5 3 6 5 7
FLX: Fluoxetine, PRX: Paroxetine, SRT: Sertraline, MIC: Minimum 
Inhibitory Concentrations
CONCLUSIONS:
Biofilm production can vary depending on the 
species of Candida. Sub-MIC concentrations of 
SSRI molecules have inducing or reducing effects on 
different species of Candida sp. 
P-026: DETERMINATION OF ACID 
DISSOCIATION CONSTANT AND ANTI 
MICROBIAL ACTIVITY OF CONDENSED 
1,4-DIHYDROPYRIDINE DERIVATIVES
1 Gunduz, MG., 2 Ozkul C., 3 Kocak E.
1Hacettepe University, Faculty of Pharmacy, 
Department of Pharmaceutical Chemistry, Ankara, 
Turkey
2Hacettepe University, Faculty of Pharmacy, 
Department of Pharmaceutical Microbiology, Ankara, 
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INTRODUCTION:
Determination of acid dissociaition constant (pKa) 
that provides the ratio of ionized form concentration 
and unionized form concentration  of a drug molecule 
inside body is the first stage for  drug development. 
Drug absorption, distribution, metobolism, excretion 
process are depend on pKa value of molecules (1). 
To evaluate  molecular properties of ethyl (CE2)/ 
2-(Methacryloyloxy)ethyl (CE7) 2,6,6-trimethyl-4-(1-
naphthyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-
carboxylate derivatives, pka values were calcualted. 
Moreover, antimicrobial activity was evaluated to 
understand whether new molecules could be used as 
antimicrobial agents.
MATERIALS AND METHODS:
Antimicrobial activity of these compounds were 
determined by broth microdilution method reported by 
the Clinical and Laboratory Standards Institute (CLSI) 
against the bacteria (Escherichia coli ATCC 25922, 
Enterococcus faecalis ATCC 29212, Pseudomonas 
aeruginosa ATCC 27853, Staphylococcus aureus 
ATCC 29213) and the fungi (Candida albicans ATCC 
90028, C. krusei ATCC 6258, C. parapsilosis ATCC 
90018). Piperacillin/Tazobactam and Fluconazole 
used as control agents. pka value was calculated with 
potentiometric titration.
RESULTS:
CE2 was the most active compound against E. 
faecalis with a minimum inhibitory concentration 
(MIC) value of 64 (μg/mL). CE7 has a MIC value of 
128 μg/mL against E. faecalis. Both CE2 and CE7 
compounds has a MIC value of 512 μg/mL against S. 
aureus and E.coli. Moreover Both compounds have 
antimicrobial activity against P. aeruginosa with a 
MIC value of 256 μg/mL. Both compounds have an 
antifingal effect against C. albicans, C. parapsilosis 
and C. krusei (MIC values range between 256 and 
512 μg/mL). pka values were calculated as 5,02 and 
7,29 for CE2 and CE7, respectively.
CONCLUSIONS:
CE2 and CE7 have both antibacterial and antifungal 
effect. However the MIC values are high.
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Botany, Ankara, Turkey
3Ataturk University, Department of Pharmaceutical 
Chemistry, Erzurum, Turkey
4Ankara University, Department of Pharmaceutical 
Microbiology, Ankara, Turkey
5Erzincan University, Department of Pharmacognosy, 
Erzincan, Turkey
INTRODUCTION:
Ferulago species are used as anthelmintic, sedative 
and aphrodisiac, along with in salads or as seasoning 
for their special odors (1). The study reports the 
antibacterial, anticholinesterase, α-amylase and 
α-glucosidase inhibitory activities of essential oils 
(EOs) of fruits and extracts, fractions from roots and 
aerial parts and isolated compounds from CH2Cl2 
fraction of roots from F. mughlea and F. sandrasica.
MATERIALS AND METHODS:
Antibacterial activities were carried out against 
S.aureus, E.coli, P.aeruginosa and B.subtilis by 
broth dilution methods (2). Anticholinesterase activity 
was assessed via Ellman’s method (3), α-amylase 
and α-glucosidase inhibitory activities via methods 
reported in Karakaya et al., 2018 (4). Compounds’ 
structures were elucidated by detailed analyses 
(NMR and MS).
RESULTS:
EOs and extracts showed antibacterial activity against 
all bacteria between 0.097-12.5 and 31.25-1000 μg/mL 
values, respectively. Activity of EOs were significant. 
The CH2Cl2 fraction of root from F. mughlae best 
inhibited AChE (48.55%) and the CH2Cl2 fraction 
of root from F. sandrasica best inhibited BuChE 
(97.09%). Felamidin showed significant α-glucosidase 
inhibitory activity (94.57%) when compared to the 
reference standard acarbose (50.81%). None of the 
samples were shown α-amylase inhibitory activity.
CONCLUSIONS:
Antibacterial activity of F. sandrasica EO, antioxidant 
and anticholinesterase activities of CH2Cl2 fraction 
of roots from F. mughlae and F. sandrasica promises 
hope to study on to be converted into a pharmaceutical 
product.
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INTRODUCTION:
Discovering new anthelmintic compounds from 
natural plants is important especially due to increasing 
resistance against classical anthelmintic drugs (1, 2). 
Nigella sativa (N. sativa), a medicinal plant, is used as 
antidiabetic, anticancer, immunomodulator, analgesic, 
antimicrobial, anti-inflammatory, spasmolytic, 
bronchodilator, hepato-protective, renal protective, 
gastroprotective, and antioxidant (3). However, 
seeds of N. Sativa extracts are slightly toxic against 
Caenorhabditis elegans (C. elegans) (4), a free 
living nematode that is used very commonly as a 
model organism. C. elegans has also been used to 
screen anthelmintic activity of plant extracts, because 
of its short life span, simple structure, and easy 
maintenance. In our study, we aimed to evaluate 
nematocidal activity of N. sativa by using C. elegans 
as a model.
MATERIALS AND METHODS:
Anthelmintic activity of N. sativa was evaluated by 
toxicity assays in C. elegans during its early larval 
and adult stages. Different concentrations of N. 
sativa oil (900, 450, 270 and 0 mg/mL) were tested, 
and Levamisole (2,5 mg/ml) was used as positive 
control. The toxicity assessments were done under 
stereomicroscope after 24, 48 and 72 hours from the 
start of treatments. The number of survived nematodes 
was counted for lifespan (survival) analyses every 
day. This evaluation was performed for both larval 
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and adult stage worms. Statistical significance was 
assessed with Student T-test (p < 0.05).
RESULTS:
This study showed that N. sativa essential oil 
significantly decreases lifespan/survival of adult C. 
elegans in both larval and adult stages after 24 hours 
just when N. sativa was used at 900mg/mL final 
concentration. After 48 and 72 hours, the number 
of live adult animals in treatment group significantly 
decreased compared with untreated control group. 
Additionally, larval stage worms were more sensitive 
to N. sativa essential oil than the adults. 
CONCLUSIONS:
This study demonstrates anthelmintic and toxic 
activities of N. sativa essential oil against both larval 
and adult worms. Larval animals were more sensitive 
than adults.   We recommend further studies on other 
effects of N. sativa on C. elegans after removing toxic 
compound(s) from the extract.
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INTRODUCTION:
The aim of this study was to develop and optimize 
a selective high-performance liquid chromatography 
method for the determination and validation of 
Pediococcus acidilactici strain’s lactic acid content. 
Also to determine the antimicrobial activity of tested 
strain against different bacterial ATCC standards.
MATERIALS AND METHODS:
Antimicrobial activity of P. acidilactici strain against 
standard test microorganisms was determined by 
the spot lawn method and the quantitation of its 
lactic acid was carried out by high performance 
liquid chromatography on a Rezex ROA organic acid 
(300x7.8 mm) analytical column.
RESULTS:
The lactic acid amount of the P. acidilactici strain was 
found in the range between 5.59 - 5.94 mg mL-1 and the 
strain was able to inhibit the growth of Pseudomonas 
aeruginosa ATCC PAO-1, Pseudomonas aeruginosa 
ATCC 27853, Pseudomonas aeruginosa ATCC 9027, 
Enterococcus faecalis ATCC 29212 by its lactic acid 
content.
CONCLUSIONS:
This study explains a simple, selective, and fully 
validated procedure for the determination of lactic 
acid from lactic acid bacteria.
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INTRODUCTION:
Nowadays, knowledge of ancient botanical medicinal 
practices and application of modern phytochemical 
techniques have provided the excellent tools for 
the purification and structural elucidation of various 
phyto-compounds, which, in turn, has given insights 
into their mode of action on the human body (1). This 
study has been designed to investigate for the first 
time the effects of the ethyl acetate, methanolic, and 
water extracts of Iberis sempervirens on key enzymes.
MATERIALS AND METHODS:
Plant material was collected during the flowering 
period in 2015 from Adana, Turkey (between 
Pozantı and Camlibel village). The methanol, ethyl 
acetate, and water extracts were prepared from 
Iberis sempervirens. The total phenolic and flavonoid 
content were determined using colorimetric methods. 
Enzyme inhibitory properties were detected against 
cholinesterase, tyrosinase, α- amylase and α- 
glucosidase.  
RESULTS:
The ethyl acetate extract was more potent against 
cholinesterases (1.93 mgGALAE/g extract for 
AChE and 1.99 mgGALAE/g extract for BChE) 
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and α-amylase (0.81 mmolACAE/g extract), while 
the methanol extract were most active against 
α-glucosidase (7.69 mmolACAE/g extract). The water 
extract was also exhibited notable inhibitory activity 
against tyrosinase (5.25 mgKAE/g extract). 
CONCLUSION:
The present findings suggest that Iberis sempervirens 
can be considered as a potential source of bioactive 
compounds for novel phytopharmaceuticals 
development in the treatment and/or management of 
noncommunicable diseases.
REFERENCES:
1.  Khan ZR, Moni F, Sharmin S, Al-Mansur MA, Gafur 
A, Rahman O, Afroz F (2017). Pharmacology & 
Pharmacy 8, 253.
P-031: ANTIOXIDANT PROPERTIES OF 
LOTUS AEGAEUS EXTRACTS
Zengin, G. Aktumsek, A
Selcuk University, Faculty of Science, Department of 
Biology, Konya, Turkey
INTRODUCTION:
Plant secondary metabolites have been used for 
ages in folk medicine due to their known pluripotential 
biological attributes. Nowadays, they are regarded 
as valuable sources of bioactive compounds used 
in the development of pharmaceutics, cosmetics, 
fine chemicals, or recently as nutraceuticals (1,2). 
This study has been designed to investigate for the 
first time the antioxidant effects of the ethyl acetate, 
methanolic, and water extracts of Lotus aegaeus.
MATERIALS AND METHODS:
Lotus aegaeus was collected during the flowering 
period in 2015 from Konya (Balcılar, Taskent). The 
methanol, ethyl acetate, and water extracts were 
prepared for antioxidant ability. The antioxidant 
abilities of the investigated extracts were tested using 
different assays including free radical scavenging, 
reducing power, phosphomolybdenum, and metal 
chelating. The total phenolic and flavonoid content 
were also determined using colorimetric methods.
RESULTS:
All the extracts showed strong antioxidant abilities. 
The water extract exhibited the strongest free radical 
scavenging ability on both DPPH (37.90 mgTE/g 
extract) and ABTS (101.30 mgTE/g extract).  The 
ethyl acetate extract had the greatest cupric reducing 
power (72.88 mgTE/g extract). However, the water 
extract had good metal chelation ability (14.91 
mgEDTAE/g extract).
CONCLUSION:
L. aegaeus showed potent biological attributes, which 
advocates for further studies to explore its potential 
use as active phytopharmaceuticals.
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INTRODUCTION:
The Apiaceae is well-known flowering plant family. 
Seseli L. is one of the Apiaceae genus, annual or 
biennial herbaceous plants (1, 2). So far, various 
phytochemical studies on Seseli species showed 
that these plants contain particularly coumarins, 
cinnamic acid derivatives, sesquiterpene lactones, 
phenylpropanoids and essential oils (3-5). The 
subject of this work is to the determination of the 
coumarins by chromatographic methods from Seseli 
petraeum M. Bieb. growing in a small place in Black 
Sea Coastal Region. 
MATERIALS AND METHODS:
The plant was collected from the roadside cliffs 
in Trabzon. The extracts with different polarities 
(n-hexane, ethyl acetate, and methanol) were 
obtained from both parts using Soxhlet apparatus. 
Then all extracts were applied to TLC (Thin Layer 
Chromatography). On the other hand, the n-hexane 
extract has been subjected to CC (Column 
Chromatography).
RESULTS:
Thin Layer Chromatography (TLC) experiments were 
carried out by 6 types of extracts (from aerial parts and 
roots). In addition, the n-hexane extract of the roots 
of S. petraeum L. have been subjected to column 
chromatography, and 10 fractions were obtained 
at the end, together with pure pyranocoumarin type 
coumarins (A and B).
CONCLUSIONS:
In the present study, the chromatographic profile 
obtained by TLC have been clarified and given 
by the photos. The tentative structures of the 
pyranocoumarins will be given all details in future 
studies. Moreover, the results showed that the 
coumarins are rich in S. petraeum. The fractions had 
a strong potential for the isolation of other coumarinic 
type compounds. The study has been focused not 
only isolation but also the chromatographic profile of 
the species were also clarified. 
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INTRODUCTION:
Seseli L. from Apiaceae family (1) comprises 
coumarins, terpenoids, and essential oils. The 
genus has been exhibited antimicrobial, antioxidant, 
antipyretic, anti-inflammatory, and many other 
important activities. The studies on its phytochemical 
constituents and biological activities are very limitedly 
performed (2, 3). There are several studies on volatile 
oils of Seseli species (3). It is necessary to emphasize 
that the Seseli species are very important for their 
phytoconstituents and effects. Therefore, in this study, 
it is aimed to clarify the essential oil composition of 
Seseli petraeum M. Bieb. called as Stone Seseli, Taş 
Seseli, Taş Çaşırı), which grows in a narrow part of 
the Black Sea coastal region in Turkey.
MATERIALS AND METHODS:
The fruits of the plant was roughly crushed. The 
crashed fruits were subjected to hydro-distillation 
in the Clevenger apparatus for 3 hours. The oil was 
analyzed by Gas Chromatography (GC) and Gas 
Chromatography/Mass spectroscopy (GC/MS).
RESULTS:
The volatile oil was obtained by the yield of 1.5-
2% from the fruits of the plant (65 g). The major 
components have been determined as carotol 
(17.25%), γ-terpinene (10.73%), p-cymene (7.93%), 
germacrene-D (7.65%), trans-β-ocimen (7.31%), and 
β-farnesene (8.50%). 
CONCLUSION:
In the present study, the essential oil composition 
of Seseli petraeum M. Bieb. has been determined 
by GC/MS. The most dominant compound has 
been found as carotol (17.25%) which is the most 
significative constituents of the other Seseli species. 
In the end, it is understood that the volatile oil is rich in 
sesquiterpenoids.
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INTRODUCTION:
Cranberry (Vaccinium macrocarpon) from Ericaceae 
family grows in Eastern North America. Cranberry 
displays several biological activities such as 
antioxidant, anticancer, etc. due to mostly phenolic 
contents. Various cranberry forms (juice, tablets, 
capsules, and syrup) have been used widely for 
many years for the management of urinary tract 
infections (UTIs) (1,2). Although effects of cranberry 
products may have a beneficial effect on the erectile 
dysfunction (ED) (3), the scientific evidence is limited.
MATERIALS AND METHODS:
Male Sprague-Dawley rats (n=8) were used in this 
study. We evaluated the effects of one of the dietary 
supplements present in the market, containing 
concentrated extract of cranberry fruit-(E) on rat 
corpus cavernosum (CC). After phenylephrine (Phe, 
10 µM) contraction, the relaxant responses were 
determined in the presence of some inhibitors. 
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RESULT:
The relaxant responses of rat CC strips were 
observed in the presence or the absence of 
cranberry-E. Cranberry-E induced relaxation of 
rat CC (maximum response: 76.1±3.6%) after 
Phe-contraction. Cranberry-E evoked long-lasting 
relaxations. The nitric oxide synthesis inhibitor 
N(omega)-nitro-L-arginine methyl ester (L-NAME; 10 
µM), the soluble guanylate cyclase inhibitor ODQ (10 
µM), and endothelial disruption all failed to affect the 
relaxations. The relaxant responses to acetylcholine 
(10 µM), electrical field stimulation (10 Hz), and sodium 
nitroprusside (0.01 µM) in rat CC were increased after 
incubation with cranberry-E. The results of the current 
study could be used by physicians to recommend 
cranberry extract ingestion to decrease the incidence 
of ED patients with UTI as an alternative therapy.
CONCLUSION:
The underlying mechanism of cranberry products is 
likely independent of the nitric oxide-cyclic guanosine 
monophosphate pathway. Overall, these in vitro 
studies suggested that consumption of cranberry-E 
may be efficient and represent an exciting new 
strategy to prevent and diminish ED in men.
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INTRODUCTION:
Fluoroquinolones are a popular group of snythetic 
antibiotics with a broad antibacterial spectrum 
showing a good distribution in tissues (1). However, 
this type of compounds were shown to have a high 
likelihood of overuse as well as side effects such 
as neuropathy and psychiatric disorders (2). In this 
present study, it was aimed to determine the in vitro 
activity of fluoroquinolones on ten different probiotic 
microorganisms, which are thought to have a positive 
effect on neuropathy and psychiatric disorders 
especially associated with endogenous acetyl choline 
secretion (3).
MATERIALS AND METHODS
Three quinolones were evaluated by using the 
microdilution method against probiotic bacteria and 
yeast, where ketoconazole and chloramphenicol was 
used as control group. 
RESULTS:




































Bacillus subtilis var. 
clausii  ATCC-9799 25 <1.56 6.25 <0.16 <0.16
B.subtilis var. natto 
BN 6.25 <1.56 6.25 2.5 0.31
Streptococcus 
thermophilus TH-4 100 <1.56 <1.56 5 1.25
S. salivarius K12 6.25 50 >800 0.16 0.15
Lactobacillus 
acidophilus La-14 6.25 <1.56 <1.56 2.5 1.25
L. reuterii  DSM 
17938 6.25 <1.56 <1.56 2.5 1.25
L. rhamnosus GG 6.25 <1.56 <1.56 2.5 1.25
Bacillus coagulans  
SNZ 1969 6.25 1.56 1.56 2.5 1.25
Saccharomyces 
cerevisae   
ATCC - MYA9763
400 200 800 <0.16
>80
S. cerevisae var. 
boulardii  
ATCC - MYA976
>800 >800 >800 5
>80
CONCLUSIONS:
According to this study, levafloxacin and ciprofloxacin 
were more effective at lower concentrations on 
probiotic microorganisms compared to moxifloxacin. 
S. thermophilus was the most resistant bacterium 
when compared to ciprofloxacin. S. salivarius 
was the most resistant bacterium compared to 
moxifloxacin and levafloxacin. It was also observed 
that S. boulardii was the most resistant yeast against 
fluoroquinolones. Ciprofloxacin can be safely used 
in the concentration range in which L. acidophilus 
is thought to be effective. The standard antifungal 
ketokonazole showed growth inhibition against the 
probiotics except S.c. var. boulardii. The standart 
antibacterial agent chloramphenicol showed 
inhibitory activity against the bacteria at reasonable 
concentrations. The incidence and prevalence of 
neuropathy and psychiatric disorders may be reduced 
in the endogenous acetylcholine metabolism in 
humans as previously reported (3). Further detailed 
work is on going.
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INTRODUCTION:
Spices are a part of the plants used for many 
purposes as colorants, preservatives, or medicines 
(1,2). The objective of this study was to evaluate to 
the potential antimicrobial activity of some spices 
from Apiaceae family such as Amni visnaga (Diş 
otu, Hıltan), Anethum graveolens (Dereotu), Apium 
graveolens (Kereviz), Coriandrum sativum (Kişniş), 
Cuminum cyminum (Kimyon), Daucus carota (Havuç), 
Foeniculum vulgare (Rezene), Petroselinum sativum 
(Maydanoz), Pimpinella anisum (Anason).
MATERIALS AND METHODS:
The spices have been extracted by n-hexane in a 
reflux. After that, all extracts have been subjected 
to Thin Layer Chromatography to examine their 
chromatographic profile. Then, the n-hexane extracts 
were screened for their potential in vitro antibacterial 
activity against Staphylococcus aureus ATCC 29213, 
Enterococcus faecalis ATCC 29212, Escherichia 
coli ATCC 25922, Klebsiella pneumoniae ATCC 
13883, Pseudomonas aeruginosa ATCC 27853 
and antifungal activity against Candida albicans 
ATCC 10231. Microbroth dilution method was 
used for determination of the minimum inhibitory 
concentrations (MIC) [3,4]. Serial two-fold dilutions 
ranging from 10 to 0.078 mg/mL were prepared in 
the medium. A set of wells containing only inoculated 
broth, 10% DMSO, ampicillin, ofloxacin, ciprofloxacin, 
and fluconazole were used as a control.
RESULTS:
Coriandrum sativum, Anethum graveolens, Daucus 
carota and Pimpinella anisum did not show 
antimicrobial activity against test microorganisms. 
Except these, extracts possessed activity having 
MIC values of 2.5-5-10 mg/mL against the tested 
microorganisms
CONCLUSION:
The extracts showed antimicrobial activity for their 
nonpolar components which are accumulated to the 
hexane. Therefore, spices may have a great potential 
to be developed as new and safe antimicrobial agents.
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INTRODUCTION:
In this study the antioxidant activity of Lycium 
barbarum L. was determined.  The fruits of L. barbarum 
L. (Solanaceae), have wide range of pharmacological 
activities. The major bioactive compounds of 
L. barbarum are polysaccharides, flavonoids, 
carotenoids and phenolic acids, which mainly account 
for immunomodulatory and antioxidant activities (1). 
L. barbarum L. also known as wolfberry, goji berry 
has been used as a preventative and curative agent 
for thousands of years (2). Free radicals are known 
to be the main cause of aging, heart disease, stroke, 
diabetes mellitus, cancer and rheumatism (3). The 
fruits of L. barbarum L. are rich of polysaccharides 
that had significant free radical-scavenging activity 
(4). 
MATERIALS AND METHODS:
L. barbarum L. was obtained from Temmuz Organik 
Üretim Çiftliği Konya. 100g of dried fruit L. barbarum 
L. were grinded and extracted by different solvents; 
methanol, 70% methanol and 70% acetone. 
The extracts were dried under vacuum. Different 
concentrations of extracts were attempted to evaluate 
the antioxidant activity by DPPH and superoxide 
radical scavenging methods and the IC50 of the 
extracts were calculated (5). Ascorbic acid and 
quercetin were used as standards. 
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RESULTS:
According to the results of DPPH and superoxide 
radical scavenging methods 70% aseton extract 
(IC50: 2.2 ± 1.3 mg/ml) was shown better antioxidant 
activity than the metanolic and 70% metanolic extracts 
(IC50: 2.6 ± 1.4 mg/ml). 
CONCLUSIONS:
In conclusion, the present study demonstrated that 
Turkish L. barbarum L. fruits have sufficient antioxidant 
activity such as Chinese samples. L. barbarum L. 
could use as a potential source of natural antioxidant. 
Further studies will be continue to identify the active 
compound/s responsible for antioxidant activity.
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MACRANTHERA SUBSP. SYSPIRENSIS
1 Dursunoglu, B., 1 Yuca, H., 2 Gozcu, S., 1 Guvenalp, 
Z.
1 Ataturk University, Faculty of Pharmacy, 
Department of Pharmacognosy, Erzurum, Turkey 
2 Erzincan University, Faculty of Pharmacy, 
Department of Pharmacognosy,Erzincan, Turkey
INTRODUCTION:
The genus Quercus is represented with 24 species 
and 15 subspecies in Turkish flora. Quercus 
macranthera subsp. syspirensis (Fagaceae) is an 
ecologically important endemic species and known as 
İspir oak (1). It contains some phenolic compounds 
such as tannins in its shell (2). In our previous study, 
α-glucosidase inhibitory activity of ethyl acetate 
extract from fruits of this plant was determined. In 
the present study, performing the qualitative and 
quantitative analysis of active compounds in ethyl 
acetate extract by HPLC method and preparing the 
standardized extracts based on the α-glucosidase 
inhibition were aimed. 
MATERIALS AND METHODS:
In the present study, rapid, precise and accurate 
HPLC methods have been developed and validated 
for epigallocatechin gallate (EGCG), epigallocatechin 
(EGC), epicatechin gallate (ECG) and catechin (C) 
in ethyl acetate extract obtained from fruits of Q. 
macranthera subsp. syspirensis. In vitro α-glucosidase 
inhibitory activities were investigated according to the 
method of Tao et al., 2013 (3).
RESULTS:
α-Glucosidase inhibitory activities of active 
compounds have found as EGCG > ECG > EGC > 
C. Their IC50 values were determined as 0.0235, 
0.0519, 0.2409, and 0.3401 mg/ml, respectively. The 
concentrations of ECG, EGCG, C and EGC in ethyl 
acetate extract (10 mg/ml) were found 0.717, 0.270, 
0.0813 and 0.004%, respectively.
CONCLUSIONS:
Catechins-enriched standardized ethyl acetate extract 
has the best α-glucosidase inhibitory activity. 
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P-040: ANATOMY OF ANCHUSA AZUREA 
MILLER (BORAGINACEAE)
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Erzurum, Turkey
INTRODUCTION:
The genus Anchusa L. (Boraginaceae) is mainly 
distributed along the Mediterranean coast, Africa, 
Europe and Western Asia that is represented with 
about 35 species (1). There are 15 species of the 
genus Anchusa found in Turkey (2). A. azurea is 
used traditionally as stimulant, tonic, demulcent, 
diuretic and for fever, cough and wound healing (2, 
3). It contains pyrrolizidine alkaloids, flavonoids, 
triterpene saponins, fatty acids, phenolic acids and 
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polysaccharides (2, 3). Anticancer, antioxidant, 
antiviral and anti-inflammatory activities of A. azurea 
were reported in the literature (3). 
MATERIALS AND METHODS:
The plant was collected from Erzurum (Turkey) in 
2017. Specimens were dried according to standard 
herbarium techniques and stored in the Herbarium of 
Atatürk University, Faculty of Pharmacy. The materials 
for anatomical study were preserved in 70% alcohol. 
Characteristic elements of stem, leaf and petiole 
were identified with preparing the sections and their 
structures were illustrated with photographs. 
RESULTS:
The leaf is monofacial and stomata were located in 
the upper and lower leaf epidermises. The trichomes 
were observed in the leaf and stem of A. azurea. The 
secretory channels were located in the stem. The 
petiole anatomy of A. azurea was similar to anatomy 
of the stem.
CONCLUSIONS:
In the present study, anatomical structures of the 
stem, petiole and leaf of A. azurea were investigated. 
The anatomical properties given in this study provide 
description of A. azurea. Our results should be useful 
in future studies about this genus.
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P-041: ANATOMY OF EPILOBIUM 
ANGUSTIFOLIUM L. (ONAGRACEAE)
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INTRODUCTION:
The genus Epilobium belongs to Onagraceae family 
and represented with 21 species in Turkey (1). One 
of these species, E. angustifolium, is an annual 
plant so green leafy, flowering with a height of 0.5-
3 m (2) which known as “yakı otu” in our country 
(1). The infusion prepared from the plant is used for 
migraine, insomnia, anemia, delirium, infections and 
colds in folk medicine (3). Its usage in the treatment 
of mucous membrane lesions is also reported (4). 
The plant contains polyphenolic compounds such as 
flavonoids, phenolic acids and ellagitannins (3). 
MATERIALS AND METHODS:
The plant was collected from Erzurum City Forest 
(Turkey) in September 2017. Specimens were dried 
and stored in the Herbarium of Atatürk University, 
Faculty of Pharmacy. The materials for anatomical 
study were preserved in 70% alcohol. In this study, 
anatomical structures of the characteristic elements 
from the stem, leaf, sepal, petal, anther, and filament 
of E. angustifolium were identified with taking the 
sections. Their structures were illustrated with 
photographs.
RESULTS:
Leaf is bifacial which located stoma in the lower 
epidermis. Very dense and unicellular trichome (only 
stem, leaf, petiole) and abundant cluster crystals of 
calcium oxalate were shown in sections of stem, leaf, 
petiole and petal. Thin short and thick long raphides 
were shown all over the leaf. Trichomes with single 
cell and glandular hair with a unicelular stalk and 
secretory head were found at sepal anatomy which 
was similar to petal.
CONCLUSIONS:
In the present study, anatomical structures of the 
stem, leaf, sepal, petal, anther and filament of E. 
angustifolium were investigated. The anatomical 
properties given in this study provide description of E. 
angustifolium. Our results should be useful in future 
studies about this genus.
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P-042: COMPARISON OF ALPHA-
GLUCOSIDASE INHIBITORY AND 
ANTIOXIDANT ACTIVITIES OF DIFFERENT 
SUMAC PRODUCTS
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Guvenalp, Z.
1 Erzincan University, Faculty of Pharmacy, 
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INTRODUCTION:
Rhus coriaria L. belongs to Anacardiaceae family 
which is commonly known as “sumac”. Mature 
fruits are used as spice and to prepare sumac 
sauce (1). This plant is one of the export products 
of Turkey. Sumac is used as hemostatic, antiseptic 
and constipating agent in traditional medicine (2). 
Previous studies have shown that Rhus coriaria has 
anti-fungal, antibacterial, antioxidant, hypoglycemic 
and DNA protective effects (1). The aim of our study is 
to compare the activity of 3 different products obtained 
from this plant.
MATERIALS AND METHODS:
Three different products were the naturally mature 
fruits of the sumac plant (M), commercial spice (C) 
and commercial sauce (S). Antioxidant activity was 
determined by ABTS•+ (3) and DPPH• (4) scavenging 
activity, and antidiabetic activity by alpha-glucosidase 
inhibitory activity assay (5).
RESULTS:
In the ABTS•+ scavenging activity trolox (TR) was 
used as standard, the extract of the naturally collected 
sumac fruits (M) showed highest activity compared 
to commercial spice (C) and sauce (S) [TR>M>C>S 
(13.5>11.0>7.0>0%; 5 μg/ml)].  The results of the 
DPPH• scavenging activity are similar to those of 
the ABTS•+ test. Sumac fruit collected from the 
nature and commercial spice were found to be more 
active than the standard compound α-tocopherol 
(TK) [M>C>TK>S (21.5>11.8>11.1>3.2%; 10 μg/
ml)]. In the alpha-glucosidase inhibitory activity 
assay, all samples showed higher inhibition effect 
than acarbose (A) used as standard [M>C>S>A 
(97.4>93.2>29.3>0.5%; 50 µg/ml)].
CONCLUSIONS:
We conclude that the sumac fruits are very effective on 
alpha-glucosidase inhibitory activity, but commercial 
spices and sauces are not as effective as naturally 
collected sumac.
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P-043: ANTIMICROBIAL ACTIVITIES AND 
FATTY ACID COMPOSITIONS OF KUMQUAT, 
LIMEQUAT AND MEXICAN LIME SEEDS
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of Pharmacognosy, Eskişehir, Turkey
INTRODUCTION:
Citrus fruits are of great economic importance 
because of their in nature consumption and varies 
industrial applications. The wastes of these industries 
such as peels, seeds and pulps represent about 50% 
of the raw processed fruit. Large amounts of citrus 
seeds are discharged at the processing plants. This 
not only wastes a potentially valuable resource, but 
also aggravates already serious disposal problems 
(1). Therefore, in the present study, the seeds of 
small citrus fruits were evaluated for their potential 
antimicrobial activities and fatty acid compositions.
MATERIALS AND METHODS:
Mature Kumquat, Limequat and Mexican lime fruits 
were harvested from Subtropical Fruits Research and 
Development Center at Çukurova University, Adana in 
December, 2017. The seeds separeted from the fruits 
were dried. Each seed oil was extracted with n-hexane 
for 8 h using a Soxhlet apparatus. The solvent was 
then evaporated under reduced pressure at 40ᵒC. 
Fatty acids in all fixed oils were methylated by BF3. 
The fatty acid compositions were analyzed by GC-
FID and GC-MS systems, simultaneously. The fixed 
oils were evaluated for their potential antimicrobial 
activity by CLSI M7-A7 method. Escherichia coli 
NRRLB-3008, Pseudomonas aeruginosa ATCC 
27853, Salmonella typhimurium ATCC 13311, Bacillus 
cereus NRRL-B3711 and Streptococcus sanguinis 
ATCC 10556 were used as test microorganisms. 
Ciprofloxacin was used as a positive control.
RESULTS:
The seed oils yields of kumquat, limequat and 
mexican limes were calculated as 4.0%, 5.4%, 
35.8%,respectively. Palmitic acid (52.3%), oleic acid 
(26.4%) and stearic acid (8.6%) were the major fatty 
12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 149
acids of kumquat seed oil; palmitic acid (35.4%), oleic 
acid (26.4%) and linoleic acid (17.5%) were the major 
in limequat seed oil; linoleic acid (35.5%), palmitic 
acid (25.4%), oleic acid (19.8%) were the major in 
mexican lime seed oil. Limequat seed oil showed 
noticable antimicrobial effect against P.aeruginosa 
ATCC 27853 and B.cereus NRRL-B3711 at 52 µg/mL 
(MIC) concentration.
CONCLUSIONS:
Limequat seed oil can be used as antimicrobial agent 
for lipophilic formulations. Extensive further studies 
were planned by our group.
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P-044: NEW HPLC METHOD FOR THE 
PHARMACOPOEIA ANALYSIS OF VIOLA 
HERBA CUM FLORE
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INTRODUCTION:
Viola tricolor L. and Viola arvensis Murray which 
are widely grown in Europe and Asia, belong to the 
Violaceae family and the aerial parts of the plants 
are used as folk medicine for several purposes such 
as diuretic, laxative, antirheumatismal effects and 
against skin disorders (1-3). The monograph of dried 
flowering aerial parts of V. tricolor and V. arvensis is 
documented as Viola herba cum flore in European 
Pharmacopoeia (EP 11.0). In this monograph, a 
spectrophotometric method is conducted to determine 
the total flavonoid content expressed as violanthin. 
The aim of this study was to develop a new method 
for the assay of Viola Herba cum Flore. 
MATERIALS AND METHODS:
A gradient solvent system consisting of acetonitrile 
and water containing 0.02% o-phosphoric acid is 
used for the analysis. Besides, system suitability tests 
(resolution, capacity factor, tailing factor, theoretical 
plate number, linearity, reproducibility, LOD and LOQ 
values) are also conducted for the developed method. 
Ten samples supplied from different suppliers in 
different countries were tested and flavonoid contents 
were determined.
RESULTS:
Total flavonoid contents of the samples were found 
between 1.1742% ± 0.0039 and 2.0058% ± 0.0030. 
LOD and LOQ values were calculated as 0.2804 x 
10-3 and 0.9346 x 10-3 respectively. 
CONCLUSIONS:
In current study, we developed an HPLC method, 
which is more sensitive and accurate, for the 
determination of total flavonoid content expressed as 
rutoside. 
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P-045: ISOLATION AND QUANTIFICATION 
OF FLAVONOIDS FROM ZOSIMA 
ABSINTHIFOLIA 
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INTRODUCTION:
Zosima absinthifolia (Vent.) Link (Apiaceae), grows 
naturally in Turkey as the only species of this genus 
(1), and its medicinal usage has been recorded; 
fruits are used as digestive, carminative and anti-
inflammatory agent. Aerial parts of the plant are used 
to relieve cough, indigestion and bowel disorders in 
Turkey, as well as in Iran and Pakistan (2,3). The 
aim of this study is isolation and quantitation of the 
flavonoids from Z. absinthifolia aerial parts. 
MATERIALS AND METHODS:
Aerial parts of the plant was extracted with n-hexane, 
ethylacetate and methanol respectively by stirring at 
50 ºC. The methanol extract of the Z. absinthifolia 
(22.3278 g) was subjected to column chromatography 
on silicagel to obtain 90 fraction by eluting 
chloroform:methanol:water (65:25:4) mixture. Fraction 
10-12 (259,9 mg) were purified on preparative thin 
layer chromatography (RP-18, Merck 5559) using 
chloroform:methanol: H2O (40:15:2) solvent system. 
Fraction 18-19 was separated by semi-preparative 
HPLC. Structures of the isolated compounds were 
elucidated on the basis of their MS and NMR data as 
well as chemical correlations with known compounds 
described in the literature.
To prepare calibration curve, peak area of 
isorhamnetin-3-O-rutinoside-7-O-glucoside solution 
was plotted against the concentration. The compound 
was prepared at seven different concentration levels 
(0.9, 0.45, 0.225, 0.1125, 0.09, 0.045, 0.0225 mg/
ml). Methanolic extract of plant was obtained using 
condenser during 3 hours. Triplicate injections of 10 µl 
for each solution were performed. 
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RESULTS:
Isorhamnetin-3-O-rutinoside (44 mg) and 
isorhamnetin-3-O-rutinoside-7-O-glucoside (27 
mg) were obtained as flavonoids. Quantition of the 
compounds was also performed by HPLC. Percentage 
of isorhamnetin-3-O-rutinoside-7-O-glucoside and 
isorhamnetin-3-O-rutinoside was determined as 
0,33±0.04 g/100 g and 0,50±0.08 g/100 g  plant 
material, respectively.
CONCLUSIONS:
Aerial parts of Z. absinthifolia, isorhamnetin-3-O-
rutinoside and isorhamnetin-3-O-rutinoside-7-O-
glucoside have been isolated for the first time.
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INTRODUCTION:
Physospermum cornubiense (L.) DC., belongs to 
the Apiaceae family and is the only representative 
of the genus Physosperm in Turkey (1). In Turkey, 
the species is found in Bolu, Karabük, Artvin, Bursa, 
Erzincan, Gümüşhane, Hatay, İçel, Konya provinces. 
General distribution of the species includes Southern 
and Western Europe, Cyprus, Crimea, Southern 
Russia, Caucasus, North West Iran (2). In literature, 
there are reports about essential oils of the species 
growing in Iran and Balkans (3, 4). 
MATERIALS AND METHODS:
The plant was collected during flowering in Hatay 
(Belen) province of Turkey. The dried plant material 
was subjected to hydrodistillation in Clevenger 
type apparatus to yield essential oil. The chemical 
composition was investigated with GC-FID and GC/
MS techniques (5).
RESULTS:
The main constituents of the essential oil were 
presented by the sesquiterpene hydrocarbons, 
β-bisabolene (23.8%), germacrene D (4.3%), 
β-caryophyllene (3.2%) and (Z)-β-farnesene 
(3.3%). The second major group, the oxygenated 
sesquiterpenes were presented by caryophyllene 
oxide (6.6%) and 1,5-epoxy-salvial-4(14)-ene (2.5%). 
The oil contained high amount of fatty acids like 
hexadecanoic acid (14.5%) and tetradecanoic acid 
(3.7%).
CONCLUSIONS:
The present work is the first study on essential oil of 
Physospermum cornubiense growing in Turkey. The 
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P-047: SIMULTANEOUS ANALYSIS OF 
LYCORINE AND GALANTHAMINE IN 
NARCISSUS TAZETTA L. SUBSP. TAZETTA 
L. BY HPLC-PDA
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INTRODUCTION:
Lycorine is the prototype Amaryllidaceae alkaloid 
which is extensively studied for its various biological 
activities including anti-tumor, antiviral, antibacterial 
and anti-inflammatory activities(1). Galanthamine 
is the main medicinal Amaryllidaceae alkaloid 
having application against Alzheimer’s Disease(2). 
Therefore, it is considered to be important to quantify 
these alkaloids in Amaryllidaceae species. In the 
present study, quantitative determination of lycorine 
and galanthamine, in bulbs and aerial parts of 
Narcissus tazetta L. subsp. tazetta L., collected from 
Western Turkey, were carried out. 
MATERIALS AND METHODS:
A reverse phase HPLC method entegrated with 
Thermo Scientific PDA dedector was used. For the 
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chromatographic separation, Hichrom C-18 column 
(5µm, 250mm, 4.6mm) and  an  isocratic mobile 
phase of TFA-water-ACN (0.01:90:10) at a flow rate of 
1.0 mL/min were utilized. 
RESULTS:
The contents of lycorine and galanhamine in the bulbs 
and aerial parts was given in Table 1.
Table 1: Lycorine and Galanthamine Con-
tent of N. tazetta subsp. tazetta
Sample Lycorine % SD
Galanthamine 
% SD
Bulbs 0,02498 0.00080 0,00514 0,00013
Aerial 
Parts 0,06723 0,00033 0,00548 0,00040
CONCLUSIONS:
Previously, the content of lycorine in the bulbs of 
Narcissus tazetta subsp. tazetta specimen, collected 
from Antalya has been reported(3). However to the 
best of our knowledge this is the first report on the 
quantification of galanthamine in N. tazetta subsp. 
tazetta of Turkish origin.
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INTRODUCTION:
The genus Narcissus L. belongs to the family 
Amaryllidaceae, a monocotyledonous family 
represented by about 1100 species in 85 genera(1). 
Amaryllidaceae plants reproduce alkaloids with 
a wide range of biological activities(2). Narcissus 
tazetta L. subsp. tazetta L. is a widely distributed 
bulbous plant known for its biologically active 
Amaryllidaceae alkaloids(2, 3). In this study, chemical 
characterization of alkaloids, isolated from the bulbs 
of this Amarillydaceae species collected from Muğla/
Turkey, will be described.   
MATERIALS AND METHODS:
The extraction of plant material was achieved 
using the classical acid-base extraction procedure 
for alkaloids(4). Column chromatography and 
preparative chromatography were used to isolate and 
purify alkaloids. The structures of the compounds 
were determined by using advanced spectroscopic 
techniques (1D, 2D NMR, MS).  
RESULTS:
Phytochemical studies on N. tazetta subsp. tazetta, 
resulted in the isolation of 4 Amaryllidaceae 
alkaloids including lycorine, pseudolycorine, 
11-hydroxygalanthine, and galanthamine. The 
isolated compounds excluding galanthamine belong 
to lycorine subgroup of Amaryllidaceae alkaloids. 
Galanthamine is an Amaryllidaceae alkaloid with 
acetylcholinesterase inhibitory activity used in the 
treatment of mild to moderate Alzheimer’s Disease(2, 
3).
CONCLUSIONS:
Previously, a limited number of alkaloids including 
lycorine have been isolated from a different 
specimen of N. tazetta subsp. tazetta collected 
from South Turkey(5). However, to the best of our 
knowledge, this is the first report of pseudolycorine, 
11-hydroxygalanthine and galanthamine from this 
Amaryllidaceae species. 
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INTRODUCTION:
Plant species of the genus Hypericum 
(Hypericaceae) are well known for their use in 
traditional medicine as healing sore throats, colds, 
and an antitussive, due to the therapeutic effects 
of its many different species (1,2). One of them is 
Hypericum hircinum L. subsp. majus (Aiton) N. 
Robson which thrives in Turkey, S. Europe, Cyprus, 
and Syria, a semi-evergreen shrub with sessile, 
opposite and ovate-lanceolate-shaped leaves with 
translucent glands(3). In this present work, chemical 
composition of essential oils from aerial parts and radix 
of H. hircinum subsp. majus and their antibacterial 
and antifungal properties were evaluated.
MATERIALS AND METHODS:
The radix and aerial parts of H. hircunum subsp. majus 
were collected in July 2017 from Kirazlı Waterfall, 
Eskisehir (Turkey). The essential oils (EOs) were 
obtained by hydrodistillation using a Clevenger type 
apparatus for 3h.  EOs were analyzed both by GC-
FID and GC-MS, simultaneously. EO of H. hircunum 
aerial parts was examined for antimicrobial activity 
by the microdilution broth susceptibility assay against 
Staphyloccoccus aureus, Streptococcus pynogenes, 
Escherichia coli and Candida albicans.
RESULTS:
Germacrene D (26.4%), α-pinene (8.5%), δ-cadinene 
(5.5%), γ-muurolene (4.0%), 3-methyl nonane (2.8%), 
(Z)-β-farnesene (2.8%), γ-cadinene (2.5%) and 
α-cadinol (2.4%) were found as main constituents 
of the aerial parts of H. hircinum EO. The EO of H. 
hircinum radix were characterized with undecane 
(38.9%), α-pinene (14.2%), 3-methyl nonane (9.2%), 
2-methyl-decane (5.8%) and α-cadinol (2.1%). 
The antimicrobial activity (Minimum Inhibitory 
Concentration (MIC)) against S. pyogenes ATCC 
13615 (219 µg/mL), E. coli NRRL B-3008 (8.75 mg/
mL), S. aureus ATCC 6538 (109 µg/mL) and C. 
albicans ATCC 90028 (55 µg/mL) were observed by 
EO of H. hircinum aerial parts, respectively.
CONCLUSION:
Among the tested microorganism, S. aureus and C. 
albicans were found to be more sensitive to the EO 
of H. hircinum aerial parts. The EO was founds as 
effective against skin pathogens.
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INTRODUCTION:
Ferulago W. Koch is a genus of the family Apiaceae 
having important medicinal properties. This genus 
is known with the name “Çakşır” in Turkey and 35 
taxa of the genus grow naturally in our country. [1, 
2]. Members of this genus are used in traditional 
medicine for their various biological activities (e.g. 
sedative, digestive, carminative, tonic), however they 
are mostly known for their aphrodisiac activities [3]. 
In this study we examined the composition of the 
essential oil of the roots, aerial parts and fruits of 
Ferulago macrosciadia which is an endemic species 
for Turkey. 
MATERIALS AND METHODS:
Essential oils of the grounded roots, aerial parts 
and fruits were obtained by hydrodistillation using a 
Clevenger type apparatus for 3h. Essential oils were 
analyzed both by GC-FID and GC-MS, simultaneously.
RESULTS:
The main components of the plant organs are given in 
the following table. 
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Table 1. Essential oil compositions of different parts of 
F. macrosciadia
































The obtained results are compatible with the essential 
oil profiles of different parts of various Ferulago 
species found in the literature.
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INTRODUCTION:
Alcea L. is taxonomically assigned to Malvaceae 
subfam. Malvoideae, tribe Malveae. Alcea is 
represented worldwide by about 70 species. Alcea 
shows the highest counts of species in Iran, Russia, 
and Turkey, in descending order (1). Alcea dissecta 
(Baker) Zoh. is known as Govik in Turkey. The 
leaves of plant is used for injuries and asthma (2). 
To our knowledge, there are no published reports 
on biological activity of different extracts from Alcea 
dissecta aerial parts. Therefore, the purpose of this 
study was to evaluate in vitro antioxidant, anti-urease 
and anticholinesterase activities of different extracts 
from plant.
MATERIALS AND METHODS:
 The petroleum ether, chloroform, ethanol and 
ethanol: water (1:1, v/v) extracts were obtained using 
the Soxhlet and maceration methods. The antioxidant 
activities of these different extracts from plant were 
examined using DPPH, TEAC, FRAP and CUPRAC 
methods, including total phenolic contents (3). In 
addition, the anti-urease and anticholinesterase 
activities of different extracts were investigated using 
indophenol and Ellman methods, respectively (4, 5).
RESULTS:
In this study, ethanol: water (1:1, v/v) extracts 
obtained from Soxhlet (IC50:0.091 mg/mL) and 
maceration (IC50:0.1 mg/mL methods exhibited the 
strongest DPPH radical scavenging activity. Soxhlet 
chloroform extract had higher FRAP (0.470 mM 
Fe2+/mg extract) and CUPRAC (0.092 mM trolox/mg 
extract) values other extracts. In addition, maceration 
ethanol extract showed stronger anti-urease (38.59%) 
and anticholinesterase (94.66%) activity than other 
extracts.
CONCLUSIONS:
In this study, it was revealed that maceration and 
Soxhlet methods were the most suitable technical 
for anti-urease, anticholinesterase and antioxidant 
activity, respectively.
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INTRODUCTION:
Plantago lanceolata L. is a species of the genus 
Plantago in the Plantaginaceae botanical family. 
Abundant throughout Europe, North- and Central Asia. 
There are reports of the use of Plantago lanceolata in 
folk medicine: In Turkey, fresh leaves of P. lanceolata 
are used eaten. In Guatemala, the herbal substance 
is administered in conjunctivitis/eye irritation and 
for the treatment of wounds, ulcers, bruises and 
sores. In North-West Greece, infusions of Plantago 
lanceolata leaves are used for curing stomach 
spasms. It has been determined that the plant has 
anti-inflammatory, anti-antioxidant, antibacterial, 
antiviral, immunostimulant and spasmolytic effects 
(1,2). The extraction procedures and solvents are an 
important step in processing bioactive constituents 
from the plant materials. For this reason, it is essential 
to examine in detail the effect of extraction methods 
and solvents on the biological activities of plants. 
The best of our knowledge, there are not any study 
on anti-urease and anticholinesterase activities of 
this species. Therefore, the aim of this study was 
to evaluate in vitro antioxidant, anti-urease and 
anticholinesterase activities of different extracts from 
P. lanceolate aerial parts and roots.
MATERIALS AND METHODS:
The petroleum ether, chloroform, ethanol and 
ethanol: water (1:1, v/v) extracts were obtained using 
the Soxhlet and maceration methods to root and 
aerial parts of the plant. The antioxidant activities of 
these different extracts from plant were examined 
using DPPH, TEAC, FRAP and CUPRAC methods, 
including total phenolic contents (3). In addition, 
the anti-urease and anticholinesterase activities of 
different extracts were investigated using indophenol 
and Ellman methods, respectively (4,5).
RESULTS:
According to the results of the study, it was observed 
that the Soxhlet ethanol: water (1:1, v/v) extracts 
extracts obtained from roots (69.41%) and aerial parts 
(77.27%) showed stronger free radical scavenging 
activity than other extracts. It was determined that the 
maceration chloroform extract obtained from roots 
(23.18%) and Soxhlet chloroform extract obtained 
from aerial parts (33.58%) had stronger anti-urease 
activity than the other extracts. In addition, Soxhlet 
ethanol extract obtained from roots (74.97%) and 
Soxhlet chloroform extract obtained from aerial parts 
(77.87%) exhibited the strongest anticholinesterase 
activity.
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INTRODUCTION:
Ruscus aculeatus L. (butcher’s broom) belonging 
to the Liliaceae family, is a small evergreen shrub 
widespread in western, southern and south-central 
Europe (1). Preparations from an alcoholic extract 
of its rhizome have been used for the treatment of 
veinous insufficiency, haemorrhoids, and capillary 
fragility. Recently, sulfated steroidal derivatives, 
triterpenes, and sterols were isolated from the rhizome 
of R. aculeatus (2). The extraction procedures and 
solvents are an important step in processing bioactive 
constituents from the plant materials. For this 
reason, it is essential to examine in detail the effect 
of extraction methods and solvents on the biological 
activities of plants. Therefore, the aim of this study 
was to evaluate in vitro antioxidant, anti-urease and 
anticholinesterase activities of different extracts from 
Ruscus aculeatus rhizome. 
MATERIALS AND METHODS:
 The petroleum ether, chloroform, ethanol and 
ethanol:water (1:1, v/v) extracts were obtained using 
the Soxhlet and maceration methods. The antioxidant 
activities of these different extracts from plant were 
examined using DPPH, TEAC, FRAP and CUPRAC 
methods, including total phenolic contents (3). In 
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addition, the anti-urease and anticholinesterase 
activities of different extracts were investigated using 
indophenol and Ellman methods, respectively (4,5).
RESULTS:
According to the results obtained from this study, 
Soxhlet ethanol (92.56%, 1 mg/mL) and maceration 
ethanol (91.90%, 1mg/mL) extracts showed stronger 
ABTS radical scavenging activity than the other 
extracts. In addition, Soxhlet chloroform extract 
exhibited the strongest CUPRAC (0.86±0.001 mM 
trolox/mg extract) and DPPH (IC50: 0.17± 0.004 
mg/mL) antioxidant activity. It was also found that 
the maceration ethanol (34.24%) and ethanol: water 
(1:1, v/v) (35.15%) extracts exhibited the strongest 
anti-urease activity. Soxhlet chloroform (94.37%) and 
ethanol: water (1:1, v/v) (92.68 %) extracts showed 
higher anticholinesterase activity than other extracts.
CONCLUSIONS:
According as a results, the ethanol and ethanol: 
water (1:1, v/v) extracts prepared using Soxhlet and 
maceration method and Soxhlet chloroform extract 
was found to exhibited stronger biological activity than 
the other extracts. 
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INTRODUCTION:
Rheum ribes is one of the wild rhubarb species 
belonging to Polygonaceae family and utilized as 
vegetable in various countries. It is a perennial 
vegetable species spread from North and Central 
Asia to the other continents. It has also wild forms 
in Iran and Anatolia (1). Roots of the plant are used 
to treat diabetes, hemorrhoids, ulcer, diarrhea and 
expectorant activity has been reported (2). Also, it 
has some medicinal properties such as preventing 
of stomach upset, vomiting, measles and smallpox 
and increasing appetite (3). In the literature reviews, 
it was observed that there is not any study on 
anticholinesterase activity of plant different parts. 
Therefore, the aim of this study was to evaluate in 
vitro anticholinesterase activities of methanol extracts 
from different parts of Rheum ribes.
MATERIALS AND METHODS:
 The methanol extracts of different parts (flower, radix, 
leaves, and young shoots) of the plant were prepared 
using the Soxhlet, maceration and ultrasonic bath 
extraction methods. The anticholinesterase activities 
of these different extracts were examined using 
Ellman method (4).
RESULTS:
According to the results the radix (45.97%), flowers 
(71.90%) and leaves (64.90%) methanol extracts 
obtained from ultrasonic bath method and young 
shoots extract (87.98%) obtained by Soxhlet extraction 
method exhibited stronger anticholinesterase activity 
than the other extracts.
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INTRODUCTION:
S. cana (C.A. Meyer) Hoffm. var. jacquiniana (W. 
Koch) Chamb., from Asteraceae family grows 
naturally in Europe, Anatolia, Syria, Iraq, Caucasia 
and Iran (1). In Turkish folk medicine this plant is 
known as “karakök or tekesakalı” (2). The aim of the 
current study is to investigate phytochemical content 
of the aerial parts ethyl acetate extract.
MATERIALS AND METHODS:
Dried and powdered aerial parts of the plant material 
were macerated in methanol at room temperature. 
Afterwards, the extract was filtered and evaporated 
until dryness under reduced pressure at 50°C. The 
crude extract was subjected to liquid partitioning 
yielding the fractions of petroleum ether, chloroform, 
ethyl acetate and water. Separation was carried 
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out from ethyl acetate extract on silica gel column 
chromatography by eluting with ethyl acetate: 
methanol: water (100:13,5:10) mixture. Further 
purifications from the fractions obtained from the 
ethyl acetate extract were performed by preparative 
thin layer chromatography to obtain flavonoids. 
Structure of the compounds were elucidated by using 
spectroscopic techniques (1H,13C  and 2D-NMR, 
MS).
RESULTS:
Chromatographic separation of the ethyl acetate 
extract yielded apigenin-7-O-glucoside (1), apigenin-
7-O-rutinoside (2), luteolin-7-O-glucoside (3), 
isovitexin (4), orientin (5) and isoorientin (6)   
CONCLUSIONS:
In current study S. cana var. jacquiniana aerial parts 
have been investigated for its flavonoid content for 
the first time.  
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INTRODUCTION:
Medicinal plants represent an important source of 
bioactive compounds that could be used for new 
drugs development. Most of the bulbous plants are 
known for their medicinal purposes in addition to their 
ornamental value. Turkey is one of the home countries 
of many beautiful bulbous plants (1). The ornamental 
bulbous plant member of the genus Fritillaria L. has 
a wide range of medicinal activities known and it is 
known as Bei-Mu in the Traditional Chinese Medicine. 
It is widely distributed in Asia and traditionally used 
for treatment of different human diseases, especially 
mental illnesses. In continuation of our extensive 
studies on finding new natural inhibitors from Turkish 
bulbous plants, we have now aimed to screen the 
AChE and BChE inhibitory activity of extracts prepared 
from 19 Fritillaria species  (Liliaceae) collected from 
East Anatolia that were not well studied with respect 
to their neuroprotective potentials.
MATERIALS AND METHODS:
19 Fritillaria L. were collected from different localities 
of the East Anatolia and the extracts of the bulbs were 
tested for  their cholinesterase inhibitory activities 
using Ellman’s spectrophotometric method adapted to 
ELISA microtiter assay.
RESULTS:
Our results indicated that the bulb extracts of Fritillaria 
species growing in East Anatolia exerted high to 
moderate BChE inhibition between 71.33±0.36 and 
87.50±2.08 (galanthamine 72.76±0.82) at 200 mg/mL 
with no AChE inhibition. The highest value belonged 
to the methanolic extract of F. persica. These findings 
support the traditional use of Fritillaria species in the 
treatment of neurodegenerative disorders such as 
Alzheimer’s Disease. 
CONCLUSIONS:
It can be recommended that future studies should 
aim to determine the best method for large-scale 
cultivation of the active Fritillaria species  and to detect 
the neuroprotective phytochemicals to establish the 
molecular mechanisms of neuroprotective effects of 
Fritillaria species. 
ACKNOWLEDGEMENTS: 
This study was supported by a grant of TUBITAK 
(KAMAG-110G007)
REFERENCES:
1.  Kaya, E.(ed.), (2014). In: Geophytes of 
Turkey, Vol. 1-3, Atatürk Central Horticultural 
Research Institute, Edition No: 96, Yalova. 
P-057: EVALUATION OF ENZYME 
INHIBITORY ACTIVITY OF ETAHOLIC 
EXTRACTS OF THE ROOTS OF TWO 
FERULAGO SPP. 
1 Demirci, F., 1 Karaca, N., 2 Kilic, C.S., 3 Duman, H, 4 
Gurbuz, I. 
1Anadolu University, Faculty of Pharmacy, 
Department of Pharmacognosy, Eskisehir, Turkey
2Ankara University, Faculty of Pharmacy, Department 
of Pharmaceutical Botany, Ankara, Turkey
3Gazi University, Faculty of Science, Department of 
Biology, Ankara, Turkey 
4Gazi University, Faculty of Pharmacy, Department 
of Pharmacognosy, Ankara, Turkey
12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 157
INTRODUCTION:
Inflammation is a biological response of cells and 
tissues for the stimuli of pathogens or injuries where 
cyclooxygenases (COX) and 5-lipoxygenases (5-
LOX) may produce biologically active lipid molecules 
called eicosanoids. Plant extracts as well as natural 
and synthetic coumarins are known to inhibit such 
inflammations (1-3). As Ferulago angulata (Schlecht.) 
Boiss. was reported with anti-inflammatory activity as 
well (4), it was aimed in the present work to evaluate 
the 5-LOX and COX inhibitory activities of F. cassia 
Boiss. and F. isaurica Peşmen from Turkey.
MATERIALS AND METHODS:
In vitro enzyme inhibitory activities were performed on 
the ethanol extracts of the dried underground parts of 
the Ferulago spp. spectrophotometrically on a 96-well 
format. Nordihydroguaiatic acid (NDGA) was used as 
a positive control. 
RESULTS:
LOX and COX inhibitory activity results can be seen 
in Table 1.
Table 1. Percentage (%) 5- LOX and COX inhibition 
results of the extracts
Samples LOX * COX *
F. cassia 31.3 4.6




*LOX and COX activities were performed on 50 µg/mL and 125 µg/
mL extracts, respectively
**NDGA concentration was 1 µg/mL for LOX and 125 µg/mL for COX.
CONCLUSIONS:
Both Ferulago species showed 5-LOX inhibitory 
effect, however their COX inhibitory activities were 
weak compared to the standard. Nevertheless, it can 
be concluded that the evaluated Ferulago species 
may be further elaborated for anti-inflammatory 
activity.
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INTRODUCTION:
Alzheimer’s disease is one of the most common 
variety of dementia illnesses with a rate of 60-70%. 
Currently 50 million patients have this disease 
and the number of Alzheimer patients has been 
increased by approximately 10 million every year. 
Due to the magnitude of such epidemic amongst the 
elder population, World Health Organization (WHO) 
has defined dementia as a priority issue of public 
health (1). In this project, the traditional uses of the 
Prangos genus and related genera of Apiaceae 
family such as Ferula, Ferulago and Angelica among 
the people were investigated in terms of coumarin 
derivatives and terpenic compounds. Due to the 
well documented cholinesterase inhibitor activities 
of coumarin derivatives (2), anti-Alzheimer activities 
were most likely associated with both plant extracts 
that mainly contain coumarin derivatives. Despite 
the limited number of studies performed on the 
anti-cholinesterase activities of natural coumarin 
derivatives isolated from Prangos species, these 
compounds may provide new leads for the anti-
alzheimer drug development studies. Prangos turcica 
A. Duran, M. Sağıroğlu & H. Duman, an endemic 
species growing in the southern Turkey, has only 
been previously investigated for the essential oil 
composition of its fruits (3, 4). 
MATERIALS AND METHODS:
In addition to the dichloromethane and methanol 
extracts, infusion and decoction of P. turcica fruits 
were prepared. Acetylcholine esterase (AChE) and 
butyrylcholine esterase (BChE) inhibitory activities 
have been determined according to the method 
developed by Ellman et al. in order to examine anti-
Alzheimer activity of extracts (5). 
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RESULTS:
All the extracts of P. turcica fruits inhibited 
BChE activity in a dose dependent-manner and 
dichloromethane extract was found to be the most 
active extract (86.85% at 0.1 mg/mL concentration). 
However, the extracts showed only weak inhibitor 
activity against AChE. 
CONCLUSIONS:
The results have revealed that these extracts which 
can be used for the alleviation of Alzheimer’s disease 
symptoms, also they were suitable and promising 
for anti-Alzheimer drug development. Our bioactivity 
directed isolation studies are currently in progress.
REFERENCES:
1.  World Health Organization. “Dementia, Fact 
sheet”. WHO. 2017 http://www.who.int/
mediacentre/factsheets/fs362/en/
2.  Souza LG, Renno MN, Figueroa-Villar JD (2016). 
Chemico-Biological Interactions 254: 11-23.
3.  Duran A, Sağıroğlu M, Duman H (2005). Annales 
Botanici Fennici, 42: 67-72.
4.  Özek G, Özek T, Başer KHC, Duran A, Sağıroğlu 
M, Duman H (2006). Journal of Essential Oil 
Research, 18: 511-514.
5.  Ellman GL, Courtney KD, Andres V, Featherstone 
RM (1961). Biochemical Pharmacology, 7: 88-95.
P-059: VOLATILE COMPONENTS OF THE 
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INTRODUCTION:
Neomuretia H. Wolff (Apiaceae) is a small genus of 
geophytic herbs that currently includes two species 
and distributed in the southern Turkey, and northern 
Iraq (1). N. pisidica is an endemic species growing in 
the Karaman province of Turkey and used as a food 
by local villagers.
MATERIALS AND METHODS:
The air dried plant material was macerated initially 
with n-hexane. After filtration and evaporation the 
extract prepared for GC-FID and GC-MS analysis. 
RESULTS:
Main components of aerial parts of n-hexane extract 
were characterized as 1,8-cineole (23.4%), camphor 
(21.4%), 2-ethyl hexanol (14.6%), α-pinene (7.2%), 
and verbenone (6.4%), respectively. Methyl linoleate 
(19.3%), 1,8-cineole (16.5%), camphor (13.2%), 
α-pinene (6.1%) and 2-ethyl hexanol (4.9%) were 
found in the hexane extract of root. Whereas, 
1,8-cineole (23.3%), camphor (20.3), 2-ethly hexanol 
(14.2%), α-pinene (9.9%), and limonene (4.1%) were 
the major components of the hexane extract of fruit. 
CONCLUSIONS:
When the volatile components of  n-hexane extracts 
prepared from the three different parts of plant 
material were examined, they were found to contain 
similar chemical composition. While the root extract 
was rich in fatty acid esters, the other two extracts 
were rich in monoterpene compounds.
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INTRODUCTION:
Genus Anthemis L. (Asteraceae) is represented by 50 
species and Anthemis cretica by twelve subspecies 
in Turkey (1). In the current study essential oil of the 
aerial parts of A. cretica subsp. anatolica (Boiss.) 
Grierson was analyzed by GC-FID and GC-MS.
MATERIALS AND METHODS:
The air-dried plant material was hydrodistilled for 3 
hours using a Clevenger-type apparatus, the resulting 
essential oil of A. cretica subsp. anatolica was 
analyzed by capillary GC and GC/MS using an Agilent 
GC-MSD system.
RESULTS:
Yield of essential oil obtained by hydrodistillation for 
A. cretica subsp. anatolica was found to be 0.22%. 
The essential oil of A. cretica subsp. anatolica was 
characterized by the presence of a high percentage of 
oxygenated sesquiterpenes (57.9%). Twenty-seven 
compounds were identified representing 96.6 % of the 
essential oil of A. cretica subsp. anatolica. The main 
components of the oil were spathulenol (27.0%) and 
hexadecanoic acid (14.3%). Hitherto the essential 
oil composition of A. cretica subsp. anatolica has not 
been investigated.
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CONCLUSION: 
Major components of the essential oil of A. cretica 
subsp. anatolica have been identified as spathulenol 
and hexadecanoic acid. Based on the previously 
published essential oil data (2-4), major components 
of A. cretica subsp. anatolica were quite distinct than 
those of A. cretica subsp. carpatica, subsp. columnae, 
subsp. messanensis as well as A. cretica subsp. 
pontica supporting the taxonomical separation of this 
subspecies from the aforementioned subspecies.
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INTRODUCTION:
Recent evidences suggest that plant-based extracts 
and metabolites exert a protective action on human 
health. The use of herbal medicines, phytonutrients 
and /or nutraceuticals are increasing exponentially 
throughout the world (1, 2). The present study was 
designed to evaluate biological activites (antioxidant 
and enzyme inhibitory potential) of Ajuga chamaepitys 
subsp. chia var. chia and A. bombycina. 
MATERIALS AND METHODS:
The aerial parts of two Ajuga were collected in Konya, 
Turkey (during summer of 2016).The methanol, ethyl 
acetate, and water extracts were prepared from the 
Ajuga species. Antioxidant capacity was evaluated 
using different chemical assays (DPPH, ABTS, 
CUPRAC, FRAP, phosphomolybdenum, and metal 
chelating). Enzyme inhibitory properties were tested 
against cholinesterase, tyrosinase, α-amylase, and 
α-glucosidase enzymes. 
RESULTS:
The water extract of A. chamaepitys exhibited the 
strongest antioxidant properties with a higher level of 
total phenolics (22.61 mgGAE/g extract). However, 
the ethyl acetate and methanol extracts showed 
greater enzyme inhibitory activity when compared to 
the water extracts.
CONCLUSION:
Current findings tend to suggest that both Ajuga 
species can be regarded as an important source 
of biologically-active compounds to design novel 
applications in food and pharmaceutical industry. 
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CHEMICAL COMPOSITION, ANTIOXIDANT, 
AND ENZYME INHBITORY PROPERTIES
1 Bahadori, MB., 2 Zengin, G
1 Maragheh University of Medical Sciences, 
Phytopharmacology Research Center, Maragheh, 
Iran
2 Selcuk University, Faculty of Science, Department 
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INTRODUCTION:
Mints are used as herbal tea, food additives, and 
traditional medicines all around the world (1). In 
this work, chemical composition of essential oil of 
wild mint (Mentha longifolia var. calliantha) was 
determined together with its antioxidant and enzyme 
inhibitory potential.
MATERIALS AND METHODS:
GC-MS analysis were used for identification of 
chemical composition of the essential oil. Six 
different methods were employed for examination of 
antioxidant ability including DPPH, ABTS, CUPRAC, 
FRAP, metal chelating, and Mo total antioxidant 
assays. Also, enzyme inhibitory analysis linked to 
Alzheimer’s disease, diabetes mellitus, and skin 
disorders were performed (2).
RESULTS:
Results showed that 1,8-cineol (33.5%), linalool 
(15.1%), menthone (12.9%), and trans-piperitone 
oxide (12.6%) are the main volatile compounds of 
the essential oil. Moreover, the essential oil exhibited 
promising radical scavenging, reducing power, 
antidiabetic, anticholinesterase, and antityrosinase 
effects. 
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Findings indicated that wild mint essential oil has 
valuable bioactive constituents and great potential 
for uses in food, pharmaceutical, and cosmeceutical 
industries.
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INTRODUCTION:
The genus Carica L. (Caricaceae) is presented by four 
species in Africa and India, of which Carica papaya L. 
is the most widely cultivated and best-known species 
(1). Papaya is known for its food and nutritional values 
all over the world. and for its food and nutritional 
values all over the world. Besides, medicinal uses is 
also common. It is used as antimicrobial, antihelmintic, 
antifungal, hepatoprotective and diuretic. In this study, 
it was aimed that analyzed chemical characterization 
of C. papaya fatty acids and essential oil.
MATERIALS AND METHODS:
Cultivated C. papaya leaves and seeds were supplied 
from Antalya. The dried and fresh seeds of C. papaya 
were extracted by Soxhlet appartures to obtaine 
fatty oils. C. papaya leaves were hydrodistillated for 
3 h by Clevenger-type apparatus. The components 
of essential oil and fatty acids of C. papaya were 
analysed by GC and GC/MS, simultaneously. 
RESULTS:
Oleic acid (72.0, 70.0 %), palmitic acid (15.0, 16.4 %) 
and linoleic acid (5.3, 5.1 %) were found as the major 
components of dried and fresh seeds, respectively. 
Benzyl isothiocyanate (86.3 %), benzene acetonitrile 
(5.4 %) and phytol (6.3 %) were characterized for the 
essential oil of C. papaya leaves.
CONCLUSIONS:
Benzyl isothiocyanate was reported for the first time 
in essential oil of C. papaya (2).
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INTRODUCTION:
The Salvia genus is the largest member of the 
Lamiaceae family. There are about 900 species in 
the world, 98 of them are grown in Turkey. 58 species 
are endemic (1). Salvia genus contains diterpenoids, 
triterpenoids, flavonoids, tannins and phenolic 
acids (2). Alzheimer’s disease is characterised with 
memory weakness, cognitive dysfunction, behavioral 
disorders and daily life activity deficits. In addition 
to this, it is a chronic and progressive neurological 
disease. Until today, there are no treatments that 
can stop or prevent the disease. Furthermore, 
according to the World Health Organization in 2017, 
approximately 10 million new cases are reported 
every year. Thus, the discovery and development 
of new drugs for the treatment of the Alzheimer’s 
disease is extremely important for the social balance 
of aging society (3). In this study, Salvia aramiensis 
roots have been investigated. Based on the literature 
survey, volatile oil and aerial parts extracts of this 
plant was studied previously for antibacterial, anti-
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Alzheimer and antioxidant activities (4). However only 
limited number of studies were reported on the roots 
of Salvia aramiensis in Turkey.
MATERIALS AND METHODS:
 Anti-Alzheimer activities of various extracts 
(infusion, decoction, dichloromethane, methanol) 
from the roots of Salvia aramiensis were 
studied for the acetylcholinesterase (AChE) and 
butyrylcholinesterase (BChE) inhibitor activities 
according the Ellman’s method (5).
RESULTS:
Among the extracts of S. aramiensis the highest 
inhibitory activity against both AChE and BChE was 
obtained with dichloromethane extract (68.51% and 
81.93% at 0.8 mg/mL concentration, respectively) 
followed by the methanol extract (51.44% and 58.54% 
at 0.8 mg/mL concentration, respectively). Whereas, 
infusion and decoction did not show any detectable 
inhibitor activity on AChE and BChE. 
CONCLUSIONS:
Current study confirms the traditional use of Salvia 
species for the treatment of Alzheimer symptoms. 
Previous studies suggest that the AChE and BChE 
inhibitor activity of Salvia species were due to their 
terpenoid compounds. Thus, a bioactivity directed 
isolation study is currently in progress to identify the 
AChE and BChE inhibitor compounds of S. aramiensis 
root extracts. 
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INTRODUCTION:
Hazelnut (Corylus avellana) which is one of the 
traditional products of our country, has been exported 
since the 18th century. More than 300 thousand tons 
of green crust is obtained per year from C. avellana, 
thus it has an important place in Turkey’s economy 
(1, 2). At present, hazelnut pests are left on the fields 
after harvest or used as animal litter. However, there 
is no study on the purification and recovery of the 
main ingredients in its composition.
MATERIALS AND METHODS:
Bracts of hazelnuts were dried and powdered and 
then extracted with methanol. The crude methanol 
extract was suspended in water and extracted 
respectively with n-hexane, dichloromethane, ethyl 
acetate and water to obtain sub-fractions of different 
polarity. The sub-extracts were studied with various 
chromatographic methods (column chromatography, 
vacuum liquid chromatography and medium pressure 
liquid chromatography). The fractions were collected 
and monitored with TLC. Those shows the same 
chromatographic pattern were pooled. 6 compounds 
were isolated. The structures of the isolated 
compounds were elucidated by 1 H, 13C-NMR and 
2D-NMR spectrometric techniques (1D and 2D). 
RESULTS:
The structures of the isolated compounds were 
determined as; β-amirine: α-amirine: lupeol as a 




When the isolated compounds were searched in the 
literature, it was observed that the kaempferol-3-O-
α-L-rhamnopyranoside was previously isolated from 
C. heterophylla and C. avellana species and the rest 
of the compounds was previously isolated from C. 
avellana (3). Future studies are planned to investigate 
the quantities of these components.
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INTRODUCTION:
The genus Xeranthemum L. (Asteraceae) is 
represented by four species in Flora of Turkey 
(1). Xeranthemum annuum L. known as ‘common 
immortelle or everlasting flower’, is an annual herb 
widely distributed in Turkey (2). X. annuum is used 
against burn pains and toothache by mixing with 
tobacco in the folk medicine of Turkey (3,4). Aim of 
this study is to determine the essential oil composition 
of aerial parts of X. annuum collected from Tokat 
province of Turkey.
MATERIALS AND METHODS:
The aerial parts of X. annuum was distilled with 
water for 3 h using a Clevenger-type apparatus. 
The essential oil was analyzed by GC and GC-MS 
simultaneously.
RESULTS:
The main constituents were identified as hexadecanoic 
acid (17.7 %), β-pinene (12.6 %), germacrene D (11.7 
%), β -caryophyllene (5.9 %) and limonene (4.9 %) in 
the essential oil. 
CONCLUSIONS:
In a study conducted in Greece, β-pinene, (15.2%) 
β-caryophyllene (8.6%) and γ-muurolene (6.8%) 
were the main components in the essential oil (5). 
The present work is the first contribution into the oil 
composition of X. annuum from Turkey.
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INTRODUCTION:
Crataegus sp. (Hawthorn), which belongs to the family 
Rosaceae, is comprising approximately 300 species 
and have been used for the treatment of various 
diseases such as digestive problems, hyperlipidemia, 
cardiovascular system disorders in different cultures 
for many centuries (1,2). Crataegus oxyacantha 
L. (syn. C. laevigata) and Crataegus monogyna 
Jacq.  are commonly used species in commercial 
products (3). Major chemical constituents of the 
leaves, fruits and flowers include flavonoids such as 
vitexin, hyperoside, vitexin-2- rhamnoside, isovitexin, 
quercetin (3,4). The main objective of this study was 
to determine the total flavonoid contents of Crataegus 
extracts and four commercial products which were 
prepared using different methods. 
MATERIALS AND METHODS:
The dried flowers, leaves and fruits of C. oxyacantha 
and C. monogyna were extracted with the mixtures of 
ethanol: water (70:30, 50:50, 45:55) and quantitative 
analysis  (percentage of hyperoside, vitexin-2-
O-rhamnoside and total flavonoids expressed as 
hyperoside) was performed by HPLC. Besides, the 
hyperoside and vitexin-2-O-rhamnoside contents of 
four different products supplied from the market were 
determined using external standard method. 
RESULTS:
Our results indicated that total flavonoid contents 
expressed as hyperoside of the C. oxyacantha and C. 
monogyna were in the range of 0.5272 to 0.9189%. 
Vitexin-2-O-rhamnoside and hyperoside amounts in 
the preparations (C.oxyacantha, C.monogyna and 
four commercial products) were calculated in the 
range of 0.1714 to 5.9716%, and 0.0463 to 1.6463%, 
respectively. 
12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 163
CONCLUSIONS:
In this study hyperoside and vitexin-2-O-rhamnoside 
contents of Crataegus species and 4 commercial 
products were determined. According to the results, 
extraction with 45% ethanol yielded higher flavonoid 
content and among commercial products, the one 
in phytosome form was found to involve the highest 
content by far. These results showed that the highest 
content of the flavonoid by 45% ethanol extraction 
was noted in the commercial product which is in the 
phytosome form. 
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INTRODUCTION:
The aim of this study is the investigation of 
antihyperglycemic effect of Elaeagnus rhamnoides 
(L.) A. Nelson subsp. caucasica Rousi and 
determination of its phytopharmaceutical potential for 
treating of Diabetes Mellitus. Elaeagnus belongs to 
Elaeagnaceae family and it is represented with two 
species in Turkey. E. rhamnoides is known as “yalancı 
iğde, çıçırgan” in Turkey. The fruits of the plant are 
used as constipating, tonic and antiseptic agent. Also 
fruits are used against influenza and colds due to 
high vitamin C content in Turkish folk medicine (1). 
E. rhamnoides has been found to have anticancer, 
antimutagenic, antioxidant and antibacterial effects in 
previous studies and to be effective in the treatment 
of cardiovascular disorders, gastric ulcer, liver 
damage, burn and atopic dermatitis (2). According 
to the previous studies, its extracts were found to 
have flavonoids, proanthocyanidins, vitamins C 
and E, tocopherols, carotenoids (3). E. rhamnoides 
subsp. caucasica grows in Anatolia (1). Its fruits are 
consumed traditionally because of their aphrodisiac 
and antitussive effects in Elazığ/Turkey (4).
MATERIALS AND METHODS:
In this study, 70% methanol extract and its different 
polarity fractions (n-hexane, dichloromethane, ethyl 
acetate, n-butanol and water) prepared from leaves 
of the plant were evaluated for in vitro α-glucosidase 
inhibitory activity (5).
RESULTS:
The methanol extract and fractions (ethyl acetate, 
n-butanol and water) showed inhibitory activities with 
10.8% (IC50=0.2632 mg/mL), 93.1% (IC50=0.0456 
mg/mL), 92.6% (IC50=0.0494 mg/mL) and 79.0% 
(IC50=0.0698 mg/mL) values, respectively at 100 µg/
mL concentration. n-Hexane and dichloromethane 
fractions didn’t show any inhibition. 
CONCLUSIONS:
The ethyl acetate and n-butanol fractions showed 
the best α-glucosidase inhibitory activities when 
compared with the standard compound acarbose that 
displayed 0.2% inhibitory activity (IC50=2.8488 mg/
mL) at 100 µg/mL concentration.
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P-069: SCREENING FOR ALPHA-
GLUCOSIDASE INHIBITION ACTIVITY OF
PALIURUS SPINA-CHRISTI MILLER
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1Guvenalp, Z.
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INTRODUCTION:
The aim of this study is the investigation of 
antihyperglycemic effect of Paliurus spina-christi 
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Mill., used in folk medicine for the treatment of 
hyperglycemia which causes a lot of illnesses, and 
determination of whether it has phytopharmaceutical 
potential. Paliurus Mill. belongs to Rhamnaceae 
family and it is represented with one species in 
Turkey. P. spina-christi is known as “karaçalı, çaltı 
dikeni” in our country (1). This species is a very spiky 
hedge with a height of 2-4 m. The fruits of the plant 
are used in Turkish folk medicine as antidiabetic, 
diuretic, constipating agent and against kidney 
stones. Moreover, it is known that it has been used 
in the past against eye diseases (2-3). Flavonoids, 
tannins, amino acids, alkaloids and sterol content (3) 
in addition to antibacterial and antioxidant activities 
of this species have been reported (4) in previous 
studies.
MATERIALS AND METHODS:
In this study, the 70% methanol extract and its 
different polarity fractions (n-hexane, chloroform, 
ethyl acetate, n-butanol and water) prepared from 
fruits of P. spina-christi were evaluated for in vitro 
α-glucosidase inhibitory activities (5).
RESULTS:
The methanol extract and fractions (n-hexane, 
chloroform, ethyl acetate, n-butanol and water) 
showed inhibitory activities with 59.1% (IC50=0.5292 
mg/mL), 74.5% (IC50=0.4502 mg/mL), 50.7% 
(IC50=0.7971 mg/mL), 16.1% (IC50=3.9219 mg/
mL), 29.0% (IC50=1.0561 mg/mL) and 73.3% 
(IC50=0.4765 mg/mL), respectively at 750 µg/mL 
concentration. 
CONCLUSIONS:
The n-hexane and water fractions showed the best 
α-glucosidase inhibitory activities when compared 
with the standard compound acarbose that displayed 
4.6% inhibitory activity (IC50=2.9438 mg/mL) at 750 
µg/mL concentration.
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INTRODUCTION:
The water extract of Opuntia-ficus indica (L.) Mill. 
(Cactaceae) is used in folk medicine in South Anatolia 
(1). The aim of this study is to search antimicrobial 
activity of Opuntia-ficus indica and isolate new and 
active compounds. 
MATERIALS AND METHODS:
The fruits of Opuntia-ficus indica were collected from 
Alanya district and water-methanolic extract of the 
dried and fleshy residue was prefractionated with 
n-hexane, ethylacetate and n-buthanol respectively. 
n-butanol, ethylacetate fractions and the water-
methanolic extract were tested for antimicrobial activity 
against to bacteria (E.coli ATCC 25922, E. faecalis 
ATCC 29212, S. aureus ATCC 29213) and mycetes 
(C. albicans ATCC 90028, C. krusei ATCC 6258, C. 
parapsilosis ATCC 90018) with agar microdilution 
method. Also, we have a serial chromatographic 
studies on the buthanolic and ethylacetate fractions.
RESULTS:
Four flavonoid glycosides and two flavonoid aglycones 
were isolated after a serial chromatographic studies 
on the buthanolic and ethyl acetate fractions. The 
n-butanol, ethyl acetate fractions and the water-
methanolic extract were tested for antimicrobial 
activity against to bacteria and mycetes. And 
according to minimum inhibition concentration of 
fractions they were found active for mycetes.
CONCLUSIONS:
Four flavonoid glycosides and two flavonoid aglycones 
were isolated after a serial chromatographic studies 
on the buthanolic and ethyl acetate fractions. 
Their structural elucidation of the pure compounds 
were done by 1D- and 2D-NMR analysis and 




rhamnopyranosyl)- glucopyranoside were identified 
from the buthanolic fraction, while isorhamnetin and 
3-O-methyl quercetin were from the ethylacetate 
fraction. Isorhamnetin-3-O-β-(2’’-O-β-xylopyranosyl-
6’’-O-α-rhamnopyranosyl)- glucopyranoside was 
isolated for the first time from the nature in this study. 
The NMR data of the isolated known compounds are 
in good accordance with the references (2, 3).
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P-071: EVALUATION OF Α-AMYLASE, 
Α-GLUCOSIDASE AND PANCREATIC LIPASE 
INHIBITION OF TWO PHLOMIS SPECIES
Ekin, H.N., Deliorman Orhan, D., Aslan, M.
Gazi University, Faculty of Pharmacy, Department of 
Pharmacognosy, Ankara, Turkey
INTRODUCTION:
Diabetes mellitus is a chronic metabolic disorder 
which characterized by hyperglycaemia resulting from 
defects in insulin mechanism. Obesity is characterized 
by excess adipose tissue and leads to various 
chronic diseases. The inhibition of the α-glucosidase 
and α-amylase enzymes, which play a role in the 
digestion of carbohydrates, can significantly reduce 
the postprandial blood sugar increase. Pancreatic 
lipase inhibition is a focus in obesity treatment due 
to reduced lipid absorption. The aim of the study is 
to determine in vitro antidiabetic and antiobesity 
effects of leaves and flowers of Phlomis grandiflora 
H. S. Thompson var. grandiflora H. S. Thompson and 
Phlomis nissolii L. 
MATERIALS AND METHODS:
80% Ethanol extracts were prepared. α-Amylase and 
α-glucosidase enzyme inhibition methods were used 
to examine antidiabetic activity.Pancreatic lipase 
inhibition method was used to determine antiobesity 
activity.
RESULTS:
Our results revealed that P. grandiflora var. grandiflora 
leaf (84.70±0.78%), flower (95.54±0.41%) extracts and 
P. nissolii leaf (88.18±0.49%), flower (79.41±0.83%) 
extracts displayed strong inhibitory activity against 
α-glucosidase enzyme. All plant extracts displayed 
lower than 50% α-amylase inhibition. P. nissolii leaf 
and flower extracts showed pancreatic lipase enzyme 
inhibitory activity with 25.96±1.74% and 28.34±6.06% 
values respectively while leaf and flower extracts of P. 
grandiflora var. grandiflora was ineffective.
CONCLUSIONS:
Our findings indicated that P. grandiflora 
var. grandiflora and P. nissolii contain potential 
compounds having selective α-glucosidase inhibitory 
activity and our work is in progress to identify their 
active components.
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INTRODUCTION:
The sesquiterpene lactones have chemo-systematic 
significance in Asteraceae family. Phytochemical 
research revealed that sesquiterpene lactones are the 
principal secondary metabolites in Tanacetum genus. 
The investigations of Tanacetum L. species are 
important to find new bioactive compounds, to find out 
of the species of economic value and the elimination 
of systematic classification errors of the species (1). 
Here we report for the first time phytochemistry of 
ethyl acetate and methanol extracts of Tanacetum 
balsamita L.
MATERIALS AND METHODS:
Tanacetum balsamita L. collected from Güzeldere-
Çuh breach (Van) in Turkey. Comparative 
phytochemical investigation was carried out on the 
ethyl acetate and methanol extracts of the plant. The 
sesquiterpene lactones were isolated and purified by 
means of chromatographic methods. Structures of 
isolated compounds were determined by means of 
spectroscopic methods and some chemical reactions 
were carried out.
RESULTS:
The extracts of the aerial parts of Tanacetum 
balsamita yielded a new eudesmanolide; 1α-Acetoxy-
3-epi-erivanin, seventeen known sesquiterpene 
lactones; 1α-Acetoxy-11β(H),13-dihydrodouglanin, 
Taurin, Artesin, Germacranolide with an 1,5-ether 
linkage, Artemin, Chrysanthemolide, Santonin, 
Pallensis, 1,10-epoxyspiciformin, 1-Acetylerivanin, 
8α-Hydroxysantamarin, Tamirin, Tavulin, 1α,8α-
Dihydroxy-10-epi-arbusculin A, 1α-Hydroxy-
desacetylirinol-4α,5β-epoxide, Tanachin and 
Desacetyl-β- cyclopyrethrosin.
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CONCLUSIONS:
Here we report a new sesquiterpene lactone 
1α-Acetoxy-3-epi-erivanin isolated from a natural 
source for the first time. Additionally, sesquiterpene 
lactones 1α-Acetoxy-11β(H),13-dihydrodouglanin, 
Chrysanthemolide, pallensis, 1-Acetylerivanin, 1α,8α-
Dihydroxy-10-epi-arbusculin A are reported for the 
first time from Tanacetum genus. These compounds 
previously isolated from different natural sources.
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INTRODUCTION:
Many new compounds with bioactive properties have 
been identified from Tanacetum L. species. Biological 
activities of the genus seem to be associated with 
sesquiterpene lactones, flavonoids, sesquiterpenes, 
monoterpenes, triterpenes and coumarins (1,2). 
Due to the various beneficial biological activities, 
Tanacetum genus attracted the attention of scientists. 
Here we report phytochemistry of ethyl acetate and 
methanol extracts of Tanacetum mucroniferum Hub.-
Mor. & Grierson for the first time.
MATERIALS AND METHODS:
Tanacetum mucroniferum Hub.-Mor. & Grierson 
collected from Sakaltutan-Erzincan in Turkey. 
Comparative phytochemical investigation was carried 
out on the ethyl acetate and methanol extracts of 
the plant. The secondary metabolites were isolated 
and purified by means of chromatographic methods. 
Structures of isolated compounds were determined 
by means of spectral methods and some chemical 
reactions were carried out.
RESULTS:
The extracts of the aerial parts of Tanacetum 
mucroniferum yielded three new compounds; 
Mucronolide, Ajanolide A epoxide and 1α,3β,10α-
Trihydroxy-7α,11αH-germacra-4-en-12-6α-olide, 
some known compounds: two sesquiterpene lactones; 
Arsanin, 9α-Acetoxyartecanin, six flavonoids; 
Salvigenin, 5-Hydroxy-3′,4′,6,7-tetramethoxyflavone, 
Cirsilineol, Cirsimaritin, Jaceosidin, 5,3′,4′-Trihydroxy-
3,6,7,5′-tetramethoxyflavone, three coumarins; 
Scoparone, Scopoletin, Umbelliferone and one 
triterpene; α-Amyrin.
CONCLUSIONS:
Here we report three new sesquiterpene lactones 
Mucronolide, Ajanolide A epoxide and 1α,3β,10α-
Trihydroxy-7α,11αH-germacra-4-en-12-6α-olide 
isolated from a natural source for the first time. 
Additionally, we report the flavone 5,3′,4′-Trihydroxy-
3,6,7,5′-tetramethoxyflavone for the first time from 
Asteraceae family and the sesquiterpene lactone 
9α-Acetoxyartecanin for the first time Tanacetum 
genus. These compounds previously isolated from 
different natural sources.
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P-074: ESSENTIAL OIL QUANTITY AND 
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ORGANICALLY GROWN LAVENDER AND 
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INTRODUCTION:
Lavender (Lavandula sp.) is a very worthful essential 
oil plant from the Lamiaceae family. There are 39 
lavender species (Lavandula sp.) among them, 
three[(Lavander (Lavandula angustifolia = L. officinalis 
= L. vera), Lavandin (Lavandula x intermedia = L. 
hybrida) Spike lavander (Lavandula spica)] have high 
commercial value.  
Lavander sp.  plays an important role in the 
pharmacology and perfumery industries since it 
contains essential and aromatic oils. The lavender 
provides several  important essential oils to the 
fragrance industry including perfumes, colognes, 
soaps and other cosmetics, flavoring, pharmaceutical, 
and food industries. Lavandula oil is especially useful 
for use in nervous system stimulants, sedatives, 
antibacterial, antifungal, carminative (smooth muscle 
relaxing), and effective for burns and insect bites [1-
4].
In this study, we compared essential oil quantity and 
quality of 4 cultivars of certified organically grown 
lavender (Lavandula sp). 
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MATERIALS AND METHODS:
The composition of the essential oils obtained 
from dried aerial parts of four Lavandula sp., were 
analyzed by GC, GC-MS. Fifteen compounds have 
been identified in these essential oils.
1.  Lavandula angustifolia var. Drujba
2.  Lavandula angustifolia var. Sevtopolis
3.  Lavandula angustifolia var. Yubileina
4.  Lavandin L.x intermedia var. Super A
RESULTS:
Lavandin cultivars (Lavandula x intermedia Super 
A.) produced significantly higher oil yield ( 5 %)) 
compared to  three lavender cultivars ( 2-2,5 % ). The 
major constituents of the oil of Lavender 1, 2 and 3 
were linalool (18-14,82-16,71 %) and 1,8 cineol in 
Lavender 4 (16,82 %).
CONCLUSIONS:
Our results demonstrate that organically-grown 
lavender and lavandin in Southeastern Anatolia 
region. The essential oils obtained from these 
lavender species are commercially evaluated.
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INTRODUCTION:
Serapias L. is a genus of Orchidaceae family, 
which occurs naturally from the east-central and 
eastern Mediterranean to the western Transcaucasus 
that was represented by 30 cosmopolite taxa (1). 
Some of the Orchidaceae species have been used as 
herbal medicine. In the literature, volatile constituent 
analyses of Serapias L. species were not mentioned. 
In this work, volatile components and solvent extracts 
(n-hexane, methanol and water) obtained from 
Serapias orientalis subsp. orientalis were investigated 
by SPME GC-FID/MS (2-4).
MATERIALS AND METHODS:
The plant (S. orientalis subsp. orientalis) used in the 
study was collected from the Karadeniz Technical 
University Campus (115 g, fresh) at an altitude of 130 
meters. Identification of the plant was made by Prof. 
Dr. Salih Terzioğlu and herbarium number was given. 
Solvent extracts, SPME Method were performed 
according to the literature.
RESULTS:
SPME GC-FID/MS analyzes for the fresh plant and 
solvent extract (n-hexane, methanol, and water) 
of S. orientalis subsp. orientalis revealed 7, 12, 7, 
and 4 natural compounds with in the ratio of 99.7% 
to 100.0%, respectively. Limonene (76.6%, 41.8%, 
61.6%, and 45.4%) was found to be major compound 
in the SPME of the fresh plant and SPME of the 
n-hexane, methanol and water extracts of S. orientalis 
subsp. orientalis, respectively. SPME of the methanol 
extract of it revealed p-methoxymethylphenol (52.9%) 
as main component.
CONCLUSIONS:
Limonen was the major compound of all there 
extraction method (SPME, n-hexane, and 
methanol) obtained from fresh S. orientalis subsp. 
orientalis in the range of 41.8% to 76.6%. However, 
p-methoxymethylphenol was found as a major 
component only in methanol extract of the plant. 
This clearly showed that various extraction methods 
that was used in this work gave the identification of 
different components as in the literature.
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P-076: ESSENTIAL OIL AND SPME 
ANALYSIS OF IPOMEA PURPUREA
Erik, I., Korkmaz, B., Yayli, N.
Karadeniz Technical University, Faculty of 
Pharmacy,Trabzon, Turkey
INTRODUCTION:
The genus Ipomoea comprises the largest number of 
species (500-600 species) within the Convolvulaceae 
(1) and found throughout subtropical and tropical 
regions of the world. Several species of Ipomoea have 
been used as an herbal medicine to treat rheumatism, 
hydrocephaly, diabetes, hypertension, dysentery, 
fatigue, arthritis, meningitis, and kidney ailments etc. 
Some of these species showed various biological 
activities such as antimicrobial, anticancer, anti-
inflammatory, analgesic, hypotensive, spasmolitic, 
and anticoagulant. Phenolic, glycolipids, and alkaloid 
type compounds were the most common active natural 
components mentioned from these plant extracts. In 
the literature, essential oil (EO) and SPME analyses 
of Ipomea purpurea were not mentioned. In this work, 
essential oil, wet and dry SPME of I. purpurea were 
investigated by GC-FID/MS (2-4).
MATERIALS AND METHODS:
The plant (I. purpurea) used in the study was collected 
from the Şinik-Akçaabat, Trabzon (215 g, wet) at a 
height of 355 meters. Identification of the plant was 
made by Prof.Dr. Salih Terzioğlu and herbarium 
number was given. EO analysis and SPME method 
were done according to the literature.
RESULTS:
GC-FID/MS analyzes for EO,SPME for the fresh 
and dry plant of I. purpurea have revealed 33, 12, 
and 11 natural compounds within the ratio of 79.1%, 
99.6% and 99.4%, respectively. Caryophyllene oxide 
(30.6%), germacrene-D (28.2%), and trans-(β)-
caryophyllene (22.5%) were the major component 
in the EO of I. purpurea. D-limonene (42.1% and 
42.6%) and germacrene-D (34.2% and 33.6%) were 
the main compounds in both wet and dry I. purpurea, 
respectively.
CONCLUSIONS:
Terpenes and terpenoids constituent of I. purpurea 
were the major class of compounds. Wet and dry 
SPME analysis of I. purpurea gave almost the same 
compounds with small differentiation in the ratio.
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INTRODUCTION:
Plectranthus zeylanicus Benth (Lamiaceae), is 
a perennial herb widely utilized in Ayurvedic and 
folk medicine in Sri Lanka for thousands of years 
(1). Although the plant is traditionally used as an 
antimicrobial remedy, its pharmacological features and 
the phytochemistry have not been comprehensively 
explored yet to rationalize the reported ethnobotanical 
significance. Therefore, the present study was 
undertaken to evaluate the antimicrobial potential of 
different extracts of P. zeylanicus and to characterize 
the bioactive phytochemicals thereof. 
MATERIALS AND METHODS:
Organic extracts prepared from the whole plants of 
P. zeylanicus were tested against Gram positive 
and Gram negative bacteria; Enterococcus 
faecalis, Staphylococcus aureus, Staphylococcus 
saprophyticus, Escherichia coli, Pseudomonas 
aeruginosa, Salmonella serotype Typhi and nine 
clinical isolates of methicillin-resistant Staphylococcus 
aureus (MRSA). Besides, the antifungal activity was 
evaluated against the opportunistic fungal pathogen, 
Candida albicans. Disc diffusion and broth micro-
dilution methods were employed in the determination 
of the antimicrobial activity of these extracts. Based on 
the preliminary observations, the most active extract 
was subjected to activity guided fractionation and the 
isolated compounds were extensively studied for the 
antimicrobial activity. Furthermore, the quantitative 
surface disinfectant assay was employed to determine 
the disinfectant potential of the compounds against 
MRSA strains on smooth and rough surfaces.
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RESULTS:
A potent antimicrobial activity was observed in 
dichloromethane extract, hence subjected to the activity 
guided fractionation. The extract was also analyzed 
by gas chromatography coupled mass spectrometry, 
and it revealed the presence of phytosterols, fatty 
acids, sesquiterpenes, acyclic diterpenes and 
several other metabolites. Among the compounds 
isolated from this extract, the structure of the most 
active compound was elucidated as 7α-acetoxy-6β-
hydroxyroyleanone by liquid chromatography coupled 
mass spectrometry and nuclear magnetic resonance 
data. This compound displayed a prominent 
antibacterial activity especially against S. aureus, S. 
saprophyticus, P. aeruginosa and MRSA isolates with 
a minimum inhibitory concentration (MIC) in the range 
of 31.25-250 µg/mL. Furthermore, the compound has 
inhibited the growth of C. albicans and also exhibited 
a significant disinfectant potential against MRSA 
isolates in comparison to the commercially available 
disinfectants. 
CONCLUSIONS:
The MIC values observed as 31.25 µg/mL for 
7α-acetoxy-6β-hydroxyroyleanone was significantly 
better than the MIC values reported in literature for 
most of the ubiquitous phyto-constituents. Further 
studies on disinfectant activity and self-assembly 
properties of the isolated secondary metabolites 
are in progress in the pursuit of new antimicrobial/
disinfectant agents.
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INTRODUCTION:
Anchusa strigosa, a member of the Boraginaceae 
family, is distributed in temperate climatic regions, 
especially in the tropical zone and in the Mediterranean 
(1). The aerial parts of Anchusa strigosa were used 
in digestive disorders and cancer treatment as folk 
medicine in Turkey (2, 3). Phytochemical studies 
on Anchusa strigosa have shown that pyrrolizidine 
alkaloids and phenolic compounds were isolated from 
the roots (4). 
MATERIALS AND METHODS:
The roots of the Anchusa strigosa were collected in 
Malatya, cleaned and then sliced into small pieces 
and dried. Methanol extract was prepared for activity 
studies. n-Hexane, dichloromethane, ethyl acetate, 
n-butanol and residual aqueous fraction were obtained 
from the methanol extract respectively, by liquid-liquid 
fractionation. The extract and fractions were applied 
to the 5-lipoxigenase (5-LOX) inhibition assay. The 
determination of 5-LOX (soybean) inhibition levels of 
all samples was performed according to the reference 
method with a spectrophotometric kinetic method 
adapted to some modifications (5).
RESULTS:
As a result, when the percentages of inhibition on 
the enzyme of the liquid-liquid fractions and the 
methanolic extract were evaluated, it was found that 
the ethyl acetate fraction inhibited 67.96% of the 
enzyme at 100 µg / ml with the highest activity. Serial 
dilutions from the ethyl acetate fraction were prepared 
for determining the IC50 value, the IC50 value was 
determined to be 40.875 μg / ml. Nordihydroguaiaretic 
acid (NDGA) was used as the standard reference and 
the IC50 value was determined to be 6.95 μg / ml.
CONCLUSIONS:
According to our results, Anchusa strigosa may be a 
potential source for obtain an anti-inflammatory drug. 
Our further studies are in progress.  
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INTRODUCTION:
The genus Marrubium has a common traditional 
usage such as, pulmonary infections, inflammation 
and hypotension, as cholagogue and sedative agent, 
and for pain relief. It contains several diterpenoids 
(e.g. marrubiin) and phytochemical constituents 
comprise mainly diterpenes, polyphenols, steroids, 
phenylpropanoids and flavonoids with important 
biological properties (1).
MATERIALS AND METHODS:
Aerial parts of Marrubium heterodon (Local name: 
Kınalı Kekik) were collected at flowering stage 
from Bolkar mountain, Niğde-Turkey. The aqueous, 
methanolic and ethyl acetate extracts were obtained 
by macerating plant materials for 3x24h. Experiments 
were performed with a Shimadzu 20A HPLC system 
coupled to an Applied Biosystems 3200 Q-Trap LC- 
MS/MS instrument equipped with an ESI ion source 
was used in the negative ionization mode. Separations 
were performed on an ODS 150 x 4,6 mm, i.d., 3 µm 
particle sizes, octadecyl silica gel analytical column 
operating at 40ºC at a flow rate of 0.5ml/min. 
RESULTS:
According to the LC-MS/MS analysis, Anisofolin is the 
only compound determined in the ethyl acetate extract 
which was previously identified  in Marrubium vulgare 
(2). Main compound of the ethyl acetate extract 
was determined as a quercetin derivative. Methanol 
extract was found to be rich in phenyl propanoid and 
flavonoid derivatives. Kaempferol rutinoside and rutin 
were determined in the aqueous extract.
CONCLUSIONS:
The compounds we have identified in Marrubium 
heteredon have also been detected in other 
Marrubium species. The pharmacological activity of 
the identified compounds may be indicative of the 
noteworthy conclusion of the biological activity studies 
to be performed on this endemic species.
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INTRODUCTION:
The genus Polygonum (Polygonaceae) contains about 
300 species in the world. It consists of 41 species as 7 
of them endemic in Turkey (1). Some species possess 
antioxidant, antitumor and antidiabetic effects, etc. 
Numerous Polygonum species are frequently used as 
food, as well as in traditional medicine. Some of the 
secondary metabolites identified in the species of the 
Polygonum genus are flavonoids, anthraquinones, 
stilbenes, terpenes, tannins and lignans (2).This study 
was focused on the determination of the total phenolic 
and flavonoid contents together with antioxidant 
capacity of Polygonum equisetiforme Sibth. & Sm.
MATERIALS AND METHODS:
Methanol extract of the aerial parts of P. equisetiforme 
was dissolved in water and partitioned with petroleum 
ether. Aqueous extract was subjected to polyamide 
coloumn to give six main fractions.Total phenolic 
and flavonoid content of extracts and fractions were 
measured by Folin-Ciocalteau and AlCl3 assays 
(3). Determination of in vitro antioxidant capacity of 
samples are done by DPPH, ABTS,NO, SO, FRAP 
and CUPRAC assays.
RESULTS:
Total phenolic content was measured as 835.9 mg 
gallic acid/100 g material for fraction 16-18 and 
total flavonoid content was measured as 284.6 
mg quercetin/g for fraction 16-18. IC50 values for 
DPPH, NO and SO assays measured as 18.88 μg/
ml for fraction 5-8, 104.37μg/ml for fraction 23-28 and 
12.87μg/ml for fraction 9-12 respectively. CUPRAC, 
FRAP and ABTS antioxidant capacities were 
measured as 797.9 mg gallic acid/g for fraction 23-28, 
826.9 mg trolox/g for fraction 16-18, 448.6 mg trolox/g 
for fraction 16-18 respectively.
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CONCLUSIONS:
Fraction 16-18 shows the highest antioxidant capacity, 
total phenolic and flavonoid contents. Fractions 9-12 
and 23-28 have promising antioxidant capacities. 
Further studies will continue on these highly effective 
fractions.
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INTRODUCTION:
Asparagus (Asparagus officinalis L., Liliaceae) spears 
which widely consumed all over the world, are highly 
valued for their abundance of bioactive compounds 
such as saponins, flavonoids, hydroxycinnamic 
acids, sterols, fructan, carotenoids, and amino 
acids (1). According to the literature, A. officinalis 
is an herbal medicine with remarkable antioxidant, 
anti-inflammatory, and antihepatotoxic, antitumor, 
and anti-diabetic activities as well as possessing 
hypocholesterolemic, hypotensive and renal 
protective properties (1, 2). The objective of this 
investigation was, to evaluate the influence of different 
cultivation region on the anti-inflammatory activity and 
chemical profile of Asparagus officinalis.
MATERIALS AND METHODS:
Fresh Asparagus spears were purchased from 
a supermarket, in Turkey. Ethanolic extracts of 
A. officinalis, cultivated in Peru(P) and Turkey(T) 
obtained with different extraction techniques such 
as maceration, soxhelet apparatus. The in vitro 
anti-inflammatory effects of the extracts (P, T1, and 
T2) were determined by applying HRBC method; 
reference chemically acetylsalicylic acid. 
RESULTS:
All extracts exhibited in vitro anti-inflammatory 
activities with different IC50 values ranging from 2.63 
to 9.16 mg/ml. The results showed that the extract 
of samples cultivated from Turkey and obtained by 
using soxhlet technique was the most effective when 
compared with the other extracts.
CONCLUSIONS:
According to the results of current study, the extract 
prepared by using soxhlet apparatus exhibited 
better anti-inflammatory activity. This result suggests 
that soxhlet extraction yielded higher content of the 
components which are responsible for the anti-
inlammatory activity of the plant.
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INTRODUCTION:
Microalgae and Cyanobacteria are prominent 
microorganisms with their unique features. 
Cyanobacteria, itself, and their metabolites are 
potentially of therapeutical importance, such as 
antiviral, immune-modulators, inhibitors (such as 
trypsin, plasmin, thrombin, chymotrypsin inhibitor etc.), 
or cytostatics and the most important cyanobacteria 
is Spirulina platensis biotechnologically (1, 2). 
C-phycocyanin is one of the major biliproteins in S. 
platensis, which has high commercial value as natural 
dye but an increasing number of investigations have 
shown on its health promoting properties and broad 
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range of pharmaceutical applications (3). In this study, 
four cyanobacteria were isolated from three different 
geothermal sources from Afyonkarahisar. Our aim is 
to investigate these species for their therapeutically 
active bioproducts, which have commercial potential, 
as an alternative of S. platensis.
MATERIALS AND METHODS:
DNA analyses of cyanobacteria were made in 
Refgen Gene Research and Biotech. Co. in Turkey. 
HPLC-DAD system was used for determination of 
carotenoid profiles. C-phycocyanins were isolated by 
using stepwise chromatography methods and were 
compared with standard C-phycocyanin with SDS-
Page (4). Antioxidant activity was determined with 
DPPH and cytotoxic activity experiments were also 
conducted against HEp-2 cell line by MTT assay (5).
RESULTS:
Strains were determined as Geitlerinema sp. (M1), 
Oscillatoria sp. (M2) and two Leptolyngbya sp. 
(M3 and M4). HPLC-DAD showed that lutein is a 
major carotenoid in all species. C-phycocyanin was 
isolated with highest yield (36%) from freeze-dried 
M3 biomass. M3 extracts showed highest cyctotoxic 
(IC50 =66 µg/ml) and antioxidant activity (IC50 =68,52 
µg/ml), among other strains. 
CONCLUSIONS:
Globally, alternative therapeutic and nutritive source 
seeking is increasing. Leptolyngbya sp. (M3) can be 
an alternative of Spirulina sp. market with its bioactive 
compounds for humans’ health and nutrition.  
REFERENCES:
1.  Pulz O, Gross W (2004). Appl Microbiol 
Biotechnol, 65:635-648.
2.  Skulberg OM (2000). J Appl Phycol, 12:341-348.
3.  Spolaore P, Joannis Cassan C, Duran E, 
Isambert A (2006). Journal of Bioscience and 
Bioengineering, 101: 87-96.
4.  Herrera A, Boussiba S, Napoleone V, Hohlberg A 
(1989). J of Appl Phycol, 1: 325-331.
5.  Harput S, Genc Y, Saracoglu I (2012). Food 
Chem Toxicol, 50: 1554-1559.
P-084: DETERMINATION OF ANTIAGING 
POTENTIAL OF RUMEX CRISPUS’  MAIN 
COMPOUNDS BY MOLECULAR DOCKING 
STUDIES
Uzun, M., Demirezer, LO. 
Hacettepe University, Department of 
Pharmacognosy, Ankara, Turkey
INTRODUCTION:
MMP-1, MMP-8 and MMP-13 enzymes are interstitial 
collagenases and play an important role in the 
breakdown of collagenase, which provides skin youth 
and tightness (1). Rumex species (Polygonaceae) 
have various biological effects and contain 
anthranoids, tannins, flavonoids and naphthalenes as 
main secondary metabolites (2-4). In this study, we 
aimed to determine the MMP inhibitory activities of 
these secondary metabolite skeletons by molecular 
docking method.
MATERIALS AND METHODS:
AutoDock-Vina 1.5.4 program (5) was used as the 
basic docking software for docking calculations. 
RCSB Protein Data Bank, PDB Sum, SDSC Biology 
Work Bench, Notepad++, Discovery Studio 3.5 Client, 
MGLTools 1.5.4, VMD 1.9, Pymol programs have 
been used as utilities. MMP-1, MMP-8 and MMP-13 
enzymes were selected as targets, tannin, flavone, 
naphthalene and anthraquinone skeletons were 
selected as ligands. The target MMP-1, MMP-8 and 
MMP-13 enzymes were constructed with pDB:966C, 
pdb:1BZS and pdb:3ZXH codes, respectively. 3-D 
structures of ligands were drawn with Discovery 
Studio 3.5 Client. Docking simulations between 
ligands and targets were repeated 50 times.
RESULTS:
The binding energies were found as: to MMP-1; 
tannin (-9.9 kcal/mol), flavonoid (-8.5 kcal/mol), 
antrhraquinone (-7.5 kcal/mol), naphthalene (-6.7 
kcal/mol) , to MMP-8; tannin (-10.3 kcal/mol), 
flavonoid (-9.5 kcal/mol), naphthalene (-7.4 kcal/mol), 
antrhraquinone (-6 kcal/mol), to MMP-13; tannin (-8 
kcal/mol), flavonoid (-7.9 kcal/mol), antrhraquinone 
(-7.6 kcal/mol) and naphthalene (-6.3 kcal/mol).
CONCLUSIONS:
According to the results of molecular docking studies, 
all of the ligands have lower binding energies ( 
< -2 kcal / mol ), which shows they could inhibit 
MMP-1, MMP-8 and MMP-13 enzymes. Molecular 
docking studies of anthranoid, tannin, flavonoid and 
naphthalene skeletons on MMP-1, MMP-8 and MMP-
13 enzymes were carried out for the first time.
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INTRODUCTION:
MMPs (Matrix Metalloproteinases) are called 
proteolytic enzymes and responsible for breaking 
down extracellular matrix and cause of cell-aging (1). 
A member of this family MMP-13 play an important 
role in the breakdown of collagenase, thus causing 
premature aging of the skin (2-3). Therefore inhibition 
of MMP-13 enzyme should be a part of treatment 
strategy in skin aging. In this study, we aimed to 
determine the MMP-13 inhibitory activities of Rumex 
crispus L. (Polygonaceae) extracts.
MATERIALS AND METHODS:
Standardized n-hexane, dichloromethane, ethyl 
acetate, ethanol and ethanol:water (70:30) extracts 
were prepared from roots, leaves and fruits and 
inhibitory effects on MMP-13 were investigated. MMP-
13 inhibitor screening assay kit -including microplate, 
MMP-13 enzyme (3.45 U/ µl), MMP inhibitor (1.3 mM 
NNGH in DMSO), MMP substrate (25 mM in DMSO) 
and colorimetric assay buffer- was used. NNGH was 
used as potent MMP-13 inhibitor. Inhibitor activities of 
all extracts were measured in 50 μg/mL, 100 μg/mL, 
200 μg/mL, 300 μg/mL, 400 μg/mL and 800 μg/mL 
concentrations at 412 nm.
RESULTS:
The aqueous alcoholic extracts showed the 
highest inhibitory effect among other extracts at all 
concentrations. Inhibition values were 87.08% for root 
extracts, 85.41% for leaf extracts and 89.38% for fruit 
extracts, while NNGH was 91.94%. 
CONCLUSIONS:
The MMP-13 inhibitor acitivities of Rumex crispus L. 
extracts were first determinated. This study shows 
that aqueous alcoholic extracts of Rumex crispus L. 
may be potential novel MMP-13 inhibitors and may 
fight against skin aging.
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INTRODUCTION:
Rumex acetosella L. is a member of Rumex genus 
from Polygonaceae family and widely distributed over 
the world with a wide scale of traditional usage (1). 
MATERIALS AND METHODS:
We used various chromatography techniques to view 
phytochemical profile of Rumex acetosella. In this 
respect, roots of R. acetosella were extracted with 
methanol, which was subjected to diverse column 
chromatographies based on different seperation 
techniques for isolation of pure compounds. Following 
isolation of the pure compounds, the structures of 
which were identified based on the spectroscopic 
data such as IR, Mass and NMR spectra. 
RESULTS:
As a result of phytochemical studies, total of 12 
compounds in which one as a new compound 
were elucidated on the basis of spectroscopic 
data. Structures of those compounds were 
identified as (E)-piceid (a stilbene derivative), 
ethanone, 1-[2-(β-glucopyranosyloxy)-4-hydroxy-6-
methylphenyl)] (an ethanone derivative), nepodin-
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8-O-β-glucoside (naphthalene derivative), catechin 
(tannin derivative), lyoniside and isolariciresinol- 
9-O-β-xyloside (lignan derivatives), a mixture of 
rumejaposide G and rumejaposide H, emodin, emodin-
8-O-β-glucoside, a mixture of chrysophanol-8-O-β-
glucoside and physcion-8-O-β-glucoside (anthranoid 
derivatives). IR spectrum of new compound pointed 
out the presence of aromatic C=C (1464, 1605 cm-1), 
aromatic C-H (3000-3100 cm-1), alkane C-H (1328, 
2928 cm-1), C-C (944, 1023 cm-1), O-H (3300-3650 
cm-1), C-O (1077, 1173 cm-1), and C=O (1654 cm-1) 
functions. For the new compound, 1H-NMR spectrum 
indicated H atoms with their integrating proton signals, 
while 13C-NMR spectrum detected the data of carbon 
atoms in the structure. Additionally, COSY spectrum 
presented H signals coupled with each other. HMQC 
spectrum exhibited H atoms and their binding carbons 
in the structure, whereas HMBC displayed long-
range couplings between protons and carbons in the 
molecule. Following the analysis of NMR spectra, 
molecular formula of the new compound was detected 
as C15H20O8, which was further confirmed by HR-
MS (ESI) m/z as [M+Na] + 351.1047. 
CONCLUSIONS:
The structures of the compounds isolated from 
R. acetosella roots were identified based on 
spectroscopic data in the literature. The structure of 
the new compound was checked in the literature, as 
well; however any substance with those data was 
found. Therefore, the new compound as an ethanone 
derivative was named as acetoselloside.
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INTRODUCTION:
The genus Cephalaria Schrad. ex Roem. (family 
Caprifoliaceae) comprises about 94 species, which 
are widespread, mainly in the Mediterranean region 
and the Middle East. Cephalaria is represented by 
39 species in Turkey (3). Cephalaria procera Fisch. 
& Avé-Lall. is called as Ganteper, Gulinga and 
Cevrük and its stems are used for wound healing 
and antihemorhagic in Turkey (4).  This study aims 
to investigate the antimicrobial activites of the several 
extracts obtained from aerial parts of C. procera 
species. 
MATERIALS AND METHODS:
The whole plants of C. procera were collected from 
Eastern Turkey (Erzurum) in July 2017 by Dr. Yeter 
Yeşil, Nurdan Yazıcı Bektaş and Burak Bektaş; 
identified by Dr. Yeter Yeşil. These specimens were 
stored at the Herbarium of Istanbul University (ISTE 
115 326, ISTE 115 327). The aerial part of C. procera 
was extracted with methanol at room temperature 
for overnight three times. The methanol extract was 
concentrated under reduced pressure. The methanol 
extract was solved with distilled water and extracted 
with n-buthanol. N-buthanol extract was dried and 
extracted with n-hexane. By this way methanol, water, 
n-buthanol and n-hexane extracts were obtained 
(5). Antimicrobial activity was analyzed using a 
microdilution assay against several microorganisms 
(1, 2).
RESULTS:
According to our results, it is observed that n-hexane 
extract exhibited antifungal activity  with the lowest 
MIC (156.2 µg/mL) value against tested Candida 
tropicalis. Also, n-hexane and n-buthanol extracts 
showed antibacterial activity with the lowest MIC 
(312.5 µm/mL) value against Escherichia coli. 
CONCLUSIONS:
To the best our knowledge, evaluation of the some of 
these C. procera species antimicrobial activity is the 
first of its kind.
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INTRODUCTION:
The genus Cephalaria is one of the largest genus 
in family Caprifoliaceae with 94 species, it is 
widespread, mainly in the Mediterranean region and 
the Middle East. Cephalaria is represented by 39 
species in Turkey (2). Some Cephalaria species are 
used medicinally such as Cephalaria procera Fisch. 
& Avé-Lall in Turkey. It is known as Ganteper, Gulinga 
and Cevrük, its stems are traditionally used for 
wound healing and antihemorhagic in Turkey (1, 4). 
The scope of this work was to investigate biological 
properties of C. procera exracts to determine its 
potential therapeutic usage in neurodegenerative 
diseases. 
MATERIALS AND METHODS:
The plant materials were collected from Erzurum in 
July 2017. Methanol, water, n-buthanol and n-hexane 
extracts of C. Procera aerial parts were prepared (3). 
Antioxidant activities (2,2-diphenyl-1-picrylhydrazyl, 
phosphomolibdenum-reducing antioxidant power 
assays), acetylcholinesterase , butyrylcholinesterase 
and tyrosinase inhibitory properties of these extracts 
were determined according to literature (5).
RESULTS:
Methanol and water extracts showed the highest 
radical scavenging activities with SC50 values of 83.21 
± 3.20 and 89.91 ± 0.13 µg/mL, respectively among 
the tested extracts. All of extracts demonstrated the 
lowest reducing power activities all of concentrations 
when compared to quercetin. N-buthanol extract had 
the highest cholinesterase inhibitory properties with 
IC50 values of 134.63 ± 4.49 and 62.76 ± 0.63 µg/mL. 
In addition, n-buthanol extract (51.95 ± 0.35 µg/mL) 
and methanol extract (56.13 ± 1.17 µg/mL) showed 
higher inhibitory effects against Tyr than kojic acid 
(58.26 ± 0.25 µg/mL) as a positive control.
CONCLUSIONS:
Our results demonstrated that C. procera exracts 
would be a potential therapeutic agent for the 
neurodegenerative treatment.
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INTRODUCTION:
Taxus baccata L. (Taxaceae), the single 
representative in the flora of Turkey, is an evergreen 
and widespread shrub commonly cultivated as an 
ornamental in gardens (1). Until now, the isolation 
of a great number of secondary metabolites, majorly 
taxoids as well as lignans, flavonoids, steroids, and 
sugar derivatives has been reported from genus 
Taxus. Our phytochemical investigations of T. baccata 
using chromatographic methods have led to the 
isolation of the lignans; lariciresinol (1), taxiresinol (2), 
3’-demethylisolariciresinol-9’-hydroxyisopropylether 
(3), isolariciresinol (4), and 3-demethylisolariciresinol 
(5) as well as taxoids. These lignans (1-5) have 
evaluated for their several biological activities such as 
anti-inflammatory, antinociceptive, anti-ulcerogenic, 
antimicrobial, cytotoxic, and antioxidant as well as 
acetylcholinesterase, butyrylcholinesterase and 
lipoxygenase inhibitory activities (2,3). In continuation 
of our studies on screening of Turkish medicinal 
plants and their secondary metabolites for various 
biological activity to be explore as potential leading 
compounds, we have now evaluated the lignans (1-5) 
obtained from T. baccata for their antiplatelet activity.
MATERIALS AND METHODS:
Platelet aggregation was determined by in vitro 
turbidimetric method using an aggregometer (4). 
Antiplatelet activities of isolated lignans from the 
woods of T. baccata against platelet aggregation 
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induced by collagen at 1 mM and 200 µM were 
evaluated and compared with those of aspirin. 
Inhibition of platelet aggregation was expressed as 
percentage of inhibition in triplicate experiments.
RESULTS:
All investigated lignans, except 4, were showed 
inhibitory activity on platelet aggregation induced by 
collagen at a concentration of 1 mM with a range from 
87.62±2.07 to 94.79±2.29. Otherwise, 1, 3 and 5 were 
exerted a low inhibition on platelet aggregation at 200 
µM with inhibiton % of 11.43±1.79, 13.41±3.07 and 
12.37±7.14, respectively.
CONCLUSIONS:
Our results considered that lignans from T. baccata 
might be investigate other platelet aggregation 
agonists such as arachidonic acid, thrombin and ADP 
to evaluate their antiplatelet activity. 
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INTRODUCTION:
The genus Salsola L. (Chenopodiaceae) is represented 
by sixteen species in Turkish Flora. Among them, 
Salsola grandis Freitag, Vural & N. Adıgüzel, a 
halophytic endemic species, is narrowly distributed 
at Nallıhan Kuş Cenneti, Ankara (1). Salsola species 
have been reported to contain various bioactive 
constituents that have displayed several biological 
activities such as analgesic, anti-inflammatory, 
antioxidant, antihypertensive, hepatoprotective, 
and tyrosinase and acetylcholinesterase inhibitory 
activities. Our previous phytochemical studies on the 
aerial parts of S. grandis have led to the isolation of the 
flavonols and saponosides as well as one amino acid 
derivative compound exhibiting anti-inflammatory, 
antinociceptive and anticholinesterase activities. The 
chemical structures of the flavonols were identified 
as isorhamnetin-3-O-rutinoside (1), quercetin-
3-O-rutinoside (2), quercetin-3-O-metyhylether 
(3), tiliroside (4), isorhamnetin-3-O-glucoside (5), 
quercetin-3-O-galactoside (6), and quercetin (7) using 
spectral techniques (2,3). In our continuing research 
on bioactive natural compounds from Turkish plants, 
we have now aimed to investigate antiplatelet activity 
of the isolated flavonols (1-7) from S. grandis in the 
present study.
MATERIALS AND METHODS:
Platelet aggregation was measured by using an 
aggregometer according to the turbidimetric method 
described by Born et al. (4). Antiplatelet activities of 
isolated compounds from the aerial parts of S. grandis 
against platelet aggregation induced by collagen at 1 
mM and 200 µM were evaluated and compared with 
those of aspirin. Inhibition of platelet aggregation was 
expressed as percentage of inhibition in triplicate 
experiments.
RESULTS:
All flavonols were found effective in inhibiting 
platelet aggregation induced by collagen with % 
inhibitions ranging from 19.54±1.43 to 97.25±1.9 at a 
concentration of 1 mM. Among the isolated flavonols, 
only compound 7 exerted a notable inhibition of 
61.45±12.09 at 200 µM, while compound 2 and 5 
displayed a low inhibition (4.20±4.94 and 18.94±3.64).
CONCLUSIONS:
The data indicated that quercetin (7) have powerful 
antiplatelet activity among investigated flavonol 
derivatives from S. grandis.
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INTRODUCTION:
 Marine sources are known to produce structurally 
unique pharmaceutically potent secondary 
metabolites. In the past few decades, scientists 
have realized the importance of marine macro- and 
microorganisms as rich sources of new structural 
classes of secondary metabolites (1). Many fungi and 
bacteria were found to inhabit the intercellular spaces 
of marine macroorganisms, including marine plants 
as algae and sea grasses, and marine invertebrate 
animals as sponges and corals. Because many of 
these marine microorganisms have grown in unique 
and extreme environments, they can produce a wide 
variety of unusual secondary metabolites (2). The 
aim of this study was investigation on secondary 
metabolites from promising marine fungi Trichoderma 
saturnisporum. 
MATERIALS AND METHODS:
Samples of sponge were collected from west coast 
of Turkey. Marine fungi were isolated from this host 
sponge. After the fungi were purified, identification of 
the fungal strains was achieved by DNA amplification. 
Small scale fermentation on rice and in liquid medium 
used for screening purposes. The chemical screening 
was mainly done by TLC, using different spray re-
agents and by HPLC. According to the screening 
results, rice medium was chosen for large- scale 
fermentation.  Three weeks later, culture medium was 
extracted with ethyl acetate. This extract fractionated 
by using VLC to yield eleven fractions. And different 
chromatographic techniques (CC, HPLC, TLC etc.) 
were performed to get pure compounds. Structure 
elucidation of pure compounds was done by Nuclear 
Magnetic Resonance Spectroscopy. 
RESULTS:
Four compounds were isolated. First compound is 2- 
methyl 2,5,7 nonatriene 4- one and third compound is 
3,5- di hydroxyl benzene acetic acid methyl ester. For 
the second compound main structure was determined 
but because of the quantity deficiency alkyl groups 
couldn’t be determined. Fourth compound is a mixture 
of two sterols and one of these sterols has been 
determined as ergosterol.
CONCLUSIONS:
This is the first report on isolation and characterization 
of bioactive compounds of marine derived fungus in 
Turkey.
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INTRODUCTION:
Endophytes, spends whole/part of its life cycle inside 
the healthy tissues of the host plant within a mutual 
benefit relationship, and do not cause apparent 
disease symptoms. In recent years they are one of 
the most compelling group of microorganism due to 
the contiously interaction with the host plant and other 
microorganisms. Also they are promising source of 
new bioactive secondary metabolites (1). Pancratium 
maritiumum L. (Amaryllidaceae) is distributed in the 
Mediterranean, the Atlantic, the Black and Caspian 
coasts and has attracted attention due to its alkaloid 
content with significant therapeutic properties (2). The 
aim of this study is to investigate the antimicrobial 
activities of the endophytic fungi of P. maritimum.
MATERIALS AND METHODS:
Ethylacetate extracts of the fermentation brothsof 
endophytic fungi, Talaromyces cellulolyticus 
(1), Penicillium chrysogenum (2), Chaetomium 
globosum (3), Fusarium solani (4) and co-culture 
(5) of 1 and 4 tested for antimicrobial activity against 
Staphylococcus aureus ATCC 29213, Enterococcus 
faecalis ATCC 29212, Escherichia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27953 and Candida 
albicans ATCC 90026 strains. Inhibitory effects of the 
extracts were examined by disc diffusion method by 
determining of inhibition zone diameters. Minimum 
inhibitory concentrations (MIC) of the extracts were 
also determined by microdilution method.
RESULTS:
As a result of disc diffusion method 2 exhibited 
antimicrobial activity to all strains. Moreover C. 
albicans and E. faecalis were also inhibited only by 2 
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at studied concentrations. Except 1 all of the extracts 
were active againts E. coli. Extracts of 3 and 5 showed 
activity againts S. aureus and E. coli, 4 and 5 showed 
activity againts P. aeruginosa. MICs of the extracts 
against bacteria and yeast were shown in Table 1.
Table 1. MICs of the extracts against bacteria and 
yeast (µg/ml)
Microorganisms Extracts Control
1 2 3 4 5 K CIP FLU
Gram-
positive
S. aureus ˃4096 64 1024 1024 256 - 0.125 -
E. faecalis ˃4096 256 ˃4096 ˃4096 ˃4096 - 0.5 -
Gram-
negative
E. coli ˃4096 128 1024 1024 1024 - 0.004 -
P. aeruginosa ˃4096 256 ˃4096 ˃4096 ˃4096 - 0.5 -
Yeast C. albicans 512 64 256 1024 512 - - 1
(-): No inhibitory effect, CIP:Ciprofloxacin, Flu: Fluconazole, K: EtOAc 
extract of broth medium
CONCLUSIONS:
This study showed potent antibiotic activity of 
endophytic fungi from P. maritimum. As far as can 
be ascertained from the literature this is the first 
endophytic fungi isolation study of P. maritimum. 
Bioactivity- guided isolation and purification study of 
these endophytes is planned for further studies. 
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INTRODUCTION:
Scorzonera tomentosa L., belonging to Asteraceae 
family is an endemic species to Turkey (1). In Turkish 
folk medicine this plant roots and latex obtained 
from the roots are used for treatment of wounds (2). 
Current study is aimed to investigate phytochemical 
content of the S. tomentosa aerial parts.
MATERIALS AND METHODS:
Aerial parts of the S. tomentosa (AEF No: 23841) 
were dried, powdered and macerated in methanol 
at room temperature. The extract was filtered and 
evaporated until dryness under reduced pressure 
at 50°C. The crude extract was subjected to liquid 
partitioning yielding the fractions of petroleum ether, 
chloroform, ethylacetate and water. Separation was 
carried out from an aqueous extract on C18 column 
chromatography by eluting with water:methanol 
mixture in different ratio; from 90:10 to 0:100. 
Obtained fractions (210 fractions) from the column 
were combined according to the TLC  and HPLC 
profiles. Different chromatographic methods such as 
column chromatography on Silicagel, sephadex LH-
20, preparative TLC, preparative HPLC were used 
for isolation and purification of the compounds from 
fractions. Structure elucidation of the compounds 
were performed by using spectroscobic techniques 
(1H, 13C and 2D-NMR, MS).
RESULTS:
Chlorogenic acid,  hydrangenol-8-O-glucoside, 
cichoriin, 7-O-methyl isoorientin, isoorientin, swertisin, 
7-methoxy apigenin-6-C-apiofuranosyl-(1′′′ → 2′′) 
glucoside and  apigenin-6-C-apiofuranosyl-(1′′′ → 2′′) 
glucoside were obtained from water fraction of the 
methanolic extract. 
CONCLUSIONS:
In the current study, S. tomentosa aerial parts have 
been investigated for its chemical content for the first 
time.  Results have revealed that aerial parts contain 
flavonoids mainly.
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INTRODUCTION:
The genus Sideritis comprises more than 150 species 
distributed in the temperature and tropical regions of 
Northern Hemisphere especially in the Mediterranean 
basin (1). Sideritis species have been traditionally 
used as teas and therapeutics (1). The aim of this 
study, was to explore the methanol extracts of two 
Sideritis (Sideritis arguta Boiss Et Heldr and Sideritis 
bilgerana P. H. Davis) for their bioactive compounds 
and enzyme inhibitory effects. 
MATERIALS AND METHODS:
We investigated enzyme inhibitory properties of 
the methanol extracts of S. arguta and S. bilgerana 
against cholinesterase (AChE and BChE), tyrosinase, 
amylase and glucosidase as well as total phenolic 
and flavonoid contents via colorimetric methods. 
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RESULTS:
S. arguta extract exhibited higher cholinesterase 
abilities (4.23 mgGALAE/g for AChE and 2.35 
mgGALAE/g for BChE) than S. bilgerana extract 
(3.86 mgGALAE/g for AChE and 0.81 mgGALAE/g 
for BChE). Similar results have been founded for the 
other enzymes (tyrosinase, amylase, glucosidase). 
However, S. arguta showed lower total phenolic 
and flavonoid contens (112. 21 mgGAE/g and 31.03 
mgRE/g, respectively) in comparison with S. bilgerana 
(117.23 mgGAE/g and 51. 78 mgRE/g, respectively).
CONCLUSIONS:
On the basis of our results, S. arguta and S. bilgerana 
methanol extracts might be considered as a potential 
source of natural enzyme inhibitors in food, medicinal, 
and pharmacological areas.  
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INTRODUCTION:
Onosma species (Boraginaceae) widely distributed 
in Turkey. Several Onosma species are used as folk 
medicine (1). The focus of this research was the 
antioxidant potential and cholinesterase enzymes 
inhibitory effect of the Onosma sericea Willd and 
Onosma stenoloba Hausskn. ex Riedl.
MATERIALS AND METHODS:
In this study, antioxidant capacities (DPPH 
and ABTS radical scavenging, CUPRAC 
and FRAP, phosphomolibdenum assay, and 
metal chelating activity) and cholinesterase 
enzymes (Acetylcholinesterase:AChE and 
Butyrlcholinesterase:BChE) inhibition prorperties of 
O. sericea and O. stenoloba methanol extracts were 
investigated with colorimetric methods.
RESULTS:
O. sericea extract showed higher antioxidant activity 
on DPPH and ABTS radicals (170.23 mg TE/g and 
235.53 mg TE/g, respectively) in comparison with 
O. stenoloba (53.96 mgTE/g and 95.60 mg TE/g, 
respectively). Similar pattern was observed for the 
other antioxidant tests, including CUPRAC and 
FRAP assays, phosphomolybdenum assay, and 
metal chelating activity. However, O. sericea extract 
demonstrated lower cholinesterase inhibitory abilities 
(both AChE and BChE) than O. stenoloba extract. 
CONCLUSIONS:
According to our results, O. sericea and O. stenoloba 
extracts may be considered as a valuable source of 
natural antioxidants and cholinesterase inhibitors 
for discovering novel functional products, such as 
pharmaceutical preparations and nutraceuticals. 
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INTRODUCTION:
The genus Taraxacum is a member of the family 
Asteraceae, subfamily Cichorioideae, tribe Lactuceae. 
Taraxacum species are cosmopolite plants and have 
long been used traditionally in folk medicine for its 
curative properties such as dyspepsia, heartburn, 
spleen and liver complaints, anorexia, diabetes, 
cancer and gastric, renal and hepatic ailments [1, 2]. 
Taraxacum mirabile Wagenitz is an endemic species 
to Turkey and grows in the central part of the country. 
In this study, the antioxidant activity of ethyl acetate, 
buthanol, dichloromethane and petroleum ether 
fractions of the ethanol extract from the aerial parts of 
T. mirabile Wagenitz were investigated.
MATERIALS AND METHODS:
Antioxidant activity was assayed by 6 different 
methods including the total phenols assay by 
Folin-Ciocalteu reagent (FCR), ferric ion reducing 
antioxidant power (FRAP), DPPH free radical and 
thiobarbituric acid test using the lipid peroxidation of 
liposomes. Total flavonoid content was determined by 
using a colorimetric method [3]. Antioxidant activities 
exhibited by the extracts evaluated by these assays 
reflect the capacity of the extracts to act as electron or 
hydrogen atom donors, a necessary requirement for 
antioxidant function in biological systems.
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RESULTS:
It was found that the extracts are able to scavenge 
DPPH, ABTS radicals, and reduce Fe3+ to Fe2+ in 
the ferric reducing antioxidant power (FRAP) assay. 
Ethyl acetate (including 49.53 mg/g total phenolic 
compounds) and dichloromethane extracts (45.03 
mg/g) from the aerial parts of the plant showed 
the highest antioxidant activity due to their richest 
phenolic contents, followed by buthanol extracts 
(26.93 mg/g), whereas,  petroleum ether extracts 
(15.97 mg/g) containing the least phenolics, were 
weakest in activity. 
Conclusion: We found that ethyl acetate extract from 
aerial parts of T. mirabile Wagenitz is an alternative 
source of phenolic compounds, which may contribute 
to the overall antioxidant activity of the extracts.
REFERENCES:
1.  Schütz K et al., (2006). Journal of 
Ethnopharmacology, 107: 313 – 323.
2.  Martinez M et al., (2015).  Journal of 
Ethnopharmacology, 169: 244-262.
3.  Sakanaka S et al., (2005). Food Chemistry, 89 
(4): 569-575.
P-098: PHYTOCHEMICAL STUDIES  
ON ACANTHUS DIOSCORIDIS L. VAR. 
DIOSCORIDIS
1 Sarikaya Aydin, S., 2 Duez, P., 3 Harput, U.S., 1 
Saracoglu, I.
1Hacettepe University, Department of 
Pharmacognosy, Ankara, Turkey
2Mons University, Laboratory of Therapeutic 
Chemistry and Pharmacognosy, Mons, Belgium
3Hacettepe University, Department of 
Pharmacognosy, Ankara, Turkey
INTRODUCTION:
The genus Acanthus L. (Acanthaceae), represented 
by five species in Turkish flora, is important traditional 
Turkish medicine and a series of biological activity 
such as antioxidant, hepatoprotective, antitumor 
and anti-carsinogenic effects were reported for 
some species from genus Acanthus. The chemical 
constituents isolated from Acanthus sp. include 
alkaloids and glycosides of lignans, benzoxazinoids, 
megastigmanes, phenylethanoids, flavones and 
aliphatic alcohols (1).  Acanthus dioscoridis L. (Bear’s 
breeches) and Acanthus hirsutus Boiss  leaves 
decoction is used in Eastern Anatolia for wound 
healing, expectorant and antidiarrheal effects (2).
Materials and Methods The aqueous extract was 
subjected to polyamide column chromatography. 
RESULTS:
Repeated column chromatographies of polyamide 
column fractions resulted in the isolation of three 
known phenylethanoid glycosides.
CONCLUSIONS:
The structures of the compounds were identified as 
martynoside, leucoceptoside A and acteoside on the 
basis of spectroscopic (1D/2D NMR and FAB-MS) 
data. 
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INTRODUCTION:
The genus Hypericum L. (Hypericaceae) is 
represented by 100 taxa grouped under 19 sections 
45 of which are endemic in Turkey. Hypericum species 
are used as antispasmodic, sedative and antihelmintic 
internally; antiseptic and for wound healing externally 
in Anatolia (1,2). They contain naphthodianthrones, 
flavonoids, tannins, xanthones, essential oils. 
MATERIALS AND METHODS:
Hypericum microcalcinum Boiss. & Heldr. was studied 
on the fractions with the highest radical scavenging 
effect against radicals DPPH, NO and SO, which 
were found to be rich in flavonoids obtained from the 
polyamide column by aqueous extract. The effect 
of this fraction on inflammatory mechanisms was 
investigated by luciferase reporter gene assay in 
terms of agonist activity in liver X receptors (3).  
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RESULTS:
When the aqueous extract and the LXR agonist 
activities of the tested fraction were examined, while 
there was no significant activity in the aqueous extract, 
there was moderate activity in the fraction and fold 
change was calculated to be 1,37.  As a result of the 
phytochemical studies 6 phenolic substances were 
obtained from the active fraction.
CONCLUSIONS:
The structures of the isolated compounds were 




glucopyranoside on the basis of spectroscopic data. 
Apigenin-8-C-(2-O-acetyl)-glucopyranoside was 
isolated for the first time in Hypericum genus.
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INTRODUCTION:
The genus Polygonum (Polygonaceae) is 
represented by 40 species and 6 subspecies in 
Turkish flora (1,2). Polygonum cognatum Meissn. is 
one of these species and known as madımak and 
çoban ekmeği in Anatolia. Its leaves are used in 
Turkish folk medicine as antidiabetic and diuretic (3). 
It is reported that quercetin-3-glycoside, quercetin-
3-rutinoside, quercetin-3-methylether, kaempferol-
3-methylether, kaempferol-3-glycoside, β-sitosterol, 
p-hydroxybenzoic acid, vanillic acid, gallic acid and 
protocatechuic acid were purified from the leaves of 
P. cognatum (4). The aim of this study is to evaluate 
the α-glucosidase inhibitory activity of herba from P. 
cognatum.
MATERIALS AND METHODS:
In the present study, the methanol extract from herba 
of P. cognatum and its different polarity fractions 
(petroleum ether, dichloromethane, ethyl acetate, 
n-butanol) were evaluated for in vitro α-glucosidase 
inhibitory activities according to the method of Tao et 
al., 2013 (5). 
RESULTS:
The ethyl acetate fraction showed the best 
α-glucosidase inhibitory activity with 85.59% 
(IC50=0.0097mg/ml) when compared with the 
standard compound acarbose that displayed 2.21% 
inhibitory activity (IC50=3.5148 mg/ml) at 50 µg/
ml concentration. The methanol, n-butanol, hexane 
and dichloromethane extracts showed 55.47% 
(IC50=0.0463 mg/ml), 51.43% (IC50=0.0478 mg/
ml), 36.93% (IC50=0.0643 mg/ml) and 9.29% 
(IC50=1.3158 mg/ml) inhibition activity at the same 
concentration, respectively.
CONCLUSIONS:
These results indicate that the ethyl acetate extract 
has a high potential for α-glucosidase inhibitory 
activity.
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INTRODUCTION:
The genus Paeonia (Paeoniaceae) is represented 
by six species and four subspecies in Turkey (1). 
Paeonia mascula (L.) Mill.  is one of these species 
and known as “Gülorç, Gülhorç, Ayı gülü, Eşek gülü” 
in Turkey (2). The leaves of the plant are used in 
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Turkish folk medicine as antidiabetic, sedative and 
antitussive (2,3). It is reported that the aerial parts of 
P. mascula  contain tannin, flavonoid, essential oil and 
alkaloids (4). The aim of this study is to investigate the 
anatomical structures of the stem, leaf, petiole, petal 
and fruit of P. mascula.
MATERIALS AND METHODS:
The plant material was collected from Aşkale/
Erzurum (Turkey) in July 2017. Specimens were dried 
according to standard herbarium techniques and 
stored in the Herbarium of Atatürk University, Faculty 
of Pharmacy. The materials for anatomical study were 
preserved in 70% alcohol. In this study, anatomical 
structures of the stem, leaf, petiole, petal and fruit of 
P. mascula were investigated. Characteristic elements 
of these parts of the plant were identified with taking 
the sections. Their structures were illustrated with 
photographs. 
RESULTS:
The leaf is bifacial and stoma were located in the 
lower leaf epidermises. The unicellular trichomes 
and druses were observed in the leaf and stem of 
P. mascula. The petiole anatomy of P. mascula is 
similar to anatomy of the stem. Cuticula is striated. In 
anatomy of pericarp starch-bearing parenchyma was 
found. Druses were also found in the seed.
CONCLUSIONS:
In the present study, anatomical structures of the 
stem, leaf, petiole, petal and fruit of P. mascula 
were investigated. The anatomical properties given 
in this study provide description of P. mascula. The 
findings obtained in this study propose that this 
anatomical diversity may be beneficial in taxonomical 
classification.  
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INTRODUCTION:
Olea europaea L. is the symbol of Mediterranean. Its 
leaf’s main component is oleuropein; a polyphenol 
that can help lower bad cholestrol, prevent cancer and 
oxidative damage (1,2).Several researches showed 
that olive leaf extract decreases the blood pressure (3) 
and increases the blood flow in arteries (4).The aim of 
this study is to determine the oleuropein amount in 
olive leaf varieties of different regions of Turkey and 
some commercial olive leaf extracts, according the 
European Pharmacopoeia 6.0.(EP6.0).
MATERIALS AND METHODS:
Olive leaves collected from different regions (Kilis, 
Nizip Gemlik) of Turkey and North Cyprus (Nicosia).
Three different commercial olive leaf extracts 
obtained from local markets of Turkey.All samples are 
extracted by according the EP6.0.
Samples were analysed with Agilent Technologies 
1200 series HPLC and seperated with Eclipse 
XDB-C18 column(150 mmx4.6 mm,5µm). Gradient 
solvent system consist of (A):methanol and (B):water 
with 1%glacial acetic acid was used as mobile phase 
at a flow rate of 1 mL min-1. Detection wavelength 
was set at 254 nm. 
RESULTS:
Oleuropein was observed in all samples (Table 1). 
According to the results, sample from Kilis and the 
commercial extract P3 has the highest oleuropein. 
Sample from N.Cyprus and the commercial extract P2 
has the lowest oleuropein. 
CONCLUSIONS:
The percentages of oleuropein are varies for each 
sample. When compared, sample from Kilis and 
commercial extracts P1 and P3 are compatible with 
EP6.0.
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INTRODUCTION:
Black cumin is a medicinally and economically 
important plant. Most  important component of it’s 
essential oil is thymoquinone.Acoording to recent 
researches, major fatty acids of black cumin 
seed oils are linoleic, oleic and palmitoleic 
acids(1–4).
MATERIALS AND METHODS:
Seed oil capsules were supplied from local markets 
in Ankara. For fatty acid methyl esterification 
(FAME);150 mg oils were placed in 25ml of volumetric 
flasks, saponified by adding 4ml 0.5 N NaOH/MeOH, 
and heated on a steam bath until the fat globules 
disappeared. 4ml of BF3 /MeOH was added to each 
flask and were boiled for 2 minutes.After the solutions 
were cooled down at room temperature, they were filled 
upto 25ml with saturated sodium chloride solution.
The obtained FAMEs were dissolved in 2ml n-hexane 
and 1µl of samples was injected and analyzed by 
GC-MS.Chromatographic analysis was carried out 
on Agilent 6890N Network GC system combined 
with Agilent 5973 Network MS Detector (GC-MS). 
The capillary column used was HP Innowax Capillar 
y;60.0m ×0.25mm×0.25µm.Helium was used as 
carrier gas (5).
RESULTS:
Fatty acid profiles were given in Table1. Major fatty 
acids (linoleic, oleic and palmitic acids) were observed 
in all samples. According to the given table below, 
Samples 8, 7 and 6 has the highest linoleic, oleic and 
palmitic acid respectively.
CONCLUSIONS:
The percentages of fatty acids are varies of each 
samples. Major fatty acid amouts are compatible with 
other researches.
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INTRODUCTION:
The genus Anthemis, represented by 81 taxa, 51 
species including 29 endemic in Turkey, has various 
applications in Turkish folk medicine (1). In present 
study, antimicrobial and antioxidant properties of 
A. tinctoria var. tinctoria aerial parts have been 
investigated.
MATERIALS AND METHODS:
Maceration method was used in order to obtain 
sesquiterpenes and phenolic compound extracts. 
The antimicrobial activity of the dichloromethane 
extracts was determined by the microbrothdilutions 
technique using the Clinical Laboratory Standards 
Institute (CLSI) recommendations (2, 3). Antioxidant 
properties of methanol and %80 aqueus methanol 
extracts were determined in terms of total phenolic 
contents, DPPH radical scavenging activity, Ferric 
reducing/antioxidant power (FRAP) assay, Cupric 
reducing antioxidant capacity (CUPRAC) assay(4).
RESULTS:
All of the dicholoromethane extracts showed 
antimicrobial activity at 1250 µg/ml against S. 
epidermidis and E. faecalis. Extracts were more 
effective against gram positive bacteria, except S. 
aureus and none of them has potential against gram 
negative bacteria and C. albicans. Methanol and 80% 
aqueous methanol extracts, especially methanol 
extract coded ATVT2 ( DPPH; %83.45±0.2,at 200 
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µg/mL, FRAP assay;  0.247±0.006 mM Fe2+/mg 
extract, CUPRAC;b1.250±0.001 and Total phenolic; 
100±0.009 mgGAE/g extract) had promising 
antioxidant activity, 
CONCLUSIONS:
According to the results phenolic extracts, or isolated 
components, obtained from A. tinctoria var. tinctoria 
might serve as preventive agents in the future. Further 
studies are currently in progress.
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INTRODUCTION:
Herbal teas are commonly consumed beverage due to 
their therapeutic and healing properties for worldwide. 
The popularity of herbal teas associates with their 
high availability, the low prices, and the minimal 
side effects (1). Foeniculum vulgare (Apiaceae), 
commonly known as fennel, is a well-known and 
commercially important medicinal and aromatic plant. 
Its fruits are widely used as carminative, digestive, 
galactagogue and diuretic and in treating respiratory 
and gastrointestinal disorders (2, 3). The functional 
properties of fennel, are commonly used, are mainly 
derived from their volatile oil. Consequently, our 
study concentrated on a comparison of the volatile 
composition of some fennel herbal teas from Turkey.
MATERIALS AND METHODS:
For this study, three herbal fennel tea were purchased 
from a major supermarket and coded as Fennel 1–3. 
Contents of the herbal fennel tea were subjected 
to water distillation with a Clevenger apparatus for 
4 hours. The essential oil samples were analyzed 
by GC–MS using the Agilent 6890N Network GC 
system combined with an Agilent 5973 Network mass 
selective detector.
RESULTS:
In this study, components were identified in the oil. 
The main components of the essential oils were found 
as anethole, carvone, carvacrol, estragole, limonene, 
anisaldehyde, α-fenchone. Anethole was the major 
component of the essential oils (Fennel-1 (85.43%), 
Fennel-2 (89.08%) and Fennel 3 (93.22%)).
CONCLUSIONS:
GC-MS results are in agreement with the current 
literature and there commended limit in Turkish 
Pharmacopoeia 2016 for anethole, estragole, 
α-fenchone. According to the pharmacopoeia, the 
fennel essential oil must contain at least 80% anethole 
(2, 3). 
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INTRODUCTION:
The genus Achillea belongs to the Asteraceae family, 
comprises more than 100 species throughout the 
world, mainly distributed in Northern hemisphere 
as a mythological plant. The genus is represented 
by 47 species and 24 of them are endemic in 
Turkey(1).Achillea species have several components 
such as essential oils, phenolic acids, flavonoids, 
terpenes, lignans. Achillea species have been used 
in traditional medicine as antimicrobial, antioxidant, 
antispasmodic, estrogenic, antiulcer agents. In this 
study, essential oil composition of Achillea coarctata 
Poir. was investigated.
MATERIALS AND METHODS:
Aerial parts of A. coarctata were collected near 
Develi-Kayseri in their flowering stage (2016). The 
air-dried and milled inflorescences and leaves of plant 
were hydrodistilled for 3 h using a Clevenger-type 
apparatus. The oils were analyzed by GC/MS and 
the components of essential oils were identified by 
comparison of retention times and their mass spectra 
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to those from MS library.
RESULTS:
The amount of oil calculated per weight of the dried 
plant was (v/w) 0.12%. Thirty-two components were 
identified representing approximately 96.0% of the 
total oil. 1,8-cineol (17%), viridiflorol (13%), borneol 
(7%) and camphor (6%) were found as the main 
components of the essential of A. coarctata.
CONCLUSIONS:
The essential oil composition of A. coarctata has 
been reported in previous studies. 1,8-cineol (20%), 
camphor (16%) and viridiflorol (12%) were found to 
be the major components by Toker et al. (2) while, 
viridiflorol (26%), camphor (10%) and caryophyllene 
oxide (10%) were reported as main components by 
Turkmenoglu et al. (3). Comparing the previous data 
with this study, it becomes evident that viridiflorol 
and camphor are one of the major components of A. 
coarctata in both studies.
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INTRODUCTION:
Peucedanum species have medical uses primarily in 
traditional Chinese medicine, Japan, Iran, Bulgaria 
and Turkey. Some species are well-known herbal 
drugs in Chinese medicine and listed in the Chinese 
Pharmacopoeia (1). In Turkey, there are 21 species, 
9 of them are endemic and they are also used as 
a therapeutic and protective agent. (2-3). Recent 
studies have shown that Peucedanum species have 
several bioactive substances, including coumarins 
and essential oils are considered to be the main 
constituents in nearly all Peucedanum species 
and can be responsible for many of their biological 
activities. (4-5). In this study, volatile oil contents were 
determined aerial parts and fruits of Peucedanum 
palimbioides Boiss., P. chryseum (Boiss. &Heldr.) 
D.F.Chamb., P. graminifolium Boiss., and P. 
ozhatayiorum Akpulat & Akalın. species  which are 
endemic in Turkey.
MATERIALS AND METHODS:
In this study, essential oils were obtained from 
aerial parts of the plants (from fruits of P. Chryseum, 
exceptionally) by hydrodistillation, using Clevenger 
type apparatus. Essential oil contents of aerial parts 
and fruits were determined by  GC and GC-MS.
RESULTS:
The major contents were α-pinene (71.5%), β-pinene 
(22.1%), for P. chryseum fruits; α-pinene (66.2%) 
and β-pinene (25.4%), for P. palimbioides; trans-
pinocarveol (7.7%), myrtenol (6.7%), lauric acid 
(11.9%) and palmitic acid(21.7%) for P. graminifolium; 
p-cymen-8-ol (6.2%), spathulenol (13.4%), lauric acid 
(6.4%) and palmitic acid (21.7%) for P. ozhatayiorum 
species respectively. 
CONLUSION:
The composition of the oils present dissimilar 
variations among the species.
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INTRODUCTION:
Hawthorn (Crataegus spp.) has been used since 
1800s for the treatment of heart problems such as 
hypertension, angina, arrhythmia and congestive heart 
failure (1, 2). Crataegus spp. contain the flavonoids 
including hyperoside, vitexin and their glycosides 
which have been shown to have pharmacological 
activity (3). The aim of the study is to investigate 
the influence of the extraction mode on the yield of 
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bioactive compounds from Crataegus monogyna in 
order to evaluate plant productivity. 
MATERIALS AND METHODS:
Air-dried and powdered aerial parts of C. monogyna 
were extracted with different ratio of ethanol and 
methanol in water and with different extraction 
technics. Vitexin-2-O-rhamnoside and hyperoside 
were calculated as main compounds in the extracts 
and the results were compared to each other. The 
aerial parts of C. monogyna (1 g) were dissolved in 
10 mL of methanol and filtered from 0.45 μm filter 
and directly injected. The stock solution is prepared 
by dissolving 10 mg vitexin-2-O-rhamnoside and 
hyperoside in 10 mL methanol (1 mg/mL). The dilutions 
in five concentrations of the standards (0.1, 0.2, 0.4, 
0.5 and 0.7 mg/mL) were diluted from stock solution. 
The calibration equation was obtained by using five 
peak areas of standard solutions. Eleven Hawthorn 
capsules which were coded A1-A11 were purchased 
from the market in Turkey. The HPLC profiles of the 
standardized extracts were examined and compared 
with C. monogyna extract chromatogram.
RESULTS:
It was observed that the amount of extract prepared by 
maceration with 70% ethanol at 50°C for 30 min was 
higher. This extract contained 0,2146±0,0002% of the 
amount of vitexin-2-O-rhamnoside; and the amount 
of hyperoside was 0.144±0.0232%. In addition, the 
HPLC profile of the A1, A5 and A7 preparations did not 
show similarity with the hawthorn extract. Vitexin-2-
O-rhamnoside and hyperoside could not be detected 
in the contents of A1 and A7. In the preparation of 
A5, a substance which could be a low amount of 
hyperoside was observed, however, no viteksin-2-O-
rhamnoside was detected. In the other preparations, 
the mentioned substances were not identified.
CONCLUSIONS:
Hyperoside and vitexin-2-O-rhamnoside quantification 
in different plant extracts was developed and 
successfully applied to study and optimize extraction 
protocols. Different extraction methodologies 
(different temperature, different extraction time, and 
different extraction mode) were compared under 
different experimental conditions.
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INTRODUCTION:
Achillea L. (Asteraceae) is a widely distributed 
medicinal plant in the world and represented by 
140 species in the world (1). Achillea L. species 
are commonly used in Turkish traditional medicine 
for the treatment of wounds, bleedings, headache, 
inflammation, pain, against spasmodic diseases, 
flatulence, dyspepsia and hemorrhoids for years (1). 
In this study, it is aimed to determine the essential oil 
contents of Achillea monocephala, A. nobilis and A. 
goniocephala species by GC-MS.
MATERIALS AND METHODS:
In this study, the essential oils content of Achillea 
monocephala, A. nobilis and A. goniocephala were 
analyzed by GC-MS/FID. The dried aerial parts of 
species were cut into small pieces and subjected to 
hydro-distillation with water for 4 h, using a Clevenger-
type apparatus to produce essential oils which were 
dried over anhydrous sodium sulphate and stored at 
+4°C until required. Identification of the compounds 
was based on the comparison of their retention times 
and mass spectra with those obtained from authentic 
samples and/or the NIST and Wiley spectra as well as 
the literature data.
RESULTS:
The essential oil contents of A.monocephala, A. nobilis, 
A. goniocephala species were determined %95.87, 
%95.31, %96.10, respectively. The major components 
of A. monocephala were artemisia ketone (31.90%), 
camphor (12.60%) and β-phellandrene (12.54%). 
Major components of A. nobilis were eucalyptol 
(22.89%), chrysanthenone (14.31%) and α-pinene 
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(8.16%). The major components of A. goniocephala 
were found to be endo-borneol (30.07%), eucalyptol 
(25.59%) and camphor (24.45%).
CONCLUSIONS:
It has been determined that there are differences 
in the major components and diversity of the three 
species studied in general. But it can be said that the 
essential oils in the three species studied are rich in 
monoterpenes.
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INTRODUCTION:
The genus Thymus L. is a member of Lamiaceae 
family and represented by 318 species in the world, 
40 species in Turkey and 18 of them are endemic for 
Turkey (45%) (1). In recent years, plant derivatives, 
especially essential oils, have gained significant 
interest in academic society and food industry (2). In 
this study, it was aimed to determine the essential oil 
contents of Thymus brachychilus subsp. brachychilus 
and T. brachychilus subsp. bahcesarayensis species 
by GC-MS.
MATERIALS AND METHODS:
In this study, the essential oils content of T.brachychilus 
subsp. brachychilus and T. brachychilus subsp. 
bahcesarayensis were analyzed by GC-MS/FID. 
The dried aerial parts of species were cut into small 
pieces and subjected to hydro-distillation with water 
for 4 h, using a Clevenger-type apparatus to produce 
essential oils which were dried over anhydrous 
sodium sulphate and stored at +4°C until required. 
The essential oils were diluted by dichloromethane 
(1:3, v/v) before the GC run. Identification of the 
compounds was based on the comparison of their 
retention times and mass spectra with those obtained 
from authentic samples and/or the NIST and Wiley 
spectra as well as the literature data.
RESULTS:
The essential oil contents of T.brachychilus 
subsp. brachychilus and T.brachychilus subsp. 
bahcesarayensis species were determined 
95.58%, 98.82% respectively. Major components 
for T.brachychilus subsp. brachychilus species 
are eucalyptol (11.05%), geranylacetate (6.1%) 
and thymol (5.1%), and for T. brachychilus subsp. 
bahcesarayensis species are linalool (33.92%), 
thymol (11.02%) and caryophyllene (6.98%).
CONCLUSIONS:
The essential oil contents of the.T.brachychilus 
subsp. brachychilus and T. brachychilus subsp. 
bahcesarayensis species were determined. It was 
seen that T.brachychilus subsp. bahcesarayensis 
species can be used as a linalool source.
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INTRODUCTION:
Biofilms can have negative effects on human 
activities in many ways, including energy waste,heat 
transfer resistance,requirement for excess equipment 
capacity, decreased life of equipment, quality control 
problems, safety problems (1,2). The genus Erica 
L. (Ericaceae) is represented by more than 700 
species in the world, Erica manipuliflora Salisb. are 
widespread species common in the coastal sides in 
Turkey (3).  
The main objectives of this study were to investigate 
the antibiofilm activity of the CH2Cl2 extract (EC) 
obtained from the plant, a major compound: Ursolic 
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acid (UA) isolated from EC by MIC test against some 
biofilm bacteria. As far as our literature survey could 
ascertain,antibiofilm potential of the plant extract,a 
major secondary metabolite are reported for the first 
time.
MATERIALS AND METHODS:
A major compound was isolated from EC, elucidated 
by extensive 1D-and 2D-NMR, mass spectroscopic 
techniques. Of the fraction EC, a major compound 
UA were tested against bacteria (Pseudoalteromonas 
agarivorans,Alteromonas genoviensis, 
Exiguobacterium homiense, Vibrio lentus) at 
varying concentrations. Inhibition concentrations of 
the fractions against marine biofilm bacteria were 
analyzed with the MIC test (4).
RESULTS:
The phytochemical investigation of EC led to the 
characterization of one pentacyclic triterpene saponin: 
Ursolic acid,its’ structure was confirmed by literature 
data (5). As a result of the screening of inhibition 
concentrations of the extract and compound, the 
species A. genoviensis (for UA in dilution of 1/1024 
corresponded to 2.58 µg/ml;for EC in dilution of 
1/1024 corresponded to 3.07 µg/ml),P. agarivorans 
(same dilution,concentration with A. genoviensis) 
were determined as the most sensitive bacteria. 
CONCLUSIONS:
 It was also determined that it would be worth doing 
further studies in which pure substances to be 
obtained could be used as an antifouling additive in 
industrial areas to prevent marine biofilms.
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INTRODUCTION:
Fungal infections have emerged as a growing 
threat to human health.Two important reasons 
for this are the increasing number of HIV infected 
patients and the number of patients being treated 
with cancer chemotherapy drugs (1). The genus 
Erica L.(Ericaceae) is represented by more than 700 
species in the world, mainly found in the South Africa, 
furthermore Mediterranean and West European (2). 
Our present work was designed to assess the in 
vitro antifungal activity of Erica manipuliflora Salisb.
extract (EC), the n-BuOH fractions (EBA-EBE) and a 
major secondary metabolite:Ursolic acid on Candida 
albicans.
MATERIALS AND METHODS:
All the extracts (n-Hexane,CH2Cl2,MeOH) were 
prepared from the powdered dried aerial parts of 
the plant by extracting with Soxhlet apparatus.The 
MeOH extract was partitioned with n-BuOH. The 
five fractions codded EBA-EBE were obtained from 
the n-BuOH extract. A major compound was isolated 
from the CH2Cl2 extract(EC), elucidated by extensive 
1D-,2D-NMR, mass spectroscopic techniques. 
Of the fractions,EBA-EBB-EBC (flavonoids, 
phenylethanoid glycosides), EBD-EBE (triterpenoid 
saponins),EC,Ursolic acid were tested against 
C. albicans at varying concentrations.Inhibition 
concentrations of the fractions were analyzed with 
disk diffusion method (3).
RESULTS:
In this study, we have isolated a pentacyclic triterpene 
saponin (Ursolic acid) from the CH2Cl2 extract,its’ 
structure was confirmed by literature data (4). As a 
result of the screening of inhibition concentrations of 
the samples,Ursolic acid(in dilution 1/16 corresponded 
to 0.16 mg/ml),EC extract(in dilution 1/4 corresponded 
to 0.78 mg/ml) and the fraction EBA (in dilution 1/16 
corresponded to 0.47 mg/ml) were determined as the 
most effective samples against Candida albicans. 
CONCLUSIONS:
C.albicans is known to have resistance mechanisms 
against antimicrobial drugs.The detection of the 
interactions with relatively under-researched 
biomolecules are important to overcome the problem 
of these resistance mechanisms.Therefore, studies 
on biomolecules need constantly progress to reduce 
for resistance of C.albicans to antimicrobial drugs.
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Our data extended the basic for the designing and 
modeling of new compounds as antimicrobial agents.
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INTRODUCTION:
Black cumin seeds and the oil extracted from the 
seeds are generally safe for use as a home remedy 
to prevent diseases and promote good health. 
According to recent researches, black cumin 
seed oil’s major fatty acids are linoleic, oleic and 
palmitoleic acids (1-4). In this study we aimed to 
examine the compositions of some of the black 
cumin oil brands that are sold in Turkish market.
MATERIALS AND METHODS:
Seed oils were supplied from local markets in Ankara. 
Fatty acid methyl esterification (FAME) was conducted 
by using BF3/MeOH reagent. Chromatographic 
analysis was carried out on Agilent 6890N Network 
GC system combined with Agilent 5973 Network MS 
Detector (GC-MS). The capillary column used was 
HP Innowax Capillary;60.0m ×0.25mm×0.25µm. Run 
time for the analysis was 35min (5).
RESULTS:
Fatty acid profile was given in Table 1. Major fatty 
acids (linoleic, oleic and palmitic acids) were observed 
in all samples. Even though Samples 6 and 10 tried to 
be esterified three times, a chromatogram could not 
be obtained.
CONCLUSIONS:
Analyzed samples are found to be rich in especially 
oleic and linolenic acids. GC-MS analysis of the fatty 
acids obtained from ten commercial seed oil showed 
that the qualitative composition of the fatty acid profile 
was almost identical with each other.
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INTRODUCTION:
Juniperus macrocarpa Sibt. & Sm. (Cupressaceae) is 
one of the Juniper species growing in Turkey that is 
used for medicinal purposes. We aimed to evaluate 
in-vitro antidiabetic and antioxidant activities of the 
extracts prepared from leaves and branches of J. 
macrocarpa. 
MATERIALS AND METHODS:
The leaves and branches of J. macrocarpa, were 
collected from İzmir on June 2010. α-amylase and 
α-glucosidase inhibitory effects and antioxidant 
activities of the water, ethyl acetate, and methanol 
extracts of the plant were evaluated. Antioxidant 
activities of the extracts were determined by DPPH 
radical scavenging, ferric reducing, metal chelating 
and phosphomolybdenum assays. Additionally, total 
phenol and flavonoid contents of the extracts were 
investigated (1).
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RESULTS:
All extracts showed excellent and dose dependent 
inhibitory effect on α-glucosidase enzyme. Moreover, 
branch (99.78 ± 0.03 %) and leaf methanol extracts 
(99.16 ± 0.45%) were more effective than Acarbose 
(98.88 ± 0.07%) at 1 mg/ml. Additionally, the 
extracts rich in flavonoids (9.99-45.16 mg quercetin 
equivalent/g extract) and phenolics (92.18-230.54 mg 
gallic acid equivalent/g extract) showed remarkable 
antioxidant activity.
CONCLUSIONS:
It has been determined that J. macrocarpa leaves 
and branches are natural source of antidiabetic and 
antioxidant activity, which can be a subject of in-vivo 
research.
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INTRODUCTION:
Lavandula stoechas L. subsp. stoechas (LS) belongs 
to the Lamiaceae family and occurs naturally in 
Mediterranean countries. The major secondary 
metabolites of LS are terpenoids and phenolic 
constituents. Essential oil of lavender has been used 
in folk medicine since ancient times and relaxing, 
sedative, antistress, anticonvulsive, spasmolytic, 
anticancer, repellent, antibacterial, antimicrobial and 
antifungal properties are known, also is used for 
cosmetic purposes due to its scent and aroma. The 
studies on lavender has focused on essential oils. 
In this study, we aimed to determine the antioxidant 
capacity and total phenolic content of LS hydrophilic 
extracts.
MATERIALS AND METHODS:
The aqueous and aqueous-ethanolic (70%) extracts 
were prepared from the aerial parts of LS collected 
from Muğla-Fethiye in 2017. The extracts of LS 
were investigated for their antioxidant capacities 
using nitric oxide radical (NO), superoxide radical 
(SO), 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical, 
2,2’-azinobis-(3-ethylbenzothiazoline-6-sulfonic 
acid) (ABTS) radical scavenging activities and Ferric 
Reducing Antioxidant Power (FRAP), Cupric Ion 
Reducing Antioxidant Capacity (CUPRAC) assays. 
The total phenolic contents were measured by Folin–
Ciocalteau assay. 
RESULTS:
The IC50 values for DPPH, SO, NO radical scavenging 
activities were measured as 43.01mg/mL, 43.02mg/
mL, 317.13mg/mL for aqueous extract and 50.19 
mg/mL, 48.35mg/mL, 243.05mg/mL for aqueous-
ethanolic extract, respectively.CUPRAC, FRAP 
and ABTS antioxidant capacities were determined 
as118.258 mg gallic acid/g, 783.33 mg trolox/g, 277 
mg trolox/g for aqueous extract and 172.8548 mg 
gallic acid/g, 926.44 mg trolox/g, 354.4 mg trolox/g 
for aqueous-ethanolic extract, respectively.The total 
phenolic contents were found as 152.2 mg gallic 
acid/g for aqueous extract and 180.1 mg gallic acid/g 
for aqueous-ethanolic extract.
CONCLUSIONS:
The extracts of LS are similar when evaluated in terms 
of antioxidant capacity and total phenolic content of 
aqueous-ethanolic extract was found more.
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INTRODUCTION:
Cancer has become the reason for high morbidity and 
mortality rates throughout the world (1). Therefore 
scientists are searching for efficient treatment 
alternatives, including medicinal plants. As a result of 
recent studies on herbal resources, some Ferulago 
species, i.e. F. angulata (Schlecht) Boiss. was revealed 
to possess anticancer activity against lymphoma and 
leukemia cells (2). Therefore we decided to study 
the cytotoxic activity of F. macrosciadia, an endemic 
species for our country, against different cancer cell 
lines. 
MATERIALS AND METHODS:
In this study, ethanolic extracts of the roots of F. 
macrosciadia Boiss & Balansa, an endemic species 
for Turkey (3) and its buthanol, dimethyl chloride, 
ethylacetate fractions and aqueous remainder 
were tested for their cytotoxic activities against 
SW480 (colorectal carcinoma) and MCF-7 (breast 
carcinoma) cell lines in concentrations of 1, 0.1, 0.05, 
0.025, 0.01 mg/ml via (3-(4,5-dimethylthiazolyl-2)-2, 
5-diphenyltetrazolium bromide (MTT) assay. Cell 
viabilities were measured with spectrophotometry (at 
540 nm) and the nontreated cells in the control group 
were used as reference. 
RESULTS:
Dimethyl chloride fraction was found to be more 
active compared to others and the total extract; The 
viable cell amount was has significantly decreased 
(15.06±1.64% and 45.15±6.50%, p<0.05) at 0.1 mg/
ml treated concentration in SW480 and MCF-7 cells, 
respectively.
Conclusion: According to our results, we can 
conclude that F. macrosciadia is cytotoxic against the 
above mentioned cell lines and further studies have 
to be performed to isolate and identify the responsible 
active substances.
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INTRODUCTION:
In the Flora of Turkey, the genus Digitalis is 
represented by nine species (1). In this research 
D. davisiana Heywood, D. grandiflora Miller and D. 
viridiflora Lindley were compared phytochemically 
via LC-MS/MS analysis. Phytochemical studies 
on Digitalis genus have already identified 
cardioactive glycosides, flavonoids, anthroquinones, 
phenylethanoid glycosides and other similar phenolic 
compounds (2).
MATERIALS AND METHODS:
Plants were collected and voucher specimens for all 
plants were deposited in Hacettepe University Faculty 
of Pharmacy Herbarium with codes HUEF11004, 
HUEF13007, HUEF13008. Aerial parts of the selected 
plants were extracted by methanol. Methanolic 
extracts and 18 standard compounds applied to a 
new LC-MS/MS assay developed for this research. 
LC-MS/MS system: HPLC (Shimadzu 20A), column 
[Intersil ODS column (4.6 x 250 mm, 5 μm particle 
size), UV detector (SPD20A Shimadzu DAD Detector) 
and 3200 Q TRAP (AB Sciex, Toronto, Canada) with 
electron spray ionization interface (ESI). The mobile 
phase was acetonitrile:water:formic acid (10:89:1, 
v/v/v) (solvent A) and acetonitrile:water:formic acid 
(89:10:1, v/v/v) (solvent B) at a flow rate of 0.5 mL/
min. The gradient elution started with 10% solvent 
B at 0 min, 100% solvent B reached at 40 min. The 
column temperature was kept at 40ºC. 
RESULTS:
D.davisiana, D. grandiflora and D.viridiflora were 
compared for their secondary metabolites through 
24 compounds. Lugrandoside, isolugrandoside, 
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maxoside, digidavisoside B, isoacteoside, chyrsoeriol, 
apigenin, luteolin, luteolin glucuronide, apigenin 
glucuronide, luteolin-7-O-glucoside were detected 
in all extracts. Lugrandoside and maxoside were 
detected as major compounds. When the results 
were evaluated, from total 24 compounds 19, 17 and 
14 compounds were detected in D. davisiana, D. 
grandiflora and D. viridiflora respectively.
CONCLUSIONS:
These results showed us that even though all extracts 
were similar in content, D. davisiana was found to 
be more rich in secondary metabolite content. Our 
findings support chemotaxonomic and phylogenetic 
studies on Digitalis genus and Plantaginaceae family.
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INTRODUCTION:
Nuclear receptors are regulators of gene transcription 
and intracellular function. They control various 
biological events. Liver X receptors (LXR) play 
role in de novo synthesis of cholesterol, excretion 
and detoxification of bile acids, or lipids, glucose 
homeostasis and neurological functions. LXR is 
also known to play an inhibitory role in inflammatory 
signaling pathway (1). Turkish medicinal plant 
species, Plantago holosteum, P. major, P. lagopus, P. 
scabra and Scutellaria salviifolia were investigated for 
their LXRα agonist activity. 
MATERIALS AND METHODS:
5 plant extracts were screened for liver X receptor 
(LXR) agonist activity using LXRE reporter gene assay 
(2). HEK293 cells were used in LXRE reporter gene 
assay. Plants were collected and voucher specimens 
for all plants were deposited in Hacettepe University 
Faculty of Pharmacy Herbarium. Air-dried aerial parts 
of the plants were extracted with methanol. Methanol 
was evaporated under vacuum to yield extract. 
Then it was dissolved in water and partitioned with 
petroleum ether to remove chlorophylls and other 
lipophilic compounds. The aqueous fractions were 
lyophilized and used in the biological activity tests at a 
concentration of 100 μg/ml. 
RESULTS:
In this study, LXRα agonist, T09011317 was used 
as positive control at the concentrations of 1, 10 
and 100nM. The results were given as fold induction 
values normalized by β-galactosidase. P. holosteum, 
P. major, P. lagopus, P. scabra extracts showed weak 
LXRα agonist activity with the fold values in a range 
of 0.95-1.39. P. major showed highest agonist activity 
between Plantago species. Scutellaria salviifolia 
extract has a fold value of 2.37. 
CONCLUSIONS:
In this study, the potential LXRα agonist activity 
of extracts were evaluated. The agonist activity of 
Scutellaria salviifolia was found to be comparable 
with the positive control T09011317. While the agonist 
activity of tested Plantago species found to be lower. 
Scutellaria species are widely used as traditional 
medicine especially in eastern Asia due to its anti-
inflammatory effects. As LXRα plays important role in 
inflammation, anti-inflammatory effect of Scutellaria 
species may be due to this pathway. 
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P-119: COMPARATIVE LC-MS/MS STUDIES 
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INTRODUCTION:
Scutellaria is represented by 32 taxa and 14 of 
them are endemic in the flora of Turkey (1). In the 
revision of the genus, there are three sections; sect. 
Scutellaria, Salviifoliae, Lupulinaria. Scutellaria 
species are one of the most popular herbs in 
traditional Chinese medicines and are used in the 
treatment of gastrointestinal disorders, inflammation, 
cardiovascular diseases, bacterial and viral infections 
(2). In the present study, three endemic Scutellaria 
species (S. salviifolia Benth., S. glaphyrostachys 
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Rech.f. and S. rubicunda Stapf. subsp. brevibracteata) 
selected from two different section (sect. Scutellaria 
and sect. Salvifoliae) were studied by LC-MS/MS to 
evaluate differences in phytochemical compositions 
of sections. 
MATERIALS AND METHODS:
Plants are collected and voucher species are 
deposited in Hacettepe University Faculty of Pharmacy 
Herbarium with codes HUEF 12003, 14066, 14065. 
LC-MS/MS analyses were performed on the aqueous 
fractions of methanol extracts of the titled plants. 
LC-MS/MS system: HPLC (Shimadzu 20A), column 
[Intersil ODS column (4.6 x 250 mm, 5 μm particle 
size), UV detector (SPD20A Shimadzu DAD Detector) 
and 3200 Q TRAP (AB Sciex, Toronto, Canada) with 
electron spray ionization interface (ESI). The mobile 
phase was acetonitrile:water:formic acid (10:89:1, 
v/v/v) (solvent A) and acetonitrile:water:formic acid 
(89:10:1, v/v/v) (solvent B) at a flow rate of 0.5 mL/
min. The gradient elution started with 10% solvent 
B at 0 min, 100% solvent B reached at 40 min. The 
column temperature was kept at 40ºC.
RESULTS:
When chromatograms of aqueous extracts 
were compared; phytochemical profiles of 
S. glaphyrostachys and S. rubicunda subsp. 
brevibracteata, which belong to sect. Scutellaria, 
were seemed to be quite similar to each other. While 
the chemical content of the S. salviifolia (from sect. 
Salviifoliae) was different from the other two extracts. 
Isolation and LC-MS/MS studies were evaluated 
together and it was found that the Salviifoliae section 
was rich in phenolic compounds, while the Scutellaria 
section contains iridoid glucosides more than phenolic 
compounds. Luteolin, luteolin-7-O-β-glucuronide and 
baicalin were found as common compounds in all 
tested aqueous extracts.
CONCLUSIONS:
This study supports to botanical revision of Scutellaria 
genus grown in Turkey by phytochemically, too. 
Clarification of chemical compositions of three 
Scutellaria species in detailed contributed to the 
chemotaxonomy of the genus.
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INTRODUCTION:
There are 24 species and 15 subspecies of the genus 
Quercus in flora of Turkey. Quercus macranthera 
subsp. syspirensis (Fagaceae) is an ecologically 
important endemic species and known as İspir oak 
(1). It has been reported that it contains some phenolic 
compounds such as tannins (epicatechin, catechin) in 
its shell (2), and shows antioxidant and antimicrobial 
activities (3,4). In this study, determination of 
the α-glucosidase inhibitory activity of Quercus 
macranthera subsp. syspirensis fruits is aimed. 
MATERIALS AND METHODS:
In the present study, the methanol extract of Quercus 
macranthera subsp. syspirensis fruits and its fractions 
prepared by n-hexane, chloroform, ethyl acetate, 
n-butanol and water respectively, were investigated 
for their α-glucosidase inhibitory activities using the 
method of Tao et al., (5). 
RESULTS:
The ethyl acetate fraction showed the best 
α-glucosidase inhibitory activity with 89.716 % 
(IC50= 0.0052 mg/ml) value when compared with the 
standard compound acarbose that displayed 0.45 
% inhibitory activity (IC50= 3.3642 mg/ml) at 25 µg/
ml concentration. n-Butanol, methanol, chloroform, 
n-hexane extracts showed 88.577% (IC50 = 0.0065 
mg/ml), 86.703 % (IC50 = 0.0200 mg/ml), 40.659 % 
(IC50 = 0.0918 mg/ml), 36.585 %  (IC50 = 0.1159 
mg/ml) inhibitory activity at the same concentration, 
respectively. However, the water extract showed no 
inhibition on α-glucosidase.
CONCLUSIONS:
These results indicate that the ethyl acetate extract 
has a high potential for α-glucosidase inhibitory 
activity.
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INTRODUCTION:
Pain is an important physiopathological signal, 
originating from pain signal generating receptors and 
ion channels. Transient Receptor Potential (TRP) 
channels are ligand-gated ion channels which are 
shown to play role in various functions including 
inflammation and pain (1). TRPM2 is a member of 
TRPM family involved in pain and described as a 
chanzyme but its mechanism is not well known (2). 
The presence and important of GXXXG  (GG4) motifs 
are shown on many proteins (3).  The aim of this study 
was to investigate the presence and location of GG4 
motifs on TRPM2 ion channels. 
MATERIALS AND METHODS:
 The protein sequences (TRPM2_HUMAN, TRPM2_
MOUSE and TRPM2_RAT) were downloaded from 
uniprot database (www.uniprot.org). Ion channel 
sequences were extracted using Slackware GNU/
Linux operating system. R/Bioconductor packages, 
Protr. Bio3d and ClustalW were used for alignment 
of proteins, statistical evaluation and plotting.  Swiss-
model, Swiss Pdb-viewer were used for 3D modelling.
RESULTS:
 The results of our investigations showed the presence 
of GG4 motifs on the human, mouse and rat TRPM2 
ion channels. Alignment of the ion channels showed 
%82 similarity. Difference for number and locations 
of GG4 motifs were found using GNU/Linux bash 
commands. There were 2 GG4 motifs on human and 
mouse TRPM2, whereas 3 GG4 motifs were found 
on rat TRPM2 ion channel. Of these GG4 motifs, only 
one of them (GSHTG) was found on all of the species 
(human, mouse and rat) and at the same location of 
the proteins. 
CONCLUSIONS:
The number of GG4 motif for the human and mouse 
TRPM2 ion channels was similar, but differed from 
the rat TRPM2 ion channel. Since role of the motif 
on ligand-TRP channels is very difficult by wet lab 
experiments (3), the in silico results of our investigation 
suggest more reliable results will be obtained using 
mice but not rats in pain research where TRPM2 ion 
channels are involved.
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P-122: THE NORMALIZATION OF 
CONTRACTILE RESPONSE IN DIABETIC 
RAT AORTA
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Karaomerlioglu, I., 2 Martin, MC., 1 Arioglu Inan, E.
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Ankara, Turkey
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INTRODUCTION:
Vascular dysfunction is an important feature of 
diabetes. Thus, the accurate evaluation of vascular 
function is crucial. In vitro organ bath experiments 
have been usually used to determine contractile 
response in the thoracic aorta. However, the length 
and the weight of the aorta does not seem to be 
unique in each experiment. Therefore, it is essential 
to normalize the contractile response. Various 
normalization parameters such as cross-sectional 
area (CSA) (1,2), weight or length of the rings have 
been used so far to exclude these differences. The 
aim of our study was to compare different approaches 
to determine the most appropriate normalization 
parameter for the contractile response of the aorta.
MATERIALS AND METHODS:
6-week old male 21 Sprague Dawley rats were used 
in this study. Some of them (n=17) were fed with 
high fat diet. After 4 weeks, the rats fed with high fat 
diet were injected with STZ (35 mg/kg, ip) to induce 
experimental type 2 diabetes model. 2 weeks after 
STZ injection, some of the diabetic rats were treated 
with Dapagliflozine (1mg/kg, orally). After 8 week-
treatment period, all rats were euthanasied. The 
thoracic aorta was dissected and the connective 
and adipose tissues were removed. A precontraction 
was induced with 80 mM KCl and the cumulative 
concentration-response curve of phenylephrine (10 
nM - 30 uM) was generated. At the end of the each 
experiment, the weight and the length of the rings 
were measured and the CSA was calculated as 
described previously (2). CSA was used to normalize 
aortic wall thickness differences and aneurysms.
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RESULTS:
r2 values for each normalization parameters 
CSA Weight Length








All of the three normalization approaches seem to 
have poor correlation with contraction responses. 
Thus, we conclude that increasing sample size 
of experiments could help to further explain this 
discrepancy.
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INTRODUCTION:
Cardiovascular complications are the most common 
complications of insulin resistance (IR). The use of 
renin-angiotensin-aldosteron system (RAAS) blockers 
in patients with IR or diabetes and hypertension has 
positive effects and is recommended by guidelines. 
Aliskiren (ALI) is the only available direct renin 
inhibitor in the market approved for the treatment 
of hypertension (1). However, the efficacy of ALI in 
IR-induced cardiomyocyte dysfunction remains to 
be defined. The aim of this study is to investigate 
whether ALI tretment has positive effects on IR-
induced cardiomyocyte dysfunction. 
MATERIALS AND METHODS:
IR was induced in male Wistar rats by high-fat diet 
(HFD) feeding for 20 weeks. Oral administration of 
ALI (50 mg/kg, daily) or vehicle was started in the 
last 12 weeks. At the end of treatment period oral 
glucose tolerance test (OGTT) was carried out. 
Blood pressure, heart rate were measured by non-
invasive method. Ventricular cardiomyocytes were 
isolated and contractile properties including cell 
peak shortening (PS), time to PS (TPS), time to 
90% relengthening (TR90) and maximal velocity of 
shortening/relengthening (± dL/dt) were analysed 
using video-based edge detection (2).
RESULTS:
Cardiomyocytes from HFD group displayed 
significantly reduced ± dL/dt associated with prolonged 
duration of TPS and TR90. ALI treatment had overall 
positive effects on cardiomyocyte dysfunction. 
Furthermore ALI treatment significantly improved 
the metabolic parameters (blood glucose and serum 
insulin levels, OGTT), systolic blood pressure, heart 
rate, and body weight gain in HFD group.
CONCLUSIONS:
Our data suggest that renin inhibition by ALI has 
protective effect on cardiomyocyte dysfunction 
in IR model of rat through a decrease in IR. We 
need comparative benefit studies with ALI and the 
drugs which inhibit the RAAS cascade by different 
mechanisms.
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P-124: CLINICAL PHARMACIST’S 
CONTRIBUTION TO ROUTINE TREATMENT 
IN INTENSIVE CARE UNIT
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INTRODUCTION:
The contribution of the clinical pharmacist to the 
intensive care unit (ICU) has been accepted in many 
countries since 1960s. This contribution has often 
been related to prescribing errors, adverse drug 
effects, cost, length of hospital stay, and mortality. The 
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purpose of this study is to evaluate the contribution 
of the clinical pharmacist to routine treatment in ICU 
in Turkey as pioneering this sentence seems to be 
incomplete (1,2).
MATERIALS AND METHODS:
This prospective cross-sectional study was conducted 
by clinical pharmacy students from October 1, 2017 
to April 1, 2018 at the 9-bed tertiary hospital ICU. All 
patients over the age of 18 years were included in the 
study. The clinical pharmacist interventions during 
patient visits with the physicians and interventions’ 
acceptance rate were evaluated and classified 
according to the Pharmaceutical Care Network 
Europe - Classification V 8.01.
RESULTS:
Thirtyeight of the 72 patients in ICUs were followed 
and 31 recommendations were made for these 38 
patients. The number of suggestions per patient was 
found as 0.82. While 67.7% of the proposals were 
accepted and implemented, 16.1% were accepted 
but not implemented or partially implemented. The 
problems identified in the interventions reached a 
solution rate of 74.2%. Most of the recommendations 
(77.4%) were found to be related to dose error. In 
addition, interventions have been made regarding 
drug selection, drug form and therapeutic drug 
monitoring.
CONCLUSION:
Clinical pharmacist’s contribution in the ICU 
multidisciplinary team would be beneficial to improve 
the management of drug related problems.
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P-125: THE FORMATION OF COMPLEXES 
BETWEEN GLUTATHIONE REDUCED- 
OXIDIZED AND COPPER IONS
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INTRODUCTION
Glutathione (GSH) is a tripeptide of glutamate, 
cysteine and glycine (1). GSH as a low molecular 
mass antioxidant is the most abundant intracellular 
thiol which plays an essential role in maintaining the 
intracellular redox environment. Glutathione exists 
in both reduced (GSH) and oxidized (GSSG) states. 
Under oxidative stress conditions, GSH is generally 
oxidized to GSSG. It is less known that GSH is also 
a copper chelator (2). The aim of this study was to 
analyze the interaction of glutathione in both reduced 
and oxidized states with copper ions (Cu2+ and Cu+).
MATERIALS AND METHODS:
First, absorption spectra were scanned, and the 
wavelength of the absorption maximum of pure GSH/
GSSG and their Cun+ complexes were determined. 
The assessment of the interaction with copper was 
performed at four (patho)physiologically relevant pH 
values (4.5. 5.5, 6.8 and 7.5) in both competetive 
(hematoxylin and bathocuproine)  and non-
competetive (Job’s method (3) and Complementary 
approach (4)) settings in order to find the most 
probably stoichiometry.
RESULTS:
 Under most conditions in which the metal complex 
was formed, the dominant stable detected form was 
the complex of the 1:1 stoichiometry. However the 
stoichiometry changed depending on conditions. In 
order to assess more detailed the capacity of GSH/
GSSG to interact with copper ions, competitive 
measurements were performed. In these assays, the 
indicator competes with GSH/GSSG for the chelated 
metal. Mild competetive assay with hematoxylin 
suggested the formation of 1:1 complex with GSSG 
and 1:2 with GSH (metal to glutathione). More 
competetive assay with bathocuproin showed that 
GSH complex was not stable, while that of GSSG was 
stable only in very high ratios, GSSG to Cun+. The 
reduction ability of GSH seemed to be responsible for 
this phenomenon.
CONCLUSIONS:
This study showed that glutathione in both reduced 
(GSH) and oxidized (GSSG) forms are the chelators 
of copper ions. 
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P-126: THE EFFECT OF CARVEDILOL 
TREATMENT ON ERECTILE DYSFUNCTION 
IN STREPTOZOTOCIN INDUCED DIABETIC 
RATS.
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INTRODUCTION:
Diabetes is associated with an increased risk of erectile 
dysfunction (ED). Diabetic men having problems 
with achieving and/or maintaining an erection could 
take phosphodiesterase type 5 inhibitors as first-line 
therapy. A nonselective β blocker, carvedilol, inhibits 
β-1 and β-2 adrenergic as well as α-1 adrenergic 
receptors, thereby causes vasodilation (1). In addition, 
carvedilol has been shown to improve the heart rate 
variability and systolic blood flow in cavernous and 
dorsal arteries in patients with arterial hypertension 
(2). The present study aimed to evaluate the effect 
of carvedilol treatment on ED in streptozotocin (STZ)-
induced diabetic rats.
MATERIALS AND METHODS:
Thirty adult male Sprague-Dawley rats were divided 
into four groups: 1) Control, 2) carvedilol (orally, 
10mg/kg/day, 4-week)-treated control, 3) STZ (40 mg/
kg, i.p., 8-week)-induced diabetic and 3) carvedilol-
treated diabetic rats. Carvedilol was given after 8-week 
of diabetes. The relaxation and contraction responses 
of corpus cavernosum (CC) were examined after 12 
weeks in organ bath studies.
RESULTS:
The carvedilol treatment had no effect on body 
weight and blood glucose in diabetic rats. In organ 
bath studies, endothelium-dependent acetylcholine 
relaxation of corpus cavernosum was significantly 
decreased in the diabetic group. However, no 
improvement was observed after carvedilol treatment. 
Surprisingly, neurogenic relaxation responses were 
significantly diminished in the cavernosal tissues of 
diabetic rats (15.6±5.0, p<0.01) which was normalized 
by the treatment (58.9±9.3). The relaxation response 
to sodium nitroprusside, a nitric oxide donor, was 
not changed in the groups. Furthermore, decreased 
relaxation responses to sildenafil, phosphodiesterase 
type 5 inhibitor, at 10µM dose in diabetic rats (diabetic, 
22.6±2.4; control 45.8±3.8, p<0.05) were ameliorated 
after carvedilol treatment (47.9±5.0). Neurogenic 
(25.9±2.6, p<0.01) and phenylephrine (22.0±2.4, 
p<0.01) contractile responses in the diabetic group 
were lower than in the control group (51.4±7.5 and 
54.7±5.3), which was restored after the treatment 
(45.6±3.4 and 65.0±6.1, respectively).
CONCLUSIONS:
Our data demonstrate that the carvedilol treatment is 
likely to improve the activity of neurogenic relaxation 
and contraction response as well as the relaxation 
response to phosphodiesterase type 5 inhibitor in 
erectile tissue of diabetic rats. Carvedilol may be a 
useful candidate for ED in diabetic men who have 
a potential risk of cardiovascular diseases. Further 
studies could help to confirm these findings and 
clarify the effect of combined treatment with carvedilol 
and phosphodiesterase type 5 inhibitors on diabetes-
induced ED.
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INTRODUCTION:
Erectile dysfunction (ED) worsening in diabetic men 
with heart failure is not surprising as the endothelial 
dysfunction is a pathophysiologic sign of diabetes. 
Ivabradine, a selective inhibitor of the If channel and 
used for the treatment of heart failure, can improve the 
endothelial function in mice with hypercholesterolemia 
(1). The present study aimed to determine the effect 
of ivabradine treatment on ED in streptozotocin (STZ)-
induced diabetic rats.
MATERIALS AND METHODS:
Thirty adult male Sprague-Dawley rats were divided 
into four groups: 1) Control, 2) ivabradine (orally, 
10mg/kg/day, 4-week)-treated control, 3) STZ 
(40 mg/kg, i.p., 8-week)-induced diabetic and 4) 
ivabradine-treated diabetic rats. Ivabradine was given 
after 8-week of diabetes. Corpus cavernous (CC) 
responses were evaluated after 12 weeks.
RESULTS:
Treatment with ivabradine had no effect on blood 
glucose in diabetic rats. In organ bath studies, 
endothelium-dependent acetylcholine relaxation of 
corpus cavernosum was significantly decreased in 
the diabetic group (18.0±2.4, p<0.01) which was 
further restored after ivabradine treatment (43.4±7.5). 
In addition, neurogenic relaxation responses were 
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significantly reduced in the cavernosal tissues of 
diabetic rats (17.0±5.7, p<0.001) which was improved 
by the treatment (55.0±7.1). The relaxation response 
to nitric oxide donor, sodium nitroprusside, was not 
altered in groups. However, relaxantion response 
to phosphodiesterase type 5 inhibitor, sildenafil, 
was increased after ivabradine treatment in diabetic 
rats. However, the maximum relaxation response 
to sildenafil was not changed in groups. Contractile 
responses were significantly attenuated in the diabetic 
group which was normalized after the treatment.
CONCLUSIONS:
These results indicate that mechanism of action of 
ivabradine treatment may involve the cooperative 
activity of endothelial and neurogenic erectile 
response in corpus cavernosum in diabetic rats. 
Further studies could help to identify the molecular 
mechanisms underlying the beneficial effect of 
ivabradine treatment on diabetic ED.
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P-128: ANTI-NOCICEPTIVE ACTIVITIES OF 
SOME THIADIAZOLE DERIVATIVES
Eker, D., Ucel, UI., Can, OD., Ozkay Demir, U. 
1Anadolu University, Department of Pharmacology, 
Eskişehir, Turkey
INTRODUCTION:
Thiadiazole is an important pharmacophore group 
frequently used in the drug development studies (1). 
Various thiadiazole derivatives have been reported 
for many different pharmacological effects, so far 
(2,3). One of the well-known activity induced by these 
derivatives is analgesia. Previous studies indicated 
that both of central and peripheral mechanisms 
may mediate the anti-nociceptive effects of these 
derivatives. Therefore, in the present study, we aimed 
to investigate possible anti-nociceptive activities of 
some thiadiazole derivative compounds.
MATERIALS AND METHODS:
Male CD1 mice, weighing 30-35 g, were used for 
the tests. Possible anti-nociceptive effect of the test 
compounds (30 mg/kg, i.p) on thermal, mechanical, 
and chemical nociceptive pathways were assessed 
by hot-plate, tail-clip and acetic acid induced writhing 
tests, respectively. Besides, assessment of motor 
coordination was carried out using Rota-Rod test. 
The experimental protocol of this study was approved 
by the Anadolu University Animal Experiments Local 
Ethics Committee.
RESULTS:
Compounds 2c, 2d, 2e, 2f, 2g and 2h increased the 
reaction time of animals recorded in hot-plate and 
tail-clip tests, indicating the centrally mediated anti-
nociceptive activities of these derivatives. Besides, 
compounds 2e and 2f decreased the total number 
of writhing behaviors in the acetic acid induced 
writhing test suggesting that peripheral mechanisms 
are also contributed the anti-nociceptive activities of 
these compounds, as well as central ones. None of 
the tested compounds changed the falling latencies 
of mice in the Rota-rod tests, so the exhibited anti-
nociceptive activities are specific. 
CONCLUSIONS:
Among the tested thiadiazole derivatives, compounds 
2c, 2d, 2e, 2f, 2g and 2h have significant anti-
nociceptive activities. However, further clinical studies 
are needed to clarify their potentials as analgesic 
drug candidates.
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P-129: A RISK ASSESSMENT OF FEBRILE 
NEUTROPENIA IN AN ONCOLOGY 
OUTPATIENT CLINIC
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1 Hacettepe University, Faculty of Pharmacy, 
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INTRODUCTION:
Febrile neutropenia (FN) is a serious complication 
of myelosuppressive therapy, which can lead to 
reduction in dose and/or termination of chemotherapy. 
The use of granulocyte colony-stimulating factor 
(G-CSF) reduces the severity and duration of FN. 
An initiation of G-CSF treatment in patients receiving 
chemotherapy protocols with a risk of developing 
FN ≥20% for primary prophylaxis is strongly 
recommended. In chemotherapy protocols where the 
risk of FN is 10-20%, the G-CSF treatment should 
be initiated if patients have identified risk factors. 
Therefore, aim of this study was to assess the pattern 
of G-CSF use by the Patient Risk Score (PRS)1 in 
oncology outpatients.
MATERIALS AND METHODS:
This prospective, cross-sectional study was 
conducted at the Hacettepe University Oncology 
12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 199
Hospital outpatient clinic between April-August 2017. 
The risk assessment for FN was undertaken on each 
cycle of chemotherapy by a clinical pharmacist at 
the clinic by using PRS. The patients who are ≥18 
years of age and receive a chemotherapy protocol 
of developing FN risk is 10-20% and >20% were 
included and followed for 3 months during the study.
RESULTS:
A total of 118 patients (50% female) were included 
in the study; 49 and 67 patients use lenograstim and 
filgrastim, respectively.  Among those, 69 (58.5%) 
patients used G-CSF for primary prophylaxis and 49 
(41.5%) for secondary prophylaxis. Lenograstim was 
the most commonly used drug for primary prophylaxis. 
Although the risk of developing FN at the initial visit 
(PRS <3) was low in 45 (38.5%) patients, they were 
initiated to use G-CSF treatment. There were no 
significant differences in PRS values  of patients on 
each cycle during 3 months follow-up (p>0.05).
CONCLUSIONS:
Although no statistically significant difference 
was found in the assessment of PRS values , it is 
important to assess patients individually in terms 
of risk of developing FN before each cycle during 
chemotherapy. PRS assessment can be used in 
a routine daily practice since it has easy-to-apply 
scoring systems and allows interpretation of risk 
factors individually.
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INDUCED NEPHROTOXICITY IN RATS
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INTRODUCTION:
Cisplatin (cis- diamminedichloroplatinum(II)) is a 
potent antineoplastic agent that is widely used to 
treat both adult and pediatric malignancies (1). 
The main dose-limiting side effect of cisplatin is its 
nephrotoxic effects (2). Clinical symptoms of cisplatin 
nephrotoxicity include; intense inflammatory response, 
injury in renal vasculature, reduced glomerular 
filtration and histopathologic abnormalities of acute 
tubular necrosis (3). Current literature suggests 
that necrostatin-1, a potent receptor-interacting 
serine/threonine-protein kinase 1 (RIPK1) inhibitor, 
prevents necroptosis through RIPK1 inhibition (4). 
This study aimed to investigate the protective effects 
of necrostatin-1 administration on cisplatin-induced 
nephrotoxicity in rats.
MATERIALS AND METHODS:
Male Wistar Albino rats weighted 250-350 gr were 
used in this study. Animals were separated into 
groups and treated with a single dose cisplatin (5 mg/
kg; CIS) and necrostatin-1 (1,65 mg/kg/d for 5 days; 
NEC) or saline (%0.9) intraperitoneally (ip). Twenty 
hours after the injections, rats were sacrificed, and 
blood samples were collected to measure serum 
urea and blood creatinine levels. Left kidneys of 
rats were isolated and put on the Langendorff 
apparatus, perfused with Krebs solution to measure 
renal perfusion pressures. The right kidneys of rats 
were isolated to measure malondialdehyde (MDA) 
levels. The data were analyzed with Kruskal-Wallis 
Test, followed by Tukey’s post hoc test if significant 
differences were detected.
RESULTS:
Blood serum urea levels were higher in CIS group 
(p<0.01) vs. control, and lower in CIS-NEC group 
(p<0.01) vs. CIS group. Serum creatinine levels were 
higher in CIS group (p<0.01) vs. control, and lower 
in CIS-NEC group (p<0.01) vs. CIS group. MDA 
levels were higher in CIS group (p<0.01) vs. control, 
and lower in CIS-NEC group (p<0.05) vs. CIS group. 
Renal perfusion pressures were higher in CIS group 
(p<0.01) vs. control, and lower in CIS-NEC group 
(p<0.01) vs. CIS group. NEC alone didn’t alter renal 
perfusion pressures.  
CONCLUSIONS:
Necrostatin-1, a RIPK1 inhibitor did successfully 
reduce cisplatin-induced nephrotoxic symptoms. 
To minimize the nephrotoxic side-effects of cisplatin 
treatment, necrostatin-1 appears as a promising 
supplementary agent to chemotherapy.  
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P-131: EVALUATION OF DRUG-DRUG 
INTERACTIONS ENCOUNTERED IN 
PEDIATRIC INFECTIOUS DISEASES UNIT
Polat, EC., Ozdemir, N., Bayraktar Ekincioglu, A., 
Demirkan, K.
Hacettepe University, Faculty of Pharmacy, 
Department of Clinical Pharmacy, Ankara, Turkey
INTRODUCTION:
Drug-drug interaction is described as an alteration of 
at least one drug’s effect (such as increase, decrease 
or loss of effect) through various mechanisms where 
both drugs are administered concurrently. Drug-drug 
interaction leads to increase in morbidity and mortality, 
failure in treatment and also increase in health care 
expenditure indirectly. This study aimed to evaluate 
drug-drug interactions encountered in pediatric 
infectious diseases unit in a university hospital.
MATERIALS AND METHODS:
The study was conducted between 2nd-16th April 
2018 at Hacettepe University Ihsan Dogramaci 
Children’s Hospital Pediatric Infectious Diseases 
Unit. Patients’ demographics and drug orders were 
collected by a clinical pharmacist through patients’ 
medical records. Drug interactions were assessed 
on the first day of patient’s drug order by using 
Micromedex® and Medscape online databases and 
the results were analyzed by IBM SPSS v.23.
RESULTS:
A total of 15 patients were included in the study. Of 
those, 80% were male (n=12), the mean (±standard 
deviation) age was 9.13 (±4.62) years and the 
number of drugs used per day was 5.53 (±2.5). A 
total of 14 drug interactions were identified by the 
Micromedex® and 55 interactions by the Medscape 
database. Among drug interactions identified by the 
Micromedex® (n=14); 7, 5 and 2 were categorized as 
major, moderate and minor interactions respectively. 
However, according to the Medscape, 5 (9.09%) 
interactions were indicated as contraindicated and 
serious, 16 (29.09%) as monitor closely and 34 
(61.82%) as minor. Drug interactions were indicated 
as pharmacodynamic [19 (34.55%) and 12 (85.71%)] 
and pharmacokinetic [36 (65.45%) and 2 (14.29%)] by 
the Medscape and Micromedex, respectively. While 
the majority of the pharmacokinetic drug interactions 
identified by the Medscape were at absorption level 
(43.64%), interactions identified by the Micromedex® 
were predominantly pharmacodynamic (85.71%).
CONCLUSIONS:
The characteristics and management of drug 
interactions varies among interaction checker 
databases. Therefore, pharmacists should be aware 
of the mechanism of drug interactions, should compile 
scientific knowledge from various information sources 
then interpret them and provide appropriate strategies 
for its management.
P-132: EVALUATION OF POTENTIAL 
DRUG-DRUG INTERACTIONS AMONG 
PRESCRIPTIONS OF OUTPATIENTS FROM 
TRABZON, TURKEY
1 Engin, S., 1 Barut, EN., 1 Eroglu, G., 2 Yaris, E., 1 
Sezen, FS
1 Karadeniz Technical University, Faculty of 
Pharmacy, Department of Pharmacology, 
Trabzon,Turkey
2 Karadeniz Technical University, Faculty of Medicine, 
Department of.Pharmacology, Trabzon, Turkey
INTRODUCTION:
Drug-drug interactions (DDIs) defined as an altered 
response of one drug by cocurrent use of another drug 
is a major concern in polypharmacotherapy (1). Many 
studies based on primary care reports have revealed 
the prevalence for potential DDIs (pDDIs) ranging 
12% to 80% (2). However, limited data is available 
about the prevalence of in outpatients in Turkey. The 
study was aimed to evaluate the prevalence and the 
severity of pDDIs in the prescriptions of outpatients 
from Trabzon. 
MATERIALS AND METHODS:
A retrospective observational study was carried out 
and a total of 169 prescriptions from fifteen family 
practitioner centres were collected for a period of 4 
months (February - May 2016) in Trabzon. Demografic 
information (age and gender), prescription details and 
the number of  additional drug use were collected. 
pDDIs were checked by using the Drug Interactions 
Checker within the drugs.com database. Data were 
presented as mean±standart deviation or percentage 
of case. Independent sample t-test was used to 
assess differences among groups. The Pearson 
correlation coefficient was used to determine the 
relationship between two variables. p<0.05 was 
considered significant.
RESULTS:
A total of 169 prescription with mean age 42.10±25.20 
years were analysed. The mean number of prescribed 
drugs per patient was 2.99±1.08. A total of 151 pDDIs 
were identified with mean of 0.89±1.83. Respiratory 
system drugs were the most frequently prescribed 
group (n = 78; 15.4 %). The prevalence of pDDIs 
was 39%. Acetylsalicylic acid was the most frequently 
prescribed drug involved in pDDIs (n=21, 13.9%), 
The most common pDDIs was Acetysalycilic acid with 
Metoprolol (n=4, 2.6%). Out of all pDDIs, 113 (74.8%) 
were of moderate, 27 (17.8%) were of minor, and 
11(7.2%) were of major severity. The number of pDDIs 
are significantly correlated with age of the patients 
(r=0.33, p<0.01) and the number of prescribed drugs 
(r=0.46, p<0.01).
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CONCLUSIONS:
Based on the study findings, the majority of 
interactions were moderate. Our results confirm the 
significant association of polypharmacy and age with 
the occurrence of pDDIs. Clinicians and pharmacists 
should be aware of the pDDIs to improve patient 
compliance and drug safety.
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P-133: EFFECTS OF THREE 
DIFFERENT FLAVONOIDS ON CARDIAC 
CONTRACTILITY UNDER HIGH GLUCOSE 
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INTRODUCTION:
Hyperglycemia results in detrimental effects in heart 
including hypertrophy and functional abnormalities 
(1). On the other hand, dietary polyphenols are known 
to have preventive effects on the development of 
cardiac diseases (2). These polyphenols have been 
shown to regulate blood glucose leves and have 
protective effects in diabetes (3). Nevertheless, to our 
knowledge, their direct cardiac effect at the cellular 
level is not known. Thus, we aimed to investigate 
the effects of various polyphenolic substances from 
different classes under high glucose concentrations. 
MATERIALS AND METHODS:
Ventricular cardiomyocytes were isolated from 
adult male Sprague–Dawley rats (300-400 g). Cells 
were treated with high glucose (25 µM) for 3 hours. 
Resveratrol, quercetin and apigenin was added 30 
min prior to high glucose to a group of cells. A video-
based edge detection system (IonOptix) was used to 
record changes in cell length during cell shortening 
and relengthening. Cardiac contractility was 
assessed using peak shortening (PS) as an indicative 
of contractility, time to PS (TPS) as an indicative of 
systolic duration, time to  90% relengthening (TR90) as 
an indicative of diastolic duration, maximal velocities 
of shortening/relengthening (± dL/dt) as indicatives of 
maximal velocities of ventricular pressure changes. 
RESULTS:
Short term culture with high glucose concentrations 
elongated resting cell length. Moreover, those 
hyperglycemic cells showed decreased peak 
shortening (PS), speed of contraction and relaxation 
(± dL/dt). Resveratrol co-treatment improved these 
contractile parameters, however quercetin and 
apigenin did not. 
CONCLUSIONS:
Resveratrol appears to improve cardiac parameters 
under hyperglycemia. However, quercetin and 
apigenin did not show any cardioprotective effects 
against hyperglycemia at the concentrations we 
used. Future studies using different polyphenolic 
substances are planned to be done. 
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AND THE ROLE OF THE COMMUNITY 
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INTRODUCTION:
Rational drug use (RDU) is described by World 
Health Organization as the administration of drugs 
at appropriate doses, using for sufficient time with 
the lowest cost for both patients and community (1). 
The correct explanation of effective use, side-effects 
and interactions of drugs to patients will prevent 
inappropriate usage of the drugs. Hypertension is 
one of the most common chronic disease in the 
world and the cost of the disease are increasing day 
by day with the aging of world population. RDU in 
the management hypertension will be reduced the 
cost of treatment. A multidisciplinary team-work and 
cooperation especially between doctor-pharmacist-
patient require for a successful RDU. It was reported 
in many studies that in the treatment of hypertension, 
the blood pressure was controlled more effectively 
with the contribution of the community pharmacist 
(2). Therefore, informing the pharmacist about RDU 
is very important for the success of the treatment. The 
aim of this study is to assess the knowledge of the 
community pharmacist and the information that were 
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provided to patients about the drugs in hypertension 
treatment in Greater Ankara area. 
MATERIALS AND METHODS:
A survey was applied to 110 pharmacists who were 
accepted to participate the study. 
RESULTS:
According to survey, 1.8% of the pharmacists reported 
that the prescription of hypertension treatment was 
dispensed rarely, 9.1% occasionally, 70% frequently 
and 19.1% contstantly. The pharmacists stated 
that, 35.5% of the participants were educated about 
rational use of hypertension drugs and 64.5% of them 
did not take an extra-education after graduation. The 
88.1% of the pharmacists were reported that they 
informed the patient about lifestyle changes, 75.5% 
about the importance of the compliance to treatment 
and 87.2% informed the patients about the disease.
CONCLUSIONS:
These results underline the importance of the 
community pharmacist in the rational use of 
hypertension drugs. Therefore, raising awareness 
about RDU in the management of hypertension for 
the patients and pharmacists will provide significant 
benefits to public health and cost-effective drug use. 
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EFFECTS OF HUPERZINE-A ON OPTIC 
NERVE IN ALZHEIMER’S MODEL 
1 Bayrak, G., 2 Turkseven, CH., 3 Marasligil, B., 4 
Dinc, E., 1 Balli, E., 2 Buyukakilli, B.
1 Mersin University, Faculty of Medicine, Department 
of Histology and Embryology, Mersin, Turkey
2 Mersin University, Faculty of Medicine, Department 
of Biophysics, Mersin, Turkey
3 Mersin University, Faculty of Medicine, Department 
of Physiology, Mersin, Turkey
4 Mersin University, Faculty of Medicine, Department 
of Ophthalmology, Mersin, Turkey
INTRODUCTION:
Alzheimer’s disease (AD) is a chronic 
neurodegenerative disease which is characterized 
by the neuronal loss, cerebrovascular inflammation, 
the accumulation of amyloid plaques (Aβ) on the 
cerebral vessels and the brain parenchyma (1). It 
is known that estrogen replacement therapy may 
protect postmenopausal women from AD and help 
improve their cognitive function (2,3). Long-term 
intraperitoneal administration of D-gal can lead to 
oxidative stress, neuronal damage, and a decline 
in learning and memory capacity in rats (4). In the 
experimental AD model, female rats ovariectomized 
to avoid the protective effects of the estrogen and 
were injected intraperitoneal D-gal. In this study, we 
aimed to investigate the possible therapeutic effects 
of Huperzin-A (Hup-A) against the possible damage 
of the optic nerve in the ovariectomized experimental 
AD model with ultrastructurally.
MATERIALS AND METHODS:
Sixty-eight female Sprague-Dawley rats were 
divided control, sham, ovariectomy, ovariectomy+D-
galactose, ovariectomy+D-galactose+Hup-A 
groups. For the model of AD, D-galactose (i.p.) was 
administered at 100 mg/kg dose every day for 10 
weeks ovariectomy+D-galactose and ovariectomy+D-
galactose+Hup-A groups after the ovariectomy. At 
the end of the experiment, the rats were sacrificed 
and the removed optic nerves were examined with 
electron microscopy ultrastructurally.
RESULTS:
In the control, sham, and ovariectomy groups glial 
cells, myelinated and unmyelinated nerve fibers 
and perivascular areas were normal. Findings in 
the ovariectomy+D-galactose and ovariectomy+D-
galactose+Hup-A groups were similar to the other 
groups.
CONCLUSIONS:
As a result of the study, it was determined that long-
term D-galactose administration did not cause optic 
nerve damage after ovariectomy. In our next study, it 
is considered to improve the duration of D-galactose 
administration and / or dose and to reevaluate the 
possible effects on the optic nerve.
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INTRODUCTION:
The aim of our study is the evaluation of quality of 
life, illness perception, attitude toward medication 
of patients with benign prostatic hyperplasia in the 
urology outpatient department.
MATERIALS AND METHODS:
The study group was composed of seventy-four 
patients with benign prostatic hyperplasia over 40 years 
old.  All patients were using at least one medication 
for BPH with a period of at least last 4 weeks. The 
following scales were used: 1.Morisky Green Levine 
Medication Adherence Scale to measure medication 
adherence, 2. Benign Prostatic Hyperplasia-Quality of 
Life Questionnaire to degree disease specific quality 
of life, 3.Brief Illness Perception Questionnaire and 
4.Beliefs about Medicines Questionnaire (BMQ-T) to 
measure patients’ perceptions of illness, treatment 
beliefs, and moods.
RESULTS:
The mean age of the participants were 64.86 ± 
7.90 in the present study. Of them, 25.9% were 
defined as polypharmacy which is the use of five 
or more medication, out of 74 patients, 48 (64.9%) 
were adherent to their medication. The mean score 
of quality of life was 19.08±9.80 (2-44). The mean 
scores of BMQ-T for the necessity, concerns, harm, 
and overuse domains were 2.88±0.62, 3.47±0.71, 
3.02±0.59, and 2.60±0.58, respectively. The mean 
score of brief illness perception was 39.72±13.41. 
There was significant correlation between the 
number of medication used and the score of specific 
concerns-BMQ-T (r=0.328, p<0.05). However, there 
was negative correlation between the number of 
medication used and the score of general overuse-
BMQ-T (r=-0.341, p<0.05). There was a negative 
correlation between the scores of illness perception 
and specific concerns-BMQ-T (r=-0.314, p<0.05). 
CONCLUSIONS:
According to our study results, the patients with BPH 
have moderate scores for brief illness perception and 
beliefs about medicines. Pharmacists could play an 
important role in patient education to improve their 
knowledge and perception regarding illness and 
medication in BPH.
P-137: ADHERENCE TO 
IMMUNOSUPPRESIVE MEDICATIONS IN 
RENAL TRANSPLANT PATIENTS.
Tecen Yucel, K., Aras, E., Ozdemir, N., Bayraktar 
Ekincioglu, A., Demirkan, K.
Hacettepe University, Department of Clinical 
Pharmacy, Ankara, Turkey
INTRODUCTION:
Patient adherence to immunosuppresive medication 
is one of the most important factor for the survival of a 
graft in transplant patients. The study aimed to assess 
patient adherence to immunosuppresive medications 
and factors that may affect adherence (1).
MATERIALS AND METHODS:
A prospective, observational study was conducted 
in a nephrology outpatient clinic at the Hacettepe 
University Hospitals between November 
2017-February 2018. A clinical pharmacist was 
involved in clinic visits with specialist physicians and 
interviewed with patients who had transplantation, 
are taking tacrolimus, cyclosporine or everolimus 
and are willing to participate in the study. The data on 
patients’ demographics and serum drug concentration 
were collected and the Immunosuppressive Therapy 
Adherence Scale (ITAS) at the clinic which consists of 
4 questions (total score:12) was administered at the 
clinic. The patients with ITAS scores of 12 points were 
considered to have a perfect adherence. Factors that 
may affect adherence were evaluated by a logistic 
regression analysis.
RESULTS:
A total of 100 patients included in the study. The 
mean age (± standard deviation) was 39.73±1.20 and 
56% were male. With regards to immunosuppressive 
medication; 67, 26 and 7 patients were using 
tacrolimus, cyclosporine and everolimus, respectively. 
Only 32 patients had ITAS score of 12 (perfect 
adherence), of those 22, 9 and 1 were on tacrolimus, 
cyclosporine and everolimus. A significant difference 
was found in serum drug concentration between 
patients who have ITAS score of 12 and score of ≤11 
for patients taking tacrolimus (p=0.022). There were 
no statistically significant association established 
between patient adherence and factors such as 
age, body mass index, marital status, education 
level, number of additional diseases, number of 
medications used, pre-transplant dialysis history, 
transplantation type (cadaver/live), duration since 
transplantation, duration of immunosuppressive 
medication and thyroid stimulating hormone (p>0.05). 
Only a level of vitamin D was found to be a significant 
factor on adherence (p=0.017) where a unit increase 
has a positive effect on adherence [Odds Ratio (95% 
Confidence Interval): 0.819 (0.694-0.966)].
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CONCLUSIONS:
Adherence to immunosuppressive medication in 
renal transplant patients is important. Healthcare 
professionals should be aware of the level of patient’s 
adherence and its associated factors. A clinical 
pharmacist may play a critical role in identifying 
patient’s level of adherence to maintain effective 
therapy. 
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INTRODUCTION:
Rheumatoid arthritis is a progressive autoimmune 
disease which affects the functional ability and 
decrease the quality of life, due to polyarticular 
inflammation and joint damage. Leflunomide is a 
disease modified drug which is orally administered 
to be rapidly metabolized to active teriflunomide 
(TFL). TFL is responsible for its therapeutic action 
(1,2).  The aim of this work was to evaluate the use 
of polymeric film containing two polymers, poly(ε-
caprolactone) (PCL) and poly(butylene adipate) 
(PBAd) as a possible management of controlling the 
release of TFL from the product. Characterization, in 
vitro release and in vivo studies were performed. 
MATERIALS AND METHODS:
PCL and PBAd were prepared as previously reported 
(2). PCL/PBAd patches were developed via solvent 
evaporation technique, by using dichloromethane 
(DCM). Immiscible PCL/PBAd blends were produced 
by dissolving the polymers to DCM until full solvent 
evaporation.  90/10, 70/30 and 50/50 were loaded 
with 5, 10 and 15 wt% TFL. In vitro degradation 
rate using Simulated Body Fluid ruled out increased 
hydrolysis. A skin irritation experiment was done  with 
healthy BALB-c mice. Mice were divided into four 
groups (saline (SP), TFL loaded blends (70/30 and 
50/50), and TFL loaded suspension).
RESULTS:
Compatibility studies between drug and polymeric 
blends as conducted via FTIR, XRD and SEM 
analysis exhibited amorphization of the drug into the 
matrix which led to improved solubility of the drug 
(Fig 1). In vitro release showed the expected high 
dissolution rate which it was time dependent and 
associated with the hydrolysis degradation (1,2). In 
further, histopathology studies manifest the safety 
of the above patches claiming that TFL loaded PCL/
PBAd blends are appropriate vehicles for the dermal 
application of TFL (Fig 1c).
Fig 1. a) FT-IR and b)DSC studies of PCL and 
PBAd blends c) Images of treated mice skin with 
a)70/30+5% TFL, b)with 50/50+5% TFL, c)with SP 
and d)with 5% TFL suspension.
CONCLUSIONS:
It can be concluded that the prepared carriers are 
quite promising for patients since they can limit the 
side effects rising from TFL drug.
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P-141: INCREASED ANTILEUKEMIC 
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INTRODUCTION:
Sunitinib is a multitargeted receptor tyrosine kinase 
inhibitor with selectivity against PDGFR and 
VEGFRs, approved for treatment of patients with 
advanced renal cell cancer. Furthermore, sunitinib 
has been shown to be active against acute myeloid 
leukemia (AML) cells in vitro and in vivo, and the 
synergistic growth inhibition of these cells occurred 
when sunitinib was combined with the conventional 
anticancer agents (1). The serine/threonine kinase 
mammalian target of rapamycin (mTOR) is activated 
by phosphatidylinositol 3-kinase/Akt signaling and 
regulates cell proliferation. The mTOR inhibitors, 
rapamycin or its analogue everolimus (RAD001), 
have been shown to be active against many types of 
solid tumors, as well as subsets of leukemia, and are 
now being used in clinical trials (2). The present study 
aimed to determine whether everolimus can enhance 
anticancer effect to sunitinib; for this purpose the 
combined effects of everolimus with sunitinib on K562 
cells were investigated.
MATERIALS AND METHODS:
K562 cells were cultured and treated with different 
concentrations (100, 10, 1, 0.1, 0.01 µM) of everolimus/
sunitinib alone and everolimus in combination with 
sunitinib. The cell viability was determined by 2,3-
bis (2-methoxy-4-nitro-5-sulfophenyl)-2-tetrazolium 
5-carboxanilide (XTT) cell proliferation assay. 
RESULTS:
Our results showed that everolimus, sunitinib and 
everolimus-sunitinib combination exposure inhibited 
K562 cell proliferation (p<0.05) in a dose-dependent 
manner compared to the control cells. The IC50 
of everolimus, sunitinib and everolimus-sunitinib 
combination in K562 cell line were calculated as 
73 µM, 91 µM and 51 µM after 24 h of treatment, 
respectively.
CONCLUSIONS:
In conclusion, our cytotoxicity results revealed that 
the everolimus-sunitinib combination is more toxic 
than sunitinib alone on K562 cells. Taken together, 
sunitinib may be useful for the treatment of individuals 
with leukemias possessing activating mutations in 
RTK; and the combination of sunitinib and everolimus 
represents a promising novel treatment strategy. 
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INTRODUCTION:
Veronica officinalis (V. officinalis) is a widespread 
species found growing long forest edges, in 
underwood and meadows up to subalpine altitudes 
(1, 2). Especially in the 16th and 17th centuries, 
V. officinalis was recommended for stomach and 
intestinal diseases, renal lithiasis, pulmonary diseases 
and colic (3). The present study aimed to evaluate 
the anti-proliferative effect of the methanol and water 
extracts of V. officinalis leaves on MDA-MB-231 cells.
MATERIALS AND METHODS:
MDA-MB-231 and L929 cell lines were cultured and 
treated with different concentrations (0.0625, 0.125, 
0.25, 0.5, 1 mg/mL) of V. officinalis for 24 h. 2,3-
bis (2-methoxy-4-nitro-5-sulfophenyl)-2-tetrazolium 
5-carboxanilide (XTT) cell proliferation assay was 
used to evaluate the antiproliferative effects of the 
water and methanolic extracts of V. officinalis leaves 
on MDA-MB-231. L929 cell lines were also used as 
healthy control cells. 
RESULTS:
The methanol extract of V. officinalis significantly 
inhibited MDA-MB-231 cell proliferation (p<0.05) 
at 0.25-1 mg/mL concentration range in a dose-
dependent manner. However, the water extract of 
V. officinalis exhibited important anticancer activity 
(p<0.05) at 0.5-1 mg/mL concentrations in a dose-
dependent manner. The IC50 values of the water and 
methanol extracts of V. officinalis in MDA-MB-231 cell 
line was calculated as 0.092 mg/mL and 0.45 mg/mL 
after 24 h of treatment, respectively. However, neither 
extract showed any significant cytotoxicity on the 
L929 cell line at the concentration range (0.0625-1 
mg/mL).
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CONCLUSIONS:
According to the experimental results the methanol 
extract of V. officinalis exhibited more significant 
anticancer activity than the water extract on MDA-
MB-231 cells. This may be due to the fact that the 
methanol extract has richer active ingredients than 
the water extract. Consequently, the methanolic 
extract of V. officinalis leaf may be considered as a 
potential therapeutic agent in cancer.
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INTRODUCTION:
During exposure to stress, neurochemical, hormonal 
and behavioral changes occur in the body(1). Studies 
revealed that subchronic stress application is related 
to oxidative stress and it increases lipid peroxidation, 
nitrite levels, catalase activity and decreases 
glutathione levels in the brain(2).In various studies, it 
is stated that melatonin is a useful agent to prevent 
oxidative damage arisen from stress with various 
mechanisms(3). Fluoxetine, on the other hand, 
has shown therapeutic benefits in the protection 
of the brain cells against oxidative damage and the 
prevention of depression and anxiety due to reduced 
serotonergic activity during stres(4). This study aimed 
to investigate the antioxidant effects of fluoxetine, 
melatonin and their combinations on subchronic 
immobilization-induced stress in mice. 
MATERIALS AND METHODS:
BALB/c mice weighted 30-40 gr were separated into 
groups and either treated intraperitoneally (ip) with 
melatonin (10 mg/kg, Mel), fluoxetine (20 mg/kg, Flu) 
for 7 days or had %0.9 saline injections. Immobilization 
(IM) groups were placed into individual cages 6 hours 
for 7 days. Mice were sacrificed by decapitation to 
assess malondialdehyde (MDA) levels. The results 
were evaluated using One-way ANOVA followed by 
Kruskal-Wallis test. Data are presented as mean and 
±SEM.
RESULTS:
The measured MDA levels in the immobilization 
applied mice group brain tissue samples were 
significantly higher than those of the control group 
(p<0.01). Melatonin, fluoxetine and their combination 
did decrease the increased MDA levels to normal 
levels.
CONCLUSIONS:
In this study, melatonin has been found as effective 
as fluoxetine in reducing oxidative damage induced 
by stress application. Secreted endogenously or 
taken as exogenous medication, melatonin could 
pose a remarkable alternative to fluoxetine, which 
has disturbing side effects. Further studies should be 
conducted to reveal beneficial effects of melatonin in 
various physiological and psychiatric disorders.
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INTRODUCTION:
Flowering herbs of Gentiana olivieri known with a 
local name as “Afat”, is traditionally been used in 
south-east Anatolia as bitter tonic, stomachic and to 
combat some mental disorders including depression 
in the different regions of Turkey (1). Studies have 
consistently showed associations between depression 
and liver diseases and also antidepressant drugs can 
cause drug-induced liver injury (2, 3). The aim of this 
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study is to investigate the hepatoprotective effect of 
G. olivieri in different doses on chronic unpredictable 
stress (CUS) induced depression and to compare the 
results with imipramine.
MATERIALS AND METHODS:
72 male Sprague dawley rats were were divided into 9 
groups (8 animals in each group) and were subjected 
to an experimental setting of CUS procedure 
according to the method of Muscat et al (1990) (4). 
The animals were orally administered imipramine (10 
mg/kg), the ethanol extract of G. olivieri (1000 mg/kg, 
500 mg/kg and 200 mg/kg) alone and in combination 
of imipramine (10 mg /kg)   for 21 days on CUS model 
of depression. CUS-induced liver injury was examined 
by measuring liver TBARS, GSH and SOD levels.
RESULTS:
CUS-induced depression increased liver TBARS 
level (p<0,001), reduced liver GSH and SOD 
levels (p<0,01). G. olivieri reversed CUS-induced 
impairment in liver antioxidant by decreasing TBARS 
level (p<0,01) and increasing GSH and SOD levels 
(p<0,01) at 1000 mg/kg dose; decreasing TBARS 
level (p<0,01) and increasing GSH level (p<0,05) at 
500 mg/kg dose and decreasing TBARS level at 200 
mg/kg dose (p<0,05). 10 mg/kg imipramine did not 
alter these parameters significantly. G. olivieri when 
used in combination of impramine also produced 
beneficial effect by decreasing TBARS level (p<0,01) 
and increasing GSH and SOD levels (p<0,001) at 
1000 mg/kg dose; decreasing TBARS level (p<0,001) 
and increasing GSH and SOD levels (p<0,001) at 500 
mg/kg dose; decreasing TBARS level (p<0,05) and 
increasing GSH level (p<0,05)  at 200 mg/kg dose.
CONCLUSIONS:
G. olivieri may be beneficial for stress induced 
impairment in liver and may reduce the side effects of 
synthetic antidepressants such as imipramine related 
to liver. Further investigations are needed on the 
potential use of G. olivieri in clinical depression.
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INTRODUCTION:
Healing of burn wounds, managed by many 
cytokines and mediators in which inflammation and 
hypermetabolism are seen. Superficial burns can be 
treated with topical pharmaceutical forms (1). This 
study aimed to examine the effects of methanolic leaf 
extracts of Cotinus coggygria plant that grows in our 
country, and phenytoin, an antiepileptic drug, on an 
experimental 2nd degree burn wound.
MATERIALS AND METHODS:
Sprague-Dawley rats (n=40) were divided into 5 
groups and 2nd degree burns were induced on the 
shaved backs by pressing a heated (100ºC) copper 
plate (3x4 cm) for 5 seconds according to the 
Khodja et al. method (2). Groups were constituted as 
Control (base ointment), Silverdin®, 1% methanolic 
C.coggygria extract, 2% Phenytoin, 1% C.coggygria 
+ 2% Phenytoin. For treatment, 0.5 g of ointment was 
applied to the burned areas for 14 days. The blood 
samples were analyzed for the levels of neopterin and 
interleukin-6. The tissue levels of some parameters 
related to oxidative stress such as lipid peroxidation 
(TBARs), glutathione (GSH), total thiol groups (T-
SH) as well as hydroxypyroline and caspase-3 were 
determined. Digital photographs were taken on 3rd, 
7th and 14th days to examine the prognosis of the 
wounds. The burned areas were standardized using 
Cam-Scanner and Photoshop software, compared 
in terms of number of pixels. One-way analysis of 
variance (ANOVA) and Tukey’s test were used to 
compare the groups with the control group.
RESULTS:
In the Cotinus group, statistically significant 
differences compared to controls were found in terms 
of TBARs (p<0.001) and other parameters (p<0.05) 
except for neopterin. Phenytoin significantly improved 
all parameters (p<0.001), In the Cotinus+Phenytoin 
group, significant results were obtained in all 
parameters (p<0.05 and p<0.01). The sizes of the 
wounds were markedly reduced in the Cotinus 
(p<0.05) and phenytoin (p<0.001) group compared to 
the control on 14th day.   
CONCLUSIONS:
C.coggygria plant significantly contributes to healing 
possibly by means of the main component of its 
methanolic extract that possesses strong antioxidant 
and anti-inflammatory capabilities, i.e gallic acid (3). 
Phenytoin may have strengthened the connective 
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tissue by means of its epithelizing effect. Combined 
administration of Cotinus and phenytoin may have 
synergistic effect especially on GSH that forms the 
antioxidant defense pool. Since the sizes of the wound 
areas tend to reduce, it could be suggested that this is 
a promising preparation which may contribute to the 
treatment of burn wounds. 
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INTRODUCTION
Electroconvulsive therapy (ECT), with external 
electrical stimulation; Triggering epileptic grand mal 
epileptic seizures for treatment in patients with high 
suicide risk, not responding to antidepressant drugs, 
in situations where drug use is high risk, such as 
pregnancy / lactation, in patients with severe mania, 
schizophrenia, schizoaffective disorder. Studies 
shown that, in severe depression situations, it has a 
positive effect and limited side effects in a short time. 
The treatment may be administered in a total of 12-20 
sessions, twice a week; This number varies according 
to the clinical response of the patient. After acute 
treatment, maintenance treatment is started when 
necessary.
MATERIALS AND METHODS
Effect of concurrent administration of ECT with 
pregabalin which is one of the antiepileptic drugs 
on seizure threshold and duration was intended to 
shown.
RESULTS 
A 38-year-old, married, 1 child-admitted male 
patient was admitted to the hospital with alcohol and 
benzodiazepine dependence and depression.
The patient uses risperidone 2mg, fluoxetine 40mg, 
pregabalin 300mg, clonazepam 4mg and vitamin B 
complex. It was first decided in 1998 that the patient 
diagnosed with depression had started ECT on the 
patient after the depressive episodes had increased 
in the last two years.
When the patient receives the first ECT, the target 
energy-induced seizure is not achieved with the 
applied energy. Therefore, because of the failure with 
the energy applied for the first seizure patient need 
an increased dose of energy at the same day and 
the application was repeated once more, but couldn’t 
achieved an effective result. Clinical pharmacist was 
found that the condition of inability to achieve the 
desired treatment of seizures due to concomitant use 
of pregabalin. Pregabalin an anticonvulsant drug that 
affects the threshold and duration of seizures. Clinical 
pharmacist suggest that in the next ECT session 
pregabalin dose should be reduced half of the normal 
dose. In the second session of the treatment, the 
targeted active attack is provided with the applied 
energy. The patient’s treatment was terminated 
successfully and ECT applied 12 sessions in total. 
CONCLUSIONS
Due to the prevalence of seizure threshold and 
duration in patients who are scheduled to undergo 
ECT is critical, the medications used by the patient 
should be evaluated with a multidisciplinary team 
before to initiate for ECT treatment.
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INTRODUCTION:
Reboxetine is a potent and selective noradrenaline 
re-uptake inhibitor prescribed for the treatment 
of major depression in many countries. We have 
recently reported the anti-hyperalgesic and anti-
allodinic effects of reboxetine in diabetic rats. We also 
have demonstrated the contribution of dopaminergic 
system to these effects. Based on the role of delta 
opioid receptors (δOR) in the processes related to 
pain (1-3), in this study, we planned to investigate the 
possible involvement of δOR in the anti-hyperalgesic 
effect of reboxetine in order to provide further 
mechanistic approach for the mode of action.
MATERIALS AND METHODS:
Male Sprague-Dawley rats (250-300 g) were used 
for the experiments. Diabetes was induced by a 
single i.v. injection of streptozotocin (STZ, 50 mg/
kg). Reboxetine (8 mg/kg/day, p.o.) treatment was 
started after 4-week diabetic period which is required 
for neuropathy development. After 2 weeks treatment 
period, mechanical and thermal hyperalgesia were 
assessed using the Randall-Selitto and Hargreave’s 
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tests, respectively. Potential involvement of the δOR 
in the pharmacological effect of the reboxetine was 
assessed using naltrindole (a δOR antagonist, 3 mg/
kg, i.p.). The experimental protocol of this study was 
approved by the Local Ethical Committee of Anadolu 
University.  
RESULTS:
Subacute administration of reboxetine for 2 weeks 
induced a significant increase in the declined paw-
withdrawal thresholds of diabetic rats in the Randall-
Selitto tests. Similarly, reduced paw-withdrawal 
latencies of diabetic rats in Hargreave’s tests were 
significantly prolonged by reboxetine. Moreover, 
the observed anti-hyperalgesic activity of this drug 
against mechanical and thermal nociceptive stimuli 
was antagonized by naltrindole pre-treatment.
CONCLUSIONS:
The results suggest that δOR subtype plays a 
role in the anti-hyperalgesic activity of reboxetine. 
However, the contribution of the opioid system to this 
pharmacological activity should be further clarified.
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INTRODUCTION:
Based on the potential of benzimidazole and piperidine 
pharmacophores for central nervous system related 
activity (1,2), we have recently synthesized some 
novel benzimidazole-piperidine derivative compounds 
and reported their anti-nociceptive effects (3). In the 
present study, we aimed to examine the possible 
antidepressant-like actions of these benzimidazole-
piperidine derivative compounds by using different in 
vivo techniques. 
MATERIALS AND METHODS:
Adult BALB/c mice (30-35 g) were used for the 
tests. The potential of the benzimidazole-piperidine 
derivatives for antidepressant-like activity was 
evaluated by tail suspension test (TST) and modified 
forced swimming test (MFST). Moreover, the effects 
of the test compounds on spontaneous locomotor 
activity were explored by activity cage measurements. 
The experimental protocol of this study was approved 
by the Local Ethical Committee of Anadolu University 
(Turkey).
RESULTS:
In this study, data obtained from the TST and MFST 
indicated that reference drug fluoxetine (20 mg/kg) 
and the compounds 2c–2h significantly decreased the 
immobility time of mice compared to the control group. 
The decreased immobility time of the animals in both of 
the screening tests pointed out the antidepressant-like 
activity of these compounds. Moreover, in the MFST, 
the same compounds increased the swimming time of 
mice, without any alteration in the climbing duration. 
These data demonstrate that the serotonergic rather 
than the noradrenergic system plays a significant role 
in the antidepressant-like effects of the compounds 
2c–2h. Unchanged horizontal and vertical locomotor 
activities of the animals revealed that the observed 
antidepressant-like effects were specific.
CONCLUSIONS:
In this study, antidepressant-like effects of the tested 
benzimidazole-piperidine derivatives have been 
demonstrated. Moreover, serotonin was suggested 
as the mechanism of action for the test compounds. 
Nevertheless, the exact mechanism of this 
pharmacological activity needs to be further clarified.
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INTRODUCTION:
Pediatric patients are different  from adults  in terms 
of  drug pharmacokinetics because of physiological 
development, age and weight. Additionally, most of 
the drug formulations are produced for adults and it 
is a troublesome process adjusting them for pediatric 
patients’ convenience. It may be necessary to modify 
adult solid dosage forms by tablet splitting or capsule 
opening  in order to give the exact dose in pediatric 
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patients. In this study, it was aimed to evaluate the 
modifiability of the solid dosage forms requiring 
splitting  or opening  in  a childrens hospital.
MATERIALS AND METHODS:
This is a retrospective point prevalence study 
conducted in Hacettepe University Ihsan Doğramacı 
Children’s Hospital inpatient services on 22nd January 
2018.  Patients using oral medication were included 
in the study. Clinical pharmacist reviewed patients’ 
orders  in terms of  modifiability of solid dosage forms 
by using package inserts, Micromedex Solutions®, 
and the Handbook of Drug Administration via Enteral 
Feeding Tubes (Third Edition, 2015). Splittabilty for 
tablets and openability for capsules  were evaluated. 
Descriptive statictics were used for results.
RESULTS:
One hundred and seventeen patients were using oral 
medication. The median number of the total drugs 
used by patients  was  5 (min: 1, max: 30). Fifty 
nine percent of the patients were taking one or more 
medications in tablet form, 32.5% in capsule form. 
In 53.8% of the patients, it was necessary to split 
the tablets or open the capsules in order to give the 
calculated doses according to weight and age. Only 
18 tablets (18.94%) could be splitted and 7 (7.36%) 
tablets should not be splitted in 95 tablets requiring 
modification. There was not any information about 
splitting for rest of the tablets in their package inserts. 
Twenty four capsule forms were required opening 
and  5 of them (20.83%) could be opened and 11 of 
them (45.83%) should not be opened. For 8 (33.33) 
capsule forms there was not any information about 
the openability.
CONCLUSIONS:
Administration of adult formulations to pediatric 
patients due to the unavailability of pediatric drug 
formulations may have negative consequences on 
the treatment process. It is necessary to pay attention 
to whether tablets and capsules are splittable 
or openable in order to avoid problems such as 
inadequate or increased efficacy.
REFERENCES:
1.  Ivanovska V, Rademaker MAC, et al., (2014). 
Pediatric Drug Formulations: A Review of 
Challenges and Progress. Pediatrics; 134:361-
372.
P-150: CLINICAL PHARMACIST 
INTERVENTIONS IN GERIATRIC 
OUTPATIENT CLINIC AND CLINICAL 
NUTRITION UNIT
1 Firat, O., 1 Kelleci, B., 2 Balci, C., 2 Esme, M., 2 
Aycicek Sengul G., 1 Ekincioglu, A., 2 Halil, M., 1 
Demirkan, K.
1Hacettepe University, Faculty of Pharmacy, 
Department of Clinical Pharmacy, Ankara, Turkey
2Hacettepe University, Faculty of Medicine, 
Department of Internal Disease, Division of Geriatric 
Medicine, Ankara, Turkey
INTRODUCTION:
Clinical pharmacy services needed up most in 
geriatric medicine and clinical nutrition units due to 
common polypharmacy and complicated medication 
administration process. Clinical pharmacists are 
monitoring the patients in collaboration with physician 
to provide rational therapy including appropriate drug 
administration and to reduce hospital stay (1, 2). 
The aim of this study was to evaluate the medication 
treatment and to identify the related problems by 
the clinical pharmacist in routine monitoring of the 
patients in outpatient clinics and in hospital.
MATERIALS AND METHODS:
Patients over 65 years old or followed up by nutritional 
support team (NST) in the university hospital 
were included in this study. Related information 
was recorded from patients’ hospital files, hospital 
database (Nucleus), and the physicians during rounds 
by two clinical pharmacists. Online databases such as 
“Micromedex Trusted Evidence And Solutions - Truven 
Health Analytics®” and Medscape Drug Interaction 
checker® and various books such as “Handbook of 
Drug. Administration via. Enteral Feeding Tubes. 
Third Edition.” were used to identify the interventions. 
RESULTS:
During the study, 150 patients who were eligible 
according to the inclusion criteria were evaluated 
between February 1st and March 31st, 2018. 
Interventions categorized according to the types of 
problems such as drug-drug interaction (n=4, 13.3%), 
drug-nutrient interaction (n=2, 6.6%), drug side effect 
(n=10, 33.3%), counseling to the clinicians (n=7, 
23.3%), wrong drug administration (n=5, 16.7%), 
clinical nutrition complication (n=2, 6.6%). Total of 30 
interventions were made during the study period. Of 
those, 23 (76.6%) of them belong to geriatric outpatient 
clinic and 7 (23.3%) of them belong to clinical nutrition 
unit. Only 2 (6.6%) of these interventions has been 
not accepted by clinicians. 
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CONCLUSION:
The interventions made by clinical pharmacists would 
be beneficial to improve treatment outcomes and also 
to reduce drug-related problems and complications 
while working as a team member in these units.
REFERENCES:
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P-151: DETERMINATION OF POTENTIAL 
DRUG-DRUG INTERACTIONS IN 
NEPHROLOGY CLINIC
Gun, ZU., Gok, S., Bahcecioglu, OF.
Inonu University, Department of Clinical Pharmacy, 
Malatya, Turkey
INTRODUCTION:
The main goals of drug treatment include increasing 
the quality of life of the patient and minimizing drug-
related problems. Hospitalized patients need more 
attention regarding potential drug-drug interactions 
(pDDIs) due to complexity of their disease (1). 
Our study aimed to determine the prevalence and 
significancy of pDDIs in nephrology patients.
MATERIALS AND METHODS:
This was a prospective study to find out types and 
prevalence of pDDIs in the Department of Nephrology 
and to share relevant interactions with physicians. 
Charts were assessed for prevalence and severity of 
pDDIs using the Medscape drug reference database. 
Severity was classified as “contraindicated”, “serious/
use alternative”, “monitor closely” and “minor”; 
significancy was evaluated by clinical pharmacists. 
RESULTS:
The evaluation of pDDIs were observed in 46 charts 
and 3 patients were excluded since they were not 
using any medications. Eightynine (20.22%) out of 
440 interactions were evaluated as “not significant”, 
because of the expected beneficial effects or different 
administration routes. Ninetyeight (22.27%) of pDDIs 
do not require any intervention. Interactions which 
need monitoring intervention classified as “monitor 
electrolytes” 93 (21.13%)  (potassium etc.), “monitor 
blood drug levels” 40 (9.09%) (cyclosporin etc.); 
“monitor blood pressure” 41 (9.31%), “monitor blood 
sugar” 17 (3.82%). Intervention for changing route 
of administration was 27 out of 440 (6.13%) and 
changing administration time was 16 (3.63%). Also, 4 
(0.91%) of these interactions were solved by changing 
of drug like gabapentin to pregabalin. Most detected 
pDDI was monitor potassium (16,59%).
CONCLUSIONS:
According to a review of 21 studies, clinical 
pharmacist-led programmes increase medication 
knowledge, decrease hospitalization rates, and 
improve quality of life (2). A study in Australia has 
shown that pharmacists play a vital role in reducing 
drug-related problems and increasing treatment 
efficacy (3). It was a limiting factor that the patient 
count in our study was low. It is necessary to study 
more about the pharmaceutical care service and the 
results of the pharmacist’ role in a larger population. 
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P-152: EVALUATION OF KNOWLEDGE 
AND ATTITUDES OF PATIENTS USING EYE 
DROPS / OINTMENTS
Kilicaslan, O., Sancar, M., Tezcan, S., Izzettin, FV.
Marmara University, Faculty of Pharmacy, Clinical 
Pharmacy Department, Kadıköy, Istanbul, Turkey
INTRODUCTION:
Administration of ocular medications should be done 
according to the principles of rational drug use. 
The aim of our study was to evaluate the level of 
knowledge and attitudes of patients using eye drops/
ointments.
Material and Methods: A total of 105 patients who 
were prescribed eye drops/ointments between 20 
January and 1 March 2018 were included in the study.
The study was conducted on a community pharmacy 
in Istanbul/Turkey Knowledge and attitudes of 
patients using eye drop / ointment were evaluated by 
a questionnaire consisted of a total of 20 questions. 
The results were considered to be significant at p 
<0.05 in the 95% confidence interval.
RESULTS:
The mean age of the patients was 36.42 ± 1.23 
(18-77) and 65.7% (n = 69) were female patients. 
Fifty six point two percent (n = 59) of the patients 
were graduated from university and 87.6% (n=92) 
of patients were prescribed two or more eye drops/
ointments. Sixty two point nine percent of the patients 
(n=66) reported that they had patient education about 
usage of eye drugs and 45.5% (n =30) of these 
patients were informed by the pharmacist. When the 
patients were asked if eye drops and eye ointment 
were prescribed together, which one of them should 
be applyed firstly, 73.3% (n =77) of the patients stated 
that they first applied eye drops. The patients with 
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university degree answered correctly this question 
statistically higher than the other patients (p<0.05). 
Forty percent of the patients (n =42) stated that they 
waited five minutes between eye drop and ointment 
application. Thirty five point two percent of patients 
reported that the ointment had to be kept for 28 
days after opening and 27.6% (n =29) of the patients 
reported that eye drop bottles should be kept for 15 
days after opening. 
CONCLUSIONS:
In our study, application errors were observed with the 
usage of eye drugs. We believe that pharmacists will 
have a significant contribution in rational use of eye 
drugs by the patient education.
P-153: THE EFFECT OF ATOMOXETINE 
TREATMENT ON MECHANICAL- AND 
THERMAL-HYPERALGESIA DEVELOPING IN 
DIABETIC RATS
Barbaros, MB., Can, OD. Demir Ozkay, U.
 Anadolu University, Faculty of Pharmacy, 
Department of Pharmacology, Eskişehir, Turkey
INTRODUCTION:
Peripheral neuropathy is one of the common 
complications of Diabetes mellitus. Enhanced 
sensitivity to touch; severe pains or cramps; sensation 
of burning or tingling, reduced ability to feel nociception 
or temperature alterations, loss of reflexes, loss 
of balance and coordination are among the chief 
symptoms of peripheral neuropathy (1). Strengthen of 
monoaminergic neurotransmission in the supraspinal 
pain pathways are known to induce analgesic effect 
against neuropathic pain. Based on this knowledge, 
we planned to investigate possible therapeutic effect 
of atomoxetine, a selective noradrenaline reuptake 
inhibitor, on mechanical- and thermal-stimuli induced 
hyperalgesia perception, developing in diabetic rats.
MATERIALS AND METHODS:
Male Sprague-Dawley rats were used for the 
experiments. A single 50 mg/kg dose of streptozotocin 
were intravenously injected to induce diabetes. Four 
weeks after the induction of diabetes, time required 
for development of hyperalgesia, daily atomoxetine 
administrations (50 mg/kg/day, po) was started. At 
the end of the two weeks treatment period, effect of 
atomoxetine on mechanical and thermal hyperalgesia 
was assessed using Randall-Selitto and Hargreave’s 
tests, respectively (2). The experimental protocol of 
this study was approved by the Anadolu University 
Animal Experiments Local Ethics Committee.
RESULTS:
“Paw-withdrawal threshold” and “paw-withdrawal 
latency” values of diabetic rats, measured in Randall-
Selitto and Hargreave’s tests respectively, were 
significantly lower than that of the normoglycemic 
animals. However, treatment with atomoxetine for two 
weeks significantly increased both of these reduced 
values, indicating the notable anti-hyperalgesic 
efficacy of this drug.
CONCLUSIONS:
Obtained data revealed that atomoxetine has 
a potential for treatment of diabetes-induced 
hyperalgesia. However, further clinical studies are 
needed to confirm the results of this preclinical study.
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P-154: ANTI-NOCICEPTIVE EFFECT OF 
SOME BENZOTHIAZOLE DERIVATIVES
Turan Yucel, N., Ucel, UI., Can, OD., Demir Ozkay, 
U.
Anadolu University, Faculty of Pharmacy, Department 
of Pharmacology, Eskisehir, Turkey
INTRODUCTION:
Our research group has recently reported the 
synthesis and antidepressant-like activities of some 
novel benzothiazole derivatives (3a–3h) (1). In the 
present study, based on the analgesic activity potential 
of antidepressants (2) as well as the central nervous 
system related pharmacological activity capacity of 
benzothiazole pharmacophore (3), we planned to 
investigate anti-nociceptive efficacy potential of these 
compounds.
MATERIALS AND METHODS:
Experiments were performed with adult BALB/c mice 
(30-35 g). Anti-nociceptive effect was evaluated by 
tail-clip, hot-plate and acetic acid-induced writhing 
tests. Probable effects of test compounds on motor 
coordination of mice were evaluated by the Rota-
Rod test. The experimental protocol of this study was 
approved by the Local Ethics Committee on Animal 
Experimentation of Anadolu University, Turkey.
RESULTS:
In the tail-clip and hot-plate tests, reference drug 
morphine (10 mg/kg) and compounds 3f, 3g and 3h 
administrated at 40 mg/kg doses significantly increased 
the reaction time of animals against mechanical and 
thermal nociceptive stimulus, respectively. According 
to this data, it may be suggested that anti-nociceptive 
activities of these compounds are related to both 
supraspinal and spinal mechanisms. Moreover, in 
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acetic acid-induced writhing test, morphine and 
compound 3e significantly reduced the number of 
abdominal contractions and stretches induced by 
chemical noxious stimuli, indicated the peripherally 
mediated anti-nociceptive activity of this compound. 
In the Rota-rod tests, falling latencies of mice did not 
change upon the administration of test compounds, 
therefore observed anti-nociceptive effect seemed to 
be specific. 
CONCLUSIONS:
Results obtained from the nociceptive tests indicated 
that compounds 3f, 3g and 3h show centrally mediated 
anti-nociceptive activities whereas anti-nociceptive 
effect of compound 3e was related to peripheral 
mechanisms. Nevertheless, the exact mechanisms 
of the observed anti-nociceptive action required to be 
clarified with further detailed investigations.
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P-155: WOUND HEALING EFFECT OF 
VITEXIN FORMULATION
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INTRODUCTION:
Skin is a protective barrier for the human body 
against the environmental attacks such as infections, 
injury and incision. The wound is described as the 
deterioration of anatomical and functional integrity 
of the living tissue (1). Wound healing is one of the 
major medical issues. It is known that several natural 
products, like flavonoids, promote the process of 
wound healing (2). Vitexin is a known flavonoid 
found in many medicinal plants composition. It has 
antinociceptive, anti-oxidant, anti-inflammatory, anti-
viral, cardioprotective, and antibacterial effects (3). In 
the present study, we aimed to investigate the in vivo 
and in vitro healing effect of vitexin loaded chitosan 
gel formulations.
MATERIALS AND METHODS:
The rats were anaesthetized and their dorsal hairs 
were removed by shaving. The circular wound (10-
12mm) was created on the dorsal interscapular region 
of each animal by excising the skin with a scissors. 
Animals were divided into 4 groups: control (no 
treatment), positive control (madecassol® treatment), 
vehicle (chitosan), formulation treated group 
(chitosan+vitexin). The animals were anaesthetized 
and wound area was removed for histological 
analysis. Extracted parts were stained with H & E and 
Masson Trichrome and histopathologic changes in 
dermis and epidermis were investigated. The wound 
healing effect of the formulations were assessed by 
measuring the diameter of the wound by a digital 
caliper and photographs of wounds were taken at 0, 
7th, 14th and 21st days of treatment. Chitosan-based 
gel formulation containing vitexin, madecassol and 
vehicle were applied every morning and evening (4). 
RESULTS:
When compared to the control group, progressive 
healing were observed on wound in treated rats with 
vitexin formulation. According to our macroscopic 
results, it is determined that vitexin formulation was 
about as potent as positive control madecassol®. 
Histological examinations showed that, epidermal and 
dermal regeneration, granulation and angiogenesis 
was promoted by vitexin formulation. It was found 
that Vitexin formulation provide reepithelization and 
wound healing in shorter time.
CONCLUSIONS:
This study demonstrated that vitexin formulation 
possess an accelerating effect on wound healing. We 
think that vitexin loaded formulations will contribute 
to new therapeutic approaches and new drug 
development studies on wound healing. 
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COUNSELING IN NICOSIA, NORTHERN 
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INTRODUCTION:
Antidepressants are group of drugs which need 
an appropriate consultation to be used rationally. 
Non-adherence to antidepressant medications is a 
common problem in the treatment of depression, 
and has been associated with adverse outcomes (1). 
Effective interactions between patients and health 
care practitioners as community pharmacists have 
been shown to be important in patients’ acceptance 
of antidepressant (2). The study is aimed to evaluate 
the community pharmacists’ counseling practices in 
response to antidepressant medication compliance.
MATERIALS AND METHODS:
In Nicosia, Northern Cyprus, 80 community 
pharmacists received two simulated patient visits at 
different times. The scenarios were concerning the 
use of antidepressant medications and adherence 
with therapy. These scenarios were developed by 
a research team based on literature (1). The first 
scenario was of a patient receiving a first-time 
antidepressant prescription and hesitant to begin 
treatment. The second scenario was of a patient 
perceiving lack of treatment efficacy for antidepressant 
after starting treatment for 2 weeks. The interactions 
were recorded and analyzed to evaluate the content 
of consultations in terms of information gathering, 
information provision including key educational 
messages, and treatment recommendations.
RESULTS:
Each pharmacist received 2 simulated patient visits, 
resulting in 160 encounters. Information gathering in 
both scenarios was 28.8%. In scenario 1, 18.3% of 
gathering questions were asked while in scenario 2, 
39.3% were asked. In scenario 1 the question most 
frequently asked by pharmacists was about the 
information given by the general practitioner about 
antidepressants (61%). In scenario 2, the question 
“if the patient has sought medical help for depression 
or is taking an antidepressant” was asked by 81%. 
In scenario 1 no one asked if the patient has any 
other medication whereas in scenario 2 only one 
pharmacist asked. In terms of information provision, 
information items most frequently provided in scenario 
1 were the technical information “how to use and the 
dosage” (99%), but no one provides information about 
serotonin reuptake inhibitors (SRI). In scenario 2 
most information provided were the time frame to use 
antidepressant (90%) and precaution about use of St 
John’s wort together with antidepressants (56%).
CONCLUSION:
This study shows poor information role practice 
of pharmacists in North Cyprus related to 
antidepressants use and their delivery of adherence 
message. The results highlight the need of the 
community pharmacists for further training in the 
area of antidepressant medications’ consultation to 
enhance the care provided for psychiatric patients.
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INTRODUCTION:
Fraxinus (F.) angustifolia is commonly used for 
inflammation and pain in folk medicine. We showed 
that the methanol extract (MEFA) of F. angustifolia 
Vahl barks has dose-dependent antinociceptive 
and antiinflammatory activity in mice (1). In this 
study, effects of the sub-extracts of MEFA were 
evaluated using hot-plate and formalin-induced 
edema test to further investigate the fractions of this 
plant responsible for the antinociceptive and anti 
inflammatory actions. 
   15. minute 30. minute 45. minute 60. minute
Control (%5 
DMSO-saline)
6.24±2.02 7.23±4.09 3.34±1.68 0.68±0.68
WAS 4.67±3.94 17.90±6.66 17.36±5.54 13.83±5.38
EAS 13.50±2.66 11.68±4.76 23.40±6.30 17.44±5.94
DMS 30.48±5.18* 22.94±5.27 30.70±6.58* 37.60±10.13**
Morphine 58.59±9.03# 54.10±10.67# 62.73±10.11# 55.26±9.46#
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Table 1. MPE% values of vehicle, sub-extracts and morphine. The 
data were expressed as mean±SEM (n=6-8). 
*P<0.05, **P<0.01, #P<0.001, significantly different from control.
MATERIALS AND METHODS:
The barks of F. angustifolia Vahl were collected from 
Ortahisar, Trabzon; water (WAS), ethyl acetate (EAS) 
and dichloromethane (DMS) sub-extracts of MEFA 
were prepared.  In the hot-plate test, vehicle, sub-
extracts (100 mg/kg) or morphine (10 mg/kg) were 
administered intraperitoneally (i.p.) to male mice 
(Balb/c; 20-30 g); beginning time of paw licking and 
jumping behavior were measured before (baseline) 
and after the applications (latency) at 15 minutes 
intervals and the analgesic activity was calculated as 
the maximum possible effect (MPE%). In the formalin-
induced edema test, 30 minutes before the epidermal 
injection of 1% formalin, vehicle, sub-extracts (100 
mg/kg) or diclofenac (10 mg/kg) were administered 
i.p.mice; paw thickness (measured with a compass) 
and paw volume (measured with a plethysmometer) 
were recorded before and 30 minutes after formalin 
injection and the amount of edema was calculated 
as the difference between the two values. Statistical 
analysis was performed by using ANOVA/Tukey; 
P<0.05 is considered significant. 
Paw thickness (mm) Paw volume (ml)








Table 2. Paw volume and thickness values of vehicle, sub-extracts 
and diclofenac. The data were expressed as mean±SEM (n=8). 
*P<0.05 significantly different from control (saline) 
#P<0.05 significantly different from control (5% DMSO-saline).
RESULTS:
DMS and morphine significantly increased MPE% 
values compared to control; whereas WAS and EAS 
did not alter MPE% values (Table 1). WAS, EAS and 
diclofenac significantly reduced the paw thickness; 
while WAS and diclofenac significantly decreased 
paw volume compared to control (Table 2). 
CONCLUSIONS:
DMS and WAS sub-extracts of MEFA demonstrated 
potent antinociceptive and antiinflammatory activity, 
respectively, indicating that selective compounds in 
these fractions are responsible for the bioactivity of 
F. angustifolia. Investigation of the contents of the 
sub-extracts and the mechanism of action of these 
compounds in future studies will be essential for the 
development of potential new therapeutics.
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P-158: ASSESSMENT OF BREAST 
CANCER THERAPY IN A HOSPITAL: A 
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INTRODUCTION:
Breast cancer is the most common cancer type in 
women in both developed and developing countries. 
It is one of the major cause of cancer deaths in 
women.1 It is estimated that the incidence of female 
breast cancer worldwide will reach approximately to 
3.2 million annually in 2050.2 The objective of this 
study was to examine the assessment of breast 
cancer therapy in a hospital.
MATERIALS AND METHODS:
This study is a retrospective study that conducted in 
women over the age of 18 years. It was performed 
in a hospital between the years of 2017 and 2018. 
Patient files were reviewed after having the approval 
of the committee of ethics. The rate of cancer was 
assessed in terms of the age of the patients. The 
incidence of breast cancer, calcium supplementation, 
medications used and metastasis were studied.The 
data were analyzed with SPSS V21 statistic program.
RESULTS:
The results of the study showed that the age range 
of the 40% of the patients were between 31 and 
45 years and 43% of the patients were between 
45 and 60 years. 70% of the patients had calcium 
supplementation. There is no significance between 
the right and left breast which has cancer(p<0.05). 
80% of patients had combined drug treatment. 
CONCLUSION: 
Breast cancer is common among women between 
the ages of 30-60. Additionally, most of the patients 
received combination therapy with calcium 
supplementation. 
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P-159: PRESENCE OF GXSXGY MOTIF 
ON N-TYPE VOLTAGE-DEPENDENT 
CALCIUM CHANNELS AND ANDROCTONUS 
CRASSICAUDA SCORPION TOXINS.
1 Aydin, S., 2 Cakmak, A.
1 Anadolu University, Faculty of Pharmacy, 
Department of Pharmacology, Eskisehir, Turkey
2 Bozok University, Faculty of Medicine, Department 
of Pharmacology, Yozgat, Turkey
INTRODUCTION:
It is well known that among various actions, animal 
and scorpion envenomation results with severe 
painful conditions (1). On the other hand, analgesic 
actions of some animal toxins and the role of N-type 
calcium channels on these analgesic actions have 
been reported (2).  In silico investigations of the 
structures of proteins and motifs residing on proteins, 
ion channels and receptors have been reported to 
have many important roles on their function.  One 
of the motifs shown to be crucial on protein-protein 
interactions is GG4 motifs (3, 4).  The aim of this 
study was to investigate the presence of GG4 motifs 
on Androctonus crassicauda toxins and calcium 
channels that are reported to play role on pain 
sensations.
MATERIALS AND METHODS:
The protein sequences belonging to voltage-
dependent N-type calcium channel of human 
(CAC1B_HUMAN) and 24 toxins of Androctonus 
crassicauda scorpion were downloaded from uniprot 
database (www.uniprot.org).  Protein sequences 
were extracted using Slackware GNU/Linux operating 
system. R/Bioconductor packages, Protr and Bio3d 
and ClustalW were used for alignment of proteins, 
statistical evaluation and plotting.  Swiss-model, 
Swiss Pdb-viewer were used for 3D modelling and 
viewing. 
RESULTS:
 The results of our investigations showed the presence 
of GG4 motifs on voltage-dependent N-type calcium 
channel of human and only on 4 types toxins (SCX6, 
TX23, TX31 and TX32). There were 19 GG4 motifs on 
the calcium channel but there was only one GXSXGY 
motif having similarity with Androctonus crassicauda 
toxins.  Alignment of these toxins and N-type calcium 
channel using ClustalW programme showed similar 
and shared GG4 motif with a tyrosine amino acid 
(GXSXGY motif). 
CONCLUSIONS:
The presence of GXSXGY motif on Androctonus 
crassicauda toxins (TX23, TX31, TX32 and SCX6) 
and on voltage-dependent N-type calcium channel 
raised the question whether these toxins exert 
any action on N-type calcium channels resulting in 
unexpected analgesic effect.  Further studies are 
required on these purified toxins.
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P-160: BEXAROTENE, A RXRΑ AGONIST, 
PREVENTS LIPOPOLYSACCHARIDE-
INDUCED INFLAMMATORY HYPERALGESIA 
IN MICE
Kucukkavruk, SP., Temiz Resitoglu, M., Guden, DS., 
Sari, AN., Sahan Firat, S., Tunctan, B.
Mersin University, Department of Pharmacology, 
Mersin, Turkey
INTRODUCTION:
Inflammation leads to hyperalgesia which means 
decreased pain threshold or increased pain sensitivity. 
A selective retinoid X receptor α agonist, bexarotene 
(BEX), has been approved for the treatment of 
patients with cutaneous T-cell lymphoma. If used 
at appropriated doses, BEX is also reported to be 
beneficial in treating neurodegenerative diseases 
associated with systemic inflammation such as 
Parkinson’s disease, Alzheimer’s disease, and 
schizophrenia. The aim of this study was to determine 
the effective dose of BEX in lipopolysaccharide (LPS)-
induced inflammatory hyperalgesia model in mice.
MATERIALS AND METHODS:
Male Balb/c mice were divided into 8 groups: (1) 
Saline, (2) LPS, (3) dimethyl sulfoxide (DMSO), (4) 
LPS+BEX (0.1 mg/kg), (5) LPS+BEX (1 mg/kg), (6) 
LPS+BEX (3 mg/kg), (7) saline+BEX (10mg/kg), and 
(8) LPS+BEX (10mg/kg). DMSO or BEX (4 ml/kg; 
s.c.) were administrated simultaneously with saline 
(10 ml/kg, i.p.) or LPS (10 mg/kg, i.p.). Reaction 
time to thermal stimuli within 1 min evaluated in mice 
received saline, LPS, DMSO, or BEX after 6 h.
RESULTS:
LPS caused a significant decrease in hot plate 
latency 6h after injection when compared to saline 
treated group (P<0.05). Only at 10 mg/kg dose BEX 
prevented the LPS-induced hyperalgesia 6 h after 
drug injection (P<0.05). The other doses of BEX were 
not effective to prevent the LPS-induced hyperalgesia 
(P>0.05). BEX at 10 mg/kg dose or DMSO had no 
effect on the hot plate latency in saline-treated mice 
(P>0.05).
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Fig.1. * P<0.05 vs. saline-treated group. # P<0.05 vs. LPS-treated 
group.
CONCLUSIONS:
These results demonstrate that BEX prevents 
inflammatory hyperalgesia induced by systemic LPS 
administration.
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P-161: COMPARATIVE ASSESSMENT 
OF AWARENESS AND ATTITUDES 
OF COMMUNITY PHARMACISTS IN 
NORTHWEST NIGERIA AND MUĞLA, 
TURKEY TOWARDS CHRONOTHERAPY
Chukwunyere, U., Bilge, S., Abacioglu, N.
1Near East University, Faculty of Pharmacy, 
Department of Pharmacology, Lefkosa/Mersin10, 
Turkey
INTRODUCTION:
Chronotherapy refers to the use of endogenous 
biologic rhythms to optimize therapy. The importance 
of time of administration of medication cannot be 
overemphasized in clinical practice. Therefore, this 
study was designed to assess and compare the 
awareness and attitudes toward chronotherapy 
among community pharmacists practicing in 
Northwest Nigeria and Muğla, Turkey.
MATERIALS AND METHODS:
A three month cross sectional study of 125 and 152 
community pharmacists practicing in Northwest 
Nigeria and Muğla respectively, was conducted 
in 2017 and data was collected using a modified 
questionnaire based on current literature (1). The 
questionnaire which comprised of twenty seven items, 
explored the participants’ demography, knowledge, 
attitude and willingness to apply the principles of 
chronotherapy in future practice. Descriptive statistics 
were used to report the demographics while Mann–
Whitney U test was used to compare the mean total 
awareness and attitude scores.
RESULTS:
Data analysis showed that community pharmacists 
in Muğla have a statistically significant higher mean 
total awareness score 9.46 ± 1.63 (P < 0.05) and a 
lower mean total attitude score 44.26 ± 6.25 when 
compared with community pharmacists in Northwest 
Nigeria with lower mean toal awareness score 8.49 
± 1.38 and a statistically significant higher mean 
total attitude score 46.19 ± 5.92 (P < 0.05). Results 
also showed that years of practice influenced the 
awareness scores in both regions. 
CONCLUSIONS:
The community pharmacists in Muğla have more 
knowledge about chronotherapy; however, their 
attitudes toward applying their knowledge in future 
practice was lower when compared with community 
pharmacists in Northwest Nigeria. These findings 
reaffirm the need for educational programs targeted 
at sensitizing pharmacists on the importance of 
chronotherapy in pharmacy practice.
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P-162: THE EFFECT OF TOFISOPAM 
TREATMENT ON GLIAL PLASTICITY IN RAT 
HIPPOCAMPI
1 Ucel, UI., 1 Demir Ozkay, U., 2 Ulupinar E, 1 Can 
OD.
1.  Anadolu University, Department of Pharmacology, 
Eskisehir, Turkey
2.  Eskisehir Osmangazi University, Department of 
Anatomy, Eskisehir, Turkey
INTRODUCTION:
We have recently reported beneficial effects of 
tofisopam, a 2,3-benzodiazepine derivative anxiolytic 
drug, on scopolamine-induced amnesia model (1). 
Furthermore, we have demonstrated that tofisopam 
treatment increases proliferation of the neurons in 
the sub-granular zone of dentate gyrus, suggesting 
a beneficial potential for tofisopam on hippocampal 
neurogenesis (2). In the present study, based on 
the functional capacities of astrocytes on learning 
and memory processing (3), we aimed to investigate 
probable effect of this drug on glial plasticity in the 
hippocampus.
MATERIALS AND METHODS:
Rats were treated with tofisopam (50 mg/kg/
day p.o.) for one week. Amnesia was induced by 
scopolamine administration (0.5 mg/kg i.p). After 
anesthesia, rats were transcardially perfused with 
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PBS and PBS - 4% paraformaldehyde solution. 
Brain hemispheres including the dorsal hippocampus 
were embedded in paraffin, sectioned at 3 μm 
thickness and stained immunohistochemically for 
further quantitative analysis. The boundaries of the 
hippocampal subregions were defined according 
to the stereotaxic rat brain atlas. Photomicrographs 
were taken under light microscope by integrated 
camera. GFAP immunoreactive area per unit area 
was calculated by using Image J analysis program. 
The experimental protocol of this study was approved 
by the Anadolu University Animal Experiments Local 
Ethics Committee.
RESULTS:
Obtained data indicated that, in amnesic rats, GFAP 
densities per unit area in the hippocampal DG, CA1 
and CA3 subregions were significantly reduced with 
respect to the control group. However, tofisopam 
treatment increased the GFAP immunoreactivity in 
amnesic rats compared to untreated amnesic animals 
in all regions of hippocampal formation.
CONCLUSIONS:
Our findings demonstrate that tofisopam treatment 
restored the impaired astrocyte activation of amnesic 
rats. This effect of tofisopam on glial plasticity might 
be contributed to its anti-amnesic efficacy. However, 
further detailed studies are needed to clarify exact 
mechanisms underlying the nootropic action of 
tofisopam.
REFERENCES:
1.  Ucel UI et al., (2017). IVEK 3rd International 
Convention of Pharmaceuticals and Pharmacies 
P(0778), 1028.
2.  Ucel UI et al., (2017). 2nd International Gazi 
Pharma Symposium Series P(76), 145
3.  Kurosinski P, Götz J (2002) Archives of Neurology 
59 (10):1524-1528.
P-163: ANXIOLYTIC-LIKE EFFECT OF 
METHANOLIC EXTRACT PREPARED 
FROM HYPERICUM HIRCINUM L. 
SUBSP. MAJUS (AITON) N. ROBSON HERBA
1 Saltan, N., 2 Ucel UI., 1 Kose YB., 2 Can OD. 
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INTRODUCTION:
Several Hypericum L. (Hypericaceae) species, 
Hypericum perforatum L. in particular, have been 
reported to induce various pharmacological activities 
related to the central nervous system such as 
antidepressant, anxiolytic, analgesic and sedative 
effects (1). On the other hand, psychopharmacological 
effects of H. hircinum L. subsp. majus (Aiton) 
N. Robson, another well-known medicinal plant 
belonging to this family, have not been investigated 
in detail, so far.  Therefore, in the present study, we 
aimed to examine anxiolytic potential of H. hircinum 
extract by using two different validated in vivo 
methods.
MATERIALS AND METHODS:
Male CD1 mice (30-35 g) were used for the 
experiments. Anxiolytic potential of the extract was 
assessed by using hole-board and plus maze tests, 
as described previously (2). In addition, probable 
effect of the extract on motor activity of animals was 
tested by Rota-rod tests. The experimental protocol 
of this study was approved by the Anadolu University 
Animal Experiments Local Ethics Committee.
RESULTS:
In the hole-board tests, methanolic extract of H. 
hircinum (2.5 and 5 mg/kg, i.p) increased the total 
number of head-dipping behavior together with 
the total number of holes explored. Additionally, in 
the plus-maze tests percentage of open entries as 
well as the percentage of time spent in the open 
arms increased by both of the administrated doses. 
Besides, in the Rota-rod tests, extract administrations 
did not change the falling latencies of animals.
CONCLUSIONS:
Acquired results indicated that H. hircinum has a 
significant anxiolytic-like activity, similar to some other 
species in the Hypericum genus. However, further 
clinical studies are needed to validate therapeutic 
potential of H. hircinum extract as an anxiolytic drug 
candidate.
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P-164: ANXIOLYTIC-LIKE ACTIVITIES OF 
SOME 1,3,4-THIADIAZOLE DERIVATIVES
1 Can, OD., 1 Demir Ozkay, U., 2 Altintop, MD., 2 
Kaplancikli, ZA. 
1 Anadolu University, Department of Pharmacology, 
Eskisehir, Turkey
2 Anadolu University, Department of Pharmaceutical 
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INTRODUCTION:
Thiadiazole is a five membered ring system carrying 
two nitrogen and one sulfur atom as chemical structure. 
Thiadiazoles may exist in four isomeric forms as 
1,2,3-thiadiazole, 1,2,5-thiadiazole, 1,2,4-thiadiazole 
and 1,3,4-thiadiazole. Among them, especially 
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1,3,4-thiadiazoles are of great interest in the drug 
development studies as important pharmacophore 
groups (1). For example, antidepressant, anxiolytic, 
analgesic and anticonvulsant activities have been 
reported for various 1,3,4-thiadiazole derivatives 
so far (2,3). Based on the aforementioned central 
nervous system related efficacy potential of 
thiadiazole derivatives (4), in the present study we 
aimed to investigate possible anxiolytic-like activities 
of some 1,3,4-thiadiazole derivatives.
MATERIALS AND METHODS:
Balb/c mice, weighing 30-35 g, were used for the 
tests. Anxiolytic-like activity potential of the thiadiazole 
derivatives (100 mg/kg, i.p) was assessed using 
hole-board and plus-maze tests. Besides, motor 
coordination of the animals was evaluated using 
Rota-rod tests. The experimental protocol of this 
study was approved by the Anadolu University Animal 
Experiments Local Ethics Committee.
RESULTS:
In the plus-maze tests, reference drug diazepam, 
N-(benzothiazol-2-yl)-2-[(5-((4-nitrophenyl)amino)-
1,3,4-thiadiazol-2-yl)thio]acetamide (3g) and N-(6-
nitrobenzothiazol-2-yl)-2-[(5-((4-nitrophenyl)amino)-
1,3,4-thiadiazol-2-yl)thio]acetamide (3h) increased 
the percentage of open arms entries as well as the 
percentage of time spent in these arms. Besides, in 
the hole-board tests, reference drug diazepam and 
the same compounds increased the total number of 
the head-dipping behavior as well as the total number 
of holes explored. Moreover, these two compounds 
did not alter the falling latencies of animals examined 
in the Rota-rod tests. 
CONCLUSIONS:
Obtained data indicated that compounds 3g and 3h 
possess significant anxiolytic-like activities without 
any non-specific effect on motor coordination of 
animals. Moreover, the results of this study supported 
the previous papers reporting the efficacy potential of 
1,3,4-thiadiazole derivatives on the central nervous 
system.
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P-165: ANTIDEPRESSANT-LIKE EFFECT 
OF NOVEL BENZAZOLE DERIVATIVES
1 Tokgoz, G., 1 Demir Ozkay, U., 2 Osmaniye, D.,1 
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1 Anadolu University, Department of Pharmacology, 
Eskisehir, Turkey
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INTRODUCTION:
The benzazole type compounds including 
benzimidazole and benzothiazole rings have been 
reported to exhibit central nervous system (CNS) 
related effects such as antidepressant, anticonvulsant 
and analgesic activities (1-3). In the present study, 
based on the CNS-related activity potential of 
benzimidazole and benzothiazole scaffolds, we 
synthesized some novel compounds carrying 
these ring systems and investigated their potential 
antidepressant-like activities.    
MATERIALS AND METHODS:
Target compounds (4a-4h) were obtained by the 
reaction of corresponding 2-(benzazol-2-ylthio)
acetohydrazide and appropriate 4-substituted 
benzaldehyde. Pharmacological studies were carried 
out with adult BALB/c mice (30-35 g). Antidepressant-
like activities of the test compounds (50 mg/kg) were 
evaluated using the tail suspension (TST) and the 
modified forced swimming tests (MFST). Besides, 
locomotor activity was assessed by activity cage 
measurements. The experimental protocol of this 
study was approved by the Local Ethics Committee 
on Animal Experimentation of Anadolu University, 
Turkey.
RESULTS:
Reference drug fluoxetine and the test compounds 
4a, 4b, 4e and 4f significantly reduced the immobility 
duration of mice in both of the TST and MFST, 
pointing out the antidepressant-like effects of these 
compounds. Moreover, the same compounds 
augmented the swimming time of animals in 
MFST without any change in the climbing duration 
indicated that the observed antidepressant-like 
effects may probably be related to serotonergic 
rather than noradrenergic mechanisms in the CNS. 
Antidepressant-like effects of compounds 4a, 4b, 4e 
and 4f seemed to be specific since total number of 
horizontal or vertical locomotor activities of the mice 
was not changed upon the administration of these 
compounds.  
CONCLUSIONS:
Antidepressant-like activities of compounds 4a, 4b, 4e 
and 4f seem to be related to the serotonergic system 
rather than the noradrenergic system. However, this 
consideration needs to be confirmed with further 
detailed studies.
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P-166: CENTRALLY MEDIATED 
ANTINOCICEPTIVE ACTIVITIES OF SOME 
PIPERAZINE DERIVATIVE COMPOUNDS
Ucel, Uİ., Kandemir, U., Ozkay Demir, U., Can, OD.
Anadolu University, Department of Pharmacology, 
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INTRODUCTION:
Piperazine is a six-membered ring system containing 
two nitrogen atoms at 1th and 4th positions. 
Derivatives of the piperazine scaffold have been 
reported to possess various central nervous 
system (CNS) related pharmacological effects 
such as antidepressant, anxiolytic, antipsychotic, 
anticonvulsant, anti-Alzheimer and analgesic actions 
(1). Based on the activity potential of piperazine 
derivative compounds on CNS, in this study, we 
planned to synthesize some new compounds carrying 
piperazine pharmacophore in their structure and 
investigate their anti-nociceptive activity by some in 
vivo methods.
MATERIALS AND METHODS:
Wistar rats, weighing 250-350 g, were used for the 
experiments. Anti-nociceptive activity potential of 
the piperazine derivatives (10 mg/kg, i.p) was tested 
using hot-plate and Randall-Selitto tests, two well-
known methods using to evaluate centrally mediated 
pain perception (2). Moreover, motor activity of the 
animals were assessed using a Rota-rod device. The 
experimental protocol of this study was approved by 
the Anadolu University Animal Experiments Local 
Ethics Committee.
RESULTS:
All of the tested compounds (2a-2h) increased the 
percentages of maximum possible effect as well as 
enhanced the paw withdrawal threshold values of 
animals assessed in the hot-plate and Randall-Selitto 
tests, respectively. Furthermore, in the Rota-rod 
tests, none of the test compounds changed the motor 
coordination of animals. 
CONCLUSIONS:
Results of the present study showed that our new 
piperazine derivative compounds 2a, 2b, 2c, 2d, 2e, 
2f, 2g and 2h have significant antinociceptive activities 
on central pathways carrying mechanical and thermal 
nociceptive stimuli. Besides, exhibited antinociceptive 
effects are specific, since the obtained data does not 
influenced by any possible impairments in the motor 
activity of rats. 
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P-167: DEONTOLOGICAL VIOLATIONS IN 
TURKEY’S COMMUNITY PHARMACIES
Kiran, B., Karaca, EG.
Ege University, Faculty of Pharmacy, Department of 
Pharmacy Management, Izmir, Turkey
INTRODUCTION:
Deontological violations are important in terms of 
reputation of public health, pharmacy profession, 
protection of public finance (1). The study aim is to 
determine types and prevalence of deontological 
violations reflected in records of High Honor Court 
(HHC) in Turkish Pharmacists’ Association(TPA), 
to develop proposals on corrective and preventive 
occupational policies.
MATERIALS AND METHODS:
Cross-sectional. Violation types in disciplinary files in 
TPA Period-40 Working Report between 10.12.2015-
30.09.2017 of HHC in TPA and submitted from 54 
Regional Pharmacists Chamber in Turkey were 
classified according to classification method of 
deontological violations in 3-groups, and results were 
evaluated by frequency and percentage distributions 
(2).
RESULTS:
In the study, 32 deontological violation types 
and 112 criminal cases were detected. These 
violations were classified in 3-groups according 
to classification method used in the first and only 
study on deontological violations committed in 
Turkey’s community pharmacies (1,2). Accordingly, 
it was found that “competition-based deontological 
violations” are in the first rank with 51 cases (45.6%), 
“TPA, Drug-Pharmacy Legislation violations” in the 
second with 50 cases (44.6%) and “Social Security 
Institution (SSI) protocol provisions violations” in the 
last rank with 11 cases (9.8%), and in all types of 
violation, “collusion” is in the first rank (30.4%).
CONCLUSIONS:
When compared Turkey’s the first study based on 25-
year records with 2015-2017 Report of HHC Period-40; 
it was seen that “competition-based deontological 
violations” in the first rank with 53% decreased to 46%, 
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“TPA, Drug-Pharmacy Legislation violations” with 
24.6% increased to 44.6% and “SSI violations” with 
22.4% decreased to 9.8%, but the frequency of case 
types didn’t change (2). The most common violation 
types; “prescription collection and transfer”(17%), 
“non-compliance to watch and working hours” 
(10.7%) among “competition-based deontological 
violations”, and “not delivering medication to patients 
and invoicing drugs to the institution” (3.6%) among 
SSI violations. In TPA, Drug-Pharmacy Legislation 
Violations; it is thought-provoking that “collusion” 
violation in the past (76.3%) is still the most common 
violation (68%) and being in the first rank increasing 
its share from (18.6%) to (30.4%) in all violations 
despite increasing punishments (1,2). Persistence 
of violation despite punitive sanctions aggravated by 
recent regulations suggests that it is not possible to 
solve only by punitive sanctions, and it must be get to 
the bottom of the problem.
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P-168: A VIEW ON PATIENTS’ VIEW TO 
PHARMACIST-PATIENT COMMUNICATION 
FROM COMMUNITY PHARMACIES
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INTRODUCTION:
Today, change in pharmacy worldwide is based on 
“patient-centered care” paradigm. In this change, 
“communication” is one of the most important 
arguments (1). This study is planned to determine 
communication level between pharmacists and 
patients receiving counseling from community 
pharmacies and the effective factors upon it, identify 
patients’ expectations from community pharmacies 
and pharmacists.
MATERIALS AND METHODS:
Cross-sectional. 20-question survey in two parts 
developed by researchers was used as data collection 
tool. The survey was applied by face-to-face interview 
technique to 330-persons over 18-years who served 
from Ege University, Medical Faculty Hospital and 
went to a community pharmacist between 19.01.2018-
28.02.2018. Obtained data in 95% confidence interval 
was evaluated by frequency, percentage distribution, 
Chi-square, Mann-Whitney U, Kruskal-Wallis and 
post-hoc tests using SPSS-16 package program.
RESULTS:
330 people participated to the survey (54.2% female 
- 45.8% male). 50.9% of patients are college or 
faculty graduates and 80.9% stated that they always 
take their medicines from the same pharmacy. 
Relationship between educational background and 
taking medication from the same pharmacy was 
found statistically significant (Fisher’s exact test 
p=0.033). 86.4% of patients said that they were asked 
and trusted for information from the pharmacist, 90% 
that they were answered clearly, 81.2% stated that 
all information about medicines and treatment were 
explained clearly, 75.5% indicated that they can 
easily ask again pharmacist the points they do not 
understand. It was determined that 70.6% expressed 
that they had enough time and 60.3% stated that they 
wanted to ask questions to the pharmacist instead 
of a foreman or a technician. In another study, 71% 
of patients stated that pharmacists did not give 
comprehensive medicine counseling, 49% expressed 
that pharmacist did not encourage to ask questions, 
53.2% indicated that they do not trust pharmacists’ 
knowledge (2).
CONCLUSIONS:
In this study, it was found that when educational level 
decreases, pharmacy dependency and confidence 
level to pharmacist increase, more than 3/4 participants 
are satisfied with counseling services. Concordantly, 
it is thought that inclusion of “Communication in 
Pharmacy” course to the pharmacy curriculum and 
post-graduation trainings can improve the  counseling 
services’ quality provided by community pharmacists.
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P-169: STRATEGIC COOPERATION IN THE 
TURKISH PHARMACEUTICAL INDUSTRY
Aydin Guldur, E., Ozcelikay, G.
Ankara University, Faculty of Pharmacy, Department 
of Pharmacy Management, Ankara, Turkey
INTRODUCTION:
Since companies operate on international markets, 
they need to develop new products and create new 
technologies to keep pace with global competition (1).
To provide a sustainable competitive advantage, the 
relationship of businesses to strategic partnerships, 
mergers or acquisitions with other businesses is 
increasingly important and this situation is seen as 
a strategic necessity (2). The aim of this study is to 
examine the current situation and future outlook of 
strategic partnerships and acquisitions in Turkey 
between the years 2007-2017 in the pharmaceutical 
industry.
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MATERIALS AND METHODS:
In this study, mergers and acquisitions data for 
pharmaceutical companies are obtained from reports 
prepared by PricewaterhouseCoopers (PwC), Ernst & 
Young and Deloitte.
RESULTS:
In 2009, there were 563 mergers or acquisitions 
worldwide with a total value of $ 161.2 billion.The 
effects of the global crisis were also seen in the 
pharmaceutical sector, and in 2010 mergers and 
acquisitions amounted to 548 contracts worth $ 51.5 
billion, down by 68% in value. In 2013, Turkey was 
ranked 18th in the world pharmaceutical industry.
Turkey’s pharmaceutical market is estimated to take 
place 16th in the world in 2018 (3).
In Turkey’s pharmaceutical industry, acquisitions 
took place rather than mergers between the years 
2007-2017. It seemed that the general tendency was 
to purchase the near-total share of the company. 
According to the deal values announced to the 
market, the highest sales volume in terms of value 
was realized in 2007 and 2012.
CONCLUSIONS:
The advantages of mergers and acquisitions are: to 
benefit from advantages such as sales / marketing, 
finance, production capacity and market share, to 
catch synergy in the research portfolio, to reduce 
the need for excess and to focus on therapeutic 
categories.
Turkey is attracting the attention of companies 
operating on a global scale with a growing elderly 
population, increasing average life expectancy and 
drug consumption per person (4).
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INTRODUCTION:
In this project, a study on pharmacy software products 
has been deployed and some brief information is 
given under some specific topics. Additionally, a 
survey was conducted by some specific areas and 
pharmacists’ opinions are noted in order to create 
a better-developed pharmacy program. Facts like 
the increase in number of drugs sold in pharmacies, 
the necessity of putting every sale into accounting 
process immediately, diversification of personal 
and corporate sales, supplying drugs from different 
chains of distribution, drug stock control etc. made 
it mandatory to create and develop supporting 
programs in pharmacies.
MATERIALS AND METHODS:
Survey forms about software products establish 
the base of this research method. For the survey, 
community pharmacy managing directors operating 
at 10 specific regions located in central Ankara were 
asked 19 questions face-to-face. As of 2017 working 
year, there are 2033 active community pharmacies 
at 10 specific regions located in central Ankara. The 
sample size is found to be n=323 and 318 of these 
surveys are put into perspective.
RESULTS:
It’s found that 77.1% of the pharmacists think 
information transfer is much easier and faster with 
the program. 51,1% of the pharmacists believe that 
they can equip their patient without any electronic 
information sources whereas 29% of the pharmacists 
seem to have no solid opinion about the subject. 
79.6% of them think automation programs are user-
friendly. 59.1% of the pharmacists put their priority 
on stock control feature while choosing a program. 
72.7% of the pharmacists believe they know how 
many products they have on their shelves and 74.6% 
believe they keep track of the products’ expiry dates.
CONCLUSIONS:
Pharmacists choose among programs depending 
on the location of their pharmacies. They prefer 
one program over the other on financial reasons, 
not administrative ones. The usage and properties 
of software products for pharmacist is considerably 
high. With the advanced technology, pharmacists 
should also stay up to date and they should follow the 
developments on their field.
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INTRODUCTION:
In addition to patient consultancy and dispensing 
duties, pharmacists in pharmacies also carry out 
administrative tasks such as inventory control, 
expiration date control, ordering medicines, employee 
training, and drug disposal. It is important in terms of 
pharmacy management to carry out all these works 
in a healthy way (1). In order to operate a community 
pharmacy in a healthy manner, it is necessary to 
determine workload and workflow of the employees. 
Increasing the quality of community pharmacy 
services will be possible through workload and 
workflow analyzes (2). This study is aimed to reveal 
the workflow in community pharmacies and evaluate 
the workflow in terms of pharmacy management and 
pharmaceutical care services.
MATERIALS AND METHODS:
 In this study, a questionnaire form was used as data 
collection tool. The questionnaire consists of four 
parts. The first part consists of demographic data of 
community pharmacies. The second part consists of 
questions about the employees, third part consists of 
patient counseling duties and the last part consists of 
administrative duties in community pharmacies. The 
questionnaire forms were sent to pharmacists via 
e-mail. The data obtained; It was also evaluated in 
SPSS Version 23.0.
RESULTS:
58% of the pharmacists in the study are women and 
42% are men. The majority of pharmacies (41.3%) 
did not have a task distribution among staff. This may 
cause the pharmacy services to be interrupted.  Half 
of the pharmacists (50.0%) stated that they do not 
inform their patients about traditional and alternative 
therapies. On the basis of this, pharmacists may feel 
that they are inadequate on this issue or they may 
be opposed to traditional and alternative treatment 
or they may not have enough time to advise on this 
issue.
CONCLUSIONS:
With the determination of workload and workflow in 
community pharmacies, the quality of community 
pharmacy services can increase.
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INTRODUCTION:
Adam Smith, the writer of the Wealth of the Nations, 
says that the architecture of the politics in society 
is the merchants and manufacturers (1). As his 
sentence applied to nowadays the legislations of the 
governments get in shape through the sectors. One 
example of this condition is the dietary supplement 
sector which took in form in 1990s and expanded 
to other countries after that via its own legislation 
changes in each government. Dietary supplements 
are the most popular formulas which are consumed 
and thought to be safe by most of people in order to 
maintain health conditions and get enough nutrition 
due to lower nutrition levels of foods. However natural 
does not mean safe and dietary supplements can 
interact with most of medications which can result 
adverse effects. Thus legislations associated with 
dietary supplements are important for public health.
MATERIALS AND METHODS:
This research is a descriptive study consists of 
literature and legislation review associated with 
dietary supplements in Turkey and comparison 
with USA, EU and Japan regulations. In this paper, 
DSHEA (Dietary Supplement Health Education Act) of 
USA, Directive 2001/83/EC and Directive 2004/24/EC 
of European Union and regulations of Japan Health 
and Food Association were investigated to compare 
dietary supplement policy of Turkey.
RESULTS:
Dietary supplements, in other words food 
supplements are subject to similar legislations in 
different countries. Turkish dietary supplement 
legislation is the most liberalistic and Japan legislation 
has the most strict rules as compared with EU and 
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USA. Dietary supplement sector has been growing 
since 1994. Turkish legislations is the harmonization 
of USA and EU regulations. Vitamins, minerals, amino 
acids, probiotics, prebiotics, carbohydrates, proteins, 
fatty acids and plant origin substances are included in 
the name of dietary supplements in Turkish legislation 
(2). Although herbal formulations are evaluated 
under herbal medicine or traditional herbal medicines 
in EU, those got approval easily in Turkey. GMP is 
one of the basic requirement for dietary supplement, 
however it is recommended in Turkey (3). Adverse 
effect following and reporting is very important in USA 
whereas it is not important in Turkey and EU (4). In 
addition, health claims and advertising of dieatary 
supplements is very liberalistic as in USA, on the 
other hand it is very strictly controlled in Japan (5).
CONCLUSIONS:
Turkey imitates the legislations of developed 
countries. However through globalization each 
countries’ legislations become similar to each 
other. Also legislations of developed countries does 
not always mean the best legislation. So, Turkish 
legislation is urgently needed to be reevaluted.
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INTRODUCTION:
Pharmacoeconomics is a scientific discipline handling 
the comparison of drugs used for prevention, 
diagnosis, and treatment of diseases within the scope 
of economy and efficiency (1). For making comments 
according to the results being reached by using the 
findings obtained, extrapolation of them may be 
required. Pharmacoeconomic modeling methods have 
been developed according to this need (2). Ethics 
refers to the moral judgments of a person concerning 
right and wrong (3). The aims of this study are to 
determine the usage rates of pharmacoeconomic 
evaluation methods by the Turkish Pharmaceutical 
Industry (TPI) and to investigate ethical approach of 
the TPI while using these methods. 
MATERIALS AND METHODS:
In this study, the questionnaries were held 
regarding the pharmacoeconomics and ethics to 
the TPI. According to the findings obtained from 
questionnaires,  usage rates of pharmacoeconomic 
analysis and modelling methods in TPI are discussed 
by considering the ethical approach.
RESULTS:
It is determined that pharmacoeconomic evaluations 
are not performed at high rate in the TPI and 
pharmacoeconomic analysis methods are used 
higher than the modeling methods, the most used 
pharmacoeconomic analysis method is the cost-
effectiveness analysis and the most used modeling 
method is the decision analysis in the TPI and there is 
a lack of information on pharmacoeconomic modeling 
methods in TPI and these methods are mostly not 
used.
CONCLUSIONS:
The TPI needs training in pharmacoeconomics and 
ethical issues and does not attach high importance 
to the ethical principle of beneficence which is one 
of the basic ethical principles within the scope of 
pharmacoeconomic evaluations.
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INTRODUCTION:
Drug pictograms are tools that help both health 
professionals and patients to understand and read 
drug related information easier (1). In the literature, 
there are some studies examining drug pictograms, 
however to the best of the authors’ knowledge, a 
study in pharmacy field has not been found in Turkey. 
To fill this gap, the attitude scale for drug side effect 
pictograms was developed.
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MATERIALS AND METHODS:
This study was conducted with the 5th class pharmacy 
students in Ankara University (n=70). The proposed 
scale consists 20 items related to attitudes towards 
drug side effect pictograms prepared with 5 point 
Likert Scale [(1) Absolutely disagree to (5) Absolutely 
agree]. The content validity ratios developed by 
Lawshe (1975) were used in determining the 
content validity of the scale (2), and the number of 
items decreased to 13. Exploratory factor analysis 
(EFA) and confirmatory factor analysis (CFA) were 
conducted via SPSS 18.0 and LISREL 8.80 package 
programs for reliability and validity of the scale. 
RESULTS:
As a result of the analysis, 3 items were extracted 
from the 13-item scale and the KMO value was 
calculated as 0.817. As a result of EFA, it was found 
that the one-factor structure explained 53.367% of the 
total variance. The Cronbach alpha value of the scale 
was 0.896. This value indicates that the reliability of 
the developed scale is high. CFA showed that the 
one-dimensional structure of the scale was valid and 
goodness of fit indexes for the CFA model were in 
acceptable levels.
CONCLUSIONS:
The “drug side effect pictogram attitude scale” was 
found reliable and valid by this study. This scale can 
be applied to the community or hospital pharmacists 
for future studies. 
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INTRODUCTION:
Pharmaceutical Track & Trace System is a successful 
implementation of Track & Trace approach which 
has been applied since 2010 on the pharmaceutical 
field in Turkey. Briefly, it defines the infrastructure 
framework for all units/single pack belonging to each 
pharmaceutical product in Turkey and works by using 
the Datamatrix code, which provides the sureness of 
the uniqueness of the units (1). The system gathers 
main shareholders of pharmaceutical Industry, as 
pharmaceutical companies, pharmacy warehouses, 
pharmacies and social security institution, who have 
in part in the product life cycle of the drug and share 
the responsibility, together (2,3). Aim of this study was 
to evaluate the community pharmacy personnel’s 
attitudes and knowledge about the Pharmaceutical 
Track & Trace System in order to reveal their 
expectations and identify their problems about the 
system. 
MATERIALS AND METHODS:
Community pharmacies located in Beyoglu district of 
Istanbul were included into the study (n=120). The 
personnel were voluntarily conducted in the study by 
the permission of the Istanbul Chamber of Pharmacy. 
56 pharmacies participated in the study. The data 
were collected from 15th of April to 30th of April 2017 
by using a structured questionnaire. The study is 
cross-sectional and qualitative.
RESULTS AND DISCUSSION:
44 % of the attendees were female, 56 % male, 
respectively. The average age of the personnel was 
35.5 and their average of service year was 15.14. 86 
% of personnel described that the system was useful 
in terms of counterfeit drugs, expired drugs, and 
smuggling of drugs.  While 57% percent of attendees 
thought that the system provides an advantage for the 
patients about reach drugs, only 37 % of personnel 
said a positive effect of the system on the availability 
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of the drugs on the market. 71% of personnel 
stated that the positive contribution of the system 
to the withdrawal process of drug. Consequently, 
Pharmaceutical Track & Trace System is useful in 
terms of drug safety/patient and withdrawal process 
of a drug from the market. On the other hand the 
system needs to be simplified and the infrastructure 
process should be improved.
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INTRODUCTION:
Universities are organizations that pursue their 
existence through research, learning and teaching 
activities. Academicians are also the main actors 
of these organizations in terms of organizational, 
educational and psychological aspects such as mutual 
interaction, motivation, professional commitment, self-
efficacy, and productivity. In this study, the relationship 
between academicians’ self-efficacy perceptions and 
occupational commitment was examined. 
MATERIALS AND METHODS:
The sample of the research consists of 46 
academicians working at the Faculty of Pharmacy 
of Ankara University.  The data obtained in the study 
were collected by applying a questionnaire to the 
sample size. Surveys contains the basic demographic 
questions with general self-efficacy scale and three-
dimensional scale occupational commitment. In the 
analysis of the data, descriptive statistical tools and 
t-test and one-way ANOVA and Pearson correlation 
analysis were used. 
RESULTS:
When the demographic characteristics of the 
academicians participating in the research are 
examined; Of 73.8% were female, 21.7% male, 84.8% 
married, 15.2% were found to be the single. It was 
found that general self-efficacy perceptions of male 
academicians were higher than female academicians, 
while the general self-efficacy perceptions of 
academicians were found to be significant and positive 
effect on their level of occupational commitment.
CONCLUSIONS:
In this study, the general self-efficacy perceptions 
of academicians were found to be high. At the 
same time, it was found that there was a significant 
relationship with professional commitment levels. It is 
thought that all the results of the study will contribute 
to the literature of both education and management.
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PKA VALUES OF SOME AMPHOTERIC 
DRUGS FROM THEIR PKA AT 25˚C BY 
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INTRODUCTION:
A large proportion of organic molecules relevant 
to medicine contain one or more ionizable groups, 
which means that fundamental physical and chemical 
properties depend on pH of the solution via the 
corresponding ionization constant (pKa) values 
of the molecules. However, for many compounds 
experimental pKa values are not available, and for 
others the measured values are sometimes uncertain. 
In practice, the common reference value is 25°C and 
reported pKa values are mainly clustered around 
room temperatures. There is limited number of study 
at biorelevant temperature (37°C).
MATERIAL: 
In this study, aqueous pKa values for some 
cephalosporins (2.10-3 M) were determined by 
potentiometric method. Mettler Toledo MA 235 pH/
ion analyzer system were used for pH measurements. 
pKa values were deduced graphically form Bjerrum 
plots by using Solver aproach. Moreover aqueous 
pKa values of some amphoteric sulfonamides (1.10-5 
M) were determined by spectrophotometric method. 
The UV-Vis spectra were recorded at each pH using 
Perkin Elmer LAMBDA 20. The cell was thermostated 
at 25±0.5 0C. 
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RESULTS:
Acidity constant is a very important property of drug 
candidates, because it is of main importance for 
their ADME properties. In this study, pKa values of 
some amphoteric drugs were determined by using 
potentiometric and spectroscopic methods. We have 
developed a computational method for estimating 
biorelevant pKa using a quantitative structure property 
relationship (QSAR) approach. The Abraham’s  five 
LFER solvation descriptors ( E, S, A, B, V values) 
were considered as molecular descriptors. In the 
present study, the difference between their pKa values 
at 25˚C and 37˚C for some amphoteric drugs were 
predicted by using special equation. The biorelevant 
pKa values of amphoteric drugs were calculated by 
fitting the molecular descriptor equation to their pKa 
at 25˚C. 
CONCLUSION: 
Values of the ionization constants at 37°C, are more 
meaningful for interpreting mechanisms of cellular 
transport by ionizable molecules.  A simple equation 
for predicting the biorelevant pKa from knowledge 
of the value at 25°C was derived. This investigation 
is expected to be a useful contribution, since pKa 
determinations are scarcely reported at 37°C. 
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INTRODUCTION:
Non-steroidal anti-inflammatory drugs (NSAIDs) 
are a class of weak acidic compounds which cover 
a number of different chemical types. Reversed 
phase liquid chromatography (RPLC) is one of the 
most powerful analytical methodologies used for 
quantitative determination of these compounds. 
Quantitative structure retention relationships 
play an important role in enhancing the quality of 
chromatographic method optimisation. Molecular 
descriptors are numerical values that characterize the 
properties of molecules. It is possible to investigate 
retention behaviour of solutes in RPLC employing 
Abraham solvation parameters. The Abraham solute 
parameters (E, S, A, B and V) and Abraham equation 
coefficients (c, e, s, a, b and v) represent the extent of 
all known interactions between solute, mobile phase 
and stationary phase.
MATERIALS AND METHODS:
The chromatographic analysis of the analytes was 
performed using an isocratic system. Effect of 
percentage of organic modifier (acetonitrile-water 
binary mixture containing 25 mM phosphoric acid; pH 
range 2.5-7.0) were investigated on retention in RP 
column using solvation parameter model. A Nucleosil 
300-5 C4 RP column (25 cm×4.6 mm, 5μm) was used 
for the analysis. This study was performed at 37oC. 
Gemini C6 phenyl analytical column was also used 
for chromatographic studies at 25°C.
RESULTS:
In the present study, quantitative structure-
retention equation describing relations between 
the solute descriptors of some NSAIDs (etodolac, 
tolmetin, ketorolac, deksketoprofen, diclofenac, 
ketoprofen, naproxen, ibuprofen, flurbiprofen) and 
their chromatographic behaviour were derived. 
To quantitatively characterize the structure of the 
analytes the following five structural descriptors are 
employed: McGowan volume, the polarizability/
dipolarity, the overall hydrogen bond basicity, the 
overall hydrogen bond acidity, an excess molar 
refraction. The constants reflect whether the analyte 
prefer the interaction with the stationary phase or 
the mobile phase. Positive values in the regression 
coefficients indicate that the descriptor contributes 
positively to the value of capacity factor, whereas 
negative values indicate that the greater the value 
of the descriptor, the lower value of log k. It may be 
concluded that polar interactions have negative effects 
on retention. Conclusions:This work represents the 
first study dealing with the reversed phase retention 
mechanism of some NSAIDs at different proportions 
of acetonitrile-water binary mixtures.The linear 
solvation energy relationship (LSER) methodology 
was used to explain the retention mechanism. The 
results showed some regularity in retention behaviour 
of the compounds studied.
P-181: QUANTITATIVE ANALYSES OF 
DAPAGLIFLOZIN, A SODIUM-GLUCOSE 
COTRANSPORTER II INHIBITOR, BY 
DIFFERENTIAL PULSE VOLTAMMETRY
Ates, AK., Erk, N.
Ankara University, Department of Analytical 
Chemistry, Ankara, Turkey
INTRODUCTION:
Type II diabetes, which accounts for more than 90% 
of all diabetes, is a complex progressive metabolic 
derangement associated with comorbidities such 
as obesity, hypertension, and hyperlipidemia (1). 
Dapagliflozin is a stable and highly selective Sodium-
glucose cotransporter II (SGLTII) inhibitor. Binding 
of dapagliflozin to SGLTII inhibits renal glucose 
reabsorption, promotes urinary glucose excretion, 
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and thereby lowers hyperglycemia by an insulin-
independent mechanism (2).
Herein, for the first time, quantitative analyses 
of dapagliflozin (DPG) was carried out using 
voltammetric method. 
MATERIALS AND METHODS:
A three electrode cell was employed using an Ag/
AgCl as a reference electrode, Pt wire as a counter 
electrode and a glassy carbon electrode (GCE) as 
a working electrode. Since DPG exhibits a diffusion-
controlled process on GCE, DPG was analysed by 
differential pulse voltammetry.
RESULTS:
The voltammetric responses of DPG presented a 
good linearity with an increase in concentration within 
two concentration ranges of 10–48 µM and 48–100 
µM with a low detection limit of 0.41 µM and RSD of 
% 4.89.
CONCLUSIONS:
In this study, for the first time, a simple, rapid, sensitive 
and cost-effective electrochemical analyses method 
was developed for the quantitative determination of 
DPG and applied to DPG in bulk with satisfactory 
results. The developed method could be a promising 
alternative for routine analysis of DPG in real samples.
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INTRODUCTION:
Hypertension, also known as high or raised blood 
pressure, is a condition in which the blood vessels 
have persistently raised pressure. Amlodipine (AML) 
is a potent dihydropyridine calcium antagonist 
useful in the management of angina pectoris and 
hypertension. Nebivolol hydrochloride (NEB) is a 
beta adrenergic blocker. It selectively blocks the β1- 
adrenoceptor (1,2).
MATERIALS AND METHODS:
Induced dual wavelength spectrophotometric method 
is applied for the simultaneous determination of two 
active ingredients in mixture with complete overlapped 
zero order spectra at two wavelengths.
RESULTS:
The proposed  method  is the application of induced 
dual wavelength method where the linearity range 
and percentage recoveries for  AML , and NEB 
were 5.0 -35.0 ug/ml   and  100.05 ± 1.11 ,99.05  ± 
0.89, respectively. The absorbance of the zero order 
spectra at 237.53  and 287.41 nm  (equality factor 
was found as 9.22)  for AML   and 281.46 and 266.30 
nm  (equality factor was found  as 18.14)  for NEB 
were measured .
CONCLUSIONS:
The proposed method permit simple, rapid, and direct 
determination of binary mixtures without previous 
separations.  Moreover, it has many advantages over 
other separation techniques such as high-performance 
liquid chromatography or gas chromatography.  
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INTRODUCTION:
Granisetron (GRA) is a potent and selective 
5-hydroxytryptamine receptor antagonist with 
antiemetic activity indicated for prevention and 
treatment of nausea and vomiting associated with 
cytotoxic chemotherapy and radiotherapy, and 
postoperative nausea and vomiting (1). The aim of 
the study is to develop a rapid and sensitive capillary 
electrophoretic (CE) method for the determination of 
GRA in pharmaceutical preparations.
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MATERIALS AND METHODS:
All chemicals used were analytical grade. An Agilent 
7100 model CE with DAD (205.5 nm) was used for 
CE experiments. Separation was achieved by a fused 
silica capillary with 40 cm effective (48.5 cm total, 75 
µm i.d.) length. The run buffer was composed of 20 
mM phosphate buffer (pH 2.75) and applied voltage 
was 22.5 kV. Metoprolol was used as IS.
RESULTS:
All parameters effecting separation were investigated. 
Under optimum conditions the migration times for GRA 
and IS were 6.71 min and 6.94 min, respectively. The 
method was validated for linearity, precision, accuracy, 
sensitivity, stability, specificity and robustness. The 
LOQ was found to be 4.30×10-7 M. The developed 
and validated method was successfully applied to 
GRA tablets and ampoules containing 1 mg and 3 mg/
mL GRA, respectively.
CONCLUSIONS:
The CE method proposed here is rapid, sensitive and 
specific. The method was applied to pharmaceutical 
preparations of GRA and the contents were found to 
be in the limits of USP39 (2). This method is proposed 
for the routine analysis of GRA.
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INTRODUCTION:
Ceftiofur (CEF) is a third-generation semi-synthetic 
cephalosporin antibiotic, which is licensed for use 
in veterinary medicine (1). The aim of this study 
was to develop a fast and reliable HPLC method 
for determination of CEF in veterinary suspensions. 
Analysis of CEF and benzocaine (internal standard, 
IS) was performed using a fused core silica column.
MATERIALS AND METHODS:
Analyses were performed using a Prominence series 
of HPLC instrument from Shimadzu (Japan). A C18 
bonded fused-core silica particle column (2.7 μm 
particle size, 10x4.6 mm from Supelco) was used for 
separation. The mobile phase, which was pumped at 
the rate of 1.0 mL/min, was consisted of acetonitrile: 
phosphate buffer (0.025 M, pH 2.4): water (28:10:62, 
v/v/v). The analytes were detected at 289 nm by using 
a PDA detector. A simple sample preparation step 
was applied, in which only dissolution in THF-ACN 
mixture, subsequent dilution and filtration through 
0.22-μm PTFE filter steps are required; 1000 µL of the 
resulting solution was spiked with 200 µL 1.87x10-4 M 
IS solution prior to injection. The validity of the method 
was verified according to ICH guidelines using quality 
control solutions (2).
RESULTS:
The method was linear in the range of 1.98x10-8 M 
- 0.97x10-5 M (y= 310801x - 0,0088; R2 =1.000). 
LOD and LOQ of the method were 1.76x10-7 M 
and 5.85x10-7 M, respectively. The developed 
method permits quantitative determination of CEF in 
pharmaceutical suspensions with high accuracy and 
precision.
CONCLUSIONS:
The method proposed in this study was found to 
be applicable for fast analysis of CEF in veterinary 
preparations. This is the first study in which a fused-
core column was utilized for the analysis of CEF in 
veterinary preparations.
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P-185: GREEN HPLC USING ECO-
FRIENDLY ETHANOL BASED MOBILE 
PHASES IN PHARMACEUTICAL ANALYSIS
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INTRODUCTION:
Green analysis techniques based on solvent 
consumption and substitution are the two major 
applications in greening chromatographic analysis. 
Decreasing the toxicity of solvents used in mobile 
phases by substituting them with less or non-
hazardous ones or revealing the consumption 
amounts by using lower diameter columns or 
miniaturizing instruments are a fact that can be 
implemented to an analysis (1, 2). Environmentally 
friendly water and ethanol based mobile phases 
reduce the use of toxic solvents such as methanol and 
acetonitrile, and consequently the necessary cleaning 
of waste is reduced. In the presented study, ethanol 
having less toxic and hazardous effects has been 
selected as organic modifier. Famotidin, paracetamol 
and thiocolchicoside were selected molecules for 
demonstration of the applicability of green HPLC in 
pharmaceutical analysis. Famotidine is a histamine 
H2 receptor antagonist inhibiting stomach acid 
production. Paracetamol is a medication used to treat 
pain and fever. Thiocolchicoside is a muscle relaxant 
with anti-inflammatory and analgesic effects.
MATERIALS AND METHODS:
Experiments were carried out using an LC system 
connected to a Shimadzu LC–DAD (at 254 nm). 
HiChrom Nucleosil C18 (150 × 4.6 mm, 5 µm) and 
C8 (150 × 4.6 mm, 5 µm) analytical columns were 
tested as stationary phases. In the mobile phase 
optimization, EtOH and phosphate buffer contents 
were adjusted to the desired concentrations for the 
elution of selected analytes both in isocratic and 
gradient elution modes. İnitial flow rate of the mobile 
phase was set to 1.0 mL/min and the injection volume 
was 20 µL.
RESULTS:
Developed mobile phase was consisted of NaH2PO4 
(50 mM, pH:4.6) + EtOH (95:5, v/v) in gradient elution 
mode. Famotidin, paracetamol and thiocolchicoside 
were well separated both form baseline and each 
other with the capacity factors of 2.14, 2.53 and 4.26 
min, respectively. The developed EtOH based mobile 
phase in RP-HPLC was validated in terms of ICH 
requirements (3) and found to be accurate, precise, 
repeatable, rugged and robust. Developed method 
was also successful in pharmaceutical analysis of 
famotidin, paracetamol and thiocolchicoside from 
Turkish drug market.
CONCLUSIONS:
Our objective in this study is to evaluate 
chromatographic behaviors of api’s in terms of green 
mobile phase. The usage of buffer much more than the 
organic phase shows that this kind of analysis can be 
performed using more aqueous phases. The findings 
of the presented study suggested that environmentally 
friendly ethanol and water based mobile phases can 
successfully apply in the pharmaceutical analysis.
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INTRODUCTION:
Epirubicin is an anthracycline drug used for 
chemotherapy. It can be used in combination with 
other medications to treat many cancers including 
lung cancer (1). There are some HPLC methods 
reported in the literature for the analysis of epirubicin 
in its pharmaceutical dosage forms and biological 
materials (2-4). However, none of these methods 
are sensitive and specific for the determination of 
epirubicin in nanoparticulate drug delivery system. 
Therefore, an HPLC method for epirubicin was 
developed and validated.
MATERIALS AND METHODS:
In this work, an ACE C18 column (250 x 4.6 
mm, 5µm) was used for separation of epirubicin 
from nanoparticulate system matrix components. 
Acetonitrile and phosphate buffer (25 mM pH: 3.0) 
40:60 mixture was used as mobile phase. Flow rate 
was 1.0 mL/min and detection wavelength was 234 
nm. Injection volume was 20 µL where column was in 
ambient temperature.
RESULTS:
Epirubicin was successfully determined in the 
presence of matrix components coming from 
nanoparticulate drug delivery system. Total analysis 
was shorter than 12 minutes. The method was 
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validated according to the guidelines and found that 
it is precise, accurate, sensitive for determination of 
epirubicin in the prepared nanoparticulate system.
CONCLUSIONS:
Although there are various analytical techniques for 
determination of epirubicin in pharmaceutical dosage 
forms and biological materials, a specific method 
was developed for determination of epirubicin in 
nanoparticulate formulation. The analytical method 
was successfully applied for investigation of the 
encapsulation efficiency and drug release profile of 
epirubicin.
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INTRODUCTION:
Hypoxanthine accumulates in biological tissues 
as the main product of the degradation of adenine 
nucleotides in biological materials. The concentration 
of inosine and / or hypoxanthine can be used 
as a fish freshness determinant. The amount of 
hypoxanthine available is often used in the detection 
of meat freshiness in the food industry and in some 
pathological processes in the human body. Therefore, 
the quantification of hypoxanthine content is important 
for the quality control of fish and other fish products in 
the food industry. 
MATERIALS AND METHODS:
Polypyrrole-polyvinylsulphonat films have been 
prepared on the platinum electrode by the 
electropolymerization of pyrrole was carried out 
in the presence of polyvinylsulphonate. Optimum 
conditions of polypyrrole-polyvinylsulphonate film 
was determined. Xanthine oxidase and uricase 
enzymes have been immobilized in polyanpyrrole-
polyvinylsulphonate via the entrapment method. The 
linear working range of biosensor for hypoxanthine 
was determined. The effects of pH and temperature 
on the response of the hypoxanthine biosensor were 
investigated. Reusability and storage stability were 
determined of the biosensor. 
RESULTS:
Linear working range of prepared enzyme electrode 
was determined 1 μM to 10 mM. The prepared 
enzyme electrode maintains 74.5% of its performance 
at the end of 20 measurements. The values of Km and 
Vmax for the Pt / PPy-PVS / KO-U enzyme electrode 
system were found to be 3.7 μM and the 0.19 μA / 
min respectively. The optimum pH and temperature 
values for the enzyme electrode system were found 
to be 8.2 and 30 °C.
CONCLUSIONS:
Electrochemical studies show reliable and good 
results over very low concentration ranges. This 
method is relatively fast and cheap compared to other 
methods.
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INTRODUCTION:
Nucleoside and nucleotide reverse transcriptase 
inhibitors are synthetic nucleoside and nucleotide 
analogs used for the treatment of viral infections. 
In HIV-infected patients, combined therapy of the 
lamivudine, zidovudine and abacavir shows superior 
efficacy compared to single therapy. Hydrophilic 
interaction liquid chromatography (HILIC) is an 
interesting alternative for the analysis of polar 
substances. It can be defined as a separation method 
that combines stationary phases usually used in 
normal phase method and mobile phases used in 
reversed phase separations. Main advantages of 
HILIC is the efficient retention and separation of 
polar compounds, which is difficult to achieve using 
reversed phase condition. The aim of this study is to 
demonstrate of a HILIC method for the simultaneous, 
determination of abacavir, lamivudine, and zidovudine. 
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MATERIALS AND METHODS:
Agilent 1100 series LC system, equipped with a diode 
array detector was used for analysis. Analysis have 
been realized with the Kinetex HILIC (150 mm x 4.6 
mm, 2.6 µm), analytical column, the mobile phase 
consists of acetonitrile: ammonium acetate buffer 
solution, 80:20 (v/v) at 25°C. Detection wavelength 
was selected as 280 nm. Forced degradation studies 
were carried out by using tablet form. The degradation 
studies were performed under certain conditions 
included acid hydrolysis, base hydrolysis, oxidation, 
UV light exposure at 254 nm, heating in the oven at 
80°C and keep the solution in water bath at 80°C. 
The results were compared to the untreated tablet 
solution.
RESULTS:
Degradation studies were carried out to examine the 
selectivity of the analytical method. Tablet sample 
was subjected to light stress conditions such as (acid 
hydrolysis with 0.1 M HCl, base hydrolysis with 0.1 M 
NaOH, oxidation with 0.3% H2O2). It was observed 
that the degradation products did not interfere with 
the active substances in 6 different degradation 
conditions. Therefore, the developed method 
is suitable for analysis of the active ingredients 
simultaneously with possible degradation products.
CONCLUSIONS:
As a result of this study, fast, simple, sensitive, 
selective and fully validated HILIC method has been 
developed under developed conditions. The proposed 
rapid and sensitive HILIC method will be readily 
applicable in quality control laboratories since for 
simultaneous quantification of abacavir, lamivudine 
and zidovudine. Thus, the feasibility of the method 
in complex matrices such as drug samples has also 
been demonstrated. 
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INTRODUCTION:
Deep Eutectic Solvents (DESs) are known as the 
new generation and green solvents. Because of 
their polarity and ability to form hydrogen bonds, 
DES make excellent solvents, meaning that they can 
dissolve many different kinds of molecules.  Moreover, 
they are defined as environmental friendly because 
of their low toxicity and they are also biodegradable 
and biocompatible (1). Due to these properties, deep 
eutectic solvents are used in many different areas. 
Especially studies aiming to seriously increase 
the solubility of medicines, with solubility problems 
compared to water, are particularly promising 
according to preclinical studies (2).
On the other hand, when the literature was examined 
it was seen that there were not enough studies on 
this topic. For this purpose different DESs were 
prepared and characterizations were performed and 
antibacterial activities were determined.
MATERIALS AND METHODS:
Characterization of the different DESs were 
performed by the Fourier Transform Infrared (FTIR) 
Spectrometry and the Nuclear Magnetic Resonance 
(NMR) Spectrometry. The Resazurin Microplate 
method was used to determine antibacterial activity.
RESULTS:
The DESs used in the study were clarified. 
Antibacterial activity assays were investigated for 
five different bacteria and MIC (minimum inhibitory 
concentration) values were calculated.
CONCLUSIONS:
According to the results, DESs showed low 
antibacterial activity compared to ampicillin. Taking 
into account the interesting applications of the 
pharmaceutical industry, in addition to other industries, 
a large number of DESs have been concluded 
to be able to expand their work by investigating 
more physicochemical, antibacterial and cytotoxic 
properties of DES.
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INTRODUCTION:
Recently, deep eutectic solvents (DESs) were 
introduced as a green alternative to conventional 
solvents for sample preparation and extraction 
procedures. A deep eutectic solvent is consist of 
an eutectic mixture of two solid and has a lower 
melting point than its components (1).  DESs 
are biodegradable, non-toxic, non-volatile, non-
flammable, inexpensive, and easily accessible and 
environmentally friendly (2,3). In this study, we aimed 
to develop a new procedure to extract fenolic species 
from olive fruits using deep eutectic solvents.  For this 
purpose, choline chloride -urea mixture was used as 
DES. 
MATERIALS AND METHODS:
The synthesized DES were characterized by Fourier 
transform infrared spectroscopy (FT-IR). After 
extraction of the olive fruits which planted in Mersin 
region, phenolic substances were determined by 
High-Performance Liquid Chromatography with 
Diode-Array Detection (HPLC/DAD).
RESULTS:
Concentrations of vanillin, vanillic acid, 
2,3-dihydroxybenzoic acid and 4- hydroxybenzoic 
acid concentrations were determined in the olive fruit 
samples. Recovery, limit of detection (LOD) and limit 
of quantification (LOQ) values were calculated for 
each phenolic species. 
CONCLUSIONS:
Results of studies have shown that DESs can be 
suggest as a green alternative to conventional 
solvents for extraction of phenolic species from olive 
fruits.
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INTRODUCTION:
Antazoline (ANT) is a histamine H1 receptor 
antagonist(1). Ephedrine (EPD) is used to excite 
the central nervous system, and is also used 
as decongestant(1). Naphazoline (NPZ) is a 
sympathomimetic agent and decongestant(1). 
Chlorbutanol (CLO) is a chemical preservative, 
sedative hypnotic and weak local anaesthetic(1). 
These four compounds are pharmacologically active 
constituents found in pomade. There have been 
numerous publications describing various methods 
for the quantification of these compounds individually 
and in combination with other drugs(2,3). However, 
literature survey reveals that no method has been 
reported for determination of ANT, NPZ, EPD 
and CLO, simultaneously. This study involves the 
development of reversed-phased chromatographic 
method for simultaneous determination of ANT, NPZ, 
EPD and CLO present in a pharmaceutical pomade. 
MATERIALS AND METHODS:
Stock solutions of ANT, NPZ, EPD and CLO were 
prepared in methanol. Standard solutions were 
prepared from stock solutions by dilution with 
mobile phase consisted of 10 mM phosphate 
buffer pH 3 and methanol (80:20, v/v). Shimadzu 
UV spectrophotometer (UV- 2450) was used for 
all measurements. The quantification was carried 
out using an HPLC system (Agilent 1200) with UV 
detector. 
RESULTS:
UV spectra of ANT, NPZ, EPD and CLO(Fig1) 
indicated that ANT, NPZ, EPD and CLO could not 
determined by UV spectrophotometry. Optimum 
chromatographic separations of ANT, NPZ, EPD and 
CLO have been achieved within 12 minutes at flow 
rate of 0.6 mL/min by using Agilent Zorbax Eclipse 
XDB C18 (3.0x75mm, 3.5µm) column and detection 
was performed at 210 nm. The method was validated 
in accordance with ICH guidelines. Regression 
analysis showed good correlations (R2  > 0.999) for 
ANT in concentration range of 0.05 µg/mL to 100 µg/
mL, NPZ in 0.005 µg/mL to 10 µg/mL EPD in 0.166µg/
mL to 332 µg/mL and CLO in 1.66 µg/mL to 332 µg/
mL. 























Fig1. UV spectra of ANT, NPZ, EPD and CLO
Fig2. HPLC Chromatogram of ANT, NPZ, EPD and CLO
CONCLUSION:
In this study, RP-HPLC method is presented for the 
determination of ANT, NPZ, EPD and CLO in pomade 
which offers numerous advantages, such as good 
resolution, accuracy, precision, selectivity and ease of 
operation.
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INTRODUCTION:
According to the World Health Statistics 2017 
Report (1), published by World Health Organization, 
an estimated 40 million deaths occurred due to 
Noncommunicable diseases (NCDs). The majority 
of such deaths were caused by the four main NCDs, 
namely: cardiovascular disease, 17.7 million deaths 
(45% of all NCD deaths); cancer, 8.8 million deaths 
(22%); chronic respiratory disease, 3.9 million deaths 
(10%); and diabetes, 1.6 million deaths (4%). For 
the diagnosis and management of Diabetes mellitus 
mean fasting plasma glucose (FPG) (mmol/L) level 
is a golden standard as indicated in the same report 
(1). For non-invasive glucose monitoring there are 10 
technologies present in R&D or marketing level (2). 
One of the most promising approach among these 
technologies is reverse iontophoresis (RI). RI is 
based on the flow of a low electrical current through 
the skin and glucose measurement is possible 
because glucose is extracted through the epidermis 
surface during this convective flow. In this study some 
experimental parameters are optimized for the RI 
determination of glucose in an artificial skin model.
MATERIALS AND METHODS:
Methyl cellulose (MC), carboxymethyl cellulose, 
sodium  carboxymethyl cellulose, hydroxypropylmethyl 
cellulose (Sigma-Aldrich) were used as the electrolyte 
in the collection chamber. Cellulose ester (CE) 
membranes with 2000, 12000 and 14000 Daltons 
MWCO values (Visking) were used as the artificial 
skins. pH value (pH 1-13) and the ionic strength (7 
different combinations) of the extraction medium 
was investigated. Extraction electrodes distance (1, 
2.5, 7 and 10mm) and material (Ag, Pd, Rh, Pt, Ru), 
extraction potential type (pulse, cyclic, continous) and 
magnitude (+0.5, +1.0, +1.5 and +2.0V vs Ag/AgCl) 
and extraction time (3, 12 and 24 hours) were the 
other parameters employed. During RI procedures 
extracted glucose samples were quantified by 
Accu-Chek Active blood glucose monitor (Roche 
Diagnostics).
RESULTS:
MC gel and CE membrane with 12000 Daltons 
MWCO combination displayed best responses. 
Glucose extraction was the highest at physiological 
pH (pH 7.4) in 0,05M PBS as the optimum ionic 
strength. Extration electrodes fabricated by 
electrodeposition of Ag should be located at 7.0mm 
distance from each other. With a continous potential 
of +2.0V (chronoamperometric) for 3h, glucose could 
successfully extracted for 24h. 
CONCLUSIONS:
A noninvasive determination method for glucose was 
developed and optimized. Experimental results were 
summarized and displayed as tables.
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P-194: LC-MS/MS METHOD FOR THE 
DETERMINATION OF LAMOTRIGINE IN RAT 
PLASMA AND BRAIN MICRODIALYSATE
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1Anadolu University, Faculty of Pharmacy, 
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INTRODUCTION:
A fast, specific and highly sensitive liquid 
chromatography tandem mass spectrometry (LC-MS/
MS) method for the direct determination of lamotrigine 
which is an anti-epileptic compound in rat plasma 
and brain microdialysate has been developed and 
validated.
MATERIALS AND METHODS:
The analysis was performed on a Supelco Ascentis 
Express C18 (100x2.1 mm, 2.7 μm particle) core shell 
column using a binary gradient elution with the mobile 
phases consisting of acetonitrile and ammonium 
formate buffer (10 mM). Ionization of the compound 
was achieved by electrospray ionization (ESI) in 
positive ion mode. Signals of the compound were 
monitored under the multiple reaction monitoring 
(MRM) for quantification. The brain microdialysates 
and the blood samples were collected simultaneously 
after intraperitoneal injection of the compound (50 
mg.kg-1) during 12 hours from freely moving rats. 
Plasma samples were analyzed after simple two-step 
protein precipitation using with MeOH after sampling 
from rat and 10% perchloric acid before analysis, 
however clean-up for microdialysis samples was not 
necessary, enabling direct injection of the samples 
into the LC-MS/MS system.
RESULTS:
The precursor to product ion transition of m/z 256 
> m/z 144.8 was used to measure concentrations 
of lamotrigine with a retention time of 5.4 min. 
The method was validated in both plasma and 
microdialysate samples and the obtained lower 
limit of quantification (LLOQ) was 0.1 ng.mL-1 for 
lamotrigine in both matrices. The intra- and inter- day 
assay variability was less than 15 % for both analytes.
CONCLUSIONS:
The proposed LC-MS/MS method provided simple 
sampling, rapid clean-up and short analysis time 
(<6 min), and is applicable to the routine therapeutic 
monitoring and pharmacokinetic studies of 
lamotrigine.
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P-195: AN ELECTROCHEMICAL SENSOR 
FOR SENSITIVE AND FAST DETECTION 
OF MITOXANTRONE BASED ON NANO-
SEPIOLITE ELECTRODE
Eskikoy Bayraktepe, D., Yildiz, C., Yazan, Z.
Ankara University, Department of Chemistry, Ankara, 
Turkey
INTRODUCTION:
Mitoxantrone (MTX) is a significant antitumor drug 
against breast and prostate cancers, acute leukemia 
and non-Hodgkin’s lymphoma (1, 2). The overdose 
of MTX in human can cause serious side effects 
such as fever, chills, sore throat, flu symptoms, easy 
bruising or bleeding (nosebleeds, bleeding gums), 
loss of appetite, mouth sores, unusual weakness etc. 
(3). Hence, it is very important to develop simple and 
reliable methods for fast and accurate detection of 
MTX. For his reason, in this study is to develop a new, 
sensitive and selective electrochemical method for 
determination of MTX in serum and pharmaceutical 
samples.
MATERIALS AND METHODS:
Mitoxantrone, graphite powder, mineral oil and 
sepiolite clay were purchased from Sigma Aldrich 
Company. 0.1 M H2SO4 solution was used for 
supporting electrolyte. Cyclic voltammetry (CV), 
Differential Puls Adsorptive Stripping Voltammetry 
(AdsDPV) and Electrochemical Impedance 
Spectroscopy (EIS) measurements were carried 
out by using CHI 760B (from USA) connected with 
electrochemical workstation and C3 cell stand (BASi). 
A three-electrode system was used and nano-
sepiolite clay modified carbon paste sensor (NSC/
CPE) was used as working electrode, Ag/AgCl (BAS 
MW-1032) was used as reference electrode and 
platinum electrode was used as auxiliary electrode 
(BAS MF-2052).
RESULTS:
Firstly, sepiolite modified carbon paste sensor was 
prepared by adding appropriate amounts of sepiolite 
clay, graphite and mineral oil  and then, newly designed 
surface of sensor was characterized by using SEM, 
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EIS and CV techniques. Secondly, AdsDPV method 
was developed to determine MTX in biological and 
pharmaceutical samples based on NSC/CPE sensor. 
The anodic peak current of MTX in AdsDPV varies 
linearly with the concentration range of 2.42 – 100 n 
mol L-1. Dedection (LOD) and quantification (LOQ) 
limits were calculated as 0.7261 n mol L-1 and 2.42 
n mol L-1, respectively. The voltammetric technique 
was applied to MTX analysis in human serum and 
flacon samples. The results found satisfactorily.
CONCLUSIONS:
For the first time, sensitive, selective and reproducible 
electrochemical method was developed for the 
electro-analysis of MTX in pharmaceutical and human 
serum samples using NSC/CPE sensor.
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P-196: ELECTROCHEMICAL SENSOR FOR 
THE DETERMINATION OF ANTI-CANCER 
SHIKONIN BASED ON NSC/TIO2/MWCNTS 
COMPOSITE
Eskikoy Bayraktepe, D., Yazan, Z.
Ankara University, Department of Chemistry, Ankara, 
Turkey
INTRODUCTION:
A number of pharmaceutical studies have shown that 
Shikonin (SHI) has some antibacterial, antifungal, 
antimicrobial, anti-inflammatory and antithrombotic 
activity in humans (1). It has a cytotoxic effect on 15 
different cancer cell lines, including some multidrug 
˗ resistant ones (2).  For this reason, it is very 
important to develop simple and reliable methods for 
accurate detection of SHI. In this study, we aimed 
to develop a new sensor based on sepiolite clay, 
TiO2 nanoparticles and multiwall carbon nanotubes 
composite for sensitive determination of SHI in human 
urine and serum samples.
MATERIALS AND METHODS:
Shikonin, graphite powder, mineral oil and nano-
sepiolite clay, multiwall carbon nanotubes (MWCNTs) 
were purchased from Sigma Aldrich Company. 0.1 M 
H2SO4 solution was used for supporting electrolyte. 
Cyclic voltammetry (CV), Square wave adsorptive 
stripping voltammetry (AdsSWV) and Electrochemical 
Impedance Spectroscopy (EIS) measurements 
were carried out by using CHI 760B (from USA) 
electrochemical workstation and C3 cell stand (BASi). 
Traditional three-electrode system was used and 
nano-sepiolite clay, TiO2 nanoparticles and MWCNTs 
modified carbon paste sensor (NSC/TiO2/MWCNTs/
CPE) was used as working electrode, Ag/AgCl (BAS 
MW-1032) was used as reference electrode and 
platinum electrode was used as auxiliary electrode 
(BAS MF-2052).
RESULTS:
AdsSWV method was developed to determine SHI 
in biological samples based on NSC/TiO2/MWCNTs/
CPE sensor. Firstly, the composite sensor (NSC/
TiO2/MWCNTs/CPE) was prepared and the surface 
characterization of this sensor was carried out by using 
EIS, CV and SEM techniques. Secondly, based on 
anodic peak current of SHI in AdsSWV, the calibration 
study was done and linear concentration range varies 
linearly with the concentration range of 1.30 – 1000 
nmol L-1. Detection (LOD) and quantification (LOQ) 
limits were calculated as 0.39 nmol L-1 and 1.30 nmol 
L-1, respectively. The voltammetric technique was 
applied to SHI analysis in human serum and urine 
samples. The recovery results are about 100%.
CONCLUSIONS:
A new, sensitive, selective and reproducible AdsSWV 
method was developed for the analysis of SHI in 
human serum and urine samples using NSC/TiO2/
MWCNTs/CPE sensor.
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P-198: VOLTAMMETRIC AND 
SPECTROELECTROCHEMICAL BEHAVIOR 
OF NOVEL OCTA SUBSTITUTED 
METALLOPHTHALOCYANINES
Orman, EB., Huraibat, B., Atajanov, R., Odabas, Z., 
Ozkaya, AR.
Marmara University, Department of Chem., Istanbul, 
Turkey 
INTRODUCTION:
Phthalocyanines owe their importance to the 
applications in various fields such as press ink dye 
and pigments, non-linear optics, photodynamic 
therapy (PDT), and semiconductors since their first 
synthesis early in the last century (1). Their classical 
use has been broadened in recent years by other 
areas of current interest including applications in 
electrocatalysis, electrochromism, energy producing 
systems as fuel cells, which are closely related 
to their unique electron transfer properties (2). 
Thus, the identification of electrochemical and 
in-situ spectroelectrochemical properties of the 
newly synthesized metallophthalocyanine (MPc) 
compounds has vital importance in terms of their 
technological applications. In recent years, some 
metallophthalocyanines, especially iron and cobalt 
Pcs have been used in catalytic reactions because 
of their rich and modifiable electrochemical and 
spectroelectrochemical properties resulting from 
metal-based redox activity (3).
In this study, the electrochemical and in-
situ spectroelectrochemical characterization 
of the novel Co(II), Cu(II), Fe(II) and Mn(II) 
2 , 3 , 9 , 1 0 , 1 6 , 1 7 , 2 3 , 2 4 - o c t a ( 2 - i s o p r o p y l - 5 -
methylphenoxy)phthalocyanine complexes have 
been performed in non-aqueous solution. 
MATERIALS AND METHODS:
Cyclic voltammetry (CV) and square wave 
voltammetry (SWV) techniques were used to identify 
electrochemical redox properties in solution medium. 
RESULTS:
The compounds displayed both Pc ring- and/
or central metal-based rich redox properties. 
Spectroelectrochemical measurements provided 
strong support for identification of their redox 
processes.  
CONCLUSIONS:
Complex Cu(II) shows Pc ring-based one electron 
redox processes whereas Co(II), Fe(II) and Mn(II) 
complex produce both Pc ring and metal-based one 
electron redox processes.
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P-199: DEVELOPMENT OF AN ACCURATE 
AND SENSITIVE ANALYTICAL METHOD 
FOR THE DETERMINATION OF DIOSMIN BY 
USING HPLC
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1Ankara University, Faculty of Pharmacy, Department 
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INTRODUCTION:
Diosmin (Dio)  is a type of plant chemical found mainly 
in citrus fruits. Dio is a semisynthetic drug indicated 
for the treatment of venous disease. Diosmin is 
a flavone that can be found in the plant Teucrium 
gnaphalodes. Other name is 3’,5,7-trihydroxy-4’-
methoxyflavone-7-rhamnoglucoside, Bioflavonoid, 
Bioflavonoid Complex. In this study, rapid, simple and 
Sensitive  reversed-phase liquid chromatographic 
determination was described for the assay of Dio  in 
bulk and tablet formulations.
MATERIALS AND METHODS:
Optimal separation and determination of Dio was 
achieved with a Nucleosil 100 C18 125 x 4.6 mm, 5 
µm analytical column using water :glacial acetic acid 
:methanol  (61.5:4.5:34.0 v/v/v) as a mobile phase in 
isocratic mode with flow rate of 1.5 mL/min-1,loop of 
10 µL. 
RESULTS:
The maximum absorption wavelength of Dio  is 275.0 
nm  was studied as the detection wavelength and 
column at 400C temperature. The retention time of Dio 
was observed at 5.88nm. Under optimized conditions, 
RP-HPLC method exhibited the wide linear working 
regions with the coefficient value r2 of > 0.9996, and 
the mean recovery value was 99.3 % .
CONCLUSIONS:
The present successfully validated method with 
selectivity, linearity, sensitivity, precision and accuracy 
was applicable for the assay of Dio in bulk drug 
substance an pharmaceutical dosage forms.
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INTRODUCTION:
The use of human chroionic gonadotropin (hCG, a 
glycoprotein hormone) as a performance enhancing 
drug has been prohibited by the World Anti-Doping 
Agency (1). Determination of hCG in urine is 
used to detect illicit use of hCG. In this study, we 
demonstrated a fluorescamine based method which 
includes magnetic separation of hCG.
MATERIALS AND METHODS:
Magnetic nanoparticles were synthesized 
by solvothermal method and modified with 
mercaptoacetic (MAA) acid to induce MOF growth 
onto the nanoparticles. Fe3O4@MAA nanoparticles 
were dispersed in FeCl3.6H2O and then kept 
standing for 15 min. The obtained nanoparticles 
were collected by a magnet and washed with plenty 
of ethanol. Subsequently, the nanoparticles were 
dispersed in benzenetricarboxylic acid, kept stewing 
for half an hour at 70 °C, separated by a magnet and 
washed with ethanol. After repeating for 30 cycles, the 
synthesized nanoparticles were dried under vacuum 
at 200 °C.
The newly synthesized magnetic nanoparticles were 
conjugated with hCG antibodies using EDC/NHS 
activation approach. Then antibody conjugated MNPs 
were used to capture hCG molecules. The captured 
hCG molecules were taken into borate buffer (pH: 
9.0). Finally, fluorescamine solution was added to form 
a fluorescent product with primary amines of proteins. 
Then the fluorescence intensity was measured to 
quantify the hCG molecules.
RESULTS AND CONCLUSIONS:
Analytical performance of the system was investigated 
by examining with different concentration of hCG. 
A linear response (0.9123) was obtained between 
fluorescence intensity and hCG concentration in the 
range of 11 U/L to 10400 U/L. The results indicate that 
the developed fluorometric method can be used in 
quantitative analysis of hCG samples. 
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P-201: NEW SAMPLE PREPARATION 
METHOD FOR ANALYSIS OF POLAR AND 
NON-POLAR METABOLITES 
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INTRODUCTION:
The metabolome is the terminal downstream product 
of the genome and consists of the total complement of 
all the low molecular weight molecules (metabolites) 
in a cell, tissue or organism. Metabolomics aims to 
measure a wide breadth of small molecules in the 
context of physiological stimuli or in disease states 
(1). Metabolomics methodologies fall into two distinct 
groups; untargeted metabolomics, an intended 
comprehensive analysis of all the measurable 
analytes in a sample including chemical unknowns, 
and targeted metabolomics, the measurement of 
defined groups of chemically characterized and 
biochemically annotated metabolites. For untargeted 
metabolomics main goal is to reach maximum number 
of identified metabolites. New sample preparation 
methods, analytical techniques and bioinformatics 
have been developed for this purpose in recent years. 
In this study a new sample preparation method was 
used to separate polar and non-polar metabolites and 
it was proposed for further studies.
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MATERIALS AND METHODS:
Metabolites were separated from other biomolecules 
like lipids and proteins by using extraction.  Methanol/
chloroform/water mixture was used for the extraction 
of polar and non-polar metabolites where ultrafiltration 
system was used for the purification of metabolites 
from lipids. Polar metabolites were dissolved in 
methanol/water phase and non-polar metabolites 
and lipids were dissolved in chloroform phase. Polar 
and non-polar metabolites were analyzed with LC/MS 
and MS data were evaluated by using XCMS data 
processing system.
RESULTS:
249 polar metabolite and 60 non-polar metabolite 
were identified with this method. 
CONCLUSIONS:
New sample preparation method could be used 
for metabolite enrichment and in the futher this 
methodology could be used for clinic samples.  
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INTRODUCTION:
Fatty acid synthase (FASN), which catalyzes the 
synthesis of long-chain fatty acids, is a key protein 
for cell structure. Especially, FASN is very important 
for lipid formation and energy production in cancer 
cells. Therefore FASN expression level is important 
on tumor development (1). In recent years, the 
studies showed that FASN expression level in 
cancer cells was higher than normal cells. FASN has 
been become cancer marker and therapeutic target 
for cancer treatment. FASN inhibitors have been 
evaluated as new anticancer agents for treatment 
of many cancer types. Therefore, determination of 
FASN expression is crucial for monitoring of cancer 
development and developing of new alternative 
cancer treatment methods. In this study UPLC/MS 
method was evaluated to determine FASN in MCF-7 
breast cancer cells. 
MATERIALS AND METHODS:
Proteins of MCF-7 cells, which were isolated with 
methanol/chloroform/water mixture, digested with 
trypsin enzyme. Peptide mixtures were separated 
in C18 UPLC column (2,1x100mm, 1,8μm). Flow 
rate was adjusted at 0,2 mL/min.  A gradient elution 
program was performed for 150 minutes. Water and 
acetonitrile were used as mobile phases. Peptides 
were analyzed with Q-TOF-MS system and recorded 
MS-MS data were matched with in silico data to 
identify peptides and FASN. Label free quantification 
algorithm was also used to observe whether UPLC 
system was suitable for semi quantitative analysis of 
FASN. Protein identification and quantification were 
processed with Maxquant proteomics software.
RESULTS:
12 peptides belonging to FASN were identified with 
three replicates. Identified peptides showed %10,9 
coverage of FASN.  Method reproducibility and 
robustness were evaluated with peptide retention 
times, matching scores, peptide intensity and protein 
intensity. 
CONCLUSIONS:
Easy, robust and reproducible UPLC/MS system 
offered new approach to determine the cancer marker 
and therapeutic target FASN. In the future, UPLC/
MS method could be used for FASN determination in 
tissue and body fluid samples.  
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P-203: PLS AND PCR CALIBRATION 
MODELS FOR SPECTRAL ANALYSIS OF 
ATORVASTATIN AND EZETIMIBE 
Dinc, E., Ertekin, ZC.
Ankara University, Faculty of Pharmacy, Department 
of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
The combination of atorvastatin (AT) and ezetimibe 
(EZ) is mainly used for the treatment of elevated LDL-
cholesterol levels (1). In this study, we aim to develop 
fast and reliable spectrophotometric analysis for the 
concurrent analysis of AT and EZ in tablets. 
MATERIALS AND METHODS:
Standard solutions of AT and EZ were prepared 
between of 4.0-36.0 µg/mL. Absorbance spectra of 
the solutions were recorded between 200-350 nm. 
Classical least squares was unable to quantify AT 
and EZ in their combination due to their overlapping 
spectra. Partial least squares (PLS) and principle 
component regression (PCR) calibrations were 
constructed using the actual concentration values 
and absorbance data (2). As can be seen in Figure 1, 
the number of components were found as 2 for both 
drugs in both models.
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Figure 1. Estimated mean squared prediction error values for (a) PLS 
and (b) PCR models
The coefficients of the regression between the actual 
and predicted concentrations of PLS and PCR 
models were reported to be greater than 0.99991 for 
both drugs. The proposed methods were validated 
by analyzing synthetic binary mixtures, intra-day and 
inter-day samples, and standard addition samples. 
Then, they applied to the analysis of commercial 
samples containing 10 mg EZ and 10 mg AT per 
tablet.
RESULTS:
The validation studies were found to be satisfactory for 
both PLS and PCR models. The proposed methods 
were successfully applied to the analysis of tablets.
CONCLUSIONS:
The proposed PLS and PCR calibration models were 
suitable for the quality control and routine analysis 
of tablets containing AT and EZ without the use of a 
preliminary separation step.
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P-204: SIMULTANEOUS DETERMINATION 
OF ATENOLOL AND CHLORTHALIDONE IN 
TABLETS BY PLS AND PCR METHODS
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INTRODUCTION:
The combination of atenolol (ATE) and chlorthalidone 
(CHL) is commonly used for the treatment of 
hypertension. The purpose of this study was to 
develop a simple and low-cost analysis method for 
the concurrent analysis of ATE and CHL in a tablet 
formulation.
MATERIALS AND METHODS:
A classical spectrophotometric calibration curve for 
ATE and CHL was not possible to obtain because 
of the overlapping spectra of the mentioned drug. 
In this study, we used two standard chemometric 
techniques, partial least squares (PLS) and principle 
component regression (PCR) in order to quantify ATE 
and CHL in their mixtures (1). 
A calibration set of 25 binary mixtures containing ATE 
and CHL in the working range of 6-30 µg/mL and 4-16 
µg/mL was prepared and their UV absorbance spectra 
were recorded between 200-3 nm. PLS and PCR 
algorithms were applied to nominal concentration and 
absorbance data of the concentration set. Recovery 
studies were performed by analyzing 12 laboratory-
made mixtures of ATE and CHL, using the constructed 
calibration equations. Standard addition, inter-day 
and intra-day studies were also performed in order to 
evaluate the validity of the methods. 
RESULTS:
The proposed PLS and PCR methods were applied 
to the analysis of pharmaceutical preparations 
containing 100 mg ATE and 25 mg CHL per tablet. 
The assay results of PLS were reported as 99.41 mg 
and 25.60 mg, and PCR results were reported as 
99.61 mg and 25.66 mg per tablet for ATE and CHL, 
respectively. 
CONCLUSIONS:
PLS and PCR methods proposed in this study were 
successfully used for the simultaneous determination 
of ATE and CHL in tablets without the need of any 
separation step.
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P-205: LC-MS/MS METHOD FOR THE 
DETERMINATION OF OXCARBAZEPINE 
IN RAT PLASMA AND BRAIN 
MICRODIALYSATE
1 Sener, E., 1 Dogrukol Ak, D., 2 Korkmaz, OT.
1Anadolu University, Faculty of Pharmacy, 
Department of Analytical Chemistry, Eskişehir, Turkey
2Osmangazi University, Faculty of Medicine, 
Department of Physiology, Eskişehir, Turkey
INTRODUCTION:
A fast, specific and highly sensitive liquid 
chromatography tandem mass spectrometry 
(LCMS/MS) method for the direct determination of 
oxcarbazepine which is an anti-epileptic compound 
in rat plasma and brain microdialysate has been 
developed and validated.
MATERIALS AND METHODS:
The analysis was performed on a Supelco Ascentis 
Express C18 (100x2.1 mm, 2.7 μm particle) core shell 
column using a binary gradient elution with the mobile 
phases consisting of acetonitrile and ammonium 
formate buffer (10 mM). Ionization of the compound 
was achieved by electrospray ionization (ESI) in 
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positive ion mode. Signals of the compound were 
monitored under the multiple reaction monitoring 
(MRM) for quantification. The brain microdialysates 
and the blood samples were collected simultaneously 
after intraperitoneal injection of the compound (50 
mg.kg-1) during 12 hours from freely moving rats. 
Plasma samples were analyzed after simple two-step 
protein precipitation using with MeOH after sampling 
from rat and 10% perchloric acid before analysis, 
however clean-up for microdialysis samples was not 
necessary, enabling direct injection of the samples 
into the LC-MS/MS system.
RESULTS:
The precursor to product ion transition of m/z 253 
> m/z 179.8 was used to measure concentrations 
of oxcarbazepine with a retention time of 6.2 min. 
The method was validated in both plasma and 
microdialysate samples and the obtained lower 
limit of quantification (LLOQ) was 0.1 ng.mL-1 for 
oxcarbazepine in both matrices. The intra- and inter- 
day assay variability was less than 15 % for both 
analytes.
CONCLUSIONS:
The proposed LC-MS/MS method provided simple 
sampling, rapid clean-up and short analysis 
time (<6.5 min), and is applicable to the routine 
therapeutic monitoring and pharmacokinetic studies 
of oxcarbazepine.
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INTRODUCTION:
A fast, specific and highly sensitive liquid 
chromatography tandem mass spectrometry (LC-MS/
MS) method for the direct determination of topiramate 
which is a polar anti-epileptic compound in rat plasma 
and brain microdialysate has been developed and 
validated.
MATERIALS AND METHODS:
The analysis was performed on a Supelco Ascentis 
Express C18 (100x2.1 mm, 2.7 μm particle) core shell 
column using a binary gradient elution with the mobile 
phases consisting of acetonitrile and ammonium 
formate buffer (10 mM). Ionization of the compound 
was achieved by electrospray ionization (ESI) in 
negative ion mode. Signals of the compound were 
monitored under the multiple reaction monitoring 
(MRM) for quantification. The brain microdialysates 
and the blood samples were collected simultaneously 
after intraperitoneal injection of  the compound (50 
mg.kg-1) during 12 hours from freely moving rats. 
Plasma samples were analyzed after simple two-step 
protein precipitation using with MeOH after sampling 
from rat and 10% perchloric acid before analysis, 
however clean-up for microdialysis samples was not 
necessary, enabling direct injection of the samples 
into the LC-MS/MS system.
RESULTS:
The precursor to product ion transition of m/z 388 
> m/z 77.6 was used to measure concentrations of 
topiramate with a retention time of 6.4 min. The method 
was validated in both plasma and microdialysate 
samples and the obtained lower limit of quantification 
(LLOQ) was 2.0 ng.mL-1 for topiramate in both 
matrices. The intra- and inter-day assay variabilities 
were less than 15 % for both analytes.
CONCLUSIONS:
The proposed LC-MS/MS method provided simple 
sampling, rapid clean-up and short analysis time 
(<7 min), and is applicable to the routine therapeutic 
monitoring and pharmacokinetic studies of topiramate.
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INTRODUCTION:
Isoquinolines, the largest group of alkaloids, have 
been found to exhibit interesting pharmacological 
and/or biological properties.  Berberine, stylopine, 
isocorydine and glaucine, the isoquinoline alkaloids 
distributed in some genus of Papaveraceae, 
Magnoliaceae, Rutaceae, Ranunculaceae, 
Annonaceae, Berberidaceae, Menispermaceae are 
extensively investigated due to their therapeutic 
actions (1). Berberine is one of the most studied 
among the protoberberine alkaloids with multiple 
biological activities such as antiinflammatory, 
antiplatelet, antimicrobial, cytotoxic, vasorelexant and 
hypotensive effect (2). Stylopine, isocorydine and 
glaucine are major component of various medicinal 
plants, they have been reported to important 
pharmacological effects including anti-inflammatory, 
antipsychotic, neuroleptic, sedative, antitussive and 
anticancer activity.
Due to their bioactivity and wide potential applications, 
a number of analytical methods including liquid and gas 
chromatography, mass spectrometry, fluorescence 
have been reported for the determination of these 
alkoloids (3). Although chromatographic methods are 
sensitive and reliable, they have some disadvantages 
such as being time and labor consuming, expensive, 
require sample pretreatment and qualified personnel. 
Electroanalytical methods, which can offer high 
sensitivity, rapid response, easy operation and low 
cost detection.
MATERIALS AND METHODS:
MWCNT’s were modified with pencil graphite 
electrode surfaces. SWV voltammetry was used for 
detect the electrochemical behaviours of berberine, 
isocorydine, protopine and glaucine. These alkaloids 
were spiked into human serum and urine samples. 
And SWV responses were evalutaed before and after 
spiked.
RESULTS:
Figure: SWV voltammograms obtained from, berberine, isocorydine, 
protopine and glaucine at MWCNT/PGE surfaces.
CONCLUSIONS:
In this study, MWCNTs enhanced graphite sensor 
surfaces were used for direct electrochemical 
detection of isoquinoline alkoloids including berberine, 
isocorydine, protopine and glaucine for the first 
time. Investigation of electrochemical behaviours of 
these alkoloids in human serum and urine samples 
were also evaluated devoted to pharmaceutical 
applications.
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P- 208: VOLTAMMETRIC DETERMINATION 
OF EPHEDRINE ON POLY (NILE BLUE) 
MODIFIED GLASSY CARBON ELECTRODE 
IN PHARMACEUTICAL DOSAGE FORMS 
AND URINE SAMPLES
Agin, F., Ozturk, G., Kul, D.
Karadeniz Technical University, Faculty of Pharmacy, 
Department of Analytical Chemistry,  Trabzon, Turkey
INTRODUCTION:
Ephedrine, is a naturally occurring sympathomimetic 
drug derived from the botanical plant Ephedra. 
Its principal mechanism of action relies on its 
indirect action on the adrenergic receptor system. 
Ephedrine was used as a drug in the treatment of 
asthma, allergic states, catalepsy and myasthenia 
gravis; to raise the arterial pressure; as nasal 
decongestive; as an antidote for poisoning by central 
nervous system depressants and in spinal anesthesia. 
Ephedrine was included in the doping list published by 
the International Olympic Committee (1). Therefore, 
monitoring ephedrine levels is a very important in 
both urine samples and pharmaceutical formulations. 
For this reason, the modified electrode was prepared 
for voltammetric determination of ephedrine. 
MATERIALS AND METHODS:
A three-electrode electrochemical cell was used for the 
experiments. It contained a (BAS, ɸ: 3 mm diameter) 
as working electrode, a platinum wire as counter 
electrode and Ag/AgCl electrode as reference. All 
measurements by cyclic voltammetry and differential 
pulse voltammetry were performed using a computer-
controlled Autolab potentiostat/galvanostat with Nova 
10.0 software (Metrohm-Autolab, The Netherlands).
 RESULTS:
The modified electrode was prepared 
electropolymerisation of monomer Nile blue (NB). The 
electropolymerisation of monomer NB on the surface 
of the GCE was carried out in 0.1 M phosphate buffer 
solution, at pH 6.0 containing 0.5 mM NB monomer 
by cyclic voltammetry (2). The electrochemical 
behavior of ephedrine was investigated using cyclic 
and differential voltammetry poly(NB) modified glassy 
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carbon electrode at different pH values between 5.0-
9.0. A diffusion-controlled irreversible oxidation peak 
was observed in cyclic voltammetry for ephedrine. 
Quantitative determination of ephedrine was carried 
out at poly(NB) modified glassy carbon electrode 
using differential pulse voltammetry in 0.04 M Britton-
Robinson buffer at pH 9.0. The peak current showed 
a linear dependence with concentration in the range 
of 0.6-100 µM with 0.00291 µM limit of detection for 
differential pulse voltammetry. 
CONCLUSIONS:
Simple, selective, sensitive, fully validated, rapid, 
reliable, differential pulse voltammetry and poly(NB) 
modified glassy carbon electrode  was used for 
the voltammetric determination of ephedrine in 
human urine and pharmaceutical formulations. No 
electroactive interferences from the pharmaceutical 
dosage forms excipients were found.
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P-209: ELECTROANALYTICAL 
DETERMINATION OF NIMESULIDE USING 
MULTIWALLED CARBON NANOTUBES 
MODIFIED CARBON PASTE ELECTRODE
Agin, F., Serdaroglu, V.
Karadeniz Technical University, Faculty of Pharmacy, 
Department of Analytical Chemistry, Trabzon, Turkey
INTRODUCTION:
Nimesulide is a new non-steroidal anti-inflammatory 
drug that is selective for cyclooxygenase-2 and 
effective in reducing the pain which is associated with 
rheumatoid arthritis and osteoarthritis (1).
Applications of carbon nanotubes as electrode 
materials or modifiers of conventional working 
electrodes in analytical chemistry can be found in 
the literature, because of a lower over potential 
and higher peak currents are observed in the 
voltammetric response at electrodes modified (2). In 
this study, a sensitive multiwalled carbon nanotubes 
modified carbon paste electrode was prepared 
for electroanalytical determination and it used to 
investigate electro-oxidative behavior of nimesulide 
with cyclic and differential pulse voltammetry.
MATERIALS AND METHODS:
A three-electrode electrochemical cell was used 
for the experiments. It contained a carbon paste 
electrode (BAS, ɸ: 3 mm diameter) as working 
electrode, a platinium wire as counter electrode and 
Ag/AgCl electrode as reference. All measurements by 
cyclic voltammetry and differential pulse voltammetry 
were performed using a computer-controlled Autolab 
potentiostat/galvanostat with Nova 10.0 software 
(Metrohm-Autolab, The Netherlands).  
RESULTS:
The voltammetric behavior and determination of 
nimesulide was investigated by cyclic voltammetry 
and differential pulse voltammetry on multiwalled 
carbon nanotubes modified carbon paste electrode in 
various buffer solutions at different pH values between 
2.0 and 8.0. The oxidation process of nimesulide 
exhibited irreversible and diffusion-controlled behavior 
in cyclic voltammetry. The best peak shape with peak 
current of nimesulide for quantitative determination 
were obtained in 0.1 M phosphate buffer solution at 
pH 5.0.  The multiwalled carbon nanotubes modified 
carbon paste electrode showed linearity in the 
range from 0.06 and 10 μM of nimesulide with limit 
of detection 1.07×10-3 µM and limit of quantification 
3.24×10-3 µM by differential pulse voltammetry.
CONCLUSIONS:
Carbon paste electrode was modified with multiwalled 
carbon nanotubes and optimized for nimesulide. 
The prepared modified carbon paste electrode was 
used electroanalytical determination of nimesulide 
cyclic voltammetry and differential pulse voltammetry. 
The multiwalled carbon nanotubes modified carbon 
paste electrode for electroanalytical determination 
of nimesulide using differential pulse voltammetry 
was carried out highly selectively, simply and stably 
from pharmaceutical dosage forms and human serum 
samples.
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INTRODUCTION:
Hypertension is a complex disease, with numerous 
cardiovascular complications. The combination of 
amlodipine  (AML) and atorvastatin (ATR)  are used 
hypertension and dyslipidemia. Up to now, there is no 
official method for the determination of binary mixture 
of AML and ATR in any national pharmacopoeia. 
Novel spectrophotometric techniques were presented 
as useful alternatives for determination of AML and 
ATR in their binary mixtures.
METHODS:
The absorption spectra of AML and ATR show 
highly overlapped spectra. The  constant center 
spectrophotometric technique was applied for the 
determination of AML and ATR  without any pre-
separation process. first derivative spectra ratio 
spectrophotometry is used solutions of standard and 
samples in methanol.
RESULTS:
 The amplitudes 236.17 , 275.0 ,  284.0 and 310.0 
nm wavelengths were selected to  determine of 
AML and ATR in binary mixture, respectively by the 
constant center  spectrophotometric technique. The 
determination of AML, and ATR in  (AML+ATR)  binary 
mixtures   could  be  done  using   the  following 
equations : y= 0.9105 x- 0.4177 (r2 : 0.9999)  for ATR 
; and     y=0.09243 x-0.0401 (r2 : 0.9999)   for AML, 
respectively.    The drugs obey Beer’s Lambert law in 
the linear ranges are 5.0-35.0 ug/mL  and 3.0-30.0 
ug/mL for AML and ATR, respectively. The results of 
the assay were found to be 99.96 ± 0.96 for AML  and 
100.48 ± 1.14 for ATR.
CONCLUSION:
This validated  technique is potentially useful for a 
routine laboratory analysis.The presented method 
was found to be simple, precise and accurate  which 
can be directly and easily applied to the determination 
of pharmaceutical dosage forms. 
P-213: VOLTAMMETRIC DETERMINATION 
OF CETIRIZINE IN PHARMACEUTICALS BY 
DIFFERENTIAL PULSE AND SQUARE WAVE 
VOLTAMMETRIC METHODS
Sofu, U., Ifsat, ZD., Ozturk, G., Kul, D.
Karadeniz Technical University, Faculty of Pharmacy, 
Department of Analytical Chemistry, Trabzon, Turkey
INTRODUCTION:
Cetirizine, (±)-[2-[4-[(4-chlorophenyl)phenylmethyl]-
1-piperazinyl]ethoxy]acetic acid dihydrochloride, is 
one of the first second-generation H1 antihistamines 
developed to provide selective H1 receptor inhibition 
without central nervous system depression (1, 2). 
It is used for the symptomatic treatment of allergic 
conditions including allergic rhinites, chronic urticaria, 
and another allergic disorders (3). The aim of this 
work is to establish a method for the determination 
of cetirizine using modified glassy carbon electrodes.
MATERIALS AND METHODS:
All electrochemical experiments were performed with 
a three-electrode system including modified glassy 
carbon electrode as a working electrode, an Ag/AgCl 
as reference electrode and a platinum wire as counter 
electrode. Stock solutions of cetirizine (1x10-3 M) 
were prepared with doubly-distilled water. Phosphate 
buffer, Britton Robinson buffer and acetate buffer 
solutions at different pH values were prepared.
RESULTS:
Voltammetric methods were used for the determination 
of cetirizine in pharmaceuticals. For this purpose, 
modified glassy carbon electrodes were prepared 
according to the previous report (4). The effect of 
supporting electrolyte and voltammetric parameters 
were investigated. The optimum conditions were 
obtained in acetate buffer at pH 4.5. A well-defined 
peak was observed for cetirizine at about 0.9 V for 
both voltammetric methods. The linear response 
ranges for the determination of cetirizine were 0.4-
100 µM and 0.2-100 µM with the detection limits 
of 2.70 nM and 5.80 nM for differential pulse and 
square wave voltammetry, respectively. The proposed 
methods were used to determine the cetirizine 
content of commercial tablets and satisfactory results 
were obtained.
CONCLUSIONS:
We have described sensitive, simple, rapid and 
selective voltammetric methods for the analysis of 
cetirizine in its pharmaceutical formulation.
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INTRODUCTION:
Specific molecular recognition is a key feature 
of biological processes. In order to substitute 
biomacromolecules by “biomimetic recognition 
elements”, fully synthetic receptors so-called 
molecularly imprinted polymers (MIPs) have been 
developed. Molecular imprinting is a method, 
pioneered by Wulff and Mosbach to create so-
called plastic antibodies or plastibodies by the 
polymerization of functional monomers with or 
without cross-linkers in the presence of target analyte 
(template)(1,2). Subsequent removal of the template 
leads to the formation of binding cavities, which 
mimics size, shape, and functionality of the template. 
Although MIPs for low molecular-weight substances 
have been successfully prepared, it is still challenging 
for biomacromolecules like proteins. This is reflected 
by the annual number of publications for protein-
MIPs, which is only 10 % including enzymes. The 
aim of the work is to prepare MIP-based sensors for 
the diagnostically relevant Butyrylcholine esterase 
(BuChE).
MATERIALS AND METHODS:
The o-phenylenediamine (o-PD) films were prepared 
by the electropolymerization of the o-PD monomer in 
the absence or in the presence of a BuChE Template 
molecules were removed by incubation in NaOH. All 
the steps of the MIP preparation were characterized 
by cyclic voltammetry and amperometry. 
RESULTS:
The anodic current for the oxidation of thiocholine, 
which reflects the activity of the BuChE bound to 
the MIP increased almost linearly in the picomolar 
concentration range and did not approach saturation 
up to 2 nM. In the semilogarithmic plot saturation 
seems to be reached at 2 nM. On the other hand, 
for the MIP the signal were almost identical after 
electropolymerization, template removal and 
rebinding. 
CONCLUSIONS:
A new electrochemical sensor based on a molecularly 
imprinted polymer has been developed for the 
detection of BuChE based on electropolymerization. 
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INVESTIGATION OF ENTACAPONE USING 
NH2 FUNCTIONALIZED MULTI WALLED 
CARBON NANOTUBES MODIFIED 
NANOSENSOR
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INTRODUCTION:
Entacapone (ENP), is a selective, reversible catechol-
O-methyl transferase inhibitor for the treatment of 
Parkinson’s disease. It is a member of the class of 
nitrocatechols. When administered concomitantly 
with levodopa and a decarboxylase inhibitor 
(e.g., carbidopa), increased and more sustained 
plasma levodopa concentrations are reached as 
compared to the administration of levodopa and 
a decarboxylase inhibitor. Nanomaterials such as 
carbon based nanomaterials; (graphene, fullerene, 
carbon nanotubes, carbon nanofibers etc.), metal 
oxide nanoparticles, metal nanoparticles (gold, silver, 
platinum etc.), play important role in electrochemical 
determination of many drugs (1). In this study, 
electrochemical investigation of Entacapone using 
NH2 functionalized multi walled carbon nanotubes 
(NH2MWCNT) modified nanosensor was achieved.
MATERIALS AND METHODS:
NH2MWCNT (1mg/mL) suspension was prepared in 
dimethylformamide. A stock solution of 1.0×10−3 ENP 
was prepared with methanol. 20% (v/v) methanol 
percent was kept as constant in all pH values and 
buffers to avoid the solubility problems. Different 
amount of 1mg/mL NH2MWCNT was carefully 
dropped on the surface of pre-cleaned glassy carbon 
electrode (GCE). Then modified GCE was allowed 
to dry in vacuum oven at temperature of 45 ͦ C. 
NH2MWCNT/GCE electrode was thus obtained.
RESULTS:
NH2MWCNT was used as a recognition layer over 
the surface of GCE for the sensitive electroanalytical 
detection of antiparkinson drug Entacapone. The 
conditions were optimized for the getting intense 
electrochemical signals of the ENP. Surface 
morphology of the NH2MWCNT/GCE is assessed 
by SEM armed with EDX analysis. Analysis was 
made while imaging at different parts and at different 
resolutions. Electrochemical impedance spectroscopy 
(EIS) was used to investigate the electron transfer 
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capability of modified and bare electrodes with 
reference to 5.0 mM [Fe(CN)6]3-/4- and 0.1 M KCl 
redox couple system. Interfacial electron resistance 
can be changed during the electrode modification 
process. Cyclic voltammetry technique was 
successfully used to compare the redox response 
of ENP on the surface of modified and unmodified 
electrode. The electrochemical response of ENP was 
studied in 0.5M H2SO4 for modified and unmodified 
GCE with scan rate of 100mV/s. ENP shows an 
oxidation peak around 0.693 V and a reduction peak 
around 0.369 V for both electrodes.
CONCLUSIONS:
 Generally, the electrocatalytic property of any catalytic 
material is judged by the electrochemical response, 
and if it facilitates an electron transfer process then 
the peak current. In this study, electrochemical 
investigation of Entacapone using NH2MWCNT/GCE 
is achieved. The influence of interfering agents was 
also studied to examine the selectivity of designed 
sensors because selectivity is one of the most 
important point to judge the reliability of a sensor 
for practical applications. For the purpose of the 
practical applicability of the proposed method, DPV 
method was effectively applied for the investigation of 
ENP in tablet, human serum and urine. Recoveries 
obtained for tablet, serum and urine samples were 
acceptable with RSD values less than 2% for all the 
samples with excellent recovery percentage close 
to 100%, thus, suggesting that NH2MWCNT/GCE 
has promising applicability and would be useful 
electrochemical sensor for quantitative analysis of 
ENP in pharmaceutical dosage and real samples.
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P-216: NOVEL “TURN OFF-ON” SENSORS 
FOR DETECTION OF DNA-ACRYLAMIDE 
INTERACTION USING ZNS QUANTUM DOTS 
AS A PHOSPHORESCENT PROBE
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INTRODUCTION:
A novel “Turn off-on” sensor for detection of interaction 
between deoxyribonucleic acid (DNA) and Acrylamide 
(ACR) was developed.
MATERIALS AND METHODS:
In this method L-cysteine capped Mn doped 
ZnS quantum dots (QDs) were used as a room 
temperature phosphorescent probe. At the turn-off 
mode, ACR absorbed into the surface of QDs via 
electrostatic interaction which caused quenching 
effect of RTP signal by photo induced electron-
transfer (PIET) mechanism. However, ACR removed 
from the QDs surface with the addition of DNA. Thus, 
the phosphorescence emission of QDs was recovered 
and the system consequently was rendered into ‘‘turn-
on’’ mode.
RESULTS:
The quenching mechanism of QDs by ACR was 
collisional (dynamic) and quenching constant, binding 
constant, and binding site number were calculated as 
3.2 × 104 M-1, 2.04 × 104 M-1, and 1.2, respectively. 
Besides, absorption spectrometric method was 
used to evaluate ACR-DNA interaction and binding 
constant (K) was found as 2.4 × 105 M-1.
CONCLUSIONS:
The developed this kind of biosensor is simple, free 
from the interferences coming from autofluorescence 
and scattering light, does not need any derivatization 
step and sample pretreatment. Thus, this biosensor 
can be used for the DNA analysis in the biological 
samples.
P-217: INVESTIGATION OF 
CHROMATOGRAPHIC BEHAVIOUR OF 
CLASS III ANTIARRHYTHMIC AGENT IN 
ACETONITRILE-WATER BINARY MIXTURES 
Konce, I., Ortak, H., Daldal, YD., Nane, ID., Cubuk 
Demiralay, E., Alsancak, G.
Süleyman Demirel University, Faculty of Science and 
Literature, Department of Chemistry, 32260 Isparta, 
Turkey
INTRODUCTION:
Dofetilide is a sulfonamide class III antiarrhythmic 
agent and potassium channel blocker (Figure 1). 
Unlike other antiarrhythmic agents, oral dofetilide 
did not increase mortality in patients with a recent 
myocardial infarction or congestive heart failure. The 
available literature was scanned thoroughly, there was 
no reported methods for chromatographic behavior 
of dofetilide. In this study, method was preferred to 
investigate the retention behavior of dofetilide. The 
influence of eluent pH on the retention behavior of 
dofetilide was explored and the pKa values of this 
compound were determined. On the other hand, this 
study investigates on use of different percentages of 
acetonitrile-water binary mixtures and extrapolation to 
100% water.
Figure 1. Structure of dofetilide
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MATERIALS AND METHODS:
This study was performed at biorelevant temperature 
(37 0C) with Kinetex Core-Shell EVO C18 (5 μm, 
250×4.6 mm) column. In this study, mobile phases 
used were different proportions of acetonitrile ranging 
from 20 to 30% (v/v). The pH of the mobile phase 
containing 30 mM o-phosphoric acid was adjusted by 
adding 1 M sodium hydroxide.
RESULTS:
The pKa values together with the tRHA and tRA from 
tR/pH data were calculated by using the nonlinear 
least squares fitting. The logtRHA is the retention time 
of the neutral form of the solute. The logtR values 
at different mobile phase sspH were calculated by 
considering the ionization of the solute. Based on the 
initial estimate, the predicted logtR was computed 
again and the best fit was obtained by minimizing 
the sum of squares of residual. The results show that 
better fit is clearly obtained by using nonlinear least 
squares curve fitting approach. 
CONCLUSIONS:
This work represents the first study dealing with the 
chromatographic determination of pKa values of 
dofetilide at different proportions of acetonitrile-water 
binary mixtures.
ACKNOWLEDGEMENTS:
This study was supported by a grant of TUBITAK 
(116Z837).
P-218: OPTIMIZATION AND VALIDATION 
OF VALPROIC ACID BY REVERSED PHASE 
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INTRODUCTION:
Valproic acid (2-propylpentanoic acid) is a simple 
eight carbon branched-chain fatty acid with unique 
anticonvulsant properties against several types of 
epileptic seizures. Due to the widespread use of 
Valproic acid as an antiepileptic drug, there is no 
specific methods for the determination of this drug. 
In this study, simple, efficient and selective reversed 
phase liquid chromatography (RPLC) method has 
been developed for the determination of Valproic 
acid in tablet formulation. The aim of this study was 
to identify the optimum separation condition and 
the retention factor for Valproic acid based on a 
relationship between mobile phase pH and retention 
factors (1<k<10).
MATERIALS AND METHODS:
Column used was with flow rate of 1 mL min-1using 
UV visible detector for Valproic acid at 215 nm. The 
UV detector was operated at 210 nm for Oxacillin as 
internal standard. Experiments were performed with 
a commercially available column (Restek Pinnacle 
DB cyano, 250 x4,6 mm,5µm). All procedures were 
carried out at 298 K.
RESULTS:
The variation of retention factors at different pH values 
of the mobile phase is presented in Figure 1. The 
inflexion points of the curve specify the pKa value.
Figure 1. Dependence of retention factor values of Valproic acid on 
the pH of the mobile phase (20%MeOH v/v).
The described method was linear over a concentration 
range of 200-600 µgmL-1 for the assay of Valproic 
acid. LOD and LOQ values for studied compound 
were found to be 33.60 and 101.81 µgmL-1, 
respectively. Mean of recovery values for Valproic 
acid was 99.40%. The results obtained showed a 
good agreement with the declared content. 
CONCLUSIONS:
No references have been found for optimization study 
using chromatographic behavior of Valproic acid in 
pharmaceutical formulation. The difference of this 
study, combined effect of methanol content and pH of 
the mobile phase on the retention behavior of Valproic 
acid was used. The results obtained are of practical 
importance in the determination of Valproic acid by 
RPLC, and also are generally useful prediction of 
effects of pH of mobile phase.
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NTRODUCTION:
In order to understand the reasons of a dual behavior 
of polysaccharide-based chiral stationary phases and 
the role of hydrogen-bonding and of hydrophobic 
interactions in analyte retention and chiral recognition 
with these materials, the gradual transition from 
polar-organic to aqueous-organic mobile phases 
was investigated with chiral weak acids as test 
compounds. Special attention was paid to changes in 
enantiomer elution order. 
MATERIALS AND METHODS:
Enantioseparation of chiral weak acids, such 
as acenocoumarol, benzobamyl, carprofen, 
2-(3-chlorophenoxy)-propionic acid, coumachlor, 
coumatetralyl, difenacoum, fenoprofen, flurbiprofen, 
halonal, hexobarbital, ibuprofen, indoprofen, 
ketoprofen, ketorolac, mandelic acid, mandelic acid 
ethylester, naproxen, Nembutal, 2-phenoxypropionic 
acid, pyranocoumarin, proglumide, suprofen, 
sulindac, warfarin, zaltoprofen, was studied by using 
chiral columns Lux Amylose-1, Lux Amylose-2, Lux 
Cellulose-1, Lux Cellulose-2, Lux Cellulose-3, Lux 
Cellulose-4 and chiral column prepared with cellulose 
tris(3,5-dichlorophenylcarbamate) covalently 
immobilized on silica in combination with pure polar 
organic and aqueous-organic mobile phases in high-
performance liquid chromatography.
RESULTS:
In the present study additional examples of 
non-reversed-phase behavior are described in 
enantioseparations for the first time for weak acidic 
chiral analytes. In addition, the reversal of enantiomer 
elution order was observed again for the first time for 
several analytes based on water-content in the mobile 
phase.
CONCLUSIONS:
The results represented allow for drawing the 
following Conclusions:
(1) polysaccharide-based chiral columns when used 
with aqueous-organic mobile phase may not always 
behave like typical reversed-phase chromatographic 
systems; this is especially true at low content of 
water (<20% v/v) in acetonitrile. (2) When the 
hydrogen-bonding interactions-based affinity pattern 
of enantiomers towards a chiral selector is opposite 
to that based on hydrophobic-type interactions, a 
reversal of enantiomer elution order may be observed 
based on the content of water in the mobile phase; 
this phenomenon seems to be more common in 
aprotic solvent-water systems than in protic solvent-
water systems. Detailed studies on the effect of 
water addition to organic mobile phase may provide 
useful information for better understanding of chiral 
recognition mechanisms with polysaccharide-based 
chiral selectors.
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INTRODUCTION:
Antioxidants are the most important species and 
the play a major role in the protecting biological 
systems against many diseases. Over the last few 
years, reasonable supplementations of antioxidants 
have been widely practiced in different fields of 
industry and medicine to prevent and delay oxidative 
stress (1). Antioxidants can inhibit or stop oxidation 
reactions promoted by free radicals, which are 
related to DNA degradation, membrane peroxidation 
and protein denaturation. The reactions promoted 
by the free radicals lead to the aging process and 
are also responsible for the occurrence of many 
diseases such as cancer, diabetes, neurological 
problems, as well as cardiovascular problems (2). 
1,4-Dihydropyridines (1,4-DHPs) are well known as 
calcium channel modulators. 1,4-DHPs are the most 
feasible heterocyclic ring with various substitutions 
at several positions. The present paper is aimed at 
studying the electrochemical behavior of the 1,4 
DHPs by differential pulse voltammetry and hence 
the assessment of its antioxidant activity from the 
cathodic reduction peak of oxygen values. 
MATERIALS AND METHODS:
All experiments were performed using a Gamry 
Reference 600 model (Gamry Instruments, PA, 
USA) potentiostat/galvanostat. A three-electrode 
system which consisted of disposable pencil graphite 
electrode (PGE) as working electrode, a Ag/AgCl 
electrode with saturated 3 M KCl as reference 
electrode and a platinum wire as counter electrode 
were used. 0.1 M of tetrabutylammonium iodide salt 
in 3 mL of dichloromethane solvent was used. The 
voltammograms were recorded in the conditions 
of potential range from 0.0 V to -2.0 V vs. Ag/AgCl 
reference electrode.
RESULTS:
The peak current of oxygen reduction was found to 
be directly proportional to the 1,4 DHPs concentration 
in the range of 0.1 - 0.5 mg/mL. The oxygen peak 
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currents were linearly decreased with increasing 
concentration of 1,4 DHPs. The coefficient of 
antioxidant activity (K) of 1,4 DHPs were calculated. 
CONCLUSIONS:
Antioxidant properties of the 1,4 DHPs derivative 
were compared each other.
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INTRODUCTION:
Transition metal oxides have display unique 
electrocatalytic properties and display strong 
interactions with noble metal nanoparticles. Pulsed 
Deposition (PD) provides a high dispersion of 
the metallic NPs compared to other methods (1). 
Genosensor technology promises a real time, label 
free, sensitive and rapid approach for mutation 
detections as an alternative to conventional methods 
in microbiological analysis (2). 
Genosensors, based on electrochemical transduction 
of hybridization, have great importance for the 
detection of pathogen microorganisms, viruses, point 
mutations in medical applications (3). Such devices 
couple the high specificity of DNA hybridization 
reactions with the high sensitivity, low cost and 
portability of electrochemical transducers (4). Present 
study describes a novel platform for the genosensing 
applications depending on AuNP dispersed on 
transition metal oxides film at a pencil graphite 
electrode (PGE).
MATERIALS AND METHODS:
The PGE/MeOx/Au electrode was prepared by PD 
technique where the potential was set at −0.25 V 
for 5 s and then 1.0 V for 5 s, sequentially for 100 
times. Then, the electrode was immersed in Au3+ 
solution and a similar procedure was applied for 20 
cycles. dsDNA was immobilized onto PGE/MeOx/Au 
surfaces via both adsorption and covalent attachment. 
The binding of DNA onto PGE/MeOx/Au surfaces 
were monitored by electrochemical impedance 
spectrometric (EIS) transduction of the Rct in the 
presence of 5mM [Fe(CN)6]3-/4-. 
RESULTS:
Designed nanogenosensor was performed by 
evaluating the changes in EIS responses obtained 
before and after dsDNA immobilized onto, bare, MeOX 
and MeOx/Au modified surfaces. From the impedance 
spectra, high charge transfer resistances of PGE/
MeOx has shown a sharp decrease after depositing 
AuNPs onto the surface and this electrode has shown 
a  significant increase after DNA immobilization. 
CONCLUSIONS:
This novel electrochemical approach offered a label 
free, highly sensitive genosensing, with capable of a 
reliable method for the clinical applications. 
REFERENCES:
1.  Ozdokur et al., (2016). Sensors and Actuators B, 
237:291–297.
2.  Garcia et al., (2012). Sensors and Actuators B: 
Chemical, 161:1030-1037.
3.  Kara et al., (2016). J. of Electrochemical Society, 
163: 293 -299.
4.  Subak H, Ozkan Arıksoysal D (2018). Sensors 
and Actuators B: Chemical, 263:196 -207.
P-222: ELECTROCHEMICAL 
INVESTIGATION OF ELETRIPTAN USING 
GO/PT/IR BASED NANOSENSOR
1 Kaya, SI., 2 Demirkan, B., 1 Kurbanoglu, S., 2 
Kuyuldar, E., 2 Sen, F., 1 Ozkan, SA.
1Ankara University, Faculty of Pharmacy, Department 
of Analytical Chemistry, Ankara, Turkey
2Dumlupinar University, Faculty of Art and Science, 
Department of Biochemistry, Sen Research Group, 
Kutahya, Turkey
INTRODUCTION:
Eletriptan (ELE) which is chemically designated 
as (R)-3-[(1-methyl-2- pyrrolidinyl)methyl]-5-[2-
(phenylsulfonyl)ethyl]-1H-indole is a member of 
drug class named triptans that are used for migraine 
treatment. ELE is a selective 5-hydroxytryptamine 
(5-HT1B/1D) receptor agonist and highly effective 
for relieving or reducing severeness of migraine 
headaches. Graphene which is an allotrope form of 
carbon has hexagonal configuration of sp2 hybridized 
carbon atoms. Due to its great ability to promote 
electron transfer, great catalytic behavior toward 
small compounds and high surface area; graphene 
is widely used in electrochemical sensing. Graphene 
oxide (GO) has a similar structure to graphene but the 
layers of GO have oxygen-containing groups. Metal 
nanoparticles, such as gold, platinum, palladium, are 
materials which have sizes ranging from 1 to 50 nm. 
Due to their unique physical, chemical and electronic 
properties; metal nanoparticles modified electrodes 
show faster redox activity towards compounds 
compared to bare electrodes. The aim of the present 
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work is to investigate the voltammetric behavior 
and determination of ELE in pharmaceuticals using 
platinum and iridium nanoparticles and graphene 
oxide modified GCE (GO/Pt/Ir/GCE) nanosensor.
MATERIALS AND METHODS:
The 1×10−3 M stock solution of ELE was prepared 
in methanol. The working solutions of ELE were 
prepared daily by accurate dilution with pH desired 
buffer solution containing 20% methanol. In this 
study; pH 0.3,0.5 M and pH 0.5, 0.1 M H2SO4 
solutions, pH 1.5, pH 2.5, pH 3, pH 6.02, pH 6.5, 
pH 7.0 and pH 8.0 phosphate buffer (PB) solutions, 
pH 3.7, pH 4.7 and pH 5.7 acetate buffer solutions 
were used as supporting electrolyte for the effect of 
pH studies. The GO/Ir/Pt suspension was prepared 
by dispersing 1 mg of GO/Ir/Pt in 1 mL distilled water 
and the suspension ultrasonicated for 2hours using 
ultrasonic bath. Before the modification, the surface 
of bare GCE was polished with alumina slurry on a 
polishing cloth then washed with distilled water and 
dried. Different volumes of GO/Ir/Pt suspension was 
dropped to electrode surface and dried in a vacuum 
oven.
RESULTS:
The pH of the supporting electrolyte has a significant 
influence on the oxidation peak potentials and peak 
currents of ELE. The influence of the pH was studied 
using H2SO4 solutions, acetate and phosphate 
buffers in the pH range between 0.3 and 8.0 by DPV 
and OSWV. With increasing pH; the Ep shifted to less 
positive values. Ep showed linear response versus 
pH. The equations above and the Ep versus pH plot 
indicate that the Ep is pH dependent. Moreover, 
since the slope values are close to theoretical value 
of -59 mV equal amounts of electrons and protons 
may involve in the rate-determining steps. LOD value 
confirmed the sensitivity of the proposed method 
which was found as 4.46 × 10-7 M.
CONCLUSIONS:
In this study, the voltammetric behavior and 
determination of ELE in pharmaceutical dosage forms 
were investigated using GO/Pt/Ir/GCE nanosensor by 
DPV. The effect of various parameters such as pH, 
scan rate and nanomaterial amount were also studied. 
The electrochemical process was found irreversible, 
pH dependent and controlled by the adsorption of 
ELE onto the electrode. The results showed that the 
GO/Pt/Ir/GCE nanosensor significantly enhanced the 
oxidation peak current of ELE and also revealed a 
shift of peak potential of ELE to less positive values 
due to electrocatalytic effect compared to bare 
electrode using DPV.
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INTRODUCTION:
To resolve environmental pollution problem, 
scientific studies have recently focused upon the 
development of environmentally friendly or green 
processes, methods and techniques. These methods, 
applications and techniques are known as green 
chemistry (1). Glibenclamide is the most extensively 
used sulphonylurea in many parts of the world for 
the management of non-insulin-dependent diabetes 
mellitus (NIDDM) (2). 
MATERIALS AND METHODS:
All studies were performed on a Agillent Capillary 
Electrophoresis System with a diode array detector. 
A 55 cm × 50 µm i.d. fused silica capillary (Polymicro 
Technologies, Tucson, AZ) with an effective length of 
45 cm was used. Buffer, containing 20 mM Na2B4O7, 
was adjusted to pH 6.0 with 0.5 M H3BO3. The 
Applied voltage was 30 kV, pressure injection was at 
10 psi for 5 s, and the detection was performed at 
230 nm.
RESULTS:
Under these conditions, retention times of 
glibenclamide is 2.5 minute. Linearity range is between 
1 – 12 ppm. LOD and LOQ values were calculated as 
0.054 and 0.164 ppm. Relative Standard deviations 
(%) and recovery (%) values were calculated for 4 
and 8 mg/L glibenclamide in intra day as 0.123 % and 
99.99 % and 0.674 % and 99.99 %. This developed 
method was applied to analysis of glibenclamide in a 
pharmaceutical dosage form 
CONCLUSIONS:
A simple, rapid, precise and environmentally friendly 
capillary electrophoresis method for the determination 
of glibenclamide in pharmaceutical dosage form.
12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 251
ACKNOWLEDGEMENTS:
This study was supported by a project of BAP of Uşak 
University (2014MF008)
REFERENCES:
1.  Koel M, Kaljurand M (2006). Pure Appl Chem., 
78:1993–2002. 
2.  Nanovskaya T, Nekhayeva Hankins G, Ahmed M, 
(2006). BioChem Pharmacol.,72: 632-639. 
P-224: GOLD NANOPARTICLES MODIFIED 
SCREEN PRINTED ELECTRODE FOR 
SENSITIVE DETECTION/ENHANCED 
SENSING OF ANTICANCER DRUG 
IRINOTECAN-DNA INTERACTION
1,2 Shahzad, S., 2 Kurbanoglu, S., 2,3 Karadurmus, L., 
1 Shah, A., 2 Ozkan, SA.
1Quaid-i-Azam University, Department of Chemistry, 
Islamabad, Pakistan
2Ankara University, Department of Analytical 
Chemistry, Ankara, Turkey
3Adiyaman University, Department of Analytical 
Chemistry, Adiyaman
INTRODUCTION:
The clinical pharmacokinetic profile of irinotecan 
has always attracted researchers to explore the use 
of this anticancer drug. In high dosage this drug 
causes problems like severe diarrhea, abdominal 
cramping and nausea. It is important to develop a 
sensitive sensor which can detect minute amounts of 
Irinotecan. Electrochemical biosensors have received 
great attention due to their easy fabrication, reduced 
the attempts to manipulate the surface of sensor 
chips utilizing nanomaterials to enhance the sensing 
signals especially metallic nanoparticles. In this work 
gold nanoparticles (AuNPs) were used to develop a 
sensitive nanobiosensor to detect DNA –Irinotecan 
interaction.
MATERIALS AND METHODS:
AuNPs were used to modify electrode by using two 
strategies. A mixture of DNA and gold nanoparticles 
was deposited on electrode and its response was 
measured in acetate buffer of pH 4.65. In other case 
layer of gold nanoparticles was deposited and dried at 
room temperature followed by DNA layer deposition. 
Different concentrations of AuNPs were dropped on 
the surface of SPE and air dried to know the optimized 
concentration. The optimized amount obtained was 
10 µL of AuNPs with 5 µL drop on surface of electrode 
left to air dry followed by another 5 µL drop of AuNPs. 
After 15 µL of dsDNA were dropped on the surface 
and the response was measured via differential pulse 
voltammetry
RESULTS:
The developed modified nanobiosensor was 
interacted with Irinotecan and a remarkable decrease 
in the guanine signal of DNA was observed as 
compared to unmodified sensor. The low intensity 
peak signal was attributed to DNA condensation 
caused by irinotecan. This result was further validated 
by poly guanine and spectrophotometric studies.
CONCLUSIONS:
A disposable screen printed modified nanobiosensor 
was developed to sense the electrochemical response 
of irinotecan-DNA interaction.
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INTRODUCTION:
Idarubicin (IDA) is an antineoplastic in the 
anthracycline class. IDA is a DNA-intercalating 
analog of daunorubicin which has an inhibitory effect 
on nucleic acid synthesis and interacts with the 
enzyme topoisomerase II. IDA intercalates into DNA 
and interferes with the activity of topoisomerase II, 
thereby inhibiting DNA replication, RNA transcription 
and protein synthesis. Due to its high lipophilicity, 
IDA penetrates cell membranes more efficiently than 
other anthracycline antibiotic compounds. Drug–DNA 
interaction studies can give us brief information about 
the mechanism of the drug in the human body.
MATERIALS AND METHODS:
Electroanalytical methods are widely used in drug 
analysis, due to high sensitivity and selectivity, their 
low cost, reagents consumption and relatively short 
analysis time. Subsequently the use of chemically 
modified electrodes as electrochemical sensors 
have been highly recommended, as they since the 
modification enhances electron transfer rate and the 
sensitivity of working electrode by decreasing the redox 
potential of analyte (1). Nowadays, nanomaterials are 
generally used in designing nanobiosensors due to 
their high surface area, good mechanical properties, 
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inertness etc. Especially, silver nanoparticles (AgNPs) 
and platinum nanoparticles (PtNPS) are reason of 
choice depending on their biocompatibilities.
RESULTS:
In this study, an electrochemical DNA-based 
biosensor was developed for the detection of DNA–
IDA interaction through the electroactive properties 
of guanine and adenine nucleotides. Interaction time, 
nanoparticle amount (AgNPs, PtNPs), modification 
strategy and concentration of drug in response to 
guanine were optimized
CONCLUSIONS:
Layer-by-layer modification of the screen-printed 
electrode-based DNA biosensor gave the highest 
guanine response and resulted in a well-followed 
decrease in guanine signal after interaction with 0.5 
ppm IDA. With 5 min interaction time, the SPE/PtNPs/
AgNPs/AgNPs DNA biosensor gave a linear response 
between 0.05 and 1.0 ppm IDA.
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INTRODUCTION:
The chromatographic separation of enantiomers is one 
of the most difficult challanges in analitical chemistry. 
The advantages of superficially porous silica (SPS) 
over fully porous silica (FPS) chiral separations are 
documented (1). Shorter diffusion path-length and 
consequently higher column efficiency belong to the 
major advantages of these materials as well as to a 
lesser extent more uniform particle-size distribution of 
core–shell particles compared to their totally porous 
analogues.The aim of present work is to evaluate 
chiral columns prepared by covalent immobilization 
of cellulose 3,5-dichlorophenylcarbamate on core-
shell silica for separation of enantiomers in high-
performance liquid chromatography (HPLC).
 
MATERIALS AND METHODS:
In the frame of this study, enantioseparation of 
seven chiral sulfoxides including 2-(benzylsulfinyl)-




benzylsulfinyl) benzamide and 2-(4-methyl- 
benzylsulfinyl) benzamide were performed with 
varying flow rates of mobile phase from 0.1 to 5.0 
mL/min. Polar organic solvents like methanol and 
acetonitrile were used as mobile phases. The effect of 
the detection frequencies of 5 and 160 Hz were also 
compared.
RESULTS:
High  separation potential of SPS-based CSPs and 
high column efficiency was demonstrated, both at 
the optimal flow rate of the mobile phase as-well-as 
at the highest possible flow-rate of the mobile phase 
provided by the instrumentation used in this study. 
The difference in plate counts estimated at optimal 
and at instrument imposed maximal flow rates was 
small.
CONCLUSIONS:
 The results of this study indicate that a combination 
of polysaccharide based chiral selectors with 
superficially porous silica is a very useful approach for 
the preparation of chiral stationary phases for fast and 
highly efficient separations of enantiomers in HPLC. 
Even working with higher flow rates (5.0 mL/min), 
highly efficient separation of enantiomers can be 
achieved with the analysis time in the range between 
15-30 seconds.
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INTRODUCTION:
Separation of enantiomers is a hot topic for academic 
research, as well as in modern pharmaceutical 
industry. The reason for this is that more than 50 
% of the small molecule drugs currently in use are 
chiral compounds and significant part of them are 
racemates consisting of an equimolar mixture of 
two enantiomers. Chiral pyrazoline derivatives are 
in general well-known five-membered nitrogen-
containing heterocyclic compounds. In this study, 
relationships between structure of chiral analytes on 
one hand, and the nature of chiral selector and mobile 
phase on the other hand were investigated.
MATERIALS AND METHODS:
Recently synthesized 41 pyrazoline derivatives (1) 
were used in this study. HPLC grade acetonitrile 
and methanol were acquired from Sigma Aldrich. 
Commercially available chiral columns of Lux 
series from Phenomenex Inc. (Torrance, CA, USA) 
namely Lux Cellulose 2 and Lux Cellulose 3 with the 
dimensions 4.6x250 mm and 3 µm  and Lux Cellulose 
4 with the dimension 4.6x250 mm and 5 µm were 
used. The Agilent Technologies HP 1200 series 
(Santa-Clara, CA, USA) LC system was equipped 
with a degasser, quaternary pump, auto sampler 
and diode array detector was used in the present 
study. HPLC separations were performed at room 
temperature with 1 mL/min mobile phase flow rate.
RESULTS:
In order to achieve this goal, the enantiomers of 41 
chiral pyrazoline derivates were separated by using 
polysaccharide based chiral columns and polar 
organic mobile phases in HPLC.
CONCLUSIONS:
As this study illustrates, the affinity of enantiomers of 
chiral pyrazoline derivatives towards polysaccharide-
based chiral stationary phase is dependent on the 
nature of the polar organic mobile phase (2). Further 
studies in this direction may provide useful information 
for understanding the chiral recognition mechanisms 
with polysaccharide-based chiral stationary phases.
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INTRODUCTION:
Schizophrenia is one of the most frequently seen 
physiologic diseases in many countries and affects 
1.1% of the world’s population. It comes with many 
negative symptoms such as thinking disorder. 
Drugs in the market today are not effectively 
sufficient to cure the disease, they only regulate the 
symptoms. Risperidone, with active ingredient4-[2-
[4-(6-fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl]-
3-methyl-2,6-diazabicyclo[4.4.0]deca-1,3-dien-5-
one , is one of these drugs and can be prescribed 
to youths in the age of 13-18 which makes up for 
the its most remarkable feature. The analytical 
determination of the drug have been studied mostly 
with chromatographic methods including HPLC 
(1,2), liquid chromatography in combination with 
UV detection (3), capillary zone electrophoresis and 
first order derivative spectrophotometry (4). On the 
other hand, application of electrochemical methods 
in pharmaceutical formulations was achieved in 
two studies using differential pulse polarography 
(5) and square-wave cathodic adsorptive stripping 
voltammetry (6). Even though an attempt to identify 
the electroactive grouping on the molecule was 
made by cyclic voltammetry (7), a mechanism for the 
reduction of the compound was not proposed. 
MATERIALS AND METHODS:
In this study, the solution chemistry of Risperidone 
has been investigated by the aid of polarography. The 
electrochemical behavior of Risperidone is compared 
with that of OH-Risperidone. Simple buffer systems 
were used with pH values between 1 and 12 and 
the chemicals used to prepare these buffer solutions 
were of analytical grade. 
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RESULTS:
The purpose was to elucidate the electron transfer 
mechanism of Risperidone in different pH ranges 
and propose a mechanism for its reduction. DC 
Polarography is used for this purpose since it is one of 
the most informative methods for such investigations. 
DP Polarography was used for determination 
purposes. This method is easy to apply for such 
formulations and requires no pre-treatment of the 
metabolites. The calculated validation parameters are 
as follows: LOD: 1.9x10-7; LOQ: 6.5x10-7; Slope of 
the calibration curve: 46504. 
Conclusion: The electron transfer mechanism of 
Risperidone has been elucidated at different a pH 
ranges. Another contribution of this study lays in a 
proposed electrochemical method for its determination 
by using DP Polarography.
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INTRODUCTION:
Glucose is one of the main molecules that act as an 
energy source for the human body. In addition, living 
cells use glucose as a metabolic intermediate in the 
synthesis of more complex molecules such as fats 
(1). The significance of glucose in human metabolism 
is well known, as is the fact that the defects in glucose 
level lead to complications of diabetes (2).
MATERIALS AND METHODS:
The glassy carbon electrode surface was covered 
with a platinium nanoparticle graphene solution 
by dropping. The glucose oxidase enzyme was 
immobilized by cross-linking on the electrode modified 
by graphene / platinium nanoparticles / nafion 
solution. Optimum conditions of GR / PtNps / Nf film 
and biosensor were determined. The linear working 
range of biosensor for glucose was determined. The 
effects of pH and temperature on the response of the 
glucose biosensor were investigated. Reusability and 
storage stability were determined of the biosensor. 
RESULTS:
Linear working range of prepared biosensor 
was determined 5 μM to 50 μM. The  activitiy of 
biosensor was maintained 94.5% at the end of 20 
measurements. The values of Km and Vmax for the 
GR / PtNps / Nf-GOD enzyme electrode system were 
found to be 0,94 mM and 0,775 µA / min, respectively. 
The optimum pH and temperature values for glucose 
biosensor were found 8.0 and 50 °C.
CONCLUSIONS:
Electrochemical studies show GR / PtNps / Nf film 
can provide a biocompatible and electrochemical 
microenvironment for immobilization of enzyme, 
making this material a good candidate for the 
fabrication of highly sensitive and selective glucose 
biosensors.
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INTRODUCTION:
The aim of the study is to examine the effect 
of particle size and particle size distribution on 
Montelukast Sodium dissolution. Montelukast 
Sodium is a leukotriene receptor antagonist,is used 
commercially as a maintenance treatment for asthma 
and to relieve allergic symptoms (1). According 
to physicochemical characterization Montelukast 
Sodium is defined as a Class II molecule in BSC 
(biopharmaceutical classification).It has low solubility 
and high permeability.Increasing the effectiveness 
of the Montelukast sodium depends on the rate 
of dissolution of the molecule since it is a Class 
II molecule. Most important parameters affecting 
the solubility are the particle size and particle size 
distribution of the active substance.
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MATERIALS AND METHODS:
In this study the effect of different particle size 
distributions on solubility has been investigated. 
Active substance particle size distribution results 
obtained by using a Malven Masterizer 3000 laser 
light scattering method and supplied from the same 
supplier are presented in Table 1 below.
Table 1: Montelukast Sodium Particle Size  Distribution 
Montelukast Sodium Particle Size Distribution (μm)
D10 D 50 D90
11001-161001 4.42 μm 18.9 μm 77.9 μm
11 0 0 1 - 1 7 0 6 0 2 
(micronized)
1.8 μm 9.2 μm 35.5 μm
Solubility studies of tablets manufactured with the 
API lot number 11001-161001 and 11001-170602 
(micronized) were performed by using a validated 
dissolution method;which is 900 mL of 0.5% SDS at a 
rotation speed of 50 rpm(USP Pallet).
RESULTS:
A profile dissolution study was performed at 10th 
minute,15th minute,20th minute,30th minute,45th 
minute and 60th minute.Dissolution and RSD values 
have been calculated as 78% and 7.4% respectively 
for the product manufactured with the API lot 
numbered 11001-161001,at 15th minute. When the 
product is manufactured with the 11001-170602 
lot numbered micronized API dissolution and RSD 
results have been calculated as 94% and 4.3% at 15th 
minute. When compared with the reference product 
which have 94% dissolution and 2% RSD value it can 
be concluded that test product manufactured with 
micronized API is similar to reference product. It has 
been proved with this study that the efficiency of the 
dissolution rate profile has increased as the particle 
size reduced and the product becomes similar to the 
reference product.
CONCLUSIONS:
Micronized active substance is preferred for use in 
product formulations.
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INTRODUCTION:
Recent reports indicate that liver cancer is one 
of the most prevalent malignancies in both men 
and women worldwide (1). The anticancer effect 
of the components of commercial herbal mixture 
(CHM) on various cancer types is well known and 
previously been investigated by proteomic studies. 
Two-dimensional (2-D) gel electrophoresis is the first 
step in the classical proteomic strategy to resolve the 
complex nature of cellular content. The procedure 
combines two types of gel electrophoresis: pI based 
protein separation by isoelectric focusing (IEF), and 
molecular weight separation by SDS-PAGE (2, 3).
MATERIALS AND METHODS:
In this study, HepG2 liver cancer cell line was chosen 
for proteomic analysis. Cells treated with CHM (Group 
T) were compared to the control (Group C). Cytosolic 
fractions of proteins in group T and C were separated 
by 2-D gel electrophoresis. SYPRO Ruby was used 
for gel staining. The 2-D gels were scanned and the 
relative gel images were analyzed using PDQuest 
software. After image filtration for background 
removal, spots were automatically detected and 
manually edited. PDQuest was used for the statistical 
analysis and selection of the up or downregulated 
proteins in both groups.
RESULTS:
The PDQuest detected an average of 298 spots for 
two groups. Then, PDQuest software defined ‘t-test’ 
and ‘Quant’ group, where t-test was the proteins 
statistically identical in the same group regarding their 
spot intensities and the Quant group comprised of 
proteins having 2-fold change amongst the groups T 
and C. The intersection of these groups was detected 
to be 88 spots.
CONCLUSIONS:
According to proteomic studies, CHM changes the 
level of certain proteins in HepG2 cells. To determine 
whether overexpressed and under expressed proteins 
are associated with anticancer activity, spot should 
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further be analyzed by MALDI-TOF MS and identified 
by peptide mass fingerprint. 
REFERENCES:
1.  Bosch FX et al., (2004). Gastroenterology, 
127(5): S5-S16.
2.  Liu H et al., (2013). Journal of Proteome 
Research, 12(3): 1300-1315.
3.  Rabilloud T et al., (2007). Plant Proteomics: 
Methods and Protocols, 111-119.
P-232: IDENTIFICATION OF 
ORGANOCHLORINE PESTICIDES (OCPS), 
IN SPIKED COMMERCIAL COW MILK 
SAMPLES BY GC-MS 
1,2 Nenni, M., 1 Zeki, OC., 1 Suslu, I., 1 Celebier, M., 1 
Altinoz, S. 
1Hacettepe University, Faculty of Pharmacy, 
Department of Analytical Chemistry, Ankara, Turkey
2Cukurova University, Faculty of Pharmacy, 
Department of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
Milk-producing animals (cows) accumulate residues 
of these insecticides through contaminated feed, 
grass and inhaled air. Due to their lipophilic 
properties, OCPs are primarily stored in fat-rich 
tissues and subsequently translocated and excreted 
through milk fat (1). The evidence of organochlorine 
hormone-disruption activity has been reported. 
This fact has caused concern since milk and dairy 
products play a central role in human nutrition (2). The 
aim of this study is to develop an analysis technique 
for identification of 6 different OCPs (1 ppm β-HCH, 
δ-HCH, 4,4’DDT, 4,4’DDD, 2,4’DDD and 4,4’DDE) in 
spiked commercial cow milk samples by GC-MS.
MATERIALS AND METHODS:
Commercial cow milk samples were extracted by using 
liquid–liquid extraction. After extraction, supernatant 
was dried with vacuum centrifuged and dissolved by 
adding hexane (The process was done to increase the 
OCPs concentration in the sample). Then they were 
injected into the GC-MS system where an Agilent 
J&W DB-624UI (e.g., plot columns) was used. The 
injector temperature was 250°C, the purge flow was 
5 mL.min-1, and the column temperature was held at 
60°C for 1 min, then the increased to 325°C and held 
there for 10 min. The interface and the ion source 
temperatures were 230 and 290°C, respectively. Ions 
were generated by a 70-eV electron beam. A more 
detailed overview presenting separate data for OCPs 
given Table1.
Table1. Identification parameters by GC-MS
OCPs Migration Time Fragment Ions(m/z)
β-HCH 17.965 109, 181, 183
δ-HCH 17.025 109, 181, 183
4,4’DDT 24.736 235, 237, 165
4,4’DDD 22.946 235, 237, 165
2,4’DDD 24.031 235, 237, 165
4,4’DDE 22.244 246, 248, 316
RESULTS:
In this procedure, which combines liquid-liquid 
extraction technique with GC-MS, a qualitative assay 
of 6 different OCPs was made from commercial cow 
milk.
CONCLUSIONS:
It is important to know what the exposure agent 
is so that the correct treatment can be applied to 
the exposure to the pesticides. For this purpose, 
qualitative analysis of spiked milk samples of OCPs 
was performed by using a GC library, suggesting 
a procedure that combines liquid-liquid extraction 
technique with GC-MS.
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INTRODUCTION:
Fluoroquinolones constitute an essential class of 
antibacterials, and widely used in clinical applications. 
This study describes the spectroscopic and theoretical 
investigation of Gatifloxacin. The experiment results 
were performed with IR spectroscopy, UV- visible 
spectroscopy and NMR spectroscopy. 
MATERIALS AND METHODS:
Theoretical calculations were performed with 
Gaussian 16 and GaussView 6 software Packages. 
The geometry optimization of structure, and 
vibrational frequencies of Gatifloxacin (GATI) have 
been calculated by density functional theory DFT-
B3LYP methods with the 6-31++G(d,p) basis set. The 
Mulliken atomic charges of our molecule were also 
performed using the DFT method.
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RESULTS AND CONCLUSION:
The presented spectroscopic investigations on 
GATI shows the good agreement between observed 
spectra and theoretical predictions of the drug. In IR 
spectra, the difference in intensities is seen may be 
due the intramolecular H-bonding in experimental 
study. In the experimental and theoretical studies 
of UV absorption energy of GATI are almost similar. 
For the 1H NMR observed and theoretical predicted 
spectra are shows the same results.
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INTRODUCTION:
Rivaroxaban (RIV) is an oral oxazolidinone-based 
anticoagulant and a potent and selective direct 
inhibitor of factor Xa; mainly, RIV is in use for the 
prevention of venous thromboembolism in adult 
patients (1). The aim of this study was to develop a 
new liquid chromatography method for determination 
of RIV in tablets.
MATERIALS AND METHODS:
Analysis were performed using a Nexera-i series 
of ultra high performance liquid chromatography 
(UHPLC) system from Shimadzu (Japan). 
Escitalopram (ESC) was used as an internal standard 
(IS). The separation was performed by a C18 bonded 
fused-core silica column (Phenomenex Kinetex® 2,6 
μm, 150x4.6 mm). The mobile phase was consisted 
of water, acetonitrile and methanol (55:20:25, v/v/v), 
which was pumped at 0.5 mL/min flow-rate. The 
analytes were injected as 10 µL aliquots and detected 
using a photodiode array detector set at 249 nm. 
The method was validated according to ICH Q2(R)1 
regulations (2), and system suitability parameters 
were checked according to USP.
RESULTS:
Conventional chromatographic parameters were 
investigated for optimization of method such as 
organic solvent ratio, flow rate, injection volume etc. 
Retention times of RIV and ESC were observed as 
3.90 and 6.40 min respectively; total runtime was 
8 min. Analysis of RIV was achieved with very high 
efficiency; the number of theoretical plates were about 
19600 and 12200 for RIV and ESC, respectively. 
Isocratic elution of RIV was successful with observing 
good system suitability values. Capacity factor was 
about 2.2 for RIV and 4.2 for ESC; on the other hand 
tailing factor of RIV peak was 1.2, while it was 1.9 for 
ESC. Besides, effects of mobile phase composition 
and detection wavelength on the retention time and 
signal intensity was evaluated.
CONCLUSIONS:
A simple, rapid, accurate and precise UHPLC method 
has been developed and validated for the routine 
quantitative analysis of RIV in tablets.
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INTRODUCTION:
Metabolomics is the scientific study of chemical 
processes involving metabolites. Specifically, 
metabolomics is the “systematic study of the unique 
chemical fingerprints that specific cellular processes 
leave behind”, the study of their small-molecule 
metabolite profiles (1). In this study, a metabolomic 
approach was performed to understand the effect of 
amphiphilic cyclodextrin nanoparticles on MDA-MB 
cancer cells.
MATERIALS AND METHODS:
Control group (Group C) of MDA-MB cells were 
compared with the one treated with the amphiphilic 
cyclodextrin nanoparticles (Group T). Metabolomic 
studies were carried on Q-TOF LC/MS. Metabolites 
in cytosolic fractions were purified by ultrafiltration 
method and separated by Zorbax HILIC Plus 
chromatography column. XCMS on-line (2) was 
used to find the metabolites affected by cyclodextrin 
nanoparticle treatment.
RESULTS:
Mainly 2758 and 208 peaks were found by using 
XCMS centwave and matchedFilter algorithims, 
respectively. However, 15 peaks having fold change 
more than 2 and statistically significant (p<0.05) were 
the intersection of these algorithms. These peaks 
were matched with metabolites by using Human 
Metabolome Database (HMDB) and it was found the 
some of the affected metabolites were involved in 
cancer metabolism.
CONCLUSIONS:
According to the results, it could be concluded 
that metabolomics is one of the  key strategy to 
understand the effect of small molecules on cancer 
cells. Various algorithms to identify the metabolite 
peaks in chromatograms provide identical results 
after statistical analysis.
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INTRODUCTION:
The reactivity of the flavonoids’ C4 carbonyl led 
to synthesis of new chiral products of iminoflavan 
derivatives, and our work is concentrated on the 
chiral separation of these molecules by liquid 
chromatography on six polysaccharide-based CSPs 
under polar and normal organic phase modes (1-3).
MATERIALS AND METHODS:
4-iminoflavans was successfully accomplished in the 
normal phase mode using six polysaccharide-based 
chiral stationary phases namely, Chiralcel®OD-H, 
Chiralcel®OD, Chiralcel®OJ, Chiralpak®AD, 
Chiralpak®IA and Chiralpak®IB under normal and 
polar organic phase modes.
RESULTS:
The resolution depended on nature and concentration 
of alcoholic modifer. The results demonstrate 
clearly that the chromatographic system based 
on the coated and immobilized type Chiralpak®IB 
and Chiralcel®OD-H CSPs provide a powerful 
analytical tool for enantiomeric separation of all the 
4-iminoflavans used in this study.
CONCLUSIONS:
A chiral HPLC method for the separation of eight 
racemic aryl iminoflavanone derivatives was 
developed. The separation was successfully 
performed on the six polysacharride-based chiral 
stationary phases under normal and polar organic 
phase modes.
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INTRODUCTION:
Tasimelteon (TAS), which was approved for treatment 
of non-24-hour sleep–wake disorder in 2014, is a 
selective agonist for the melatonin receptors MT1 
and MT2 (1). The main purpose of the described 
study herein was to investigate optimum LC-MS/
MS conditions to develop a selective, sensitive 
and validated analytical method for quantitative 
determination of TAS.
MATERIALS AND METHODS:
The experimental work was succeed using an LCMS-
8040 series liquid chromatograph mass spectrometer. 
The LC part of the instrument (Nexera XR series from 
Shimadzu, Japan) was composed of two LC-20AD 
binary pumps with a three-way degasser (DGU-
20A3R), an SIL-20AC autosampler, a CTO-10ASVP 
column oven, a CBM-20A communications bus 
module. Conventional reversed phase LC solvents 
and MS additives were used for method development 
applications.
RESULTS:
The separation of TAS was achieved using a second-
generation monolithic silica column (Chromolith® 
High Resolution RP-18e, 100 × 4.6 mm from Merck 
KGaA). The mobile phase was a mixture of 0.1% 
(v/v) formic acid in water and 0.1% (v/v) formic acid in 
acetonitrile (60: 40 (v/v), pH=2.6). The flow rate was 
0.5 mL/min. The mass spectrometer was operated 
at a mass range from m/z 100 to m/z 800 using an 
electrospray ionization in positive mode (ESI+). The 
MS conditions were optimized to drying gas (nitrogen) 
flow 15 L/min, nebulizing gas (nitrogen) flow 3.0 L/
min, collision gas (argon), CDL temperature 250 °C 
and heat block temperature 450 °C. Multiple Reaction 
Monitoring (MRM) mode were used throughout all 
analysis.
CONCLUSIONS:
TAS is considered to be one of the promising insomnia 
drugs of the future; it is the first approved treatment in 
US for non-24-hour sleep–wake disorder (2). This is 
the first study, in which LC-MS/MS conditions were 
characterized for quantitative analysis of TAS.
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INTRODUCTION:
Combinations of zofenopril calcium  (ZOF) and 
hydrochlorothiazide (HYD) are used for the treatment 
of arterial hypertension. Dosages values different 
from those presented on the label of pharmaceuticals 
can significantly impact a consumer’s health (1-2).   
Methods: Development and comparison of two 
different spectrophotometric techniques, one with 
absorbance subtraction and the other with ratio 
difference,  were presented  for simultaneous 
determination of ZOF  and HYD , in pharmaceutical 
formulations. 
RESULTS:
The zero order absorption spectra of the ZOF 
and HYD were recorded. The zero order spectra 
recorded of ZOF at 233.0 nm was measured. The 
absorbance factor  (AF) was calculated as 2.87. 
The ratio difference spectrophotometric technique 
was applied for simultaneous determination of each 
drugs. The difference amplitudes in the ratio spectra 
at 241.0 – 288.9 nm  and  at  271.3 – 324.1  nm were 
selected to determine ZOF  and HYD  in the binary 
mixture.  Linearity was found to be acceptable over 
the concentration ranges of 5-35 mu g mL(-1) and  3 
-20 mu g mL(-1)    for ZOF and HYD,  respectively.
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CONCLUSIONS:
 Based on the exprimental results,  the developed 
methods enables and simultaneous determination 
of ZOF and HYD in pharmaceutical dosage forms. 
The simplicity of the method allows its use in routine 
analysis for quality control.  
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P-242: RESOLUTION OF TWO-
COMPONENT MIXTURE IN COMBINED 
DOSAGE FORMS CONTAINING PROTON 
PUMP INHIBITORS BY USING RATIO FIRST 
DERIVATIVE UV SPECTROPHOTOMETRY
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1Ankara University, Faculty of Pharmacy, Department 
of Analytical Chemistry, Ankara, Turkey
2Turkish Medicines and Medical Devices Agency, 





benzimidazol-2-one  is a dopamine antagonist 
with antiemetic property similar to metoclopramide 
and neuroleptic drugs (1,2). Lansoprazole (LA), 
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]
methylsulfinyl]-1H-benzimidazole  is a proton pump 
inhibitors. There are many combinations of proton 
pump inhibitors with Domperidone and Lansoprazole, 
available in local markets.
METHODS: 
First derivative UV and ratio derivative 
spectrophotometric methods are described for the 
simultaneous determination of benzimidazole proton 
pump inhibitor used for the treatment of gastrointestinal 
disorders. In the first derivative spectrophotometry 
with a zero-crossing technique of measurement is 
used for the cited drugs in binary mixtures without 
previous separation step. The other  method, is based 
on ratio derivative spectrophotometry, the amplitudes 
in the first derivative of the ratio spectra were selected 
to determine DOM and LA in the binary mixture. 
RESULTS:
The first derivative spectrophotometry, the signals 
in the first derivative UV spectra at 282.8 and 230.5 
nm are selected to simultaneous determination DOM 
and LA in the binary mixture. The linear regression 
of derivative absorbance signals on concentration 
gave the equation; y= -0.047x – 0.0046 (R2: 0.9961) 
at 282.8 nm and y = -0.0028x - 0.0071 (R2 : 0.9997) 
at 230.5 nm for DOM and LA, respectively. The 
calibration curves were linear over the ranges of 
8-20 µg mL-1 and  6 - 24 µg mL-1  for DOM and LA, 
respectively. The results of assay of DOM and LA are 
100.4 ± 1.06 and 99.1 ± 1.25, respectively. 
CONCLUSIONS:
The proposed methods, which gives thoroughly 
comparable data, are simple, fast, require no 
preliminary separation steps, can reliably be used 
for routine analysis of DOM and LA in bulk drug and 
laboratory prepared binary mixtures. 
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P-243: ELECTROCHEMICAL BEHAVIOURS 
OF ANTHISTAMINES; LEVOCETRIZINE AND 
DESLORATADINE IN AQUEOUS SOLUTIONS
1,2 Bakirhan, NK. Ozturk, K., Uslu, B., Ozkan, SA.
1Ankara University, Faculty of Pharmacy, Department 
of Analytical Chemistry, Ankara, Turkey
2Hitit University, Faculty of Art&Science, Department 
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INTRODUCTION:
Levosetirizine (LCZN) and Desloratadine (DESL) are 
used as antihistamines. In this study, it is aimed to 
investigate the electrochemical behavior of them in the 
direction of oxidation by using glassy carbon electrode 
(GCE) and modified forms with nanoparticles. In 
this way, it is planned to obtain information about 
the mechanisms. The main purpose of this study is 
examine in detail the mechanisms of drug substances 
and to use them to illuminate these mechanisms of 
oxidation /reduction reactions in drug metabolism in 
the human body.
MATERIALS AND METHODS:
Autolab 100N was used as electrochemical analyzer. 
Ag/AgCl electrode as reference, platin electrode 
as counter and modified GCEs were used as 
working electrodes. pH, supporting electrolyte and 
scanning speed parameters were investigated by 
cyclic, differential pulse voltammetry methods. The 
influence of the pH on the oxidation peak current of 
5.0×10−5 M LCZN on β-cyclodextrin modified glassy 
carbon electrode (β-cyclodextrin/GCE) and 1.0×10−4 
DESL on ZnO:MWCNT composite modified GCE 
(ZnO:MWCNT/GCE) were checked via phosphate 
(pH 2.0, 3.0 and 6.0, 7.0, 8.0), acetate (pH 3.5-4.5-
5.5), Britton-Robinson (BR) (pH 2.0-11.0) buffers. 
Scan rate study was applied by cyclic voltammetry 
between 10 and 350 mV s−1.
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RESULTS:
Shifts in potential, peak current, smoothness of peak 
shape are all considered; the optimum pH and buffer 
solution were determined as pH 2.0 and B-R buffer 
for LCZN and pH 5.5 and acetate buffer for DESL. 
LCZN gave a linear relationship on the oxidation 
peak current (Ip) with the scan rate (ν) that showed 
predominantly adsorption control process. On the 
other hand, the results of the scan rate for DESL, the 
slope of the logv - logIp curve (~ 0.236) was less than 
the theoretical value of 0.5, which resulted in diffusion 
control of the electrode surface.
CONCLUSIONS:
Electrochemical behaviors of antihistamines LCZN 
and DESL were investigated in aqueous solutions. 
Redox reactions were investigated on developed 
electrodes.
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P-245: COMPARISON OF SAMPLE 
PREPERATION TECNIQUES ON 
HUMAN BLOOD PLASMA FOR LC/MS 
METABOLOMIC STUDIES
Kaplan, O., Kocak, E., Celebier, M.
Hacettepe University, Faculty of Pharmacy, 
Department of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
Although there are many sample preparation 
procedures for metabolomic studies in the literature, 
which method is superior to the other is still a question 
mark (1). In this study, four methods including 
ultrafiltration, methanol precipitation, solid phase 
extraction and solid liquid extraction were compared 
within each other and it was tried to find out which 
method performs better results for metabolite profiling.
MATERIALS AND METHODS:
In this work, 4 methods including ultrafiltration, 
methanol precipitation, solid phase extraction and 
solid liquid extraction were compared within each 
other. Metabolite extraction methods were applied 
individually on same plasma sample to evaluate the 
differences in a true way. For each method, the final 
plasma concentration kept equal and all samples 
were analyzed by LC/MS Q-TOF using a C-18 
chromatographic column. The results and data mining 
were evaluated using the same statistical tests and 
methodologies and interpreted accordingly.
RESULTS:
The results were examined by XCMS (a R computer 
language-based metabolite profiling software). 
The method with the highest number of peaks 
was referred as the optimum method for sample 
preparation in human plasma samples. In addition, 
principal component analysis (PCA) results were 
compared within each other. According to these 
data, precipitation method with methanol gives 
maximum number of peaks with 624 peak counts, 
the ultrafiltration method is the second one with 444 
peak counts, where the liquid extraction method 
and the solid phase extraction method are third and 
fourth, with 325 peak counts and 193 peak counts 
respectively. As term of peak count is peaks which 
have p<0.05 and R>0.90 values as statistically valid 
peaks.
CONCLUSIONS:
Metabolites do not have a universal sample 
preparation method because of their chemical and 
physical properties. In the present study, it was tried 
to indicate the optimum sample preparation technique 
for human blood plasma samples to identify maximum 
number of peaks in LC / MS Q-TOF based experiment.
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P-246: ANALYTICAL METHOD 
DEVELOPMENT ON LIQUID 
CHROMATOGRAPHY/ MASS 
SPECTROMETRY (LC/MS Q-TOF) FOR 
METABOLOMIC STUDIES AT DIFFERENTIAL 
DIAGNOSIS OF ASCITES
Kaplan, O., Celebier, M., Suslu, I.
Hacettepe University, Faculty of Pharmacy, 
Department of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
Pathological fluid collected in the peritoneal cavity 
is called ascitic fluid. The concept of the differential 
diagnosis of ascites is the process of diagnosing 
the disease that causes ascites formation. In this 
study, metabolomic studies were performed by liquid 
chromatography/mass spectrometry (LC/MS Q-TOF) 
to tell nonmalignant ascitic samples (Group C) and 
malignant ascitic samples (Group T) apart.
MATERIALS AND METHODS:
Study text consist of three main experimental 
parts: Analytical method development, metabolite 
profiling and targeted metabolomics. In the method 
development step, two different sample preparation 
methods, ultrafiltration and methanol precipitation, 
two different chromatography columns, HILIC and 
C18 columns, two different MS modes, positive and 
negative MS modes, were tried and compared within 
each other. XCMS and MetaboAnalyst were used for 
data mining process (1).
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RESULTS:
Ultrafiltration technique, HILIC column and positive 
mode MS methods were determined as the method 
giving the maximum number of peaks and the study 
was performed under these optimum conditions. 
Metabolite profiling studies were carried out and 
141 peaks were found as minimum two times 
differentiating between two groups. Six of these 
peaks were identified in targeted metabolomic studies 
and chemical structures were characterized.
CONCLUSIONS:
This study aimed to find the differences in metabolome 
level between T and C groups by using LC/MS method. 
Thus, ascites differential diagnosis was performed in 
metabolome level. The results showed that 141 peaks 
between the two groups were statistically reliable 
and significant in quantity. This situation suggests 
that there are differences in metabolome level in the 
ascites fluid resulting from different diseases and 
these differences can be determined by the method 
developed in the present study.
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P-247: DEVELOPMENT AND VALIDATION 
OF A HILIC METHOD FOR SIMULTANEOUS 
DETERMINATION OF CARBOPLATIN AND 
DECITABINE 
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INTRODUCTION:
Carboplatin (CRB) is an anticancer drug which 
is widely used as first line chemotherapeuetic for 
treatment of ovarian cancer. The major problem with 
ovarian cancer treatment is acquired carboplatin 
resistance. The use of decitabine (DEC), which is 
a DNA methyltransferase inhibitor, combined with 
carboplatin is a new perspective for modulating 
carboplatin resistance. The aim of this study is to 
develop and validate a Hydrophilic Interaction Liquid 
Chromatography (HILIC) method for the selective and 
reliable simultaneous determination of CRB and DEC 
from their bulk and pharmaceutical dosage forms. 
MATERIALS AND METHODS:
Agilent 1100 series LC system (Wilmington, DE, 
USA), equipped with a G1379A degasser, G1311A 
quaternary pump, G1313 auto injector and G1315B 
diode array detector (DAD) was used for method 
development and validation studies. 
A Kinetex HILIC (150x4,6 mm, 2,6 µm, 100Ao) 
(Phenomenex, USA) analytical column was used 
as stationary phase. An isocratic mobile phase 
consisting of acetonitrile:5 mM ammonium acetate 
buffer (92:8) was selected. Both CRB and DEC was 
detected at 220 nm wavelength. In order to optimize 
the chromatographic conditions, effects of flow rate 
and column oven temperature were also investigated. 
The optimized HILIC method was validated according 
to the ICH guidelines (1) from the view point of 
linearity, accuracy, precision, limit of detection (LOD) 
and quantitation (LOQ), etc.
RESULTS:
 As a result of optimization studies, separation of CRB 
and DEC performed by using 5 μL injection volume, 1 
mL/min flow rate and 15◦C column oven temperature. 
The retention times were 3.7 min and 7.8 min for DEC 
and CRB, respectively. Developed method was found 
linear in the range between 1 and 100 µg.mL-1 with 
correlation coefficient of 0.9996 and 0.9994 for CRB 
and DEC, respectively. Accuracy of the method was 
demonstrated by the application of pharmaceutical 
formulations as real samples.
CONCLUSIONS:
A sensitive and rapid determination method which can 
be used for the simultaneous determination of CRB 
and DEC from their bulk and pharmaceutical dosage 
forms was developed. 
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P-248: QUANTITATIVE ANALYSIS OF A 
BINARY MIXTURE IN A PHARMACEUTICAL 
DOSAGE FORM BY CONTINUOUS WAVELET 
TRANSFORM TECHNIQUE
Ustundag, O., Dinc, E.
Ankara University, Faculty of Pharmacy, Department 
of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
Wavelet transform (WT) has gained wide acceptance 
as a valuable tool for signal processing tasks, due to 
their wide range of applications (1).
MATERIALS AND METHODS:
In this context, a new signal processing approach, 
ratio spectra - continuous wavelet transform 
(RS-CWT) method was developed for the 
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simultaneous determination of irbesartan (IRB) 
and hydrochlorothiazide (HCT) in a pharmaceutical 
dosage form.
RESULTS:
The RS-CWT method was applied to the UV spectra 
of the IRB and HCT. After applying many wavelet 
functions, the family consisting of bior1.3 was found 
to be suitable for the quantitative determination of the 
mentioned drugs.
CONCLUSIONS:
After the name (RS-bior1.3-CWT) was given, 
the calibration equations were obtained by 
measuring the CWT-amplitudes at 235.9 nm for 
the IRB determination and at 262.8 nm for the HCT 
determination, respectively. The proposed methods 
were successfully applied to the analysis of the IRB- 
HCT in the pharmaceutical tablets. 
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P-249: SIMULTANEOUS QUANTITATIVE 
RESOLUTION OF ACTIVE COMPOUNDS 
IN A TABLET DOSAGE FORM BY UPLC 
TECHNIQUE
Ustundag, O., Dinc, E.
Ankara University, Faculty of Pharmacy, Department 
of Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
An ultra performance liquid chromatography (UPLC) 
method was developed for the analysis of active 
compounds in a tablet.
MATERIALS AND METHODS:
A rapid and sensitive chromatographic approach, 
ultra performance liquid chromatography (UPLC) 
method was developed for the simultaneous 
quantitative resolution anti-hypertensive compounds 
(hydrochlorothiazide and irbesartan) of a tablet 
dosage form. Ultra performance chromatographic 
analysis was performed on a UPLC system consisting 
of a Waters Acquity equipped with binary solvent 
delivery pump, an auto-sampler and photo diode 
array (PDA) detector.
RESULTS:
The chromatographic separation was carried out by 
using a Waters Acquity UPLCTM BEH C18 column 
(50 mm x 2.1 mm, 1.7 μm i.d.). Integration was 
automatically performed by computer using Acquity 
UPLC software. Detection responses were measured 
in terms of peak area.
CONCLUSIONS:.
In conclusion, UPLC method may be considered 
more specific than other approaches. The developed 
UPLC method can be applied with great success to 
the routine quality control of the tablets containing 
IRB and HCT.
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P-250: INTERACTION STUDIES OF 
CARBIDOPA WITH FISH SPERM DOUBLE 
STRAIN DNA USING UV-SPECTROSCOPIC 
TECHNIQUE
Senel, P., Golcu, A.
Istanbul Technical University, Faculty of Arts and 
Sciences, Department of Chemistry, Istanbul, Turkey 
INTRODUCTION:
Carbidopa (Lodosyn) is a drug given to people with 
Parkinson disease or Parkinson-like symptoms (e.g. 
shakiness, stiffness, difficulty moving)  to reduce 
peripheral adverse effects of levodopa. It is known 
as an enzyme blocker. It works by preventing the 
breakdown of levodopa in the bloodstream. This 
allows more levodopa to enter the brain, where it can 
decrease Parkinson’s symptoms.
MATERIALS AND METHODS:
Drugs interact with the double helix DNA in either 
covalent or noncovalent way. The non-covalent 
way includes three modes of binding;  electrostatic 
effects, groove binding and intercalation, among 
which intercalation is the most important binding 
mode (1). Small molecules when bind to DNA through 
intercalation, can damage DNA in disease cells (2). 
Many techniques have been applied for investigation 
of the interaction of drugs with DNA. These include; 
molecular spectroscopy methods such as UV 
spectrophotometry , fluorescence , circular dichroism 
spectroscopy , dynamic viscosity measurements, and 
high-performance liquid chromatography (3).
RESULTS:
In this study, the molecular interactions between 
Carbidopa and fish sperm double strain DNA have 
been studied using UV–Vis spectrophotometry 
technique and the binding constant (Kb) of drug to 
DNA was determined.
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CONCLUSIONS:
When the results of the absorption spectra of carbidopa 
in the absence and presence of DNA are examined, 
it is understood that upon increasing the ratio of the 
concentration of DNA to drug, the absorption bands 
of carbidopa  exhibited hypochromism, with red shifts.
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INTRODUCTION:
Sulpiride is a substituted benzamide derivative 
drug and a selective dopamine D2 antagonist with 
antipsychotic and antidepressant activity. In contrast 
to most other neuroleptics which block both dopamine 
D1 and D2 receptors, Sulpiride is more selective and 
acts primarily as a dopamine D2 antagonist. It appears 
to lack effects on norepinephrine, acetylcholine, 
serotonin, histamine, or gamma-aminobutyric acid 
receptors (1).
MATERIALS AND METHODS:
The application of electrochemical methods to the 
study of organic and metallointeraction to DNA 
provides a useful complements to the previously 
used methods of investigation. Small molecules, 
which are not amenable to such methods or because 
of overlap of electronic transition with those of the 
DNA molecules, can be studied via voltammetric 
techniques. In addition, an electrochemical system 
can also serve as a versatile and illuminating model 
for gaining insight into the in vivo action in living cells 
(2).
RESULTS:
The electrochemical investigation of interaction 
of sulpiride with double strain DNA  has been 
investigated by cyclic voltammetric studies on glassy 
carbon electrode at physiological pH and the binding 
constant (Kb) of drug to DNA was determined.
CONCLUSIONS:
Cyclic voltammetry based assay was developed 
for the assessment of the effect of the medium, 
substituents, potential scan rate and a number of 
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P-253: DEVELOPMENT OF NEW 
MONOLITHIC POLYSACCHARIDE-
BASED CHIRAL HPLC COLUMNS FOR 
ENANTIOMERIC SEPARATION 
Ratih, Asmari, M., El Deeb, S.
Institute of Medicinal and Pharmaceutical Chemistry, 
TU Braunschweig, Germany
INTRODUCTION:
The planar polysaccharide, chondroitin sulfate A 
(CSA) and the maltodextrin (MD) which is a mixture 
of malto-oligo polysaccharide have been studied as 
potential chiral selectors.  Through hydrolysis, MD 
is differentiated in various polymerization degrees 
known as dextrose equivalent (DE) values. CSA 
and MD have shown promising chiral recognition 
in capillary electrophoresis (CE). However, the 
enantiomeric separation using immobilized CSA and 
MD as chiral stationary phases (CSPs) in HPLC have 
not been reported. In this study, CSA and MD (DE 
4-7) have been immobilized onto monolithic HPLC 
columns and tested as new polysaccharide-based 
CSPs. A CE method has been involved to figure 
out the enantiomeric recognition behaviour in the 
presence of chiral selector at certain concentrations.
MATERIALS AND METHODS:
Chromolith® Widepore 300 Epoxy 100-4.6 mm column 
and Chromolith® NH2 100-4.6 mm column were 
kindly provided by Merck KGaA Darmstadt, Germany. 
H2SO4, NaIO4, NaCNBH3, NH2CH2CH2NH2, 
Na2HPO4, CSA sodium salt (bovine trachea), MD (DE 
4-7), (R, S)-amlodipine, and (R, S)-verapamil were 
acquired from Sigma-Aldrich (Steinheim, Germany). 
Acetonitrile (HPLC grade) were obtained from Merck 
(Darmstadt, Germany). Water was purified by Arium® 
Sartophore 0.2 µm, Sartorius (Gottingen, Germany). 
CSA and MD were introduced by circulating them 
into monolithic epoxy and monolithic amine column 
under basic condition at a constant low flow rate, 
respectively. Afterward, the immobilization process 
was followed by a Schiff base reaction. The 
enantiomeric separations were performed using CE 
Agilent® and HPLC Hitachi®. 
RESULTS:
The immobilized CSA-based and MD-based HPLC 
chiral columns have shown enantiomeric separations 
of amlodipine and verapamil as model compounds.
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CONCLUSION:
The optimal concentrations of the chiral selectors 
which were obtained by CE method showed 
successful separations after immobilization on 
HPLC columns. Further studies will be conducted 
by experimental design for method optimization and 
by molecular modelling to investigate the possible 
interaction mechanisms between the two chiral 
selectors and target drugs. 
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P-254: DETERMINATION OF 
CIPROFLOXACIN IN AN OPHTHALMIC 
SOLUTION BY DERIVATIVE 
SPECTROPHOTOMETRIC METHOD
Dermis, S., Kilic, S., Ertekin, ZC., Dinc, E.
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INTRODUCTION:
Ciprofloxacin is an antiinfective agent which belongs 
to the class of fluoroquinolones. Beside its systemic 
use, it is also indicated for the bacterial eye infections 
(1). The purpose of this study was to develop and 
validate a first derivative spectrophotometric method 
and its application to the analysis of ciprofloxacin eye 
drops. 
MATERIALS AND METHODS:
The absorbance spectra of calibration samples 
were recorded between 200-400 nm in the linear 
working range of 3.0-28.0 µg/mL. Zero order and first 
derivative spectra of the calibration set were given in 
Figure 1. The calibration equation was obtained using 
the derivative values at 283.2 nm. The method was 
validated by means of recovery, standard addition 
and repeatability studies. After validation studies, 
the proposed method was applied for the analysis 
of eye drop solution which contained 3.5 mg/mL 
ciprofloxacin.
Figure 1. Zero order and first derivative spectra of calibration set
RESULTS:
The proposed method was proved to be accurate, 
precise, selective and reliable by the validation 
studies. The average of ten assay results were 
calculated as 3.47 mg/mL (s=0.03 mg/mL). 
CONCLUSIONS:
A simple derivative spectrophotometric method 
was developed, validated and then it was applied 
to the determination of ciprofloxacin in eye drop 
formulations.
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P-255: A COMPARATIVE STUDY ON THE 
LIQUID CHROMATOGRAPHIC RETENTION 
& SEPARATION CHARACTERISTICS 
OF SEVEN PARABEN DERIVATIVES IN 
DIFFERENT COLUMNS 
1,2 Ozcan, S., 1,2 Kozanli, M., 1,2 Can, NO.
1Anadolu University, , Faculty of Pharmacy, 
Department of Analytical Chemistry Eskisehir, Turkey
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INTRODUCTION:
Paraben derivatives are widely used as antimicrobial 
preservatives in foods, cosmetics and pharmaceuticals 
(1). Variations on the liquid chromatographic retention 
and separation of seven paraben derivatives, 
namely methylparaben (MP), ethylparaben (EP), 
n-propylparaben (NPP), i-propylparaben (IPP), 
n-butylparaben (NBP), i-butylparaben (IBP) and 
benzylparaben (BP) were studied by utilizing different 
types of stationary phases (n=3). The effect of particle 
structure, retention characteristics, system suitability 
parameters were investigated, and the results were 
compared with each other for a brief performance 
evaluation.
MATERIALS AND METHODS:
Analyses were performed using a Nexera series 
of UHPLC system, which was composed of the 
following components (all from Shimadzu, Japan): 
Two LC-30AD binary pumps equipped with a DGU-
A5R on-line degasser for each, an SIL-30AC 
autosampler, a CBM-20A system controller and an 
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SPD-M20A photodiode array detector. Acceptable 
chromatographic separation was succeeded under 
gradient elution conditions without use of buffer, 
and compounds were monitored at 254 nm. The 
proposed method was applied on real cosmetics and 
pharmaceuticals samples.
RESULTS:
The highest separation efficiency with acceptable 
resolution and reasonable retention was obtained 
when Kinetex® C18 (2.6 μm particle size, 150 x 3.0 
mm, Phenomenex Co.) column was used, which was 
followed by C18 BEH (1.7 μm, 50 × 2.1 mm, Waters) 
and Kinetex® C18 (1.3 μm particle size, 50 x 2.1 mm, 
Phenomenex Co.).
CONCLUSIONS:
Moderate differences in the system suitability 
results were observed regarding the examined 
columns, which were inferred to be associated to 
the differentiations in the particle size and pathway 
length. Among the columns tested, the best choice 
for separation of mentioned compounds seem to be 
Kinetex® C18 with 2.6 μm particles.
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INTRODUCTION:
Nitrating agents act as reactive compounds and help 
formation of nitric oxide and peroxynitrit. They can 
react with a number of biomolecules such as DNA, 
proteins and lipids. Tyrosine nitration changes the key 
properties of amino acids such as redox potential, 
hydrophobicity and the values of pKa. They also react 
with Tyrosine (Tyr) to form 3- Nitro-L-tyrosine (3-NT) 
replacing by hydrogen in the ortho position of the 
phenolic ring of the Tyr residues with a nitro group 
(-NO2). Therefore, 3-NT could be used a marker of 
nitrative stress.
MATERIALS AND METHODS:
In this work, we aim to detect 3-NT and its interaction 
with DNA oligonucleotides by using its oxidation/
reduction properties with differential pulse voltammetry 
(DPV). In our platform, we activate electrodes to 
provide effective surface area, immobilize the probe 
sequences were onto the electrodes by dipping 
electrodes into the probe solution and we activate 
the probe coated electrodes with its target sequence 
to create hybrid form on the surface of electrodes 
(Figure A).
RESULTS:
In order to detect the hybridization and interaction 
events, we measured the changes in the oxidation 
signal of the guanine bases of DNA versus Ag/
AgCl reference electrode with DPV. 3-NT behaves 
as a ‘hybridization indicator’ due to its distinct 
electrochemical behavior to different strands of DNA. 
After interaction with 3-NT, guanine oxidation signals 
of probe signals decreased dramatically whereas 
hybrid signals remain almost unchanged. The signal 
differences enabled us to distinguish single stranded 
DNA (ssDNA-probe) and double stranded DNA 
(dsDNA-hybrid) without using a label or tag. We also, 
for the first time, showed the detection of hybridization 
of DNA by using the reduction signal of 3-NT. We 
observed the changes of the reduction signals of 3-NT 







We demonstrated a new hybridization indicator, 
3-NT, by utilizing both its reduction and guanine 
oxidation signal changes, where the total time of our 
measurements as short as 1hr., including activation 
of electrodes, hybridization, attachment of DNA 
oligonucleotides to the surface and interaction with 
3-NT.
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INTRODUCTION:
Montelukast Sodium, a specific cystenyl leukotriene 
receptor antagonist belong to styryl quinolines and 
Desloratadine is a non-sedating H1 ant,-histamine. 
Fixed dose combination tablet containing Montelukast 
Sodium and Desloratadine used for the treatment 
of asthma and allergic rhinitis. UPLC refers to ultra-
performance liquid chromatography, which enhance 
mainly in three areas: “speed, resolution and 
sensitivity. This new category of analytical separation 
science retains the practicality and principles of 
HPLC. In the last decade, Bilayer tablet technology 
interested in developing a combination of two or 
more Active Pharmaceutical Ingredients (API) in a 
single dosage form (bilayer tablet) has increased 
in the pharmaceutical industry, promoting patient 
convenience and compliance. Bilayer tablets can be 
a primary option to avoid chemical incompatibilities 
between API by physical separation. The aim of this 
study is to demonstrate an UPLC method for the 
simultaneous, determination of montelukast sodium, 
desloratadine and their impurities from fixed dose 
combination.  
MATERIALS AND METHODS:
Waters Acquity UPLC H-Class system equipped 
with a diode array detector was used for analysis. 
Analyses have been conducted with the the Zorbax 
SB-PHENYL (50 mm x 4.6 mm, 1.8 µm), analytical 
column. The mobile phase consisted of acetonitrile 
with triflouroaceticacid: ammonium acetate buffer 
solution by flowing program at 25°C. Detection 
wavelength was selected as 238 nm. Forced 
degradation studies were carried out by using tablet 
form. The degradation studies were performed under 
certain conditions included acid hydrolysis, base 
hydrolysis, oxidation, fotostability, heating in the oven 
at 70°C. The results were compared to the untreated 
tablet solution.
Lorclast 5/10 mg Film Coated Tablets (Nobel 
Pharmaceutical Company) was used as a test product. 
These tablets are bilayer tablets. Montelukast sodium 
on one layer and desloratadine on the other layer 
are present as active ingredient. In addition, bilayer 
Lorclast 5/10 mg Film Coated tablets containing 
montelukast and desloratadine in different layers as 
well as monolayer tablets containing both in the same 
layer were also analyzed.
RESULTS:
Degradation studies were carried out to examine the 
selectivity of the analytical method. It was observed 
that the degradation products did not interfere with 
the active substances in 6 different degradation 
conditions. Therefore, the developed method 
is suitable for analysis of the active ingredients 
simultaneously with possible degradation product. 
Bilayer tablets are lower in impurity degradation under 
ICH accelerated stability conditions (40°C ± 2°C/75% 
RH ± 5% RH ) and the product is more stable.
CONCLUSIONS:
As a result of this study, fast, simple, sensitive, 
selective and fully validated UPLC method has been 
developed under developed conditions. The proposed 
rapid and sensitive UPLC method will be readily 
applicable in quality control laboratories since for 
simultaneous quantification of Montelukast Sodium 
and Desloratadine. Thus, the feasibility of the method 
in complex matrices such as drug samples has also 
been demonstrated. 
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INTRODUCTION:
Granisetron (GRA) is a selective 5-hydroxytryptamine 
receptor antagonist that has proved to be effective 
in the prevention and treatment of chemotherapy-
induced nausea and vomiting following intravenous 
administration (1). In this study a rapid, sensitive and 
specific liquid chromatographic (RRLC) method was 
developed, validated and applied to pharmaceutical 
preparations of GRA.
MATERIALS AND METHODS:
The instrument was Agilent Technologies 1200 LC 
series with RF detection. All chemical solutions were 
analytical grade. GRA was dissolved in MilliQ water. 
Metoprolol was used as an IS. The excitation and 
emission wavelengths were 223 nm and 340 nm, 
respectively. Separation was achieved by a C6 phenyl 
column (3.0×150.0 mm, 5.0 µm i.d.). 30 mM acetate 
buffer:methanol (7:3, v/v) (pH 4.0) system was used 
as a mobile phase at a flow rate of 0.85 mL/min.
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RESULTS:
For the optimization of method, buffer concentration, 
organic solvent ratio, pH, flow rate and injection 
volume were investigated. Retention times for GRA 
and IS were 4.57 min 2.95 min, respectively under the 
optimum conditions. The validation of the developed 
method was examined by linearity, precision, 
accuracy, sensitivity, stability, specificity and 
robustness parameters. The LOQ of the method was 
found to be 2.04×10-8 M. The developed method was 
successfully applied to GRA tablets and ampoules. 
CONCLUSIONS:
The method described here is simple, fast, sensitive 
and reproducible. It was applied to tablets containing 
1 mg GRA and ampoules containing 3 mg/mL GRA. 
The contents of the pharmaceutical preparations were 
found to be in the limits of USP39 (2). This method is 
proposed for the routine analysis of GRA.
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INTRODUCTION:
Nonsteroidal anti-inflammatory drugs (NSAIDs) are 
among the most widely used medications in the world 
due to their demonstrated efficacy in reducing pain 
and inflammation (1). NSAIDs have a crucial role in 
management and treatment of many diseases and 
disorders as headaches, dental pain management, 
osteoarthritis, rheumatoid arthritis, dysmenorrheal, 
ankylosing spondylitis and gout (2). In this study, 
we aim first to determine the pKa values of twenty 
3-(4-substituted piperazinomethyl) benzoxazolinone 
derivatives (HH01-20) using spectrophotometric 
methods. Potentiometry is used later to confirm 
acidity constants obtained. The relevance of this 
study lays in the importance of determining the acidity 
constant of the studied compounds thus to further 
understand their chemical characteristics and other 
pharmacological effects (3). Furthermore, we also 
discuss the relationship between the acidity constant 
and analgesic/anti-inflammatory activities of these 
drug candidates.
MATERIALS AND METHODS:
In this study, the pKa values of twenty compounds 
have been investigated by using Agilent 8453 UV-
Vis spectrophotometer. The concentration of the 
stock solutions of all studied compounds was 0.01 
M in acetonitrile. The final concentration in the buffer 
solution was 2x10-5 M. Simple buffer systems were 
used with pH values between 1 and 12 and the 
chemicals used to prepare these buffer solutions were 
of analytical grade. In the potentiometric method, 
Metter Toledo pH 2100 Series was used. 
RESULTS:
To understand the chemical interaction between the 
compounds and their pharmacological effects, the 
acidity constant (Ka) is a considerable important 
parameter. The link between Ka and the compound is 
used as a part of the investigations of new synthesis 
method for a drug candidate and in the explanation of 
the biopharmaceutics properties of these substances. 
The position of the equilibrium reaction was suggested 
based on the experimental evidence for studied 
compounds. The pKa values of these compounds 
were determined to be between 7.36 and 8.99. In 
view of the experimental confirmation, the equilibrium 












N N NO2 + H+
It was suggested that the protonation b should b be 
on the nitrogen atom of piperazine ring. Analgesic 
activities of molecules were compared with pKa 
values of molecules. Due to the acidic and / or basic 
character of the compounds that show different 
activities, the ionization degrees of them could be 
determined by pH values and acidity constant with 
regarding its medium. 
Conclusion: Our results suggest that analgesic/anti-
inflammatory activities of HH01-20 changed when the 
pKa values of compounds were changed. Based on 
the experimental data, the electron withdrawing groups 
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(chlorine or fluorine atom) on benzoyl derivatives at 
the 6th position of benzoxazolinone or on the main 
structure of benzoxazolinone ring showed more basic 
character. Acetyl substituted derivatives have shown 
more basic characters than the other compounds and 
have given more pharmacologic activities.
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dioxolan-4-yl]methoxy}piperazine (KC), is a highly 
effective broad spectrum antifungal agent (1). KC is 
one of the most famous antifungal medications and a 
potent inhibitor against the enzyme cytochrome P450. 
Several statins, including simvastatin and lovastatin, 
interact with this hepatic microsomal enzyme, which 
is responsible for a significant portion of the statin 
clearance (2). It suppresses testosterone and cortisol 
synthesis. KC has a strong antifungal activity against 
dermatophytes and yeast. KC containing shampoo 
rapidly exfoliates and pruritus, which is associated 
with pityriasis versicolor, seborrheic dermatitis and 
pityriasis capitis (3).
MATERIALS AND METHODS:
The method is based on a carbon paste electrode 
modified by the addition of sepiolite clay. Square 
wave adsorptive stripping voltammetry (AdsSWV) 
technique was employed with the electrode as the 
anode. Electrochemical redox properties of KC were 
investigated by using cyclic voltammetry (CV) on the 
same electrode. 
RESULTS:
The CV studies show that KC has one oxidation 
signal at about +0.580 V in pH: 9.0 0.1M BR buffer. 
The anodic peak current of KC in AdsSWV varies 
linearly with the concentration range of 0.1 – 10 nmol 
L-1. Dedection limits and quantification limits were 
calculated as 0.025 nmol L-1 and 0.08 nmol L-1, 
respectively. 
CONCLUSIONS:
This voltammetric technique has been applied to KC 
analysis in cosmetic preparation (ketoral shampoo) 
and acceptable results were obtained.
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INTRODUCTION:
Cancer is the second leading cause of death after 
heart attack. Biosensors application holds great 
potential in cancer detection and clinical diagnosis. 
Electrochemical biosensors are most preferred in 
this regard owing to their small size, and ease of use, 
portability and cost effectiveness. This work is focused 
on improving the sensitivity of a nanobiosensor 
by modifying a screen-printed electrode with gold 
nanoparticles (AuNPs) and graphene oxide (GO) to 
detect interaction of anticancer drug Daunorubicin 
hydrochloride with DNA.
MATERIALS AND METHODS:
10 µL GO was dropped on electrode surface and 
allowed to dry at room temperature followed by 
placement of 5 µL AuNPs and 15 µL ct-dsDNA on 
screen printed electrode surface. All experiments 
were done in phosphate buffer of pH 4.65. Scanning 
electron microscopy (SEM) and UV-Visible 
spectroscopy were done to support drug-DNA 
interaction.
RESULTS:
Nanobiosensor developed with modification 
techniques implied an enhanced sensitivity of 
electrode in terms of surface area and the active sites 
that must increase on the electrode. By immobilizing 
nanoparticles and GO, the electrode surface 
became rich in active sites and thus the active area 
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(1). Physically it can be seen from SEM Images of 
electrode before and after modification with clear 
demarcation of granule like appearance of electrode 
after modification. Spectroscopic results supported 
these electrochemical results (2).
CONCLUSION:
A highly sensitive novel DNA electrochemical 
nanobiosensor was successfully developed for 
anticancer drug detection.
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INTRODUCTION:
Perindopril (PER) is an angiotensin converting enzyme 
(ACE) inhibitor used either alone or in combination 
in the treatment of hypertension. Indapamide (IND) 
is a benzamide-sulfonamide-indole derived diuretic 
and antihypertensive drug. Amlodipine (AML) is a 
member of the drug class long-acting dihydropyridine 
calcium channel blocker used to treat of hypertension 
and angina pectoris. Combination of Perindopril/
Indapamide/Amlodipine used for the treatment of 
arterial hypertension.
MATERIALS AND METHODS:
There exists no literature for the simultaneous 
detection of these ternary mixture using liquid 
chromatography with using new generation core-shell 
silica columns and ratio derivative spectrophotometry. 
Proposed study aimed to develop environmentally 
friendly, rapid, more sensitive and selective method 
for the simultaneous determination of PER, IND and 
AML using new generation HPLC columns. On the 
other hand, accuracy and precision of the developed 
liquid chromatography method and the ratio derivative 
spectrophotometry were compared by the help of 
student-t and F tests (1).
RESULTS:
In chromatographic separations, several mobile 
phase compositions were tested for the efficient 
separation, with using a new column technology 
related with superficially porous particles. Optimum 
chromatographic separation was achieved using a 
Kinetex C18 (150 x 4.6 mm I.D.5 µm) column at a flow 
rate of 1.5 mL min-1. The separation was carried out 
at 30 ºC and the diode array detector adjusted to 215 
nm. As a comparison, a spectrophotometric method 
depends on the first derivative of the ratio spectra 
was developed. This method was based on a division 
of the absorption spectrum of the ternary mixture 
by a standard spectrum of the binary mixture of the 
components and then calculating the first derivative of 
the ratio spectrum. 
CONCLUSIONS:
Finally, proposed methods were successfully applied 
for the simultaneous assay of the drug combination 
in pharmaceutical dosage forms with high recoveries.
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INTRODUCTION:
Schiff base compounds which are synthesized from 
the amine and aldehyde (ketone), can interact with 
most of the metal ions to produce various complexes. 
Schiff bases are very important materials, these 
are widely used in medicinal chemistry due to their 
diverse biological, pharmacological, antitumor 
activities. These are also used as optical and electro 
sensors, in various chromatographic methods, to 
enhance selectivity and sensitivity. Schiff bases 
have gained much importance in biomimetic 
modelling applications, designing molecular magnet 
molecules and in liquid crystals aspect. Heterocyclic 
scaffolds containing an azole ring system and phenol 
derivatives have been known to possess a wide 
range of biological application such as antifungal, 
antimicrobial and antipyretic applications. Generally, 
these are excellent chelating agents, also used as 
catalysts, intermediates in organic synthesis, dyes, 
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pigments, polymer stabilizers.
MATERIALS AND METHODS:
In this study, the ligand of 5-hydroxysalicylidene-
4-chloro-o-aminophenol was synthesized by the 
reaction of 5-hydroxysalicylaldehyde and 4-chloro-
o-aminophenol in the absolute ethanol at 60 oC by 
the catalyzed of p-toluenesulfonic acid. Later, the 
complexes of this ligand were prepared with Co(II), 
Ni(II), Cu(II) and Zn(II) in acetate forms in pure EtOH. 
Than compounds characterized by spectroscopic 
techniques.
RESULTS:
All of the Schiff bases were found to be bidentate 
ligands involving the imino nitrogen and phenolic 
oxygen atoms in the complexes and M:L ratio were 
found to be 1:2 for all the complexes. The structures 
of ligands and complexes were identified using 
Elemental Analysis, FT-IR, 1H-NMR, 13C-NMR, 
UV-Vis, Magnetic Susceptibility, SEM, X-Ray and 
Thermogravimetric Analysis as techniques. After 
characterization, these Schiff bases were investigated 
for their biological activity and antimicrobial activity.  
CONCLUSIONS:
One Schiff base ligand and six metal complexes 
were synthesized and the structures of ligands and 
complexes were characterized by various techniques 
and ensured the formation of compounds. Results 
of biological activities reveal that some of these 
compounds have good potential to be used in drug 
development. 
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INTRODUCTION:
Compounds containing the –C=N (azomethine 
group) structure are known as Schiff bases, usually 
synthesized from the condensation of primary 
amines and active carbonyl groups. Schiff bases 
are considered as a very important class of organic 
compounds, having wide ranges of applications, such 
as a reagent of analysis. Schiff’s bases considered as 
an important class of compounds in both the medical 
and pharmaceutical fields. Schiff bases are especially 
studied due to their synthetic flexibility, selectivity and 
sensitivity towards transition metals. Schiff base metal 
complexes have a variety of biological applications 
in clinical, pharmacological areas and several 
derivatives have been used as drugs. Schiff base 
Heterocyclic containing nitrogen, oxygen and sulfur 
atoms constitute a class of compounds which shows 
momentous biological activities, such as antiviral 
activity, antifungal, antioxidant, anti-malarial, 
anti-proliferative, anti-inflammatory, antitumor, 
anticancer, antibacterial activities, 
and antipyretic applications. They have important 
physiological activity and applications in analytical 
chemistry. 
MATERIALS AND METHODS:
In this study, the ligand of 3-metoxy-5-nitrosalicylidene-
4-chloro-o-aminophenol was synthesized by the 
reaction of 3-metoxy-5-nitrosalicylaldehyde and 
4-chloro-o-aminophenol in the absolute ethanol at 
60 oC by the catalyzed of p-toluenesulfonic acid. 
Later, the complexes of this ligand were prepared 
with Co(II), Ni(II), Cu(II) and Zn(II) in acetate forms 
in pure EtOH. Than compounds characterized by 
spectroscopic techniques.
RESULTS:
All of the Schiff bases were found to be bidentate 
ligands involving the imino nitrogen and phenolic 
oxygen atoms in the complexes and M:L ratio were 
found to be 1:2 for all the complexes. The structures 
of ligands and complexes were identified using 
Elemental Analysis, FT-IR, 1H-NMR, 13C-NMR, 
UV-Vis, Magnetic Susceptibility, SEM, X-Ray and 
Thermogravimetric Analysis as techniques. After 
characterization, these Schiff bases were investigated 
for their biological activity.
CONCLUSIONS:
One Schiff base ligand and six metal complexes 
were synthesized and the structures of ligands and 
complexes were characterized by various techniques 
and ensured the formation of compounds. Results 
of biological activities reveal that some of these 
compounds have good potential to be used in drug 
development. 
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INTRODUCTION:
In metabolomics, the purpose is to identify and 
quantify as much as metabolites in a living organism. 
Metabolomic is very sensitive to a variety of external 
stimuli, drug exposures, genetic modifications, and 
disease pathways. Therefore metabolomics can help 
identifying the phenotype/pathophysiology of diseases 
and finding new therapeutic targets. Combined gas 
chromatography with mass spectrometry (GC/MS) is 
one of the most powerful techniques and commonly 
used in metabolomics studies.
Airway inflammation is an important component of 
various airway diseases such as asthma and chronic 
obstructive pulmonary disease (COPD). Identifying 
the possible changes in the plasma metabolomic 
profile in airway inflammation can help to find 
new biomarkers and therapeutic targets in these 
diseases. Therefore in the present study we aimed to 
investigate the systemic effect of airway inflammation 
in metabolomic profile of mouse plasma.
MATERIALS AND METHODS:
Lipopolysaccharide (LPS) was used in order to induce 
experimental airway inflammation. For this purpose, 
LPS was applied intranasally (60 µL; 0.1 mg/mL in 
PBS) to mice. The control group received vehicle 
(60 µL PBS) by the same route. 48 hours after LPS/
vehicle application mice were sacrificed by cervical 
dislocation, and the blood was collected by cardiac 
puncture. 
Metabolomic profiling of plasma samples were 
performed using GC-MS (Shimadzu). The derivatized 
sample was injected split (1:10) by an auto sampler 
into a gas chromatograph equipped with a 30 m (+10 
m duraguard)×0.25 mm i.d. fused-silica capillary 
column with a chemically bonded 0.25-µm DB-5MS 
stationary phase. The column temperature was held 
at 60°C for 1 min, then increased to 325°C, and held 
there for 10 min.
RESULTS:
Comparative metabolomic analysis of plasma 
samples from mouse was carried out based on the 
GC-MS metabolomic profiling to scan wide range of 
metabolites. The plasma samples were compared 
with control group in order to identified metabolites in 
a biological system. Urea, linoleic acid and L-alanine 
levels were significantly (p<0.05) altered in the LPS 
group.
CONCLUSIONS:
The altered level of alanine may indicate the oxidative 
stress, but interestingly not in the lactic acid level. The 
urea and linoleic acid levels were indicating changing 
in urea cycle and fatty acid metabolism.
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INTRODUCTION:
Today’s innovative technologies permit comprehensive 
screening of the genome, transcriptome, proteome, 
and metabolome. In metabolomics, the purpose is 
to identify and quantify as much as metabolites in a 
biological system. Combined gas chromatography 
with mass spectrometry (GC/MS) is one of the 
most powerful techniques and commonly used in 
metabolomics studies. In this study, metabolomics 
analyzes were performed in maternal plasma by 
GC-MS to determine the metabolites to be used 
in the differentiation of pregnant women with 
methylenetetrahydrofolate reductase polymorphisms 
(MTHFR).
MATERIALS AND METHODS:
This study was consisted of 11 pregnancies with 
MTHFR polymorphisms as a study group and 10 
normal pregnancies as a control group. Study group 
enrolls MTHFR C677T homozygosity, compound 
heterozygosity (C677T and A1298C) and MTHFR 
C677T heterozygosity in 3, 3 and 2 cases respectively. 
The plasma sample was by centrifugation for 20 min 
at 1500 rpm at +4°C temperature. 100 µL of plasma 
was extracted with 900 µL methanol:water (8:1, v/v). 
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After extraction, 300 µL of the extract was evaporated 
to dryness in a vacuum dryer concentrator. Then, 
20 µL of methoxyamine hydrochloride (20 mg mL-
1) solution in pyridine was added to the sample for 
methoxymation. After 90 min at 30 °C, the sample 
were took out and derivatized with trimethylsilyl for 
30 min at 37 °C by adding 80 µL of MSTFA with 1% 
TMCS. After derivatization, 50 µL of the samples were 
transferred into GC-MS vials. 
RESULTS:
21 plasma samples were collected from pregnancies 
with MTHFR polymorphisms and healthy pregnant 
women. The data from GC-MS analysis is 
transformed into meaningful data through multivariate 
analysis of global profiling by PLS-DA allowing 
deeply investigation of the metabolomic profile 
differences between the groups. The PLS-DA scores 
plots demonstrate that genetic polymorphisms and 
gestational age caused changes in the metabolomics 
profile. 
CONCLUSIONS:
The pre-existing differences determined by the 
genetic polymorphisms of the pregnancies were less 
marked than the effects of the gestational age. This 
is indicated that MTHFR polymorphic pregnant are 
more susceptible / sensitive to the gestational age.
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INTRODUCTION:
Mercury is one of the most well-known toxic 
contaminants in aquatic ecosystems and even low-
level Hg(II) exposure is considered to be a significant 
human health hazard. Because accumulation of 
Hg(II) through the food chain in the human body 
can lead to serious problems to the central nervous 
system and damage to the brain, kidney, lungs, and 
the developing fetus (1). Many analytical methods 
of mercury determination are also used. Of them; 
atomic absorption spectroscopy, inductively coupled 
plasma-mass spectrometry, spectrophotometry and 
voltammetry are the most common methods.
MATERIALS AND METHODS:
CHI 1230B model electrochemical analyzer was used 
in this study. The three electrode system consisting of 
a pencil graphite electrode as the working electrode, 
a platinum electrode as the counter electrode and 
Ag / AgCl (3M NaCl) as the reference electrode were 
used. The solutions used in the experiment were 
prepared using deionized water from the analytical 
purity salts of the respective chemicals. Optimal 
supporting electrode, optimum working electrode and 
working potential were determined. The interference 
effects of some ions in the Hg2+ assay were studied. 
The synthetic Hg2+ samples were then prepared. The 
synthetic samples were determined by Hg2+ standard 
addition method using square wave voltammetry.
RESULTS:
When studying the best working conditions for the 
determination of Hg2+, it was seen that the best 
working electrode was the pencil graphite electrode, 
the best supporting electrolyte was pH =7.0 phosphate 
buffer, and the working potential range was -1.20 
to +0.60 V. In those conditions, it was observed of 
Hg2+ had a very low cathodic peak at -0,097 V and 
a well observed oxidation peak at +0,223 V in the 
cyclic voltammetry and square wave voltamograms. 
Hg2+ was determined using a +0,223 V anodic peak. 
It was observed that the detection limit of the work 
was 1.961×10-7 M and the limit of the quantity was 
5.882×10-7 M.
CONCLUSIONS:
Electrochemical methods are more advantageous 
because they are faster and less costly than other 
methods. This study does not require any preliminary 
work with the reason that pencil graphite electrode is 
used as working electrode.
REFERENCES:
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INTRODUCTION:
Adrenaline, also known as epinephrine 
[1-(3,4-dihydroxyphenol)-2-ethylaminoethanol], is 
found in body fluids and nerve tissues. Adrenaline is an 
important catecholamine that is secreted in response 
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to internal and external stressors and functions in the 
central nervous system of the mammals and acts as a 
hormone. Adrenaline increases digestion of glycogen, 
especially in the striated muscle, and reduces 
glycogen biosynthesis. It is effective on the heartbeat. 
In emergency situations, adrenalin can increase 
the heart rate and activate the whole organism. It 
is frequently used in emergency clinics, especially 
during a heart attack (1,2). Because of these reasons, 
determine of adrenaline is important. In this study, 
a novel modified carbon paste electrode using the 
Tryptophan-attached nanomaterial (4-Formyl-3-
methoxyphenoxymethyl)-polystyrene (AMEBA-Trp) 
for determination of adrenaline was prepared. For this 
purpose, firstly, these compounds were synthesized. 
Then the optimal working conditions of the modified 
carbon paste electrode were determined.
MATERIALS AND METHODS:
Tryptophan-attached nanomaterial(AMEBA-Trp) 
was synthesized. Modified carbon paste electrode 
was prepared by mixing graphite powder, nujol and 
nanomaterial. Electric contacts were made by platinum 
wire. The electrochemical studies were carried out 
using an CHI 1230B electrochemical analyzer. The 
working electrode was a carbon paste electrode. The 
auxiliary and reference electrodes were a Pt wire and 
Ag/AgCl electrode, respectively. The determination 
of adrenaline is based on the oxidation of adrenaline 
by using square wave voltammetry with modified 
electrode.
RESULTS:
When studying the best working conditions for the 
determination of adrenaline, it was seen the best 
supporting electrolyte was pH =6.5 phosphate buffer. 
The oxidation peak at of adrenaline was observed 
+0,188 V by using square wave voltammetry. 
Determination of adrenaline was determined using a 
+0,188 V anodic peak of adrenaline. It was observed 
that the detection limit 8.6067×10-7 M and the limit 
of the quantity was 2.4938×10-6 M for adrenaline 
determination.
CONCLUSIONS:
The modified carbon paste electrode was found to be 
sensitive to adrenaline. With the prepared electrode, 
adrenaline can be determined in various samples.
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INTRODUCTION:
Benign prostatic hyperplasia (BPH); is one of the 
most common diseases affecting the quality of life for 
elderly men, resulting in prostate enlargement due to 
proliferation of epithelial and smooth muscle cells in the 
lower urinary tract symptoms (LUTH) and the prostatic 
transition zone(1). Chemically (1- (3-hydroxypropyl) 
-5 - [(2R) -2- (2- (2,2,2-trifluoroethoxy) phenoxy] 
ethylamino) propyl] -2,3- indole-7-carboxamide), 
‘silodosin’ is an α-1-adrenoceptor antagonist with high 
urogenic activity that does not affect other tissues 
used in the symptomatic treatment of BPH. alpha-1-
adrenoceptor antagonist silodosin; it is used by elderly 
men to remove the symptoms of enlarged prostate 
such as urinary compression, frequency of urination, 
pauses when urinating, weak flow and incomplete 
bladder emptying(2,3).
MATERIALS AND METHODS:
In this study a sensitive, simple and accurate method 
was suggested for development of chromatographic 
method for the determination of  solifenacin in 
pharmaceutical preparations. Analysis was carried 
out using an Agilent® HPLC unit equipped. The 
chromatographic separation was achieved using an 
Agilent Eclipse XDB C18 (150 × 4.6 mm, 5 μ) column, 
the mobile phase was made up of 10mM ammonium 
formate buffer (pH of 4), acetonitrile and methanol 
at a ratio of 55:32,5:12,5 v/v/v, running through the 
column at a flow rate of 1ml/min and with ultraviolet 
(UV) detection set at  210nm. Zolmitriptan is used as 
internal standart.
RESULTS:
Silodosin and the internal standard zolmitriptan 
eluted whose retention time were 1,52 and 2,45 
minutes respectively. The method was validated 
for linearity in the working concentration range of 
1-90µg/ml. Linearity was observed with a coefficient 
of determination (r2 ) of 0.9998. The recoveries 
obtained were all better than 101,2% and the limit of 
quantification and limit of detection were 0,9 µg/ml 
and 0.30 µg/ml, respectively. 
CONCLUSIONS:
The proposed method was successfully used for the 
determination of solifenacin in pharmaceutical tablet 
with no significant interferences of excipients.
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INTRODUCTION:
Overactive bladder (OAB) is a prevalent condition 
that has a significant impact on quality of life. The 
first-line pharmacological treatment commonly 
utilizes anticholinergic agents, which may be 
limited by their tolerability, efficacy, and long-term 
compliance. Solifenacine succinate, which is a 
chemical name [(3R)-1-azabicyclo [2.2.2] octan-
3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-
2-carboxylate, butanedioic acid; is a selective M3 
muscarinic antagonist and it is an anticholinergic and 
antispasmodic agent used in the treatment of urinary 
incontinence and overactive bladder syndrome 
(1). The aim of this study to develop simple, rapid, 
sensitive, reproducible and accurate method that can 
be applied to pharmaceutical preparations containing 
solifenazine. 
MATERIALS AND METHODS:
In this study a sensitive, simple and accurate method 
was suggested for development of chromatographic 
method for the determination of the amount of 
solifenacin in pharmaceutical preparations. Analysis 
was carried out using an Agilent® HPLC unit 
equipped. The chromatographic separation was 
achieved using an Agilent Eclipse XDB C18 (150 × 
4.6 mm, 5 μ) column, the mobile phase was made 
up of 10mM ammonium format buffer (pH of 4), 
acetonitrile and methanol at a ratio of 55:32,5:12,5 
v/v/v, running through the column at a flow rate of 
1ml/min and with ultraviolet (UV) detection set at a 
wavelength of 210nm. Zolmitriptan is used for internal 
standard.
RESULTS:
Solifenacin and the internal standard zolmitriptan 
eluted after 1,52 and 5,9 minutes respectively. The 
method was validated for linearity in the working 
concentration range of 1-60µg/ml. Linearity was 
observed with a coefficient of determination (r2) 
of 0,9998. The recoveries obtained were all above 
99,7% and the limit of quantification and limit of 
detection were 1 µg/ml and 0.33 µg/ml, respectively. 
CONCLUSIONS:
The proposed method was successfully used for the 
determination of solifenacin in pharmaceutical tablet 
with nosignificant interferences of excipients.
REFERENCES:
1.  Finney SM, Andersson KE, Gillesple JI, Stewart 
LH (2006). BJU International, 98: 503-507.
P-272: DEVELOPMENT AND VALIDATION 
OF HPLC METHOD FOR SIMULTANEOUS 
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INTRODUCTION:
Topical corticosteroid betamethasone dipropionate 
(BET), which is a medium potency anti-inflammatory 
that is more potent than hydrocortisone and has 
anti-inflammatory, anti-pruritic and vasoconstrictive 
properties. Betamethasone in the cream formulations 
works by blocking the production of inflammatory 
chemicals, like prostaglandins and leukotrienes, 
which are hormone-like substances involved in the 
inflammatory process.  It also narrows and constricts 
causes blood vessels that have become dilated 
(widened) and leaky allowing other inflammatory 
cells into the skin to escalate the inflammatory 
response.  This reduces symptoms of inflammation 
associated with fungal infection.  Ketoconazole (KET), 
a synthetic broad-spectrum antifungal is administered 
both in orally and topical formulations to treat a variety 
of fungal infections.  This drug is classified as a BCS 
Class II due to its high permeability but low aqueous 
solubility.
MATERIALS AND METHODS:
There exists no literature for the simultaneous 
detection of BET and KET in fixed dose combination 
using liquid chromatography. Proposed study aimed 
to develop environmentally friendly, rapid, more 
sensitive and selective method for the simultaneous 
determination of BET and KET. This study also 
proposed a novel fixed dose topical formulation to 
enhance the solubility and permeability of active 
substances. The proposed HPLC method was applied 
to these formulations. On the other hand, validation 
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parameters such as accuracy, precision and recovery 
studies were also performed (1).
RESULTS:
In chromatographic separations, several mobile 
phase compositions and columns were tested for 
the efficient separation using system suitability 
parameters. Optimum chromatographic separation 
was achieved using a Thermo BDS Hypersil C18 
(250 x 4.6 mm I.D.5 µm) column at a flow rate of 1.5 
mL.min-1. The separation was carried out at 40 ºC 
and the UV detector adjusted to 239 nm. 
CONCLUSIONS:
Finally, proposed methods were successfully applied 
for the simultaneous assay of the drug combination 
in pharmaceutical dosage forms with high recovery 
values for KET 99.85%, for BET 100.10%. 
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INTRODUCTION:
Inorganic compunds have had gained great 
importance in the area of ‘Medicinal Chemistry’ which 
focuses on development of potential anticancer 
drugs. Preparation of various metal based anticancer 
drugs have been under study for several decedes 
and the milestone of these studies was the discover 
and the use of the cis-platinium ([Pt(NH3)2Cl2]) as an 
anticancer drug in 1969 (1). Although the cis-platinium 
is still the most frequently used chemotherapeutic 
drug today it has some drawbacks (2). Since then 
the researchers were focused on synthesis of novel 
and more convenient metal based drugs with using 
various metal ions such as Pt(II), Cu (II), Zn(II), Ru(III) 
and Mn(III). During the synthesis of the metal based 
complexes the drug molecules acts as ligands and 
generally donate their one or two pairs of electrons 
to the central metal atom. This work focussed on the 
design of a novel compound of Pt(II).
MATERIALS AND METHODS:
In the present study the Pt(II) based complex of 
the chemotherapeutic drug epirubicin (Fig) was 
synthesized in water-methanol mixture.  The 
analytical conditions were investigated on the 
complex formation between central metal ion and 
epirubicin molecule such as time and pH. The T80 
PG UV-Visible spectrometer, Agilent VNMRS 500 




The complex formation between drug that is the ligand 
molecule and metal ion was obtained by pH control. 
pH values greater than 7, the complex was obtained. 
Obtained Pt(II) based compound was characterized 
by using UV-visible spectroscopy and additionally by 
H-NMR and LC-MS-MS.
CONCLUSIONS:
A novel metal based compound was synthesized as 
a potential drug for treatment of cancer diagnossed 
patients where chemotherapeutic drugs were 
frequently in use. 
Acknowledgements::This study was supported by 
a grant of Istanbul Technical University under TGA-
2017-40917 project name.
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INTRODUCTION:
Cordycepin (3’-deoxyadenosine) is a bioactive 
compound found in the caterpillar fungi (Cordyceps 
and Ophiocordyceps). These fungi are commonly 
used in traditional Chinese medicines and exhibits 
anti-inflammatory, anti-bacterial, antifungal, and 
anticancer effects (1-3).  The accumulation of 
phosphorylated metabolites of cordycepin has been 
observed in some cell lines treated with cordycepin 
(4-5). However, the cellular metabolism of cordycepin 
still remains to be elucidated.  Thus, the aims of this 
study are to develop a quantitative LC-MS/MS method 
for investigation the cellular metabolism of cordycepin 
and to observe the effects of cordycepin treatment on 
the cellular level of nucleotides in HeLa cells.
MATERIALS AND METHODS:
A LC-MS/MS method using the volatile ion pairing 
agent DMHA has been developed and established 
with the validation results. The method was used to 
analyse the metabolites of cordycepin in HeLa cells 
which treated with 50 µM cordycepin with or without 1 
µM pentostatin for two, eight, and 24 hours .
RESULTS:
Cordycepin very rapidly converted to 3’-deoxyinosine 
in the cell culture medium and pentostatin could be 
inhibited this deamination.  Cordycepin, cordycepin 
5’-triphosphate, and 3’-deoxyinosine accumulated in 
cells with the triphosphate as its major metabolite. It 
also was observed that the drug treatment results in 
reduction of intracellular adenine nucleotides in HeLa 
cells.  
CONCLUSIONS:
The LC-MS/MS method has been shown to have 
sufficient sensitivity and selectivity to measure 
the metabolites of cordycepin and the intracellular 
nucleotides. Using this method, the metabolism of 
cordycepin has been observed in HeLa cell and 
the cell culture medium as well. Cordycepin might 
contribute to induction intracellular of nucleotides 
depletion in HeLa cells at the long term, and this effect 
appeared to be enhanced by pentostatin.
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P-275: USE OF DAUBECHIES WAVELET 
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AND CHLORTHALIDONE IN TABLETS
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INTRODUCTION:
Atenolol (AT) is a selective beta-blocker and 
chlorthalidone (CH) is a diuretic agent. They have 
additive impacts on the cardiovascular system and are 
used for the treatment of hypertension (1). The tablets 
containing these two drug substances are commonly 
prescribed and efficient methods are needed for 
their analysis. The aim of the study was to develop 
a fast and reliable spectrophotometric method for the 
simultaneous analysis of AT and CH.
MATERIALS AND METHODS:
For the spectrophotometric determination of AT 
and CH, the overlapping spectral bands of these 
drugs were resolved by Daubechies 8-continuous 
wavelet transform (db8-CWT) method (2,3). The 
amplitudes at 244.1 nm and 224.9 nm were used 
for the determination of atenolol and chlorthalidone, 
respectively. Calibration equations were obtained 
by measuring the db8-CWT amplitudes in the 
concentration range of 6-30 μg/mL and 4-16 μg/mL for 
AT and CH, respectively. The proposed CWT method 
was validated by analyzing various binary synthetic 
mixtures of AT and CH.
Figure 1. a) Zero-order absorption spectra of AT and CH b) db8-CWT 
absorption spectra of AT and CH
RESULTS:
After the validation studies, the proposed method was 
successfully performed to analyze the commercial 
samples. The assay results were found as 98.07 mg 
and 25.38 mg per tablet for AT and CH, respectively 
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(Label claim: 100 mg AT and 10 mg CH per one mL 
solution).
CONCLUSIONS:
The amounts of AT and CH in tablets were successfully 
determined by the use of Daubechies wavelet family 
without any separation step. This simple and accurate 
method is suitable for the routine analysis and quality 
control of the tablets containing AT and CH. 
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INTRODUCTION:
Spectrophotometry is the method of choice for a lot 
of laboratories owing to its simplicity and low-cost 
equipment. However, in case of overlapping spectra, 
classical spectrophotometric methods fail to perform 
analysis of mixtures. Partial least squares (PLS) 
and principle component regression (PCR) methods 
are standard techniques devoted to multicomponent 
analysis of mixtures (1,2). The aim of this study was 
to develop simple and reliable spectrophotometric 
methods for to quantify rosuvastatin (ROS) and 
amlodipine (AML) in tablets without a separation step.
MATERIALS AND METHODS:
Standard solutions containing ROS and AML were 
prepared between 2-48 µg/mL for both drugs. After 
recording their absorbance spectra between 200-400 
nm, PLS and PCR calibrations were obtained using 
the nominal concentrations (y-block) and absorbance 
data (x-block). Number of factors were determined by 
cross-validation method. The regression coefficients 
of PLS model were reported to be 0.9994 and 0.9998 
for ROS and AML, respectively. In case of PCR model, 
the values of regression coefficients for ROS and AML 
were calculated as 0.9991 and 0.9995, respectively. 
For the validation of the methods, synthetic mixtures, 
standard addition, intra- and inter-day samples were 
analyzed. Then, the sample analysis was performed 
using these methods without any separation step.
RESULTS:
The recovery percentage values obtained by PLS 
were 101.8 for ROS and 89.7 for AML, whereas by 
PCR model, the recovery percentage values were 
reported to be 99.4 and 103.1 for ROS and AML, 
respectively. Tablet analysis results were summarized 
in Table 1.
Table 1. Tablet analysis results. (Label claim: 20 mg 
ROS/10 mg AML per tablet)
 PLS (mg/tablet) PCR (mg/tablet)
ROS AML ROS AML
Mean* 20.6 10.2 20.4 9.99
S t a n d a r d 
deviation 0.19 0.12 0.18
0.12
R e l a t i v e 
s t a n d a r d 
deviation 0.90 1.18 0.89
1.22
* n = 10
CONCLUSIONS:
The proposed multivariate methods were found to be 
simple, fast and suitable for the analysis of ROS and 
AML in tablets. These methods did not require any 
separation method for the multicomponent analysis.
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ORGANIC DROP MICROEXTRACTION 
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PEPPER PRIOR TO ITS DETERMINATION BY 
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INTRODUCTION:
Solidification of floating organic drop microextraction 
(SFODME) has recently been developed by Leong 
and Huang (1) in which a mixture of an organic 
extraction solvent with lower density than water, low 
toxicity and melting point near room temperature (in 
the range of 10–30 °C) and a disperser solvent such 
as methanol, ethanol and acetonitrile are used. In this 
study, SFODME was used prior to high-performance 
liquid chromatography (HPLC) for the extraction of 
piperine from black and white pepper from different 
origins.
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MATERIALS AND METHODS:
A 1200 SERIES Agilent Technologies Gradient 
HPLC equipped with a Diode-Array Detector (DAD), 
and a reversed-phase column (i.e., Agilent Eclipse 
XDB-C18. 4.6 mm ID  150 mm, 5 µm) was used for 
separating the analyte from other matrix components 
using a mobile phase composition of 45/55 (%, 
v/v) ACN/H2O, 5 µL injection volume, at ambient 
temperature and a flow rate of 1.2 mL min-1. Piperine 
was monitored at its maximum absorption wavelength 
of 346 nm using DAD. All chemicals used in this study 
were at least of analytical reagent grade.
RESULTS:
Piperine was extracted from the solid sample (0.10 
mg) into ACN by salting-out extraction, which was 
then used as the disperser solvent in SFODME. 
Optimum extraction conditions were as follows: 50 
µL of 1-dodecanol (extraction solvent), 950 mL of 
acetonitrile (disperser solvent) and 60 s extraction 
time. The analyte was back-extracted into 150 µL of 
50 mM acetic acid in 45/55 (%, v/v) ACN/H2O before 
being injected into HPLC. Calibration graphs showed 
good linearity with coefficients of determination () 
higher than 0.9964. Relative standard deviations 
(%RSD) for intra- and interday precisions were lower 
than 5.2 and 11.3, respectively. Limits of detection 
(LOD) ranged from 7.5 to 10.8 mg g-1 with a recovery 
of 95.0% or higher.
CONCLUSIONS:
The proposed method was proven to be fast, cost-
effective and relatively green compared to the use 
of heavy chlorinated solvents for the extraction of 
piperine from white and black pepper.
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INTRODUCTION:
S-adenosyl-L-methionine (SAMe) is an endogenic 
methyl donor naturally present in all cells. It is involved 
in many chemical reactions primarily in methylation. 
SAMe is an important alternative in the treatment of 
depression due to its non-toxic and endogenic nature 
(1). 
SAMe has two diastereoisomers. While S,S 
diastereoisomer is active, R,S diastereoisomer is 
inactive. However, there is not enough method for the 
separation of these two diastereoisomers (2).
The aim of the present work is to develop and validate 
a selective High Performance Liquid Chromatography 
(HPLC) method for the selective and sensitive 
determination of S- Adenosyl L Methionine (SAMe) 
from its bulk form and rat plasma samples. 
MATERIALS AND METHODS:
Shimadzu Prominence-LC2030C HPLC system with 
UV detector was used for method development and 
validation studies. 
A Kinetex F5 (150x4,6 mm, 5 µm; Phenomenex, USA) 
analytical column was selected as stationary phase 
due to its separation ability for the diastereomers. 
An isocratic mobile phase consisting of 0.45 % 
Trifluoroacetic acid, 5 mM ammonium acetate buffer 
(pH 4.0) was used in whole study. In order to optimize 
the chromatographic conditions, effects of injection 
volume, column oven temperature and flow rate 
were also examined. Finally, optimized method was 
validated in accordance to the International Council 
on Harmonization (ICH) guidelines by the means of 
precision, linearity, accuracy, etc.
RESULTS:
 Optimized conditions can be summarized as follows; 
20 μL injection volume; 0.8 mL.min-1 flow rate and 
25°C column oven temperature. The retention 
times for both isomers were obtained less 10 min. 
Developed method was found linear in the range 
between 25 and 4000 ng.mL-1 with correlation 
coefficient of 0.9995. Accuracy and applicability of the 
method was demonstrated by the application of rat 
plasma samples after extraction steps.
CONCLUSIONS:
A sensitive and selective HPLC method was 
developed for the determination of diastereomers of 
SAMe from bulk form and rat plasma samples with 
high recovery values. 
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INTRODUCTION:
Capsaicin has been employed topically to treat some 
peripheral painful states, such as rheumatoid arthritis, 
cancer pain and diabetic neuropathy. The high degree 
of pre-systemic metabolism of intragastric capsaicin 
and very rapid elimination half-life of capsaicin made 
topical application of capsaicin advantageous. The 
aim of this study was to evaluate differences in the 
dissolution characteristics of capsaicin patches 
purchased from the local market (formulation I, II and 
III).
MATERIAL AND METHODS:
The fabricated patch area contains 18-145 µg of 
capsaicin/cm2 of adhesive. USP Apparatus 5 (Paddle 
Over Disc) is used for transdermal patch testing at 
fixed rotation speed (50 rpm). The fabricated patch 
was cut into 9 cm2 and placed against a disc (delivery 
side up) retained with the stainless-steel screen and 
exposed to 500 mL of phosphate buffer solution pH 
4.0. All dissolution studies were carried out at 32± 
0.5°C and samples were collected at various time 
intervals (60 and 240 minutes) and analyzed for 
capsaicin content using high-performance liquid 
chromatography (HPLC). Optimized and Validated 
HPLC method uses a ProntoSIL 120-3-C18AQ 
125x4.0 mm (3μm) column maintained at 600C. 
The mobile phase consisted of acetonitrile: water 
(50:50v/v), the flow rate of 0.9 mL/min, the injection 
volume 10μL and the detection wavelength 222nm 
(1). 
RESULTS:
According to the results obtained in this study, we can 
conclude that the relative difference of dissolution rate 
of capsaicin was slightly decreased after 240 minutes: 
formulation I vs II (2.9± 0.3%), formulation I vs III (3.3± 
0.2%) and formulation II vs III (0.29± 0.07%).
CONCLUSIONS:
Although several apparatus and procedures (USP 
apparatus 5, 6, 7 and a paddle over extraction cell 
method) have been used to study in vitro release 
characteristics of transdermal patches, USP 
Apparatus 5 could be considered as a discriminatory 
test that would be able to point out the differences in 
the dissolution rate of all tested capsaicin patches at 
short sampling intervals (60 and 240 minutes).
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INTRODUCTION:
Mirtazapine is an active ingredient used in 
antidepressant drugs in tetracyclic form. Besides 
an antidepressant effect, it also shows an anxiolytic 
character (1). Mirtazapine has slightly hygroscopic 
properties, however it is insoluble in water, freely 
soluble in methanol (2).  Mirtazapine has many orally 
disintegrating tablet formulations in the market. The 
aim of this study was to develop a new dissolution 
method for orally disintegration tablets.
MATERIALS AND METHODS:
The mirtazapine used in the study is a kindly gift 
by Abdi İbrahim company (Istanbul, Turkey). UV 
spectrophotometer was used for quantitative 
analysis of mirtazapine. The calibration graph and 
standard linear equation of mirtazapine solutions 
with different concentrations prepared by serial 
dilution was obtained using the method of Özdemir 
et al. (3). Disintegration tests of mirtazapine-
containing tablets were performed. Artificial saliva 
fluids with and without carbopol were prepared and 
permeability studies of tablets were carried out on the 
Franz diffusion cell during the period of dispersion. 
After that, the dissolution rate profiles of donor 
compartment contents were evaluated by simulating 
the gastrointestinal medium, using USP Apparatus II. 
RESULTS:
The spectrophotometric method applied for 
quantitative analysis provides a fast and effective 
solution. Disintegration test results of tablets were 
meet the compendial requirements. Permeability 
differences and dissolution profiles, which they 
exhibited in two different artificial saliva fluid mediums, 
were evaluated. It has been found that the pass 
through the membrane is very limited. 
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CONCLUSIONS:
It has been found that the membrane permeation of 
the mirtazapine-containing tablet formulations of the 
appropriate physicochemical properties is negligible, 
so that liquid chromatographic methods may be 
preferred for quantitative analysis, on the other hand 
USP Apparatus II is considered to be sufficient for 
dissolution studies.
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INTRODUCTION:
The pain situation has a very important effect on the 
biological, psychological, sociological and economic 
situation of the patient (1). Dexketoprofen trometamol 
(DT) has been developed as a water-soluble 
trometamine salt. DT is a rapidly acting analgesic agent 
in the treatment of painful musculoskeletal disorders 
such as back pain and osteoarthritis (2). In this study; 
DT loaded PLGA Nanoparticles (NPs) formulated with 
Double emulsions Solvent evaporation method which 
is the most suitable method for preparing PLGA NPs 
for hydrophilic drugs. 
MATERIALS AND METHODS:
PLGA-based NPs were prepared by following 
the ‘Double Emulsification Solvent Evaporation 
Technique’. Structures of nanoparticles were 
characterized by particle size (PS) and zeta potential 
(ZP) measurements, morphology, thermal analysis 
(DSC), X-ray difraction (XRD) , FTIR and  1H-NMR.  
RESULTS:
Table 1. Result of particle size, PDI, zeta potantial
Figure 1. SEM images of PLGA NPs a: Alp-blank b: 
Alp-5 c: Alp-10
CONCLUSIONS:
NPs were prepared for chronic pain by Double 
Emulsification Solvent Evaporation Technique’. The 
PS,  PDI, ZP, DSC, XRD, FT-IR  and 1H-NMR analysis 
of formulations justified that DT was incorporated into 
PLGA NPs successfully. 
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INTRODUCTION:
Hypertension (HT), which defines systolic blood 
pressure as >140 mmHg or diastolic blood pressure 
>90 mmHg. There are now several drugs that 
are available in the market, including carvedilol 
(CVL) which is used for the management of 
cardiovascular disease and HT (1). CVL-containing 
PLGA nanoparticles (NPs) were prepared by 
nanoprecipitation method. 
MATERIALS AND METHODS:
PLGA-based NPs were prepared by following the 
nanoprecipitation technique with modification (2).
Structures of nanoparticles were characterized 
by particle size (PS) and zeta potential (ZP) 
measurements, morphology, thermal analysis (DSC) 
and FTIR.  The entrapment efficiency (EE%) and 
dissolution study of each formulation was performed 
with HPLC. In vitro release study of the NPs 
formulations was investigated over 10 days and that 
performed in phosphate buffer (pH 6.8) containing 
30 % PEG 400. Data obtained from the in vitro drug 
release studies were further investigated for release 
kinetics using DDSolver software program.
RESULTS:
Table 1. Result of PS, PDl, ZP and EE% (n=3)
Figure 1. In vitro dissolution profile of prepared 
formulation and pure CVL
CONCLUSIONS:
The PS,  PDI, ZP, DSC, FT-IR analysis of formulations 
justified that CVL was incorporated into PLGA NPs 
successfully. NPs formulations is promising to be for 
extended delivery of CVL with succesfully loaded and 
Peppas-Sahlin kinetic model was found to fit best to 
carvedilol release from nanoparticles.
ACKNOWLEDGEMENTS:
The authors would like to thank University of Sevilla, 
Faculty of Pharmacy, Department of Pharmacy and 
Pharmaceutical Technology is appreciated for offering 
their study facilities.
REFERENCES:
1.  Kipriye Z et al. (2017) Preparation and evaluation 
of carvedilol-loaded solid lipid nanoparticles for 
targeted drug delivery. Trop J Pharm Res, 16(9): 
2057-2068.
2.  Martín Banderas L, et al. (2012) Cannabinoid 
derivate-loaded PLGA nanocarriers for oral 
administration: formulation, characterization, 
and cytotoxicity studies. International Journal of 
Nanomedicine 7:5793-5806
P-284: DETERMINING THERAPEUTIC 
RESPONSE OF MULTIPLE MYELOMA BY 
MASS ACCUMULATION AT SINGLE CELL 
LEVEL
1,2 Cetin, AE., 2,3 Stevens, MM., 2 Calistri, NL.,3 
Fulciniti, M., 2 Olcum, S., 2 Kimmerling, RJ., 3 Munshi, 
N., 2 Manalis, SR.
1Izmir Dokuz Eylul University, International 
Biomedicine and Genome Institute, Izmir, Turkey
2Koch Institute for Integrative Cancer Research, 
Massachusetts Institute of Technology, Cambridge, 
MA, USA
3Harvard Medical School, Dana-Farber Cancer 
Institute, Boston, MA, USA
INTRODUCTION:
Multiple myeloma (MM) is the second most common 
hematologic malignancy in the world. Despite 
improvement in outcome, the disease is still incurable 
for most patients. With the same treatment, patient 
survival varies, suggesting that there is an underlying 
heterogeneity in the disease. Therefore, a clear 
delineation of heterogeneity in therapeutic response 
could provide unique opportunities for personalized 
treatment of myeloma.
MATERIALS AND METHODS:
Here, we introduce an approach for defining the 
sensitivity of single cells using an apparatus called 
suspended microchannel resonator (SMR) (1). 
By measuring the mass repeatedly in a device 
configuration with multiple SMRs connected in serial, 
where each SMR is separated in time by delay 
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channels, we can determine cell growth (Figure A). 
Mass accumulation rate (MAR) is a measurement of 
the rate at which the cells gain mass (Figure B). The 
platform can measure ~100 cells per hour and over a 
20-minute period, each cell is weighed 10 times, which 
is enough to get an accurate MAR measurement 
(Figure C). A decrease in MAR following drug 
treatment means the cells are sensitive to the drug, 
but if they are resistant, there is no change in MAR.
RESULTS:
We tested a variety of drugs on tumor cells from 
MM patients. For each patient, we tracked the cells’ 
response to different drug combinations including 
bortezomib, dexamethasone, and lenalidomidev 
(Figure C). We showed an excellent correlation 
between our MAR tests and the outcomes seen in 
patients, as measured by clinical protein biomarkers 
found in the bloodstream, which are classically used 
by doctors to determine whether a drug is killing the 
tumor cells (1).
CONCLUSIONS:
The major outcome of this work is to open doors for 
personalized medicine. At the point of a bone marrow 
biopsy, we would be able to inform the clinicians as 
to which therapy or combinations of therapies the 
patient seems to be most sensitive.
Acknowledgements: 
We acknowledge Bridge Project, a partnership 
between Koch Institute for Integrative Cancer 
Research and Dana-Farber Cancer Institute. 
References
1. Cetin et al., (2017). Nature Communications, 
8:1613.
P-285: EVALUATION OF 
PHYSICOCHEMICAL CHARACTERIZATION 
OF BERBERINE FOSPHOLIPID COMPLEX 
1 Karatas, A., 2 Gungor, A.,
1Ankara University, Faculty of Pharmacy, Department 
of Pharmaceutical Technology, Ankara, Turkey
2Bulent Ecevit University, Faculty of Pharmacy, 
Department of Pharmaceutical Technology, 
Zonguldak, Turkey
INTRODUCTION:
Transfer of plant-derived active ingredients to the 
modern treatment is becoming increasingly common. 
However, a significant portion of these active 
ingredients have long side chains and high polarities. 
This acts as a barrier to absorption by passive diffusion 
through the gastrointestinal mucosa or skin. At this 
point, the new complexing technique denominated 
“phyto- phospholipid complex” or “phytosomes” plays 
an important role in easing absorption and increasing 
bioavailability (1). Berberine (BER) has been 
demonstrated to posses various pharmacological 
functions. However, due to its poor aqueous solubility 
and low gastrointestinal absorption. The phospholipid-
drug molecular complexation technique has improved 
the lipophilicity of drug, reduced adverse drug 
effects and enhanced bioavailability and therapeutic 
efficacy of drug. The primary goal in this project is 
preparing the BER-phospholipid complex which was 
reported to have low absorption and bioavailability 
The physicochemical properties of the complex 
obtained by optimal parameters were investigated 
by means of differential scanning calorimetry (DSC), 
Fourier transform infrared (FTIR) and N-octanol/water 
partition coefficient (Po/w).
MATERIALS AND METHODS:
Thermograms of BER, phospholipid, BER-
phospholipid physical mixture and BER complex were 
recorded to study the thermal behavior by a DSC. 
FTIR analysis of the BER-phospholipid complex was 
used to investigate the interaction between BER and 
phospholipid. The BER, phospholipid and physical 
mixture and BER-phospholipid complex were used 
as controls for comparison. The Po/w of BER-
phospholipid complex were determined by the usual 
agitation method.
RESULTS:
It has been shown that berberine-phospholipid 
complex could be successfully prepared. The 
crystallographic and thermal analysis results 
has indicated that the BER complexed with 
phospholipid was in an amorphous form. The Po/w 
of BER-phospholipid complex studies showed BER 
phospholipid complex increased the lipophilicify of 
BER.
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CONCLUSIONS:
Our studies demonstrated that may have the potential 
for facilitating the oral drug delivery of BER.
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INTRODUCTION:
Ibuprofen, a propionic acid derivative, is a nonsteroidal 
anti-inflammatory drug used for the treatment of pain 
and inflammation. Ibuprofen is a poor water soluble 
drug (1). So that in this study we have aimed to 
investigate the solubility of ibuprofen in different oils, 
surfactants, co-surfactants and buffers and develop 
a soft gelatin capsule formulation containing 200 mg 
Ibuprofen.
MATERIALS AND METHODS:
Solubility studies of ibuprofen were carried out by 
shaking an excess amount of each drug with 1 mL of 
the different oils (oleic acid etc.), surfactants(Tween 
80 etc), co-surfactants(Transcutol HP etc.) and 
buffers(3). The samples were incubated in a 37 ̊C 
water bath at 150 rpm for 48 hours. After 48 hours, the 
samples were centrifuged in Sigma centrifuge at 3000 
rpm for 15 minute. The supernatants were collected 
and injected into HPLC (Schimadzu HPLC-PDA) 
vials for analysis. After, a high-performance liquid 
chromatography (HPLC) method was developed 
and validated for determination of ibuprofen and 
4 impurities (impurity A, impurity F, impurity J and 
impurity N). The method, a gradient condition of 
mobile phase A containing 0.1 M Disodium hydrogen 
phosphate buffer (pH 6.9) and mobile phase B 
containing acetonitrile, at a flow rate of 1.0 mL/
minute with C18 (INERSTIL (ODS 3), 150×4.6 
mm,5μm,Hichrom) column, 224nm as wavelength (2), 
was validated according to ICH guideline. The method 
showed excellent linear response with correlation 
coefficient (R2) values of 0.999. We have developed 
different soft gelatin capsule formulations with the 
combination of appropriate compounds mentioned 
above and performed the dissolution studies with 
USP Apparatus 1 (37ºC, 150 rpm, 900 mL phosphate 
buffer pH 7.2) to compare the test formulations with 
the reference formulation(Advil Liquid Gels 200mg).
RESULTS:
As a result of the solubility studies we have chosen 
some combinations of appropriate compounds 
mentioned above. According to our dissolutions 
results we have calculated f1-f2 value by comparing 
the test formulations with reference product.
CONCLUSIONS:
We have chosen the formulation with the highest 
similarity as our final test formulation according to 
f1-f2 value obtained by comparing the developed 
formulations with reference product.
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INTRODUCTION:
Eletriptan Hydrobromide is a second generation 
triptan class drug designated as R-3-[(1-methyl-2-
pyrrolidinyl) methyl]-5-[2-(phenyl sulfonyl) ethyl]-
1hindole mono hydrobromide with a molecular weight 
of 463.40 g/mol. It is used to treat migraine but not 
prevention (1). The objective of this study was to 
develop a modified W/O/W double emulsion process 
using dichloromethane as organic solvent to prepare 
Eletriptan Hydrobromide loaded nanoparticle with 
high yield, high entrapment efficiency. 
MATERIALS AND METHODS:
PLGA nanoparticles were prepared using the W/ 
O/W emulsion technique. Briefly, different amount of 
Eletriptan Hydrobromide and PVA was dissolved into 
1 ml of distilled water (internal aqueous phase) and 
then added to 3 ml of dichloromethane containing 
PLGA (oil phase). The primary W /O emulsion was 
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prepared by a probe sonicator (Bandelin, Germany) at 
30 W for 45 s. The primary emulsion was re-emulsified 
with the external aqueous phase containing PVA and 
10 mL distilled water (external aqueous phase), using 
the probe sonicator at 50 W for 60 s. Afterwards, 
the organic solvent was evaporated using rotary 
evaporator. 
RESULTS:
The difference in the particle sizes, zeta potentials, 
PDI and EE% of the nanoparticles prepared with 
W/O/W emulsification method that the water pH plays 
a key role on the resultant nanoparticle encapsulation 
efficieny 
CONCLUSIONS:
It can be concluded from the study that it is possible 
to prepare Eletriptan Hydrobromide −PLGA 
nanoparticles using double emulsification solvent 
evaporation method. The effects of variations 
in the drug, polymer, surfactant concentrations 
were evaluated through changes in the size 
of the nanoparticles. F4 was predicted as the 
optimal formulation with minimum polydispersity 
index. However encapsulation efficiency was found 
43,24±5,19 % and this result can be enhanced 
by changing polymers, surfactants or preparation 
methods. As further studies, this nanoparticles can be 
used in various root of administration for drug delivery 
studies.
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INTRODUCTION:
Flurbiprofen (FB) is one of non-steroidal anti-
inflammatory drugs. Its low water solubility causes 
lower bioavailability. To solve this problem FB 
nanosuspensions are prepared. However, nanosized 
particles demonstrate tendency toward agglomeration 
or crystal growth; so, they should be stabilized with 
stabilizers (1). The aim of this study is to evaluate the 
physical stability of optimum FB nanosuspension with 
stabilized polymeric stabilizer during 6 months. 
MATERIALS AND METHODS:
24 (2 levels, 4 factors) full factorial design using 
Design Expert® Software Version 9 was employed 
to optimize of the FB nanosuspension. The four 
independent variables and two levels studied in this 
investigation were, percentage of FB (1%- 4%) FB: 
stabilizer ratio (1:4, 4:1), type of stabilizer (HPMC-
PVP), homogenization cycle (10 pass-30 pass). FB 
nanosuspensions were prepared using Microfluidics 
LV1 (Microfluidizer® USA).  To characterize the 
formulation and investigate the physical stability of 
optimum formulation particle size (PS), polydispersity 
index (PDI) and zeta potential (ZP) values were 
measured during 6 months (initial, 1., 7.,15. days, 
1.,3.,6. months) at 25°C. The results were evaluated 
using univariate ANOVA at p<0.05 as the minimum 
level of significance. 
RESULTS:
DoE results showed that PS values decreased at 
high level of FB:stabilizer ratio regardless of type of 
stabilizer. When PVP is used as a polymeric stabilizer, 
the percentage of FB should be higher to obtain lower 
PDI.  High percentage of FB also provides to obtain 
higher ZP values. According to these results; optimum 
formulation was determined with these parameters: 
PVP as a stabilizer; 4% as percentage of FB and 4:1 
as FB:PVP ratio and 10 cycle as a homogenization 
cycle. HPMC stabilized nanosuspension was obtained 
with these optimum parameters and its stability 
compared with PVP stabilized nanosuspension. Up 
to one month, PS increased from 837,70±14,64 nm 
to 1060±10 nm for PVP stabilized nanosuspensions 
and from 1151,67±36,75 to 1686,67±6,35 nm for 
HPMC stabilized nanosuspensions at 25°C. The PDI 
values did not change significantly during six months 
(p>0.05). On the basis of ZP; whereas it was found 
lower than initial value after one week, by the end of 
six months ZP values were found constant. 
CONCLUSIONS:
Optimum formulation stabilized with PVP was found 
better to improve stabilization of FB nanosuspensions 
comparison with HPMC at 25°C during six months.
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P-289: INVESTIGATION OF 
HEALTH MINISTRY OF LICENSED 
BIOTECHNOLOGICALLY MEDICINES 
FOUND IN PHARMACIES IN TURKEY
Onbasli, D., Yuvali Celik, G., Ceylan, A., Dal, A.
Erciyes University, Department of Pharmaceutical 
Biotechnology, Kayseri, Turkey
INTRODUCTION:
The importance of biotechnology in the healthcare 
field and the pharmaceutical industry is increasing 
day by day. So, recently, the use of biotechnological 
drugs has begun to come into being from traditional 
medicines (1). In the health field, new biotechnological 
drugs have begun to be produced with the 
development of technologies like Recombinant DNA 
Technology, Monoclonal Antibody Technology. In this 
study, found in pharmacies in Turkey in 2017, the 
ministry of health licensed biotechnological active 
ingredients of drugs, mechanism of action, approved 
indications, the preparations containing these 
active ingredients in these drugs and the pregnancy 
category of these drugs by considering it is aimed to 
understand the number of these drugs, the place of 
treatment and the importance of the treatment.
MATERIALS AND METHODS:
RxMediaPharma® 2017, on the basis of domestic 
and imported biotechnological drugs in Turkey were 
scanned..
RESULTS:
In this study, a total of 191 active substances, either in 
the research phase or in the preparation phase, were 
identified, 5 of which were imported from domestic 
sources, 212 imported from drugs including these 
active substances and only 83 of them were biotech 
drugs licensed by the Ministry of Health.
CONCLUSIONS:
Located in pharmacies in Turkey in 2017, the Ministry 
of Health licensed 83 units biotechnological drugs 
have been identified.
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P-291: DESIGN AND EVALUATION OF 
ORODISPERSIBLE TABLETS (ODTS) 
CONTAINING CARBAMAZEPINE AND 
LEVETIRACETAM 
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 Ataturk University, Department of Pharmaceutical 
Technology, Erzurum, Turkey
INTRODUCTION:
Levetiracetam (LEV) and carbamazepine (CBZ) are 
antiepileptics and synergistic effect is observed when 
used together (1). Oral disintegrating tablets (ODTs) 
have advantages for patients with swallowing difficulty 
and improve patient complience, especially geriatric 
and pediatric groups (2). The aim of this study is to 
formulate LEV+CBZ ODTs by lyophilization method.
MATERIALS AND METHODS:
LEV and CBZ were generous gifts from DEVA Holding 
A.Ş. (İstanbul, Türkiye) and Biofarma İlaç San. Tic. 
A.Ş. (İstanbul, Türkiye), respectively. LEV+CBZ 
ODTs were prepared by lyophlization method and 
quality control tests (thickness, diameter, hardness, 
friability, weight variation, in vitro dispersion time and 
dissolution). In vitro dispersion time was measured by 
dropping ODT in a glass cylinder containing 6 mL pH 
6.8 of simulated saliva fluid or water (for each, n=6). 
The in vitro dissolution study was performed in pH 6.8 
phosphate buffer containing %5 Tween 80 using USP 
apparatus II (at 50 rpm) and at 37ºC.
RESULTS:
The mean diameter and thickness of ODTs (n=20) 
were 16.870±0.113 mm and 5.120±0.111 mm, 
respectively. The average hardness of ODTs was 
11.960±2.204 N and also, the percentage friability 
for ODTs was within the limit (<1%). Weight variation 
was found as 0.363±0.005 g and none of ODTs were 
found to deviate from average weight of tablets. 
In addition, in vitro dispersion time was less 30 sec 
(7.917±1.569 sec in water and 15.675±1.822 sec in 
SSF). 99.481±2.755% (LEV) and 99.899±3.822% 
(CBZ) of drugs were dissolved in dissolution medium 
within 10 and 30 minutes at 37±2 ºC, respectively 
(Figure 1). 
Figure 1. Dissolution profiles of ODTs (n=6).  
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CONCLUSIONS:
Lyophilized LEV+CBZ ODTs were successfully 
prepared and they might be useful for treatment of 
epilepsy.
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P-292: INVESTIGATION OF THE 
SOLUBILITY OF NYSTATIN AND NIFURATEL 
FOR SELECTING THE APPROPRATE 
DISSOLUTION MEDIA FOR THE OVULE 
FORMULATION
1 Ayan, C., 1,2 Karasulu, E. 
1Ege University, Center for Drug Research & 
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ARGEFAR, Izmir, Turkey
2Ege University, Faculty of Pharmacy, Pharmaceutic 
Technology Department, Izmir, Turkey
INTRODUCTION:
Intravaginal administration is an alternative drug 
administration route because of vagina’s specific 
features and it allows both systemic and local drug 
administration (1). “Macmiror Complex Vaginal 
Ovules” is the only approved drug containing 500 
mg Nifuratel and 200.000 IU Nystatin and indicated 
for the treatment of vulvovaginal diseases caused 
by pathogenic microorganisms. As well in the most 
of vaginal formulations in-vivo assays cannot be 
performed for ovules. But also, it is impossible to 
show in vitro dissolution profile because of the 
molecules’ low solubility. In this study we have aimed 
to investigate the solubility of Nystatin and Nifuratel in 
different medias to choose the best one for dissolution 
studies to compare the ovule formulation we will 
develop and the developed formulation with the 
reference product. 
MATERIALS AND METHODS:
Solubility studies of Nystatin and Nifuratel were 
performed by shaking an excess amount of each 
drug with 2 mL of the following dissolution mediums 
simulated vaginal fluid(SVF), Na2HPO4 buffer 
pH4:0.5% sodium lauryl sulfate(SLS), Na2HPO4 buffer 
pH4:1% SLS, Na2HPO4 buffer pH4:methanol(ratio 
60:40), Na2HPO4 buffer pH4 and methanol(ratio 
40:60) (2) and acetate buffer pH4.5. The samples 
were incubated in 37 ̊C water bath (130rpm). After 
24 hours, the samples were centrifuged at 10000rpm 
for 15 minutes. The supernatants were collected and 
injected into vials, analyzed with Schimadzu HPLC-
PDA by using a Phenomenex Luna-5u column, 
250mm×4.6mm and Methanol:10 mM Ammonium 
acetate buffer (pH 5.5) (70:30 v/v) as mobile phase 
with a detection wavelength of 254nm (Nifuratel(3)) 
and 306nm (Nystatin(4)). The method was developed, 
validated according to ICH guidelines.
RESULTS:
According to the results no peaks were observed 
for Nystatin and the lowest concentrations were 
observed for Nifuratel in SLS containing medias, SVF 
and acetate buffer. The media containing Na2HPO4 
buffer pH4:methanol(40:60) showed the best result 
for both Nystatin and Nifuratel.
CONCLUSIONS:
 It has been concluded that the best media for the 
former dissolution studies will be Na2HPO4 buffer 
pH4:methanol(40:60) containing media.
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Ankara University, Faculty of Pharmacy, Department 
of Pharmaceutical Technology, Ankara, Turkey
INTRODUCTION:
Rheumatoid arthritis is a disease characterized by 
diffuse and symmetrical chronic inflammation in the 
joints. Morning stiffness, loss of function and severe 
joint pain are seen especially in the early morning 
hours. The adverse effects of rheumatoid arthritis at 
certain times have led to a focus on these hours in 
the treatment of the disease. For ideal therapeutic 
efficacy, time controlled systems design to mimic 
the circadian rhythm of the rheumatoid arthritis by 
releasing the drug at the specific time (1).  The aim 
of this study was to develop time-controlled multi-
compressed tablet formulations of dexketoprofen 
trometamol (DT) used in the treatment of rheumatoid 
arthritis and to examine the effective formulation and 
process parameters on the rate of drug release from 
tablets. 
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MATERIALS AND METHODS:
Multi-compressed tablets prepared containing DT 
in the inner core were formulated by compression-
coating with ethylcellulose as the outer layer in 
different amount. All tablet formulations were prepared 
by direct compression method. Prepared tablets were 
evaluated for various physical parameters such as 
hardness, thickness, diameter, weight variation and in 
vitro drug release characteristics. In vitro dissolution 
rate studies were performed at three different pH 
using the USP pallet method.
RESULTS:
It has been observed that the increase in the amount 
of polymer in the outer layer has adversely affected 
the in vitro dissolution rate properties of DT. It has 
been determined that the increase in the compression 
pressure during the press-coating of the outer shell 
layer increases the lag time. Optimized formulation 
achieved a burst release of the drug from tablets after 
4 h lag time.
CONCLUSIONS:
A time controlled dosage form was formulated by 
press coating technique. Tablet formulations exhibited 
two stages of release performance, a period of 
lag time and rapid drug release, which was mainly 
dependent upon the compression force and amount 
of the outer coating layer.
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P-294: EFFECT OF POLYMER TYPE AND 
CONCENTRATION ON CHARACTERISTICS 
OF DIHYDROERGOTAMINE MESYLATE 
SUBLING FILMS
1 Ozkan, CK.; 1 Esim, O.; 2 Kurbanoglu, S., 1 Savaser 
A.,1 Tasi C., Arslan, A. 2 Ozkan SA., 1 Ozkan, Y.
1University of Health Sciences, Department of 
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INTRODUCTION:
In this study, it is aimed to develop fast 
disintegrating sublingual film formulations containing 
Dihydroergotamine Mesylate (DHE) active substance 
and to investigate the bioavailability of those that are 
suitable for use in the treatment of migraine.
MATERIALS AND METHODS:
Film formulations were prepared using pullulan, 
maltodextrin and propylene glycol as plasticizer. Box 
Behnken design was used to investigate the effects 
of the polymer formulations on the disintegration, 
durability and dissolution rate of the film formulations. 
DHE in sublingual films were determined with HPLC 
coupled with florescence dedector (1).
RESULTS:
It is found that pullulan and maltodextrin concentration 
have significant effect on disintegration, tensile 
strength of sublingual films (p<0.05). higher pullulan 
concentration coused a retention in disintegration 
time and increased the tensile strength. The effect of 
polymer type on disintegration, tensile strength and 
dissolution was shown in Fig.1.
 
Fig.1. Effect of polymer type and concentration on 
disintegration (A), tensile strength (B) and mean 
dissolution time (C) of DHE sublingual films.
CONCLUSIONS:
According to the obtained data, it can be said that DHE 
sublingual films can be prepared by solvent casting 
method and both polymer type and concentration 
have a significant effect on sublingual films. 
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P-295: PREPARATION AND OPTIMIZATION 
OF CUCURBITACIN B LOADED CORE-
SHELL TYPE HYBRID NANOPARTICLES 
USING A FULL FACTORIAL DESIGN STUDY 
1 Sengel Turk, C.T., 2 Ozmen, N., 2 Bakar Ates, F.
1 Ankara University, Faculty of Pharmacy, 
Department of Pharmaceutical Technology, Ankara, 
Turkey
2 Ankara University, Faculty of Pharmacy, 
Department of Biochemistry, Ankara, Turkey
INTRODUCTION:
Cucurbitacin B is a triterpenoid derived natural 
compound which is present in plants and it’s been 
reported that this compound has antiproliferative 
efficiency in various cancer cells (1). Although some 
drug carrier formulations loaded with cucurbitacin 
B have been developed (2), there is no data about 
the development of a new generation drug delivery 
system of cucurbitacin B named as core-shell type 
lipid-polymer hybrid nanoparticles that involved 
architectural advantages of biodegradable polymeric 
nanoparticles and biomimetric characteristics of 
liposomes within stable structure of a combined 
carrier system. In this context, the present study 
aimed to develope cucurbitacin B-loaded core-shell 
type lipid-polymer hybrid nanoparticles by one-
step self-assembly approach method. A systematic 
screening research was employed to optimize the 
hybrid formulations by using a 32 full factorial design 
with center points.     
MATERIALS AND METHODS:
Nine batches were prepared as a per 32 full factorial 
design to optimize the amount of DSPE-PEG/PLGA 
ratio (X1) and the total lipids/L-α-phosphatidylcholine 
molar percentage ratio (X2) investigated based on the 
particle size of cucurbitacin B-loaded hybrid systems. 
Design Expert 6.0.8 software was utilized to carry out 
the optimization of the system. RSM approaches and 
also contour and linearity plots were used to optimize 
the process. Encapsulation efficiency values were 
determined by using a HPLC validated method to 
evaluate the particle characteristics of the developed 
hybrid formulations.  
RESULTS:
The particle size of the all core-shell type hybrid 
nanoparticles ranged from 94.5 to 127.2 nm with 
polidispersity in the range between 0.097-0.118 
inhibited a narrow size distribution. Considering the 
influence of X1 and X2 on the particle size of the 
hybrid nanocarriers indicated that size of the core 
shell type hybrid particles increased as the X2 level 
increased at each X1 level.   
CONCLUSIONS:
This research demonstrated that the particle size of 
the core-shell type hybrid nanoparticles loaded with 
cucurbitacin B could be manipulated by variation of 
the contents of the lipids and polymer.  
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MATERIAL ON PHYSICOCHEMICAL 
PROPERTIES OF SOLID LIPID 
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INTRODUCTION:
Solid lipid nanoparticles (SLNs) which are new 
promising drug delivery systems for dermal 
application have been proven to be effective against 
various skin conditions. These property results from 
the ability of the solid lipid nanoparticles to penetrate 
the skin layers easily (1). SLNs which are colloidal 
drug delivery systems are produced with lipids in solid 
state at both body and room temperature such as fatty 
acids (e.g. stearic acid), triglycerides (e.g. tristearin), 
partial glycerides (e.g. glyceryl behenate) and 
waxes (e.g. cetly palmitate) or mixtures of them. The 
physcochemical properties of SLNs mostly depend on 
the lipid material. The purpose of the present study 
is to investigate the infuluence of the various type of 
solid lipids on the physcochemical properties of SLNs. 
MATERIALS AND METHODS:
Hot homogenization method was prefered to produce 
SLNs. Because organic solvents can be avoided and 
it provides easy production. This method is carried out 
at temperatures above the melting point of the lipid 
and is similar to the homogenization of an emulsion. 
Three kind of lipid materials with various melting point, 
Compritol 888 ATO which is partial glycerides, Precirol 
5 ATO consists of esters of palmitic and stearic acids 
and Stearic acid which is a fatty acid were used to 
prapere SLNs in this study. Poloxamer 188 was 
used as stabilizer and the SLNs were characterized 
according to particle size, size distribution and surface 
charge.
RESULTS:
When all results were evaluated, it is possible to 
obtain SLNs in the nanometer range with all solid 
290  12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey
lipids successfully.  It was also observed that the 
increment of the melting point of solid lipid has a 
significant effect on the particle size and the particle 
size has decreased, as the melting point increased. 
Narrow particle size distrubition was achieved by all 
SLN formulations and negatively high zeta potential 
value which shows the stability of colloidal system 
was obtained by Compritol 888 ATO based SLNs. 
CONCLUSIONS:
Although SLNs have many advantages, drug leakage 
from carrier system during storage may ocur because 
of the crystal lattice of SLNs. The melting point of 
lipid is important since solid lipids may significantly 
decrease the mobility of the drug molecules within 
the lipid core and thus reduce drug leakage (2). This 
study has shown it is possible to obtain SLNs which 
has suitable physicochemical properties with a partial 
glyceride, Compritol 888 ATO which has relatively 
high melting point.
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INTRODUCTION:
Periodontal disease is defined as infections of the 
tissues surrounding and supporting the teeth. The 
delivery of antibacterial agents to the disease site has 
been carried out by systemic or topical administration 
(1-3). The aim of this study was to develop a controlled 
release formulation including doxycycline hyclate 
using hydrolyzed gelatin as a drug carrier material.
MATERIAL AND METHOD:
The hydrolyzed gelatin films (10%) containing 30% 
glycerin and 125 mg doxycycline hyclate were prepared 
by the solvent evaporation technique (4). These 
mixtures were poured on teflon plates and evaporated 
at 37ºC temperature 44 hours. The films were then 
cut in a desired form. The cut films were hardened 
with 10% formaldehyde solution in isopropyl alcohol 
for 1, 4, 8, 12 and 24 h and then washed with acetone 
and dried at room temperature for crosslinking. In 
vitro release studies were performed using a syringe 
pump (Kd Scientific) in pH 7.4 phosphate buffer and 
the flow rate was 50 ml/hour. Determinations were 
done spectrophotometrically (Shimadzu UV-1280) 
at 341 nm and the release profiles were plotted as 
a function of time. The thicknesses were measured 
from 6 different places with digital calipers and the 
averages were taken. The films spectra were taken 
with ATR FT-IR (Perkin-Elmer Spectrum 100).
RESULTS:
Doxycycline hyclate was released immediately from 
10% hydrolyzed gelatin film, 1 and 4 hours hardened 
films. The formulations were hardened for 8, 12 and 
24 hours and doxycycline hyclate was released for 
3 days. The release profiles of all formulations were 
fitted to Higuchi kinetic model.
CONCLUSIONS:
In conclusion, doxycycline hyclate containing 
hydrolyzed gelatin film can be used in the treatment 
of periodontal disease.
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P-298: PREPARATION AND 
CHARACTERIZATION OF W/O/W DOUBLE 
EMULSION CONTAINING TENOFOVIR
Bektas, D., Tugcu Demiroz, F., Teksin ZS.
Gazi University Faculty of Pharmacy, Department of 
Pharmaceutical Technology, Ankara, Turkey
INTRODUCTION:
Water-in-oil-in-water (w/o/w) double emulsions are 
able to enhance oral bioavailability of BCS Class 
3 drugs with high solubility and low permeability. 
Tenofovir (TNF) is a BCS Class 3 drug and it has low 
bioavailability (1). The aim of this study was to develop 
double emulsion (DE) for TNF and characterization of 
TNF-DE. 
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MATERIALS AND METHODS:
Tenofovir was obtained as a gift sample from 
Pharmactive Ltd, Turkey. Imwitor 742 was obtained 
from IOI Oleo GmbH, Germany. Solubility of TNF 
was determined in imwitor 742, abilem-90, labrafil 
M1944 CS, and propylene glycol by shake flask 
method (24 hours, 37±0,5°C). Double emulsions 
are prepared by a modified two-step emulsification 
method, using imwitor 742 (oil phase), labrafil M 
1944 CS, propylene glycol (hydrophilic emulsifier) 
and abilem-90 (hydrophobic emulsifier).The droplet 
sizes, polydispersity index (PDI), zeta potential, 
turbidity, and viscosity was measured and evaluated 
characterization for TNF-DE. Double emulsion was 
analyzed under polarized light microscope. The in 
vitro release studies of TNF-DE was performed in 
USP Apparatus II. The TNF-DE formulation was 
put in hard gelatin capsules (00, Coni-snap®). TNF 
was quantified by UV validated spectrophotometric 
method (2).
RESULTS:
The solubility of TNF in imwitor 742, abilem-90, labrafil 
M1944 CS, propylene glycol is 64.4± 0.007 mg/mL, 
84.3±0.05 mg/mL,105.1±0.06 mg/mL,172.7±0.02 
mg/mL, respectively. The droplet sizes of developed 
primary emulsion and double emulsion were 
126.3±4.79 nm and 1459±58.39 nm and then PDI 
values of 0.053±0.046 and 0.74±0.08, respectively.
The zeta potential and turbidity values of TNF-DE 
were −3.39±0.32 and 31.3±0.153 and the viscosity 
value was 54.66±0.58cp in 40 rpm. It was observed 
with a polarized light microscope(40x) that the 
emulsion was of multiple character. The percentage 
of TNF released was over 85% within 30 minutes for 
pH 1.2, pH 4.5 and pH 6.8.
CONCLUSIONS:
In this study, w/o/w emulsion containing TNF 
was successfully developed by a modified two-
step emulsification process. In vitro release and 
characterization studies showed that w/o/w emulsion 
could be potential as a new oral delivery system for 
TNF. Furthermore, the bioavailability study will be 
conducted to compare in vivo performance of TNF-
DE with the commercial product in future.
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INTRODUCTION:
Rutin is a herbal flavonoid with prominent 
pharmacological activities such as anti-inflammatory, 
anti-oxidant and anti-asthmatic properties (1,2). 
However, its bioavailability is poor due to its 
low aqueous solubility (3-5). In this study, rutin 
nanoparticles were prepared and effect of the rate of 
the solvents used in formulation on the release rate 
was investigated.
MATERIALS AND METHODS:
Rutin nanoparticles were prepared using o/w solvent 
evaporation method. The polymer poly-ε-caprolactone 
was dissolved in dichloromethane and rutin was 
dissolved in methanol, by varying the solvent ratios 
(1:1, 1:3 and 1:5). The solutions were mixed and 
emulsified in the aqueous phase containing 0.3% 
polyvinyl alcohol. The emulsion was sonicated and 
the solvents were removed by evaporation. Particles 
were analyzed for their size and Zeta potential. 
Drug entrapment efficiency was determined in the 
supernatant. In vitro released drug amount was 
determined by UV spectroscopy. Release study was 
performed by dialysis membrane method in pH 7.4 
phosphate buffer solution at 37ºC with 50 rpm by 
shaker.
RESULTS:
Optimum formulation had the rate of 1:3 with a particle 
size of 275 ± 22 nm and Zeta potential -13.0 ± 0.2 
mV. Entrapment efficiency was 95.0% ± 0.3 and the 
release rate was 88.67% ± 12.72 in 48 h, unlike from 
pure rutin solution which had a release rate of 20.31% 
± 2.63 in 48 h (Figure 1).
CONCLUSIONS:
In our study, it was shown that rutin nanoparticles 
could be formulated and dissolution rate of the drug 
was increased clearly. It was observed that, when 
methanol amount in the formulation was decreased, 
the release rate of rutin was decreased due to its 
declined solubility degree in methanol.
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Figure 1. Release rates of rutin and rutin nanoparticles with different 
solvent rates (n=3).
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P-300: MECHANICAL PROPERTIES AND 
EX-VIVO SKIN PERMEATION EVALUATIONS 
OF IBUPROFEN EMULSION GEL FOR 
TOPICAL DELIVERY
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INTRODUCTION:
Ibuprofen (IBU) is commonly used for the treatment 
of pain, fever, rheumatoid arthritis and osteoarthritis. 
However, it is a BCS 2 drug which is poorly water-
soluble, which may affect its absorption and 
therapeutic effects (1). Because of its poor skin 
permeability, it is difficult to obtain an effective 
therapeutic concentration from topical preparations 
(2). The aim of this study was to evaluate the 
mechanical properties, mucoadhesive value and ex 
vivo rabbit skin permeability of IBU emulsion gel for 
topical delivery.
MATERIALS AND METHODS:
Carbopol®974 and Carbopol®934 were purchased 
from Noveon, Parkoteks Chemical, Turkey. IBU was 
supplied from Sanovel, Turkey. In this study, four 
different ibuprofen emulsion gel (F1, F2, F3, and F4) 
were prepared with isopropanol, Tween 80, propylene 
glycol, isopropyl myristate, ethanol, Carbopol®974 or 
Carbopol®934. IBU emulsion gel were prepared by 
mixing and homogenising an oil phase and a water 
phase to contain 5% IBU. Their viscosity, mechanical 
properties (back extrusion test and spreadability 
test) and mucoadhesive value were assessed with 
a Brookfield Rheometer and TA.XTplusTexture 
Analyzer (Stable MicroSystems, Godalming,U.K) 
for topical delivery. Moreover, their skin permeation 
was evaluated using Franz diffusion cell with the 
hairless rabbit skin. These tests were performed 
according to the methods used in our previous study 
(3). All experiments were repeated in the commercial 
hydrogel (Neoprofen Gel® (N), Pensa Drug, Turkey) 
for comparison purposes. Neoprofen was a 5% IBU 
hydrogel prepared with carbopol as a base.
RESULTS:
The viscosity of all formulations was found suitable for 
topical application. Formulation F3 gave significantly 
higher firmness and work of shear cohesiveness than 
the commercial hydrogel (140±5 g vs. 417±8g; 78,3±4 
g.sec vs. 311±12 g.sec). It was found the excellent 
mechanical properties compared to the commercial 
hydrogel. The work of mucoadhesion of the 
formulation F3 to the rabbit skin is about three times 
that of the commercial hydrogel (F3: 0.100±0.276, 
N: 0.041±0.215 mJ/cm2). IBU emulsion gel gave a 
significant higher permeability coefficient of about 1.4 
fold compared to the commercial hydrogel. Thus, the 
IBU emulsion gel improved the skin permeability.
CONCLUSIONS:
In conclusion, the F3 emulsion gel formulation 
with good mechanical properties, mucoadhesive 
properties and good skin permeation would be an 
alternative candidate for topical delivery.
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P-301: DEVELOPMENT AND 
CHARACTERIZATION OF NANOEMULSIONS 
CONTAINING SILYMARIN FOR COSMETIC 
PURPOSES
Altuntas, E., Yener, G., Akar, E.
Istanbul University, Department of Pharmaceutical 
Technology, Istanbul, Turkey
INTRODUCTION:
Silymarin is a polyphenolic flavonoid obtained from 
seeds of the milk thistle which is of great interest to 
protect skin against UV radiation (1). Recent studies 
showed that silymarin constituents could strongly 
protect against photocarcinogenesis and inhibit skin 
inflammation and edema (2,3,4). It is reported that 
the main component of silymarin, silibinin, has a low 
skin tissue distribution by oral administration in mice 
(5). For this purpose, we aimed to develop a silymarin 
nanoemulsion in order to benefit from the anti-aging 
potantial of silymarin sufficiently.
MATERIALS AND METHODS:
Silymarin (0.2%, 0.5%, 1% w/w) (Sigma-Aldrich, USA) 
laden topical nanoemulsions were prepared using 
Pluronic® F-68  (Sigma-Aldrich, USA) (15% w/w) as 
a surfactant and Transcutol® P (Gattefossé, France) 
(20% w/w) as a cosurfactant by ultrasonication 
method. Sonication process was carried out for 
different emulsification time (10, 15, 20, and 30 min, 
in which each cycle consisted of 30 s pulses on and 
30 s pulses off). Subsequently, nanoemulsions were 
characterized according to their mean droplet size, 
zeta potential, pH, conductivity, viscosity, and stability. 
In order to evaluate the stability, firstly, centrifugation 
test and thermal stress test were conducted. Suitable 
formulations were then subjected to heating-cooling 
test (six cycles) and physicochemical stability tests for 
3 months. The in vitro release of silymarin was also 
evaluated.
RESULTS:
The formulation composition containing 1% w/w 
silymarin and 4% w/w oily phase was selected as 
the optimized formulation with a 20 minute sonication 
time. The optimized nanoemulsion demonstrated a 
nanometric particle size of 287,6±0,5 nm, a PDI of 
0,257, a negative zeta potential of -34,1±0,6 mV, a pH 
value of 5.63, and a conductivity value of 50.5 μs/cm. 
Comparative in-vitro release study showed the ability 
of the nanoemulsion to significantly enhance silymarin 
release (98.4% drug release after 6 h) compared with 
conventional emulsion (only 54.7% drug released 
after 6 h).
CONCLUSIONS:
The studied nanoemulsion enhanced silymarin 
release while maintaining adequate physical and 
chemical stability. The use of silymarin laden 
nanoemulsion via topical skin route may provide an 
effective strategy for mitigating the adverse biological 
effects of solar UV radiation.
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P-302: EVALUATION OF IN VITRO 
EFFECTIVENESS OF NANOEMULSIONS 
CONTAINING PIPERINE FOR THE 
TREATMENT OF VITILIGO DISEASE 
1 Ozkan B., 1 Budama Kilinc, Y., 1 Cakir Koc, R., 1 
Kaya, Z., 2 Altuntas, E. 
1 Bioengineering Department, Yildiz Technical 
University, İstanbul, Turkey
2 Pharmaceutical Technology Department, İstanbul 
University, İstanbul, Turkey
INTRODUCTION:
Leukoderma, also known as vitiligo, is a chronic skin 
disease occurs as a result of pigment loss that causes 
irregular distribution of pigment in the skin.  Especially 
in the body areas exposed to the sun, pigment 
gradually fades and causes visible color change(1). 
Nowadays, the methods that are used in treatment 
are known to have many side effects in the long 
term and are not always efficient(2). Stimulants that 
increase the melanocyte proliferation are a potential 
teratment type for skin diseases like vitiligo. Piperine, 
an alkaloid obtained from pepper (Piper nigrum L.). 
Its synthetic derivatives can stimulate pigmentation 
in the skin and has shown appreciable capacity to 
repigment skin. In this study, it was aimed to produce 
a piperine nanomemulsion for topical use of the 
formulation in the treatment of vitiligo disease.
MATERIALS AND METHODS:
After the preparation of the nanoemulsions, their 
physico-chemical stability tests and characterization 
studies were carried out. Then, in vitro cytotoxicity 
experiments were performed with XTT assay. Finally, 
stimulation of melanin production by nanoemulsions 
were analyzed by in vitro experiments on Melanoma 
B16 cell line. 
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RESULTS:
According to data obtained from thermal stress, 
centrifugation tests and droplet size analyzes; two 
nanoemulsion formulations were found stable and 
they were used for in vitro experiments.
CONCLUSIONS:
Using nanoemulsions in treatment of diseases can 
provide several advantages such as creating a 
large surface area due to having small droplet size, 
increasing the rapid and deep penetration of the 
reagents into the skin and having high stability. In 
this study, the physicochemical stability, cytotoxicity, 
melanin content of piperine loaded nanoemulsions 
were evaluated.
ACKNOWLEDGEMENTS:
This study was supported by a grant of Yildiz Technical 
University Scientific Research Projects Coordination 
Department (Project No. FKG-2017-306).
REFERENCES:
1.  Thambirajah R (2009). Cosmetic Acupuncture, 97-
135.
2.  Lakhani DM, Deshpande AS (2014). Journal of 
Applied Pharmaceutical Science, 4 (11), 101-105.
P-304: PREPARATION OF SIO2 DOPED 
BIODEGRADABLE POLYACRYLIC ACID 
NANOCOMPOSITE HYDROGELS FOR 
UPGRADING OF LIFE UNDER WATER
Gokmen, F.O., Yaman, E., Temel, S. 
Bilecik Seyh Edebali University, Central Research 
Laboratory, Bilecik, Turkey
INTRODUCTION:
Because of their well swelling behavior, synthesized 
nanocomposite hydrogels were used as a super 
adsorbent (1). Aim of this study is production of 
nanocomposite hydrogels to upgrade of aquatic 
organisms’ living area. 
MATERIALS AND METHODS:
In this study, a biodegradable super adsorbent 
nanocomposite hydrogel was synthesized by in-situ 
free radical polymerization technique. 
RESULTS:
Fig.2. Fig.1. Swelling Behavior (A), FT-IR spectrums (B), SEM 
images of undoped (C) and doped (D) hydrogels
CONCLUSIONS:
The results of this study showed that, the increase of 
nano SiO2 doping causes the decrease of hydrogel 
porosity. Thus the adsorption studies can be chosen 
as superadsorbents for improve of life under water.
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P-305: BIOCOMPATIBLE TIO2 DOPED 
HYDROGEL PRODUCTION FOR DRUG 
DELIVERY SYSTEMS
1 Gokmen, FO., 1 Yaman, E., 1 Temel, S., 2 Ozbay, N.
1Bilecik Seyh Edebali University, Central Research 
Laboratory, Bilecik, Turkey
2Bilecik Seyh Edebali University, Chemical 
Engineering Department, Bilecik, Turkey
INTRODUCTION:
Smart drug-delivery system has a significant role in 
the treatment of various diseases. Nowadays, with the 
advance of material science, particles, hydrogels and 
insert films have been designed and prepared to be 
drug carriers. TiO2 doped biodegradable hydrogels 
that can form gels in situ have been widely utilized for 
biomedical applications, such as cell/drug delivery as 
well as tissue engineering (1).
MATERIALS AND METHODS:
A biocompatible composite hydrogel was synthesized 
by in situ free radical polymerization technique. 
TiO2 was commercially purchased and used as a 
reinforcing material into composite hydrogel varying 
mass ratio of 0.05%, 0.5% and 1%. 
RESULTS:
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Fig.1. Swelling behavior and FT-IR spectrums of TiO2 doped AA-co-
VP composite hydrogels
CONCLUSIONS:
Swelling behavior and structural properties of 
obtained hydrogels were specified to determine drug 
delivery properties.
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P-307: INVESTIGATION OF RIBOFLAVIN 
AND RIBOFLAVIN-5-PHOSPHATE SODIUM 
RELEASE FROM OCULAR HYDROGELS
Aytekin, E., Bozdag Pehlivan, S., Calis,S.
Hacettepe University, Department of Pharmaceutical 
Technology, Ankara, Turkey
INTRODUCTION:
Riboflavin is a vitamin that can be used as 
photosensitizer for collagen crosslinking procedure 
which is a method for stopping progression of 
keratoconus disease (1). Thermosensitive hydrogels 
can be defined as thermally induced reversible gel 
forming systems that can absorb high amount of 
water in their three dimensional structure (2). The 
aim of this study is to evaluate drug release from 
thermosensitive hydrogels containing Riboflavin or 
Riboflavin-5-Phosphate Sodium. 
MATERIALS AND METHODS:
Thermosensitive hydrogel formulations were 
prepared by cold method (2). The formulations 
consisted of 0.1% (w/v) Riboflavin (RB coded 
formulations) or 0.1% (w/v) Riboflavin-5-Phosphate 
Sodium (RS coded formulations), Pluronic F-128, 
NaCl, Benzalkonium Chloride, without (RB coded 
formulations or RS coded formulations) or with (RB+T 
coded formulations or RS+T coded formulations) 
Transcutol P. In vitro release studies were performed 
using in vitro dialysis bag method (dialysis tubing 
14.000 MWCO) with pH 7.4 phosphate buffer at 32oC 
by using Memmert Shaking Bath (WNB 7, Germany) 
at 100 rpm. Samples were collected at 15 min, 30 
min, 1 hour, 2 hours, 6 hours, 24 hours and 48 hours. 
Then, the samples were analyzed with validated 
HPLC method for drug content. All experiments 
carried out in triplicate.
RESULTS:
In vitro release studies showed that 86.7±0.6% or 
89.3±0.9% of Riboflavin-5-Phosphate Sodium were 
released from RS coded formulations or RS+T coded 
formulations, respectively, at the end of 24 hours. 
Furthermore, 67.6±1.1% or 58.7±1.6 % Riboflavin 
were released from RB coded formulations or RB+T 
coded formulations, respectively, at the end of 48 
hours.
CONCLUSIONS:
It could be concluded that the developed formulations 
were promising for the treatment of keratoconus as 
they provided sustained Riboflavin or Riboflavin-5-
Phosphate Sodium release.
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P-308: DETERMINATION OF 
CYTOTOXICITY OF LAMOTRIGINE ON L929 
CELL LINE.
1,2 Pezik, E., 2 Oztürk, N., 2 Sahin, S., 2 Vural, I.
1 Hacettepe University, Department of 
Pharmaceutical Technology, Ankara, Turkey
2 Erzincan University, Department of Pharmaceutical 
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INTRODUCTION:
Epilepsy is a disorder of the brain characterized by an 
enduring predisposition to generate epileptic seizures 
(1). Lamotrigine (LTG) is a phenyltriazine derivative 
compound and is used as an antiepileptic agent (2). 
In this study, we aimed to investigate  the cytotoxicity 
of LTG on the L929 cell line, which is derived from 
normal subcutaneous connective tissue of an adult 
mouse.
MATERIALS AND METHODS:
L929 cells were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM)  and seeded at a density of 
50,000 cells / mL ( 5000 cells in per well) in a 96-well 
plate. Seven different concentrations of LTG were 
applied to the L929 cells. LTG stock solutions were 
prepared in dimethyl sulfoxide (DMSO) and dilutions 
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were prepared using complete medium. Maximum 
DMSO concentration applied to cells was 0.28 %. Cell 
viability was evaluated by MTT assay after 24 h and 
48 h incubation with LTG dilutions.
RESULTS:
Cell viability of L929 cells after 24 h incubation were 
99.4, 104.9, 106.1, 130.1, 123.9, 116.5, 121.3 % for 
2, 4, 6, 8,10, 12, 14 µg/mL of LTG concentrations, 
respectively. After 48 h incubation cell viability values 
of the L929 cells were determined as 95.0, 102.5, 
99.8, 149.3,221.2, 156.9 and 161.8 % at the same 
concentrations.
CONCLUSIONS:
It was found that LTG had proliferative effects on the 
L929 cells at both low and high concentrations. As a 
result of this study, we may conclude that LTG does 
not have a cytotoxic effect on the L929 cell line.
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P-309: POLY-LACTIC-CO-GLYCOLIC 
ACID NANOPARTICLES CONTAINING 
KETOPROFEN LYSINE: PREPARATION AND 
CHARACTERIZATION 
Elmaskaya, A., Özturk, AA., Yenilmez, E. 
 Anadolu University, Faculty of Pharmacy, Depart. of 
Pharmaceutical Technology, Eskisehir, Turkey
 INTRODUCTION:
Ketoprofen lysine (KL), the water soluble lysine salt 
of Ketoprofen, is one of the most widely used non-
steroidal anti-inflammatory drugs (NSAIDs) in the 
symptomatic treatment of various chronic inflammatory 
diseases for its analgesic efficacy (1). However, due 
to its short half-life of 1–2 h, a multiple dose regimen 
is required therefore, KL is an ideal candidate for 
the development of controlled drug delivery systems 
which are able to release the drug at a desired rate 
and in desired amount (1). PLGA exhibits many of 
the ideal properties of a nanoscale delivery system, 
providing long term release of the encapsulated agent 
and degrading into the biocompatible products of 
lactic and glycolic acid (2). According to the aim of 
this study, KL-containing PLGA nanoparticles were 
prepared by spray drying method (2). 
MATERIALS AND METHODS:
 KL is kind gift from Berko İlaç (Istanbul/Turkey). PLGA 
(Resomer® RG 504, PLGA 50:50) was obtained from 
Sigma(Germany). Formulations were prepared by 
spray drying method with Büchi B-290 spray dryer 
(Switzerland). Particle size (PS), poly dispersity 
index (PDI) and zeta potential (ZP) measurements 
were performed on freshly prepared samples using 
a Malvern analyzer. The entrapment efficiency 
(EE%) and dissolution study of each formulation 
was performed with HPLC. In vitro release study of 
the formulations was investigated over 15 days and 
performed in phosphate buffer (pH 7.4). Results:
Figure 1. In vitro dissolution profile of formulations 
and pure KL
Table 1. Result of PS, PDl, ZP and EE% (n=3)
CONCLUSIONS:
According to the characterization and dissolution 
studies we can conclude that this polymeric system 
seems to be promising for controlled and sustained 
delivery of KL for pain treatment. 
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Figure 1. In vitro dissolution profile of formulations 
and pure KL
Table 1. Result of PS, PDl, ZP and EE% (n=3)
Code
P a r t i c l e 
Size
PDI Zeta %EE
S-Blank 490.3 ± 2.2 0,27± 002 -28±0.21 -
S-1 512.6 ± 5.2 0.43±0.03 -27±1.13 %78.789±0.953
S-2 518.3 ± 3.1 0.44±0.02 -20±1.21 %59.634±1.624
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P-310: PREPARATION AND 
CHARACTERIZATION OF KETOCONAZOLE 
AND CAFFEINE LOADED SELF-
NANOEMULSIFYING DRUG DELIVERY 
SYSTEMS
 1 Gulpinar E., 2 Tirnaksiz F.
1Ezgi Gulpinar Pharmacy, Ankara, Turkey
2Gazi University, Department of Pharmaceutical 
Technology, Ankara, Turkey
INTRODUCTION:
Ketoconazole (KET) and caffeine (CAF) are known as 
active molecules which provide their effects via hair 
follicles on the scalp. Topical KET is used for treatment 
of seborrhoeic dermatitis (SD) and dandruff. The topical 
using of its shampoo was also reported to be effective 
against androgenetic alopecia. It can be useful for 
treating SD accompanied by hair regression. Caffeine 
has potent antioxidant properties and increases 
microcirculation in the skin; and also stimulates hair 
growth. Unfortunately, limited penetration through the 
skin of these components causes decreasing of their 
therapeutic effects. The follicular route is important for 
targeted delivery of the topical drugs to pilosebaceous 
unit and nanoemulsions can increase penetration of 
topical drugs through transfollicular pathway.  
The aim of this study is to develop and characterize 
of a new self-nanoemulsifying delivery system which 
contains ketoconazole in inner oil phase and caffeine 








• Construction of Ternary Phase Diagrams,
• Preparation of Formulations;
• Characterization of Formulations;
• Droplet size and pDı measurement;
• Dilution Test;
• Viscosity and Flow  Properties Determination;
• Surface Tension Measurement;
• Ostwald Ripening Measurements;
RESULTS:
The appropriate carrier system was composed of 
Cremophor RH40, Transcutol P, the mixture of argan 
oil-mglyol 818 and distilled water. The mean droplet 
size and polidispersity index of self-nanoemulsion 
system was determined as 23.50 nm and 0.247, 
respectively.
CONCLUSION:
Our in-vitro system parameters represented that the 
KET and CAf loaded self-nanoemulsion system could 
be promising to use topically for the treatment of 
some hair loss pathologies.
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P-311: OPTIMIZATION OF POLY (ACRYLIC 
ACID-CO-N-VINYL 2-PYRROLIDONE) / SIO2 
NANOCOMPOSITE HYDROGELS FOR DRUG 
DELIVERY SYSTEMS
Gokmen, FO., Temel, S., Yaman, E.
Bilecik Seyh Edebali University, Central Research 
Laboratory, Bilecik, Turkey
INTRODUCTION:
The unique properties of hydrogels, including the 
ability to change from solution to solid form, make 
them excellent platforms for localized drug delivery 
applications (1). Aim of this study, to obtain best 
hydrogel to release drug into human body.
MATERIALS AND METHODS:
Acrylic acid and N-vinyl 2-pyrrolidone were used in this 
study to synthesized nano SiO2 based copolymeric 
nanocomposite hydrogels. 
RESULTS:
Table.1. %C and %CL values of AA-co-VP 
nanocomposite hydrogels
AA-co-VP/nSiO2 ratio %C %CL
%1 n SiO2 85.06 94
%o.5 n SiO2 84 93
%0.05 n SiO2 93 92
Fig.1. Swelling behavior and FT-IR spectrums of AA-
co-VP nanocomposite hydrogels
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CONCLUSIONS:
Swelling behavior of nanocomposite hydrogels were 
calculated to find % conversion (%C), % crosslinking 
(%CL) and % swelling (%S) values. The chemical 
structures of the hydrogels were measured by FT-IR 
analysis. 
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P-312: PREPARATION, 
CHARACTERIZATION AND SWELLING 
BEHAVIOR OF PAA/PVP COPOLYMERIC 
HYDROGEL AS A DRUG CARRIER AGENT
1 Gokmen, FO., 1 Temel, S., 1 Yaman, E., 2 Ozbay, N.
1Bilecik Seyh Edebali University, Central Research 
Laboratory, Bilecik, Turkey
2Bilecik Seyh Edebali University, Chemical 
Engineering Department, Bilecik, Turkey
INTRODUCTION:
Hydrogels are 3-D polymer networks capable of 
swelling in water or biological liquids, and retaining a 
large amount of liquids in the swollen state (1). 
MATERIALS AND METHODS:
In this study, free radical polymerization technique 
was chosen for production. Acrylic acid and Vinyl 
pyrrolidone were used as monomers in solution due 
to their biodegradability to perform as a drug carrier 
agent. 
RESULTS:
Table.1. %C and %CL values of AA-co-VP 
copolymeric hydrogels




Fig.1. Swelling behavior of AA-co-VP copolymeric 
hydrogels
CONCLUSIONS:
Acrylic acid hydrogels were obtained in the presence 
of a radicalic initiator. Acrylic acid and vinyl pyrrolidone 
polymers obtained under optimum conditions were 
synthesized by free radical polymerization method 
using crosslinking agent. % Conversion (%C), % 
crosslinking (%CL) and % swelling (%S) values of the 
hydrogels were calculated.
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P-313: EVALUATION OF INTRAVAGINAL 
DELIVERY OF POLYVINYLPYRROLIDONE- 
METRONIDAZOLE NANOFIBERS FOR THE 
TREATMENT OF BACTERIAL VAGINOSIS
Tugcu Demiroz, F., Saar, S., Tort, S., Kara, AA., 
Acartürk, F.
Gazi University, Department of Pharmaceutical 
Technology, Ankara, Turkey
INTRODUCTION:
Bacterial vaginosis (BV) is one of the most common 
genital conditions occurring in women. BV, when 
treated, is generally managed by using metronidazole 
(MTZ), which belongs to the nitro-imidazole class 
of antibiotics and exhibits broad spectrum activity 
against most gram-negative and gram-positive 
anaerobic bacteria (1). Nanofibers offer many 
advantages for vaginal drug delivery, including high 
loading and encapsulation efficiency and relatively 
prolonged residence time (2). The aims of this study 
were to develop mucoadhesive nanofibers containing 
metronidazole via electrospinning method and to 
characterize them for the treatment of BV.
MATERIALS AND METHODS:
Polyvinylpyrolidone (PVP) solutions were prepared in 
the concentration of 10, 12,5 and 15% (w/v) in ethanol 
and the nanofibers were produced by electrospinning 
method. The MTZ loaded polymer solution at different 
PVP concentrations were compared in terms of 
viscosity, conductivity and surface tension. MTZ 
nanofibers were characterized by fourier transform 
infrared spectroscopy (FTIR), differential scanning 
calorimetry (DSC) and scanning electron microscopy 
(SEM). Drug loading and mechanical properties of 
MTZ nanofibers were also investigated.  
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RESULTS:
An increase in the polymer concentration from 10 to 
15 % led to a decrease in the solution conductivity 
and surface tension values and an increase in the 
viscosity values for both polymer solutions and MTZ-
loaded polymer solutions. DSC and FT-IR analyses 
indicate that there were no interactions between MTZ 
and PVP. The mean diameters of the MTZ nanofibers 
were found to be 955, 1344 and 2385 nm for PVP 
concentrations of 10, 12,5 and 15 %, respectively. 
The MTZ nanofibers were found very hydrophilic 
with contact angle values of 0°. Tensile strength and 
elongation at break values increased from 2,91 to 
5,36 MPa and from 28 to 32 % for PVP concentrations 
between 10-15%, respectively. Entrapment efficiency 
of MTZ in the nanofiber mats was found to be 50, 
66 and 63 µg/cm2 for PVP concentrations of 10, 
12,5 and 15 %, respectively. SEM images show that 
homogeneous structure was observed for PVP-MTZ 
nanofibers (Fig 1).
Figure 1. SEM images of PVP-MTZ nanofiber
CONCLUSIONS:
In the present study, we successfully developed MTZ 
incorporated PVP nanofibers for the treatment of BV. 
PVP nanofibers incorporating MTZ are potentially 
capable of eradicating in vivo one of the principal 
microorganisms implicated in the pathogenesis of BV.
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P-314: DEVELOPMENT AND EVALUATION 
OF EXTENDED RELEASE TABLET 
FORMULATIONS OF VENLAFAXINE 
HYDROCHLORIDE 
Saar, S., Yıldız A., Unal, IS., Ozdal, ZD., Olgac, S., 
Kodan, E., Duran, C., Tort S., Tugcu Demiroz, F. 
1 Gazi University, Department of Pharmaceutical 
Technology, Ankara, Turkey
INTRODUCTION:
Venlafaxine hydrochloride(VH), an antidepressant, is 
used in treatment of major depressive disorder, social 
anxiety disorder and panic disorder(1). The half-life of 
VH following immediate release formulations is 5±2 h. 
Therefore, immediate release VH formulations must 
be given two or three times to maintain adequate 
plasma drug concentration(2).  The aim of present 
study was to develop VH extended release tablets 
to be given once daily which have dissolution profile 
similar to commercial VH extended release tablets.
MATERIALS AND METHODS:
VH extended release tablets were prepared by 
direct compression method(Table 1). The powders of 
formulations were evaluated for angle of repose, flow 
rate, Carr’s index and Hausner ratio. The prepared 
tablets were characterized for weight variation, 
hardness, friability and in-vitro drug release studies. 
The in-vitro drug release was studied in two different 
pH media (2h at pH 1,2 and then 10h at pH 6,8) 
using USP apparatus I. The difference factor(f1) and 
similarity factor(f2) were calculated for all formulations 
and similarity of the tested commercial tablet was 
determined. 
RESULTS:
The angle of repose, flow rate, Carr’s index and 
Hausner ratio of powder formulations were given in 
Table 1. The results of the powder characterization 
obtained for powders were taken as an indication of 
good compressibility of tablets. The friability values 
were less than 1% within the acceptable limits for 
all formulations. Hardness of the tablet formulations 
were found to be between 43-142N. Based on the in-
vitro dissolution studies, the drug release from F1 was 
found similar as compared to the commercial tablets. 
The f1 and f2 factors for F1 with reference commercial 
tablets were 15,09 and 54,49 respectively.
Table 1. Composition of formulations and 
characterization of powders
                                        
Formulation Code
Ingredients(mg)
F1 F2 F3 F4
Venlafaxine hydrochloride 84,85 84,85 84,85 84,85
Avicel PH-102 115 115 115 115
Aerosil200 5 5 5 5
Magnesium Stearate 5 5 5 5
Carbapol974 20 - - -
HPMC K100M 120 - - -
Polyethylene 
oxide(PolyoxWSR303)
- 140 - -
Guar Gum(SupercolNF) - - 140 -
Alginate(ProtanalLF240) - - - 140
POWDER CHARACTERIZATIONS
Angle of Repose(°) 28,9±3,19 28,8±1,91 32,1±5,57 56,75±7,96
Flow Rate(g/s) 35,1±7,12 4,3±0,27 3,8±1,3 33,02±3,26
Carr’s Index(%) 17,5 13,2 21,42 16,67
Hausner Ratio 1,21 1,15 1,27 1,20
CONCLUSIONS:
VH extended release tablets were successfully 
prepared by direct compression method. It was 
shown that the release profile of F1 was similar to 
the commercial tablet. Thus, results of the current 
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study clearly indicate a promising potential of the 
venlafaxine hydrochloride extended release tablet as 
an alternative to the conventional tablet. 
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P-315: METRONIDAZOLE INCORPORATED 
POLYMERIC NANOPARTICLES FOR 
VAGINAL APPLICATION
1 Katerji, F., 2 Basaran, E.
1Anadolu University, Institute of Health Sciences, 
Eskisehir, Turkey
2Anadolu University, Department of Pharmaceutical 
Technology, Eskisehir, Turkey
INTRODUCTION:
Despite being so effective on many bacterial 
infections, Metronidazole (MET) showed many side 
effects when administered orally in a number of 
patients which may necessitate its withdrawal from 
therapy (1). In our study for the avoidance of proposed 
side effects, preliminary studies on novel formulations 
were developed for the vaginal application of MET.
MATERIALS AND METHODS:
Metronidazole and Kollidon® SR (KSR) were kindly 
gifted by Haver Ilac (Istanbul, Turkey) and BASF 
(Istanbul, Turkey) respectively. Tween® 80 (T80) was 
obtained from Merck (Hohenbrunn, Germany). All 
other chemicals were in analytical grade.
Nanoparticles were prepared by emulsification-
solvent evaporation method (2). In vitro characteristic 
properties of the nanoparticles were evaluated by 
particle size and zeta potential, DSC, XRD, FT-IR and 
1H-NMR analyses. MET amount was evaluated by a 
modified HPLC method. 
RESULTS:
Compositions of the MET incorporated polymeric 
nanoparticle formulations were presented in Table 1.
Table 1. Compositions of the formulations prepared 
Code KSR (mg) MET (mg) T80 (0.5 % w/v) (mL)
F0 250 - 25
F1 250 10 25
F2 250 25 25
F3 250 50 25
F4 250 75 25
The in vitro characterization analyses results 
revealed that the MET incorporated nanoparticles 
were formulated emulsification-solvent evaporation 
method and dry particles were collected after being 
lyophilized. Particle size analyses revealed that 
the particles were within the nanometer range with 
relatively high polydispersity index data. DSC and 
1H-NMR analyses revealed the physical incorporation 
of MET into the polymeric nanoparticles.
CONCLUSIONS:
Incorporation of MET into the polymeric nanoparticles 
were achieved successfully and the in situ gelling 
formulations will be formulated for vaginal application 
of MET. 
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P-316: PREPARATION OF HEPARIN-
LOADED NANOFIBERS USING TWO 
DIFFERENT CORE SOLUTIONS
Ruzgar Ozemre, G., Tort, S., Acarturk, F.
Gazi University, Faculty of Pharmacy, Department of 
Pharmaceutical Technology, Etiler Ankara Turkey
INTRODUCTION:
Low-molecular-weight heparins(LMWH) are 
negatively charged, water soluble, highly sulfated 
oligosaccharride fragments derived from commercial 
grade heparin by controlled depolymerization. 
Heparin and its derivatives are only used parenterally. 
Administration of oral heparin is thought to be a 
good alternative to parenteral heparin and other 
anticoagulant drugs1 .
The aim of this study was to prepare coaxial 
LMWH nanofiber for oral delivery by using co-
axial electrospinning method with two different core 
solutions.
MATERIALS AND METHODS:
Materials: LMWH (Enoxaparin Sodium), Eudragit® 
S100 and Polyox® WSRN10(PEO) was kindly 
donated by Atabay Chemicals (Turkey),Evonik 
(Germany) and Dow Chemicals(Germany) 
respectively. Ethanol, toluidin blue, hexane, propylene 
glycol(PG), dimethylformamide was purchased from 
Sigma (Germany). All other chemicals and reagents 
were of analytical grade.
Properties of Shell and Core Solutions:The 
nanofibers prepared in the core-shell structure by 
coaxial electrospinning. The purpose of preparing 
two different core solutions was to prevent clogging 
of the nozzle with polymer solution.Two different 
core solutions were prepared. One of them core was 
obtained by adding of 500 mg LMWH and 250mg 
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PEO into 5 mL distilled water; the other  was consist 
of 500mg LMWH, 2.5mL propylene glycol and 2.5 
mL distilled water. Shell solution was obtained by 
solving of 1,5gr  Eudragit S100 in 6mL ethanol:4mL 
dimethyformamide mixture. 
Electrospinning Process: Electrospinning process 
was conducted using NE-300 Laboratory Scale 
Electrospinning Unit. The distance between coaxial 
needle and collector was 12cm. Applied voltage was 
set to 14kV. The flow rates of core and shell solutions 
were set 0,5ml/h and 1ml/h, respectively. 
The Amounf of Loaded Heparin: Drug content of 
LMWH in nanofibers was assayed in pH 7,4 buffer 
with spectrophotometric measurement method based 
on methachromatic assay with toluidine blue.
RESULTS:
Viscosity, conductivity and the surface tension values 
of the polymer solutions used in the electrospinning 
process are the most criticial parameters for 
production2.The properties of the shell and core 
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Co-axial electrospinning process was successfully 
performed with these parameters. The amount of 
encapsulated heparin loaded to nanofiber containing 
PEO was found to be more than that of the fiber 
containing PG.
CONCLUSIONS:
LMWH was succesfully loaded in to the nanofibers 
by adding of PEO to the core solution. Co-axial 
nanofibers prepared with Eudragit and PEO may be 
a promising delivery system for oral administration of 
LMWH.
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P-317: SOLID LIPID NANOPARTICLES FOR 
ORAL ADMINISTRATION: HIGH PRESSURE 
HOMOGENIZATION METHOD
Erkan, O., Amasya, G., Sezgin-Bayındır, Z., Yuksel, 
N.
Ankara University, Faculty of Pharmacy, Department 
of Pharmaceutical Technology, Ankara, Turkey
INTRODUCTION:
Solid lipid nanoparticles (SLNs) which combine the 
features of liposomes, nanoemulsions and polymeric 
nanoparticles are rapidly developing field of nano drug 
delivery systems. SLNs prepared by physiological 
and biodegradable lipids can be administered via 
various routes such as parenteral, oral, dermal and 
transdermal. The advantage of orally administrated 
SLNs is the enhancement of oral absorption/
bioavailability of the drug molecules and providing 
sustained drug release (1). Hot homogenization 
which is carried out at temperatures above the 
melting point of lipids does not require organic solvent 
usage. Initially, a pre-emulsion of the melted lipid - 
aqueous emulsifier phase should be prepared by a 
high-shear mixing device like ultraturrax, and then the 
size of the droplets must be reduced to nanoscale via 
ultrasonication or high pressure homogenization (2).
The main goal of this study is to prepare SLNs with 
suitable particle size, polydispersity index and zeta 
potential for oral absorption. For this purpose High 
Pressure Homogenization (HPH) and ultrasonication 
methods were compared for the nanonization of the 
pre-emulsion and obtaining stable SLNs. 
MATERIALS AND METHODS:
In this study two different techniques namely 
ultrasound and high pressure homogenization were 
used to reduce droplet size of hot pre-emulsions 
and as a process parameter different number of 
cycles were applied in HPH. Compritol 888ATO and 
Tristearin were selected as solid lipids and SLNs were 
stabilized by Ploxamer 188. The full characterizations 
of SLNs were exhibited by measuring the particle 
size, PDI and zeta potentials. The most suitable SLN 
formulation for oral drug administration was estimated. 
RESULTS:
The results revealed that, it is possible to obtain 
lipid nanoparticles by combining high shear 
homogenization and HPH when tristearin was used 
as solid lipid at different concentrations. The particle 
sizes were in the nanometer range for all prepared 
SLN formulations with Tristearin and it was observed 
that both the particle size and the PDI values were 
decreased with the number of homogenization cycle.
CONCLUSIONS:
The findings showed that HPH which is combined with 
high shear homogenization seem to be an appropriate 
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method for SLN production. On the other hand, lipid 
type was found to be important for obtaining stable 
SLNs. The obtained SLN formulations demonstrate 
suitable physicochemical properties for oral drug 
administration and further studies will be conducted to 
develop drug loaded SLNs for this purpose.
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P-318: FORMULATION AND EVALUATION 
OF SPRAY DRIED CHITOSAN 
NANOPARTICLES OF LEVOCETIRIZINE 
DIHYDROCHLORIDE FOR ANTIHISTAMINIC 
TREATMENT
 Yurtdas Kirimoglu, G., Özturk, AA., 
1 Anadolu University, Department of Pharmaceutical 
Technology, Eskisehir, Turkey
INTRODUCTION:
Levocetirizine dihydrochloride (LCD) is a third 
generation non-sedative antihistamine. LCD works 
by blocking histamine receptors. It does not prevent 
the actual release of histamine from mast cells, but 
prevents it binding to receptors. In addition, it is an 
important drug in the treatment of allergies and 
idiopathic urticaria (1). Chitosan (CS) is a natural 
biodegradable and biocompatible polysaccharide (2). 
In this study; LCD loaded CS nanoparticles prepared 
by spray-drying method for extended antihistaminic 
delivery of oral use was aimed in this study.
MATERIALS AND METHODS:
LCD is kind gift from Neutec Pharma (Sakarya/
Turkey). CS (LMW) purchased from Sigma, Germany. 
Spray drying technology (B-190, BUCHI) was used 
for the preparation of nanoparticles with an inlet 
temperature of 120°C ± 1°C and outlet temperature 60 
°C ± 5 °C. Compositions of formulations prepared are 
summarized in Table 1. During the characterization 
studies particle size, polydispersity index, morphology, 
zeta potential and thermal analyses were performed. 
Table 1. Compositions of formulations prepared








Placebo 1 - 120 120 
F-1 1 0.05 120 120
F-2 1 0.1 120 120
RESULTS:
Particle size, zeta potential measurements (Table 2), 
morphological analyses (Figure 1) were shown for the 
characterization of the systems prepared.
Table 2. Mean particle size, PI, zeta potential of 
formulations prepared (SE: Standard Error) (n=3)




Placebo 487.42 ± 7.25
0.426 ± 
0.085 24.3 ± 2.1
F-1 521.70 ± 8.50
0.512 ± 
0.090 25.7 ± 1.8
F-2 538.46 ± 5.74
0.498 ± 
0.074 25.9 ± 2.5
Figure 1. SEM Images of pure drug and formulations 
prepared (a: LCD, b: Placebo, c: F-1, d: F-2) 
CONCLUSIONS:
LCD could be incorporated successfully into polymeric 
nanoparticles. Smaller particle size, cationic zeta 
potential indicated by characterization methods, 
possible LCD polymeric matrix interaction were 
determined to be a promising approach for extended 
delivery of LCD.
REFERENCES:
1.  Vino S et al. (2012). Journal of Applied 
Pharmaceutical Science 02(08):221-225
2.  Thapa B, Narain R (2016). In:Narain R (ed.) 
Polymers and Nanomaterials for Gene Therapy. 
Woodhead Publishing is an imprint of Elsevier, 
London, UK. pp 1-27
P-319: NOVEL STRATEGIES TO 
SYNTHSESIS OF POLYMER-DRUG 
CONJUGATE BY CHARGE TRANSFER 
COMPLEX COPOLYMERIZATION 
Kaplan Can, H., Parvizi Khosroshahi, S.
Hacettepe University, Faculty of Science, Department 
of Chemistry, Ankara, Turkey
INTRODUCTION:
Interdisciplinary research at the interface of polymer 
chemistry and the biomedical sciences has produced 
polymer-based nanomedicines for the diagnosis 
and treatment of cancer. Water-soluble hybrid 
materials as polymer-drug conjugates are designed 
for intravenous administration. 5- Fluorouracil (5-FU) 
with the wide range of usage and is one way the need 
as well as a single agent administered to the patient 
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intravenously in combination with anticancer drugs. 
It is possible to increase the activity of 5-FU and 
eliminate/or minimize side effects with polymer/5-FU 
conjugation in biological systems (1).
MATERIALS AND METHODS:
Synthesis of copolymer and copolymer/5-FU are 
characterized and enlightened the conjugation 
mechanism by Fourier Transform Infrared (FTIR) 
and Nuclear Magnetic Resonance (1H, 13C NMR), 
X-ray Diffraction (XRD) and HR-Raman spectroscopic 
methods (Scheme 1). Biological activity of copolymer 
and its 5FU conjugate were investigated via Saos-
2 cells by using the dsDNA method to assess the 
number of viable cells and cell proliferation.
RESULTS:
Obtained poly(maleic anhydride-alt-vinyl pyrrolidone) 
poly(MA-alt-NVP) and poly(MA-alt-NVP)-5FU via 
charge transfer complex (CTC) copolymerization 
properties were clarified by using FTIR, NMR (1H, 
13C), XRD and HR-Raman spectroscopic methods 


















70 oC, 4 hr
5FU
Scheme 1. Conjugation of of Poly(MA-alt-NVP) with 
5-FU
CONCLUSIONS:
The results confirmed that copolymerization of 
MA:NVP system formed CTC and reaction preceded 
via alternating copolymerization mechanism. 
Obtained results from the dsDNA method, copolymer 
shows higher cell viability against Saos-2 cells than 
the copolymer-drug conjugate.
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P-320: DETERMINATION OF IN-VITRO 
SIMILARITY BY AERODYNAMIC PARTICLE 
SIZE DISTRIBUTION BETWEEN TEST 
PRODUCT AND REFERENCE PRODUCT IN 
NEBULISATION FORM INCLUDING SABA / 
ANTICHOLINERGIC COMBINATION
Icin H., Turk M., Keskin G., Isik E., Tanriver K., 
Gokalp M., Dude U.
Abdi İbrahim Pharmaceuticals, Research and 
Development Center, Istanbul, Turkey
INTRODUCTION:
Establishing relationships between in vitro and in 
vivo data for Drug Products is an important goal of 
development process. For pulmonary Drug Product 
an in vitro characterized aerodynamic particle size 
distributions (APSDs) are expected to have some 
predictive power not only for drug deposition in 
various area of lungs, but also for clinical effects. 
In this study, in-vitro profiles of the test product and 
the reference product were compared in the form of 
nebulization containing selective beta-2-adrenoceptor 
agonist and anticholinergic, used in the treatment of 
reversible bronchospasm associated with obstructive 
airway diseases, in patients in need of more than one 
bronchodilator. 
MATERIALS AND METHODS:
In-vitro profiles were obtained by Aerodynamic 
Particle Size Distribution analysis using Next 
Generation Impactor (NGI) (1). The conditions set out 
in the European Medicines Agency’s (EMA) guidelines 
(2,3) were considering during the study. Justified 
groups of impactor stages were generated in order 
to provide in-vitro profiles. Justification was based 
on the expected deposition sites in the lungs. Three 
batches of the test product and three batches of the 
reference product were tested during the study. The 
% difference between mean values of test product 
and reference product and 90% confidence intervals 
for the differences were calculated for each group. 
RESULTS:
The in-vitro profile similarity of the test product and 
the reference product has been proved by checking 
the conformity of difference to +/- 15% acceptance 
criteria.
CONCLUSIONS:
According to EMA Guideline, establishment of such 
degree of similarity between Reference and Generic 
Product is evidence for expected equivalence in 
terms of both safety and efficacy of pharmaceutical 
products.
REFERENCES:
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P-321: 3D PRINTING AS A NEW TOOL FOR 
THE DEVELOPMENT OF SOLID DOSAGE 
FORMS
Gultekin, HE., Tort, S., Acarturk, F.
Gazi University, Faculty of Pharmacy, Department of 
Pharmaceutical Technology, Etiler Ankara Turkey
INTRODUCTION:
3D printing (3DP) is a layer-by-layer manufacturing 
process which is used to prepare a 3D object utilizing 
computer aided design data.1 Fused deposition 
modeling (FDM) is a recently used 3DP technology.2 
Pramipexole is a widely used drug which treats the 
symptoms of Parkinson’s disease.3 It was chosen as 
a model drug for the personalized treatment purpose 
of the 3D printing.
The aims of the present study were to prepare 
3D printed pramipexole tablets, to determine the 
pharmaceutical properties of the obtained tablets and 
to evaluate the 3D printability of a hot melt extrudable 
form of hypromellose.
MATERIALS AND METHODS:
Pramipexole dihydrochloride monohydrate, 
polyethylene oxide N80 (PEO N80) and AffinisolTM 
were kindly donated from Deva Pharmaceuticals and 
Dow Chemical Company, respectively. A hot melt 
extrusion (HME) method was carried out using Filabot 
Filament Extruder in order to fabricate drug loaded 
filaments. By using the obtained filaments 3D printed 
tablets were fabricated via MakerBot® Replicator_ 2X 
Experimental 3D Printer. The physico-pharmaceutical 
properties of the 3DP tablets were measured and 
the amount of drug in the tablets and filaments were 
determined. Also in vitro dissolution study for the 3DP 
tablets was performed.
RESULTS:
The physico-pharmaceutical properties of the 3DP 
tablets are shown in Table 1 and the in vitro drug 
release profile of the 3DP tablets is shown in Figure 1.
The physico-pharmaceutical properties showed that 
the 3DP tablets have good reproducibility and the in 
vitro drug release profile of the tablets demonstrated 
that more than 85% of the drug was relesed from the 
tablets within 5 hours.
CONCLUSION:
Drug loaded filaments were successfully fabricated 
by HME and the tablets were successfully printed by 
FDM. This study demonstrates that FDM-3D printing 
is an effective technology for the development of solid 
dosage forms. AffinisolTM, as a hot melt extrudable 
form of hypromellose, is a suitable polymer for FDM. 
By combining different polymers with AffinisolTM, 
the drug release profile of the 3DP tablets can be 
optimized.    
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P-322: PREFORMULATION STUDIES 
OF NANOPARTICLES FOR PSORIASIS 
DISEASE TREATMENT
1 Erol, I., 2 Ustundag Okur, N., 1 Ozer, O. 
1Ege University, Faculty of Pharmacy, Department of 
Pharmaceutical Technology, Izmir, Turkey
2Istanbul Medipol University, School of Pharmacy, 
Department of Pharmaceutical Technology, Istanbul, 
Turkey
INTRODUCTION:
Psoriasis is one of the most common human skin 
diseases and is considered to have key genetic 
underpinnings. It is characterized by excessive growth 
and aberrant differentiation of keratinocytes (1). The 
aim of the study is to develop  topical nanocarriers 
of tazarotene to treat psoriasis disease with minimal 
side effects and maximum efficiency.
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 MATERIALS AND METHODS:
Solid lipid nanoparticles (SLNs) were prepared by 
high shear homogenization method at 24000 rpm (2). 
Suppocire was chosen as solid lipid, Poloxamer 188 
as surfactant and bidistilled water as water phase. 
Preformulation studies carried out using several 
amounts of Suppocire (100, 200 and 300 mg) and 
Poloxamer 188 in order to prepare the most desirable 
carrier. Finally, 100 mg of Suppocire were chosen 
for SLN formulation. The unloaded SLN formulations 
were characterized by means of their particle size and 
polydispersity index (PDI). The average particle size 
and PDI measurement were performed via dynamic 
light scattering method using Malvern Zetasizer 
(Nano ZS, Malvern Instruments, U.K.) at an angle of 
173° at 25 °C.
RESULTS:
The SLN carriers were successfully developed 
using 100 mg Suppocire in 25 ml of water (Table 1). 
Particle size of SLNs ranged from 204-1146 nm. As 
it can be seen from Table 1, better PDI (<0.5) could 
be observed using higher poloxamer amount (F3, 
F4, F5 and F6). Therefore F3 formulation (100 mg 
Suppocire and 350 mg poloxamer in 25 ml of water) 
was selected as the optimized formulation which can 
be used against psoriasis. 
Table1. Compositions, particle size and PDI 












































F1 100 15 25 1446±240.30 0.780±0.070
F2 100 25 25 1389±449 0.766±0.207
F3 100 350 25 204.9 15.49 0.311±0.116
F4 100 400 25 364±13.46 0.405±0.029
F5 100 450 25 315±13.17 0.451±0.115
F6 100 500 25 292±50.16 0.468±0.030
CONCLUSIONS:
SLNs prepared by high shear homogenization method 
could be offered as a promising strategy for topical 
drug delivery.
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P-323: PREPARATION, 
CHARACTERIZATION AND CELL VIABILITY 
STUDIES OF CISPLATIN LOADED SELF-
MICROEMUSIFYING DRUG DELIVERY 
SYSTEM (SMEDDS)
1 Akartas, I., 2 Karasulu, HY.
1European University of Lefke, Faculty of Pharmacy, 
Lefke, Turkish Republic of Northern Cyprus
2Ege University, Faculty of Pharmacy, Department of 
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INTRODUCTION:
Cisplatin is an antineoplastic drug, used for the 
treatment of ovarian cancer. SMEDDS has many 
advantages such as enhanced bioavailability, 
lymphatic absorption and ease of manufacture (1,2). 
The aim of this study was to prepare and characterize 
Cisplatin loaded SMEDDS formulation and to evaluate 
in vitro release studies and antitumoral activity with 
cell viability studies.
MATERIALS AND METHODS:
Firstly, pseudoternary phase diagrams were 
constructed using water titration method in order 
to determine the stable microemulsion range. The 
physicochemical properties of microemulsions 
such as physical appearance, pH, refractive index, 
viscosity, droplet size, polydispersity index (PDI), zeta 
potential, distribution stability was measured in order 
to evaluate characteristic properties of microemulsion. 
In vitro release studies of Cisplatin loaded SMEDDS 
were performed with dialysis membrane. Samples 
were analysed considering the calibration curve with 
HPLC method (Shimadzu, Japan) which is validated. 
The effect of Cisplatin SMEDDS formulation was 
determined by MTT assay on A2780 cell line. A2780 
cell line is a human ovarian carcinomic cell line which 
is procured by European Collection of Cell Cultures 
(ECACC). Cell viability was evaluated with ELISA 
microplate reader-UV spectrophotometer (Thermo 
vario scan-FHA multiplate reader) at 570 nm
RESULTS:
Cisplatin SMEDDS were measured as 25,4±1,9 nm 
and PDI was 0,241±0,018. Refractive index of the 
formulation measured as 1,471±0,001. pH value of 
Cisplatin SMEDDS diluted by water with the dilution 
ratio 1:10 was measured as 5,84±0,09 and Cisplatin 
SMEDDS diluted by pH 6,8 PBS with the dilution 
ratio 1:10 was measured 6,51±0,14. Viscosity of 
formulation was measured as 284 mPa and in vitro 
release studies were performed and 78,17% of 
cisplatin was released. The formulation performed 
cytotoxic effect to A2780 cells with 20,26% vitality at 
0,02 µg/mL.
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CONCLUSIONS:
It was concluded that, Cisplatin SMEDDS is an 
advantageous formulation for the treatment of ovarian 
cancer with its antitumoral activity. This formulation 
could be a promising alternative due to its less side 
effects and enhanced lymphatic absorption.
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P-324: TRANSDERMAL DELIVERY OF AN 
ANTIEPILEPTIC DRUG: LACOSAMIDE 
1 Aykac, K., 2 Basaran, E.
1 Anadolu University, Institute of Health Sciences, 
Eskişehir, Turkey
2 Anadolu University, Department of Pharmaceutical 
Technology, Eskişehir, Turkey
INTRODUCTION:
Among the antiepileptic agents, Lacosamide (LAC); 
a third-generation antiepileptic-drug has a novel 
mechanism of action (1). In our study considering the 
frequent incidance of epilepsy in infants and elderly 
people, preliminary formulation studies of transdermal 
delivery systems for Lacosamide, which will be very 
confortable in use for the proposed aged groups, 
were conducted.
MATERIALS AND METHODS:
Lacosamide and Kollidon® SR (KSR) were gifted 
kindly from Santa Farma (İstanbul, Turkey) and 
BASF (İstanbul, Turkey) respectively. Chitosan 
was purchased from Fluka Chemicals (Steinheim, 
Germany). Eudragit® RS 100 (ERS 100) was 
purchased from Röhm Pharma Polymers (Darmstadt, 
Germany). Tween® 80 (T80) was obtained from 
Merck (Hohenbrunn, Germany). All other chemicals 
were in analytical grade.
Nanoparticles were prepared by emulsification-
solvent evaporation method (2). In vitro characteristic 
properties of the nanoparticles were evaluated. 
Lacosamide amount was evaluated by a modified 
HPLC method. Due to the unique cationic character, 
gel and film forming properties transdermal 
formulation were prepared with chitosan.
RESULTS:
Formulations were prepared by different amounts of 
Lacosamide in order to achieve highest incorporation 
efficiency (Table 1). 
Table 1. Compositions of the formulations prepared 










































F0 100 100 - 4 1 1
F1 100 100 20 4 1 1
F2 100 100 50 4 1 1
F3 100 100 100 4 1 1
The in vitro characteristic properties of the particles 
were evaluated by particle size and zeta potential, 
DSC, XRD, FT-IR and 1H-NMR analyses. The 
analyses results revealed that the particles were in 
amorphous state and Lacosamide was molecularly 
dispersed within the polymeric structure.
CONCLUSIONS:
As the preliminary study, the in vitro characteristic 
properties of the nanoparticles were evaluated in 
detail and analyses results revealed that Lacosamide 
incorporated polymeric nanoparticles were prepared 
successfully by emulsification-solvent evaporation 
method. 
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P-325: PREPARATION AND 
CHARACTERIZATION OF QUERCETIN 
LOADED CYCLODEXTRIN/CHITOSAN/TPP 
NANOPARTICLES
1 Guven, UM., 2 Gulec, K., 3 Berkman, MS., 3 Demirel, 
M.
1 Cukurova University, Faculty of Pharmacy, 
Department of Pharmaceutical Technology, Adana, 
Turkey
2 Anadolu University, Graduate School of Health 
Sciences, Department of Biochemistry, Eskisehir, 
Turkey
3 Anadolu University, Faculty of Pharmacy, 
Department of Pharmaceutical Technology, Eskisehir, 
Turkey
INTRODUCTION:
Quercetin (Qu) is a polyphenolic flavonoid that has 
been shown to have anti-inflammation, anti-viral, 
anti-allergic, anti-oxidant and anti-cancer activities 
(1). Its use in pharmaceutical field is limited by 
its low aqueous solubility. Cyclodextrin/chitosan/ 
pentasodium tripolyphosphate nanoparticles (CD/CS/
TPP-NPs) has been developed as a new carrier for 
poorly water-soluble drugs. The aim of this study was 
to prepare, characterize the Qu loaded CD/CS/TPP-
NPs and evaluate their potential for the anti-oxidant 
activity.
MATERIALS AND METHODS:
The Qu-CD/CS/TPP-NPs were prepared with Qu-
methyl beta-CD inclusion complex and MMW CS. 
Ionotropic gelation technique was used for the 
preparation of NPs (2). The characteristics of NPs 
were evaluated by particle size, DSC, XRD, NMR, 
FT-IR, SEM, encapsulation efficacy, in vitro release 
and anti-oxidant activity studies. In vitro release 
studies were carried out for 24h with PBS at pH6.8 in 
a dialysis tube (MWCO:14,000Da) (n=3). Anti-oxidant 
activity studies on NPs were carried out with DPPH 
test (n=6).
RESULTS:
The prepared NPs were formed with controlled size 
of 202.3-335.6nm and a PDI ranged from 0.449 to 
0.585 with good encapsulation efficiency of up to 
67.71%. FT-IR, DSC and NMR studies revealed that 
CD and Qu were effectively integrated into the NPs. 
NPs showed a higher release than pure Qu and lower 
release than Qu-CD. DPPH test results showed that 
NPs exhibited high anti-oxidant activity up to 99.00% 
(Table 1).
Table 1. Anti-oxidant activity of plasebo (PL), Qu, Qu-


















































































In vitro release of Qu from the NPs showed controlled 
release compared to the Qu-CD alone, but the 
moderate release rate of Qu-CD/CS/TPP-NPs 
could be better to sustain the time of drug action. 
Additionally, the increased anti-oxidant activities of Qu 
were correlated with improvement in physicochemical 
characterization.
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P-326: PHYSICOCHEMICAL STABILITY 
AND COMPATIBILITY TESTING OF 
METRONIDAZOLE IN PARENTERAL 
NUTRITION MIXTURES
Dettlaff K., Popielarz Brzezińska M., Gostyńska A.
Poznan University of Medical Sciences, Department 
of Pharmaceutycal Chemistry, Poznań, Poland
INTRODUCTION:
Co-administration of parenteral nutrition (PN) with 
medicines without proven compatibility and stability 
tests is considered as a medical error. Addition of 
the drug to the PN can lead to incompatibilities of the 
components of the mixture with the drug, decrease in 
the stability of o/w emulsions and catalyze of the drug 
degradation [1]. However, coadministration of the 
drugs in one bag with a PN mixture could reduce the 
risk of vascular access complications and infections, 
as well as protect against overhydration of the patient.
The aim of this study was to determine the possibility 
of addition of metronidazol to selected PN mixtures 
before administration to the patient.
MATERIALS AND METHODS:
PN mixtures (6 compositions) with the tested drug at a 
daily dose of 1500 mg, as well as analogous mixtures 
without drug were stored for 7 days at 5±1 ºC, then 
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for another 24 hours at 23±1 ºC with light exposure 
(conditions of PN administration to the patient). The 
pH of the mixtures, the color (CIEL*a*b* system), 
the size of the lipid emulsion particles and the zeta 
potential was determined every 24 hours. The 
metronidazole content was determined using HPLC 
method.
RESULTS:
During the 8 days of the study, no macroscopic signs 
of emulsion degradation were observed and the color 
of PN mixtures was unchanged (∆E<1). The pH of 
the mixtures was in the range 6.19-6.38 depending 
on the composition of the mixture and did not change 
during storage (maximum different ± 0.05). The 
lipid emulsion particle size was in the range 210-
230 nm (pharmacopoeial limit < 500 mn) and the 
zeta potential varied form 22.0 mV to 8.3 mV. The 
maximum decrease in the content of metronidazole in 
studied PN mixtures after 8 days was 5%.
CONCLUSIONS:
Previous reports have shown the possibility of 
simultaneous administration of metronidazole via the 
Y-site together with some ready-to-use mixtures [2], 
in this study we showed that Metronidazole B.Braun 
5 mg/ml can be added to 6 different mixtures and 
stored up to 7 days at 5 ºC before administration to 
the patient.
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P-327: IS COMBINING OF DRUGS WITH 
TPN MIXTURES SAFE? COMPATIBILITY 
STUDIES OF SOME FLUOROQUINOLONES 
WITH TPN
Gostyńska A., Stawny M., Dettlaff K., Jelińska A.
University of Medical Sciences, Department of 
Pharmaceutical Chemistry, Poznań, Poland
INTRODUCTION:
Pharmacotherapy of patients receiving total parenteral 
nutrition (TPN) is a common clinical problem due to the 
limitation of oral medications administration. This is 
very important especially for critically ill patients who, 
in extreme cases, receive even several intravenous 
infusions at the same time, which raises real technical 
problems with the method of their administration, 
due to the limited number of venous access. One of 
the solution is co-administration of drugs with TPN 
mixture via Y-site. However, this procedure have to 
be preceded by tests confirming compatibility of the 
drug with the TPN mixture. The aim of the study was 
to determine the compatibility of ciprofloxacin and 
levofloxacin with TPN mixtures when administrating 
via Y-site.
MATERIALS AND METHODS:
Twelve different compositions of TPN mixtures were 
mixed together with ciprofloxacin and levofloxacin 
in the ratio 1:1, 2:1 and 1:1, 1:2, respectively. The 
ratio was calculated based on infusion rates of both 
medications and TPN mixtures. The compatibility of 
the drugs with studied TPN mixtures was evaluated 
by visual and microscopic assessment, the pH, the 
osmolality, the lipid emulsion particles size (Dynamic 
Light Scattering method), and the zeta potential (Laser 
Doppler-Electrophoresis method). Each parameter 
was determined just after mixing (t=0), after 4 and 24 
hours.
RESULTS:
Obtained results differed completely depending on 
the tested drug. In all samples with ciprofloxacin 
precipitation process occurred after 4 or 24 hours 
of storage, what was confirmed by microscopic 
assessment. On the other hand samples with 
levofloxacin show no macroscopic signs of 
precipitation nor emulsion degradation. The lipid 
emulsion particle size after addition of levofloxacin to 
TPN mixtures, within first 24 hour, was in the range 
212.2 nm – 243.0 nm and meets the pharmacopoeial 
limit (< 500 nm). The zeta potential differ depending of 
TPN mixture composition and it was in the rage -13.3 
mV to -4.8 mV. The pH of the mixtures was in the 
range 5.90 – 6.32  and 5.77 – 6.20 just after addition 
of the drugs and decreased by maximum 0.35 and 
0.05 for ciprofloxacin and levofloxacin, respectively.
CONCLUSIONS:
The results of this study have shown that levofloxacin 
is compatible with TPN mixtures when administrating 
via Y-site in ratio 1:1 and 1:2. In contrary, it is 
impossible to co-administrated ciprofloxacin with TPN 
mixtures due to the drug precipitation.
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P-328: VALIDATION OF AN HPLC 
METHOD FOR THE DETERMINATION OF 
BESIFLOXACIN HCL FROM OCULAR 
INSERT BASED ON POLYCAPROLACTONE
1 Polat, K., 1 Bozdag Pehlivan S., 2 Kır, S.,1 Calıs S., 
1 Hacettepe University, Faculty of Pharmacy, Dept. of 
Pharmaceutical Technology, Ankara, Turkey
2 Hacettepe University, Faculty of Pharmacy, Dept. of  
Analytical Chemistry, Ankara, Turkey
INTRODUCTION:
 Besifloxacin, a broad spectrum antibiotic of the fourth 
generation fluoroquinolone group, has been reported 
to be effective in the treatment of bacterial keratitis 
(1).  Validation is an important issue in pharmaceutical 
analysis and widely required in formulation 
development.  In this study, it is aimed to  develop 
and validate an  HPLC method for the determination 
of Besifloxacin HCl (BH) from polycaprolactone (PCL) 
insert for the treatment of bacterial keratitis. 
MATERIALS AND METHODS:
The selective assay of BH was carried out by HPLC 
according the to the modified method of Rajput 
et al. (2). HPLC system consisted of Agilent 1100 
Separations Module equipped with ultraviolet (UV) 
detector (297 nm) and a C8 column (250 nm x 4,6 
mm x 5 µm). The mobile phase was phosphate buffer 
adjusted  pH 3 with ortophosphoricacid: methanol: 
acetonitrile in the ratio of 50:25:25 at flow rate of 1mL/
min. In order to determine the amount of BH in PCL 
inserts, the drug loaded inserts were dissolved in 2 
mL of dichlorometane:dimethylformamide:methanol 
mixture. The samples were then put on an ultrasonic 
bath for 30 minutes and 1 mL PBS was added. Then, 
final mixture was centrifuged at 14000 rpm for 10 
minutes. The supernatants were separated and 
filtered through 0.45 µm membrane filters and then 
injected to the HPLC column. The amount of BH in 
inserts was calculated through the peak area values 
by the calibration curve.
RESULTS:
The retention time was about 5.5 min. Calibration 
curve was linear over the concentration range of 
0,03-1 µg.mL-1 . The intra- and inter-day precision 
relative standard deviation was 2.03 % or less, 
and the accuracy was within 0.78 % of the nominal 
concentration.
CONCLUSIONS:
The developed HPLC method was succesfully applied 
to quantitate BH in ocular insert based on PCL.
ACKNOWLEDGEMENTS: 
This study was supported by a grant of TUBITAK 
(SBAG-217S126).
REFERENCES:
1.  Stapleton F, Edwards K,  Keay L  et al., 
Ophthalmology, 119(8), 1516–1521, 2012.
2.  Rajput S, Pandya C, Chaundhari  P, Int. J. Chem. 
Pharm. Anal., 3(2),1-7, 2016.
P-329: BIOFUNCTIONALIZATION OF 
GRAPHENE OXIDE FOR DRUG DELIVERY 
APPLICATIONS
Demirhan, K.,Caliskan Salihi, E.
Marmara University, Faculty of Pharmacy, 
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Istanbul, Turkey
INTRODUCTION:
Graphene is a basic building block for carbon 
materials with different geometries and unique 
physical and chemical properties. Graphite oxide 
is an oxygen-containing and water-dispersible 
derivative of graphite, it can be exfoliated and well 
suspended in an aqueous medium even down to 
the single-layer level form of graphene oxide (1). 
Graphene-based materials have attracted strong 
interest in the recent studies in order to produce 
functionalized biosystems. Furthermore modification 
with biomolecules is advantageous because it 
improves the biocompatibility of the materials. In this 
context, biofunctionalization of graphene oxide using 
fatty acids was investigated in this study for drug 
delivery applications (2).  
MATERIALS AND METHODS:
Graphene oxide was produced using Hummers method 
revised in our laboratory (1). Biofunctionalization was 
thereafter conducted by the addition of undecylenic 
acid followed by a heat treatment using a green route. 
RESULTS:
Biofunctionalization experiments were conducted 
under several experimental conditions (i.e. 
temperature, treatment time etc.) in order to set up 
optimum conditions. Functionalization was followed 
by UV-Visible spectrophotometry. Then the samples 
were characterized by using XRD, FTIR and electron 
microscopy. Results of the characterization studies 
showed the successful functionalization of graphene 
oxide sheets. 
CONCLUSIONS:
A new graphene based biofunctionalized material was 
produced in this study for drug delivery applications 
using green chemistry approach. 
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P-332: DEVELOPMENT AND 
CHARACTERIZATION OF SELF 
NANOEMULSIFIYING FORMULATION FOR 
ORAL PEPTIDE DELIVERY
1,2 Celik Tekeli, M.,2 Aktas, Y.,1 Celebi, N.
1Gazi University Faculty of Pharmacy, Department of 
Pharmaceutical Technology, Ankara, Turkey
2Erciyes UniversityFaculty of Pharmacy, Department 
of Pharmaceutical Technology, Kayseri, Turkey
INTRODUCTION:
Self nanoemulsifiying drug delivery systems 
(SNEDDS) are isotropic mixtures of oils, 
surfactants, solvents and co-solvents/surfactants 
which form nanoemulsions with aqueous dilution 
in gastrointestinal tract by gentle agitation (1). 
The objective of this study was to develop a self 
nanoemulsifying formulation for oral peptide delivery.
MATERIALS AND METHODS:
In this study while preparing SEDDS; ethyl oleate 
was the oil phase whereas Cremophor EL® and 
Labrasol® were used as surfactant, absolute alcohol 
and propylene glycolwere used as co-surfactant. 
Pseudoternary phase diagrams were established 
by titration. The ratio of surfactant/co-surfactant (S/
co-S) was selected as 3:1 from previous studies (2). 
The ratio of Cremophor EL® and Labrasol® was 
optimized using the following ratios: 1:1, 2:1, 3:1, 
1:2, 1:3. Around the center of gravity, nanoemulsion 
existence field determined points of SEDDS were 
prepared. Prepared SEDDS were characterized for 
emulsification time, droplet size, polidispersity index 
and zeta potential at 40C storage conditions during 
one month. Statistical analysis were evaluated by 
one-way analysis of variance (ANOVA) test.
RESULTS:
The emulsification time of formulations are below 
one minute with bluish white appearance referred 
as Grade B formulations. The mean droplet size and 
polydispersity index of nanoemulsion containing 15% 
ethyl oleate in a ratio of Cremophor EL®/Labrasol® 
in different proportions were approximately 18-50 
nm and 0.08-0.204 respectively. These formulations 
displayed no significant changes in both droplets size 
polydispersity index and emulsification times for one 
month (p>0.05).
CONCLUSIONS:
Five formulations containing 15% ethyl oleate as 
the oil phase, Cremophor EL®/ Labrasol® 2:1 and 
3:1 as the surfactant mixture and propylene glycol 
as the co-surfactant were selected according to the 
characterization tests. These formulations will be 
evaluated for peptide encapsulation efficiency in 
further studies.
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P-333: THE EFFECT OF CHITOSAN TYPE 
AND CONCENTRATION ON COMPLEXATION 
WITH SODIUM ALGINATE IN FILM 
FORMULATIONS 
Ilhan, M., Kilicarslan, M.
 Ankara University, Faculty of Pharmacy, Department 
of Pharmaceutical Technology, Ankara, Turkey
INTRODUCTION:
Water-soluble sodium alginate is very popular natural 
polymer for many medical applications. Its anionic 
structure provides it cross-linking with cationic 
materials such as chitosan, a chemically active 
polymer because of its amino and hydroxyl groups. 
Carboxyl and amine groups of alginate and chitosan, 
respectively, can form polyelectrolyte complexes 
easily in suitable conditions (1-3). In this study 
clindamycin phosphate loaded alginate-chitosan 
adhesive polyelectrolyte complex films were prepared 
for periodontal drug delivery. The aim was to examine 
the effects of the chitosan type and concentration 
onto the formation of alginate-chitosan polyelectrolyte 
complex film.
MATERIALS AND METHODS:
Clindamycin phosphate loaded (1% (w/v)) 
polyelectrolyte complex films were prepared by 
solvent casting method (2,3) using alginate solution at 
1%(w/v) concentration and chitosan (medium (F1-F3) 
and low (F4-F6) molecular weight) solutions at different 
concentrations (1% (F1, F4), 2% (F2, F5), 3% (F3, 
F6) (w/v)). CaCl2 (0.1%, w/v) and propylene glycol 
(5%, v/v) were used in all formulations. Thickness, 
viscosity, degree of swelling, adhesiveness of films, 
DSC analysis and in-vitro drug release studies were 
performed and evaluated for each film formulation.
RESULTS:
The viscosity of the mixture of polymer solutions 
before drying was significantly increased by the 
increase in concentration in both types of chitosan 
(from 0.23 ± 0.06 Pa.s (F4) to 5.63 ± 0.12 Pa.s (F3)). 
Polyelectrolyte complex formation was clearly showed 
by DSC thermograms. The highest swelling degree 
values were obtained with formulations prepared 
with 2% chitosan in both groups (F2 and F5). But the 
lowest peak force values obtained with formulations 
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prepared with 1% chitosan (F1 (1.101 ± 0.34 N) and 
F4 (1.317 ± 1.08 N)). These results showed that there 
was no correlation between swelling and adhesion 
due to non-homogenous complex formation. Drug 
release rate could be extended up to 6 hours with 
low molecular weight chitosan because of the higher 
complexation degree than that of medium molecular 
weight chitosan.
CONCLUSIONS:
The data obtained from present study clearly showed 
that solutions prepared with different molecular 
weight and concentrations of chitosan affected the 
film properties, significantly. Higher complexation was 
obtained with the formulations prepared using low 
molecular weight chitosan.
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P-334: FORMULATION AND 
CHARACTERIZATION STUDIES OF 
ORNIDAZOLE INCORPORATED EUDRAGIT® 
S 100 BASED NANOPARTICLES 
1 Ali, MS., 2 Basaran, E.
1Anadolu University, Institute of Health Sciences, 
Eskisehir, Turkey
2Anadolu University, Department of Pharmaceutical 
Technology, Eskisehir, Turkey
INTRODUCTION:
Due to its excellent penetration, high tolerability, 
prolonged half-life and more favorable side-effects 
profiles than metronidazole, Ornidazole (ORN) is 
used for the treatment of many bacterial infection 
(1). In our study Eudragit® S 100 (ES-100) based 
polymeric nanoparticles were formulated and in 
vitro characteristic properties of the particles were 
evaluated.
MATERIALS:
ORN was kindly gifted by Abdi İbrahim İlaç (İstanbul, 
Turkey). ES-100 was purchased from Röhm Pharma 
Polymers (Darmstadt, Germany). Tween® 80 (T80) 
was obtained from Merck (Hohenbrunn, Germany). 
All other chemicals were in analytical grade.
METHODS:
Nanoparticles were prepared by emulsification-
solvent evaporation method (2). A modified HPLC 
method was used for the determination of ORN. In 
vitro characteristic properties of the nanoparticles 
were evaluated in detail.
RESULTS:
Compositions of the formulations were presented in 
Table 1. 
Table 1. Compositions of the formulations prepared
Code ES-100 (mg) ORN (mg) T80 (0.5 % w/v) (mL)
M0 250 - 25
M1 250 10 25
M2 250 25 25
M3 250 50 25
M4 250 75 25
The in vitro characteristic properties of the particles 
were evaluated by particle size and zeta potential, 
DSC, XRD, FT-IR and 1H-NMR analyses. The 
analyses results revealed that the particles were 
in amorphous state and formulation stages did not 
influence the characteristic properties of the active 
agent.
CONCLUSIONS:
The in vitro characteristic properties of the 
nanoparticles were evaluated in detail and the 
analyses results showed that ORN incorporated 
polymeric nanoparticles were prepared successfully 
by emulsification-solvent evaporation method. 
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P-335: DRY GRANULATION: 
DETERMINATION OF OPTIMUM 
TABLETTING PARAMETERS USING 
COMPACTION SIMULATOR
Chunu, JT., Jiwa, N.,Ozalp Y.
Near East University, Faculty of Pharmacy, 
Department of Pharmaceutical Technology, Lefkosa, 
TRNC
INTRODUCTION:
Compaction simulator is an equipment which is 
capable of mimicking the exact cycle of any tablet 
press in real time and using the data to define 
tabletting parameters. Dry granulation slugging 
process was used to improve the compactibility of 
paracetamol powder and formulations were designed 
to obtain optimum formulation and compressibility 
characteristics.
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MATERIALS AND METHODS:














Paracetamol Kimetsan 45 45 45 45
Granulac® 70 Meggle 45 - 45 -
Flowlac® 100 Meggle - 45 - 45
Stearic Acid Kimetsan 2 2 2 2
Starch 1500® Colorcon 4 4 8 8
Primogel® FMC 2 2 - -
Kollidon®PVPK90 BASF 2 2 - -
The method used for obtaining paracetamol granules 
was slugging. The paracetamol powder was mixed 
with filler in a cubic mixer (Erweka) and 1% stearic 
acid was added as intragranular phase. Slugs were 
pressed using 18mm single punch (Korsch XP1), 
milled (Erweka) and sieved with 0.68mm sieve.
Average tablet weight was 555.5mg, using a 
compaction simulator (Stylcam 200R) 11mm flat 
faced Euro B punch for pressing. Formulations were 
pressed at different compaction forces; 15, 20, 25, 
30, 38 and 43kN to understand and characterize 
formulations as a function of each compaction force, 
therefore obtain the optimum tablet formulation. 
Tablets were controlled for weight variation, thickness 
and hardness for evaluation.
RESULTS AND DISCUSSION: 
Results in Fig. 1 indicate that  formulations reached 
optimum breaking force from 25kN. Optimun 
compaction force was determined as 30kN. Table 
2 shows hardness and thickness results of DG-45-
1 and DG-45-2 formulations.  DG-45-2 is seen to 
have  optimum tabletability profile as a result of its 
composition. 
Fig.1: Comparison of Breaking Force  profiles of 
different formulations.
Table 2: Effect of compaction force 
Tablet Controls DG-45-1 DG-45-2 COMPACTION 
FORCE (kN)
Hardness (N) 45±0,299 54±0,208
15
Thickness (mm) 4,20 4,26
Hardness (N) 54±0,321 76±0,361
20
Thickness (mm) 4,13 4,15
Hardness (N) 77±0,252 102±0,306
25
Thickness (mm) 4,05 4,07
Hardness (N) 91±0,2 103±0,153
30
Thickness (mm) 3,99 4,01
Hardness (N) 72±0,416 84±0,436
38
Thickness (mm) 3,9 3,91
Hardness (N) 74±0,321 70±0,265
43
Thickness (mm) 3,86 3,86
CONCLUSION: 
With compaction simulator its possible to define the 
mechanical properties and optimum tabletability 
profile for designed formulations. 
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P-336: IN VITRO EVALUATION OF 
ANTIOXIDANT & CYTOTOXICITY 
ACITIVITIES OF AL2O3 NANOPARTICLES, 
BLACK CUMIN OIL AND CO-ENZYME Q10 
ON MCF-7 CELL LINE
1 Sahin, NO., 1 Cavdar, B., 2 Cetin, B.,3 Sirin, S.
1 Mersin University, Faculty of Pharmacy, Department 
of Pharmaceutical Biotechnology, Mersin, Turkey
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INTRODUCTION:
Breast cancer is the second leading cause of cancer 
death in Turkish women. It’s important to find a 
less toxic, but more effective way of treating breast 
cancer patients. Antioxidants such as cumin oil, co-
enzyme Q10, can scavenge free radicals and, thus, 
decrease the occurrence of oxidative stress induced 
cell death or damage (1,2). Also, it has been proven 
that nanoparticles can act as synthetic antioxidants 
in the body and their enlarged surface area can bind 
specifically to cancerous cells and, thus, offer an 
approach for cancer therapy (3-4). Taking all these, 
information into account, the aim of this study was set 
to evalaute antioxidant and cytotoxic effect of black 
cumin oil, co-enzyme Q10, and aluminium oxide 
(Al2O3) nanoparticles,  using MCF-7 cancer cell line. 
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MATERIALS AND METHODS:
Nanoparticles were synthesized by Nanografi, METU. 
Co-enzyme Q10 and black cumin oil were from Turkish 
market.  The antioxidant activity of all substance 
under investigation was evaluated by DPPH free 
radical scavenging assay (3). The cytotoxic effects 
were investigated on MCF-7 after incubation for 24 h, 
48 h and 72 h using MTT assay. 
RESULTS:
It is evident from the results (DPPH scavenging 
activity) that nanoparticles (%28.31 ± 1.12), black 
cumin oil capsules (%41.3 ± 1.42), and  co-enzyme 
Q10 (%32 ± 1.56)  exhibited potent antioxidant 
activity.  Nanoparticles showed sginificant cytotoxict 
effect alone and in combination with co-enzyme Q10 
and black cumin oil (Figure 1).
Figure 1. IC50 values for tested substances 
(nanoparticles, K1: nanoparticles + Co-enzyme Q10, 
K2: nanoparticles + black cumin oil, K3: nanoparticles 
+ Co-enzyme Q10 + black cumin oil.)
CONCLUSIONS:
In conclusion, it can be suggested that combined 
use of these three substances possesses significant 
potential application in nanomedicine as a therapeutic 
tool.
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1 Siafaka, P., 1 Caglar, ES.,1 Ustundag Okur, N.
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Department of Pharmaceutical Technology, Istanbul, 
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INTRODUCTION:
Diabetes mellitus(DM), is a metabolic disorder in 
which high sugar levels found in blood for a long 
period (1). Polymeric microparticles by biocompatible 
and biodegradable polymers such as poly(ε-
caprolactone) and poly(butylene adipate) used so as 
to entrap active molecules and to release them in a 
controllable manner (2). In this work, Glibenclamide 
(GLI) was loaded into poly(ε-caprolactone) (PCL) 
and poly(butylene adipate)(PBAd)  in the form of 
microparticles in order to improve its solubility. 
MATERIALS AND METHODS:
PCL and PBAd were prepared as previously 
reported (2). Poly(vinyl alcohol)(PVA) was used 
as an emulsifier. Microparticles were prepared by 
solid-oil-water (s/o/w) emulsification method (3). 
100mg of PCL or PBAd were dissolved in 5mL of 
dichloromethane. 10mg of GLI was added to prepare 
loaded microparticles.  The polymeric solution was 
inserted dropwise in 20mL of PVA solution (1% w/v) 
and homogenized for 1min. After that, it was added in 
100mL water and left under magnetic stirring till total 
evaporation of dichloromethane. The microspheres 
were collected after centrifugation (8000rpm, 10min) 
and washed three times with distilled water to 
remove residuals of solvent and PVA. The resulting 
microspheres were finally dried and then stored at 
4oC for further evaluation. The microparticles were 
characterized via FT-IR, SEM analysis, and hydrolysis 
studies.
RESULTS:
The microparticles with or without GLI presented a size 
of 8-12μm. It was found out that PBAd microparticles 
were of lower diameter than PCL microparticles while 
drug incorporation seems to enlarge microparticles. 
PCL microparticles had a porous structure due 
to the rigorous solvent evaporation (Fig1). FT-IR 
spectroscopy studies depicted the successful loading 
of GLI into the polymeric microparticles. Interactions 
between carriers and drug have not been revealed 
(Fig2) (3). Hydrolysis study also demonstrated that 
PCL microparticles are being degraded slower than 
PBAd microparticles. In vitro release results found 
analogous to hydrolysis pattern.
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Figure 1: SEM images of microparticles






































Figure 2: FT-IR spectroscopy results
a) neat PBAd, b) PCL, c) PBAd+GLI  d)PCL+GLI 
CONCLUSIONS:
It can be concluded that the prepared microparticles 
seem to be ideal carriers for hydrophobic drugs so as 
to ensure improved solubility and controlled release 
pattern.
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INTRODUCTION:
Mupirocin (MUP), a topical antibiotic agent is 
effectively used for treatment of primary and 
secondary skin infections (1). The aim of this study 
was to develop and investigate bioadhesion, ex 
vivo permeation study of MUP film formulations 
as a dermal therapeutic system for wound healing 
applications. 
MATERIALS AND METHODS:
MUP loaded films were prepared via solvent casting 
evaporation method (2). The composition of the film 
formulations is shown in Table 1. Pure MUP drug, 
composite films and MUP loaded composite films 
were characterized by FTIR spectroscopy in order 
to determine possible interactions between used 
polymers and MUP. The surface morphology of all 
formulations were examined by scanning electron 
microscopy (SEM) at 12 kV. Bioadhesion study was 
conducted with a texture analyzer. The ex vivo studies 
were performed for F6, F7, and F8 films using Franz 
diffusion cell. Mice abdominal skin was used as a 
model tissue in permeation and bioadhesion studies.
Table 1 : Composition of the films
Fig.1. SEM images of MUP dermal films.
RESULTS:
Films had homogeneous appearances and could 
be easily removed from the petri dishes. FT-IR 
spectrosocpy studies reveal interactions between 
polymers in case of unloaded films. When drug was 
entrapped into the film matrix, possible interactions 
between MUP and the  other ingredients within the 
formulation did not depict, thus the formulations will 
present strong stability during its shelf life. SEM 
morphology revealed that some of the developed 
formulations (F3, F4, F5) had an interesting 
architectural structure however most of them don’t 
show any morphology (Fig.1). These results are 
rational when solvent evaporation technique is 
applied. The ex vivo permeation results of F6, F7, 
F8 films were found %12.14+0.951, %9.37+ 2.640, 
%4.10+1.864 respectively. After bioadhesion study, 
F6-coded formulation present higher bioadhesive 
properties than the others.
CONCLUSIONS:
According to the above results, F6-coded formulation 
found to the most desirable carrier of mupirocin 
delivery which it is believed to induce wound healing 
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process. Future studies will involve in vivo examination 
of the formulation to determine the efficacy of the 
formulation on wound healing.
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INTRODUCTION:
Ketoprofen lysinate (KL), the water soluble lysine 
salt of ketoprofen, is one of the most commonly used 
non-steroidal anti-inflammatory drug (NSAIDs) in the 
symptomatic treatment of various chronic inflammatory 
diseases. However, due to its short half-life of 1–2 h, a 
multiple dose regimen is required. Therefore, KL is an 
ideal candidate for the development of controlled drug 
delivery systems which are able to release the drug 
at a desired rate and in desired amount (1).  Eudragit 
S 100 is an anionic copolymer based on methacrylic 
acid and methyl methacrylate. It is generally used for 
the formulation of transdermal patches, nanoparticles, 
microparticles, solid dispersions and spherical 
crystals. Eudragit S 100 has been used for various 
applications such as sustain release, bioavailability 
enhancement, improvement in micrometric properties 
(2). According to the aim of this study, KL-containing 
Eudragit S100 nanoparticles were prepared by double 
emultion solvent evaporation method (3).
Material and Methods: KL is kind gift from Berko İlaç 
(Istanbul/Turkey). Eudragit S100 was obtained from 
Evonik (Germany). Formulations were prepared 
by double emulsion solvent evaporation method. 
Particle size (PS), poly dispersity index (PDI) and 
zeta potential (ZP) measurements were performed on 
freshly prepared samples using a Malvern analyzer. 
The entrapment efficiency (EE%) was performed with 
HPLC with reversed-phase column and also thermal 
analysis and FT-IR analysis were performed.
RESULTS:
Table 1. Result of PS, PDl, ZP and EE% (n=3)




















Figure 1. a: KL, b: Eudragit® S 100, c: Physical 
mixture, d: I-Blank, e: I-KL
CONCLUSIONS:
Characterization studies suggest that the active agent 
is successfully loaded into the polymeric nanoparticle 
system. In future studies, release experiments will be 
conducted to determine the release characteristics of 
the formulations.
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P-341: FACTORIAL DESIGN 
AND DEVELOPMENT OF PLGA 
MICROPARTICLES FOR PROTIEN DELIVERY 
SYSTEM
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INTRODUCTION:
Several scientific hurdles still have to be overcome 
before preparing drug delivery systems. One of them 
is to develop a safe and an efficient protein delivery 
system. Here, we have employed factorial design 
to optimize the production of  poly(lactic-co-glycolic 
acid) (PLGA) microparticles for protein delivery. A 2 
x 4 full-factorial experimental design was used for the 
optimization of the formulations. The variables were 
defined by the components of the formulation: amount 
316  12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey
of albumin (BSA), type of PLGA, mixing aparatus and 
type of solvent at two levels (-1, 1) with 2 extra repated 
points. Formulations were prepared by varying the 
selected points and several properties were tested, 
including their encapsulation efficiency, particle size 
and zeta potential value. 
MATERIALS AND METHODS:
Eighteen formulations of PLGA microspheres 
containing BSA were fabricated using a spontaneous 
modified single-emulsion/solvent evaporation method 
(1). Briefly 200 mg of PLGA were dissolved in 10 mL 
of 4:1 DCM:Acetone and mixed with 300 mL of BSA 
in water. Mixing formed a clear, single-phase solution 
that was subsequently added to 200 mL of 5% (w/v) 
PVA in water. The emulsion formed spontaneously 
and was stirred for 3 h at room temperature. Particles 
were then centrifuged, washed five times with water, 
and lyophilized. 
RESULTS:
The single-emulsion/solvent evaporation technique we 
use for the preparation of microparticles in this study 
is a very useful technique in which microparticles are 
readily obtainable and the production method is easy 
to scale up (2). The possible formulation parameters 
affecting the preparation of the microparticles were 
optimized to achieve the optimum BSA concentration. 
In this study, it was found that formulations were 
produced with small particle size, in the range of 
80.98–263.4 µm. A high percentage of the DCM 
increases the polymer load in the aqueous medium 
during the emulsification process. Zeta potential is the 
estimate of the surface charge that particles gain in 
the dispersed state. When the zeta potential values 
of nanoparticles are close to ±30 mV, the colloidal 
systems show no aggregation and they form stable 
dispersions that depends on the repulsion forces 
between particles. In this study, the zeta potential 
values  of formulations ranged between -5.33 and 
-25.66 mV. 
CONCLUSIONS:
BSA loaded PLGA microparticles were successfully 
prepared and optimized with 24 factorial design study. 
The optimized formulation has been found that BSA is 
effectively encapsulated in microparticles with 150 µm 
size and above -20 mV.
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Technology, Ankara, Turkey
INTRODUCTION:
The most commonly used dermal analgesics are 
lidocaine, tetracaine, prilocaine, or combinations 
thereof, and the most common topical anesthetic 
which is regarded as the gold standard is EMLA 
cream, but it requires occlusion and its effect has 
a short duration. The object of this study was to 
develop topical cream and gel formulations of 
lidocaine-tetracaine (LT) combination with a suitable 
consistency, and to maintain an effective pain 
alleviation for a longer duration with a faster onset of 
action that may be an alternative to EMLA in the drug 
market. 
MATERIALS AND METHODS:
 Two different type of formulations of LT combination; a 
water-in-oil (w/o) emulsion and an emulgel thickened 
with Carbomer 974 were manufactured. Rheological 
and pH measurements, quantitative analysis (1) and 
in vitro studies using Franz diffusion cell at pH=7,4 (2) 
were performed at day 1 (t0), and formulations were 
subjected to 25°C/60% RH for 30 days for stability 
studies. All controls were done at day 30 (t30) to 
determine the changes in the formulations. 
RESULTS:
All formulations were white in appearance, 
homogeneous and odorless after inspection. The 
emulgels’ pH levels changed between 7,2-7,7 at 
t0, and 8,2-8,9 at t30, respectively. The w/o cream 
and emulgel formulations showed shear thinning 
thixotropic behaviour at t0, and rheologic behaviour 
did not change at t30. The yield percentage of 
lidocaine was 65-100%, and tetracaine was 45-
100% in emulgels, and 39-79% and 47-67% in 
creams according to quantitative analysises. It has 
been shown that LT release was faster in emulgel 
formulations (Figures 1 and 2), and tetracaine release 
had a longer duration.
CONCLUSIONS:
Cream and gel formulations of lidocaine-tetracaine 
(LT) combination with a suitable consistency, pH 
level and longer duration of action have been 
manufactured. With conducted studies, it can be 
interpreted that these formulations can maintain pain 
alleviation for longer because of tetracaine’s release 
profile.
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INTRODUCTION:
Melatonin is an indolic hormone mainly synthesized 
and secreted from the mammalian pineal gland. 
Melatonin production is regulated by photoperiod, 
which is repressed by light but induced at night 
in response to darkness (1). Melatonin has been 
shown cytoprotective effect in normal cells and it 
inhibits growth of a variety of cancer cells, both in 
physiological and pharmacological concentrations 
(2). The therapeutic potential of novel melatonin 
analogs motivated us to investigate their ability to 
inhibit proliferation in breast cancer cell lines (MDA-
MB-231).
MATERIALS AND METHODS:
Human breast cancer cell lines MDA-MB231 were 
cultured in DMEM high glucose medium, supplemented 
with 10% fetal bovine serum, 2 mM L-Glutamine and 
1% Penicillin/Streptomycin. MDA-MB231 cells were 
seeded in 96-well plates and incubated at 37°C with 
5% CO2 humidified atmosphere. 24 hours later, cells 
were treated with 0.1% DMSO dissolved in culture 
medium or with different doses of melatonin and 19 
different melatonin analogs diluted in 0.1% DMSO 
and cultured for 24 and 48 hours. The cell viability and 
proliferation were investigated with colorimetric MTT 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] assay, according to the manufacturer’s 
protocol. 10 µL MTT (5 mg/mL dissolved in 
phosphate-buffered saline) was added to each well 
and plate was incubated for 4 h. MTT containing 
media were removed, and the purple formazan 
crystals were dissolved in 100 µl dimethyl sulfoxide. 
The absorbance was recorded on a microplate reader 
at the wavelength of 570 nm. The experiments were 
performed in triplicate and repeated three times.
RESULTS:
The sensitivity of human breast cancer cell line, MDA-
MB-231, to the melatonin and newly synthesized 19 
different melatonin analogs was assessed by using a 
MTT cellular survival assay. The experiments revealed 
that melatonin and new melatonin analogs inhibited 
the growth of MDA-MB231 breast cancer cells in a 
dose and time dependent manner. In addition, MDA-
MB231 breast cancer cells were more sensitive 
to melatonin analogs KD11, KD12 and KD13 and 
these analogs displayed the most anti-proliferative 
and cytotoxic effects at low concentrations (0.5uM) 
in a shorter time of exposure. These data indicate 
that novel melatonin analogs are potent inhibitors of 
human breast tumor cell proliferation.
CONCLUSIONS:
We demonstrated that novel melatonin analogs 
inhibit the growth of breast cancer cell lines in vitro 
and suggesting the oncostatic / cytotoxic role of these 
compounds.
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P-344: PREPARATION AND IN-VITRO 
CHARACTERIZATION OF AMPICILLIN 
SODIUM-LOADED ALGINATE BEADS 
FOR ORAL ANTIBIOTIC TREATMENT: A 
PRELIMINARY STUDY
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Ataturk University, Faculty of Pharmacy, Department 
of Pharmaceutical Technology, Erzurum, Turkey
INTRODUCTION:
Oral drug delivery is the most popular and convenient 
method for decades. The high level of patient 
compliance in taking oral dosage forms is due to 
the ease of administration, patient compliance, 
flexibility in formulation and handling of these forms 
(1). Antibiotics such as ampicillin sodium (A.Na) are 
commonly used for systemic therapy as well as for 
gastric or intestinal infections. Among the semi-
synthetic penicillins, ampicillin has found widespread 
use owing to its broad spectrum of activity (2). It is 
acid resistant and therefore can be given orally (3). 
The aim of this study is to develop calcium alginate 
beads with improved properties for controlled delivery 
of A.Na. 
MATERIALS AND METHODS:
A.Na (a generic drug in pharmacies, Turkey), sodium 
alginate (Alfa Aesar, Germany). Calcium alginate 
beads containing A.Na were prepared by ionotropic 
gelation method. For characterization study, 
encapsulation efficiency (EE, %), drug loading (DL, 
%), yield (%), surface morphology, particle size, and 
in vitro release were evaluated. The beads were failed 
in buoyancy test. The particle sizes of the beads were 
measured with an manual calliper. An incubation 
method was used for determination of A.Na release 
from beads in pH 1.2 HCl buffer at 37 °C for 4 hours.
RESULTS:
Digital photographs of wet blank and A.Na-loaded 
beads show the spherical morphology. In vitro 
release of A.Na into HCl buffer from the beads was 
slow and sustained but insufficient. The results of the 
characterization studies of beads are showed below. 
 













Mean - - 81.23 1.40




Mean 25.09 3.92 80.30 1.57
SD 4.30 0.74 5.40 0.28
*PS: Particle size of dry beads, SD: Standard deviation.
CONCLUSIONS:
Experiments were done to establish the optimum 
conditions for the preparation of homogenous and 
spherical beads with a smooth surface. A.Na beads 
provides a controlled release formulation with 
sustained-release properties for prolonged periods. 
But in order to improve the EE, DL or in vitro release 
results, further studies should be performed. 
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INTRODUCTION:
One of the most feasible approaches for achieving 
a prolonged and predictable drug delivery profiles 
in gastrointestinal tract with different mechanisms 
is to control the gastric residence time using 
gastroretentive drug delivery systems that offer a new 
and better option for drug delivery (1). Gelispheres 
are spherical crosslinked hydrophilic polymeric drug 
delivery systems capable of extensive gelation and 
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swelling characteristics in simulated biological fluids 
(2). Ampicillin sodium (A.Na), being a potent, broad 
spectrum antibiotic, is commonly used for systemic 
therapy as well as locally for gastric or intestinal 
infections (3). The aim of this study is to develop 
cellulose gelispheres with improved properties for 
gastroretention of A.Na. 
MATERIALS AND METHODS:
A.Na (a generic drug in pharmacies, Turkey), 
synthetic cellulose (Doga Ilac, Turkey). Gelispheres 
containing A.Na were prepared by ionotropic gelation 
method. For characterization study, encapsulation 
efficiency (EE, %), drug loading (DL, %), yield (%), 
surface morphology, particle size, floating, swelling 
and in vitro release were evaluated. The particle sizes 
of the beads were measured with an manual calliper. 
An incubation method was used for determination of 
A.Na release from gelispheres in pH 1.2 HCl buffer at 
37 °C for 24 hours.
RESULTS:
Digital photographs of wet/dry A.Na-loaded and 
floating gelispheres show the spherical morphology. 
All of the gelispheres were floating for 5 days. The 














Mean - - 39.16 1.98




Mean 18.55 2.78 39.17 1.96
SD 1.03 0.04 1.84 0.73
*PS: Particle size of dry beads, SD: Standard deviation.
CONCLUSIONS:
Gastroretentive drug delivery systems have emerged 
as an efficient means of enhancing the bioavailability 
and controlled delivery of many drugs. These systems 
might be beneficial over the conventional oral dosage 
forms for therapeutic efficacy of A.Na.
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INTRODUCTION:
The aim of this study was to prepare and evaluate 
cell culture of Dexamethasone (DEX) loaded PLGA 
nanoparticles (NPs) for oral cancer chemoprevention.
MATERIALS AND METHODS:
The DEX loaded PLGA NPs were prepared by 
a emulsification/solvent evaporation method (1). 
Cytotoxicity potential of the NPs was evaluated 
by MTT assay (2). Human kidney proximal tubular 
epithelial cell line (HK-2, ATCC) were cultured in 
10% fetal bovine serum (FBS) supplemented DMEM: 
F12 medium. Mouse embryo fibroblast cell line 
(NIH-3T3) were grown in 10% FBS supplemented 
DMEM. Cells were maintained at 37°C in a humidified 
atmosphere at 37 ºC. Cells were plated in 96-well 
plates at a density of 5×103 cells/ well and incubated 
in a humidified atmosphere for 24 hours for cell 
attachment. Then, the cells were treated for 48 hours 
with a 1:1,000 dilution of the tested formulation. Cells 
treated with medium only used as a control. After 
removing the medium, cells were washed with PBS. 
Medium and MTT solution were added to each well 
to determine the cell viability. After incubation, blue-
colored formazan crystals were dissolved in dimethyl 
sulfoxide. The absorbance of the formazan solution 
was measured in a plate reader. The ratio of the 
absorbance of treated samples to the absorbance of 
control was expressed as % cell viability. Cell survival 
was expressed as the percentage of formazan 
absorbance. Statistical analysis was conducted by 
ANOVA followed by Tukey’s test.
RESULTS:
The NPs were prepared successfully. Cytotoxicity 
is a key factor while choosing a suitable drug 
delivery carrier. It was determined that NPs caused 
a significant increase in cell viability of HK-2 and 
NIH-3T3 cells compare to control cells. On the other 
hand, it was not found any cytotoxic effect of the NPs 
to HK-2 cell nor 3T3 cell. These cytotoxicity results 
signified that NP had the potential to be used as a 
carrier for DEX delivery.
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CONCLUSIONS:
The objective of the present work of formulation and 
evaluating cell culture studies of DEX loaded NPs has 
been achieved with success.
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P-347: A COMPERISON OF PLGA 
NANOPARTICLE PREPARATION METHODS 
FOR BEVACIZUMAB ENCAPSULATION
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1 Hacettepe University, Department of 
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2 Hacettepe University, Department of 
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INTRODUCTION:
Bevacizumab is a recombinant monoclonal antibody 
that approved by Food and Drug Administration 
(FDA), for treatment of patients with metastatic renal 
cell cancer, non-small-cell lung cancer, metastatic 
colorectal cancer, epithelial ovarian and fallopian 
tube cancer in the USA and Europe (1). The 
nanotechnological approaches have emerged to 
maintain antibody stability, achive controlled release 
and targeted delivery of the antibody via encapsulation 
of antibodies into polymeric nanoparticles (2). In 
the studies conducted, researchers are focused on 
PLGA since it is an biodegredable and bioavailable 
FDA approved polymer (3). Encapsulation efficiency 
of the antibody alters with the preparation method 
of nanoparticles. In this study, bevacizumab loaded 
nanoparticles were prepared by two different methods 
and characterization studies were performed.
MATERIALS AND METHODS:
Bevacizumab, Altuzan®, Shikari Bevacizumab Elisa 
Kit, PLGA-PEG (Sigma-Aldrich), Pluronic F-68 
(Cellgro)
Methods: Double Emulsion Method and modified 
solvent diffusion technique were compared (4-5). 
Nanoparticle characterizations were performed with 
Zetasizer Nano ZS and Elisa Kit. 
RESULTS:
The average particle sizes of the nanoparticles 
obtained by the modified solvent diffusion technique 
and double emulsion method were 250 nm and 120 nm 
respectively. It was found that encapsulation activities 
of the nanoparticles obtained by the  modified solvent 
diffusion technique (70%) were higher than the 
encapsulation activities of the nanoparticles obtained 
by the double emulsion method (20%).
CONCLUSIONS:
It is crucial to maintain the stability of antibodies 
during nanoparticle preparation since stress factors 
such as sonication can disrupt antibody stability and 
decrease encapsulation efficiency. In this study, it was 
pointed out that modified solvent diffusion technique 
is a better alternative for antibody encapsulation than 
double emulsion method.
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P-348: DEVELOPMENT OF MONO 
AND BILAYERED BIOADHESIVE FILM 
FORMULATIONS FOR ORAL MUCOSAL 
DRUG DELIVERY
Timur, SS., Yüksel, S., Senel, S.
Hacettepe University, Faculty of Pharmacy, 
Department of Pharmaceutical Technology, Ankara, 
Turkey
INTRODUCTION:
Various delivery systems have been developed for 
delivery of drugs into oral cavity for local effect or 
across oral mucosa for systemic effect. Major limitation 
in developing an oral mucosal delivery system is the 
movement of the tongue as well as salivation. For an 
effective drug delivery, systems based on bioadhesive 
polymers have been investigated to enhance the 
retention time of the system in contact with the 
tissue and also provide prolonged release of the 
drug. Chitosan, which is a bioadhesive and bioactive 
polymer, has been widely utilised in different forms for 
local delivery into oral cavity. 
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MATERIALS AND METHODS:
In this study, chitosan based mono and bilayered 
films were developed for oral mucosal delivery. The 
monolayer films were prepared using solvent casting 
method, and bilayered films using double-casting 
method. Cefuroxime axetil (5 % w/w), which is a 
wide-spectrum antibiotic was used as model drug. 
Morphology of the formulations was examined using 
scanning electron microscopy. Mechanical (tensile 
strength) and physical properties (water absorption 
capacity, bioadhesion, thermal behaviour) as well 
as disintegration properties of the formulations were 
investigated. In vitro drug release studies were 
performed using Franz diffusion cells. 
RESULTS:
Homogenously dispersed mono and bilayered 
films were obtained with chitosan. All formulations 
incorporated with drug remained intact without 
disintegration up to 5 to 6 h. DSC thermograms 
confirmed that the drug was consistently incorporated 
into the formulations. With monolayer films, 
bioadhesion (13.71±2.73 (mJ/cm2) was decreased 
in presence of drug, whereas with bilayered films, 
bioadhesion was found to increase (105.3±23.4 (mJ/
cm2). Water absorption capacity of the bilayered 
films (288.4±8.7%) was found to be higher than that 
of monolayer films (111.4 ±14.9 %). A prolonged drug 
release was obtained up to 5 h.   
CONCLUSION:
Chitosan based films were developed successfully 
with suitable bioadhesive property and disintegration 
time which would enable the system to remain 
attached on the application site and release drug in a 
prolonged fashion.     
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P-349: COMPARISON OF DIALYSIS VS 
SAMPLE AND SEPARATION METHODS FOR 
IN VITRO RELEASE DETERMINATION OF 
LEVODOPA FROM NANOPARTICLES
Arısoy, S., Sayıner, O., Comoglu, T.
 Ankara University, Department of Pharmaceutical 
Technology, Ankara, Turkey
INTRODUCTION:
The aim of the present study was to compare 
dialysis (DM) and sample and separation (SS) 
methods for determining in vitro release of levodopa 
from nanoparticles. Nanoparticles were prepared 
by double emulsion-solvent evaporation method, 
using methylene chloride as an organic solvent and 
polyvinyl alcohol as the surfactant.  Samples were 
withdrawn and drug concentration was determined 
using HPLC. The rate and extent of drug release from 
nanospheres was dependent on the drug/polymer 
ratio, and drug loading of nanoparticles. The ƒ1 and 
ƒ2 statistics were used to compare the two methods 
(1).
MATERIALS AND METHODS:
In vitro release studies were performed by incubating 
nanoparticles (equavalent to 45 µg levodopa) in 5 ml 
of buffer, pH 4,5. The tubes were stirred continuously 
at 37± 0.5 °C  in a water bath nd shaken horizontally 
at 100 rpm. To practice the SS method the tubes 
were taken out of the water bath and centrifuged. 
The precipitated nanoparticles were resuspended in 
5 ml of fresh buffer. Unlike SS method, in DM method 
nanoparticles were suspended in 0,5ml of buffer 
solution in a dialysis bag than placed in 4,5 mL buffer. 
At predetermined time intervals all media replaced 
with fresh buffer solution.
RESULTS :
Table 1. ƒ1and ƒ2 statistics for the dissolution profile 
using the DM as reference and the SS as test model
SS method DM method
Time 
(minute)










Figure 1. Comparative release pattern of levodopa 
from nanoparticles using the DM and SS methods.
CONCLUSIONS:
DM and SS methods gave similar shapes of in vitro 
release profiles at acceptable precision (‹10%,CV). 
The SS method tended to show faster release rates 
from formulations than those observed using dialysis 
bag (Table 1). The difference between DM and 
SS methods in the release kinetics did not reach 
significance (f1 < 15 and f2 > 50). 
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P-350: PREPARATION AND 
CHARACTERIZATION OF NANOFIBERS 
CONTAINING ORNIDAZOLE FOR BUCCAL 
APPLICATION 
Tort,S., Yıldız, A., Tugcu Demiroz, F., Tuncel, E., 
Acarturk F.
Gazi University, Department of Pharmaceutical 
Technology, Ankara, Turkey
INTRODUCTION:
Gingivitis is a common and mild form of periodontal 
disease that causes irritation, redness and swelling of 
gingiva(1). Ornidazoles, as a nitroimidazole derivative, 
are antibiotics that are widely used to treat anaerobic 
infections(2). Nanofibers are suitable for a wide range 
of applications owing to their capability for accepting 
various types of loading materials in their structures, 
such as antibiotics, anticancer drugs, nucleic acids, 
and proteins(3). The aim of this study, was to develop 
buccal application of ornidazole for treatment of 
gingivitis by loading ornidazole into nanofibers.
MATERIALS AND METHODS:
 Polyvinylpyrolidone (PVP) solutions at different 
concentrations (10, 12.5 and 15%,w/v) in ethanol 
were prepared, and the nanofibers were produced 
by electrospinning technique using these solutions. 
The ornidazole loaded solutions (0.5%, w/v) at 
different PVP concentrations were compared in terms 
of viscosity, conductivity and surface tension. The 
ornidazole-loaded nanofibers were characterized 
by fourier transform infrared spectroscopy (FTIR), 
differential scanning calorimetry (DSC) and scanning 
electron microscopy (SEM). Mechanical properties of 
nanofibers were investigated using a texture analyzer.
RESULTS:
An increase in the polymer concentration from 10 to 
15% led to a decrease in the solution conductivity and 
surface tension values and an increase in the solution 
viscosity values. Similar results were observed in 
ornidazole-loaded polymer solutions. DSC and FT-
IR analyses suggest that ornidazole is present in the 
nanofibers and there were no interactions between 
ornidazole and PVP. The increase of polymer 
concentration from 10 to 15% led to an increase in 
average nanofiber diameter. The average diameters 
of the ornidazole-loaded nanofibers were found to 
be 680, 1350 and 1320nm for PVP concentrations 
of 10, 12,5 and 15%, respectively. The developed 
buccal nanofiber comprises with a contact angle of 
0°, a tensile strength of between 1,67-5,12MPa and 
an elongation at break value of 14-19% for PVP 
concentrations between 10-15% (Fig.1). Entrapment 
efficiencies of ornidazole in the nanofibers were found 
to be 57, 83 and 71µg/cm2 for PVP concentrations 
of 10, 12,5 and 15%, respectively. PVP concentration 
directly affected nanofiber diameter and mechanical 
properties of nanofibers.  
Figure 1. Stress-strain curves of ornidazole-loaded 
PVP nanofibers
CONCLUSIONS:
In the present study, ornidazole-loaded nanofibers 
were successfully developed for the treatment of 
gingivitis. The antibacterial efficacy of ornidazole-
loaded nanofibers could offer improved efficacy in the 
treatment of gingivitis. 
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P-352: PH-DEPENDENT DISSOLUTION 
BEHAVIOR OF A WEAKLY BASIC BCS 
CLASS II DRUG, CLOPIDOGREL 
Olgac, S., Yildiz, A., Saar, S., Kodan, E., Incecayir, T.
Gazi University, Department of Pharmaceutical 
Technology, Ankara, Turkey
INTRODUCTION:
The aim of this study was to investigate the pH-
dependent dissolution of a weakly basic BCS II (low-
solubility and high-permeability) drug, clopidogrel 
and compare the in vitro dissolution of its innovator 
and three generic products to assess the in vivo 
dissolution and intestinal permeability of this oral 
antiplatelet agent.
MATERIALS AND METHODS:
Clopidogrel bisulfate was kindly supplied from Deva 
Holding(Turkey). Four commercial IR tablets of 75 
mg clopidogrel were purchased from local market. 
Dissolution tests were carried out using a Varian 
VK7000 dissolution apparatus(USA). The reference 
and test tablets were placed in 900 mL of dissolution 
media at 37oC using USP Apparatus II at 50 rpm. pH 
1.2 HCl, pH 4.5 acetate and pH 6.8 phosphate buffers 
were used as dissolution media. An aliquot of medium 
was withdrawn at predetermined time intervals, and 
an equivalent amount of fresh medium was added. 
Withdrawn samples were filtered using a 0.45 µm filter 
and analyzed at 220 nm spectrophotometrically. All 
dissolution experiments were carried out in triplicate 
and mean cumulative percentages of drug dissolved 
from the tablets were plotted against time. f2 similarity 
test was used to compare dissolution profiles of 
reference and test products. Dose numbers(DO) 
were calculated. The un-ionized drug fraction(fu) at a 
given pH was calculated using Wagner and Sedman’s 
equation (3). 
RESULTS:
DO at pH 1.2, 4.5 and 6.8 are 0.010, 0.170 and 39.1, 
respectively. At least 85% of the labeled amount was 
dissolved within 30 min for reference and all test 
products except one test (86% dissolved in 45 min) 
at pH 1.2. At pH 4.5 and 6.8, drug dissolved from 
all products were in the range of 78-101% and 37-
51% in 90 min. Only one of the test product showed 
dissolution profile similarity(f2>50) to reference in 
each case. The un-ionized fraction(fu) of clopidogrel 
(pKa:4.56, log P:3.9) is nearly zero up to pH 2, and 
then gradually increases as pH increases giving 
the sigmoidal profiles around pH 6.5. fu values of 
clopidogrel in jejunal pH 6.0 and ileal pH 7.4 are high 
and similar, which may explain our previous data on 
clopidogrel’s high Peff with no regional dependency 
(4). 
CONCLUSIONS:
This study shows that the dissolution of all test and 
reference products of clopidogrel is likely to be 
complete in stomach, and entering the upper intestine, 
it is likely to be present in a supersaturated state, and 
rapidly absorbed before precipitating at the high pH of 
the small intestine.
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P-353: FORMULATION AND EVALUATION 
OF DEXKETOPROFEN MINI TABLETS FOR 
CHRONOTHERAPY
Ilhan, E., Sahbaz, S., Ugurlu, T., Aldeniz, EE. 
Marmara University, Department of Pharmaceutical 
Technology, İstanbul, Turkey
INTRODUCTION:
Dexketoprofen trometamol is indicated for the 
management of acute pain including dental pain, 
dysmenorrhoea and muscular pain and used more 
than one dose in a day without exceeding 75mg/day 
(1). In order to increase the patient’s compliance and 
to keep the pain under better control, a novel pulsatile 
release drug delivery system of dexketoprofen was 
designed by filling mini tablets into hard gelatine 
capsule. 
MATERIALS AND METHODS:
Dexketoprofen trometamol was purchased from 
Huangshi Shixing Pharmaceutical Co, Ltd., (China), 
maize starch from Roquette Pharma (France), 
microcrystalline cellulose from JRS Pharma 
(Germany), sodium starch glycolate from DFE Pharma 
(Germany), glyceryl behenate from Gattefossé 
(France), Eudragit L 100 and Eudragit S 100 from 
Evonik Röhm GmbH, (Darmstadt, Germany). Talc, 
triethyl citrate, acetone and isopropyl alcohol all were 
in analytical grade.
Mini tablets (1mg dexketoprofen per tablet) were 
prepared by wet granulation method. As designed 
for immediate release (IR) and colon targeted drug 
delivery (CTDD) combination, half of tablets (25 
tablets) were coated with pH sensitive polymers 
(Eudragit L 100 and/or Eudragit S 100) and the other 
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half remained uncoated. After preparing all tablets, 
they all (50 tablets) filled into hard gelatine capsule. 
Drug release test was initiated in a buffer system at 
pH1.2 (750 ml); after 2 h, the pH was altered to 6.8 
(1000 ml) by sodium phosphate solution to mimic the 
pH in the stomach and colon (2).
RESULTS:
IR formulations were found to have similar dissolution 
profile with the reference product. As developing 
CTTD, after trying different processes, spray coating 
gave better coating performance  and dissolution 
profiles than pan coating. 
CONCLUSIONS:
As the formulations are mini tablets, it gave different 
coating results compared with the basic tablets. Mini 
tablets were coated more homegenously with spray 
coating method and it was seen that  Eudragit S 
100 coating was more resistant than Eudragit L 100 
coating to colonic condition.
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P-354: PREPARATION AND 
CHARACTERIZATION OF EGF CONTAINING 
HYDROGEL FORMULATIONS
1 Dogan, M., 1 Sezer, AD., 2 Sahbaz S., 2 Ugurlu, T.
1Marmara University Department of Pharmaceutical 
Biotechnology, İstanbul, Turkey
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INTRODUCTION:
Wound is known as the impairment of tissue integrity. 
Wound healing include; homeostasis, inflammation, 
cell proliferation, extracellular matrix production and 
wound closure respectively(1,2). Epidermal Growth 
Factor (EGF)  play an important role in dermal wound 
healing proceses which accelerate the epidermal cell 
regeneration and stimulate keratinocyte proliferation 
and  migration (3). Chitosan and PVA are widely 
used in hydrogel formulations for wound healing 
process. (3,4). Our main goal was to prepare different 
hydrogel formulations and investigate the mechanical 
properties and therapeutic efficacy (1,4).
MATERIALS AND METHODS:
Materials: EGF(h), EGF(m), chitosan(m), chitosan(h), 
PVA, mPEG propiyonaldehyde (MW 5kD) and 
mPEG propiyonaldehyde ( MW 10 kD ) was used in 
our studies. All materials used in this studies are in 
analytical grade.
Methods: The concentration of chitosan which will 
form the hydrogel formulation will be determined as 
3%.The concentration of PVA, the other polymer to be 
used, will be determined as 2%(2). EGF Pegylation 
reaction  take places between the aldehyde group 
of PEG and the α amine moiety in the N-terminal 
region of the protein and consist of Schiff base moiety.
The swelling behavior of the hydrogels is strongly 
dependent on the gel ionization and the ionic strength 
around the solution(3).In order to investigate the 
mechanical properties of hydrogel formulations, 
TA.XT Plus Texture Analysis (Stable Micro Systems, 
UK) device and the Texture Exponent software of the 
device was used(4). Brookfield DV-E viscometer was 
used to measure the viscosities of the hydrogels(4). 
RESULTS

























































A1.1 0,039 -0,0282 0,865 0,971 0,017 0,146 0,237
A1.2 0,041 -0,0184 0,839 0,984 0,000 0,313 0,247
D1.1 0,030 -0,0232 0,950 1,247 0,000 0,398 0,221
D1.2 0,038 -0,0206 0,847 0,987 0,017 0,260 0,232
E1.1 0,057 -0,0705 0,835 0,934 0,010 0,271 0,252
E1.2 0,044 -0,0901 0,838 0,931 0,019 0,159 0,240
H1.2 0,052 -0,1024 0,846 0,939 0,018 0,142 0,256
CONCLUSIONS:
The results showed that hydrogels which consist 
of high molecular weight chitosan is more viscous, 
adhesive and has more hardness than the hydrogels 
including medium molecular weight chitosan.
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P-355: PREFORMULATION STUDIES OF 
CYCLOSPORINE A NANOSUSPENSION 
STABILIZED BY HYDROXYPROPYL 
METHYLCELLULOSE AND SOLUPLUS®
Gulbag, S., Karakucuk, A., Mutlu Agardan, B., Celebi, 
N.
Gazı University, Faculty of Pharmacy, Department of 
Pharmaceutical Technology, Ankara, Turkey
INTRODUCTION:
Cyclosporine A (CsA) is a well-known 
immunosuppressive agent that has used following 
organ transplantion (1). Nanosuspensions are 
colloidal dispersions containing nanoscale drugs 
stabilized by surfactants and polymeric steric 
stabilizers. Nanosuspensions are currently very 
attractive because they can increase the solubility, 
dissolution and bioavailability of water insoluble drugs 
(2).
In the present study, CsA nanosuspension was 
prepared by high pressure homogenization method 
using Design of Experiment (DoE) approach and 
in vitro characterization studies including particle 
size (PS), polydispersity index (PDI), zeta potential 
(ZP) measurement, surface morphology, differential 
scanning calorimetry (DSC) were evaluated.
MATERIALS AND METHODS:
Preparation of CsA nanosuspansions using 
microfluidization technique was performed. Firstly, 
HPMC and Soluplus® (CsA:stabilizer 1:1, 1:2, 
1:4) were used to stabilize the nanosuspension 
separately. Secondly, the combination of HPMC and 
Soluplus® (CsA:HPMC:Soluplus® 1:1:0.25, 1:1:0.5) 
were used to obtain nanosuspension formulation. 
Stabilizers were dissolved in distilled water and 1% 
CsA was dispersed in this solution. The Ultraturrax (at 
15.000 rpm for 10 minutes) was used to minimize PS 
of the coarse suspensions. Different homogenization 
cycles (5, 15, 30) were applied at 30.000 psi 
process pressure on the microfluidizer to obtain CsA 
nanosuspensions. 32 (3 levels, 2 factors) full factorial 
design was applied to optimize the formulations. 
PS, PDI and ZP values of nanosuspensions were 
measured after the initial, 1 week and 1 month and 
compared for short term physical stability. Obtained 
CsA nanosuspensions were lyophilized for 48 hours 
and in vitro characterization studies were performed.
RESULTS:
PS values were measured between 700 nm and 1750 
nm and ZP values were measured -20 mV with HPMC 
stabilized nanosuspensions. PS and ZP values 
were noticed 200 nm and -8 mV with Soluplus® 
stabilized nanosuspensions respectively. Therefore, 
combination HPMC and Soluplus® was used to 
obtain smaller PS and higher ZP values. The PS, PDI 
and ZP values were found for CsA:HPMC:Soluplus® 
1:1:0.5 formulation 366.8±9.6 nm, 0.48±0.02 and 
-14.4±0.4 mV, respectively.
CONCLUSIONS:
CsA nanosuspensions were successfully obtained 
using the DoE approach by selecting HPMC and 
Soluplus® combination as stabilizers.
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P-356: CONTROLLED DRUG RELEASE 
FROM 2-HYDROXYETHYLCELLULOSE-
GRAPHENE NANOCOMPOSITE FILMS
Salih Hussein, H., Alemdar, S., Pekel Bayramgil, N.
Hacettepe University, Faculty of Science, Department 
of Chemistry, 06800, Beytepe, Ankara, Turkey
INTRODUCTION:
Nanotechnology is an engineering science at the 
atomic and molecular level. It is a scientific discipline 
in which new nano-sized structures are designed and 
synthesized, or the existing nano-sized structures are 
made unique, and these properties are used in new 
applications. Graphene is the only atomic layer of 
graphite (the other diamond), one of the two purest 
forms of carbon. This form of carbon atoms arranged 
in a two-dimensional hexagonal structure provides 
not only a two-dimensional example of the material 
in nature, but also the extraordinary properties of 
graphene. With its mechanical, electrical, thermal 
and optical properties, graphene has revolutionized 
science in the last decade. Thanks to these features 
graphene is used in many fields such as transistors, 
battery technology, sensors, hydrogen storage, 




(HEC) nanocomposite films, with or without drug 
(Doxorubicine), were prepared by solvent evaporation 
technique. We examined the film properties depending 
on the amount of graphene and HEC. We made 
structural, thermal and surface characterizations 
using FT-IR, TGA and SEM methods. The drug 
release was studied at two different pH values.
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RESULTS:
The structure of DOXO loaded 2-HEC-graphene 
nanocomposite films was confirmed by DSC, XRD, 
FT-IR and elemental mapping methods. After 1 
day, 60 % of DOXO was released at the acidic pH 
(pH = 4.5), while only 40 % of DOXO was released 
at the physiological pH of 7.4. The pH-dependent 
DOXO release of graphene-doped 2-HEC films is 
useful for treating tumor site with slightly acidic pH 
microenvironment. 
CONCLUSIONS:
The presence of a graphene in the cellulosic structure 
contributes to the development of controlled drug 
release.
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P-357: PREPARATION OF POLY 
N-VINYLTRIAZOLE HYDROGELS 
HAVING ACID FUNCTIONALITIES FOR 
CONTROLLED DRUG RELEASE
Alemdar, S., Pekel Bayramgil, N.
Hacettepe University, Faculty of Science, Department 
of Chemistry, 06800, Beytepe, Ankara, Turkey
INTRODUCTION:
Hydrogels exhibit great similarities to living tissues 
because of their physical properties, such as their ability 
to absorb large amounts of water in their structures 
and their soft and flexible structures. Hydrogels are 
also used in controlled release technology in recent 
years due to their high biocompatibility. Tuberculosis 
remains an important health problem in our country 
and all over the world. Mycobacterium tuberculosis 
is the most common cause of death from single 
infectious agent-related deaths. 8 million new cases 
are reported annually and 2 million people die due 
to this disease. Today, the first drugs used in the 
treatment of tuberculosis are streptomycin, isoniazid, 
rifamycin, ethambutol and pyrazinamide. In this study, 
a series of polyvinyltriazole hydrogels containing 
vinylsulfonic acid, vinylphosphoric acid, itaconic acid 
group were investigated for the efficacy of rifamycin, a 
drug used in the treatment of tuberculosis. 
MATERIALS AND METHODS:
Structural and thermal characterizations of hydrogels 
were examined using FTIR and TGA methods and 
rifamycin release using UV-vis spectrophotometer at 
522 nm. The drug molecules are adsorbed onto the 
hydrogel structure. For this purpose, hydrogels were 
poured into the drug solutions prepared at pH = 7 and 
UV measurements were made with the part taken 
from the drug solution for a certain period of time. The 
drug release was studied at two different pH values 
and the release rates were calculated according to 
the amount of drug adsorbed per dry gel.
RESULTS:
In drug adsorption to hydrogels, it was observed that 
the most drug was held in hydrogels containing VSA 
and at least VPA. This result is explained by both 
swelling and acidity. According to the swelling curves, 
the water swelling ratio of hydrogel containing VSA 
is 65000%. However, as the acidity of sulfuric acid 
is higher than the other two, more rifamycin diffuses 
along with the water as a consequence of the high 
swelling. Rifamycin has 2 pKa since it is a Zwitterion, 
pKa 1.7 related to 4-hydroxy and pKa 7.9 related to 
3-piperazine nitrogen. Therefore, it is also possible to 
say that the coupling of sulfuric acid groups via the 
basic piperazine group is carried out. 
CONCLUSIONS:
Due to the chemical structure and the pKa values 
of the acid group added with polyvinyltriazole, it is 
concluded that it influences the drug release.
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P-358: STABILITY OF GEMCITABINE 
HYDROCHLORIDE LOADED LPHNS IN 
PHOSPHATE BUFFER SOLUTION AND 
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Gazi University, Faculty of Pharmacy, Department of 
Pharmaceutical Technology, Ankara, Turkey
INTRODUCTION:
Analysis of properties of nano-sized drug carrier 
systems in various physiological media is very 
important for in vivo applications. Serum proteins 
would alter the colloidal characteristics of 
nanocarriers such as particle size. The aim of this 
study was to evaluate colloidal stability of gemcitabine 
hydrochloride loaded LPHNs in various media.
MATERIALS AND METHODS:
To determine the colloidal stability of gemcitabine 
hydrochloride loaded LPHNs, lyophilized LPHNs 
were resuspended in different media (pH 7,4 
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phosphate buffer solution, fetal bovine serum (FBS) 
and phosphate buffer solution containing 10% FBS) 
and incubated at 37±1°C for 5 days (1). The mean 
particle size, polydispersity index and zeta potential 
were measured at predetermined time points to 
evaluate the stability of LPHNs.
RESULTS:
In pH 7,4 phosphate buffer solution media, the particle 
size of the LPHNs did not statistically change (p>0,05) 
for a period of 5 days. The LPHNs formulations had a 
size increase from 241 nm to 253 nm within 3 days of 
incubation in FBS 10% media (p>0,05), while
formulations had a significant size increase from 248 
nm to 456 nm at the same incubation time in FBS 
100% media (p<0,05). All formulations had negative 
zeta potential in all media.
CONCLUSIONS:
The particle size of LPHNs remained unchanged in all 
media at least 2 days. In FBS media (10% and 100%) 
the increase in particle size could be explained by the 
fusion of protein molecules on the surfaces of LPHNs. 
These results show that, LPHNs formulations can be 
stable for longer periods of time in blood. 
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INTRODUCTION:
Liposomes and polymeric nanoparticles are two 
important classes of the nano-sized drug carrier 
systems. Recently, a new class of therapeutic 
nanocarriers known as lipid–polymer hybrid 
nanoparticles (LPHNs) have emerged as a promising 
drug delivery system to overcome the possible 
drawbacks and to integrate the positive attributes of 
liposomes and polymeric nanoparticles (1). The aim 
of this study was to investigate storage stability of 
gemcitabine hydrochloride loaded LPHNs. 
MATERIALS AND METHODS:
A double emulsion solvent evaporation method was 
used to prepare gemcitabine hydrochloride loaded 
LPHNs (2). The stability of gemcitabine hydrochloride 
loaded LPHNs was monitored at 4°C, 25°C for 12 
months and 40°C for 6 months. The mean particle 
size, polydispersity index, zeta potential, and retention 
rate of LPHNs were measured during the stability 
study. To characterize the surface morphology of 
the LPHNs, they were also imaged by transmission 
electron microscopy (TEM).
RESULTS:
At 4°C and 25°C, the particle size of gemcitabine 
hydrochloride loaded LPHNs showed physical stability 
for a period of 9 and 6 months, respectively (p>0,05). 
However, formulation showed stability for a storage 
period of 3 months at 40°C (p>0,05), by the end of 6 
months, the particle size significantly increased from 
216 to 336 nm with a high polydispersity index (0,648) 
at the same climatic condition.
CONCLUSIONS:
LPHNs were physically stable until 12 months at 4°C 
and 9 months at 25°C. When accelerated conditions 
are employed (40°C/75% RH), LPHNs lost the 
physical stability.
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P-360: EFFECT OF VARIOUS 
FORMULATION PARAMETERS ON THE 
CHARACTERISTICS OF BLANK PLGA 
NANOPARTICLES 
Copur, T., Bozdag Pehlivan, S., Öner,L. 
Hacettepe University, Department of Pharmaceutical 
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INTRODUCTION:
The purpose of this study is to examine the 
effects of various formulation parameters on the 
physicochemical properties of PLGA nanoparticles.
MATERIALS AND METHODS:
PLGA nanoparticles were prepared by W/O/W 
multiple emulsion solvent evaporation method (1). 
Briefly, aqueous phase (inner) containing Polysorbate 
80 was added to organic phase ((0.1%(w/v) PLGA 
in dichloromethane), then was emulsified by means 
of sonication for 3 min at 60 W (Bandelin Ultrasonic 
Probe). This emulsion was dispersed in the first 
outher phase including Polysorbat 80 and sonicated 
for 5 min at 60 W then was diluted in second outer 
phase and was stirred for 4 h at room temperature 
(Table 1). Nanoparticles washed, frozen at -80°C and 
lyophilized.
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amount in first / 
second outher 
phase (%)
Volume of first / 
second outher 
phase (mL)
F1 2.5 0.1 / 0.36 15 / 15
F2 3 0.1 / 0.36 15 / 15
F3 4 0.1 / 0.36 15 / 15
F4 2.5 0.3 / 0.36 15 / 15
F5 3 0.3 / 0.36 15 / 15 
F6 4 0.3 / 0.36 15 / 15
F7 3 0.3 / 0.36 5 / 25
F8 3 0.3 / 0.36 7.5 / 22.5
F9 3 0.3 / 0.36 10 / 20
RESULTS:
Increase in the volume of organic phase caused 
increasing particle sizes of the F1 and F3 formulations, 
while no significant changes were measured in particle 
size values of the F4, F5 or F6 coded formulations. 
Also, increase in the volume of first outher phase 
caused the decreasing the particle size of the F7, 
F8 or F9 coded formulations. No significant changes 
were observed in zeta potential values prepared with 
different formulation parameters (from 37.5 mV to 
-31.2 mV).
CONCLUSIONS:
It can be concluded that formulation parameters such 
as volume of organic phase or volume of first outher 
phase have significant effect of the particle size of 
PLGA nanoparticles prepared. 
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P-361: THE EFFECT OF TYPE AND 
CONCENTRATION OF CHITOSAN ON THE 
ELECTROSPUN POLY(CAPROLACTON) 
NANOFIBERS
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INTRODUCTION:
Poly(caprolactone)(PCL) and chitosan are polymers 
used in the production of controlled release 
formulations (1-3). The aim of the study is to 
produce PCL and PCL/chitosan nanofibers, which 
have attracted considerable interest in recent years 
due to the high tissue compatibility. In this study, 
electrospinning was used for the production of 
nanofibers. Furthermore the effects of the amount 
and type of chitosan on the fiber diameter and in vitro 
drug release from nanofibers were investigated.  
Materials and Methods:. Polymers and glasial acetic 
acid (GAA) were purchased from Sigma-Aldrich. 
Nanofibers were producted by an electrospinning 
system (Ne-200, Inovenso/Turkey).10 % PCL or the 
mixture of 1-1,5 % v/w of chitosan/10 % v/w of PCL 
were dissolved in GAA, then active material (linezolid) 
was added to this solution. The solutions were 
poured in a plastic syringe. For electrospinning of the 
solution the voltage was applied at 15 kV with 1,5 ml/h 
flow rate and the distance between the needle and 
collector was fixed at 18 cm. The average diameters 
of fibers were calculated using ImageJ from SEM 
images. Static method was used for dissolution tests 
in 20 mL of PBS at 37°C (n=3).The results were used 
to fit to the different kinetics.
RESULTS:
Drug release was extended to10 days with PCL/
MMW chitosan formulations when compared with the 
PCL nanofiber. The changes in the concentration of 
chitosan did not cause a significant difference on the 
release of linezolid. The diameter of nanofibers was 
increased when chitosan  was incorporated into the 
formulations.
CONCLUSIONS:
It can be stated that nanofibers were produced from 
PCL and PCL/chitosan. The release of active material 
from fibers can be modified by changing the molecular 
weight of chitosans. 
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P-362: THE EFFECT OF GOLD 
NANOPARTICLES, SOLID LIPID 
NANOPARTICES AND GLYCOIN 
COMBINATIONS ON THE VIABILITY OF 
DERMAL FIBROBLASTS
1 Payze, U., 2 Aydın Kose, F., 1 Gokce, EH.
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Pharmaceutical Technology, Izmir, Turkey
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INTRODUCTION:
Gold nanoparticles(AuNP) have been widely employed 
for biomedical applications and diagnostics, and have 
seen increasing use in the area of therapeutics (1).
This study was undertaken to evaluate the effects of 
gold nanoparticles, vitaminE-loaded SLNs and glycoin 
combinations on NIH/3T3-cells for screening the right 
ratio of the formulation of a new product for lip care.
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MATERIALS AND METHODS:
Cells were grown in conventional cell culture conditions 
and fed with DMEM medium containing 10%FBS 
at 37 ̊C as, in a 5%CO2 incubator.The intervals 
were controlled by phase contrast microscopy.
AuNP, vitaminE-SLN, Glycoin and trehalose(as 
cryoprotectant) were examined by MTT cell viability 
assay in NIH/3T3-cells for 24-hours, separately and 
in combination (2).The formulation was produced 
by melting/fusion-method. AuNP, vitaminE-SLN, 
Glycoin and trehalose were added according to the 
data of cell culture studies. SLN was prepared by hot 
homogenization followed by high shear mixing.
RESULTS:
The size of SLN was 647.5nm±16.2;zeta potential 
was -27.8±2.71mV and polydispersity index was 
0.4.Cell viabilities were examined for toxicity and 
IC50 value by using cell culture studies for Glycoin 
as first step. Formulation experiments containing 
Glycoin in different ratios were evaluated and the 
ideal was determined(2%).Formulation experiments 
with Trehalose-added-SLN at different ratios and 
SLN-without-vitaminE, vitaminE-SLN and vitaminE-
alone were examined and the effect on the 
formulation was observed.The significant positive 
effects of vitaminE-SLN and 1%(w/v)trehalose on cell 
viability were determined.Formulation experiments 
containing AuNP were evaluated the ideal value 
was determined,keeping the 2%Glycoin content 
constant(AuNP0.0025%(w/w)).The final formulation, 
which was optimized by cell culture, was compared.
The proliferation of the final formulation obtained was 
227.2%. 
CONCLUSIONS:
In this study, synergistic effect was observed by 
taking advantage of the natural and biocompatible 
ingredients of the formulation, which was proven by 
the cell culture.The proliferation effect was obtained 
by vitaminE- loaded SLNs as well as by the effect 
of the gold-nanoparticles and Glycoin.The ratio of 
the ingredients was screened by their effect on cell 
proliferation and the final formulation enhanced 
the viability up to 227.2%. According to the studies 
carried out gold-nanoparticles, vitaminE loaded SLNs 
and Glycoin is a promising formulation because of its 
unique structure in the field of lip care.
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CHARACTERIZATION OF CARVEDILOL 
LOADED POLYMERIC NANOPARTICLES 
FOR DRUG DELIVERY 
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INTRODUCTION:
Nanoparticles are one of the multiparticulate delivery 
systems and are prepared to improve bioavailability or 
stability (1). The object of the study was to formulate 
and characterize Eudragit® Nanoparticles containing 
carvedilol by determining their size and zeta potential, 
their external morphology for the treatment of 
hypertension. 
MATERIALS AND METHODS:
Carvedilol loaded polymeric nanoparticles were 
prepared by Spray Dryer (Spray-Dryer B-90, BÜCHI, 
Switzerland) (2). The polymeric nanoparticles were 
characterized by a Zetasizer Nano ZS (Malvern 
Instruments, UK). The morphology of the nanoparticles 
were determined with a scanning electron microscopy. 
Interaction of drug with the polymers were determined 
by XRD and FT-IR. 
RESULTS:
Particle size data showed submicron size with low 
polydispersity. The studies showed that carvedilol 
loaded particles have considerably high zeta 
potentials (Table 1). XRD and FT-IR analyses showed 
that neither active agent nor polymeric structure were 
affected from the production parameters.  
Table 2: Particle size, zeta potential and PDI of 
carvedilol-loaded polymeric nanoparticles





CL-P 418.2±18.5 0.4±0.02 40.1±1.1
CS-P 402.3±22.0 0.5±0.01 42.3±1.4
CSL-P 416.3±12.5 0.5±0.07 42.4±1.5
CL-1 535.5±13.8 0.4±0.07 41.2±.1.3
CS-1 529.4±10.2 0.5±0.06 40.6±2.4
CSL-1 530.4±10.4 0.6±0.02 40.6±2.3
CONCLUSIONS:
The carvedilol loaded polymeric nanoparticle systems 
developed in this study represent a promising safe 
system for the sustained and controlled delivery of 
carvedilol. The developed formulation is suitable, 
and represents a promising system for the sustained 
delivery of carvedilol to target cells, tissues and 
organs. 
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INTRODUCTION:
Nanoparticle systems are one of the multiparticulate 
delivery systems and are prepared to improve 
bioavailability or stability (1). Many advantages 
of nanoparticle-based drug delivery have been 
recognized. In vitro drug release studies are important 
and this studies help in evaluation of sustained and 
prolonged release dispersion systems (2). In this 
study, carvedilol loaded polymeric nanoparticles 
are determined of drug entrapment efficiency and 
characterized for in vitro release studies. 
MATERIALS AND METHODS:
Entrapment efficiency was estimated by using the 
HPLC method. In vitro drug release of carvedilol from 
polymeric nanoparticles were studied through dialysis 
bag membrane. The temperature was maintained at 
37 ± 0.5°C under sink conditions. 
RESULTS:
The HPLC method developed was validated for 
precision, accuracy, specificity and linearity for 
carvedilol. HPLC conditions are shown in Table 1. 
Carvedilol loaded nanoparticle formulations were 
analyzed for entrapment efficiency by HPLC. The in 
vitro release studies indicated that, although there 
was an important burst release of the drug in 1 h, it 
continued in a sustained release way for 48 h.  
Table 1. Chromatographic conditions
Stationary Phase InertSustaine® column (4.6mmx150 mm, C18 Gravity, 3 μm)
Mobile Phase
0.03M potassium dihydrogen phosphate 
(pH 3.0) buffer: acetonitrile: methanol 
(60:50:10, v:v:v)
Oven Temperature 40 °C
Flow Rate 0.5 mL/min
İnjection Volume 20 µL
Detection Wavelenght 242 nm
CONCLUSIONS:
This developed HPLC method was also successfully 
applied for the determination of carvedilol in polymeric 
nanoparticle formulations, encapsulation efficiency 
and in vitro release study. The developed formulation 
is suitable, and represents a promising system for the 
sustained delivery of carvedilol. 
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INTRODUCTION:
The aim of this research is utilization of membrane 
formulation as a barrier material for guided bone 
regeneration (GBR). The principal idea was developing 
a biodegradable barrier material preventing soft tissue 
migration through defect area during bone formation 
period and promoting osteoblast cells activity with 
minimized dose of Zoledronic Acid (ZA).
MATERIALS AND METHODS:
Membranes were prepared by polymer solution 
casting and evaporation. During the process, various 
amounts of PDLA, TEC, Pluronic F-127 and ZA were 
dissolved respectively in 5 mL of acetone and poured 
onto PTFE mold. Afterwards, solvent was evaporated 
at 37°C during 24 hours.
The morphology of membrane was observed using 
scanning electron microscopy (SEM) with acceleration 
voltage of 10kV.
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The membranes were cut into 0.5 cm x 1 cm strips. 
Strain and tensile strength measurements were 
performed using a TA-XT plus texture analyser.
The in vitro release of zoledronic acid from membrane 
formulations was performed using the dialysis 
membrane method. 
Efficacy of GBR membranes was investigated 
by implanting in 0.5x0.5 cm critical size defect in 
tibia and femur of New Zealand female rabbits. 
Histopathological analysis were performed to check 
bone healing.
RESULTS:
The SEM image of the membrane clearly 
demonstrated that the surface of membrane was 
essentially smooth. Testing of tensile strength was 
carried out to determine the effect of TEC on the 
mechanical properties of PDLA membranes. This 
test provides an indication of the ease of bending 
and shaping or cutting of the membranes when the 
periodontists or orthopedists need to apply them to the 
scar tissue. The tensile strength results revealed that, 
with increasing TEC content of membranes, higher 
tensile strength values were observed. Findings 
indicate the complete release of the water soluble 
drug (ZA) from the prepared membrane was achieved 
over a 6 h period. According to the histopathological 
results at the 8th week of the “control group” where 
any membrane application was performed, 70% of 
the defect area did not fill and only fibroblast formation 
(fibrosis) was observed in 30% of the defect area with 
very poor cartilage tissue formation. Fibrosis was 
observed on the surface of all periodic specimens, 
but no cartilage structure was observed. In ZA loaded 
membranes, woven bone formation was observed in 
the first 4 weeks, lesion and single bone formation 
were observed up to 6 weeks and complete healing 
was observed at the end of 8th week.
CONCLUSION:
Here in this report, we propose the utilization of 
bisphosphonate loaded biodegradable membrane 
formulations at GBR for the first time. Results 
suggests that local application of bisphosphonate 
loaded membrane formulations enhances bone 
formation compared to blank membranes and control 
group.
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INTRODUCTION:
Fungal keratitis is a leading cause of serious ocular 
morbidity and blindness (1). Voriconazole (VCZ) is a 
potent new triazole derivative with a broad spectrum 
of antifungal activity against many fungal pathogens 
(Candida, Cryptococcus and Aspergillus species)(2). 
The aim of this study was to develop VCZ loaded 
ocular in situ gels and to evaluate microbiological 
activities and ex vivo permeation/penetration 
properties of these formulations. 
MATERIALS AND METHODS:
In situ gel formulations were prepared by cold 
method (1) using poloxamer 188, poloxamer 407 
(IS-1, IS-2, IS-3 and IS-4) and 0.3% carboxymethyl 
cellulose (IS-5, IS-6, IS-7 and IS-8). These 
formulations were evaluated for clarity, sol-gel 
transition temperature, gelling capacity, pH, viscosity 
and drug content. Sterility studies, determination of 
MIC of VCZ, disk diffusion testing were performed. 
C.albicans, C.tropicalis, A.fumigatus, A.niger, 
A.terreus and A.Flavus microorganisms were used 
for microbiological studies. IS-1 and IS-5 coded 
formulations were selected for ex vivo studies. Ex-
vivo penetration/permeation studies were performed 
with rabbit cornea in diffusion cells. 
RESULTS:
In situ gels were developed successfully and the 
characterization of the formulations has shown 
that formulations were suitable for the ophthalmic 
application. Formulations were detected to be sterile. 
MIC90 values of VCZ were determined as 0.25μg/
ml for all of the microorganisms. According to disk 
diffusion test results, VCZ loaded formulations were 
found to be more effective on filamentous fungi than 
yeasts. The amount of VCZ permeated through cornea 
from IS-1 and IS-5 was determined approximately 38 
– 39 % in the receptor compartment. The penetrated 
amount in the cornea was determined for IS-1 and 
IS-5 formulations 4.991±1.056% and 7.569±0.252%, 
respectively.
CONCLUSIONS:
According to obtained results, developed in situ gels 
are suitable for ocular drug delivery. VCZ loaded 
formulations were determined sterile and they 
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are effective to against C. albicans, C. tropicalis, 
A.fumigatus, A.niger, A.terreus and A.flavus which 
they may cause fungal keratitis. Ex vivo permeation/
penetration results also indicate that the formulations 
are suitable for the ocular drug delivery. So, in situ 
gelling systems could be offered a promising strategy 
for eye treatment.
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INTRODUCTION:
Lipid-polymer nanoparticles,  which  are  made  up 
of a  polymer  nanoparticle  core  and  a  lipid  coat, 
present  a  more clinically  feasible  than  liposomes 
and polymeric nanoparticles because  they  are 
physically  robust  as  result  of  their  polymer  matrix 
cores , less toxic than polymeric nanoparticles and 
likely  to  possess  penetrating  abilities  of  liposomes, 
which  are  attributed  to  the  phospholipid  layers  on 
the  polymer nanoparticle  surface (1).
MATERIALS AND METHODS:
To  prepare  PLGA-lecithin nanoparticles,  1 mL  of 
Eletriptan Hydrobromide solution (3 mg/mL) water 
was  emulsified  using probe sonicator for 60  s  at 30 
W in  3  mL  of  DCM  containing  90  mg  of  PLGA, 
30  mg  of  PC,  and 9  mg  of  TPGS  to  form  the 
primary  water/oil  (w/o)  emulsion.  This emulsion 
is  subsequently  poured  into  12  mL  of  deionized 
water and  emulsified  again  for  another  60  s at 
30 W to  form  the  water/oil/water (w/o/w)  emulsion. 
The DCM was evaporated using rotary evaporator. 
The  resulting nanoparticles  were  washed  three 
times  by  centrifugation  and  re-suspension  to 
remove  any  non-entrapped  drug  and  excess  PC. 
The encapsulation efficiency  and  drug  loading  were 
determined  by  HPLC.  The  volume-averaged  sizes 
and  the  zeta  potentials  of  the  nanoparticles  were 
measured.  The nanoparticle  morphologies were 
characterized  by  transmission  electron  microscopy.
RESULTS:
The nanoparticle size  raised from 228.0±11.2 nm 
to 916.5 ± 23.8 nm when lechitin was added to the 
formulation,  which  shows the lechitin coating of 
nanoparticles.  The  TEM  image  of  the  loaded  hybrid 
nanoparticles  illustrates  their spherical  morphology. 
CONCLUSIONS:
It can be concluded from the study that it is possible 
to prepare PLGA-lecithin nanoparticles. The effects 
of variations in surfactant were evaluated through 
changes in the size of the nanoparticles. As further 
studies, this nanoparticles can be used in various root 
of administration for drug delivery studies.
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INTRODUCTION:
Morphine-like analgesics are particularly effective in 
the treatment of neuropathic pain, but have serious 
side effects. As an alternative, it has been shown that 
Endomorphin-1 is more effective in the treatment of 
neuropathic pain and the side effects are less due 
its endogenous nature (1). However End-1 is not 
clinically used due to its instability and inability of 
crossing the Brain-Blood-Barrier. A lipid-modified 
derivate of Endomorphine-1 peptide (End-LAA) was 
previously synthesized and loaded in polymeric 
micelles to overcome these problems and improve in 
vivo performance of the drug (2). The aim of current 
study is to test the efficiency of End-LAA loaded 
polymeric micelles with in vivo experiments and 
compare the outcomes with pure Endomorphine-1.  
MATERIALS AND METHODS:
End-LAA was loaded into Pluronic F127 micelles by 
film formation method as previously reported (2). A 
thermally stimulated tail flick test device sensitive to 
opioids (Columbus, OH, USA; Type 812) was used 
in evaluating the efficacy of drugs in acute pain. 
The tail flick test was performed on Wistar rats upon 
oral and intravenous administration of End-LAA, 
Endonorphine 1 and micellar formulation. Tail flick 
times at 1, 1.5, 2, and 3 hours after 15, 30, and 45 
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minutes after oral administration and 1, 1.5, 2, and 3 
hours after 10, 20, and 30 minutes after intravenous 
administration were measured and the percentages 
of maximum possible effect (% MPE) were calculated. 
The increase in tail flick time compared to baseline 
values  was considered an analgesic effect.
RESULTS:
Intravenously administered micelle formulation 
significantly extended the tail flick time in rats 
compared to pure End-LAA, Endo-1 and control 
groups. Pure End-LAA prolonged the tail flick time of 
rats significantly after oral administration compared to 
Endo-1 and control groups. 
CONCLUSIONS:
Overall study revealed that, upon intravenous 
administration micelle formulation increased the 
analgesic effect in acute pain. This is thought to be 
due to the fact that polymeric micelles can prolong 
the drug circulation time in blood. Besides oral End-
LAA was found to be effective as an oral analgesic for 
acute pain.
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INTRODUCTION:
Diabetes is a metabolic disorder characterized by 
increased blood glucose resulting from changes in 
carbohydrate, protein and lipid metabolism. These 
changes are likely to lead to the development of 
cardiovascular diseases(1). Prolonged QT may be a 
potentially sensitive marker of increased risk of cardiac 
arrhythmias and sudden cardiac death. Exenatide, 
sitagliptin and insulin are effective antihyperglycemic 
agents used in the treatment of diabetes(2). In this 
study, we aim to evaluate the effects of exenatide, 
sitagliptin and insulin  on QT interval of diabetic rats.
MATERIALS AND METHODS:
Male Wistar rats were divided in five groups: control 
(C), diabetics (D; single dose 43 mg/kg streptozotocin), 
diabetic  treated with exenatide (D+E; exenatide; 
single dose 43 mg/kg streptozotocin and 0.1 µg/kg 
exenatide per day for 15 days), diabetic  treated with 
sitagliptin (D+S; single dose 43 mg/kg streptozotocin 
and 10 mg/kg sitagliptin per day for 15 days) and 
diabetic  treated with insülin (D+I; single dose 43 mg/
kg streptozotocin and 3 IU insuline per day for 15 
days). Electrocardiography was recorded using Ag/
AgCl electrodes. QT intervals were measured from 
this recordings. 
RESULTS:
Rats of  the D+I group presented significant prolonged 
QT interval (p<0.05), whereas rats of the D+S and 
D+E groups presented less prolonged intervals 
(p>0.05) than  C and D rats. These prolongations 
were by 2.9% in group D, 11.7% in group D+E, 16.1% 
in group D+S and 33.3% in group D+I.
CONCLUSIONS:
Our findings have demonstrated that insulin treatment 
in diabetes causes the prolongation of QT interval, 
which is associated with ventricular arrhythmias and 
sudden death. This cardiovascular risk was less in 
rats of D+S and D+E groups. Further studies are 
needed to determine the mechanisms of QT interval 
prolongation induced by antihyperglycemic agents.
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INTRODUCTION:
Colorectal cancer (CRC), also known as bowel 
cancer, develops in the colon and/or the rectum 
(the last several inches of the large intestine before 
the anus) (1). As reported by Turkish Ministry of 
Health, colon cancer is one of the five most common 
cancer types in Turkey (2). Coenzyme Q0 (CoQ0; 
2,3-dimethoxy-5-methyl-1,4-benzoquinone) is a 
unique type of ubiquinone which mainly accumulates 
in mitochondria (3). It has been shown that different 
types of ubiquinones inhibit the opening of the pores 
such as PTP (permeability transition pore) which 
plays a significant role in mitochondrial transition, 
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maintains cellular redox balance and have strong 
antioxidant properties (4). In addition, studies have 
shown that types of Coenzyme Q0 have therapeutic 
effects for cancer, inflammation and metabolic 
disorders, and studies have reported apoptotic activity 
for Coenzyme Q0 in various cancer types (5,6). The 
effects of Coenzyme Q0 on colon cancer cells are 
largely unknown and therefore in this study we aimed 
to investigate the modulation of colon cancer cell 
viability by Coenzyme Q0.
MATERIALS AND METHODS:
HCT116 p53-/- colon cancer cells were seeded to 96 
well plates and incubated with different concentrations 
of Coenzyme Q0 (0.5 uM-200 uM) for 24, 48 and 
72 hours and then 20 ul of MTT solution (5 mg/ml) 
was added to cells for incubation. After 4 hours of 
incubation, formazan crystals were dissolved before 
measuring absorbance at 550 nm. Absorbance of 
cells treated without Coenzyme Q0 was served as 
control and the cell viability of Coenzyme Q0 treated 
cells was given as percentage of control group. 
Coenzyme Q0 treated and untreated cells were also 
collected and lysed for western blotting to detect 
PARP fragmentation. 
RESULTS:
Coenzyme Q0 inhibited HCT 116 p53-/- cell viability 
at 25 uM and higher concentrations significantly 
(p<0.05) at 24, 48 and 72 hours of incubation 
periods. Coenzyme Q0 also induced apoptotic PARP 
fragmentation in HCT 116 p53 -/- cells.
CONCLUSIONS:
According to the results, Coenzyme Q0 decreases cell 
viability at certain doses. In conclusion, we showed 
that Coenzyme Q0 modulated cell viability in HCT 
116 p53 -/- colon cancer cells. Further work is needed 
to clarify the biological mechanisms mediating these 
effects. 
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INTRODUCTION:
Cancer, one of the major health problems, is the 
second leading cause of death in worldwide (1). 
Despite the most common modalities for cancer 
are surgery, chemotherapy and radiotherapy, they 
have serious side effects such as cardiotoxicity, 
neurologic disorders. Thus, scientists continue to 
seek for discovery and development of novel effective 
anticancer agents. Phthalocyanines, significant class 
of macrocyclic compounds, have biological and 
pharmacological properties including anticancer, 
antioxidant, antimicrobial, photodynamic therapy, 
topoisomerase inhibition (2, 3). In this research, 
silicon phthalocyanine, naphthalocyanine (1-2) 
and their water soluble derivatives (1a, 2a) were 
investigated against lung (A549), breast (BT-20), liver 
(SNU-398), prostate (DU-145), and melanoma (SK-






























Figure 1. Water soluble silicon phthalocyanine and 
naphthalocyanine
MATERIALS AND METHODS:
The silicon phthalocyanine, naphthalocyanine and 
their water soluble derivatives were synthesized and 
characterized on previous studies. In this study, the 
cytotoxic activities of the compounds were determined 
against A549, BT-20, SNU-398, DU-145 and SK-Mel 
128 carcinoma cell lines using MTT assay. Cisplatin 
was used as positive control.
RESULTS:
The Cell Cytotoxicity50 (CC50) values of the 
compounds (1-2a) were determined for five carcinoma 
cell lines. Compound 1a showed higher cytotoxic 
activities than among other tested compounds for all 
of five carcinoma cell lines. The CC50 values of the 
compound 1a were 2.24, 3.96, 0.86, 4.63 and 1.47 
µM against A549, BT-20, SNU-398, DU-145 and SK-
Mel 128 carcinoma cell lines whereas cisplatin CC50 
values were 9.66, 21.99, 4.33, 1.66 and 13.99 µM 
against carcinoma cell lines. In addition compound 2a 
displayed higher cytotoxic properties with 11.85 µM 
than cisplatin against SK-Mel 128 carcinoma cell line. 
Compounds 1 and 2 had low and similar cytotoxic 
effect on A549 cell lines with CC50 values of 47.48 
and 47.51 µM.
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CONCLUSIONS:
Our studies results showed that compound 1a had 
considerable anticancer activities compare to positive 
control against all of five carcinoma cell lines. Thus, 
compound 1a is potential compound to be further 
developed as novel anticancer agent.
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INTRODUCTION:
To test the effects of some chemical, biologic, 
synthetetic or herbal products on cell culture models, 
the first step is testing their solubulity in organic 
solvents (1). It is very important that the selected 
organic solvents don’t exhibit any toxic effects to the 
cells (2).  In this study, we aimed to find out the toxicity 
induced by different solvents (ethanol, methanol, 
acetone, kloroform, hexane, ethyl acetate, DMSO) to 
three different cancer cell lines.
MATERIALS AND METHODS:
Human chronic myelogenous leukemia cell line 
(K562), colorectal cancer cell line  (HCT 116), acute 
promyelocytic leukemia cell line (HL-60) were treated 
with different solvents (ethanol, methanol, acetone, 
kloroform, hexane, ethyl acetate, DMSO) at %0.5-
%10 concentration range for 24, 48 and 72 hours. 
After incubation times, MTT (3-(4,5-Dimethylthiazol-
2-yl)-2,5-Diphenyltetrazolium Bromide) test was 
performed.
RESULTS:
We found that all tested solvents had differently 
effected the proliferation of HCT 116, K562 and HL-
60 cells. When the cells were incubated with DMSO, 
ethyl acetate, acetone, methanol, ethanol, hexane 
and chloroform for 24, 48 and 72 h, all solvents 
decreased cell viability significantly (p< 0.05) at 
different concentrations in K562, HCT 116 and HL-60 
cell lines.
CONCLUSIONS:
Since the solvents used in this study are widely used 
to dissolve different compounds and drugs for the 
treatment of cells, detailed information about their 
toxicity is valuable. In this study, we contributed to 
the literature with novel toxicity data of the solvents 
in different cell lines. Further research may reveal the 
underlying mechanisms of diminished cell viability 
induced by these different solvents.          
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INTRODUCTION:
The metabolic syndrome (MetS) is a global public-
health problem worldwide with the increasing 
prevalence. MetS is characterized by a cluster of risk 
factors, including insulin resistance (IR), dyslipidemia, 
central adiposity and elevated blood pressure 
that increase risk for cardiovascular disease, type 
2 diabetes (T2DM) and all cause mortality (1-
3). Inflammation is involved in insulin resistance, 
adiposity and other aspects of metabolic syndrome. 
Ferritin, acute phase reactant, has also been related 
to insulin resistance, MetS and diabetes. However, 
the association between increased serum ferritin 
levels and the metabolic syndrome still remains 
controversial (4,5). This study aimed at assessing 
whether ferritin and proinflammatory cytokine IFN-γ 
are associated with MetS patients with or without DM.
336  12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey
MATERIAL AND METHOD:
A total of 50 MetS patients and 30 controls without 
MetS were included in the analysis. The study group 
of MetS patients were divided into two subgroups 
according to have DM: the first MetS group who 
had DM included 26 subjects with the mean aged 
52.73±1.4 years and mean BMI 36.7±1.5, the 
second group who had no DM included 24 subjects 
with the mean aged 34.7±2.1 years and mean BMI 
32±1.1. The control group who had no DM included 
30 subjects with the mean age 28.6±1.6 years 
and mean BMI 29.6±0.8. Serum ferritin and IFN-γ 
levels were determined by elisa kits. In addition, 
demographic data, body mass index, antrophometric 
measurements and biochemical parameters were 
evaluated. 
RESULTS:
The levels of ferritin and IFN-γ of total patients were 
found significantly higher compared to controls 
(p<0.05). Significant differences were observed 
among serum insulin, glucose, total cholesterol, 
HDL-cholesterol, triglycerides levels, BMI, systolic 
and diastolic blood pressure, HOMA-IR, waist 
circumference in total patients compared to controls 
(p<0.05). There was no significant difference between 
subgroups according to ferritin and IFN-γ levels. The 
levels of ferritin of patients subgroups were found 
significantly higher compared to controls. Compared 
to controls, IFN-γ levels were found significantly 
higher in second group (p<0.05). Significant 
differences were determined among serum glucose, 
total cholesterol, waist circumference, HOMA-IR and 
BMI between subgroups (p<0.05). 
CONCLUSIONS:
Our findings suggested that hyperferritinemia and 
inflammation may occur in MetS patients. Additional 
studies in larger groups are needed to confirm 
association of these parameters with the MetS.
ACKNOWLEDGEMENTS:
This study was supported by a grant of Gazi University 
Research Foundation (02/2017-17).
REFERENCES:
1.  Kaur J (2014). Cardiol Res Pract, 2014:943162.
2.  Marsland et al., (2010). Metabolism, 59(12):1801-
8.
3.  Kang et al., (2012). Clin Chim Acta, 413(5-6):636-
41.
4.  González et al., (2006). Eur J Clin Nutr, 60(6):802-
9.
5.  Jin et al., (2015). Int J Clin Exp Med, 8(8):13317-
22.
P-374: PHENYLBUTYRIC ACID MAY BE 
PHARMACOLOGICAL AGENT TO OBESITY 
ASSOCIATED INFLAMMATION
1 Baba, B., 2 Caliskan, M., 2 Boyuk, G., 1 Hacısevki, A.
1 Gazi University, Faculty of Pharmacy, Department 
of Biochemistry, Ankara, Turkey
2 Ankara Yıldırım Beyazıt Training and Research 
Hospital, Ankara, Turkey
INTRODUCTION:
Obesity is a growing widespread epidemic 
with an alarming high prevalence (1, 2) and is 
closely associated with an increased risk for the 
development of metabolic diseases such as insulin 
resistance, type 2 diabetes mellitus, hypertension, 
hyperlipidemia, atherosclerosis, metabolic syndrome 
and cardiovascular disease (3). Obesity, which is 
defined as abnormal or excessive fat accumulation 
in adipose tissues, is a chronic inflammation disease 
(4). Adipose tissue is a complex organ that comprises 
a wide range of cell types with diverse functions. It 
contains various immune cells, the adipose tissue is 
now considered as an immune organ, at the cross-
road between metabolism and immunity (2). A major 
player in systemic low-grade chronic inflammation in 
obesity is the increased numbers of adipose tissue 
proinflammatory macrophages and deregulated 
production and function of cytokines (5). The purpose 
of this study was to examine changes in inflammatory 
cytokines and the effect of chemical chaperon 
phenylbutyric acid on cytokine levels in ob/ob mice. 
MATERIALS AND METHODS:
Twelve wild-type (lean) controls and ob/ob mice 
were recruited to the study. Oral vehicle or chemical 
chaperon administrations performed to lean and 
ob/ob mice for 1 month. Observed blood glucose 
concentrations at the fed state and body weights were 
evaluated in all mice. Blood samples collected at day 
30. Plasma IL-10 and IL-12 levels were determined 
by using elisa kits.
RESULTS:
It was found that antiinflammatory cytokine IL-10 
levels were increased and proinflammatory cytokine 
IL-12 levels were reduced in chaperon-treated ob/
ob mice compared to ob/ob controls (p<0.05). Ob/ob 
controls demonstrated higher IL-12 levels compared 
to lean mice (p<0.05). However, there was no 
significant difference in terms of IL-10 levels in lean 
mice compared to ob/ob controls. When chaperon-
treated ob/ob and lean mice compared, there was no 
significant difference in cytokine levels of groups. We 
found that IL-10 levels were higher and IL-12 levels 
were lower in chaperon-treated ob/ob mice compared 
to vehicle-treated lean mice (p<0.05). Blood glucose 
concentrations at the fed state in ob/ob controls 
were significantly higher compared to other groups. 
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According to body weights, there were significant 
differences between lean mice and ob/ob mice.    
CONCLUSIONS:
Our results demonstrated that obesity is associated 
with inflammation and chemical chaperon 
administration ameliorate inflammation. Phenylbutyric 
acid may be a pharmacological agent to obesity 
associated inflammation but further investigation still 
requires to confirm these findings. 
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INTRODUCTION:
Heat shock protein 70 (Hsp70) is a chaperone has 
several physiological roles, such as folding of nascent 
proteins, refolding of misfolded proteins, inhibition of 
protein aggregation, and involvement in intracellular 
protein transport (1). Hsp70 is marginally expressed 
in normal cells, but is excessively expressed in 
many types of cancer cells, helping cancer cells to 
survive in hard conditions (2). This protein plays 
important roles in many processes related to poor 
prognosis, including resistance to chemotherapy, 
inhibition of apoptosis, metastasis, and invasion. 
Therefore, specific inhibition of Hsp70 in cancer cells 
is a significant strategy in the treatment of cancer (3). 
The present study aimed to determine whether MKT-
077 can enhance chemosensitivity to paclitaxel; for 
this purpose the combined effects of MKT-077 with 
paclitaxel on MDA-MB-231 cells were investigated. 
MATERIALS AND METHODS:
Human breast adenocarcinoma MDA-MB-231 cells 
were cultured and treated with serial concentrations 
(100-10-1-0,1 µM) of MKT-077 alone or in combination 
with paclitaxel for 24 h. Antiproliferative activity of 
MKT-077, paclitaxel and combination treatment were 
evaluated using the XTT colorimetric assay.
RESULTS:
Our results revealed that the combination treatment 
synergistically inhibited cell proliferation in a dose-
dependent manner. The IC50 values were calculated 
as 9,73 µM, 2,13 µM and 1,01 µM for MKT-077, 
paclitaxel and MKT-077-paclitaxel combination 
respectively. 
CONCLUSIONS:
In conclusion, our findings showed that MKT-077 
increased the antiproliferative effect of paclitaxel. 
This result suggests that MKT-077 in combination 
with paclitaxel may serve as a potentially useful 
therapeutic strategy for breast cancer patients.
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INTRODUCTION:
Lichens produces a variety of secondary metabolites, 
many of which are unique to lichen symbioses 
(1). There has been an ever growing interest in 
pharmaceutical studies with many medicinally 
important organisms having been investigated as 
potential sources for new drug candidate molecules 
(2, 3). Usnic acid (UA), one of the most important 
secondary metabolites in lichens, is known to have 
many biological activities. The aim of this study was 
to investigate the effects of UA on proliferation and the 
changes of gene expression profile in breast cancer 
cells, MCF-7, BT-474, MDA-MB-431 and SKBR-3 and 
non-cancerous breast cell line MCF-12A.
MATERIALS AND METHODS:
Cell viability of UA treatment was assessed by MTT 
assay. Differential expression of apoptosis related 88 
genes in breast cancer was determined by real-time 
PCR using the Human Apoptosis Primer Library qRT-
PCR Array.
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RESULTS:
Examined breast cancer cells were treated with UA 
(100, 50, 35, 25, 15, 12.5, 6.25, 3.125, and 1.562 
µM) for 24, 48 and 72 h. UA exhibited time and dose 
dependence in all cell lines. UA showed almost no 
toxic effect on non-cancerous breast epithelial cell in 
this study. Thus its antiproliferative effects on cancer 
cells and less toxicity towards non-cancerous breast 
cells offers UA. MCF-7 cells were more sensitive to UA 
than other examined breast cancer cell lines (MDA-
MB-231, BT-474, SK-BR-3). IC50 for UA in MCF-7, 
BT-474, MDA-MB-431 and SKBR-3 cells were 13.11, 
12.65, 12.84, and 27.2 μM at 48 h, respectively. The 
cells were treated with IC50 values of the UA for 
apoptosis primer library array. Treatment of MCF-
7 cells with UA (IC50=13.11 μM) for 48 h resulted 
in significant differential expression of 34 apoptosis 
related genes in breast cancer.
CONCLUSIONS:
In this study demonstrate that UA inhibits cell 
proliferation and alters expression of apoptosis related 
genes in breast cancer cells. This is the first report on 
full screen of apoptosis-related gene expression after 
treatment of UA. As a result of this study, UA may be a 
potential therapeutic agent for the treatment of breast 
cancer.
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INTRODUCTION:
High expression of cysteinyl leukotriene D4 receptor, 
CysLT1R, is associated with a poor prognosis in 
several human cancers. Also, LTD4 was found to 
induce proliferation and survival in cancer patients. 
Here, we have determined serum leukotriene D4 
(LTD4) levels in patients with breast cancer and 
examined its relationships with various parameters, 
including age, grade, menopausal status.
MATERIALS AND METHODS:
For that purpose, serum samples were taken from 
58 patients diagnosed with breast cancer and 8 
healthy controls. The patients were divided into five 
subgroups, as Luminal A, Luminal B, HER (+), Luminal 
B-HER (+) and triple negative. Leukotriene D4 levels 
were measured by ELISA method. 
RESULTS:
Mean levels of LTD4 in the patients were significantly 
higher when compared with healthy controls [3,43 
(2,21) ng/mL vs 1,47 (0,46) ng/mL; p < 0.05]. According 
to the molecular subtypes, serum LTD4 levels were 
found to be significantly higher in the Luminal B and 
Triple (-) subgroups than the controls (p <0,05). Post-
menopausal patients had higher levels of LTD4 than 
premenopausal patients (p <0,05).  
CONCLUSIONS:
Our study supports other studies showing the role of 
leukotrienes in cancer. Because of LTD4’s ability to 
induce proliferation and inhibit apoptosis, increased 
levels of LTD4 in our study may be associated with 
cancer development, especially in post-menopausal 
women.
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INTRODUCTION:
p53 plays a role in restraining DNA exchange between 
imperfectly homologous sequences and thereby in 
suppressing tumorigenic genome rearrangements. 
Cells missing p53 can accumulate chromosomal 
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abnormalities because of the absence of p53-
mediated cell-cycle arrest after double-stranded DNA 
breaks (1). The absence of p53 is a major predictor 
of poor response to classic chemotherapeutic agents 
(2). The objective of this study was to evaluate the 
expression of p53 gene and protein. 
MATERIALS AND METHODS:
Real-time polymerase chain reaction (RT-PCR) test 
and Western blot were used to detect the expression 
of p53 in 24 breast cancer patients who have already 
been diagnosed with breast cancer due to their illness 
during surgery and 4 healthy women who haven’t 
got any benign or malign histories and admitted to 
macromastia and breast reduction surgery as already 
decided by doctors. 
RESULTS:
According to our data, tumor tissue p53 mRNA 
expressions were higher in 58% of patients than in 
normal tissues. Mean mRNA expression levels of p53 
were higher, but not statistically significant, in tumor 
tissues than those in normal tissues of the same 
patients (p>0.05). Conversely, p53 protein levels were 
higher in normal tissues than in tumor tissues. There 
were positive correlations between normal and tumor 
tissue mRNA expressions and negative correlations 
between normal and tumor tissue protein expressions. 
CONCLUSIONS:
Because p53 plays a role in DNA repair, decreased 
expression of p53 protein may be part of cancer 
development due to DNA damage. In contrast to 
p53 mRNA expression, decreased tumor tissue 
protein expression can reduce patients’ response to 
chemotherapeutic agents.
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INTRODUCTION:
Inhibition of acetylcholinesterase (AChE), the 
key enzyme in the breakdown of acetylcholine, is 
considered as a promising strategy for the treatment 
of neurological disorders such as Alzheimer’s 
disease, senile dementia, ataxia and myasthenia 
gravis. Alzheimer’s Disease(AD) is a chronic 
neurodegenerative disease which characterized by 
memory loss, difficulty in speaking, problems with 
communication and reasoning (1). There are many 
causes about the emergence of this disease, like 
genetic factors, autoimmune reactions and protein 
plaques (2). One of these reasons is cholinergic 
hypothesis that AD is caused by reduced synthesis 
of the neurotansmitter acetylcholine(ACh).One of 
these reasons is cholinergic hypothesis that AD is 
caused by reduced synthesis of the neurotansmitter 
acetylcholine(ACh). AChE inhibitors inhibit the 
hydrolysis reaction of ACh, so low ACh level at AD 
patients is raised (2,3). Many inhibitors such as tacrine, 
donepezil, physostigmine are used as drugs for AD 
treatment (3). In current study, we report synthesis, 
characterization and AChE inhibition properties of 
novel Schiff bases of based on 3,3’-(piperazine-1,4-
diyl)bis(propan-1-amine).
MATERIALS AND METHODS:
Ligand of based on piperazine and its’ Pt(II) 
complex were synthesized with 5-fluoro-3-methyl-
salicylaldehyde. Inhibitors were characterized by 
elemental analysis, TGA, FT-IR, 1H-NMR, 13C-NMR 
spectroscopy. AChE activity of the synthesized 
compounds were investigated by spectrophotometric 
Ellman method (4). Inhibitors’ IC50 values were 
determined.
RESULTS:
Synthesized inhibitors’ elemental analysis, TGA, 
FT-IR, 1H-NMR, 13C-NMR spectroscopy results 
were observed at the expected values. As a result 
of spectrophotometric studies, it was seen that all 
compounds had reversible AChE inhibitor property. 
Piperazine-based Pt(II) complex showed a higher 
inhibition compared to the ligand. For the studied 
complexes all IC50 against AChE were in the 
micromolar range.
CONCLUSIONS:
In summary, new ligand of based on piperazine and 
its’ Pt(II) complex were prepared. The structural 
characterizations of synthesized compounds were 
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made by using different spectroscopic methods. 
Novel Schiff bases of based on 3,3’-(piperazine-1,4-
diyl)bis(propan-1-amine) have been prepared for 
preliminary screening as inhibitors against AChE.  All 
the synthesized compounds behaved as inhibitors 
against AChE.
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INTRODUCTION:
Indirubin-3’-oxime is a selective and potent inhibitor 
of CDKs. Indirubin and its derivatives showed 
antıproliferative effect at 10-20 µM concantration 
(1). With this effect, we want to sythesis a new 
imidazole-linked mono and di-ketoxime derivatives 
via unknown and simple method and to evaluate their 































Mono- and di-ketoxime derivatives were synthesized 
via condensation reaction. Both propargyl and 
carbonyl groups were affected by hydroxyl amine 
resulting in mono- or di-ketoxime derivatives. 
RESULTS:
Various mono- and di-ketoxime derivatives were 
synthesized and selectivity for condensation with 
hydroxylamine was observed. 
CONCLUSIONS:
We have found out an unknown and simple strategy for 
mono- and di-ketoxime derivatives. With this strategy, 
18 different ketoxime compounds were synthesized 
which were subjected to MTT test with LN-405 cell line 
in order to observe their antiproliferative effects. We 
have assumed that we might reveal a good candidate 
for glioblastoma.
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INTRODUCTION:
Colorectal cancer (CRC) comprises approximately 
10% of all cancers (1). DNA damage and altered 
DNA replication through the deregulation of related 
genes cause genomic instability in sporadic CRC. 
DNA repair is very complex; many factors play a 
role to ensure that the restoration of errors occurs 
during the transfer of genetic material. MutL homolog 
1 (MLH1) is one of the vital DNA repair genes 
responsible for genomic stability (2, 3). Together with 
environmental factors, the genetic background may 
be associated with CRC development; thus, genetic 
polymorphisms are considered as risk factors. The 
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present prospective case–control study aimed to 
determine the association between 93G>A and I219V 
polymorphisms of MLH1 and CRC susceptibility in a 
Turkish population.
MATERIALS AND METHODS:
A prospective case-control study was conducted with 
Turkish participants. The genotyping of 158 patients 
and 164 controls was performed by PCR-RFLP. HWE 
was tested by using chi-square. Data comparisons 
were done by using Fisher’s exact test; and, the odds 
ratios (ORs) and 95% confidence intervals (CIs) were 
estimated to evaluate the association between cases 
and controls. A two-tailed p<0.05 was considered to 
indicate a statistically significant difference.
RESULTS:
All samples were genotyped with high successful rate 
and concordance. Genotype distribution was found 
to be consistent with the HWE (p>0.05). The -93G>A 
and I219V minor allele frequencies were 0.494 and 
0.469 in cases whereas 0.307 and 0.250 in controls, 
respectively. Individuals with A allele of -93G>A had 
about 2-fold (OR=1.92; 95% CI=1.22-3.04; p<0.01) 
and G allele of I219V had about 3-fold (OR=2.82; 95% 
CI=1.76-4.52; p<0.01) risk of developing sporadic 
CRC.
CONCLUSION: 
The data is the first in understanding the influence 
of MLH1 on CRC risk in Turkish population, and 
suggested that -93G>A and I219V polymorphisms 
might be associated with sporadic CRC susceptibility. 
However, further studies conducted with different 
populations are needed.
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INTRODUCTION:
Alzheimer’s disease (AD) is a progressive, fatal 
neurodegenerative disorder characterized by 
accumulation of β-amyloid peptide (Aβ, 40-42 aa) in 
neuritic plaques, formation of neurofibrillary tangles 
caused by abnormal aggregation of tau protein and 
neural cell loss (1). Following the discovery of Aβ, 
which has a critical early role in AD pathogenesis, it 
soon became clear that the β-site amyloid precursor 
protein cleaving enzyme 1 (BACE1) is a prominent 
therapeutic target for the treatment of AD (1). Aβ, 
a peptide of 36-43 amino acids is derived from the 
amyloid precursor protein (APP) through sequential 
proteolytic cleavages by β- and γ-secretase enzyme 
activities (2). Recently, it was shown that methylene 
blue (MethB), which is a phenothiazine-structured 
compound acts as a modulator of BACE1 in a cell free 
system (3). The aim of our study was to investigate 
whether toluidine blue O (TBO) and azure B, a major 
metabolite of MethB, inhibit BACE1 activity directly. 
MATERIALS AND METHODS:
The inhibitory effects of azure B and TBO on BACE1 
activity were determined using a cell-free BACE1 
assay kit which utilizes a fluorescence resonance 
energy transfer (FRET) technology. BACE1 inhibitor 
IV was used as a positive control for inhibition.
RESULTS:
Azure B and TBO significantly inhibited BACE1 
activity in a dose-dependent manner. The inhibitory 
effects for 2.5 µM, 5 µM, 10 µM, 20 µM and 40 µM 
of azure B were 13%, 20%, 46%, %70 and 93%, 
respectively. On the other hand, the inhibitory effects 
for 2.5 µM, 5 µM, 10 µM, 20 µM and 40 µM of TBO, 
were 23%, 29%, 45%, %65 and 85% respectively. 
CONCLUSIONS:
TBO and azure B were found to be potent inhibitors of 
BACE1. These results suggest that both compounds 
reduce β-secretase-mediated cleavage of APP and 
formation of Aβ.
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INTRODUCTION:
Prostate cancer is the most commonly diagnosed 
malignancy among men in the United States and 
the second leading cause of male cancer-related 
mortalities. Cisplatin is one of the most strong 
chemotherapeutic drugs for the treatment of many 
types of solid tumours. However, as prostate cancer 
cells exhibit resistance to cisplatin, it is not the first-line 
drug for prostate cancer chemotherapy (1, 2). Hsp70 is 
a chaperone that possess several physiological roles. 
This protein is also greatly overexpressed in tumor 
cells, contributing to resistance to chemotherapy and 
tumor cell survival (3). In the present study, we aimed 
to investigate the therapeutically chemosensitizing 
effect of Hsp70 inhibitor VER-155008 on cisplatin 
anti-tumour efficacy in prostate cancer cells PC-3.
MATERIALS AND METHODS:
The human androgen-independent prostate 
cancer cells were cultured and treated with serial 
concentrations (200- 100- 10- 1- 0,1 µM) of VER-
155008 alone or in combination with cisplatin for 24 h. 
The anti-proliferative effect of cisplatin or cisplatin in 
combination with VER-155008 was assessed by XTT 
assay.
RESULTS:
Our results revealed that the VER-155008 significantly 
increased cisplatin cytotoxicity in the androgen-
independent prostate carcinoma cell lines PC-3. 
The IC50 value of cisplatin was calculated as 68,5 
µM in the absence of VER-155008. When cisplatin 
was combined with VER-155008 the IC50 value of 
combination was reduced to 9,37 µM at 24 h.
CONCLUSIONS:
In conclusion, our findings showed that VER-155008 
increases the sensitivity of PC-3 cells to cisplatin-
induced growth inhibition. This result suggests that 
VER-155008 in combination with cisplatin may serve 
as a potentially useful therapeutic strategy for prostate 
cancer patients.
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INTRODUCTION:
Vaccinium myrtillus L. is a traditional Eurasian 
medicine that has been used in the treatment of 
diabetes (1-3). However, the mechanism of Vaccinium 
myrtillus L. activity is still unclear. This study aims 
to examine the effect of Vaccinium myrtillus L. on 
the oxidative stress in testis tissues of experimental 
diabetic rats.
MATERIALS AND METHODS:
In this study, 28 rats were disturbed into 4 different 
groups. Group I was control group, group II was 
diabetes group which was administered single dose of 
streptozotocin (45 mg/ kg), in Group III, rats were not 
made diabetic but given extract of Vaccinium myrtillus 
L. (1.2 g/kg) by gavage for 21 days; Group IV rats 
were made diabetic and given extract of Vaccinium 
myrtillus L. (1.2 g/kg) by gavage for 21 days. After 
these practices, all the animals were sacrificed, and 
the testis tissues of each animal were isolated. These 
tissues were homogenized and superoxide dismutase 
(SOD), catalase (CAT) activities and malondialdehyde 
(MDA) and glutathione (GSH) levels were examined.
RESULTS:
In our study, MDA levels increased, CAT, SOD 
activities and GSH level decreased in group II 
comparing with group I (p<0.05). Furthermore, MDA 
levels decreased, CAT, SOD activities and GSH 
level increased in group IV comparing with group II 
(p<0.05).
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CONCLUSIONS:
According to these results, it can be suggested 
that Vaccinium myrtillus L. was found to reduce the 
oxidative stress. As a result, we can suggest that 
extract of Vaccinium myrtillus L. may be used for the 
treatment of diabetes. 
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INTRODUCTION:
Benzoxazoles have been known to act as potential 
anticancer compounds. Recently, different authors 
have reported cytotoxic, anticancer or apoptotic 
potential of these compounds. (1,2). In this study, 
some new 2-subtituted benzoxazole derivatives were 
synthesised and evaluated for their cytotoxic effects 
on A549 human lung adenocarcinoma cell line.
MATERIALS AND METHODS:
The structural elucidation of the compounds was 
performed by 1H-NMR, 13C-NMR and LC-MS/
MS spectral data and elemental analyses. A549 cell 
lines were used in the studies. The cytotoxic activities 
of the tested compounds were determined by cell 
proliferation analysis using standard MTT assay. 
Detection of apoptosis was performed using Annexin 
V-FITC apoptosis detection kit BD, Pharmingen 
according to the manufacturer’s instruction.
RESULTS:
According to assay results, The most effective 
cytotoxic agent against A549 cancer cell line was 
found as compounds 4, 5, 7, 8, 9, 10  (IC50 values 
were  < 3.9, 10,33±1.53, 11,67±0.58, 5.00±1.00, 
<3.9, 4,5±0.71 μg/mL respectively) followed by 
compounds 6 and 11 (IC50 values were 22,67±2.52, 
and 23.00±2.00 μg/mL respectively ). However, 
compounds 1, 2 and 3 were the less active 
compounds on  A549 cell line  (IC50 values were as 
>500, 170.0±34,64, 58,33±2.89 μg/mL respectively) 
compared to cisplatin  (19,00±1,41 respectively). 
After 24h incubation period, the apoptotic effects of 
compounds 4,5,7, 8, 9 and 10 were increased on 
A549 cells based on Annexin V-PI binding capacities 
in flow cytometry.
CONCLUSIONS:
According to these findings, compounds  4 
(3-pyridyl substituted),  5 (3-indolyl substituted) , 7 
(4-methylphenyl substituted) , 8 (4-methoxyphenyl 
substituted), 9 (4-chlorophenyl substituted), 
10 (4-fluorophenyl substituted)  were the most 
effective anticancer compounds among these novel 
2-substituted benzoxazole derivatives. 
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INTRODUCTION:
The fact that oxidative stress plays an important 
role in many diseases has increased interest in 
studies on antioxidants. Among natural antioxidants, 
polyphenols play a very important role (1). Phenolic 
acids are the simplest phenolic compounds in plants. 
It consists of two subgroups, namely hydroxybenzoic 
acid and hydroxycinnamic acid, and is the precursor 
of flavonoids. Numerous studies have been carried 
out to reveal the antioxidant activity of phenolic 
compounds in plants (2). Pesticides that are widely 
used in agriculture and pose a great threat to fish by 
entering aquatic environment, catalyzing oxidative 
reactions; lead to formation of reactive oxygen species 
such as hydrogen peroxide, superoxide and hydroxyl 
radical. These radicals are highly reactive compounds 
which cause the oxidation and degradation of 
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important biological molecules such as proteins and 
lipids. Imidacloprid (IMI) is a neurotoxic insecticide, 
competitively similar to nicotine and competes with 
acetylcholine for its receptor site. Malondialdehyde 
(MDA) is a major and most studied peroxidation 
product. The most commonly measured product of 
protein oxidation is protein carbonyls. In this study, the 
protective effect of ferulic acid (FA) against oxidative 
stress was investigated in a 2.80 mg/L sublethal 
concentration of IMI, a neonicotinoid insecticide, in 
Cyprinus carpio. For this purpose, MDA and protein 
carbonyl levels of liver tissue were determined in fish 
fed with FA supplemented feed.
MATERIALS AND METHODS:
The fish treated with 2.80 mg/L imidocloprid were fed 
with 5% FA supplemented feed. Liver tissue samples 
were taken on days 4 and 10 of the study, which 
included control, FA, IMI and IMI + FA groups. Tissue 
MDA level was determined according to Yagi method. 
The identification of carbonyl groups formed on 
oxidative stress-affecting proteins has been reported 
by Levine et al. method. 
RESULTS:
Liver tissue MDA and PCO levels were increased 
compared to control with IMI effect during the 
experimental periods. No statistical difference was 
found when the individuals of the FA + IMI group had 
enzyme activity on the 4th day compared to the IMI 
group. On the 10th day, however, it was determined 
that the enzyme activity of the FA application and the 
MDA and PCO amounts were improved on the 10th 
day.
CONCLUSIONS:
Ferulic acid (4-hydroxy-3-methoxycinnamic acid) is 
a phenolic compound found in plant tissues during 
phenylalanine and tyrosine metabolism. In some 
countries, it has been approved as a food additive to 
prevent oxidation because it has an active role on free 
radicals. FA has proven to be a powerful membrane 
antioxidant and end free radical chain reactions.
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INTRODUCTION:
Cell phones have become an integral part of 
everyday life. As cell phone usage has become more 
widespread, concerns have increased regarding the 
harmful effects of radiofrequency electromagnetic 
radiation from these devices. The current study was 
undertaken to investigate the effects of the emitted 
radiation by cell phones on heart tissue (1)
MATERIALS AND METHODS:
Thirty-seven female Wistar albino rats were 
divided into three groups; study group (n=9), sham 
group (n=9) and control group (n=9). The rats in 
the study group were exposed to 1800 MHz RF-
EMF (Radiofrequency electromagnetic field). 
Malondialdehyde (MDA, an index of lipid peroxidation) 
were used as markers of oxidative stress-induced 
heart impairment. Superoxide dismutase (SOD), 
catalase (CAT), paraoxonase (PON), arylesterase 
(ARE) and glutathione peroxidase (GSH-Px) activities 
were studied to evaluate the changes of antioxidant 
status.
RESULTS:
In the 1800 MHz RF-EMF exposed group, while 
tissue MDA level increased, SOD, CAT and PON, 
ARE activities were reduced. 
CONCLUSIONS:
These results show that cell phone radiation can 
be reason free radical mediated oxidative heart 
impairment in rats.
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INTRODUCTION:
Hepatocellular carcinoma (HCC), is one of the 
deadliest cancer types, where the treatment options 
are limited. Therefore, it is important to design and 
test compounds in HCC cells with effects against 
cancer growth and metastasis. We have synthesized 
and identified several promising phenothiazines 
with anticancer properties in HCC. In this study 
we present molecular effects and biochemical 
activities of selected phenothiazines with respect to 
different signaling pathways including cholesterol 
biosynthesis, cell division, RNA processing along with 
cholinesterase activity. In silico structural comparisons 
also have been made.
MATERIALS AND METHODS:
Commercial phenothiazines (phenothiazine, 
perphenazine, prochlorperazine dimaleat, 
trifluoperazine HCl) were purchased from SIGMA 
while novel derivatives were synthesized at Ankara 
University, Turkey. qRT-PCRs were performed for 
selected genes with gene specific primers after 
exposure to 10 µM and 20 µM of the prioritized 
compounds for 24 hours in SKHep1 and Hep3B 
cell lines. Different target prediction softwares 
such as Swiss Target Prediction (1) and SPiDER 
(2) were used to identify molecular targets of the 
phenothiazines. Obtained similarity scores were 
used for hierarchical clustering with Ward linkage 
in MATLAB ®. Cholinesterase activity was studied 
colorimetrically using AchE assay.
RESULTS:
In silico results indicated acetylcholinesterase as one 
of the top consensus molecular targets. Comparison of 
the most active molecules indicated that the piperazine 
ring might be important for acetylcholinesterase 
activity. This was parallel with our results showing 
that cholinesterase inhibitory activity of some of the 
novel derivatives were relatively higher than many 
of the commercial phenothiazines. Moreover, gene 
expression analyses have shown significant effects 
on expression of several genes, e.g., SQLE, DDIT3, 
SRSF7, NIP7, LSS, CCNE2 and RRM2 with dose- 
and cell-line dependent differences. Currently, we are 
focusing on molecular and biochemical analyses of 
other newly synthesized molecules before finalizing 
lead compounds for high throughput transcriptomics.   
CONCLUSIONS:
Studied phenothiazines exhibited important 
modulations in cellular signaling and activity in HCC 
cell lines and in silico studies have opened new 
avenues for our future studies.
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INTRODUCTION:
Cancer is one of the most important health issues 
worldwide. Conventional treatments, such as 
chemotherapy, surgery, and radiotherapy possess 
several side effects (1, 2). To overcome this hurdle, 
targeted treatment has been widely employed 
to enhance therapeutic efficacies and reduce 
systemic toxicity of pharmaceutical agents. Polo-
like kinases (PLKs) are a family of serine/threonine 
protein kinases and consist of five isoforms. Among 
them, PLK1 plays an important role in the initiation, 
maintenance, and completion of mitosis. This protein 
also overexpressed in many cancers and this high-
level expression causing poor prognosis in cancer 
patients (3). Therefore, specific inhibition of PLK1 in 
tumor cells is an important strategy in the treatment of 
cancer. In the present study, we aimed to investigate 
the antiproliferative effects of Ro380 and SBE 13 
hydrochloride on MDA-MB-231 cells. 
MATERIALS AND METHODS:
MDA-MB-231 cells were cultured and treated with 
different concentrations (100- 50- 25- 12.5- 6.25- 
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3.12- 1.56 µM) of Ro380 and SBE 13 hydrochloride. 
The antiproliferative activity of the inhibitors was 
evaluated using the XTT assay.
RESULTS:
Our findings showed that Ro380 and SBE 13 
hydrochloride exposure inhibited MDA-MB-231 cell 
proliferation (p<0.05) in a dose-dependent manner 
compared to the control cells. The IC50 of Ro380 and 
SBE 13 hydrochloride in MDA-MB-231 cell line were 
calculated as 11.29 µM and 21.51 µM after 24 h of 
treatment, respectively.
CONCLUSIONS:
In conclusion, our cytotoxicity results clearly revealed 
that the Ro380 is more toxic than the SBE 13 
hydrochloride on MDA-MB-231 cells. However, further 
studies are needed to be able to utilize Ro380 and 
SBE 13 hydrochloride derivatives in breast cancer.
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INTRODUCTION:
Cancer is a serious life-threatening disease and 
the second-leading cause of death worldwide after 
cardiovascular diseases (1). PLK1 plays multiple 
roles in the cell cycle and highly expressed in most 
of human cancers, furthermore, its overexpression 
is associated with poor prognosis in cancer patients. 
Thus, it has been suggested that PLK1 could be an 
attractive target for cancer therapy (2). This study 
aimed to investigate the antiproliferative effects of 
Ro380 and SBE 13 hydrochloride on DU 145 prostate 
and SH-SY5Y neuroblastoma cells.
MATERIALS AND METHODS:
DU145 and SH-SY5Y cells were cultured and treated 
with different concentrations (100- 50- 25- 12.5- 6.25- 
3.12- 1.56 µM) of Ro380 and SBE 13 hydrochloride. 
The antiproliferative activity of the inhibitors was 
evaluated using the XTT assay.
RESULTS:
Our results demonstrated that the Ro380 and SBE 
13 hydrochloride exposure inhibited DU 145 and SH-
SY5Y cell proliferation (p<0.05) in a dose-dependent 
manner compared to the control cells. The IC50 
of Ro380 in DU 145 and SH-SY5Y cell lines were 
calculated as 1.84 µM and 10.97 µM, respectively. 
The IC50 of SBE 13 hydrochloride in DU 145 and SH-
SY5Y cell lines were calculated as 1.97 µM and 13.51 
µM after 24 h of treatment, respectively.
CONCLUSIONS:
In conclusion, our cytotoxicity results clearly 
revealed that the Ro380 is more toxic than SBE 
13 hydrochloride on DU 145 and SH-SY5Y cells. 
However, further studies are needed to be able to 
utilize Ro380 and SBE 13 hydrochloride derivatives in 
prostate and neuroblastoma cancer.
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INTRODUCTION:
Breast cancer is the most common metastatic 
and invasive cancer in women worldwide, so that 
prolongation of survival and improvement of quality 
of the life is the biggest goal in breast cancer (1). 
MCF-7 cell lines are used for breast cancer studies 
because of their several ideal properties specific to 
mammary epithelium and retaining their estrogen 
sensitivity (2). The aim of this study was to investigate 
functionalized pyrrolidine-indole hybrid heterocycles 
(3,4) on vascular endothelial growth factor (VEGF), 
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one of the most important mediators of angiogenesis 
in MCF-7 cell lines. 
MATERIALS AND METHODS:
Functionalized pyrrolidine-indole hybrid compounds, 
1a and 1b were synthesized as part of our previous 
studies and characterized by analytical techniques. 
The compounds were screened for their cytotoxicity 
on MCF-7 cell lines. VEGF levels were assayed 
respect to the manufacturer’s guidance. The results 
were stated in ng/mg protein. 
RESULTS:
A statistically significant increase in VEGF level was 
observed in the DMSO (solvent) 24h group compared 
to the Control. VEGF levels significantly decreased in 
both 1a and 1b 24h groups compared with the DMSO 
24h groups (p<0.05). Although VEGF levels also 
decreased in both 1a and 1b 48h groups compared 
with the DMSO 48h groups, these results were not 
significant.
CONCLUSIONS:
The obtained results displayed that functionalized 
pyrrolidine - indole hybrid compounds 1a and 1b may 
be considered as anti-angiogenic agents. Further 
studies needed to be carried out different solvents.
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INTRODUCTION:
Edible mushrooms have been part of the human 
diet for several centuries. It is the total diet or overall 
eating pattern that is most important in disease 
prevention and achieving good health. It is better 
to eat a diet with variety than to concentrate on 
individual foods as the key to good health.Nowadays 
there is a growing interest in new drugs against 
secondary metabolites derived from fungi and for the 
discovery of precursor compounds. These bioactive 
components are becoming popular sources of natural 
antioxidant, antitumor, antiviral, antimicrobial and 
immunomodulatory agents. 
MATERIALS AND METHODS:
In this study, the ethanol extracts of Lactarius 
delicious and Lactarius salmonicolor species were 
analyzed for the polyphenolic contents by using 
spectrophotometrically methods. The free radical 
scavenging activities of extracts were evaluated by 
DPPH assay. Besides, the mushroom extract effects 
were examined on the glutathione peroxidase (GPx) 
enzyme activity by kinetic assay (1). 
RESULTS:
Ethanol extract of L. salmonicolor has been shown 
the highest total of phenolic compounds with 
8.615±0.0008 mg GAE/g and L. delicious also has 
been shown the highest amount of flavonoid contents 
with 7.822 ±0.0041 mg QE/g values. The highest 
DPPH radical scavenging activity was measured as 
80% at 10 mg/mL concentration for ethanol extract of 
L. delicious. Also, the best activity profile for GPx was 
observed with the crude ethanol extract of L. delicious 
at 2.5 mg/mL concentration. 
CONCLUSIONS:
L. delicious may be considered as a good source of 
functional food for the detoxification and antioxidant 
defense systems.
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INTRODUCTION:
Bilberry fruit extracts have been studied for the 
prevention and treatment of chronic pathologies, 
such as diabetes, cardiovascular disease and obesity. 
This study aims to examine the effect of Vaccinium 
myrtillus L. on the oxidative stress in lung tissues of 
experimental diabetic rats. 
MATERIALS AND METHODS:
In this study, 28 rats were disturbed into 4 different 
groups. Group I was control group, group II was 
diabetes group which was administered single dose of 
streptozotocin (45 mg/ kg), in Group III, rats were not 
made diabetic but given extract of Vaccinium myrtillus 
L. (1.2 g/kg) by gavage for 21 days; Group IV rats 
were made diabetic and given extract of Vaccinium 
myrtillus L. (1.2 g/kg) by gavage for 21 days. After 
these practices, all the animals were sacrificed, and 
the lung tissues of each animal were isolated. Lung 
tissues were homogenized and superoxide dismutase 
(SOD), catalase (CAT) activities and malondialdehyde 
(MDA) and glutathione (GSH) levels were examined.
RESULTS:
In our study, MDA levels increased, CAT, SOD 
activities and GSH level decreased in group II 
comparing with group I (p<0.05). Furthermore, MDA 
levels decreased, CAT, SOD activities and GSH 
level increased in group IV comparing with group II 
(p<0.05).
CONCLUSIONS:
According to these results, it can be suggested 
that Vaccinium myrtillus L. was found to reduce the 
oxidative stress. As a result, we can suggest that 
extract of Vaccinium myrtillus L. may be used for the 
treatment of diabetes. 
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INTRODUCTION:
Radiotherapy (RT) has been widely used as a 
curative treatment for local prostate cancer (1). 
However, prostate cancer radioresistance causes in 
a number of patients, leading to cancer recrudesce. 
The combination of pharmacologic drugs and RT in 
prostate cancer increases the effectiveness of RT 
with minimal side effects (2). Imipramine, a tricyclic 
antidepressant,  when present in the growth medium 
of Eag1-expressing tumor cells, and  slows cell 
proliferation by blocking Eag 1 K+ channel (3). In this 
study, it was aimed to investigate the radiosensitive 
effect on RT of imipramine.
MATERIALS AND METHODS:
In this study, DU-145 prostate cancer cell lines were 
used. The cells were divided into 4 groups (n=4 each 
group). Group 1 is the control group. Group 2 is the 
imipiramine group (1 μM imipramine was given to 
the prostate cells). Group 3 is the RT group (6 Gy 
radiation as a single fraction) (4). Group 4 is the 
RT+ imipramine group (6 Gy radiotherapy and 1 μM 
imipramine). Cells were incubated 24 hours after RT 
with imipramine. Superoxide dismutase (SOD) and 
catalase (CAT) activities and malondialdehyde (MDA) 
levels were measured 72 hours after incubation in all 
groups.                                      
RESULTS:
In all experimental groups, SOD and CAT activity 
significantly decreased compared to control group 
(p<0.05). MDA level was significantly higher in all 
experimental groups than control group (p<0.05). In 
the RT+imipramine group, MDA level significantly 
lower than imipramine and RT groups and significantly 
higher than control group (p<0.05). 
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CONCLUSIONS:
Our findings have suggested that individual treatment 
of radiotherapy and imipramine enhanced oxidative 
stress than combined treatment of RT and imipramine. 
Another important finding of this study was that 
imipramine increased oxidative stress in DU 145 cell 
lines as much as radiotherapy. This result suggests 
that imipramine may be an alternative to radiotherapy 
in the treatment of prostate cancer. 
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INTRODUCTION:
Besides GGT1, pre-genome researches had showed 
that the human genome contains additional related 
genes or sequences. One of these genes, GGT6 
(formerly rat ggt6 homologue) had limited amino acid 
sequence homology to GGT1 and its function as 
an enzyme has not yet been described. The aim of 
this study was to evaluate the gene expressions of 
GGT1 and GGT6 in breast cancer. Also, we aimed to 
investigate the relationship of GGT genes with GGT 
enzyme activity.
MATERIALS AND METHODS:
Normal and tumor tissue samples were collected from 
58 patients diagnosed with breast cancer. As controls, 
8 healthy persons admitted to the clinic for breast 
reduction surgery were also included to the study. 
mRNA expressions of GGT1 and GGT6 in normal and 
tumor tissue samples of breast cancer patients and 
healthy controls examined by qRT-PCR method. In 
addition, GGT enzyme activity in serum samples was 
measured by spectrophotometric method.
RESULTS:
In contrast to GGT1, GGT6 mRNA expressions were 
higher in tumor tissues than those in normal tissues 
(p=0.020 for GGT1 and p=0.045 for GGT6). Also, 
GGT enzyme activity was significantly higher in 
patients than those in controls (p<0.05). We did not 
find any correlation between GGT and GGT genes. 
CONCLUSIONS:
Although the function is unknown, we believe that 
GGT6, which shows significant mRNA expressions 
in tissue samples of most patients, needs to be 
further investigated. It is not surprising that there is 
no correlation between GGT activity and tissue GGT 
expressions because serum GGT enzyme levels are 
predominantly liver-derived.
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INTRODUCTION:
Single strand DNA binding proteins (SSBs) have 
crucial roles in the DNA metabolism (1). A well-known 
SSB called Replication Protein A (RPA) is the major 
player in initiating the DNA-damage checkpoint 
signaling cascade (2, 3). Two novel SSB proteins, 
hSSB1 and hSSB2, were discovered by sequence 
homology to an archeal SSB (4). It was found that 
cells deficient of hSSB1 cannot phosphorylate Chk1, 
a step required to transduce checkpoint signals in 
response to IR induced DNA damage (4). In order 
to determine the role hSSB1 and hSSB2 play in UV-
induced DNA damage checkpoint pathway, an in vitro 
checkpoint system was developed in which Chk1 is 
phosphorylated in an ATR-dependent manner in the 
presence of TopBP1 and ATP. In this system, ATR 
kinase activity is stimulated by TopBP1 and this effect 
is improved by single strand DNA (ssDNA) addition to 
the reaction. 
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MATERIALS AND METHODS:
To address the question, firstly His tagged hSSB1 and 
hSSB2 were purified using an Ni-NTA affinity column 
and their ability to bind ssDNA was tested by EMSA 
using 5’ end labeled oligomers, d30T and d30AC. 
Then, Chk1 phosphorylation in the presence of 
hSSB1 and hSSB2 was assayed using a combination 
of kinase assay and immunoblotting with Chk1 
phospho-S345 antibody.
RESULTS:
Our results showed that hSSB1 efficiently binds to 
ssDNA. It was demonstrated that hSSB1 does not 
improve Chk1 phosphorylation in response to UV-
induced damage. hSSB2 on the other hand was found 
to inhibit phosphorylation in response to UV damage. 
CONCLUSIONS:
These results indicate that, unlike IR-induced damage, 
hSSB1 is not directly involved in UV-induced damage 
response. Moreover, hSSB2 might interfere and 
alleviate ATR-kinase activity on Chk1 phosphorylation 
to initiate UV-damage response. Further experiments 
are requied to evaluate the specific roles of both 
hSSB1 and hSSB2. 
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INTRODUCTION:
Infertility is defined as the inability to obtain a 
pregnancy for at least one year, despite desiring 
of couples to have children and having regular 
unprotected sexual intercourse (1). Unexplained 
infertility is a group under infertility and had a share 
of 15-30%. Our knowledge is quite less in the 
unexplained infertility cases because of no reason to 
explain infertility. Inhibin B, is accepted as a marker 
to show the follicular growth and ovarian reserve. 
It is known that, serum inhibin B concentration is 
negatively correlate with FSH level, which have been 
shown to have an association with decreased oocyte 
quality and fertility (2). Serum Inhibin B concentration 
can be a useful tool in the management of unexplained 
infertility. Thus, it was aimed to characterize hormone 
levels in women with unexplained infertility, and 
measure the serum inhibin B concentration in both 
patients and controls in order to determine their roles 
in unexplained infertility.   
MATERIALS AND METHODS:
In this study, 47 unexplained infertility patients and 
41 controls, matched for age (32.2±4.7, 30.4±4.8, 
respectively), were enrolled. The study was approved 
by Ethics Committee, and written informed consent 
was obtained from the patients or their relatives. 
Serum inhibin B concentration were measured 
spectrophotometrically by using a commercial assay 
kit, according to the manufacturer’s instructions. The 
data were evaluated with SPSS packed programme 
(version 17.0 software, SPSS Inc. Chicago, Illinois, 
USA). Serum FSH, LH, E2, TSH and progesteron 
concentrations were measured by using Siemens 
enzyme immunometric assay kit on the ADVIA 
centeaur CP analyzer in the hospital’s biochemistry 
laboratory.    
RESULTS:
Serum Inhibin B concentration were significantly 
increased in unexplained infertility patients 
(61.14±43.30 pg/mL) as compared to controls 
(46.88±8.20 pg/mL) (p<0.05). The Inhibin B level 
was found to significantly correlate with LH/FSH ratio 
(r=0.222, p<0.05). It was also correlated with quetelet 
index positively (r=0.270, p<0.05), while there were 
no correlation between inhibin B and others endocrine 
parameters in patients with unexplained infertility 
(p>0.05). There was no statistically significant 
difference between patient and control group in terms 
of age, quetelet index, E2, TSH and progesterone 
concentrations. On the other hand, there was a 
significant difference in terms of FSH and LH in two 
groups (p<0.05).           
CONCLUSIONS:
Serum Inhibin B levels in unexplained infertility were 
significantly differ from control group, while these 
values were in normal range in both groups. Thus, 
it can be useful for evaluating unexplained infertility. 
Further studies are warranted to confirm this finding, 
especially with a larger population. 
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INTRODUCTION:
Unexplained infertility refers to a diagnosis made in 
couples in which all the standard examinations, which 
are usually seen in about 30-40% of infertile couples, 
are usually normal, such as ovulation, tubal opening, 
and sperm analysis. One of the possible causes of 
unexplained infertility have been reported to arise 
from disorder that occur in productive physiology. 
Carbonic anhydrase is a zinc enzyme widely found 
in the living world and has been detected in the 
human reproductive tract, over, fallopian tube and 
uterine endometrium. Oxidative stress affects the 
reproductive system in various stages and free 
oxygen radicals play a role in several infertility related 
diseases. Serum Carbonic Anhydrase I (CA I) and 
TOS values were evaluated for possible association 
in patients with unexplained infertile patients.
Materials and Method: Our study group, a total of 
85 females (age range 18–40 years), including 44 
with unexplained infertility and 41 control group. 
In serum samples CA I levels were measured at 
450 nm using an ELISA kit. Total oxidant status 
(TOS) levels were measured by 530 nm wavelength 
in a spectrophotometer by manual methods. 
Measurements were made at Gazi University Faculty 
of Pharmacy Department of Biochemistry Department. 
The results were evaluated statistically by SPSS 17.0 
package program.
RESULTS:
There was no significant difference in carbonic 
anhydrase 1 levels between women with unexplained 
infertility and control group (p>0.05). However, we 
detected TOS levels were statiscally significantly 
different between the patient and control groups 
(p<0.05).
CONCLUSIONS:
Carbonic anhydrase I concentrations in patiens with 
unexplained infertility (784.86±56.61) were different 
from those of controls (752.13±13.10) higher but 
statiscally not significant. Serum TOS levels in women 
with unexplained infetility have a lower concentration 
(6.00±0.16) when compared to controls (6.70±0.31). 
TOS may have a critical role to unexplained infertility. 
We hope that this result will applied in larger 
populations and illuminate the work to be done in the 
future. 
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INTRODUCTION:
Chitosan, a natural biopolymer, has become a 
remarkable material in recent years due to its 
positive properties (nontoxic against living organisms, 
biodegradable, biocompatible, antitumor and 
antioxidant activity) and its availability in different 
fields (1-4). The chitosan is obtained with a certain 
degree deacetylation of chitin for removal of acetyl 
groups. Some parameters and properties including 
deacetylation degree, molecular weight, viscosity 
and solubility determine its using area. Molecular 
weight has changed with temperature, time and base 
(NaOH) concentration applied during deacetylation. 
This study aimed characterization, antioxidant activity 
and enzyme inhibition of different molecular weights 
chitosan samples.
MATERIALS AND METHODS:
FT-IR, XRD, TGA and SEM analyzes were used 
for characterization. For antioxidant activity, DPPH 
scavenging activity, ferric ion reducing power and 
FRAP tests were conducted. To determine the 
diabetes linked enzyme inhibition activities, inhibition 
of α-amylase and α-glucosidase were investigated.
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RESULTS:
The molecular weights of the chitosan deacetylated at 
4, 8, 16 and 42 hours were calculated as 1.9, 7.3, 16.9 
and 75.1 kDa, respectively. DPPH scavenging and 
ferric reducing power activities were increased with 
increasing molecular weight. In other words, when the 
duration of deacetylation was increased, antioxidant 
activity was improved. However, there was no relation 
between the FRAP test and the molecular weight. 
For both enzymes, increases in the deacetylation 
time enhanced enzyme inhibition activities. Inhibition 
activity of α-glucosidase was observed approximately 
4 times higher than that of α-amylase.
CONCLUSIONS:
As a result, it was observed that the molecular weight 
of chitosan positively affected both antioxidant activity 
and enzyme inhibition. In particular, due to its high 
inhibition of diabetes-related enzymes, chitosan 
could be used as a natural alternative to acarbose (a 
standard substance).
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INTRODUCTION:
Nonsteroidal anti-inflammatory drugs (NSAIDs) are 
one of the most important therapeutic agents used for 
the treatment of a variety of inflammation. Tenoxicam, 
which is used to relieve inflammation, swelling, 
and pain associated with rheumatoid arthritis, is a 
member of NSAIDs. In this study, the effect of metal 
complexation of tenoxicam on the anti-inflammatory 
activity was searched. 
MATERIALS AND METHODS:
The inhibition of pro-inflammatory cytokine namely 
tumor necrosis factor-α (TNF-α) is one of the most 
common approach in the treatment of inflammatory 
(1).
The serum levels of TNF-α of tenoxicam and Pd, Pt, 
Zn, and Cu complexes of tenoxicam were determined 
by in vitro enzyme linked immunosorbent assay 
(ELISA) kit (Thermo Fisher Scientific, Waltham, 
MA). Measurements were carried out on a 96-well 
microplate reader. 
RESULTS:
The results were given as the inhibition of TNF-α in 
percent (I %). Metal complexes of tenoxicam inhibited 
the TNF-α between 50.6% and 93.6% whereas 
the TNF-α inhibition of tenoxicam was 47.3%. It 
means that the anti-inflammatory effects of the 
metal complexes of tenoxicam are higher than that 
of tenoxicam. The highest TNF-α inhibition rate was 
performed by Cu complex (93.6%) which showed 
comparable bioactivity with the standard drug used 
(96.3%).  
Conclusions:The complexation with metal ions was 
considerably enhanced the anti-inflammatory activity 
of tenoxicam which offers a potential application for 
pharmaceutical industry.
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INTRODUCTION:
Azoles are by far the most widely used class of 
antifungal agents. They show their antifungal activity 
via the inhibition of cytochrome P450-dependent 
enzyme 14α-lanosterol demethylase (CYP51) 
(1). Due to the importance of azoles in the field of 
antifungal drug design, we aimed to design and 




subs t i tu ted-1H-benzazo l -2 -y l ) th io ]e than-1-
one (1–8) were synthesized via the reaction of 
1-[5-(1,3-benzodioxol-5-yl)-3-(thiophen-2-yl)-4,5-
dihydro-1H-pyrazol-1-yl]-2-chloroethan-1-one with 
aryl thiols. These compounds were evaluated for 
their in vitro antifungal effects on Candida albicans, 
Candida glabrata, Candida parapsilosis and Candida 
krusei. Their minimum inhibitory concentration 
(MIC, µg/mL) values were determined by a broth 
microdilution assay. Docking studies were also 
carried out to predict the affinity of the most effective 
anticandidal agents to the active site of CYP51 (PDB 
code: 5JLC) using Schrodinger’s Maestro molecular 
modeling package (Schrödinger Release 2016-2: 
Schrödinger, LLC, New York, NY, USA). In silico 
ADME properties of all compounds were determined 
using Molinspiration software (2).
RESULTS:
Compounds 2, 4 and 6 showed selective antifungal 
activity against C. albicans with a MIC value of 62.5 
µg/mL when compared with ketoconazole (MIC= 
62.5 µg/mL). Docking results indicated that chloro 
substituted compounds 2 and 6 formed cation-π with 
the iron of Heme group in the active site of CYP51. 
According to in silico ADME studies, compound 2 
only violated one parameter of Lipinski’s rule of five 
making it a potential orally bioavailable agent.
CONCLUSIONS:
According to in vitro and in silico studies, compound 
2 stands out as a promising orally bioavailable 
anticandidal drug candidate for further studies.
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INTRODUCTION:
Pyrazolines have attracted a great deal of interest in 
medicinal chemistry related to their diverse biological 
activities. In particular, recent studies have indicated 
that antimicrobial activity of pyrazolines was observed 
predominantly (1). For this purpose, herein we 




benzodioxol-5-yl)-2-pyrazolines (1–6) were 
synthesized via the reaction of 1-(chloroacetyl)-3-
(2-thienyl)-5-(1,3-benzodioxol-5-yl)-2-pyrazoline 
with aryl thiols. In vitro antifungal effects of these 
compounds were evaluated on Candida albicans, 
Candida glabrata, Candida parapsilosis and Candida 
krusei. Their minimum inhibitory concentration 
(MIC, µg/mL) values were determined by a broth 
microdilution assay. Molecular docking simulation 
was performed for compound 5 in the active site of 
lanosterol 14α-demethylase enzyme (CYP51) (PDB 
code: 5JLC) using Schrodinger’s Maestro molecular 
modeling package (Schrödinger Release 2016-2: 
Schrödinger, LLC, New York, NY, USA). Molinspiration 
software was used for in silico pharmacokinetic 
evaluation of all compounds (2).
RESULTS:
Compound 5, methyl substituted tetrazole-based 
agent, revealed high antifungal effect on C. albicans 
with a MIC value of 62.5 µg/mL when compared with 
ketoconazole (MIC= 62.5 µg/mL). Docking resuts 
indicated that the thiophene and the thioacetyl groups 
of compound 5 presented π-π interaction and H-bond 
with Phe385, His406 and Tyr73 residues, respectively. 
Besides the methyltetrazole moiety of this compound 
also formed π-π interaction and H-bond with His382 
and Ser383 residues, respectively. These docking 
results emphasized that compound 5 might show its 
anticandidal activity via the inhibition of ergosterol 
biosynthesis. Therefore, this study must be supported 
with further in vitro enzyme studies. According to 
in silico ADME studies, compound 5 did not violate 
Lipinski’s rule making it a potential orally bioavailable 
anticandidal agent.
CONCLUSIONS:
Compound 5 was identified as a promising 
anticandidal agent for further mechanistic studies. 
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INTRODUCTION:
Isomerism finds its importance in the area of medicinal 
chemistry, as isomers differ in their pharmacokinetic 
and pharmacodynamic properties. Drug isomerism 
has opened a new field for drug development (1). 
Oximes also show geometric isomerism because 
they carry carbon-nitrogen double bonds. The 
geometric isomers E and Z of oxime and oxime 
esters are important since their physical, chemical, 
steric properties are different. There are different 
activities among the isomers. The oxime isomers 
should be considered as two different substances 
because of their properties (2-4). From this point of 
view, in the present study some aryl ethanone oxime 
derivatives bearing pyrazole moieties were designed, 
synthesized and separated.
MATERIALS AND METHODS:
We synthesized compounds by the reaction of oxime 
derivate (d) with various acyl chlorides using Nao. 
The compounds were separated E/Z isomer by using 
several solvents. Their structures were confirmed by 
IR, 1H-NMR, 13C-NMR and elemental analysis data.
RESULTS:
Compounds were obtained as E and Z  isomer. E/Z 
structure was determined by 1H-NMR. Melting point 
and Rf values were detected.
CONCLUSIONS:
E/Z isomers with different configurations have different 
physicochemical and pharmacological properties and 
pharmacological activities. Thus, we obtained the 
compounds separately as E and Z and evaluated 
their pharmacological activities separately.
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INTRODUCTION:
The incidence of fungal infections, which became 
a serious threat to human health, has increased in 
recent years. Especially, systemic mycoses have 
higher morbidity and mortality rates in conditions that 
suppress the immune system such as patients with 
AIDS, cancer patients. It is an infectious disease that 
is often acquired at the hospital. Candida species 
are main cause of mycoses in humans. Invasive 
candidiasis with a high mortality rate is the most 
frequently isolated C.albicans. However, infections 
caused by other candida species are increasing 
recently (1,2). In this study, we have investigated the 
interactions between new oxime ester compounds 
and active enzyme sites.
MATERIALS AND METHODS:
Structure of synthesized compound were determined 
by spectral and elemental analyses. “Structure of 
CYP51 from the pathogen Candida albicans” pdb 
file with resolution 2.9Å (PDB ID:5v5z) was received 
(www.rcsb.org) and was modified using the ADT 
package version 1.5.6rc3. To validate the docking 
program, the co-crystallized ligand Itraconazole (PDB 
ID:1YN) was redocked on the target enzyme and 
RMSD value of 1.846 was found for Itraconazole-
bound CYP51. RMSD value was obtained using 
Lamarckian Genetic Algorithm and scoring function of 
AutoDock 4.2 release 4.2.5.1 software (3).
RESULTS:
In order to rationalize their mechanism of action, we 
performed computational analysis utilizing molecular 
docking on the C.albicans CYP51 homology models 
we built. 4a occupied van der Waals interactions with 
Tyr118, Thr122, Phe126, Phe228, Gly307, Thr311, 
Leu376, Ser378, Phe380, Met508, HEM. 4b occupied 
van der Waals interactions with Tyr118, Thr122, 
Phe126, Phe228, Phe233, Gly307, Thr311, Leu376, 
Ser378, Phe380, Met508, HEM.
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CONCLUSIONS:
Docking studies were performed for the most active 
compounds. As a result of these studies, a strong 
interaction between these compounds and the active 
sites of enzyme was revealed.
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INTRODUCTION:
Benzimidazoles have become an important 
pharmacophore in drug design and have been 
screened for a wide range of biological activities e.g. 
antimicrobial (1), antiparasitic (2),  antihistaminic 
(3), anticancer (4), and antioxidant (5). The aim 
of this study was to clarify the restricted rotation 
around the –CH2-N bond of the compounds, 
5-(2-(p-chlorophenylbenzimidazol-1-yl-methyl)-
4-(o-methylphenyl)-2,4-dihydro-[1,2,4]-triazole-3 
thione (1), 4-(o-florophenyl)- (2), 4-(o-chlorophenyl)- 
(3) and 4-(o-bromophenyl)-  (4), which are some 
benzimidazole derivatives showing antioxidant 
properties, as a comparatively the experimental 
results (NMR and X-ray) with DFT. We also present 
here the crystal, and molecular structure of the 
compound 3 and 4 with the X-ray diffraction method.
MATERIALS AND METHODS:
Solid state geometry was determined in order to see 
intra- and inter-molecular interactions by X-Ray. We 
determined by the NMR experiments whether the 
effect of temperature and solvents on the rotation 
barrier. The geometric and conformational parameters 
of the molecules were investigated with DFT.
RESULTS:
In NMR spectra of relevant compounds, because of 
the hindered rotation around the methylene bridge, 
methylene protons appear as an AB quartet in 
DMSO-d6. The high temperature NMR spectra for 
the compound 1 show similar behavior in DMSO-d6. 
The NMR spectra in different solvents point out the 
same manner. The preventing of free rotation in 
the methylene bridge caused by the existence of 
substituents at the second position of the phenyl 
group connected to triazole ring was supported by 
both the experimental results (NMR and X-ray) and 
the theoretical results.
CONCLUSIONS:
The single crystal X-ray structures of these 
compounds show the presence of the strong intra-
molecular interaction and close contact, preventing of 
free rotation in the methylene bridge. Also, DFT scans 
of the relevant compounds are in line with hindering 
of rotation.
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INTRODUCTION:
Pathogenic organisms cause of the communicable 
or infectious diseases may be classified by size as 
microscopic organisms, macroscopic organisms 
and microscopic particles. Bacterial and fungal 
(microscopic organisms) infections are sort of highly 
prevalent diseases. Since the first report about 
antimicrobial resistance in 1940’s, researchers 
have discovered the new, safer and efficient 
antimicrobial agents has been became required (1, 
2). Among various aromatic compounds, naphthalene 
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derivatives have displayed very different biological 
activities. Especially, their anticancer, antifungal and 
antibacterial activities (3, 4) drew our attention. By the 
reason of the above information, we synthesized new 
twelve N-(naphthalene-2-yl)propanamide derivatives 
as potential antimicrobial agent.
MATERIALS AND METHODS:
The synthesis reaction was carried out via two steps. 
After amidation reaction, the obtained product (1) 
was separated to two pieces. One of these pieces 
was reacted with 2-mercapto azole derivatives. The 
other of them was reacted with dithiocarbamate salts 
attached to different heterocyclic amines. MIC values 
of final compounds (2a-2l) were determined against 
ten fungi and ten bacteria.
RESULTS AND DISCUSSION:
All compounds (2a-2l) have shown an antimicrobial 
activity. Especially 2a, 2b, 2c, 2e and 2f have 
demonstrated high activity against Staphylococcus 
aureus (ATCC 6538), Yersinia enterocolitica (Y53), 
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Be specified due to results, 2-mercopta azole 
derivatives’ activities are better than dithiocarbamate 
salt derivatives’ activity.
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INTRODUCTION:
Microbial infections cause millions of people to die 
each year due to lack of effective treatment and 
microbial resistance to antibiotics. The formation 
of antibiotic resistance pathogens has become a 
serious health problem, and a number of studies have 
been conducted to improve existing antimicrobial 
treatments (1). In researches, the biological activities 
of heterocyclic ring-containing compounds are also 
remarkable. Triazoles have attracted interest because 
they exhibits a large number of biological activities 
such as antimicrobial, analgesic, anti-inflammatory, 
anticancer, antioxidant (2,3). In this work, the 
synthesis of some new 3,4,5-trisubstituted triazole 
derivatives, spectroscopic methods of structure 
elucidation and evaluation of antimicrobial activities of 
compounds are aimed.
MATERIALS AND METHODS:
8-Hydroxyquinoline and ethyl chloroacetate were 
mixed by boiling. After reaction is completed, the 
solvent was evaporated and the material was washed 
with water to acquire the intermediate. The obtained 
product, ethyl 2-(quinolin-8-yloxy)acetate (1) was 
reacted with hydrazine hydrate in ethanol. At the end 
of the reaction, hydrazinated compounds was gained 
by filtration. 2-(Quinolin-8-yloxy)acetohydrazide 
(2) was dissolved in ethanol and boiled with 
phenylisothiocyanate to synthesize N-phenyl-2-(2-
(quinolin-8-yloxy)acetyl)hydrazine-1-carbothioamide 
(3) and then in next step this compound was refluxed 
with 2N potassium hydroxide prepared in ethanol. 
The reaction was terminated by controlling the TLC. 
The pH was set to 7 to allow the material to settle 
in a cold environment. At last, the resulting triazole 
molecule (4) was treated with appropriate 2-chloro-
N-substitute acetamide derivates to get final twelve 
derivatives (5a-l). The antimicrobial activity of the 
compounds was screened on eight bacteria and three 
fungi. Fluconazole and chloramphenicol were used 
as standard drugs. Minumum inhibitor concentrations 
(MIC) were determined for each compound and 
standards.
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RESULTS:
The aimed twelve compounds (5a-l) were obtained 
purely and the structures of the compounds were 
elucidated with spectroscopic methods. The activities 
of the compounds against Salmonella and Candida 
species have been determined higher and comparable 
to standards. 
CONCLUSIONS:
Compounds 5a bearing 6-nitrobenzothiazole and 5k 
bearing 2-acetyl-3-methyl thiazole showed the highest 
antibacterial activity at 7.8, 7.8 µg/ml, respectively. 
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INTRODUCTION:
Melatonin is a direct scavenger of free radicals, which 
is associated to its ability to protect cells from oxidative 
stress (1, 2). We have revealed from our previous 
research that MLT-related compounds exhibit good 
antioxidant activity in vitro (3,4).
MATERIALS AND METHODS:
In this study 5-chloroindole hydrazide/hydrazone 
derivatives which was synthesized from 
5-chloroindole-3-carboxaldehyde and various phenyl 
hydrazine derivatives. All synthesized compounds 
characterized and in vitro antioxidant activity was 
investigated against MLT and BHT. 
RESULTS:
Most of the compounds showed strong inhibitory 
effect on the superoxide radical scavenging assay at 
1 mM concentration (79 to 95%). Almost all the tested 
compounds possessed strong scavenging activity 
against the DPPH radical scavenging activity with 
IC50 values (2 to 60 μM). 
CONCLUSIONS:
These results found promising for further research on 
melatonin analogue compounds.
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INTRODUCTION:
Hypoxia is a common occurrence in solid tumors 
largely due to inadequate vascularization, which 
eventually leads to the development of tumor necrosis. 
Hypoxic conditions are well known to hinder the 
effectiveness of chemotherapy and radiation therapy. 
HIF-1 activity in tumors depends on availability of 
the HIF-1α subunit, the levels of which increase 
under hypoxic conditions and through activation of 
oncogenes and/or inactivation of tumor suppressor 
genes (1-3). In this work, the novel compounds 
bearing benzoxadiazole and chiral sulfonamide 
moieties on the same molecule were designed and 
synthesized.
MATERIALS AND METHODS:
The chemical structures of the synthesized 
compounds were confirmed by elemental analysis, 
IR, 1H NMR, 13C NMR, and mass spectral data. Their 
possible in vitro cytotoxic activities against broncho-
alveolar carcinoma cell line (A549) were evaluated 
and cell viability was assessed using MTT assay at 
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the hypoxia and normoxia conditions. Additionally, 
interaction mechanisms among these compounds 
and HIF-1α at the molecular level were identified by 










Higher concentrations (225µM) of 2a and 7a 
(p<0.05), 1a, 1b, 4b, 6a and 7b (p<0.01), 2b, 3b, 5a, 
5b and 6b (p<0.001) were significantly decreased 
in normoxia condition on A549 cell viability after 
24 hours. Similarly, for hypoxia conditions; higher 
concentrations (225µM) of 1a, 1b and 7b (p<0.001) 
were significantly decreased A549 cell viability after 
24 hours. 75 µM of compounds 3b, 4b, 6a, 6b and 7a 
(p<0.01) significantly decreased A549 cell viability as 
compared to controls.
CONCLUSIONS:
These findings demonstrated that the novel 
sulphonamide derivatives exhibited cytotoxic activity 
against A549 cell line under hypoxia and normoxia 
conditions.
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INTRODUCTION:
1,3-diphenyl-2-propen-1-ones are named as 
chalcones, α,β-unsaturated ketone compounds which 
belong to the flavonoid family. Chalcones and their 
heterocyclic derivatives have been known to possess 
many pharmacological activity such as anticancer, 
antiinflammatory, antimicrobial, antioxidant, 
antimalarial, antileishmanial, antiulcer, antiviral, 
antiprotozoal and anti-HIV (1-3). 
MATERIALS AND METHODS:
In the present work, the new chalcones with 
potential biological activity were synthesized. 
3-[(4-substituted-1-yl)phenyl]-1-aryl/heteroaryl-2-
propen-1-one derivatives (1a-d, 2a-d, 3a-d, 4a-d and 
5a-d) were synthesized starting from 4-substituted- 
benzaldehydes and aromatic/heteroaromatic methyl 
ketones by Claisen-Schmidt condensation reaction 
(4). The chemical structures of chalcone derivatives 
were eludicated by FT IR, 1H NMR, 13C NMR and 





























The antioxidant activity of 3-[(4-substituted-1-yl)
phenyl]-1-aryl/heteroaryl-2-propen-1-one derivatives 
was determined as β-carotene-linoleic acid, DPPH 
radical scavenging, superoxide anion radical 
scavenging, ABTS cation radical scavenging, and 
CUPRAC methods. In vitro inhibitory activity of 
acetylcholinesterase and butyrylcholinesterase 
enzymes related with Alzheimer’s disease was 
determined using Ellman’s method (5).
CONCLUSIONS:
Compound 1, 2 and 5 series may be used as 
pharmaceutical agents for antioxidant. 1, 2 and 5 
series were found to be active against AChE. We 
conclude that all synthesized compounds can be 
considered as a candidate for BChE inhibitor.
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INTRODUCTION:
The generation of oxygen free radicals is known to 
be involved in the development of the inflammatory 
process.  These radicals are highly reactive 
molecules with an unpaired electron and can 
damage or destroy the normal function of a living 
cell, and allow for the development of many different 
diseases, including inflammation, cancer, diabetes, 
cardiovascular, neurodegenerative and pulmonary 
diseases (1). Finding novel anti-inflammatory agents 
are important.  Indole structure seems to protect body 
against inflammation and oxidative stress. 
MATERIALS AND METHODS:
In this study, the membrane stabilizing activity of the 
compounds was evaluated by using heat induced 
human erythrocyte hemolysis. Fresh whole human 
blood was collected from healthy human volunteer. 
The tubes were centrifuged at 3000 rpm for 10 min 
and then the packed cells were washed with isotonic 
saline. All the centrifuge tubes containing reaction 
mixture were incubated at 56ºC for 30 min. Then 
the tubes were cooled and centrifuged at 2500 rpm 
for 5 min. The absorbance of the supernatant was 
measured at 560nm. The experiment was performed 
in triplicates for all the test samples The results were 
expressed as IC50(2).
RESULTS:
In this study, all the synthesized compounds were 
tested to evaluate the red blood cell membrane 
stabilizing effect as an indicator of anti-inflammatory 
activity. Compound A-11 demonstrated the strongest 
membrane stabilizing effect (IC50:0,33mM) among 
the other compound followed by A-10 and A-05 
respectively. 
CONCLUSIONS:
Our study showed that some of the newly synthesized 
compounds possess anti-inflammatory properties.
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INTRODUCTION:
1,3-Oxazolidine-2-one is an important heterocyclic 
ring participating in chemical structure of many drugs. 
In this research, new 1,3-oxazolidin-2-one derivatives 
were designed and synthesized in order to be used in 
the treatment of infections caused by gram positive 
bacteria’s which were resistant to different antibiotics 
(1-3).
MATERIALS AND METHODS:
The twenty two new amide/sulfonamide/thiourea 
derivatives were obtained by the reaction of (S)-
4-(4-aminobenzyl)-2(1H)-1,3-oxazolidinone with 
4-substituted benzoyl chlorides/4-substitutedbenzene 
sulfonyl chlorides and 4-substitutedphenyl 
isothiocyanates (4). The structures of all synthesized 
compounds were clarified by FTIR, NMR, mass 
spectroscopic data and elemental analysis. All 
compounds were screened for their antimicrobial 
activity. Antimicrobial susceptibility and cellular 
physiology were evaluated using Microbroth dilution 
assay and flow cytometry method.
RESULTS:
As a result, it was determined that compound 
16 displayed better antimicrobial activity than 
chloramphenicol aganists gram positive bacteria 
especially Staphylocuccus aures. In addition, 
genotoxicity, cytotoxicity and ADME parameters of 
compound 16 was examined and it was found as non-
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mutagenic and non-cytotoxic at the concentration it 
showed antimicrobial activity.
 CONCLUSIONS:
According to calculated ADME parameters and drug 
likeness scores, the compounds can be good drug 
candidates especially compound 16.
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INTRODUCTION:
During recent years there have been intense 
investigations on the different classes of thiourea 
compounds. N,N’-Disubstituted thioureas belong 
to biologically highly active skeletons. Various 
thiourea derivatives were extensively studied 
for their anticancer, antitubercular, antiviral, 
antifungal, antibacterial, anti-HIV, antihypertensive, 
anticonvulsants activities. In this research, 
sulfonylthiourea derivatives were synthesized with the 
aim of new pharmalogical drug development (1-3). 
MATERIALS AND METHODS:
A series of new sulfonylthiourea derivatives (4-methyl-
N-[(4-substitutedphenyl)carbamothioyl]benzene-1-
sulfonamides) were obtained by the condensation 
of 4-methylbenzene-1-sulfonamide with appropriate 
isothiocyanates in prensence of K2CO3 (4). The 
chemical structures of the synthesized compounds 
were illuminated using IR, 1H-NMR, mass 
spectroscopy and elemental analysis.
RESULTS:
The 1H-NMR spectrum of 4-methylbenzene-1-
sulfonamide showed a singlet corresponding to NH2 
protons at 7.20 ppm. The disappearance of aniline 
protons (NH2) and the appearance of thiourea NH 
at 7.60–8.94 ppm proved the formation of the target 
molecules. All other protons were detected expected 
values.
CONCLUSIONS:
The spectral data demonstrated that the compounds 
were synthesized. The sulfonylthiourea derivatives 
will be tested their antioxidant activity.
REFERENCES:
1.  Faidallah HM, Basaif SA et al., (2002) 
Phosphorus, Sulfur, and Silicon and the Related 
Elements, 177:671-683.
2.  Zaib S, Saeed A et al., (2014). European Journal 
of Medicinal Chemistry, 78:140-150.
3.  Bashir R, Yaseen S et al., (2012). Medicinal 
Chemistry Research, 21:428-436.
4.  Kocyigit-Kaymakcıoglu B, Aker RG et al., (2011). 
Medicinal Chemistry Research, 20:607-614.
P-415: SYNTHESIS, ANTIOXIDANT 
ACTIVITY AND ANTICHOLINESTERASE 
INHIBITORY ACTIVITY OF SOME NEW 
PYRAZOLE DERIVATIVES
1 Sicak, Y., 2 Kursun Aktar, BS., 3 Emre Oruc, EE.,4 
Ozturk, M., 1 Aydogmus Ozturk, F., 5 Demirtas, I., 4 
Nademm, S., 4 Ozler, MA., 3 Iyidogan Karakucuk, A.
1 Mugla Sıtkı Kocman University, Department of 
Aromatic and Medicinal Plants, Mugla Turkey
2 Cankırı Karatekin University, Department of 
Property Protection and Security, Cankırı Turkey 
3 Gaziantep University, Department of Chemistry, 
Gaziantep Turkey
 4 Muğla Sıtkı Koçman University, Department of 
Chemistry, Mugla Turkey
5 Cankırı Karatekin University, Department of 
Chemistry, Cankırı Turkey
INTRODUCTION:
Pyrazole, which is used clinically applicable,consists 
of two nitrogen atoms, two unsaturated bonds and 
5-membered ring. Pyrazole derivatives have been 
focused great attention some drugs which posess 
anti-inflammatory, analgesic and antipyretic activiy, 
are containing pyrazole ring such as celecoxib, 
rimonabant, antipyrine and ramifenazone. In 
this study, new pyrazole derivatives (1-12) were 
synthesized carrying morpholine ring. The synthesized 
compounds were screened for their antioxidant 
activity and anticholinesterase inhibitory activity.
MATERIALS AND METHODS:
New pyrazole derivatives (1-12) synthesized 
from cyclization of substitued hydrazine with 
morphonylbenzaldehyde in ethanole (1). The 
structures of the synthesized compounds were 
elucidated by spectroscopy methods as FTIR, ¹H 
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NMR, 13C NMR and elemental analysis (C, H, N, 
S). The antioxidant capacity of the compounds was 
evaluated by using four complementary tests. The 
anticholinesterase inhibitor activity test was screened 
according to the Ellman method (2).
RESULTS:
According to test results β-carotein-lineloic acid, 
DPPH radical scavenging assay, ABTS cation 
scavenging assay, and CUPRAC assay compound 
11 and 12 exihibited better activity than the other 
compounds. The anticholinesterase activity was 
performed against acetylcholinesterase (AChE) and 
butyrylcholinesterase (BChE) enzymes. Compound 
12 (IC50: 30.54 ± 0.45 mM) inhibited BChE better 
than galantamine (IC50: 56.65 ± 0.27 mM).
CONCLUSIONS:
We conclude that the compound 12 can be considered 
as a candidate for BChE inhibitor.
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INTRODUCTION:
Pyrazole and piperidine rings are very commonly 
used in the medicinal chemistry in the new 
drug design. Therefore, this study was aimed to 
synthesize new pyrazole derivatives (1-12) starting 
piperidinylbenzaldehyde. And also, the synthesized 
compounds were screened for their antioxidant 
activity and anticholinesterase inhibitory activity.
MATERIALS AND METHODS:
New pyrazole derivatives (1-12) synthesized 
from cyclization of substitued hydrazine with 
piperidinylbenzaldehyde in ethanole (1). The 
structures of synthesized compounds were elucidated 
by spectroscopy methods as FTIR, ¹H NMR, 13C NMR 
and elemental analysis (C, H, N, S). The antioxidant 
capacity of the compounds was evaluated by using 
four complementary tests. The anticholinesterase 
inhibitor activity test was screened according to the 
Ellman method (2).
RESULTS:
The results showed that compound 11 and 12 had 
the higher lipid peroxidation inhibitory activity than 
the other compounds. In DPPH radical scavenging 
assay, compounds 6 and 12 demonstrated better 
activity than reference standard BHT, while in 
ABTS cation scavenging assay compound 11 
and 12 exhibited better activity among the other 
compounds. The CUPRAC assay compound 11 
and 12 founded better activity among the other 
compounds. The anticholinesterase activity was 
performed against acetylcholinesterase (AChE) and 
butyrylcholinesterase (BChE) enzymes . Compound 
12 (IC50: 46.42 ± 0.48 mM) inhibited BChE better 
than galantamine (IC50: 56.65 ± 0.27 mM).
CONCLUSIONS:
Compound 11 and 12 may be developed as 
pharmaceutical agents for antioxidant. We conclude 
that the compound 12 can be considered as a 
candidate for BChE inhibitor.
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INTRODUCTION:
Oxidative damage caused by reactive oxygen 
species was considered relevant to diseases such as 
cancer, neurodegenerative diseases, cardiovascular 
diseases and diabetes. Antioxidants act by clearing 
or preventing ROS formation, thus protecting 
against the formation of free radicals and delaying 
the progress of many chronic diseases including 
cancer (1). 4,5-Dihydro-1H-pyrazole and hydrazone 
derivatives have been reported to possess diverse 
pharmacological activities such as antidepressant, 
antibacterial, and antioxidant (2, 3). In light of these 
findings, we synthesized some 4,5-Dihydro-1H-
pyrazole and hydrazone derivatives and evaluate 
them for their antioxidant activities.
MATERIALS AND METHODS:
The total antioxidant activity of compounds was 
measured by ABTS•+ radical cation decolorization 
assay (4) using trolox as the standard. The DPPH 
radical scavenging activities of compounds were 
examined and compared to known antioxidant BHT, 




yl)methanone) (SH44) and (N’-((E)-1-(4-fluorophenyl)-
3-p-tolylallylidene)furan-2-carbohydrazide) (SH37) 
were found to interact with the stable free radical 
DPPH•. The most active compound on DPPH• free 
radical scavenging capacity is         SH 44 with IC50 
value of 0,50 mM followed by SH37. Similar to the 
results of this assay,           SH 44 demonstrated strong 
scavenging activity (IC50: 0.06 mM) on ABTS•+ 
radical, compared to trolox. ((5-(4-methoxyphenyl)-3-
(naphthalen-2-yl)-4,5-dihydropyrazol-1-yl)(pyridin-4-
yl) methanone) (SH25) showed no effect on both free 
radicals.
CONCLUSIONS:
2-Hydroxy-4-methoxy phenyl substitution at the third 
position of pyrazoline ring increased the antioxidant 
activity. 
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INTRODUCTION:
Antioxidant defensive system in human body 
protected people from the damages of oxidative 
stress. Capacity of the defensive system is affected by 
health status of the individual, diet and age. With the 
diminishing in capacity of the defensive system, free 
radicals can cause oxidation of protein, nucleic acids 
or lipids and toxic products may form. Damages of free 
radicals produce illnesses such as diabetes, cancer, 
neural disorders (1). New antioxidants are required to 
diminish the cumulative effects of oxidative damage. 
Pyrazoline derivatives have antioxidant activity (2). In 
this study, we evaluated antioxidant activity of some 
previously reported pyrazoline derivatives. 
MATERIALS AND METHODS:
The free radical scavenging activities of these 
compounds were tested by the stable radical 2,2, 
diphenyl-1-picrylhydrazyl (DPPH•) as described 
by Blois (3). The total antioxidant activity of the 
samples was measured by [2, 2’-azino-bis(3-
ethylbenzthiazoline-6-sulphonic acid)] (ABTS•+) 
radical cation decolorization assay according to the 
method of Re et al (4).
RESULTS:
We reported the synthesized pyrazoline derivatives 
before, for their hMAO inhibitory activities. In this 
study, all the synthesized compounds were tested 
for evaluate the antioxidant activity by using in vitro 
ABTS•+ and DPPH• free radical scavenging activity 
assays. Except ((3-(5-bromo-2-hydroxyphenyl)-5-
(4-methoxyphenyl)-4,5-dihydropyrazol-1-yl)(phenyl)
methanone (BEA28), all compounds were found to 
interact with the stable free radical ABTS•+. However, 
(3-(5-chloro-2-hydroxyphenyl)-5-(3-methoxyphenyl)-
4,5-dihydropyrazol-1-yl)(pyridin-4-yl)methanone (BEA 
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46) and (3-(2-hydroxy-4-methoxyphenyl)-5-p-tolyl-
4,5-dihydropyrazol-1-yl)(pyridin-4-yl)methanone (BEA 
61) were found to interact with the stable free radical 
DPPH• which indicates their radical scavenging 
activity in an iron-free system where as the others 
show no effect on it.
CONCLUSIONS:
Compound BEA 46 and BEA 61 were found potent 
antioxidant compounds for ABTS•+ (IC 50: 0.07 mM 
and 0.08 mM respectively), and their antioxidant 
activities are comparable with the known standard, 
trolox (IC 50: 0.05 mM).
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INTRODUCTION:
In particular, selective neuronal loss in the brain regions 
triggers various neurodegenerative diseases such as 
Alzheimer’s disease (AD) and Parkinson’s disease 
(PD). Because of the complex and multifactorial 
nature of neurodegenerative diseases, it is unlikely 
that a monotherapy will provide a comprehensive and 
satisfactory therapeutic solution. Such a therapy is 
more likely to be obtained by the use of multitarget-
oriented ligands, which allow multiple pharmacological 
properties to be incorporated into a single molecular 
structure and work synergistically. The strategy of 
multitarget-directed ligands targeting monoamine 
oxidases (MAO-A and MAO-B) and cholinesterases 
(ChE) represents one of the promising approaches 
due to their neuroprotective, neurorestorative and 
cognitive enhancing abilities in addition to their 
effects on monoaminergic neurotransmission (1-3). In 
this study, we described the synthesis of some new 
benzothiazole-thiadiazole derivatives as potential 
anticholinesterase and monoamine oxidase inhibitory 
compounds.
MATERIALS AND METHODS:
The structure confirmation of the synthesized 
compounds was performed using FT-IR, 
1H-NMR, 13C-NMR, and HRMS spectral data. Th 
anticholinesterase activity assay of the synthesized 
compounds was performed using Ellman’s 
spectroscopic method (4). Their inhibitory activity 
of the compounds against hMAO-A and hMAO-B 
enzymes was evaluated by using in vitro Amplex 
Red® reagent based fluorometric method (5). In 
vitro cytotoxic effects of the final compounds were 
determined by MTT assay. 
RESULTS:
It was observed that the synthesized compounds 
have promising inhibitory potential against ChE and 
MAO enzymes. Docking studies of the most active 
compound 5 revealed that this compound has a 
notable binding capacity to enzyme active sites.
CONCLUSIONS:
Consequently, synthesized benzothiazole-thiadiazole 
derivatives have been shown to possess an inhibitory 
potency of ChE and MAO enzymes.
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INTRODUCTION:
Parkinson’s disease (PD) is a common, long-
term neurodegenerative disorder characterized by 
the degeneration of dopaminergic neurons in the 
substantia nigra pars compacta. Recent studies have 
reported that oxidative stress plays an important 
role in the underlying pathology of PD (1). The main 
aspect of oxidative stress in PD has been investigated 
with toxin-based models such as 6-hydroxydopamine 
(6-OHDA) which is based on its ability to generate 
reactive oxygen species in neurons (2).
MATERIALS AND METHODS:
Owing to the prominence of pyrazolines in the treatment 
of neurodegenerative disorders (3), herein a series of 
pyrazoline derivatives (1-9) was synthesized via the 
treatment of 3-(4-methylphenyl)-1-(furan-2-yl)prop-
2-en-1-one (A) with phenylhydrazine hydrochloride 
derivatives in acetic acid. The neuroprotective effects 
of these compounds were detected using in vitro 
6-OHDA induced neurotoxicity model of PD in PC-12 
Adh cell line. 
RESULTS:
Treatment with the compounds at 100 μg/mL did 
not reduce cell viability significantly according to 
IC50 values and demonstrated their protective 
effects against cell death in differentiated PC-
12 Adh cells treated with 6-OHDA (150 μM) 
for 24 hours. The reduction in cell viability with 
6-OHDA (150 μM) was found 42.91%, whereas 
the percentages were determined as 28.88, 35.22, 
37.24, 30.43, 31.34, 28.97, 19.71, 29.82, and 
35.83%, respectively following the treatment with 
100 µg/mL of compounds 1-9. According to these 
results, all compounds might have neuroprotective 
potential against 6-OHDA induced neurotoxicity in 
PC-12 Adh cells. In particular, the induction in cell 
viability% with 1-(4-methylsulfonylphenyl)-3-(2-furyl)-
5-(4-methylphenyl)-2-pyrazoline (7) was found to be 
significant when compared to the 6-OHDA positive 
control group according to the statistical analysis 
(**P< 0.01).  
CONCLUSIONS:
Compound 7 stands out as a potential neuroprotective 
agent for further studies in the treatment of PD.
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INTRODUCTION:
Monoamine oxidase enzymes (MAOs) are 
flavoenzymes bound to the outer mitochondrial 
membrane and responsible for the oxidative 
deamination of neurotransmitters and dietary amines 
thereby play a vital role in the control of intracellular 
concentration of them. Since MAO enzymes effect on 
the metabolism of neurotransmitters, MAO inhibitors 
have therapeutic interest in search of agents used 
in the therapy of Alzheimer’s, Parkinson’s diseases 
and mental disorders (1,2). There are some studies 
that confirm 1,3,4-thiadiazole ring and benzylamine 
moiety possess monoamine oxidase inhibitory 
potential (3,4).  In this study, new 1,3,4-thiadiazole 
derivates having benzylamine functional moiety were 
synthesized and their MAO-A and MAO-B inhibitory 
activities were investigated.
MATERIALS AND METHODS:
The synthesized compounds were tested for their 
human monoamine oxidase A and B (hMAO-A 
and hMAO-B) inhibitory potential by an in vitro 
fluorometric method (5). The chemical structures of 
the compounds were confirmed by IR, 1H NMR, 13C 
NMR and MS spectral data.
RESULTS:
Some of the compounds displayed inhibitory activity 
towards MAO enzymes.
CONCLUSIONS:
In this paper, we detected that the combination of 
1,3,4-thiadiazole ring and benzylamine moiety have a 
contribution on the MAO inhibitory activity.
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INTRODUCTION:
Benzimidazole nucleus is very important in 
several categories of therapeutic molecules such 
as antimicrobial (2,3), proton pump inhibitor (4), 
antihypertensive (5), anticoagulant, anti-inflammatory, 
antioxidants (1) have made it an important part in the 
development of novel therapeutic agents. 
MATERIALS AND METHODS:
In this research, benzimidazole nucleus has been 
used to find novel drugs targeting the human uPA 
and uPAR systems with potential antineoplastic and 
antimetastatic activities. Moreover, the cytotoxicity 
and in vitro anticancer evaluation of the prepared 
compounds against hepatocellular carcinoma cell 
and colorectal carcinoma cell lines and the effect of 
the compounds on the expression of uPA have been 
assessed.  
RESULTS:
5-FU is a reference agent and significantly reduced 
uPA and uPAR levels in both colorectal and 
hepatocellular carcinoma cells (p<0.05). Compound 2 
reduced uPA and uPAR levels in both carcinoma cells 
(p<0.05), too.
CONCLUSIONS:
uPA levels obtained from 2 administration better 
than 5-FU for both colorectal and hepatocellular 
carcinoma cells (p<0.05). uPAR levels obtaining from 
2 administration were similar to 5-FU for both cell 
lines (p<0.05).
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INTRODUCTION:
Benzamidine group is an attractive target for 
complexation studies. It has a very important place 
in the drug class (1). In this study, we prepared 
4-(5-chloro-6-fluoro-1H-benzo[d]imidazol-2-yl)-N-
isopropyl benzamidine.HCl. Biological activity studies 
of it were displayed.
MATERIALS AND METHODS:
Herein, synthesis, antimicrobial and antioxidant 
activity evaluation of 4-(5-chloro-6-fluoro-1H-benzo[d]
imidazol-2-yl)-N-isopropyl benzamidine.HCl (7) were 
reported. Condensation of the 3-chloro-4-fluoro-
o-phenylenediamine with the Na2S2O5 adduct of 
4-cyanobenzaldehyde gave compound 5. The nitrile 
group of compound 5 was converted to iminester 6. 
The final compound 7 was obtained via reaction of 
iminester with isopropanol.
RESULTS:
The assigned structure was substantiated by IR, 1H 
NMR, and MS analysis data. All data were seen as 
expected. Antioxidant properties of compound 7 was 
evaluated by determination of microsomal NADPH-
dependent inhibition of lipid peroxidation levels (LP 
assay) and microsomal ethoxyresorufin O-deethylase 
activity (EROD assay) was investigated. At the same 
time, the antimicrobial activity of compound 7 was 
evaluated.
CONCLUSIONS:
Compound 7 showed activity as 25 µg/ml against 
Staphylococcus aureus and it has 82 % EROD 
activity. Compound 7 has a similar EROD activity as 
caffeine.
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INTRODUCTION:
Microbial infectious diseases continue to be the one 
of the leading causes of morbidity and mortality. 
Antibiotics and antimicrobial agents are still the most 
potent weapons to fight against bacterial infections, 
but the evolution of resistance has increasingly 
been becoming problem. Benzoxazoles constitute 
an important class of heterocyclic compounds with 
antimicrobial activity (1-3). 
MATERIALS AND METHODS:
The benzoxazoles [2 – 8] were evaluated for their 
antimicrobial activity with microdilution technique 
described by CLSI (4-5), against some Gram-positive/
negative bacteria and fungus Candida albicans 
and their drug-resistant isolates in comparison with 
standard drugs.
Results and Discussion: The minimum inhibitory 
concentrations (MIC) of the new some benzoxazoles, 
were determined against standard bacterial and 
fungal strains and drug-resistant isolates and 
compared to those of several reference drugs and all 
the observed in vitro antimicrobial activity results of 
the tested compounds are given Table 1.
CONCLUSIONS:
In this study, we aimed to develop new effective 
antimicrobial agents possessing benzoxazole nuclei 
in their structure. So, we put a para-substituted-phenyl 
sulfonylamido moiety on fifth position and a lipophilic 
group that is a para-tert-butylphenyl moiety on second 
position of benzoxazole ring. Microbiological results 
showed that new benzoxazole derivatives possess 
an antimicrobial activity having MIC values of 64-128 
µg/ml against the tested microorganisms except for 
C. albicans and the standard drugs were more active 
against the tested pathogens.
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INTRODUCTION:
Cancer is one of the most widespread and feared 
diseases in the world today, because it is known to be 
difficult to cure (1). The aberrant activity of EGFR has 
been involved in the pathogenesis and progression 
of different types of tumors (2, 3). Accordingly, it 
has been regarded as an attractive target for cancer 
therapy and many anti-EGFR inhibitors including small 
molecule Tyrosine Kinase Inhibitors (TKIs) have been 
developed and investigated (3). 4-Anilinoquinazoline-
based derivatives represent an attractive scaffold for 
small molecular EGFR-TKIs in the field of medicinal 
chemistry (4).
MATERIALS AND METHODS:
In the present study, new series of quinazolines 
have been synthesized and will be screened in vitro 
for antitumor activity. First, Methyl 2-amino-4,5-
dimethoxybenzoate was reacted with formamide to 
give 6,7-dimethoxyquinazolin-4-ol. Treatment of the 
quinazolinol with thionyl chloride formed 4-chloro-
6,7-dimethoxyquinazoline. Chloride atom was then 
reacted with various amines to afford the desired 
quinazolines.
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RESULTS:
Compounds 2, 3, 5, 7 (Figure) were prepared for the 
first time. The 1H-NMR, 13C-NMR and mass spectra 
results of all compounds agree with those of the 
proposed structures. 
CONCLUSIONS:
In the present investigation, we aimed to develop 
new effective anticancer agents possessing 
quinazoline analogues. Consequently, a series 
of new N-(substituted phenyl)-4-amino-6,7-
dimethoxyquinazolines and N-(substituted pyridine-
3-yl)-4-amino-6,7-dimethoxyquinazoline were 
synthesized and the structures of the new derivatives 
were elucidated by spectral techniques.
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INTRODUCTION:
Over the last decade, there has been substantial 
growth in the field of melatonin (MLT) and use of MLT-
like compounds in the treatment of several diseases. 
MLT is is a hormone that is produced by the pineal 
gland in animals. It is also detected in non-vertebrates 
like bacteria and fungus as well as endogenously 
produced in edible plants. MLT can scavenge different 
reactive oxygen species and can also stimulate the 
synthesis of antioxidant enzymes. 
MATERIALS AND METHODS:
Our ongoing study relies on changing the groups 
in the different modifiable sites of the indole ring to 
increase the antioxidant activity. In this study a new 
approach for substitution of indole ring as indole-
based MLT analogue was proposed. We report the 
synthesis and characterization of a series of new 
indole-7-aldehyde hydrazide/hydrazone derivatives 
as indole-based MLT analogues. Anticancer potential 
of the compounds were evaluated both by their 
antioxidant and CYP1 inhibitory activities. Antioxidant 
capacity of the compounds was investigated in a 
cell-based (DCFH assay) and a cell-free (DPPH 
assay) in vitro assays. Potential inhibitory effects 
of the compounds on CYP1 catalytic activity were 
investigated via EROD assay. Cytotoxic activity of the 
compounds was further evaluated by the MTT assay 
in CHO-K1 cells.
RESULTS:
MLT analogues having an o-halogenated aromatic 
moiety exhibited effective antioxidant properties 
without having any cytotoxic effect. 
CONCLUSIONS:
MLT derivatives represent promising scaffolds for 
discovery of effective antioxidant agents. 
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INTRODUCTION:
Antioxidants could be helpful for prevention of several 
diseases related with oxidative stress including 
neurodegenerative disorders. Carbazoles have been 
reported to exhibit diverse biological activities such as 
antimicrobial, antitumor, antiepileptic, antihistaminic, 
antioxidative, anti-inflammatory, antidiarrhoeal, 
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analgesic, neuroprotective and pancreatic lipase 
inhibition properties. Recently, it has been shown to 
exhibit promising antioxidant activities. 
MATERIALS AND METHODS:
A series of 9-ethyl-9H-carbazole hydrazone 
derivatives were synthesized, purified and chemical 
structures are characterized using NMR (1H,13C), 
Mass Spectrometer and Elemental Analysis. Their in 
vitro antioxidant activity and possible cytotoxic effects 
were investigated.
 RESULTS:
Newly synthesized carbazoles were found to have 
radical scavenging activity with a varying potency 
both in cell-free and cell-based in vitro assays. 
Several compounds were found to have cytotoxic 
activity, however this cytotoxic activity was not more 
than melatonin. Several compounds also significantly 
protected neuronal PC12 cells against amyloid 
β-induced damage, which reflects their capacity as 
neuroprotective agents. 
CONCLUSIONS:
These findings might provide an alternative strategy 
for development of novel carbazole derivatives for 
management of neurodegenerative diseases such as 
Alzheimer’s disease. This work was supported by the 
Scientific and Technological 
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INTRODUCTION:
Due to the importance of indole ring and 
thiosemicarbazide moiety in medicinal chemistry 
area (1-4), novel indol based thiosemicarbazide 
compounds were synthesized by using indomethacin 
as a starting material.
MATERIALS AND METHODS:
Indomethacin,  [1-(4-chlorobenzoyl)-5-methoxy-2-
methyl-1H-indol-3-yl]acetic acid, converted their 
ester (1) which is followed by reacted with hydrazine 
hydrate to form hydrazide derivative (2). Reaction 
of compound 2 and several isothiocyanates yielded 
N-alkyl/aryl thiosemicarbazides (3).
RESULTS:
The aim of this study is to synthesize novel indol 
based thiosemicarbazide derivatives and confirm 
their structures by FT-IR, 1H-NMR and elemental 
analysis data.
Conclusion: Indol based thiosemicarbazide derivatives 
were synthesized and their structures were confirmed 















Figure: Indol based thiosemicarbazide compounds [3]
REFERENCES:
1.  Yılmaz O, Turan SO, Akbuğa J, Tiber PM, Orun 
O, Supuran CT, Kucukguzel SG (2015).  Journal 
of Enzyme Inhibition and Medicinal Chemistry, 
30(6): 967-980.
2.  Çıkla P, Arora P, Basu A, Talele TT, Kaushik-
Basu N, Kucukguzel SG (2013). Marmara 
Pharmaceutical Journal, 17, 138-146.
3.  Kucukguzel SG, Coskun GP (2016). Anti-Cancer 
Agents in Medicinal Chemistry, 16(10): 1288-
1300. 
4.  Dadas Y, Coskun GP, Bingol ÖA, Özsavci 
D, Kucukguzel SG (2015). Marmara 
Pharmaceutical Journal, 19: 259-267.
12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 369
P-429: SYNTHESIS OF NEW 
THIAZOLYLHYDRAZINE DERIVATIVES AS 
MONOAMINOXIDASE INHIBITORS 
1,2 Osmaniye, D., 1,2 Levent, S., 1,2 Ozkay, Y., 1 
Kaplancikli, ZA., 1,2 Saglik, BN., 1 Cavusoglu Kaya, 
B., 3 Inci, B., 1,2 Acar Cevik, U.
1Anadolu University, Faculty of Pharmacy Eskişehir, 
Department of Pharmaceutical Chemistry Eskişehir, 
Turkey
2Anadolu University, Faculty of Pharmacy, Doping 
and Narcotic Compounds Analysis Laboratory, 
Eskişehir, Turkey
3Anadolu University, Faculty of Pharmacy, 
Department of Pharmaceutical Toxicology, Eskişehir, 
Turkey
INTRODUCTION:
MAO (Monoamine oxidase) a flavoprotein located 
at the outer membrane of mitochondriain neuronal, 
glial, and other cells are extensive enzymes that 
play a key role in the degradation of exogenous and 
endogenous amines. MAO including two isoforms, 
namely MAO-A and MAO-B can be separated by their 
individual substrate preferences. MAO-A oxidizes 
norepinephrine and serotonin [5-hydroxytryptamine, 
5-HT], while MAO-B preferentially deaminates 
2-phenylethylamine (2-PEA) and benzylamine. 
Actually, hMAO-B is responsible for >80% of the 
MAO activity in the brain, where it metabolizes 
dopamine and other amines in serotonergic and 
histaminergic neurons and astrocytes. In addition 
hMAO-B activity is considerably higher in the brains 
of patients with Alzheimer’s and Parkinson’s disease 
(PD) (1-3) During the last five decades, there are a 
number of studies in the literature corresponding with 
thiazolylhydrazine derivatives display hMAO inhibitory 
activity in the range of micromolar concentration (3,4). 
Prompted from above information, in this study we 
designed and synthesized new thiazolylhydrazine 
derivatives as potential MAO inhibitors.
MATERIALS AND METHODS:
The structures of the synthesized compounds were 
elucidated using FT-IR, 1H-NMR, 13C-NMR, and 
HRMS spectral data. The inhibitory activity of the 
obtained compounds against hMAO-A and hMAO-B 
enzymes was evaluated by using in vitro Amlex Red® 
reagent based fluorometric method (5).
RESULTS:
It was observed that the synthesized compounds 
displayed inhibitory activity against both MAO 
isoforms to different extends.
CONCLUSIONS:
Consequently, synthesized thiazolylhydrazine 
derivatives have been shown to possess an inhibitory 
potency of MAO enzymes.
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INTRODUCTION:
Indole and its derivatives display an extensive range of 
biological activities such as anticancer (1), analgesic 
and anti-inflammatory (2) and carbonic anhydrase 
inhibition activities (3). In view of the literature data 
reported above we synthesized a series of new indole 
derivatives.
MATERIALS AND METHODS:
Melting points were determined on a Büchi B-540 
melting point apparatus in open capillary tubes and 
are uncorrected. Elemental analyses were done on a 
Thermo Finnigan Flash EA 1112 elemental analyzer. 
IR spectra were recorded on KBr discs, using a 
Shimadzu IR Affinity-1 FT-IR spectrophotometer. 
1H-NMR spectra were measured on a Varian UNITY 
INOVA (500 MHz) spectrometer using DMSO-d6.
RESULTS:
Hydrazide and suitable aryl aldehyde were heated in 
ethanol to yield N’-(substituted benzylidene)-2-(1H-
indole-3-yl)acetohydrazide derivatives (Scheme 1). 
Structures of title compounds were confirmed based 








Scheme 1. Synthesized compounds
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CONCLUSIONS:
A series of new hydrazide-hydrazones bearing indole 
moieties were synthesized. The new compounds 
were characterized by spectral data (IR, 1H-NMR) 
and elemental analyses. Structures proposed have 
been confirmed by spectral data. 
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INTRODUCTION:
Alzheimer’s disease (AD) is the most common 
form of dementia, affecting 4-8% of the elderly 
population across the globe (1). Despite extensive 
efforts devoted to the discovery of potent anti-AD 
drugs, three cholinesterase inhibitors (donepezil, 
galantamine, rivastigmine) and memantine (N-methyl-
D-aspartate receptor antagonist) are the only drugs 
currently used for the management of AD (1,2). These 
agents only provide symptomatic relief but do not halt 
the progression of the disease (2). Due to the urgent 
need to develop new anti-AD drugs (1,2), herein we 
aimed to evaluate the inhibitory effects of a series of 





8) were evaluated for their inhibitory effects on 
AChE and BuChE using a modification of Ellman’s 
spectrophotometric method. Molecular docking 
studies were also carried out for the most effective 
compounds in the active site of AChE (3). The X-ray 
crystallographic structure of AChE complex with 
donepezil was retrieved from the Protein Data Bank 
server (PDB code: 4EY7).
RESULTS:
N,N-diethyl-2-[(5-((4-nitrophenyl)amino)-1,3,4-
thiadiazol-2-yl)thio]acetamide (1) and N-(1,3-
benzodioxol-5-ylmethyl)-2-[(5-((4-nitrophenyl)amino)-
1,3,4-thiadiazol-2-yl)thio] cetamide (5) were identified 
as the most potent AChE inhibitors in this series with 
IC50 values of 9.87±0.32 µg/mL and 11.73±0.31 
µg/mL, respectively.  Compounds 1 and 5 showed 
good affinity to the active site of AChE forming 
π-π interactions with Trp286 residue due to their 
4-nitrophenyl moieties. The benzodioxole ring system 
of compound 5 also presented π-π interactions 
with Trp86 residue. On the other hand, the tested 
compounds did not show any significant BuChE 
inhibitory activity. 
CONCLUSIONS:
According to the in vitro and in silico studies, 
compounds 1 and 5 stand out as promising candidates 
for further studies. 
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Ankara University, Faculty of Pharmacy, Department 
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INTRODUCTION:
Histone deacetylases (HDAC) can affect many vital 
regulatory processes, including gene expression, 
mRNA stability, protein interactions, protein stability, 
and enzymatic activity via the removal of acetyl groups 
attached to lysine residues in histone and non-histone 
proteins. HDAC6 which is the one of the non-histone 
deacetylase has become a target for treatment 
of serious diseases like cancer, Alzheimer and 
autoimmune disorders 1,2). HDAC6 is responsible 
for deacetylation of non-histone cytoplasmic proteins 
such as microtubule (α/β tubulin), Hsp90 (heat shock 
protein 90), cortactin and chaperon. Inhibition of 
HDAC6 results in the loss of microtubule stability and 
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function and causes increased protein aggregation 
(3). Using these disadvantages as an advantage in 
favor of cancer treatment, histone deacetylase 6 
inhibitors (HDAC6i) are valuable pharmacological 
targets.
MATERIALS AND METHODS:
A mixture of 5-methoxyflavonesulfonylpiperazine, 
appropriate acyl chloride/bromide compounds, 
Na2CO3 and 10 ml dimethylformamide were stirred at 
room temperature for 48 h. 
RESULTS:
In this study, in the light of anticancer properties 
of HDAC6i, flavon sulfonamide compounds have 
been synthesized. The structural evaluation of the 
synthesized compounds was based on the 1H NMR, 
Mass and elementary analysis data. Their cytotoxic 
activity are under investigation. We are expecting that 
synthesized compounds can bind the enzymes active 
site and make the inhibition of HDAC6.
CONCLUSIONS:
Their docking studies are shown that they have 
enough interactions for the HDAC6 enzyme inhibition. 
Synthesized new flavone compounds are under 
investigation within the scope of anticancer properties 
and HDAC6 inhibitory activities.
ACKNOWLEDGEMENTS:
This work was supported by Research Organization 
of Ankara University, Turkey (No:17L0237003).
REFERENCES:
1.  Li Y, Shin D, Kwon SH. FEBS J. 2013;280:775.
2.  Lin X, Chen W, Qiu Z, Guo L, Zhu W, Li W, Wang 
Z, Zhang W, Zhang Z, Rong Y, Zhang M, Yu 
L, Zhong S, Zhao R, Wu X, Wong JC, Tang G. 
Journal of Medicinal Chemistry.2015;58:2809-20.
3.  Namdar M, Perez G, Ngo L, Marks PA, PNAS. 
2010;107:20003-20008.
P-433: SYNTHESIS AND ANTIMICROBIAL 
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HYDRAZONES
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INTRODUCTION:
Sulfonyl hydrazone scaffold has important role 
in medicinal chemistry and exhibited different 
biological activities such as antioxidant, anticancer, 
anticonvulsant, antidepressant, antimicrobial, 
anticholinesterase,analgesic and anti-inflammatory 
activities (1,2). 
MATERIALS AND METHODS:
4-fluorobenzenesulfonyl hydrazones were obtained 
by the reaction of 4-fluorobenzenesulfonyl hydrazide 
with some substituted aldehydes in methanol. 
Physical and chemical properties of compounds have 
been characterized and comfirmed by IR, 1H-NMR, 
13C-NMR, mass spectroscopy and elemental 
analysis. For the bacterial culture; first, Nutrient Broth 
liquid culture was prepared to replicate the bacteria 
(Staphylococcus aureus, Enterococcus-faecalis, 
E-coli, Klebsiella-pneumoniae). These bacterias 
were added to the liquid media and kept at 37 oC 
for a day in a shaking incubator. After 24 hours, drug 
concentrations were tested at different concentrations 
on bacterial cultures. The MIC (minimum inhibition 
concentration) value was obtained after the culture 
study. MBC (minimum bactericidal concentration) 
value was found by using MIC value (3,4).
RESULTS:
All compounds have been performed for antimicrobial 
performance against several bacterias such as 
Staphylococcus aureus, Enterococcus-faecalis, 
E-coli, Klebsiella-pneumoniae) bacteria. Minimum 
inhibitor and bactericidal concentration (MIC and 
MBC) values were examined in these experiments. 
It was observed that the 4-fluorobenzenesulfonyl 
hydrazones has potential antimicrobial effect in 
accordance with the outcome results. 
CONCLUSIONS:
As a conclusion, the antimicrobial activity of sulfonyl 
hydrazones was reported. The prepared sulfonyl 
hydrazones compounds indicated very good 
antimicrobial performance for mentioned bacterial 
cultures. 
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P-434: SYNTHESIS AND 
CHARACTERIZATION OF NOVEL AMIDE 
DERIVATIVES BEARING MORPHOLINE RING
Oruc Emre, EE., Ece, S., Karakucuk Iyidogan, A.
Gaziantep University, Faculty of Arts and Sciences, 
Department of Chemistry, Gaziantep, Turkey.
INTRODUCTION:
Amide derivatives have been demonstrated to 
posses anticonvulsant, antimicrobial, analgesic, 
antiinflammatory and anticancer activities. In this 
research, a series of amide derivatives bearing 
morpholine ring were synthesized (1,2).
MATERIALS AND METHODS:
2-Chloro-N-[4-(morpholin-4-yl)phenyl]acetamide 
was obtained by the reaction of 4-morpholinoaniline 
with chloroacetyl chloride in dioxane. The acetamide 
derivative was reacted with various amines to 
obtain N-[4-(morpholin-4-yl)phenyl]-2-substituted 
acetamides (3). The structures of these amide 
derivatives were confirmed by IR, 1H NMR, 13C NMR 
and mass spectral data besides elemental analysis. 
RESULTS:
In the ¹H NMR spectra, the amide -NH- signals 
appeared as a singlet at 9.53-10.07 ppm. The CH2 
resonances of amide compounds were observed at 
3.08-4.20 ppm. All the aromatic protons were observed 
at the expected region in their NMR spectrum. 
CONCLUSIONS:
All spectral data were consistent with the proposed 
structures. The new amide  compounds will be tested 
for their antioxidant and anticholinesterase activities.
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EF., 3 Karadag, AE.
1 Anadolu University, Faculty of Pharmacy, 
Department of Pharmaceutical Chemistry, Eskişehir, 
Turkey 
2 Istanbul Medipol University, Faculty of Pharmacy, 
Department of Pharmaceutical Chemistry, Istanbul, 
Turkey
 3 Istanbul Medipol University, Faculty of Pharmacy, 
Department of Pharmacognosy, Istanbul, Turkey
INTRODUCTION:
Pyrazoline has been recognized as a structural 
core for building a huge variety of biologically active 
agents. The therapeutic applications of pyrazolines 
extend from central nervous system applications to 
antimicrobials (1). In particular, the significance of 
pyrazolines as antimicrobial agents prompted us to 
design and synthesize pyrazoline-based antibacterial 
agents.
MATERIALS AND METHODS:
New thiazolyl-pyrazoline derivatives (Fig. 1) were 
synthesized and evaluated for their antibacterial 
effects on S. aureus, E. coli, E. faecalis, B. subtilis, 
S. typhi and P. aeruginosa using a broth microdilution 
assay. Amoxicillin, tetracycline, clarithromycin were 
used as standard drugs. 
RESULTS:
The synthesized compounds were found to be 
effective on B. subtilis and E. faecalis. According to 
MIC values, compounds 2, 4, 6 and 8 were more 
effective on B. subtilis than all standard drugs. In 
particular, methylsulfonyl-substituted compound 8 
was identified as the most potent antibacterial agent 
with a MIC value of 3.9 µg/µL in this series. 
CONCLUSIONS:
Further studies are needed to clarify the mechanism 
of action for the antibacterial activity of compound 8.
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Figure 1. The structures of compounds 1-8
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P-436: NEW THIAZOLYL-PYRAZOLINE 
DERIVATIVES AS ANTIBACTERIAL AGENTS.
1 Ozdemir, A., 1 Altintop, MD., 1 Sever, B., 2 Bulbul, 
EF., 3 Karadag, AE.
1 Anadolu University, Faculty of Pharmacy, 
Department of Pharmaceutical Chemistry, Eskişehir, 
Turkey 
2 Istanbul Medipol University, Faculty of Pharmacy, 
Department of Pharmaceutical Chemistry, Istanbul, 
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 3 Istanbul Medipol University, Faculty of Pharmacy, 
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INTRODUCTION:
Thiazoles and pyrazolines have attracted a 
great deal of interest due to their pivotal role in 
medicinal chemistry as therapeutic agents ranging 
from antibacterial agents to diuretics (1,2). As a 
result, herein we aimed to design and synthesize 
antibacterial agents based on molecular hybridization 
of thiazole and pyrazoline scaffolds.
MATERIALS AND METHODS:
New thiazolyl-pyrazoline derivatives (1-8) (Fig. 1) 
were synthesized and evaluated for their antibacterial 
effects on S. aureus, E. coli, E. faecalis, B. subtilis, 
S. typhi and P. aeruginosa using a broth microdilution 
assay. Amoxicillin, tetracycline, clarithromycin were 
used as standard drugs. 
RESULTS:
It was observed that the synthesized compounds 
were effective on E. faecalis. Compounds 2, 5, 6 and 
8 were identified as the most effective compounds 
in this series on E. faecalis with a MIC value of 15.6 
µg/mL. Compound 6 (MIC= 31.2 µg/mL) was also 
found to be more effective on S. aureus than other 
compounds. Additionally, compound 2 was the most 
effective compound in this series on E. coli with a MIC 
value of 31.2 µg/mL. 
CONCLUSIONS:
In the view of this work, further studies are needed to 
clarify the mechanism of action for the antibacterial 
activities of compounds 2, 5, 6 and 8.
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P-437: SYNTHESIS OF SOME NEW 
BENZOXAZOLES AS HTOPO IIΑ INHIBITORS
1 Karatas, E., 2 Foto, E., 3 Zilifdar, F., 1 Yildiz I.
1Ankara University, Faculty of Pharmacy, Department 
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2Necmettin Erbakan University, Faculty of Science, 
Department of Biotechnology, Konya, Turkey.
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INTRODUCTION:
DNA topoisomerases are nuclear enzymes that 
make transient strand breaks in DNA to allow a cell 
to manipulate its topology (1,2). DNA topoisomerases 
have been classi- fied into two types. Type I DNA 
topoisomerase breaks and rejoins only one of the 
two strands during catalysis, while type II DNA 
topoisomerase acts on both strands for each DNA 
strand-passing reaction and it requires ATP for 
full activity (3). Investigation of inhibitory activities 
of eukaryotic topoisomerases is widely used in 
anticancer drug development. The aim of this study 
is that exploring a new benzoxazole derivatives as 
anticancer compounds targeting hTopo IIα.  
MATERIALS AND METHODS:
The derivatives were synthesized by heating 
2-amino-4-nitrophenol  with  suitable acid in 24 g 
polyphosphoric acid (PPA) and stirring for 2-3 hours at 
120 -130°C. Human DNA Topoisomerase IIα inhibition 
activity of benzoxazoles was performed by using DNA 
relaxation assay in a cell free system. 
RESULTS:
In this study, we have synthesized some 
2-substitutedphenyl-5-nitrobenzoxazole derivatives 
and investigated their hTopo IIα enzyme inhibition 
effects. All tested compounds showed moderate 
inhibition activity for h Topo IIα enzyme. Moreover, 
their activity were compared to clinically used  Topo II 
inhibitor drug, etoposide.  
CONCLUSIONS:
Some 5-nitrobenzoxazoles as possible hTopo IIα 
enzyme inhibitors were synthesized in order to 
develope new antitumor compounds.  According 
to this work, it can be considered that the para 
position of the phenyl moiety in the second position 
of the benzoxazole is very important for advanced 
anticancer investigations.  
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INTRODUCTION:
Urea and carbohydrazide are important functional 
groups exhibiting a variety of biological activities. 
PARP-1 enzyme, repairs DNA damage, is a new 
target for cancer therapy.  In this study, a series of 
new urea and carbohydrazide derivatives containing 
an pyridine ring were designed and synthesized (1, 
2).
MATERIALS AND METHODS:
In the first step, nicotinate derivatives bearing amine 
group were solved in acetone and urea compounds 
were synthesized with substituted isocyanates. In the 
second step, ester functional group was converted 
to the hydrazide group in ethanol with reflux. In the 
last step, carbohydrazide structures were obtained by 
reacting these hydrazide compounds with substituted 
benzoyl chloride in dichloromethane.
RESULTS:
The synthesized compounds were elucidated by 
FT-IR, 1H-NMR, 13C-NMR, HSQC, MS and their 
purity were checked with TLC, HPLC and elemental 
analysis. PARP enzyme inhibition of synthesized 
compounds was determined by fluorometric method. 
Some compounds showed significant PARP inhibition.
CONCLUSIONS:
According to activity results, compounds bearing 
thiomethyl substituent were demonstrated remarkable 
PARP inhibition among the tested compounds. 
Electron donating and hydrophobic groups increased 
the potency of activity.
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INTRODUCTION:
Alzheimer’s Disease (AD) is described as a 
degenerative disease of the central nervous system 
(CNS) and described especially by premature 
senile mental degradation (1). Acetylcholinesterase 
(AChE) is the main enzyme responsible for the 
hydrolysis of the ACh at the cholinergic synapses, 
while butyrylcholinesterase (BuChE) acts as a co-
regulator of the activity of AChE. Therapeutic agents 
that function as inhibitors of both enzymes can 
ensure additional benefits in AD. Present therapies 
for AD mainly focus on the use of FDA accepted 
acetylcholinesterase inhibitors (AChEIs), i.e. 
donepezil, rivastigmine, galantamine, tacrine. These 
medications are counted as solely symptomatic. Thus, 
there is a need to find more efficient agents to stop 
the disease progression (2). The pyrazolinone ring 
system is significant in medicinal chemistry research 
because of high affinity against a variety of enzymes 
and protein receptors. In this study, we synthesized 
new compounds bearing pyrazolinone moiety and 
investigated their ChE inhibitory activity to gain new 
biologically active compounds.
MATERIALS AND METHODS:
The structure confirmation of the synthesized 
compounds was performed using FT-IR, 1H-NMR, 
13C-NMR, and HRMS spectral data. The 
anticholinesterase activity assay of the synthesized 
compounds was performed using Ellman’s 
spectroscopic method (3). To evaluate the binding 
modes of the most active compound, docking studies 
were performed by using Schrödinger Maestro 
interface (4).
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RESULTS:
According to the enzyme activity studies, none of the 
synthesized compounds displayed significant activity 
on BChE enzyme. On the other hand, compounds 
ANT-3, ANT-6 and ANT-10 showed remarkable 
enzyme inhibition profile against AChE enzyme. 
Compound ANT-10 was the most potent derivative in 
the series with IC50 value of 0.0568±0.0018 µM. Also, 
it was carried out with the help of the docking studies 
that compound ANT-10 showed a notable binding 
capacity to enzyme active sites.
CONCLUSIONS:
Consequently, some of the synthesized compounds 
have been shown good inhibition profile against AChE 
enzyme.
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INTRODUCTION:
Phenothiazines have recently been associated 
with anticancer effects (1,2) however, there is a 
need for synthesis and structure analysis of novel 
phenothiazines with higher efficiency and less side 
effects. In this study, we designed, synthesized and 
structurally identified novel phenothiazine derivatives 
and tested their anticancer effects along with 
commercial phenothiazines in HCC cell lines.  
MATERIALS AND METHODS:
Syntheses of the compounds were carried out 
starting from commercially available nonsubstitue/2-
substitue-10H-phenothiazine. This was followed 
by reaction with chloro acetyl chloride to give 
10-chloroacetylphenothiazine. The reaction of 
10-chloroacetylphenothiazine with appropriate alkyl 
amines gave the targeted phenothiazine derivatives 
(3, 4). To test effects of commercial and novel 
phenothiazines on HCC cell lines, we used naive or 
GFP expressing SKHep1 and Hep3B cell lines and 
identified effective compounds inhibiting cell viability 
using MTT assays. 
RESULTS:
Eight novel compounds that include different chemical 
groups, e.g –H, –Cl, -SCH3 at R1 and different aliphatic 
amines at R2, were synthesized, and structurally 
analyzed using 1H, 13C-NMR, Mass spectrometers. 
MTT assays showed that commercial phenotiazines 
prochlorperazine dimaleat and trifluoperazine HCl 
exhibited effective cell viability inhibition along with 
a group chemically related novel phenothiazines 
providing new lead molecules. Ongoing studies focus 
on synthesis of novel derivatives that contain -OCH3 
substituted benzyl piperazine groups and will be 
tested in the given paradigm in SKHEP1 and HEP3B 
cells.  
CONCLUSIONS:
In the long term, we will synthesize and test lead 
novel phenotiazines that can provide more effective 
therapies for HCC.  
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P-442: SYNTHESIS, BIOLOGICAL ACTIVITY 
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INTRODUCTION:
1,4-dihydropyridine (1,4-DHP) derivatives were 
designed as calcium channel blocking compounds 
and then other biological activities of these 
compounds, including antimicrobial activity, were 
also investigated. The 1,4-DHP ring was converted to 
some other heterocyclic ring systems by condensing 
with various cyclic structures to obtain some 
derivatives have achieved both molecular diversity 
and more active compounds with the substitution 
of some aryl groups. Among these aryl groups, the 
compounds with biphenyl structure are notable for 
their high antimicrobial activity (1, 2). In view of the 
aforementioned findings, the condensed 1,4-DHP 
derivative bearing the biphenyl substituent was 
synthesized, the structure of the compound was 
proved and biological activity was investigated.
MATERIALS AND METHODS:
The compound was obtained with modified Hantzsch 
reaction. The structure of the compound was proved 
and the antibacterial and antifungal activity of the 
compound have been elucidated.
RESULTS:
In this study the title compound was synthesized 
and the structure of the compound was elucidated 
by using spectral methods and subjected to in vitro 
antibacterial and antifungal studies. The crystal 
structure of (I) has been determined by single 
crystal X-ray diffraction method (3-5). It crystallizes 
in orthorhombic space group Pca 21, with unit cell 
dimensions a = 16.9900(7), b = 10.0073(8), c = 
14.0230(8) Å, V = 2384.2(3) Å3, Z = 4. This structure 
has been refined as a nonmerohedral twin and the 
nonmerohedral twin matrix has been identified. 
CONCLUSION:
In this study new benzyl 4-([1,1’-biphenyl]-4-yl)-2-
methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-
carboxylate was synthesized and characterized by 
using spectral methods. The in vitro antibacterial and 
antifungal studies was realized.  
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DERIVATIVES AS K-RAS(G12C) INHIBITORS 
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INTRODUCTION:
Cancer is a complex of diseases that shows itself in 
various tissues and cell types in people with symptoms 
includes numerous endogenous and exogenous 
carcinogenic agents and different etiologies. The 
common properties all these diseases share are 
irregular cell growth, impaired cell differentiations, 
tendency to metastasize, and invasiveness (1). Ras 
proteins a member of small GTPases family have a 
large variety of important roles on controlling cellular 
signaling pathways such as cellular growth, migration, 
adhesion, cytoskeletal organization, survival and 
differentiation (2). The mutations occur on Ras 
genes, causes active Ras proteins are uncontrollably 
proliferate and survive in tumorigenic cells. There are 
several therapeutic approaches proposed targeting 
Ras proteins in the treatment of cancer one of 
them is directly inhibition of Ras proteins (2). The 
theurapetic strategies of directly inhibiting active Ras 
have a difficulty in designing inhibitors to compete 
with the high concentrations of GTP and GDP at the 
nucleotide binding site due to their affinity in picomolar 
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range for Ras proteins (3). The mutation of position 
12 glycine replaces to cysteine (mutation G12C) 
enables a electrophilic targeting to the mutant form 
but not the wild type form. The inhibitors irreversibly 
bind the mutant G12C Ras and stabilizes the protein 
in inactive GDP form (4).
MATERIALS AND METHODS:
Molecular docking calculations were performed 
to understand the interactions between several 
designed benzothiazole derivatives and K-Ras G12C 
(pdb: 4L8G) enzyme, by using CDocker method in 
Accelerys Discovery Studio 3.5 software (5).
RESULTS:
Binding properties of benzothiazole derivatives were 
investigated and it was found that Tyr32, Thr35 and 
Gly60 amino acids were playing an important role 
for enzyme-ligand interactions and compounds were 
bound to enzyme with -71,89 to -34,39 kcal/mol 
binding energies.
CONCLUSIONS:
With the results of the study, it is inevitable that, the 
strategy on mutation-selective inhibitors will be the 
important milestone in the mutation-specific anti-Ras 
treatments.
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INTRODUCTION:
Erlotinib HCl and Gefitinib  (4-aminophenylquinazoline 
derivatives) are anticancer agents that act as a protein 
kinase inhibitors for epidermal growth factor receptor 
(EGFR) associated tyrosine kinase. They are both 
used in the treatment of chemoresistant Non-Small 
Cell Lung Cancer (NSCLC) and Erlotinib has been 
reported to be effective in the treatment of several 
other types of cancer as well. There is a complexity 
about the previously published NMR data of Erlotinib 
and its HCl salt.
MATERIALS AND METHODS:
In this work, total structural assignments of Erlotinib, 
Erlotinib HCl and Gefitinib have been achieved by 
using 2D-NMR experiments. 2D NMR data of Erlotinib, 
Erlotinib HCl and Gefitinib have been performed by a 
detailed 2D NMR study using COSY, DEPT, 1H-13C 
correlated HSQC and HMBC, and ROESY methods, 
leading to a full 1H and 13C signals assignments.
RESULTS:
ROESY experiment gives the best important data 
for their structural elucidation. In addition, virtual 3D 
conformational data of Erlotinib and Gefitinib also 
support these findings.
CONCLUSIONS:
Total structural assignments of Erlotinib, Erlotinib HCl 
and Gefitinib have been achieved by using 2D-NMR 
experiments, including DEPT, COSY, ROESY, HSQC 
and HMBC.
ROESY experiment gives the best important data for 
their structural elucidation.  
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INTRODUCTION:
1,4-Dihydropyridines (1,4-DHPs) interact at a specific 
class of voltage-gated calcium channel to produce 
their cardiovascular effects and are used to treat 
conditions such as hypertension and angina (1). 
Although their primary target in the cardiovascular 
system is the L-type calcium channel isoform, 
however, a number of 1,4-DHPs also block different 
kinds of calcium channels, mainly low-voltage-
activated T-type calcium channels (2). In the present 
study, we synthesized eight 1,4-DHP derivatives in 
which substituted cyclohexane rings are fused to the 
DHP ring, and determined how different substituents 
on the phenyl ring affect L- and T-type calcium 
channel block.
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MATERIALS AND METHODS:
The general procedure for the synthesis of 1,4-
DHP derivatives was as follows: 4,4-dimethyl-1,3-
cyclohexanedione, substituted benzaldehyde, benzyl 
acetoacetate and ammonium acetate were subjected 
to microwave irradiation in absolute ethanol. Calcium 
channel blocking effects of these compounds were 










R1, R2: H, Cl, NO2, Br
RESULTS:
The obtained results indicated that the synthesized 
compounds produced moderate blocking effects on 
both L- and T-type calcium channels. Only compound 
8 blocked T-type calcium channel very effectively. As 
the only difference between the compounds is their 
substituents on C-4 phenyl ring, this suggests that 
types of the substituents on the aromatic ring play 
a key role in the ability of these compounds to block 
calcium current.
CONCLUSIONS:
In this study, eight condensed 1,4-DHP 
(hexahydroquinoline) derivatives were achieved via 
a modified Hantzsch reaction and their effects on 
L-/T-type calcium channels were reported. Compound 
8, bearing two nitro groups on the phenyl ring, was 
found to block T-type calcium channel selectively. 
Our data reveal that this compound can be used for 
pain therapies.
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INTRODUCTION:
Indoles and hydrazone-type molecules establish 
significant classes of pharmacologically active agents 
against especially multi-drug-resistant microbial 
infections. This presented research represent 
the anti-bacterial and anti-fungal activity results 













These derivatives were tested for their in vitro 
antimicrobial activities using the two-fold serial dilution 
technique against Staphylococcus aureus, methicillin-
resistant S. aureus, methicillin-resistant S. aureus 
isolate, Escherichia coli, Bacillus subtilis, and Candida 
albicans. The minimum inhibitory concentration 
(MIC) was determined for the test compounds and 
for the reference standards sultamicillin, ampicillin, 
fluconazole and ciprofloxacin (3).
RESULTS:
All tested molecules showed a broad spectrum of 
activity having MIC values of 6.25–100 µg/ml against 
the tested microorganisms. Aromaticity and side 
chain as well as the halogens of the phenyl ring with 
especially fluorine and chlorine atoms were found to 
be noteworthy for the antimicrobial activity.
CONCLUSIONS:
These results found promising for further antimicrobial 
research on melatonin analogue compounds.
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INTRODUCTION:
Oxidative stress, defined as a disturbance in the 
balance between the production of free radicals 
and antioxidant defenses which results in terminal 
macromolecular damage and related diseases (1, 
2). Antioxidants are molecules that can neutralize 
free radicals by accepting or donating electrons to 
eliminate the unpaired condition of the radical before 
important and essential molecules are damaged. 
The aim of this study was to synthesize and examine 
possible in vitro antioxidant effects of indole-based 
melatonin analogue compounds (3). 
MATERIALS AND METHODS:
As a part of our ongoing study twenty one indole 
hydrazide/hydrazone derivatives were synthesized, 
characterized and their in vitro antioxidant activity was 
investigated (4). The synthesized compounds were 
tested for their antioxidant activities using Antioxidant 
effects on ROS-induced DCFH-DA oxidation and 
Membrane stabilizing effect; LDH leakage.
RESULTS:
Almost all compounds were found to exhibit higher 
antioxidant activity when they are challenged with 
H2O2. N methylation of the indole ring decreased 
the antioxidant capacity of all MLT derivatives. We 
determined LDH activity in the culture medium in 
order to assess the membrane stabilizing effect of 
MLT analogues. No increases in LDH activity were 
observed with any of the tested compounds. Several 
compounds were found to decrease LDH leakage 
indicating membrane stabilizing effect.
CONCLUSIONS:
Antioxidants protect cells from damage caused by 
unstable molecules known as free radicals. These 
results found promising for further research on the 
synthesis of antioxidant activity studies of melatonin 
analogue compounds.
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INTRODUCTION:
Alzheimer’s  disease  (AD)  is  a  chronic  progressive 
neurodegenerative  disorder. It is connected with a 
selective loss of cholinergic neurons, which occurs 
due to  various neuropathological conditions (1). 
Two important enzymes from the group of serine 
hydrolases, acetylcholinesterase (AChE) and 
butyrylcholinesterase (BChE) are usually defined as 
cholinesterases (ChEs). The major role of AChE is 
to catalyse the hydrolysis of acetylcholine (ACh) in 
cholinergic synapses, whereas the function of BChE 
is less clearly defined because it can hydrolyse ACh 
as well as other esters (2-3). A series of hydrazone 
derivatives were designed, synthesized, and their 
inhibitory effects on acetylcholinesterase and 
butyrylcholinesterase were evaluated in pursuit of 
potent dual inhibitors.
MATERIALS AND METHODS:
We synthesized the compounds by the reaction 
of hydrazone derivates according to literature (4). 
We determined their anticholinesterase activities 
according to the Ellman’s method. 4EY7 pdb file with 
resolution 2.3509Å and 4BDS pdb file with resolution 
2.1Å were received (www.rcsb.org) and were modified 
using the ADT package version 1.5.6rc3. To validate 
the docking program, the co-crystallized ligands 
Donepezil (PDB ID:E20) and Tacrin (PDB ID:THA) 
were redocked on the target enzymes.
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RESULTS:
It was understood that the synthesized compounds 
have more potent inhibitory activity against BChE 
enzyme compared to AChE enzyme. Compound 
C11 was the most active compound against BChE 
with 89.43±1.94% inhibition potency at 10-6M 
concentration and IC50 value of 4.27±0.36μM. Most 
of the compounds showed BChE inhibition at very 
low concentrations according to reference drug. 
Molecular modeling studies indicated that compounds 
bind to AChE and BChE enzymes in a similar position 
with co-crystals.
CONCLUSIONS:
In the present study, cholinesterase inhibitory 
potency of some novel hydrazone derivatives was 
investigated. Compound C11 was found as the 
most active compound aganist BChE. None of 
the compounds showed AChE activity as much as 
standard drug Galantamine HBr. Otherwise, methoxy 
substitutions on phenyl ring positively affected 
cholinesterase activity.
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INTRODUCTION:
Cancer is a major health problem that causes deaths 
worldwide (1) and a fatal disease characterized 
by uncontrolled cell proliferation, invasive 
characterization and metastasis (2). There are 
intensive studies in chemotherapy fields in order to 
develop effective compounds against cancer cells. 
Heterocyclic compounds are frequently used in 
medicinal chemistry, especially in the development 
of active biological compounds (3). For this, we 
designed oxime ester derivative compounds 
containing the pyrazole ring. Also, the ketone group 
in the main structure was replaced by alcohol and 
oxime groups which are bioisosters of this group. 
The ester derivatives of the oxime groups have been 
synthesized to obtain more lipophilic compounds. The 
in vitro cytotoxic activity was evaluated for all of the 
synthesized compounds against the SH-SY5Y cell 
lines.
MATERIALS AND METHODS:
Their structures were determined by 1H-NMR, 
13C-NMR, elemental analyses and mass spectrum. 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay was performed to determine 
effect of the formulations on cell viability. 
Measurements were performed at 48th hours. The 
color density was measured in 570 nm with a multiwell 
Elisa Platten reader. Results were evaluated using 
cell viability (%) parameter.
RESULTS:
Cell viability values for the compounds were found 
in the range of 65.99-105.94 %. Compound d3 is the 
most active compound with a value of 65.99%.
CONCLUSIONS:
Most of the compounds showed moderate to high 
activity with cell viability values. It is considered that 
the alkyl substitution of the R group increases the 
activity.
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INTRODUCTION:
Water-soluble polymer have been designed as drug 
carrier with biologically active agents that can be 
attacked by amino (-NH2) or hydroxyl groups (-OH) 
of nucleophilic reagents (1). Acriflavine (AF) has an 
anticancer activity and used in AIDS treatments (2). 
Hydroxyurea (HX) is an antineoplastic agent that 
has antiretroviral properties in (HIV/AIDS) with limited 
use due to its many side effects depending on its 
cytotoxicity on tissues (3).
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MATERIALS AND METHODS:
Maleic anhydride-alt-acrylic acid (MAAA) were 
conjugated with AF and HX by ring opening reaction or 
anticancer and antibacterial active conjugates in N,N-
dimethylformamide (DMF), 48 h, using triethylamine 
(TEA) as the catalyst, at 70 °C for MAAA/AF and 
75 ºC for MAAA/HX. Structural characterization was 
performed by Fourier Transform Infrared Spectroscopy 
(FTIR) and Proton Nuclear Magnetic Resonance 
Spectroscopy (1H-NMR). Physical characterization 
of MAAA/HX was performed by Thermogravimetric 
Analysis (TGA) and Differential Scanning Calorimetry 
(DSC). Previously, Antimicrobial activity of the MAAA/
AF was evaluated by Kirby Bauer Disc Diffusion 
method using four different strains. Antiproliferative 
activity of MAAA/HX was performed by BrdU cell 
proliferation ELISA assay on C6 (rat brain tumor) and 
HeLa (human cervix carcinoma) (4).
RESULTS:
MAAA/AF had antibacterial activity on EHEC 
(Enterohaemorrhagic Escherichia coli) and S. aureus 
(5). MAAA/HX significant antiproliferative activity 
against C6 and HeLa, increased antitumor activity 
and also decreased toxicitycompared to crude drug.
CONCLUSIONS:
Activity test results confirmed that conjugation reaction 
of MAAA performed via ring-opening reactions (4). 
In our previous study drug carrier MAAA copolymer 
conjugated for antibacterially active MAAA/AF, in 
this study it is especially suggested for MAAA/HX 
conjugate having highly antiproliferative activity.
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INTRODUCTION:
Monoamine oxidases (MAOs) that belong to the 
family of flavin-containing amine oxidoreductases and 
catalyze  the oxidative deamination of monoamines 
as serotonin, dopamine, histamine. Subtypes of 
MAO are MAO-A and MAO-B were distinguished by 
their substrate and inhibitor specificity (1). Increased 
oxidative stress and decreased antioxidative 
protection that is a result of oxidation activity of 
MAOs, are important causes of neurodegeneration 
which play a role in the pathophysiology of 
several neuropsychiatric disorders as depression, 
Alzheimer’s disease (AD), and Parkinson’s disease 
(PD). Therefore MAO inhibition is thought drug 
target for therapy of these diseases and disorders 
(2). It has been reported that hydrazone and 
acylhydrazone derivatives exhibits anticonvulsant, 
antiinflammatory, antidepressant, analgesic, 
antithrombocyte and anti-cancer activities. There 
have been also many reports on the antidepresant/
MAO-inhibition activity of hydrazones derived 
from substituted hydrazides and their reduction 
products (3). In this study, the synthesis of some 
new substituted benzoxazolinehydrazones (figure 
1) were aimed to reach more potent MAO inhibitory 
compunds. These derivatives were synthesized 
by reacting 5-substitutedbenzoxazolinone-3-
carboxylic acid hydrazide with various aldehydes, 
their structures were confirmed using IR, 1H-NMR, 
mass and elemental analysis. The compounds were 
investigated for their ability to inhibit hMAO isoforms 
by in-vitro tests. Molecular docking studies were done 
to provide insights into enzyme-inhibitor interactions 








Figure 1. General structure of new substituted 
benzoxazolinehydrazones
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RESULTS:
All of the designed compounds have exhibited good 
inhibitory efficacy against hMAO-B.
CONCLUSIONS:
In comparison with our previous study, although the 
electron withdrawing groups in aromatic aldehyde 
ring that used in hydrazone synthesis generally 
have a positive effect on the MAO inhibition activity, 
electron donating groups as ethyl were found to have 
a higher contrubution to the MAO inhibition potential 
of these derivatives. 
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INTRODUCTION:
Classical Mannich reaction is a way for the introduction 
of aminomethyl function into the molecules. Mannich 
bases can be classified into four main categories 
according to the atom involving aminoalkylation 
reaction: C-Mannich bases (ketonic mannich bases, 
phenolic mannich bases, alkyne mannich bases 
etc.), N-Mannich bases (amide mannich bases, 
sylfonamide mannich bases etc.), S-Mannich 
bases (mannich bases of thiophenols), P-Mannich 
bases (mannich bases of dialkyl phoshites). These 
derivatives represent a class of synthetic compounds 
with a wide spectrum of biological activities. Many 
type of Mannich derivatives have been reported 
to have high activity against certain cancer types 
through variable pathways (1). Due to the increasing 
prevalence of cancer with resistance against existing 
chemotherapeutics, discovery of new molecules in this 
area is still a challenging topic. 1,2,4-Triazole is one of 
the important core fragments which is incorporated in 
some anticancer drugs such as anastrozole, letrozol 
etc. Therefore 1,2,4-triazole ring constituted our 
starting point to generate novel N-Mannich bases as 
putative anticancer agents. 
MATERIALS AND METHODS:
The synthesis of target compounds were performed 
via the classical Mannich reaction, a one-pot three 
component condensation reaction, by reacting 
triazole molecule, formaldehyde and diverse 
secondary amines in ethanole (2). The structures of 
the compounds were confirmed by both spectroscopic 
and elemental analysis. For initial screening, the 
cytotoxic activity against four different cancers and a 
normal cell line was measured by SRB assay using 
the compounds at the concentration of 10 microMolar. 
The selected compounds at a broad range of 
concentrations were further evaluated by ATP viability 
assay to calculate the IC50 values. 
RESULTS:
Pharmacological studies of the compounds are under 
investigation. The results will be discussed in the 
poster. 
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INTRODUCTION:
Infectious diseases remain a great health problem 
throughout the world. Although there are several 
drugs in the market, there is an emerging crisis of 
antimicrobial resistance for microbial pathogens (1,2). 
The evolution rate of bacterial resistance to antibiotics 
is evidently higher than the development rate for new 
classes of antibiotics. Thus, new drug needs are 
increasing. In this study a new series of oxime ester 
were synthesized and evaluated for their antibacterial 
activity towards S. aureus (ATCC 29213), P. 
aeruginosa (ATCC 27853), E. faecalis (ATCC 29212), 
E. coli (ATCC25922) species.
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MATERIALS AND METHODS:
We synthesized the final compounds by the reaction 
of oxime derivate (d) with various acyl chlorides using 
4-dimethylaminopyridine. Then, c was converted 
to its oxime derivate (d) by refluxing with NH2OH.
HCl under alkali conditions. Acetophenone derivate 
(b) was converted to the ketones by N-alkylation of 
1H-imidazole. We prepared b by brominating a. Their 
structures were determined by 1H-NMR, 13C-NMR, 
elemental analyses and mass spectral. All newly 
synthesized compounds were screened for their 
antibacterial activities against laboratory strains by 
using microdilution method.
RESULTS:
The antibacterial activity results indicate that all 
compounds were more effective against the Gram-
(+) bacteria than the Gram-(-) bacteria. Most of the 
compounds showed moderate to high activity with 
MIC values in the range of 4-512 µg/mL.
CONCLUSIONS:
The objective of this work was to design and synthesize 
new compounds with antibacterial properties. 
Compound 2, 4 and 5 have good antibacterial activity 
against S.aureus and P.aeruginosa.  p-Substituted 
benzene groups showed better activity and the alkyl 
substitution of the R group increased activity.
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INTRODUCTION:
Neuroblastoma is a tumor that occurs in the adrenal 
medulla and sympathetic ganglia, originating from 
primitive neural crest cells. It is also the most common 
extracranial solid tumor and is responsible for 8-10% 
of all childhood malignancies. There are about  800 
new patients per year in the US (1). It is thought 
that about 22% of all neuroblastoma patients have 
germinal mutation (2). The aim of this  study was to 
investigate  the  cytotoxic  effects  of new oxime ester 
compounds on  SH-SY5Y  neuroblastoma cells.
MATERIALS AND METHODS:
The structures of the compounds were confirmed by 
IR, 1H-NMR, 13C-NMR, and elemental analyses. Cell 
viability  was  assessed  with  3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium  bromide  (MTT)  assay. 
Neuroblastoma cells were cultured in appropriate 
culture medium. They were transferred to 96-well 
plates and were incubated at 48 hours.  Paclitaxel 
was used as a positive control. The color density was 
measured in 570 nm with a multiwell Elisa Platten 
reader. Results were determined using cell viability 
(%) parameter.
RESULTS:
The cell viability values of the compounds were 
in the range of 51.02-65.37%. The activity 
results showed that compound (E/Z)-1-(4-
trifluoromethylphenyl)-2-(1H-imidazol-1-yl)ethanone 
O-4-trifluoromethylbenzoyl oxime is the most active 
derivative in the series. Cell viability values of the 
ketone (1-(4-trifluoromethylphenyl)-2-(1H-imidazol-
1-yl)ethanone), alcohol (1-(4-trifluoromethylphenyl)-
2-(1H-imidazol-1-yl)ethanol) and oxime 
(1-(4-trifluoromethylphenyl)-2-(1H-imidazol-1-yl)
etanone oxime) compounds were 73.153%, 76.491%, 
65.528%, respectively.
CONCLUSIONS:
It is considered that the presence of alkyl groups 
in the ester moiety of the compound increased the 
effect. The ketone, alcohol and oxime structures 
showed good activity. 
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INTRODUCTION:
EGFR kinases are being high rate expression in a 
lot of cancer types, particularly in lung and breast 
cancer. In that cancer types are highly expressed 
more rate %40-80 EGFR according to normal cell 
(1). Benzimidazole derivatives have been found as 
anticancer inhibitors including tyrosine kinases (2-4).
MATERIALS AND METHODS:
Thiosemicarbazides were obtained by condensing 
acyl hydrazides with the methyl, ethyl, propyl, 
phenethyl and cyclohexyl isothiocyanates in ethanol-
DMF mixture (1:1). Triazoles were synthesized from 
that thiosemicarbazides (3.4 mmol) in 10 ml 1 N 
NaOH by refluxing for 1 h (4b-8b)/ from the reaction of 
hydrazides with 2-piperidinoethyl or 2-(4-morpholino)
ethyl isothiocyanate in DMF (9b-10b). Following 
the structure elucidation (1H NMR, 13C NMR, 
MS), benzimidazole compounds bearing bis-
thiosemicarbazide and bis-triazole were tested for 
their EGFR kinase inhibitory activities. ADP-Glo™ 
kinase assay determines kinase activity based on the 
quantification of the amount of ADP produced during 
a kinase reaction.




























































Synthetic route for the preparation of compounds 4a-8a
 and 4b-10b. Reagents: (a) Na2S2O5; (b) ClCH2COOEt/KOH-DMSO; (c) 














We measured the activity of EGFR kinase 
and evaluated the inhibitory efficiencies of 
the benzimidazole compounds bearing bis-
thiosemicarbazide and bis-triazole ring by comparing 
them with erlotinib. 
Conclusions:In this study, a series of new 
benzimidazole derivatives 4a–8a and 4b–10b having 
bis-thiosemicarbazide and bis-triazole synthesized, 
and their anti-EGFR kinases activities were evaluated. 
In summary, promising results were obtained for 
further studies.
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INTRODUCTION:
Recently, the oxadiazole and benzimidazole 
rings in heterocyclic compounds have attracted 
many medicinal chemists and other researchers. 
Compounds including 1,3,4-oxadiazole and 
1H-benzimidazole have a lot of pharmaceutical 
activity as antimicrobial, antifungal, anticancer, anti-
inflammatory, anticonvulsant, antioxidant, antiviral, 
antiulcer, antiangiogenic and antiproliferative effects 
etc. For this reason, we are synthesized new 
oxadiazole linked benzimidazole compounds (1-3).
MATERIALS AND METHODS:
For the target compounds, the reaction sequences 
are summarized in Scheme1. Firstly, 2-phenyl/
s u b s t i t u t e d p h e n y l - 1 H - B e n z o [ d ] i m i d a z o l e 
was prepared via oxidative condensation of 
o-phenylenediamine, benzaldehyde and sodium 
metabisulfite. Reaction of the benzimidazole 
compound with ethyl chloroacetate gave the ethyl 
2-(2-substitutedphenyl)-1H-benzo[d]imidazol-l-yl)
acetate derivatives (6-10). Hydrazine hydrate and the 
esters (6-10) in ethanol were refluxed for 4 h to give 
2-(2-phenyl/substitutedphenyl)-1H-benzo[d]imidazol-
l-yl)acetohydrazides (11-15). Thiosemicarbazides (16-
20) were obtained by condensing acyl hydrazides with 
the cyclohexylisothiocyanate in ethanol. Oxadiazoles 
were synthesized from that thiosemicarbazides (0.5 
mmol) in 1 ml DMSO by refluxing for 4 h at 140 0C 
(4). All synthesized molecules were crystallized from 
ethanol or acetone/water (3:1) and melting point was 
revealed. NMR and Mass spectral analysis were 
performed at Ankara University, Faculty of Pharmacy.


























Synthetic route for the preparation of compounds 16a-20a. Reagents: (a) Na2S2O5; (b) ClCH2COOEt/KOH-



















The mass spectra of synthesized compounds 
showed a M+H ion peak, which is confirming with 
the molecular formula of the compounds. In the NMR 
spectral data, all protons were seen according to the 
expected chemical shift and integral values.
CONCLUSIONS:
The structures of the synthesized compounds were 
consistent with the 1H, 13C-NMR, and mass spectra.
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acid is a non-steroidal anti-inflammatory drug (NSAID) 
reported to be which is anticancer effect in the 
literature (1). Anticancer activity of thiosemicarbazides 
(2), 1,2,4-triazoles-3-thiones (3) and thioethers (4) 
have been reported in literatures. In the light of these 
literatures, we synthesized and studied anticancer 
effects of new naproxen derivatives on prostat cancer 
cell lines PC-3, DU-145 and LNCaP.
MATERIALS AND METHODS:
The naproxen ester (methyl (S)-2-(6-
methoxynaphthalen-2-yl) propanoate) [1] and 
naproxen hydrazide ((S)-2-(6-methoxynaphtalen-
2-yl)propanoic acid hydrazide) [2] were prepared 
according to the literature method (5).Compound 
2 and substitutedphenylisothiocyanate refluxed 
to form new (S)-2-(2-(6-methoxynaphthalen-2-yl)
propanoyl-N-arylthiosemicarbazide [3]. The naproxen 
thiosemicarbazides reacted with 4N NaOH solution 
and obtained (S)-5-(1-(6-methoxynaphthalen-
2-yl)ethyl)-4-subst i tued-1,2,4-tr iazole-3-thiol 
[4]. In addition, naproxen thioethers ((S)-3-
(substituedbenzylthio)-5-(1-(6-methoxynaphthalen-
2-yl)ethyl)-4-substituted-1,2,4-triazoles) [5a-h] were 
synthesized by the reaction of compound 4 and 
substitued benzyl chloride with the presence of 
potassium carbonate in ethanolic medium.
RESULTS:
The aim of this study is synthesize and study 
anticancer activity of new naproxen derivatives [3,5a-
h] which structures were identified by FT-IR, 1H-NMR 
and impurity profiles were controlled by elemental 
analysis and TLC. Compounds 5b (6) and 5h showed 
the most potent anticancer activity against PC-3 
cell line (IC50 = 34.7 μM, 16.3 μM, respectively), 
compounds 5b, 5e (6) showed the most potent 
anticancer activity against DU-145 cell line (IC50 
= 36.1 μM, 44.3 μM respectively) and compounds 
3a (6) and 5g showed the most potent anticancer 
activity against LNCaP cell line (IC50 = 92.8 μM, 73.7 
μM respectively). In this study, we also investigated 
molecular modeling of compounds on methionine 
aminopeptidase (type II) enzyme active site in order 
to get insight into binding mode and energy. 
CONCLUSIONS:
The new naproxen derivatives [3,5a-h] were proven 
by FT-IR, 1H-NMR and elemental analysis data, 
which were evaluated for anticancer effect against 
PC-3, DU-145 and LNCaP cell lines. We observed 
best anticancer activity against PC-3 and DU-145 cell 
lines.
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INTRODUCTION:
Diabetes Mellitus is a metabolic disease affecting 
around millions of people worldwide and it is 
anticipated a 85 % increase by the year 2025 (1). 
In diabetic condition, polyol pathway contributes for 
metabolism of 30% sugar as compared to 3% in 
normal condition. Aldose reductase enzyme is crucial 
due to polyol pathway involved in conversion of 
glucose into sorbitol (2).
MATERIALS AND METHODS:
In this study, in order to gain new insight concerns the 
possible binding modes of aldose reductase inhibitors. 
Docking studies of some 2-amino benzothiazole 
derivatives (3) were carried out by using Biovia 
Discovery Studio 3.5 software (4).
RESULTS:
Known inhibitor, Zopolrestat (ZST), and our 
compounds were docked into the aldose reductase 
enzyme. Docking results demonstrated that our 
compounds are bound to the enzyme active site 
and some of the compounds showed interactions 
with some aminoacids which is similar to the X-ray 
structure of the protein and ZST.
CONCLUSIONS:
According to the docking results, it can be considered 
that this results can lead the way for development of 
new aldose reductase inhibitors.
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INTRODUCTION:
Reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) are generated in different parts of the 
body and has toxic effects on macromolecules like 
lipids, proteins and even DNA. Antioxidant molecules 
can scavenge free radicals and prevent the damage 
on the vital molecules. Therefore a balance between 
antioxidants and the free radicals is necessary (1). 
Melatonin and some of its metabolites behaves 
as an antioxidant by scavenging free radicals and 
increasing the activity of antioxidant enzymes existing 
in body (2). The aim of this study was to synthesize 
and examine possible in vitro antioxidant effects of 
indole-based melatonin analog compounds.
MATERIALS AND METHODS:
As a part of our ongoing study nineteen indole 
hydrazide/hydrazone derivatives were synthesized, 
characterized and their in-vitro antioxidant activity was 
investigated by measurement of ROS with DCFH and 
DPPH methods. Cytotoxicity study of the synthesized 
compounds were established by MTT method.
RESULTS:
According to the studies, none of the products 
possessed vital decrease in cell viability so they 
don’t have the potential of cytotoxicity. Also, we have 
observed antioxidant activity for all the synthesized 
compounds. Three compounds with methyl group 
substituted on the phenyl ring have shown less 
antioxidant activity than the others. For the DCFH 
method, the compounds haven’t shown radical 
scavenging activity. 
CONCLUSION:
Antioxidants can prevent the damage free radicals 
cause on macromolecules and tissues. These 
results have found promising for further research on 
antioxidant  activity studies of indole-based melatonin 
analogs. 
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INTRODUCTION:
Focal adhesion kinase (FAK) is a non-receptor 
cytoplasmic tyrosine kinase that is activated and/or 
overexpressed in a variety of human cancers. FAK 
promotes tumor progression and metastasis through 
effects on both tumor cells and stromal cells (1). As a 
result, inhibition of FAK has been recognized as an 
attractive therapeutic approach in oncology. Due to 
the significance of 1,3,4-oxadiazoles as potential FAK 
inhibitors (2), we aimed to design and synthesize new 
oxadiazole-based FAK inhibitors.
MATERIALS AND METHODS:
New oxadiazole derivatives (1-9) were synthesized 
via the reaction of 5-[((5,6,7,8-tetrahydronaphthalen-
2-yl)oxy)methyl]-1,3,4-oxadiazole-2(3H)-thione with 
2-chloro-N-(thiazol/benzothiazol-2-yl)acetamides. 
The inhibitory effects of the compounds on FAK 
(Phospho-Tyr397) activity in C6 rat glioma cell line 
were determined using Colorimetric Cell-Based ELISA 
FAK (Phospho-Tyr397) activity kit. Molecular docking 
studies were also performed to provide reasonable 
explanations for the most effective inhibitor in the 
active site of FAK (PDB code: 5TO8) (3) using 
Schrödinger’s Maestro molecular modeling package.
Results:N-(6-Fluorobenzothiazol-2-yl)-2-[ [5-
[((5,6,7,8-tetrahydronaphthalen-2-yl)oxy)methyl]-
1,3,4-oxadiazol-2-yl]thio]acetamide (2) showed 
significant FAK inhibitory activity (46.56±2.65%) in 
C6 cell line. This outcome indicated that the fluoro 
substituent at the 6th position of the benzothiazole 
ring enhanced FAK inhibitory activity. According to 
molecular docking studies, 6-fluorobenzothiazole ring 
of compound 2 displayed π-π interaction with Phe568 
residue. Moreover, acetamido moiety of compound 2 
presented H-bond and salt bridge formation with the 
in pocket residue Lys457 of the binding site of FAK.
CONCLUSIONS:
According to the in vitro and in silico studies, 
compound 2 stands out as a promising candidate for 
further studies. 
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INTRODUCTION:
In our previous papers, we have reported the 
synthesis of benzimidazole derivatives and their 
promising anticancer activity results (1,2). These 
results promted us to synthesis and evaluation of 
some novel N-Substituted 4-(1H-benzimidazol-1-yl)-
benzamide derivatives.
MATERIALS AND METHODS:
The 1H-benzimidazole ring was built by cyclization 
of the o-phenylenediamine and formic acid (3). 
And then reaction of the 1H-benzimidazole with 
ethyl 4-fluorobenzoate in DMF in the presence of 
anhydrous K2CO3 gave ethyl 4-(1H-benzimidazol-
1-yl)benzoate. The acid derivative was obtained 
by hydrolyzing the ethyl ester in 5% NaOH (4). 
A solution of 4-(1H-benzimidazol-1-yl)benzoic 
acide in DMF is treated with substituted amines, 
1-ethyl-3(3- dimethylaminopropyl)carbodiimide and 
N-hydroxybenzotriazole, stirred at stirred at 80 0C for 
12 hours and concentrated in vacuo. Purification of 
this resultant residue oil by column chromatography 
provides the corresponding benzimidazoles (Scheme 
1).
RESULTS:
1H-NMR and 13C-NMR spectra were recorded 
employing a Varian Mercury 400 MHz FT-NMR 
spectrometer. Mass spectra were taken on a Waters 
Micromass ZQ connected with a Waters Alliance 
HPLC, using the ESI(+) method, with a C-18. 
Elemental analyses were performed using a Leco 
CHNS-932. All instrumental analysis results of the 
synthesized compounds were found to be consistent 
with their chemical structures.
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CONCLUSIONS:







Scheme 1. General formula of novel benzimidazole 
derivatives
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INTRODUCTION:
The Aldose reductase (AR) is the first enzyme of 
the polyol pathway. At normal physiological glucose 
concentrations, the majority of metabolic flux is 
directed through the glycolic pathway. However, 
under the hyperglycemic conditions frequently 
found in diabetics, a significant portion is directed 
through the polyol pathway where AR is responsible 
for the NADPH-dependent reduction of glucose to 
sorbitol (1). The acceleration of the polyol pathway 
thus elicits various metabolic imbalances in those 
tissues that undergo insulin-independent uptake 
of glucose. Such metabolic perturbation provokes 
the early tissue damage in the “target” organs of 
diabetic complications, such as ocular lens, retina, 
peripheral nerve, and renal glomerulus (2). Currently, 
epalrestat is the only Aldose reductase inhibitor (ARI) 
available for the therapy (3). Despite the difficulties 
in developing effective ARIs, the inhibition of AR has 
continued to be considered an attractive route to 
prevent or manage diabetic complications. As a part of 
our ongoing study a new series of 2-(pyrrolidin-1-yl)/
morpholino thiazolyl-2,4-thiazolidinedione / rhodanine 
compounds was synthesized and tested for their AR 
inhibition activities.
MATERIALS AND METHODS:
All compounds were synthesized via Knoevenagel 
Condensation reaction of substituted thiazole 
and TZD/rhodanine rings. Thiazolidinedione ester 
compounds were hydrolyzed for obtaining the acidic 
compounds. Their structure was characterized by 
1H NMR, Mass and elementary analysis data. All 
compounds were tested for their in vitro aldose 
reductase inhibitory activities. Aldose reductase 
enzyme is isolated from rat lenses and the activity 
of the enzyme is determined by spectrophotometric 
method.
RESULTS:
All 1H NMR, Mass and elementary analysis data were 
in accordance with assumed structures. It was found 
that rhodanine acetic acid derivatives have significant 
inhibitor activities with the 83.39-91.94% inhibition.
CONCLUSIONS:
Among the synthesized compounds, rhodanine 
acetic acid moiety is found to be important for the ARI 
activity. These compounds can be the key formula of 
future studies.
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INTRODUCTION:
Alzheimer Disease (AD) having a devastating effect 
on people is a mortally progressing neurodegenerative 
disorder (1). On the neuropathology of AD, amyloid 
plaques consisting of β-amyloid (Aβ) aggregation 
and storing, play an important role. Pursuant to this 
hypothesis some of the aims of new drug development 
activities are to reduce the Aβ formation, hinder the 
aggregation and increase the fragmentation (2). 
According to various studies some compounds 
carrying benzothiazole structure have shown 
inhibitory effect on the formation of Aβ fibrils which 
are playing a role at AD (3). The aim of this study is 
to clarify the structure of some new benzo[d]thiazole 
derivatives carrying 4-substitutedphenyl structure and 
to evaluate their Aβ fibril inhibitory activities.
MATERIALS AND METHODS:
The starting compounds, 4-substitutebenzaldehydes 
were obtained by treating 4-fluorobenzaldehyde 
with appropriate amines. The target compounds, 
2-(4-substitutedphenyl)benzo[d]thiazoles (Fig.) were 
gained by the reaction of 4- substitutedbenzaldehydes 
with 2-aminothiophenol. The compounds were tested 
for their ability to inhibit self-mediated Aβ aggregation 
using the thioflavin T (ThT) fluorescence assay. 






Fig.: General structure of 2-(4-substitutedphenyl)
benzo[d]thiazole derivatives
RESULTS:
In this study, a series of 2-(4-substitutedphenyl)
benzo[d]thiazole were synthesized. Structures of the 
synthesized compounds were elucidated by using 
spectral methods (IR, 1H-NMR, 13C-NMR, ESI-MS) 
and elemental analysis. Among the synthesized 
compounds, the derivatives carrying azole moities 
(imidazole, triazole and benzimidazole) showed more 
potent activity on Aβ aggregation than donepezil and 
rifampicin. 
CONCLUSIONS:
All these results suggested that 2-phenylbenzo[d]
thiazole with azole moities could be promising lead 
candidates against AD.
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INTRODUCTION:
The usage of most antimicrobial agents is limited, not 
only by the rapidly developing drug resistance, but 
also by the unsatisfactory status of  present treatments 
of microbial infectious and by drug side effects (1). 
Benzimidazole compounds are important fragments 
in medicinal chemistry because of their wide range of 
biological activities  including antimicrobial activity (2). 
MATERIALS AND METHODS:
The benzimidazoles (compounds 2-8) were evaluated 
for their antimicrobial activity with microdilution 
technique described by CLSI. (3-4).
RESULTS:
The minimum inhibitory concentrations (MIC) of 
the new some benzimidazoles, were determined 
against standard bacterial and fungal strains and 
drug-resistant isolates and compared to those of 
several reference drugs and all the observed in vitro 
antimicrobial activity results of the tested compounds 
are given Table 1.
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Table 1. Antimicrobial activity results (MIC μg/ml)  of 
the compounds with the standard drugs
CONCLUSIONS:
In this study, we aimed to develop new effective 
antimicrobial agents possessing benzimidazole nuclei 
in their structure. Microbiological results showed 
that new benzimidazole derivatives possess an 
antimicrobial activity having MIC values of 8-512 µg/
ml against the tested microorganisms.
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INTRODUCTION:
Benzoxazoles are structural isosteres of natural 
nucleotides that can interact with biopolymers, 
constitute an important class of heterocyclic 
compounds. So that benzoxazoles showed several 
activities like antitumor, antiviral and antimicrobial 
activities (1-4).
MATERIALS AND METHODS:
Melting points were determined on a Buchi B-540 
melting point apparatus in open capillary tubes and 
are uncorrected. Elemental analyses were done a 
Leco CHNS 932 elemental analyzer. 1H-NMR and 
13C-NMR spectra were recorded on a Varian Mercury 
400 MHz spectrometer using DMSO-d6. Mass spectra 
were acquired on a Waters Micromass ZQ using the 
ESI(+) method. 
RESULTS:
In this study, firstly, 5-Amino-2-(p-tert-butylphenyl)-
benzoxazole (1) was synthesized by heating 
2,4-diaminophenol with p-tert-butyl benzoic acid in 
PPA.   Then  compound 2 was obtained by treating a 
solution of 3-choloropropionylchloride  with 5-amino-
2-(p-tert-butyl phenyl)-benzoxazole. To obtaine 
result compounds (3-12) (Figure), finally, compound 
2 was treated by some morpholine, 4-(p-substituted 
piperazine/piperidine derivatives.     
Figure. Synthesized compounds
CONCLUSIONS:
All the results compounds (compound 3-12) were 
prepared as original products. The structures of them 
were supported by spectral data. The 1H-NMR, 13C 
NMR, mass spectra and elemental analysis results 
agree with those of the proposed structures. 
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INTRODUCTION:
Tuberculosis (TB) is one of the most important 
infectious diseases caused by Mycobacterium 
tuberculosis and still remains a major global health 
problem (1). 1,4-Dihydropyridines (1,4-DHPs) 
block L-type calcium channel and therefore are 
used to treat hypertension. While designing 1,4-
DHPs as antitubercular agents, calcium channel 
blocking activity can be one of the most important 
side effects (2). In this study, we aimed to present 
sixteen condensed 1,4-dihydropyridine derivatives 
with reduced calcium channel blocking effects as 
antimycobacterial agents.
MATERIALS AND METHODS:
Target compounds were achieved using modified 
Hantzsch reaction under microwave irradiation. 
In vitro anti-tubercular activity of the compounds 
was evaluated against Mycobacterium tuberculosis 
H37Rv. Their effects on L-type calcium channel were 








Ar:  1-Naphthyl, 2-Naphthyl
R:   CH3, C2H5, CH(CH3)2, CH2CH(CH3)2, C(CH3)3, 
CH2CH2OCH3, CH2CH2OCOC(=CH2)CH3, CH2C6H5 
 
RESULTS:
The obtained results indicated that some compounds 
bearing liphophilic ester groups exhibited very good 
antimycobacterial activity (MIC: 0.78-1.56 µg/ml). 
Introducing naphthl ring as an aromatic substituent at 
4-position of the 1,4-DHP ring lead to a decrease in 
calcium channel blocking activity compared to phenyl 
ring.
CONCLUSIONS:
In this study, antitubercular activities of sixteen 
condensed 1,4-DHP (hexahydroquinoline) derivatives 
were reported. Four compounds, which were found 
to be very active, were also tested for their calcium 
channel blocking activity. Our data suggest that a 
condensed dihydropyridine-based scaffold with the 
naphthyl ring may serve as a new pharmacophore 
for antimycobacterial activity with reduced calcium 
channel blocking effects.
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1Marmara University, Faculty of Pharmacy, 
Department of Pharmaceutical Chemistry, İstanbul, 
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INTRODUCTION:
Hydrazide-hydrazones have been reported various 
pharmacological activities (1-6). Ethyl paraben, 
ethyl-4-hydroxybenzoate, is a protective compound 
which has used for stability effects in drugs, foods or 
cosmetic preparates. Ethyl paraben was chosen as 
a starting substance to synthesize new hydrazide-
hydrazones.
MATERIALS AND METHODS:
Ethyl-4-hydroxybenzoate was used as the starting 
compound to design several novel hydrazide-
hydrazones. The reaction of ethyl-4-hydroxybenzoate 
with hydrazine-hydrate in ethanol resulted in 
4-hydroxybenzoic acid hydrazide. 4-Hydroxybenzoic 
acid hydrazide was condensed with substituted 
aromatic aldehydes in ethanolic medium with refluxed 
to obtain new hydrazide-hydrazones. The synthesized 
compounds evaluated anticancer activity against 
MCF-7 (breast adenocarcinoma) and AU565 (breast 
adenocarcinoma) cancer cell lines (7).
RESULTS:
The purity of synthesized compounds was controlled 
by thin layer chromotgraphy, elemental analysis, high 
pressure liquid chrotomography and melting points. 
Their structures were elucidated with FT-IR and 
1H-NMR spectroscopy. FT-IR spectral data of novel 
hydrazide-hydrazones were observed hydrazone 
N-H, hydrazone C=O and C=N streching data 
between 3041-3072, 1687-1680, and 1606-1602 cm-
1, respectively. The chemical shift of the azomethine 
proton and –NH-proton of acylhydrazone moiety in 
hydrazide-hydrazones were detected in the range of 
8.45-8.71 ppm and 11.73-12.07 ppm, respectively.
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CONCLUSIONS:
New 4-hydroxybenzoic acid hydrazide-hydrazones 
were synthesized, characterized and evaluated 
anticancer activity against breast adenocarcinoma 
cancer cell lines.
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INTRODUCTION:
Malignant melanoma is one of the most serious 
type of skin cancers with increasing prevalence and 
mortality rates. Although it constitutes only 4% of the 
skin cancers, melanoma accounts for 75% of skin 
cancer-related deaths. Numerous agents are currently 
under development to provide alternative therapeutic 
options (1). Previously, a large number of Mannich 
bases using kojic acid (5-hydroxy-2-(hydroxymethyl)-
4H-pyran-4-one) as the starting material were 
synthesized and examined in our laboratory for 
their various types of biological actions including 
anticonvulsant, antiviral, anti-bacterial, anti-fungal, 
anti-mycobacterial, anti-oxidant, anti-aging and anti-
tyrosinase  activities besides cytotoxic effects (2-4). 
MATERIALS AND METHODS:
Chlorination of the 2-hydroxymethyl moiety of kojic 
acid using thionyl chloride at room temperature 
produced chlorokojic acid (2-chloromethyl-5-hydroxy-
4H-pyran-4-one), with the ring hydroxyl being 
unaffected. Allomaltol (5-hydroxy-2-methyl-4H-pyran-
4-one) was obtained by the reduction of chlorokojic 
acid with zinc dust in hydrochloric acid. Mannich 
bases with the structure of 2-substituted-3-hydroxy-
6-hyroxymethyl/chloromethyl/ methyl/4H-pyran-4-
one (compounds 1-14) were synthesized by the 
reaction of kojic acid/chlorokojic acid/allomaltol and 
substituted benzylpiperazine derivatives in presence 
of formaline at room temperature. Viability of A375 
human malignant melanoma cell exposed to the 
compound was assessed by sulforhodamine B (SRB) 
assay. SRB assay is a colorimetric method based on 
measurement of cellular protein content and used for 
the determination of cytotoxicity (5). Vemurafenib, 
dacarbazine, temozolomide, lenalidomide and 
fotemustine currently used in the treatment of malign 
melanoma were utilized as control agents. 
RESULTS:
New eleven Mannich bases having structure 
of 2-substituted-3-hydroxy-6-hydroxymethyl/
chloromethyl/methyl/-4H-pyran-4-one were 
synthesized with quite significant yield. The structures 
of the compounds were identified by using techniques 
IR, 1H-NMR, 13C-NMR, mass spectroscopy and 
elementary analysis. None of the compounds 1-14 
showed activity as much as vemurafenib (IC50: 
4.6 µM) and dacarbazine (IC50: 69.6 µM). It was 
found that the cytotoxicity effect of the compounds 
1-14 (IC50: 73.74-95.59 µM) were higher than 
temozolomide (IC50: 95.6 µM) and lenalidomide 
(IC50: 143.1 µM).
CONCLUSIONS:
This study suggests that in the future together with 
in vivo applications, these compounds can be used 
as a promising research model on the treatment of 
malignant melanoma.
ACKNOWLEDGEMENTS:
This research was funded as a project by TÜBİTAK 
(SBAG-315S067) and Hacettepe University Scientific 
Research Fond (THD-2015-7392).
REFERENCES:
1.  Chang, TW, Weaver AL, Brewer JD, Kyle RA, 
Baum CL (2017). Journal of the American 
Academy of Dermatology, 78(3):621-371. 
2.  Aytemir MD, Ozcelik B (2010). European Journal 
of Medicinal Chemistry, 45(9):4089-95. 
3.  Karakaya G, Aytemir MD, Ozcelik B, Calis, 
Ü (2013). Journal of Enzyme Inhibition and 
Medicinal Chemistry, 28(3):627-38.
4.  Aytemir M, Ozcelik B, Orhan IE, Karakaya G 
Senol FS (2015) Biological effect of Mannich 
bases of kojic acid derivatives. Turkish Patent TR 
2015 07653 B.
5.  Vichai V, Kirtikara K (2006). Natural Protocol, 
1:1112-6.
12th International Symposıum on Pharmaceutical Sciences, 26-29 June 2018, Ankara/Turkey 393
P-469: DOCKING STUDIES OF 
KOJYLMETHYL DICHLOROBENZYL 
PIPERAZINE AS A TYROSINASE INHIBITOR
1 Aytemir, MD., 2 Demirci, A., 1 Karakaya, G. 
1Hacettepe University, Faculty of Pharmacy, 
Department of Pharmaceutical Chemistry, Ankara, 
Turkey.
2Marmara University, Faculty of Pharmacy, 
Department of Pharmaceutical Chemistry, Istanbul, 
Turkey.
INTRODUCTION:
Tyrosinase is a key regulatory enzyme responsible 
for melanin production in melanocytes and widely 
distributed in nature. Since tyrosinase plays a 
critical role in melanin production, inhibitors of 
tyrosinase enzyme have become increasingly 
important in medicinal chemistry for developing new 
depigmenting agents used in pharmacological and 
cosmetic fields. Among the many kinds of tyrosinase 
inhibitors, kojic acid (5-hydroxy-2-hydroxymethyl-
4H-pyran-4-one) is commonly used and well known 
with its antityrosinase property (1). In our previous 
study, Mannich bases of kojic acid (5-hydroxy-
2-(hydroxymethyl)-4H-pyran-4-one) including 
3,4-dichlorobenzylpiperazine substituent (KOJI 
MG84; 3-hydroxy-6-(hydroxymethyl)-2-[[4-(3,4-
dichlorobenzyl)piperazine-1-yl]methyl]-4H-pyran-4-
one) and 2,6-dichlorobenzyl- piperazine substituent 
were synthesized by the reaction of kojic acid with 
substituted benzylpiperazine derivatives in the 
presence of formaline without by-product formation 
at room temperature. Their anti-tyrosinase, anti-
aging, anti-mycobacterial, anti-dermatofitic and 
anti-oxidant activities were evaluated. The results 
were reported and patented with the title of “Kojic 
Acid-Derived Mannich Bases with Biological Effect” 
(2). The potential inhibitory activity of KOJI MG84 
was investigated in silico using molecular docking 
simulation method (3). 
MATERIALS AND METHODS:
Agaricus bisporus tyrosinase enzyme (PDB ID: 2X9Y) 
was derived from Protein Data Bank. MGLTools and 
Biovia Discovery Studio Visualizer software were 
used to prepare data before docking. Holmium atom 
was removed from the structure and polar hydrogen 
atoms were added to protein for docking calculations. 
3D structures of ligands were also prepared. 
Gasteiger charges were assigned to the ligands and 
the receptor. Protonation states of histidine amino 
acid residues were determined. Histidines apart from 
His61, His85, His94, His259, His263 and His296 were 
prepared as charged forms while mentioned histidine 
residues which bind to copper ions were assigned as 
0HD1 forms. Autodock Vina software was used for 
docking calculations. Binding modes of the ligands 
were evaluated with PMV and PyMOL.
RESULTS:
We suggest a tyrosinase inhibition mechanism of 
Mannich bases through this study. Possible H-bond 
and hydrophobic interactions between the side chain 
of Mannich bases and tyrosinase enzyme active 
site are visualized with molecular modeling studies. 
According to the predicted conformation of KOJI 
MG84 in the A. bisporus tyrosinase enzyme binding 
site, hydroxymethyl group provides a metal complex 
with copper ions and enzyme.  His61, His85, His94, 
His259, His263 and His296 residues prominently 
support this complex. Chlorine substitution to phenyl 
ring makes a weak hydrogen bond with Asn81. The 
4th position oxygen atom of pyranone ring makes 
hydrogen bond interaction with Ser282.
CONCLUSIONS:
These in silico results can thus serve as a template 
for further in vitro and in vivo studies.
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INTRODUCTION:
Current antifungal therapy is limited by the short 
arsenal of antifungal agents, toxicity problems and the 
development of resistance (1). Due to the significance 
of dithiocarbamates in the field of antifungal drug 
design (2), we aimed to design and synthesize new 
dithiocarbamate-based anticandidal agents.
MATERIALS AND METHODS:
New dithiocarbamate derivatives (Fig. 1) were 
synthesized via the reaction of 1-(chloroacetyl)-3-
(2-furyl)-5-(3,4-methylendioxyphenyl)-2-pyrazoline 
with sodium salts of N,N-disubstituted dithiocarbamic 
acids. These compounds were evaluated for their in 
vitro antifungal effects on Candida albicans, Candida 
glabrata, Candida parapsilosis and Candida krusei 
using a broth microdilution assay. Besides, molecular 
docking studies were carried out for the most effective 
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anticandidal agent in the active site of lanosterol 
14α-demethylase enzyme CYP51 (PDB code: 5FSA) 
to provide any mechanistic insights into further in vitro 
enzyme studies (3).
RESULTS:
1 - [ ( ( 4 - ( 4 - F l u o r o p h e n y l ) p i p e r a z i n - 1 - y l )
th iocarbamoyl th io)acety l ] -3-(2- fury l ) -5-(3,4-
methylendioxyphenyl)-2-pyrazoline (2) was the 
most potent antifungal agent on C. parapsilosis 
with a MIC value of 15.63 µg/mL when compared 
with ketoconazole (MIC= 31.25 µg/mL). The fluoro 
substituent on the phenyl group at the 4th position 
of the piperazine ring enhanced antifungal activity 
against C. parapsilosis. According to molecular 
docking studies, compound 2 displayed π-π 
interaction with Tyr118 residue in the active site of 
CYP51. In silico studies suggest that 4-fluorophenyl 
moiety is crucial for the interactions with the binding 
area of the target structure. 
CONCLUSIONS:
According to the in silico and in vitro studies, 
compound 2 stands out as a promising candidate for 
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Figure 1. The structures of compounds 1-10
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INTRODUCTION:
Cyclooxygenase-2 (COX-2)-selective inhibitors 
are safer anti-inflammatory agents with fewer 
gastrointestinal side effects than nonselective 
NSAIDs. In many studies, inhibition of COX-2 is 
proposed as a treatment option in several cancer 
types and neurological diseases [1]. 2-Imino-5-
methylidene-1,3-thiazolidin-4-one derivatives are 
known to posses anti-inflammatory activity due to 
COX-2 inhibition, besides other biological effects (2-
4).
MATERIALS AND METHODS:
In this study, sixteen 5-arylidene-2-[(4-chloropyridin-
2-yl)imino]-1,3-thiazolidin-4-one derivatives were 
synthesized via Knoevenagel condensation of 
aromatic aldehydes with 2-[(4-chloropyridin-2-yl)
imino]-1,3-thiazolidin-4-one, and identified by the 
help of IR, 1H-NMR, 13C-NMR and mass spectral 
data while their purities were proved by TLC and 
elemental analysis. The inhibitory potential of 
synthesized sixteen arylidene derivatives on COX-1 
and COX-2 enzymes were evaluated using a “COX 
Inhibitor Screening Kit” at 10µM dose. The assay was 
conducted in duplicate and statistical analysis was 
carried out using GraphPad Prism 6.1 Software. The 
crystal structures of COX-1 (PDB code: 1Q4G) and 
COX-2 (PDB code: 3LN1) were used for docking after 
cleaning the enzyme structures from co-crystallized 
compounds and from water molecules. Three-
dimentional structures of the synthesized compounds 
were optimized with semi-empirical PM3 method 
and used for initial geometry in docking calculations. 
The resultant docking files were analyzed to explain 
the mechanism of binding using Accelrys Discovery 
Studio Visualizer 4.0 program.
RESULTS:
The inhibitory effects on COX-1 and COX-2 enzymes 
of synthesized compounds were evaluated at 10 µM 
dose and were observed that 2-[(4-chloropyridin-2-
yl)imino]-1,3-thiazolidin-4-one has lower than 50% 
inhibition value for both of enzymes while 5-arylidene 
derivatives exhibited selective COX inhibition by 
>70% COX-2 inhibition value. When interaction of 
synthesized compounds with the active site of the 
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COX enzymes were examined, it has been observed 
that 2-[(4-chloropyridin-2-yl)imino]-1,3-thiazolidin-4-
one interacted with the active site of both enzymes. 
However 5-arylidene derivatives interacted only with 
the active site of COX-2 enzyme.
CONCLUSIONS:
These results showed that 5-arylidene substition 
of 2-imino-1,3-thiazolidinone derivatives enhances 
COX-2 selectivity. This study reveals important 
findings for the design of the new selective COX-2 
inhibitors for further researchs.
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INTRODUCTION:
MetAP2 appears to play a critical role in cell 
proliferation and tumor growth. In recent years, 
containing of 1,2,4-triazoles moiety thioethers are 
reported as potential MetAP2 inhibitors (1).
MATERIALS AND METHODS:
Flurbiprofen, (R,S) 2-(2-fluoro-[1,1’-biphenyl]-4-il)
propanoic acid, that have the structural skeleton 
of 2-arylpropionic acid was chosen as a starting 
substance to synthesize thioethers. Flurbiprofen 
was refluxed in the presence of methanol by catalyst 
saturated sulfuric acid to form methyl 2-(2-fluoro-
[1,1’-biphenyl]-4-yl)propanoate (1). Methanolic 
solution of compound 1 and hydrazine hydrate were 
refluxed to obtain 2-(2-fluoro-[1,1’-biphenyl]-4-yl)
propanehydrazide (2). Compound 2 and several 
isothiocyanates yield 2- (2- (2-fluoro- [1,1’-biphenyl] 
-4-yl) propanoyl) -N-alkyl /aryl thiosemicarbazides 
(3a-c). The thiosemicarbazides react with NaOH 
solutions (4N) and after cyclization reaction 
3-(1-(2-fluoro[1,1’-biphenyl]-4-yl)ethyl)-4-substituted-
1H-1,2,4-triazole-5(4H)-thiones(4a-d) are gained. To 
a suspension of 4-substituted-1,2,4-triazole-3-thione 
in ethanol containing anhydrous K2CO3, substituted 





The structures of synthesized compounds were 
confirmed their structures by FT-IR, 1H-NMR and 
elemental analysis data, their impurty profiles 
were controlled by TLC. Among these compounds, 
compunds5 (2) and 21 showed the most potent 
anticancer activity against PC-3 cell line (IC50 = 27.1 
μM , 5.12 μM, respectively), compounds 3c, 5 (2) 
and 23 showed the most potent anticancer activity 
against DU-145 cell line (IC50 = 11.55 μM , 6.9 μM , 
9.54 μM, respectively), compounds 4d and 16showed 
the most potent anticancer activity against LnCAP cell 
line (IC50 = 11.45 μM , 26.91 μM, recpectively). In 
this study,we also investigated apoptotic mechanism 
and molecular modeling of compounds on methionine 
aminopeptidase (type II) enzyme active site in order 










































(a) CH3OH / H2SO4; (b) NH2NH2.EtOH, (c) R1–NCS 
/ EtOH; (d) NaOH (4N); (e) R2/ EtOH / K2CO3 
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INTRODUCTION:
The synthetically available and pharmacologically 
active indole scaffold has provided the incentive 
for the development of a number of antimicrobial 
compounds. Indoles and hydrazone-type molecules 
establish significant classes of pharmacologically 
active agents against especially multi-drug-resistant 
microbial infections. This presented research 
represent the anti-bacterial and anti-fungal activity 
results of 2-methylindole-3-carboxaldehyde 
hydrazone derivatives. (1)
MATERIALS AND METHODS:
These derivatives were tested for their in vitro 
antimicrobial activities using the two-fold serial dilution 
technique against Staphylococcus aureus, methicillin-
resistant S. aureus, methicillin-resistant S. aureus 
isolate, Escherichia coli, Bacillus subtilis, and Candida 
albicans. The minimum inhibitory concentration 
(MIC) was determined for the test compounds and 
for the reference standards sultamicillin, ampicillin, 
fluconazole and ciprofloxacin. (2,3)
RESULTS:
All tested molecules showed a broad spectrum of 
activity having MIC values of 6.25–100 µg/ml against 
the tested microorganisms. Aromaticity and side chain 
as well as the halogens of the phenyl ring were found 
to be noteworthy for the antimicrobial activity
CONCLUSIONS:
The results may be instructive to researchers 
attempting to gain more understanding of the 
antimicrobial activity of indole hydrazide/hydrazone-
type compounds. More research is needed to find 
effective indole-hydrazine type antimicrobial agent.
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INTRODUCTION:
A benzoxazole derivative; calcimycin is a carboxylic 
polyether antibiotic from a strain of Streptomyces 
chartreusis (NRRL 3882). It was found to very active 
against gram-positive bacteria. So that benzoxazoles 
constitute an important class of heterocyclic 
compounds with antimicrobial and antibiotic activities 
[1-2].  
MATERIALS AND METHODS:
The  compounds   were evaluated for their 
antimicrobial activity with microdilution technique 
described by CLSI. [4-5].
Results:The minimum inhibitory concentrations (MIC) 
of the new some benzoxazoles were determined 
against standard bacterial and fungal strains and 
drug-resistant isolates and compared to those of 
several reference drugs and all the observed in vitro 
antimicrobial activity results of the tested compounds 
are given Table 1.
Table 1. Antimicrobial activity results (MIC μg/ml)  of 
new compounds with the standard drugs.
A: E. coli ATCC 25922, B: E. coli isolate, C: 
P.aeruginosa ATCC 27853, D: P. aeruginosa isolate, 
E: S.aureus ATCC 29213, F: MRSA, G: E.faecalis 
ATCC 29212, H: VRE, I: C.albicans ATCC 10231 
CONCLUSIONS:
In this study, we aimed to develop new effective 
antimicrobial agents possessing benzoxazole ring 
as heterocyclic structure. Microbiological results 
showed that new heterocyclic compounds possess an 
antimicrobial activity having MIC values of 8-512 µg/
ml against the tested microorganisms.
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INTRODUCTION:
The aromatic amidines, such as berenil, pentamidine, 
propamidine and furamidine are well-known 
antimicrobial drugs also the antibiotic  and anticancer 
activity of this kind of compounds has been described 
[1-2].  On the otherhand benzimidazole ring is 
structural isosteres of natural nucleotides and can 
interact with the biopolymers that they constitute 
an important class of heterocyclic compounds with 
antimicrobial and antifungal activity [3-4]. 
MATERIALS AND METHODS:
Melting points were determined on a Buchi B-540 
melting point apparatus in open capillary tubes and 
are uncorrected. Elemental analyses were done a 
Leco CHNS 932 elemental analyzer. 1H-NMR and 
13C-NMR spectra were recorded on a Varian Mercury 
400 MHz spectrometer using DMSO-d6. Mass spectra 
were acquired on a Waters Micromass ZQ using the 
ESI(+) method. 
RESULTS:
In the present investigation, a new series of amidine 
derivatives was synthesized using a multiple step 
procedure and the synthetic pathways for preparation 
of the target compounds are shown in Scheme. 
Scheme. Synthesis of the target compounds
CONCLUSIONS:
In this study,  we put some heterocyclic rings on 
second position and an amidine group on the fifth 
position of benzimidazole ring and synthesized them, 
the synthetic pathways for preparation of the target 
compounds are shown in Scheme. The structures of 
them were supported by spectral data. The 1H-NMR, 
13C NMR and mass spectra and elemental analysis 
results agree with those of the proposed structures. 
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INTRODUCTION:
Heterocycles containining thiazole and/or pyrrolidine 
are useful building block for the construction of 
pharmaceutically important heterocycles and play 
important role in medicinal chemistry (1-3). In 
many report hybridization and modification of the 
heterocycles allow to obtain potential bioactive 
molecules and improve the pharmaceutical and 
biological activity comparing to starting lead 
compounds (4).Continuation of our ongoing research 
study (5), in this work we report the efficient preparation 
of such these new heterocycles, containining thiazole 
and/or pyrrolidine ring systems and determine their 
biological properties. 
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MATERIALS AND METHODS:
Azomethine ylide-1,3-dipolar cycloadditions cascade 
reaction applied to prepare highly functionalized 
polysubstituted pyrrolidine derivatives from 
corresponding iminoester and condensation reaction 
of pyrrolidine with aroyl isothiocyanate afforded desired 
aroylaminocarbo-N-thioylpyrrolidine intermediates. 
Further modification of these prepared compounds 
allowed to access novel highly functionalized hybrid 
heterocycles. Structures and stereochemistry of novel 
compounds were determined by NMR, MS, IR HRMS 
analytical techniques. Biological evaluation of these 
compounds were screened against antibacterial and 
anti-tuberculosis(TB) activity.
RESULTS:
The above mentioned process allowed us to obtain the 
desired novel potential bioactive hybrid compounds in 
good to excellent yields.The bioactivity of the tested 
compounds were found to be potential bioactive when 
screened against Staphylococcus aureus (ATCC 
25925), Escherichia coli (ATCC 25923), Acinetobacter 
baumannii (ATCC 02026), Bacillus subtilis (ATCC 
6633), Aeromonas hydrophila (ATCC 95080) and M. 
tuberculosis H37RV.
CONCLUSIONS:
The structural variation of the prepared hetereocycles 
depend on the nature of substituent at 2, 3 and 
4-positions of the prolinates which originated from 
imines, dipolarophiles and its further modification. 
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INTRODUCTION:
Current interest in the preparation and their biological 
evaluation for the  Cu complexes is getting increase 
because of their potential use as bioactive agents such 
as antitumoral,  antiviral and  antimicrobial properties 
(1) and some Cu complexes  were found to be potential 
non-steroidal anti-inflammatory drugs (2). Pyrrolidine 
and carbothioamide derivatives are important 
structural features owing to their pharmaceutical 
properties and  can be utilised for the preparation 
of bioactive hetereocycles (3, 4). In this study, we 
focused on to design and efficient preparation for 
novel Copper(II) complexes of N-benzoyl-2-(1H-indol-
2-yl)pyrrolidine-1-carbothioamide and determine 
some of their biological properties.
MATERIALS AND METHODS:
The pyrrolidines based ligands  were synthesis from 
corresponding imine via azomethineylide 1,3-dipolar 
cycloadditions and aroyl isothiocyanate condensation 
reactions. The prepared ligands were then treated 
with appropriate salts of Cu metal which  afforded the 
desired Cu(II) complexes in good to excellent yields. 
The synthesied compounds were characterized 
by various analytical techniques. The biological 
evaluation of prepared compounds were made by 
using S. aureus (ATCC 25925), E. coli (ATCC 25923), 
A. baumannii (ATCC 02026), B. subtilis (ATCC 6633), 
A. hydrophila (ATCC 95080) and M. tuberculosis 
H37RV
RESULTS:
The Cu (II)  complexes  were obtained as green solid 
and the  result of biological evaluation shown that 
the compounds are potential bioactive when tested 
against anti-TB and the bacteria mentioned above. 
CONCLUSIONS:
A simple method was developed to prepare 
novel  Cu (II) complexes  based on pyrrolidine and 
carbothioamide derivatives. The complexes were 
showing the coordination occur through the sulfur and 
oxygen atom of carbamothioyl moieties and found to 
be potential bioactive.
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INTRODUCTION:
Thioesters have important preeminent role in the 
accomplishment of biological, pharmaceutical and 
industrial processes. Thioesters are the key bioactive 
compounds in many biosynthetic pathways to 
fatty acids, esters, polyketides, and nonribosomal 
peptides. They are also versatile intermediates 
in food, medicinal and cosmetic chemistry, and in 
production of new materials (1,2). As part of our 
previous works (3), we prepared some novel thioester 
derivatives which can be consider as useful potential 
bioactive compounds.
MATERIALS AND METHODS:
The novel compounds were prepared from 
corresponding aroyl isothiocyanate in presence of 
oximes/imines and characterized by NMR, MS and IR 
techniques. Anti-TB activity of the tested compound 
was performed utilizing the resazurin microtitre 
assay-REMA according to literature method against 
M. tuberculosis H37Rv strain (4). Isoniazid and 
ethambutol were used as standard reference drugs. 
Antibacterial activity of the compound was performed 
against a range of Gram-positive and Gram-negative 
bacteria. Ampicillin was used control drug for testing 
antibacterial activity. (5).
RESULTS:
Some novel thioester derivatives bearing benzamido-
2-oxo alkyl moieties were obtained in good to 
excellent yield and their structure were elucidated. 
The tested compounds showed potential anti(myco)
bacterial activity. 
CONCLUSIONS:
A simple method was applied to synthesize the novel 
thioester derivatives bearing benzamido moiety and 
showed potential bioactivity when tested against 
M. tuberculosis H37Rv strain and Staphylococcus 
aureus (ATCC 25925), Escherichia coli (ATCC 
25923), Acinetobacter baumannii (ATCC 02026), 
Bacillus subtilis (ATCC 6633), Aeromonas hydrophila 
(ATCC 95080) bacteria.
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INTRODUCTION:
The indole ring is an important moiety found in many 
pharmacologically active compounds with a certain 
biological activities and its anticancer effectiveness 
was described in the literature (1). On the other 
hand, retinoids play essential roles in a variety of 
physiological processes including mediation of cell 
growth, differentiation, modulation of apoptosis (2). 
These properties of retinoids confer a significant 
therapeutic potential for the treatment of cancer (3). 
In the present study, we aim to reveal more active 
and less toxic some novel retinoid compounds 
consisting of tetrahydronaphthalene ring system 
which is integrated with substituted indole. For this 
purpose, novel N-(5-Substituted 1H-indol-1-yl)-
5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-
2-carboxamide derivatives (Fig.1) were synthesized 
and their anticancer effects were determined against 
the human leukemia cell line HL-60 in vitro.  




Figure 1. General structure of novel indole retinoid 
derivatives.
MATERIALS AND METHODS:
The targeted compounds were prepared by using 
the synthetic procedures described in our previous 
studies (4,5). Cytotoxic effects of compounds were 
tested in HL-60 cell line. For this purpose, MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) assay was performed
RESULTS:
Our results showed that compound 5a and 5b 
decreased HL-60 cell viability significantly (p <0.05) at 
different concentrations. 
CONCLUSIONS:
In this study, novel retinoid-indole hybride compounds 
were prepared and evaluated for their in vitro 
antiproliferative activities against HL-60 AML cells. 
Compound 5a exhibited remarkable cytotoxic 
activities. Further research is needed to elicit the 
mechanisms of their actions on cell viability. 
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INTRODUCTION:
Epidermal growth factor receptor (EGFR) tyrosine 
kinase is a member of the human epidermal growth 
factor receptor family, the overexpression of EGFR 
is observed in tumors from more than 60% of 
patients with metastatic non-small cell lung cancer 
and is correlated with poor prognosis. Therefore, 
EGFR is an attractive target for anticancer therapy 
and a larger number of EGFR inhibitors have been 
developed. Benzimidazoles have various activities 
and have versatile use in medicinal chemistry, it has 
been reported that third generation EGFR inhibitor 
nazartinib, which has benzimidazole structure (1). In 
this study, docking analysis of novel EGFR inhibitors 





















The X-ray structure of EGFR tyrosine kinase (2) in 
complex with erlotinib was obtained from protein data 
bank, PDB ID: 1M17. MGL Tools v.1.5.6. (3) was used 
to prepare the ligands and the receptor. Autodock_
vina v.1.1.2 (4) was used to dock the ligands into the 
binding site of EGFR. Docked ligands were analyzed 
with UCSF Chimera-1.7 (5).
RESULTS:
One hydrogen bond (2.26 Å) was observed between 
C=O of the compound 16 and LYS721 side chain. 
One hydrogen bond (2.36 Å) was also observed 
between NH of the triazole ring of the compound 16c 
and LYS721 side chain. It was shown that 16 and 16c 
were compatible with the active binding site thanks to 
van der Waals interactions between the molecule and 
the residues LEU694, LYS721, PHE699, THR766 in 
the binding pocket.
CONCLUSIONS:
Docking studies of some novel benzimidazole linked 
thiosemicarbazide and triazole derivatives were 
performed by using the X-ray structure of EGFR 
tyrosine kinase [2]. The docking analysis of the 
compounds revealed that hydrogen bonding with 
LYS721 and van der Waals interactions observed in 
the active site stabilize the molecules in the protein.
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P-481: IN VIVO ANTICONVULSANT 
ACTIVITY AND MOLECULAR MODELING 
STUDIES OF SOME NEW 1-PHENYL-2-(1H-
IMIDAZOL-1-YL)ETHANONE OXIME ESTERS
1,2 Yurtoglu, S., 1 Sari, S., 1 Sarac, S., 1 Dalkara, S.
1 Hacettepe University, Department of 
Pharmaceutical Chemistry, Ankara, Turkey
2Permanent address: Yenisehir Laboratory, Ankara, 
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INTRODUCTION:
(Arylalkyl)azoles emerged as a new class of 
anticonvulsants with nafimidone and denzimol (1). 
In this study a set of 1-phenyl-2-(1H-imidazol-1-
yl)ethanone oxime esters (1-5) were designed, 
synthesized, and their anticonvulsant activities 
were evaluated in vivo under the Epilepsy 
Therapy Screening Program (ETSP) of NIH. 
Their pharmacokinetic properties and possible 
anticonvulsant mechanisms were predicted in silico.






6 Hz MES Rotorod
Comp. R 0.5 h 2 h 0.5 h 2 h 0.5 h 2 h
1 -(CH2)2CH3 300 - 300 300 300 -
2 -CH=CHCH=CHCH3 300 - 300 300 300 -
3 -C6H11 100 300 100 - 300 -
4 -CH=CHC6H5 - - 300 - - -
5 -(CH2)2COC6H5 300 300 300 - 300 -
Results indicate the minimum dose (mg/kg) at which 
activity or toxicity was observed, “-” means no activity/
toxicity.
MATERIALS AND METHODS:
1-5 were prepared by the reaction of various 
carboxylic acids with 1-phenyl-2-(1H-imidazol-1-yl)
ethanone oxime. Their anticonvulsant identification 
was performed by the ETSP using 6 Hz, MES, and 
rotorod test in mice ip. ADMET descriptors were 
calculated using QikProp and molecular docking was 
run on Glide (Schrödinger, LLC, NY, 2018) (2) using a 
GABAAR homology model (3).
RESULTS:
Most of the compounds were found protective against 
certain seizures induced by 6 Hz and/or MES method. 
3 was active in 6 Hz test at 100 mg/kg and 0.5 h 
(Table). The compounds showed druglikeness and 
favorable ADMET properties according to the Qikprop 
calculations. The active compounds showed high 
affinity binding to the benzodiazepine binding site of 




esters proved promising regarding anticonvulsant 
activity, which might be due to allosteric activation of 
GABAAR.
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INTRODUCTION:
Cancer is a disease that requires long-term struggle in 
the material and spiritual direction besides the health 
problems brought with it. In the world, 14 million 
people have cancer every year, resulting in the death 
of 8.2 million people. In the family of metal-NHCs, 
Ag-NHCs have received a many attention because 
of their medicinal applications (1). In this study, we 
aimed to investigate the synthesis, characterization 
and anticancer activities of two new NHC ligands and 
their Ag(I) complexes on DU-145 human prostate 
cancer cells.
MATERIALS AND METHODS:
In this study we synthesized two novel 
unsymmetrically substituted NHC ligands (1a-b) 
and their Ag(I) complexes. All new compounds were 
characterized using elemental analysis, FT-IR, 1H 
NMR and 13C NMR spectroscopy. Compounds were 
further evaluated for their in vitro anticancer activities 
againts on DU-145 prostate cancer cells and L-929 
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RESULTS:
In vitro anticancer activitiy assays indicated that 
these novel compounds showed the dose and time-
dependent anticancer activity on DU-145 prostate 
cancer cells for 24 h, 48 h and 72 h treatment under 
identical conditions. Further, the ligands (1a-b) and 
their Ag-complexes (2a-b) had relatively higher 
cytotoxicity to DU-145 cancer cells than to L-929 non-
cancerous cell lines.
CONCLUSIONS:
The in vitro anticancer activity studies indicate that 
Benzimidazole-Based N-Heterocyclic Carbene(-
NHC) ligands and their silver-(I) complexes can inhibit 
the DU-145 prostate cancer cells proliferation.  
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INTRODUCTION:
Breast cancer represents the most commonly 
diagnosed cancer and the leading cause of cancer 
death in women worldwide, with approximately 1.7 
million cases (25% of all cancers) and 521,900 deaths 
recorded in 2012 (1). Recently, Ag-N-heterocyclic 
carbene (NHC) complexes appeared as an emerging 
field of research in medicinal chemistry (2). In 
this study, we aimed to investigate the synthesis, 
characterization and cytotoxic activities of two new 
benzimidazole-based NHC ligands and their Ag(I) 
complexes on breast cancer cells. 
MATERIALS AND METHODS:
In this study, two new NHC ligands (1a-b) and their 
Ag(I)-NHC complexes (2a-b) has been synthesized 
and characterized by elemental analysis, FT-IR, 1H 
NMR and 13C NMR spectroscopies. The cytotoxic 
activities of compounds were tested againts on MCF-
7, MDA-MB-231 human breast cancer cells and L-929 
non-cancerous cells  for 24 h, 48 h, 72 h using the 
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RESULTS:
The results showed that ligands and Ag(I)-NHC 
complexes exhibited cytotoxic activity against tested 
cell lines to a different degree. The cytotoxicity of 
the compounds were found to be concentration and 
time dependent. In addition, additional CH3 group in 
benzene ring increases the anticancer activity of the 
complexes.
CONCLUSIONS:
In vitro cytotoxicity assays indicated that these novel 
compounds showed the dose and time-dependent 
cytotoxic activity on breast cancer cells. The ligands 
(1a-b) and their Ag-complexes (2a-b) are more 
cytotoxic on breast cancer cell line than  L-929 healthy 
cells.
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IDENTIFICATION OF NOVEL INDOL-
THIAZOLIDINEDIONE DERIVATIVES
Baran, S., Zengin, F., Ates Alagoz, Z. 
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INTRODUCTION:
As part of an ongoing program aimed at recognizing 
novel antioxidant, antimicrobial, and anticancer 
molecules, herein we designed and synthesized new 
indole-thiazolidinedione derivatives as antimicrobial 
agents. Previously, we reported that synthesis and 
antimicrobial activity of new tetrahydro-naphthalane-
thiazolidinedione derivatives. Some of our compounds 
showed equal and /or greater antimicrobial activity 
against MRSA and EC than ampicillin and sultamicillin. 
To provide more effective therapeutic agents with the 
beneficial effects of indole rings but reduced side 
effects, we developed conformationally constrained 
indole moiety, which is integrated with thiazolidinedion 
ring system.  
MATERIALS AND METHODS:
Syntheses of the compounds were carried out 
starting from chloro acetic acide and thiourea to give 
thiazolidinedione(1). This was followed by reaction 
with potassium hydroxide to get potassium salt. 
Due to the labile hydrogen atom at the 3-position, 
the thiazolidine2,4-dione was N-alkylated with 
appropriate phenacyl halides in alkaline medium(2). 
The condensation of N-phenacyl intermediates 
with indole carboxaldehydes in methanol and in the 






derivatives were synthesized.  Purity control and 
structural elucidation were controlled by using 
elemental analyser and 1H, 13C-NMR, Mass 
spectrometers, respectively.Due to the labile hydrogen 
atom at the 3-position, the thiazolidine-2,4-dione was 
N-alkylated with appropriate phenacyl.
CONCLUSIONS:
Future studies will include testing antimicrobial 
activities of the synthesized compounds for their in 
vitro growth inhibitory activity against different bacteria 
and yeasts, and also determination of the minimal 
inhibitory concentration (MIC) of the compounds by 
the tube dilution technique. In order to improve the 
antimicrobial activity, chemical synthesis of additional 
indole-thiazolidinedione derivatives are warranted.
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INTRODUCTION:
Monoamine oxidase (MAO) possess two isoforms 
recognized as MAO-A and MAO-B and it plays an 
important role in the metabolism of endogenous and 
exogenous amines (1,2). The previous studies have 
displayed that benzothiazole derivatives have potent 
MAO enzymes inhibitor activity (3). Additionally, 
thiazolylhydrazine derivatives are frequently used 
due to their MAO enzyme inhibitor activities (4). 
Information of MAO enzyme inhibitor activities in both 
scaffolds (benzothiazole and thiazolylhydrazine) has 
prompted interest about the MAO enzyme inhibitor 
effects of compounds including these two scaffolds. 
Consequently, within the scope of this study, a series 
of new benzothiazole-thiazolylhydrazine derivatives 
were synthesized as MAO enzyme inhibitor. 
MATERIALS AND METHODS:
In this study, benzothiazol-2-yl-N-(4-phenylthiazol-2-
yl) benzohydrazonothioate was synthesized and 14 
final compounds were obtained by derivatizing ortho 
and para position of phenyl directly bonded to thiazole 
ring. The structures of the synthesized compounds 
were elucidated using FT-IR, 1H-NMR, 13C-NMR, 
and HRMS spectral data. The inhibitory activity of the 
obtained compounds against hMAO-A and hMAO-B 
enzymes was evaluated by using in vitro Amlex Red® 
reagent based fluorometric method (5).
RESULTS:
Most of the obtained compounds displayed important 
inhibition against MAO enzymes. 
CONCLUSIONS:
According to results of activity studies, it is obvious 
that the benzothiazole-thiazolylhydrazine derivatives 
are potent monoamine oxidase inhibitors 
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INTRODUCTION:
The discovery of antibiotics made it possible to treat 
the infectious diseases that were once untreatable 
and enabled to save millions of lives by taking 
many dangerous bacterial infections under control. 
However, with the occurrence of bacterial resistance 
and in regard to the increasing incidence of multidrug 
resistance in pathogenic bacteria, the identification 
of alternative antimicrobial drug targets to develop 
novel treatment strategies have become a necessity. 
One such new strategy is the disruption of bacterial 
quorum sensing (QS) system. By using this system, 
in an attempt to develop potent anti-biofilm agents, 
herein we represented the synthesis, characterization 
and anti-biofilm activities of novel urea/thiourea 
derivatives.
MATERIALS AND METHODS:
The final compounds were obtained by the 
reaction of gabapentine with different isocyanates/
isothiocyanates and tested for their quorum sensing 
inhibitory (QSI) capacity using quorum sensing 
inhibitor selector 1 (QSIS1) bioassay (1,2).
RESULTS:
The structures of the compounds were characterized 
by various spectroscopic methods (IR, 1H-NMR, 
13C-NMR, MS), besides elemental anaysis. 
Additively, their anti-biofilm activity was examined by 
using the QS system which has been shown to control 
production of an array of extracellular virulence factors 
and the formation of biofilm in a variety of bacterial 
pathogens including Pseudomonas aeruginosa (3).
CONCLUSIONS:
In summary, a new series of urea/thiourea derivatives 
have been successfully synthesized starting from 
[1-(aminomethyl)cyclohexyl]acetic acid, their 
structures were elucidated and finally they were 
evaluated as potential anti-biofilm agents.
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INTRODUCTION:
Today, a great number of antibiotics and synthetic 
drugs are used in clinic for the treatment of commonly 
occurring microbial infections. But along with their 
widespread use, the emergence of multidrug-
resistant strains of pathogens reduce the efficacy 
of these drugs. Imidazole nucleus, which exhibit a 
wide range of medicinal potential, is a quite important 
heterocycle for drug design due to its ability to readily 
interact with diverse biological targets such as DNA, 
receptors and critical enzymes (1). Ornidazole is a 
chiral 5-nitroimidazole class antimicrobial agent and 
used for the prophylaxis and treatment of susceptible 
protozoal and anaerobic bacterial infections (2). In 
this study, new ether linked ornidazole derivatives 
were designed, synthesized and characterized 
for evaluation of their antimicrobial activity, since 
imidazole-containing derivatives exhibit various 
biological activities and pharmacological properties 
including antimicrobial activity (3).
MATERIALS AND METHODS:
All solvents and reagents were obtained from 
commercial sources and used without purification. For 
antimicrobial activity, the sensitivity of the bacterial 
strains towards the compounds was evaluated from 
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the minimal inhibitory concentration (MIC) and zone 
diameter (mm) values obtained by the micro-well 
dilution and disk diffusion methods. The antibacterial 
activity of the compounds were evaluated against 6 
cultures. The microorganisms used were Escherichia 
coli ATCC 10536, Staphylococcus aureus ATCC 6538, 
Pseudomonas aeruginosa ATCC 15442, Bacillus 
subtilis ATCC 6633,  Candida albicans ATCC 10231 
and Aspergillus niger ATCC 16404. Antimicrobial 




5-nitroimidazole was reacted with various phenolic 
compounds using acetonitrile as a solvent  in order to 
obtain new ether-linked derivatives. Characterization 
of the synthesized compounds were achieved by the 
elemental analysis,  IR, 1H-NMR and mass spectral 
data while their purities were proved by TLC and 
HPLC. According to biological evaluation findings, 




propan-2-ol showed best activity against Bacillus 
subtilis with MIC values of  4mg/ml.
CONCLUSIONS:
In the present research, we aimed at obtaining new 
1-(2-methyl-5-nitro-1H-imidazol-1-yl)-3-(substituted 
phenoxy)propan-2-ol derivatives as potential 
antimicrobial agents which were synthesized 
from ornidazole. As conclusion, the synthesized 
compounds have been exhibited moderate to high 
activities against Bacillus subtilis.
REFERENCES:
1.  Wen et al., (2016). Bioorganic and  Medicinal 
Chemistry Letters, 26:2768-2773.
2.  Singh et al., (2003). Profiles of Drug Substances, 
30:123-184.
3.  Kim et al., (2013).  Bioorganic and  Medicinal 
Chemistry Letters, 23:4315-4318.
4.  Kalaycı et al., (2016). Infectious Disorders - Drug 
Targets,  16:44-53.
5.  Kalaycı et al., (2014). Current 
Psychopharmacology,  3:195-202.
P-489: ANTIBACTERIAL SCREENING 
OF AN IN-HOUSE AZOLE OXIME ESTER 
LIBRARY
1 Sari, S., 2 Kart D., 3 Karakurt, A.,1 Sarac, S., 1 
Dalkara, S.
1 Hacettepe University, Department of 
Pharmaceutical Chemistry, Ankara, Turkey
1 Hacettepe University, Department of 
Pharmaceutical Microbiology, Ankara, Turkey
1 Inonu University, Department of Pharmaceutical 
Chemistry, Malatya, Turkey
INTRODUCTION:
Azoles are a rare class of antibiotics used against 
some anaerobes and parasites (1). Some (arylalkyl)
azoles in oxime ether structure were previously 
reported to show potent antibacterial effects (2). 
Thus, we performed antibacterial testing of an 
in-house library made up of 37 compounds in 
1-(2,4-dichlorophenyl)-2-(1H-imidazol/1,2,4-triazol-1-





















Synthesis of 1-37 was previously reported (3). Their 
minimum inhibitor concentration (MIC) values were 
determined against ATCC strains of Staphylococcus 
aureus, Enterococcus faecalis, Pseudomonas 
aeruginosa, and Escherichia coli using Broth 
microdilution method according to the Clinical & 
Laboratory Standards Institute (CLSI) guidelines (4). 
Ciprofloxacin and gentamicin were used as positive 
controls.
RESULTS:
Most of the compounds showed growth inhibition 
against the tested bacteria although their MIC values 
were higher than the reference drugs. Compound 4, 
12, and 14 were the most potent with a MIC value of 
64 µg/mL. 
CONCLUSIONS:
Although less potent than the reference drugs, 
1-(2,4-dichlorophenyl)-2-(1H-imidazol/1,2,4-triazol-
1-yl)ethanone oxime esters proved promising 
antibacterial compounds for the future studies.
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INTRODUCTION:
Quinoxaline which is one of the Heterocyclic rings 
containing nitrogen exhibits a broad spectrum of 
biological activity such as antimicrobial, antiviral 
and anticancer (1). It may act as bioisostere of both 
pteridine and quinazoline rings present in the most 
representative drugs as methotrexate, trimetrexate 
and tomude (2). On the other hand, literature survey 
revealed that hydrazone moiety has significant role 
as antitumoral activity which makes it  important for 
the anticancer drugs (3). In the light of these facts, 
a series of quinoxaline derivatives were synthesized 
and evaluated for their cytotoxic activity against A549, 
U2OS, HeLa and 293T cell lines.
MATERIALS AND METHODS:
2,3-dihydroxyquinoxaline, 2,3-dichloroquinoxaline 
and 2 different quinoxaline dedicated with heterocyclic 
rings  substituted to hydrazone derivatives (Figure 1) 
were prepared following the procedure (4). Structures 
of the target compounds were verified by spectral 
analysis. Cytotoxic  activities of the compounds 
were determined by WST-1 cell proliferation assay. 
Doxorubicin was used as positive control.
RESULTS:
All synthesized compounds exhibited cytotoxic activity 
with comparable  IC50 values against tested cell lines, 
In general, all synthesized compounds have lower 
cytotoxic activity than the reference drug doxorubicin. 
Compound 2 was the most active against U2OS cell 
line.
CONCLUSIONS:
Our preliminary activity screening results have 
demonstrated that this class of quinoxaline derivatives 
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Figure 1
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INTRODUCTION:
Infectious diseases remain a major worldwide health 
problem due to the rapid development to the existing 
antimicrobial drugs. The increasing of usage or 
misusage of the existing antimicrobial drugs have 
resulted in the development of resistant pathogens 
(1, 2). Recent studies reflect that considerable 
antibacterial and antifungal activity had been exhibited 
by 1,3,4-oxadiazole structure and in this experiment 
pharmaceutically active 1,3,4-oxadiazole ring is 
suitably substituted with piperidine derivatives from 
its spesified positions with modified organic reaction 
mechanisms. Motivated by the previous studies, we 
are purposed to investigate the antibacterial and 
antifungal activity of our newly synthesized compound 
series. 
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MATERIALS AND METHODS:
The synthetic pathway was started with Fischer 
esterification of substituted benzoic acid in acidic 
media with alcohol and resulted ester functional 
group was converted to acid hydrazide with hydrazine 
hydrate. Produced hydrazid group was cyclized with 
carbon disulfide and potassium hydroxide to obtain 
main structure. For the last step by using Mannich 
reaction procedure; substitutedpiperidine derivatives 
and oxadiazole ring were combined with methylene 
bridge (3). For biological activity; derived compounds 
were screened for their antimicrobial performance 
against a series of bacteria and fungus by disc-
diffusion method.
RESULTS:
Synthesized compounds were characterized by 
IR, 1H-NMR , 13C-NMR and all of them gave 
satisfactory analytical and spectroscopic data 
which were in full accordance with their depicted 
structure. The molecular structures were confirmed 
on the basis of their spectral data and the purity was 
checked by elemental analysis. Most of them were 
displayed variable inhibitory effects on the growth of 
microorganisms.
CONCLUSIONS:
A total analysis of the antibacterial, antifungal and 
antiyeast activity revealed that new structures were 
showed severe activity against Bacillus cereus, 
Bacillus ehimensis and Bacillus thuringiensis species 
according to oflaxacin and these observations may 
promote a further development through structural 
modification of 1,3,4-oxadiazole from different 
position-derivative combinations in which may result 
as better antimicrobial activity on more species.
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methyl-4H-pyrido  [1,2- a]  pyrimidin-4-one), is an 
antipsychotic agent used for the treatment of both 
positive and negative symptoms of schizophrenia. 
Its effects is observed by blocking seratonin 5-HT2 
and dopamine D2 receptors (1,2). Risperidone 
is mainly metabolized in the liver by cytohrome 
p450 isoenzymes (CYP2D6) to main metabolite of 
risperidone, 9-hydroxyrisperidone which has a similar 
pharmacological activity as the parent compound. For 
adequate support of clinical studies with risperidone, 
an analytical method is required for the determination 
of plasma levels of both risperidone itself and its 
active metabolite 9-hydroxyrisperidone. 
MATERIALS AND METHODS:
The chromatographic separation was performed on 
a Sunfire C18 analytical column at a temperature of 
25 ºC. The mobile phase was ammonium acetate: 
acetonitrile (60:40 v/v) with 0.15 mlmin-1 flow rate and 
injection volume of sample was 20 µl. 
RESULTS:
In these conditions retention times for risperidone, 
9-hydroxyrisperidone and the IS were approximately 
1.46 min., 1.32 min. and 2.68 min., respectively 
and the total run time was 6 min. The analytes 
were ionized in the positive electrospray ionization 
ion source (ESI+) of the mass spectrometer in the 
selected ion monitoring mode (SIM). Risperidone, 
9-hydroxyrisperidone and the internal standard 
quetiapine fumarate were identified at m/z 411, 427, 
and 384, respectively. 
CONCLUSIONS:
A simple and sensitive LC-MS method for the 
determination of risperidone and 9-hydroxyrisperidone 
in human plasma has been developed and validated.
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INTRODUCTION:
The incidence of infection by opportunistic and 
pathogenic fungi has been increasing in recent years 
(1).Currently, the available antifungal agents to treat 
fungal infections can be divided into four categories 
based on their mode of action, including the polyenes, 
echinocandins, azoles, and antimetabolites. Clinically, 
representative antifungal drugs have certain 
limitation such as, narrow spectrum of activity and 
the emergence of drug resistance (generally azoles).
Therefore, there is an urgent need for development 
of antifungal agents of new molecular scaffolds 
with high efficiency, broad spectrum and optimal 
pharmacokinetics are highly desirable (2,3).  
MATERIALS AND METHODS:
Target compounds (2a-2j) were synthesized via 
reaction of 2-bromo-4’-trifluoromethylacetophenone 
and corresponding mercaptobenzazole. Antifungal 
activity studies were performed according to EUCAST 







Synthesized compounds showed antifungal activity 
against Candida species to different rates. In the 
series, compound 2i was the most active derivative 
that displayed noncytotoxicity.
CONCLUSIONS:
The synthesized compounds displayed promising 
antifungal activity compared to the standard drugs. 
We expect that findings of the present study may 
have an effect on medicinal chemists to discover more 
active anticandidal compounds in further studies.
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INTRODUCTION:
Quinazolinones are important compounds possessing 
wide range of biological applications. Some of these 
could be list as antimalarial, anticonvulsant, anti-
inflammatory and analgesic agents, antiviral, CNS 
depressant, antimicrobial(1). The aim of this study is to 
synthesize and investigate antimicrobial and cytotoxic 
activity of derivatives of 2-metil-3H-quinazolinone, 
which are 2-metil-3-fenil-3,4-dihidrokinazolin-4-on 
(2), 2-metil-3(4-hidroksifenil)-3,4-dihidrokinazolin-4-
on (3), 2-metil-3(4-nitrofenil)-3,4-dihidrokinazolin-4-on 
(4), compounds.
MATERIALS AND METHODS:
Compounds 1-4 have been prepared according to the 
published methods (2).
All compounds were characterized via infrared, 
1H-NMR, 13C-NMR, elemental and mass spectral 
analysis. In antimicrobial activity studies were used 
microdilution methods. In this study, the compounds 
2-4 were examined antimicrobial activity against 
some selected Gram-negative and Gram-positive 
bacteria and compared with commercial antibiotics.
The compounds were screened for their antimicrobial 
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activity in vitro against E. faecalis ATCC 29212, P. 
aeruginosa ATCC 27853, S. aureus ATCC 29213, 
E. Coli ATCC 25922 bacteria and compared with 
commercial antibiotics (Ampicillin and Gentamicin). 
Effects of compounds on the proliferation of gingival 
fibroblasts observed. Cells were examined for 88h 
using a real-time cell analyzer.
Results:2 and 4 showed the lowest MIC value (64 
µg/mL) against Pseudomonas aeruginosa strain and 
this value is higher than the gentamicin but lower 
than ampicillin. Clear cytotoxic effects on proliferation 
of the gingival fibroblasts were observed in 3 and 4 
chemical substance applications immediately after 
treatment when compared to the control group
CONCLUSIONS:
MIC value (128 µg/mL) of compounds 3 against 
Pseudomonas auriginosa is the same as with 
ampicillin, while the MIC value (64 µg/mL) of 
compounds 2, and 4 is lower than ampicillin.
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INTRODUCTION:
Monoamine oxidase (MAO) enzymes have been 
crucial targets in drug design for the treatment of 
psychiatric and neurological disorders (1). MAO-A 
inhibitors are clinically used mostly as antidepressants 
(2) whereas MAO-B inhibitors are generally used in 
dealing with symptoms associated with Parkinson’s 
and Alzheimer’s diseases (3). Despite their long 
clinical success, first-generation MAO inhibitors 
have several problems including interactions with 
other drugs and tyramine, which is a dietary amine 
and may cause a fatal hypertensive crisis. In view of 
these adverse actions and restrictions, the clinical 
use of first generation of MAO inhibitors have 
been decreased whereas second generation MAO 
inhibitors such as selegiline and moclobemide have 
come into prominence due to lack of above problems. 
In view of information mentioned above, researchers 
have shown an increased interest in developing 
novel and potent MAO inhibitors. In the light of above 
information, herein we report the synthesis and 
MAO inhibitory activity of some novel pyrazolinone 
derivatives.
MATERIALS AND METHODS:
The structure confirmation of the synthesized 
compounds was performed using FT-IR, 1H-NMR, 
13C-NMR, and HRMS spectral data. Their inhibitory 
activity of the final compounds against hMAO-A and 
hMAO-B enzymes was evaluated by using in vitro 
Amplex Red® reagent based fluorometric method 
(4). Docking studies were carried out by using 
Schrödinger Maestro interface (5) to view the binding 
modes of most potent derivative in the enzyme active 
site.
RESULTS:
According to the enzyme inhibitory studies, enzyme 
inhibition profile of the synthesized compounds against 
MAO-B enzyme were better than those of MAO-A 
enzyme. So, it was shown that compounds displayed 
MAO-B inhibition selectivity. Among the series, ANT-
13 was found as the most active derivative with IC50 
value of 0.0489 ±0.0016 µM. Docking studies have 
shown that this derivative is well placed in the active 
site of the enzyme.
CONCLUSIONS:
Consequently, synthesized compounds have been 
found as selective MAO-B inhibitors and some of final 
compounds displayed potent inhibition profile. 
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INTRODUCTION:
2(3H)-Benzoxazolone derivatives are considered 
ideal scaffolds for synthesis of drug candidates (1). 
They have been of interest in medicinal chemistry 
since they are readily available, affordable, 
susceptible to chemical modifications and most 
importantly exhibit wide range of biological activities. 
Their pharmacological activities include antibacterial, 
antifungal, analgesics-antiinflammatory,anti-
nociceptive, antiulcer, anticancer, and anti-HIV (2-3). 
MATERIALS AND METHODS:
All chemicals and reagents were obtained from 
Sigma Aldrich Chemical Co. or Riedel Chemical Co. 
and were used without further purification. The FT-
IR spectra of the compounds were recorded on a 
Perkin Elmer Spectrum 100 spectrophotometer with 
attenuated total reflection (ATR) (in wave numbers) 
in cm-1. The 1H and 13C NMR spectra of the 
compounds were recorded on a Mercury Varian 400 
MHz NMR Spectrometer using deuterated chloroform 
(CDCl3) as solvent. Chemical shifts (δ) values were 
reported in parts per million (ppm). 
RESULTS:
We have already synthesized and characterization of 
two sets of 6-acyl-2(3H)-Benzoxazolone derivatives. 
One is piperazino ketone family and the other is the 
reduced form, piperazino ethanol family. General 



















R = 2-(pyrimidyl), 1-Naphthylmethyl,  Diphenylmethyl, 
2-Furoyl, 2,5-Dimethylphenyl, 2-Methylbenzyl, 
4-bromophenyl, 4-Nitrophenyl
CONCLUSIONS:
In conclusion, we have synthesized 6-acyl substituted 
2(3H)-Benzoxazolinone derivatives. The antimicrobial 
studies ongoing at Microbiology Laboratories at Near 
East University Hospital.
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INTRODUCTION:
Cancer is still a prominent public health problem 
which is characterized by the uncontrolled cellular 
proliferation and invasion to other parts of the body. 
Although the treatment of cancer comprises surgery, 
chemotherapy and radiotherapy, the main approach 
is chemotherapy which is more common, easy and 
practicable. However, low bioavailability, toxicity and 
non-selective nature of anticancer drugs and drug-
resistance are certain obstacles that limit their usage 
(1,2). Therefore, the identification of novel, more 
potent, selective, and less toxic antitumor agents is 
a vital need. Diverse bis(1,3,4-thiadiazole) derivatives 
have exhibited anticancer activity (3).  Some studies 
showed that 1,3,4-thiadiazole compounds have been 
reported to act through many mechanisms including 
caspase activators, tyrosine kinase inhibitors, 
carbonic anhydrase inhibitors (4). In this present 
study, some novel bis(1,3,4-thiadiazole) derivatives 
were synthesized and their potential anticancer 
activities were examined.
MATERIALS AND METHODS:
The cytotoxicity of the compounds was evaluated 
against some tumor cells and NIH/3T3 (mouse 
embryonic fibroblast cells) healthy cells by MTT assay 
(5). The chemical structures of the compounds were 
confirmed by IR, 1H NMR, 13C NMR and MS spectral 
data.
RESULTS:
The synthesized compounds indicated cytotoxic 
activity to different extends.
CONCLUSIONS:
This study increased the importance of bis(1,3,4-
thiadiazole) compounds in the investigation of 
chemotherapeutic drugs. 
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INTRODUCTION:
Fungal infections have a continuous and serious 
threat to human health. The increased incidence of 
fungal infections is mainly due to an increase in the 
number of patients resistant to antifungal agents 
(1). It is obvious that azole derivatives represent 
a series of synthetic compounds of significant 
antifungal activity. The azoles show antifungal activity 
by inhibiting lanosterol 14α-demethylase. In other 
respects, it is well known that 1,3,4-thiadiazoles plays 
an important role for anticandidal activity (2,3). By 
virtue of the above consequence, in the present study 
novel 1,3,4-thiadiazole derivatives were synthesized 
to evaluate their antifungal activity.
MATERIALS AND METHODS:
The structures of the synthesized compounds were 
elucidated using FT-IR, 1H-NMR, 13C-NMR, and 
HRMS spectral data. Antimicrobial activity screening 
was performed according to EUCAST definitive method 
EDef 7.1 (4). Synthesized compounds were tested 
for their in vitro growth inhibitory activity against C. 
glabrata (ATCC 2001), C. parapsilosis (ATCC 22019), 
C. krusei (ATCC 6258), C. tropicalis (ATCC 13803), 
C. famata (Abant İzzet Baysal University Medical 
Faculty Hospital, clinic izolate), C. lusitaniae ( Abant 
İzzet Baysal University Medical Faculty Hospital, clinic 
izolate) and C. albicans (ATCC 90028, ATCC 10231).
RESULTS:
Antimicrobial activity test revealed that the most 
active compound 3m (MIC=5 µg/ml) possesses 4 fold 
greater anticandidal effect than fluconazole (MIC=20 
µg/ml) against C.albicans.
CONCLUSIONS:
It was observed that presence of 2,4-dichlorophenyl 
moiety enhances the anticandidal activity, significantly.
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INTRODUCTION:
Syntheses of new benzimidazoles substitued at 
C-5 with several amidine derivatives were reported 
by us recently. These compounds showed a good 
activity profile as to Gram-positive bacteria and fungi. 
Compounds having bulky alkyl substituted at the 
N1-position of benzimidazole exhibited the greatest 
activity against S. aureus, MRSA, C. albicans and C. 
krusei of 0.78 - 1.56 μg/mL MIC values. In an attempt 
to find more active agents, we describe herein 
the synthesis of new analogues benzimidazoles 
substitued at C-5 with amidine and linked with indole 
ring at C-2 positions.  
MATERIALS AND METHODS:
Several 1-substitue-2-(1H-indol-3-yl)-N-substitue-
1H-benzimidazole-5-carboxamidine analogues were 
synthesized for their biological activities. Syntheses of 
new amidinobenzimidazoles were carried out starting 
from aromatic nucleophilic substitution of the chlorine 
atom of 4-chloro-3-nitrobenzonitrile with appropriated 
amines to provide the corresponding 3-nitro-4-
substituted-aminobenzonitriles in good yields. The 
nitriles were converted to imidate esters with dry HCl 
gas in absolute ethanol and following reaction with 
various amines in ethanol gave the intermediate-
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amidines. Reduction of nitro group with hydrogen gas 
by using palladium carbon and condensation of these 
derivatives with indole carboxaldehyde gave the 
targeted indole-benzimidazoles. Antimicrobial activity 
of all final compounds was evaluated in vitro against 
Gram positive bacteria S. aureus (ATCC 25923), 
Methicillin-resistant S. aureus (MRSA, ATCC 43300), 
and S. epidermidis (ATCC 12228). 
RESULTS:
In this group, compound 11 showed the best result 
with a MIC value of 3.12 lg/mL against to MRSA, which 
is equal to Ampicilline. Also, compound 11 has activity 
against S. aureus, and S. epidermidis with 3.12 lg/mL, 
6.25 lg/mL MIC values, respectively. Due to the labile 
hydrogen atom at the 3-position, the thiazolidine-2,4-
dione was N-alkylated with appropriate phenacyl
CONCLUSIONS:
Future studies will include testing antimicrobial 
activities of the synthesized compounds against 
different bacteria and yeasts. In order to improve the 
antimicrobial activity, chemical synthesis of additional 
Novel Monocationic Indole-Benzimidazole derivatives 
are warranted.
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INTRODUCTION:
Receptor tyosine kinases (RTK) play a major role in 
signal transduction pathway that regulates critical 
cellular processes such as cell growth, proliferation, 
differentiation, migration and metabolism (1). 
Pyrrolo[2,3-d]pyrimidine are purine analogs that 
demonstrate a variety of biological activities such as 
antibacterial, antiviral, anticancer, anti-inflammatory, 
and antihyperglycemic activities (2). There are 
several pyrrolo[2,3-d]pyrimidine derivatives of RTK 
inhibitors such as AE788 and PKI166. In this paper, 
in vitro VEGFR-2, EGFR and PDGFR-β tyrosine 
kinase inhibitory activities of several pyrrolo[2,3-d]
pyrimidines were evaluated. In addition, molecular 
docking studies of the active compounds with 
VEGFR-2, EGFR and PDGFR-β tyrosine kinases 
were carried out to speculate the possible binding 
mode of these molecules in the active site of target 
enzymes.
MATERIALS AND METHODS:
At present study, we evaluated the effects of test 
compounds on receptor tyrosine kinases such as 
VEGFR-2, EGFR ve PDGFR-β. The assays were 
performed using KDR Kinase Enzyme System 
Analysis Kit (Promega, #V2681), EGFR Kinase 
Enzyme System Analysis Kit (Promega, #V3831) 
and PDGFR-β Kinase Enzyme System Analysis Kits 
(Promega, #V3731) according to the manufacturer’s 
instructions. The molecular docking studies were 
confirmed using Autodock vina program.
RESULTS:
Among the tested compounds, 9a, 9b and 11b 
exhibited the weak inhibitory activities against 
VEGFR-2, EGFR and PDGFR-β, respectively. 
Molecular docking studies showed that one or 
two hydrogen bonding interactions were found 
between compounds 9a, 9b, 11b and VEGFR-2, 
EGFR,PDGFR-β tyrosine kinases, respectively. 
CONCLUSIONS:
All of the compounds exhibited poor inhibition on the 
tested RTKs. To obtain better activity results, it may 
be necessary to design some compounds showing 
more interaction with the target proteins 
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INTRODUCTION:
Obesity is a chronic disorder with increasing 
prevalence worldwide and occurs when energy intake 
is greater than energy expenditure. Oxidative stress is 
one of the factors that cause obesity and arises from 
an imbalance between the reactive oxygen species 
and cell’s antioxidant defense system. Increasing 
ROS in obesity has an effect on the hypothalamic 
neurons which are involved in hunger and satiety 
control and consequently body weight control. On the 
other hand, weight loss due to calorie restriction or 
exercise reduces oxidative stress. Mitochondria is the 
most important source for ROS formation. In electron 
transfer system, reactive oxygen species forming as 
a result of oxidative phosphorylation reactions are 
involved in various physiological processes such as 
cell proliferation and differentiation. For the first time 
in our work, we investigated the role of GSTM1 and 
GSTT1 isoenzymes in obesity which has apoptosis 
mechanisms and cell cycle regulation in Turkish 
population.
MATERIALS AND METHODS:
In this study planned, in the light of this information, 
the role of GSTM1 and GSTT1 isoenzymes in 152 
patients diagnosed with obesity was investigated.
RESULTS:
Findings have been shown to increase oxidative 
stress by GSTM1 and GSTT1 isoenzymes mutation in 
obese patients. There were no statistically significant 
associations between BMI, TSH, glucose, satiety 
blood glucose, triglyceride and cholesterol levels with 
GSTM1 and GSTT1 isoenzymes mutation in obesity 
patients. 
CONCLUSIONS:
Our study supports the role of GSTM1 and GSTT1 
isoenzymes, an important gene, in the development 
of obesity.
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INTRODUCTION:
Chemotherapy is widely administered for the treatment 
of breast cancer. However, despite its success, 
resistance to chemotherapeutic agents is a common 
occurrence that is often attributable to mechanisms 
of multidrug resistance (MDR) (1). Chemoresistance 
is a multifactorial phenomenon and many studies 
clearly show that a coordinated expression of efflux 
transporter proteins and glutathione S-transferases 
(GSTs) in tumor cells is linked to the development 
of the multidrug resistance phenotype (2, 3). GST 
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is known to mediate biotransformation of various 
anticancer drugs and its elevated has been reported 
in various resistant cancer cell lines like MCF-
7. In particular, the overexpression of glutathione 
S-transferases and efflux pumps in tumors may 
reduce the reactivity of various anticancer drugs. 
p38, bcl-2 and caspase-3 have a role in apoptosis (4, 
5). In this study, immunocytochemical expressions 
of GST Alpha-1 (GSTA-1), GST Mu-1 (GSTM1), 
GST Theta-1 (GSTT1), GST Pi-1 (GSTP1), GST 
Omega-1 (GSTO1), GST Zeta-1 (GSTZ1), GST 
Sigma-1 (GSTS1), GST Kappa-1 (GSTK1), p38, bcl-
2 and caspase-3 were examined in MCF7 human 
breast cancer cell line before and after Doxorubicin 
treatment.
MATERIALS AND METHODS:
Doxorubicin was added at a concentration of 0, 1, 2,5 
or 5 μM and cells were continuously treated at 37°C 
and 5% CO2 for 10–12 days for colony formation. 
After incubation, colonies were washed in PBS, fixed 
with methanol for 15 min and washed in PBS. The 
harvested breast cells were immunostained. 
RESULTS:
Treated and untreated cancer cells were scored 
according to their immunostaining intensity. The 
GSTP1, GSTT1, GSTM1, GSTA1, GSTO1, GSTZ1 
and GSTK1 expressions were higher in treated breast 
cancer cells than those in untreated doxorubicin 
human breast cancer cells. Similarly, the p38, bcl-2 
and caspase-3 expressions were higher in treated 
breast cancer cells than that in untreated doxorubicin 
human breast cancer cells. However, there was no 
statistical difference in GSTS1 expression.
CONCLUSIONS:
In conclusion, elevated expressions of GSTP1, 
GSTT1, GSTM1, GSTA1, GSTO1, GSTZ1, GSTK1, 
p38, bcl-2, p53 and caspase-3 might be important in 
doxorubicin resistance in breast cancer.
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INTRODUCTION:
Risk assessment is a multi step procedure that 
comprises data collection, exposure assessment, 
toxicity assessment and risk characterisation. Due to 
the children’s low tolerance to pollutants, the health 
risk is very high for children’s population. The aim of 
this study was to estimate the risk posed to children’s 
health based on the content of heavy metals found 
in the soils of the children’s playgrounds in Sarajevo 
urban area.Cd, Pb, Cr, Ni, Cu, Zn, Co, Fe, Se and As 
were identified as potential hazardous agents in soils 
at playgrounds.
MATERIAL AND METHODS:
Analysis of contamination of soil samples has been 
carried out, with soil samples having been taken from 
selected children’s playgrounds which are situated 
close to potential polluters in the area of Sarajevo city. 
In order to asses the health risk posed to children and 
adults, the content of heavy metals, namely of Cd, Pb, 
Cr, Ni, Cu, Zn, Co, Fe, As, has been measured and 
the hazard coefficient (HQ) and non-cancerogenic 
hazard index (HI) have been calculated. 
RESULTS:
The results have shown that the soil in the children’s 
public playgrounds in Sarajevo city can be identified 
as mildly to excessively contaminated, and mildly to 
moderately soiled with heavy metals. Calculations 
have shown that values obtained for HQ and HI in 
children’s playgrounds are lower than the standard 
values equal to 1, so that they do not pose risk for 
adults. The highest values of HI are obtained if taken 
orally, and the lowest if inhaled. The highest values of 
HI are obtained for Cr.  
CONCLUSIONS:
In conclusion, public children’s playgrounds in 
Sarajevo can be regarded as areas of high risk for 
children’s health and children represent the highest 
portion of visitors to such places. Generally speaking, 
the soil contaminated with heavy metals can be used 
as a diagnostic  tool to assess health risks posed to 
children and adults. 
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INTRODUCTION:
Fluorescence carbon nanoparticles (CNPs or 
C-dots, CDs) are often used in bio-imaging, sensor 
applications, and photocatalytic processes etc.. 
Moreover, due to their small size, they also have 
been investigated for their potential as multifunctional 
vehicles for drug delivery, with a specific focus on 
drug delivery to the nucleus (1-4). This opens the 
questions on the requirement of genotoxicity studies 
combined with cytotoxicity assessments. 
Material and methods: In this study, in vitro genotoxicity 
and clastogenicity of carbon dots synthesized from 
both ethanolic (C-DotE@PEG) and aqueous(C-
DotW@PEG) extract of Nerium oleander were 
performed on human breast cancer cell lines (MCF-
7). Three different C-dots concentrations (0.25, 2.5 
and 50 ppm) were evaluated via comet assay (Single 
Cell Gel Electrophoresis, (SCGE)) and cytokinesis-
block micronucleus test (CBMN) methods in a time 
range of 72 h. In this study, in vitro cytokinesis-block 
micronucleus testing of nanomaterials was based on 
the draft OECD guideline (OECD TG 487) (5).  
RESULTS:
As a summary, although cytotoxicity findings 
showed that C-dots were synthesized from aqueous 
(C-DotW@PEG) and ethanolic (C-DotE@PEG) 
extracts of Nerium oleander were not dramatically 
toxic on MCF-7 cells they showed different levels of 
genotoxicty and clastogenicity over the cells due to 
time and concentration. 
CONCLUSIONS:
Further studies are warranted to evaluate the toxicity 
of C-dots depending on particle size and surface 
properties along with investigating the mutagenicity or 
carcinogenicity of C-DotE@PEG and C-DotW@PEG 
on mammalian cells for offering certain cautions and 
assessing their risks on humans.
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INTRODUCTION:
Bisphenol A (BPA) and di (2-ethylhexyl) phthalate 
(DEHP) are endocrine disruptor chemicals which 
are used in a wide variety of industrial products (1). 
Exposure to these substances is increasing due to 
their abundant use in daily life (1). Prenatal and early 
postnatal exposures is more critical and can lead to 
serious toxic effects like reproductive problems and 
hormonal disturbances (1). The aim of this study was 
to evaluate the prenatal and early postnatal (lactation) 
effects of BPA and/or DEHP exposure on sperm 
parameters and testicular oxidative stress in rats.
MATERIALS AND METHODS:
Pregnant Sprague-Dawley rats were divided 
randomly to four groups (n=3/group). Control group, 
DEHP group (30 mg/kg/day), BPA group (50 mg/kg/
day) and DEHP-BPA group (30 mg/kg/day DEHP 
and 50 mg/kg/day BPA) were exposed through 6-21 
gestational days and lactation period by intra-gastric 
lavage. Male offspring (n=6/group) from each mother 
were fed until the end of twelfth postnatal week, 
were then euthanized and sperm parameters (count, 
motility and morphology) were readily determined. 
Oxidative stress parameters (lipid peroxidation, 
protein oxidation, glutathione levels, and oxidative 
DNA damage) were investigated in testicular tissue 
homogenates. 
RESULTS:
Both sperm counts and motilities were significantly 
lower in all of the study groups vs. control (p<0,05). 
Normal sperm morphology was also markedly lower 
in all of the study groups vs. control (91% in control, 
72% in DEHP group, 61% in BPA group and 42% in 
DEHP+BPA group) (p<0,05). Total glutathione levels 
were significantly decreased in BPA, DEHP and 
BPA+DEHP groups versus control (31%, 27% and 
26%, respectively). Lipid peroxidation (MDA) levels 
were higher in DEHP and DEHP+BPA groups versus 
control (%28 and %60, respectively; p <0,05, both). 
These results show that early-life exposure to EDCs 
can cause significant unwanted effects on sperm 
parameters and can lead to oxidative stress in testis 
tissues of rats.
CONCLUSIONS:
Deterioration in sperm parameters indicate that both 
single and combined exposures to BPA and DEHP 
may reduce fertility in rats. Combined exposure to 
BPA and DEHP particularly caused more significant 
effects on sperm parameters and testicular oxidative 
stress parameters. In BPA plus DEHP group, 
decreases in total glutathione levels and increases in 
lipid peroxidation suggest that oxidative stress may 
be one of the possible underlying mechanisms for the 
combined adverse effects of these chemicals. More 
studies are needed to show the reprotoxic effects of 
combined exposure to EDCs in biological systems.
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INTRODUCTION:
Boric acid and zinc borate are among the most 
important exportation products of Turkey. Zinc borate 
is typically composed of 45% ZnO and 34% boric 
anhydride (B2O3), with 20% water of hydration. Zinc 
borate readily breaks down in the stomach to zinc 
oxide and boric acid. Boron compounds have been 
considered as being toxic to reproduction system in 
animal experiments. In addition, reproductive data 
of boron exposure is very limited. Because of the 
limited information in the literature on the toxicity of 
zinc borate, this study is substantial as we use the 
reproductive system cell which is the target of boron 
exposure.  The aim of our study is to investigate the 
cytotoxic and genotoxic effects of boric acid and zinc 
borate on Sertoli cell culture in vitro. These data will 
contribute our previous studies and support the health 
and environmental authorities for preparation of the 
legal regulation about boron compouds.
MATERIALS AND METHODS:
 The cytotoxicity of boric acid and zinc borate was 
determined by using Neutral Red Uptake (NRU) 
assay. Comet assay was performed to investigate the 
DNA integrity of boric acid and zinc borate in different 
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concentrations.  Muse Annexin V& Dead Cell Kit was 
used to determine apoptosis Muse Oxidative Stress 
Kit was used to determine Reactive Oxygen Species 
(ROS) by using Muse Cell Analyser on Sertoli cell 
culture.
RESULTS:
Acording to our results, boric acid has no cytotoxic 
effect and does not induce apoptosis up to 1000 µM. 
In addition, boric acid does not induce comet tail 
intensities and ROS up to 500 µM on human Sertoli 
cells. Besides, zinc borate is cytotoxic on human 
Sertoli cells (IC50=90µM) and significantly induces 
apoptosis at 100 µM. In addition, zinc borate is 
significantly induces comet tail intensities and reactive 
oxygen species at 50 µM on human Sertoli cells. 
CONCLUSIONS:
The results of our study demonstrates that zinc borate 
causes oxidative stress, induces cell death and 
apoptosis and DNA strand breaks at relatively high 
concentrations.
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INTRODUCTION:
Metal oxide nanoparticles (NP) such as titanium 
dioxide have been used increasingly in various 
cosmetics especially sunscreens. Because of 
widespread environmental exposure to metal oxide 
nanoparticles, it is urgent to elucidate their effects 
on human health. Recently, various toxic effects of 
TiO2 NPs have been investigated in cell lines using 
different endpoints. The EpiDerm Skin Irritation Test 
is a validated in vitro method for investigating the skin 
irritation potency of the ingredients of the cosmetics 
and finished cosmetic products as well. The aim of 
this study was to investigate the irritation effects 
of sunscreen formulations containing two different 
nanosize and two different concentrations of TiO2 
NPs by EpiDerm Skin Irritation Test. 
MATERIALS AND METHODS:
 The sunscreen formulation samples that contained 
two different particle size and two different 
concentration of TiO2 NPs were prepared as oil-
in-water (o/w) emulsions. The concentrations were 
selected as 5% and 10% by considering the TiO2 
NPs contained sunscreen formulations in the market. 
Irritation potency of the samples were detected by 
EpiDerm Skin Irritation Test.  The irritant chemicals 
have abilities to penetrate stratum corneum, after 
penetration  they are cytotoxic to the cells in the below 
layers. Therefore the princible of the multilayer 3D 
EpiDerm Skin Irritation Test procedure based on the 
MTT cytotoxicity assay. Sodium Dodecyl Sulphate 
(SDS) in 5% concentration and Dulbecco’s Phosphate 
Buffer Solution (DPBS) were used as positive and 
negative controls, respectivly. The optical density 
(OD) values obtained with each sample were used 
to calculate the percentage of viability compared with 
the negative control that is set at 100%.
RESULTS:
Exposure to sunscreen formulation that contained 
20 nm 10% TiO2 resulted in significantly decreased 
cell viability in EpiDerm Skin Irritation Test. According 
to our results it might be suggested that %5 TiO2 
NPs contained sunscreen products can considered 
safe. However sunscreen products containing small 
naoparticles and high concentration of TiO2 NP may 
cause skin irritation.  
CONCLUSIONS:
Our results are shown a valuable and original 
information on the skin irritation potency of TiO2 NPs 
contained sunscreen products.
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INTRODUCTION:
Dimethoate is one of the most important 
organophosphate insecticides that has been shown 
to induce oxidative stress through the generation of 
free radicals and alteration of the cellular antioxidant 
defense system. The aim of the study was to assess 
the protective effects of chlorogenic acid and vitamin C 
as an antioxidant compounds on dimethoate-induced 
oxidative stress in human erythrocytes in vitro.
MATERIALS AND METHODS:
Human fresh blood were collected in tubes from three 
healthy female volunteers by venipuncture. Heparin 
was used as an anticoagulant. Erythrocytes were 
separated from blood plasma by centrifugation (4400 
rpm for 10 min at 4°C) and then washed three times 
with a cold isotonic saline solution (0.9% NaCl). The 
supernatant and the buffy coat were carefully removed 
after each wash. After separation, erythrocytes were 
suspended in phosphate buffer saline (PBS) pH 7.4 
and used for different incubations. Erythrocytes were 
divided into portions. The first portion was incubated 
for 4 h at 37°C with different doses (10, 35, 70 mM) 
of dimethoate. The other portions were preincubated 
with chlorogenic acid (20 mM) and vitamin C (1 mM) 
for 30 min, followed incubation with dimethoate for 4 
h at 37°C. Malondialdehyde (MDA) concentrations 
as a lipid peroxidation index and antioxidant 
enzyme activitiy of catalase (CAT) were measured 
in all treatment portions of erythrocytes. Erythrocyte 
morphology were evaluated by light microscopy at 
40x magnification.
RESULTS:
Treatment with dimethoate alone increased the 
level of MDA and activitiy of CAT in erythrocytes as 
compared with nontreated control cells (P˂0.05). 
Treatment of cells with chlorogenic acid + dimethoate 
or vitamin C + dimethoate prevented dimethoate-
induced changes in antioxidant enzyme activity and 
lipid peroxidation. However, this effect was seen 
only at low concentration of dimethoate (10 mM). 
In addition, deleterious morphological changes in 
erythrocyte were also observed in the presence of 
dimethoate.
CONCLUSIONS:
These results suggest that chlorogenic acid or vitamin 
C may play a role in reducing dimethoate-induced 
oxidative stress in human erythrocytes in vitro. 
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1 Perk, BO., 2 Ozkan, T., 1 Guven, NM., 2 Sunguroglu, 
A., 1 Eke, BC.
1 Ankara University, Faculty of Pharmacy, 
Department of Pharmaceutical Toxicology, Ankara, 
Turkey
2Ankara University, Faculty of Medicine, Department 
of Medical Biology, Ankara, Turkey
INTRODUCTION:
Alzheimer’s disease (AD) which is a chronic, complex 
and multifactorial neurodegenerative disorder is the 
most common cause of progressive cognitive and 
functional decline in the elderly. Many genes have 
been identified as AD risk factors and CD33 is a new 
genetic risk factor associated with AD. CD33 which is 
a type I transmembrane protein is involving in immune 
regulation. CD33 expression has been shown to be 
increased in microglia cells in the Alzheimer brain 
and has a positive correlation with the severity of 
the disease. Additionally, it is demonstrated that 
CD33 levels are down-regulated in peripheral blood 
mononuclear cells (PBMCs) of AD subjects. In this 
preliminary study, blood CD33 levels were compared 
with AD patients and normal controls over 65 years of 
age [1,2].
MATERIALS AND METHODS:
Our preliminary study was comprised of 6 AD patient 
(mean age = 79.5 ± 7.3 years) and 12 cognitively 
normal controls (mean age = 80.83 ± 5.6 years) 
matched for sex and age. Samples of peripheral 
blood were collected into tubes containing EDTA, 
from each of the 6 AD patients and 12 controls. 
PBMCs from 10 ml of the peripheral blood with EDTA 
were obtained by density gradient centrifugation with 
lymphoprep and then washed in phosphate buffer 
phosphate saline. CD33 protein levels were examined 
using BD Accuri™ C6 flow cytometer with FITC anti-
human CD45, PE anti-human CD33, PE Mouse IgG1 
κ Isotype Ctrl and FITC Mouse IgG1 κ Isotype Ctrl 
(BIOLEGEND). All experimental data were expressed 
as mean ± standard deviation (SD). 
RESULTS:
We found that the percentage of CD33 positive 
monocytes was lower in AD group than control (7.63 ± 
1.81% versus 11.47 ± 2.00%).
CONCLUSIONS:
The results obtained in this study need further 
investigations in order to clarify CD33 level and AD.
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INTRODUCTION:
Genetic variations in human genome have long 
been studied to understand how genetic variation 
influences the risk of diseases. In this perspective, 
population based-genetic association studies 
represents us a unique opportunity to understand the 
genetic underpinnings of complex diseases for a given 
population. CYP19A1 is a polymorphic gene that 
encodes aromatase enzyme which catalyzes the last 
step of estrogen biosynthesis converting androgens 
to estrogens. Recently, rs2414096 SNP (A/G) in 
CYP19 gene have been associated with several 
endocrinologic diseases such as hyperandrogenism, 
male infertility and polychistic ovary syndrome (1,2). 
In this study, we aimed to determine the genotype 
and allele frequencies of rs2414096 variant of CYP19 
gene in Turkish population.
MATERIALS AND METHODS:
182 unrelated healthy Turkish volunteers (109 
females and 73 males, aged 12-80) recruited the 
study. Other ethnic groups were excluded. Blood 
samples were taken into the blood collection tubes 
(EDTAK2) and genomic DNA was extracted from 
whole blood by using High Pure PCR Template 
Preparation Kit (Roche, Germany). Genotyping of 
rs2414096 was performed with the RT-PCR method 
by using LightSNiP assay (TibMolbiol, Germany). 
RESULTS:
The frequencies of AA, AG and GG genotypes 
were found 15.4%, 46.7% and 37.9%, respectively. 
Genotype distributions were in Hardy–Weinberg 
Equilibrium (p>0.05). The mutant allele (A) frequency 
was 0.38, compatible with the genomic databases (3). 
CONCLUSIONS:
In conclusion, this study will contribute the 
understanding of biological basis of genetic 
susceptibility to several diseases in Turkish 
population. In the future, verifying genetic markers 
through case-control studies in Turkish population 
is needed to analyze potential genetic factors which 
contribute to etiology of complex diseases such as 
polycystic ovary syndrome.
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INTRODUCTION:
The current rate of the use of antiepileptic drugs 
in pregnancies is 0.3-0.4% (1,2). Exposure to a 
teratogenic substance during organogenesis period 
affects fetal development and functions of the organs. 
During this period, structural damage can occur which 
can not be repaired because the tissues are capable 
of rapid differentiation. In animal experiments, 
Levetiracetam (LEV) has been reported to transport 
the fetus directly through the placenta. Although there 
are limited informations on the teratogenic effect of 
LEV, there is no adequate information about testicular 
toxicity (2,3). 
MATERIALS AND METHODS:
15 adult Spraque Dawley female rats (the weight 
range; 200-250 g) were left to mate with male rats. 
These 15 healthy pregnant rats were divided into 
5 groups. No treatment was administered to the 
control group. Levetiracetam (100 mg / kg = 1 ml) 
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was administered to the LEV-A group (1st trimester, 
0-7th day), LEV-B group (2nd trimester, 8-14th day), 
LEV-C group (3rd trimester, 15-21th day) and LEV-D 
group (throughout the pregnancy) by oral gavage. 
Testicular specimens were removed from offsprings. 
The fibrotic connective tissue formed during testicular 
development was evaluated morphometrically. Skull 
and extremity specimens were removed from pups. 
The samples prepared with haematoxylin-eosin 
staining were evaluated with a light microscope.
 RESULTS:
Eyelid malformation was observed in the skull 
specimens of the LEV-D group while no malformation 
was found in the pups of the LEV-A, LEV-B and 
LEV-C groups, Cleavages (palate deformities) 
between the oral cavity and the nasal cavity was 
observed in the skull specimens of some of the LEV-D 
group rats. Significant increase was observed in the 
areas of testicular fibrotic connective tissue indicating 
testicular toxicity in the LEV-C and LEV-D groups 
when compared to the control group (p<0.05, p>0.05).
CONCLUSIONS:
The data revealed that levetiracetam exposure in the 
third trimester and throughout the pregnancy may 
cause testicular toxicity in offsprings. Additionally, LEV 
may cause possible mild teratogenic effects. Further 
studies are needed to confirm the testis toxicity and 
teratogenicity effects of LEV in the pregnancy.
ACKNOWLEDGEMENTS:
This study was supported by a grant of BAP (TYL-
2017-5738)
REFERENCES:
1.  Richmond JR, Krishnamoorthy P, et al., 
(2004). Epilepsy and pregnancy : An obstetric 
perspective. Am J Obstet and Gynecol 2004; 190: 
371.
2.  Kayaalp S, et al., Rasyonel Tedavi Yönünden 
Tıbbi Farmakoloji. Hacettepe Taş Kitapçılık 
Limited Sti., 2005.
3.  Hill, Denise S, et al., “Teratogenic effects 
of antiepileptic drugs.” Expert review of 
neurotherapeutics 10.6 (2010): 943-959.
P-513: QUANTITATIVE DETERMINATION 
OF URINARY DOPAMINE BY A HIGHLY 
SENSITIVE LC-MS/MS ASSAY
1,2 Battal, D., 3 Aktas Sukuroglu, A., 2 Alkas, FB.,4 
Unlusayin, I.
1Mersin University, Department of Toxicology, Mersin, 
Turkey.
2Near East University, Department of Toxicology, 
Nicosia, Cyprus
3 Gazi University, Department of.Toxicology, Ankara, 
Turkey
4 Acıbadem Labmed, İstanbul, Turkey.
INTRODUCTION:
Dopamine (DA) is a prominent neurotransmitter. 
Depending on the postsynaptic receptor, it produces 
either excitatory and inhibitory postsynaptic 
potentials. In the central nervous system (CNS), DA is 
involved in the control of mood, movement, cognition, 
motivation and reward pathways. In the peripheral 
nervous system (PNS), it controls Na+ homeostasis in 
kidney, renal blood flow and cardiovascular functions. 
Additionally, it is a hypothalamic neurohormone 
regulating prolactin release from the anterior 
pituitary, and recent evidence suggests that it has 
immunoregulatory functions. The determination of 
DA facilitates better understanding of the complex 
brain disorders in the central nervous system and 
the regulation of endocrine system, cardiovascular 
functions and renal functions in the periphery (1, 2). 
The purpose of this study was to develop a highly 
sensitive and reliable assay for the quantification of 
DA in urine using liquid chromatography-tandem 
mass spectrometry (LC-MS/MS).
MATERIALS AND METHODS:
The aim of the present study was to develop a rapid, 
sensitive and simple LC-MS/MS method for the 
simultaneous and quantitative analysis of dopamine 
levels in urine. The LC-MS/MS separation was 
performed on a Zorbax SB-C18 3.0 x 50 mm 3.5 
micron 600 BAL with a gradient elution system of 
formic acid-water as the mobile phase. 
RESULTS:
A rapid, sensitive and robust method was developed, 
validated and used for the trace analysis of dopamine 
in urine by LC-MS/MS. The method was validated in 
artificial urine samples following the guidelines of the 
European Medicines Agency in terms of selectivity, 
linearity, calibration range, limit of detection (LOD), 
limit of quantitation (LOQ), carryover, accuracy, 
precision, dilution integrity, matrix effect, robustness, 
and stability, obtaining adequate results in all 
parameters. The linear ranges for dopamine were 20 
- 2000 ng/mL. The correlation coefficient was greater 
than 0.998. The LOD and LOQ for dopamine were 
0.36 and 1.215 ng/mL, respectively. The recoveries 
were 95.622 - 101.200 with RSD<5%.
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CONCLUSIONS:
The required functional sensitivity was achieved by 
this method, quantitating analytes over a sufficiently 
wide dynamic range. It will be also demonstrated 
that precise quantification of dopamine concentration 
levels in urine yield better understanding of the 
pathophysiology and pathogenesis of neuropsychiatric 
disorders and of research for new drugs. This new 
LC-MS/MS-based method significantly simplifies the 
detection procedure for  DA in urine.
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INTRODUCTION:
Protective effects of nonsteroidal anti-inflammatory 
drugs (NSAIDs) against cancer and anticancer effects 
have become a remarkable topic. In vitro, in vivo, and 
epidemiological studies have all demonstrated that 
NSAIDs appear to be effective in the chemoprevention 
and possible treatment of many cancers including 
colorectal, breast, prostate, pancreatic, squamous 
cell carcinoma of the head and neck, ovarian, lung, 
and bladder cancers (1). In this study, our aim 
was to assess cytotoxic and genotoxic effects of 
“flurbiprofen”, a propionic acid derived NSAI, in the 
human cervical cancer cell (HeLa).
MATERIALS AND METHODS:
Cytotoxicity of flurbiprofen in HeLa cells was 
measured by using Thiazolyl Blue Tetrazolium Blue 
(MTT) assay for 24 h, 48 h, 72 h and at dose range of 
5-3000 µM, and genotoxicity was evaluated by using 
alkaline comet assay at doses determined according 
to cytotoxicity results/pharmacokinetic properties 
of drug, non-cytotoxic doses for 48 h. DNA damage 
was expressed as tail length, tail intensity, and tail 
moment.
RESULTS:
The IC50 doses of flurbiprofen in HeLa cells were 
found to be 2594 µM, 990 µM, and 907 µM according 
to exposure times, respectively and cytotoxicity was 
increased by dose-dependent. DNA damage was 
observed in HeLa cells exposed to flurbiprofen for 48 
h at the indicated doses and statistically significant 
manner compared to the negative control (p<0.05). 
This DNA damage was also increased by dose-
depended.
CONCLUSIONS:
According to the results of our study; flurbiprofen have 
been cytotoxic effect by dose-depended manner and 
caused DNA damage in the HeLa cell line at low non-
cytotoxic doses. Therefore, it is thought that it may 
contribute to antitumor effect against cervical cancer. 
Otherwise, since there isn’t enough data on the 
mutagenicity of flurbiprofen, our study will contribute 
to the literature.
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INTRODUCTION:
One of the growing environmental problems is the 
presence of drugs in the environment.  Especially, the 
presence of antibiotic residues in waters leads to a 
variety of adverse effects, such as chronic toxicity and 
microorganism antibiotic resistance. The adsorption 
method becomes an effective and attractive 
alternative for the treatment of waters containing 
drug residues. Because the adsorption method is 
economical, flexible in design, easy to operate and 
insensitive to toxic pollutants (1). Recent studies 
showed that graphene based materials can be used 
as adsorbents for water treatment (2). So the aim 
of the present study is to investigate the adsorption 
characteristics of isoniazid on graphene oxide.
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MATERIALS AND METHODS:
Graphene oxide was produced using Hummers 
method revised in our laboratory (2). Adsorption 
experiments were done as a function of time, initial 
concentrations, graphene oxide amount and pH. 
RESULTS:
Results of the experiments showed that the adsorption 
process reached the equilibrium in 1 hour and it 
occurs according to L-type of the Giles classification.   
CONCLUSIONS:
Adsorption characteristics of isoniazid on graphene 
oxide was studied at various experimental conditions. 
Graphene oxide was capable of being an adsorbent 
for the adsorption of the selected antibiotic molecule, 
isoniazid. The main driving force of the adsorption 
of isoniazid on graphene oxide was electrostatic 
attraction with the contribution of π-π dispersion 
interactions. 
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INTRODUCTION:
Mutagenic agents act through the production of 
free radicals and free radicals are damage to DNA. 
Antimutagens agents are capable to deactivate of 
radicals (1). So, new compounds demonstrating 
antimutagenic activities are of great practical 
importance, especially for cancer therapy. Numerous 
compounds are synthesized and investigated for their 
antimutagenic activities each year. The purpose of 
the research is to evaluate the genotoxic and anti-
genotoxic properties of Methionine-Schiff base. 
The anti-genotoxic properties of this compound in 
human lymphocytes cells were investigated by sister 
chromatid exchanges (SCEs) test system against 
aflatoxin Bı (AFBı). 
MATERIALS AND METHODS:
Cytogenetic Analysis; Peripheral blood lymphocytes 
were taken from four (two men and two women) 
non-smoking healthy individuals. Lymphocyte 
cultures were set up by adding 0.5 mL of heparinised 
whole blood to RPMI-1640 chromosome medium 
supplemented with 15% heat-inactivated fetal calf 
serum, 100 IU/Ml streptomycine, 100 IU/mL penicillin 
and 1% L-glutamine. Lymphocytes were stimulated to 
divide by 1% phytohaemaglutinin (2).
RESULTS:
SCE frequency significantly decreased after treatment 
with the different concentrations of (Met-Sch) in 
DMSO solution and AFBı. 5 μg/mL concentration of 
(Met-Sch) in DMSO solution was the most effective 
against AFBı.
CONCLUSIONS:
In the present study, it has been revealed that this 
compound is the active inhibitors of anti-genotoxic 
activity of AFBı. Antimutagenic effects of this 
compound is probably related to its action on the 
enzymatic activation system.
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INTRODUCTION:
Microsomal epoxide hydrolase gene (EPHX1) 
contains polymorphisms which may be linked to 
several cancer types. (Tyr113His) polymorphism 
that located in exon-3 of human EPHX1 gene is 
associated with %50 decrease in enzyme activity. 
There are studies that investigate a relationship 
between mEH3 polymorphism and several cancers 
like breast, bladder, colon, esophageal, over and 
lung but they are limited and inconclusive. In addition, 
studies in regard to the association between mEH3 
polymorphism and response to chemotherapy and 
survival in lung cancer patients are rather limited and 
inconclusive. In this study, we aimed to investigate 
the effects of mEH3 polymorphism on the response 
to platinum based chemotherapy and survival in 
advanced stage non-small cell lung cancer (NSCLC) 
patients.
MATERIALS AND METHODS:
The 136 patients with the mean age of 56 ± 9 (mean 
± SD; range: 34-75) who had a histological diagnosis 
of primary NSCLC with stages III or IV, and who 
were treated with platinum based chemotherapy 
were enrolled in this study. The mEH3 Tyr113His 
(rs1051740) gene polymorphism was determined by 
Real-Time PCR method modified from Tranah et al., 
(2005). Chi-square analysis and Fisher exact tests 
were used to compare the distribution of genotypes 
between subgroups and response to chemotherapy. 
Hazard ratios (HRs) were estimated from a multivariate 
Cox proportional hazards model with adjustment for 
age, gender, smoking status, chemotherapy regimen, 
tumor stage and tumor histology.
RESULTS:
The mEH3 Tyr113His (rs1051740) polymorphism did 
not significantly influence the responses to platinum 
based chemotherapy. No significant associations 
were noted between the responses of genotypes 
to chemotherapy and age, sex, smoking status, 
chemotherapy regimen, tumor stage or histology. 
Mutant carriers of mEH gene did not significantly 
survive shorter or longer than the wild type carriers 
of the gene (mean survival of 17.4 months for wild 
type genotype and 21.6 months for heterozygous/
mutant genotype; p=0.906). Multivariate analysis also 
revealed no significant altered adjusted hazard ratio 
(HR) of death associated with mEH genotypes. (HR, 
0.747; 95 % CI, 0.41-1.35, p=0.33).
CONCLUSIONS:
These results show that the mEH3 Tyr113His 
(rs1051740) gene polymorphism is not likely to 
be associated with response to platinum based 
chemotherapy and survival in the patients with 
advanced stage NSCLC. 
REFERENCES
1.  Tranah GJ, Chan AT, et al., (2005). Molecular 
Carcinogenesis, 44:21-30. 
P-518: HISTOPATHOLOGICAL BRAIN 
TISSUE EVALUATIONS AFTER REPETITIVE 
LOW-DOSE KETAMINE ADMINISTRATIONS 
IN MICE
1 Erdinc, M., 1 Kelle, I., 1 Akkoc, H., 1 Uyar, E., 2 
Erdinc, L., 3 Nergiz, Y., 3 Seker, U.
1Dicle University Medical Faculty, Department of 
Medical Pharmacology, Diyarbakir, Turkey.
2Dicle University Medical Faculty, Department of 
Biochemistry, Diyarbakir, Turkey.
3Dicle University Medical Faculty, Department of 
Histology and Embryology, Diyarbakir, Turkey.
INTRODUCTION:
N-methyl-D-aspartate receptors (NMDAR) are known 
to have fundamental functions in the formation of 
long-term potentiation (LTP), long-term depression 
(LTD) and maintaining synaptic plasticity (1,2). An 
increase or decrease in the activity of glutamatergic 
receptors alters cognitive performance (3). Literature 
suggests that low-dose ketamine (an NMDA receptor 
antagonist) induces neuroprotection (4), while high 
doses and extended applications are related to 
neurodegenerative symptoms (5).
In this study, we aimed to perform histopathological 
evaluations of the mice brain tissue after repetitive 
low-dose ketamine administrations.
MATERIALS AND METHODS:
Male BALB/c mice weighted 30-40 gr were treated 
with S(+) ketamine (20 mg/kg) for a single time and 
six consecutive times. Drugs were freshly prepared, 
dissolved in %0.9 saline and given intraperitoneally 
(ip). After sacrification, mice brain were isolated and 
embedded in paraffin. The obtained coronal slices of 
a broad range brain areas were practiced to execute 
histopathological assessments.
RESULTS:
Histopathological assessments of ketamine 
administered group for six consecutive times 
has shown partial neurodegenerative symptoms 
including; loss of cerebellar Purkinje cells, perineural 
edema in pyramidal neurons, thrombosis in the 
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subpial vascular area and necrosis in hippocampal 
neurons. Furthermore, proliferation in oligodendria 
cells was observed in this group. A single application 
of ketamine did not alter the morphologic appearance 
of the brain tissue.
CONCLUSIONS:
Consecutive applications of low-dose ketamine did 
induce neurodegeneration while a single dose didn’t 
alter the morphologic structure of the brain. Extensive 
research should be conducted with ketamine to 
reveal its effects on memory processes and to find 
therapeutic ways to minimize its side effects.
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INTRODUCTION:
Adverse drug reaction (ADR) reporting is an important 
component of the health system. ADRs are one of 
the major causes of morbidity and mortality during 
drug therapy and a major contributor to healthcare 
costs. Spontaneous reporting of ADRs by health-
care professional is considered as one of the basic 
methods for the prevention and detection of new 
and serious adverse effects to drugs in market 
(1,2). In this study, it was aimed to determine the 
frequency of observed ADRs in Erzincan province; 
the pharmacotherapeutic drug groups causing the 
ADRs and the most frequently affected system-organ 
classes. Moreover, it was also planned to improve the 
awareness of patients about ADR reporting. 
MATERIALS AND METHODS:
The research was carried out as a questionnaire 
survey conducted face to face with adult patients who 
applied to community pharmacies in Erzincan. A total 
of 252 survey were completed. 
RESULTS:
6% (n=15) of the survey were found to include one 
or more ADRs. ADRs were evaluated according to 
the System Organ Classes and the most frequently 
affected system- organ classes by ADRs were 
determined to be gastrointestinal disorders (23,3%), 
followed by skin and subcutaneous tissue disorders 
(16,7%) and general disorders (10%). The drug 
groups most frequently caused the ADRs were 
“Respiratory system drugs” (20,5%), Alimentary 
tract and metabolism drugs (18%) and Anti-infective 
for systemic use (15,3%). 13.3 % (n=2) of ADR’s 
determined were classified as serious. 26,7% of 
ADRs needed to be treated. The relationship of the 
ADRs with the suspected drugs were evaluated, 
and the relationship was determined as “probable” 
in 46,7% of the ADRs and “possible” in 53,3% of the 
ADRs. 43,3% of the detected ADRs were not found 
in the Summary of Product Characteristics (SmPC) of 
the drug and classified as “unexpected”. 
CONCLUSION:
This was the first study to determine the frequency 
of ADRs and the drugs more frequently associated 
with ADRs in Eastern Anatolia Region. The incidence 
of ADRs related to drugs in Erzincan was observed 
to be lower than the finding obtained from Ankara. 
The most common drug group causing ADRs and 
most frequently affected system-organ class were 
also different. Post-marketing surveillance is the 
most important tool for pharmacovigilance systems 
for early detection of unexpected and serious ADRs. 
Suspected adverse events can be minimized and 
prevented by monitoring and reporting ADRs.
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INTRODUCTION:
One of the most important groups of metabolic 
enzymes responsible for the elimination of toxic 
substances is the Cytochrome P450 (CYP). Changes 
in CYP expression are considered to be effective 
toxicological factors when many carcinogenic 
compounds are thought to be bioactivated by 
first-phase enzymes and this metabolic activation 
is carried out intensely by CYPs. CYP1B1, an 
important isozyme of this family, is involved in the 
formation of reactive estrogen metabolites and in 
the activation of environmental carcinogens such as 
polycyclic aromatic hydrocarbons (PAHs). There are 
4 known alleles of the human CYP1B1 gene (namely 
CYP1B1*2, CYP1B1*3, CYP1B1*4 and CYP1B1*7) 
that cause changes in and enzyme activity. 
CYP1B1*2 has two linked polymorphism in exon 2, 
rs10012 and rs1056827, resulting in the Arg48Gly 
and Ala119Ser amino acid substitutions, respectively. 
Individuals with high CYP1B1 activity may be at high 
risk of certain cancers such as lung due to the excess 
bioactivation of carcinogens. It has been reported 
that the frequencies of polymorphic genes in different 
populations are different in various ethnic groups. 
There are a few studies on CYP1B1 polymorphism 
and there is no clear data about the frequency of this 
gene polymorphism in Turkish population. Therefore, 
in this study, we aimed to determine the CYP1B1*2 
allele frequency in a Turkish population.
MATERIALS AND METHODS:
150 volunteer individuals who do not have a diagnosis 
of any cancer were included in our study. In order 
to evaluate the results in detail, all individuals filled 
their informed consent forms with a questionnaire 
containing age, gender, occupation, smoking, 
alcohol and coffee habits, nutritional patterns and 
other necessary information.  CYP1B1 m1 and m2 
mutations were determined by allele specific PCR 
method. The study was approved by the ethics 
committee of Ankara University. 
RESULTS:
The frequency of Arg/Arg (wild type), Arg/Gly 
(heterozygous variant), Gly/Gly (homozygous variant) 
CYP1B1*2 m1 genotypes were 47.33%, 44.66% and 
8%, respectively. The frequency of Ala /Ala (wild type), 
Ala/Ser (heterozygous variant), Ser/Ser (homozygous 
variant) CYP1B1*2 m2 genotypes were 42.85%, 
42.85% and 14.28%, respectively. 
CONCLUSIONS:
The results of this study will provide basic data in 
determining the extent of the effect of this polymorphic 
gene in cancer and various diseases in Turkish 
population prospectively by giving a comprasion with 
other populations.
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INTRODUCTION:
With the rapid development of nanotechnology and 
the widespread use of nanoparticles in the biomedical 
area, the toxicity of nanomaterials has begun to 
attract attention. 
Generally, toxicity originates from small size and 
high surface-to-volume ratio of nanomaterials. In 
comparison to similar ones with large structures, the 
nanoparticles can lead to higher intracellular reactive 
oxygen species (ROS) levels and cytotoxicity. Gold 
nanoparticles (AuNPs) are colloidal or clustered 
particles consisting of a gold core and a surface 
coating around the core. They are considered to be 
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outstanding delivery systems in medicine. In order 
to reduce their toxicity, it was suggested that their 
surface properties should be altered by various 
polymeric coatings. The aim of this study was to 
examine the effects of AuNPs induced cytotoxicity, 
lipid peroxidation and protein oxidation on HepG2 
cells and investigate the toxicity modifying effects of 
“polyethylene glycol (PEG) and polyethylene imine 
(PEI) (molecular weights of 2000 (LMW) and 25000 
(HMW)) coatings. 
MATERIALS AND METHODS:
The study groups were determined as AuNPs, 
AuNPs/PEG, AuNPs/PEI LMW) and AuNPs/PEI 
HMW. Cytotoxicity was determined by MTT assay. 
Lipid peroxidation and protein oxidation were 
determined by using commercial spectrophotometric 
kits. Malondialdehyde (MDA) levels were measured 
as an indicator of lipid peroxidation and protein 
carbonyl levels were determined as an indicator of 
protein oxidation. 
RESULTS:
After incubating HepG2 cells with different 
concentrations of nanoparticles for 24 h, half maximal 
inhibitory concentrations (IC50) were determined as 
166.77, 257.73 and 198.44 µg/ml for AuNPs, AuNPs/
PEG and AuNPs/PEI LMW groups, respectively. 
However, IC50 dose could not be determined in 
AuNPs/PEI HMW group due to high cytotoxic potential 
of PEI HMW. In AuNPs/PEI HMW group, MDA levels 
were 253.53% higher than control group and 311.17% 
higher than Au group (p <0.05, both). The increases 
in carbonyl levels in AuNPs/PEG and AuNPs/PEI 
HMW groups were found be significantly higher than 
control (61.67% and 462.41%, respectively; p<0.05, 
both). The carbonyl levels measured in AuNPs/PEG, 
and AuNPs/PEI HMW groups were also higher than 
in the Au group (33.97% and 366.07%, respectively; 
p<0.05, both).
CONCLUSIONS:
 These results suggest that PEG coating does not 
have an impact on cytotoxic and oxidative properties 
of AuNPs; however coating AuNPs with PEI 
(particularly by PEI HMW) can induce both cytotoxicity 
and oxidative stress. Therefore, coating materials of 
AuNPs should be chosen with caution in order not to 
increase the toxic effects of the nanoparticles. 
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INTRODUCTION:
It is known that the death from cancer has been 
increasing day by day. According to a report published 
WHO (1), approximately nine million people died 
from cancer in 2015. Lung cancer is the first among 
the most common cancer types throughout the 
world. Current compounds for treatment of Lung 
cancer are yet too limited, and so new compounds 
should be developed. Previously, we have designed 
and synthesized a series of bis-sulfonamide Schiff 
bases as an efficient and potent carbonic anhydrase 
inhibitors, which are related to cancer detection and 
treatment. In the current work, the compound A4B3 
was selected since it is one of the most efficient 
compounds from the series. Hence, the present study 
was designed to show the anti-proliferative effect of 
A4B3 on Human Lung Cancer Cells (A549).
MATERIALS AND METHODS:
In order to determine the anti-proliferative activity 
of the compound, MTT (3-[4,5- dimethylthiazol- 2- 
yl]- 2,5- diphenyl- tetrazolium bromide) method was 
used. A549 cells exposed to different doses of the 
compound (25, 50, 100 and 200 µl) at 37ºC with 5% 
CO2 for 24h. 
RESULTS:
It was determined that anti-proliferative effect of the 
compounds was increased in a dose dependent 
manner.
Figure 1. Chemical structure and anti-proliferative 
effect (µg/ml)
CONCLUSIONS:
Consequently, the compound has an anti-proliferative 
effect, but in order to make enough to explain about its 
anticancer activity, it should be examined by other test 
systems, including the methods such as apoptosis 
induction, cell cycle and so on.
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INTRODUCTION:
 Silica (SiO2) is an abundant mineral in rock, sand 
and soil (1). The International Agency for Research 
on Cancer (IARC) classified crystalline silica as a 
known human carcinogen (2). Occupational exposure 
to silica dust in workers is still considered to be an 
important health problem especially in developing 
countries. The present study aimed to investigate 
the plasma 8-hydroxy-2’-deoxyguanosine (8-oxodG) 
levels, a sensitive biomarker of oxidative DNA 
damage, in Turkish ceramic workers (3). The influence 
of confounding factors like age, smoking, alcohol 
drinking, duration of exposure on plasma 8-oxodG 
levels were also analyzed. 
MATERIALS AND METHODS:
Blood samples were taken from the ceramic workers 
(n=99) and their controls (n=81). Each participant 
completed a detailed questionnaire. Plasma 8-oxodG 
levels (pg/ml) were determined by using kit at a 
wavelength between 405 and 420 nm. 
RESULTS:
Plasma 8-oxodG levels of the workers were found 
to be significantly higher than the control group 
(p<0.05). Workers working in the ceramic plant more 
than 16 years and smokers had significantly higher 
plasma 8-oxodG levels when compared to the other 
workers (p<0.05). There were correlation between 
using alcohol, age and 8-oxodG levels, but it was 
not statistically significant. There was no correlation 
between using protective equipments and plasma 
8-oxodG levels. Workers with silicosis have slightly 
higher 8-oxodG levels when compared to the other 
workers.
CONCLUSIONS:
These results showed that occupational silica 
exposure can cause oxidative DNA damage that may 
lead to important health problems in ceramic workers.
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INTRODUCTION:
Type 2 diabetes is a hyperglycaemic metabolic 
disease related with the decrease of insulin secretion. 
Genetic and environmental factors are playing major 
role in the development of the disease. Relationship 
between the inflammation generation and diabetic 
complications has been showed in recent studies. 
Following the formation of the oxidative stress after 
the disorder of the lipid metabolism, the levels of 
the reactive oxygen species (ROS) increase and 
insulin resistance develops consequently. Cytokines 
are important in regulation of the homeostatic 
mechanisms such as inflammation and tissue 
repair. Thus, variations in their levels and structures 
can cause several diseases. The single nucleotide 
polymorphisms (SNP) forming on the cytokine genes 
increase the risk of disease development. Recent 
studies showed the relationship between some 
inflammatory cytokine gene polymorphisms and the 
development of complication in patients with diabetes. 
Based on this, our aim was searching and the 
evaluating the possible relations between the TNF-α 
(-308), IL-1β (+3953), IL-6 (-174) gene polymorphisms 
and the development of the complications in a Type 
2 diabetic Turkish patient population by using PCR-
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RFLP method.
MATERIALS AND METHODS:
A total of 150 Turkish individual participants were 
grouped in three groups as controls, patients with 
and withoutdiabetic complications consisting of 50 
individuals in each. All the patients were selected 
from the the Diabetes Clinic at the Ankara Training 
and Research Hospital. 50 patients were free of 
complications, whereas the others suffered from 
complications including nephropathy, retinopathy, 
neuropathy and coronary heart disease. DNA 
samples of all the subjects were isolated from the 
blood samples and stored at -200C until the analysis. 
Genotyping was performed using a polymerase chain 
reaction-restriction fragment length polymorphism 
(PCR-RFLP) technique. 
RESULTS:
Due to our data, both TNF-α and IL-1β gene 
polymorphisms are significantly related with the 
development of both disease and complications. 
CONCLUSIONS:
TNF-α and IL-1β gene variations enhance the risk of 
Type 2 diabetes and its complications development.
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INTRODUCTION:
Despite the recent popularity of e-cigarettes, to date 
only limited data is available on their safety and 
effectiveness  for users. Recent chemical  analysis 
of  e-cigarettes  has  showed  that variety toxicants 
and  carcinogens  were  detected in the refill solutions 
and aerosols of e-cigarettes such as formaldehyde, 
metals, nitrosamines, acrolein, acetaldehyde and 
polycyclic aromatic hydrocarbons (PAHs). PAHs 
belong to a class of ubiquitous carcinogens and are 
possibly associated with adverse health effects. In 
this study, we aimed to assess PAH exposure by 
measuring the 1-hydroxypyrene (1-OHP) in urine 
samples of e-cigarette users and to explore the 
possible associations between PAH exposure and 
oxidative DNA damage indicated by urinary  8-hydroxy-
2′-deoxyguanosine (8-OHdG). Urinary 8-OHdG 
and 1-OHP are biological markers of oxidative DNA 
damage and PAH metabolism, respectively. We 
investigated the relationship between urinary 8-OHdG 
and 1-OHP in e-cigarette users.
MATERIALS AND METHODS:
Between May 2016 and September 2017, spot urinary 
samples were collected from e-cigarette users (n:28), 
cigarette smokers (n:25), passive smokers (n:25) 
and healthy non smokers (n:25). Urinary 8-OHdG 
and 1-OHP levels were determined using Liquid 
chromatography tandem-mass spectrometry (LC-MS/
MS) and expressed as ng/g creatinine.
RESULTS:
The urinary 1-OHP concentrations (mean± SD) has 
been found for cigarette smokers as 100.52±120.55, 
for e-cigarette users as 80.86±161.0, for passive 
smokers as 44.07±34.17 and for control group 
as 28.21±27.3 ng/g creatinine. Maximum value 
for 8-OHdG was  recorded in cigarette smokers 
(22.97±10.34 ng/g creatinine) followed by e-cigarette 
smokers (16.59±12.56 ng/g creatinine) and passive 
smokers (15.62±10.83 ng/g creatinine) and controls 
(7.36±7.39 ng/g creatinine). 8-OHdG  levels in 
e-cigarette users (16.59±12,56) were significantly 
higher (p>0,0023) than those of healthy controls 
group (7,36±7,39). Significantly higher level) of 
urinary 1-OHP(2.86-fold increase in mean 1-OHP 
values)  and 8-OHdG (2.25-fold  increase in mean 
8-OHdG) was found among e-cigarette users 
compared to controls in this study. Individual urinary 
8-OHdG concentrations were directly correlated with 
urinary 1-OHP concentrations for cigarette smokers 
(p=0.0461). For e-cigarette users this correlation was 
high but not statisticaly significant (p=0.1666).
CONCLUSIONS:
Our findings suggest that urinary 1-OHP and 8-OHdG 
reflect  PAH exposure and oxidative DNA damage in 
cigarette smokers and e-cigarette users.
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INTRODUCTION:
The genus Thymus L. is a member of Lamiaceae 
family and represented by 318 species in the world, 
40 species in Turkey and 18 of them are endemic 
for Turkey (45%) (1). In this study, it is aimed to 
determine the antioxidant activities and cytotoxic 
effects of essential oils obtained from T. brachychilus 
subsp. brachychilus and T. brachychilus subsp. 
bahcesarayensis.
MATERIALS AND METHODS:
In this study, the cytotoxic activity of essential oil of T. 
brachychilus subsp. brachychilus and T. brachychilus 
subsp. bahcesarayensis was determined by MTT 
method. Human-derived cancer cell series and the 
Primary Dermal Fibroblasts series were used in 
this study. For this purpose, the breast cancer cell 
line (MCF-7), the colon cancer series (HT-29) and 
the Primary Dermal Fibroblast Series (PDF) were 
provided (2). Aditionally, β-Carotene method, ABTS 
cation radical decolorisation method and DPPH free 
radical scavenging activity were carried out to indicate 
the antioxidant activity.
RESULTS:
In method β-Carotene,  essential oil of T. brachychilus 
subsp. brachychilus was determinated more 
active. Also in ABTS cation radical decolorisation 
method and DPPH free radical scavenging activity 
methods, essential oil of T. brachychilus subsp. 
bahcesarayensis species was found more active. 
In the MCF-7 cell series, it was determinated that 
the eseential oil gained from T. brachychilus subsp. 
brachychilus species was highly active. In the MCF-
7 cell series, it was determinated that the eseential 
oil gained from T. brachychilus subsp. brachychilus 
species was highly active. And in the HT-29 and PDF 
cell series it was determinated that the eseential oil 
gained from T. brachychilus subsp. bahcesarayensis 
species showed more cytotoxic activity.
CONCLUSIONS:
Generally it has been determined that obtained 
essential oils have high antioxidant and moderate 
cytotoxic potentials.
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INTRODUCTION:
Since ancient times, plants belonging to the Labiatae 
family have been used for treating various diseases, 
including cancer, in many countries (1). In this study, it 
is aimed to determine the cytotoxic effects of essential 
oils obtained from Salvia multicaulis, S. spinosa, S. 
montbretii, S. suffruticosa and S. Xanthocheila in one 
healthy cell line (PDF) and two cancer cell line (MCF-
7 and HT-29).
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MATERIALS AND METHODS:
In this study, the cytotoxic activity of essential oils of S. 
multicaulis, S. spinosa, S. montbretii, S. suffruticosa 
ve S. xanthocheila were determined by MTT method. 
Human-derived cancer cell series and the Primary 
Dermal Fibroblasts series were used in this study. For 
this purpose, the breast cancer cell line (MCF-7), the 
colon cancer series (HT-29) and the Primary Dermal 
Fibroblast Series (PDF) were provided. 
RESULTS:
While in the terms of the essential oils S. multicaulis 
showed a rather cytotoxic effect on MCF-7, S. spinosa 
showed cytotoxic effect on HT-29, S. suffruticosa 
showed highly cytotoxic effect both on HT-29 and 
MCF-7 and also S. xanthocheila showed cytotoxic 
effect on MCF-7 cell lines, also it has been determined 
that S. montbretii does not have cytotoxic effects on 
any cell line. In particular, it has been determined that 
the essential oil obtained from S. suffruticosa does 
not show toxicity on the healthy cell line but has a very 
high cytotoxic effect on MCF-7 and HT-29 (5% and 
20% viability, respectively) cell lines at 200 μg / ml 
concentration.
CONCLUSIONS:
Generally it has been determinated that obtained 
essential oils have highly cytotoxic potentials. For this 
reason it can be said that the essential oil obtained 
from S. suffruticosa has especially more useful in the 
field of health.
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INTRODUCTION:
Cannabinoid receptors found in two important 
systems of our body are involved in many vital and 
vital biological processes. These receptors are termed 
CB1 and CB2. CB1 is present in brain cells while 
CB2 is in the immune system (1). The rimonabant 
molecule used as a drug for this purpose and known 
to affect cannabinoid receptors is the tetrasubstitüed 
pyrazole derivative. Among the ligands used for 
cannabinoid receptors, the pyrazole ring plays an 
important role (2). In this work, four different poly-
substituted pyrazole derivatives were synthesized 
using a suitable synthetic method.
MATERIALS AND METHODS:
Ph Ph
O O Oxalyl chloride












The tetrasubstituted pyrazole molecules were 
synthesized according to the above synthesis steps 
and the in vitro effects were investigated by the MTT 
assay method.
RESULTS:
The effects of the synthesized compounds on the 
LN-405 cell line were examined. All compounds were 
found to have a similar biologic property and had a 
significant toxic effect on cell lines at concentrations 
of 0.01 μM.
CONCLUSIONS:
it was observed that cell proliferation was triggered 
and cells were excessively increased when 
concentrations exceeded 0.01 μM in all the molecules. 
At concentrations of 0.01 μM antiproliferation was 
observed in the compounds at approximately 20-30%. 
Further experiments are needed to determine which 
mechanism of antiproliferation and / or proliferation is 
working.
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INTRODUCTION:
Nano sized materials are increasingly used in the fields 
of industry, science, pharmacy, medicine, electronics, 
communication and consumer products (1). However, 
there is still considerable lack of information about the 
toxicity of some NPs. Barium sulfate nanoparticles 
(BaSO4 NP) are widely used in as fillers in coatings, 
orthopedic medicine, diagnostic medicine and other 
applications (2). This presentation aims to investigate 
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the possible cytotoxic effects of BaSO4 NP in human 
lung adeocarcinoma cell line (A549).
MATERIALS AND METHODS:
the reaction of lung cells to particle exposure (24 h 
and 72 h) was measured as cytotoxicity by resazurin 
assay.
RESULTS:
A concentration dependent decline was seen in 
the viability of cells exposed to BaSO4 NP in both 
exposure times. After 24 h incubation, cell viability was 
further reduced when compared to 72 h incubation. 
The concentrations of BaSO4 NP up to 0,005 mg/
ml did not affect the viability of A549 cells in both 
incubation periods. However, at the concentration of 
0,25 mg/ml, the cell viability decreased significantly.
CONCLUSIONS:
According to our results, it seems that BaSO4 NP 
are cytotoxic against human lung cancer cells. 
Nevertheless, he mechanism behind these effects 
deserves further clarification.
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INTRODUCTION:
It is believed that some natural compounds might 
reduce the development of cancer through the 
antioxidant activity. Curcumin (CUR) obtained from 
Curcuma longa is commonly administered as a dietary 
antioxidant food supplement. The anticancer effect of 
CUR has been great concern in many researches. 
Cisplatin is known to be one of the chemotherapeutic 
drugs used in the therapy of many solid tumors. In 
the treatment of cancer, plant-derived phenolic 
compounds are suggested to be used with various 
chemotherapeutic drugs to increase anticancer effect 
and decrease cytotoxicity. Since the mechanisms 
of the interactions of CUR with cisplatin are not well 
clarified, we aimed to determine the effects of CUR 
on cisplatin cytotoxicity in Chinese lung fibroblast cell 
lines (V79) (1,2).
MATERIALS AND METHODS:
MTT assay was used to determine the cell viability for 
24 h and 48 h.
RESULTS:
The IC50 values of CUR were found to be 877 μM and 
119 μM for 24h and 48h, respectively. CUR (1.71 fold 
at 1000 μM, for 24 h; 2.08 fold, 3.07 fold, 7.77 fold, 
and 14.76 fold at 125 μM, 250 μM, 500 μM and 1000 
μM, respectively, for 48 h vs. IC50 doses of cisplatin) 
significantly increased the cytotoxicity of cisplatin in a 
dose dependent manner.
CONCLUSIONS:
It seems that curcumin may affect the cytotoxicity 
of cisplatin and have an important interaction with 
cisplatin in the chemotherapy; however, further in 
vitro and in vivo studies are required to confirm their 
interactions with cisplatin.
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INTRODUCTION:
Bipolar disorder (BPD) is a chronic severe 
neuropsychiatric disorder, with high lifetime 
prevalence [1]. Despite recent investigations and 
new researches, the exact mechanism of BPD is still 
unknown. Besides physiological and environmental 
factors, genetic factors play important role in the 
development of BPD. The brain-derived neurotrophic 
factor (BDNF), might be an interesting candidate 
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gene for bipolar disorder because of its important 
role in the neurodevelopment of the central nervous 
system[2]. The G to A transition in exon 5 of the 
BDNF gene, results valine substitution to methionine 
amino acid. This change results in BDNF functional 
polymorphisms in this region as Val66Val, Val66Met, 
and Met66Met genotypes and might be associated 
with the susceptibility to the BPD. On this basis, our 
aim was to evaluate the association between Val66Met 
polymorphism in BDNF gene and susceptibility to the 
BPD.
MATERIALS AND METHODS:
Genomic DNA was isolated from 28 control subjects 
and 30 BPD patients. The BDNF gene Val66Met 
polymorphism analyzed by using PCR-RFLP 
technique. Genotypes and allele frequencies were 
compared between groups using Chi-square test.
RESULTS:
We have found that, the frequency of the Val allele 
was lower in BPD patients when compared to the 
healthy control subjects. (X2=1.16, p=0.28, OR=1.97 
95%CI=0.49-8.19).
CONCLUSIONS:
The present study demonstrated that the BDNF 
gene Val66Met polymorphism might be associated 
with susceptibility to the BPD. However, there is 
no compelling evidence of BDNF gene playing an 
important role in susceptibility to BPD as sex, onset 
age, comorbidity, impairment in brain morphology and 
function have also role in the occurrence. 
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INTRODUCTION:
Pharmacovigilance is defined as the science and 
activities relating to the detection, assessment, 
understanding and prevention of adverse effects 
or any other drug-related problem. The main aim of 
pharmacovigilance is to enhance patient care and 
patient safety in relation to the use of medicines. 
When the both negative effects of adverse drug 
reactions (ADR) on the human health and magnitude 
of the resources spent for treatment of the noxious 
effects of drugs were considered, importance of the 
prediction and prevention of the potential unintended 
effects of drugs are understood. Drug-related 
problems, including ADR, can vary between countries 
and even regions. In this study, it was aimed to collect 
data for the frequency of observed ADR in Ankara 
province and to identify possible regional differences 
for the drug groups causing the ADRs and the most 
frequently affected system-organ classes (1-3). 
MATERIALS AND METHODS:
The research was carried out as a questionnaire 
survey conducted face to face with patients who 
applied to pharmacies determined by random 
sampling method in Cankaya, Yenimahalle and 
Elmadag. 
RESULTS:
A total of 428 questionnaires [170 questionnaires 
(39,7%) in Cankaya, 127 questionnaires (29,7%) 
in Yenimahalle and 131 questionnaires (30,6%) 
in Elmadag region] were completed. 21.8% of 
the questionnaires in Cankaya, 18.9% of the 
questionnaires in Yenimahalle and 17.6% of the 
questionnaires in Elmadag region included one 
or more ADRs. When the ADR’s were evaluated 
according to the System Organ Classes, it was 
determined that the most frequently affected system-
organ class were “Gastrointestinal Disorders” in 
Yenimahalle and Elmadag (7.9%-5.3%),  “Skin and 
Subcutaneous Tissue Diseases” (8,2%) in Cankaya. 
The drug groups most frequently caused the ADRs 
were also classified according to ATC groups. 
Musculoskeletal System Drugs (4.1%) in Cankaya, 
Anti-infectives  for systemic use in Yenimahalle and 
Elmadag (5,5%, 5,3%) were in the first place.
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CONCLUSION:
The frequency of ADRs and the drugs more frequently 
associated with ADRs were identified for the first time 
in the different regions of Ankara and some differences 
were detected between the regions. The causes of 
these differences may be related to the average age 
of the inhabitants of the region, disease distributions 
observed, drug use practices / habits, and dietary 
habits that differ by region and consumption of plant 
products (3).
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INTRODUCTION:
Silicosis is one of the prolonged and irreversible 
occupational diseases. Oxidative stress plays a role 
in many lung diseases including silicosis. Oxysterols 
are molecules that result in the oxidation of 
cholesterol. Oxysterols are formed by enzymatic and 
non-enzymatic reactions. Enzymatic derivatives act in 
the regulation of biological activities. Non-enzymatic 
derivatives are related to different pathologies. For this 
reason, these molecules can be used as biomarkers 
in the diagnosis and monitoring of diseases. The 
aim of the study is to evaluate possible cholesterol 
oxidation in silicosis by measuring 7-KC and triol 
levels and investigation of lipid peroxidation.
MATERIALS AND METHODS:
In this study, blood and urine samples were 
collected from 47 silicosis patients and 30 controls. 
7-ketocholesterol (7-KC) and cholestane-3β, 5α, 
6β-triol (Triol) levels were measured using HPLC-
MS/MS. In order to evaluate lipid peroxidation, 
8-isoprostane, human-4-hydroxynonenal (4-HNE) 
and human malondialdehyde (MDA) levels were 
determined by commercial ELISA kits.
RESULTS:
The measured levels of 7-KC were 40,61 ± 2,07 ng/
ml and 20,26 ± 1,38 ng/ml. in silicosis patients and 
control group respectively. Triols were measured as 
16,15 ± 2,22 ng/ml in the patients and 13,83 ± 1,75 
ng/ml in the control group (p<0,001; r=0,494). The 
measured levels of plasma and urine human-8-
isoprostane, 4-HNE and MDA levels were significantly 
higher in silicosis patients compare to control group. 
(p<0.01)
CONCLUSIONS:
Increased plasma 7-KC and Triol levels in silicosis 
may presumably be a result of increased LDL 
oxidation in these patients. 7-KC and Triol levels 
were moderately correlated in all groups. In addition 
lipid peroxidation significantly increased depending 
on oxidative stress in silicosis patients. The results 
confirm that cholesterol auto-oxidation can occur 
in silicosis as a result of oxidative stress induced 
inflammation. Any possible metabolic role of 
cholesterol oxidation products in silicosis warrants 
further research considering the tremendous nuclear 
effects of these oxysterols. 
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INTRODUCTION:
To investigate the protective effect of Beta glucan (βg) 
on cisplatin (CP)-induced nephrotoxicity in rats.
MATERIALS AND METHODS:
Twenty eight rats were randomly distributed into four 
groups. The first group was kept as a control. In the 
second group, CP was given at the single dose of 
7 mg/kg intraperitoneally. In the third group, βg was 
orally administered at the dose of 50 mg/kg/day for 
14 days. In the fourth group, CP and βg were given 
together at the same doses.
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RESULTS:
CP treatment caused significant oxidative damage 
via induction of lipid peroxidation and reductions 
antioxidant defense system potency in the kidney 
tissue. In addition, histopathological damage 
increased with CP treatment. On the other hand, 
βg treatment largely prevented oxidative and 
histopathological negative effects of CP.
CONCLUSIONS:
Cisplatin has severe nephrotoxic effects in rats and 
βg supplementation has significant beneficial effects 
against CP toxicity depending on its antioxidant 
properties. Thus, it appears that βg might be useful 
against CP toxicity in patients with cancer in terms of 
nephrotoxic system.
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INTRODUCTION:
Hearth toxicity induced by anticancer chemotherapy 
is not uncommon, but underestimated and under-
reported.Cisplatin (CP), a heavy metal compound, 
is used in the treatment of many types of tumours. 
The aim of this study was to investigate the possible 
beneficial effects of Diosphorus Lotus (DL) on hearth 
tissue oxidative status and histological alterations 
against CP-induced in the rats. 
MATERIALS AND METHODS:
Twenty-eight male rats were randomly divided 
into four groups: group 1 - control, given isotonic 
saline solution; group 2 - CP 7 mg kg(-1) given 
intraperitoneally as single dose; group 3 - DL 1000 mg 
kg(-1) per day given orally for 10 days; group 4 - CP 
and DL given together at the same doses
RESULTS:
CP caused a significant increase in thiobarbituric acid-
reactive substances (TBARS) level and a significant 
decrease in superoxide dismutase (SOD), glutathione 
peroxidase (GPx), catalase (CAT) and glutathione 
(GSH) levels in rats hearth tissues compared to the 
control group. CP caused a significant increase in lipid 
peroxidation in hearth tissues compared to the control 
group, whereas DL led to a significant increase in 
SOD and GSH levels. In addition histological changes 
were increased with CP. However, these effects of CP 
were eliminated by DL treatment.
CONCLUSIONS:
 In conclusion, our study demonstrated that the 
hearth toxicity caused by CP may be prevented by DL 
treatment.
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INTRODUCTION:
Nickel-Titanium Archwires (Ni-Ti) materials which 
are metal alloy products are frequently used for the 
treatment of the dental structural defects (1). However, 
little is known about the possible genotoxic effects of 
using these devices in children who consider them 
as sensitive. Therefore, the aim of the study is to 
investigate the genotoxic effects of fixed orthodontic 
devices by micronucleus (MN) test in children using 
orthodontic devices.
MATERIALS AND METHODS:
This study was conducted in the Department of 
Orthodontics and Toxicology in Gulhane Military 
Medical Academy. 32 volunteer subjects of both sexes 
(16 women, 16 men), aged 12-17, provided informed 
consent and agreed to participate. Right and left 
buccal epithelial cells were collected from 32 patients 
at 0th as control and 7th, 15th, 30th, 45th, 60th and 
90th days after placement of fixed appliances. The 
samples were stained with feuellgen reaction and 
fast-green techniques. Micronuclei frequency was 
scored for each slide sample in total 1000 cells. The 
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frequency result was determined per thousand (‰). 
The criteria by Tolbert et al. (2) and Thomas et al. (3) 
were adopted in the evaluation. 
RESULTS:
The mean MN frequencies were significantly 
increased in day 7, 15, 30, 45 and 90 experimental 
groups when we consider compared to day 0 
(p<0.05). MN frequencies in day 60 were determined 
as nearly same levels in day 0 and there is no 
statistically significant difference between in day 0 
and 60. On the other hand, MN frequencies in day 90 
were significantly lower than day 0 (p<0.05). 
CONCLUSIONS:
Using of fixed orthodontic appliances induce 
increased MN frequency especially in the first weeks 
of treatment period due to the corrosion of the 
materials. However, these genotoxic effects tends to 
approach baseline levels in later period.  
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INTRODUCTION:
Fanconi aplastic anemia (FAA) is a rare bone marrow 
failure that is inherited autosomal recessive. Many 
congenital anomalies may accompany and various 
complications such as cancer and endocrinopathies 
may develop with FAA. Although trace element levels 
were investigated for different chronic diseases, there 
are no detailed studies and data for FAA patients. In 
this respect, the aim of this study was to investigate 
some trace element levels in FAA patients.
MATERIALS AND METHODS:
The study was carried out between June 2015 and 
April 2016 in patients with a confirmed FAA diagnosis. 
17 patients selected as FAA group and 16 subjects 
were selected as control group in this study. The 
levels of copper (Cu), zinc (Zn), iron (Fe) cobalt (Co), 
chromium (Cr), selenium (Se) was measured using 
the method of graphite furnace atomic absorption 
spectroscopy (GFAAS). The results of experimental 
group were compared with the control groups. 
RESULTS:
Median age of the patients was nine years (1-30), 
male to female ratio was 9/8. One of the patient 
underwent stem cell transplantation and four patients 
were transfusion dependent. When we analyze our 
results for control and FAA groups, we found that Cr 
and Cu levels in FA group were significantly higher 
than control group (p<0.05). In contrast to this Se 
levels of FAA group were significantly lower than 
those of control group (p<0.001). The levels of Cr 
and Se were found in the normal range for both of 
the groups. However, Cu levels were found outside of 
normal range in two samples from FAA patients and 
control subjects.
CONCLUSIONS:
In our study, we found a higher Cr and Cu levels in 
FAA patients compared to control group. We believe 
that the changes in trace element and toxic metal 
levels should be taken into consideration as regards 
the FAA patients when we consider our results. But, it 
is obvious that further studies are necessary to clarify 
this aspects and to explore the possible causes of the 
changes of homeostasis of bioelement levels.
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INTRODUCTION:
Melanogenesis is a physiological process resulting 
in the biosynthesis of melanin pigments which are 
responsible for hyperpigmentation. The control 
of melanogenesis is an important strategy in the 
treatment of abnormal skin pigmentation for cosmetic 
purposes. Tyrosinase is one of the key enzymes in 
melanin biosynthesis and its inhibitors have become 
increasingly popular owing to their potential use 
as hypopigmenting agents especially in cosmetic 
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industry (1). However, most of them are unsatisfactory 
due to the weak clinical effects and/or to the various 
safety concerns (2,3). Therefore, it seems important 
to find out new tyrosinase inhibitory molecules. The 
aim of the present study was to investigate the anti-
melanogenic effect of 9 different Viola sp methanol 
extracts by using mushroom tyrosinase assay. 
MATERIALS AND METHODS:
Mushroom tyrosinase inhibitory activity of the extracts 
was carried out according to the standard method with 
minor modifications (4). The results were expressed 
as IC50±SD and statistical analysis was performed 
using SPSSv.25.0.
RESULTS:
All the tested extracts showed inhibitory effects 
against tyrosinase. Viola sieheana demonstrated 
the highest anti-tyrosinase activity among the other 
extracts (IC50:0,10 mg/ml) followed by Viola occulta 
with IC50 values of 0,21 mg/ml. 
CONCLUSIONS:
Most of the tyrosinase inhibitors derived from 
higher plants such as polyphenols, flavonoids, 
aldehydes and their derivatives (3). Further 
experiments are necessary in order to evaluate and 
fractionate the active components responsible for the 
inhibition activity. These molecules might be useful 
in the food industry as antibrowning agents or in the 
medical field to treat hyperpigmentation disorders.
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INTRODUCTION:
Overproduction of free radicals can cause damage 
to biomolecules such as lipids, proteins, enzymes 
and DNA in cells and tissues. This may result in 
many diseases such as: cancer, diabetes, aging, 
cardiovascular, autoimmune, neurodegenerative 
disorders.  Antioxidants are important compounds that 
reduce or neutralize the free radicals, thus protecting 
the cells from oxidative injury (1). Therefore, 
considerable research has been directed towards 
the identification of new antioxidants to prevent 
radical-induced damage. Pyrazoline derivatives are 
acknowledged to possess a wide range of bioactivities 
such as anti-inflammatory (2), anticancer and 
antioxidant (3). In pursuing the antioxidant potential 
of pyrazolines, we synthesized some pyrazoline 
derivatives and screened them for their antioxidant 
activity.
MATERIALS AND METHODS:
The in vitro antioxidant effect of some pyrazoline 
derivatives was determined by 2, 2’-azino-bis(3-
ethylbenzthiazoline-6-sulphonic acid (ABTS•+) (4) 
and 2,2, diphenyl-1-picrylhydrazyl (DPPH•) (5) radical 
scavenging capacity assays.
RESULTS:
Previously reported eight 2-pyrazoline derivatives 
have been screened for their antioxidant activity. 
All tested compounds except (3-(3,5-dichloro-2-
hydroxyphenyl)-5-p-tolyl-4,5-dihydropyrazol-1-yl)
(phenyl)methanone (BEA 23) and (3-(3,5-dichloro-
2-hydroxyphenyl)-5-p-tolyl-4,5-dihydropyrazol-1-yl)
(furan-2-yl)methanone (BEA 24) showed ability 
to capture ABTS.+ free radical. Only compounds 
(3-(5-bromo-2-hydroxyphenyl)-5-(2-methoxyphenyl)-
4,5-dihydropyrazol-1-yl)(pyridin-4-yl)methanone 
(BEA 1) and (3-(5-chloro-2-hydroxyphenyl)-5-(2-
methoxyphenyl)-4,5-dihydropyrazol-1-yl)(pyridin-4-yl)
methanone (BEA 2) showed ability to capture DPPH. 
free radical.
CONCLUSIONS:
( 3 - ( 3 , 5 - d i c h l o r o - 2 - h y d r o x y p h e n y l ) - 5 - ( 2 -
methoxyphenyl)-4,5-dihydropyrazol-1-yl)(pyridin-4-yl)
methanone (BEA12) (IC50 = 0.09 mM) revealed the 
highest antioxidant potential for ABTS.+. The value is 
comparable with that of standard trolox (IC50 = 0.05 
mM).
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INTRODUCTION:
Cinnamomum cassia (C. cassia) leaves and bark 
extracts have several biological activities including 
antioxidant, antidiabetic, antimicrobial, and, antitumor 
effects(1). In our previous studies, we showed that 
C. cassia chloroform extract (CcCE) was effective 
against H2O2-induced increase of ROS levels in V79 
cells, while it increased H2O2-induced oxidative DNA 
damage in these cells. However, we also showed the 
protective effect of CcCE in human lymphocytes using 
Comet assay (2). In the present study, we aimed to 
investigate the effect of CcCE in human promyelocytic 
leukemia (HL-60) cells. 
MATERIALS AND METHODS:
HL-60 cells were treated with different concentrations 
of chloroform extract (0,78-100 µg/mL). Cytotoxic 
effect was determined by WST-1 test, at 24 hours 
intervals for three days. The extent of DNA damage 
was evaluated by alkaline comet assay (3) in HL-60 
cells. For each concentration, 100 randomly selected 
cells (50 cells from each of the two replicate slides) 
were analyzed using comet analysis software (Comet 
Score 15, Tritek Corp.). The DNA damage was 
represented by percentage of DNA in the tail (tail DNA 
%).
RESULTS:
IC50 values of the extract were 6.27, 5.97 and 
6,24 μg/mL for 24, 48 and 72 h incubation periods, 
respectively. Comet assay results indicated significant 
(p<0,05) and concentration-dependent increase of 
DNA damage in CcCE-treated HL-60 cells compared 
to controls. 
CONCLUSIONS:
Our results display anti-cancer function of CcCE due 
to its cytotoxic and DNA damaging effects in HL-60 
cells. Further in vitro and in vivo studies are necessary 
to confirm the chemopreventive potential of CcCE, at 
least in leukemia.  
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INTRODUCTION:
Type 2 diabetes is the most common form of diabetes. 
Metformin is a prescription drug commonly used for 
treating type 2 diabetes in adults and children (1). 
Metformin has been suggested to be responsible 
for anti-cancer activity via enhancing oxidative DNA 
damage under oxidative condition (2). However there 
are contradictory results in the literature. This study 
was aimed to evaluate the cytotoxic and genotoxic 
effects of metformin in human liver cancer (HepG2) 
cells. 
MATERIALS AND METHODS:
The cytotoxicity of metformin (0.5-64 μM) was 
determined by Thiazolyl Blue Tetrazolium Blue (MTT) 
assay and its genotoxicity (5-1000 μM) was evaluated 
by alkaline comet assay in HepG2 cells treated with/
without H2O2. DNA damage was expressed as DNA 
tail intensity.  
RESULTS:
The cell viability significantly decreased at the doses 
above 4 μM. The IC50 dose of metformin was 57.3 
μM for 24h in HepG2 cells. Metformin alone did not 
induce DNA damage at all studied concentrations 
(5-1000 μM) for 24h. However, at the concentration 
ranges between 5 μM and 1000 μM, it did not change 
H2O2-induced DNA strand breakage damage. 
CONCLUSIONS:
In conclusion, our results suggest that metformin has 
no potential effect in increasing or decreasing the 
oxidative stress-related genotoxicity in HepG2 cells. 
More mechanistic studies should be required in order 
to get more clear results.
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INTRODUCTION:
Type 2 diabetes is the most common form of diabetes. 
Metformin is a prescription drug commonly used for 
treating type 2 diabetes in adults and children (1). 
Metformin has been suggested to be responsible 
for anti-cancer activity via enhancing oxidative DNA 
damage under oxidative condition (2). However there 
are contradictory results in the literature. This study 
was aimed to evaluate the cytotoxic and genotoxic 
effects of metformin in human liver cancer (HepG2) 
cells. 
MATERIALS AND METHODS:
The cytotoxicity of metformin (0.5-64 μM) was 
determined by Thiazolyl Blue Tetrazolium Blue (MTT) 
assay and its genotoxicity (5-1000 μM) was evaluated 
by alkaline comet assay in HepG2 cells treated with/
without H2O2. DNA damage was expressed as DNA 
tail intensity.  
RESULTS:
The cell viability significantly decreased at the doses 
above 4 μM. The IC50 dose of metformin was 57.3 
μM for 24h in HepG2 cells. Metformin alone did not 
induce DNA damage at all studied concentrations 
(5-1000 μM) for 24h. However, at the concentration 
ranges between 5 μM and 1000 μM, it did not change 
H2O2-induced DNA strand breakage damage. 
CONCLUSIONS:
In conclusion, our results suggest that metformin has 
no potential effect in increasing or decreasing the 
oxidative stress-related genotoxicity in HepG2 cells. 
More mechanistic studies should be required in order 
to get more clear results.
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INTRODUCTIONS: 
Glutathione S-Transferases (GSTs) are enzyme 
groups that biotransform several compounds known 
to be risk factors for urothelial carcinoma. By catalysis 
to the -SH group of the antioxidant glutathione, 
they protect normal cells from potentially harmful 
environmental substances such as carcinogens and 
xenobiotics (1,2). Detoxification of these compounds 
accelerates their dissolution in aqueous cells and 
their excretion from the body (3). GST enzyme 
system is important for drugs, enviromental pollution 
and carcinogen biotransformation.  In this study, 
we investigated GST Kappa (K1) isoenzyme with 
immunohistochemical staining for possible effect on 
the patogenesis of bladder cancer. 
MATERIALS AND METHODS:
For immunohistochemical studies, tissues were 
obtained from 49 patients with bladder carcinoma. 
GSTK1 expression in tumor and control tissues of 
patients was compared according to their staining 
intensity. Relationships between GSTK1 expressions 
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in tumor and control tissue were examined by the 
Mann Whitney-U test, and the clinicopathological data 
were examined by the Spearman correlation rank 
test. 
RESULTS:
When the tissues of these cases were compared 
according to their staining intensity, GSTK1 expression 
in bladder carcinoma was significantly higher than 
normal bladder tissues (p=0,0000; 0,000<0,05). When 
the immunohistochemical result of GSTK1 isoenzyme 
was correlated with the clinical parameters, they were 
not correlated with age, gender, tumor stage, grade, 
smoking status, (p>0,05). 
CONCLUSIONS:
According to these findings, it is likely to be of 
importance GSTK1 isozyme in the diagnosis of 
bladder cancer. In bladder cancer patients the higher 
expressions of GSTK1 proteins in tumor than normal 
bladder tissues might be important in papillary 
urothelial bladder cancer development.
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INTRODUCTION:
Recently, a study group conducted a study in a 
boron exposed females in Northern Argentina and 
reported a negative association between high level 
of boron exposure and birth size (1). This is the only 
study that suggest a negative association between 
boron exposure and birth size so far. Therefore the 
results of this study should be clarified in a population 
exposed to high level of boron in daily life. The aim 
of the present study is to investigate the birth weight 
of newborns in a highly boron exposed population 
in Bandırma and Bigadiç in order to corroborate or 
refute the above reported association between birth 
weight of newborns and boron exposure.
MATERIALS AND METHODS:
The study protocols approved by the Ethics committee 
of the Ankara University School of Medicine (no: 
20-853-14, date: 08.12.2014). The blood samples 
(n=199) were sampled from females residing in 
Bandırma and Bigadiç. Information on the birth weight 
of newborn was gathered by the questionnaire. Blood 
boron concentrations of the participated females 
were determined by using ICP-MS (Agilent 8800 
ICP-QQQ) in the “no gas” mode. The females were 
classified into low, medium and high exposure groups 
according to their blood boron concentrations in order 
to investigate the boron mediated effects on birth 
weights of newborns.
RESULTS:
The mean blood boron concentrations of low, medium 
and high exposure groups were 39.74 ± 27.60, 124.19 
± 13.10 and 274.58 ± 213.00 ng B/g blood respectively. 
The mean blood boron concentrations of the medium 
and high exposure group were significantly higher 
(p<0.05) than the low exposure group. This result 
indicates to high level of boron exposure in medium 
and high exposure groups. The mean birthweights of 
newborns in low medium and high exposure groups 
were 3213.47 ± 560.67, 3082.81 ± 562.80 and 
3112.42 ± 708.95 gram respectively. The pairwise 
difference in mean birthweights were statistically not 
significant (p>0.05)
CONCLUSIONS:
In spite of a high level of boron exposure, negative 
association between boron exposure and birth 
weights of newborns were not observed. Our results 
refute the negative association suggested by Igra et 
al (1) between boron exposure and birthweight of 
newborns. 
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INTRODUCTION:
In 2008, Robbins et al reported an association 
between high level of boron exposure and decreased 
Y:X sperm ratio in mail workers employed in boron 
mines/processing plants in Kuandian City, China 
(1). The authors have reported a boron mediated 
decrease in Y:X sperm ratio in male workers (n=63). 
The results of this study, however, have been 
criticized by other authors due to many weaknesses 
of the study design (2). Nevertheless, it is still a matter 
of debate whether high level of boron exposure is 
leading to a decrease in Y:X sperm ratio in men. Our 
study is aimed to investigate Y:X sperm ratio in highly 
boron exposed male workers in order to corroborate 
or refute the above reported association between Y:X 
ratio and boron exposure. 
MATERIALS AND METHODS:
The blood and semen samples were sampled 
and used in accordance with the study protocols 
approved by the Ethics committee of the Hacettepe 
University School of Medicine (no: HEK 08/167, date: 
22.10.2008). The semen and blood samples were 
sampled from the Bandrma Boric Acid Production 
plant and its surrounding facilities. The total number 
of sampled blood and semen samples were 163 and 
86 of them were belonging to the boron exposed 
group. Blood boron concentrations of the participated 
workers were determined by using ICP-MS with flow 
injection system. Y- or X- bearing sperm cells in 
semen samples were detected by using fluorescence 
in situ hybridization (FISH) technique. The “Cytocell 
FAST FISH prenatal X, Y and 18 Enumeration Probe 
Kit (LPF 002) was used in detection and quantification 
of chromosomes X, Y and 18 by FISH. The probes are 
specific for the alpha satellite DNA sequences at the 
DXZ1, DYZ3 and D18Z1 regions of the chromosome 
X (green), Y (orange) and 18 (blue) respectively. 
RESULTS:
The mean blood boron concentrations in control and 
boron exposed male workers were 63.56 ± 43.89 
(<LOQ – 252) and 141.55 ± 80.43 (25.20 – 454) ng 
B/g blood respectively. The significantly high level 
of blood boron concentrations (p<0.05) of exposed 
workers proved the high level of boron exposure in our 
study population. The Y:X sperm ratios in control and 
exposed group were determined as 0.99 ± 0.03 (0.85 
– 1.10) and 0.99 ± 0.02 (0.86 – 1.04) respectively. The 
difference between control and exposed groups was 
statistically not significant (χ2 test, p>0.05).
CONCLUSIONS:
In spite of the high level of boron exposure boron 
mediated decrease in the Y:X sperm ratio was not 
determined in our study population. Our results refute 
the association suggested by Robbins et al between 
high level of boron exposure and decreased Y:X 
sperm ratio in men. 
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INTRODUCTION:
Introduction: Morphine is one of the most commonly 
abused drugs, and it can be detected by certain 
methods. Many toxicologists, forensic professionals 
still seek cheaper and faster ways to detect 
morphine. In this manner, Surface Enhanced Raman 
Spectroscopy (SERS) has many advantages over 
other methods. However, there are still controversies 
in the literature about SERS signature of morphine. 
This study aims to find out SERS spectra of morphine 
in order to set an alternative method.
MATERIALS AND METHODS:
Morphine, in acetonitrile solution, in concentration 
of 1 mg/mL was used as sample solution. Morphine 
solution was dropped as 2 µL on to Raman active Au 
surface. After an incubation period of five minutes, 
2 µL of colloidal Ag nanoparticles was dropped 
on sample. Raman spectra gathered by a Raman 
Spectroscope with 785 nm laser source.
RESULTS:
Major peaks of morphine were determined as 534, 
611, 630, 872 and 1348 s-1, respectively. Gathered 
spectra of morphine have been compared with those 
given in related literature.
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CONCLUSIONS:
SERS spectra of morphine presented in the literature 
reflects Raman signature of morphine partially, 
compared to our study. Therefore presented method 
shows more accurate peaks with higher intensities 
when compared to related studies in the literature. 
P-547: PHYSICAL COMPATIBILITY OF 
LOOP DIURETICS IN TOTAL PARENTERAL 
NUTRITION IN Y-SITE ADMINISTRATION
Tomczak SZ., Stawny M., Dettlaff K., Jelińska A.
Poznan University of Medical Sciences, Department 
of Pharmaceutical Chemistry, Poznań, Poland
INTRODUCTION:
Loop diuretics (e.g. furosemide and torsemide) are an 
effective drugs used in the treatment of hypertension 
in many regimens. In the case of patients on 
parenteral nutrition, a considerable challenge is posed 
by the need to combine pharmacotherapy and total 
parenteral nutrition (TPN). When the same venous 
access site is used for drug administration and for 
TPN, it is necessary to discontinue the infusion and 
cleanse the cannula. Before TPN is resumed, the 
venous access site must be cleansed again to prevent 
any unwanted interactions, such as sedimentation, 
stratification or discoloration, which may endanger the 
patient’s health or life. For those reasons, Y-site drug 
delivery is a helpful solution that reduces the handling 
of the venous access site and thus the intervals 
between infusions, which improves patient nutrition. 
In any case, the co-administration of a drug and TPN 
may be considered only after completion of analytical 
tests performed to confirm that a particular drug-TPN 
combination is therapeutically safe. 
The purpose of this study was to evaluate the physical 
compatibility of total parenteral nutrition and drugs in 
Y-site administration.
MATERIALS AND METHODS:
The compatibility of furosemide and torsemide with 
6 TPN mixtures of different compositions based on 
Lipidem MCT/LCT emulsions was studied.  Undiluted 
drugs were mixed 1:1 at ratios determined by infusion 
flow rates. Visual assessment was used to monitor the 
physical stability of the drugs and emulsions to detect 
any sedimentation, stratification and discoloration. In 
addition, the pH and osmolarity of the mixtures as well 
as the size of mixture particles were found. The study 
was conducted immediately after mixing (t =0h) and 
at 4 h. 
RESULTS:
During the study no discoloration, stratification or 
sedimentation was observed. The pH  and osmolarity 
of the mixtures did not change after 4 h of the 
experiment. The average particle size was 206,3-
226,8 nm and satisfied requirements for parenteral 
emulsions (<500 nm).
CONCLUSIONS:
The study demonstrated the physical compatibility 
of furosemide and torsemide with TPN mixtures for 
Y-site administration. This indicates that the co-
administration of furosemide and torsemide with TPN 
mixtures ensures therapeutic safety in the treatment 
of those patients with hypertension who require 
parenteral medication. 
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INTRODUCTION:
The stability of medicinal substances is an 
important element in the safety of pharmacotherapy. 
Administration to the patients' drugs without 
confirmed stability is a direct threat to their health and 
life. It is particularly important to confirm the possibility 
of co-administrate the medicinal product with other 
medicines or adding them to a medium not described 
in the SPC. A major problem in clinical practice is 
the use of intravenous pharmacotherapy in patients 
receiving total parenteral nutrition (TPN). TPN mixture 
is a compound drug resulting from the mixing at least 
7 different solutions and lipid emulsion. Thus, it is very 
problematic to add other concomitant medications to 
such complex mixture. The aim of the study was to 
determine the possibility of adding ampicillin to TPN 
mixtures and to determine if content or type of any 
individual component of TPN affect the stability of this 
antibiotic.
MATERIALS AND METHODS:
The study material consisted of 2400 ml of TPN 
mixture (five different compositions) with the addition 
of 10 g ampicillin and the reference samples were 
prepared without addition of the drug. Studied 
mixtures were stored for 7 days at 5±1°C with light 
protection and analyzed each 24 hours. The content 
of the drug was determined by HPLC. At the same 
time, physical properties of the studied mixtures were 
evaluated: the pH (Mettler Toledo Seven Compact PH 
/ ion S220®), the zeta potential and the lipid emulsion 
particle size (ZestaSizer Nano ZS). 
RESULTS:
The highest stability of the oil-water system was 
found in the TPN mixtures containing the omega-3 
fatty acids, whereas the lowest stability was observed 
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in TPN mixture with the increased amount of 
monovalent and divalent ions. Addtion of ampicillin to 
the TPN mixtures caused an increase in the pH value, 
small changes in the particle size of the lipid emulsion 
and a reduction in the zeta potential values. The 
degradation of ampicillin in the TPN mixtures occured 
according to the first order kinetics, and the rate of 
decomposition was dependent on the composition of 
the mixture and the storage conditions.
CONCLUSIONS:
Based on these results it can be concluded that 
the ampicillin did not cause changes in the physical 
properties of TPN mixtures. However, the obtained 
results indicate that ampicillin shows the highest 
stability in a high energy TPN mixture, and the lowest 
in the TPN with high electrolyte composition.
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İsmail Yalçın yalcin@ankara.edu.tr Turkey
İsmet Çok ismetcok@gmail.com Turkey
İzel Ezgi Topaloğlu itopaloglu@ankara.edu.tr Turkey
Jean Luc Balligand jean-luc.balligand@uclouvain.be Belgıum
Jerka Dumic jdumic@gmail.com Croatıa
John Mcanaw john.mcanaw@nhs24.scot.nhs.uk Unıted Kıngdom
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Jose Manuel Pingarron Carrazon  pingarro@quim.ucm.es Spaın
Joseph T. Chunu josephchunu@gmail.com Turkısh Republıc Of Northern Cyprus
Jun Haginaka haginaka@mukogawa-u.ac.jp Japan
Junichi Tanaka jtanaka@sci.u-ryukyu.ac.jp Japan
Kaan Birgül kaanbirgul93@gmail.com Turkey
Kader Çömlekçi kcömlekci@bieameilac.com.tr Turkey
Kadir Aykaç kadirr050@gmail.com Turkey
Kadir Yazıcı  Turkey
Kadri Güleç kadrigulec@gmail.com Turkey
Kamer Tecen Yücel kamertecen@hacettepe.edu.tr Turkey
Karel Šmejkal karel.mejkal@post.cz Czech Republıc
Kartini kartini@staff.ubaya.ac.id Indonesıa
Katarzyna Dettlaff dettlaff@ump.edu.pl Poland
Kayhan Bolelli bolelli@ankara.edu.tr Turkey
Kerem Polat kerem_hybt@hotmail.com Turkey
Kerem Şentürk eczkeremsenturk@hotmail.com Turkey
Keriman Özadalı Sarı kozadali@hacettepe.edu.tr Turkey
Kevser Biberoğlu kevser.biberoglu@gmail.com Turkey
Kıvılcım Öztürk Atar kivilcimozturk@gmail.com Turkey
Kibar Demirhan demirhan.9082@gmail.com Turkey
Kousha Zakeri kooshazakeri@gmail.com  
Ksehiia Zazhyhina   
Kubilay Varol kubilaymehmetvarol@gmail.com Turkey
Kübra Durgun kubradurgn@gmail.com Turkey
Kürşat Kaya kkaya@adiyaman.edu.tr Turkey
Lali Tchankvetadze progresixxichankv@yahoo.com Georgıa
Levent Canyurt  Turkey
Levent Öner loner@hacettepe.edu.tr Turkey
Leyla Karadurmuş leylakrdrms@gmail.com Turkey
Lia Bezhitashvili bezhitashvililia@yahoo.com Turkey
M. Nazlı Şencan nazlisencan@gmail.com Turkey
Maciej Stawny mstawny@ump.edu.pl Turkey
Mahmoud Abudayyak abudayyak@ktu.edu.tr Turkey
Mahmoud F. Elsebai elsebai72@yahoo.com Egypt
Maja Peraica mperaica@imi.hr Croatıa
Maksut Coşkun mcoskun@ankara.edu.tr Turkey
Malek Hassan malekamhassan@yahoo.com Turkey
Marie-Aleth Lacaille-Dubois m-a.lacaille-dubois@u-bourgogne.fr France
Marlia Singgih Wibowo  Indonesıa
Mayuri Napagoda mayurinapagoda@yahoo.com Srı Lanka
Mehlika Dilek Altıntop mdaltintop@anadolu.edu.tr Turkey
Mehmet Alp malp@ankara.edu.tr Turkey
Mehmet Barlas Uzun mehmetbarlasuzun@gmail.com Turkey
Mehmet Berköz mehmet_berkoz@yahoo.com Turkey
Mehmet Can Sezgin  Turkey
Mehmet Evren Okur evrenokurecz@gmail.com Turkey
Mehmet Gökhan Çağlayan caglayangokhan@gmail.com Turkey
Mehmet Gümüştaş mgumustas@hotmail.com Turkey
Mehmet Levent Altun altun@pharmacy.ankara.edu.tr Turkey
Mehmet Murat Kışla  Turkey
Mehmet Onur Aksoy onuraksoi@gmail.com Turkey
Mehmet Sina İçen sina.icen@inonu.edu.tr Turkey
Mehmet Taşpınar mtaspinartr@gmail.com Turkey
Mehmet Uçuk persmehmet@yandex.ru Turkey
Mehmet Uzun uzuneczanesi@hotmail.com Turkey
Mehtap Kara mehtap.kara@istanbul.edu.tr Turkey
Melda Bahap melda_610@hotmail.com Turkey
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Melek Karacaoğlu mkaracaoglu@ankara.edu.tr Turkey
Melek Kurtaran melekkurtaran@hacettepe.edu.tr Turkey
Melek Sirin Baymak msbaymak@marmara.edu.tr Turkey
Meliha Ekinci meliha.ekinci@ege.edu.tr Turkey
Melike Yüksel mel_yuksel@yahoo.com Turkey
Meltem Ceylan Ünlüsoy munlusoy@pharmacy.ankara.edu.tr Turkey
Meral Tunçbilek tuncbile@pharmacy.ankara.edu.tr Turkey
  Meriam Elhouid   meriam.elhouid@gmail.com Tunusıan
Mert İlhan eczmertilhan@gmail.com Turkey
Merve Asena Öncül asenaoncul@gmail.com Turkey
Merve Bacanlı mervebacanli@gmail.com Turkey
Merve Becit mervebecit@hotmail.com Turkey
Merve Çelik Tekeli merve.clk.145@gmail.com Turkey
Merve Dalkıran merve.dalkiran@pharmactive.com.tr Turkey
Merve Demirbügen demirbugen@ankara.edu.tr Turkey
Merve Ergül mergulmerve@gmail.com Turkey
Merve Eryılmaz merve.eryilmaz@gazi.edu.tr Turkey
Merve Eylül Kıymacı pharmaeyll@gmail.com Turkey
Merve İnci Çamçi merveinci21@hotmail.com Turkey
Merve Memişoğlu mmemisoglu@biruni.edu.tr Turkey
Merve Mercan mervemercan93@hotmail.com Turkısh Republıc Of Northern Cyprus
Merve Nenni merve.ecz@gmail.com Turkey
Merve Şensoy algalbiotek@gmail.com Turkey
Merve Zengin merveozdagli@hacettepe.edu.tr Turkey
Meryem Erol eczacimeryem@gmail.com Turkey
Metin Emrah Kartal eczmetinkartal@gmail.com Turkey
Metin Yıldırım metinyildirim4@gmail.com Turkey
Mimouni Fatima Zohra mimouni2401@yahoo.fr Algerıa
Mine Günay İçtüzer eczgny@gmail.com Turkey
Mine Uzun minebdr@gmail.com Turkey
Mine Zanbak eczminez@gmail.com Turkey
Miray Aslan msevuktekin@ankara.edu.tr Turkey
Miray İlhan mgorgoz@ankara.edu.tr Turkey
Mircan Gürsel  Turkey
Miyase Gözde Gündüz miyasegunduz@yahoo.com Turkey
Mohammed Ali Selo selom@tcd.ie Iraq
Mohammed Saad Naji Ali mohammadalgoli0@gmail.com Turkey
Muhammad Sohail Arshad sohail_arshad79@yahoo.com Pakıstan
Muhammad Uzair muhammaduzair@bzu.edu.pk Pakıstan
Muhammed İhsan Han hanihsan@gmail.com Turkey
Muhammed Mesud Hürkul mhurkul@ankara.edu.tr Turkey
Murat Kozanlı mrtkznl@gmail.com Turkey
Murat Oral ecz.murat.oral@gmail.com Turkey
Murat Yaman murat.yaman@bilkent.edu.tr Turkey
Murat Yiğit  Turkey
Mustafa Bahadır Kaymaz kaymazbahadir@gmail.com Turkey
Mustafa Çelebier celebier@hacettepe.edu.tr Turkey
Mustafa Emrah Kılınç kilincemrah@hotmail.com Turkey
Mustafa Ergül m.ergul@yahoo.com.tr Turkey
Mutlu Aytemir mutlud@hacettepe.edu.tr Turkey
Müge Kılıçarslan muge.kilicarslan@pharmacy.ankara.edu.tr Turkey
Müge Savaş mugeesavas@gmail.com Turkey
Müjde Eryılmaz meryilmaz@ankara.edu.tr Turkey
Mümtaz İşcan iscan@pharmacy.ankara.edu.tr Turkey
Nadıa Bounoua bounoua_nadia@yahoo.fr Algerıa
Nadir Yalçın nadir.yalcin@hotmail.com Turkey
Nadire Özenver nadire@hacettepe.edu.tr Turkey
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Nafız Öncü Can nafizoc@anadolu.edu.tr Turkey
Naile Merve Güven nmguven@ankara.edu.tr Turkey
Nailla Jiwa  Turkısh Republıc Of Northern Cyprus
Nalan Yılmaz nalan_y@anadolu.edu.tr Turkey
Narin Sadıkoğlu origanum@hotmail.com Turkey
Nazlı Erdoğar nerdogar@gmail.com Turkey
Nazlı Turan Yücel nazlituran@anadolu.edu.tr Turkey
Necla Kulabaş necla.kulabas@marmara.edu.tr Turkey
Necmiye Canacankatan ncanacankatan@gmail.com Turkey
Neda Taner ntaner@medipol.edu.tr Turkey
Nefise Özlen Şahin nefisesahin@gmail.com Turkey
Nesligül Özdemir nesliozdmr@hotmail.com Turkey
Neslihan Aksu neslihany.aksu@gmail.com Turkey
Neslihan Üstündağ Okur neslihanustundag@yahoo.com Turkey
Nesrin Hökenek nesrinhokenek@gmail.com Turkey
Neşe Başak Türkmen nesebasak86@gmail.com Turkey
Nevena Ivanović nevenam@pharmacy.bg.ac.rs Serbıa
Nevin Erk erk@pharmay.ankara.edu.tr Turkey
Neziha Yağmur Diker yagmurkumser@gmail.com Turkey
Nil Demir nildemir94@gmail.com Turkey
Nilay Aleyna Durmaz nadurmaz97@gmail.com Turkey
Nilay Tarhan eczmirayarslan@gmail.com Turkey
Nilgün Günden Göğer ngoger@gazi.edu.tr Turkey
Nilüfer Yüksel bozkir@pharmacy.ankara.edu.tr Turkey
Nur İlge Çinar nurilgecinar@gmail.com Turkey
Nuray Arı ari@ankara.edu.tr Turkey
Nurdan Yazıcı Bektaş ecz.nurdanyazici@gmail.com Turkey
Nurettin Abacıoğlu nabaci@gazi.edu.tr Turkey
Nurgül Karadaş Bakırhan nurgulk44@gmail.com Turkey
Nuri Özmen nuri.ozmen@ankara.edu.tr Turkey
Nursel Sürmelioğlu nurselisci@gmail.com Turkey
Nurten Altanlar naltanlar@ankara.edu.tr Turkey
Oğuz Söğüt o_sogut@yahoo.com Turkey
Oğuzhan Fırat ogzhnfrt@gmail.com Turkey
Okan Arıhan okanarihan@gmail.com Turkey
Okan Onar okanonar@gmail.com Turkey
Okhtay Mousavigajlar okhtay.m@gmail.com  
Omar Horani  Turkısh Republıc Of Northern Cyprus
Ongun Mehmet Saka omsaka@gmail.com Turkey
Onur Aşar onur.asar@servier.com Turkey
Osman Karabudak  Turkey
Oya Bozdağ Dündar bozdag@pharmacy.ankara.edu.tr Turkey
Ozan Kaplan kaplan.ozan@hotmail.com Turkey
Ömer Faruk Bahçecioğlu omerfb92@hotmail.com Turkey
Öncü Usluer  Turkey
Özge Akkoyun Muhiddin  Turkey
Özge Cansın Zeki  Turkey
Özge Demir demirozge_@hotmail.com Turkey
Özge Eşim gun@ankara.edu.tr Turkey
Özge İnal inal@pharmacy.ankara.edu.tr Turkey
Özge Kılıçaslan ozgeeebayram@gmail.com Turkey
Özge Özçınar ozge.ozcinar7@gmail.com Turkey
Özge Ülker oulker@pharmacy.ankara.edu.tr Turkey
Özgecan Gül Hizal ozgehizal@outlook.com Turkey
Özgün Sayıner osayiner@ankara.edu.tr Turkey
Özgür Devrim Can ozgurdt@anadolu.edu.tr Turkey
Özgür Eşim ozgur.esim@sbu.edu.tr Turkey
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Özgür Karban  Turkey
Özgür Üstündağ ustundag@pharmacy.ankara.edu.tr Turkey
Özgür Yılmaz yilmaz.ozgur@tubitak.gov.tr Turkey
Özlem Akbal Dağıstan eczoslem@gmail.com Turkey
Özlem Bahadır Acıkara obahadir@ankara.edu.tr Turkey
Özlem Öztürk Ceylan ozturkozlemm@gmail.com Turkey
Özlem Palancı ozlem69@windowslive.com Turkey
Özlem Temiz Arpacı temiz@pharmacy.ankara.edu.tr Turkey
Özüm Öztürk ozozturk@ankara.edu.tr Turkey
Patrick Walsh asymmetriccat@gmail.com Usa
Pelin Şenel senelpelin88@gmail.com Turkey
Pelin Telkoparan Akıllar pelinta@yiu.edu.tr Turkey
Pervin Betül Tekiner Gülbaş btekiner@pharmacy.ankara.edu.tr Turkey
Pınar Aslaner  Turkey
Pınar Bakır pinar.bakir55@gmail.com Turkey
Pınar Kara Kadayıfçılar pinar.kara@ege.edu.tr Turkey
Pınar Kul pkul@ankara.edu.tr Turkey
Pınar Namlı Uyanık  Turkey
Pierre Kondiah pierre.kondiah@wits.ac.za South Afrıca
Rabia Akman   
Ramazan Akçan akcanmd@hotmail.com Turkey
Ramazan Ceylan biyoram7@gmail.com Turkey
Rana Arslan rbeis@anadolu.edu.tr Turkey
Ratih ratih.ratih@tu-braunschweig.de Germany
Recai İnam rinam@gazi.edu.tr Turkey
Rengin Reis renginreis@gmail.com Turkey
Reyhan Neslihan Gürsoy ngursoy@hacettepe.edu.tr Turkey
Rukiye Sevinç Özakar rukiyeso@atauni.edu.tr Turkey
Rusudan Kakava rusudan.kakava@gmail.com Georgıa
Saadet Dermiş dermis@pharmacy.ankara.edu.tr Turkey
Safa Gümüşok safagumusok@gmail.com Turkey
Safiye Akkın akkinsafiye@gmail.com Turkey
Sakine Atila Karaca sakineatila@anadolu.edu.tr Turkey
Salvatore Fanali salvatore.fanali@cnr.it Italy
Samet Belveren bvrnsamet@mersin.edu.tr Turkey
Samet Poyraz s.poyraz88@gmail.com Turkey
Saniye Özcan saniyeozcan@anadolu.edu.tr Turkey
Sarah Khamis dskhamis@gmail.com North Cyprus
Sebila Özdemir sebilaozdemir@gmail.com Turkey
Seçil Karahüseyin secil.karahuseyin@istanbul.edu.tr Turkey
Seçil Sarıkaya Aydın secilsarikaya@gmail.com Turkey
Seda Ateş  Turkey
Seda Fandaklı sedaf_84@hotmail.com Turkey
Seda İpek ipekseda94@gmail.com Turkey
Seda Nur Topkaya sedanur6@gmail.com Turkey
Seda Önder onderseda91@gmail.com Turkey
Seda Rençber sedarencber@gmail.com Turkey
Sedef Kır  Turkey
Sedenay Akbaş sedenayakbas@gmail.com Turkey
Sefa Gözcü h.sefa.gozcu@gmail.com Turkey
Selda Zengin Kurnalı selda.zengin@nobel.com.tr Turkey
Selen Duygu Çeçen  duygucecen94@gmail.com Turkey
Selen Gürkan Alp selengurkan@gmail.com Turkey
Selenay Sadak   
Selim Gök  Turkey
Selin Işık selin.isik@neu.edu.tr Trnc
Selin Tufan eczselintufan@gmail.com Turkey
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Selin Yüksel selins.dogan@gmail.com Turkey
Selma Saraç Tarhan sesarac@hacettepe.edu.tr Turkey
Selma Şahin  Turkey
Selman Şabanoğlu sabanoglu@ankara.edu.tr Turkey
Sema Arısoy sarisoy@ankara.edu.tr Turkey
Sema Çalış scalis@hacettepe.edu.tr  Turkey
Semra Altunterim semraterim@hotmail.com Turkey
Sena F. Sezen senasezen@ktu.edu.tr Turkey
Serap Arabacı Anul seraparabaci@gmail.com Turkey
Serap Durkut durkut@science.ankara.edu.tr Turkey
Serap Gür serapgur@ankara.edu.tr Turkey
Serap İpek Dingiş ipekdingis@gmail.com Turkey
Serap Şahin Bölükbaşı wserap@yahoo.com Turkey
Serap Yalın syalin01@hotmail.com Turkey
Serap Yılmaz  Turkey
Sercan Baran sercanbaran58@icloud.com Turkey
 Serdar Çetinkaya serdarctnkaya@gmail.com Turkey
Serdar Demir serdar.demir@ege.edu.tr Turkey
Serdar Tort serdartort@gmail.com Turkey
Serhat Sevgi serhat_svg@hotmail.com Turkey
Serkan Levent serkanlevent@anadolu.edu.tr Turkey
Serkan Özbilgin ozbilgin@pharmacy.ankara.edu.tr Turkey
Serkan Yiğitkan syigitkan@hotmail.com Turkey
Setyo Nurwaini setyo.nurwaini@ums.ac.id Indonesıa
Seval Olğaç sevalolgac94@gmail.com Turkey
Sevda Aydar sevda.aydar@gmail.com Turkey
Sevda Şenel ssenel@hacettepe.edu.tr Turkey
Sevda Türk sevdaturk61@gmail.com Turkey
Sevgi Şar sevgisar98@gmail.com Turkey
Sevgi Takka takka@gazi.edu.tr Turkey
Sevgi Yardım Akaydın syakaydi@hotmail.com Turkey
Sevil Şenkardeş sevil.aydin@marmara.edu.tr Turkey
Sevinç Kurbanoğlu skurbanoglu@gmail.com Turkey
Sevinç Şahbaz sevren@marmara.edu.tr Turkey
Seyhan Şahan Fırat seyhansahan@mersin.edu.tr Turkey
Sezen Yılmaz Sarıaltın sezen.yilmaz@ankara.edu.tr Turkey
Sezin Mert  Turkey
Shabuddin Memon shahabuddinmemon@yahoo.com Pakıstan
Shan Khazei shankhazei1373@gmail.com Turkey
Sıla Gülbağ silagulbag@hotmail.com Turkey
Sibel A. Özkan ozkan@pharmacy.ankara.edu.tr Turkey
Sibel Avunduk sibelavunduk@mu.edu.tr Turkey
Sibel Bozdağ Pehlivan sbozdag@hacettepe.edu.tr Turkey
Sibel İlbasmış Tamer ilbasm@yahoo.com Turkey
Sibel Süzen sibel@pharmacy.ankara.edu.tr Turkey
Sidar Bereketoğlu sbereketoglu@ankara.edu.tr Turkey
Sima Durmazpınar simadurmazpinar@gmail.com Turkey
Simla Olğaç csimla@yahoo.com Turkey
Sinan Süzen suzen@pharmacy.ankara.edu.tr Turkey
Sinem Aslan Erdem saslan@pharmacy.ankara.edu.tr Turkey
Sinem Saar sinem.saar@gmail.com Turkey
Slavica Razic slavica.razic@pharmacy.bg.ac.rs Serbıa
Slawomira Skrzypek slawomira.skrzypek@chemia.uni.lodz.pl Poland
Soner Alboy  Turkey
Suat Sarı suat.sari@hacettepe.edu.tr Turkey
Sulhiye Yıldız suyildiz@ankara.edu.tr Turkey
Sultan Pekacar sultanpkcr94@gmail.com Turkey
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Sumru Sözer Karadağlı sozersumru@yahoo.com Turkey
Suna Sibel Gürpınar ssgurpinar@ankara.edu.tr Turkey
Süleyman Aydın saydin@anadolu.edu.tr Turkey
Süleyman Kayan eczkayan@hotmail.com Turkey
Sülünay Parlar sulunay.parlar@ege.edu.tr Turkey
Sümeyra Tuna Yıldırım stuna@erzincan.edu.tr Turkey
Sümeyye Çoban smeyyecoban@gmail.com Turkey
Sündüz Alemdar nurselbayramgil@gmail.com Turkey
Şebnem Sarışan sebnem.sarisan@abdiibrahim.com.tr Turkey
Şefika Pınar Küçükkavruk pnr.snl@hotmail.com Turkey
Şirin Uysal sirin.uysal@gmail.com Turkey
Şule Dinç Zor sule_dinc@yahoo.com Turkey
Şura Baykan sura.baykan@ege.edu.tr Turkey
Şükran Öztürk sukranozturk79@gmail.com Turkey
Tahir Emre Yalçın tahiremreyalcin@gmail.com Turkey
Tamara Bakic tbakic@pharmacy.bg.ac.rs Serbıa
Tangül Şen kilinc@pharmacy.ankara.edu.tr Turkey
Tansel Çomoğlu comoglu@pharmacy.ankara.edu.tr Turkey
Taylan Turan taylanturan35@gmail.com Turkey
Tayyibe Beyza Yücel beyza.cansu@gmail.com Turkey
Thomas Olivier olivier.thomas@nuigalway.ie Ireland
Timuçin Uğurlu  Turkey
Tuba İnceçayır tubaincecayir@hotmail.com Turkey
Tuba Reçber tuba.recber@hacettepe.edu.tr Turkey
Tuba Taşkan tubaataskan@gmail.com Turkey
Tugrul Cagri Akman eczcagri87@gmail.com Turkey
Tuğba Adak adaktuba@hotmail.com Turkey
Tuğba Çopur tugba-copur@hotmail.com Turkey
Tuğba Eren Böncü ecz.tugbaeren@gmail.com Turkey
Tuğba Ertan Bolelli tbolelli@ankara.edu.tr Turkey
Tuğba Günbatan tugbagunbatan86@yahoo.com Turkey
Tuğbagül Çal tgcal89@gmail.com Turkey
Tuğçe Çapan tugcecapan@gmail.com Turkey
Tuğçe Demiröz demirozt@hotmail.com Turkey
Tuğçe Öğüt tugceogut.94@gmail.com Turkey
Tuğçe Özyazıcı tugceozyazici90@gmail.com Turkey
Tuğrul Mert Serim serim@pharmacy.ankara.edu.tr Turkey
Tunca Gül Altuntaş altuntas@pharmacy.ankara.edu.tr Turkey
Tutku Ceren Karabulut tutkuceren.tck@gmail.com Turkey
Tülay Çoban coban@pharmacy.ankara.edu.tr Turkey
Ufuk İnce ecz.ufuk.ince@gmail.com Turkey
Ugochukwu Chukwunyere ugochux90@gmail.com North Cyprus
Uğur Tamer utamer33@yahoo.com Turkey
Ukde Payze ukdepayze@hotmail.com Turkey
Ulviye Acar Çevik uacar@anadolu.edu.tr Turkey
Umay Merve Güven umaymerveguven@gmail.com Turkey
Umut Can Öz umutcanoz@ankara.edu.tr Turkey
Umut İrfan Üçel uiucel@anadolu.edu.tr Turkey
Ural Ufuk Demirel ural.demirel@altinbas.edu.tr Turkey
Ümide Demir Özkay udemir@anadolu.edu.tr Turkey
Ümmühan Kandemir ummuhan_kandemir@hotmail.com Turkey
Ümran Albuz  Turkey
Üzeyir Doğan doganuzeyir@gmail.com Turkey
Vahap Murat Kutluay muratkutluay@hacettepe.edu.tr Turkey
Veselina Adımcılar adimcilar@itu.edu.tr Turkey
Vesna Matovic vesna.matovic@pharmacy.bg.ac.rs Serbıa
Vildan Yozgatlı vildanyozgatli@gmail.com Turkey
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Vincent  C.o. Njar vnjar@som.umaryland.edu Usa
Wafa Al-Jamal  Unıted Kıngdom
Wahyu Utami wahyu.utami@ums.ac.id Turkey
Wan Mohd Azizi Bin Wan Sulaiman drwanazizi@iium.edu.my Malaysıa
Y. Murat Elçin elcin@ankara.edu.tr Turkey
Yağmur Kılıçdağı yagmursfl89@hotmail.com Turkey
Yağmur Pirinçci yagmur.pirincci@gmail.com Turkey
Yahdiana Harahap yahdiana03@yahoo.com Indonesıa
Yalçın Duydu duydu@pharmacy.ankara.edu.tr Turkey
Yalçın Eroğlu yeroglu24@hotmail.com Turkey
Yalçın Özkan yalcin.ozkan@sbu.edu.tr Turkey
Yavuz Selim Çakmak yavuzselimcakmak@gmail.com Turkey
Yeşim Aktaş yaktas@erciyes.edu.tr Turkey
Yıldız Özalp  Turkısh Republıc Of Northern Cyprus
Yusuf Mülazim  yusuf.mulazim@neu.edu.tr Turkey
Yusuf Özkay yozkay@anadolu.edu.tr Turkey
Zehra Ceren Ertekin certekin@ankara.edu.tr Turkey
Zehra Yazan  Turkey
Zekiye Ceren Arıtuluk cerenarituluk@hotmail.com Turkey
Zeliha Büyükbingöl zbuyukbingol@ankara.edu.tr Turkey
Zelihagül Değim  Turkey
Zerrin Sezgin Bayındır zsezgin@pharmacy.ankara.edu.tr Turkey
Zeynep Ateş Alagöz zates@pharmacy.ankara.edu.tr Turkey
Zeynep Doğan zeynep.ocak2@gmail.com Turkey
Zeynep Kalaycıoğlu kalayciogluz@itu.edu.tr Turkey
Zeynep Şafak Teksin zsteksin@gazi.edu.tr Turkey
Zeynep Ülkü Gün  Turkey
Zia Ur Rahman ziaurrahman0938@gmail.com Turkey
Zühal Güvenalp guvenalp@atauni.edu.tr Turkey
Zühal Kılıç Kurt zkurt@ankara.edu.tr Turkey


